data_1mgs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mgs _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.466 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 97.2 m . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.504 ' NE2' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.66 -26.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 109.763 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 39' ' ' GLU . 97.1 m -122.22 66.17 0.93 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.996 . . . . 0.0 109.799 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.85 -38.9 4.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.967 . . . . 0.0 108.735 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.42 -173.3 2.44 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -160.15 158.06 29.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.04 -1.038 . . . . 0.0 109.935 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.5 mt -116.93 142.76 46.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.474 -0.766 . . . . 0.0 109.043 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -44.04 -33.3 1.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 109.362 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.481 ' O ' ' CG2' ' A' ' 18' ' ' ILE . . . 147.34 -166.47 28.59 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.586 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.3 pp -171.53 163.45 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.44 -1.035 . . . . 0.0 109.076 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.543 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -57.39 149.74 47.39 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.204 -0.935 . . . . 0.0 109.234 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -77.25 -4.34 14.66 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.516 2.144 . . . . 0.0 110.19 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.18 -24.02 21.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.362 -0.836 . . . . 0.0 109.197 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.0 m-20 -84.01 -15.87 46.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -0.855 . . . . 0.0 109.213 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.586 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 17.3 mt -89.32 169.04 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.434 -0.791 . . . . 0.0 110.245 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -137.49 -39.98 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.425 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 5.9 p -128.2 173.36 10.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.458 -0.776 . . . . 0.0 109.029 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.522 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 47.7 t -142.22 95.5 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.464 ' HB3' HD11 ' A' ' 41' ' ' ILE . 5.1 t-20 -93.06 111.58 23.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.925 . . . . 0.0 109.417 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -109.35 97.69 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.404 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.504 ' HD2' ' NE2' ' A' ' 10' ' ' GLN . 1.9 ttmt -90.59 110.28 21.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.2 p -63.68 167.72 6.8 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.355 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.6 Cg_endo -77.61 145.62 23.41 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.603 2.202 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.95 -140.05 2.97 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.448 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 36.1 Cg_endo -77.87 10.71 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.596 2.197 . . . . 0.0 111.023 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.506 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 3.3 p-80 -127.76 -32.91 2.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.559 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -145.45 115.89 7.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 109.265 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.92 6.97 11.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.694 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.42 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 1.6 mp0 -120.71 124.62 45.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 m -46.76 156.85 0.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 109.317 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 7.1 mm-40 -141.37 107.56 5.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.933 . . . . 0.0 109.627 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.53 ' CG1' HD12 ' A' ' 63' ' ' ILE . 41.2 t -90.56 150.4 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.225 -0.922 . . . . 0.0 109.272 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.51 ' N ' HG11 ' A' ' 40' ' ' VAL . 3.4 mt -140.29 147.79 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.71 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.525 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -135.39 120.05 18.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.404 -0.81 . . . . 0.0 109.162 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 8.6 m -89.3 100.95 13.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.94 -1.1 . . . . 0.0 109.01 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 84.5 mt -46.08 172.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.47 -0.769 . . . . 0.0 109.732 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HD2' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -87.93 10.47 18.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.215 -0.928 . . . . 0.0 109.179 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.502 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -114.04 27.52 9.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.325 -0.86 . . . . 0.0 109.134 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.13 11.14 70.2 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.502 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 3.8 mtp180 -100.18 165.91 11.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -1.157 . . . . 0.0 109.443 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.83 154.06 50.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.214 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.18 123.7 9.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.213 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.7 m -79.49 144.96 33.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.956 . . . . 0.0 109.169 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 15.4 mt -121.99 167.54 12.97 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.447 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.549 ' N ' HG23 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -97.14 118.08 65.06 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.467 -0.771 . . . . 0.0 109.201 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.412 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 33.1 Cg_endo -74.24 -0.35 9.51 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.175 1.917 . . . . 0.0 110.376 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.28 -14.08 27.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.325 -0.859 . . . . 0.0 108.906 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.11 162.61 34.56 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.392 -0.818 . . . . 0.0 109.391 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.463 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.06 -36.17 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.694 2.263 . . . . 0.0 110.659 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.468 HG21 HD13 ' A' ' 62' ' ' ILE . 65.3 mt -66.41 -36.39 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 109.661 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.549 HG23 ' N ' ' A' ' 53' ' ' ASN . 37.7 t -67.95 -51.36 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.258 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.444 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.1 OUTLIER -54.3 -30.23 50.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 108.992 179.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.504 ' HB3' ' NZ ' ' A' ' 65' ' ' LYS . 9.6 mmmm -81.98 -28.85 32.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 109.108 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.547 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 11.9 mt -59.61 -38.1 73.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.577 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 1.7 mp -76.15 -61.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -43.02 -28.73 0.29 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.817 . . . . 0.0 109.646 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.504 ' NZ ' ' HB3' ' A' ' 61' ' ' LYS . 2.0 mtmt -74.74 -60.24 2.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.522 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 1.4 mmm -44.17 -47.78 9.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 109.272 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.587 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -43.65 -51.26 7.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.452 -0.78 . . . . 0.0 109.353 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 69' ' ' SER . 11.9 t30 -66.41 -34.82 78.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.495 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 68' ' ' ASN . 1.2 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.562 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.466 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 96.6 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.509 ' NE2' ' HD2' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -42.75 -26.4 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.796 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' B' ' 39' ' ' GLU . 97.4 m -122.18 66.25 0.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.786 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.83 -38.95 4.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.147 -0.971 . . . . 0.0 108.753 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.49 -173.25 2.43 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.451 HG23 ' O ' ' B' ' 52' ' ' LEU . 0.4 OUTLIER -160.17 158.08 29.49 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.994 -1.066 . . . . 0.0 109.896 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' B' ' 16' ' ' GLN . 7.6 mt -116.96 142.77 46.52 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.4 OUTLIER -44.04 -33.36 1.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.363 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.48 ' O ' ' CG2' ' B' ' 18' ' ' ILE . . . 147.45 -166.49 28.63 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.3 pp -171.51 163.44 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.454 -1.027 . . . . 0.0 109.07 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.543 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -57.43 149.73 47.95 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.186 -0.946 . . . . 0.0 109.237 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.0 Cg_endo -77.15 -4.36 14.73 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.477 2.118 . . . . 0.0 110.231 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HD2' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.21 -23.89 21.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.413 -0.804 . . . . 0.0 109.177 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.0 m-20 -84.05 -15.84 46.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.227 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 17.0 mt -89.4 169.12 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 110.25 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.528 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.0 OUTLIER -137.58 -39.94 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.432 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 6.0 p -128.18 173.4 10.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.423 -0.798 . . . . 0.0 108.971 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.528 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 47.5 t -142.31 95.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.961 . . . . 0.0 109.646 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.461 ' O ' HD13 ' B' ' 41' ' ' ILE . 5.1 t-20 -93.03 111.49 23.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.869 . . . . 0.0 109.428 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -109.24 97.73 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.509 ' HD2' ' NE2' ' B' ' 10' ' ' GLN . 1.9 ttmt -90.65 110.38 21.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 109.504 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.2 p -63.61 167.7 6.72 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.346 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 36.0 Cg_endo -77.66 145.57 23.22 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.556 2.171 . . . . 0.0 110.432 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.89 -140.03 2.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.448 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.1 Cg_endo -77.87 10.74 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.602 2.201 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.515 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 3.2 p-80 -127.8 -32.83 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 109.532 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -145.48 115.89 7.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.03 7.07 11.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.695 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.411 ' O ' ' HG2' ' B' ' 39' ' ' GLU . 1.6 mp0 -120.79 124.6 45.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.123 -0.986 . . . . 0.0 109.473 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.402 ' C ' ' HG2' ' B' ' 39' ' ' GLU . 1.6 m -46.74 156.83 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.319 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' B' ' 11' ' ' CYS . 7.1 mm-40 -141.36 107.63 5.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.038 -1.039 . . . . 0.0 109.685 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.525 ' CG1' HD12 ' B' ' 63' ' ' ILE . 41.4 t -90.56 150.47 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.183 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.518 ' N ' HG11 ' B' ' 40' ' ' VAL . 3.4 mt -140.3 147.85 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.154 -0.967 . . . . 0.0 109.709 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.519 ' CB ' HG22 ' B' ' 23' ' ' ILE . . . -135.48 120.03 18.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.115 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 8.6 m -89.26 100.83 13.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.934 -1.104 . . . . 0.0 109.038 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' B' ' 22' ' ' ASN . 84.5 mt -45.99 172.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.427 -0.795 . . . . 0.0 109.814 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -87.92 10.63 18.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.144 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.514 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -114.11 27.53 9.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.055 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.05 11.22 69.97 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.514 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 3.8 mtp180 -100.22 165.94 11.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -1.158 . . . . 0.0 109.471 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.513 ' N ' ' HD2' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.82 154.08 50.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.176 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.21 123.65 9.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.26 -0.9 . . . . 0.0 109.297 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 7.7 m -79.49 144.87 33.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.103 -0.998 . . . . 0.0 109.17 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.529 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 15.3 mt -121.88 167.48 12.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.547 ' N ' HG23 ' B' ' 59' ' ' VAL . 1.0 OUTLIER -97.04 118.04 65.19 Favored Pre-proline 0 C--N 1.299 -1.608 0 O-C-N 121.426 -0.797 . . . . 0.0 109.227 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.409 ' HB3' ' CG2' ' B' ' 40' ' ' VAL . 32.9 Cg_endo -74.33 -0.28 9.47 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.224 1.949 . . . . 0.0 110.344 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.31 -14.1 27.35 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.311 -0.868 . . . . 0.0 108.916 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.09 162.73 34.26 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.368 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -78.22 -36.13 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.591 2.194 . . . . 0.0 110.626 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.448 HG23 HD11 ' B' ' 58' ' ' ILE . 65.5 mt -66.29 -36.46 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.139 -0.975 . . . . 0.0 109.709 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.547 HG23 ' N ' ' B' ' 53' ' ' ASN . 37.8 t -67.89 -51.35 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.266 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' B' ' 56' ' ' SER . 0.1 OUTLIER -54.39 -30.21 51.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.322 -0.861 . . . . 0.0 108.941 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.509 ' HB3' ' NZ ' ' B' ' 65' ' ' LYS . 9.6 mmmm -81.97 -28.82 32.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.126 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.544 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 11.9 mt -59.61 -38.14 74.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.587 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 1.7 mp -76.16 -61.57 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -43.09 -28.73 0.3 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.4 -0.813 . . . . 0.0 109.617 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.509 ' NZ ' ' HB3' ' B' ' 61' ' ' LYS . 2.0 mtmt -74.71 -60.27 2.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.337 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.528 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 1.4 mmm -44.09 -47.87 8.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.873 . . . . 0.0 109.257 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.577 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -43.63 -51.19 7.13 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.401 -0.812 . . . . 0.0 109.408 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' B' ' 69' ' ' SER . 11.9 t30 -66.48 -34.77 78.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.4 -0.813 . . . . 0.0 109.516 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.42 ' C ' ' O ' ' B' ' 68' ' ' ASN . 1.2 p . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 109.502 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 20.1 m . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -42.28 -26.91 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.815 . . . . 0.0 109.853 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 39' ' ' GLU . 72.4 m -124.17 63.3 1.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.769 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.71 -39.69 5.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.117 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -123.26 126.47 46.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 109.061 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.4 HG21 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -103.12 162.86 12.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.118 -0.989 . . . . 0.0 109.935 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.491 ' CD1' ' HB2' ' A' ' 50' ' ' ALA . 6.2 mt -115.44 140.96 48.67 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 15' ' ' LEU . 2.7 tt0 -44.34 -26.52 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.306 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.451 ' HA2' HD23 ' A' ' 52' ' ' LEU . . . 138.32 -171.34 23.47 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.538 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.4 pp -161.48 162.74 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -1.117 . . . . 0.0 109.399 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.577 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -56.36 153.97 17.95 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 109.274 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -76.9 -7.39 17.39 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.438 2.092 . . . . 0.0 109.971 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.512 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 3.1 mttm -80.91 -23.32 39.01 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.532 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 25.0 m-20 -98.35 59.47 1.33 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.538 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 2.7 mm -142.49 169.93 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.181 -0.95 . . . . 0.0 110.044 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -160.18 -40.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.517 ' CB ' ' HB ' ' A' ' 43' ' ' THR . 1.5 p -133.53 -173.79 3.32 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 50.8 t -159.62 97.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.037 -1.04 . . . . 0.0 109.74 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.462 ' O ' HD11 ' A' ' 41' ' ' ILE . 3.7 t-20 -94.62 111.42 23.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.396 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.432 HG11 HG21 ' A' ' 40' ' ' VAL . 1.8 t -117.35 103.48 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -107.05 108.43 19.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.43 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.1 p -50.97 168.68 0.24 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.8 Cg_endo -77.99 131.64 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.523 2.149 . . . . 0.0 110.508 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.04 -143.35 5.39 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.57 5.18 4.94 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.594 2.196 . . . . 0.0 110.643 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.405 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 14.1 p-80 -124.39 -10.89 7.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.647 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 4.0 t -160.2 104.51 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.316 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.92 -3.59 23.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.653 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 4.6 mm-40 -114.52 124.67 52.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.426 ' C ' ' HG2' ' A' ' 39' ' ' GLU . 14.1 m -49.43 148.18 2.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.331 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.465 ' OE2' ' CA ' ' A' ' 9' ' ' CYS . 0.8 OUTLIER -131.22 107.12 8.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 109.743 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.432 HG21 HG11 ' A' ' 28' ' ' VAL . 30.8 t -91.75 156.12 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.245 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.462 HD11 ' O ' ' A' ' 27' ' ' ASN . 2.1 mp -143.44 144.79 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.799 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -129.45 124.13 33.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.361 -0.837 . . . . 0.0 109.12 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 23.0 m -89.4 101.76 14.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.075 -1.016 . . . . 0.0 109.207 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.532 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 84.5 mt -43.59 164.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 109.266 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 11.3 ptpt -85.76 13.36 7.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.465 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.476 ' ND2' ' HD2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.56 11.04 19.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.174 179.506 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.39 21.17 45.68 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.476 ' HD2' ' ND2' ' A' ' 46' ' ' ASN . 95.6 mtt-85 -116.11 171.43 7.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -1.156 . . . . 0.0 109.468 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -137.45 153.76 50.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.477 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HB2' ' CD1' ' A' ' 15' ' ' LEU . . . -150.22 125.36 10.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.413 -0.804 . . . . 0.0 109.029 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.457 ' SG ' HG13 ' A' ' 41' ' ' ILE . 13.9 m -79.57 140.59 37.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.006 . . . . 0.0 109.045 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.521 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 11.9 mt -122.25 167.81 12.77 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 1.4 t-20 -101.29 121.4 51.91 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.474 -0.766 . . . . 0.0 109.199 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.92 -7.1 18.91 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.324 2.016 . . . . 0.0 110.321 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.17 -14.83 49.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 108.95 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.06 162.76 34.27 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.48 -0.763 . . . . 0.0 109.369 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.73 -37.5 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.733 2.289 . . . . 0.0 110.584 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 52.2 mt -61.88 -52.94 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.081 -1.012 . . . . 0.0 109.019 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.533 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 56.1 t -53.28 -51.74 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.549 -0.719 . . . . 0.0 109.723 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -50.18 -33.16 18.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.077 -1.014 . . . . 0.0 108.958 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.529 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 3.2 mmpt? -75.74 -34.71 60.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 0.0 109.458 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -60.2 -41.69 87.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.088 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.586 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -70.42 -62.32 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.864 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.461 ' OE2' ' HA ' ' A' ' 61' ' ' LYS . 5.9 pt-20 -57.6 -16.57 10.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.047 -1.033 . . . . 0.0 109.439 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.468 ' HG2' ' HB3' ' A' ' 20' ' ' PRO . 5.7 tptm -81.65 -40.66 22.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 108.664 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.517 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -61.97 -44.81 95.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.579 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -43.38 -51.8 6.26 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.551 -0.718 . . . . 0.0 109.308 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.28 -50.73 72.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.392 -0.818 . . . . 0.0 109.497 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.449 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.514 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 20.1 m . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -42.18 -27.0 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.466 -0.771 . . . . 0.0 109.884 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.456 ' HB2' ' HB3' ' B' ' 39' ' ' GLU . 72.6 m -124.22 63.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 109.688 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.514 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.72 -39.78 5.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 0.0 109.062 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -123.19 126.49 47.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 109.085 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.14 162.88 12.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.195 -0.941 . . . . 0.0 110.015 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.492 ' CD1' ' HB2' ' B' ' 50' ' ' ALA . 6.3 mt -115.48 140.93 48.71 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' B' ' 15' ' ' LEU . 2.7 tt0 -44.27 -26.57 0.33 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.471 ' HA2' HD23 ' B' ' 52' ' ' LEU . . . 138.35 -171.27 23.52 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.548 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.4 pp -161.53 162.74 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.34 -1.094 . . . . 0.0 109.379 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.576 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -56.28 153.89 17.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.346 -0.846 . . . . 0.0 109.322 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -76.88 -7.35 17.4 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.451 2.1 . . . . 0.0 109.963 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.519 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 3.1 mttm -80.9 -23.37 39.02 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.539 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 25.0 m-20 -98.37 59.46 1.33 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.548 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 2.6 mm -142.47 169.97 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.216 -0.927 . . . . 0.0 110.042 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.3 OUTLIER -160.16 -40.43 0.05 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.515 ' CB ' ' HB ' ' B' ' 43' ' ' THR . 1.5 p -133.55 -173.83 3.34 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.524 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 51.0 t -159.58 97.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.963 -1.086 . . . . 0.0 109.773 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.463 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 3.7 t-20 -94.67 111.38 23.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.412 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.442 HG11 HG21 ' B' ' 40' ' ' VAL . 1.8 t -117.3 103.52 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.464 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -107.12 108.48 19.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.388 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.439 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.1 p -51.05 168.64 0.24 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.8 Cg_endo -77.97 131.63 11.17 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.594 2.196 . . . . 0.0 110.459 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.01 -143.29 5.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.61 5.22 4.94 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.598 2.199 . . . . 0.0 110.64 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -124.38 -10.96 7.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 109.584 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 4.0 t -160.18 104.54 1.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 109.347 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.87 -3.64 23.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.716 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' B' ' 39' ' ' GLU . 4.6 mm-40 -114.48 124.7 52.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.096 -1.003 . . . . 0.0 109.522 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.408 ' C ' ' HG2' ' B' ' 39' ' ' GLU . 14.3 m -49.44 148.22 2.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.308 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.479 ' OE2' ' CA ' ' B' ' 9' ' ' CYS . 0.9 OUTLIER -131.24 107.29 8.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.669 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.442 HG21 HG11 ' B' ' 28' ' ' VAL . 31.2 t -91.9 156.22 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.213 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 2.1 mp -143.54 144.78 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.152 -0.968 . . . . 0.0 109.778 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -129.49 124.29 33.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.044 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 23.0 m -89.45 101.76 14.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.934 -1.104 . . . . 0.0 109.156 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.539 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 84.9 mt -43.61 164.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.5 -0.75 . . . . 0.0 109.245 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 11.3 ptpt -85.74 13.35 7.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.472 ' ND2' ' HD2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.52 11.05 19.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.888 . . . . 0.0 109.256 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.36 21.21 45.68 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.472 ' HD2' ' ND2' ' B' ' 46' ' ' ASN . 95.5 mtt-85 -116.19 171.49 7.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.503 ' N ' ' HD2' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -137.51 153.7 49.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.425 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.492 ' HB2' ' CD1' ' B' ' 15' ' ' LEU . . . -150.22 125.32 9.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.303 -0.873 . . . . 0.0 109.081 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.449 ' SG ' HG13 ' B' ' 41' ' ' ILE . 13.8 m -79.54 140.59 37.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.029 -1.045 . . . . 0.0 109.109 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.525 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 11.9 mt -122.19 167.78 12.79 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.344 -0.847 . . . . 0.0 109.409 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 1.4 t-20 -101.32 121.37 51.96 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.195 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.96 -6.92 18.7 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.262 1.975 . . . . 0.0 110.321 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.28 -14.84 48.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.22 -0.925 . . . . 0.0 108.946 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.02 162.7 34.56 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.468 -0.77 . . . . 0.0 109.406 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.77 -37.4 0.9 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.613 2.209 . . . . 0.0 110.65 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.52 ' O ' ' CD1' ' B' ' 62' ' ' ILE . 52.3 mt -61.86 -53.01 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.963 . . . . 0.0 109.004 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.533 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 55.9 t -53.2 -51.73 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.55 -0.719 . . . . 0.0 109.796 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.462 ' O ' ' OE2' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -50.24 -33.17 18.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.256 -0.902 . . . . 0.0 108.899 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.527 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 3.2 mmpt? -75.58 -34.92 60.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.468 -0.77 . . . . 0.0 109.477 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -60.1 -41.73 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.31 -0.869 . . . . 0.0 109.077 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.579 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -70.39 -62.32 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.888 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.464 ' OE2' ' HA ' ' B' ' 61' ' ' LYS . 5.9 pt-20 -57.54 -16.61 10.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.063 -1.023 . . . . 0.0 109.437 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' B' ' 61' ' ' LYS . 5.7 tptm -81.61 -40.79 22.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.275 -0.891 . . . . 0.0 108.644 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.524 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -61.85 -44.88 95.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.398 -0.814 . . . . 0.0 108.85 179.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.586 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -43.36 -51.76 6.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.511 -0.743 . . . . 0.0 109.34 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.37 -50.66 72.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.495 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.449 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.22 -0.925 . . . . 0.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.518 ' HG3' ' CB ' ' A' ' 29' ' ' LYS . 7.1 mm-40 -42.88 -26.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.457 ' SG ' HG13 ' A' ' 41' ' ' ILE . 60.3 m -148.74 72.63 1.19 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.085 -1.009 . . . . 0.0 109.903 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.464 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.87 -46.05 15.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 108.799 179.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -116.17 121.69 42.83 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -98.26 166.18 11.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 110.056 -179.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.1 mt -115.02 146.01 41.7 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.52 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -44.05 -42.76 6.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.413 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.51 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 147.36 -167.5 28.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.3 pp -169.5 163.43 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.396 -1.061 . . . . 0.0 109.252 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.561 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -55.74 151.14 23.85 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.263 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.561 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.44 -2.31 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.551 2.167 . . . . 0.0 110.175 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.452 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -90.23 -24.79 20.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.43 -0.794 . . . . 0.0 109.136 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.7 m-20 -83.47 -9.59 58.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.391 -0.818 . . . . 0.0 109.288 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 7.9 mt -101.97 165.81 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.882 . . . . 0.0 110.436 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.581 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -139.07 -31.67 0.7 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.581 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.3 p -128.68 168.66 15.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 108.84 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.508 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 56.1 t -141.18 105.65 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.026 -1.046 . . . . 0.0 109.857 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 5.2 t-20 -105.79 111.67 24.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -0.941 . . . . 0.0 109.457 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.05 103.44 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.537 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.518 ' CB ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -95.96 105.94 18.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.905 . . . . 0.0 109.395 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.1 p -51.92 167.87 0.31 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.401 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.52 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 35.7 Cg_endo -78.01 131.95 11.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.566 2.177 . . . . 0.0 110.514 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.47 -143.32 4.82 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.55 4.93 5.11 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.57 2.18 . . . . 0.0 110.636 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.4 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 14.6 p-80 -123.95 -10.6 7.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 0.0 109.595 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.5 t -160.08 124.13 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 109.269 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -80.74 -38.03 29.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.868 . . . . 0.0 109.658 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.435 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 2.0 mp0 -86.73 140.21 29.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.619 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.511 HG21 ' N ' ' A' ' 39' ' ' GLU . 50.6 m -60.79 153.88 23.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.511 ' N ' HG21 ' A' ' 38' ' ' THR . 2.5 mp0 -130.33 107.06 8.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 109.688 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.492 HG11 ' N ' ' A' ' 41' ' ' ILE . 38.9 t -89.59 154.13 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.84 . . . . 0.0 109.148 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.492 ' N ' HG11 ' A' ' 40' ' ' VAL . 3.1 mp -141.99 153.08 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.109 -0.994 . . . . 0.0 109.782 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.524 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -140.45 121.55 14.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.823 . . . . 0.0 109.063 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.528 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 3.1 m -89.17 103.94 16.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.887 -1.133 . . . . 0.0 108.798 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 79.7 mt -48.75 177.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.541 -0.724 . . . . 0.0 109.742 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -90.03 8.53 32.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 109.187 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.497 ' ND2' ' HD2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -113.79 28.97 8.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.81 11.77 66.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HD2' ' ND2' ' A' ' 46' ' ' ASN . 57.9 mtt180 -98.77 168.83 9.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -1.154 . . . . 0.0 109.434 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 16.3 mttt -140.24 151.25 45.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -0.869 . . . . 0.0 109.242 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.22 123.42 8.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.286 -0.884 . . . . 0.0 109.08 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.455 ' SG ' HG13 ' A' ' 41' ' ' ILE . 15.3 m -79.56 144.69 33.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.082 -1.011 . . . . 0.0 109.258 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.526 ' O ' ' CG2' ' A' ' 14' ' ' THR . 15.2 mt -121.33 167.59 12.59 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.278 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 2.8 t-20 -100.18 121.1 54.84 Favored Pre-proline 0 C--N 1.298 -1.668 0 O-C-N 121.385 -0.822 . . . . 0.0 109.103 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.03 -9.27 20.66 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.137 1.891 . . . . 0.0 110.271 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.96 -14.8 57.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 108.804 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -89.97 159.87 41.88 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.404 -0.81 . . . . 0.0 109.376 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.68 -34.36 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.667 2.245 . . . . 0.0 110.722 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 12.5 tt -66.65 -46.76 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 109.11 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.537 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 38.6 t -57.08 -48.62 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 109.048 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 1.1 mttp -55.14 -31.28 61.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -76.28 -30.62 57.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.615 -0.678 . . . . 0.0 109.297 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -65.16 -44.51 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.352 -0.842 . . . . 0.0 109.015 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.581 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -67.53 -61.66 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.613 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -52.61 -27.94 19.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.633 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.525 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -71.48 -40.91 69.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.187 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.508 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -63.36 -46.9 84.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.838 . . . . 0.0 109.185 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.58 -51.12 9.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.522 -0.736 . . . . 0.0 109.455 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -71.97 -29.08 63.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.878 . . . . 0.0 109.546 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.452 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.451 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.352 0.596 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.517 ' HG3' ' CB ' ' B' ' 29' ' ' LYS . 7.1 mm-40 -42.9 -26.26 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.853 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' B' ' 39' ' ' GLU . 60.2 m -148.68 72.6 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.083 -1.011 . . . . 0.0 109.953 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.451 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.8 -46.04 15.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.935 . . . . 0.0 108.773 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -116.19 121.59 42.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.414 -0.804 . . . . 0.0 108.896 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.5 OUTLIER -98.25 166.15 11.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.146 -0.972 . . . . 0.0 110.068 -179.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' B' ' 16' ' ' GLN . 7.1 mt -115.0 146.09 41.6 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.526 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 0.7 OUTLIER -44.18 -42.66 6.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.386 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.518 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 147.31 -167.56 28.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.3 pp -169.44 163.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.509 -0.995 . . . . 0.0 109.272 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.573 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -55.72 151.1 23.76 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.267 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.573 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.9 Cg_endo -77.4 -2.3 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.515 2.143 . . . . 0.0 110.224 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HD2' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -90.25 -24.83 20.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.159 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.7 m-20 -83.37 -9.58 58.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.295 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 8.0 mt -102.02 165.83 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 110.438 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.586 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -139.05 -31.79 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.586 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.3 p -128.62 168.56 15.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 108.85 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.505 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 55.7 t -141.13 105.78 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.145 -0.972 . . . . 0.0 109.77 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.46 ' O ' ' CD1' ' B' ' 41' ' ' ILE . 5.2 t-20 -105.9 111.72 24.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.09 103.42 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.938 . . . . 0.0 109.525 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.517 ' CB ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -96.05 105.89 17.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.408 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.1 p -51.88 167.92 0.31 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.518 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 36.2 Cg_endo -78.03 131.99 11.34 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.599 2.199 . . . . 0.0 110.51 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.57 -143.39 4.82 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.6 5.07 5.03 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.5 2.133 . . . . 0.0 110.581 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -123.93 -10.71 7.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.565 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 3.5 t -160.07 124.1 3.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -80.64 -38.09 29.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.75 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.428 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 2.0 mp0 -86.71 140.17 30.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.505 HG21 ' N ' ' B' ' 39' ' ' GLU . 50.6 m -60.72 153.93 22.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.505 ' N ' HG21 ' B' ' 38' ' ' THR . 2.5 mp0 -130.37 107.08 8.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 109.631 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.504 HG11 ' N ' ' B' ' 41' ' ' ILE . 39.1 t -89.68 154.2 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.102 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.504 ' N ' HG11 ' B' ' 40' ' ' VAL . 3.1 mp -142.03 153.07 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.125 -0.984 . . . . 0.0 109.842 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.517 ' CB ' HG22 ' B' ' 23' ' ' ILE . . . -140.45 121.57 14.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 108.972 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 3.1 m -89.18 103.87 16.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.871 -1.143 . . . . 0.0 108.856 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' B' ' 22' ' ' ASN . 80.1 mt -48.71 177.03 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.489 -0.757 . . . . 0.0 109.747 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -90.03 8.63 31.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.248 -0.907 . . . . 0.0 109.156 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HD2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -113.86 29.05 8.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.876 . . . . 0.0 109.139 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.85 11.73 66.69 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HD2' ' ND2' ' B' ' 46' ' ' ASN . 57.8 mtt180 -98.78 168.8 9.91 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 109.466 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.428 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 16.3 mttt -140.22 151.36 45.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 109.219 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.31 123.38 8.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.039 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.454 ' SG ' HG13 ' B' ' 41' ' ' ILE . 15.3 m -79.56 144.7 33.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.252 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.526 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 15.3 mt -121.38 167.5 12.7 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.913 . . . . 0.0 109.222 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 2.8 t-20 -100.12 121.13 54.82 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.169 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.95 -9.39 20.82 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.214 1.943 . . . . 0.0 110.292 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.89 -14.77 57.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 108.851 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -90.01 159.88 41.74 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.0 109.304 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.413 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.71 -34.22 1.96 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.675 2.25 . . . . 0.0 110.727 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.552 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 12.6 tt -66.76 -46.75 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.994 . . . . 0.0 109.083 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.552 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 38.4 t -57.11 -48.58 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.363 -0.835 . . . . 0.0 109.059 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 1.1 mttp -55.18 -31.28 61.27 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' B' ' 65' ' ' LYS . 0.9 OUTLIER -76.3 -30.56 57.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.566 -0.709 . . . . 0.0 109.329 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -65.07 -44.69 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 109.009 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.588 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -67.41 -61.7 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.629 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.2 OUTLIER -52.61 -28.01 19.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 109.579 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.528 ' HG2' ' CB ' ' B' ' 20' ' ' PRO . 0.0 OUTLIER -71.47 -40.85 70.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.114 -0.991 . . . . 0.0 109.225 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.505 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -63.36 -46.94 84.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.207 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.581 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.63 -51.08 9.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.323 -0.861 . . . . 0.0 109.451 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -71.94 -29.13 63.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 109.536 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.449 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.524 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 10.4 m . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.52 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 16.0 mm-40 -43.01 -26.44 0.14 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.735 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.443 ' SG ' HG13 ' A' ' 41' ' ' ILE . 96.8 m -125.61 63.16 1.2 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.82 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.524 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.09 -38.28 4.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.051 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -125.29 131.54 53.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.408 -0.808 . . . . 0.0 108.962 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -108.42 163.18 13.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.098 -1.001 . . . . 0.0 109.995 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.3 mt -120.78 146.04 46.93 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 15' ' ' LEU . 1.9 tt0 -44.26 -40.68 5.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.41 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.464 ' HA2' HD23 ' A' ' 52' ' ' LEU . . . 150.12 -168.11 30.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.579 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.3 pp -168.49 163.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.487 -1.007 . . . . 0.0 109.213 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.521 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -57.89 150.63 48.15 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.92 . . . . 0.0 109.434 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.527 ' CB ' ' HG2' ' A' ' 65' ' ' LYS . 34.9 Cg_endo -77.44 -2.78 12.97 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.571 2.18 . . . . 0.0 110.202 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.24 -24.85 20.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 109.069 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.524 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 3.4 m-20 -83.31 -5.53 59.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 109.354 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 7.0 mt -107.07 145.57 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 110.103 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.552 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -117.78 -26.19 6.6 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.552 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -143.53 172.24 13.07 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 25' ' ' SER . 50.6 t -159.52 137.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.943 -1.098 . . . . 0.0 109.98 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 43.3 t30 -112.47 169.21 9.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.203 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 t -151.27 92.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.543 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.52 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 0.6 OUTLIER -100.19 116.12 31.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.559 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.24 167.49 9.99 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 109.355 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.5 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.6 Cg_endo -78.0 131.33 10.94 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.677 2.251 . . . . 0.0 110.483 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.62 -144.1 4.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.95 6.9 3.89 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.593 2.196 . . . . 0.0 110.736 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.408 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 12.4 p-80 -125.09 -7.3 7.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.141 -0.975 . . . . 0.0 109.551 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.0 t -160.04 116.34 2.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.963 . . . . 0.0 109.418 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.12 45.79 1.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.556 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.5 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 6.1 pt20 -174.47 139.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.462 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 m -57.58 151.32 17.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.334 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.464 ' OE2' ' HG2' ' A' ' 29' ' ' LYS . 6.4 pt-20 -138.05 114.97 10.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.616 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.81 154.02 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 109.222 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.464 ' O ' HG12 ' A' ' 26' ' ' VAL . 4.2 mt -138.39 154.28 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.729 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.516 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -137.24 118.77 14.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 1.2 m -89.17 96.4 10.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.962 -1.086 . . . . 0.0 108.63 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 89.4 mt -43.18 167.36 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.572 -0.705 . . . . 0.0 109.881 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -80.67 7.59 9.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.645 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.98 23.42 13.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 109.299 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.33 7.41 82.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.516 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -95.54 167.64 11.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -1.202 . . . . 0.0 109.497 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HD3' ' OG1' ' A' ' 43' ' ' THR . 18.5 mttt -138.75 151.36 47.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.3 122.19 8.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.29 -0.881 . . . . 0.0 109.114 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.457 ' SG ' HG12 ' A' ' 41' ' ' ILE . 4.4 m -79.64 142.16 35.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.065 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.49 ' HB3' HG23 ' A' ' 59' ' ' VAL . 12.7 mt -120.03 167.44 12.18 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.292 -0.88 . . . . 0.0 109.492 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.545 ' N ' HG23 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -97.2 115.75 65.81 Favored Pre-proline 0 C--N 1.299 -1.627 0 O-C-N 121.434 -0.791 . . . . 0.0 109.226 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.483 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.3 Cg_endo -74.17 0.17 8.8 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.275 1.984 . . . . 0.0 110.433 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.05 -13.85 24.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -0.887 . . . . 0.0 108.944 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 164.61 27.25 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.423 -0.798 . . . . 0.0 109.407 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.9 -37.63 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.676 2.251 . . . . 0.0 110.568 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 10.0 mt -61.4 -51.88 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 109.058 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.545 HG23 ' N ' ' A' ' 53' ' ' ASN . 54.4 t -54.56 -54.3 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.739 . . . . 0.0 109.744 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.483 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 5.1 mttt -47.5 -33.71 6.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 108.971 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -74.61 -38.56 62.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.494 -0.754 . . . . 0.0 109.328 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -58.13 -41.96 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.429 -0.794 . . . . 0.0 109.146 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.587 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -70.12 -67.87 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.762 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -44.02 -28.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.663 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.527 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -72.88 -59.93 2.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.183 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' LYS . 0.8 OUTLIER -44.12 -44.42 7.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.388 -0.82 . . . . 0.0 109.183 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.573 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 1.3 mt -55.16 -58.68 6.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.705 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -80.86 6.85 11.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.734 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 65' ' ' LYS . 10.0 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.465 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 10.3 m . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.526 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 15.8 mm-40 -43.01 -26.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.72 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.449 ' SG ' HG13 ' B' ' 41' ' ' ILE . 95.9 m -125.64 63.29 1.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.981 . . . . 0.0 109.784 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.18 -38.35 5.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -125.2 131.57 53.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.818 . . . . 0.0 108.966 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.453 HG23 ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -108.43 163.17 13.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.12 -0.988 . . . . 0.0 110.025 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mt -120.74 146.0 46.93 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -44.29 -40.64 5.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.974 . . . . 0.0 109.42 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.455 ' HA2' HD23 ' B' ' 52' ' ' LEU . . . 150.09 -168.08 30.1 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.3 pp -168.52 163.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.454 -1.027 . . . . 0.0 109.255 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.524 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -57.81 150.45 48.15 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.251 -0.906 . . . . 0.0 109.401 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.524 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.3 Cg_endo -77.32 -2.79 13.0 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.59 2.194 . . . . 0.0 110.231 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.465 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.21 -24.88 20.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.383 -0.823 . . . . 0.0 109.057 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 3.4 m-20 -83.33 -5.56 59.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.463 -0.773 . . . . 0.0 109.217 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 7.1 mt -107.13 145.46 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.878 . . . . 0.0 110.112 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.543 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -117.71 -26.09 6.66 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.543 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -143.57 172.22 13.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' B' ' 25' ' ' SER . 50.4 t -159.49 137.58 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.969 -1.082 . . . . 0.0 109.993 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 43.2 t30 -112.48 169.26 9.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.293 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 t -151.32 92.97 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.436 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.526 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 0.6 OUTLIER -100.26 116.19 31.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.27 167.45 10.14 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.413 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.505 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.7 Cg_endo -77.98 131.3 10.93 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.632 2.222 . . . . 0.0 110.494 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.58 -144.1 4.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.93 6.87 3.91 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.552 2.168 . . . . 0.0 110.763 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.413 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 12.3 p-80 -125.01 -7.37 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.046 -1.034 . . . . 0.0 109.505 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.9 t -160.07 116.25 2.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.355 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.01 45.76 1.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.64 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.505 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 6.1 pt20 -174.54 139.47 0.57 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -0.956 . . . . 0.0 109.549 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 1.3 m -57.6 151.34 17.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.862 . . . . 0.0 109.338 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.454 ' OE2' ' HB2' ' B' ' 10' ' ' GLN . 6.4 pt-20 -138.02 114.94 10.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.611 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.86 154.0 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.153 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.462 ' O ' HG12 ' B' ' 26' ' ' VAL . 4.2 mt -138.36 154.21 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.746 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.507 ' CB ' HG22 ' B' ' 23' ' ' ILE . . . -137.19 118.77 14.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.221 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' B' ' 24' ' ' GLN . 1.2 m -89.17 96.41 10.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.027 -1.046 . . . . 0.0 108.63 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.6 mt -43.22 167.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.581 -0.699 . . . . 0.0 109.895 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -80.67 7.68 9.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 109.652 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.11 23.46 13.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.95 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.29 7.44 82.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 0.7 OUTLIER -95.54 167.66 11.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -1.177 . . . . 0.0 109.507 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.445 ' HD3' ' OG1' ' B' ' 43' ' ' THR . 18.4 mttt -138.71 151.31 47.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.902 . . . . 0.0 109.511 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.26 122.27 8.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.117 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.452 ' SG ' HG12 ' B' ' 41' ' ' ILE . 4.4 m -79.7 142.26 35.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 109.125 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.492 ' HB3' HG23 ' B' ' 59' ' ' VAL . 12.8 mt -120.19 167.41 12.28 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.285 -0.884 . . . . 0.0 109.356 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.541 ' N ' HG23 ' B' ' 59' ' ' VAL . 1.0 OUTLIER -97.14 115.73 65.81 Favored Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 109.278 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.471 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.4 Cg_endo -74.18 0.14 8.84 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.265 1.976 . . . . 0.0 110.46 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.03 -13.85 24.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.267 -0.896 . . . . 0.0 108.918 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' B' ' 53' ' ' ASN . 0.0 OUTLIER -90.09 164.52 27.68 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 109.403 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.79 -37.74 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.668 2.245 . . . . 0.0 110.508 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' B' ' 62' ' ' ILE . 10.0 mt -61.42 -51.89 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 0.0 109.026 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.541 HG23 ' N ' ' B' ' 53' ' ' ASN . 54.8 t -54.45 -54.42 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.542 -0.724 . . . . 0.0 109.745 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.471 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 5.1 mttt -47.44 -33.65 6.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 109.078 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' B' ' 65' ' ' LYS . 0.2 OUTLIER -74.6 -38.61 62.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 0.0 109.372 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -58.05 -41.99 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.825 . . . . 0.0 109.168 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.573 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -70.1 -67.86 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.766 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.2 OUTLIER -44.01 -28.31 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 109.747 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.522 ' HG2' ' CB ' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -72.81 -59.95 2.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 0.0 109.237 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.425 ' C ' ' O ' ' B' ' 65' ' ' LYS . 0.8 OUTLIER -44.05 -44.43 7.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.155 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.587 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 1.3 mt -55.21 -58.63 6.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.52 -0.738 . . . . 0.0 109.701 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -80.9 6.94 11.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 109.749 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' B' ' 65' ' ' LYS . 10.0 p . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.122 -0.986 . . . . 0.0 109.402 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.403 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 19.7 m . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.342 0.592 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.525 ' CG ' ' HE3' ' A' ' 29' ' ' LYS . 22.5 mm-40 -49.78 -21.66 1.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.715 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.463 ' HB2' ' OE1' ' A' ' 39' ' ' GLU . 49.9 m -144.98 67.43 1.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 0.0 109.909 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 11' ' ' CYS . 14.5 mt -45.12 -45.53 11.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 108.817 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.09 119.41 35.76 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -94.52 167.14 11.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 110.101 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.4 mt -114.38 144.99 42.4 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.4 tt0 -44.29 -39.06 4.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.176 -0.952 . . . . 0.0 109.41 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.509 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 144.99 -164.72 27.85 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.576 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.3 pp -170.82 163.74 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.488 -1.007 . . . . 0.0 109.094 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.51 ' ND1' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -53.54 149.48 15.11 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 109.354 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.51 ' HD2' ' ND1' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.19 -3.98 14.3 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.53 2.153 . . . . 0.0 110.176 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HE2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.25 -24.38 20.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.376 -0.828 . . . . 0.0 109.089 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.523 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 2.5 m-20 -82.87 -6.47 59.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 109.258 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.576 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 8.5 mt -104.94 148.89 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.575 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -120.54 -27.27 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.575 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -137.69 168.51 19.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.092 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 90.5 t -140.87 114.46 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.011 . . . . 0.0 109.776 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.449 ' HB3' HD11 ' A' ' 41' ' ' ILE . 3.8 t-20 -109.62 110.65 21.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 109.348 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -110.1 105.54 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 109.516 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.525 ' HE3' ' CG ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -98.51 114.71 27.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.402 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.98 167.82 5.54 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.462 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 36.2 Cg_endo -78.13 151.44 26.93 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.615 2.21 . . . . 0.0 110.44 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.84 -141.3 3.14 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.466 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 36.3 Cg_endo -77.89 10.96 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.649 2.233 . . . . 0.0 111.008 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.506 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 3.6 p-80 -128.27 -34.48 2.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.058 -1.026 . . . . 0.0 109.441 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.9 t -145.39 88.03 1.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.287 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -52.59 -19.93 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.706 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.462 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 33.8 mm-40 -92.85 131.93 37.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 3.6 m -54.79 161.3 1.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.33 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.488 ' HB2' ' CG ' ' A' ' 29' ' ' LYS . 22.5 mm-40 -145.33 107.53 4.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 0.0 109.635 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.506 HG11 ' N ' ' A' ' 41' ' ' ILE . 43.1 t -91.77 152.84 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.326 -0.859 . . . . 0.0 109.311 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.506 ' N ' HG11 ' A' ' 40' ' ' VAL . 2.7 mp -140.34 155.42 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.949 . . . . 0.0 109.709 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.9 117.99 11.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 109.103 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.537 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.4 m -89.22 97.66 11.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.892 -1.13 . . . . 0.0 108.787 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 87.1 mt -43.53 162.8 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.464 -0.772 . . . . 0.0 109.583 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.501 ' HB3' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -79.1 7.17 7.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.805 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -108.85 16.87 22.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.132 -0.98 . . . . 0.0 109.198 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.57 -0.8 89.45 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.508 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 13.7 mtt180 -89.68 162.97 15.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -1.201 . . . . 0.0 109.426 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.3 mptt -134.5 151.06 50.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.24 123.93 9.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 109.033 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 22.9 m -79.47 143.99 34.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.078 -1.014 . . . . 0.0 109.189 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.529 ' O ' ' CG2' ' A' ' 14' ' ' THR . 15.2 mt -121.19 167.69 12.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -0.856 . . . . 0.0 109.437 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 2.8 t-20 -100.84 123.48 45.36 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.413 -0.804 . . . . 0.0 109.177 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.19 -7.04 18.64 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.219 1.946 . . . . 0.0 110.398 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.45 -13.1 55.47 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 108.961 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -90.06 161.65 37.4 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.374 -0.829 . . . . 0.0 109.429 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.92 -35.66 1.33 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.648 2.232 . . . . 0.0 110.574 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.543 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 16.8 tt -67.31 -45.74 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.426 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.543 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 42.7 t -58.62 -46.82 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.413 -0.804 . . . . 0.0 109.369 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 1.3 mmpt? -59.47 -29.48 67.85 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.46 ' HA ' ' CG ' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -79.72 -23.84 42.08 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 22.7 mt -70.58 -37.76 70.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.584 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -74.75 -56.48 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 0.0 109.321 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER -59.35 -27.87 66.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.296 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.514 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 1.7 tptt -71.78 -50.68 27.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.058 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.517 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -51.85 -45.78 64.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 109.081 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.578 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -44.27 -52.15 7.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.335 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.9 OUTLIER -62.14 -38.1 87.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.393 -0.817 . . . . 0.0 109.456 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.445 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 2.5 p . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.416 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 19.4 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.372 0.605 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.512 ' CG ' ' HE3' ' B' ' 29' ' ' LYS . 22.5 mm-40 -49.75 -21.66 1.16 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.757 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' OE1' ' B' ' 39' ' ' GLU . 50.8 m -145.01 67.51 1.24 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.126 -0.984 . . . . 0.0 109.893 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' B' ' 11' ' ' CYS . 14.5 mt -45.12 -45.57 11.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -0.972 . . . . 0.0 108.854 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.06 119.44 35.85 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.6 OUTLIER -94.55 167.1 11.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.242 -0.911 . . . . 0.0 110.098 -179.365 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' B' ' 16' ' ' GLN . 7.4 mt -114.36 144.97 42.42 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.52 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.4 tt0 -44.27 -39.09 4.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 109.395 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.519 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 144.95 -164.62 27.85 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.3 pp -170.82 163.7 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.442 -1.034 . . . . 0.0 109.145 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.51 ' ND1' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -53.53 149.46 15.13 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.326 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.51 ' HD2' ' ND1' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -77.29 -3.89 14.17 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.586 2.191 . . . . 0.0 110.189 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HE2' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.3 -24.31 20.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.151 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 2.5 m-20 -82.87 -6.42 59.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.332 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 8.4 mt -104.95 148.88 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 110.269 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.558 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -120.55 -27.31 5.17 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.237 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.558 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -137.64 168.47 19.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.141 179.337 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.506 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 91.3 t -140.81 114.43 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.802 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.436 ' HB3' HD11 ' B' ' 41' ' ' ILE . 3.8 t-20 -109.6 110.63 21.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.295 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -110.03 105.62 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.275 -0.89 . . . . 0.0 109.592 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -98.6 114.67 27.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.387 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.95 167.89 5.4 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.423 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 36.2 Cg_endo -78.16 151.47 26.85 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.518 2.146 . . . . 0.0 110.456 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.82 -141.34 3.15 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.46 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -77.92 10.98 2.41 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.603 2.202 . . . . 0.0 110.993 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.512 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 3.7 p-80 -128.27 -34.44 2.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.016 -1.052 . . . . 0.0 109.474 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.465 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 2.0 t -145.43 88.07 1.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.296 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -52.6 -20.0 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.708 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.453 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 33.5 mm-40 -92.8 131.9 37.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.457 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 3.6 m -54.74 161.33 1.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.396 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.493 ' HB2' ' CG ' ' B' ' 29' ' ' LYS . 22.5 mm-40 -145.35 107.58 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.515 HG11 ' N ' ' B' ' 41' ' ' ILE . 42.9 t -91.8 152.8 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 109.299 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.515 ' N ' HG11 ' B' ' 40' ' ' VAL . 2.7 mp -140.31 155.35 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.719 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.88 118.05 11.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.093 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 1.5 m -89.13 97.55 11.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.92 -1.113 . . . . 0.0 108.817 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 86.9 mt -43.45 162.8 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.479 -0.763 . . . . 0.0 109.661 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.505 ' NZ ' ' HB3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -79.15 7.29 7.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 109.83 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -108.88 16.76 22.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.134 -0.979 . . . . 0.0 109.121 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.68 -0.87 89.4 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.506 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 13.7 mtt180 -89.64 162.95 15.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.082 -1.246 . . . . 0.0 109.445 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.512 ' N ' ' HD2' ' B' ' 49' ' ' LYS . 1.3 mptt -134.46 151.06 50.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 109.435 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.21 123.91 9.18 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 109.057 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' B' ' 41' ' ' ILE . 22.8 m -79.49 143.93 34.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.063 -1.023 . . . . 0.0 109.169 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.536 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 15.2 mt -121.14 167.61 12.47 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 2.7 t-20 -100.79 123.55 45.2 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.13 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.24 -7.05 18.62 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.225 1.95 . . . . 0.0 110.4 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.5 -13.13 55.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.229 -0.919 . . . . 0.0 108.868 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.3 OUTLIER -90.06 161.66 37.39 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.99 -35.53 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.609 2.206 . . . . 0.0 110.504 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.539 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 16.8 tt -67.33 -45.79 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.417 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.546 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 42.5 t -58.72 -46.72 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.812 . . . . 0.0 109.333 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 1.3 mmpt? -59.47 -29.59 67.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.466 ' HA ' ' CG ' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -79.63 -23.89 42.29 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 23.0 mt -70.52 -37.8 71.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.56 -0.712 . . . . 0.0 109.079 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.578 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -74.67 -56.49 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.427 -0.795 . . . . 0.0 109.398 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.4 OUTLIER -59.32 -27.86 66.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.294 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 1.6 tptt -71.79 -50.71 27.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.047 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.506 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.4 OUTLIER -51.82 -45.68 64.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.282 -0.886 . . . . 0.0 109.114 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.584 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -44.27 -52.35 7.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.314 -0.867 . . . . 0.0 109.258 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' B' ' 69' ' ' SER . 0.9 OUTLIER -61.95 -38.12 87.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.529 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.45 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 2.5 p . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.518 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 50.7 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.506 ' OE1' ' NZ ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.59 -26.79 0.13 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.347 -0.846 . . . . 0.0 109.761 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' CYS . 72.0 m -118.25 58.33 0.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.2 -37.91 3.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.234 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.37 123.86 41.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.383 -0.823 . . . . 0.0 109.11 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -100.05 161.1 13.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.2 mt -115.07 141.16 48.38 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.1 tt0 -44.12 -26.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.271 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.509 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 139.41 -162.68 26.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.481 ' CG2' ' O ' ' A' ' 17' ' ' GLY . 1.3 pp -171.0 163.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.466 -1.02 . . . . 0.0 109.267 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.577 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -58.12 154.27 31.1 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 0.0 109.201 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -76.99 -9.31 17.99 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.415 2.077 . . . . 0.0 109.927 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.51 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 35.5 mttm -77.34 -27.85 52.85 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.537 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 22.9 m-20 -93.33 59.29 2.97 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.525 ' CD1' ' O ' ' A' ' 22' ' ' ASN . 1.5 mm -147.17 169.01 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 110.028 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.564 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -160.38 -36.0 0.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.564 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.7 p -134.83 -175.17 3.81 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.521 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 50.7 t -158.82 98.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.946 -1.096 . . . . 0.0 109.867 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 3.5 t-20 -91.33 110.74 22.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.218 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.7 t -114.32 104.11 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.478 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.522 ' HE2' ' CD1' ' A' ' 41' ' ' ILE . 0.9 OUTLIER -108.19 110.45 22.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.04 168.88 0.47 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.365 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.525 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.4 Cg_endo -78.13 131.95 11.21 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.556 2.171 . . . . 0.0 110.5 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.08 -143.55 5.42 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.86 5.86 4.6 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.519 2.146 . . . . 0.0 110.709 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.418 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 12.2 p-80 -124.28 -12.66 7.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.979 . . . . 0.0 109.623 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 2.7 t -160.22 98.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.214 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.98 -8.48 30.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 109.651 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.455 ' OE1' ' CA ' ' A' ' 37' ' ' GLN . 6.5 mm-40 -106.0 125.44 51.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.451 HG21 ' N ' ' A' ' 39' ' ' GLU . 25.9 m -49.7 152.61 1.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.417 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' N ' HG21 ' A' ' 38' ' ' THR . 2.2 mt-10 -137.66 107.32 6.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.984 . . . . 0.0 109.791 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 41' ' ' ILE . 3.8 t -93.8 157.73 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.12 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.522 ' CD1' ' HE2' ' A' ' 29' ' ' LYS . 1.9 mp -144.28 143.8 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 109.835 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.42 ' HB3' HG21 ' A' ' 23' ' ' ILE . . . -126.88 125.25 41.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 109.016 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 25.8 m -89.65 104.71 17.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.031 -1.043 . . . . 0.0 109.051 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.537 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 80.1 mt -47.35 164.92 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.223 -0.923 . . . . 0.0 109.155 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' A' ' 21' ' ' LYS . 13.4 ptpt -84.93 12.97 6.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.148 -0.97 . . . . 0.0 109.566 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -111.2 10.68 21.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.888 . . . . 0.0 109.181 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.04 20.81 48.44 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.419 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 9.4 mtt180 -115.95 173.68 6.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -1.148 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 4.2 mttt -139.71 154.66 47.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB3' ' CD1' ' A' ' 15' ' ' LEU . . . -150.17 125.45 10.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.097 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.453 ' SG ' HG13 ' A' ' 41' ' ' ILE . 16.8 m -79.51 144.52 33.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 0.0 109.192 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.527 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 15.1 mt -122.53 168.34 12.26 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.538 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 0.9 OUTLIER -98.04 120.96 58.79 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.368 -0.833 . . . . 0.0 109.112 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.83 -6.79 18.61 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.196 1.931 . . . . 0.0 110.284 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.3 -14.25 53.42 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.257 -0.902 . . . . 0.0 108.833 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.455 ' OG ' HG22 ' A' ' 59' ' ' VAL . 1.1 p -90.05 158.3 44.47 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.474 -0.766 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.0 Cg_endo -77.14 -32.27 3.24 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.614 2.209 . . . . 0.0 110.509 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.534 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 9.0 tt -69.2 -45.16 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.112 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.538 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 25.2 t -57.45 -46.2 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.522 -0.736 . . . . 0.0 109.248 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -61.08 -30.32 70.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 3.4 mmpt? -79.05 -20.58 48.53 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.521 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 26.7 mt -75.51 -37.34 37.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.578 -0.701 . . . . 0.0 109.181 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.588 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -74.28 -50.33 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.516 ' OE2' ' NZ ' ' A' ' 61' ' ' LYS . 8.7 pt-20 -66.12 -35.95 81.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 109.328 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 32.9 mttm -61.38 -40.44 94.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 108.945 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.521 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -61.1 -45.33 95.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.087 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.579 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -49.59 -54.88 15.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 109.69 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.2 -16.18 60.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.895 . . . . 0.0 109.724 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 28.4 p . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 109.468 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.526 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 50.9 m . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.517 ' OE1' ' NZ ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -42.59 -26.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.359 -0.838 . . . . 0.0 109.722 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' B' ' 9' ' ' CYS . 72.1 m -118.28 58.38 0.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.13 -37.99 3.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 109.256 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.32 123.91 41.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.1 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.4 OUTLIER -100.13 161.12 13.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' B' ' 16' ' ' GLN . 7.2 mt -115.17 141.15 48.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.461 -0.775 . . . . 0.0 108.952 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.522 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 3.1 tt0 -44.08 -26.73 0.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.35 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.505 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 139.36 -162.67 26.1 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.474 ' CG2' ' O ' ' B' ' 17' ' ' GLY . 1.3 pp -170.96 163.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.404 -1.056 . . . . 0.0 109.217 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.572 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -58.16 154.21 31.77 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.25 -0.907 . . . . 0.0 109.27 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.9 Cg_endo -76.88 -9.31 18.15 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.449 2.099 . . . . 0.0 109.924 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.495 ' O ' ' NZ ' ' B' ' 45' ' ' LYS . 35.4 mttm -77.38 -27.87 52.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 23.0 m-20 -93.38 59.38 2.97 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' B' ' 22' ' ' ASN . 1.4 mm -147.23 168.93 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.141 -0.974 . . . . 0.0 110.047 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.551 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -160.38 -35.98 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.551 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.7 p -134.82 -175.19 3.82 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.512 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 50.4 t -158.81 98.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.96 -1.087 . . . . 0.0 109.79 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.459 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 3.6 t-20 -91.48 110.76 22.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.235 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.7 t -114.35 104.09 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.492 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.527 ' HE2' ' CD1' ' B' ' 41' ' ' ILE . 0.9 OUTLIER -108.16 110.41 22.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.96 168.84 0.47 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 109.414 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 36.0 Cg_endo -78.0 131.8 11.25 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.67 2.247 . . . . 0.0 110.507 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.01 -143.58 5.43 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.72 5.68 4.66 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.642 2.228 . . . . 0.0 110.68 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.405 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 12.1 p-80 -124.3 -12.68 7.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.181 -0.949 . . . . 0.0 109.585 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 2.7 t -160.18 98.88 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.25 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.9 -8.59 30.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.631 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.448 ' CA ' ' OE1' ' B' ' 37' ' ' GLN . 6.4 mm-40 -105.85 125.42 50.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.591 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.446 HG21 ' N ' ' B' ' 39' ' ' GLU . 26.0 m -49.79 152.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.868 . . . . 0.0 109.341 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.446 ' N ' HG21 ' B' ' 38' ' ' THR . 2.1 mt-10 -137.58 107.36 6.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.724 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.463 ' O ' HG13 ' B' ' 41' ' ' ILE . 3.8 t -93.85 157.64 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.115 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.527 ' CD1' ' HE2' ' B' ' 29' ' ' LYS . 1.9 mp -144.24 143.8 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.96 . . . . 0.0 109.81 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.414 ' HB3' HG21 ' B' ' 23' ' ' ILE . . . -126.93 125.18 41.1 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' B' ' 24' ' ' GLN . 26.2 m -89.53 104.73 17.26 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.981 -1.074 . . . . 0.0 109.05 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 80.8 mt -47.44 164.98 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.354 -0.841 . . . . 0.0 109.123 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' B' ' 21' ' ' LYS . 13.4 ptpt -84.98 13.11 6.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.594 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -111.28 10.68 21.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.878 . . . . 0.0 109.064 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.03 20.73 48.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.427 ' C ' ' HG2' ' B' ' 49' ' ' LYS . 9.4 mtt180 -115.96 173.72 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -1.128 . . . . 0.0 109.394 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.427 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 4.2 mttt -139.67 154.69 47.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.423 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.41 ' HB3' ' CD1' ' B' ' 15' ' ' LEU . . . -150.19 125.34 10.02 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.276 -0.89 . . . . 0.0 109.175 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.453 ' SG ' HG13 ' B' ' 41' ' ' ILE . 17.1 m -79.45 144.47 34.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.957 . . . . 0.0 109.152 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.534 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 15.0 mt -122.52 168.33 12.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.891 . . . . 0.0 109.35 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 0.9 OUTLIER -98.01 120.91 58.94 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.37 -0.831 . . . . 0.0 109.093 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.83 -6.68 18.46 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.126 1.884 . . . . 0.0 110.35 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.35 -14.21 53.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 0.0 108.826 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 1.1 p -90.05 158.26 44.5 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.383 -0.823 . . . . 0.0 109.402 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.467 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 35.5 Cg_endo -77.06 -32.29 3.28 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.676 2.25 . . . . 0.0 110.522 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.543 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 9.1 tt -69.23 -45.16 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 0.0 109.113 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.543 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 25.2 t -57.55 -46.1 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.474 -0.766 . . . . 0.0 109.163 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' B' ' 56' ' ' SER . 0.0 OUTLIER -61.17 -30.28 70.31 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' B' ' 65' ' ' LYS . 3.4 mmpt? -78.96 -20.77 48.38 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 26.7 mt -75.38 -37.34 38.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.641 -0.662 . . . . 0.0 109.267 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.579 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -74.29 -50.34 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.624 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 8.7 pt-20 -66.09 -35.93 81.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.998 -1.064 . . . . 0.0 109.353 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 32.8 mttm -61.42 -40.53 94.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 108.939 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.2 OUTLIER -61.0 -45.3 95.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.149 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -49.64 -54.78 16.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 109.698 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.32 -16.19 60.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.687 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 28.3 p . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.537 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.523 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 68.7 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.515 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.52 -26.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.874 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.437 ' N ' ' O ' ' A' ' 9' ' ' CYS . 83.0 m -116.8 58.71 0.76 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 109.71 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.523 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.82 -37.14 3.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.178 -0.951 . . . . 0.0 109.147 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -127.28 127.72 44.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.374 -0.829 . . . . 0.0 109.059 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -101.94 165.37 11.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.217 -0.927 . . . . 0.0 109.953 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 16' ' ' GLN . 6.9 mt -124.21 143.42 50.53 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 15' ' ' LEU . 1.3 tt0 -44.17 -40.89 5.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -0.946 . . . . 0.0 109.402 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.515 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 140.41 166.67 10.76 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.591 ' CD1' ' CG1' ' A' ' 23' ' ' ILE . 1.9 pp -139.31 162.8 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.549 -0.971 . . . . 0.0 109.083 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.545 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -46.49 151.61 0.99 Allowed Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 109.204 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -76.91 -4.87 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.502 2.135 . . . . 0.0 110.083 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.44 -23.41 21.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.331 -0.855 . . . . 0.0 109.237 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.523 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 4.8 m-20 -82.52 -4.7 57.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 0.0 109.44 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.591 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 9.0 mt -105.61 155.3 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 110.304 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.583 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -127.27 -29.19 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.32 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.583 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -135.11 171.12 14.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.029 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.526 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 46.4 t -143.78 101.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.959 . . . . 0.0 109.733 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.453 ' HB3' HD11 ' A' ' 41' ' ' ILE . 3.8 t-20 -95.71 110.4 22.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.364 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -107.0 100.72 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.504 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' CD ' ' HB2' ' A' ' 10' ' ' GLN . 10.2 ptmt -95.54 109.41 21.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.44 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.442 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -61.88 171.52 1.45 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.4 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.3 Cg_endo -77.54 144.57 22.67 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.611 2.207 . . . . 0.0 110.444 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.89 -141.3 3.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.9 39.96 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.746 2.297 . . . . 0.0 110.759 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.48 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 6.4 p-80 -159.41 -38.82 0.06 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.082 -1.011 . . . . 0.0 109.13 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -141.14 99.0 3.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.865 . . . . 0.0 109.146 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.87 -11.85 42.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 0.0 109.679 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.457 ' OE1' ' CA ' ' A' ' 37' ' ' GLN . 4.0 mm-40 -98.92 124.4 43.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.457 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.459 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 9.4 m -47.72 157.85 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.252 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.466 ' HB2' ' HG3' ' A' ' 29' ' ' LYS . 7.3 mm-40 -145.57 107.29 4.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 109.702 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 41' ' ' ILE . 6.5 t -89.74 156.23 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.154 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 40' ' ' VAL . 2.6 mp -141.09 148.43 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.145 -0.972 . . . . 0.0 109.838 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.04 118.18 18.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.007 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.532 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 2.1 m -89.12 98.91 12.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.931 -1.106 . . . . 0.0 108.885 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 88.9 mt -44.41 166.6 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.504 -0.747 . . . . 0.0 109.593 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.4 ptpt -81.88 8.21 10.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.639 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.15 25.04 11.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.216 -0.928 . . . . 0.0 109.242 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.18 2.64 67.23 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.511 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 5.8 mtt180 -92.1 164.32 13.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.193 -1.181 . . . . 0.0 109.436 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.6 mptt -135.92 153.13 51.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.174 -0.954 . . . . 0.0 109.393 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.29 122.45 8.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.065 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.4 m -79.46 143.07 35.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.102 -0.999 . . . . 0.0 109.036 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.523 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 14.2 mt -119.74 167.59 11.91 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.29 -0.881 . . . . 0.0 109.611 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 2.1 t30 -97.64 119.0 63.52 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.518 -0.739 . . . . 0.0 109.172 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.11 -0.0 9.0 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.136 1.891 . . . . 0.0 110.443 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.79 -13.07 25.97 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.296 -0.877 . . . . 0.0 108.835 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.11 165.35 24.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.389 -0.82 . . . . 0.0 109.399 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.478 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.17 -42.18 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.707 2.271 . . . . 0.0 110.816 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.449 HG21 HD13 ' A' ' 62' ' ' ILE . 47.1 mt -61.52 -39.71 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.734 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.548 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 47.5 t -64.42 -49.46 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.794 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 8.7 mttm -53.73 -32.33 51.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.071 -1.018 . . . . 0.0 108.706 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.524 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -78.06 -29.93 49.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.55 -0.719 . . . . 0.0 109.268 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.533 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 15.2 mt -64.43 -38.55 82.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.219 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.579 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 1.4 mp -76.01 -64.65 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.858 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -49.65 -55.22 14.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 109.449 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 61' ' ' LYS . 42.8 tptt -46.62 -55.79 7.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.128 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.526 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -44.38 -43.19 7.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 0.0 109.169 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.589 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -55.83 -55.27 34.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.419 -0.8 . . . . 0.0 109.579 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.28 10.31 17.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 109.679 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 66' ' ' MET . 91.2 p . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.495 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.514 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 68.6 m . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.508 ' HB2' ' CD ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -42.67 -26.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.436 -0.79 . . . . 0.0 109.761 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' B' ' 9' ' ' CYS . 82.9 m -116.85 58.77 0.76 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.729 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.514 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.18 3.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -127.31 127.64 44.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.016 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.449 HG21 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -101.88 165.42 11.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.968 . . . . 0.0 109.958 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' B' ' 16' ' ' GLN . 6.9 mt -124.2 143.43 50.52 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' B' ' 15' ' ' LEU . 1.3 tt0 -44.22 -40.97 5.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.28 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.521 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 140.45 166.72 10.78 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.583 ' CD1' ' CG1' ' B' ' 23' ' ' ILE . 1.9 pp -139.37 162.82 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.496 -1.002 . . . . 0.0 109.034 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.534 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -46.49 151.61 0.99 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.982 . . . . 0.0 109.134 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.534 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -76.91 -4.84 15.37 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.475 2.117 . . . . 0.0 110.008 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.477 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.47 -23.28 21.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.389 -0.819 . . . . 0.0 109.229 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 4.8 m-20 -82.61 -4.69 58.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.583 ' CG1' ' CD1' ' B' ' 18' ' ' ILE . 8.9 mt -105.59 155.35 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.564 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -127.36 -29.14 2.73 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.564 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -135.11 171.06 14.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 109.055 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.52 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 46.2 t -143.73 101.82 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.047 -1.033 . . . . 0.0 109.752 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.459 ' HB3' HD11 ' B' ' 41' ' ' ILE . 3.9 t-20 -95.65 110.4 22.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.321 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -107.01 100.71 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.481 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.508 ' CD ' ' HB2' ' B' ' 10' ' ' GLN . 10.1 ptmt -95.57 109.52 21.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 109.441 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.431 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -61.99 171.49 1.5 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 109.447 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.8 Cg_endo -77.43 144.6 22.96 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.615 2.21 . . . . 0.0 110.455 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.84 -141.25 3.29 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.9 39.94 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.684 2.256 . . . . 0.0 110.826 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.482 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 6.5 p-80 -159.37 -38.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.073 -1.017 . . . . 0.0 109.202 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -141.21 99.02 3.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 109.154 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.9 -11.93 43.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.7 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' B' ' 37' ' ' GLN . 4.0 mm-40 -98.77 124.45 43.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.519 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.454 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 9.4 m -47.78 157.89 0.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.313 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.454 ' HB2' ' HG3' ' B' ' 29' ' ' LYS . 7.3 mm-40 -145.58 107.27 4.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.732 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.463 ' O ' HG13 ' B' ' 41' ' ' ILE . 6.3 t -89.72 156.2 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.846 . . . . 0.0 109.182 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.463 HG13 ' O ' ' B' ' 40' ' ' VAL . 2.6 mp -141.07 148.47 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.777 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.09 118.19 18.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.057 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.518 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 2.1 m -89.08 98.82 11.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.909 -1.12 . . . . 0.0 108.896 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.1 mt -44.4 166.5 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.523 -0.736 . . . . 0.0 109.697 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.477 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.4 ptpt -81.73 8.09 10.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 109.692 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.07 25.01 11.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.26 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.28 2.55 67.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 5.8 mtt180 -92.01 164.28 13.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -1.204 . . . . 0.0 109.436 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.515 ' N ' ' HD2' ' B' ' 49' ' ' LYS . 1.6 mptt -135.86 153.2 51.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.382 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.39 122.36 8.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.835 . . . . 0.0 109.075 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 5.4 m -79.4 142.96 35.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.021 . . . . 0.0 109.08 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.525 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 14.0 mt -119.65 167.63 11.84 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.262 -0.899 . . . . 0.0 109.678 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.547 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 2.1 t30 -97.62 118.99 63.56 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.506 -0.746 . . . . 0.0 109.182 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.413 ' HA ' HG13 ' B' ' 59' ' ' VAL . 32.3 Cg_endo -74.26 0.14 8.89 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.07 1.846 . . . . 0.0 110.339 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.72 -13.16 26.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 108.867 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.1 165.4 24.23 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.835 . . . . 0.0 109.419 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.479 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.5 Cg_endo -78.1 -42.23 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.742 2.295 . . . . 0.0 110.831 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.464 HG21 HD13 ' B' ' 62' ' ' ILE . 47.2 mt -61.61 -39.62 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.189 -0.944 . . . . 0.0 109.706 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.547 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 47.6 t -64.43 -49.48 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.347 -0.845 . . . . 0.0 109.832 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' B' ' 64' ' ' GLU . 8.7 mttm -53.77 -32.28 51.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 108.741 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -78.04 -29.89 49.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.615 -0.678 . . . . 0.0 109.285 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.537 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 15.0 mt -64.6 -38.43 82.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 109.138 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.589 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 1.4 mp -75.99 -64.79 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 109.786 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -49.61 -55.2 14.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.01 -1.057 . . . . 0.0 109.449 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' B' ' 61' ' ' LYS . 42.9 tptt -46.57 -55.81 7.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.135 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.52 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.0 OUTLIER -44.43 -43.2 7.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.948 . . . . 0.0 109.116 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.578 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -55.72 -55.39 32.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.434 -0.791 . . . . 0.0 109.63 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.2 10.35 17.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 0.0 109.623 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' B' ' 66' ' ' MET . 90.6 p . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.459 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 67.1 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.511 ' NE2' ' HD3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -40.66 -40.01 1.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.587 -0.695 . . . . 0.0 109.857 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.445 ' SG ' HG13 ' A' ' 41' ' ' ILE . 82.5 m -132.09 80.49 1.91 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 109.878 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.517 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 3.9 mm? -49.2 -45.35 44.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 108.993 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -116.89 122.71 45.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.429 -0.794 . . . . 0.0 108.923 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.12 166.83 10.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.952 . . . . 0.0 110.006 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.408 ' HB2' HD21 ' A' ' 52' ' ' LEU . 6.0 mt -115.27 146.21 41.7 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.512 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -44.74 -35.65 2.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.109 -0.994 . . . . 0.0 109.38 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.464 ' HA3' HG22 ' A' ' 58' ' ' ILE . . . 146.37 -176.98 25.01 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.564 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.7 pp -157.04 162.39 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -1.06 . . . . 0.0 109.372 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.575 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -59.24 156.21 30.25 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 0.0 109.343 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.575 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -77.04 -13.3 17.36 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.501 2.134 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.533 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 22.0 mttt -74.17 -30.86 62.45 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.538 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 26.5 m-20 -89.59 58.41 4.32 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.564 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 1.5 mm -145.63 169.16 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -0.974 . . . . 0.0 110.098 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.563 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -160.18 -35.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.563 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 3.0 p -136.37 -172.59 3.18 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.529 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 52.1 t -159.24 115.16 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.891 -1.131 . . . . 0.0 109.97 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 3.9 t-20 -109.11 110.76 22.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 109.111 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.71 109.8 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.3 -0.875 . . . . 0.0 109.729 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.511 ' HD3' ' NE2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -108.87 102.03 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.37 -0.831 . . . . 0.0 109.309 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -48.81 171.31 0.1 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 36.0 Cg_endo -78.03 140.87 18.32 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.586 2.191 . . . . 0.0 110.462 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.48 -141.49 3.68 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.45 8.82 3.13 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.544 2.163 . . . . 0.0 110.878 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.491 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 4.4 p-80 -125.53 -21.33 4.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.047 -1.033 . . . . 0.0 109.807 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' OE1' ' A' ' 37' ' ' GLN . 2.1 t -160.02 122.44 3.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.012 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.42 16.2 4.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.637 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 2.0 mp0 -124.13 124.83 43.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.9 m -54.88 137.54 45.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.406 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 39' ' ' GLU . 1.7 mp0 -118.77 107.02 13.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 109.683 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.438 HG13 HD12 ' A' ' 63' ' ' ILE . 13.5 t -95.12 146.94 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.244 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.514 ' CG1' ' SG ' ' A' ' 51' ' ' CYS . 2.1 mp -138.23 152.58 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.874 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.62 125.25 23.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.411 -0.805 . . . . 0.0 109.041 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.529 HG23 ' CG ' ' A' ' 24' ' ' GLN . 33.4 m -89.51 106.86 18.73 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.008 -1.058 . . . . 0.0 109.093 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 71.9 mt -49.03 166.11 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.183 -0.948 . . . . 0.0 109.114 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.533 ' CD ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -84.27 11.04 8.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.057 -1.027 . . . . 0.0 109.533 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.488 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -111.12 19.26 18.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.325 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 14.61 80.1 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.488 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 49.1 mtt180 -109.15 175.23 5.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -1.173 . . . . 0.0 109.502 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -145.15 155.25 43.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.48 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.1 124.99 9.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.365 -0.834 . . . . 0.0 109.116 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.514 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 12.0 m -79.55 140.35 37.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.091 -1.006 . . . . 0.0 109.267 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.508 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 11.4 mt -122.93 168.67 12.01 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.253 -0.904 . . . . 0.0 109.266 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 2.2 t30 -104.68 124.79 35.77 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 109.276 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.11 -13.48 21.18 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.165 1.91 . . . . 0.0 110.531 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.417 ' HB1' ' ND2' ' A' ' 53' ' ' ASN . . . -73.55 -16.65 61.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.261 -0.899 . . . . 0.0 108.875 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.47 ' OG ' HG21 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -90.16 161.16 38.51 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.453 -0.779 . . . . 0.0 109.419 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.408 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -78.12 -37.17 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.679 2.253 . . . . 0.0 111.044 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 17.6 tt -64.73 -47.2 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.06 -1.025 . . . . 0.0 109.13 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.549 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 39.5 t -56.68 -48.23 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.509 -0.745 . . . . 0.0 109.163 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 56' ' ' SER . 4.6 mmtt -54.21 -31.18 52.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.497 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 9.6 mmmm -78.3 -30.66 48.49 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.35 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -58.0 -43.59 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.571 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 1.6 mp -68.7 -61.76 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -42.6 -29.03 0.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.344 -0.847 . . . . 0.0 109.584 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 66' ' ' MET . 0.7 OUTLIER -74.32 -60.57 2.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.858 . . . . 0.0 109.271 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.529 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 1.2 mmm -44.05 -48.37 8.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.564 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -43.64 -51.21 7.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 0.0 109.342 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.97 -37.04 86.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.467 -0.771 . . . . 0.0 109.497 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.846 . . . . 0.0 109.465 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.52 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 67.4 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.51 ' NE2' ' HD3' ' B' ' 29' ' ' LYS . 0.9 OUTLIER -40.74 -40.03 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.549 -0.719 . . . . 0.0 109.899 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.449 ' SG ' HG13 ' B' ' 41' ' ' ILE . 83.2 m -132.0 80.63 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.854 . . . . 0.0 109.882 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 3.9 mm? -49.38 -45.33 45.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.104 -0.998 . . . . 0.0 108.921 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -116.92 122.78 45.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.417 -0.802 . . . . 0.0 108.911 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.18 166.78 10.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.999 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' B' ' 16' ' ' GLN . 6.0 mt -115.2 146.18 41.67 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.515 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 0.8 OUTLIER -44.67 -35.67 2.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.142 -0.973 . . . . 0.0 109.438 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' B' ' 58' ' ' ILE . . . 146.32 -177.02 24.94 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.563 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.7 pp -157.01 162.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -1.105 . . . . 0.0 109.428 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.583 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -59.25 156.24 30.22 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.291 -0.881 . . . . 0.0 109.233 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.583 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.06 -13.19 17.37 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.467 2.112 . . . . 0.0 109.961 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.525 ' O ' ' CD ' ' B' ' 45' ' ' LYS . 22.1 mttt -74.17 -30.85 62.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.549 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 26.4 m-20 -89.65 58.41 4.29 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.563 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 1.5 mm -145.65 169.21 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.072 -1.018 . . . . 0.0 110.135 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.565 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -160.16 -35.68 0.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.565 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 3.0 p -136.37 -172.64 3.19 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.524 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 52.0 t -159.2 115.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.915 -1.115 . . . . 0.0 109.984 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.46 ' O ' HD13 ' B' ' 41' ' ' ILE . 3.9 t-20 -109.09 110.71 22.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.111 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.74 109.81 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.661 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.51 ' HD3' ' NE2' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -108.78 102.04 11.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.282 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.0 OUTLIER -48.84 171.29 0.1 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.377 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 36.3 Cg_endo -77.98 140.87 18.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.641 2.227 . . . . 0.0 110.497 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.57 -141.46 3.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.47 8.82 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.563 2.175 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.471 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 4.4 p-80 -125.56 -21.32 4.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.053 -1.03 . . . . 0.0 109.775 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.445 ' SG ' ' OE1' ' B' ' 37' ' ' GLN . 2.1 t -160.03 122.59 3.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.092 -1.005 . . . . 0.0 109.333 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.57 16.28 4.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.603 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.455 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 2.0 mp0 -124.17 124.87 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 109.474 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 15.3 m -54.78 137.58 44.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.939 . . . . 0.0 109.413 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.472 ' OE1' ' N ' ' B' ' 39' ' ' GLU . 1.7 mp0 -118.85 107.06 13.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.94 . . . . 0.0 109.632 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.44 HG13 HD12 ' B' ' 63' ' ' ILE . 13.5 t -95.14 146.91 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.515 ' CG1' ' SG ' ' B' ' 51' ' ' CYS . 2.1 mp -138.2 152.63 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.089 -1.007 . . . . 0.0 109.899 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.6 125.29 23.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.085 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.525 HG23 ' CG ' ' B' ' 24' ' ' GLN . 33.8 m -89.6 106.87 18.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.973 -1.08 . . . . 0.0 109.071 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.549 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 72.8 mt -49.07 166.17 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.151 -0.968 . . . . 0.0 109.013 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -84.34 11.03 9.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 0.0 109.442 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -111.12 19.3 18.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.345 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.63 80.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.486 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 49.2 mtt180 -109.16 175.24 5.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -1.209 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -145.19 155.33 43.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.425 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.14 124.98 9.83 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.391 -0.818 . . . . 0.0 109.112 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.515 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 12.0 m -79.64 140.3 37.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.166 -0.959 . . . . 0.0 109.244 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.508 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 11.4 mt -122.91 168.69 11.98 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.259 -0.901 . . . . 0.0 109.229 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 2.2 t30 -104.78 124.86 35.48 Favored Pre-proline 0 C--N 1.299 -1.601 0 O-C-N 121.344 -0.847 . . . . 0.0 109.171 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.06 -13.58 21.25 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.263 1.975 . . . . 0.0 110.452 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.429 ' HB1' ' ND2' ' B' ' 53' ' ' ASN . . . -73.53 -16.68 61.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 108.804 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.471 ' OG ' HG21 ' B' ' 58' ' ' ILE . 0.7 OUTLIER -90.2 161.13 38.46 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.342 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.5 Cg_endo -78.07 -37.19 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.703 2.269 . . . . 0.0 111.08 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 17.5 tt -64.69 -47.26 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.053 -1.029 . . . . 0.0 109.162 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.56 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 39.4 t -56.75 -48.28 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' B' ' 56' ' ' SER . 4.6 mmtt -54.15 -31.24 51.93 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.498 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 9.7 mmmm -78.27 -30.64 48.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.498 -0.751 . . . . 0.0 109.302 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -58.08 -43.57 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.564 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 1.6 mp -68.72 -61.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -42.7 -28.99 0.27 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.347 -0.845 . . . . 0.0 109.583 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' B' ' 66' ' ' MET . 0.7 OUTLIER -74.38 -60.47 2.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.942 . . . . 0.0 109.276 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.524 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 1.2 mmm -44.16 -48.28 9.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.83 . . . . 0.0 109.207 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.571 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -43.75 -51.16 7.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.379 -0.825 . . . . 0.0 109.317 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.91 -37.09 86.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.523 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.499 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.513 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 7.7 m . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -42.25 -27.25 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.415 -0.803 . . . . 0.0 109.797 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.435 ' SG ' HG13 ' A' ' 41' ' ' ILE . 98.7 m -131.26 67.18 1.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.185 -0.947 . . . . 0.0 109.616 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.513 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.43 -40.44 5.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.228 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -121.43 126.44 49.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.405 -0.81 . . . . 0.0 109.173 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.459 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -106.52 160.51 15.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.1 mt -110.38 140.64 44.39 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.519 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.2 tt0 -44.07 -26.62 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.371 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.471 ' HA2' HD21 ' A' ' 52' ' ' LEU . . . 151.78 -165.88 30.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.51 HD11 ' CD1' ' A' ' 23' ' ' ILE . 1.2 pp -169.14 162.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -1.064 . . . . 0.0 109.842 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.603 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.7 t60 -56.83 149.07 45.09 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -80.37 -15.99 10.99 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.318 2.012 . . . . 0.0 108.922 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.53 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 5.7 mttm -77.99 -22.8 48.83 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.564 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 17.9 m-20 -94.25 57.85 2.39 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.512 ' CD1' ' O ' ' A' ' 22' ' ' ASN . 2.4 mm -143.27 169.97 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.044 -1.035 . . . . 0.0 110.129 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -160.09 -40.47 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.518 ' CB ' ' HB ' ' A' ' 43' ' ' THR . 2.2 p -133.18 174.98 9.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.515 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 50.4 t -156.48 122.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.952 -1.092 . . . . 0.0 109.759 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 56.0 t30 -104.77 155.97 18.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' B' ' 26' ' ' VAL . 2.9 t -145.59 76.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.503 ' CE ' ' NE2' ' A' ' 34' ' ' HIS . 11.0 tptt -87.36 100.4 12.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.3 p -51.65 166.34 0.38 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 109.41 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.9 Cg_endo -78.15 131.75 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.594 2.196 . . . . 0.0 110.537 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.54 -144.34 4.91 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.19 7.77 3.54 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.59 2.194 . . . . 0.0 110.767 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.503 ' NE2' ' CE ' ' A' ' 29' ' ' LYS . 11.5 p-80 -125.98 -6.91 6.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.089 -1.007 . . . . 0.0 109.616 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.6 t -160.04 116.97 2.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.41 45.83 1.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.508 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.497 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 4.3 pt20 -172.55 139.14 0.93 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.53 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.424 ' HB ' ' CG ' ' A' ' 54' ' ' PRO . 2.4 m -57.52 144.06 38.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 109.373 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -124.77 107.64 11.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.592 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.424 ' CG1' HD12 ' A' ' 63' ' ' ILE . 44.2 t -100.39 150.02 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.867 . . . . 0.0 109.297 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 2.5 mp -136.06 159.66 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.848 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.435 ' N ' ' CG2' ' A' ' 41' ' ' ILE . . . -141.73 121.53 13.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.803 . . . . 0.0 109.11 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 16.4 m -89.53 101.27 13.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.973 -1.079 . . . . 0.0 109.17 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.564 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 73.7 mt -44.56 165.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.323 -0.861 . . . . 0.0 109.02 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.53 ' CD ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -83.64 9.93 10.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 109.494 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -109.99 16.88 21.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.364 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.83 18.54 67.6 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.453 ' HB2' HD13 ' A' ' 44' ' ' LEU . 1.7 mtp180 -111.89 169.43 8.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -1.134 . . . . 0.0 109.502 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -136.18 153.65 51.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.943 . . . . 0.0 109.478 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.27 123.36 8.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.113 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.409 ' SG ' HG13 ' A' ' 41' ' ' ILE . 11.8 m -79.51 143.19 35.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.096 -1.002 . . . . 0.0 109.14 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.522 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 14.0 mt -123.63 168.12 13.07 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.372 -0.83 . . . . 0.0 109.305 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.531 ' O ' ' CG2' ' A' ' 59' ' ' VAL . 1.9 t-20 -100.48 122.39 49.89 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.151 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.506 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.6 Cg_endo -75.14 -10.2 20.89 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.205 1.937 . . . . 0.0 110.283 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.08 -14.76 58.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.273 -0.892 . . . . 0.0 108.969 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -89.96 159.53 42.62 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.435 -0.791 . . . . 0.0 109.426 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.432 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.7 -33.49 2.27 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.578 2.185 . . . . 0.0 110.671 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.536 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 16.8 tt -68.07 -46.96 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.015 . . . . 0.0 109.232 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.536 ' N ' ' CG2' ' A' ' 58' ' ' ILE . 37.3 t -56.23 -48.78 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.414 -0.804 . . . . 0.0 109.076 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.506 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 14.9 mttt -56.32 -31.51 63.78 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.468 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -74.52 -29.93 61.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.604 -0.685 . . . . 0.0 109.284 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -68.88 -43.59 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.555 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -65.17 -65.86 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.523 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -48.04 -42.73 29.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 109.593 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -55.58 -49.24 73.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 109.3 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.515 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -53.48 -47.47 69.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.265 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.565 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -46.89 -52.48 14.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.462 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' SER . 13.4 t-20 -63.52 -31.73 72.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.466 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 68' ' ' ASN . 5.9 p . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 109.509 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.52 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 7.8 m . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -42.16 -27.3 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.833 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.435 ' SG ' HG13 ' B' ' 41' ' ' ILE . 98.9 m -131.27 67.15 1.52 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.598 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.37 -40.59 5.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.164 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -121.34 126.54 49.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.167 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.442 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -106.56 160.59 15.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.841 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' B' ' 16' ' ' GLN . 7.0 mt -110.38 140.58 44.45 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.461 -0.774 . . . . 0.0 108.928 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.528 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.2 tt0 -44.04 -26.59 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.119 -0.988 . . . . 0.0 109.422 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.474 ' HA2' HD21 ' B' ' 52' ' ' LEU . . . 151.76 -165.86 30.69 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.522 HD11 ' CD1' ' B' ' 23' ' ' ILE . 1.2 pp -169.13 162.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -1.068 . . . . 0.0 109.837 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.586 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 1.7 t60 -56.89 149.05 45.83 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.586 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.6 Cg_endo -80.32 -16.03 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.383 2.055 . . . . 0.0 108.915 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.537 ' O ' ' CD ' ' B' ' 45' ' ' LYS . 5.7 mttm -78.04 -22.71 48.77 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.562 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 17.8 m-20 -94.34 57.96 2.38 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.522 ' CD1' HD11 ' B' ' 18' ' ' ILE . 2.3 mm -143.31 169.98 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.093 -1.004 . . . . 0.0 110.157 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.0 OUTLIER -160.11 -40.62 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.514 ' CB ' ' HB ' ' B' ' 43' ' ' THR . 2.1 p -133.13 174.93 9.85 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.52 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 50.4 t -156.38 122.5 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.939 -1.101 . . . . 0.0 109.759 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.454 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 55.6 t30 -104.71 155.9 18.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.244 -0.91 . . . . 0.0 109.357 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 2.9 t -145.52 76.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.516 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.503 ' CE ' ' NE2' ' B' ' 34' ' ' HIS . 11.0 tptt -87.32 100.49 12.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.3 p -51.75 166.29 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.502 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.8 Cg_endo -78.05 131.71 11.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.648 2.232 . . . . 0.0 110.524 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.5 -144.41 4.93 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.11 7.74 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.649 2.233 . . . . 0.0 110.819 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.503 ' NE2' ' CE ' ' B' ' 29' ' ' LYS . 11.4 p-80 -125.98 -6.86 6.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.993 . . . . 0.0 109.67 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.7 t -160.15 116.93 2.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.415 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.4 45.73 1.22 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.576 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.502 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 4.2 pt20 -172.48 139.17 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 109.55 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.426 ' HB ' ' CG ' ' B' ' 54' ' ' PRO . 2.4 m -57.46 144.12 37.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -124.84 107.59 11.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.554 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.421 ' CG1' HD12 ' B' ' 63' ' ' ILE . 44.3 t -100.39 150.05 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.281 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 2.5 mp -136.03 159.63 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.121 -0.987 . . . . 0.0 109.87 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.429 ' N ' ' CG2' ' B' ' 41' ' ' ILE . . . -141.69 121.47 13.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.822 . . . . 0.0 109.135 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 16.4 m -89.43 101.32 14.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.024 -1.047 . . . . 0.0 109.23 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.562 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 73.8 mt -44.56 165.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 109.058 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.537 ' CD ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -83.66 9.88 10.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.161 -0.962 . . . . 0.0 109.434 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -109.91 16.79 21.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.92 18.46 67.58 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.462 ' HB2' HD13 ' B' ' 44' ' ' LEU . 1.7 mtp180 -111.82 169.29 8.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -1.173 . . . . 0.0 109.512 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.415 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 0.3 OUTLIER -136.04 153.61 51.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 109.592 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.21 123.31 8.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 109.072 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.405 ' SG ' HG13 ' B' ' 41' ' ' ILE . 12.0 m -79.45 143.21 35.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.091 -1.006 . . . . 0.0 109.239 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.529 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 14.0 mt -123.7 168.07 13.16 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.222 -0.924 . . . . 0.0 109.344 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 1.9 t-20 -100.52 122.31 50.08 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.182 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.51 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.6 Cg_endo -74.99 -10.17 21.1 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.143 1.895 . . . . 0.0 110.388 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.1 -14.74 58.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -0.919 . . . . 0.0 108.892 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.3 OUTLIER -90.01 159.55 42.44 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.409 -0.807 . . . . 0.0 109.421 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.71 -33.43 2.29 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.622 2.215 . . . . 0.0 110.652 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 16.9 tt -68.2 -46.88 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.099 -1.0 . . . . 0.0 109.151 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.554 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 37.1 t -56.3 -48.69 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 109.072 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.51 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 14.9 mttt -56.44 -31.43 63.93 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.465 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -74.63 -29.85 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.604 -0.685 . . . . 0.0 109.266 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -68.89 -43.67 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.565 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.1 mp -65.17 -65.89 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.499 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -47.99 -42.82 28.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 109.549 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -55.52 -49.24 73.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.308 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.52 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -53.49 -47.39 69.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.299 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.555 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -46.9 -52.47 14.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.454 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' B' ' 69' ' ' SER . 13.4 t-20 -63.53 -31.75 73.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.41 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.402 ' C ' ' O ' ' B' ' 68' ' ' ASN . 5.8 p . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.497 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.512 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' A' ' 9' ' ' CYS . 13.7 mm-40 -42.16 -27.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -0.818 . . . . 0.0 109.798 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.456 ' SG ' HG13 ' A' ' 41' ' ' ILE . 79.1 m -136.55 81.06 1.86 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 109.716 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.512 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -53.93 -41.44 67.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.16 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -118.5 117.93 30.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.16 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -99.78 163.18 12.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.792 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 51' ' ' CYS . 4.4 mt -106.18 137.2 44.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.83 . . . . 0.0 108.963 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -44.49 -41.39 6.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.979 . . . . 0.0 109.366 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.528 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 177.54 168.84 37.82 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.462 ' CG2' HD23 ' A' ' 52' ' ' LEU . 8.0 tp -153.67 158.37 3.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.473 -1.016 . . . . 0.0 108.772 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.576 ' CB ' ' ND2' ' A' ' 22' ' ' ASN . 2.6 t-80 -45.04 139.89 3.77 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.226 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.475 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.7 Cg_endo -77.77 -25.44 7.78 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.491 2.127 . . . . 0.0 110.292 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -90.12 -14.83 32.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 0.0 108.987 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.576 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 51.7 m-20 -70.33 -11.61 61.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.325 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.525 ' CG2' ' HB3' ' A' ' 42' ' ' ALA . 3.1 mt -105.44 149.01 9.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.263 -0.898 . . . . 0.0 110.611 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.527 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -115.61 -27.69 7.03 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.527 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -136.1 160.72 37.79 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.468 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 2.0 t -146.16 101.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.941 -1.1 . . . . 0.0 109.932 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.449 ' OD1' ' OD1' ' B' ' 27' ' ' ASN . 29.1 t30 -79.96 116.73 20.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.198 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -98.23 84.68 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -0.923 . . . . 0.0 109.49 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER -89.59 93.91 9.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.364 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.09 167.26 0.25 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.376 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.5 Cg_endo -77.96 131.84 11.32 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.619 2.213 . . . . 0.0 110.38 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.22 -145.97 6.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.96 5.48 4.93 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.628 2.219 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -121.81 -16.83 7.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.614 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 9.1 t -160.12 96.88 1.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.33 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.76 -10.57 28.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.595 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.445 ' OE1' ' SG ' ' A' ' 9' ' ' CYS . 2.0 mp0 -96.24 125.26 40.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.57 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.435 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 3.8 m -50.68 150.7 2.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.944 . . . . 0.0 109.385 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.456 ' OE2' ' HB3' ' A' ' 35' ' ' CYS . 3.3 mp0 -129.39 107.7 9.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.959 . . . . 0.0 109.571 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.521 ' CG1' HD12 ' A' ' 63' ' ' ILE . 1.7 t -102.59 95.34 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.257 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.456 HG13 ' SG ' ' A' ' 11' ' ' CYS . 5.2 mp -86.03 140.73 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.742 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.525 ' HB3' ' CG2' ' A' ' 23' ' ' ILE . . . -124.14 119.14 28.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.202 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.48 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -89.17 100.07 12.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.02 -1.05 . . . . 0.0 108.459 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 72.5 mt -41.49 165.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.541 0.686 . . . . 0.0 110.073 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.5 ptpt -80.36 6.96 10.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.539 -0.726 . . . . 0.0 109.686 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.456 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -111.95 8.54 20.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.406 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.35 -6.11 71.42 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.42 ' C ' ' HG2' ' A' ' 49' ' ' LYS . 7.3 mtt180 -84.46 170.52 13.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.13 -1.218 . . . . 0.0 109.537 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.42 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 10.0 mttt -133.86 153.73 51.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.22 118.12 6.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.037 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.465 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 19.4 m -79.57 139.02 37.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.129 -0.982 . . . . 0.0 109.166 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.537 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 11.3 mt -126.9 168.25 14.74 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.15 -0.969 . . . . 0.0 109.329 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 1.1 t-20 -108.26 129.16 24.42 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.554 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.435 ' HG3' ' HB ' ' A' ' 38' ' ' THR . 34.4 Cg_endo -76.1 4.45 5.3 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.407 2.071 . . . . 0.0 110.747 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.38 -21.31 27.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.249 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.06 163.97 29.86 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.843 . . . . 0.0 109.466 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.84 -29.1 4.61 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.654 2.236 . . . . 0.0 110.143 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.528 ' CG2' ' HA3' ' A' ' 17' ' ' GLY . 8.6 mm -68.18 -47.33 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.549 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 51.1 t -62.38 -48.61 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 109.675 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 56' ' ' SER . 2.8 mmpt? -56.91 -30.52 64.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.93 . . . . 0.0 108.809 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.52 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -81.66 -24.69 36.15 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.513 ' CG2' HD11 ' A' ' 23' ' ' ILE . 16.0 mt -67.97 -38.25 79.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.25 -0.906 . . . . 0.0 108.592 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.586 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 1.5 mp -76.36 -63.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.383 -0.823 . . . . 0.0 109.117 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -43.92 -50.84 7.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.253 -0.904 . . . . 0.0 109.428 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 66' ' ' MET . 4.4 tmtm? -52.03 -57.58 9.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.211 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.468 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -44.12 -46.2 8.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 109.127 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.571 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -55.59 -49.54 72.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.452 -0.78 . . . . 0.0 109.527 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -96.26 33.91 1.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.474 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.473 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.517 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 1.7 m . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' B' ' 9' ' ' CYS . 13.6 mm-40 -42.14 -27.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.796 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.447 ' SG ' HG13 ' B' ' 41' ' ' ILE . 78.4 m -136.61 81.1 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 109.595 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.517 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.3 OUTLIER -53.94 -41.47 67.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.202 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -118.39 117.97 30.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.283 -0.886 . . . . 0.0 109.146 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.463 HG23 ' O ' ' B' ' 52' ' ' LEU . 0.6 OUTLIER -99.85 163.09 12.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.825 -179.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' B' ' 51' ' ' CYS . 4.3 mt -106.0 137.17 44.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.321 -0.862 . . . . 0.0 108.995 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.0 OUTLIER -44.56 -41.28 6.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 109.4 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.518 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 177.5 168.8 37.73 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.472 ' CG2' HD23 ' B' ' 52' ' ' LEU . 8.0 tp -153.64 158.39 3.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.493 -1.004 . . . . 0.0 108.784 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.576 ' CB ' ' ND2' ' B' ' 22' ' ' ASN . 2.6 t-80 -45.05 139.86 3.8 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.02 -1.05 . . . . 0.0 109.156 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.462 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.1 Cg_endo -77.8 -25.36 7.8 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.501 2.134 . . . . 0.0 110.256 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.2 OUTLIER -90.18 -14.84 32.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.405 -0.81 . . . . 0.0 108.974 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.576 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 52.0 m-20 -70.29 -11.61 61.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.451 -0.781 . . . . 0.0 109.318 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.525 HD11 ' CG2' ' B' ' 62' ' ' ILE . 3.0 mt -105.41 148.99 9.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.238 -0.914 . . . . 0.0 110.584 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.524 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -115.63 -27.75 7.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.524 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -136.04 160.81 37.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.473 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 2.0 t -146.24 101.5 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.03 -1.044 . . . . 0.0 109.917 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.449 ' OD1' ' OD1' ' A' ' 27' ' ' ASN . 29.0 t30 -79.88 116.79 20.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.247 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.8 t -98.24 84.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER -89.58 93.87 9.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.214 -0.929 . . . . 0.0 109.396 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.02 167.21 0.25 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.266 -0.896 . . . . 0.0 109.399 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.9 Cg_endo -77.91 131.87 11.4 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.56 2.173 . . . . 0.0 110.455 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.22 -146.12 6.05 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -76.87 5.47 4.88 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.623 2.216 . . . . 0.0 110.654 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -121.86 -16.75 7.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.951 . . . . 0.0 109.555 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 9.1 t -160.14 96.92 1.23 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 109.353 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.77 -10.56 28.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.638 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.446 ' OE1' ' SG ' ' B' ' 9' ' ' CYS . 2.0 mp0 -96.28 125.21 40.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.494 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.435 ' HB ' ' HG3' ' B' ' 54' ' ' PRO . 3.8 m -50.62 150.67 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 109.375 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.459 ' OE2' ' HB3' ' B' ' 35' ' ' CYS . 3.3 mp0 -129.4 107.81 9.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.603 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.517 ' CG1' HD12 ' B' ' 63' ' ' ILE . 1.7 t -102.61 95.26 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.288 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.447 HG13 ' SG ' ' B' ' 11' ' ' CYS . 5.2 mp -86.02 140.72 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.52 ' HB3' ' CG2' ' B' ' 23' ' ' ILE . . . -124.16 119.13 28.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.845 . . . . 0.0 109.226 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.474 ' O ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -89.13 100.08 12.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.035 -1.041 . . . . 0.0 108.437 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 72.1 mt -41.48 165.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.573 0.702 . . . . 0.0 110.031 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.5 ptpt -80.49 7.04 10.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.472 -0.767 . . . . 0.0 109.647 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -111.91 8.48 20.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.473 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.01 71.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.409 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 7.3 mtt180 -84.6 170.56 13.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.239 . . . . 0.0 109.513 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.406 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 9.9 mttt -133.84 153.81 51.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 109.507 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.34 118.11 6.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 108.971 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.455 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 19.6 m -79.56 138.95 37.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.169 -0.957 . . . . 0.0 109.237 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.531 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 11.3 mt -126.84 168.3 14.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 1.1 t-20 -108.26 129.32 24.21 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.521 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.435 ' HG3' ' HB ' ' B' ' 38' ' ' THR . 34.6 Cg_endo -76.27 4.52 5.32 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.342 2.028 . . . . 0.0 110.755 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.43 -21.27 27.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.162 -0.962 . . . . 0.0 109.231 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -90.12 163.93 29.87 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.477 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.74 -29.18 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.683 2.255 . . . . 0.0 110.171 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.518 ' CG2' ' HA3' ' B' ' 17' ' ' GLY . 8.6 mm -68.1 -47.28 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.442 -0.786 . . . . 0.0 109.264 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.55 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 50.7 t -62.49 -48.46 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.328 -0.858 . . . . 0.0 109.731 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' B' ' 56' ' ' SER . 2.8 mmpt? -56.96 -30.54 64.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -0.929 . . . . 0.0 108.797 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.517 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -81.6 -24.68 36.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.524 -0.735 . . . . 0.0 109.247 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.525 ' CG2' HD11 ' B' ' 23' ' ' ILE . 16.1 mt -67.93 -38.23 79.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.571 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 1.5 mp -76.33 -63.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.505 -0.747 . . . . 0.0 109.097 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -43.93 -50.84 7.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.289 -0.882 . . . . 0.0 109.444 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' B' ' 66' ' ' MET . 4.4 tmtm? -52.14 -57.45 9.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.269 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.473 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.4 OUTLIER -44.1 -46.2 8.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.149 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.586 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -55.67 -49.54 72.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 0.0 109.484 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -96.2 33.87 1.68 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 179.951 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.461 ' HB2' HD21 ' A' ' 12' ' ' LEU . 72.8 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.525 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 30.2 mm-40 -43.16 -26.09 0.15 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.714 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.46 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 19.4 m -145.19 75.12 1.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.633 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.66 -50.72 9.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.168 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 7.8 pt20 -108.95 103.25 12.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.157 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.43 ' HB ' ' C ' ' A' ' 52' ' ' LEU . 1.1 p -79.89 144.93 32.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.668 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.442 ' HB2' HD21 ' A' ' 52' ' ' LEU . 22.3 mt -78.6 -174.06 3.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 109.336 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.461 ' O ' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -84.23 -40.76 17.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 0.0 109.502 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.504 ' O ' ' CG2' ' A' ' 18' ' ' ILE . . . 155.61 -172.07 33.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.579 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.3 pp -172.11 164.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -1.056 . . . . 0.0 109.213 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.471 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -58.92 150.14 61.8 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.319 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.3 Cg_endo -77.14 -4.47 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.512 2.141 . . . . 0.0 110.176 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.465 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -90.35 -23.49 21.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.385 -0.822 . . . . 0.0 109.198 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.47 ' O ' HD21 ' A' ' 44' ' ' LEU . 3.3 m-20 -85.18 -18.99 32.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.305 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 22.0 mt -83.38 169.22 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.441 -0.787 . . . . 0.0 110.07 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -139.37 -40.93 0.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.462 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 1.7 p -124.9 177.31 6.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.838 . . . . 0.0 108.892 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.52 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 47.7 t -146.8 100.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.018 -1.051 . . . . 0.0 109.698 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.461 ' O ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -100.05 111.15 23.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.266 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.435 HG12 ' CG2' ' A' ' 40' ' ' VAL . 1.8 t -120.98 102.3 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.525 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -103.94 117.22 33.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.919 . . . . 0.0 109.397 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.439 ' OG ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -57.31 171.68 0.46 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.153 -0.967 . . . . 0.0 109.284 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.8 Cg_endo -77.83 153.07 29.23 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.693 2.262 . . . . 0.0 110.456 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.98 -140.56 2.9 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.557 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 36.4 Cg_endo -78.28 12.14 2.17 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.654 2.236 . . . . 0.0 110.982 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.557 ' CE1' ' HD2' ' A' ' 33' ' ' PRO . 1.9 p-80 -127.49 -32.71 2.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.988 -1.07 . . . . 0.0 109.53 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.31 121.4 12.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.381 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.8 44.41 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.933 . . . . 0.0 109.625 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.489 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 5.2 pt20 -169.98 139.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.54 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.6 m -55.91 141.39 39.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.93 107.54 10.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.532 ' CG1' HD12 ' A' ' 63' ' ' ILE . 47.7 t -95.1 149.24 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.21 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.508 ' N ' HG11 ' A' ' 40' ' ' VAL . 3.4 mp -142.0 151.13 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.863 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.523 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -135.13 123.08 22.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 108.886 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 7.4 m -89.77 100.18 13.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.089 . . . . 0.0 109.375 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.47 HD21 ' O ' ' A' ' 22' ' ' ASN . 60.7 mt -42.43 164.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 0.0 109.606 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 13.0 ptpt -82.83 9.78 9.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.468 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -113.91 19.55 16.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.458 ' O ' ' HD2' ' A' ' 49' ' ' LYS . . . 87.6 -17.64 43.23 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 42.8 mtt180 -77.3 163.19 26.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -1.116 . . . . 0.0 109.416 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -144.01 122.65 12.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.148 -0.97 . . . . 0.0 109.541 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.18 127.94 55.21 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.24 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 92.2 m -79.65 155.34 28.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.062 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.525 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 12.8 mt -135.19 170.98 15.08 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.141 -0.974 . . . . 0.0 109.702 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 15.3 p-10 -105.39 127.6 28.26 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.78 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.467 ' HA ' HG13 ' A' ' 59' ' ' VAL . 33.0 Cg_endo -75.08 -4.66 15.71 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.087 1.858 . . . . 0.0 110.224 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 -19.29 53.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 108.778 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 159.39 42.5 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.349 -0.844 . . . . 0.0 109.022 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.92 -32.25 3.44 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.582 2.188 . . . . 0.0 110.778 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -69.53 -44.66 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 109.168 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.564 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 31.4 t -58.0 -46.94 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.834 . . . . 0.0 109.152 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 56' ' ' SER . 9.6 mtmt -60.51 -30.49 69.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.492 ' CE ' ' CD ' ' A' ' 64' ' ' GLU . 4.9 mmpt? -76.67 -23.56 53.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 19.0 mt -71.39 -37.16 63.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.532 HD12 ' CG1' ' A' ' 40' ' ' VAL . 2.3 mp -73.21 -58.14 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.492 ' CD ' ' CE ' ' A' ' 61' ' ' LYS . 5.7 pt-20 -59.2 -52.19 66.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.045 -1.034 . . . . 0.0 109.652 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 6.5 mtpp -46.35 -52.43 12.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.112 -0.992 . . . . 0.0 109.132 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.52 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -49.38 -46.41 47.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.214 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.518 HD13 ' CG2' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -45.93 -52.08 12.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.432 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -64.39 -33.59 76.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.843 . . . . 0.0 109.531 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.462 ' HB2' HD21 ' B' ' 12' ' ' LEU . 71.8 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.521 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 30.2 mm-40 -43.22 -26.07 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 0.0 109.704 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.454 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 19.9 m -145.18 75.09 1.43 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.983 . . . . 0.0 109.601 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.462 ' O ' HD12 ' B' ' 12' ' ' LEU . 0.2 OUTLIER -44.61 -50.72 9.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 109.238 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' B' ' 13' ' ' GLN . 7.8 pt20 -108.95 103.25 12.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.831 . . . . 0.0 109.144 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.424 ' HB ' ' C ' ' B' ' 52' ' ' LEU . 1.0 OUTLIER -79.9 144.89 33.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.608 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.465 ' HB2' HD21 ' B' ' 52' ' ' LEU . 22.2 mt -78.46 -174.07 3.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.854 . . . . 0.0 109.33 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.457 ' O ' HG22 ' B' ' 59' ' ' VAL . 0.0 OUTLIER -84.33 -40.74 17.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.176 -0.952 . . . . 0.0 109.474 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' B' ' 18' ' ' ILE . . . 155.66 -172.04 33.71 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.3 pp -172.2 163.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -1.013 . . . . 0.0 109.161 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.489 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -58.91 150.19 61.55 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.299 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.3 Cg_endo -77.14 -4.47 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.55 2.167 . . . . 0.0 110.173 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.463 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -90.3 -23.61 21.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.3 m-20 -85.16 -18.88 32.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.24 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 21.8 mt -83.43 169.22 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.389 -0.819 . . . . 0.0 110.066 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.4 OUTLIER -139.35 -41.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.448 ' CB ' ' HB ' ' B' ' 43' ' ' THR . 1.7 p -124.88 177.26 6.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.451 -0.781 . . . . 0.0 108.899 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.525 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 48.2 t -146.76 100.46 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.461 ' OD1' ' OD1' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -100.09 111.18 23.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 109.217 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.432 HG12 ' CG2' ' B' ' 40' ' ' VAL . 1.8 t -120.97 102.37 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.521 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 0.2 OUTLIER -103.95 117.16 33.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.401 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.454 ' OG ' ' HD2' ' B' ' 31' ' ' PRO . 0.0 OUTLIER -57.18 171.63 0.45 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.306 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.493 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.8 Cg_endo -77.83 153.09 29.24 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.623 2.215 . . . . 0.0 110.435 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.98 -140.64 2.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.552 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -78.33 12.34 2.12 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.513 2.142 . . . . 0.0 111.006 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.552 ' CE1' ' HD2' ' B' ' 33' ' ' PRO . 1.9 p-80 -127.6 -32.63 2.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.013 -1.054 . . . . 0.0 109.509 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.34 121.34 12.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.393 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.78 44.52 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.701 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.493 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 5.2 pt20 -170.08 139.3 1.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.494 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 2.7 m -55.98 141.28 40.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.78 107.54 10.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.659 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.52 ' CG1' HD12 ' B' ' 63' ' ' ILE . 47.7 t -95.2 149.31 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.204 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.512 ' N ' HG11 ' B' ' 40' ' ' VAL . 3.4 mp -141.96 151.17 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.875 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.523 ' HB2' ' CG2' ' B' ' 23' ' ' ILE . . . -135.14 122.92 22.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 108.962 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 7.4 m -89.66 100.16 13.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.955 -1.09 . . . . 0.0 109.392 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' B' ' 22' ' ' ASN . 60.4 mt -42.49 164.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.63 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.463 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 12.9 ptpt -82.79 9.8 9.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.708 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.468 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -113.94 19.62 16.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.23 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . 0.462 ' O ' ' HD2' ' B' ' 49' ' ' LYS . . . 87.62 -17.77 42.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.468 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 42.7 mtt180 -77.25 163.06 26.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -1.151 . . . . 0.0 109.405 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' B' ' 47' ' ' GLY . 0.0 OUTLIER -143.97 122.67 12.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.546 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.19 127.94 55.2 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.445 -0.784 . . . . 0.0 109.33 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' B' ' 41' ' ' ILE . 91.2 m -79.66 155.32 28.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.047 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.518 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 12.8 mt -135.18 170.92 15.18 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.152 -0.968 . . . . 0.0 109.744 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 15.4 p-10 -105.34 127.54 28.38 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.845 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.466 ' HA ' HG13 ' B' ' 59' ' ' VAL . 33.5 Cg_endo -75.04 -4.57 15.6 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.111 1.874 . . . . 0.0 110.308 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.45 -19.25 53.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.923 . . . . 0.0 108.761 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.477 ' HB3' ' OD1' ' B' ' 53' ' ' ASN . 0.0 OUTLIER -90.01 159.42 42.72 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.109 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.04 -32.25 3.31 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.578 2.185 . . . . 0.0 110.792 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 0.1 OUTLIER -69.45 -44.72 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.102 -0.999 . . . . 0.0 109.153 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.565 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 32.1 t -57.97 -46.94 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 109.177 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' B' ' 56' ' ' SER . 9.6 mtmt -60.49 -30.55 69.78 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.487 ' CE ' ' CD ' ' B' ' 64' ' ' GLU . 4.9 mmpt? -76.64 -23.61 53.32 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.541 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 19.2 mt -71.25 -37.25 65.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.52 HD12 ' CG1' ' B' ' 40' ' ' VAL . 2.3 mp -73.23 -58.09 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.876 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.487 ' CD ' ' CE ' ' B' ' 61' ' ' LYS . 5.6 pt-20 -59.33 -52.09 67.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.013 -1.054 . . . . 0.0 109.614 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 6.5 mtpp -46.39 -52.41 13.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 109.056 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.525 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.2 OUTLIER -49.41 -46.35 47.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.282 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.519 HD13 ' CG2' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -45.96 -52.05 12.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 0.0 109.41 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' B' ' 69' ' ' SER . 2.4 t30 -64.41 -33.6 76.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.855 . . . . 0.0 109.52 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 68' ' ' ASN . 4.9 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.46 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.52 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 93.2 m . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.505 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -42.76 -26.21 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.865 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.521 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 78.1 m -130.85 72.25 1.49 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.642 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.55 -44.3 8.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.937 . . . . 0.0 109.214 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.32 117.5 33.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.283 -0.886 . . . . 0.0 109.198 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.426 ' OG1' ' CG ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -103.09 156.43 17.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.697 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.465 ' HB2' HD22 ' A' ' 52' ' ' LEU . 5.5 mt -98.08 135.76 39.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.293 -0.879 . . . . 0.0 109.004 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 15' ' ' LEU . 1.1 tt0 -44.09 -26.79 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.952 . . . . 0.0 109.252 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.535 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 156.25 149.32 5.32 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.52 ' CG2' HD23 ' A' ' 52' ' ' LEU . 6.9 tt -128.34 149.97 33.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.375 -1.073 . . . . 0.0 108.883 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.447 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -43.64 146.37 0.98 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.257 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.447 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.2 Cg_endo -76.61 -13.03 18.32 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.435 2.09 . . . . 0.0 109.996 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.532 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 7.6 mttp -78.95 -15.42 58.32 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 44' ' ' LEU . 86.5 m-20 -100.43 54.75 0.89 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 22' ' ' ASN . 0.7 OUTLIER -146.08 163.33 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.039 -1.038 . . . . 0.0 110.35 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.544 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -153.02 -36.21 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.544 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 4.9 p -128.47 179.5 5.62 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 25' ' ' SER . 51.0 t -160.14 115.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.897 -1.127 . . . . 0.0 109.891 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 20.3 t-20 -104.87 153.3 21.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.951 . . . . 0.0 109.117 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.457 HG22 ' O ' ' B' ' 26' ' ' VAL . 2.6 t -143.67 91.82 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HD2' ' NE2' ' A' ' 10' ' ' GLN . 4.2 mttm -95.3 93.45 7.28 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 0.0 109.524 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 4.3 p -44.71 164.26 0.18 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 0.0 109.303 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.484 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.7 Cg_endo -77.78 131.87 11.54 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.648 2.232 . . . . 0.0 110.502 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.27 -138.48 3.28 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.22 7.98 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.562 2.175 . . . . 0.0 110.778 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.488 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 4.9 p-80 -126.86 -16.74 5.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.017 . . . . 0.0 109.883 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.17 125.23 3.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.024 -1.047 . . . . 0.0 109.229 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' O ' ' CD ' ' A' ' 37' ' ' GLN . . . -87.42 18.95 3.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.719 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.484 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 13.6 mm-40 -143.35 125.06 14.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.497 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 m -50.29 140.55 13.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.505 ' OE1' ' N ' ' A' ' 10' ' ' GLN . 8.5 mt-10 -117.66 106.83 13.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.654 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 54' ' ' PRO . 1.7 t -98.47 106.71 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 109.186 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.521 ' CG1' ' SG ' ' A' ' 11' ' ' CYS . 2.9 mp -94.74 157.31 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.224 -0.923 . . . . 0.0 109.83 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . . . -136.47 125.88 25.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.798 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.519 ' OG1' ' CD ' ' A' ' 49' ' ' LYS . 22.4 m -89.66 105.52 17.85 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.026 -1.046 . . . . 0.0 109.111 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 22' ' ' ASN . 82.9 mt -43.79 168.7 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.322 -0.861 . . . . 0.0 109.597 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.532 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.3 ptpt -90.16 17.52 6.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 109.35 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.517 ' OD1' ' CB ' ' A' ' 44' ' ' LEU . 19.6 p-10 -119.49 7.21 11.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.402 -0.812 . . . . 0.0 109.143 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.28 -17.9 54.91 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 8.8 mtt85 -83.73 171.97 12.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -1.185 . . . . 0.0 109.169 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.519 ' CD ' ' OG1' ' A' ' 43' ' ' THR . 9.9 mtmt -144.49 125.21 14.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 109.553 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.24 131.14 55.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.891 . . . . 0.0 109.132 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.458 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 61.7 m -79.74 140.21 37.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.186 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.543 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 12.5 mt -129.41 168.64 16.01 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.218 -0.926 . . . . 0.0 109.441 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.553 ' O ' ' CG2' ' A' ' 59' ' ' VAL . 1.8 m-20 -111.02 130.85 22.53 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.333 -0.854 . . . . 0.0 109.62 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.528 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 33.8 Cg_endo -75.26 -14.54 20.55 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.217 1.945 . . . . 0.0 110.21 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.91 -19.13 61.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.875 . . . . 0.0 108.879 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.03 163.16 33.06 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.493 -0.754 . . . . 0.0 109.206 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.14 -41.78 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.665 2.243 . . . . 0.0 110.635 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.535 ' CG2' ' HA3' ' A' ' 17' ' ' GLY . 11.7 mm -54.48 -55.48 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.154 -0.966 . . . . 0.0 109.411 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.553 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 89.1 t -54.48 -53.7 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.755 . . . . 0.0 110.053 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -45.81 -31.72 2.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.046 -1.034 . . . . 0.0 108.941 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.524 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -79.5 -38.32 34.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.52 -0.738 . . . . 0.0 109.6 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.8 mp -55.4 -41.88 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.164 -0.96 . . . . 0.0 108.811 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.588 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.1 mp -72.11 -65.78 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.353 -0.842 . . . . 0.0 109.49 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -42.23 -27.28 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.445 -0.784 . . . . 0.0 109.67 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -73.86 -49.31 25.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 108.93 179.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.457 ' HA ' ' HB3' ' A' ' 69' ' ' SER . 0.4 OUTLIER -55.14 -45.57 75.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.368 -0.832 . . . . 0.0 109.018 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.578 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 3.7 mt -53.56 -60.09 3.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.52 -0.738 . . . . 0.0 109.598 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -73.51 -3.98 31.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.632 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.457 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 4.1 p . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 109.393 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.525 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 94.5 m . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.509 ' N ' ' OE1' ' B' ' 39' ' ' GLU . 0.1 OUTLIER -42.77 -26.23 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.839 . . . . 0.0 109.866 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.517 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 78.2 m -130.78 72.2 1.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.621 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.55 -44.29 8.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.932 . . . . 0.0 109.147 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.32 117.5 33.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.29 -0.881 . . . . 0.0 109.275 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.426 ' OG1' ' CG ' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -103.09 156.44 17.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.865 . . . . 0.0 109.641 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.463 ' HB2' HD22 ' B' ' 52' ' ' LEU . 5.6 mt -98.04 135.77 39.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.79 . . . . 0.0 109.05 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' B' ' 15' ' ' LEU . 1.1 tt0 -44.07 -26.78 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 109.313 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.53 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 156.21 149.23 5.3 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.527 ' CG2' HD23 ' B' ' 52' ' ' LEU . 6.9 tt -128.25 150.03 33.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.511 -0.994 . . . . 0.0 108.803 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.449 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -43.74 146.41 1.01 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.945 . . . . 0.0 109.289 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.449 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.4 Cg_endo -76.6 -13.03 18.34 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.424 2.083 . . . . 0.0 109.991 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.534 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 7.6 mttp -78.93 -15.42 58.33 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.531 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 86.5 m-20 -100.46 54.8 0.88 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.515 ' CD1' ' O ' ' B' ' 22' ' ' ASN . 0.7 OUTLIER -146.11 163.41 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.032 -1.042 . . . . 0.0 110.337 -179.359 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.563 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -153.08 -36.26 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.563 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 5.0 p -128.41 179.52 5.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' B' ' 25' ' ' SER . 51.4 t -160.11 115.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.786 -1.196 . . . . 0.0 109.99 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 20.4 t-20 -104.83 153.31 21.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 109.097 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 25' ' ' SER . 2.6 t -143.71 91.83 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 109.654 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.431 ' HD2' ' CD ' ' B' ' 10' ' ' GLN . 4.3 mttm -95.3 93.43 7.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 4.3 p -44.7 164.21 0.18 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.843 . . . . 0.0 109.301 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.479 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.7 Cg_endo -77.77 131.96 11.6 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.592 2.195 . . . . 0.0 110.527 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.26 -138.5 3.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.27 8.09 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.498 2.132 . . . . 0.0 110.782 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.484 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 5.0 p-80 -126.92 -16.79 5.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.063 -1.023 . . . . 0.0 109.849 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -160.12 125.21 3.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.075 -1.016 . . . . 0.0 109.278 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.419 ' O ' ' CD ' ' B' ' 37' ' ' GLN . . . -87.41 18.9 3.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.674 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.479 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 13.4 mm-40 -143.31 124.97 14.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.961 . . . . 0.0 109.558 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.5 m -50.26 140.65 12.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.937 . . . . 0.0 109.255 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' B' ' 10' ' ' GLN . 8.5 mt-10 -117.76 106.81 13.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 109.619 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.531 ' CG2' ' HB3' ' B' ' 54' ' ' PRO . 1.7 t -98.5 106.76 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.166 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.517 ' CG1' ' SG ' ' B' ' 11' ' ' CYS . 2.9 mp -94.77 157.29 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.872 . . . . 0.0 109.803 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.417 ' HB2' ' CG2' ' B' ' 23' ' ' ILE . . . -136.38 125.85 25.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 108.866 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.519 ' OG1' ' CD ' ' B' ' 49' ' ' LYS . 22.4 m -89.68 105.57 17.89 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.958 -1.089 . . . . 0.0 109.151 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 82.4 mt -43.83 168.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.312 -0.868 . . . . 0.0 109.583 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.534 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.2 ptpt -90.15 17.49 6.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.525 ' OD1' ' CB ' ' B' ' 44' ' ' LEU . 19.5 p-10 -119.42 7.23 11.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.22 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.3 -17.97 54.73 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' B' ' 49' ' ' LYS . 8.8 mtt85 -83.73 171.95 12.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 109.15 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.519 ' CD ' ' OG1' ' B' ' 43' ' ' THR . 10.0 mtmt -144.42 125.21 14.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.509 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.27 131.18 55.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.163 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 61.7 m -79.83 140.2 36.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -0.979 . . . . 0.0 109.186 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.546 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 12.5 mt -129.41 168.63 16.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.218 -0.926 . . . . 0.0 109.378 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.55 ' O ' ' CG2' ' B' ' 59' ' ' VAL . 1.8 m-20 -110.94 130.91 22.45 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.587 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.531 ' HB3' ' CG2' ' B' ' 40' ' ' VAL . 33.7 Cg_endo -75.31 -14.56 20.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.312 2.008 . . . . 0.0 110.248 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.99 -19.11 61.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 108.829 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.465 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -89.91 163.09 33.61 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.152 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.16 -41.76 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.59 2.193 . . . . 0.0 110.632 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.53 ' CG2' ' HA3' ' B' ' 17' ' ' GLY . 11.7 mm -54.46 -55.54 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.351 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' B' ' 53' ' ' ASN . 90.0 t -54.46 -53.67 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.528 -0.732 . . . . 0.0 110.054 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 0.4 OUTLIER -45.86 -31.66 2.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.028 -1.045 . . . . 0.0 108.966 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.522 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -79.57 -38.27 34.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 109.647 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.8 mp -55.32 -41.85 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 108.856 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.578 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.1 mp -72.17 -65.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -42.14 -27.26 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -73.82 -49.37 25.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 108.947 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.463 ' O ' ' HB3' ' B' ' 69' ' ' SER . 0.4 OUTLIER -55.18 -45.53 75.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.415 -0.803 . . . . 0.0 109.002 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 3.7 mt -53.67 -60.07 3.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.734 . . . . 0.0 109.52 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -73.51 -3.93 30.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.686 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.463 ' HB3' ' O ' ' B' ' 66' ' ' MET . 4.1 p . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 109.455 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.464 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.486 ' HG3' ' CB ' ' A' ' 29' ' ' LYS . 56.6 mm-40 -42.08 -27.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.791 . . . . 0.0 109.842 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.445 ' SG ' HG13 ' A' ' 41' ' ' ILE . 81.1 m -146.04 72.04 1.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.162 -0.961 . . . . 0.0 109.61 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.464 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -44.07 -45.65 8.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.068 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -110.13 120.87 43.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.414 -0.804 . . . . 0.0 109.072 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -105.99 161.43 14.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.236 -0.915 . . . . 0.0 109.986 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 51' ' ' CYS . 3.1 mt -108.66 143.08 38.21 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 15' ' ' LEU . 2.4 tt0 -44.9 -26.54 0.42 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.061 -1.025 . . . . 0.0 109.065 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.444 ' HA2' HG21 ' A' ' 59' ' ' VAL . . . 152.37 177.65 26.25 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.522 ' O ' ' CG1' ' A' ' 62' ' ' ILE . 6.4 tp -148.56 159.99 6.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.42 -1.047 . . . . 0.0 109.071 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.575 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.5 t-80 -50.2 144.23 11.63 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.243 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.575 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.37 -22.66 10.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.504 2.136 . . . . 0.0 110.264 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.27 -15.2 31.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -0.871 . . . . 0.0 109.108 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.569 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 95.0 m-20 -79.55 -11.89 59.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.317 -0.865 . . . . 0.0 109.455 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.475 HG22 ' CB ' ' A' ' 42' ' ' ALA . 4.3 mt -101.0 155.55 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.308 -0.87 . . . . 0.0 110.422 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.543 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -124.5 -30.04 3.41 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.543 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -132.02 169.05 16.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 108.855 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.526 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 49.9 t -139.45 111.2 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 109.801 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.447 ' O ' ' CD1' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -106.15 110.99 23.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.158 179.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -113.8 106.36 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.655 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.486 ' CB ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -97.25 94.81 7.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.222 -0.924 . . . . 0.0 109.319 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.1 p -45.2 169.25 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.479 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 35.6 Cg_endo -77.84 132.15 11.67 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.582 2.188 . . . . 0.0 110.408 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.84 -140.29 4.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.06 41.61 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.718 2.278 . . . . 0.0 110.708 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.438 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 9.7 p-80 -161.93 -38.1 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.053 -1.029 . . . . 0.0 109.244 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 6.2 t -135.82 112.78 10.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.285 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 31' ' ' PRO . . . -71.45 -32.06 67.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 109.646 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.437 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 2.5 mm-40 -87.63 130.51 34.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.586 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.2 m -53.31 142.97 19.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.38 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.465 ' CB ' ' HB2' ' A' ' 10' ' ' GLN . 30.6 mm-40 -117.46 107.33 14.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.568 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.494 HG22 ' CG ' ' A' ' 54' ' ' PRO . 9.5 t -92.48 148.32 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.511 HG21 ' N ' ' A' ' 42' ' ' ALA . 3.5 mp -140.6 153.87 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 0.0 109.7 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.511 ' N ' HG21 ' A' ' 41' ' ' ILE . . . -137.5 121.93 18.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.418 -0.801 . . . . 0.0 109.215 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.485 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 1.2 m -89.29 98.99 12.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.998 -1.064 . . . . 0.0 108.783 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 73.7 mt -41.78 165.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.434 0.635 . . . . 0.0 109.919 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 13.9 ptpt -81.22 7.87 10.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.811 . . . . 0.0 109.745 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.465 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.25 16.27 21.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.391 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.49 3.75 88.24 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.465 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 2.4 mtp-105 -94.04 174.95 6.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -1.158 . . . . 0.0 109.562 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -141.24 152.96 44.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.29 120.45 7.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 108.889 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.425 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 33.0 m -79.7 140.35 37.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.488 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.527 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 14.7 mt -126.36 166.94 16.24 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.38 -0.825 . . . . 0.0 108.899 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -101.52 123.94 42.61 Favored Pre-proline 0 C--N 1.299 -1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.386 -179.607 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.494 ' CG ' HG22 ' A' ' 40' ' ' VAL . 33.8 Cg_endo -75.03 -9.89 20.93 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.152 1.901 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.43 -14.14 57.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 108.862 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -89.69 162.22 36.75 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.325 179.824 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.0 Cg_endo -77.56 -39.93 0.48 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.63 2.22 . . . . 0.0 110.626 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 32.4 mt -61.13 -51.86 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.973 . . . . 0.0 109.17 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.537 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 54.4 t -53.48 -52.03 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.511 -0.743 . . . . 0.0 109.762 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 6.9 mmtt -50.14 -33.22 18.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.077 -1.015 . . . . 0.0 108.813 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 57' ' ' PRO . 2.5 mmpt? -74.36 -36.02 63.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.448 -0.783 . . . . 0.0 109.26 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -61.53 -41.14 89.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.419 -0.801 . . . . 0.0 109.079 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.539 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -69.68 -68.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 0.0 109.766 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -43.82 -33.75 1.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 0.0 109.6 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 69' ' ' SER . 10.7 mmtm -66.07 -59.12 4.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.169 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.526 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -44.4 -45.7 9.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.051 179.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.55 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 1.9 mt -56.88 -56.38 22.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.501 -0.749 . . . . 0.0 109.4 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -85.91 13.64 7.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 65' ' ' LYS . 93.7 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.461 ' HA ' ' HB2' ' B' ' 35' ' ' CYS . 1.8 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.496 ' HG3' ' CB ' ' B' ' 29' ' ' LYS . 56.7 mm-40 -41.91 -27.53 0.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.46 -0.775 . . . . 0.0 109.829 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.448 ' SG ' HG13 ' B' ' 41' ' ' ILE . 80.7 m -145.98 72.04 1.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.661 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.3 OUTLIER -44.12 -45.57 8.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.092 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -110.1 121.0 44.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 109.047 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.469 HG23 ' O ' ' B' ' 52' ' ' LEU . 0.5 OUTLIER -106.06 161.46 14.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.221 -0.925 . . . . 0.0 109.897 -179.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' B' ' 16' ' ' GLN . 3.1 mt -108.76 143.19 38.24 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' B' ' 15' ' ' LEU . 2.4 tt0 -44.95 -26.46 0.42 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.994 . . . . 0.0 109.116 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.452 ' HA2' HG21 ' B' ' 59' ' ' VAL . . . 152.3 177.66 26.2 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.52 ' O ' ' CG1' ' B' ' 62' ' ' ILE . 6.4 tp -148.51 160.06 6.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.434 -1.039 . . . . 0.0 109.029 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.579 ' CB ' ' ND2' ' B' ' 22' ' ' ASN . 1.5 t-80 -50.29 144.22 11.93 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.086 -1.009 . . . . 0.0 109.141 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.578 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -77.46 -22.53 10.73 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.483 2.122 . . . . 0.0 110.237 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.465 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.23 -15.36 31.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.36 -0.837 . . . . 0.0 109.096 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.579 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 95.0 m-20 -79.52 -11.87 59.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' B' ' 44' ' ' LEU . 4.3 mt -101.01 155.55 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 110.406 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -124.58 -30.0 3.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.325 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.553 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -132.02 169.04 16.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 108.912 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.524 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 50.3 t -139.46 111.3 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.013 . . . . 0.0 109.836 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.435 ' O ' ' CD1' ' B' ' 41' ' ' ILE . 0.1 OUTLIER -106.14 110.93 23.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.149 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.8 t -113.77 106.37 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.696 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.496 ' CB ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -97.25 94.74 7.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.44 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.1 p -45.13 169.23 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.452 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.8 Cg_endo -77.77 132.17 11.75 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.562 2.175 . . . . 0.0 110.46 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.85 -140.35 4.02 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.12 41.68 1.17 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.69 2.26 . . . . 0.0 110.679 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.446 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 9.6 p-80 -161.9 -38.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.142 -0.974 . . . . 0.0 109.324 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 6.3 t -135.82 112.81 10.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.276 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' B' ' 31' ' ' PRO . . . -71.56 -32.03 67.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.611 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.426 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 2.5 mm-40 -87.68 130.65 34.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.486 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 62.4 m -53.47 143.06 20.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.353 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.462 ' CB ' ' HB2' ' B' ' 10' ' ' GLN . 30.4 mm-40 -117.47 107.38 14.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.635 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.489 HG22 ' CG ' ' B' ' 54' ' ' PRO . 9.7 t -92.51 148.35 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.894 . . . . 0.0 109.267 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.494 HG21 ' N ' ' B' ' 42' ' ' ALA . 3.5 mp -140.65 153.83 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.961 . . . . 0.0 109.679 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.494 ' N ' HG21 ' B' ' 41' ' ' ILE . . . -137.42 121.97 18.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.356 -0.84 . . . . 0.0 109.186 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.485 ' O ' ' HG3' ' B' ' 24' ' ' GLN . 1.2 m -89.31 99.01 12.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.976 -1.077 . . . . 0.0 108.78 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.473 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 73.9 mt -41.82 164.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.565 -0.709 . . . . 0.0 109.981 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 13.9 ptpt -81.18 7.89 10.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 0.0 109.775 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -111.25 16.16 21.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.384 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.5 3.78 88.21 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.48 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 2.4 mtp-105 -94.05 174.93 6.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.5 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -141.23 152.89 44.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 0.0 109.501 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.22 120.43 7.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 108.959 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.432 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 33.0 m -79.66 140.24 37.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.125 -0.984 . . . . 0.0 109.46 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.518 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 14.7 mt -126.29 166.99 16.1 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.4 -0.812 . . . . 0.0 108.924 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.54 ' N ' HG23 ' B' ' 59' ' ' VAL . 0.7 OUTLIER -101.49 123.94 42.67 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.489 ' CG ' HG22 ' B' ' 40' ' ' VAL . 33.8 Cg_endo -75.02 -9.99 20.98 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.177 1.918 . . . . 0.0 110.244 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.29 -14.18 57.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.268 -0.895 . . . . 0.0 108.944 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.2 OUTLIER -89.65 162.15 37.04 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.432 -0.793 . . . . 0.0 109.323 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.439 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 35.9 Cg_endo -77.53 -39.87 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.636 2.224 . . . . 0.0 110.658 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' B' ' 62' ' ' ILE . 32.4 mt -61.14 -51.87 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 109.118 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.54 HG23 ' N ' ' B' ' 53' ' ' ASN . 54.5 t -53.53 -52.03 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.509 -0.744 . . . . 0.0 109.746 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' B' ' 56' ' ' SER . 6.9 mmtt -50.13 -33.18 17.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 108.844 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' B' ' 57' ' ' PRO . 2.5 mmpt? -74.34 -36.08 63.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.6 -0.688 . . . . 0.0 109.303 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -61.5 -41.13 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.38 -0.825 . . . . 0.0 109.048 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.55 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -69.76 -69.0 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.643 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -43.67 -33.71 1.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.137 -0.977 . . . . 0.0 109.671 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' B' ' 69' ' ' SER . 10.7 mmtm -66.14 -59.22 3.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.102 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.524 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.6 OUTLIER -44.37 -45.68 8.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.832 . . . . 0.0 109.097 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.539 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 1.9 mt -56.88 -56.27 23.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.394 -0.816 . . . . 0.0 109.48 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -85.95 13.5 7.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.506 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.482 ' N ' ' O ' ' B' ' 65' ' ' LYS . 93.0 p . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.507 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 18.0 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.454 ' HB2' ' HD2' ' A' ' 29' ' ' LYS . 21.4 mm-40 -42.68 -26.53 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.365 -0.835 . . . . 0.0 109.773 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.462 ' HB2' ' HG2' ' A' ' 39' ' ' GLU . 73.5 m -122.38 58.33 1.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.962 . . . . 0.0 109.777 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.64 4.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 108.839 179.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -123.94 123.56 40.67 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -97.99 172.87 7.35 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.185 -0.947 . . . . 0.0 110.243 -179.273 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 16' ' ' GLN . 4.5 mt -128.85 143.11 50.81 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.526 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.7 tt0 -44.4 -44.73 8.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.519 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 142.28 161.42 8.76 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.538 ' CD1' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -130.76 156.54 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -1.093 . . . . 0.0 109.137 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.564 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -43.23 150.82 0.46 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.321 -0.862 . . . . 0.0 109.291 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -76.54 -0.51 10.52 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.472 2.115 . . . . 0.0 110.12 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HG3' ' N ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER -90.03 -27.12 19.93 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.265 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.57 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 8.9 m-20 -84.97 6.0 26.9 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.467 ' CG1' ' HA ' ' A' ' 20' ' ' PRO . 2.5 mm -94.26 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.936 . . . . 0.0 110.552 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.473 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.5 OUTLIER -154.54 -41.5 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.468 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 1.3 p -135.73 174.59 10.44 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.523 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 52.7 t -150.3 89.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.949 -1.094 . . . . 0.0 109.962 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 3.2 t-20 -79.67 105.49 11.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.23 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -98.49 91.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.527 ' HE3' ' CD1' ' A' ' 41' ' ' ILE . 1.3 ptpm? -98.23 112.5 24.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.366 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.421 ' OG ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -63.99 171.2 2.65 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.253 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.517 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.8 Cg_endo -77.98 130.91 10.67 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.626 2.218 . . . . 0.0 110.412 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.11 -144.56 5.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.87 5.48 4.88 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.546 2.164 . . . . 0.0 110.545 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -123.14 -11.54 8.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 0.0 109.595 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' OE2' ' A' ' 39' ' ' GLU . 7.9 t -160.14 118.8 2.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.382 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.68 29.56 1.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.559 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.517 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 17.8 mm-40 -141.93 127.97 19.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.522 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -53.37 152.29 4.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.335 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 37' ' ' GLN . 2.4 mp0 -138.32 112.0 8.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.681 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.524 ' CG1' HD12 ' A' ' 63' ' ' ILE . 1.6 t -103.64 90.59 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.227 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.527 ' CD1' ' HE3' ' A' ' 29' ' ' LYS . 3.5 mt -79.9 144.01 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.961 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.471 ' N ' HG21 ' A' ' 41' ' ' ILE . . . -124.13 120.48 32.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.418 -0.801 . . . . 0.0 108.864 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 9.0 m -89.22 101.21 13.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.92 -1.113 . . . . 0.0 109.071 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.57 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 81.4 mt -46.28 167.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.366 -0.834 . . . . 0.0 109.573 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.472 ' HA ' ' HG3' ' A' ' 24' ' ' GLN . 14.6 ptpt -83.79 9.95 10.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -111.37 16.71 20.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.93 . . . . 0.0 109.372 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.89 6.92 87.94 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.513 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 45.8 mtt-85 -99.37 168.81 9.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -1.151 . . . . 0.0 109.429 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -135.63 155.95 49.63 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.4 120.16 7.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 109.178 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 11.1 m -79.15 138.95 38.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.027 -1.045 . . . . 0.0 108.537 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.538 HD23 ' CD1' ' A' ' 18' ' ' ILE . 11.6 mt -119.55 167.47 11.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 4.7 t-20 -98.76 119.72 60.52 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.72 -3.92 14.63 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.052 1.834 . . . . 0.0 110.269 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.27 -13.0 42.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 108.823 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.47 ' OG ' HG22 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -89.91 161.24 38.97 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.839 . . . . 0.0 109.371 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.71 -35.52 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.7 2.266 . . . . 0.0 110.714 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 16' ' ' GLN . 9.2 tt -67.73 -44.3 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 109.296 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.549 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 31.2 t -58.57 -47.1 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.533 -0.729 . . . . 0.0 109.161 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 8.9 mttt -59.22 -30.32 68.16 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -79.36 -23.54 43.29 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 16.5 mt -71.22 -38.1 68.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.535 -0.728 . . . . 0.0 109.056 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.583 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -73.84 -55.86 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 109.284 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -59.9 -28.34 67.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.95 . . . . 0.0 109.35 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.512 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -70.08 -43.28 71.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 108.978 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.523 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -60.24 -46.04 91.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.085 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.578 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.7 OUTLIER -48.72 -54.71 13.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.45 -0.781 . . . . 0.0 109.511 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' SER . 17.1 t-20 -68.11 -23.25 64.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 109.614 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 68' ' ' ASN . 9.9 p . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.509 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.516 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 17.9 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.447 ' HB2' ' HD2' ' B' ' 29' ' ' LYS . 21.3 mm-40 -42.63 -26.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.356 -0.84 . . . . 0.0 109.78 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.456 ' HB2' ' HG2' ' B' ' 39' ' ' GLU . 73.6 m -122.39 58.35 1.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.516 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.63 4.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 108.925 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -123.95 123.63 40.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.412 HG23 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -98.04 172.82 7.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.232 -0.917 . . . . 0.0 110.212 -179.259 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' B' ' 16' ' ' GLN . 4.5 mt -128.77 143.14 50.84 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.53 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.7 tt0 -44.32 -44.88 8.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.096 -1.003 . . . . 0.0 109.1 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.525 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 142.29 161.37 8.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.536 ' CD1' HD23 ' B' ' 52' ' ' LEU . 0.1 OUTLIER -130.67 156.58 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.373 -1.075 . . . . 0.0 109.171 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.568 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -43.38 150.82 0.48 Allowed Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.258 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.568 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.5 Cg_endo -76.43 -0.59 10.57 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.434 2.089 . . . . 0.0 110.181 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -89.98 -27.21 19.93 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.574 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 9.0 m-20 -84.84 5.91 26.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.474 HG13 ' HA ' ' B' ' 20' ' ' PRO . 2.5 mm -94.14 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.869 . . . . 0.0 110.506 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.468 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.5 OUTLIER -154.59 -41.51 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.195 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.459 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 1.3 p -135.71 174.63 10.41 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.525 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 52.9 t -150.23 89.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.924 -1.11 . . . . 0.0 109.941 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 3.2 t-20 -79.78 105.38 11.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.192 -0.942 . . . . 0.0 109.242 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.9 t -98.49 91.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.52 ' HE3' ' CD1' ' B' ' 41' ' ' ILE . 1.3 ptpm? -98.21 112.46 24.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 109.373 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.427 ' OG ' ' HD2' ' B' ' 31' ' ' PRO . 0.0 OUTLIER -63.8 171.09 2.59 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.327 -0.858 . . . . 0.0 109.381 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.517 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.1 Cg_endo -77.97 130.87 10.67 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.606 2.204 . . . . 0.0 110.478 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.02 -144.6 5.77 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.81 5.45 4.87 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.553 2.169 . . . . 0.0 110.586 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -123.18 -11.47 7.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.559 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 7.8 t -160.18 118.73 2.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.68 29.47 1.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.584 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.517 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 17.9 mm-40 -141.89 128.01 19.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.208 -0.933 . . . . 0.0 109.566 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -53.27 152.33 4.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.896 . . . . 0.0 109.396 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' B' ' 37' ' ' GLN . 2.4 mp0 -138.39 111.9 8.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -0.961 . . . . 0.0 109.695 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.531 ' CG1' HD12 ' B' ' 63' ' ' ILE . 1.6 t -103.59 90.64 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.163 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.52 ' CD1' ' HE3' ' B' ' 29' ' ' LYS . 3.5 mt -79.94 144.0 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.897 . . . . 0.0 109.957 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.457 ' N ' HG21 ' B' ' 41' ' ' ILE . . . -124.16 120.49 32.46 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 9.1 m -89.21 101.26 13.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.908 -1.12 . . . . 0.0 109.128 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.574 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 81.3 mt -46.33 167.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.388 -0.82 . . . . 0.0 109.587 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.6 ptpt -83.88 10.05 10.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -111.37 16.69 20.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.349 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.86 7.02 87.85 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.512 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 45.8 mtt-85 -99.45 168.85 9.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -1.163 . . . . 0.0 109.432 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -135.63 155.99 49.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.41 120.21 7.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.337 -0.852 . . . . 0.0 109.118 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 11.1 m -79.14 138.9 38.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.042 -1.037 . . . . 0.0 108.579 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.536 HD23 ' CD1' ' B' ' 18' ' ' ILE . 11.5 mt -119.41 167.49 11.88 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.236 -0.915 . . . . 0.0 109.856 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 4.7 t-20 -98.84 119.7 60.45 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.55 -0.719 . . . . 0.0 109.061 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.64 -3.92 14.62 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.05 1.834 . . . . 0.0 110.319 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.34 -12.86 42.22 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.317 -0.864 . . . . 0.0 108.901 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.464 ' OG ' HG22 ' B' ' 59' ' ' VAL . 1.0 OUTLIER -90.0 161.23 38.73 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.299 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.446 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.0 Cg_endo -77.77 -35.54 1.44 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.649 2.232 . . . . 0.0 110.697 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.531 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 9.2 tt -67.69 -44.31 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.31 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.551 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 31.6 t -58.54 -47.05 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.466 -0.771 . . . . 0.0 109.178 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 8.9 mttt -59.21 -30.36 68.17 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.496 ' O ' ' CG ' ' B' ' 65' ' ' LYS . 0.0 OUTLIER -79.28 -23.59 43.49 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.515 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 16.4 mt -71.24 -38.06 68.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.506 -0.746 . . . . 0.0 109.081 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.578 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -73.82 -55.85 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.366 -0.833 . . . . 0.0 109.336 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.517 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.3 OUTLIER -59.85 -28.39 67.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 109.379 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.517 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 0.1 OUTLIER -70.08 -43.21 71.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.002 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.525 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.6 OUTLIER -60.35 -45.91 91.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 109.072 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.583 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -48.78 -54.73 13.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.445 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' B' ' 69' ' ' SER . 17.2 t-20 -68.15 -23.28 64.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.425 ' C ' ' O ' ' B' ' 68' ' ' ASN . 9.9 p . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.525 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.467 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -45.53 -24.84 0.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 12' ' ' LEU . 60.8 m -148.7 71.16 1.14 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.082 -1.011 . . . . 0.0 109.822 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.467 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.04 -45.87 11.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 108.948 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -115.27 119.69 37.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.443 -0.786 . . . . 0.0 108.961 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -97.45 163.51 12.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.193 -0.942 . . . . 0.0 110.011 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.4 mt -115.17 146.26 41.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.487 -0.758 . . . . 0.0 108.981 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.9 tt0 -44.22 -46.91 9.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.339 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.516 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 156.03 -164.82 32.49 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.46 HG13 HD23 ' A' ' 52' ' ' LEU . 1.2 pp -170.26 162.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.436 -1.038 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.604 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 13.0 t60 -44.8 144.58 1.83 Allowed Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.604 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.6 Cg_endo -77.76 -13.93 15.91 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.29 1.994 . . . . 0.0 109.889 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' CE ' ' HG2' ' A' ' 20' ' ' PRO . 1.9 mmpt? -90.86 -19.87 22.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.401 -0.812 . . . . 0.0 108.861 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 5.2 m-20 -78.61 -12.96 60.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.237 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.518 HG22 ' CB ' ' A' ' 42' ' ' ALA . 12.0 mt -91.93 165.89 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.981 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -131.88 -41.96 1.02 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.8 p -125.11 173.49 8.69 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.528 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 48.3 t -144.33 95.53 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.01 -1.056 . . . . 0.0 109.694 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.46 ' O ' HD13 ' A' ' 41' ' ' ILE . 5.3 t-20 -96.83 112.4 24.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.406 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.428 ' CG1' HG21 ' A' ' 40' ' ' VAL . 1.8 t -115.6 102.65 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 109.597 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -94.35 110.92 22.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.394 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.67 165.36 0.73 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.424 ' HB3' ' C ' ' A' ' 37' ' ' GLN . 35.8 Cg_endo -78.12 136.43 14.57 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.61 2.207 . . . . 0.0 110.419 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.67 -145.3 4.59 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.19 7.41 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.633 2.222 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.413 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 11.5 p-80 -124.32 -7.73 7.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.628 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.9 t -160.1 117.35 2.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 109.449 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.15 45.71 1.2 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.594 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.463 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 1.6 pt20 -171.11 140.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.474 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.457 ' HB ' ' CG ' ' A' ' 54' ' ' PRO . 1.4 m -60.64 145.19 50.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 109.368 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.463 ' OE2' ' O ' ' A' ' 37' ' ' GLN . 0.7 OUTLIER -127.3 107.4 9.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.582 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.508 HG11 ' N ' ' A' ' 41' ' ' ILE . 32.0 t -93.09 151.82 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.207 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.508 ' N ' HG11 ' A' ' 40' ' ' VAL . 2.5 mp -140.19 146.61 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.067 -1.021 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.518 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -133.87 119.16 18.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.416 -0.802 . . . . 0.0 109.08 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 6.8 m -89.39 97.51 11.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.944 -1.098 . . . . 0.0 109.131 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 87.0 mt -43.13 166.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.477 -0.765 . . . . 0.0 109.731 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.8 ptpt -82.56 9.84 8.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 109.704 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -113.69 27.69 9.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.143 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.29 6.21 64.68 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 40.5 mtt180 -96.23 160.99 14.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -1.188 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.57 150.23 48.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.177 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.21 124.73 9.64 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.213 -0.929 . . . . 0.0 109.191 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.453 ' SG ' HG13 ' A' ' 41' ' ' ILE . 15.7 m -79.51 148.08 31.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.104 -0.997 . . . . 0.0 109.225 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.526 ' O ' ' CG2' ' A' ' 14' ' ' THR . 15.7 mt -122.76 167.22 13.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.271 -0.893 . . . . 0.0 109.329 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.534 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 3.0 t-20 -98.86 119.45 61.0 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.152 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.457 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 32.9 Cg_endo -74.87 -6.12 17.71 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.137 1.891 . . . . 0.0 110.23 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.95 -14.69 46.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 108.886 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -90.0 160.7 40.02 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.398 -0.813 . . . . 0.0 109.355 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.8 -34.39 1.84 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.627 2.218 . . . . 0.0 110.686 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 2.7 tt -66.5 -46.67 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.138 -0.976 . . . . 0.0 109.09 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.54 ' N ' ' CG2' ' A' ' 58' ' ' ILE . 38.1 t -57.02 -48.2 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.403 -0.81 . . . . 0.0 109.023 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -55.23 -31.28 61.36 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 2.8 mmpt? -76.23 -30.62 57.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -65.48 -44.65 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.346 -0.846 . . . . 0.0 108.936 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.578 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -66.82 -61.78 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.489 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -52.67 -27.7 18.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.481 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.516 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 13.9 mttt -71.43 -43.03 67.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.197 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.528 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -61.8 -47.13 86.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.31 -0.869 . . . . 0.0 109.185 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.589 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.75 -50.89 9.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -69.32 -31.32 69.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.498 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.508 -179.99 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.45 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -45.55 -24.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 109.698 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.429 ' O ' ' C ' ' B' ' 12' ' ' LEU . 60.7 m -148.7 71.11 1.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.086 -1.009 . . . . 0.0 109.884 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.94 -45.94 10.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.007 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -115.24 119.61 36.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.461 -0.775 . . . . 0.0 108.954 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.6 OUTLIER -97.31 163.6 12.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 110.014 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' B' ' 16' ' ' GLN . 7.4 mt -115.27 146.2 41.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.479 -0.763 . . . . 0.0 108.949 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.522 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.9 tt0 -44.16 -46.88 9.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.527 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 155.99 -164.94 32.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.467 HG13 HD23 ' B' ' 52' ' ' LEU . 1.2 pp -170.19 162.77 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.399 -1.059 . . . . 0.0 109.503 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.597 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 12.8 t60 -44.75 144.6 1.8 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -77.78 -13.99 15.85 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.347 2.031 . . . . 0.0 109.87 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.516 ' CE ' ' HG2' ' B' ' 20' ' ' PRO . 1.9 mmpt? -90.77 -19.96 22.91 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.487 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 5.1 m-20 -78.63 -12.92 60.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 0.0 109.234 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.52 HG22 ' CB ' ' B' ' 42' ' ' ALA . 12.0 mt -91.96 165.91 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.276 -0.89 . . . . 0.0 109.982 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.0 OUTLIER -131.92 -41.87 1.02 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.496 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 3.7 p -125.25 173.45 8.79 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.524 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 48.7 t -144.26 95.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.077 -1.014 . . . . 0.0 109.728 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.451 ' HB3' HD11 ' B' ' 41' ' ' ILE . 5.3 t-20 -96.95 112.39 24.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 0.0 109.392 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.417 ' CG1' HG21 ' B' ' 40' ' ' VAL . 1.8 t -115.64 102.62 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.56 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -94.34 110.93 22.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.7 165.34 0.74 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.457 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.416 ' HB3' ' C ' ' B' ' 37' ' ' GLN . 35.7 Cg_endo -78.04 136.45 14.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.629 2.219 . . . . 0.0 110.451 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.66 -145.24 4.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.22 7.41 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.738 2.292 . . . . 0.0 110.746 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.415 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 11.7 p-80 -124.43 -7.66 7.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.9 t -160.13 117.29 2.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.357 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.18 45.72 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.476 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.448 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 1.6 pt20 -171.14 140.93 1.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 109.528 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.462 ' HB ' ' CG ' ' B' ' 54' ' ' PRO . 1.4 m -60.58 145.09 50.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.448 ' OE2' ' O ' ' B' ' 37' ' ' GLN . 0.7 OUTLIER -127.23 107.32 9.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.499 HG11 ' N ' ' B' ' 41' ' ' ILE . 31.5 t -92.99 151.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.257 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.499 ' N ' HG11 ' B' ' 40' ' ' VAL . 2.6 mp -140.15 146.57 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.788 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.52 ' CB ' HG22 ' B' ' 23' ' ' ILE . . . -133.91 119.16 18.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 109.073 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 6.7 m -89.32 97.49 11.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.924 -1.11 . . . . 0.0 109.17 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.487 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 86.9 mt -43.13 166.14 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.507 -0.746 . . . . 0.0 109.673 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.8 ptpt -82.56 9.95 8.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -0.823 . . . . 0.0 109.676 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -113.77 27.75 9.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.324 -0.86 . . . . 0.0 109.152 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.3 6.16 64.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 40.6 mtt180 -96.23 161.03 14.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.171 -1.193 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.506 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.62 150.25 48.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.154 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . 0.409 ' HB2' HD11 ' B' ' 15' ' ' LEU . . . -150.21 124.71 9.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.35 -0.844 . . . . 0.0 109.137 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.456 ' SG ' HG13 ' B' ' 41' ' ' ILE . 15.6 m -79.49 148.08 31.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.124 -0.985 . . . . 0.0 109.184 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.527 ' CD2' ' HA2' ' B' ' 17' ' ' GLY . 15.9 mt -122.88 167.2 13.85 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.538 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 3.0 t-20 -98.82 119.38 61.23 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.163 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.462 ' CG ' ' HB ' ' B' ' 38' ' ' THR . 33.4 Cg_endo -74.66 -6.31 18.04 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.182 1.921 . . . . 0.0 110.304 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.93 -14.68 46.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.36 -0.838 . . . . 0.0 108.846 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -90.02 160.75 39.89 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.288 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.85 -34.35 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.582 2.188 . . . . 0.0 110.709 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.552 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 2.7 tt -66.49 -46.65 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.108 -0.995 . . . . 0.0 109.136 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.552 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 38.1 t -57.1 -48.08 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.017 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.1 OUTLIER -55.28 -31.3 61.49 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' B' ' 65' ' ' LYS . 2.8 mmpt? -76.16 -30.6 58.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.591 -0.693 . . . . 0.0 109.391 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -65.46 -44.7 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.353 -0.842 . . . . 0.0 108.987 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.589 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -66.69 -61.8 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.1 OUTLIER -52.73 -27.72 18.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.462 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.519 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 13.9 mttt -71.38 -43.0 67.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 109.236 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.524 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -61.81 -47.11 86.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.378 -0.826 . . . . 0.0 109.248 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.578 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.7 -50.91 9.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.504 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -69.32 -31.28 69.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.486 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.918 . . . . 0.0 109.523 179.991 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.446 ' HB3' ' OE2' ' A' ' 39' ' ' GLU . 17.2 m . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.469 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 45.2 mm-40 -40.69 -39.89 1.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.482 -0.761 . . . . 0.0 109.756 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 10' ' ' GLN . 1.7 m -165.85 70.19 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.4 -0.812 . . . . 0.0 109.506 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.508 ' O ' ' CD1' ' A' ' 12' ' ' LEU . 1.5 tm? -44.22 -34.46 1.89 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.342 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -93.6 81.4 4.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.244 -0.91 . . . . 0.0 109.099 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.434 ' OG1' ' ND2' ' A' ' 53' ' ' ASN . 10.1 p -87.78 158.65 18.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.291 -0.881 . . . . 0.0 109.91 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.428 ' O ' ' C ' ' A' ' 16' ' ' GLN . 2.4 mt -100.24 144.25 29.48 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.463 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.9 tt0 -45.41 -25.91 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.074 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.516 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 154.09 171.54 21.19 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.449 HG21 HD12 ' A' ' 52' ' ' LEU . 7.7 tp -145.32 151.96 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.336 -1.096 . . . . 0.0 109.166 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.496 ' ND1' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.92 146.98 1.82 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.935 . . . . 0.0 109.303 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.496 ' HD2' ' ND1' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.15 -13.85 16.95 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.549 2.166 . . . . 0.0 110.04 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.526 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -80.92 -16.34 53.84 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.234 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.534 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 80.1 m-20 -101.34 55.59 0.83 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.459 -0.776 . . . . 0.0 108.988 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -139.79 170.83 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.133 -0.979 . . . . 0.0 110.041 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -160.06 -40.72 0.05 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.456 ' OG ' ' OG1' ' A' ' 43' ' ' THR . 4.8 p -131.13 -177.97 4.62 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 51.9 t -157.22 111.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.025 -1.047 . . . . 0.0 109.748 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -94.87 124.61 39.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -0.85 . . . . 0.0 109.358 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' B' ' 26' ' ' VAL . 1.9 t -119.91 89.7 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.196 -0.94 . . . . 0.0 109.53 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 104.22 15.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.279 -0.888 . . . . 0.0 109.547 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.2 p -54.31 168.42 0.46 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.445 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 35.9 Cg_endo -78.01 133.15 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.664 2.242 . . . . 0.0 110.434 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.85 -141.05 3.8 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.55 10.25 2.59 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.531 2.154 . . . . 0.0 110.992 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.499 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 3.7 p-80 -127.16 -10.21 5.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.023 -1.048 . . . . 0.0 109.813 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' OE1' ' A' ' 39' ' ' GLU . 1.8 t -160.27 121.4 3.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.002 . . . . 0.0 109.372 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.72 44.16 1.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.577 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.424 ' C ' ' HB3' ' A' ' 31' ' ' PRO . 5.8 pt20 -172.36 139.76 1.04 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 m -56.49 142.28 39.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.452 ' OE1' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -127.62 122.59 33.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.899 . . . . 0.0 109.623 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.465 HG22 ' HB3' ' A' ' 54' ' ' PRO . 74.6 t -114.48 151.44 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.371 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.449 HG21 ' N ' ' A' ' 42' ' ' ALA . 3.3 mp -141.82 155.18 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.607 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.449 ' N ' HG21 ' A' ' 41' ' ' ILE . . . -134.21 126.63 30.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.397 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 51.9 m -89.81 105.87 18.09 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.111 -0.993 . . . . 0.0 109.089 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.534 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 77.1 mt -41.73 164.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.464 -0.772 . . . . 0.0 109.587 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.4 ptpt -87.44 17.81 4.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.748 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 1.1 p-10 -120.46 -3.53 9.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.97 . . . . 0.0 109.349 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.4 -25.31 8.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.514 ' CB ' HD13 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -79.34 172.9 13.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -1.172 . . . . 0.0 109.255 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.544 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -147.24 125.55 12.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.66 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.74 124.77 51.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.422 -0.799 . . . . 0.0 108.847 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.418 ' SG ' HG12 ' A' ' 41' ' ' ILE . 83.9 m -79.55 140.99 37.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.947 . . . . 0.0 109.317 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.548 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 14.3 mt -127.78 168.25 15.39 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 108.975 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 0.8 OUTLIER -106.12 132.95 20.46 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.321 -0.862 . . . . 0.0 109.125 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.465 ' HB3' HG22 ' A' ' 40' ' ' VAL . 33.9 Cg_endo -75.62 -25.23 11.12 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.12 1.88 . . . . 0.0 110.298 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.87 -16.15 26.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.212 -0.93 . . . . 0.0 108.843 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 37.1 p -88.66 158.18 48.43 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.433 -0.792 . . . . 0.0 109.395 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.419 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.86 -38.74 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.695 2.263 . . . . 0.0 110.744 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.543 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 5.9 tt -66.04 -46.63 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.974 . . . . 0.0 109.235 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.559 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 40.3 t -56.81 -48.46 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.494 -0.753 . . . . 0.0 109.241 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -55.45 -31.42 61.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HE2' ' OE2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -74.89 -31.25 61.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.614 -0.679 . . . . 0.0 109.226 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.531 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -67.0 -42.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.401 -0.812 . . . . 0.0 108.848 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.568 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.1 mp -65.87 -66.64 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -46.23 -39.32 9.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 0.0 109.496 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.462 ' HG3' ' OE1' ' A' ' 64' ' ' GLU . 12.2 mttm -59.08 -50.9 72.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.209 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.438 ' HG3' HG22 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -51.45 -48.1 62.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 109.216 179.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.567 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -47.02 -51.8 16.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.387 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 69' ' ' SER . 11.7 t30 -58.46 -38.47 77.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' ASN . 4.2 p . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.448 ' O ' ' C ' ' B' ' 10' ' ' GLN . 17.4 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.471 ' O ' ' SG ' ' B' ' 11' ' ' CYS . 45.1 mm-40 -40.52 -39.97 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.56 -0.712 . . . . 0.0 109.767 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' B' ' 10' ' ' GLN . 1.7 m -165.85 70.24 0.13 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.506 ' CD1' ' O ' ' B' ' 12' ' ' LEU . 1.5 tm? -44.3 -34.46 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.266 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -93.63 81.53 4.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.266 -0.897 . . . . 0.0 109.118 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.432 ' OG1' ' ND2' ' B' ' 53' ' ' ASN . 10.2 p -87.88 158.63 18.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.332 -0.855 . . . . 0.0 109.859 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mt -100.18 144.26 29.41 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.461 ' O ' HG22 ' B' ' 59' ' ' VAL . 1.9 tt0 -45.44 -25.88 0.48 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.043 -1.036 . . . . 0.0 109.063 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.519 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 154.1 171.55 21.2 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.446 HG21 HD12 ' B' ' 52' ' ' LEU . 7.7 tp -145.3 151.91 14.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.405 -1.056 . . . . 0.0 109.247 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.496 ' ND1' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -45.9 147.01 1.79 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.496 ' HD2' ' ND1' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.17 -13.94 16.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.622 2.215 . . . . 0.0 109.963 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -80.9 -16.39 53.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.538 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 80.1 m-20 -101.31 55.64 0.84 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.448 -0.782 . . . . 0.0 108.935 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -139.78 170.78 14.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.091 -1.005 . . . . 0.0 109.947 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.1 OUTLIER -159.99 -40.7 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.463 ' OG ' ' OG1' ' B' ' 43' ' ' THR . 4.8 p -131.14 -177.99 4.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' B' ' 41' ' ' ILE . 51.5 t -157.16 111.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.981 -1.075 . . . . 0.0 109.771 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.402 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 18.8 t-20 -94.89 124.7 39.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.882 . . . . 0.0 109.281 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.442 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 1.9 t -119.99 89.83 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.47 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.23 104.28 15.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.2 p -54.53 168.43 0.48 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.381 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 35.6 Cg_endo -77.93 133.11 12.22 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.609 2.206 . . . . 0.0 110.414 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.79 -141.04 3.8 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.66 10.35 2.58 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.541 2.16 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.499 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 3.7 p-80 -127.16 -10.26 5.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.981 -1.074 . . . . 0.0 109.855 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 1.8 t -160.3 121.37 3.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.357 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.69 44.1 1.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.588 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.425 ' C ' ' HB3' ' B' ' 31' ' ' PRO . 5.9 pt20 -172.24 139.86 1.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.515 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 1.5 m -56.69 142.33 40.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.451 ' OE2' ' SG ' ' B' ' 35' ' ' CYS . 0.0 OUTLIER -127.53 122.59 33.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' B' ' 54' ' ' PRO . 76.9 t -114.55 151.46 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.321 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 3.3 mp -141.79 155.25 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.643 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.438 ' N ' HG21 ' B' ' 41' ' ' ILE . . . -134.33 126.56 29.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -0.866 . . . . 0.0 109.335 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.516 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 52.2 m -89.9 105.96 18.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 109.089 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 77.0 mt -41.71 164.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.467 -0.771 . . . . 0.0 109.667 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.4 ptpt -87.33 17.76 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.877 . . . . 0.0 109.865 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.454 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 1.1 p-10 -120.42 -3.54 9.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.386 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.52 -25.49 8.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.524 ' CB ' HD13 ' B' ' 44' ' ' LEU . 0.3 OUTLIER -79.31 172.95 13.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -1.186 . . . . 0.0 109.273 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.547 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -147.27 125.46 12.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.657 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.68 124.76 51.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.395 -0.816 . . . . 0.0 108.915 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' B' ' 41' ' ' ILE . 84.3 m -79.49 141.07 37.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.15 -0.969 . . . . 0.0 109.289 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.543 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 14.2 mt -127.89 168.16 15.59 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.418 -0.802 . . . . 0.0 109.001 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 0.8 OUTLIER -106.01 132.84 20.55 Favored Pre-proline 0 C--N 1.299 -1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.205 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.462 ' HB3' HG22 ' B' ' 40' ' ' VAL . 33.7 Cg_endo -75.59 -25.22 11.18 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.09 1.86 . . . . 0.0 110.324 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.83 -16.16 26.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.274 -0.891 . . . . 0.0 108.792 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 36.9 p -88.68 158.21 48.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.478 -0.764 . . . . 0.0 109.297 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -77.88 -38.7 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.666 2.244 . . . . 0.0 110.741 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.556 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 5.8 tt -66.05 -46.61 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.096 -1.003 . . . . 0.0 109.248 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.556 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 40.0 t -56.87 -48.52 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.407 -0.808 . . . . 0.0 109.174 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.468 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.5 OUTLIER -55.48 -31.29 61.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.432 ' HE2' ' OE2' ' B' ' 64' ' ' GLU . 0.1 OUTLIER -74.95 -31.23 61.44 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -67.04 -42.96 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.567 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.1 mp -65.83 -66.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.356 -0.84 . . . . 0.0 109.466 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -46.36 -39.26 10.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.942 . . . . 0.0 109.43 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.458 ' HG3' ' OE1' ' B' ' 64' ' ' GLU . 12.2 mttm -59.1 -50.88 72.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 109.269 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.43 ' HG3' HG22 ' B' ' 26' ' ' VAL . 0.1 OUTLIER -51.44 -48.07 62.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 0.0 109.219 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.568 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -46.97 -51.9 15.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' B' ' 69' ' ' SER . 11.8 t30 -58.42 -38.54 77.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.405 ' C ' ' O ' ' B' ' 68' ' ' ASN . 4.1 p . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 109.466 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.414 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 43.8 m . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.503 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 75.8 mm-40 -53.04 -18.48 2.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 12' ' ' LEU . 53.0 m -135.63 65.96 1.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.076 -1.015 . . . . 0.0 109.889 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -44.7 -44.86 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 108.895 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.41 119.44 34.6 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -93.31 168.55 11.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.186 -0.946 . . . . 0.0 110.09 -179.385 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 16' ' ' GLN . 6.8 mt -119.13 145.5 45.92 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.52 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -43.99 -46.63 8.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.254 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.521 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 151.39 -170.88 30.99 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.4 pp -164.95 162.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -1.028 . . . . 0.0 109.33 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.564 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -53.97 150.69 14.05 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.22 -0.925 . . . . 0.0 109.328 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.5 Cg_endo -77.44 -3.89 14.12 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.598 2.199 . . . . 0.0 110.29 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 3.1 pttm -90.21 -24.19 21.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.865 . . . . 0.0 109.207 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.519 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 3.1 m-20 -83.19 -7.31 59.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.385 -0.822 . . . . 0.0 109.268 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 6.8 mt -104.26 162.12 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.874 . . . . 0.0 110.1 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.571 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -135.12 -31.36 1.0 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.526 -0.734 . . . . 0.0 109.177 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.571 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.1 p -132.82 175.14 9.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 0.0 108.854 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.528 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 46.6 t -149.69 115.77 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.045 -1.034 . . . . 0.0 109.922 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.442 ' HB3' HD11 ' A' ' 41' ' ' ILE . 4.1 t-20 -111.85 110.76 21.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.147 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.12 113.65 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.709 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -105.74 114.76 29.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.251 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.404 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -55.23 167.29 0.71 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.544 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.414 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.3 Cg_endo -77.53 140.25 18.89 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.607 2.205 . . . . 0.0 110.378 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.92 -139.6 3.03 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.66 38.73 0.76 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.594 2.196 . . . . 0.0 110.903 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.493 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 3.9 p-80 -154.99 -38.73 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.031 . . . . 0.0 109.375 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.415 ' SG ' ' CD ' ' A' ' 39' ' ' GLU . 1.8 t -133.58 124.77 27.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.23 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.53 42.43 0.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.736 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.453 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -170.76 148.48 2.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.153 -0.967 . . . . 0.0 109.631 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 m -63.49 144.94 56.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.325 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 37' ' ' GLN . 0.5 OUTLIER -126.64 110.27 13.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 109.628 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.479 ' CG2' ' HB3' ' A' ' 54' ' ' PRO . 3.3 t -97.53 144.84 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.273 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.442 HD11 ' HB3' ' A' ' 27' ' ' ASN . 3.6 mt -132.4 153.08 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.58 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.523 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -137.69 120.21 16.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.174 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 2.3 m -89.23 102.69 15.35 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.973 -1.08 . . . . 0.0 108.737 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 88.6 mt -49.22 164.59 0.07 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.432 -0.792 . . . . 0.0 109.549 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -79.12 6.78 8.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 109.978 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HD2' ' A' ' 48' ' ' ARG . 41.7 p30 -109.36 20.72 17.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.124 -0.985 . . . . 0.0 109.363 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.87 14.08 82.73 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.509 ' HD2' ' ND2' ' A' ' 46' ' ' ASN . 1.6 mtp-105 -103.56 171.64 7.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -1.151 . . . . 0.0 109.452 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -141.9 151.19 42.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.25 123.03 8.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.294 -0.879 . . . . 0.0 109.074 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 15.6 m -79.77 141.1 36.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.521 ' CD2' ' HA2' ' A' ' 17' ' ' GLY . 12.3 mt -119.6 167.82 11.63 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.321 -0.862 . . . . 0.0 109.195 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.542 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -98.15 119.34 62.17 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.337 -0.852 . . . . 0.0 108.983 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.479 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 33.3 Cg_endo -75.2 -6.76 18.31 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.103 1.869 . . . . 0.0 110.327 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.75 -14.66 47.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 108.865 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -90.07 162.12 36.06 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.317 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.479 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 36.7 Cg_endo -78.29 -37.72 0.7 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.644 2.229 . . . . 0.0 110.944 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -63.26 -48.13 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.073 -1.017 . . . . 0.0 108.917 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.568 ' N ' ' CG2' ' A' ' 58' ' ' ILE . 37.2 t -55.75 -48.48 77.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -51.33 -33.62 30.02 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.298 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -72.94 -36.37 67.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.549 -0.719 . . . . 0.0 109.261 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 58' ' ' ILE . 1.3 mp -57.91 -44.05 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.878 . . . . 0.0 109.051 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.577 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.1 mp -69.76 -68.95 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.874 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.484 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -43.43 -27.82 0.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -0.957 . . . . 0.0 109.584 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.484 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 10.3 mmtt -72.49 -58.66 3.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 108.931 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.528 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 1.1 tmm? -44.62 -45.72 9.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 108.911 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.58 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 2.5 mt -55.38 -49.29 72.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 109.409 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.06 33.9 1.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.574 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.465 -179.978 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.407 ' HA ' ' OE2' ' B' ' 39' ' ' GLU . 43.1 m . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.498 ' HB2' ' CD ' ' B' ' 29' ' ' LYS . 75.9 mm-40 -53.01 -18.45 2.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.699 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' B' ' 12' ' ' LEU . 54.3 m -135.62 66.0 1.52 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 109.779 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.2 OUTLIER -44.81 -44.85 9.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.895 . . . . 0.0 108.881 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.38 119.46 34.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.447 ' OG1' ' ND2' ' B' ' 53' ' ' ASN . 0.5 OUTLIER -93.43 168.6 10.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.303 -0.873 . . . . 0.0 110.037 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' B' ' 16' ' ' GLN . 6.9 mt -119.19 145.55 45.93 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.524 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 0.0 OUTLIER -43.97 -46.62 8.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 109.342 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.521 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 151.36 -170.91 30.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.4 pp -164.86 162.96 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -1.023 . . . . 0.0 109.303 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.577 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -53.99 150.79 13.85 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 109.314 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.2 Cg_endo -77.55 -3.9 14.08 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.554 2.17 . . . . 0.0 110.251 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 3.1 pttm -90.2 -24.19 21.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 0.0 109.128 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 3.1 m-20 -83.21 -7.35 59.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 6.8 mt -104.13 162.1 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.574 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -135.1 -31.3 1.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.504 -0.748 . . . . 0.0 109.231 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.574 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.1 p -132.87 175.1 9.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 108.828 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.527 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 46.4 t -149.66 115.82 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.042 -1.036 . . . . 0.0 109.919 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.444 ' HB3' HD11 ' B' ' 41' ' ' ILE . 4.1 t-20 -111.84 110.79 21.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.2 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.14 113.67 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.766 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' B' ' 29' ' ' LYS . 0.4 OUTLIER -105.77 114.75 29.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.249 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.401 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.0 OUTLIER -55.18 167.38 0.69 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.87 . . . . 0.0 109.461 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.409 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.0 Cg_endo -77.54 140.16 18.79 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.606 2.204 . . . . 0.0 110.435 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.84 -139.56 3.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.74 38.76 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.587 2.191 . . . . 0.0 110.91 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.507 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 3.8 p-80 -154.95 -38.86 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.026 -1.046 . . . . 0.0 109.359 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.41 ' SG ' ' CD ' ' B' ' 39' ' ' GLU . 1.8 t -133.52 124.75 27.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.54 42.47 0.96 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.876 . . . . 0.0 109.709 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.446 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 0.0 OUTLIER -170.74 148.46 2.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.12 -0.988 . . . . 0.0 109.618 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 1.4 m -63.53 144.98 56.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.331 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.446 ' OE1' ' O ' ' B' ' 37' ' ' GLN . 0.5 OUTLIER -126.69 110.27 12.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 0.0 109.604 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' B' ' 54' ' ' PRO . 3.4 t -97.53 144.78 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.206 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.444 HD11 ' HB3' ' B' ' 27' ' ' ASN . 3.6 mt -132.41 153.08 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.586 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.517 ' CB ' HG22 ' B' ' 23' ' ' ILE . . . -137.61 120.26 16.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.208 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.527 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 2.3 m -89.28 102.63 15.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.999 -1.063 . . . . 0.0 108.709 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 88.8 mt -49.12 164.5 0.07 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.416 -0.802 . . . . 0.0 109.651 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -79.04 6.77 8.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 -179.67 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.516 ' ND2' ' HD2' ' B' ' 48' ' ' ARG . 42.0 p30 -109.4 20.7 17.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.982 . . . . 0.0 109.415 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.93 14.0 82.8 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.516 ' HD2' ' ND2' ' B' ' 46' ' ' ASN . 1.6 mtp-105 -103.51 171.66 7.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -1.173 . . . . 0.0 109.499 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.461 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -141.95 151.18 42.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 109.367 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.23 123.0 8.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 109.078 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 15.5 m -79.83 141.16 36.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.161 -0.962 . . . . 0.0 109.262 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.521 ' CD2' ' HA2' ' B' ' 17' ' ' GLY . 12.3 mt -119.56 167.85 11.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.161 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 1.0 OUTLIER -98.13 119.2 62.5 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.057 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.485 ' HB3' ' CG2' ' B' ' 40' ' ' VAL . 33.8 Cg_endo -75.11 -6.79 18.42 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.07 1.847 . . . . 0.0 110.317 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.77 -14.51 47.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 108.882 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -90.17 162.22 35.51 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.83 . . . . 0.0 109.293 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.477 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -78.41 -37.68 0.68 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.612 2.208 . . . . 0.0 110.852 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' B' ' 62' ' ' ILE . 0.2 OUTLIER -63.32 -48.02 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.045 -1.034 . . . . 0.0 108.975 -179.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.57 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 37.5 t -55.71 -48.61 77.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.504 -0.747 . . . . 0.0 109.044 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.3 OUTLIER -51.28 -33.65 29.49 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.322 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' B' ' 61' ' ' LYS . 0.1 OUTLIER -72.82 -36.43 67.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.488 -0.758 . . . . 0.0 109.304 179.6 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' B' ' 58' ' ' ILE . 1.3 mp -57.89 -44.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.018 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.58 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.1 mp -69.85 -68.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 109.829 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.2 OUTLIER -43.51 -27.78 0.31 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -0.965 . . . . 0.0 109.549 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.481 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 10.4 mmtt -72.5 -58.64 3.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 108.973 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.527 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 1.1 tmm? -44.66 -45.64 9.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 108.914 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.577 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 2.5 mt -55.44 -49.2 73.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.518 -0.739 . . . . 0.0 109.411 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.12 33.85 1.86 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.499 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.505 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 4.7 m . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -12.66 15.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.765 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 39' ' ' GLU . 70.8 m -135.2 60.71 1.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.119 -0.988 . . . . 0.0 109.873 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.505 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.52 -38.33 6.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 108.815 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -124.87 123.05 39.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.28 173.93 7.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 110.092 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 16' ' ' GLN . 4.6 mt -129.53 145.81 51.42 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.526 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.3 tt0 -44.94 -45.67 10.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.078 -1.014 . . . . 0.0 109.202 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.525 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 139.87 156.14 6.82 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.542 ' CD1' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -129.19 157.53 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -1.095 . . . . 0.0 109.254 179.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.583 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.95 151.92 0.39 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 109.38 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.583 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.4 Cg_endo -76.66 -1.71 11.85 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.473 2.115 . . . . 0.0 110.156 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.459 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 2.2 mtmm -90.26 -25.51 20.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.806 . . . . 0.0 109.0 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 4.6 m-20 -82.37 -5.69 58.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.417 -0.802 . . . . 0.0 109.26 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 44' ' ' LEU . 9.3 mt -107.52 145.36 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.27 -0.894 . . . . 0.0 110.114 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.559 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -117.49 -26.48 6.63 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.413 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.559 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -139.68 162.99 33.77 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -146.86 99.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.945 -1.097 . . . . 0.0 109.891 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.466 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 13.0 t30 -80.07 113.43 18.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.284 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.466 ' O ' ' CE ' ' B' ' 66' ' ' MET . 1.8 t -97.17 90.53 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.511 ' HE3' ' NE2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -94.94 105.68 17.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.475 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.417 ' HA ' HG22 ' A' ' 38' ' ' THR . 0.9 OUTLIER -59.65 167.13 2.7 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 109.43 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 36.1 Cg_endo -78.11 145.85 22.28 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.527 2.151 . . . . 0.0 110.418 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.14 -142.85 3.63 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.6 10.09 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.685 2.256 . . . . 0.0 111.013 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.511 ' NE2' ' HE3' ' A' ' 29' ' ' LYS . 4.8 p-80 -126.8 -32.58 2.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.056 . . . . 0.0 109.45 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -147.31 88.74 1.73 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.207 -0.933 . . . . 0.0 109.264 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -54.07 -18.85 4.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.33 -0.856 . . . . 0.0 109.699 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.452 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 1.5 mp0 -92.84 124.78 37.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 0.0 109.516 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.464 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 2.7 m -49.5 162.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.292 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 37' ' ' GLN . 1.3 mp0 -142.78 108.98 5.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 109.663 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.557 ' CG1' ' CD1' ' A' ' 63' ' ' ILE . 57.3 t -100.62 95.12 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 109.147 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.45 HG13 ' SG ' ' A' ' 51' ' ' CYS . 2.6 mp -84.59 139.62 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.958 . . . . 0.0 109.831 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.476 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -121.25 118.36 29.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 109.133 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.485 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 1.1 m -89.07 97.36 11.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.972 -1.08 . . . . 0.0 108.668 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 90.8 mt -43.44 167.77 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.567 -0.708 . . . . 0.0 109.906 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.1 ptpt -81.29 7.96 10.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.841 . . . . 0.0 109.581 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.473 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.7 13.28 21.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.272 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.99 -1.6 86.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.473 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 2.1 mtt-85 -87.88 168.07 13.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -1.182 . . . . 0.0 109.392 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.406 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 2.0 mttt -134.26 155.17 50.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.913 . . . . 0.0 109.428 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.34 117.73 6.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.193 -0.942 . . . . 0.0 109.186 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.45 ' SG ' HG13 ' A' ' 41' ' ' ILE . 8.7 m -79.39 139.05 37.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.151 -0.968 . . . . 0.0 108.853 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.542 HD23 ' CD1' ' A' ' 18' ' ' ILE . 8.7 mt -121.16 167.85 12.22 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.148 -0.97 . . . . 0.0 109.588 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 7.1 t-20 -100.47 119.25 59.33 Favored Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.401 -0.812 . . . . 0.0 109.215 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.467 ' HA ' HG13 ' A' ' 59' ' ' VAL . 32.7 Cg_endo -74.18 0.82 7.97 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.157 1.905 . . . . 0.0 110.595 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.54 -15.69 30.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 108.904 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.459 ' OG ' HG21 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -90.28 164.21 28.36 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.455 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.78 -37.94 0.78 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.687 2.258 . . . . 0.0 111.061 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.543 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 16.0 tt -65.43 -46.87 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.991 -1.068 . . . . 0.0 109.124 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.555 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 34.0 t -55.37 -46.85 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.434 -0.792 . . . . 0.0 109.25 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 54' ' ' PRO . 18.1 mttt -57.74 -30.75 65.82 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.501 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -79.37 -24.81 42.41 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.511 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.6 mp -65.85 -43.59 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.589 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 1.6 mp -69.61 -62.94 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.547 -0.721 . . . . 0.0 109.214 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' OE2' ' CD1' ' B' ' 67' ' ' LEU . 1.3 mp0 -41.76 -48.5 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.793 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.508 ' CE ' ' HG3' ' A' ' 20' ' ' PRO . 2.8 mmtm -53.75 -59.27 4.83 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.372 -0.83 . . . . 0.0 109.342 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.459 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 1.4 mmm -43.52 -45.78 6.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.297 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.579 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 3.1 mt -55.67 -57.72 10.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.46 -0.775 . . . . 0.0 109.738 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -81.13 7.37 11.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.799 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.459 ' OG ' ' HA ' ' A' ' 66' ' ' MET . 7.8 p . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 109.384 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.506 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 4.6 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.355 0.597 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -12.7 14.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.709 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.45 ' SG ' HG13 ' B' ' 41' ' ' ILE . 71.0 m -135.25 60.78 1.68 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.913 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.506 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.56 -38.2 6.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.107 -0.995 . . . . 0.0 108.912 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -124.95 122.98 38.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 108.843 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.27 173.98 7.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 0.0 110.153 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' B' ' 16' ' ' GLN . 4.5 mt -129.51 145.82 51.41 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.522 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 2.2 tt0 -44.92 -45.65 10.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.249 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.517 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 139.84 156.18 6.84 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.539 ' CD1' HD23 ' B' ' 52' ' ' LEU . 0.2 OUTLIER -129.25 157.56 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -1.091 . . . . 0.0 109.21 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.576 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -43.0 152.01 0.39 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 0.0 109.39 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -76.75 -1.73 11.89 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.442 2.095 . . . . 0.0 110.19 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.463 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 2.2 mtmm -90.19 -25.6 20.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.273 -0.892 . . . . 0.0 108.997 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 4.7 m-20 -82.33 -5.67 58.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.413 -0.804 . . . . 0.0 109.318 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' B' ' 44' ' ' LEU . 9.3 mt -107.43 145.39 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 110.089 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.559 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -117.5 -26.46 6.63 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.269 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.559 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -139.6 163.02 33.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 52.5 t -146.86 99.38 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.081 -1.012 . . . . 0.0 109.931 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 13.2 t30 -80.01 113.43 18.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.253 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.455 ' O ' ' CE ' ' A' ' 66' ' ' MET . 1.8 t -97.15 90.48 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.513 ' HE3' ' NE2' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -94.92 105.67 17.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.548 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.418 ' HA ' HG22 ' B' ' 38' ' ' THR . 0.9 OUTLIER -59.59 167.14 2.64 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 109.422 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.47 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 36.3 Cg_endo -78.03 145.8 22.44 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.659 2.239 . . . . 0.0 110.419 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.19 -142.88 3.64 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.46 9.82 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.695 2.263 . . . . 0.0 110.983 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.513 ' NE2' ' HE3' ' B' ' 29' ' ' LYS . 4.6 p-80 -126.68 -32.44 2.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 109.42 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -147.38 88.7 1.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.213 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -54.03 -18.94 4.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.705 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.456 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 1.5 mp0 -92.67 124.62 36.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.13 -0.981 . . . . 0.0 109.596 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.451 ' HB ' ' HG3' ' B' ' 54' ' ' PRO . 2.7 m -49.47 162.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.238 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' B' ' 37' ' ' GLN . 1.3 mp0 -142.74 108.91 5.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.117 -0.989 . . . . 0.0 109.706 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.557 ' CG1' ' CD1' ' B' ' 63' ' ' ILE . 57.4 t -100.56 95.12 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.247 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.45 HG13 ' SG ' ' B' ' 11' ' ' CYS . 2.6 mp -84.57 139.63 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.892 . . . . 0.0 109.875 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.467 ' CB ' HG22 ' B' ' 23' ' ' ILE . . . -121.24 118.46 29.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' B' ' 24' ' ' GLN . 1.1 m -89.18 97.38 11.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.955 -1.091 . . . . 0.0 108.665 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 90.9 mt -43.49 167.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.61 -0.681 . . . . 0.0 109.878 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.463 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.1 ptpt -81.34 7.95 10.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.492 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -111.72 13.38 21.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.288 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.0 -1.66 86.81 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.492 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 2.1 mtt-85 -87.78 168.11 13.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -1.221 . . . . 0.0 109.436 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.413 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 2.0 mttt -134.3 155.24 50.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.37 117.75 6.06 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.348 -0.845 . . . . 0.0 109.17 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.439 ' SG ' HG13 ' B' ' 41' ' ' ILE . 8.6 m -79.45 139.02 37.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 0.0 108.852 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.539 HD23 ' CD1' ' B' ' 18' ' ' ILE . 8.7 mt -121.1 167.85 12.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.17 -0.956 . . . . 0.0 109.629 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 7.1 t-20 -100.45 119.31 59.22 Favored Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 121.51 -0.744 . . . . 0.0 109.201 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.466 ' HA ' HG13 ' B' ' 59' ' ' VAL . 32.9 Cg_endo -74.25 0.86 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.077 1.851 . . . . 0.0 110.582 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.64 -15.64 30.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 108.863 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.468 ' OG ' HG21 ' B' ' 58' ' ' ILE . 0.9 OUTLIER -90.18 164.21 28.59 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 109.498 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.77 -38.0 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.673 2.249 . . . . 0.0 111.055 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 16.0 tt -65.4 -46.9 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.065 . . . . 0.0 109.112 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.557 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 33.6 t -55.41 -46.82 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.412 -0.805 . . . . 0.0 109.221 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' B' ' 54' ' ' PRO . 18.1 mttt -57.64 -30.86 65.73 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.523 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.7 OUTLIER -79.33 -24.86 42.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.515 -0.741 . . . . 0.0 109.457 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.536 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.6 mp -65.86 -43.58 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.579 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 1.6 mp -69.6 -63.02 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 109.104 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.525 ' OE2' ' CD1' ' A' ' 67' ' ' LEU . 1.3 mp0 -41.73 -48.48 4.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.423 -0.798 . . . . 0.0 109.826 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.499 ' CE ' ' HG3' ' B' ' 20' ' ' PRO . 2.8 mmtm -53.69 -59.42 4.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.88 . . . . 0.0 109.233 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 28' ' ' VAL . 1.4 mmm -43.44 -45.77 6.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.37 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.589 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 3.1 mt -55.69 -57.68 10.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.516 -0.74 . . . . 0.0 109.753 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -81.07 7.24 11.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 109.804 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' B' ' 65' ' ' LYS . 7.6 p . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.168 -0.958 . . . . 0.0 109.443 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 4.5 m . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.517 ' NE2' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -43.08 -26.83 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.382 -0.824 . . . . 0.0 109.578 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 39' ' ' GLU . 56.4 m -127.14 65.11 1.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.48 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -43.76 -37.17 2.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.901 . . . . 0.0 109.027 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -121.65 -174.98 2.99 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -160.09 151.44 19.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.143 -0.973 . . . . 0.0 109.778 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.2 mt -114.0 144.61 42.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 0.0 108.923 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.53 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.1 tt0 -44.05 -26.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 109.293 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.523 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 142.41 -164.03 27.04 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.54 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.3 pp -170.37 162.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.376 -1.073 . . . . 0.0 109.534 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.608 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 3.3 t60 -44.84 146.61 1.29 Allowed Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.608 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.6 Cg_endo -79.1 -17.01 12.11 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.366 2.044 . . . . 0.0 109.524 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 7.7 mmtm -90.4 -19.35 24.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 16.7 m-20 -78.2 -14.62 59.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -0.841 . . . . 0.0 109.033 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.54 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 11.0 mt -91.66 168.05 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.513 -0.742 . . . . 0.0 110.1 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.525 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -135.59 -40.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.455 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 6.4 p -123.58 172.57 8.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.515 ' CG1' HG13 ' A' ' 63' ' ' ILE . 97.3 t -144.25 88.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.741 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 4.0 t-20 -84.77 108.41 17.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.36 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -108.6 91.77 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 109.439 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.517 ' HD2' ' NE2' ' A' ' 10' ' ' GLN . 0.7 OUTLIER -92.39 128.15 38.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.857 . . . . 0.0 109.521 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -76.91 171.62 11.9 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.484 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 36.1 Cg_endo -78.03 132.4 11.62 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.606 2.204 . . . . 0.0 110.465 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.46 -144.23 5.0 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.85 11.94 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.711 2.274 . . . . 0.0 111.041 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.483 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 5.9 p-80 -128.99 -33.5 1.98 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.558 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -129.42 116.99 19.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.3 45.8 1.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.484 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -173.09 141.07 0.93 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 m -58.24 153.51 15.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.459 ' OE2' ' HG2' ' A' ' 29' ' ' LYS . 15.4 pt-20 -142.12 107.9 5.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.572 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.507 HG11 ' N ' ' A' ' 41' ' ' ILE . 55.5 t -90.77 153.45 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.374 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.507 ' N ' HG11 ' A' ' 40' ' ' VAL . 3.6 mt -140.67 144.68 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.626 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.514 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -131.71 119.95 22.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.119 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 7.9 m -89.45 97.98 11.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.996 -1.065 . . . . 0.0 109.09 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 85.4 mt -43.75 163.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.448 -0.783 . . . . 0.0 109.736 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -80.05 9.12 5.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 109.931 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.58 27.52 9.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.217 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.3 9.42 72.68 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.513 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 3.4 mtt180 -99.6 163.21 12.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.207 -1.172 . . . . 0.0 109.53 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -137.68 151.83 48.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.339 -0.851 . . . . 0.0 109.257 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.15 127.99 11.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.6 m -79.6 151.83 30.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.055 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' THR . 19.3 mt -127.07 166.72 17.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.315 -0.866 . . . . 0.0 109.326 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 1.1 t-20 -93.53 115.87 65.67 Favored Pre-proline 0 C--N 1.299 -1.594 0 O-C-N 121.404 -0.81 . . . . 0.0 109.079 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HA ' HG13 ' A' ' 59' ' ' VAL . 33.2 Cg_endo -74.54 -1.21 10.75 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.106 1.871 . . . . 0.0 110.413 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.2 -12.12 36.28 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.367 -0.833 . . . . 0.0 108.835 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -90.13 160.91 39.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.443 -0.786 . . . . 0.0 109.428 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.489 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 35.6 Cg_endo -77.5 -31.16 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.661 2.241 . . . . 0.0 110.547 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 4.1 tt -72.35 -45.16 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.083 -1.011 . . . . 0.0 109.288 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.549 ' N ' ' CG2' ' A' ' 58' ' ' ILE . 19.7 t -56.96 -48.53 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.511 -0.743 . . . . 0.0 109.294 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -61.09 -32.06 71.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.186 -0.946 . . . . 0.0 108.552 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -77.41 -19.14 56.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.528 -0.733 . . . . 0.0 109.161 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.53 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 16.2 mt -75.16 -38.84 42.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.523 HG21 ' CD1' ' B' ' 67' ' ' LEU . 1.9 mp -72.68 -55.98 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.908 . . . . 0.0 109.069 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.523 ' CG ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -58.79 -38.39 78.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.283 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 61' ' ' LYS . 8.2 tttp -59.57 -40.94 89.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -0.874 . . . . 0.0 109.173 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -61.47 -46.55 89.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.45 -0.782 . . . . 0.0 109.211 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.524 ' CD1' HG21 ' B' ' 63' ' ' ILE . 0.2 OUTLIER -44.11 -51.65 7.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.835 . . . . 0.0 109.395 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.67 -30.32 66.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 0.0 109.623 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.448 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.516 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 4.5 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.516 ' NE2' ' HD2' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -43.0 -26.79 0.15 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.402 -0.811 . . . . 0.0 109.586 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.448 ' SG ' HG13 ' B' ' 41' ' ' ILE . 56.3 m -127.18 65.02 1.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.275 -0.89 . . . . 0.0 109.447 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.516 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -43.75 -37.11 2.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.019 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -121.67 -174.97 2.99 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.379 -0.826 . . . . 0.0 108.843 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -160.1 151.45 19.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.073 -1.017 . . . . 0.0 109.789 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' B' ' 16' ' ' GLN . 7.2 mt -114.05 144.63 42.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.436 -0.79 . . . . 0.0 108.874 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.524 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.1 tt0 -44.03 -26.8 0.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.353 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.521 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 142.46 -163.95 27.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.532 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.3 pp -170.42 162.66 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.419 -1.048 . . . . 0.0 109.451 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 3.4 t60 -44.95 146.67 1.3 Allowed Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -79.15 -16.98 12.06 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.327 2.018 . . . . 0.0 109.452 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 7.7 mmtm -90.42 -19.38 23.99 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 16.7 m-20 -78.25 -14.57 59.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.845 . . . . 0.0 109.002 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.532 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 10.9 mt -91.68 168.01 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 110.129 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.1 OUTLIER -135.55 -40.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.454 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 6.4 p -123.54 172.51 8.7 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.522 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 97.2 t -144.23 88.1 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.719 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.468 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.0 t-20 -84.77 108.36 17.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.393 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -108.58 91.85 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.516 ' HD2' ' NE2' ' B' ' 10' ' ' GLN . 0.7 OUTLIER -92.51 128.1 38.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.925 . . . . 0.0 109.463 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -76.8 171.59 11.93 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 109.466 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.48 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.0 Cg_endo -78.02 132.44 11.66 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.658 2.239 . . . . 0.0 110.391 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.54 -144.23 5.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.95 12.01 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.693 2.262 . . . . 0.0 111.051 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.479 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 5.8 p-80 -129.0 -33.46 1.98 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 109.614 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -129.4 116.95 19.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.31 45.92 1.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.512 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.48 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -173.19 141.01 0.91 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 2.2 m -58.14 153.55 14.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.871 . . . . 0.0 109.503 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.461 ' OE2' ' HG2' ' B' ' 29' ' ' LYS . 15.3 pt-20 -142.19 107.92 5.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.505 HG11 ' N ' ' B' ' 41' ' ' ILE . 55.7 t -90.85 153.36 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 0.0 109.34 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.505 ' N ' HG11 ' B' ' 40' ' ' VAL . 3.6 mt -140.54 144.77 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 109.646 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.515 ' CB ' HG22 ' B' ' 23' ' ' ILE . . . -131.77 119.92 21.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.869 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 7.9 m -89.41 97.92 11.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.015 -1.053 . . . . 0.0 109.095 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' B' ' 22' ' ' ASN . 85.5 mt -43.77 163.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.343 -0.848 . . . . 0.0 109.738 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -80.0 9.01 5.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.354 -0.841 . . . . 0.0 109.857 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.46 27.43 9.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 0.0 109.215 179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.33 9.43 72.81 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 3.4 mtt180 -99.56 163.2 12.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -1.174 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.529 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.2 OUTLIER -137.7 151.89 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.219 179.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.23 127.98 11.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.288 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.58 151.86 30.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 109.077 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.529 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 19.3 mt -127.15 166.65 17.27 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.275 -0.891 . . . . 0.0 109.326 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 1.2 t-20 -93.43 115.91 65.72 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 109.106 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.426 ' HA ' HG13 ' B' ' 59' ' ' VAL . 33.2 Cg_endo -74.54 -1.24 10.79 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.11 1.873 . . . . 0.0 110.401 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.13 -12.18 36.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 108.867 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 1.0 OUTLIER -90.11 160.94 39.23 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.415 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.484 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.1 Cg_endo -77.42 -31.27 3.56 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.584 2.189 . . . . 0.0 110.588 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.544 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 4.1 tt -72.28 -45.16 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.032 -1.043 . . . . 0.0 109.37 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.546 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 19.6 t -56.88 -48.58 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.435 -0.791 . . . . 0.0 109.3 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -61.14 -31.99 71.7 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.147 -0.97 . . . . 0.0 108.536 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -77.51 -19.1 56.35 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.53 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 16.3 mt -75.23 -38.74 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.524 HG21 ' CD1' ' A' ' 67' ' ' LEU . 1.9 mp -72.75 -56.04 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 108.975 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.524 ' CG ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -58.77 -38.42 78.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.3 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' B' ' 61' ' ' LYS . 8.2 tttp -59.45 -41.07 88.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.157 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.522 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -61.37 -46.6 89.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 109.22 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.523 ' CD1' HG21 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -44.0 -51.73 7.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.451 -0.781 . . . . 0.0 109.396 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.64 -30.33 66.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.352 -0.842 . . . . 0.0 109.571 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.447 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.457 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.0 m . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.528 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -47.98 -22.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.753 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.421 ' O ' ' C ' ' A' ' 12' ' ' LEU . 63.0 m -126.45 65.2 1.25 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.9 . . . . 0.0 109.872 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -44.59 -43.74 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 108.866 179.459 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -122.97 124.86 44.12 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -96.44 167.36 11.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 0.0 110.014 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.5 mt -118.92 146.27 45.08 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.523 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -44.21 -41.28 5.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.281 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.514 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 147.51 -164.33 28.75 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.3 pp -171.11 163.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -1.041 . . . . 0.0 109.197 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.561 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -54.64 149.57 21.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.371 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.561 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -77.23 -4.11 14.43 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.502 2.135 . . . . 0.0 110.213 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HG2' ' HB3' ' A' ' 19' ' ' HIS . 8.4 pttt -90.29 -24.03 21.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.118 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.521 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 2.6 m-20 -82.92 -5.5 59.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.282 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 9.2 mt -105.99 145.96 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.557 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -119.13 -25.42 6.18 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.557 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -143.0 -179.51 6.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 109.122 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 41' ' ' ILE . 47.0 t -156.76 155.6 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.994 -1.066 . . . . 0.0 109.911 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.432 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . 2.6 t-20 -138.71 114.14 9.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.405 -0.809 . . . . 0.0 109.266 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.47 108.47 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.471 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' CD ' ' HB2' ' A' ' 10' ' ' GLN . 4.2 ptmm? -113.39 108.33 17.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.893 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.83 163.94 6.66 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.377 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.51 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.8 Cg_endo -77.58 152.39 29.59 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.628 2.219 . . . . 0.0 110.336 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.25 -137.06 2.12 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.514 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 35.9 Cg_endo -77.56 8.17 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.515 2.144 . . . . 0.0 110.758 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.514 ' CE1' ' HD2' ' A' ' 33' ' ' PRO . 2.5 p-80 -125.6 -24.34 3.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.023 -1.048 . . . . 0.0 109.733 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.51 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 1.8 t -160.06 107.31 1.63 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.049 -1.032 . . . . 0.0 109.305 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.7 -5.59 26.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.895 . . . . 0.0 109.69 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.445 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 2.2 mp0 -109.17 124.74 51.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.521 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.413 ' O ' ' CD ' ' A' ' 39' ' ' GLU . 1.7 m -48.26 158.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.293 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.497 ' HG3' ' NZ ' ' A' ' 29' ' ' LYS . 25.7 mm-40 -139.93 107.36 5.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.65 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 41' ' ' ILE . 10.3 t -92.52 151.99 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 109.179 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 40' ' ' VAL . 3.2 mt -140.19 156.13 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.113 -0.992 . . . . 0.0 109.883 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.448 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -142.65 117.87 10.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 109.015 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.491 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.2 m -89.11 96.03 10.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.982 -1.074 . . . . 0.0 108.736 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 89.6 mt -42.32 165.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.586 -0.696 . . . . 0.0 109.891 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -79.52 7.22 8.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.842 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.518 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.41 24.0 13.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.139 -0.976 . . . . 0.0 109.22 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.36 -0.11 65.01 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.518 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 72.5 mtt85 -88.57 162.27 16.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -1.195 . . . . 0.0 109.397 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.4 mptt -135.55 151.23 50.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.167 -0.958 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.25 123.43 8.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.349 -0.844 . . . . 0.0 109.05 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 10.0 m -79.59 142.54 35.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.057 -1.027 . . . . 0.0 109.079 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 14.3 mt -120.43 167.74 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.243 -0.911 . . . . 0.0 109.62 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 0.9 OUTLIER -99.57 122.62 50.86 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.484 -0.76 . . . . 0.0 109.047 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.465 ' O ' ' HE2' ' A' ' 60' ' ' LYS . 33.2 Cg_endo -75.11 -3.53 14.06 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.079 1.852 . . . . 0.0 110.354 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.59 -12.4 42.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.913 . . . . 0.0 108.919 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.468 ' OG ' HG22 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -89.98 163.09 33.45 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.438 -0.789 . . . . 0.0 109.394 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.68 -38.98 0.57 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.696 2.264 . . . . 0.0 110.784 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.534 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 20.6 tt -65.16 -45.92 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.346 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.551 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 44.7 t -57.42 -45.6 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -0.82 . . . . 0.0 109.333 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 54' ' ' PRO . 7.4 mttt -59.68 -29.53 68.14 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 7.0 mmmm -79.53 -23.61 42.75 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 29.2 mt -72.1 -36.63 57.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.54 -0.725 . . . . 0.0 109.303 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.588 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -75.87 -51.14 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.752 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.469 ' OE1' ' HD2' ' A' ' 61' ' ' LYS . 9.4 pt-20 -65.8 -29.0 69.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.035 -1.04 . . . . 0.0 109.347 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 4.4 mmtt -69.47 -46.11 67.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.871 . . . . 0.0 108.994 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.45 ' SD ' ' OG ' ' A' ' 69' ' ' SER . 0.3 OUTLIER -56.12 -45.29 79.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.438 -0.789 . . . . 0.0 109.076 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.591 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.62 -51.85 8.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.421 -0.8 . . . . 0.0 109.478 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 69' ' ' SER . 6.8 t-20 -64.86 -37.29 87.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.403 -0.81 . . . . 0.0 109.476 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.45 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.1 p . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 89.0 m . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.52 ' HB2' ' CE ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -48.03 -22.78 0.66 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.742 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' B' ' 12' ' ' LEU . 63.3 m -126.42 65.22 1.24 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.825 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.2 OUTLIER -44.63 -43.79 8.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 108.818 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -122.86 124.88 44.28 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.455 HG23 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -96.45 167.43 11.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.236 -0.915 . . . . 0.0 109.968 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' B' ' 16' ' ' GLN . 7.5 mt -119.04 146.21 45.24 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 0.2 OUTLIER -44.08 -41.31 5.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.372 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.512 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 147.53 -164.21 28.75 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.584 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.3 pp -171.19 163.64 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.473 -1.016 . . . . 0.0 109.166 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.569 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -54.54 149.58 20.63 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.183 -0.948 . . . . 0.0 109.326 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.0 Cg_endo -77.22 -4.15 14.47 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.489 2.126 . . . . 0.0 110.257 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' B' ' 19' ' ' HIS . 8.4 pttt -90.26 -24.05 21.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.352 -0.843 . . . . 0.0 109.136 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 2.5 m-20 -82.92 -5.43 59.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 109.259 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.584 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 9.1 mt -105.98 145.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.557 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -119.12 -25.44 6.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.557 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -142.98 -179.45 6.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.431 -0.793 . . . . 0.0 108.98 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.465 HG11 ' O ' ' B' ' 41' ' ' ILE . 46.9 t -156.79 155.61 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.101 -0.999 . . . . 0.0 109.901 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.433 ' HB3' ' CD1' ' B' ' 41' ' ' ILE . 2.5 t-20 -138.72 114.23 9.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.364 -0.835 . . . . 0.0 109.21 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.58 108.52 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.473 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.52 ' CE ' ' HB2' ' B' ' 10' ' ' GLN . 4.2 ptmm? -113.38 108.35 17.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.433 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.8 163.92 6.63 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.521 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.6 Cg_endo -77.64 152.45 29.42 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.56 2.173 . . . . 0.0 110.357 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.24 -136.97 2.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.521 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -77.58 8.01 3.56 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.536 2.157 . . . . 0.0 110.79 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.521 ' CE1' ' HD2' ' B' ' 33' ' ' PRO . 2.4 p-80 -125.53 -24.25 3.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.983 . . . . 0.0 109.734 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.521 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 1.8 t -160.13 107.39 1.62 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.963 . . . . 0.0 109.249 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.7 -5.67 26.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.29 -0.881 . . . . 0.0 109.717 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.45 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 2.2 mp0 -109.1 124.8 51.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.154 -0.967 . . . . 0.0 109.527 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.424 ' O ' ' CD ' ' B' ' 39' ' ' GLU . 1.7 m -48.33 158.38 0.27 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.938 . . . . 0.0 109.282 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.495 ' HG3' ' NZ ' ' B' ' 29' ' ' LYS . 25.7 mm-40 -139.92 107.32 5.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 109.716 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.464 ' O ' HG13 ' B' ' 41' ' ' ILE . 10.5 t -92.56 151.95 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.18 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.465 ' O ' HG11 ' B' ' 26' ' ' VAL . 3.2 mt -140.25 156.22 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.78 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.442 ' CB ' HG22 ' B' ' 23' ' ' ILE . . . -142.6 117.98 10.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 109.047 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.48 ' HB ' ' OG ' ' B' ' 25' ' ' SER . 1.2 m -89.19 96.05 10.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.875 -1.141 . . . . 0.0 108.729 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.4 mt -42.27 165.71 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.614 -0.679 . . . . 0.0 109.917 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -79.63 7.23 8.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.452 -0.78 . . . . 0.0 109.804 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.49 24.06 12.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.249 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.31 0.06 65.33 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.513 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 72.3 mtt85 -88.67 162.22 16.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -1.157 . . . . 0.0 109.33 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' B' ' 49' ' ' LYS . 1.4 mptt -135.53 151.35 50.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.89 . . . . 0.0 109.39 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.29 123.37 8.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.254 -0.904 . . . . 0.0 109.143 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' B' ' 41' ' ' ILE . 10.1 m -79.54 142.59 35.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 109.091 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.533 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 14.4 mt -120.45 167.72 12.07 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.561 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 0.9 OUTLIER -99.55 122.5 51.28 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.453 -0.779 . . . . 0.0 109.108 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.452 ' O ' ' HE2' ' B' ' 60' ' ' LYS . 33.4 Cg_endo -75.0 -3.6 14.16 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.185 1.923 . . . . 0.0 110.385 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.59 -12.24 43.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 108.993 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.4 OUTLIER -90.06 163.06 33.37 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 109.382 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.63 -39.04 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.636 2.224 . . . . 0.0 110.746 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.544 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 20.6 tt -65.2 -45.87 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.551 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 44.2 t -57.48 -45.65 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.847 . . . . 0.0 109.304 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' B' ' 56' ' ' SER . 7.4 mttt -59.57 -29.57 68.03 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' B' ' 65' ' ' LYS . 7.0 mmmm -79.5 -23.66 42.8 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 29.4 mt -72.08 -36.6 57.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.57 -0.706 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.591 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -75.86 -51.13 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.797 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' B' ' 61' ' ' LYS . 9.4 pt-20 -65.81 -29.0 69.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.023 -1.048 . . . . 0.0 109.303 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 4.4 mmtt -69.42 -46.19 67.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 108.943 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.45 ' SD ' ' OG ' ' B' ' 69' ' ' SER . 0.3 OUTLIER -56.13 -45.22 79.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.379 -0.826 . . . . 0.0 109.051 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.73 -51.85 8.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.423 -0.798 . . . . 0.0 109.418 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' B' ' 69' ' ' SER . 6.9 t-20 -64.84 -37.25 87.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.486 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.45 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.1 p . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.453 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.512 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 8.7 m . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.526 ' HG3' ' CD ' ' A' ' 29' ' ' LYS . 13.8 mm100 -43.78 -24.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.827 . . . . 0.0 110.015 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.458 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 66.4 m -139.83 77.9 1.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.026 -1.047 . . . . 0.0 109.974 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.512 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -50.51 -43.95 55.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 108.89 179.498 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.53 121.81 41.98 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.49 170.49 8.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.144 -0.972 . . . . 0.0 110.009 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -127.54 148.84 50.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.495 ' O ' ' CG2' ' A' ' 59' ' ' VAL . 2.6 tt0 -44.43 -54.69 5.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.531 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 149.04 168.53 14.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.58 ' N ' ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -136.34 161.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -1.097 . . . . 0.0 109.374 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.601 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -43.26 147.74 0.7 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.795 . . . . 0.0 109.048 179.533 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.601 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 33.6 Cg_endo -75.59 -3.01 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.213 1.942 . . . . 0.0 110.009 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.44 -25.22 20.46 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.367 -0.833 . . . . 0.0 108.909 179.26 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 5.2 m-20 -81.92 -4.88 57.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.435 -0.79 . . . . 0.0 109.334 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 44' ' ' LEU . 13.6 mt -107.0 149.6 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 0.0 110.294 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.569 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -120.93 -28.1 4.87 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.248 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.569 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -135.93 169.17 18.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.105 179.323 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 25' ' ' SER . 48.9 t -156.66 126.27 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.718 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 55.5 t30 -108.49 157.93 18.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.339 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.07 95.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.493 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.526 ' CD ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -100.54 126.99 47.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.577 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 p -75.85 160.99 77.54 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.346 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.496 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.2 Cg_endo -77.15 145.61 24.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.509 2.14 . . . . 0.0 110.425 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.39 -133.64 1.55 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.97 41.46 1.12 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.719 2.279 . . . . 0.0 110.781 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.455 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 9.1 p-80 -162.11 -38.01 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.073 -1.017 . . . . 0.0 109.28 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 2.7 t -145.71 101.18 3.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.176 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.17 -12.46 20.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.725 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.459 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 1.9 mp0 -106.92 129.39 54.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.526 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.447 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 0.6 OUTLIER -48.49 162.82 0.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.192 -0.942 . . . . 0.0 109.292 179.887 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' A' ' 37' ' ' GLN . 2.6 mp0 -136.95 114.44 11.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.643 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 t -104.86 144.57 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.16 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.441 HD11 ' HB3' ' A' ' 27' ' ' ASN . 2.6 mp -133.34 152.35 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB3' HG23 ' A' ' 23' ' ' ILE . . . -137.6 116.49 12.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.866 . . . . 0.0 109.173 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.534 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.8 m -89.12 97.51 11.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.956 -1.09 . . . . 0.0 108.785 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 93.1 mt -44.72 166.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.522 -0.736 . . . . 0.0 109.6 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.2 ptpt -81.61 8.46 9.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.518 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.28 19.92 17.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.204 179.742 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 4.54 89.6 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.518 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 5.8 mtt180 -94.55 168.39 10.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -1.194 . . . . 0.0 109.508 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.93 156.72 48.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 179.808 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.4 120.03 7.0 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.308 -0.87 . . . . 0.0 109.098 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.526 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 8.0 m -79.74 139.08 37.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.077 -1.014 . . . . 0.0 108.948 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.537 HD23 ' CD1' ' A' ' 18' ' ' ILE . 10.4 mt -123.39 168.32 12.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.204 -0.935 . . . . 0.0 109.68 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 28.9 t-20 -101.65 119.89 55.94 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.5 -0.75 . . . . 0.0 109.334 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HA ' HG13 ' A' ' 59' ' ' VAL . 33.6 Cg_endo -74.84 1.39 7.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.127 1.885 . . . . 0.0 110.542 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.53 -17.36 30.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.219 -0.926 . . . . 0.0 108.964 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.456 ' OG ' HG23 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -90.16 164.06 29.26 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 109.456 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.29 -33.31 1.98 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.731 2.287 . . . . 0.0 110.671 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -67.26 -48.33 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.104 -0.998 . . . . 0.0 108.99 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.567 ' N ' ' CG2' ' A' ' 58' ' ' ILE . 33.7 t -57.38 -48.73 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 108.983 179.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.46 ' O ' ' OE2' ' A' ' 64' ' ' GLU . 4.9 mmmt -53.6 -32.2 50.15 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.527 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 3.1 mmpt? -73.64 -34.03 64.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.505 -0.747 . . . . 0.0 109.193 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 58' ' ' ILE . 1.5 mp -59.9 -44.68 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.807 . . . . 0.0 108.921 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.58 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -66.66 -62.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -0.869 . . . . 0.0 109.897 -179.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 60' ' ' LYS . 5.6 pt-20 -58.35 -15.81 12.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.992 -1.067 . . . . 0.0 109.517 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 7.8 mmtt -83.32 -36.18 24.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 108.795 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.457 ' HG3' HG22 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -68.99 -44.83 72.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.402 -0.811 . . . . 0.0 108.946 179.429 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.583 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -43.63 -50.74 7.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.328 179.68 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -72.84 -36.74 67.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.456 ' OG ' ' HA ' ' A' ' 66' ' ' MET . 25.2 p . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.452 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.526 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 8.8 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.521 ' HG3' ' CD ' ' B' ' 29' ' ' LYS . 13.8 mm100 -43.78 -24.92 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.336 -0.853 . . . . 0.0 109.998 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.451 ' HB2' ' HG3' ' B' ' 39' ' ' GLU . 66.3 m -139.8 77.97 1.64 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.072 -1.018 . . . . 0.0 109.986 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -50.53 -43.85 56.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 108.922 179.474 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.57 121.83 42.01 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.49 170.53 8.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 110.053 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' B' ' 51' ' ' CYS . 0.3 OUTLIER -127.61 148.74 50.37 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.754 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.496 ' O ' ' CG2' ' B' ' 59' ' ' VAL . 2.6 tt0 -44.36 -54.74 5.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.97 . . . . 0.0 109.451 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.517 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 149.1 168.59 14.88 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.572 ' N ' ' CD1' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -136.39 161.65 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -1.072 . . . . 0.0 109.359 179.746 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.59 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.5 OUTLIER -43.34 147.85 0.71 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.394 -0.816 . . . . 0.0 109.005 179.561 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 33.1 Cg_endo -75.61 -3.08 13.39 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.264 1.976 . . . . 0.0 109.941 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.457 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.49 -25.26 20.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.825 . . . . 0.0 108.807 179.383 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.53 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 5.3 m-20 -81.77 -4.96 57.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.444 -0.785 . . . . 0.0 109.398 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' B' ' 44' ' ' LEU . 13.7 mt -107.05 149.62 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 110.213 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.577 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -120.92 -28.03 4.88 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.267 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.577 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -136.05 169.1 18.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.33 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.452 HG22 ' O ' ' B' ' 25' ' ' SER . 48.7 t -156.56 126.27 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 109.752 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 55.6 t30 -108.47 157.99 17.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.329 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.13 95.42 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.521 ' CD ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -100.51 127.03 46.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.591 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.2 p -75.87 160.99 77.47 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.332 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.495 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.4 Cg_endo -77.11 145.55 24.67 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.575 2.183 . . . . 0.0 110.456 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.4 -133.63 1.54 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.0 41.53 1.14 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.595 2.197 . . . . 0.0 110.807 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.46 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 9.0 p-80 -162.09 -38.05 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.046 . . . . 0.0 109.269 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.495 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 2.7 t -145.7 101.31 3.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 0.0 109.131 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.28 -12.39 20.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.903 . . . . 0.0 109.737 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 1.9 mp0 -106.89 129.36 54.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -0.942 . . . . 0.0 109.503 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.458 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 0.6 OUTLIER -48.44 162.83 0.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 109.227 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' B' ' 37' ' ' GLN . 2.6 mp0 -136.94 114.42 10.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.687 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.1 t -104.85 144.47 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.851 . . . . 0.0 109.184 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' B' ' 27' ' ' ASN . 2.6 mp -133.24 152.37 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.81 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.458 ' HB3' HG23 ' B' ' 23' ' ' ILE . . . -137.62 116.43 12.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -0.888 . . . . 0.0 109.179 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.532 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 1.8 m -89.11 97.52 11.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.922 -1.111 . . . . 0.0 108.737 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 93.1 mt -44.62 166.75 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.556 -0.715 . . . . 0.0 109.628 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.2 ptpt -81.6 8.5 9.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.632 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -111.3 19.87 17.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.96 . . . . 0.0 109.228 179.71 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 4.59 89.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.512 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 5.8 mtt180 -94.59 168.35 10.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.162 -1.199 . . . . 0.0 109.55 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.89 156.74 48.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.82 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.39 120.08 7.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.335 -0.853 . . . . 0.0 109.052 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.526 ' O ' ' CD1' ' B' ' 15' ' ' LEU . 8.0 m -79.74 139.11 37.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 108.972 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.532 HD23 ' CD1' ' B' ' 18' ' ' ILE . 10.5 mt -123.47 168.36 12.67 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.149 -0.97 . . . . 0.0 109.67 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 29.1 t-20 -101.68 119.89 55.89 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 109.332 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.465 ' HA ' HG13 ' B' ' 59' ' ' VAL . 33.2 Cg_endo -74.84 1.3 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.183 1.922 . . . . 0.0 110.518 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.48 -17.31 30.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.912 . . . . 0.0 108.977 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.4 OUTLIER -90.2 164.01 29.3 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.82 . . . . 0.0 109.383 179.915 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.32 -33.22 1.99 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.624 2.216 . . . . 0.0 110.694 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.592 ' CD1' ' CD1' ' B' ' 62' ' ' ILE . 0.2 OUTLIER -67.21 -48.33 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.105 -0.997 . . . . 0.0 108.995 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.573 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 33.8 t -57.42 -48.72 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.414 -0.804 . . . . 0.0 108.981 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' B' ' 56' ' ' SER . 4.9 mmmt -53.63 -32.19 50.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.529 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 3.1 mmpt? -73.57 -34.19 65.01 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.592 ' CD1' ' CD1' ' B' ' 58' ' ' ILE . 1.5 mp -59.74 -44.79 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 108.955 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.583 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -66.72 -62.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 109.876 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.469 ' OE2' ' HA ' ' B' ' 61' ' ' LYS . 5.6 pt-20 -58.28 -15.85 11.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.99 . . . . 0.0 109.576 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 7.7 mmtt -83.29 -36.21 24.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 108.791 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.462 ' HA ' ' OG ' ' B' ' 69' ' ' SER . 0.2 OUTLIER -69.0 -44.79 72.1 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.484 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.58 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -43.68 -50.67 7.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.381 -0.824 . . . . 0.0 109.373 179.701 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -72.81 -36.73 67.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.884 . . . . 0.0 109.482 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' B' ' 66' ' ' MET . 25.6 p . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.381 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.455 ' HB3' ' OE2' ' A' ' 39' ' ' GLU . 58.4 m . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.515 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 22.1 mm100 -62.5 -10.01 10.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.891 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.448 ' SG ' ' HG2' ' A' ' 39' ' ' GLU . 39.7 m -138.83 67.93 1.39 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.005 -1.06 . . . . 0.0 109.851 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -45.13 -45.63 11.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.147 -0.97 . . . . 0.0 108.998 179.54 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.426 ' OE1' ' N ' ' A' ' 14' ' ' THR . 0.5 OUTLIER -118.14 116.9 27.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.463 -0.773 . . . . 0.0 108.95 179.541 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.426 ' N ' ' OE1' ' A' ' 13' ' ' GLN . 0.6 OUTLIER -90.24 171.08 9.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 110.048 -179.442 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.483 ' CD1' ' O ' ' A' ' 51' ' ' CYS . 1.0 OUTLIER -119.81 143.66 47.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.478 -0.763 . . . . 0.0 109.09 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -44.65 -38.27 4.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.084 -1.01 . . . . 0.0 109.287 -179.909 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.528 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 138.26 156.51 7.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.533 ' CD1' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -125.8 156.11 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -1.082 . . . . 0.0 109.332 179.592 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.592 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.94 153.99 0.31 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.852 . . . . 0.0 109.298 179.82 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.592 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.1 Cg_endo -76.27 -5.03 15.81 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.417 2.078 . . . . 0.0 109.943 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -81.73 -22.28 37.42 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.047 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.548 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 35.4 m-20 -98.58 60.03 1.3 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.461 ' CD1' ' O ' ' A' ' 22' ' ' ASN . 2.6 mm -143.78 167.5 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.937 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.565 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -160.18 -35.15 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.565 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.5 p -133.51 176.72 8.29 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.173 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.5 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 54.6 t -151.29 92.11 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.976 -1.078 . . . . 0.0 109.868 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 5.1 t-20 -94.03 110.63 22.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.219 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.438 HG11 HG21 ' A' ' 40' ' ' VAL . 1.9 t -121.77 100.15 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.584 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.515 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 9.6 ptpt -98.09 106.67 19.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.352 -0.843 . . . . 0.0 109.363 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 29' ' ' LYS . 1.1 p -45.87 170.54 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.398 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 35.6 Cg_endo -77.89 132.28 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.568 2.179 . . . . 0.0 110.407 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.33 -142.7 4.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.21 8.12 3.38 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.584 2.189 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.451 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 6.6 p-80 -124.44 -18.75 5.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 109.73 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -160.22 96.62 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 109.255 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -55.17 -29.16 57.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.55 125.33 35.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.505 HG21 ' N ' ' A' ' 39' ' ' GLU . 32.5 m -46.43 152.75 0.41 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.505 ' N ' HG21 ' A' ' 38' ' ' THR . 0.0 OUTLIER -129.31 121.67 27.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.65 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.522 ' CG1' HD12 ' A' ' 63' ' ' ILE . 16.2 t -108.14 150.34 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.22 179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 27' ' ' ASN . 14.4 mt -143.15 143.12 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.015 . . . . 0.0 109.846 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.428 ' N ' HG21 ' A' ' 41' ' ' ILE . . . -130.99 123.02 27.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 108.932 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.523 ' HB ' ' CB ' ' A' ' 25' ' ' SER . 40.5 m -89.39 103.26 15.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.967 -1.083 . . . . 0.0 109.097 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 73.1 mt -42.48 165.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.502 -0.749 . . . . 0.0 109.59 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.4 ptpt -87.27 16.44 5.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 44' ' ' LEU . 19.0 p-10 -117.27 6.02 12.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 109.399 179.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.53 14.46 44.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.424 ' C ' ' HG2' ' A' ' 49' ' ' LYS . 9.8 mtp180 -111.32 174.23 5.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -1.203 . . . . 0.0 109.553 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 6.8 mttt -138.26 156.69 47.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.25 120.48 7.29 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.331 -0.855 . . . . 0.0 109.058 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.483 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 20.6 m -79.31 140.59 37.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.12 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.533 HD23 ' CD1' ' A' ' 18' ' ' ILE . 10.2 mt -124.51 168.97 12.35 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.234 -0.916 . . . . 0.0 109.597 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.541 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 7.1 t30 -105.61 127.39 28.61 Favored Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.381 -0.824 . . . . 0.0 109.255 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.466 ' HA ' HG13 ' A' ' 59' ' ' VAL . 34.1 Cg_endo -75.71 2.21 7.22 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.236 1.957 . . . . 0.0 110.648 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.464 ' HB1' ' ND2' ' A' ' 53' ' ' ASN . . . -86.0 -19.03 30.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.033 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.471 ' OG ' HG23 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -90.22 162.7 34.04 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 109.526 179.95 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.76 -32.98 2.44 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.722 2.281 . . . . 0.0 111.002 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.508 HG21 ' N ' ' A' ' 59' ' ' VAL . 15.8 tt -70.54 -40.26 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.057 -1.027 . . . . 0.0 109.539 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.541 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 24.6 t -61.96 -48.19 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.343 -0.848 . . . . 0.0 108.951 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -60.9 -29.63 69.69 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -81.92 -19.7 40.24 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.867 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 16.4 mt -72.71 -38.86 59.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.546 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 1.5 mp -75.27 -61.84 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.33 -47.82 25.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.342 -0.849 . . . . 0.0 109.294 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 66' ' ' MET . 21.8 tptt -52.0 -57.3 9.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.185 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.5 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -44.36 -48.45 9.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.2 179.747 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.516 ' CD1' HG21 ' B' ' 63' ' ' ILE . 0.4 OUTLIER -48.81 -54.66 14.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.49 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' SER . 18.5 t30 -56.14 -32.82 64.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.484 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 68' ' ' ASN . 1.1 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.471 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.465 ' HB3' ' OE2' ' B' ' 39' ' ' GLU . 58.8 m . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.506 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 22.1 mm100 -62.55 -9.94 10.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.889 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.448 ' SG ' ' HG2' ' B' ' 39' ' ' GLU . 39.6 m -138.87 68.03 1.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 109.836 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.3 OUTLIER -45.28 -45.63 12.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 108.883 179.609 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . 0.417 ' OE1' ' N ' ' B' ' 14' ' ' THR . 0.5 OUTLIER -118.03 116.87 27.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 108.928 179.643 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.417 ' N ' ' OE1' ' B' ' 13' ' ' GLN . 0.6 OUTLIER -90.24 171.1 9.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -0.924 . . . . 0.0 110.042 -179.456 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.478 ' CD1' ' O ' ' B' ' 51' ' ' CYS . 1.0 OUTLIER -119.86 143.66 47.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.45 -0.781 . . . . 0.0 109.013 179.764 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.9 OUTLIER -44.58 -38.29 4.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 -179.962 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.514 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 138.26 156.52 7.14 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.537 ' CD1' HD23 ' B' ' 52' ' ' LEU . 0.2 OUTLIER -125.84 156.04 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -1.084 . . . . 0.0 109.316 179.579 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.584 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -42.8 154.03 0.31 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 109.31 179.797 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 33.6 Cg_endo -76.38 -5.0 15.74 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.377 2.051 . . . . 0.0 109.862 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -81.74 -22.2 37.44 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.532 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 35.6 m-20 -98.54 59.94 1.31 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.217 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.47 ' CD1' ' O ' ' B' ' 22' ' ' ASN . 2.6 mm -143.78 167.54 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.963 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.549 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -160.24 -35.1 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.273 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.549 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.4 p -133.46 176.77 8.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.009 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.507 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 54.0 t -151.31 92.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.897 -1.127 . . . . 0.0 109.86 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.455 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 5.1 t-20 -94.1 110.62 22.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.249 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.45 HG11 HG21 ' B' ' 40' ' ' VAL . 1.9 t -121.76 100.16 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.605 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.506 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 9.6 ptpt -98.05 106.66 18.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 109.401 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.463 ' O ' ' O ' ' B' ' 29' ' ' LYS . 1.1 p -45.9 170.57 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.399 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.525 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 35.9 Cg_endo -77.79 132.21 11.76 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.594 2.196 . . . . 0.0 110.499 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.32 -142.7 4.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.2 8.1 3.39 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.524 2.15 . . . . 0.0 110.873 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.453 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 6.6 p-80 -124.44 -18.66 5.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.006 -1.059 . . . . 0.0 109.757 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -160.22 96.59 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -0.948 . . . . 0.0 109.303 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -55.19 -29.12 57.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.941 . . . . 0.0 109.651 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.61 125.41 35.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.486 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.505 HG21 ' N ' ' B' ' 39' ' ' GLU . 32.4 m -46.41 152.74 0.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.424 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.505 ' N ' HG21 ' B' ' 38' ' ' THR . 0.0 OUTLIER -129.32 121.59 27.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.193 -0.942 . . . . 0.0 109.733 -179.929 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.518 ' CG1' HD12 ' B' ' 63' ' ' ILE . 16.2 t -108.17 150.36 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.24 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.456 HG13 ' O ' ' B' ' 40' ' ' VAL . 14.5 mt -143.19 143.12 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.438 ' N ' HG21 ' B' ' 41' ' ' ILE . . . -131.03 123.03 27.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 108.862 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' B' ' 25' ' ' SER . 41.8 m -89.31 103.24 15.88 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.943 -1.098 . . . . 0.0 109.182 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.532 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 72.5 mt -42.46 165.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.538 -0.726 . . . . 0.0 109.582 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.4 ptpt -87.26 16.38 5.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 109.555 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.523 ' OD1' ' CB ' ' B' ' 44' ' ' LEU . 19.0 p-10 -117.33 6.17 12.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.619 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.47 14.61 43.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.41 ' C ' ' HG2' ' B' ' 49' ' ' LYS . 9.7 mtp180 -111.43 174.26 5.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -1.207 . . . . 0.0 109.495 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.41 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 6.7 mttt -138.24 156.81 47.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.33 120.52 7.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.821 . . . . 0.0 109.02 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.478 ' O ' ' CD1' ' B' ' 15' ' ' LEU . 20.5 m -79.37 140.62 37.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.074 -1.016 . . . . 0.0 109.122 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.537 HD23 ' CD1' ' B' ' 18' ' ' ILE . 10.2 mt -124.51 168.96 12.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 7.1 t30 -105.57 127.39 28.62 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.795 . . . . 0.0 109.185 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.468 ' HA ' HG13 ' B' ' 59' ' ' VAL . 33.9 Cg_endo -75.74 2.27 7.17 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.208 1.939 . . . . 0.0 110.657 -179.563 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . 0.479 ' HB1' ' ND2' ' B' ' 53' ' ' ASN . . . -85.98 -19.1 30.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 0.0 109.074 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.473 ' OG ' HG23 ' B' ' 58' ' ' ILE . 0.4 OUTLIER -90.29 162.76 33.7 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.503 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.73 -33.0 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.755 2.303 . . . . 0.0 111.006 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.516 HG21 ' N ' ' B' ' 59' ' ' VAL . 15.9 tt -70.59 -40.16 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.109 -0.994 . . . . 0.0 109.51 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.549 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 24.5 t -62.07 -48.17 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.378 -0.827 . . . . 0.0 108.913 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -60.92 -29.7 69.76 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.525 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -81.81 -19.65 40.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 179.804 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.514 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 16.4 mt -72.76 -38.88 58.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.544 ' CD1' ' N ' ' B' ' 63' ' ' ILE . 1.5 mp -75.16 -61.91 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -47.86 25.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.38 -0.825 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' B' ' 66' ' ' MET . 21.9 tptt -51.85 -57.38 9.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.163 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.507 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -44.39 -48.48 9.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.173 179.783 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.527 ' CD1' HG21 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -48.77 -54.63 14.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 179.899 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' B' ' 69' ' ' SER . 18.5 t30 -56.27 -32.7 64.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 0.0 109.498 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.429 ' C ' ' O ' ' B' ' 68' ' ' ASN . 1.1 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 109.468 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.512 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 7.2 m . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.503 ' NE2' ' HG2' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -41.08 -38.38 1.02 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.515 -0.741 . . . . 0.0 109.736 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.446 ' SG ' HG13 ' A' ' 41' ' ' ILE . 72.3 m -136.56 78.21 1.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.695 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.512 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.87 -46.77 11.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.083 179.646 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -117.6 124.94 49.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.357 -0.839 . . . . 0.0 108.995 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 169.47 8.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 109.992 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 51' ' ' CYS . 4.8 mt -113.86 -167.42 1.2 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.523 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.4 mt-30 -88.92 -48.06 7.72 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 0.0 109.348 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.477 ' HA2' HD23 ' A' ' 52' ' ' LEU . . . 154.2 161.57 10.54 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -142.98 149.67 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.378 -1.072 . . . . 0.0 109.311 179.666 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.573 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.94 152.08 0.38 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 109.535 -179.865 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.573 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -77.18 -2.65 12.88 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.584 2.189 . . . . 0.0 110.177 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.47 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 3.9 mmtt -90.19 -24.55 20.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.113 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 6.1 m-20 -85.43 -5.88 59.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.323 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.517 ' CD1' HG21 ' A' ' 62' ' ' ILE . 9.4 mt -104.93 152.7 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.255 -0.903 . . . . 0.0 110.043 -179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.578 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -124.98 -28.44 3.46 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.441 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.578 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.9 OUTLIER -137.33 174.08 10.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.072 179.473 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.523 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 21.4 t -149.74 119.64 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.985 . . . . 0.0 109.788 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.46 ' O ' HD13 ' A' ' 41' ' ' ILE . 4.8 t-20 -112.85 112.7 24.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 109.338 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.33 109.89 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.489 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.567 ' CE ' ' NE2' ' A' ' 34' ' ' HIS . 7.4 tttt -107.68 107.79 18.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.445 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.433 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.1 p -50.66 168.42 0.23 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.41 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 35.8 Cg_endo -77.88 134.68 13.52 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.582 2.188 . . . . 0.0 110.422 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.8 -142.04 4.45 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.09 7.79 3.5 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.553 2.169 . . . . 0.0 110.88 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.567 ' NE2' ' CE ' ' A' ' 29' ' ' LYS . 8.0 p-80 -126.34 -7.55 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.079 -1.013 . . . . 0.0 109.628 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.446 ' SG ' ' OE2' ' A' ' 39' ' ' GLU . 4.2 t -160.3 146.47 15.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.288 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.3 0.84 23.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 37' ' ' GLN . 3.8 mp0 -126.88 124.91 40.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.004 . . . . 0.0 109.474 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.6 m -45.8 144.58 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 0.0 109.349 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 10' ' ' GLN . 4.6 mm-40 -122.47 107.24 11.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.664 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 41' ' ' ILE . 38.5 t -91.89 150.39 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.135 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 27' ' ' ASN . 3.1 mt -139.87 154.67 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.11 -0.994 . . . . 0.0 109.802 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.481 ' HB3' ' CG2' ' A' ' 23' ' ' ILE . . . -138.57 118.07 12.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.155 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.534 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.9 m -89.16 97.83 11.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.907 -1.121 . . . . 0.0 108.912 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 90.8 mt -44.0 166.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.488 -0.758 . . . . 0.0 109.66 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -81.58 8.06 10.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.699 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.517 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.01 24.68 12.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.225 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.16 3.93 71.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.517 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 6.9 mtt180 -93.2 166.56 12.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.146 -1.208 . . . . 0.0 109.454 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.4 155.6 49.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 0.0 109.433 -179.957 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.35 118.33 6.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.194 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.463 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 7.0 m -79.51 138.33 37.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.125 -0.984 . . . . 0.0 108.868 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.569 ' CD2' ' CD1' ' A' ' 18' ' ' ILE . 9.8 mt -124.0 168.61 12.6 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 65.5 t30 -101.49 121.38 51.67 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.47 -0.769 . . . . 0.0 109.446 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.494 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.7 Cg_endo -74.67 -2.25 12.2 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.163 1.909 . . . . 0.0 110.488 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.8 -17.38 41.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.304 -0.873 . . . . 0.0 108.849 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.469 ' OG ' HG21 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -90.27 163.08 32.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.443 179.919 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 35.9 Cg_endo -77.74 -35.32 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.638 2.226 . . . . 0.0 111.113 -179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.542 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 16.1 tt -67.9 -47.41 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.979 -1.076 . . . . 0.0 109.236 -179.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.55 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 32.7 t -55.04 -48.61 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.195 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.494 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 12.0 mttt -57.36 -31.32 65.63 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.525 ' CE ' ' OE2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -75.67 -27.59 58.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.655 -0.653 . . . . 0.0 109.342 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -67.33 -43.25 88.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.404 -0.81 . . . . 0.0 108.832 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.555 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.1 mp -69.53 -65.28 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.833 . . . . 0.0 109.721 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' OE2' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -49.01 -35.32 15.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.131 -0.98 . . . . 0.0 109.643 -179.703 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 21.3 mmtm -63.38 -54.0 43.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.09 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.523 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -49.06 -46.53 44.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.314 -0.866 . . . . 0.0 109.146 179.599 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.55 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 1.0 OUTLIER -56.87 -47.56 80.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.509 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.53 31.36 2.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.138 -0.976 . . . . 0.0 109.372 179.919 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.523 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 7.0 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.504 ' NE2' ' HG2' ' B' ' 29' ' ' LYS . 0.9 OUTLIER -41.02 -38.39 0.99 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.829 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.443 ' SG ' HG13 ' B' ' 41' ' ' ILE . 72.5 m -136.58 78.26 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.736 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.523 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.0 -46.74 11.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.059 179.71 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -117.57 125.06 50.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 108.968 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.99 169.42 8.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.215 -0.928 . . . . 0.0 109.992 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 51' ' ' CYS . 4.9 mt -113.89 -167.41 1.2 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.526 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.4 mt-30 -88.86 -48.17 7.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.126 -0.984 . . . . 0.0 109.299 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.483 ' HA2' HD23 ' B' ' 52' ' ' LEU . . . 154.26 161.55 10.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -143.0 149.79 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.357 -1.084 . . . . 0.0 109.267 179.589 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.57 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -42.98 152.12 0.38 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.356 -0.84 . . . . 0.0 109.468 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.57 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -77.28 -2.67 12.88 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.498 2.132 . . . . 0.0 110.092 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.469 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 3.9 mmtt -90.06 -24.61 21.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -0.847 . . . . 0.0 109.178 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.529 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 6.1 m-20 -85.33 -5.96 59.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.296 -0.878 . . . . 0.0 109.364 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.5 ' CD1' HG21 ' B' ' 62' ' ' ILE . 9.2 mt -104.89 152.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 110.089 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.576 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -124.9 -28.46 3.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.479 -0.763 . . . . 0.0 109.084 179.355 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.576 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.9 OUTLIER -137.24 174.2 10.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.902 . . . . 0.0 109.076 179.436 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.522 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 21.4 t -149.86 119.66 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.045 -1.034 . . . . 0.0 109.707 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.454 ' O ' HD13 ' B' ' 41' ' ' ILE . 4.8 t-20 -112.89 112.71 24.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.344 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.31 109.9 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 109.403 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.573 ' CE ' ' NE2' ' B' ' 34' ' ' HIS . 7.4 tttt -107.62 107.8 18.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.869 . . . . 0.0 109.444 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.416 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.1 p -50.7 168.48 0.23 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 36.0 Cg_endo -77.89 134.65 13.49 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.666 2.244 . . . . 0.0 110.424 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.81 -142.01 4.44 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.1 7.75 3.52 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.651 2.234 . . . . 0.0 110.816 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.573 ' NE2' ' CE ' ' B' ' 29' ' ' LYS . 8.0 p-80 -126.35 -7.59 6.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 109.608 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.444 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 4.2 t -160.23 146.52 15.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.287 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.29 0.76 23.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.151 -0.968 . . . . 0.0 109.706 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.42 ' CD ' ' N ' ' B' ' 37' ' ' GLN . 3.9 mp0 -126.88 125.01 40.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.129 -0.982 . . . . 0.0 109.506 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 23.8 m -45.78 144.58 1.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 109.307 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' B' ' 10' ' ' GLN . 4.6 mm-40 -122.48 107.24 11.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 109.624 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.447 ' O ' HG13 ' B' ' 41' ' ' ILE . 38.6 t -91.84 150.35 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.199 179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.454 HD13 ' O ' ' B' ' 27' ' ' ASN . 3.1 mt -139.89 154.79 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.785 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.479 ' HB3' ' CG2' ' B' ' 23' ' ' ILE . . . -138.61 118.02 12.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 109.117 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 1.8 m -89.18 97.74 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.036 -1.04 . . . . 0.0 108.966 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 90.8 mt -43.95 166.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.456 -0.778 . . . . 0.0 109.617 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.469 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -81.64 8.12 10.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 109.664 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.02 24.64 12.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 109.227 179.726 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.1 4.01 71.21 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.511 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 6.9 mtt180 -93.23 166.51 12.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.164 -1.197 . . . . 0.0 109.499 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.38 155.7 49.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.427 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.4 118.39 6.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 109.143 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 6.9 m -79.56 138.31 37.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.124 -0.985 . . . . 0.0 108.83 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.562 ' CD2' ' CD1' ' B' ' 18' ' ' ILE . 9.7 mt -123.95 168.58 12.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.129 -0.982 . . . . 0.0 109.581 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 65.5 t30 -101.56 121.5 51.12 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.44 -0.787 . . . . 0.0 109.458 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.489 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.2 Cg_endo -74.79 -2.18 12.14 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.182 1.921 . . . . 0.0 110.462 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.85 -17.45 40.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.911 . . . . 0.0 108.763 179.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.474 ' OG ' HG21 ' B' ' 58' ' ' ILE . 0.8 OUTLIER -90.25 163.15 32.53 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.442 -0.786 . . . . 0.0 109.433 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.459 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.74 -35.47 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.781 2.321 . . . . 0.0 111.082 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 16.2 tt -67.83 -47.56 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.001 -1.062 . . . . 0.0 109.189 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.557 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 33.1 t -54.97 -48.71 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.135 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.489 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 12.0 mttt -57.21 -31.37 65.4 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.22 -0.925 . . . . 0.0 108.514 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.514 ' CE ' ' OE2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -75.67 -27.6 58.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.317 179.947 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -67.44 -43.26 87.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.55 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.1 mp -69.56 -65.31 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.679 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.514 ' OE2' ' CE ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -49.04 -35.3 15.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 109.538 -179.62 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.464 ' HB3' ' CB ' ' B' ' 20' ' ' PRO . 21.3 mmtm -63.35 -54.02 43.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.069 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.522 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 1.0 OUTLIER -49.2 -46.27 45.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 0.0 109.222 179.664 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.555 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -56.96 -47.56 80.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.436 -0.79 . . . . 0.0 109.453 179.871 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.49 31.32 2.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.947 . . . . 0.0 109.572 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 56.9 p . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.364 -179.992 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.527 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 9.6 m . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.46 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 47.0 mm-40 -49.87 -21.21 1.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.453 ' SG ' HG13 ' A' ' 41' ' ' ILE . 83.1 m -141.47 71.43 1.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.598 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.29 -44.58 8.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.219 179.727 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.54 121.12 37.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.418 -0.801 . . . . 0.0 109.228 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.02 160.53 14.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.854 . . . . 0.0 109.807 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 51' ' ' CYS . 4.5 mt -103.69 142.78 33.75 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 15' ' ' LEU . 1.4 tt0 -44.75 -26.59 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.124 -0.985 . . . . 0.0 109.125 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.523 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 154.86 -178.91 31.31 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.439 HG21 HD12 ' A' ' 62' ' ' ILE . 4.6 tp -155.72 170.62 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.501 -1.0 . . . . 0.0 108.925 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.574 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.6 t-80 -60.0 143.71 87.59 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.068 -1.02 . . . . 0.0 108.973 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -77.26 -24.64 9.22 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.443 2.095 . . . . 0.0 110.267 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.473 ' O ' ' HE2' ' A' ' 45' ' ' LYS . 13.2 mttm -90.52 -13.74 34.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.81 . . . . 0.0 109.175 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.571 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 92.4 m-20 -80.18 -15.34 57.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.528 HD11 ' CG2' ' A' ' 62' ' ' ILE . 6.9 mt -90.0 162.46 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.415 -0.803 . . . . 0.0 110.696 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -128.61 -39.65 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.198 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 1.5 p -126.86 172.09 10.7 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.304 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 78.4 t -143.97 93.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.993 -1.067 . . . . 0.0 109.716 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.458 ' O ' HD13 ' A' ' 41' ' ' ILE . 3.4 t-20 -86.85 108.72 18.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.319 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -104.66 94.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.937 . . . . 0.0 109.545 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HE2' ' HG3' ' A' ' 10' ' ' GLN . 3.6 tppt? -90.6 92.58 8.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.443 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.51 ' HB3' ' CE ' ' B' ' 66' ' ' MET . 1.0 OUTLIER -45.99 170.96 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.488 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.6 Cg_endo -77.76 140.08 18.27 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.644 2.229 . . . . 0.0 110.458 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.91 -142.44 3.66 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.82 39.22 0.81 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.689 2.259 . . . . 0.0 110.782 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.482 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 6.0 p-80 -158.67 -38.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.012 -1.055 . . . . 0.0 109.301 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -138.01 102.18 4.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.277 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 31' ' ' PRO . . . -62.99 -29.16 70.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.699 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.71 125.73 34.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.512 HG21 ' N ' ' A' ' 39' ' ' GLU . 73.5 m -48.54 148.81 1.87 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.269 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.512 ' N ' HG21 ' A' ' 38' ' ' THR . 21.5 mm-40 -125.07 123.46 39.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.628 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.8 t -107.55 145.53 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.266 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 27' ' ' ASN . 3.6 mp -134.88 144.29 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.518 ' CB ' HG21 ' A' ' 23' ' ' ILE . . . -131.27 117.71 19.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.301 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 3.4 m -89.29 95.83 10.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.949 -1.094 . . . . 0.0 108.896 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 85.1 mt -42.16 163.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.548 -0.72 . . . . 0.0 109.962 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HB3' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -81.01 10.77 4.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.838 . . . . 0.0 109.872 179.905 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.477 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -110.71 14.0 22.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.13 -0.982 . . . . 0.0 109.225 179.61 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.07 15.82 68.8 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.477 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 8.9 mtp-105 -108.04 175.63 5.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -1.142 . . . . 0.0 109.414 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.439 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -143.29 152.47 41.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.21 122.23 8.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.856 . . . . 0.0 108.898 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.461 ' O ' HD13 ' A' ' 15' ' ' LEU . 23.0 m -79.76 143.16 34.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 0.0 109.277 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.544 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 18.7 mt -128.19 168.03 16.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 109.081 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 2.5 t-20 -104.87 127.72 28.23 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 109.47 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.527 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.8 Cg_endo -75.46 -11.56 20.66 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.33 2.02 . . . . 0.0 110.49 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.12 -17.41 61.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.102 -0.999 . . . . 0.0 108.969 179.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.466 ' OG ' HG21 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -90.27 162.15 35.44 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 179.941 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.411 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.08 -35.08 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.702 2.268 . . . . 0.0 111.098 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.523 ' CG2' ' HA3' ' A' ' 17' ' ' GLY . 2.9 tt -68.24 -45.15 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.065 -1.022 . . . . 0.0 109.397 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.553 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 40.3 t -59.04 -45.87 92.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 18.2 mttt -60.08 -29.39 68.54 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 2.5 mmpt? -79.55 -23.54 42.75 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 20.5 mt -70.85 -37.91 70.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.584 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -74.69 -56.74 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.475 -0.765 . . . . 0.0 109.296 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -59.36 -28.12 66.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.962 . . . . 0.0 109.226 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -70.61 -52.06 23.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 108.914 179.611 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.519 ' CE ' ' HB3' ' B' ' 30' ' ' SER . 0.4 OUTLIER -49.58 -44.37 46.88 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.276 -0.89 . . . . 0.0 108.949 179.473 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.578 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -55.08 -59.17 5.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.547 -0.72 . . . . 0.0 109.566 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -79.89 5.33 14.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.725 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.467 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 85.6 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.393 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.516 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 9.3 m . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.437 ' HG3' ' HE2' ' B' ' 29' ' ' LYS . 47.1 mm-40 -49.85 -21.13 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.713 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.453 ' SG ' HG13 ' B' ' 41' ' ' ILE . 82.6 m -141.59 71.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.062 -1.024 . . . . 0.0 109.652 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.516 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.25 -44.55 8.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.232 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.55 121.11 37.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.252 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.96 160.44 14.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.807 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.463 HD13 ' O ' ' B' ' 51' ' ' CYS . 4.4 mt -103.65 142.76 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' B' ' 15' ' ' LEU . 1.4 tt0 -44.73 -26.56 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.157 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.519 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 154.8 -178.92 31.26 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.431 HG21 HD12 ' B' ' 62' ' ' ILE . 4.6 tp -155.7 170.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.467 -1.019 . . . . 0.0 108.963 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.581 ' CB ' ' ND2' ' B' ' 22' ' ' ASN . 1.6 t-80 -59.98 143.71 87.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 108.993 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.26 -24.69 9.17 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.51 2.14 . . . . 0.0 110.318 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.46 ' O ' ' HE2' ' B' ' 45' ' ' LYS . 13.2 mttm -90.42 -13.81 34.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 109.235 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.581 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 92.5 m-20 -80.12 -15.45 57.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.526 HG21 ' CB ' ' B' ' 42' ' ' ALA . 6.9 mt -90.08 162.43 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.43 -0.794 . . . . 0.0 110.668 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.2 OUTLIER -128.61 -39.65 1.63 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.273 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 1.5 p -126.79 172.07 10.68 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.321 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' B' ' 41' ' ' ILE . 77.8 t -144.05 93.6 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.004 -1.06 . . . . 0.0 109.703 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.454 ' HB3' HD11 ' B' ' 41' ' ' ILE . 3.4 t-20 -86.85 108.77 18.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.32 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.8 t -104.63 94.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.2 -0.938 . . . . 0.0 109.609 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' B' ' 30' ' ' SER . 3.6 tppt? -90.67 92.64 8.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.423 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.519 ' HB3' ' CE ' ' A' ' 66' ' ' MET . 1.0 OUTLIER -46.11 171.03 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.0 109.483 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.9 Cg_endo -77.86 140.11 18.08 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.574 2.183 . . . . 0.0 110.473 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.9 -142.49 3.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.74 39.16 0.8 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.666 2.244 . . . . 0.0 110.893 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.479 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 6.0 p-80 -158.7 -38.52 0.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.07 -1.019 . . . . 0.0 109.32 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -138.14 102.21 4.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.231 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' B' ' 31' ' ' PRO . . . -62.92 -29.23 70.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.706 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.68 125.67 34.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.954 . . . . 0.0 109.561 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.505 HG21 ' N ' ' B' ' 39' ' ' GLU . 71.8 m -48.53 148.77 1.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.917 . . . . 0.0 109.34 179.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . 0.505 ' N ' HG21 ' B' ' 38' ' ' THR . 21.5 mm-40 -125.05 123.4 39.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.613 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 16.7 t -107.44 145.58 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.89 . . . . 0.0 109.337 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 3.6 mp -134.92 144.33 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.182 -0.949 . . . . 0.0 109.605 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.526 ' CB ' HG21 ' B' ' 23' ' ' ILE . . . -131.37 117.73 19.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.292 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 3.4 m -89.36 95.88 10.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.894 -1.129 . . . . 0.0 108.949 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 85.1 mt -42.07 163.63 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.529 -0.732 . . . . 0.0 109.926 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.504 ' HB3' ' NZ ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -81.02 10.83 4.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.377 -0.827 . . . . 0.0 109.838 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -110.77 13.96 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.142 179.678 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.08 15.79 68.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.474 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 8.9 mtp-105 -108.05 175.57 5.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -1.135 . . . . 0.0 109.484 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.438 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 0.3 OUTLIER -143.23 152.46 41.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.891 . . . . 0.0 109.438 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.18 122.2 8.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.244 -0.91 . . . . 0.0 108.983 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.463 ' O ' HD13 ' B' ' 15' ' ' LEU . 23.0 m -79.77 143.19 34.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.166 -0.959 . . . . 0.0 109.308 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.536 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 18.7 mt -128.24 167.97 16.13 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 109.013 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 2.6 t-20 -104.96 127.81 27.98 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.425 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.526 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.9 Cg_endo -75.5 -11.59 20.58 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.349 2.033 . . . . 0.0 110.45 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.07 -17.36 61.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 109.09 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.475 ' OG ' HG21 ' B' ' 58' ' ' ILE . 0.6 OUTLIER -90.29 162.16 35.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 109.504 179.916 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -78.1 -35.12 1.41 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.762 2.308 . . . . 0.0 111.086 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.525 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 2.9 tt -68.19 -45.19 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.065 -1.022 . . . . 0.0 109.424 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.553 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 40.5 t -58.9 -45.96 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.056 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 18.2 mttt -60.06 -29.47 68.57 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' B' ' 65' ' ' LYS . 2.5 mmpt? -79.53 -23.44 42.87 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 20.5 mt -70.94 -37.81 69.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.578 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -74.68 -56.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.322 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.3 OUTLIER -59.35 -28.06 66.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.329 179.838 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 0.0 OUTLIER -70.64 -52.09 23.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 108.909 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.51 ' CE ' ' HB3' ' A' ' 30' ' ' SER . 0.5 OUTLIER -49.59 -44.37 46.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.009 179.422 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.584 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -55.02 -59.19 5.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.65 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -79.87 5.34 13.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.927 . . . . 0.0 109.76 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' B' ' 66' ' ' MET . 85.5 p . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.448 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.456 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 18.7 m . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.466 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 19.1 mm-40 -64.68 -8.06 13.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.816 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.453 ' SG ' HG13 ' A' ' 41' ' ' ILE . 73.8 m -144.66 71.66 1.31 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.066 -1.021 . . . . 0.0 109.711 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.456 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 52.4 mt -46.29 -42.49 14.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.187 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -119.76 122.09 40.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.114 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -101.21 158.73 15.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.834 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 51' ' ' CYS . 3.5 mt -102.85 139.92 37.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -43.96 -26.89 0.31 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.222 179.943 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . 0.46 ' HA2' HG21 ' A' ' 59' ' ' VAL . . . 157.98 -179.89 33.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.458 HG23 HD12 ' A' ' 52' ' ' LEU . 4.6 tp -154.98 170.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.548 -0.972 . . . . 0.0 108.801 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.58 ' CB ' ' ND2' ' A' ' 22' ' ' ASN . 3.4 t-80 -59.19 141.97 86.43 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.985 -1.072 . . . . 0.0 109.055 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.3 Cg_endo -77.59 -23.62 9.63 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.499 2.133 . . . . 0.0 110.273 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 9.5 mmtp -90.25 -15.09 32.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.434 -0.791 . . . . 0.0 109.129 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.58 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 84.8 m-20 -78.94 -27.76 43.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -0.788 . . . . 0.0 109.377 179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.525 HG23 ' N ' ' A' ' 24' ' ' GLN . 6.5 mt -77.44 163.7 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.828 0.823 . . . . 0.0 110.697 -179.014 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.525 ' N ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -129.62 -41.26 1.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.109 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 10.9 p -124.97 166.69 15.88 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.075 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 50.8 t -145.2 98.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.051 -1.03 . . . . 0.0 109.772 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 49.8 t-20 -84.35 133.23 34.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.189 -0.944 . . . . 0.0 109.383 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' B' ' 26' ' ' VAL . 2.2 t -118.08 82.34 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.982 . . . . 0.0 109.516 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HD3' ' HG3' ' A' ' 10' ' ' GLN . 20.9 mtpt -87.32 103.62 15.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.524 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.1 p -57.63 163.8 3.49 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 109.334 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.44 132.21 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.598 2.199 . . . . 0.0 110.473 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.73 -141.13 3.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.06 7.61 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.663 2.242 . . . . 0.0 110.852 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.466 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 6.4 p-80 -124.88 -14.82 6.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.059 -1.026 . . . . 0.0 109.775 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.38 125.56 3.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -0.996 . . . . 0.0 109.363 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.42 ' O ' ' CD ' ' A' ' 37' ' ' GLN . . . -87.19 17.49 4.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.617 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . 0.42 ' CD ' ' O ' ' A' ' 36' ' ' ALA . 9.6 mm-40 -143.36 125.77 15.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.924 . . . . 0.0 109.524 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.458 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 3.2 m -44.32 157.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 109.313 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -132.64 107.1 8.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 109.576 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.517 ' CG1' HD12 ' A' ' 63' ' ' ILE . 1.7 t -101.98 93.64 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.907 . . . . 0.0 109.269 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 27' ' ' ASN . 3.4 mp -82.18 150.41 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.724 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.521 ' CB ' HG12 ' A' ' 23' ' ' ILE . . . -132.65 114.91 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 108.994 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 4.3 m -89.22 98.16 11.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.879 -1.138 . . . . 0.0 108.992 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 93.1 mt -41.14 163.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.305 0.574 . . . . 0.0 109.931 -179.715 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -82.06 11.09 5.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 0.0 109.921 -179.785 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' A' ' 44' ' ' LEU . 23.4 p-10 -112.56 8.09 19.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.076 -1.015 . . . . 0.0 109.419 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.59 1.66 63.82 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.414 ' C ' ' HG2' ' A' ' 49' ' ' LYS . 19.4 mtt180 -96.57 165.63 12.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -1.194 . . . . 0.0 109.545 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 2.2 mttt -133.02 153.16 51.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.466 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.3 123.39 8.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 108.908 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 35.6 m -79.62 140.94 36.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.072 -1.017 . . . . 0.0 109.305 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.54 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 16.0 mt -125.37 168.24 13.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.379 -0.826 . . . . 0.0 109.224 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.533 ' O ' ' CG2' ' A' ' 59' ' ' VAL . 1.6 m-20 -106.28 124.84 34.53 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.434 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.458 ' HG3' ' HB ' ' A' ' 38' ' ' THR . 33.5 Cg_endo -75.26 -7.01 18.57 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.359 2.039 . . . . 0.0 110.327 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 -17.52 50.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.227 -0.921 . . . . 0.0 108.963 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.465 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 163.7 30.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.413 -0.804 . . . . 0.0 109.321 179.866 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.434 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.45 -36.55 1.23 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.589 2.193 . . . . 0.0 110.678 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.452 HG21 HD13 ' A' ' 62' ' ' ILE . 52.4 mt -61.47 -48.07 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.539 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.54 ' CG2' ' HB3' ' A' ' 52' ' ' LEU . 76.6 t -62.25 -50.0 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.353 -0.842 . . . . 0.0 109.615 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 56' ' ' SER . 6.0 mttt -51.24 -30.72 18.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.122 -0.986 . . . . 0.0 108.722 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.475 ' HA ' ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -78.45 -34.54 47.67 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 14.2 mt -59.68 -38.34 75.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.551 -0.718 . . . . 0.0 109.28 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.589 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -74.52 -62.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.475 ' CG ' ' HA ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -53.14 -20.09 3.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 109.394 -179.931 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -79.64 -40.24 29.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.913 . . . . 0.0 109.026 179.729 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.449 ' SD ' ' OG ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -65.19 -45.79 83.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 108.995 179.613 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.591 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -43.5 -50.28 7.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.527 -0.733 . . . . 0.0 109.487 179.822 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -76.81 -27.07 55.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.845 . . . . 0.0 109.614 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.449 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 109.676 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . 0.466 ' HB2' HD21 ' B' ' 12' ' ' LEU . 18.5 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 10' ' ' GLN . . . . . 0.446 ' HG3' ' HD3' ' B' ' 29' ' ' LYS . 19.0 mm-40 -64.77 -8.0 13.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 0.0 109.78 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 11' ' ' CYS . . . . . 0.456 ' SG ' HG13 ' B' ' 41' ' ' ILE . 73.6 m -144.69 71.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.082 -1.011 . . . . 0.0 109.657 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' B' ' 9' ' ' CYS . 52.6 mt -46.29 -42.54 14.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.17 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -119.73 122.06 40.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 109.123 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 14' ' ' THR . . . . . 0.45 ' OG1' ' OD1' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -101.22 158.65 15.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.816 -179.692 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' B' ' 51' ' ' CYS . 3.5 mt -102.79 139.93 37.72 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 16' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.6 OUTLIER -43.96 -26.95 0.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.176 179.969 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 17' ' ' GLY . . . . . 0.442 ' HA2' HG21 ' B' ' 59' ' ' VAL . . . 158.03 -179.89 33.41 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.464 HG21 HD12 ' B' ' 62' ' ' ILE . 4.5 tp -155.03 170.9 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.571 -0.958 . . . . 0.0 108.745 -179.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.58 ' CB ' ' ND2' ' B' ' 22' ' ' ASN . 3.4 t-80 -59.14 142.03 86.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.028 -1.045 . . . . 0.0 109.109 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 20' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.1 Cg_endo -77.73 -23.53 9.52 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.517 2.145 . . . . 0.0 110.238 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.526 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 9.5 mmtp -90.29 -15.0 32.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.404 -0.81 . . . . 0.0 109.139 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 22' ' ' ASN . . . . . 0.58 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 84.8 m-20 -78.99 -27.7 43.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.431 -0.793 . . . . 0.0 109.403 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.519 HG23 ' N ' ' B' ' 24' ' ' GLN . 6.5 mt -77.45 163.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.751 0.786 . . . . 0.0 110.743 -179.029 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 24' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.2 OUTLIER -129.65 -41.25 1.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.07 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 25' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 11.0 p -124.92 166.72 15.79 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 26' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 28' ' ' VAL . 51.3 t -145.26 98.78 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.998 -1.064 . . . . 0.0 109.779 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 27' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 50.0 t-20 -84.4 133.21 34.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 28' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 25' ' ' SER . 2.2 t -118.02 82.25 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.142 -0.974 . . . . 0.0 109.591 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 29' ' ' LYS . . . . . 0.446 ' HD3' ' HG3' ' B' ' 10' ' ' GLN . 20.9 mtpt -87.36 103.64 15.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 30' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.1 p -57.56 163.85 3.37 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.342 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.44 132.21 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.581 2.187 . . . . 0.0 110.436 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.74 -141.01 3.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.18 7.69 3.58 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.592 2.194 . . . . 0.0 110.84 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 34' ' ' HIS . . . . . 0.464 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 6.4 p-80 -124.92 -14.74 6.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.007 -1.058 . . . . 0.0 109.761 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.36 125.62 3.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.97 . . . . 0.0 109.332 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 36' ' ' ALA . . . . . 0.42 ' O ' ' CD ' ' B' ' 37' ' ' GLN . . . -87.23 17.55 4.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.626 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 37' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' B' ' 38' ' ' THR . 9.7 mm-40 -143.42 125.74 15.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.504 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 38' ' ' THR . . . . . 0.448 ' HB ' ' HG3' ' B' ' 54' ' ' PRO . 3.2 m -44.32 157.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 0.0 109.309 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -132.61 107.01 8.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.571 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.528 ' CG1' HD12 ' B' ' 63' ' ' ILE . 1.7 t -101.86 93.57 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.202 -0.936 . . . . 0.0 109.335 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 41' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 3.5 mp -82.19 150.42 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.726 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 42' ' ' ALA . . . . . 0.512 ' CB ' HG12 ' B' ' 23' ' ' ILE . . . -132.68 114.9 14.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.852 . . . . 0.0 109.004 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 43' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 4.4 m -89.23 98.2 11.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.856 -1.152 . . . . 0.0 108.996 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 44' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' B' ' 22' ' ' ASN . 93.1 mt -41.16 163.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.686 -0.634 . . . . 0.0 109.877 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 45' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -82.09 11.04 5.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.921 -179.818 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 46' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' B' ' 44' ' ' LEU . 23.4 p-10 -112.44 7.98 19.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.034 -1.042 . . . . 0.0 109.535 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.56 1.84 63.76 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 48' ' ' ARG . . . . . 0.404 ' C ' ' HG2' ' B' ' 49' ' ' LYS . 19.4 mtt180 -96.66 165.67 12.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -1.226 . . . . 0.0 109.535 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.404 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 2.2 mttt -132.99 153.2 51.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.481 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.27 123.4 8.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 108.91 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 51' ' ' CYS . . . . . 0.458 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 35.7 m -79.6 140.93 36.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.035 -1.041 . . . . 0.0 109.299 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 52' ' ' LEU . . . . . 0.535 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 15.9 mt -125.41 168.3 13.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.296 -0.877 . . . . 0.0 109.227 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 53' ' ' ASN . . . . . 0.529 ' O ' ' CG2' ' B' ' 59' ' ' VAL . 1.6 m-20 -106.41 124.87 34.38 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.407 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 54' ' ' PRO . . . . . 0.459 ' HB3' HG23 ' B' ' 40' ' ' VAL . 34.1 Cg_endo -75.22 -6.92 18.49 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.308 2.005 . . . . 0.0 110.422 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.94 -17.58 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 108.915 179.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 56' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -90.02 163.76 30.78 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.356 -0.84 . . . . 0.0 109.323 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 57' ' ' PRO . . . . . 0.443 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.57 -36.46 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.633 2.222 . . . . 0.0 110.667 -179.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 58' ' ' ILE . . . . . 0.454 HG21 HD13 ' B' ' 62' ' ' ILE . 52.6 mt -61.42 -48.14 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.652 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 59' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' B' ' 52' ' ' LEU . 76.6 t -62.19 -50.05 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.83 . . . . 0.0 109.617 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 60' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' B' ' 56' ' ' SER . 6.0 mttt -51.2 -30.75 18.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.084 -1.01 . . . . 0.0 108.735 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 61' ' ' LYS . . . . . 0.487 ' HA ' ' CG ' ' B' ' 64' ' ' GLU . 0.0 OUTLIER -78.45 -34.51 47.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.856 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 14.2 mt -59.7 -38.43 75.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.543 -0.723 . . . . 0.0 109.229 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 63' ' ' ILE . . . . . 0.591 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -74.5 -62.29 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.64 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 64' ' ' GLU . . . . . 0.487 ' CG ' ' HA ' ' B' ' 61' ' ' LYS . 0.2 OUTLIER -53.14 -20.1 3.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.413 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -79.64 -40.14 29.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.868 . . . . 0.0 109.031 179.749 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 66' ' ' MET . . . . . 0.446 ' SD ' ' OG ' ' B' ' 69' ' ' SER . 0.6 OUTLIER -65.16 -45.87 83.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.841 . . . . 0.0 108.994 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 67' ' ' LEU . . . . . 0.589 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -43.42 -50.34 6.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.476 -0.765 . . . . 0.0 109.46 179.858 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -76.8 -27.09 55.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.833 . . . . 0.0 109.558 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 69' ' ' SER . . . . . 0.446 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.316 -0.865 . . . . 0.0 109.707 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.279 0.561 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 t -176.01 90.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.506 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.481 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 12.0 p -169.88 114.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.467 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.52 ' O ' ' CG2' ' A' ' 5' ' ' THR . . . -177.62 81.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.865 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 4' ' ' ALA . 13.7 t 41.88 33.45 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.424 -0.798 . . . . 0.0 109.667 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -117.74 63.47 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.534 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.502 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -124.5 101.53 7.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.183 -0.948 . . . . 0.0 109.582 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 10' ' ' GLN . 22.4 mtp180 -104.72 152.84 22.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 109.045 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.466 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 97.2 m -44.24 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.127 -0.983 . . . . 0.0 109.373 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -42.66 -26.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 109.763 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.467 ' HB2' ' HB3' ' A' ' 39' ' ' GLU . 97.1 m -122.22 66.17 0.93 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.996 . . . . 0.0 109.799 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.85 -38.9 4.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.967 . . . . 0.0 108.735 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.42 -173.3 2.44 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.451 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -160.15 158.06 29.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.04 -1.038 . . . . 0.0 109.935 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.5 mt -116.93 142.76 46.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.474 -0.766 . . . . 0.0 109.043 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -44.04 -33.3 1.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 109.362 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.481 ' O ' ' CG2' ' A' ' 18' ' ' ILE . . . 147.34 -166.47 28.59 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.586 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.3 pp -171.53 163.45 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.44 -1.035 . . . . 0.0 109.076 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.543 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -57.39 149.74 47.39 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.204 -0.935 . . . . 0.0 109.234 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -77.25 -4.34 14.66 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.516 2.144 . . . . 0.0 110.19 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.18 -24.02 21.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.362 -0.836 . . . . 0.0 109.197 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.0 m-20 -84.01 -15.87 46.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -0.855 . . . . 0.0 109.213 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.586 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 17.3 mt -89.32 169.04 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.434 -0.791 . . . . 0.0 110.245 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.524 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -137.49 -39.98 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.425 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 5.9 p -128.2 173.36 10.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.458 -0.776 . . . . 0.0 109.029 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.522 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 47.7 t -142.22 95.5 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.464 ' HB3' HD11 ' A' ' 41' ' ' ILE . 5.1 t-20 -93.06 111.58 23.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.925 . . . . 0.0 109.417 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -109.35 97.69 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.404 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.504 ' HD2' ' NE2' ' A' ' 10' ' ' GLN . 1.9 ttmt -90.59 110.28 21.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.2 p -63.68 167.72 6.8 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.355 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.6 Cg_endo -77.61 145.62 23.41 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.603 2.202 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.95 -140.05 2.97 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.448 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 36.1 Cg_endo -77.87 10.71 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.596 2.197 . . . . 0.0 111.023 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.506 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 3.3 p-80 -127.76 -32.91 2.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.559 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -145.45 115.89 7.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 109.265 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.92 6.97 11.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.694 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.42 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 1.6 mp0 -120.71 124.62 45.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 m -46.76 156.85 0.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 109.317 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 7.1 mm-40 -141.37 107.56 5.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.933 . . . . 0.0 109.627 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.53 ' CG1' HD12 ' A' ' 63' ' ' ILE . 41.2 t -90.56 150.4 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.225 -0.922 . . . . 0.0 109.272 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.51 ' N ' HG11 ' A' ' 40' ' ' VAL . 3.4 mt -140.29 147.79 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.71 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.525 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -135.39 120.05 18.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.404 -0.81 . . . . 0.0 109.162 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 8.6 m -89.3 100.95 13.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.94 -1.1 . . . . 0.0 109.01 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 84.5 mt -46.08 172.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.47 -0.769 . . . . 0.0 109.732 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HD2' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -87.93 10.47 18.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.215 -0.928 . . . . 0.0 109.179 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.502 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -114.04 27.52 9.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.325 -0.86 . . . . 0.0 109.134 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.13 11.14 70.2 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.502 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 3.8 mtp180 -100.18 165.91 11.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -1.157 . . . . 0.0 109.443 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.83 154.06 50.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.214 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.18 123.7 9.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.213 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.7 m -79.49 144.96 33.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.956 . . . . 0.0 109.169 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 15.4 mt -121.99 167.54 12.97 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.447 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.549 ' N ' HG23 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -97.14 118.08 65.06 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.467 -0.771 . . . . 0.0 109.201 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.412 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 33.1 Cg_endo -74.24 -0.35 9.51 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.175 1.917 . . . . 0.0 110.376 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.28 -14.08 27.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.325 -0.859 . . . . 0.0 108.906 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.444 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.11 162.61 34.56 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.392 -0.818 . . . . 0.0 109.391 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.463 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.06 -36.17 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.694 2.263 . . . . 0.0 110.659 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.468 HG21 HD13 ' A' ' 62' ' ' ILE . 65.3 mt -66.41 -36.39 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 109.661 -179.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.549 HG23 ' N ' ' A' ' 53' ' ' ASN . 37.7 t -67.95 -51.36 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.258 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.505 ' NZ ' ' O ' ' B' ' 70' ' ' ASP . 0.1 OUTLIER -54.3 -30.23 50.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 108.992 179.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.504 ' HB3' ' NZ ' ' A' ' 65' ' ' LYS . 9.6 mmmm -81.98 -28.85 32.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 109.108 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.547 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 11.9 mt -59.61 -38.1 73.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.577 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 1.7 mp -76.15 -61.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -43.02 -28.73 0.29 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.817 . . . . 0.0 109.646 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.504 ' NZ ' ' HB3' ' A' ' 61' ' ' LYS . 2.0 mtmt -74.74 -60.24 2.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.522 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 1.4 mmm -44.17 -47.78 9.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 109.272 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.587 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -43.65 -51.26 7.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.452 -0.78 . . . . 0.0 109.353 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 69' ' ' SER . 11.9 t30 -66.41 -34.82 78.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.495 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 68' ' ' ASN . 1.2 p -43.85 -26.88 0.29 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.562 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.505 ' O ' ' NZ ' ' B' ' 60' ' ' LYS . 0.3 OUTLIER -112.14 67.46 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.295 -0.878 . . . . 0.0 109.555 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -120.08 82.92 1.97 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 109.532 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 73' ' ' ASN . 0.2 OUTLIER 60.73 170.58 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.485 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 72' ' ' SER . 2.9 p30 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.382 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.9 t -176.14 90.09 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.455 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.482 ' O ' ' CG1' ' B' ' 3' ' ' VAL . 12.0 p -169.9 114.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.47 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.513 ' O ' ' CG2' ' B' ' 5' ' ' THR . . . -177.61 80.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.0 109.498 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.513 ' CG2' ' O ' ' B' ' 4' ' ' ALA . 13.7 t 41.92 33.51 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.461 -0.775 . . . . 0.0 109.657 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -117.83 63.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 0.0 109.553 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.501 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -124.47 101.56 7.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.211 -0.93 . . . . 0.0 109.578 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' B' ' 10' ' ' GLN . 22.4 mtp180 -104.75 152.76 22.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.315 -0.865 . . . . 0.0 109.03 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.466 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 96.6 m -44.15 96.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.359 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.509 ' NE2' ' HD2' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -42.75 -26.4 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.796 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' B' ' 39' ' ' GLU . 97.4 m -122.18 66.25 0.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.786 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.466 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.83 -38.95 4.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.147 -0.971 . . . . 0.0 108.753 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -118.49 -173.25 2.43 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.451 HG23 ' O ' ' B' ' 52' ' ' LEU . 0.4 OUTLIER -160.17 158.08 29.49 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.994 -1.066 . . . . 0.0 109.896 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.431 ' O ' ' C ' ' B' ' 16' ' ' GLN . 7.6 mt -116.96 142.77 46.52 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.4 OUTLIER -44.04 -33.36 1.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.363 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.48 ' O ' ' CG2' ' B' ' 18' ' ' ILE . . . 147.45 -166.49 28.63 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.3 pp -171.51 163.44 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.454 -1.027 . . . . 0.0 109.07 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.543 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -57.43 149.73 47.95 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.186 -0.946 . . . . 0.0 109.237 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.0 Cg_endo -77.15 -4.36 14.73 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.477 2.118 . . . . 0.0 110.231 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HD2' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.21 -23.89 21.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.413 -0.804 . . . . 0.0 109.177 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.0 m-20 -84.05 -15.84 46.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.227 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 17.0 mt -89.4 169.12 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 110.25 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.528 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.0 OUTLIER -137.58 -39.94 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.432 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 6.0 p -128.18 173.4 10.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.423 -0.798 . . . . 0.0 108.971 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.528 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 47.5 t -142.31 95.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.961 . . . . 0.0 109.646 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.461 ' O ' HD13 ' B' ' 41' ' ' ILE . 5.1 t-20 -93.03 111.49 23.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.869 . . . . 0.0 109.428 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -109.24 97.73 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.509 ' HD2' ' NE2' ' B' ' 10' ' ' GLN . 1.9 ttmt -90.65 110.38 21.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 109.504 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.464 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.2 p -63.61 167.7 6.72 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.346 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 36.0 Cg_endo -77.66 145.57 23.22 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.556 2.171 . . . . 0.0 110.432 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.89 -140.03 2.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.448 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.1 Cg_endo -77.87 10.74 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.602 2.201 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.515 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 3.2 p-80 -127.8 -32.83 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 109.532 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -145.48 115.89 7.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.03 7.07 11.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.695 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.411 ' O ' ' HG2' ' B' ' 39' ' ' GLU . 1.6 mp0 -120.79 124.6 45.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.123 -0.986 . . . . 0.0 109.473 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.402 ' C ' ' HG2' ' B' ' 39' ' ' GLU . 1.6 m -46.74 156.83 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.319 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.461 ' HB3' ' HB2' ' B' ' 11' ' ' CYS . 7.1 mm-40 -141.36 107.63 5.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.038 -1.039 . . . . 0.0 109.685 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.525 ' CG1' HD12 ' B' ' 63' ' ' ILE . 41.4 t -90.56 150.47 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.183 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.518 ' N ' HG11 ' B' ' 40' ' ' VAL . 3.4 mt -140.3 147.85 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.154 -0.967 . . . . 0.0 109.709 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.519 ' CB ' HG22 ' B' ' 23' ' ' ILE . . . -135.48 120.03 18.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.115 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 8.6 m -89.26 100.83 13.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.934 -1.104 . . . . 0.0 109.038 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' B' ' 22' ' ' ASN . 84.5 mt -45.99 172.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.427 -0.795 . . . . 0.0 109.814 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -87.92 10.63 18.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.144 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.514 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -114.11 27.53 9.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.055 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.05 11.22 69.97 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.514 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 3.8 mtp180 -100.22 165.94 11.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -1.158 . . . . 0.0 109.471 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.82 154.08 50.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.176 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.21 123.65 9.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.26 -0.9 . . . . 0.0 109.297 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 7.7 m -79.49 144.87 33.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.103 -0.998 . . . . 0.0 109.17 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.529 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 15.3 mt -121.88 167.48 12.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.547 ' N ' HG23 ' B' ' 59' ' ' VAL . 1.0 OUTLIER -97.04 118.04 65.19 Favored Pre-proline 0 C--N 1.299 -1.608 0 O-C-N 121.426 -0.797 . . . . 0.0 109.227 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.409 ' HB3' ' CG2' ' B' ' 40' ' ' VAL . 32.9 Cg_endo -74.33 -0.28 9.47 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.224 1.949 . . . . 0.0 110.344 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.31 -14.1 27.35 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.311 -0.868 . . . . 0.0 108.916 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.09 162.73 34.26 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.368 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -78.22 -36.13 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.591 2.194 . . . . 0.0 110.626 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.448 HG23 HD11 ' B' ' 58' ' ' ILE . 65.5 mt -66.29 -36.46 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.139 -0.975 . . . . 0.0 109.709 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.547 HG23 ' N ' ' B' ' 53' ' ' ASN . 37.8 t -67.89 -51.35 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.266 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.505 ' NZ ' ' O ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -54.39 -30.21 51.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.322 -0.861 . . . . 0.0 108.941 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.509 ' HB3' ' NZ ' ' B' ' 65' ' ' LYS . 9.6 mmmm -81.97 -28.82 32.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.126 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.544 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 11.9 mt -59.61 -38.14 74.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.587 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 1.7 mp -76.16 -61.57 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -43.09 -28.73 0.3 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.4 -0.813 . . . . 0.0 109.617 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.509 ' NZ ' ' HB3' ' B' ' 61' ' ' LYS . 2.0 mtmt -74.71 -60.27 2.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.337 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.528 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 1.4 mmm -44.09 -47.87 8.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.873 . . . . 0.0 109.257 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.577 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -43.63 -51.19 7.13 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.401 -0.812 . . . . 0.0 109.408 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' B' ' 69' ' ' SER . 11.9 t30 -66.48 -34.77 78.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.4 -0.813 . . . . 0.0 109.516 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.42 ' C ' ' O ' ' B' ' 68' ' ' ASN . 1.2 p -43.85 -26.92 0.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 109.502 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.505 ' O ' ' NZ ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -112.06 67.55 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 109.512 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -120.17 82.87 1.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.446 ' O ' ' CB ' ' B' ' 73' ' ' ASN . 0.2 OUTLIER 60.75 170.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.138 -0.976 . . . . 0.0 109.426 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' B' ' 72' ' ' SER . 2.9 p30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.53 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 0.2 OUTLIER 70.38 161.78 0.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' A' ' 2' ' ' SER . 7.6 p 41.95 33.51 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.444 -0.785 . . . . 0.0 109.624 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.58 103.37 11.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.445 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.89 92.29 3.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.458 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.98 122.89 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.466 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.532 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -117.12 98.42 6.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.309 -0.869 . . . . 0.0 109.594 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 9' ' ' CYS . 6.5 mtm180 -90.97 152.23 20.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.056 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 20.1 m -44.05 106.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.964 . . . . 0.0 109.359 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -42.28 -26.91 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.815 . . . . 0.0 109.853 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 39' ' ' GLU . 72.4 m -124.17 63.3 1.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.769 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.71 -39.69 5.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.117 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -123.26 126.47 46.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 109.061 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.4 HG21 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -103.12 162.86 12.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.118 -0.989 . . . . 0.0 109.935 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.491 ' CD1' ' HB2' ' A' ' 50' ' ' ALA . 6.2 mt -115.44 140.96 48.67 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.429 ' C ' ' O ' ' A' ' 15' ' ' LEU . 2.7 tt0 -44.34 -26.52 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.306 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.451 ' HA2' HD23 ' A' ' 52' ' ' LEU . . . 138.32 -171.34 23.47 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.538 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.4 pp -161.48 162.74 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -1.117 . . . . 0.0 109.399 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.577 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -56.36 153.97 17.95 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 109.274 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -76.9 -7.39 17.39 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.438 2.092 . . . . 0.0 109.971 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.512 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 3.1 mttm -80.91 -23.32 39.01 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.532 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 25.0 m-20 -98.35 59.47 1.33 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.538 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 2.7 mm -142.49 169.93 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.181 -0.95 . . . . 0.0 110.044 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -160.18 -40.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.517 ' CB ' ' HB ' ' A' ' 43' ' ' THR . 1.5 p -133.53 -173.79 3.32 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 50.8 t -159.62 97.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.037 -1.04 . . . . 0.0 109.74 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.462 ' O ' HD11 ' A' ' 41' ' ' ILE . 3.7 t-20 -94.62 111.42 23.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.396 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.432 HG11 HG21 ' A' ' 40' ' ' VAL . 1.8 t -117.35 103.48 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -107.05 108.43 19.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.43 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.435 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.1 p -50.97 168.68 0.24 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.8 Cg_endo -77.99 131.64 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.523 2.149 . . . . 0.0 110.508 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.04 -143.35 5.39 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.57 5.18 4.94 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.594 2.196 . . . . 0.0 110.643 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.532 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 14.1 p-80 -124.39 -10.89 7.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.647 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 4.0 t -160.2 104.51 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.316 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.92 -3.59 23.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.653 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.427 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 4.6 mm-40 -114.52 124.67 52.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.426 ' C ' ' HG2' ' A' ' 39' ' ' GLU . 14.1 m -49.43 148.18 2.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.331 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.465 ' OE2' ' CA ' ' A' ' 9' ' ' CYS . 0.8 OUTLIER -131.22 107.12 8.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 109.743 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.432 HG21 HG11 ' A' ' 28' ' ' VAL . 30.8 t -91.75 156.12 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.245 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.462 HD11 ' O ' ' A' ' 27' ' ' ASN . 2.1 mp -143.44 144.79 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.799 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -129.45 124.13 33.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.361 -0.837 . . . . 0.0 109.12 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 23.0 m -89.4 101.76 14.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.075 -1.016 . . . . 0.0 109.207 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.532 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 84.5 mt -43.59 164.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 109.266 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 11.3 ptpt -85.76 13.36 7.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.465 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.476 ' ND2' ' HD2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.56 11.04 19.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.174 179.506 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.39 21.17 45.68 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.476 ' HD2' ' ND2' ' A' ' 46' ' ' ASN . 95.6 mtt-85 -116.11 171.43 7.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -1.156 . . . . 0.0 109.468 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -137.45 153.76 50.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.477 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.491 ' HB2' ' CD1' ' A' ' 15' ' ' LEU . . . -150.22 125.36 10.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.413 -0.804 . . . . 0.0 109.029 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.457 ' SG ' HG13 ' A' ' 41' ' ' ILE . 13.9 m -79.57 140.59 37.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.006 . . . . 0.0 109.045 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.521 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 11.9 mt -122.25 167.81 12.77 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 1.4 t-20 -101.29 121.4 51.91 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.474 -0.766 . . . . 0.0 109.199 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.92 -7.1 18.91 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.324 2.016 . . . . 0.0 110.321 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.17 -14.83 49.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 108.95 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.46 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.06 162.76 34.27 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.48 -0.763 . . . . 0.0 109.369 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.73 -37.5 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.733 2.289 . . . . 0.0 110.584 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 52.2 mt -61.88 -52.94 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.081 -1.012 . . . . 0.0 109.019 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.533 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 56.1 t -53.28 -51.74 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.549 -0.719 . . . . 0.0 109.723 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -50.18 -33.16 18.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.077 -1.014 . . . . 0.0 108.958 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.529 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 3.2 mmpt? -75.74 -34.71 60.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 0.0 109.458 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -60.2 -41.69 87.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.088 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.586 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -70.42 -62.32 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.864 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.461 ' OE2' ' HA ' ' A' ' 61' ' ' LYS . 5.9 pt-20 -57.6 -16.57 10.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.047 -1.033 . . . . 0.0 109.439 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.468 ' HG2' ' HB3' ' A' ' 20' ' ' PRO . 5.7 tptm -81.65 -40.66 22.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 108.664 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.517 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -61.97 -44.81 95.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.579 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -43.38 -51.8 6.26 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.551 -0.718 . . . . 0.0 109.308 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.28 -50.73 72.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.392 -0.818 . . . . 0.0 109.497 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.449 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p -47.98 -25.68 1.47 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.527 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 -103.43 61.52 0.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -109.08 -64.21 1.27 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.233 -0.917 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 m -135.63 -43.4 0.68 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.523 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.499 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.414 ' O ' ' CB ' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.53 ' O ' ' CG1' ' B' ' 3' ' ' VAL . 0.2 OUTLIER 70.2 161.87 0.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.481 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' B' ' 2' ' ' SER . 7.8 p 41.84 33.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.389 -0.819 . . . . 0.0 109.629 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.65 103.32 11.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.424 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.8 92.3 3.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 0.0 109.507 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.96 122.93 0.07 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.163 -0.961 . . . . 0.0 109.498 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.52 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -117.09 98.41 6.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.632 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 9' ' ' CYS . 6.5 mtm180 -90.93 152.25 20.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.354 -0.841 . . . . 0.0 109.08 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.514 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 20.1 m -44.04 106.29 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.967 . . . . 0.0 109.403 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -42.18 -27.0 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.466 -0.771 . . . . 0.0 109.884 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.456 ' HB2' ' HB3' ' B' ' 39' ' ' GLU . 72.6 m -124.22 63.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 109.688 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.514 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.72 -39.78 5.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 0.0 109.062 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -123.19 126.49 47.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 109.085 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.14 162.88 12.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.195 -0.941 . . . . 0.0 110.015 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.492 ' CD1' ' HB2' ' B' ' 50' ' ' ALA . 6.3 mt -115.48 140.93 48.71 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' B' ' 15' ' ' LEU . 2.7 tt0 -44.27 -26.57 0.33 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.471 ' HA2' HD23 ' B' ' 52' ' ' LEU . . . 138.35 -171.27 23.52 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.548 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.4 pp -161.53 162.74 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.34 -1.094 . . . . 0.0 109.379 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.576 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -56.28 153.89 17.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.346 -0.846 . . . . 0.0 109.322 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -76.88 -7.35 17.4 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.451 2.1 . . . . 0.0 109.963 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.519 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 3.1 mttm -80.9 -23.37 39.02 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.539 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 25.0 m-20 -98.37 59.46 1.33 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.548 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 2.6 mm -142.47 169.97 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.216 -0.927 . . . . 0.0 110.042 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.3 OUTLIER -160.16 -40.43 0.05 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.515 ' CB ' ' HB ' ' B' ' 43' ' ' THR . 1.5 p -133.55 -173.83 3.34 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.524 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 51.0 t -159.58 97.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.963 -1.086 . . . . 0.0 109.773 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.463 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 3.7 t-20 -94.67 111.38 23.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.412 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.442 HG11 HG21 ' B' ' 40' ' ' VAL . 1.8 t -117.3 103.52 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.464 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -107.12 108.48 19.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.388 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.439 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.1 p -51.05 168.64 0.24 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.8 Cg_endo -77.97 131.63 11.17 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.594 2.196 . . . . 0.0 110.459 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.01 -143.29 5.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.61 5.22 4.94 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.598 2.199 . . . . 0.0 110.64 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.52 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 14.1 p-80 -124.38 -10.96 7.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 109.584 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 4.0 t -160.18 104.54 1.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 109.347 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.87 -3.64 23.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.716 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' B' ' 39' ' ' GLU . 4.6 mm-40 -114.48 124.7 52.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.096 -1.003 . . . . 0.0 109.522 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.408 ' C ' ' HG2' ' B' ' 39' ' ' GLU . 14.3 m -49.44 148.22 2.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.308 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.479 ' OE2' ' CA ' ' B' ' 9' ' ' CYS . 0.9 OUTLIER -131.24 107.29 8.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.669 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.442 HG21 HG11 ' B' ' 28' ' ' VAL . 31.2 t -91.9 156.22 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.213 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 2.1 mp -143.54 144.78 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.152 -0.968 . . . . 0.0 109.778 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -129.49 124.29 33.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.044 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 23.0 m -89.45 101.76 14.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.934 -1.104 . . . . 0.0 109.156 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.539 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 84.9 mt -43.61 164.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.5 -0.75 . . . . 0.0 109.245 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 11.3 ptpt -85.74 13.35 7.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.472 ' ND2' ' HD2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.52 11.05 19.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.888 . . . . 0.0 109.256 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.36 21.21 45.68 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.472 ' HD2' ' ND2' ' B' ' 46' ' ' ASN . 95.5 mtt-85 -116.19 171.49 7.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.503 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -137.51 153.7 49.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.425 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.492 ' HB2' ' CD1' ' B' ' 15' ' ' LEU . . . -150.22 125.32 9.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.303 -0.873 . . . . 0.0 109.081 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.449 ' SG ' HG13 ' B' ' 41' ' ' ILE . 13.8 m -79.54 140.59 37.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.029 -1.045 . . . . 0.0 109.109 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.525 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 11.9 mt -122.19 167.78 12.79 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.344 -0.847 . . . . 0.0 109.409 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.533 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 1.4 t-20 -101.32 121.37 51.96 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.195 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.96 -6.92 18.7 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.262 1.975 . . . . 0.0 110.321 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.28 -14.84 48.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.22 -0.925 . . . . 0.0 108.946 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.02 162.7 34.56 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.468 -0.77 . . . . 0.0 109.406 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.77 -37.4 0.9 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.613 2.209 . . . . 0.0 110.65 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.52 ' O ' ' CD1' ' B' ' 62' ' ' ILE . 52.3 mt -61.86 -53.01 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.963 . . . . 0.0 109.004 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.533 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 55.9 t -53.2 -51.73 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.55 -0.719 . . . . 0.0 109.796 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.462 ' O ' ' OE2' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -50.24 -33.17 18.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.256 -0.902 . . . . 0.0 108.899 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.527 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 3.2 mmpt? -75.58 -34.92 60.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.468 -0.77 . . . . 0.0 109.477 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -60.1 -41.73 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.31 -0.869 . . . . 0.0 109.077 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.579 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -70.39 -62.32 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.888 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.464 ' OE2' ' HA ' ' B' ' 61' ' ' LYS . 5.9 pt-20 -57.54 -16.61 10.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.063 -1.023 . . . . 0.0 109.437 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' B' ' 61' ' ' LYS . 5.7 tptm -81.61 -40.79 22.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.275 -0.891 . . . . 0.0 108.644 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.524 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -61.85 -44.88 95.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.398 -0.814 . . . . 0.0 108.85 179.386 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.586 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -43.36 -51.76 6.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.511 -0.743 . . . . 0.0 109.34 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.37 -50.66 72.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.495 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.449 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.2 p -48.01 -25.56 1.44 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.22 -0.925 . . . . 0.0 109.509 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -103.55 61.52 0.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.437 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -109.05 -64.22 1.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.451 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 75.6 m -135.67 -43.49 0.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.478 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.432 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.409 ' C ' HG21 ' A' ' 3' ' ' VAL . 2.8 p -97.34 -34.84 10.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.446 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.456 ' O ' ' HB1' ' A' ' 4' ' ' ALA . 12.1 t -137.29 -63.47 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.87 . . . . 0.0 109.497 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 3' ' ' VAL . . . 62.11 78.7 0.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.458 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -92.44 76.84 5.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.309 -0.869 . . . . 0.0 109.476 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 5' ' ' THR . 1.6 mt-10 -160.65 96.52 1.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.449 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.52 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -125.8 101.89 7.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 109.554 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 9' ' ' CYS . 27.2 mtt180 -96.56 155.06 16.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.112 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.464 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m -44.02 113.31 0.51 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 0.0 109.406 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.518 ' HG3' ' CB ' ' A' ' 29' ' ' LYS . 7.1 mm-40 -42.88 -26.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.457 ' SG ' HG13 ' A' ' 41' ' ' ILE . 60.3 m -148.74 72.63 1.19 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.085 -1.009 . . . . 0.0 109.903 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.464 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.87 -46.05 15.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 108.799 179.505 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -116.17 121.69 42.83 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -98.26 166.18 11.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 110.056 -179.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.1 mt -115.02 146.01 41.7 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.52 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 0.7 OUTLIER -44.05 -42.76 6.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.413 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.51 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 147.36 -167.5 28.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.3 pp -169.5 163.43 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.396 -1.061 . . . . 0.0 109.252 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.561 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -55.74 151.14 23.85 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.263 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.561 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.44 -2.31 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.551 2.167 . . . . 0.0 110.175 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.452 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -90.23 -24.79 20.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.43 -0.794 . . . . 0.0 109.136 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.7 m-20 -83.47 -9.59 58.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.391 -0.818 . . . . 0.0 109.288 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 7.9 mt -101.97 165.81 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.882 . . . . 0.0 110.436 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.581 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -139.07 -31.67 0.7 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.581 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.3 p -128.68 168.66 15.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 108.84 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.508 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 56.1 t -141.18 105.65 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.026 -1.046 . . . . 0.0 109.857 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 5.2 t-20 -105.79 111.67 24.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -0.941 . . . . 0.0 109.457 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.05 103.44 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.537 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.518 ' CB ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -95.96 105.94 18.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.905 . . . . 0.0 109.395 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.1 p -51.92 167.87 0.31 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.401 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.52 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 35.7 Cg_endo -78.01 131.95 11.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.566 2.177 . . . . 0.0 110.514 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.47 -143.32 4.82 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.55 4.93 5.11 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.57 2.18 . . . . 0.0 110.636 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.52 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 14.6 p-80 -123.95 -10.6 7.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 0.0 109.595 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.5 t -160.08 124.13 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 109.269 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -80.74 -38.03 29.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.868 . . . . 0.0 109.658 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.435 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 2.0 mp0 -86.73 140.21 29.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.619 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.511 HG21 ' N ' ' A' ' 39' ' ' GLU . 50.6 m -60.79 153.88 23.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.511 ' N ' HG21 ' A' ' 38' ' ' THR . 2.5 mp0 -130.33 107.06 8.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 109.688 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.492 HG11 ' N ' ' A' ' 41' ' ' ILE . 38.9 t -89.59 154.13 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.84 . . . . 0.0 109.148 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.492 ' N ' HG11 ' A' ' 40' ' ' VAL . 3.1 mp -141.99 153.08 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.109 -0.994 . . . . 0.0 109.782 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.524 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -140.45 121.55 14.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.823 . . . . 0.0 109.063 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.528 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 3.1 m -89.17 103.94 16.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.887 -1.133 . . . . 0.0 108.798 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 79.7 mt -48.75 177.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.541 -0.724 . . . . 0.0 109.742 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.452 ' HD2' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -90.03 8.53 32.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 109.187 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.497 ' ND2' ' HD2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -113.79 28.97 8.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.81 11.77 66.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.497 ' HD2' ' ND2' ' A' ' 46' ' ' ASN . 57.9 mtt180 -98.77 168.83 9.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -1.154 . . . . 0.0 109.434 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 16.3 mttt -140.24 151.25 45.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -0.869 . . . . 0.0 109.242 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.22 123.42 8.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.286 -0.884 . . . . 0.0 109.08 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.455 ' SG ' HG13 ' A' ' 41' ' ' ILE . 15.3 m -79.56 144.69 33.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.082 -1.011 . . . . 0.0 109.258 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.526 ' O ' ' CG2' ' A' ' 14' ' ' THR . 15.2 mt -121.33 167.59 12.59 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.278 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 2.8 t-20 -100.18 121.1 54.84 Favored Pre-proline 0 C--N 1.298 -1.668 0 O-C-N 121.385 -0.822 . . . . 0.0 109.103 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.03 -9.27 20.66 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.137 1.891 . . . . 0.0 110.271 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.96 -14.8 57.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 108.804 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.456 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -89.97 159.87 41.88 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.404 -0.81 . . . . 0.0 109.376 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.422 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.68 -34.36 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.667 2.245 . . . . 0.0 110.722 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.537 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 12.5 tt -66.65 -46.76 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 109.11 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.537 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 38.6 t -57.08 -48.62 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 109.048 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 1.1 mttp -55.14 -31.28 61.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -76.28 -30.62 57.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.615 -0.678 . . . . 0.0 109.297 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -65.16 -44.51 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.352 -0.842 . . . . 0.0 109.015 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.581 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -67.53 -61.66 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.613 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -52.61 -27.94 19.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.633 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.525 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -71.48 -40.91 69.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.187 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.508 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -63.36 -46.9 84.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.838 . . . . 0.0 109.185 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.58 -51.12 9.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.522 -0.736 . . . . 0.0 109.455 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -71.97 -29.08 63.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.878 . . . . 0.0 109.546 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.452 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p -63.83 -18.4 64.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' ' 67' ' ' LEU . 2.6 p30 -101.47 46.61 0.93 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.403 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -86.45 -35.58 19.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.4 t -157.3 -61.16 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.855 . . . . 0.0 109.474 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.8 t30 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.503 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.414 ' C ' HG21 ' B' ' 3' ' ' VAL . 2.9 p -97.21 -35.0 10.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 109.436 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.45 ' O ' ' HB1' ' B' ' 4' ' ' ALA . 12.0 t -137.25 -63.55 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.523 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' B' ' 3' ' ' VAL . . . 62.2 78.69 0.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.454 ' O ' ' HG3' ' B' ' 6' ' ' GLU . 0.6 OUTLIER -92.43 76.9 5.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.496 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' B' ' 5' ' ' THR . 1.6 mt-10 -160.68 96.52 1.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.435 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.522 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -125.84 101.92 7.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 0.0 109.593 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' B' ' 9' ' ' CYS . 27.4 mtt180 -96.64 155.09 16.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.281 -0.887 . . . . 0.0 109.073 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.451 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 1.8 m -44.02 113.35 0.51 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.398 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.517 ' HG3' ' CB ' ' B' ' 29' ' ' LYS . 7.1 mm-40 -42.9 -26.26 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.853 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' B' ' 39' ' ' GLU . 60.2 m -148.68 72.6 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.083 -1.011 . . . . 0.0 109.953 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.451 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.8 -46.04 15.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.935 . . . . 0.0 108.773 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -116.19 121.59 42.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.414 -0.804 . . . . 0.0 108.896 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.5 OUTLIER -98.25 166.15 11.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.146 -0.972 . . . . 0.0 110.068 -179.347 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' B' ' 16' ' ' GLN . 7.1 mt -115.0 146.09 41.6 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.526 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 0.7 OUTLIER -44.18 -42.66 6.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.386 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.518 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 147.31 -167.56 28.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.3 pp -169.44 163.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.509 -0.995 . . . . 0.0 109.272 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.573 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -55.72 151.1 23.76 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.267 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.573 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.9 Cg_endo -77.4 -2.3 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.515 2.143 . . . . 0.0 110.224 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HD2' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -90.25 -24.83 20.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.159 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.7 m-20 -83.37 -9.58 58.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.295 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 8.0 mt -102.02 165.83 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 110.438 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.586 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -139.05 -31.79 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.297 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.586 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.3 p -128.62 168.56 15.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 108.85 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.505 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 55.7 t -141.13 105.78 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.145 -0.972 . . . . 0.0 109.77 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.46 ' O ' ' CD1' ' B' ' 41' ' ' ILE . 5.2 t-20 -105.9 111.72 24.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.09 103.42 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.938 . . . . 0.0 109.525 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.517 ' CB ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -96.05 105.89 17.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.408 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.458 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.1 p -51.88 167.92 0.31 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.518 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 36.2 Cg_endo -78.03 131.99 11.34 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.599 2.199 . . . . 0.0 110.51 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.57 -143.39 4.82 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.6 5.07 5.03 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.5 2.133 . . . . 0.0 110.581 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.522 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 14.5 p-80 -123.93 -10.71 7.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.565 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 3.5 t -160.07 124.1 3.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -80.64 -38.09 29.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.75 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.428 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 2.0 mp0 -86.71 140.17 30.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.505 HG21 ' N ' ' B' ' 39' ' ' GLU . 50.6 m -60.72 153.93 22.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.505 ' N ' HG21 ' B' ' 38' ' ' THR . 2.5 mp0 -130.37 107.08 8.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 109.631 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.504 HG11 ' N ' ' B' ' 41' ' ' ILE . 39.1 t -89.68 154.2 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.102 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.504 ' N ' HG11 ' B' ' 40' ' ' VAL . 3.1 mp -142.03 153.07 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.125 -0.984 . . . . 0.0 109.842 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.517 ' CB ' HG22 ' B' ' 23' ' ' ILE . . . -140.45 121.57 14.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 108.972 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 3.1 m -89.18 103.87 16.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.871 -1.143 . . . . 0.0 108.856 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' B' ' 22' ' ' ASN . 80.1 mt -48.71 177.03 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.489 -0.757 . . . . 0.0 109.747 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.454 ' HD2' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -90.03 8.63 31.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.248 -0.907 . . . . 0.0 109.156 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HD2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -113.86 29.05 8.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.876 . . . . 0.0 109.139 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.85 11.73 66.69 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HD2' ' ND2' ' B' ' 46' ' ' ASN . 57.8 mtt180 -98.78 168.8 9.91 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 109.466 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.428 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 16.3 mttt -140.22 151.36 45.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 109.219 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.31 123.38 8.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.039 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.454 ' SG ' HG13 ' B' ' 41' ' ' ILE . 15.3 m -79.56 144.7 33.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.252 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.526 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 15.3 mt -121.38 167.5 12.7 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.913 . . . . 0.0 109.222 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 2.8 t-20 -100.12 121.13 54.82 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.169 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.95 -9.39 20.82 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.214 1.943 . . . . 0.0 110.292 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.89 -14.77 57.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 108.851 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.467 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -90.01 159.88 41.74 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.0 109.304 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.413 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.71 -34.22 1.96 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.675 2.25 . . . . 0.0 110.727 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.552 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 12.6 tt -66.76 -46.75 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.994 . . . . 0.0 109.083 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.552 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 38.4 t -57.11 -48.58 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.363 -0.835 . . . . 0.0 109.059 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 1.1 mttp -55.18 -31.28 61.27 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' B' ' 65' ' ' LYS . 0.9 OUTLIER -76.3 -30.56 57.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.566 -0.709 . . . . 0.0 109.329 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -65.07 -44.69 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 109.009 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.588 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -67.41 -61.7 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.629 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.2 OUTLIER -52.61 -28.01 19.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 109.579 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.528 ' HG2' ' CB ' ' B' ' 20' ' ' PRO . 0.0 OUTLIER -71.47 -40.85 70.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.114 -0.991 . . . . 0.0 109.225 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.505 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -63.36 -46.94 84.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.207 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.581 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.63 -51.08 9.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.323 -0.861 . . . . 0.0 109.451 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -71.94 -29.13 63.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 109.536 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.449 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.2 p -63.85 -18.38 64.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.452 ' OD2' ' HA ' ' B' ' 67' ' ' LEU . 2.6 p30 -101.39 46.56 0.93 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.299 -0.876 . . . . 0.0 109.505 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -86.42 -35.54 19.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.527 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 34.3 t -157.39 -61.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 51.9 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.464 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.3 p -156.54 129.61 7.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.908 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.0 m -140.14 130.45 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.449 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.46 157.52 40.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.48 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.421 ' C ' ' HG3' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -103.2 9.67 38.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.932 . . . . 0.0 109.52 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.421 ' HG3' ' C ' ' A' ' 5' ' ' THR . 1.2 mp0 -134.96 106.01 6.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 109.403 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.524 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -116.45 98.24 6.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.0 109.511 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.5 OUTLIER -90.28 151.52 21.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.34 -0.85 . . . . 0.0 109.071 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.524 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 10.4 m -43.99 108.38 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.401 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.52 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 16.0 mm-40 -43.01 -26.44 0.14 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.735 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.443 ' SG ' HG13 ' A' ' 41' ' ' ILE . 96.8 m -125.61 63.16 1.2 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.82 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.524 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.09 -38.28 4.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.051 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -125.29 131.54 53.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.408 -0.808 . . . . 0.0 108.962 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.461 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -108.42 163.18 13.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.098 -1.001 . . . . 0.0 109.995 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.3 mt -120.78 146.04 46.93 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.419 ' C ' ' O ' ' A' ' 15' ' ' LEU . 1.9 tt0 -44.26 -40.68 5.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.41 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.464 ' HA2' HD23 ' A' ' 52' ' ' LEU . . . 150.12 -168.11 30.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.579 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.3 pp -168.49 163.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.487 -1.007 . . . . 0.0 109.213 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.521 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -57.89 150.63 48.15 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.92 . . . . 0.0 109.434 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.527 ' CB ' ' HG2' ' A' ' 65' ' ' LYS . 34.9 Cg_endo -77.44 -2.78 12.97 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.571 2.18 . . . . 0.0 110.202 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.24 -24.85 20.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 109.069 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.524 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 3.4 m-20 -83.31 -5.53 59.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 109.354 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 7.0 mt -107.07 145.57 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 110.103 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.552 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -117.78 -26.19 6.6 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.552 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -143.53 172.24 13.07 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.506 ' CG2' ' O ' ' A' ' 25' ' ' SER . 50.6 t -159.52 137.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.943 -1.098 . . . . 0.0 109.98 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 43.3 t30 -112.47 169.21 9.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.203 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 t -151.27 92.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.543 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.52 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 0.6 OUTLIER -100.19 116.12 31.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.559 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.24 167.49 9.99 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 109.355 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.5 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.6 Cg_endo -78.0 131.33 10.94 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.677 2.251 . . . . 0.0 110.483 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.62 -144.1 4.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.95 6.9 3.89 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.593 2.196 . . . . 0.0 110.736 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.524 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 12.4 p-80 -125.09 -7.3 7.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.141 -0.975 . . . . 0.0 109.551 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.0 t -160.04 116.34 2.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.963 . . . . 0.0 109.418 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.12 45.79 1.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.556 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.5 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 6.1 pt20 -174.47 139.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.462 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' B' ' 70' ' ' ASP . 1.3 m -57.58 151.32 17.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.334 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.464 ' OE2' ' HG2' ' A' ' 29' ' ' LYS . 6.4 pt-20 -138.05 114.97 10.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.616 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.81 154.02 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 109.222 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.464 ' O ' HG12 ' A' ' 26' ' ' VAL . 4.2 mt -138.39 154.28 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.729 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.516 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -137.24 118.77 14.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 1.2 m -89.17 96.4 10.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.962 -1.086 . . . . 0.0 108.63 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 89.4 mt -43.18 167.36 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.572 -0.705 . . . . 0.0 109.881 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -80.67 7.59 9.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.645 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.98 23.42 13.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 109.299 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.33 7.41 82.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.516 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -95.54 167.64 11.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -1.202 . . . . 0.0 109.497 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.446 ' HD3' ' OG1' ' A' ' 43' ' ' THR . 18.5 mttt -138.75 151.36 47.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.3 122.19 8.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.29 -0.881 . . . . 0.0 109.114 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.457 ' SG ' HG12 ' A' ' 41' ' ' ILE . 4.4 m -79.64 142.16 35.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.065 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.49 ' HB3' HG23 ' A' ' 59' ' ' VAL . 12.7 mt -120.03 167.44 12.18 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.292 -0.88 . . . . 0.0 109.492 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.545 ' N ' HG23 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -97.2 115.75 65.81 Favored Pre-proline 0 C--N 1.299 -1.627 0 O-C-N 121.434 -0.791 . . . . 0.0 109.226 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.483 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.3 Cg_endo -74.17 0.17 8.8 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.275 1.984 . . . . 0.0 110.433 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.05 -13.85 24.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -0.887 . . . . 0.0 108.944 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 164.61 27.25 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.423 -0.798 . . . . 0.0 109.407 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.9 -37.63 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.676 2.251 . . . . 0.0 110.568 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 10.0 mt -61.4 -51.88 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 109.058 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.545 HG23 ' N ' ' A' ' 53' ' ' ASN . 54.4 t -54.56 -54.3 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.739 . . . . 0.0 109.744 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.483 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 5.1 mttt -47.5 -33.71 6.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 108.971 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -74.61 -38.56 62.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.494 -0.754 . . . . 0.0 109.328 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -58.13 -41.96 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.429 -0.794 . . . . 0.0 109.146 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.587 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -70.12 -67.87 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.762 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.473 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -44.02 -28.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.663 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.527 ' HG2' ' CB ' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -72.88 -59.93 2.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.183 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.411 ' C ' ' O ' ' A' ' 65' ' ' LYS . 0.8 OUTLIER -44.12 -44.42 7.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.388 -0.82 . . . . 0.0 109.183 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.573 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 1.3 mt -55.16 -58.68 6.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.705 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -80.86 6.85 11.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.734 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.451 ' HB3' ' O ' ' A' ' 65' ' ' LYS . 10.0 p -94.24 -10.21 33.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.465 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' O ' ' CG ' ' A' ' 71' ' ' LYS . 0.6 OUTLIER -107.79 27.58 9.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 0.0 109.472 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' A' ' 70' ' ' ASP . 18.3 pttm 41.78 -161.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.492 -0.755 . . . . 0.0 109.663 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.98 -63.19 0.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.459 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.502 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 53.4 p -156.56 129.58 7.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.448 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.1 130.45 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.462 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.52 157.4 41.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.429 ' C ' ' HG3' ' B' ' 6' ' ' GLU . 0.2 OUTLIER -103.1 9.68 38.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.429 ' HG3' ' C ' ' B' ' 5' ' ' THR . 1.2 mp0 -134.92 106.0 6.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.444 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.528 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -116.41 98.21 6.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.554 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.5 OUTLIER -90.15 151.56 21.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.31 -0.869 . . . . 0.0 109.142 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 10.3 m -44.15 108.44 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.898 . . . . 0.0 109.359 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.526 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 15.8 mm-40 -43.01 -26.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.72 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.449 ' SG ' HG13 ' B' ' 41' ' ' ILE . 95.9 m -125.64 63.29 1.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.981 . . . . 0.0 109.784 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.18 -38.35 5.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -125.2 131.57 53.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.818 . . . . 0.0 108.966 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.453 HG23 ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -108.43 163.17 13.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.12 -0.988 . . . . 0.0 110.025 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 7.3 mt -120.74 146.0 46.93 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -44.29 -40.64 5.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.974 . . . . 0.0 109.42 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.455 ' HA2' HD23 ' B' ' 52' ' ' LEU . . . 150.09 -168.08 30.1 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.3 pp -168.52 163.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.454 -1.027 . . . . 0.0 109.255 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.524 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -57.81 150.45 48.15 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.251 -0.906 . . . . 0.0 109.401 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.524 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.3 Cg_endo -77.32 -2.79 13.0 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.59 2.194 . . . . 0.0 110.231 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.465 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.21 -24.88 20.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.383 -0.823 . . . . 0.0 109.057 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 3.4 m-20 -83.33 -5.56 59.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.463 -0.773 . . . . 0.0 109.217 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 7.1 mt -107.13 145.46 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.878 . . . . 0.0 110.112 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.543 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -117.71 -26.09 6.66 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.543 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -143.57 172.22 13.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.419 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' B' ' 25' ' ' SER . 50.4 t -159.49 137.58 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.969 -1.082 . . . . 0.0 109.993 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 43.2 t30 -112.48 169.26 9.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.293 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 t -151.32 92.97 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.436 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.526 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 0.6 OUTLIER -100.26 116.19 31.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.27 167.45 10.14 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.413 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.505 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.7 Cg_endo -77.98 131.3 10.93 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.632 2.222 . . . . 0.0 110.494 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.58 -144.1 4.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.93 6.87 3.91 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.552 2.168 . . . . 0.0 110.763 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.528 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 12.3 p-80 -125.01 -7.37 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.046 -1.034 . . . . 0.0 109.505 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.9 t -160.07 116.25 2.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.355 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.01 45.76 1.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.64 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.505 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 6.1 pt20 -174.54 139.47 0.57 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -0.956 . . . . 0.0 109.549 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.454 ' OG1' ' HB3' ' A' ' 70' ' ' ASP . 1.3 m -57.6 151.34 17.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.862 . . . . 0.0 109.338 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.454 ' OE2' ' HB2' ' B' ' 10' ' ' GLN . 6.4 pt-20 -138.02 114.94 10.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.611 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.86 154.0 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.153 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.462 ' O ' HG12 ' B' ' 26' ' ' VAL . 4.2 mt -138.36 154.21 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.746 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.507 ' CB ' HG22 ' B' ' 23' ' ' ILE . . . -137.19 118.77 14.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.221 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.486 ' O ' ' HG3' ' B' ' 24' ' ' GLN . 1.2 m -89.17 96.41 10.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.027 -1.046 . . . . 0.0 108.63 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.6 mt -43.22 167.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.581 -0.699 . . . . 0.0 109.895 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -80.67 7.68 9.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 109.652 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.11 23.46 13.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.95 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.29 7.44 82.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 0.7 OUTLIER -95.54 167.66 11.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -1.177 . . . . 0.0 109.507 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.445 ' HD3' ' OG1' ' B' ' 43' ' ' THR . 18.4 mttt -138.71 151.31 47.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.902 . . . . 0.0 109.511 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.26 122.27 8.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.117 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.452 ' SG ' HG12 ' B' ' 41' ' ' ILE . 4.4 m -79.7 142.26 35.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 109.125 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.492 ' HB3' HG23 ' B' ' 59' ' ' VAL . 12.8 mt -120.19 167.41 12.28 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.285 -0.884 . . . . 0.0 109.356 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.541 ' N ' HG23 ' B' ' 59' ' ' VAL . 1.0 OUTLIER -97.14 115.73 65.81 Favored Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 109.278 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.471 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.4 Cg_endo -74.18 0.14 8.84 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.265 1.976 . . . . 0.0 110.46 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.03 -13.85 24.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.267 -0.896 . . . . 0.0 108.918 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.471 ' OG ' ' HB3' ' B' ' 53' ' ' ASN . 0.0 OUTLIER -90.09 164.52 27.68 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 109.403 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.79 -37.74 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.668 2.245 . . . . 0.0 110.508 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' B' ' 62' ' ' ILE . 10.0 mt -61.42 -51.89 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 0.0 109.026 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.541 HG23 ' N ' ' B' ' 53' ' ' ASN . 54.8 t -54.45 -54.42 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.542 -0.724 . . . . 0.0 109.745 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.471 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 5.1 mttt -47.44 -33.65 6.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 109.078 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.462 ' O ' ' HB2' ' B' ' 65' ' ' LYS . 0.2 OUTLIER -74.6 -38.61 62.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 0.0 109.372 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -58.05 -41.99 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.825 . . . . 0.0 109.168 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.573 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -70.1 -67.86 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.766 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.474 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.2 OUTLIER -44.01 -28.31 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 109.747 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.522 ' HG2' ' CB ' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -72.81 -59.95 2.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 0.0 109.237 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.425 ' C ' ' O ' ' B' ' 65' ' ' LYS . 0.8 OUTLIER -44.05 -44.43 7.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.155 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.587 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 1.3 mt -55.21 -58.63 6.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.52 -0.738 . . . . 0.0 109.701 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -80.9 6.94 11.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 109.749 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' B' ' 65' ' ' LYS . 10.0 p -94.34 -10.22 33.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.122 -0.986 . . . . 0.0 109.402 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.523 ' O ' ' CG ' ' B' ' 71' ' ' LYS . 0.6 OUTLIER -107.8 27.54 9.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.46 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 70' ' ' ASP . 18.3 pttm 41.77 -161.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.452 -0.78 . . . . 0.0 109.666 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.96 -63.17 0.41 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.216 -0.928 . . . . 0.0 109.484 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.493 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -120.4 119.08 32.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 0.0 109.439 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.415 HG21 ' N ' ' A' ' 4' ' ' ALA . 7.3 p -77.99 136.65 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.415 ' N ' HG21 ' A' ' 3' ' ' VAL . . . -167.36 101.01 0.51 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.468 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.1 m -143.79 -39.48 0.3 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 109.457 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -162.46 120.62 2.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.31 -0.869 . . . . 0.0 109.484 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.55 HD21 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -121.36 99.81 6.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 9' ' ' CYS . 8.9 mtm180 -97.89 153.43 18.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.24 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.429 ' C ' ' O ' ' A' ' 8' ' ' ARG . 19.7 m -44.18 107.94 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.414 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.525 ' CG ' ' HE3' ' A' ' 29' ' ' LYS . 22.5 mm-40 -49.78 -21.66 1.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.715 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.463 ' HB2' ' OE1' ' A' ' 39' ' ' GLU . 49.9 m -144.98 67.43 1.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 0.0 109.909 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 11' ' ' CYS . 14.5 mt -45.12 -45.53 11.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 108.817 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.09 119.41 35.76 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -94.52 167.14 11.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 110.101 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.4 mt -114.38 144.99 42.4 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.4 tt0 -44.29 -39.06 4.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.176 -0.952 . . . . 0.0 109.41 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.509 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 144.99 -164.72 27.85 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.576 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.3 pp -170.82 163.74 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.488 -1.007 . . . . 0.0 109.094 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.51 ' ND1' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -53.54 149.48 15.11 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 109.354 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.51 ' HD2' ' ND1' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.19 -3.98 14.3 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.53 2.153 . . . . 0.0 110.176 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HE2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.25 -24.38 20.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.376 -0.828 . . . . 0.0 109.089 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.523 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 2.5 m-20 -82.87 -6.47 59.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 109.258 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.576 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 8.5 mt -104.94 148.89 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.575 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -120.54 -27.27 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.575 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -137.69 168.51 19.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.092 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.517 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 90.5 t -140.87 114.46 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.011 . . . . 0.0 109.776 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.449 ' HB3' HD11 ' A' ' 41' ' ' ILE . 3.8 t-20 -109.62 110.65 21.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 109.348 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -110.1 105.54 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 109.516 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.525 ' HE3' ' CG ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -98.51 114.71 27.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.402 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.98 167.82 5.54 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 36.2 Cg_endo -78.13 151.44 26.93 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.615 2.21 . . . . 0.0 110.44 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.84 -141.3 3.14 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.466 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 36.3 Cg_endo -77.89 10.96 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.649 2.233 . . . . 0.0 111.008 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.55 ' CD2' HD21 ' A' ' 7' ' ' LEU . 3.6 p-80 -128.27 -34.48 2.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.058 -1.026 . . . . 0.0 109.441 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.9 t -145.39 88.03 1.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.287 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -52.59 -19.93 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.706 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.462 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 33.8 mm-40 -92.85 131.93 37.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 3.6 m -54.79 161.3 1.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.33 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.488 ' HB2' ' CG ' ' A' ' 29' ' ' LYS . 22.5 mm-40 -145.33 107.53 4.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 0.0 109.635 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.506 HG11 ' N ' ' A' ' 41' ' ' ILE . 43.1 t -91.77 152.84 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.326 -0.859 . . . . 0.0 109.311 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.506 ' N ' HG11 ' A' ' 40' ' ' VAL . 2.7 mp -140.34 155.42 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.949 . . . . 0.0 109.709 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.9 117.99 11.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 109.103 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.537 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.4 m -89.22 97.66 11.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.892 -1.13 . . . . 0.0 108.787 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 87.1 mt -43.53 162.8 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.464 -0.772 . . . . 0.0 109.583 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.501 ' HB3' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -79.1 7.17 7.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.805 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -108.85 16.87 22.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.132 -0.98 . . . . 0.0 109.198 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.57 -0.8 89.45 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.508 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 13.7 mtt180 -89.68 162.97 15.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -1.201 . . . . 0.0 109.426 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.514 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.3 mptt -134.5 151.06 50.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.24 123.93 9.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 109.033 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 22.9 m -79.47 143.99 34.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.078 -1.014 . . . . 0.0 109.189 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.529 ' O ' ' CG2' ' A' ' 14' ' ' THR . 15.2 mt -121.19 167.69 12.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -0.856 . . . . 0.0 109.437 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.543 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 2.8 t-20 -100.84 123.48 45.36 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.413 -0.804 . . . . 0.0 109.177 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.19 -7.04 18.64 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.219 1.946 . . . . 0.0 110.398 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.45 -13.1 55.47 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 108.961 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -90.06 161.65 37.4 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.374 -0.829 . . . . 0.0 109.429 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.92 -35.66 1.33 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.648 2.232 . . . . 0.0 110.574 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.543 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 16.8 tt -67.31 -45.74 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.426 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.543 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 42.7 t -58.62 -46.82 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.413 -0.804 . . . . 0.0 109.369 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 1.3 mmpt? -59.47 -29.48 67.85 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.46 ' HA ' ' CG ' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -79.72 -23.84 42.08 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 22.7 mt -70.58 -37.76 70.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.584 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -74.75 -56.48 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 0.0 109.321 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER -59.35 -27.87 66.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.296 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.514 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 1.7 tptt -71.78 -50.68 27.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.058 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.517 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -51.85 -45.78 64.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 109.081 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.578 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -44.27 -52.15 7.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.335 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.9 OUTLIER -62.14 -38.1 87.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.393 -0.817 . . . . 0.0 109.456 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.445 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 2.5 p -44.69 -30.56 0.96 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.457 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.438 ' OD1' HG23 ' B' ' 38' ' ' THR . 27.9 m-20 -59.87 -89.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.491 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.74 175.01 14.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.9 p -85.64 -156.65 0.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.439 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.485 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -120.31 119.15 32.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.462 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.409 ' O ' HG11 ' B' ' 3' ' ' VAL . 7.4 p -78.02 136.71 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.498 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.4 ' N ' HG21 ' B' ' 3' ' ' VAL . . . -167.44 101.06 0.5 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 109.458 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 40.3 m -143.81 -39.44 0.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.461 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -162.52 120.57 2.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.438 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.544 HD21 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -121.33 99.95 6.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.537 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' B' ' 9' ' ' CYS . 8.9 mtm180 -97.96 153.36 18.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.183 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.431 ' C ' ' O ' ' B' ' 8' ' ' ARG . 19.4 m -44.16 107.9 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 109.39 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.512 ' CG ' ' HE3' ' B' ' 29' ' ' LYS . 22.5 mm-40 -49.75 -21.66 1.16 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.757 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' OE1' ' B' ' 39' ' ' GLU . 50.8 m -145.01 67.51 1.24 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.126 -0.984 . . . . 0.0 109.893 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.432 ' C ' ' O ' ' B' ' 11' ' ' CYS . 14.5 mt -45.12 -45.57 11.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -0.972 . . . . 0.0 108.854 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.06 119.44 35.85 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.6 OUTLIER -94.55 167.1 11.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.242 -0.911 . . . . 0.0 110.098 -179.365 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' B' ' 16' ' ' GLN . 7.4 mt -114.36 144.97 42.42 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.52 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.4 tt0 -44.27 -39.09 4.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 109.395 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.519 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 144.95 -164.62 27.85 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.3 pp -170.82 163.7 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.442 -1.034 . . . . 0.0 109.145 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.51 ' ND1' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -53.53 149.46 15.13 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.326 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.51 ' HD2' ' ND1' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -77.29 -3.89 14.17 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.586 2.191 . . . . 0.0 110.189 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HE2' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.3 -24.31 20.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.151 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 2.5 m-20 -82.87 -6.42 59.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.332 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 8.4 mt -104.95 148.88 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 110.269 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.558 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -120.55 -27.31 5.17 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.237 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.558 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -137.64 168.47 19.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.141 179.337 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.506 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 91.3 t -140.81 114.43 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.802 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.436 ' HB3' HD11 ' B' ' 41' ' ' ILE . 3.8 t-20 -109.6 110.63 21.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.295 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -110.03 105.62 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.275 -0.89 . . . . 0.0 109.592 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -98.6 114.67 27.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.387 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.95 167.89 5.4 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.423 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 36.2 Cg_endo -78.16 151.47 26.85 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.518 2.146 . . . . 0.0 110.456 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.82 -141.34 3.15 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.46 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -77.92 10.98 2.41 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.603 2.202 . . . . 0.0 110.993 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.544 ' CD2' HD21 ' B' ' 7' ' ' LEU . 3.7 p-80 -128.27 -34.44 2.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.016 -1.052 . . . . 0.0 109.474 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.465 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 2.0 t -145.43 88.07 1.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.296 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -52.6 -20.0 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.708 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.453 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 33.5 mm-40 -92.8 131.9 37.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.457 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 3.6 m -54.74 161.33 1.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.396 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.493 ' HB2' ' CG ' ' B' ' 29' ' ' LYS . 22.5 mm-40 -145.35 107.58 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.515 HG11 ' N ' ' B' ' 41' ' ' ILE . 42.9 t -91.8 152.8 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 109.299 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.515 ' N ' HG11 ' B' ' 40' ' ' VAL . 2.7 mp -140.31 155.35 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.719 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.88 118.05 11.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.093 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 1.5 m -89.13 97.55 11.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.92 -1.113 . . . . 0.0 108.817 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 86.9 mt -43.45 162.8 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.479 -0.763 . . . . 0.0 109.661 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.505 ' HB3' ' NZ ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -79.15 7.29 7.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 109.83 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -108.88 16.76 22.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.134 -0.979 . . . . 0.0 109.121 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.68 -0.87 89.4 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.506 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 13.7 mtt180 -89.64 162.95 15.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.082 -1.246 . . . . 0.0 109.445 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 1.3 mptt -134.46 151.06 50.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 109.435 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.21 123.91 9.18 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 109.057 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.467 ' HA ' ' HA ' ' B' ' 41' ' ' ILE . 22.8 m -79.49 143.93 34.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.063 -1.023 . . . . 0.0 109.169 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.536 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 15.2 mt -121.14 167.61 12.47 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 2.7 t-20 -100.79 123.55 45.2 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.13 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.24 -7.05 18.62 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.225 1.95 . . . . 0.0 110.4 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.5 -13.13 55.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.229 -0.919 . . . . 0.0 108.868 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.3 OUTLIER -90.06 161.66 37.39 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.99 -35.53 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.609 2.206 . . . . 0.0 110.504 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.539 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 16.8 tt -67.33 -45.79 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.417 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.546 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 42.5 t -58.72 -46.72 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.812 . . . . 0.0 109.333 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 1.3 mmpt? -59.47 -29.59 67.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.466 ' HA ' ' CG ' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -79.63 -23.89 42.29 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 23.0 mt -70.52 -37.8 71.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.56 -0.712 . . . . 0.0 109.079 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.578 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -74.67 -56.49 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.427 -0.795 . . . . 0.0 109.398 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.4 OUTLIER -59.32 -27.86 66.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.294 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 1.6 tptt -71.79 -50.71 27.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.047 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.506 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.4 OUTLIER -51.82 -45.68 64.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.282 -0.886 . . . . 0.0 109.114 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.584 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -44.27 -52.35 7.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.314 -0.867 . . . . 0.0 109.258 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' B' ' 69' ' ' SER . 0.9 OUTLIER -61.95 -38.12 87.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.529 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.45 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 2.5 p -44.62 -30.65 0.95 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.437 ' OD1' HG23 ' A' ' 38' ' ' THR . 28.0 m-20 -59.81 -89.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.44 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.75 175.06 14.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.0 109.409 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 13.8 p -85.59 -156.67 0.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.494 179.992 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -149.67 -66.47 0.21 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.446 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.452 ' O ' ' HB1' ' A' ' 4' ' ' ALA . 30.7 m -138.12 128.21 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.298 -0.876 . . . . 0.0 109.478 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 3' ' ' VAL . . . 70.79 144.06 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.09 85.31 2.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.88 . . . . 0.0 109.437 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -152.57 111.37 3.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.437 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.533 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -117.72 98.79 6.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.873 . . . . 0.0 109.586 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 9' ' ' CYS . 29.9 mtt180 -92.83 150.52 20.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.32 -0.863 . . . . 0.0 109.022 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.518 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 50.7 m -43.99 102.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 109.351 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.506 ' OE1' ' NZ ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.59 -26.79 0.13 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.347 -0.846 . . . . 0.0 109.761 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' CYS . 72.0 m -118.25 58.33 0.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.518 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.2 -37.91 3.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.234 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.37 123.86 41.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.383 -0.823 . . . . 0.0 109.11 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -100.05 161.1 13.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.438 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.2 mt -115.07 141.16 48.38 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.1 tt0 -44.12 -26.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.271 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.509 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 139.41 -162.68 26.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.481 ' CG2' ' O ' ' A' ' 17' ' ' GLY . 1.3 pp -171.0 163.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.466 -1.02 . . . . 0.0 109.267 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.577 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -58.12 154.27 31.1 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 0.0 109.201 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -76.99 -9.31 17.99 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.415 2.077 . . . . 0.0 109.927 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.51 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 35.5 mttm -77.34 -27.85 52.85 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.537 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 22.9 m-20 -93.33 59.29 2.97 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.525 ' CD1' ' O ' ' A' ' 22' ' ' ASN . 1.5 mm -147.17 169.01 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 110.028 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.564 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -160.38 -36.0 0.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.564 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.7 p -134.83 -175.17 3.81 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.521 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 50.7 t -158.82 98.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.946 -1.096 . . . . 0.0 109.867 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.462 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 3.5 t-20 -91.33 110.74 22.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.218 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.7 t -114.32 104.11 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.478 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.522 ' HE2' ' CD1' ' A' ' 41' ' ' ILE . 0.9 OUTLIER -108.19 110.45 22.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -55.04 168.88 0.47 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.365 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.525 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.4 Cg_endo -78.13 131.95 11.21 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.556 2.171 . . . . 0.0 110.5 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.08 -143.55 5.42 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.86 5.86 4.6 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.519 2.146 . . . . 0.0 110.709 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.533 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 12.2 p-80 -124.28 -12.66 7.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.979 . . . . 0.0 109.623 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 2.7 t -160.22 98.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.214 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.98 -8.48 30.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 109.651 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.455 ' OE1' ' CA ' ' A' ' 37' ' ' GLN . 6.5 mm-40 -106.0 125.44 51.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.451 HG21 ' N ' ' A' ' 39' ' ' GLU . 25.9 m -49.7 152.61 1.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.417 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' N ' HG21 ' A' ' 38' ' ' THR . 2.2 mt-10 -137.66 107.32 6.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.984 . . . . 0.0 109.791 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.461 ' O ' HG13 ' A' ' 41' ' ' ILE . 3.8 t -93.8 157.73 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.12 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.522 ' CD1' ' HE2' ' A' ' 29' ' ' LYS . 1.9 mp -144.28 143.8 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 109.835 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.42 ' HB3' HG21 ' A' ' 23' ' ' ILE . . . -126.88 125.25 41.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 109.016 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 25.8 m -89.65 104.71 17.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.031 -1.043 . . . . 0.0 109.051 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.537 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 80.1 mt -47.35 164.92 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.223 -0.923 . . . . 0.0 109.155 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' NZ ' ' O ' ' A' ' 21' ' ' LYS . 13.4 ptpt -84.93 12.97 6.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.148 -0.97 . . . . 0.0 109.566 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -111.2 10.68 21.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.888 . . . . 0.0 109.181 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.04 20.81 48.44 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.419 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 9.4 mtt180 -115.95 173.68 6.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -1.148 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 4.2 mttt -139.71 154.66 47.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.415 ' HB3' ' CD1' ' A' ' 15' ' ' LEU . . . -150.17 125.45 10.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.097 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.453 ' SG ' HG13 ' A' ' 41' ' ' ILE . 16.8 m -79.51 144.52 33.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 0.0 109.192 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.527 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 15.1 mt -122.53 168.34 12.26 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.538 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 0.9 OUTLIER -98.04 120.96 58.79 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.368 -0.833 . . . . 0.0 109.112 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.83 -6.79 18.61 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.196 1.931 . . . . 0.0 110.284 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.3 -14.25 53.42 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.257 -0.902 . . . . 0.0 108.833 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.455 ' OG ' HG22 ' A' ' 59' ' ' VAL . 1.1 p -90.05 158.3 44.47 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.474 -0.766 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.0 Cg_endo -77.14 -32.27 3.24 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.614 2.209 . . . . 0.0 110.509 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.534 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 9.0 tt -69.2 -45.16 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.112 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.538 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 25.2 t -57.45 -46.2 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.522 -0.736 . . . . 0.0 109.248 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -61.08 -30.32 70.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 3.4 mmpt? -79.05 -20.58 48.53 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.521 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 26.7 mt -75.51 -37.34 37.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.578 -0.701 . . . . 0.0 109.181 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.588 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -74.28 -50.33 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' OE2' ' NZ ' ' A' ' 61' ' ' LYS . 8.7 pt-20 -66.12 -35.95 81.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 109.328 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 32.9 mttm -61.38 -40.44 94.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 108.945 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.521 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -61.1 -45.33 95.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.087 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.579 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -49.59 -54.88 15.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 109.69 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.2 -16.18 60.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.895 . . . . 0.0 109.724 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.465 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 28.4 p -46.67 -55.48 7.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 109.468 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 32.4 t70 59.01 102.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 0.0 109.403 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HG2' ' N ' ' A' ' 72' ' ' SER . 20.5 tttt 61.37 -88.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.489 ' N ' ' HG2' ' A' ' 71' ' ' LYS . 7.9 t -166.23 -59.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.41 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.072 -0.965 . . . . 0.0 109.465 -179.901 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m -149.66 -66.38 0.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.354 -0.841 . . . . 0.0 109.475 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.45 ' O ' ' HB1' ' B' ' 4' ' ' ALA . 31.1 m -138.19 128.22 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.885 . . . . 0.0 109.476 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.45 ' HB1' ' O ' ' B' ' 3' ' ' VAL . . . 70.84 144.0 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.515 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.11 85.31 2.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.915 . . . . 0.0 109.436 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -152.58 111.4 3.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.531 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -117.74 98.82 6.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.254 -0.904 . . . . 0.0 109.614 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.432 ' O ' ' C ' ' B' ' 9' ' ' CYS . 29.7 mtt180 -92.78 150.49 20.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.067 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.526 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 50.9 m -43.92 102.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 109.374 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.517 ' OE1' ' NZ ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -42.59 -26.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.359 -0.838 . . . . 0.0 109.722 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' B' ' 9' ' ' CYS . 72.1 m -118.28 58.38 0.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.13 -37.99 3.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 109.256 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.32 123.91 41.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.1 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.452 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.4 OUTLIER -100.13 161.12 13.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' B' ' 16' ' ' GLN . 7.2 mt -115.17 141.15 48.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.461 -0.775 . . . . 0.0 108.952 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.522 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 3.1 tt0 -44.08 -26.73 0.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.35 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.505 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 139.36 -162.67 26.1 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.474 ' CG2' ' O ' ' B' ' 17' ' ' GLY . 1.3 pp -170.96 163.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.404 -1.056 . . . . 0.0 109.217 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.572 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -58.16 154.21 31.77 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.25 -0.907 . . . . 0.0 109.27 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.9 Cg_endo -76.88 -9.31 18.15 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.449 2.099 . . . . 0.0 109.924 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.495 ' O ' ' NZ ' ' B' ' 45' ' ' LYS . 35.4 mttm -77.38 -27.87 52.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 23.0 m-20 -93.38 59.38 2.97 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' B' ' 22' ' ' ASN . 1.4 mm -147.23 168.93 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.141 -0.974 . . . . 0.0 110.047 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.551 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -160.38 -35.98 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.551 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.7 p -134.82 -175.19 3.82 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.512 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 50.4 t -158.81 98.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.96 -1.087 . . . . 0.0 109.79 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.459 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 3.6 t-20 -91.48 110.76 22.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.235 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.7 t -114.35 104.09 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.492 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.527 ' HE2' ' CD1' ' B' ' 41' ' ' ILE . 0.9 OUTLIER -108.16 110.41 22.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -54.96 168.84 0.47 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 109.414 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 36.0 Cg_endo -78.0 131.8 11.25 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.67 2.247 . . . . 0.0 110.507 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.01 -143.58 5.43 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.72 5.68 4.66 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.642 2.228 . . . . 0.0 110.68 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.531 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 12.1 p-80 -124.3 -12.68 7.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.181 -0.949 . . . . 0.0 109.585 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 2.7 t -160.18 98.88 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.25 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.9 -8.59 30.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.631 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.448 ' CA ' ' OE1' ' B' ' 37' ' ' GLN . 6.4 mm-40 -105.85 125.42 50.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.591 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.446 HG21 ' N ' ' B' ' 39' ' ' GLU . 26.0 m -49.79 152.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.868 . . . . 0.0 109.341 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.446 ' N ' HG21 ' B' ' 38' ' ' THR . 2.1 mt-10 -137.58 107.36 6.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.724 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.463 ' O ' HG13 ' B' ' 41' ' ' ILE . 3.8 t -93.85 157.64 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.115 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.527 ' CD1' ' HE2' ' B' ' 29' ' ' LYS . 1.9 mp -144.24 143.8 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.96 . . . . 0.0 109.81 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.414 ' HB3' HG21 ' B' ' 23' ' ' ILE . . . -126.93 125.18 41.1 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.492 ' O ' ' HG3' ' B' ' 24' ' ' GLN . 26.2 m -89.53 104.73 17.26 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.981 -1.074 . . . . 0.0 109.05 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 80.8 mt -47.44 164.98 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.354 -0.841 . . . . 0.0 109.123 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' B' ' 21' ' ' LYS . 13.4 ptpt -84.98 13.11 6.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.594 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -111.28 10.68 21.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.878 . . . . 0.0 109.064 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.03 20.73 48.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.427 ' C ' ' HG2' ' B' ' 49' ' ' LYS . 9.4 mtt180 -115.96 173.72 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -1.128 . . . . 0.0 109.394 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.427 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 4.2 mttt -139.67 154.69 47.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.423 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.41 ' HB3' ' CD1' ' B' ' 15' ' ' LEU . . . -150.19 125.34 10.02 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.276 -0.89 . . . . 0.0 109.175 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.453 ' SG ' HG13 ' B' ' 41' ' ' ILE . 17.1 m -79.45 144.47 34.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.957 . . . . 0.0 109.152 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.534 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 15.0 mt -122.52 168.33 12.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.891 . . . . 0.0 109.35 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.54 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 0.9 OUTLIER -98.01 120.91 58.94 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.37 -0.831 . . . . 0.0 109.093 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.83 -6.68 18.46 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.126 1.884 . . . . 0.0 110.35 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.35 -14.21 53.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 0.0 108.826 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.461 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 1.1 p -90.05 158.26 44.5 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.383 -0.823 . . . . 0.0 109.402 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.467 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 35.5 Cg_endo -77.06 -32.29 3.28 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.676 2.25 . . . . 0.0 110.522 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.543 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 9.1 tt -69.23 -45.16 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 0.0 109.113 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.543 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 25.2 t -57.55 -46.1 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.474 -0.766 . . . . 0.0 109.163 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' B' ' 56' ' ' SER . 0.0 OUTLIER -61.17 -30.28 70.31 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.523 ' O ' ' CG ' ' B' ' 65' ' ' LYS . 3.4 mmpt? -78.96 -20.77 48.38 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.511 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 26.7 mt -75.38 -37.34 38.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.641 -0.662 . . . . 0.0 109.267 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.579 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -74.29 -50.34 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.624 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 8.7 pt-20 -66.09 -35.93 81.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.998 -1.064 . . . . 0.0 109.353 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 32.8 mttm -61.42 -40.53 94.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 108.939 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.2 OUTLIER -61.0 -45.3 95.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.149 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -49.64 -54.78 16.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 109.698 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.32 -16.19 60.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.687 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 28.3 p -46.52 -55.59 7.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.537 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' B' ' 71' ' ' LYS . 32.3 t70 59.06 102.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.41 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' B' ' 72' ' ' SER . 20.4 tttt 61.35 -88.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.449 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.508 ' N ' ' HG2' ' B' ' 71' ' ' LYS . 7.9 t -166.27 -59.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.512 179.973 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 68.41 -86.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.476 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 4' ' ' ALA . 2.1 m -144.63 49.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.482 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 3' ' ' VAL . . . -44.05 165.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.474 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.2 69.68 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.186 -0.946 . . . . 0.0 109.475 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.85 80.89 2.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.533 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -119.28 99.71 6.87 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.329 -0.857 . . . . 0.0 109.61 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -96.14 149.83 21.19 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.325 -0.859 . . . . 0.0 108.994 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.523 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 68.7 m -44.01 98.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.139 -0.976 . . . . 0.0 109.411 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.515 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.52 -26.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.874 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.437 ' N ' ' O ' ' A' ' 9' ' ' CYS . 83.0 m -116.8 58.71 0.76 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 109.71 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.523 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.82 -37.14 3.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.178 -0.951 . . . . 0.0 109.147 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -127.28 127.72 44.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.374 -0.829 . . . . 0.0 109.059 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -101.94 165.37 11.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.217 -0.927 . . . . 0.0 109.953 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.412 ' O ' ' C ' ' A' ' 16' ' ' GLN . 6.9 mt -124.21 143.42 50.53 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.412 ' C ' ' O ' ' A' ' 15' ' ' LEU . 1.3 tt0 -44.17 -40.89 5.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -0.946 . . . . 0.0 109.402 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.515 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 140.41 166.67 10.76 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.591 ' CD1' ' CG1' ' A' ' 23' ' ' ILE . 1.9 pp -139.31 162.8 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.549 -0.971 . . . . 0.0 109.083 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.545 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -46.49 151.61 0.99 Allowed Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 109.204 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -76.91 -4.87 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.502 2.135 . . . . 0.0 110.083 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.44 -23.41 21.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.331 -0.855 . . . . 0.0 109.237 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.523 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 4.8 m-20 -82.52 -4.7 57.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 0.0 109.44 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.591 ' CG1' ' CD1' ' A' ' 18' ' ' ILE . 9.0 mt -105.61 155.3 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 110.304 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.583 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -127.27 -29.19 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.32 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.583 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -135.11 171.12 14.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.029 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.526 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 46.4 t -143.78 101.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.959 . . . . 0.0 109.733 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.453 ' HB3' HD11 ' A' ' 41' ' ' ILE . 3.8 t-20 -95.71 110.4 22.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.364 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -107.0 100.72 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.504 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' CD ' ' HB2' ' A' ' 10' ' ' GLN . 10.2 ptmt -95.54 109.41 21.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.44 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.442 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -61.88 171.52 1.45 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.4 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.524 ' HG2' ' CB ' ' B' ' 71' ' ' LYS . 35.3 Cg_endo -77.54 144.57 22.67 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.611 2.207 . . . . 0.0 110.444 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.89 -141.3 3.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.9 39.96 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.746 2.297 . . . . 0.0 110.759 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.533 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 6.4 p-80 -159.41 -38.82 0.06 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.082 -1.011 . . . . 0.0 109.13 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -141.14 99.0 3.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.865 . . . . 0.0 109.146 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.87 -11.85 42.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 0.0 109.679 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.457 ' OE1' ' CA ' ' A' ' 37' ' ' GLN . 4.0 mm-40 -98.92 124.4 43.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.457 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.459 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 9.4 m -47.72 157.85 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.252 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.466 ' HB2' ' HG3' ' A' ' 29' ' ' LYS . 7.3 mm-40 -145.57 107.29 4.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 109.702 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.466 ' O ' HG13 ' A' ' 41' ' ' ILE . 6.5 t -89.74 156.23 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.154 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 40' ' ' VAL . 2.6 mp -141.09 148.43 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.145 -0.972 . . . . 0.0 109.838 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.04 118.18 18.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.007 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.532 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 2.1 m -89.12 98.91 12.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.931 -1.106 . . . . 0.0 108.885 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 88.9 mt -44.41 166.6 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.504 -0.747 . . . . 0.0 109.593 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.4 ptpt -81.88 8.21 10.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.639 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.15 25.04 11.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.216 -0.928 . . . . 0.0 109.242 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.18 2.64 67.23 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.511 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 5.8 mtt180 -92.1 164.32 13.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.193 -1.181 . . . . 0.0 109.436 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.6 mptt -135.92 153.13 51.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.174 -0.954 . . . . 0.0 109.393 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.29 122.45 8.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.065 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.4 m -79.46 143.07 35.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.102 -0.999 . . . . 0.0 109.036 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.523 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 14.2 mt -119.74 167.59 11.91 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.29 -0.881 . . . . 0.0 109.611 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 2.1 t30 -97.64 119.0 63.52 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.518 -0.739 . . . . 0.0 109.172 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.11 -0.0 9.0 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.136 1.891 . . . . 0.0 110.443 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.79 -13.07 25.97 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.296 -0.877 . . . . 0.0 108.835 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.417 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.11 165.35 24.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.389 -0.82 . . . . 0.0 109.399 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.478 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.17 -42.18 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.707 2.271 . . . . 0.0 110.816 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.449 HG21 HD13 ' A' ' 62' ' ' ILE . 47.1 mt -61.52 -39.71 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.734 -179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.548 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 47.5 t -64.42 -49.46 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.794 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 8.7 mttm -53.73 -32.33 51.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.071 -1.018 . . . . 0.0 108.706 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.524 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -78.06 -29.93 49.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.55 -0.719 . . . . 0.0 109.268 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.533 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 15.2 mt -64.43 -38.55 82.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.219 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.579 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 1.4 mp -76.01 -64.65 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.858 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -49.65 -55.22 14.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 109.449 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.461 ' HB3' ' O ' ' A' ' 61' ' ' LYS . 42.8 tptt -46.62 -55.79 7.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.128 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.526 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -44.38 -43.19 7.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 0.0 109.169 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.589 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -55.83 -55.27 34.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.419 -0.8 . . . . 0.0 109.579 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.28 10.31 17.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 109.679 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.457 ' OG ' ' O ' ' A' ' 66' ' ' MET . 91.2 p -63.19 -40.32 97.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' A' ' 71' ' ' LYS . 2.9 m-20 59.74 66.68 0.96 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.524 ' CB ' ' HG2' ' B' ' 31' ' ' PRO . 13.9 ptpt 41.8 -163.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.49 -0.756 . . . . 0.0 109.659 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.45 ' O ' ' OXT' ' A' ' 73' ' ' ASN . 4.3 t -113.1 76.05 0.95 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 109.457 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' OXT' ' O ' ' A' ' 72' ' ' SER . 4.3 t30 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.503 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.293 0.568 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' B' ' 1' ' ' ALA . 0.6 OUTLIER 68.3 -86.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.445 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' B' ' 4' ' ' ALA . 2.2 m -144.61 49.77 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.547 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' B' ' 3' ' ' VAL . . . -44.09 165.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 109.372 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.19 69.74 0.19 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.84 80.87 2.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.42 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.53 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -119.2 99.6 6.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.204 -0.935 . . . . 0.0 109.694 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -96.05 149.86 21.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.007 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.514 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 68.6 m -43.97 98.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.893 . . . . 0.0 109.335 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.508 ' HB2' ' CD ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -42.67 -26.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.436 -0.79 . . . . 0.0 109.761 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.436 ' N ' ' O ' ' B' ' 9' ' ' CYS . 82.9 m -116.85 58.77 0.76 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.729 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.514 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.18 3.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -127.31 127.64 44.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.016 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.449 HG21 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -101.88 165.42 11.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.968 . . . . 0.0 109.958 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.415 ' O ' ' C ' ' B' ' 16' ' ' GLN . 6.9 mt -124.2 143.43 50.52 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' B' ' 15' ' ' LEU . 1.3 tt0 -44.22 -40.97 5.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.28 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.521 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 140.45 166.72 10.78 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.583 ' CD1' ' CG1' ' B' ' 23' ' ' ILE . 1.9 pp -139.37 162.82 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.496 -1.002 . . . . 0.0 109.034 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.534 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -46.49 151.61 0.99 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.982 . . . . 0.0 109.134 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.534 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -76.91 -4.84 15.37 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.475 2.117 . . . . 0.0 110.008 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.477 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.47 -23.28 21.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.389 -0.819 . . . . 0.0 109.229 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 4.8 m-20 -82.61 -4.69 58.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.583 ' CG1' ' CD1' ' B' ' 18' ' ' ILE . 8.9 mt -105.59 155.35 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.564 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -127.36 -29.14 2.73 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.564 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -135.11 171.06 14.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 109.055 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.52 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 46.2 t -143.73 101.82 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.047 -1.033 . . . . 0.0 109.752 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.459 ' HB3' HD11 ' B' ' 41' ' ' ILE . 3.9 t-20 -95.65 110.4 22.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.321 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -107.01 100.71 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.481 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.508 ' CD ' ' HB2' ' B' ' 10' ' ' GLN . 10.1 ptmt -95.57 109.52 21.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 109.441 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.431 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -61.99 171.49 1.5 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 109.447 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.524 ' HG2' ' CB ' ' A' ' 71' ' ' LYS . 35.8 Cg_endo -77.43 144.6 22.96 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.615 2.21 . . . . 0.0 110.455 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.84 -141.25 3.29 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.9 39.94 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.684 2.256 . . . . 0.0 110.826 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.53 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 6.5 p-80 -159.37 -38.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.073 -1.017 . . . . 0.0 109.202 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -141.21 99.02 3.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 109.154 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.9 -11.93 43.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.7 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.454 ' HA ' ' OE1' ' B' ' 37' ' ' GLN . 4.0 mm-40 -98.77 124.45 43.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.519 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.454 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 9.4 m -47.78 157.89 0.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.313 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.454 ' HB2' ' HG3' ' B' ' 29' ' ' LYS . 7.3 mm-40 -145.58 107.27 4.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.732 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.463 ' O ' HG13 ' B' ' 41' ' ' ILE . 6.3 t -89.72 156.2 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.846 . . . . 0.0 109.182 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.463 HG13 ' O ' ' B' ' 40' ' ' VAL . 2.6 mp -141.07 148.47 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.777 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.09 118.19 18.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.057 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.518 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 2.1 m -89.08 98.82 11.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.909 -1.12 . . . . 0.0 108.896 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.1 mt -44.4 166.5 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.523 -0.736 . . . . 0.0 109.697 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.477 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.4 ptpt -81.73 8.09 10.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 109.692 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.07 25.01 11.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.26 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.28 2.55 67.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 5.8 mtt180 -92.01 164.28 13.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -1.204 . . . . 0.0 109.436 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 1.6 mptt -135.86 153.2 51.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.382 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.39 122.36 8.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.835 . . . . 0.0 109.075 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 5.4 m -79.4 142.96 35.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.021 . . . . 0.0 109.08 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.525 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 14.0 mt -119.65 167.63 11.84 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.262 -0.899 . . . . 0.0 109.678 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.547 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 2.1 t30 -97.62 118.99 63.56 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.506 -0.746 . . . . 0.0 109.182 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.413 ' HA ' HG13 ' B' ' 59' ' ' VAL . 32.3 Cg_endo -74.26 0.14 8.89 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.07 1.846 . . . . 0.0 110.339 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.72 -13.16 26.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 108.867 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.409 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.1 165.4 24.23 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.835 . . . . 0.0 109.419 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.479 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.5 Cg_endo -78.1 -42.23 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.742 2.295 . . . . 0.0 110.831 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.464 HG21 HD13 ' B' ' 62' ' ' ILE . 47.2 mt -61.61 -39.62 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.189 -0.944 . . . . 0.0 109.706 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.547 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 47.6 t -64.43 -49.48 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.347 -0.845 . . . . 0.0 109.832 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' B' ' 64' ' ' GLU . 8.7 mttm -53.77 -32.28 51.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 108.741 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -78.04 -29.89 49.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.615 -0.678 . . . . 0.0 109.285 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.537 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 15.0 mt -64.6 -38.43 82.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 109.138 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.589 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 1.4 mp -75.99 -64.79 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 109.786 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -49.61 -55.2 14.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.01 -1.057 . . . . 0.0 109.449 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' B' ' 61' ' ' LYS . 42.9 tptt -46.57 -55.81 7.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.135 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.52 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.0 OUTLIER -44.43 -43.2 7.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.948 . . . . 0.0 109.116 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.578 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -55.72 -55.39 32.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.434 -0.791 . . . . 0.0 109.63 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.2 10.35 17.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 0.0 109.623 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' B' ' 66' ' ' MET . 90.6 p -63.29 -40.31 96.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.459 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.528 ' O ' ' CG ' ' B' ' 71' ' ' LYS . 2.8 m-20 59.67 66.74 0.96 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.94 . . . . 0.0 109.496 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' B' ' 70' ' ' ASP . 13.9 ptpt 41.78 -163.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.435 -0.791 . . . . 0.0 109.696 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.448 ' O ' ' OXT' ' B' ' 73' ' ' ASN . 4.3 t -113.13 76.13 0.96 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.456 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . 0.448 ' OXT' ' O ' ' B' ' 72' ' ' SER . 4.3 t30 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.439 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.71 172.86 6.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 10.8 p -151.36 17.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.199 -0.938 . . . . 0.0 109.468 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.421 ' HB2' ' O ' ' A' ' 3' ' ' VAL . . . 69.5 -158.11 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.483 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.41 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -158.24 117.05 3.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.433 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 5' ' ' THR . 8.5 tt0 179.97 76.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.528 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -117.14 98.52 6.5 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.175 -0.953 . . . . 0.0 109.645 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -88.42 153.33 21.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.022 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.517 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 67.1 m -44.31 118.83 1.63 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 109.403 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.511 ' NE2' ' HD3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -40.66 -40.01 1.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.587 -0.695 . . . . 0.0 109.857 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.445 ' SG ' HG13 ' A' ' 41' ' ' ILE . 82.5 m -132.09 80.49 1.91 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 109.878 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.517 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 3.9 mm? -49.2 -45.35 44.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 108.993 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -116.89 122.71 45.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.429 -0.794 . . . . 0.0 108.923 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.12 166.83 10.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.952 . . . . 0.0 110.006 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.408 ' HB2' HD21 ' A' ' 52' ' ' LEU . 6.0 mt -115.27 146.21 41.7 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.512 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -44.74 -35.65 2.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.109 -0.994 . . . . 0.0 109.38 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.464 ' HA3' HG22 ' A' ' 58' ' ' ILE . . . 146.37 -176.98 25.01 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.564 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.7 pp -157.04 162.39 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -1.06 . . . . 0.0 109.372 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.575 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -59.24 156.21 30.25 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 0.0 109.343 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.575 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -77.04 -13.3 17.36 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.501 2.134 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.533 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 22.0 mttt -74.17 -30.86 62.45 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.538 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 26.5 m-20 -89.59 58.41 4.32 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.564 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 1.5 mm -145.63 169.16 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -0.974 . . . . 0.0 110.098 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.563 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -160.18 -35.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.563 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 3.0 p -136.37 -172.59 3.18 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.529 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 52.1 t -159.24 115.16 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.891 -1.131 . . . . 0.0 109.97 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 3.9 t-20 -109.11 110.76 22.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 109.111 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.71 109.8 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.3 -0.875 . . . . 0.0 109.729 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.511 ' HD3' ' NE2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -108.87 102.03 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.37 -0.831 . . . . 0.0 109.309 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -48.81 171.31 0.1 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 36.0 Cg_endo -78.03 140.87 18.32 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.586 2.191 . . . . 0.0 110.462 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.48 -141.49 3.68 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.45 8.82 3.13 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.544 2.163 . . . . 0.0 110.878 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.528 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 4.4 p-80 -125.53 -21.33 4.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.047 -1.033 . . . . 0.0 109.807 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' OE1' ' A' ' 37' ' ' GLN . 2.1 t -160.02 122.44 3.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.012 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.42 16.2 4.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.637 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 2.0 mp0 -124.13 124.83 43.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.425 ' CG2' ' HB3' ' B' ' 70' ' ' ASP . 15.9 m -54.88 137.54 45.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.406 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 39' ' ' GLU . 1.7 mp0 -118.77 107.02 13.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 109.683 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.438 HG13 HD12 ' A' ' 63' ' ' ILE . 13.5 t -95.12 146.94 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.244 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.514 ' CG1' ' SG ' ' A' ' 51' ' ' CYS . 2.1 mp -138.23 152.58 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.874 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.62 125.25 23.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.411 -0.805 . . . . 0.0 109.041 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.529 HG23 ' CG ' ' A' ' 24' ' ' GLN . 33.4 m -89.51 106.86 18.73 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.008 -1.058 . . . . 0.0 109.093 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 71.9 mt -49.03 166.11 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.183 -0.948 . . . . 0.0 109.114 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.533 ' CD ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -84.27 11.04 8.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.057 -1.027 . . . . 0.0 109.533 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.488 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -111.12 19.26 18.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.325 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 14.61 80.1 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.488 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 49.1 mtt180 -109.15 175.23 5.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -1.173 . . . . 0.0 109.502 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -145.15 155.25 43.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.48 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.1 124.99 9.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.365 -0.834 . . . . 0.0 109.116 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.514 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 12.0 m -79.55 140.35 37.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.091 -1.006 . . . . 0.0 109.267 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.508 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 11.4 mt -122.93 168.67 12.01 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.253 -0.904 . . . . 0.0 109.266 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 2.2 t30 -104.68 124.79 35.77 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 109.276 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.11 -13.48 21.18 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.165 1.91 . . . . 0.0 110.531 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.417 ' HB1' ' ND2' ' A' ' 53' ' ' ASN . . . -73.55 -16.65 61.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.261 -0.899 . . . . 0.0 108.875 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.47 ' OG ' HG21 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -90.16 161.16 38.51 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.453 -0.779 . . . . 0.0 109.419 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.408 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -78.12 -37.17 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.679 2.253 . . . . 0.0 111.044 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.545 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 17.6 tt -64.73 -47.2 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.06 -1.025 . . . . 0.0 109.13 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.549 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 39.5 t -56.68 -48.23 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.509 -0.745 . . . . 0.0 109.163 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 56' ' ' SER . 4.6 mmtt -54.21 -31.18 52.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.497 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 9.6 mmmm -78.3 -30.66 48.49 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.35 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -58.0 -43.59 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.571 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 1.6 mp -68.7 -61.76 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -42.6 -29.03 0.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.344 -0.847 . . . . 0.0 109.584 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 66' ' ' MET . 0.7 OUTLIER -74.32 -60.57 2.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.858 . . . . 0.0 109.271 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.529 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 1.2 mmm -44.05 -48.37 8.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.564 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -43.64 -51.21 7.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 0.0 109.342 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.97 -37.04 86.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.467 -0.771 . . . . 0.0 109.497 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -46.71 -32.0 3.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.846 . . . . 0.0 109.465 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 3.4 p30 -99.25 88.17 3.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.134 -0.979 . . . . 0.0 109.448 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.411 ' HG2' ' N ' ' A' ' 72' ' ' SER . 10.5 tttt -118.7 152.44 36.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.526 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.411 ' N ' ' HG2' ' A' ' 71' ' ' LYS . 0.4 OUTLIER -168.01 71.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.411 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.413 ' O ' ' OD1' ' A' ' 73' ' ' ASN . 12.9 p30 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.126 -0.984 . . . . 0.0 109.5 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.7 172.87 6.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 109.463 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' B' ' 4' ' ' ALA . 10.8 p -151.37 17.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.482 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' B' ' 3' ' ' VAL . . . 69.41 -158.09 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.418 ' O ' ' HB2' ' B' ' 6' ' ' GLU . 0.0 OUTLIER -158.22 116.93 3.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.502 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' B' ' 5' ' ' THR . 8.5 tt0 -179.97 76.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.44 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.526 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -117.16 98.53 6.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.205 -0.934 . . . . 0.0 109.649 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -88.4 153.32 21.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.004 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.52 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 67.4 m -44.3 118.88 1.64 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.49 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.51 ' NE2' ' HD3' ' B' ' 29' ' ' LYS . 0.9 OUTLIER -40.74 -40.03 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.549 -0.719 . . . . 0.0 109.899 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.449 ' SG ' HG13 ' B' ' 41' ' ' ILE . 83.2 m -132.0 80.63 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.854 . . . . 0.0 109.882 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 3.9 mm? -49.38 -45.33 45.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.104 -0.998 . . . . 0.0 108.921 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -116.92 122.78 45.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.417 -0.802 . . . . 0.0 108.911 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.18 166.78 10.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.999 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' B' ' 16' ' ' GLN . 6.0 mt -115.2 146.18 41.67 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.515 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 0.8 OUTLIER -44.67 -35.67 2.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.142 -0.973 . . . . 0.0 109.438 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.47 ' HA3' HG22 ' B' ' 58' ' ' ILE . . . 146.32 -177.02 24.94 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.563 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.7 pp -157.01 162.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -1.105 . . . . 0.0 109.428 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.583 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -59.25 156.24 30.22 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.291 -0.881 . . . . 0.0 109.233 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.583 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.06 -13.19 17.37 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.467 2.112 . . . . 0.0 109.961 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.525 ' O ' ' CD ' ' B' ' 45' ' ' LYS . 22.1 mttt -74.17 -30.85 62.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.549 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 26.4 m-20 -89.65 58.41 4.29 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.563 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 1.5 mm -145.65 169.21 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.072 -1.018 . . . . 0.0 110.135 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.565 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -160.16 -35.68 0.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.565 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 3.0 p -136.37 -172.64 3.19 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.524 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 52.0 t -159.2 115.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.915 -1.115 . . . . 0.0 109.984 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.46 ' O ' HD13 ' B' ' 41' ' ' ILE . 3.9 t-20 -109.09 110.71 22.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.111 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.74 109.81 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.661 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.51 ' HD3' ' NE2' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -108.78 102.04 11.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.282 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.449 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.0 OUTLIER -48.84 171.29 0.1 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.377 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 36.3 Cg_endo -77.98 140.87 18.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.641 2.227 . . . . 0.0 110.497 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.57 -141.46 3.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.47 8.82 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.563 2.175 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.526 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 4.4 p-80 -125.56 -21.32 4.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.053 -1.03 . . . . 0.0 109.775 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.445 ' SG ' ' OE1' ' B' ' 37' ' ' GLN . 2.1 t -160.03 122.59 3.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.092 -1.005 . . . . 0.0 109.333 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.57 16.28 4.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.603 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.455 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 2.0 mp0 -124.17 124.87 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 109.474 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.422 ' CG2' ' HB3' ' A' ' 70' ' ' ASP . 15.3 m -54.78 137.58 44.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.939 . . . . 0.0 109.413 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.472 ' OE1' ' N ' ' B' ' 39' ' ' GLU . 1.7 mp0 -118.85 107.06 13.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.94 . . . . 0.0 109.632 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.44 HG13 HD12 ' B' ' 63' ' ' ILE . 13.5 t -95.14 146.91 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.515 ' CG1' ' SG ' ' B' ' 51' ' ' CYS . 2.1 mp -138.2 152.63 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.089 -1.007 . . . . 0.0 109.899 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . . . . . . . . . . . -136.6 125.29 23.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.085 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.525 HG23 ' CG ' ' B' ' 24' ' ' GLN . 33.8 m -89.6 106.87 18.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.973 -1.08 . . . . 0.0 109.071 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.549 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 72.8 mt -49.07 166.17 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.151 -0.968 . . . . 0.0 109.013 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -84.34 11.03 9.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 0.0 109.442 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.486 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -111.12 19.3 18.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.345 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.63 80.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.486 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 49.2 mtt180 -109.16 175.24 5.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -1.209 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -145.19 155.33 43.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.425 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.14 124.98 9.83 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.391 -0.818 . . . . 0.0 109.112 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.515 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 12.0 m -79.64 140.3 37.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.166 -0.959 . . . . 0.0 109.244 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.508 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 11.4 mt -122.91 168.69 11.98 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.259 -0.901 . . . . 0.0 109.229 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.552 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 2.2 t30 -104.78 124.86 35.48 Favored Pre-proline 0 C--N 1.299 -1.601 0 O-C-N 121.344 -0.847 . . . . 0.0 109.171 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.06 -13.58 21.25 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.263 1.975 . . . . 0.0 110.452 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.429 ' HB1' ' ND2' ' B' ' 53' ' ' ASN . . . -73.53 -16.68 61.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 108.804 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.471 ' OG ' HG21 ' B' ' 58' ' ' ILE . 0.7 OUTLIER -90.2 161.13 38.46 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.342 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.5 Cg_endo -78.07 -37.19 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.703 2.269 . . . . 0.0 111.08 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.56 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 17.5 tt -64.69 -47.26 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.053 -1.029 . . . . 0.0 109.162 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.56 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 39.4 t -56.75 -48.28 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' B' ' 56' ' ' SER . 4.6 mmtt -54.15 -31.24 51.93 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.498 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 9.7 mmmm -78.27 -30.64 48.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.498 -0.751 . . . . 0.0 109.302 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -58.08 -43.57 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.564 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 1.6 mp -68.72 -61.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -42.7 -28.99 0.27 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.347 -0.845 . . . . 0.0 109.583 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' B' ' 66' ' ' MET . 0.7 OUTLIER -74.38 -60.47 2.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.942 . . . . 0.0 109.276 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.524 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 1.2 mmm -44.16 -48.28 9.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.83 . . . . 0.0 109.207 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.571 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -43.75 -51.16 7.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.379 -0.825 . . . . 0.0 109.317 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.91 -37.09 86.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.523 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -46.74 -31.93 3.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.499 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.444 ' O ' ' OD1' ' B' ' 70' ' ' ASP . 3.4 p30 -99.29 88.18 3.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' B' ' 72' ' ' SER . 10.4 tttt -118.7 152.51 35.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.476 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.41 ' N ' ' HG2' ' B' ' 71' ' ' LYS . 0.4 OUTLIER -168.01 71.95 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . 0.403 ' O ' ' OD1' ' B' ' 73' ' ' ASN . 13.0 p30 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.066 -0.968 . . . . 0.0 109.455 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -154.82 114.33 3.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.922 . . . . 0.0 109.47 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.415 ' CG1' ' N ' ' A' ' 4' ' ' ALA . 48.7 t 58.58 -89.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.53 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 2' ' ' SER . . . -151.15 88.49 1.45 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.905 . . . . 0.0 109.415 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.2 p -87.09 -24.03 24.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.47 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.89 91.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.53 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -118.41 98.86 6.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 0.0 109.533 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 9' ' ' CYS . 1.8 mpp_? -91.16 151.64 20.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.282 -0.886 . . . . 0.0 109.141 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.513 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 7.7 m -44.06 109.97 0.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.176 -0.952 . . . . 0.0 109.361 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -42.25 -27.25 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.415 -0.803 . . . . 0.0 109.797 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.435 ' SG ' HG13 ' A' ' 41' ' ' ILE . 98.7 m -131.26 67.18 1.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.185 -0.947 . . . . 0.0 109.616 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.513 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.43 -40.44 5.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.228 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -121.43 126.44 49.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.405 -0.81 . . . . 0.0 109.173 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.459 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -106.52 160.51 15.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.1 mt -110.38 140.64 44.39 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.519 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.2 tt0 -44.07 -26.62 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.371 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.471 ' HA2' HD21 ' A' ' 52' ' ' LEU . . . 151.78 -165.88 30.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.51 HD11 ' CD1' ' A' ' 23' ' ' ILE . 1.2 pp -169.14 162.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -1.064 . . . . 0.0 109.842 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.603 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.7 t60 -56.83 149.07 45.09 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.603 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -80.37 -15.99 10.99 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.318 2.012 . . . . 0.0 108.922 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.53 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 5.7 mttm -77.99 -22.8 48.83 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.564 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 17.9 m-20 -94.25 57.85 2.39 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.512 ' CD1' ' O ' ' A' ' 22' ' ' ASN . 2.4 mm -143.27 169.97 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.044 -1.035 . . . . 0.0 110.129 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -160.09 -40.47 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.518 ' CB ' ' HB ' ' A' ' 43' ' ' THR . 2.2 p -133.18 174.98 9.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.515 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 50.4 t -156.48 122.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.952 -1.092 . . . . 0.0 109.759 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.461 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 56.0 t30 -104.77 155.97 18.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.467 ' HB ' ' HB ' ' B' ' 26' ' ' VAL . 2.9 t -145.59 76.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.503 ' CE ' ' NE2' ' A' ' 34' ' ' HIS . 11.0 tptt -87.36 100.4 12.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.3 p -51.65 166.34 0.38 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 109.41 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.9 Cg_endo -78.15 131.75 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.594 2.196 . . . . 0.0 110.537 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.54 -144.34 4.91 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.19 7.77 3.54 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.59 2.194 . . . . 0.0 110.767 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.53 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 11.5 p-80 -125.98 -6.91 6.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.089 -1.007 . . . . 0.0 109.616 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.6 t -160.04 116.97 2.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.41 45.83 1.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.508 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.497 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 4.3 pt20 -172.55 139.14 0.93 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.53 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.424 ' HB ' ' CG ' ' A' ' 54' ' ' PRO . 2.4 m -57.52 144.06 38.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 109.373 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -124.77 107.64 11.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.592 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.424 ' CG1' HD12 ' A' ' 63' ' ' ILE . 44.2 t -100.39 150.02 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.867 . . . . 0.0 109.297 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 2.5 mp -136.06 159.66 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.848 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.435 ' N ' ' CG2' ' A' ' 41' ' ' ILE . . . -141.73 121.53 13.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.803 . . . . 0.0 109.11 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 16.4 m -89.53 101.27 13.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.973 -1.079 . . . . 0.0 109.17 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.564 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 73.7 mt -44.56 165.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.323 -0.861 . . . . 0.0 109.02 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.53 ' CD ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -83.64 9.93 10.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 109.494 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -109.99 16.88 21.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.364 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.83 18.54 67.6 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.453 ' HB2' HD13 ' A' ' 44' ' ' LEU . 1.7 mtp180 -111.89 169.43 8.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -1.134 . . . . 0.0 109.502 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.417 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -136.18 153.65 51.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.943 . . . . 0.0 109.478 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.27 123.36 8.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.113 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.409 ' SG ' HG13 ' A' ' 41' ' ' ILE . 11.8 m -79.51 143.19 35.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.096 -1.002 . . . . 0.0 109.14 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.522 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 14.0 mt -123.63 168.12 13.07 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.372 -0.83 . . . . 0.0 109.305 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.531 ' O ' ' CG2' ' A' ' 59' ' ' VAL . 1.9 t-20 -100.48 122.39 49.89 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.151 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.506 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.6 Cg_endo -75.14 -10.2 20.89 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.205 1.937 . . . . 0.0 110.283 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.08 -14.76 58.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.273 -0.892 . . . . 0.0 108.969 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -89.96 159.53 42.62 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.435 -0.791 . . . . 0.0 109.426 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.432 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.7 -33.49 2.27 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.578 2.185 . . . . 0.0 110.671 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.536 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 16.8 tt -68.07 -46.96 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.015 . . . . 0.0 109.232 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.536 ' N ' ' CG2' ' A' ' 58' ' ' ILE . 37.3 t -56.23 -48.78 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.414 -0.804 . . . . 0.0 109.076 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.506 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 14.9 mttt -56.32 -31.51 63.78 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.468 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -74.52 -29.93 61.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.604 -0.685 . . . . 0.0 109.284 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.533 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -68.88 -43.59 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.555 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -65.17 -65.86 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.523 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -48.04 -42.73 29.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 109.593 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -55.58 -49.24 73.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 109.3 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.515 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -53.48 -47.47 69.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.265 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.565 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -46.89 -52.48 14.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.462 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' SER . 13.4 t-20 -63.52 -31.73 72.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.466 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 68' ' ' ASN . 5.9 p -43.94 -34.59 1.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 109.509 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -54.77 -59.51 4.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.877 . . . . 0.0 109.489 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -97.14 -160.25 0.79 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 109.474 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.0 t -164.21 -66.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.47 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.427 ' O ' ' N ' ' B' ' 4' ' ' ALA . 0.7 OUTLIER -154.78 114.29 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.459 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.407 ' HB ' ' O ' ' B' ' 2' ' ' SER . 48.7 t 58.61 -89.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' B' ' 2' ' ' SER . . . -151.1 88.37 1.45 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.486 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 35.6 p -86.94 -24.24 24.84 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.8 91.61 0.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.417 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.528 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -118.35 98.97 6.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.215 -0.928 . . . . 0.0 109.621 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' B' ' 9' ' ' CYS . 1.8 mpp_? -91.26 151.69 20.81 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.262 -0.899 . . . . 0.0 109.125 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.52 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 7.8 m -44.01 109.89 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.352 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -42.16 -27.3 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.833 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.435 ' SG ' HG13 ' B' ' 41' ' ' ILE . 98.9 m -131.27 67.15 1.52 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.598 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.37 -40.59 5.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.164 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -121.34 126.54 49.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.167 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.442 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -106.56 160.59 15.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.841 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.436 ' O ' ' C ' ' B' ' 16' ' ' GLN . 7.0 mt -110.38 140.58 44.45 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.461 -0.774 . . . . 0.0 108.928 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.528 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.2 tt0 -44.04 -26.59 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.119 -0.988 . . . . 0.0 109.422 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.474 ' HA2' HD21 ' B' ' 52' ' ' LEU . . . 151.76 -165.86 30.69 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.522 HD11 ' CD1' ' B' ' 23' ' ' ILE . 1.2 pp -169.13 162.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -1.068 . . . . 0.0 109.837 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.586 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 1.7 t60 -56.89 149.05 45.83 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.586 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.6 Cg_endo -80.32 -16.03 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.383 2.055 . . . . 0.0 108.915 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.537 ' O ' ' CD ' ' B' ' 45' ' ' LYS . 5.7 mttm -78.04 -22.71 48.77 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.562 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 17.8 m-20 -94.34 57.96 2.38 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.522 ' CD1' HD11 ' B' ' 18' ' ' ILE . 2.3 mm -143.31 169.98 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.093 -1.004 . . . . 0.0 110.157 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.0 OUTLIER -160.11 -40.62 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.514 ' CB ' ' HB ' ' B' ' 43' ' ' THR . 2.1 p -133.13 174.93 9.85 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.52 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 50.4 t -156.38 122.5 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.939 -1.101 . . . . 0.0 109.759 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.454 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 55.6 t30 -104.71 155.9 18.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.244 -0.91 . . . . 0.0 109.357 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 2.9 t -145.52 76.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.516 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.503 ' CE ' ' NE2' ' B' ' 34' ' ' HIS . 11.0 tptt -87.32 100.49 12.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.3 p -51.75 166.29 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.502 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.8 Cg_endo -78.05 131.71 11.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.648 2.232 . . . . 0.0 110.524 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.5 -144.41 4.93 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.11 7.74 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.649 2.233 . . . . 0.0 110.819 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.528 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 11.4 p-80 -125.98 -6.86 6.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.993 . . . . 0.0 109.67 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.7 t -160.15 116.93 2.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.415 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.4 45.73 1.22 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.576 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.502 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 4.2 pt20 -172.48 139.17 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 109.55 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.426 ' HB ' ' CG ' ' B' ' 54' ' ' PRO . 2.4 m -57.46 144.12 37.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -124.84 107.59 11.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.554 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.421 ' CG1' HD12 ' B' ' 63' ' ' ILE . 44.3 t -100.39 150.05 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.281 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.455 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 2.5 mp -136.03 159.63 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.121 -0.987 . . . . 0.0 109.87 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.429 ' N ' ' CG2' ' B' ' 41' ' ' ILE . . . -141.69 121.47 13.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.822 . . . . 0.0 109.135 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 16.4 m -89.43 101.32 14.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.024 -1.047 . . . . 0.0 109.23 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.562 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 73.8 mt -44.56 165.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 109.058 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.537 ' CD ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -83.66 9.88 10.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.161 -0.962 . . . . 0.0 109.434 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.466 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -109.91 16.79 21.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.92 18.46 67.58 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.462 ' HB2' HD13 ' B' ' 44' ' ' LEU . 1.7 mtp180 -111.82 169.29 8.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -1.173 . . . . 0.0 109.512 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.415 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 0.3 OUTLIER -136.04 153.61 51.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 109.592 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.21 123.31 8.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 109.072 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.405 ' SG ' HG13 ' B' ' 41' ' ' ILE . 12.0 m -79.45 143.21 35.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.091 -1.006 . . . . 0.0 109.239 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.529 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 14.0 mt -123.7 168.07 13.16 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.222 -0.924 . . . . 0.0 109.344 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 1.9 t-20 -100.52 122.31 50.08 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.182 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.51 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.6 Cg_endo -74.99 -10.17 21.1 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.143 1.895 . . . . 0.0 110.388 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.1 -14.74 58.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -0.919 . . . . 0.0 108.892 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.3 OUTLIER -90.01 159.55 42.44 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.409 -0.807 . . . . 0.0 109.421 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.71 -33.43 2.29 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.622 2.215 . . . . 0.0 110.652 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.554 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 16.9 tt -68.2 -46.88 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.099 -1.0 . . . . 0.0 109.151 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.554 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 37.1 t -56.3 -48.69 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 109.072 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.51 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 14.9 mttt -56.44 -31.43 63.93 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.465 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -74.63 -29.85 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.604 -0.685 . . . . 0.0 109.266 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -68.89 -43.67 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.565 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.1 mp -65.17 -65.89 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.499 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -47.99 -42.82 28.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 109.549 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -55.52 -49.24 73.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.308 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.52 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -53.49 -47.39 69.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.299 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.555 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -46.9 -52.47 14.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.454 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' B' ' 69' ' ' SER . 13.4 t-20 -63.53 -31.75 73.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.41 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.402 ' C ' ' O ' ' B' ' 68' ' ' ASN . 5.8 p -43.91 -34.66 1.72 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.497 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -54.78 -59.52 4.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.457 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -97.2 -160.23 0.79 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.244 -0.91 . . . . 0.0 109.5 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.1 t -164.18 -66.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.443 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 61.93 128.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.47 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.479 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 9.9 p -146.36 77.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.499 ' O ' ' CB ' ' A' ' 5' ' ' THR . . . -109.24 145.52 35.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.499 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER 164.9 133.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.184 -0.947 . . . . 0.0 109.501 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -88.83 84.31 6.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.52 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -115.89 98.07 6.45 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.274 -0.891 . . . . 0.0 109.594 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -87.43 157.68 19.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.091 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.512 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 1.8 m -44.06 114.72 0.71 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -0.983 . . . . 0.0 109.464 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' A' ' 9' ' ' CYS . 13.7 mm-40 -42.16 -27.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -0.818 . . . . 0.0 109.798 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.456 ' SG ' HG13 ' A' ' 41' ' ' ILE . 79.1 m -136.55 81.06 1.86 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 109.716 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.512 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -53.93 -41.44 67.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.16 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -118.5 117.93 30.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.16 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -99.78 163.18 12.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.792 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 51' ' ' CYS . 4.4 mt -106.18 137.2 44.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.83 . . . . 0.0 108.963 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -44.49 -41.39 6.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.979 . . . . 0.0 109.366 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.528 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 177.54 168.84 37.82 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.462 ' CG2' HD23 ' A' ' 52' ' ' LEU . 8.0 tp -153.67 158.37 3.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.473 -1.016 . . . . 0.0 108.772 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.576 ' CB ' ' ND2' ' A' ' 22' ' ' ASN . 2.6 t-80 -45.04 139.89 3.77 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.226 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.475 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.7 Cg_endo -77.77 -25.44 7.78 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.491 2.127 . . . . 0.0 110.292 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -90.12 -14.83 32.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 0.0 108.987 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.576 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 51.7 m-20 -70.33 -11.61 61.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.325 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.525 ' CG2' ' HB3' ' A' ' 42' ' ' ALA . 3.1 mt -105.44 149.01 9.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.263 -0.898 . . . . 0.0 110.611 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -115.61 -27.69 7.03 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.527 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -136.1 160.72 37.79 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.468 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 2.0 t -146.16 101.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.941 -1.1 . . . . 0.0 109.932 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.449 ' OD1' ' OD1' ' B' ' 27' ' ' ASN . 29.1 t30 -79.96 116.73 20.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.198 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.451 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -98.23 84.68 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -0.923 . . . . 0.0 109.49 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HA ' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER -89.59 93.91 9.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.364 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.09 167.26 0.25 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.376 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.466 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.5 Cg_endo -77.96 131.84 11.32 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.619 2.213 . . . . 0.0 110.38 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.22 -145.97 6.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.96 5.48 4.93 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.628 2.219 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.52 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 18.2 p-80 -121.81 -16.83 7.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.614 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 9.1 t -160.12 96.88 1.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.33 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.76 -10.57 28.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.595 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.445 ' OE1' ' SG ' ' A' ' 9' ' ' CYS . 2.0 mp0 -96.24 125.26 40.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.57 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.435 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 3.8 m -50.68 150.7 2.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.944 . . . . 0.0 109.385 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.456 ' OE2' ' HB3' ' A' ' 35' ' ' CYS . 3.3 mp0 -129.39 107.7 9.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.959 . . . . 0.0 109.571 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.521 ' CG1' HD12 ' A' ' 63' ' ' ILE . 1.7 t -102.59 95.34 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.257 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.456 HG13 ' SG ' ' A' ' 11' ' ' CYS . 5.2 mp -86.03 140.73 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.742 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.525 ' HB3' ' CG2' ' A' ' 23' ' ' ILE . . . -124.14 119.14 28.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.202 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.48 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -89.17 100.07 12.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.02 -1.05 . . . . 0.0 108.459 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 72.5 mt -41.49 165.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.541 0.686 . . . . 0.0 110.073 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.5 ptpt -80.36 6.96 10.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.539 -0.726 . . . . 0.0 109.686 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.456 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -111.95 8.54 20.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.406 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.35 -6.11 71.42 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.42 ' C ' ' HG2' ' A' ' 49' ' ' LYS . 7.3 mtt180 -84.46 170.52 13.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.13 -1.218 . . . . 0.0 109.537 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.42 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 10.0 mttt -133.86 153.73 51.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.22 118.12 6.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.037 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.465 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 19.4 m -79.57 139.02 37.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.129 -0.982 . . . . 0.0 109.166 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.537 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 11.3 mt -126.9 168.25 14.74 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.15 -0.969 . . . . 0.0 109.329 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 1.1 t-20 -108.26 129.16 24.42 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.554 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.435 ' HG3' ' HB ' ' A' ' 38' ' ' THR . 34.4 Cg_endo -76.1 4.45 5.3 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.407 2.071 . . . . 0.0 110.747 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.38 -21.31 27.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.249 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.448 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.06 163.97 29.86 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.843 . . . . 0.0 109.466 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.84 -29.1 4.61 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.654 2.236 . . . . 0.0 110.143 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.528 ' CG2' ' HA3' ' A' ' 17' ' ' GLY . 8.6 mm -68.18 -47.33 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.549 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 51.1 t -62.38 -48.61 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 109.675 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 56' ' ' SER . 2.8 mmpt? -56.91 -30.52 64.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.93 . . . . 0.0 108.809 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.52 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -81.66 -24.69 36.15 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.513 ' CG2' HD11 ' A' ' 23' ' ' ILE . 16.0 mt -67.97 -38.25 79.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.25 -0.906 . . . . 0.0 108.592 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.586 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 1.5 mp -76.36 -63.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.383 -0.823 . . . . 0.0 109.117 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -43.92 -50.84 7.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.253 -0.904 . . . . 0.0 109.428 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 66' ' ' MET . 4.4 tmtm? -52.03 -57.58 9.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.211 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.468 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -44.12 -46.2 8.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 109.127 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.571 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -55.59 -49.54 72.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.452 -0.78 . . . . 0.0 109.527 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -96.26 33.91 1.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.474 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.8 p -95.43 -38.27 10.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.473 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -80.45 76.26 7.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.433 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 72' ' ' SER . 9.9 ttpt -116.89 -58.28 2.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 0.0 109.447 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 71' ' ' LYS . 1.9 t 73.79 178.87 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.445 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.439 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.444 ' O ' ' O ' ' B' ' 1' ' ' ALA . 0.6 OUTLIER 61.91 128.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.407 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.466 ' O ' ' CG1' ' B' ' 3' ' ' VAL . 9.8 p -146.33 77.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.501 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.491 ' O ' ' CB ' ' B' ' 5' ' ' THR . . . -109.27 145.54 35.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 109.404 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.491 ' CB ' ' O ' ' B' ' 4' ' ' ALA . 0.1 OUTLIER 164.9 133.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 0.0 109.421 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' B' ' 6' ' ' GLU . 0.4 OUTLIER -88.82 84.16 6.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 109.521 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.522 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -115.82 98.05 6.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.197 -0.939 . . . . 0.0 109.585 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -87.42 157.65 19.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 109.139 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.517 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 1.7 m -44.07 114.74 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 109.436 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' B' ' 9' ' ' CYS . 13.6 mm-40 -42.14 -27.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.796 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.447 ' SG ' HG13 ' B' ' 41' ' ' ILE . 78.4 m -136.61 81.1 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 109.595 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.517 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.3 OUTLIER -53.94 -41.47 67.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.202 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -118.39 117.97 30.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.283 -0.886 . . . . 0.0 109.146 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.463 HG23 ' O ' ' B' ' 52' ' ' LEU . 0.6 OUTLIER -99.85 163.09 12.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.825 -179.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' B' ' 51' ' ' CYS . 4.3 mt -106.0 137.17 44.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.321 -0.862 . . . . 0.0 108.995 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.0 OUTLIER -44.56 -41.28 6.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 109.4 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.518 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 177.5 168.8 37.73 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.472 ' CG2' HD23 ' B' ' 52' ' ' LEU . 8.0 tp -153.64 158.39 3.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.493 -1.004 . . . . 0.0 108.784 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.576 ' CB ' ' ND2' ' B' ' 22' ' ' ASN . 2.6 t-80 -45.05 139.86 3.8 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.02 -1.05 . . . . 0.0 109.156 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.462 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.1 Cg_endo -77.8 -25.36 7.8 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.501 2.134 . . . . 0.0 110.256 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.2 OUTLIER -90.18 -14.84 32.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.405 -0.81 . . . . 0.0 108.974 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.576 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 52.0 m-20 -70.29 -11.61 61.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.451 -0.781 . . . . 0.0 109.318 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.525 HD11 ' CG2' ' B' ' 62' ' ' ILE . 3.0 mt -105.41 148.99 9.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.238 -0.914 . . . . 0.0 110.584 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.524 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -115.63 -27.75 7.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.524 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -136.04 160.81 37.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.473 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 2.0 t -146.24 101.5 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.03 -1.044 . . . . 0.0 109.917 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.449 ' OD1' ' OD1' ' A' ' 27' ' ' ASN . 29.0 t30 -79.88 116.79 20.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.247 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.8 t -98.24 84.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER -89.58 93.87 9.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.214 -0.929 . . . . 0.0 109.396 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.02 167.21 0.25 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.266 -0.896 . . . . 0.0 109.399 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.9 Cg_endo -77.91 131.87 11.4 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.56 2.173 . . . . 0.0 110.455 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.22 -146.12 6.05 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -76.87 5.47 4.88 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.623 2.216 . . . . 0.0 110.654 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.522 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 18.1 p-80 -121.86 -16.75 7.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.951 . . . . 0.0 109.555 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.462 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 9.1 t -160.14 96.92 1.23 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 109.353 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.77 -10.56 28.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.638 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.446 ' OE1' ' SG ' ' B' ' 9' ' ' CYS . 2.0 mp0 -96.28 125.21 40.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.494 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.435 ' HB ' ' HG3' ' B' ' 54' ' ' PRO . 3.8 m -50.62 150.67 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 109.375 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.459 ' OE2' ' HB3' ' B' ' 35' ' ' CYS . 3.3 mp0 -129.4 107.81 9.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.603 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.517 ' CG1' HD12 ' B' ' 63' ' ' ILE . 1.7 t -102.61 95.26 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.288 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.447 HG13 ' SG ' ' B' ' 11' ' ' CYS . 5.2 mp -86.02 140.72 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.52 ' HB3' ' CG2' ' B' ' 23' ' ' ILE . . . -124.16 119.13 28.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.845 . . . . 0.0 109.226 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.474 ' O ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -89.13 100.08 12.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.035 -1.041 . . . . 0.0 108.437 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 72.1 mt -41.48 165.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.573 0.702 . . . . 0.0 110.031 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.5 ptpt -80.49 7.04 10.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.472 -0.767 . . . . 0.0 109.647 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.464 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -111.91 8.48 20.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.473 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.01 71.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.409 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 7.3 mtt180 -84.6 170.56 13.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.239 . . . . 0.0 109.513 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.406 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 9.9 mttt -133.84 153.81 51.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 109.507 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.34 118.11 6.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 108.971 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.455 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 19.6 m -79.56 138.95 37.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.169 -0.957 . . . . 0.0 109.237 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.531 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 11.3 mt -126.84 168.3 14.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 1.1 t-20 -108.26 129.32 24.21 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.521 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.435 ' HG3' ' HB ' ' B' ' 38' ' ' THR . 34.6 Cg_endo -76.27 4.52 5.32 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.342 2.028 . . . . 0.0 110.755 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.43 -21.27 27.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.162 -0.962 . . . . 0.0 109.231 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.458 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -90.12 163.93 29.87 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.477 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.74 -29.18 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.683 2.255 . . . . 0.0 110.171 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.518 ' CG2' ' HA3' ' B' ' 17' ' ' GLY . 8.6 mm -68.1 -47.28 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.442 -0.786 . . . . 0.0 109.264 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.55 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 50.7 t -62.49 -48.46 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.328 -0.858 . . . . 0.0 109.731 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' B' ' 56' ' ' SER . 2.8 mmpt? -56.96 -30.54 64.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -0.929 . . . . 0.0 108.797 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.517 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -81.6 -24.68 36.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.524 -0.735 . . . . 0.0 109.247 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.525 ' CG2' HD11 ' B' ' 23' ' ' ILE . 16.1 mt -67.93 -38.23 79.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.571 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 1.5 mp -76.33 -63.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.505 -0.747 . . . . 0.0 109.097 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -43.93 -50.84 7.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.289 -0.882 . . . . 0.0 109.444 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' B' ' 66' ' ' MET . 4.4 tmtm? -52.14 -57.45 9.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.269 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.473 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.4 OUTLIER -44.1 -46.2 8.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.149 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.586 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -55.67 -49.54 72.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 0.0 109.484 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -96.2 33.87 1.68 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p -95.44 -38.2 10.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -80.54 76.22 7.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.922 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' B' ' 72' ' ' SER . 9.8 ttpt -116.85 -58.31 2.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 109.428 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' B' ' 71' ' ' LYS . 1.9 t 73.72 178.87 0.22 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.496 -179.992 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 t 57.48 69.79 0.71 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.51 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.443 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 8.8 p -173.12 106.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.456 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 5' ' ' THR . . . -105.8 149.83 26.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.485 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.524 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER 75.84 129.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -129.61 -144.01 0.27 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.331 -0.855 . . . . 0.0 109.102 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.517 ' O ' ' CB ' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -125.08 102.92 7.72 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.18 -0.95 . . . . 0.0 109.408 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 10' ' ' GLN . 24.0 mtp85 -109.58 154.48 22.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.251 -0.906 . . . . 0.0 109.14 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.461 ' HB2' HD21 ' A' ' 12' ' ' LEU . 72.8 m -44.32 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.363 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.525 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 30.2 mm-40 -43.16 -26.09 0.15 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.714 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.46 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 19.4 m -145.19 75.12 1.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.633 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.461 HD21 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.66 -50.72 9.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.168 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.457 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 7.8 pt20 -108.95 103.25 12.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.157 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.43 ' HB ' ' C ' ' A' ' 52' ' ' LEU . 1.1 p -79.89 144.93 32.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.668 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.442 ' HB2' HD21 ' A' ' 52' ' ' LEU . 22.3 mt -78.6 -174.06 3.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 109.336 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.461 ' O ' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -84.23 -40.76 17.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 0.0 109.502 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.504 ' O ' ' CG2' ' A' ' 18' ' ' ILE . . . 155.61 -172.07 33.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.579 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.3 pp -172.11 164.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -1.056 . . . . 0.0 109.213 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.471 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -58.92 150.14 61.8 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.319 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.3 Cg_endo -77.14 -4.47 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.512 2.141 . . . . 0.0 110.176 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.465 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -90.35 -23.49 21.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.385 -0.822 . . . . 0.0 109.198 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.47 ' O ' HD21 ' A' ' 44' ' ' LEU . 3.3 m-20 -85.18 -18.99 32.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.305 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 22.0 mt -83.38 169.22 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.441 -0.787 . . . . 0.0 110.07 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.533 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -139.37 -40.93 0.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.462 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 1.7 p -124.9 177.31 6.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.838 . . . . 0.0 108.892 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.52 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 47.7 t -146.8 100.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.018 -1.051 . . . . 0.0 109.698 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.461 ' O ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -100.05 111.15 23.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.266 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.435 HG12 ' CG2' ' A' ' 40' ' ' VAL . 1.8 t -120.98 102.3 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.525 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -103.94 117.22 33.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.919 . . . . 0.0 109.397 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.439 ' OG ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -57.31 171.68 0.46 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.153 -0.967 . . . . 0.0 109.284 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.489 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.8 Cg_endo -77.83 153.07 29.23 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.693 2.262 . . . . 0.0 110.456 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.98 -140.56 2.9 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.557 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 36.4 Cg_endo -78.28 12.14 2.17 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.654 2.236 . . . . 0.0 110.982 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.557 ' CE1' ' HD2' ' A' ' 33' ' ' PRO . 1.9 p-80 -127.49 -32.71 2.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.988 -1.07 . . . . 0.0 109.53 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.31 121.4 12.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.381 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.8 44.41 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.933 . . . . 0.0 109.625 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.489 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 5.2 pt20 -169.98 139.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.54 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.471 ' OG1' ' CB ' ' B' ' 70' ' ' ASP . 2.6 m -55.91 141.39 39.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.93 107.54 10.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.532 ' CG1' HD12 ' A' ' 63' ' ' ILE . 47.7 t -95.1 149.24 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.21 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.508 ' N ' HG11 ' A' ' 40' ' ' VAL . 3.4 mp -142.0 151.13 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.863 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.523 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -135.13 123.08 22.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 108.886 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 7.4 m -89.77 100.18 13.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.089 . . . . 0.0 109.375 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.47 HD21 ' O ' ' A' ' 22' ' ' ASN . 60.7 mt -42.43 164.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 0.0 109.606 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 13.0 ptpt -82.83 9.78 9.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.468 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -113.91 19.55 16.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.458 ' O ' ' HD2' ' A' ' 49' ' ' LYS . . . 87.6 -17.64 43.23 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.468 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 42.8 mtt180 -77.3 163.19 26.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -1.116 . . . . 0.0 109.416 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.458 ' HD2' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -144.01 122.65 12.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.148 -0.97 . . . . 0.0 109.541 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.18 127.94 55.21 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.24 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 92.2 m -79.65 155.34 28.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.062 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.525 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 12.8 mt -135.19 170.98 15.08 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.141 -0.974 . . . . 0.0 109.702 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.564 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 15.3 p-10 -105.39 127.6 28.26 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.78 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.467 ' HA ' HG13 ' A' ' 59' ' ' VAL . 33.0 Cg_endo -75.08 -4.66 15.71 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.087 1.858 . . . . 0.0 110.224 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 -19.29 53.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 108.778 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 159.39 42.5 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.349 -0.844 . . . . 0.0 109.022 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.92 -32.25 3.44 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.582 2.188 . . . . 0.0 110.778 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 0.1 OUTLIER -69.53 -44.66 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 109.168 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.564 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 31.4 t -58.0 -46.94 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.834 . . . . 0.0 109.152 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 56' ' ' SER . 9.6 mtmt -60.51 -30.49 69.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.492 ' CE ' ' CD ' ' A' ' 64' ' ' GLU . 4.9 mmpt? -76.67 -23.56 53.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.536 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 19.0 mt -71.39 -37.16 63.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.532 HD12 ' CG1' ' A' ' 40' ' ' VAL . 2.3 mp -73.21 -58.14 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.492 ' CD ' ' CE ' ' A' ' 61' ' ' LYS . 5.7 pt-20 -59.2 -52.19 66.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.045 -1.034 . . . . 0.0 109.652 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 6.5 mtpp -46.35 -52.43 12.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.112 -0.992 . . . . 0.0 109.132 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.52 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -49.38 -46.41 47.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.214 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.518 HD13 ' CG2' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -45.93 -52.08 12.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.432 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -64.39 -33.59 76.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.843 . . . . 0.0 109.531 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 p -44.11 -27.88 0.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.471 ' CB ' ' OG1' ' B' ' 38' ' ' THR . 1.0 OUTLIER -113.76 61.86 0.65 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.531 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -78.85 -71.52 0.43 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.446 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -112.3 155.38 24.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.453 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 40.8 t30 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.416 -179.992 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.3 t 57.58 69.71 0.72 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.45 ' O ' ' CG1' ' B' ' 3' ' ' VAL . 8.7 p -173.09 106.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.92 . . . . 0.0 109.461 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' B' ' 5' ' ' THR . . . -105.79 149.82 26.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.408 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' B' ' 4' ' ' ALA . 0.8 OUTLIER 75.75 129.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.494 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -129.67 -144.04 0.27 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.25 -0.906 . . . . 0.0 109.128 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.522 ' O ' ' CB ' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -125.06 102.9 7.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.134 -0.979 . . . . 0.0 109.475 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.472 ' O ' ' N ' ' B' ' 10' ' ' GLN . 23.9 mtp85 -109.6 154.49 22.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.088 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.462 ' HB2' HD21 ' B' ' 12' ' ' LEU . 71.8 m -44.32 98.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.26 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.521 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 30.2 mm-40 -43.22 -26.07 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 0.0 109.704 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.454 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 19.9 m -145.18 75.09 1.43 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.983 . . . . 0.0 109.601 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.462 ' O ' HD12 ' B' ' 12' ' ' LEU . 0.2 OUTLIER -44.61 -50.72 9.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 109.238 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . 0.463 ' O ' ' HG3' ' B' ' 13' ' ' GLN . 7.8 pt20 -108.95 103.25 12.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.831 . . . . 0.0 109.144 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.424 ' HB ' ' C ' ' B' ' 52' ' ' LEU . 1.0 OUTLIER -79.9 144.89 33.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.608 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.465 ' HB2' HD21 ' B' ' 52' ' ' LEU . 22.2 mt -78.46 -174.07 3.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.854 . . . . 0.0 109.33 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.457 ' O ' HG22 ' B' ' 59' ' ' VAL . 0.0 OUTLIER -84.33 -40.74 17.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.176 -0.952 . . . . 0.0 109.474 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.496 ' O ' ' CG2' ' B' ' 18' ' ' ILE . . . 155.66 -172.04 33.71 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.3 pp -172.2 163.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -1.013 . . . . 0.0 109.161 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.489 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -58.91 150.19 61.55 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.299 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.3 Cg_endo -77.14 -4.47 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.55 2.167 . . . . 0.0 110.173 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.463 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -90.3 -23.61 21.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.3 m-20 -85.16 -18.88 32.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.24 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 21.8 mt -83.43 169.22 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.389 -0.819 . . . . 0.0 110.066 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.4 OUTLIER -139.35 -41.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.448 ' CB ' ' HB ' ' B' ' 43' ' ' THR . 1.7 p -124.88 177.26 6.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.451 -0.781 . . . . 0.0 108.899 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.525 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 48.2 t -146.76 100.46 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.461 ' OD1' ' OD1' ' A' ' 27' ' ' ASN . 0.1 OUTLIER -100.09 111.18 23.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 109.217 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.432 HG12 ' CG2' ' B' ' 40' ' ' VAL . 1.8 t -120.97 102.37 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.521 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 0.2 OUTLIER -103.95 117.16 33.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.401 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.454 ' OG ' ' HD2' ' B' ' 31' ' ' PRO . 0.0 OUTLIER -57.18 171.63 0.45 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.306 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.493 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.8 Cg_endo -77.83 153.09 29.24 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.623 2.215 . . . . 0.0 110.435 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.98 -140.64 2.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.552 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -78.33 12.34 2.12 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.513 2.142 . . . . 0.0 111.006 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.552 ' CE1' ' HD2' ' B' ' 33' ' ' PRO . 1.9 p-80 -127.6 -32.63 2.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.013 -1.054 . . . . 0.0 109.509 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.34 121.34 12.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.393 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.78 44.52 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.701 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.493 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 5.2 pt20 -170.08 139.3 1.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.494 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.471 ' OG1' ' CB ' ' A' ' 70' ' ' ASP . 2.7 m -55.98 141.28 40.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.78 107.54 10.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.659 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.52 ' CG1' HD12 ' B' ' 63' ' ' ILE . 47.7 t -95.2 149.31 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.204 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.512 ' N ' HG11 ' B' ' 40' ' ' VAL . 3.4 mp -141.96 151.17 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.875 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.523 ' HB2' ' CG2' ' B' ' 23' ' ' ILE . . . -135.14 122.92 22.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 108.962 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 7.4 m -89.66 100.16 13.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.955 -1.09 . . . . 0.0 109.392 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.479 ' HA ' ' O ' ' B' ' 22' ' ' ASN . 60.4 mt -42.49 164.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.63 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.463 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 12.9 ptpt -82.79 9.8 9.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.708 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.468 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -113.94 19.62 16.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.23 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . 0.462 ' O ' ' HD2' ' B' ' 49' ' ' LYS . . . 87.62 -17.77 42.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.468 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 42.7 mtt180 -77.25 163.06 26.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -1.151 . . . . 0.0 109.405 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.462 ' HD2' ' O ' ' B' ' 47' ' ' GLY . 0.0 OUTLIER -143.97 122.67 12.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.546 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -116.19 127.94 55.2 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.445 -0.784 . . . . 0.0 109.33 179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' B' ' 41' ' ' ILE . 91.2 m -79.66 155.32 28.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.047 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.518 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 12.8 mt -135.18 170.92 15.18 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.152 -0.968 . . . . 0.0 109.744 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.565 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 15.4 p-10 -105.34 127.54 28.38 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.845 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.466 ' HA ' HG13 ' B' ' 59' ' ' VAL . 33.5 Cg_endo -75.04 -4.57 15.6 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.111 1.874 . . . . 0.0 110.308 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.45 -19.25 53.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.923 . . . . 0.0 108.761 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.477 ' HB3' ' OD1' ' B' ' 53' ' ' ASN . 0.0 OUTLIER -90.01 159.42 42.72 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.109 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.04 -32.25 3.31 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.578 2.185 . . . . 0.0 110.792 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 0.1 OUTLIER -69.45 -44.72 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.102 -0.999 . . . . 0.0 109.153 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.565 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 32.1 t -57.97 -46.94 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 109.177 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' B' ' 56' ' ' SER . 9.6 mtmt -60.49 -30.55 69.78 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.487 ' CE ' ' CD ' ' B' ' 64' ' ' GLU . 4.9 mmpt? -76.64 -23.61 53.32 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.541 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 19.2 mt -71.25 -37.25 65.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.52 HD12 ' CG1' ' B' ' 40' ' ' VAL . 2.3 mp -73.23 -58.09 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.876 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.487 ' CD ' ' CE ' ' B' ' 61' ' ' LYS . 5.6 pt-20 -59.33 -52.09 67.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.013 -1.054 . . . . 0.0 109.614 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 6.5 mtpp -46.39 -52.41 13.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 109.056 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.525 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.2 OUTLIER -49.41 -46.35 47.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.282 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.519 HD13 ' CG2' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -45.96 -52.05 12.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 0.0 109.41 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' B' ' 69' ' ' SER . 2.4 t30 -64.41 -33.6 76.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.855 . . . . 0.0 109.52 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 68' ' ' ASN . 4.9 p -44.14 -27.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.471 ' CB ' ' OG1' ' A' ' 38' ' ' THR . 1.0 OUTLIER -113.87 61.81 0.66 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.551 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -78.87 -71.4 0.44 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.547 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -112.35 155.36 24.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 0.0 109.448 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 40.9 t30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.453 -179.961 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m 50.59 -165.55 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.448 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.5 m -107.02 149.72 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.508 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 46.01 65.16 1.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -146.63 49.41 1.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.33 70.23 8.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -0.938 . . . . 0.0 109.427 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.526 ' O ' ' CB ' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -146.62 115.03 6.71 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -130.1 161.2 31.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.365 -0.834 . . . . 0.0 108.923 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.52 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 93.2 m -48.84 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.938 . . . . 0.0 109.367 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -42.76 -26.21 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.865 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.521 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 78.1 m -130.85 72.25 1.49 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.642 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.52 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.55 -44.3 8.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.937 . . . . 0.0 109.214 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.32 117.5 33.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.283 -0.886 . . . . 0.0 109.198 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.426 ' OG1' ' CG ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -103.09 156.43 17.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.697 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.465 ' HB2' HD22 ' A' ' 52' ' ' LEU . 5.5 mt -98.08 135.76 39.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.293 -0.879 . . . . 0.0 109.004 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 15' ' ' LEU . 1.1 tt0 -44.09 -26.79 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.952 . . . . 0.0 109.252 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.535 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 156.25 149.32 5.32 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.52 ' CG2' HD23 ' A' ' 52' ' ' LEU . 6.9 tt -128.34 149.97 33.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.375 -1.073 . . . . 0.0 108.883 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.447 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -43.64 146.37 0.98 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.257 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.447 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.2 Cg_endo -76.61 -13.03 18.32 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.435 2.09 . . . . 0.0 109.996 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.532 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 7.6 mttp -78.95 -15.42 58.32 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.527 ' HB3' ' CD2' ' A' ' 44' ' ' LEU . 86.5 m-20 -100.43 54.75 0.89 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 22' ' ' ASN . 0.7 OUTLIER -146.08 163.33 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.039 -1.038 . . . . 0.0 110.35 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.544 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -153.02 -36.21 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.544 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 4.9 p -128.47 179.5 5.62 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 25' ' ' SER . 51.0 t -160.14 115.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.897 -1.127 . . . . 0.0 109.891 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 20.3 t-20 -104.87 153.3 21.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.951 . . . . 0.0 109.117 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.457 HG22 ' O ' ' B' ' 26' ' ' VAL . 2.6 t -143.67 91.82 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.441 ' HD2' ' NE2' ' A' ' 10' ' ' GLN . 4.2 mttm -95.3 93.45 7.28 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 0.0 109.524 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.46 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 4.3 p -44.71 164.26 0.18 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 0.0 109.303 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.517 ' CG ' ' O ' ' B' ' 71' ' ' LYS . 35.7 Cg_endo -77.78 131.87 11.54 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.648 2.232 . . . . 0.0 110.502 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.27 -138.48 3.28 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.22 7.98 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.562 2.175 . . . . 0.0 110.778 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.526 ' CB ' ' O ' ' A' ' 7' ' ' LEU . 4.9 p-80 -126.86 -16.74 5.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.017 . . . . 0.0 109.883 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.17 125.23 3.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.024 -1.047 . . . . 0.0 109.229 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' O ' ' CD ' ' A' ' 37' ' ' GLN . . . -87.42 18.95 3.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.719 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.484 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 13.6 mm-40 -143.35 125.06 14.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.497 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.5 m -50.29 140.55 13.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.505 ' OE1' ' N ' ' A' ' 10' ' ' GLN . 8.5 mt-10 -117.66 106.83 13.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.654 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.528 ' CG2' ' HB3' ' A' ' 54' ' ' PRO . 1.7 t -98.47 106.71 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 109.186 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.521 ' CG1' ' SG ' ' A' ' 11' ' ' CYS . 2.9 mp -94.74 157.31 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.224 -0.923 . . . . 0.0 109.83 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.422 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . . . -136.47 125.88 25.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.798 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.519 ' OG1' ' CD ' ' A' ' 49' ' ' LYS . 22.4 m -89.66 105.52 17.85 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.026 -1.046 . . . . 0.0 109.111 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' HB3' ' A' ' 22' ' ' ASN . 82.9 mt -43.79 168.7 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.322 -0.861 . . . . 0.0 109.597 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.532 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.3 ptpt -90.16 17.52 6.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 109.35 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.517 ' OD1' ' CB ' ' A' ' 44' ' ' LEU . 19.6 p-10 -119.49 7.21 11.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.402 -0.812 . . . . 0.0 109.143 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.28 -17.9 54.91 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.464 ' O ' ' HG2' ' A' ' 49' ' ' LYS . 8.8 mtt85 -83.73 171.97 12.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -1.185 . . . . 0.0 109.169 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' CD ' ' OG1' ' A' ' 43' ' ' THR . 9.9 mtmt -144.49 125.21 14.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 109.553 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.24 131.14 55.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.891 . . . . 0.0 109.132 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.458 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 61.7 m -79.74 140.21 37.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.186 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.543 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 12.5 mt -129.41 168.64 16.01 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.218 -0.926 . . . . 0.0 109.441 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.553 ' O ' ' CG2' ' A' ' 59' ' ' VAL . 1.8 m-20 -111.02 130.85 22.53 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.333 -0.854 . . . . 0.0 109.62 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.528 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 33.8 Cg_endo -75.26 -14.54 20.55 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.217 1.945 . . . . 0.0 110.21 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.91 -19.13 61.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.875 . . . . 0.0 108.879 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.03 163.16 33.06 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.493 -0.754 . . . . 0.0 109.206 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.14 -41.78 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.665 2.243 . . . . 0.0 110.635 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.535 ' CG2' ' HA3' ' A' ' 17' ' ' GLY . 11.7 mm -54.48 -55.48 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.154 -0.966 . . . . 0.0 109.411 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.553 ' CG2' ' O ' ' A' ' 53' ' ' ASN . 89.1 t -54.48 -53.7 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.755 . . . . 0.0 110.053 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -45.81 -31.72 2.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.046 -1.034 . . . . 0.0 108.941 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.524 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -79.5 -38.32 34.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.52 -0.738 . . . . 0.0 109.6 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.8 mp -55.4 -41.88 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.164 -0.96 . . . . 0.0 108.811 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.588 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.1 mp -72.11 -65.78 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.353 -0.842 . . . . 0.0 109.49 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -42.23 -27.28 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.445 -0.784 . . . . 0.0 109.67 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -73.86 -49.31 25.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 108.93 179.708 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.457 ' HA ' ' HB3' ' A' ' 69' ' ' SER . 0.4 OUTLIER -55.14 -45.57 75.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.368 -0.832 . . . . 0.0 109.018 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.578 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 3.7 mt -53.56 -60.09 3.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.52 -0.738 . . . . 0.0 109.598 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -73.51 -3.98 31.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.632 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.459 ' OG ' ' N ' ' A' ' 70' ' ' ASP . 4.1 p -49.59 -57.1 7.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 109.393 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' N ' ' OG ' ' A' ' 69' ' ' SER . 0.7 OUTLIER 62.8 12.47 5.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.236 -0.915 . . . . 0.0 109.51 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.526 ' O ' ' CG ' ' B' ' 31' ' ' PRO . 2.3 mttt -58.94 122.65 14.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.405 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 73' ' ' ASN . 30.0 t -170.99 -90.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 109.461 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 72' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.934 -1.031 . . . . 0.0 109.477 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.8 m 50.59 -165.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 28.4 m -107.06 149.71 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.496 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 45.97 65.21 1.22 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.498 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -146.66 49.44 1.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.903 . . . . 0.0 109.441 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.39 70.23 8.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.455 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.527 ' O ' ' CB ' ' B' ' 34' ' ' HIS . 0.4 OUTLIER -146.65 115.02 6.69 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.28 -0.888 . . . . 0.0 109.608 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' B' ' 10' ' ' GLN . 0.1 OUTLIER -130.0 161.19 31.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 0.0 108.917 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.525 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 94.5 m -48.86 92.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.334 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' B' ' 8' ' ' ARG . 0.1 OUTLIER -42.77 -26.23 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.839 . . . . 0.0 109.866 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.517 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 78.2 m -130.78 72.2 1.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.621 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.55 -44.29 8.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.932 . . . . 0.0 109.147 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.32 117.5 33.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.29 -0.881 . . . . 0.0 109.275 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.426 ' OG1' ' CG ' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -103.09 156.44 17.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.865 . . . . 0.0 109.641 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.463 ' HB2' HD22 ' B' ' 52' ' ' LEU . 5.6 mt -98.04 135.77 39.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.79 . . . . 0.0 109.05 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' B' ' 15' ' ' LEU . 1.1 tt0 -44.07 -26.78 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 109.313 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.53 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 156.21 149.23 5.3 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.527 ' CG2' HD23 ' B' ' 52' ' ' LEU . 6.9 tt -128.25 150.03 33.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.511 -0.994 . . . . 0.0 108.803 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.449 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -43.74 146.41 1.01 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.945 . . . . 0.0 109.289 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.449 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.4 Cg_endo -76.6 -13.03 18.34 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.424 2.083 . . . . 0.0 109.991 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.534 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 7.6 mttp -78.93 -15.42 58.33 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.531 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 86.5 m-20 -100.46 54.8 0.88 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.515 ' CD1' ' O ' ' B' ' 22' ' ' ASN . 0.7 OUTLIER -146.11 163.41 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.032 -1.042 . . . . 0.0 110.337 -179.359 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.563 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -153.08 -36.26 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.835 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.563 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 5.0 p -128.41 179.52 5.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' B' ' 25' ' ' SER . 51.4 t -160.11 115.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.786 -1.196 . . . . 0.0 109.99 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.452 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 20.4 t-20 -104.83 153.31 21.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 109.097 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 25' ' ' SER . 2.6 t -143.71 91.83 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 109.654 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.431 ' HD2' ' CD ' ' B' ' 10' ' ' GLN . 4.3 mttm -95.3 93.43 7.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.462 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 4.3 p -44.7 164.21 0.18 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.843 . . . . 0.0 109.301 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.526 ' CG ' ' O ' ' A' ' 71' ' ' LYS . 35.7 Cg_endo -77.77 131.96 11.6 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.592 2.195 . . . . 0.0 110.527 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.26 -138.5 3.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.27 8.09 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.498 2.132 . . . . 0.0 110.782 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.527 ' CB ' ' O ' ' B' ' 7' ' ' LEU . 5.0 p-80 -126.92 -16.79 5.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.063 -1.023 . . . . 0.0 109.849 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -160.12 125.21 3.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.075 -1.016 . . . . 0.0 109.278 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.419 ' O ' ' CD ' ' B' ' 37' ' ' GLN . . . -87.41 18.9 3.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.674 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.479 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 13.4 mm-40 -143.31 124.97 14.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.961 . . . . 0.0 109.558 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 17.5 m -50.26 140.65 12.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.937 . . . . 0.0 109.255 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' B' ' 10' ' ' GLN . 8.5 mt-10 -117.76 106.81 13.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 109.619 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.531 ' CG2' ' HB3' ' B' ' 54' ' ' PRO . 1.7 t -98.5 106.76 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.166 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.517 ' CG1' ' SG ' ' B' ' 11' ' ' CYS . 2.9 mp -94.77 157.29 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.872 . . . . 0.0 109.803 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.417 ' HB2' ' CG2' ' B' ' 23' ' ' ILE . . . -136.38 125.85 25.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 108.866 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.519 ' OG1' ' CD ' ' B' ' 49' ' ' LYS . 22.4 m -89.68 105.57 17.89 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.958 -1.089 . . . . 0.0 109.151 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.531 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 82.4 mt -43.83 168.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.312 -0.868 . . . . 0.0 109.583 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.534 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.2 ptpt -90.15 17.49 6.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.525 ' OD1' ' CB ' ' B' ' 44' ' ' LEU . 19.5 p-10 -119.42 7.23 11.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.22 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.3 -17.97 54.73 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.46 ' O ' ' HG2' ' B' ' 49' ' ' LYS . 8.8 mtt85 -83.73 171.95 12.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 109.15 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.519 ' CD ' ' OG1' ' B' ' 43' ' ' THR . 10.0 mtmt -144.42 125.21 14.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.509 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.27 131.18 55.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.163 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 61.7 m -79.83 140.2 36.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -0.979 . . . . 0.0 109.186 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.546 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 12.5 mt -129.41 168.63 16.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.218 -0.926 . . . . 0.0 109.378 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.55 ' O ' ' CG2' ' B' ' 59' ' ' VAL . 1.8 m-20 -110.94 130.91 22.45 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.587 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.531 ' HB3' ' CG2' ' B' ' 40' ' ' VAL . 33.7 Cg_endo -75.31 -14.56 20.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.312 2.008 . . . . 0.0 110.248 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.99 -19.11 61.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 108.829 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.465 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -89.91 163.09 33.61 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.152 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.16 -41.76 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.59 2.193 . . . . 0.0 110.632 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.53 ' CG2' ' HA3' ' B' ' 17' ' ' GLY . 11.7 mm -54.46 -55.54 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.351 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.55 ' CG2' ' O ' ' B' ' 53' ' ' ASN . 90.0 t -54.46 -53.67 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.528 -0.732 . . . . 0.0 110.054 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 0.4 OUTLIER -45.86 -31.66 2.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.028 -1.045 . . . . 0.0 108.966 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.522 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -79.57 -38.27 34.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 109.647 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.8 mp -55.32 -41.85 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 108.856 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.578 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.1 mp -72.17 -65.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -42.14 -27.26 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -73.82 -49.37 25.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 108.947 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.463 ' O ' ' HB3' ' B' ' 69' ' ' SER . 0.4 OUTLIER -55.18 -45.53 75.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.415 -0.803 . . . . 0.0 109.002 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 3.7 mt -53.67 -60.07 3.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.734 . . . . 0.0 109.52 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -73.51 -3.93 30.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.686 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.477 ' OG ' ' N ' ' B' ' 70' ' ' ASP . 4.1 p -49.64 -57.07 7.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 109.455 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.477 ' N ' ' OG ' ' B' ' 69' ' ' SER . 0.7 OUTLIER 62.83 12.51 5.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.868 . . . . 0.0 109.416 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 2.3 mttt -58.96 122.67 14.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.282 -0.886 . . . . 0.0 109.503 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' B' ' 73' ' ' ASN . 30.2 t -170.93 -90.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' B' ' 72' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.474 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.9 -41.26 23.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 109.497 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.449 ' O ' HG11 ' A' ' 3' ' ' VAL . 11.7 p -78.12 137.79 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.926 . . . . 0.0 109.426 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -132.53 -179.75 5.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.29 -0.881 . . . . 0.0 109.488 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.489 ' CG2' ' O ' ' A' ' 5' ' ' THR . 32.4 m -118.86 61.81 0.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.5 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.52 39.05 1.02 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.42 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.519 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -115.6 98.25 6.6 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.219 -0.925 . . . . 0.0 109.532 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -83.49 154.51 23.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.132 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.464 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m -43.88 121.73 2.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 109.394 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.486 ' HG3' ' CB ' ' A' ' 29' ' ' LYS . 56.6 mm-40 -42.08 -27.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.791 . . . . 0.0 109.842 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.445 ' SG ' HG13 ' A' ' 41' ' ' ILE . 81.1 m -146.04 72.04 1.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.162 -0.961 . . . . 0.0 109.61 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.464 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -44.07 -45.65 8.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.068 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -110.13 120.87 43.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.414 -0.804 . . . . 0.0 109.072 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.465 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -105.99 161.43 14.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.236 -0.915 . . . . 0.0 109.986 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 51' ' ' CYS . 3.1 mt -108.66 143.08 38.21 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.401 ' C ' ' O ' ' A' ' 15' ' ' LEU . 2.4 tt0 -44.9 -26.54 0.42 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.061 -1.025 . . . . 0.0 109.065 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.444 ' HA2' HG21 ' A' ' 59' ' ' VAL . . . 152.37 177.65 26.25 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.522 ' O ' ' CG1' ' A' ' 62' ' ' ILE . 6.4 tp -148.56 159.99 6.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.42 -1.047 . . . . 0.0 109.071 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.575 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.5 t-80 -50.2 144.23 11.63 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.243 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.575 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.37 -22.66 10.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.504 2.136 . . . . 0.0 110.264 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.27 -15.2 31.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -0.871 . . . . 0.0 109.108 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.569 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 95.0 m-20 -79.55 -11.89 59.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.317 -0.865 . . . . 0.0 109.455 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.475 HG22 ' CB ' ' A' ' 42' ' ' ALA . 4.3 mt -101.0 155.55 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.308 -0.87 . . . . 0.0 110.422 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.543 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -124.5 -30.04 3.41 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.543 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -132.02 169.05 16.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 108.855 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.526 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 49.9 t -139.45 111.2 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 109.801 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.447 ' O ' ' CD1' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -106.15 110.99 23.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.158 179.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -113.8 106.36 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.655 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.486 ' CB ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -97.25 94.81 7.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.222 -0.924 . . . . 0.0 109.319 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.465 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.1 p -45.2 169.25 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.479 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 35.6 Cg_endo -77.84 132.15 11.67 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.582 2.188 . . . . 0.0 110.408 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.84 -140.29 4.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.06 41.61 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.718 2.278 . . . . 0.0 110.708 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.519 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 9.7 p-80 -161.93 -38.1 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.053 -1.029 . . . . 0.0 109.244 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 6.2 t -135.82 112.78 10.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.285 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 31' ' ' PRO . . . -71.45 -32.06 67.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 109.646 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.437 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 2.5 mm-40 -87.63 130.51 34.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.586 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 63.2 m -53.31 142.97 19.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.38 179.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.465 ' CB ' ' HB2' ' A' ' 10' ' ' GLN . 30.6 mm-40 -117.46 107.33 14.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.568 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.494 HG22 ' CG ' ' A' ' 54' ' ' PRO . 9.5 t -92.48 148.32 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.511 HG21 ' N ' ' A' ' 42' ' ' ALA . 3.5 mp -140.6 153.87 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 0.0 109.7 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.511 ' N ' HG21 ' A' ' 41' ' ' ILE . . . -137.5 121.93 18.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.418 -0.801 . . . . 0.0 109.215 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.485 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 1.2 m -89.29 98.99 12.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.998 -1.064 . . . . 0.0 108.783 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 73.7 mt -41.78 165.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.434 0.635 . . . . 0.0 109.919 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 13.9 ptpt -81.22 7.87 10.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.811 . . . . 0.0 109.745 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.465 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.25 16.27 21.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.391 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.49 3.75 88.24 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.465 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 2.4 mtp-105 -94.04 174.95 6.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -1.158 . . . . 0.0 109.562 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -141.24 152.96 44.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.29 120.45 7.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 108.889 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.425 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 33.0 m -79.7 140.35 37.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.488 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.527 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 14.7 mt -126.36 166.94 16.24 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.38 -0.825 . . . . 0.0 108.899 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 0.7 OUTLIER -101.52 123.94 42.61 Favored Pre-proline 0 C--N 1.299 -1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.386 -179.607 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.494 ' CG ' HG22 ' A' ' 40' ' ' VAL . 33.8 Cg_endo -75.03 -9.89 20.93 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.152 1.901 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.43 -14.14 57.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 108.862 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.462 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -89.69 162.22 36.75 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.325 179.824 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.0 Cg_endo -77.56 -39.93 0.48 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.63 2.22 . . . . 0.0 110.626 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 32.4 mt -61.13 -51.86 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.973 . . . . 0.0 109.17 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.537 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 54.4 t -53.48 -52.03 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.511 -0.743 . . . . 0.0 109.762 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 6.9 mmtt -50.14 -33.22 18.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.077 -1.015 . . . . 0.0 108.813 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 57' ' ' PRO . 2.5 mmpt? -74.36 -36.02 63.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.448 -0.783 . . . . 0.0 109.26 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.529 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -61.53 -41.14 89.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.419 -0.801 . . . . 0.0 109.079 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.539 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -69.68 -68.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 0.0 109.766 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.47 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -43.82 -33.75 1.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 0.0 109.6 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 69' ' ' SER . 10.7 mmtm -66.07 -59.12 4.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.169 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.526 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.6 OUTLIER -44.4 -45.7 9.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.051 179.627 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.55 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 1.9 mt -56.88 -56.38 22.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.501 -0.749 . . . . 0.0 109.4 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 5.2 t30 -85.91 13.64 7.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 65' ' ' LYS . 93.7 p -64.63 -49.6 70.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' A' ' 70' ' ' ASP . 6.4 p-10 40.86 83.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.509 -0.744 . . . . 0.0 109.715 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 76.17 6.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.509 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.78 -18.34 13.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.471 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.6 t30 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.507 179.939 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.293 0.568 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -41.26 23.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.51 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.455 ' O ' HG11 ' B' ' 3' ' ' VAL . 11.7 p -78.01 137.76 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -132.61 -179.75 5.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' B' ' 5' ' ' THR . 31.7 m -118.84 61.91 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.62 39.21 1.03 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.492 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.519 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -115.61 98.2 6.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.233 -0.917 . . . . 0.0 109.54 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -83.43 154.57 23.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.34 -0.85 . . . . 0.0 109.188 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.461 ' HA ' ' HB2' ' B' ' 35' ' ' CYS . 1.8 m -43.94 121.64 2.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.447 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.496 ' HG3' ' CB ' ' B' ' 29' ' ' LYS . 56.7 mm-40 -41.91 -27.53 0.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.46 -0.775 . . . . 0.0 109.829 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.448 ' SG ' HG13 ' B' ' 41' ' ' ILE . 80.7 m -145.98 72.04 1.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.661 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.459 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.3 OUTLIER -44.12 -45.57 8.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.092 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -110.1 121.0 44.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 109.047 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.469 HG23 ' O ' ' B' ' 52' ' ' LEU . 0.5 OUTLIER -106.06 161.46 14.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.221 -0.925 . . . . 0.0 109.897 -179.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' B' ' 16' ' ' GLN . 3.1 mt -108.76 143.19 38.24 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.434 ' C ' ' O ' ' B' ' 15' ' ' LEU . 2.4 tt0 -44.95 -26.46 0.42 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.994 . . . . 0.0 109.116 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.452 ' HA2' HG21 ' B' ' 59' ' ' VAL . . . 152.3 177.66 26.2 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.52 ' O ' ' CG1' ' B' ' 62' ' ' ILE . 6.4 tp -148.51 160.06 6.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.434 -1.039 . . . . 0.0 109.029 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.579 ' CB ' ' ND2' ' B' ' 22' ' ' ASN . 1.5 t-80 -50.29 144.22 11.93 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.086 -1.009 . . . . 0.0 109.141 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.578 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -77.46 -22.53 10.73 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.483 2.122 . . . . 0.0 110.237 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.465 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.23 -15.36 31.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.36 -0.837 . . . . 0.0 109.096 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.579 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 95.0 m-20 -79.52 -11.87 59.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.473 ' HA ' ' HA ' ' B' ' 44' ' ' LEU . 4.3 mt -101.01 155.55 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 110.406 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -124.58 -30.0 3.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.325 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.553 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -132.02 169.04 16.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 108.912 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.524 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 50.3 t -139.46 111.3 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.013 . . . . 0.0 109.836 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.435 ' O ' ' CD1' ' B' ' 41' ' ' ILE . 0.1 OUTLIER -106.14 110.93 23.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.149 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.8 t -113.77 106.37 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.696 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.496 ' CB ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -97.25 94.74 7.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.44 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.463 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.1 p -45.13 169.23 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.452 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.8 Cg_endo -77.77 132.17 11.75 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.562 2.175 . . . . 0.0 110.46 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.85 -140.35 4.02 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.12 41.68 1.17 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.69 2.26 . . . . 0.0 110.679 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.519 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 9.6 p-80 -161.9 -38.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.142 -0.974 . . . . 0.0 109.324 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 6.3 t -135.82 112.81 10.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.276 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' B' ' 31' ' ' PRO . . . -71.56 -32.03 67.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.611 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.426 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 2.5 mm-40 -87.68 130.65 34.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.486 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 62.4 m -53.47 143.06 20.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.353 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.462 ' CB ' ' HB2' ' B' ' 10' ' ' GLN . 30.4 mm-40 -117.47 107.38 14.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.635 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.489 HG22 ' CG ' ' B' ' 54' ' ' PRO . 9.7 t -92.51 148.35 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.894 . . . . 0.0 109.267 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.494 HG21 ' N ' ' B' ' 42' ' ' ALA . 3.5 mp -140.65 153.83 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.961 . . . . 0.0 109.679 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.494 ' N ' HG21 ' B' ' 41' ' ' ILE . . . -137.42 121.97 18.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.356 -0.84 . . . . 0.0 109.186 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.485 ' O ' ' HG3' ' B' ' 24' ' ' GLN . 1.2 m -89.31 99.01 12.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.976 -1.077 . . . . 0.0 108.78 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.473 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 73.9 mt -41.82 164.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.565 -0.709 . . . . 0.0 109.981 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 13.9 ptpt -81.18 7.89 10.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 0.0 109.775 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.48 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -111.25 16.16 21.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.384 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.5 3.78 88.21 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.48 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 2.4 mtp-105 -94.05 174.93 6.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.5 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.512 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -141.23 152.89 44.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 0.0 109.501 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.22 120.43 7.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 108.959 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.432 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 33.0 m -79.66 140.24 37.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.125 -0.984 . . . . 0.0 109.46 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.518 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 14.7 mt -126.29 166.99 16.1 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.4 -0.812 . . . . 0.0 108.924 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.54 ' N ' HG23 ' B' ' 59' ' ' VAL . 0.7 OUTLIER -101.49 123.94 42.67 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.489 ' CG ' HG22 ' B' ' 40' ' ' VAL . 33.8 Cg_endo -75.02 -9.99 20.98 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.177 1.918 . . . . 0.0 110.244 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.29 -14.18 57.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.268 -0.895 . . . . 0.0 108.944 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.2 OUTLIER -89.65 162.15 37.04 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.432 -0.793 . . . . 0.0 109.323 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.439 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 35.9 Cg_endo -77.53 -39.87 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.636 2.224 . . . . 0.0 110.658 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' B' ' 62' ' ' ILE . 32.4 mt -61.14 -51.87 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 109.118 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.54 HG23 ' N ' ' B' ' 53' ' ' ASN . 54.5 t -53.53 -52.03 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.509 -0.744 . . . . 0.0 109.746 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' B' ' 56' ' ' SER . 6.9 mmtt -50.13 -33.18 17.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 108.844 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' B' ' 57' ' ' PRO . 2.5 mmpt? -74.34 -36.08 63.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.6 -0.688 . . . . 0.0 109.303 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -61.5 -41.13 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.38 -0.825 . . . . 0.0 109.048 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.55 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -69.76 -69.0 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.643 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -43.67 -33.71 1.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.137 -0.977 . . . . 0.0 109.671 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' B' ' 69' ' ' SER . 10.7 mmtm -66.14 -59.22 3.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.102 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.524 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.6 OUTLIER -44.37 -45.68 8.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.832 . . . . 0.0 109.097 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.539 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 1.9 mt -56.88 -56.27 23.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.394 -0.816 . . . . 0.0 109.48 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.445 ' O ' ' OD1' ' B' ' 70' ' ' ASP . 5.2 t30 -85.95 13.5 7.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.506 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.482 ' N ' ' O ' ' B' ' 65' ' ' LYS . 93.0 p -64.53 -49.54 70.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.507 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.461 ' OD2' ' O ' ' B' ' 70' ' ' ASP . 6.4 p-10 40.76 83.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.51 -0.744 . . . . 0.0 109.793 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 76.08 6.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.117 -0.989 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.71 -18.31 13.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 15.8 t30 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.502 179.939 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -44.21 102.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 0.0 109.42 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 1' ' ' ALA . 30.9 m -105.34 134.06 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 0.0 109.468 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.57 75.42 1.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 109.368 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.04 117.86 3.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 0.0 109.529 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -173.81 126.45 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.526 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -112.0 96.96 6.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.509 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -87.98 155.11 20.0 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.337 -0.852 . . . . 0.0 109.099 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 18.0 m -44.11 106.29 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 109.374 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.454 ' HB2' ' HD2' ' A' ' 29' ' ' LYS . 21.4 mm-40 -42.68 -26.53 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.365 -0.835 . . . . 0.0 109.773 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.462 ' HB2' ' HG2' ' A' ' 39' ' ' GLU . 73.5 m -122.38 58.33 1.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.962 . . . . 0.0 109.777 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.64 4.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 108.839 179.64 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -123.94 123.56 40.67 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.411 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -97.99 172.87 7.35 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.185 -0.947 . . . . 0.0 110.243 -179.273 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' O ' ' C ' ' A' ' 16' ' ' GLN . 4.5 mt -128.85 143.11 50.81 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.526 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.7 tt0 -44.4 -44.73 8.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.519 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 142.28 161.42 8.76 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.538 ' CD1' HD23 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -130.76 156.54 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -1.093 . . . . 0.0 109.137 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.564 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -43.23 150.82 0.46 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.321 -0.862 . . . . 0.0 109.291 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -76.54 -0.51 10.52 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.472 2.115 . . . . 0.0 110.12 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.463 ' HG3' ' N ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER -90.03 -27.12 19.93 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.265 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.57 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 8.9 m-20 -84.97 6.0 26.9 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.467 ' CG1' ' HA ' ' A' ' 20' ' ' PRO . 2.5 mm -94.26 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.936 . . . . 0.0 110.552 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.473 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.5 OUTLIER -154.54 -41.5 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.261 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.468 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 1.3 p -135.73 174.59 10.44 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.523 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 52.7 t -150.3 89.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.949 -1.094 . . . . 0.0 109.962 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 3.2 t-20 -79.67 105.49 11.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.23 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.448 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -98.49 91.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.527 ' HE3' ' CD1' ' A' ' 41' ' ' ILE . 1.3 ptpm? -98.23 112.5 24.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.366 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.421 ' OG ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -63.99 171.2 2.65 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.253 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.517 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.8 Cg_endo -77.98 130.91 10.67 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.626 2.218 . . . . 0.0 110.412 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.11 -144.56 5.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.87 5.48 4.88 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.546 2.164 . . . . 0.0 110.545 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.526 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 17.5 p-80 -123.14 -11.54 8.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 0.0 109.595 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' OE2' ' A' ' 39' ' ' GLU . 7.9 t -160.14 118.8 2.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.382 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.68 29.56 1.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.559 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.517 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 17.8 mm-40 -141.93 127.97 19.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.522 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -53.37 152.29 4.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.335 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.463 ' OE1' ' O ' ' A' ' 37' ' ' GLN . 2.4 mp0 -138.32 112.0 8.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.681 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.524 ' CG1' HD12 ' A' ' 63' ' ' ILE . 1.6 t -103.64 90.59 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.227 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.527 ' CD1' ' HE3' ' A' ' 29' ' ' LYS . 3.5 mt -79.9 144.01 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.961 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.471 ' N ' HG21 ' A' ' 41' ' ' ILE . . . -124.13 120.48 32.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.418 -0.801 . . . . 0.0 108.864 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.473 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 9.0 m -89.22 101.21 13.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.92 -1.113 . . . . 0.0 109.071 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.57 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 81.4 mt -46.28 167.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.366 -0.834 . . . . 0.0 109.573 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.472 ' HA ' ' HG3' ' A' ' 24' ' ' GLN . 14.6 ptpt -83.79 9.95 10.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -111.37 16.71 20.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.93 . . . . 0.0 109.372 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.89 6.92 87.94 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 45.8 mtt-85 -99.37 168.81 9.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -1.151 . . . . 0.0 109.429 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -135.63 155.95 49.63 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.4 120.16 7.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 109.178 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 11.1 m -79.15 138.95 38.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.027 -1.045 . . . . 0.0 108.537 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.538 HD23 ' CD1' ' A' ' 18' ' ' ILE . 11.6 mt -119.55 167.47 11.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 4.7 t-20 -98.76 119.72 60.52 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.72 -3.92 14.63 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.052 1.834 . . . . 0.0 110.269 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.27 -13.0 42.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 108.823 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.47 ' OG ' HG22 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -89.91 161.24 38.97 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.839 . . . . 0.0 109.371 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.71 -35.52 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.7 2.266 . . . . 0.0 110.714 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 16' ' ' GLN . 9.2 tt -67.73 -44.3 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 109.296 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.549 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 31.2 t -58.57 -47.1 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.533 -0.729 . . . . 0.0 109.161 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.459 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 8.9 mttt -59.22 -30.32 68.16 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -79.36 -23.54 43.29 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 16.5 mt -71.22 -38.1 68.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.535 -0.728 . . . . 0.0 109.056 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.583 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -73.84 -55.86 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 109.284 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -59.9 -28.34 67.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.95 . . . . 0.0 109.35 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.512 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -70.08 -43.28 71.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 108.978 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.523 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -60.24 -46.04 91.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.085 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.578 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.7 OUTLIER -48.72 -54.71 13.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.45 -0.781 . . . . 0.0 109.511 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' SER . 17.1 t-20 -68.11 -23.25 64.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 109.614 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 70' ' ' ASP . 9.9 p -43.58 -45.71 6.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.509 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 69' ' ' SER . 15.5 t70 43.89 92.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.437 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt 69.39 150.69 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.891 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.419 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 24.4 m -115.7 155.6 27.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.535 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.3 m-80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.466 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.418 ' C ' ' O ' ' B' ' 1' ' ' ALA . 0.9 OUTLIER -44.23 102.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.371 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.408 HG12 ' O ' ' B' ' 1' ' ' ALA . 30.7 m -105.3 134.02 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.479 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.56 75.44 1.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.02 117.96 3.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.936 . . . . 0.0 109.48 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -173.9 126.32 0.37 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.529 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -111.84 96.89 6.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.3 -0.875 . . . . 0.0 109.606 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' B' ' 9' ' ' CYS . 17.7 mmt180 -87.96 155.21 19.95 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.299 -0.876 . . . . 0.0 109.094 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.516 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 17.9 m -44.25 106.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 109.34 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.447 ' HB2' ' HD2' ' B' ' 29' ' ' LYS . 21.3 mm-40 -42.63 -26.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.356 -0.84 . . . . 0.0 109.78 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.456 ' HB2' ' HG2' ' B' ' 39' ' ' GLU . 73.6 m -122.39 58.35 1.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.516 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.63 4.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 108.925 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -123.95 123.63 40.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.412 HG23 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -98.04 172.82 7.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.232 -0.917 . . . . 0.0 110.212 -179.259 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.432 ' O ' ' C ' ' B' ' 16' ' ' GLN . 4.5 mt -128.77 143.14 50.84 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.53 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.7 tt0 -44.32 -44.88 8.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.096 -1.003 . . . . 0.0 109.1 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.525 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 142.29 161.37 8.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.536 ' CD1' HD23 ' B' ' 52' ' ' LEU . 0.1 OUTLIER -130.67 156.58 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.373 -1.075 . . . . 0.0 109.171 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.568 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -43.38 150.82 0.48 Allowed Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.258 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.568 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.5 Cg_endo -76.43 -0.59 10.57 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.434 2.089 . . . . 0.0 110.181 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -89.98 -27.21 19.93 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.574 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 9.0 m-20 -84.84 5.91 26.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.474 HG13 ' HA ' ' B' ' 20' ' ' PRO . 2.5 mm -94.14 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.869 . . . . 0.0 110.506 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.468 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.5 OUTLIER -154.59 -41.51 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.195 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.459 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 1.3 p -135.71 174.63 10.41 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.525 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 52.9 t -150.23 89.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.924 -1.11 . . . . 0.0 109.941 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 3.2 t-20 -79.78 105.38 11.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.192 -0.942 . . . . 0.0 109.242 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.9 t -98.49 91.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.52 ' HE3' ' CD1' ' B' ' 41' ' ' ILE . 1.3 ptpm? -98.21 112.46 24.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 109.373 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.427 ' OG ' ' HD2' ' B' ' 31' ' ' PRO . 0.0 OUTLIER -63.8 171.09 2.59 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.327 -0.858 . . . . 0.0 109.381 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.517 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.1 Cg_endo -77.97 130.87 10.67 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.606 2.204 . . . . 0.0 110.478 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.02 -144.6 5.77 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.81 5.45 4.87 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.553 2.169 . . . . 0.0 110.586 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.529 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 17.4 p-80 -123.18 -11.47 7.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.559 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 7.8 t -160.18 118.73 2.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.68 29.47 1.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.584 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.517 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 17.9 mm-40 -141.89 128.01 19.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.208 -0.933 . . . . 0.0 109.566 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -53.27 152.33 4.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.896 . . . . 0.0 109.396 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' B' ' 37' ' ' GLN . 2.4 mp0 -138.39 111.9 8.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -0.961 . . . . 0.0 109.695 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.531 ' CG1' HD12 ' B' ' 63' ' ' ILE . 1.6 t -103.59 90.64 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.163 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.52 ' CD1' ' HE3' ' B' ' 29' ' ' LYS . 3.5 mt -79.94 144.0 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.897 . . . . 0.0 109.957 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.457 ' N ' HG21 ' B' ' 41' ' ' ILE . . . -124.16 120.49 32.46 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.468 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 9.1 m -89.21 101.26 13.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.908 -1.12 . . . . 0.0 109.128 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.574 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 81.3 mt -46.33 167.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.388 -0.82 . . . . 0.0 109.587 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.6 ptpt -83.88 10.05 10.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -111.37 16.69 20.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.349 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.86 7.02 87.85 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.512 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 45.8 mtt-85 -99.45 168.85 9.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -1.163 . . . . 0.0 109.432 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -135.63 155.99 49.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.41 120.21 7.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.337 -0.852 . . . . 0.0 109.118 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 11.1 m -79.14 138.9 38.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.042 -1.037 . . . . 0.0 108.579 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.536 HD23 ' CD1' ' B' ' 18' ' ' ILE . 11.5 mt -119.41 167.49 11.88 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.236 -0.915 . . . . 0.0 109.856 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 4.7 t-20 -98.84 119.7 60.45 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.55 -0.719 . . . . 0.0 109.061 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.64 -3.92 14.62 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.05 1.834 . . . . 0.0 110.319 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.34 -12.86 42.22 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.317 -0.864 . . . . 0.0 108.901 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.464 ' OG ' HG22 ' B' ' 59' ' ' VAL . 1.0 OUTLIER -90.0 161.23 38.73 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.299 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.446 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.0 Cg_endo -77.77 -35.54 1.44 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.649 2.232 . . . . 0.0 110.697 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.531 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 9.2 tt -67.69 -44.31 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.31 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.551 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 31.6 t -58.54 -47.05 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.466 -0.771 . . . . 0.0 109.178 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 8.9 mttt -59.21 -30.36 68.17 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.496 ' O ' ' CG ' ' B' ' 65' ' ' LYS . 0.0 OUTLIER -79.28 -23.59 43.49 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.515 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 16.4 mt -71.24 -38.06 68.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.506 -0.746 . . . . 0.0 109.081 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.578 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -73.82 -55.85 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.366 -0.833 . . . . 0.0 109.336 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.517 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.3 OUTLIER -59.85 -28.39 67.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 109.379 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.517 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 0.1 OUTLIER -70.08 -43.21 71.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.002 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.525 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.6 OUTLIER -60.35 -45.91 91.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 109.072 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.583 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -48.78 -54.73 13.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.445 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' B' ' 69' ' ' SER . 17.2 t-20 -68.15 -23.28 64.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.459 ' O ' ' O ' ' B' ' 70' ' ' ASP . 9.9 p -43.5 -45.82 6.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' B' ' 69' ' ' SER . 15.3 t70 44.0 92.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' B' ' 70' ' ' ASP . 11.1 ttmt 69.46 150.8 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.403 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.428 ' O ' ' HB2' ' B' ' 73' ' ' ASN . 24.3 m -115.79 155.69 27.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.925 . . . . 0.0 109.492 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . 0.428 ' HB2' ' O ' ' B' ' 72' ' ' SER . 2.3 m-80 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.444 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 m -153.95 25.57 0.49 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 109.462 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.493 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 11.6 p -156.51 78.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.527 ' O ' ' CB ' ' A' ' 5' ' ' THR . . . 174.35 -148.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.486 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.527 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 0.2 OUTLIER 76.27 91.3 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 0.0 109.56 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -131.56 67.65 1.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 0.0 109.387 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.526 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -122.28 100.31 6.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.264 -0.897 . . . . 0.0 109.615 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.4 OUTLIER -92.36 151.87 20.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.925 . . . . 0.0 109.201 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.467 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m -44.09 114.39 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.14 -0.975 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -45.53 -24.84 0.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' A' ' 12' ' ' LEU . 60.8 m -148.7 71.16 1.14 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.082 -1.011 . . . . 0.0 109.822 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.467 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.04 -45.87 11.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 108.948 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -115.27 119.69 37.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.443 -0.786 . . . . 0.0 108.961 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -97.45 163.51 12.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.193 -0.942 . . . . 0.0 110.011 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.4 mt -115.17 146.26 41.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.487 -0.758 . . . . 0.0 108.981 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.9 tt0 -44.22 -46.91 9.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.339 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.516 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 156.03 -164.82 32.49 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.46 HG13 HD23 ' A' ' 52' ' ' LEU . 1.2 pp -170.26 162.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.436 -1.038 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.604 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 13.0 t60 -44.8 144.58 1.83 Allowed Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.604 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.6 Cg_endo -77.76 -13.93 15.91 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.29 1.994 . . . . 0.0 109.889 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' CE ' ' HG2' ' A' ' 20' ' ' PRO . 1.9 mmpt? -90.86 -19.87 22.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.401 -0.812 . . . . 0.0 108.861 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 5.2 m-20 -78.61 -12.96 60.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.237 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.518 HG22 ' CB ' ' A' ' 42' ' ' ALA . 12.0 mt -91.93 165.89 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.981 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.523 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -131.88 -41.96 1.02 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.8 p -125.11 173.49 8.69 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.528 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 48.3 t -144.33 95.53 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.01 -1.056 . . . . 0.0 109.694 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.46 ' O ' HD13 ' A' ' 41' ' ' ILE . 5.3 t-20 -96.83 112.4 24.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.406 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.428 ' CG1' HG21 ' A' ' 40' ' ' VAL . 1.8 t -115.6 102.65 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 109.597 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -94.35 110.92 22.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.394 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.67 165.36 0.73 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.496 ' CG ' ' HA ' ' B' ' 71' ' ' LYS . 35.8 Cg_endo -78.12 136.43 14.57 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.61 2.207 . . . . 0.0 110.419 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.67 -145.3 4.59 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.19 7.41 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.633 2.222 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.526 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 11.5 p-80 -124.32 -7.73 7.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.628 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.9 t -160.1 117.35 2.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 109.449 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.15 45.71 1.2 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.594 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.463 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 1.6 pt20 -171.11 140.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.474 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.457 ' HB ' ' CG ' ' A' ' 54' ' ' PRO . 1.4 m -60.64 145.19 50.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 109.368 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.463 ' OE2' ' O ' ' A' ' 37' ' ' GLN . 0.7 OUTLIER -127.3 107.4 9.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.582 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.508 HG11 ' N ' ' A' ' 41' ' ' ILE . 32.0 t -93.09 151.82 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.207 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.508 ' N ' HG11 ' A' ' 40' ' ' VAL . 2.5 mp -140.19 146.61 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.067 -1.021 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.518 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -133.87 119.16 18.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.416 -0.802 . . . . 0.0 109.08 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 6.8 m -89.39 97.51 11.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.944 -1.098 . . . . 0.0 109.131 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.481 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 87.0 mt -43.13 166.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.477 -0.765 . . . . 0.0 109.731 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.475 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.8 ptpt -82.56 9.84 8.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 109.704 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -113.69 27.69 9.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.143 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.29 6.21 64.68 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 40.5 mtt180 -96.23 160.99 14.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -1.188 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.57 150.23 48.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.177 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.21 124.73 9.64 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.213 -0.929 . . . . 0.0 109.191 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.453 ' SG ' HG13 ' A' ' 41' ' ' ILE . 15.7 m -79.51 148.08 31.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.104 -0.997 . . . . 0.0 109.225 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.526 ' O ' ' CG2' ' A' ' 14' ' ' THR . 15.7 mt -122.76 167.22 13.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.271 -0.893 . . . . 0.0 109.329 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.534 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 3.0 t-20 -98.86 119.45 61.0 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.152 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.457 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 32.9 Cg_endo -74.87 -6.12 17.71 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.137 1.891 . . . . 0.0 110.23 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.95 -14.69 46.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 108.886 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.457 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -90.0 160.7 40.02 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.398 -0.813 . . . . 0.0 109.355 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.8 -34.39 1.84 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.627 2.218 . . . . 0.0 110.686 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.54 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 2.7 tt -66.5 -46.67 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.138 -0.976 . . . . 0.0 109.09 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.54 ' N ' ' CG2' ' A' ' 58' ' ' ILE . 38.1 t -57.02 -48.2 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.403 -0.81 . . . . 0.0 109.023 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -55.23 -31.28 61.36 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 2.8 mmpt? -76.23 -30.62 57.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -65.48 -44.65 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.346 -0.846 . . . . 0.0 108.936 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.578 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -66.82 -61.78 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.489 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -52.67 -27.7 18.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.481 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.516 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 13.9 mttt -71.43 -43.03 67.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.197 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.528 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -61.8 -47.13 86.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.31 -0.869 . . . . 0.0 109.185 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.589 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.75 -50.89 9.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.462 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 18.0 t-20 -69.32 -31.32 69.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.498 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 70' ' ' ASP . 1.3 p -48.82 -58.78 4.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.508 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' N ' ' OG ' ' A' ' 69' ' ' SER . 1.2 m-20 64.25 -85.37 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.542 -0.724 . . . . 0.0 109.557 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.501 ' HA ' ' CG ' ' B' ' 31' ' ' PRO . 3.8 tttt -80.98 -31.11 34.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.405 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.8 t 57.46 16.88 3.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.863 . . . . 0.0 109.48 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.491 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.295 0.569 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.0 m -153.89 25.53 0.5 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.499 ' O ' ' CG1' ' B' ' 3' ' ' VAL . 11.6 p -156.46 78.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.935 . . . . 0.0 109.387 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.516 ' O ' ' CB ' ' B' ' 5' ' ' THR . . . 174.31 -148.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.442 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.516 ' CB ' ' O ' ' B' ' 4' ' ' ALA . 0.2 OUTLIER 76.39 91.31 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.466 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -131.56 67.63 1.51 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 109.414 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.518 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -122.34 100.44 6.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.305 -0.872 . . . . 0.0 109.577 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.4 OUTLIER -92.41 151.83 20.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.245 -0.909 . . . . 0.0 109.215 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.45 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 1.8 m -44.04 114.37 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -45.55 -24.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 109.698 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.429 ' O ' ' C ' ' B' ' 12' ' ' LEU . 60.7 m -148.7 71.11 1.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.086 -1.009 . . . . 0.0 109.884 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.94 -45.94 10.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.007 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -115.24 119.61 36.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.461 -0.775 . . . . 0.0 108.954 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.6 OUTLIER -97.31 163.6 12.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 110.014 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.42 ' O ' ' C ' ' B' ' 16' ' ' GLN . 7.4 mt -115.27 146.2 41.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.479 -0.763 . . . . 0.0 108.949 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.522 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.9 tt0 -44.16 -46.88 9.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.527 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 155.99 -164.94 32.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.467 HG13 HD23 ' B' ' 52' ' ' LEU . 1.2 pp -170.19 162.77 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.399 -1.059 . . . . 0.0 109.503 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.597 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 12.8 t60 -44.75 144.6 1.8 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -77.78 -13.99 15.85 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.347 2.031 . . . . 0.0 109.87 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.516 ' CE ' ' HG2' ' B' ' 20' ' ' PRO . 1.9 mmpt? -90.77 -19.96 22.91 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.487 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 5.1 m-20 -78.63 -12.92 60.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 0.0 109.234 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.52 HG22 ' CB ' ' B' ' 42' ' ' ALA . 12.0 mt -91.96 165.91 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.276 -0.89 . . . . 0.0 109.982 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.0 OUTLIER -131.92 -41.87 1.02 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.496 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 3.7 p -125.25 173.45 8.79 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.524 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 48.7 t -144.26 95.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.077 -1.014 . . . . 0.0 109.728 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.451 ' HB3' HD11 ' B' ' 41' ' ' ILE . 5.3 t-20 -96.95 112.39 24.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 0.0 109.392 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.417 ' CG1' HG21 ' B' ' 40' ' ' VAL . 1.8 t -115.64 102.62 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.56 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -94.34 110.93 22.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.7 165.34 0.74 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.457 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.501 ' CG ' ' HA ' ' A' ' 71' ' ' LYS . 35.7 Cg_endo -78.04 136.45 14.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.629 2.219 . . . . 0.0 110.451 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.66 -145.24 4.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.22 7.41 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.738 2.292 . . . . 0.0 110.746 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.518 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 11.7 p-80 -124.43 -7.66 7.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.9 t -160.13 117.29 2.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.357 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.18 45.72 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.476 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.448 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 1.6 pt20 -171.14 140.93 1.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 109.528 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.462 ' HB ' ' CG ' ' B' ' 54' ' ' PRO . 1.4 m -60.58 145.09 50.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.448 ' OE2' ' O ' ' B' ' 37' ' ' GLN . 0.7 OUTLIER -127.23 107.32 9.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.499 HG11 ' N ' ' B' ' 41' ' ' ILE . 31.5 t -92.99 151.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.257 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.499 ' N ' HG11 ' B' ' 40' ' ' VAL . 2.6 mp -140.15 146.57 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.788 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.52 ' CB ' HG22 ' B' ' 23' ' ' ILE . . . -133.91 119.16 18.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 109.073 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 6.7 m -89.32 97.49 11.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.924 -1.11 . . . . 0.0 109.17 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.487 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 86.9 mt -43.13 166.14 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.507 -0.746 . . . . 0.0 109.673 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.482 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.8 ptpt -82.56 9.95 8.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -0.823 . . . . 0.0 109.676 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -113.77 27.75 9.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.324 -0.86 . . . . 0.0 109.152 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.3 6.16 64.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 40.6 mtt180 -96.23 161.03 14.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.171 -1.193 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.506 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.62 150.25 48.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.154 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . 0.409 ' HB2' HD11 ' B' ' 15' ' ' LEU . . . -150.21 124.71 9.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.35 -0.844 . . . . 0.0 109.137 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.456 ' SG ' HG13 ' B' ' 41' ' ' ILE . 15.6 m -79.49 148.08 31.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.124 -0.985 . . . . 0.0 109.184 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.527 ' CD2' ' HA2' ' B' ' 17' ' ' GLY . 15.9 mt -122.88 167.2 13.85 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.538 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 3.0 t-20 -98.82 119.38 61.23 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.163 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.462 ' CG ' ' HB ' ' B' ' 38' ' ' THR . 33.4 Cg_endo -74.66 -6.31 18.04 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.182 1.921 . . . . 0.0 110.304 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.93 -14.68 46.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.36 -0.838 . . . . 0.0 108.846 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.463 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -90.02 160.75 39.89 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.288 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.85 -34.35 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.582 2.188 . . . . 0.0 110.709 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.552 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 2.7 tt -66.49 -46.65 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.108 -0.995 . . . . 0.0 109.136 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.552 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 38.1 t -57.1 -48.08 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.017 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.472 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.1 OUTLIER -55.28 -31.3 61.49 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' B' ' 65' ' ' LYS . 2.8 mmpt? -76.16 -30.6 58.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.591 -0.693 . . . . 0.0 109.391 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -65.46 -44.7 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.353 -0.842 . . . . 0.0 108.987 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.589 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -66.69 -61.8 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.1 OUTLIER -52.73 -27.72 18.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.462 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.519 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 13.9 mttt -71.38 -43.0 67.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 109.236 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.524 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -61.81 -47.11 86.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.378 -0.826 . . . . 0.0 109.248 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.578 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.7 -50.91 9.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.504 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' B' ' 70' ' ' ASP . 17.8 t-20 -69.32 -31.28 69.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.486 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' B' ' 70' ' ' ASP . 1.3 p -48.82 -58.82 4.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.918 . . . . 0.0 109.523 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.506 ' N ' ' OG ' ' B' ' 69' ' ' SER . 1.2 m-20 64.23 -85.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.523 -0.736 . . . . 0.0 109.62 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.496 ' HA ' ' CG ' ' A' ' 31' ' ' PRO . 3.8 tttt -80.97 -31.06 34.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 25.6 t 57.39 16.96 3.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 109.478 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.478 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m 49.6 23.66 1.0 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.424 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 47.4 t -105.78 134.59 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.534 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -176.31 144.11 0.54 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.0 m -158.05 116.48 3.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.516 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -105.71 91.58 3.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.367 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.506 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -118.43 99.76 7.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.235 -0.916 . . . . 0.0 109.637 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 9' ' ' CYS . 16.6 mtp180 -91.52 155.42 18.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.267 -0.896 . . . . 0.0 108.885 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.446 ' HB3' ' OE2' ' A' ' 39' ' ' GLU . 17.2 m -44.28 125.5 4.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.204 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.469 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 45.2 mm-40 -40.69 -39.89 1.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.482 -0.761 . . . . 0.0 109.756 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.469 ' SG ' ' O ' ' A' ' 10' ' ' GLN . 1.7 m -165.85 70.19 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.4 -0.812 . . . . 0.0 109.506 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.508 ' O ' ' CD1' ' A' ' 12' ' ' LEU . 1.5 tm? -44.22 -34.46 1.89 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.342 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -93.6 81.4 4.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.244 -0.91 . . . . 0.0 109.099 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.434 ' OG1' ' ND2' ' A' ' 53' ' ' ASN . 10.1 p -87.78 158.65 18.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.291 -0.881 . . . . 0.0 109.91 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.428 ' O ' ' C ' ' A' ' 16' ' ' GLN . 2.4 mt -100.24 144.25 29.48 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.463 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.9 tt0 -45.41 -25.91 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.074 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.516 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 154.09 171.54 21.19 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.449 HG21 HD12 ' A' ' 52' ' ' LEU . 7.7 tp -145.32 151.96 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.336 -1.096 . . . . 0.0 109.166 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.496 ' ND1' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.92 146.98 1.82 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.935 . . . . 0.0 109.303 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.496 ' HD2' ' ND1' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.15 -13.85 16.95 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.549 2.166 . . . . 0.0 110.04 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.526 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -80.92 -16.34 53.84 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.234 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.534 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 80.1 m-20 -101.34 55.59 0.83 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.459 -0.776 . . . . 0.0 108.988 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -139.79 170.83 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.133 -0.979 . . . . 0.0 110.041 -179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -160.06 -40.72 0.05 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.525 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.456 ' OG ' ' OG1' ' A' ' 43' ' ' THR . 4.8 p -131.13 -177.97 4.62 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 51.9 t -157.22 111.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.025 -1.047 . . . . 0.0 109.748 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 18.6 t-20 -94.87 124.61 39.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -0.85 . . . . 0.0 109.358 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' B' ' 26' ' ' VAL . 1.9 t -119.91 89.7 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.196 -0.94 . . . . 0.0 109.53 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 104.22 15.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.279 -0.888 . . . . 0.0 109.547 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.458 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.2 p -54.31 168.42 0.46 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.445 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.458 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 35.9 Cg_endo -78.01 133.15 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.664 2.242 . . . . 0.0 110.434 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.85 -141.05 3.8 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.55 10.25 2.59 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.531 2.154 . . . . 0.0 110.992 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.506 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 3.7 p-80 -127.16 -10.21 5.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.023 -1.048 . . . . 0.0 109.813 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' OE1' ' A' ' 39' ' ' GLU . 1.8 t -160.27 121.4 3.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.002 . . . . 0.0 109.372 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.72 44.16 1.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.577 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.424 ' C ' ' HB3' ' A' ' 31' ' ' PRO . 5.8 pt20 -172.36 139.76 1.04 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 m -56.49 142.28 39.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.452 ' OE1' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -127.62 122.59 33.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.899 . . . . 0.0 109.623 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.465 HG22 ' HB3' ' A' ' 54' ' ' PRO . 74.6 t -114.48 151.44 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.371 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.449 HG21 ' N ' ' A' ' 42' ' ' ALA . 3.3 mp -141.82 155.18 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.607 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.449 ' N ' HG21 ' A' ' 41' ' ' ILE . . . -134.21 126.63 30.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.397 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 51.9 m -89.81 105.87 18.09 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.111 -0.993 . . . . 0.0 109.089 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.534 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 77.1 mt -41.73 164.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.464 -0.772 . . . . 0.0 109.587 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.4 ptpt -87.44 17.81 4.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.748 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.467 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 1.1 p-10 -120.46 -3.53 9.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.97 . . . . 0.0 109.349 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.4 -25.31 8.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.514 ' CB ' HD13 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -79.34 172.9 13.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -1.172 . . . . 0.0 109.255 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.544 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -147.24 125.55 12.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.66 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.74 124.77 51.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.422 -0.799 . . . . 0.0 108.847 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.418 ' SG ' HG12 ' A' ' 41' ' ' ILE . 83.9 m -79.55 140.99 37.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.947 . . . . 0.0 109.317 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.548 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 14.3 mt -127.78 168.25 15.39 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 108.975 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.559 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 0.8 OUTLIER -106.12 132.95 20.46 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.321 -0.862 . . . . 0.0 109.125 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.465 ' HB3' HG22 ' A' ' 40' ' ' VAL . 33.9 Cg_endo -75.62 -25.23 11.12 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.12 1.88 . . . . 0.0 110.298 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.87 -16.15 26.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.212 -0.93 . . . . 0.0 108.843 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 37.1 p -88.66 158.18 48.43 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.433 -0.792 . . . . 0.0 109.395 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.419 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.86 -38.74 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.695 2.263 . . . . 0.0 110.744 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.543 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 5.9 tt -66.04 -46.63 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.974 . . . . 0.0 109.235 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.559 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 40.3 t -56.81 -48.46 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.494 -0.753 . . . . 0.0 109.241 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.464 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -55.45 -31.42 61.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HE2' ' OE2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -74.89 -31.25 61.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.614 -0.679 . . . . 0.0 109.226 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.531 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -67.0 -42.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.401 -0.812 . . . . 0.0 108.848 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.568 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.1 mp -65.87 -66.64 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -46.23 -39.32 9.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 0.0 109.496 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.462 ' HG3' ' OE1' ' A' ' 64' ' ' GLU . 12.2 mttm -59.08 -50.9 72.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.209 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.438 ' HG3' HG22 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -51.45 -48.1 62.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 109.216 179.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.567 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -47.02 -51.8 16.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.387 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.457 ' HA ' ' HB2' ' A' ' 71' ' ' LYS . 11.7 t30 -58.46 -38.47 77.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' ASN . 4.2 p -44.19 -33.07 1.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.4 53.94 1.61 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.464 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.457 ' HB2' ' HA ' ' A' ' 68' ' ' ASN . 0.7 OUTLIER -100.28 117.81 35.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 109.484 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.438 ' O ' ' OXT' ' A' ' 73' ' ' ASN . 0.4 OUTLIER -131.38 118.88 20.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.438 ' OXT' ' O ' ' A' ' 72' ' ' SER . 16.0 p-10 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.473 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 18.8 m 49.58 23.59 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 47.7 t -105.82 134.59 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.171 -0.955 . . . . 0.0 109.499 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -176.27 144.12 0.54 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.124 -0.985 . . . . 0.0 109.447 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -158.11 116.5 3.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.29 -0.881 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -105.68 91.52 3.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.425 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.509 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -118.38 99.75 7.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.3 -0.875 . . . . 0.0 109.612 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' B' ' 9' ' ' CYS . 16.7 mtp180 -91.54 155.32 18.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 108.857 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.448 ' O ' ' C ' ' B' ' 10' ' ' GLN . 17.4 m -44.09 125.36 4.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -0.957 . . . . 0.0 109.294 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.471 ' O ' ' SG ' ' B' ' 11' ' ' CYS . 45.1 mm-40 -40.52 -39.97 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.56 -0.712 . . . . 0.0 109.767 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.471 ' SG ' ' O ' ' B' ' 10' ' ' GLN . 1.7 m -165.85 70.24 0.13 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.506 ' CD1' ' O ' ' B' ' 12' ' ' LEU . 1.5 tm? -44.3 -34.46 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.266 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -93.63 81.53 4.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.266 -0.897 . . . . 0.0 109.118 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.432 ' OG1' ' ND2' ' B' ' 53' ' ' ASN . 10.2 p -87.88 158.63 18.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.332 -0.855 . . . . 0.0 109.859 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . . . . . . . . . 2.4 mt -100.18 144.26 29.41 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.461 ' O ' HG22 ' B' ' 59' ' ' VAL . 1.9 tt0 -45.44 -25.88 0.48 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.043 -1.036 . . . . 0.0 109.063 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.519 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 154.1 171.55 21.2 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.446 HG21 HD12 ' B' ' 52' ' ' LEU . 7.7 tp -145.3 151.91 14.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.405 -1.056 . . . . 0.0 109.247 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.496 ' ND1' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -45.9 147.01 1.79 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.496 ' HD2' ' ND1' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.17 -13.94 16.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.622 2.215 . . . . 0.0 109.963 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -80.9 -16.39 53.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.538 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 80.1 m-20 -101.31 55.64 0.84 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.448 -0.782 . . . . 0.0 108.935 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 mm -139.78 170.78 14.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.091 -1.005 . . . . 0.0 109.947 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.1 OUTLIER -159.99 -40.7 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.463 ' OG ' ' OG1' ' B' ' 43' ' ' THR . 4.8 p -131.14 -177.99 4.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.452 ' HA ' ' O ' ' B' ' 41' ' ' ILE . 51.5 t -157.16 111.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.981 -1.075 . . . . 0.0 109.771 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.402 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 18.8 t-20 -94.89 124.7 39.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.882 . . . . 0.0 109.281 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.442 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 1.9 t -119.99 89.83 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.47 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.23 104.28 15.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.457 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.2 p -54.53 168.43 0.48 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.381 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 35.6 Cg_endo -77.93 133.11 12.22 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.609 2.206 . . . . 0.0 110.414 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.79 -141.04 3.8 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.66 10.35 2.58 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.541 2.16 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.509 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 3.7 p-80 -127.16 -10.26 5.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.981 -1.074 . . . . 0.0 109.855 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 1.8 t -160.3 121.37 3.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.357 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.69 44.1 1.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.588 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.425 ' C ' ' HB3' ' B' ' 31' ' ' PRO . 5.9 pt20 -172.24 139.86 1.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.515 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 1.5 m -56.69 142.33 40.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.451 ' OE2' ' SG ' ' B' ' 35' ' ' CYS . 0.0 OUTLIER -127.53 122.59 33.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.462 HG22 ' HB3' ' B' ' 54' ' ' PRO . 76.9 t -114.55 151.46 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.321 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 3.3 mp -141.79 155.25 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.643 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.438 ' N ' HG21 ' B' ' 41' ' ' ILE . . . -134.33 126.56 29.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -0.866 . . . . 0.0 109.335 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.516 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 52.2 m -89.9 105.96 18.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 109.089 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 77.0 mt -41.71 164.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.467 -0.771 . . . . 0.0 109.667 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.4 ptpt -87.33 17.76 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.877 . . . . 0.0 109.865 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.454 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 1.1 p-10 -120.42 -3.54 9.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.386 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.52 -25.49 8.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.524 ' CB ' HD13 ' B' ' 44' ' ' LEU . 0.3 OUTLIER -79.31 172.95 13.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -1.186 . . . . 0.0 109.273 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.547 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -147.27 125.46 12.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.657 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.68 124.76 51.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.395 -0.816 . . . . 0.0 108.915 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' B' ' 41' ' ' ILE . 84.3 m -79.49 141.07 37.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.15 -0.969 . . . . 0.0 109.289 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.543 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 14.2 mt -127.89 168.16 15.59 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.418 -0.802 . . . . 0.0 109.001 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 0.8 OUTLIER -106.01 132.84 20.55 Favored Pre-proline 0 C--N 1.299 -1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.205 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.462 ' HB3' HG22 ' B' ' 40' ' ' VAL . 33.7 Cg_endo -75.59 -25.22 11.18 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.09 1.86 . . . . 0.0 110.324 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.83 -16.16 26.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.274 -0.891 . . . . 0.0 108.792 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 36.9 p -88.68 158.21 48.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.478 -0.764 . . . . 0.0 109.297 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.423 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -77.88 -38.7 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.666 2.244 . . . . 0.0 110.741 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.556 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 5.8 tt -66.05 -46.61 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.096 -1.003 . . . . 0.0 109.248 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.556 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 40.0 t -56.87 -48.52 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.407 -0.808 . . . . 0.0 109.174 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.468 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.5 OUTLIER -55.48 -31.29 61.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.432 ' HE2' ' OE2' ' B' ' 64' ' ' GLU . 0.1 OUTLIER -74.95 -31.23 61.44 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -67.04 -42.96 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.567 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.1 mp -65.83 -66.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.356 -0.84 . . . . 0.0 109.466 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -46.36 -39.26 10.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.942 . . . . 0.0 109.43 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.458 ' HG3' ' OE1' ' B' ' 64' ' ' GLU . 12.2 mttm -59.1 -50.88 72.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 109.269 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.43 ' HG3' HG22 ' B' ' 26' ' ' VAL . 0.1 OUTLIER -51.44 -48.07 62.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 0.0 109.219 179.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.568 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -46.97 -51.9 15.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.454 ' HA ' ' HB2' ' B' ' 71' ' ' LYS . 11.8 t30 -58.42 -38.54 77.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.405 ' C ' ' O ' ' B' ' 68' ' ' ASN . 4.1 p -44.0 -33.22 1.35 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 109.466 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -126.28 53.92 1.6 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.454 ' HB2' ' HA ' ' B' ' 68' ' ' ASN . 0.7 OUTLIER -100.38 117.66 35.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.481 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.424 ' O ' ' OXT' ' B' ' 73' ' ' ASN . 0.4 OUTLIER -131.32 118.89 20.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.915 . . . . 0.0 109.523 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . 0.424 ' OXT' ' O ' ' B' ' 72' ' ' SER . 15.9 p-10 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.53 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 t -159.7 161.79 34.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.471 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 4' ' ' ALA . 1.9 t -107.91 -25.65 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.936 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.522 ' O ' ' CG ' ' A' ' 6' ' ' GLU . . . 75.27 -152.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.486 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 4' ' ' ALA . 13.5 t 42.21 27.39 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.836 . . . . 0.0 109.726 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -155.54 26.88 0.39 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.94 . . . . 0.0 109.405 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.54 HD21 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -136.65 109.47 7.58 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.31 -0.868 . . . . 0.0 109.591 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -115.62 156.22 26.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.075 179.606 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 8' ' ' ARG . 43.8 m -44.52 102.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.248 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.503 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 75.8 mm-40 -53.04 -18.48 2.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 12' ' ' LEU . 53.0 m -135.63 65.96 1.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.076 -1.015 . . . . 0.0 109.889 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -44.7 -44.86 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 108.895 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.41 119.44 34.6 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.45 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -93.31 168.55 11.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.186 -0.946 . . . . 0.0 110.09 -179.385 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 16' ' ' GLN . 6.8 mt -119.13 145.5 45.92 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.52 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -43.99 -46.63 8.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.254 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.521 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 151.39 -170.88 30.99 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.4 pp -164.95 162.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -1.028 . . . . 0.0 109.33 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.564 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -53.97 150.69 14.05 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.22 -0.925 . . . . 0.0 109.328 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.564 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.5 Cg_endo -77.44 -3.89 14.12 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.598 2.199 . . . . 0.0 110.29 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 3.1 pttm -90.21 -24.19 21.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.865 . . . . 0.0 109.207 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.519 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 3.1 m-20 -83.19 -7.31 59.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.385 -0.822 . . . . 0.0 109.268 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 6.8 mt -104.26 162.12 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.874 . . . . 0.0 110.1 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.571 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -135.12 -31.36 1.0 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.526 -0.734 . . . . 0.0 109.177 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.571 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.1 p -132.82 175.14 9.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 0.0 108.854 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.528 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 46.6 t -149.69 115.77 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.045 -1.034 . . . . 0.0 109.922 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.442 ' HB3' HD11 ' A' ' 41' ' ' ILE . 4.1 t-20 -111.85 110.76 21.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.147 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.12 113.65 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.709 -179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -105.74 114.76 29.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.251 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.404 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -55.23 167.29 0.71 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.544 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.414 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.3 Cg_endo -77.53 140.25 18.89 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.607 2.205 . . . . 0.0 110.378 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.92 -139.6 3.03 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.66 38.73 0.76 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.594 2.196 . . . . 0.0 110.903 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.54 ' CD2' HD21 ' A' ' 7' ' ' LEU . 3.9 p-80 -154.99 -38.73 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.031 . . . . 0.0 109.375 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.415 ' SG ' ' CD ' ' A' ' 39' ' ' GLU . 1.8 t -133.58 124.77 27.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.23 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.53 42.43 0.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.736 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.453 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -170.76 148.48 2.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.153 -0.967 . . . . 0.0 109.631 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 m -63.49 144.94 56.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.325 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 37' ' ' GLN . 0.5 OUTLIER -126.64 110.27 13.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 109.628 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.479 ' CG2' ' HB3' ' A' ' 54' ' ' PRO . 3.3 t -97.53 144.84 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.273 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.442 HD11 ' HB3' ' A' ' 27' ' ' ASN . 3.6 mt -132.4 153.08 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.58 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.523 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -137.69 120.21 16.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.174 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 2.3 m -89.23 102.69 15.35 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.973 -1.08 . . . . 0.0 108.737 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 88.6 mt -49.22 164.59 0.07 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.432 -0.792 . . . . 0.0 109.549 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -79.12 6.78 8.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 109.978 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HD2' ' A' ' 48' ' ' ARG . 41.7 p30 -109.36 20.72 17.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.124 -0.985 . . . . 0.0 109.363 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.87 14.08 82.73 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.509 ' HD2' ' ND2' ' A' ' 46' ' ' ASN . 1.6 mtp-105 -103.56 171.64 7.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -1.151 . . . . 0.0 109.452 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.463 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -141.9 151.19 42.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.25 123.03 8.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.294 -0.879 . . . . 0.0 109.074 179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 15.6 m -79.77 141.1 36.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.521 ' CD2' ' HA2' ' A' ' 17' ' ' GLY . 12.3 mt -119.6 167.82 11.63 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.321 -0.862 . . . . 0.0 109.195 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.542 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -98.15 119.34 62.17 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.337 -0.852 . . . . 0.0 108.983 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.479 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 33.3 Cg_endo -75.2 -6.76 18.31 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.103 1.869 . . . . 0.0 110.327 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.75 -14.66 47.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 108.865 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.418 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -90.07 162.12 36.06 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.317 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.479 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 36.7 Cg_endo -78.29 -37.72 0.7 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.644 2.229 . . . . 0.0 110.944 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -63.26 -48.13 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.073 -1.017 . . . . 0.0 108.917 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.568 ' N ' ' CG2' ' A' ' 58' ' ' ILE . 37.2 t -55.75 -48.48 77.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -51.33 -33.62 30.02 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.298 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -72.94 -36.37 67.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.549 -0.719 . . . . 0.0 109.261 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 58' ' ' ILE . 1.3 mp -57.91 -44.05 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.878 . . . . 0.0 109.051 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.577 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.1 mp -69.76 -68.95 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.874 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.484 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -43.43 -27.82 0.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -0.957 . . . . 0.0 109.584 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.484 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 10.3 mmtt -72.49 -58.66 3.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 108.931 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.528 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 1.1 tmm? -44.62 -45.72 9.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 108.911 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.58 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 2.5 mt -55.38 -49.29 72.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 109.409 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.06 33.9 1.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.574 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 p -105.04 -25.28 12.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.55 34.38 0.82 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.455 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 47.36 -149.41 0.14 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 47.7 -167.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 109.492 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.3 m-80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.505 -179.986 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.7 t -159.6 161.79 35.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.345 -0.847 . . . . 0.0 109.449 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.509 ' O ' ' CB ' ' B' ' 4' ' ' ALA . 1.9 t -107.95 -25.66 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.472 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.529 ' O ' ' CG2' ' B' ' 5' ' ' THR . . . 75.4 -152.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.871 . . . . 0.0 109.507 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' B' ' 4' ' ' ALA . 13.5 t 42.12 27.44 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 0.0 109.789 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' B' ' 4' ' ' ALA . 0.0 OUTLIER -155.58 26.91 0.39 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 109.455 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.541 HD21 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -136.63 109.53 7.63 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.251 -0.906 . . . . 0.0 109.536 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -115.62 156.28 26.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 108.97 179.638 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.409 ' C ' ' O ' ' B' ' 8' ' ' ARG . 43.1 m -44.66 102.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.97 . . . . 0.0 109.322 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.498 ' HB2' ' CD ' ' B' ' 29' ' ' LYS . 75.9 mm-40 -53.01 -18.45 2.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.699 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' B' ' 12' ' ' LEU . 54.3 m -135.62 66.0 1.52 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 109.779 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.2 OUTLIER -44.81 -44.85 9.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.895 . . . . 0.0 108.881 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.38 119.46 34.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.447 ' OG1' ' ND2' ' B' ' 53' ' ' ASN . 0.5 OUTLIER -93.43 168.6 10.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.303 -0.873 . . . . 0.0 110.037 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.427 ' O ' ' C ' ' B' ' 16' ' ' GLN . 6.9 mt -119.19 145.55 45.93 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.524 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 0.0 OUTLIER -43.97 -46.62 8.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 109.342 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.521 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 151.36 -170.91 30.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.4 pp -164.86 162.96 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -1.023 . . . . 0.0 109.303 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.577 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -53.99 150.79 13.85 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 109.314 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.2 Cg_endo -77.55 -3.9 14.08 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.554 2.17 . . . . 0.0 110.251 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 3.1 pttm -90.2 -24.19 21.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 0.0 109.128 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 3.1 m-20 -83.21 -7.35 59.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 6.8 mt -104.13 162.1 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.574 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -135.1 -31.3 1.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.504 -0.748 . . . . 0.0 109.231 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.574 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.1 p -132.87 175.1 9.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 108.828 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.527 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 46.4 t -149.66 115.82 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.042 -1.036 . . . . 0.0 109.919 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.444 ' HB3' HD11 ' B' ' 41' ' ' ILE . 4.1 t-20 -111.84 110.79 21.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.2 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 3.1 t -117.14 113.67 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.766 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' B' ' 29' ' ' LYS . 0.4 OUTLIER -105.77 114.75 29.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.249 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.401 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.0 OUTLIER -55.18 167.38 0.69 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.87 . . . . 0.0 109.461 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.409 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.0 Cg_endo -77.54 140.16 18.79 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.606 2.204 . . . . 0.0 110.435 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.84 -139.56 3.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.74 38.76 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.587 2.191 . . . . 0.0 110.91 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.541 ' CD2' HD21 ' B' ' 7' ' ' LEU . 3.8 p-80 -154.95 -38.86 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.026 -1.046 . . . . 0.0 109.359 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.41 ' SG ' ' CD ' ' B' ' 39' ' ' GLU . 1.8 t -133.52 124.75 27.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.54 42.47 0.96 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.876 . . . . 0.0 109.709 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.446 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 0.0 OUTLIER -170.74 148.46 2.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.12 -0.988 . . . . 0.0 109.618 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 1.4 m -63.53 144.98 56.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.331 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.446 ' OE1' ' O ' ' B' ' 37' ' ' GLN . 0.5 OUTLIER -126.69 110.27 12.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 0.0 109.604 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' B' ' 54' ' ' PRO . 3.4 t -97.53 144.78 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.206 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.444 HD11 ' HB3' ' B' ' 27' ' ' ASN . 3.6 mt -132.41 153.08 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.586 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.517 ' CB ' HG22 ' B' ' 23' ' ' ILE . . . -137.61 120.26 16.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.208 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.527 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 2.3 m -89.28 102.63 15.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.999 -1.063 . . . . 0.0 108.709 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 88.8 mt -49.12 164.5 0.07 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.416 -0.802 . . . . 0.0 109.651 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -79.04 6.77 8.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 -179.67 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.516 ' ND2' ' HD2' ' B' ' 48' ' ' ARG . 42.0 p30 -109.4 20.7 17.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.982 . . . . 0.0 109.415 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.93 14.0 82.8 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.516 ' HD2' ' ND2' ' B' ' 46' ' ' ASN . 1.6 mtp-105 -103.51 171.66 7.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -1.173 . . . . 0.0 109.499 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.461 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -141.95 151.18 42.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 109.367 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.23 123.0 8.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 109.078 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 15.5 m -79.83 141.16 36.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.161 -0.962 . . . . 0.0 109.262 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.521 ' CD2' ' HA2' ' B' ' 17' ' ' GLY . 12.3 mt -119.56 167.85 11.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.161 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.537 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 1.0 OUTLIER -98.13 119.2 62.5 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.057 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.485 ' HB3' ' CG2' ' B' ' 40' ' ' VAL . 33.8 Cg_endo -75.11 -6.79 18.42 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.07 1.847 . . . . 0.0 110.317 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.77 -14.51 47.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 108.882 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -90.17 162.22 35.51 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.83 . . . . 0.0 109.293 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.477 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -78.41 -37.68 0.68 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.612 2.208 . . . . 0.0 110.852 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' B' ' 62' ' ' ILE . 0.2 OUTLIER -63.32 -48.02 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.045 -1.034 . . . . 0.0 108.975 -179.837 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.57 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 37.5 t -55.71 -48.61 77.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.504 -0.747 . . . . 0.0 109.044 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.467 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.3 OUTLIER -51.28 -33.65 29.49 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.322 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' B' ' 61' ' ' LYS . 0.1 OUTLIER -72.82 -36.43 67.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.488 -0.758 . . . . 0.0 109.304 179.6 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' B' ' 58' ' ' ILE . 1.3 mp -57.89 -44.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.018 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.58 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.1 mp -69.85 -68.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 109.829 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.481 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.2 OUTLIER -43.51 -27.78 0.31 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -0.965 . . . . 0.0 109.549 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.481 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 10.4 mmtt -72.5 -58.64 3.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 108.973 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.527 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 1.1 tmm? -44.66 -45.64 9.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 108.914 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.577 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 2.5 mt -55.44 -49.2 73.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.518 -0.739 . . . . 0.0 109.411 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.12 33.85 1.86 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.499 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.0 p -104.96 -25.28 12.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -89.52 34.31 0.82 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 47.37 -149.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.449 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 47.71 -167.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.15 -0.969 . . . . 0.0 109.453 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . 0.405 ' OXT' ' HD2' ' A' ' 60' ' ' LYS . 21.4 m-80 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.506 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.09 -83.2 0.52 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.452 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.432 ' O ' ' CB ' ' A' ' 4' ' ' ALA . 1.8 t -115.14 36.84 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.432 ' CB ' ' O ' ' A' ' 3' ' ' VAL . . . 71.55 147.46 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.9 m -147.39 -41.89 0.18 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.468 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -143.97 108.08 4.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.334 -0.854 . . . . 0.0 109.449 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.527 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -118.78 99.4 6.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.253 -0.904 . . . . 0.0 109.52 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.432 ' O ' ' C ' ' A' ' 9' ' ' CYS . 19.2 mtt180 -94.19 152.23 18.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.213 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.505 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 4.7 m -44.16 113.25 0.5 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -12.66 15.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.765 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 39' ' ' GLU . 70.8 m -135.2 60.71 1.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.119 -0.988 . . . . 0.0 109.873 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.505 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.52 -38.33 6.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 108.815 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -124.87 123.05 39.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.28 173.93 7.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 110.092 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 16' ' ' GLN . 4.6 mt -129.53 145.81 51.42 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.526 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 2.3 tt0 -44.94 -45.67 10.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.078 -1.014 . . . . 0.0 109.202 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.525 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 139.87 156.14 6.82 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.542 ' CD1' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -129.19 157.53 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -1.095 . . . . 0.0 109.254 179.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.583 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.95 151.92 0.39 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 109.38 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.583 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.4 Cg_endo -76.66 -1.71 11.85 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.473 2.115 . . . . 0.0 110.156 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.459 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 2.2 mtmm -90.26 -25.51 20.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.806 . . . . 0.0 109.0 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 4.6 m-20 -82.37 -5.69 58.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.417 -0.802 . . . . 0.0 109.26 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 44' ' ' LEU . 9.3 mt -107.52 145.36 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.27 -0.894 . . . . 0.0 110.114 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.559 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -117.49 -26.48 6.63 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.413 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.559 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -139.68 162.99 33.77 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.8 t -146.86 99.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.945 -1.097 . . . . 0.0 109.891 -179.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.466 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 13.0 t30 -80.07 113.43 18.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.284 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.466 ' O ' ' CE ' ' B' ' 66' ' ' MET . 1.8 t -97.17 90.53 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.511 ' HE3' ' NE2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -94.94 105.68 17.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.475 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.417 ' HA ' HG22 ' A' ' 38' ' ' THR . 0.9 OUTLIER -59.65 167.13 2.7 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 109.43 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 36.1 Cg_endo -78.11 145.85 22.28 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.527 2.151 . . . . 0.0 110.418 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.14 -142.85 3.63 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.6 10.09 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.685 2.256 . . . . 0.0 111.013 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 4.8 p-80 -126.8 -32.58 2.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.056 . . . . 0.0 109.45 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -147.31 88.74 1.73 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.207 -0.933 . . . . 0.0 109.264 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -54.07 -18.85 4.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.33 -0.856 . . . . 0.0 109.699 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.452 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 1.5 mp0 -92.84 124.78 37.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 0.0 109.516 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.464 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 2.7 m -49.5 162.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.292 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 37' ' ' GLN . 1.3 mp0 -142.78 108.98 5.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 109.663 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.557 ' CG1' ' CD1' ' A' ' 63' ' ' ILE . 57.3 t -100.62 95.12 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 109.147 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.45 HG13 ' SG ' ' A' ' 51' ' ' CYS . 2.6 mp -84.59 139.62 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.958 . . . . 0.0 109.831 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.476 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -121.25 118.36 29.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 109.133 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.485 ' O ' ' HG3' ' A' ' 24' ' ' GLN . 1.1 m -89.07 97.36 11.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.972 -1.08 . . . . 0.0 108.668 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 90.8 mt -43.44 167.77 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.567 -0.708 . . . . 0.0 109.906 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.1 ptpt -81.29 7.96 10.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.841 . . . . 0.0 109.581 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.473 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.7 13.28 21.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.272 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.99 -1.6 86.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.473 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 2.1 mtt-85 -87.88 168.07 13.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -1.182 . . . . 0.0 109.392 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.406 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 2.0 mttt -134.26 155.17 50.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.913 . . . . 0.0 109.428 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.34 117.73 6.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.193 -0.942 . . . . 0.0 109.186 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.45 ' SG ' HG13 ' A' ' 41' ' ' ILE . 8.7 m -79.39 139.05 37.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.151 -0.968 . . . . 0.0 108.853 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.542 HD23 ' CD1' ' A' ' 18' ' ' ILE . 8.7 mt -121.16 167.85 12.22 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.148 -0.97 . . . . 0.0 109.588 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 7.1 t-20 -100.47 119.25 59.33 Favored Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.401 -0.812 . . . . 0.0 109.215 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.467 ' HA ' HG13 ' A' ' 59' ' ' VAL . 32.7 Cg_endo -74.18 0.82 7.97 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.157 1.905 . . . . 0.0 110.595 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.54 -15.69 30.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 108.904 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.459 ' OG ' HG21 ' A' ' 58' ' ' ILE . 0.9 OUTLIER -90.28 164.21 28.36 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.455 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.46 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.78 -37.94 0.78 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.687 2.258 . . . . 0.0 111.061 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.543 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 16.0 tt -65.43 -46.87 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.991 -1.068 . . . . 0.0 109.124 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.555 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 34.0 t -55.37 -46.85 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.434 -0.792 . . . . 0.0 109.25 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.462 ' HE2' ' O ' ' A' ' 54' ' ' PRO . 18.1 mttt -57.74 -30.75 65.82 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.501 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -79.37 -24.81 42.41 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.511 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.6 mp -65.85 -43.59 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.589 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 1.6 mp -69.61 -62.94 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.547 -0.721 . . . . 0.0 109.214 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' OE2' ' CD1' ' B' ' 67' ' ' LEU . 1.3 mp0 -41.76 -48.5 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.793 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.508 ' CE ' ' HG3' ' A' ' 20' ' ' PRO . 2.8 mmtm -53.75 -59.27 4.83 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.372 -0.83 . . . . 0.0 109.342 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.459 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 1.4 mmm -43.52 -45.78 6.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.297 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.579 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 3.1 mt -55.67 -57.72 10.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.46 -0.775 . . . . 0.0 109.738 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.434 ' ND2' ' HE2' ' A' ' 71' ' ' LYS . 2.3 t30 -81.13 7.37 11.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.799 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.459 ' OG ' ' HA ' ' A' ' 66' ' ' MET . 7.8 p -101.82 -12.34 18.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 109.384 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.462 ' HB2' ' OG1' ' B' ' 38' ' ' THR . 2.0 p30 -103.88 -12.9 16.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.434 ' HE2' ' ND2' ' A' ' 68' ' ' ASN . 15.4 pttt -76.3 -160.19 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.452 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 73' ' ' ASN . 62.2 p -82.96 107.8 15.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.488 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 72' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.494 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.08 -83.18 0.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.482 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.436 ' O ' ' CB ' ' B' ' 4' ' ' ALA . 1.8 t -115.17 36.84 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.478 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.436 ' CB ' ' O ' ' B' ' 3' ' ' VAL . . . 71.63 147.42 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.477 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 21.1 m -147.37 -41.86 0.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.504 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -144.05 108.01 4.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.897 . . . . 0.0 109.494 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.527 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -118.77 99.36 6.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.266 -0.897 . . . . 0.0 109.496 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 9' ' ' CYS . 19.2 mtt180 -94.16 152.24 18.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.849 . . . . 0.0 109.228 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.506 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 4.6 m -44.18 113.21 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 109.393 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -12.7 14.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.709 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.45 ' SG ' HG13 ' B' ' 41' ' ' ILE . 71.0 m -135.25 60.78 1.68 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.913 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.506 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.56 -38.2 6.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.107 -0.995 . . . . 0.0 108.912 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -124.95 122.98 38.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 108.843 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.27 173.98 7.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 0.0 110.153 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.416 ' O ' ' C ' ' B' ' 16' ' ' GLN . 4.5 mt -129.51 145.82 51.41 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.522 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 2.2 tt0 -44.92 -45.65 10.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.249 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.517 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 139.84 156.18 6.84 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.539 ' CD1' HD23 ' B' ' 52' ' ' LEU . 0.2 OUTLIER -129.25 157.56 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -1.091 . . . . 0.0 109.21 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.576 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -43.0 152.01 0.39 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 0.0 109.39 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.576 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -76.75 -1.73 11.89 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.442 2.095 . . . . 0.0 110.19 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.463 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 2.2 mtmm -90.19 -25.6 20.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.273 -0.892 . . . . 0.0 108.997 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 4.7 m-20 -82.33 -5.67 58.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.413 -0.804 . . . . 0.0 109.318 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' B' ' 44' ' ' LEU . 9.3 mt -107.43 145.39 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 110.089 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.559 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -117.5 -26.46 6.63 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.269 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.559 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -139.6 163.02 33.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . . . . . . . . . 52.5 t -146.86 99.38 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.081 -1.012 . . . . 0.0 109.931 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.466 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 13.2 t30 -80.01 113.43 18.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.253 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.455 ' O ' ' CE ' ' A' ' 66' ' ' MET . 1.8 t -97.15 90.48 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.513 ' HE3' ' NE2' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -94.92 105.67 17.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.548 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.418 ' HA ' HG22 ' B' ' 38' ' ' THR . 0.9 OUTLIER -59.59 167.14 2.64 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 109.422 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.47 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 36.3 Cg_endo -78.03 145.8 22.44 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.659 2.239 . . . . 0.0 110.419 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.19 -142.88 3.64 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.46 9.82 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.695 2.263 . . . . 0.0 110.983 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.527 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 4.6 p-80 -126.68 -32.44 2.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 109.42 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -147.38 88.7 1.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.213 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -54.03 -18.94 4.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.705 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.456 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 1.5 mp0 -92.67 124.62 36.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.13 -0.981 . . . . 0.0 109.596 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 70' ' ' ASP . 2.7 m -49.47 162.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.238 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' B' ' 37' ' ' GLN . 1.3 mp0 -142.74 108.91 5.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.117 -0.989 . . . . 0.0 109.706 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.557 ' CG1' ' CD1' ' B' ' 63' ' ' ILE . 57.4 t -100.56 95.12 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.247 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.45 HG13 ' SG ' ' B' ' 11' ' ' CYS . 2.6 mp -84.57 139.63 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.892 . . . . 0.0 109.875 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.467 ' CB ' HG22 ' B' ' 23' ' ' ILE . . . -121.24 118.46 29.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.484 ' O ' ' HG3' ' B' ' 24' ' ' GLN . 1.1 m -89.18 97.38 11.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.955 -1.091 . . . . 0.0 108.665 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 90.9 mt -43.49 167.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.61 -0.681 . . . . 0.0 109.878 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.463 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.1 ptpt -81.34 7.95 10.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.492 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -111.72 13.38 21.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.288 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.0 -1.66 86.81 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.492 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 2.1 mtt-85 -87.78 168.11 13.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -1.221 . . . . 0.0 109.436 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.413 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 2.0 mttt -134.3 155.24 50.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.37 117.75 6.06 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.348 -0.845 . . . . 0.0 109.17 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.439 ' SG ' HG13 ' B' ' 41' ' ' ILE . 8.6 m -79.45 139.02 37.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 0.0 108.852 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.539 HD23 ' CD1' ' B' ' 18' ' ' ILE . 8.7 mt -121.1 167.85 12.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.17 -0.956 . . . . 0.0 109.629 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 7.1 t-20 -100.45 119.31 59.22 Favored Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 121.51 -0.744 . . . . 0.0 109.201 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.466 ' HA ' HG13 ' B' ' 59' ' ' VAL . 32.9 Cg_endo -74.25 0.86 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.077 1.851 . . . . 0.0 110.582 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -90.64 -15.64 30.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 108.863 179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.468 ' OG ' HG21 ' B' ' 58' ' ' ILE . 0.9 OUTLIER -90.18 164.21 28.59 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 109.498 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.77 -38.0 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.673 2.249 . . . . 0.0 111.055 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 16.0 tt -65.4 -46.9 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.065 . . . . 0.0 109.112 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.557 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 33.6 t -55.41 -46.82 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.412 -0.805 . . . . 0.0 109.221 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' B' ' 54' ' ' PRO . 18.1 mttt -57.64 -30.86 65.73 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.523 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.7 OUTLIER -79.33 -24.86 42.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.515 -0.741 . . . . 0.0 109.457 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.536 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.6 mp -65.86 -43.58 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.579 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 1.6 mp -69.6 -63.02 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 109.104 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.525 ' OE2' ' CD1' ' A' ' 67' ' ' LEU . 1.3 mp0 -41.73 -48.48 4.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.423 -0.798 . . . . 0.0 109.826 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.499 ' CE ' ' HG3' ' B' ' 20' ' ' PRO . 2.8 mmtm -53.69 -59.42 4.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.88 . . . . 0.0 109.233 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 28' ' ' VAL . 1.4 mmm -43.44 -45.77 6.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.37 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.589 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 3.1 mt -55.69 -57.68 10.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.516 -0.74 . . . . 0.0 109.753 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.439 ' ND2' ' HE2' ' B' ' 71' ' ' LYS . 2.2 t30 -81.07 7.24 11.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 109.804 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' B' ' 65' ' ' LYS . 7.6 p -101.76 -12.39 18.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.168 -0.958 . . . . 0.0 109.443 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.456 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 2.0 p30 -103.85 -12.89 16.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.445 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.439 ' HE2' ' ND2' ' B' ' 68' ' ' ASN . 15.4 pttt -76.28 -160.26 0.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 109.472 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' B' ' 73' ' ' ASN . 62.3 p -82.93 107.8 15.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.463 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' B' ' 72' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.321 0.582 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.57 10.66 11.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.188 -0.945 . . . . 0.0 109.49 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.02 70.12 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.476 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.79 -149.28 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 0.0 109.516 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.1 p -127.89 73.21 1.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 109.488 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.09 41.96 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.519 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -116.97 98.1 6.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.231 -0.918 . . . . 0.0 109.534 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.1 OUTLIER -80.49 145.66 31.75 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.331 -0.856 . . . . 0.0 109.076 179.771 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 4.5 m -44.01 110.32 0.2 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.386 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.517 ' NE2' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -43.08 -26.83 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.382 -0.824 . . . . 0.0 109.578 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 39' ' ' GLU . 56.4 m -127.14 65.11 1.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.48 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.522 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -43.76 -37.17 2.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.901 . . . . 0.0 109.027 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.1 pt20 -121.65 -174.98 2.99 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -160.09 151.44 19.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.143 -0.973 . . . . 0.0 109.778 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.408 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.2 mt -114.0 144.61 42.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 0.0 108.923 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.53 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.1 tt0 -44.05 -26.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 109.293 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.523 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 142.41 -164.03 27.04 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.54 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.3 pp -170.37 162.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.376 -1.073 . . . . 0.0 109.534 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.608 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 3.3 t60 -44.84 146.61 1.29 Allowed Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.608 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.6 Cg_endo -79.1 -17.01 12.11 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.366 2.044 . . . . 0.0 109.524 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 7.7 mmtm -90.4 -19.35 24.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 16.7 m-20 -78.2 -14.62 59.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -0.841 . . . . 0.0 109.033 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.54 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 11.0 mt -91.66 168.05 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.513 -0.742 . . . . 0.0 110.1 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.525 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -135.59 -40.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.455 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 6.4 p -123.58 172.57 8.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.515 ' CG1' HG13 ' A' ' 63' ' ' ILE . 97.3 t -144.25 88.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.741 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.459 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 4.0 t-20 -84.77 108.41 17.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.36 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -108.6 91.77 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 109.439 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.517 ' HD2' ' NE2' ' A' ' 10' ' ' GLN . 0.7 OUTLIER -92.39 128.15 38.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.857 . . . . 0.0 109.521 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.429 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -76.91 171.62 11.9 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.484 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 36.1 Cg_endo -78.03 132.4 11.62 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.606 2.204 . . . . 0.0 110.465 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.46 -144.23 5.0 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.85 11.94 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.711 2.274 . . . . 0.0 111.041 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.519 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 5.9 p-80 -128.99 -33.5 1.98 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.558 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -129.42 116.99 19.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.3 45.8 1.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.484 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -173.09 141.07 0.93 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 m -58.24 153.51 15.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.459 ' OE2' ' HG2' ' A' ' 29' ' ' LYS . 15.4 pt-20 -142.12 107.9 5.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.572 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.507 HG11 ' N ' ' A' ' 41' ' ' ILE . 55.5 t -90.77 153.45 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.374 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.507 ' N ' HG11 ' A' ' 40' ' ' VAL . 3.6 mt -140.67 144.68 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.626 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.514 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -131.71 119.95 22.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.119 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 7.9 m -89.45 97.98 11.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.996 -1.065 . . . . 0.0 109.09 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 85.4 mt -43.75 163.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.448 -0.783 . . . . 0.0 109.736 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -80.05 9.12 5.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 109.931 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.58 27.52 9.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.217 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.3 9.42 72.68 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.513 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 3.4 mtt180 -99.6 163.21 12.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.207 -1.172 . . . . 0.0 109.53 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -137.68 151.83 48.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.339 -0.851 . . . . 0.0 109.257 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.15 127.99 11.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.6 m -79.6 151.83 30.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.055 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' THR . 19.3 mt -127.07 166.72 17.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.315 -0.866 . . . . 0.0 109.326 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 1.1 t-20 -93.53 115.87 65.67 Favored Pre-proline 0 C--N 1.299 -1.594 0 O-C-N 121.404 -0.81 . . . . 0.0 109.079 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.434 ' HA ' HG13 ' A' ' 59' ' ' VAL . 33.2 Cg_endo -74.54 -1.21 10.75 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.106 1.871 . . . . 0.0 110.413 -179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.2 -12.12 36.28 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.367 -0.833 . . . . 0.0 108.835 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -90.13 160.91 39.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.443 -0.786 . . . . 0.0 109.428 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.489 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 35.6 Cg_endo -77.5 -31.16 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.661 2.241 . . . . 0.0 110.547 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.549 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 4.1 tt -72.35 -45.16 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.083 -1.011 . . . . 0.0 109.288 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.549 ' N ' ' CG2' ' A' ' 58' ' ' ILE . 19.7 t -56.96 -48.53 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.511 -0.743 . . . . 0.0 109.294 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.463 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -61.09 -32.06 71.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.186 -0.946 . . . . 0.0 108.552 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.552 ' N ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -77.41 -19.14 56.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.528 -0.733 . . . . 0.0 109.161 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.53 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 16.2 mt -75.16 -38.84 42.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.523 HG21 ' CD1' ' B' ' 67' ' ' LEU . 1.9 mp -72.68 -55.98 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.908 . . . . 0.0 109.069 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.523 ' CG ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -58.79 -38.39 78.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.283 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 61' ' ' LYS . 8.2 tttp -59.57 -40.94 89.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -0.874 . . . . 0.0 109.173 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.512 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -61.47 -46.55 89.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.45 -0.782 . . . . 0.0 109.211 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.524 ' CD1' HG21 ' B' ' 63' ' ' ILE . 0.2 OUTLIER -44.11 -51.65 7.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.835 . . . . 0.0 109.395 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.67 -30.32 66.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 0.0 109.623 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.448 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p -56.95 -19.49 18.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.497 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -83.29 -83.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.453 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -154.64 127.26 8.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.527 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.6 t -73.85 -82.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.513 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.911 -1.042 . . . . 0.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.61 10.65 11.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.36 -0.838 . . . . 0.0 109.494 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.1 70.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.89 -149.27 0.44 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 18.9 p -127.91 73.21 1.45 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.422 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.1 41.96 1.0 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.902 . . . . 0.0 109.515 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.521 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -116.89 97.95 6.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.915 . . . . 0.0 109.547 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.1 OUTLIER -80.37 145.56 31.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.165 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.516 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 4.5 m -43.98 110.21 0.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.516 ' NE2' ' HD2' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -43.0 -26.79 0.15 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.402 -0.811 . . . . 0.0 109.586 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.448 ' SG ' HG13 ' B' ' 41' ' ' ILE . 56.3 m -127.18 65.02 1.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.275 -0.89 . . . . 0.0 109.447 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.516 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -43.75 -37.11 2.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.019 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 15.0 pt20 -121.67 -174.97 2.99 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.379 -0.826 . . . . 0.0 108.843 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -160.1 151.45 19.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.073 -1.017 . . . . 0.0 109.789 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.434 ' O ' ' C ' ' B' ' 16' ' ' GLN . 7.2 mt -114.05 144.63 42.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.436 -0.79 . . . . 0.0 108.874 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.524 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.1 tt0 -44.03 -26.8 0.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.353 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.521 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 142.46 -163.95 27.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.532 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.3 pp -170.42 162.66 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.419 -1.048 . . . . 0.0 109.451 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 3.4 t60 -44.95 146.67 1.3 Allowed Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -79.15 -16.98 12.06 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.327 2.018 . . . . 0.0 109.452 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 7.7 mmtm -90.42 -19.38 23.99 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 16.7 m-20 -78.25 -14.57 59.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.845 . . . . 0.0 109.002 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.532 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 10.9 mt -91.68 168.01 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 110.129 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.1 OUTLIER -135.55 -40.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.454 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 6.4 p -123.54 172.51 8.7 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.522 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 97.2 t -144.23 88.1 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.719 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.468 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.0 t-20 -84.77 108.36 17.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.393 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -108.58 91.85 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.516 ' HD2' ' NE2' ' B' ' 10' ' ' GLN . 0.7 OUTLIER -92.51 128.1 38.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.925 . . . . 0.0 109.463 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.442 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -76.8 171.59 11.93 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 109.466 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.48 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.0 Cg_endo -78.02 132.44 11.66 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.658 2.239 . . . . 0.0 110.391 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.54 -144.23 5.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.95 12.01 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.693 2.262 . . . . 0.0 111.051 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.521 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 5.8 p-80 -129.0 -33.46 1.98 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 109.614 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -129.4 116.95 19.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.31 45.92 1.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.512 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.48 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -173.19 141.01 0.91 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 2.2 m -58.14 153.55 14.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.871 . . . . 0.0 109.503 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.461 ' OE2' ' HG2' ' B' ' 29' ' ' LYS . 15.3 pt-20 -142.19 107.92 5.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.505 HG11 ' N ' ' B' ' 41' ' ' ILE . 55.7 t -90.85 153.36 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 0.0 109.34 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.505 ' N ' HG11 ' B' ' 40' ' ' VAL . 3.6 mt -140.54 144.77 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 109.646 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.515 ' CB ' HG22 ' B' ' 23' ' ' ILE . . . -131.77 119.92 21.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.869 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 7.9 m -89.41 97.92 11.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.015 -1.053 . . . . 0.0 109.095 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.49 ' HA ' ' O ' ' B' ' 22' ' ' ASN . 85.5 mt -43.77 163.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.343 -0.848 . . . . 0.0 109.738 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -80.0 9.01 5.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.354 -0.841 . . . . 0.0 109.857 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.46 27.43 9.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 0.0 109.215 179.739 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.33 9.43 72.81 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 3.4 mtt180 -99.56 163.2 12.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -1.174 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.529 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.2 OUTLIER -137.7 151.89 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.219 179.804 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.23 127.98 11.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.288 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.58 151.86 30.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 109.077 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.529 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 19.3 mt -127.15 166.65 17.27 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.275 -0.891 . . . . 0.0 109.326 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.546 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 1.2 t-20 -93.43 115.91 65.72 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 109.106 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.426 ' HA ' HG13 ' B' ' 59' ' ' VAL . 33.2 Cg_endo -74.54 -1.24 10.79 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.11 1.873 . . . . 0.0 110.401 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.13 -12.18 36.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 108.867 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 1.0 OUTLIER -90.11 160.94 39.23 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.415 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.484 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.1 Cg_endo -77.42 -31.27 3.56 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.584 2.189 . . . . 0.0 110.588 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.544 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 4.1 tt -72.28 -45.16 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.032 -1.043 . . . . 0.0 109.37 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.546 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 19.6 t -56.88 -48.58 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.435 -0.791 . . . . 0.0 109.3 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.447 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -61.14 -31.99 71.7 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.147 -0.97 . . . . 0.0 108.536 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.549 ' HD2' ' N ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -77.51 -19.1 56.35 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.53 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 16.3 mt -75.23 -38.74 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.524 HG21 ' CD1' ' A' ' 67' ' ' LEU . 1.9 mp -72.75 -56.04 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 108.975 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.524 ' CG ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -58.77 -38.42 78.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.3 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' B' ' 61' ' ' LYS . 8.2 tttp -59.45 -41.07 88.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.157 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.522 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -61.37 -46.6 89.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 109.22 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.523 ' CD1' HG21 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -44.0 -51.73 7.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.451 -0.781 . . . . 0.0 109.396 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.64 -30.33 66.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.352 -0.842 . . . . 0.0 109.571 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.447 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.2 p -57.01 -19.5 18.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.457 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -83.28 -83.63 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.536 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -154.71 127.29 8.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.501 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.6 t -73.86 -82.55 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.493 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.9 -1.048 . . . . 0.0 109.464 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.526 ' O ' ' CG1' ' A' ' 3' ' ' VAL . 38.4 p -83.02 -154.69 0.14 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.401 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 2' ' ' SER . 7.9 p 41.84 27.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.379 -0.826 . . . . 0.0 109.712 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 2' ' ' SER . . . -160.67 160.48 31.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.359 -0.838 . . . . 0.0 109.412 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.417 ' OG1' ' O ' ' A' ' 4' ' ' ALA . 2.5 m -167.31 26.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.884 . . . . 0.0 109.517 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.479 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -128.59 -145.33 0.3 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.222 -0.923 . . . . 0.0 109.176 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.575 ' HB3' ' CG ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -164.74 123.15 1.74 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -112.18 149.74 31.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 108.909 179.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 8' ' ' ARG . 89.0 m -44.5 95.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 109.385 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.528 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -47.98 -22.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.753 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.421 ' O ' ' C ' ' A' ' 12' ' ' LEU . 63.0 m -126.45 65.2 1.25 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.9 . . . . 0.0 109.872 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -44.59 -43.74 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 108.866 179.459 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -122.97 124.86 44.12 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -96.44 167.36 11.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 0.0 110.014 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 16' ' ' GLN . 7.5 mt -118.92 146.27 45.08 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.523 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 0.2 OUTLIER -44.21 -41.28 5.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.281 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.514 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 147.51 -164.33 28.75 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' A' ' 23' ' ' ILE . 1.3 pp -171.11 163.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -1.041 . . . . 0.0 109.197 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.561 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -54.64 149.57 21.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.371 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.561 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -77.23 -4.11 14.43 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.502 2.135 . . . . 0.0 110.213 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HG2' ' HB3' ' A' ' 19' ' ' HIS . 8.4 pttt -90.29 -24.03 21.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.118 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.521 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 2.6 m-20 -82.92 -5.5 59.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.282 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' A' ' 18' ' ' ILE . 9.2 mt -105.99 145.96 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.557 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -119.13 -25.42 6.18 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.557 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -143.0 -179.51 6.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 109.122 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.458 HG11 ' O ' ' A' ' 41' ' ' ILE . 47.0 t -156.76 155.6 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.994 -1.066 . . . . 0.0 109.911 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.432 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . 2.6 t-20 -138.71 114.14 9.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.405 -0.809 . . . . 0.0 109.266 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.47 108.47 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.471 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' CD ' ' HB2' ' A' ' 10' ' ' GLN . 4.2 ptmm? -113.39 108.33 17.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.893 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.83 163.94 6.66 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.377 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.51 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.8 Cg_endo -77.58 152.39 29.59 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.628 2.219 . . . . 0.0 110.336 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.25 -137.06 2.12 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.514 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 35.9 Cg_endo -77.56 8.17 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.515 2.144 . . . . 0.0 110.758 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.575 ' CG ' ' HB3' ' A' ' 7' ' ' LEU . 2.5 p-80 -125.6 -24.34 3.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.023 -1.048 . . . . 0.0 109.733 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.51 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 1.8 t -160.06 107.31 1.63 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.049 -1.032 . . . . 0.0 109.305 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.7 -5.59 26.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.895 . . . . 0.0 109.69 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.445 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 2.2 mp0 -109.17 124.74 51.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.521 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.516 ' CG2' ' HB3' ' B' ' 70' ' ' ASP . 1.7 m -48.26 158.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.293 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.497 ' HG3' ' NZ ' ' A' ' 29' ' ' LYS . 25.7 mm-40 -139.93 107.36 5.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.65 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.463 ' O ' HG13 ' A' ' 41' ' ' ILE . 10.3 t -92.52 151.99 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 109.179 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 40' ' ' VAL . 3.2 mt -140.19 156.13 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.113 -0.992 . . . . 0.0 109.883 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.448 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -142.65 117.87 10.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 109.015 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.491 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.2 m -89.11 96.03 10.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.982 -1.074 . . . . 0.0 108.736 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 89.6 mt -42.32 165.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.586 -0.696 . . . . 0.0 109.891 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -79.52 7.22 8.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.842 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.518 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.41 24.0 13.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.139 -0.976 . . . . 0.0 109.22 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.36 -0.11 65.01 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 72.5 mtt85 -88.57 162.27 16.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -1.195 . . . . 0.0 109.397 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.4 mptt -135.55 151.23 50.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.167 -0.958 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.25 123.43 8.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.349 -0.844 . . . . 0.0 109.05 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 10.0 m -79.59 142.54 35.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.057 -1.027 . . . . 0.0 109.079 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 14.3 mt -120.43 167.74 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.243 -0.911 . . . . 0.0 109.62 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 0.9 OUTLIER -99.57 122.62 50.86 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.484 -0.76 . . . . 0.0 109.047 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.465 ' O ' ' HE2' ' A' ' 60' ' ' LYS . 33.2 Cg_endo -75.11 -3.53 14.06 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.079 1.852 . . . . 0.0 110.354 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.59 -12.4 42.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.913 . . . . 0.0 108.919 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.468 ' OG ' HG22 ' A' ' 59' ' ' VAL . 0.4 OUTLIER -89.98 163.09 33.45 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.438 -0.789 . . . . 0.0 109.394 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.68 -38.98 0.57 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.696 2.264 . . . . 0.0 110.784 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.534 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 20.6 tt -65.16 -45.92 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.346 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.551 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 44.7 t -57.42 -45.6 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -0.82 . . . . 0.0 109.333 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.465 ' HE2' ' O ' ' A' ' 54' ' ' PRO . 7.4 mttt -59.68 -29.53 68.14 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 7.0 mmmm -79.53 -23.61 42.75 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 29.2 mt -72.1 -36.63 57.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.54 -0.725 . . . . 0.0 109.303 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.588 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -75.87 -51.14 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.752 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.469 ' OE1' ' HD2' ' A' ' 61' ' ' LYS . 9.4 pt-20 -65.8 -29.0 69.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.035 -1.04 . . . . 0.0 109.347 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 4.4 mmtt -69.47 -46.11 67.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.871 . . . . 0.0 108.994 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.45 ' SD ' ' OG ' ' A' ' 69' ' ' SER . 0.3 OUTLIER -56.12 -45.29 79.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.438 -0.789 . . . . 0.0 109.076 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.591 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.62 -51.85 8.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.421 -0.8 . . . . 0.0 109.478 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 69' ' ' SER . 6.8 t-20 -64.86 -37.29 87.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.403 -0.81 . . . . 0.0 109.476 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.45 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.1 p -44.14 -26.59 0.32 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.516 ' CB ' HG23 ' B' ' 38' ' ' THR . 1.6 p30 -111.88 82.51 1.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.476 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -127.94 86.44 2.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.476 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.06 157.75 15.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.444 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.425 ' N ' ' ND2' ' A' ' 73' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.484 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.518 ' O ' ' CG1' ' B' ' 3' ' ' VAL . 38.8 p -83.02 -154.69 0.14 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.434 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' B' ' 2' ' ' SER . 7.9 p 41.85 27.89 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.437 -0.789 . . . . 0.0 109.668 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.421 ' O ' ' OG1' ' B' ' 5' ' ' THR . . . -160.75 160.44 31.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.421 ' OG1' ' O ' ' B' ' 4' ' ' ALA . 2.5 m -167.21 26.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 109.534 -179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.471 ' O ' ' HG ' ' B' ' 7' ' ' LEU . 0.9 OUTLIER -128.51 -145.34 0.3 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.207 -0.933 . . . . 0.0 109.175 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.566 ' HB3' ' CG ' ' B' ' 34' ' ' HIS . 1.0 OUTLIER -164.68 123.22 1.76 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.283 -0.886 . . . . 0.0 109.619 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -112.24 149.78 31.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 108.898 179.572 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.429 ' C ' ' O ' ' B' ' 8' ' ' ARG . 89.0 m -44.45 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.149 -0.969 . . . . 0.0 109.339 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.524 ' N ' ' O ' ' B' ' 8' ' ' ARG . 0.0 OUTLIER -48.03 -22.78 0.66 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.742 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' B' ' 12' ' ' LEU . 63.3 m -126.42 65.22 1.24 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.825 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.2 OUTLIER -44.63 -43.79 8.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 108.818 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -122.86 124.88 44.28 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.455 HG23 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -96.45 167.43 11.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.236 -0.915 . . . . 0.0 109.968 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.429 ' O ' ' C ' ' B' ' 16' ' ' GLN . 7.5 mt -119.04 146.21 45.24 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 0.2 OUTLIER -44.08 -41.31 5.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.372 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.512 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 147.53 -164.21 28.75 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.584 ' CD1' ' CD1' ' B' ' 23' ' ' ILE . 1.3 pp -171.19 163.64 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.473 -1.016 . . . . 0.0 109.166 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.569 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -54.54 149.58 20.63 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.183 -0.948 . . . . 0.0 109.326 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.0 Cg_endo -77.22 -4.15 14.47 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.489 2.126 . . . . 0.0 110.257 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.467 ' HG2' ' HB3' ' B' ' 19' ' ' HIS . 8.4 pttt -90.26 -24.05 21.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.352 -0.843 . . . . 0.0 109.136 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 2.5 m-20 -82.92 -5.43 59.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 109.259 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.584 ' CD1' ' CD1' ' B' ' 18' ' ' ILE . 9.1 mt -105.98 145.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.557 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -119.12 -25.44 6.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.557 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -142.98 -179.45 6.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.431 -0.793 . . . . 0.0 108.98 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.465 HG11 ' O ' ' B' ' 41' ' ' ILE . 46.9 t -156.79 155.61 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.101 -0.999 . . . . 0.0 109.901 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.433 ' HB3' ' CD1' ' B' ' 41' ' ' ILE . 2.5 t-20 -138.72 114.23 9.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.364 -0.835 . . . . 0.0 109.21 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.58 108.52 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.473 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.52 ' CE ' ' HB2' ' B' ' 10' ' ' GLN . 4.2 ptmm? -113.38 108.35 17.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.433 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -59.8 163.92 6.63 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.521 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.6 Cg_endo -77.64 152.45 29.42 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.56 2.173 . . . . 0.0 110.357 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.24 -136.97 2.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.521 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -77.58 8.01 3.56 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.536 2.157 . . . . 0.0 110.79 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.566 ' CG ' ' HB3' ' B' ' 7' ' ' LEU . 2.4 p-80 -125.53 -24.25 3.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.983 . . . . 0.0 109.734 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.521 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 1.8 t -160.13 107.39 1.62 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.963 . . . . 0.0 109.249 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.7 -5.67 26.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.29 -0.881 . . . . 0.0 109.717 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.45 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 2.2 mp0 -109.1 124.8 51.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.154 -0.967 . . . . 0.0 109.527 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.516 HG23 ' CB ' ' A' ' 70' ' ' ASP . 1.7 m -48.33 158.38 0.27 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.938 . . . . 0.0 109.282 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.495 ' HG3' ' NZ ' ' B' ' 29' ' ' LYS . 25.7 mm-40 -139.92 107.32 5.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 109.716 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.464 ' O ' HG13 ' B' ' 41' ' ' ILE . 10.5 t -92.56 151.95 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.18 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.465 ' O ' HG11 ' B' ' 26' ' ' VAL . 3.2 mt -140.25 156.22 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.78 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.442 ' CB ' HG22 ' B' ' 23' ' ' ILE . . . -142.6 117.98 10.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 109.047 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.48 ' HB ' ' OG ' ' B' ' 25' ' ' SER . 1.2 m -89.19 96.05 10.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.875 -1.141 . . . . 0.0 108.729 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.4 mt -42.27 165.71 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.614 -0.679 . . . . 0.0 109.917 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -79.63 7.23 8.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.452 -0.78 . . . . 0.0 109.804 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.49 24.06 12.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.249 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.31 0.06 65.33 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.513 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 72.3 mtt85 -88.67 162.22 16.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -1.157 . . . . 0.0 109.33 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 1.4 mptt -135.53 151.35 50.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.89 . . . . 0.0 109.39 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.29 123.37 8.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.254 -0.904 . . . . 0.0 109.143 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.454 ' HA ' ' HA ' ' B' ' 41' ' ' ILE . 10.1 m -79.54 142.59 35.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 109.091 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.533 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 14.4 mt -120.45 167.72 12.07 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.561 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.551 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 0.9 OUTLIER -99.55 122.5 51.28 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.453 -0.779 . . . . 0.0 109.108 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.452 ' O ' ' HE2' ' B' ' 60' ' ' LYS . 33.4 Cg_endo -75.0 -3.6 14.16 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.185 1.923 . . . . 0.0 110.385 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.59 -12.24 43.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 108.993 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.459 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.4 OUTLIER -90.06 163.06 33.37 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 109.382 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.63 -39.04 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.636 2.224 . . . . 0.0 110.746 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.544 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 20.6 tt -65.2 -45.87 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.551 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 44.2 t -57.48 -45.65 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.847 . . . . 0.0 109.304 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' B' ' 56' ' ' SER . 7.4 mttt -59.57 -29.57 68.03 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' B' ' 65' ' ' LYS . 7.0 mmmm -79.5 -23.66 42.8 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 29.4 mt -72.08 -36.6 57.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.57 -0.706 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.591 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -75.86 -51.13 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.797 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.473 ' HG2' ' HA ' ' B' ' 61' ' ' LYS . 9.4 pt-20 -65.81 -29.0 69.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.023 -1.048 . . . . 0.0 109.303 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 4.4 mmtt -69.42 -46.19 67.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 108.943 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.45 ' SD ' ' OG ' ' B' ' 69' ' ' SER . 0.3 OUTLIER -56.13 -45.22 79.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.379 -0.826 . . . . 0.0 109.051 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.73 -51.85 8.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.423 -0.798 . . . . 0.0 109.418 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' B' ' 69' ' ' SER . 6.9 t-20 -64.84 -37.25 87.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.486 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.45 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.1 p -44.17 -26.66 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.453 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.516 ' HB3' ' CG2' ' A' ' 38' ' ' THR . 1.6 p30 -111.83 82.52 1.63 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.893 . . . . 0.0 109.434 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -127.95 86.47 2.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.849 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.09 157.72 15.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . 0.428 ' ND2' ' N ' ' B' ' 73' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.527 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.88 29.63 7.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.494 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.506 ' O ' ' CB ' ' A' ' 4' ' ' ALA . 1.1 m -116.75 -0.58 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.506 ' CB ' ' O ' ' A' ' 3' ' ' VAL . . . 76.16 83.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.508 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 t -106.52 30.71 5.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.83 129.66 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 109.29 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -116.17 98.22 6.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.162 -0.961 . . . . 0.0 109.582 -179.983 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -95.32 154.34 17.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.275 -0.891 . . . . 0.0 109.003 179.609 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.512 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 8.7 m -44.17 107.56 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.258 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.526 ' HG3' ' CD ' ' A' ' 29' ' ' LYS . 13.8 mm100 -43.78 -24.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.827 . . . . 0.0 110.015 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.458 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 66.4 m -139.83 77.9 1.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.026 -1.047 . . . . 0.0 109.974 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.512 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -50.51 -43.95 55.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 108.89 179.498 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.53 121.81 41.98 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.49 170.49 8.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.144 -0.972 . . . . 0.0 110.009 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -127.54 148.84 50.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.495 ' O ' ' CG2' ' A' ' 59' ' ' VAL . 2.6 tt0 -44.43 -54.69 5.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.531 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 149.04 168.53 14.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.58 ' N ' ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -136.34 161.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -1.097 . . . . 0.0 109.374 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.601 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -43.26 147.74 0.7 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.795 . . . . 0.0 109.048 179.533 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.601 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 33.6 Cg_endo -75.59 -3.01 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.213 1.942 . . . . 0.0 110.009 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.44 -25.22 20.46 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.367 -0.833 . . . . 0.0 108.909 179.26 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 5.2 m-20 -81.92 -4.88 57.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.435 -0.79 . . . . 0.0 109.334 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.47 ' HA ' ' HA ' ' A' ' 44' ' ' LEU . 13.6 mt -107.0 149.6 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 0.0 110.294 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.569 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -120.93 -28.1 4.87 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.248 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.569 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -135.93 169.17 18.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.105 179.323 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.459 HG22 ' O ' ' A' ' 25' ' ' SER . 48.9 t -156.66 126.27 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.718 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 55.5 t30 -108.49 157.93 18.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.339 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.07 95.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.493 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.526 ' CD ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -100.54 126.99 47.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.577 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.2 p -75.85 160.99 77.54 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.346 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.496 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.2 Cg_endo -77.15 145.61 24.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.509 2.14 . . . . 0.0 110.425 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.39 -133.64 1.55 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.97 41.46 1.12 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.719 2.279 . . . . 0.0 110.781 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.475 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 9.1 p-80 -162.11 -38.01 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.073 -1.017 . . . . 0.0 109.28 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 2.7 t -145.71 101.18 3.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.176 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.17 -12.46 20.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.725 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.459 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 1.9 mp0 -106.92 129.39 54.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.526 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.447 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 0.6 OUTLIER -48.49 162.82 0.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.192 -0.942 . . . . 0.0 109.292 179.887 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.459 ' OE2' ' O ' ' A' ' 37' ' ' GLN . 2.6 mp0 -136.95 114.44 11.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.643 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 19.5 t -104.86 144.57 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.16 179.798 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.441 HD11 ' HB3' ' A' ' 27' ' ' ASN . 2.6 mp -133.34 152.35 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.44 ' HB3' HG23 ' A' ' 23' ' ' ILE . . . -137.6 116.49 12.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.866 . . . . 0.0 109.173 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.534 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.8 m -89.12 97.51 11.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.956 -1.09 . . . . 0.0 108.785 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 93.1 mt -44.72 166.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.522 -0.736 . . . . 0.0 109.6 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.2 ptpt -81.61 8.46 9.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.518 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.28 19.92 17.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.204 179.742 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 4.54 89.6 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.518 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 5.8 mtt180 -94.55 168.39 10.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -1.194 . . . . 0.0 109.508 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.93 156.72 48.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 179.808 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.4 120.03 7.0 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.308 -0.87 . . . . 0.0 109.098 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.526 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 8.0 m -79.74 139.08 37.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.077 -1.014 . . . . 0.0 108.948 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.537 HD23 ' CD1' ' A' ' 18' ' ' ILE . 10.4 mt -123.39 168.32 12.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.204 -0.935 . . . . 0.0 109.68 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.555 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 28.9 t-20 -101.65 119.89 55.94 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.5 -0.75 . . . . 0.0 109.334 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HA ' HG13 ' A' ' 59' ' ' VAL . 33.6 Cg_endo -74.84 1.39 7.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.127 1.885 . . . . 0.0 110.542 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.53 -17.36 30.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.219 -0.926 . . . . 0.0 108.964 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.456 ' OG ' HG23 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -90.16 164.06 29.26 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 109.456 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.29 -33.31 1.98 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.731 2.287 . . . . 0.0 110.671 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 62' ' ' ILE . 0.2 OUTLIER -67.26 -48.33 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.104 -0.998 . . . . 0.0 108.99 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.567 ' N ' ' CG2' ' A' ' 58' ' ' ILE . 33.7 t -57.38 -48.73 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 108.983 179.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.46 ' O ' ' OE2' ' A' ' 64' ' ' GLU . 4.9 mmmt -53.6 -32.2 50.15 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.527 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 3.1 mmpt? -73.64 -34.03 64.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.505 -0.747 . . . . 0.0 109.193 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.582 ' CD1' ' CD1' ' A' ' 58' ' ' ILE . 1.5 mp -59.9 -44.68 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.807 . . . . 0.0 108.921 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.58 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -66.66 -62.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -0.869 . . . . 0.0 109.897 -179.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 60' ' ' LYS . 5.6 pt-20 -58.35 -15.81 12.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.992 -1.067 . . . . 0.0 109.517 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 7.8 mmtt -83.32 -36.18 24.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 108.795 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.457 ' HG3' HG22 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -68.99 -44.83 72.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.402 -0.811 . . . . 0.0 108.946 179.429 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.583 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -43.63 -50.74 7.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.328 179.68 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -72.84 -36.74 67.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.456 ' OG ' ' HA ' ' A' ' 66' ' ' MET . 25.2 p -88.26 39.33 0.9 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.452 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.455 ' OD1' ' O ' ' A' ' 67' ' ' LEU . 5.0 p-10 -91.67 -13.67 31.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.86 . . . . 0.0 109.468 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' C ' ' OG ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -145.0 44.3 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.493 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 0.3 OUTLIER 65.32 103.36 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.266 -0.896 . . . . 0.0 109.459 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 72' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.91 29.69 7.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.529 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' B' ' 4' ' ' ALA . 1.1 m -116.84 -0.58 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.544 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' B' ' 3' ' ' VAL . . . 76.13 83.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.134 -0.979 . . . . 0.0 109.54 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.1 t -106.58 30.67 5.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.92 129.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 109.353 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.473 ' O ' ' HB2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -116.06 98.3 6.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.127 -0.983 . . . . 0.0 109.608 179.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -95.37 154.33 17.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.356 -0.84 . . . . 0.0 108.959 179.607 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.526 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 8.8 m -44.17 107.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 109.325 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.521 ' HG3' ' CD ' ' B' ' 29' ' ' LYS . 13.8 mm100 -43.78 -24.92 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.336 -0.853 . . . . 0.0 109.998 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.451 ' HB2' ' HG3' ' B' ' 39' ' ' GLU . 66.3 m -139.8 77.97 1.64 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.072 -1.018 . . . . 0.0 109.986 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.526 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -50.53 -43.85 56.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 108.922 179.474 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.57 121.83 42.01 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.49 170.53 8.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 110.053 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' B' ' 51' ' ' CYS . 0.3 OUTLIER -127.61 148.74 50.37 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.754 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.496 ' O ' ' CG2' ' B' ' 59' ' ' VAL . 2.6 tt0 -44.36 -54.74 5.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.97 . . . . 0.0 109.451 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.517 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 149.1 168.59 14.88 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.572 ' N ' ' CD1' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -136.39 161.65 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -1.072 . . . . 0.0 109.359 179.746 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.59 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.5 OUTLIER -43.34 147.85 0.71 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.394 -0.816 . . . . 0.0 109.005 179.561 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 33.1 Cg_endo -75.61 -3.08 13.39 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.264 1.976 . . . . 0.0 109.941 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.457 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.49 -25.26 20.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.825 . . . . 0.0 108.807 179.383 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.53 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 5.3 m-20 -81.77 -4.96 57.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.444 -0.785 . . . . 0.0 109.398 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.478 ' HA ' ' HA ' ' B' ' 44' ' ' LEU . 13.7 mt -107.05 149.62 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 110.213 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.577 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -120.92 -28.03 4.88 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.267 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.577 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -136.05 169.1 18.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.33 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.452 HG22 ' O ' ' B' ' 25' ' ' SER . 48.7 t -156.56 126.27 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 109.752 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 55.6 t30 -108.47 157.99 17.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.329 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.13 95.42 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.521 ' CD ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -100.51 127.03 46.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.591 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.2 p -75.87 160.99 77.47 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.332 179.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.495 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.4 Cg_endo -77.11 145.55 24.67 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.575 2.183 . . . . 0.0 110.456 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.4 -133.63 1.54 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.0 41.53 1.14 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.595 2.197 . . . . 0.0 110.807 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' B' ' 7' ' ' LEU . 9.0 p-80 -162.09 -38.05 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.046 . . . . 0.0 109.269 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.495 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 2.7 t -145.7 101.31 3.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 0.0 109.131 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.28 -12.39 20.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.903 . . . . 0.0 109.737 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 1.9 mp0 -106.89 129.36 54.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -0.942 . . . . 0.0 109.503 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.458 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 0.6 OUTLIER -48.44 162.83 0.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 109.227 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.46 ' OE1' ' O ' ' B' ' 37' ' ' GLN . 2.6 mp0 -136.94 114.42 10.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.687 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 19.1 t -104.85 144.47 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.851 . . . . 0.0 109.184 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' B' ' 27' ' ' ASN . 2.6 mp -133.24 152.37 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.81 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.458 ' HB3' HG23 ' B' ' 23' ' ' ILE . . . -137.62 116.43 12.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -0.888 . . . . 0.0 109.179 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.532 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 1.8 m -89.11 97.52 11.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.922 -1.111 . . . . 0.0 108.737 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 93.1 mt -44.62 166.75 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.556 -0.715 . . . . 0.0 109.628 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.2 ptpt -81.6 8.5 9.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.632 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -111.3 19.87 17.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.96 . . . . 0.0 109.228 179.71 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 4.59 89.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.512 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 5.8 mtt180 -94.59 168.35 10.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.162 -1.199 . . . . 0.0 109.55 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.89 156.74 48.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.82 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.39 120.08 7.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.335 -0.853 . . . . 0.0 109.052 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.526 ' O ' ' CD1' ' B' ' 15' ' ' LEU . 8.0 m -79.74 139.11 37.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 108.972 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.532 HD23 ' CD1' ' B' ' 18' ' ' ILE . 10.5 mt -123.47 168.36 12.67 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.149 -0.97 . . . . 0.0 109.67 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 29.1 t-20 -101.68 119.89 55.89 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 109.332 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.465 ' HA ' HG13 ' B' ' 59' ' ' VAL . 33.2 Cg_endo -74.84 1.3 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.183 1.922 . . . . 0.0 110.518 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.48 -17.31 30.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.912 . . . . 0.0 108.977 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.464 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.4 OUTLIER -90.2 164.01 29.3 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.82 . . . . 0.0 109.383 179.915 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.32 -33.22 1.99 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.624 2.216 . . . . 0.0 110.694 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.592 ' CD1' ' CD1' ' B' ' 62' ' ' ILE . 0.2 OUTLIER -67.21 -48.33 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.105 -0.997 . . . . 0.0 108.995 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.573 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 33.8 t -57.42 -48.72 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.414 -0.804 . . . . 0.0 108.981 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' B' ' 56' ' ' SER . 4.9 mmmt -53.63 -32.19 50.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.529 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 3.1 mmpt? -73.57 -34.19 65.01 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.592 ' CD1' ' CD1' ' B' ' 58' ' ' ILE . 1.5 mp -59.74 -44.79 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 108.955 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.583 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -66.72 -62.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 109.876 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.469 ' OE2' ' HA ' ' B' ' 61' ' ' LYS . 5.6 pt-20 -58.28 -15.85 11.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.99 . . . . 0.0 109.576 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 7.7 mmtt -83.29 -36.21 24.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 108.791 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.462 ' HA ' ' OG ' ' B' ' 69' ' ' SER . 0.2 OUTLIER -69.0 -44.79 72.1 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.484 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.58 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -43.68 -50.67 7.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.381 -0.824 . . . . 0.0 109.373 179.701 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -72.81 -36.73 67.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.884 . . . . 0.0 109.482 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' B' ' 66' ' ' MET . 25.6 p -88.31 39.28 0.9 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.381 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' B' ' 67' ' ' LEU . 4.9 p-10 -91.59 -13.69 31.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.411 ' C ' ' OG ' ' B' ' 72' ' ' SER . 0.0 OUTLIER -145.04 44.39 1.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.399 -179.974 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' B' ' 73' ' ' ASN . 0.3 OUTLIER 65.23 103.42 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.467 -179.992 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' B' ' 72' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.482 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -178.26 57.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.516 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.524 ' O ' ' CB ' ' A' ' 4' ' ' ALA . 8.4 p -106.17 134.85 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -0.899 . . . . 0.0 109.456 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 3' ' ' VAL . . . 75.92 -153.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.552 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 4' ' ' ALA . 1.3 m -169.63 124.2 0.8 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.419 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.416 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 3.2 tt0 -119.92 -143.82 0.36 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.257 -0.902 . . . . 0.0 109.199 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.577 ' HB3' ' CG ' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -158.89 120.87 3.49 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.669 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -133.98 159.1 41.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.4 -0.813 . . . . 0.0 109.001 179.789 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.455 ' HB3' ' OE2' ' A' ' 39' ' ' GLU . 58.4 m -44.55 101.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.944 . . . . 0.0 109.289 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.515 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 22.1 mm100 -62.5 -10.01 10.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.891 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.448 ' SG ' ' HG2' ' A' ' 39' ' ' GLU . 39.7 m -138.83 67.93 1.39 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.005 -1.06 . . . . 0.0 109.851 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -45.13 -45.63 11.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.147 -0.97 . . . . 0.0 108.998 179.54 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.426 ' OE1' ' N ' ' A' ' 14' ' ' THR . 0.5 OUTLIER -118.14 116.9 27.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.463 -0.773 . . . . 0.0 108.95 179.541 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.426 ' N ' ' OE1' ' A' ' 13' ' ' GLN . 0.6 OUTLIER -90.24 171.08 9.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 110.048 -179.442 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.483 ' CD1' ' O ' ' A' ' 51' ' ' CYS . 1.0 OUTLIER -119.81 143.66 47.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.478 -0.763 . . . . 0.0 109.09 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.433 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.9 OUTLIER -44.65 -38.27 4.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.084 -1.01 . . . . 0.0 109.287 -179.909 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.528 ' HA2' ' CD2' ' A' ' 52' ' ' LEU . . . 138.26 156.51 7.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.533 ' CD1' HD23 ' A' ' 52' ' ' LEU . 0.2 OUTLIER -125.8 156.11 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -1.082 . . . . 0.0 109.332 179.592 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.592 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.94 153.99 0.31 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.852 . . . . 0.0 109.298 179.82 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.592 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.1 Cg_endo -76.27 -5.03 15.81 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.417 2.078 . . . . 0.0 109.943 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -81.73 -22.28 37.42 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.047 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.548 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 35.4 m-20 -98.58 60.03 1.3 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.461 ' CD1' ' O ' ' A' ' 22' ' ' ASN . 2.6 mm -143.78 167.5 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.937 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.565 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -160.18 -35.15 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.565 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.5 p -133.51 176.72 8.29 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.173 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.5 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 54.6 t -151.29 92.11 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.976 -1.078 . . . . 0.0 109.868 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.467 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 5.1 t-20 -94.03 110.63 22.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.219 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.438 HG11 HG21 ' A' ' 40' ' ' VAL . 1.9 t -121.77 100.15 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.584 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.515 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 9.6 ptpt -98.09 106.67 19.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.352 -0.843 . . . . 0.0 109.363 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 29' ' ' LYS . 1.1 p -45.87 170.54 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.398 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 35.6 Cg_endo -77.89 132.28 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.568 2.179 . . . . 0.0 110.407 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.33 -142.7 4.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.21 8.12 3.38 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.584 2.189 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.577 ' CG ' ' HB3' ' A' ' 7' ' ' LEU . 6.6 p-80 -124.44 -18.75 5.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 109.73 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -160.22 96.62 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 109.255 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -55.17 -29.16 57.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.55 125.33 35.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.505 HG21 ' N ' ' A' ' 39' ' ' GLU . 32.5 m -46.43 152.75 0.41 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.505 ' N ' HG21 ' A' ' 38' ' ' THR . 0.0 OUTLIER -129.31 121.67 27.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.65 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.522 ' CG1' HD12 ' A' ' 63' ' ' ILE . 16.2 t -108.14 150.34 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.22 179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.467 ' HB ' ' HB3' ' A' ' 27' ' ' ASN . 14.4 mt -143.15 143.12 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.015 . . . . 0.0 109.846 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.428 ' N ' HG21 ' A' ' 41' ' ' ILE . . . -130.99 123.02 27.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 108.932 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.523 ' HB ' ' CB ' ' A' ' 25' ' ' SER . 40.5 m -89.39 103.26 15.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.967 -1.083 . . . . 0.0 109.097 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 73.1 mt -42.48 165.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.502 -0.749 . . . . 0.0 109.59 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.4 ptpt -87.27 16.44 5.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 44' ' ' LEU . 19.0 p-10 -117.27 6.02 12.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 109.399 179.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.53 14.46 44.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.424 ' C ' ' HG2' ' A' ' 49' ' ' LYS . 9.8 mtp180 -111.32 174.23 5.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -1.203 . . . . 0.0 109.553 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 6.8 mttt -138.26 156.69 47.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.25 120.48 7.29 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.331 -0.855 . . . . 0.0 109.058 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.483 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 20.6 m -79.31 140.59 37.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.12 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.533 HD23 ' CD1' ' A' ' 18' ' ' ILE . 10.2 mt -124.51 168.97 12.35 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.234 -0.916 . . . . 0.0 109.597 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.541 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 7.1 t30 -105.61 127.39 28.61 Favored Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.381 -0.824 . . . . 0.0 109.255 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.466 ' HA ' HG13 ' A' ' 59' ' ' VAL . 34.1 Cg_endo -75.71 2.21 7.22 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.236 1.957 . . . . 0.0 110.648 -179.503 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.464 ' HB1' ' ND2' ' A' ' 53' ' ' ASN . . . -86.0 -19.03 30.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.033 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.471 ' OG ' HG23 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -90.22 162.7 34.04 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 109.526 179.95 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.76 -32.98 2.44 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.722 2.281 . . . . 0.0 111.002 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.508 HG21 ' N ' ' A' ' 59' ' ' VAL . 15.8 tt -70.54 -40.26 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.057 -1.027 . . . . 0.0 109.539 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.541 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 24.6 t -61.96 -48.19 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.343 -0.848 . . . . 0.0 108.951 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -60.9 -29.63 69.69 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -81.92 -19.7 40.24 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.867 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 16.4 mt -72.71 -38.86 59.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.546 ' N ' ' CD1' ' A' ' 63' ' ' ILE . 1.5 mp -75.27 -61.84 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.313 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.33 -47.82 25.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.342 -0.849 . . . . 0.0 109.294 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.4 ' O ' ' C ' ' A' ' 66' ' ' MET . 21.8 tptt -52.0 -57.3 9.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.185 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.5 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -44.36 -48.45 9.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.2 179.747 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.516 ' CD1' HG21 ' B' ' 63' ' ' ILE . 0.4 OUTLIER -48.81 -54.66 14.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.49 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' SER . 18.5 t30 -56.14 -32.82 64.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.484 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 1.1 p -43.9 -59.39 2.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.471 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.2 OUTLIER 77.66 -77.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.855 . . . . 0.0 109.565 179.99 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.461 ' HG2' ' HG3' ' B' ' 31' ' ' PRO . 4.9 mtmt -155.43 -46.66 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -0.955 . . . . 0.0 109.478 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -148.1 148.56 30.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.339 -0.85 . . . . 0.0 109.47 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.415 179.997 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -178.21 58.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.412 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.512 ' O ' ' CB ' ' B' ' 4' ' ' ALA . 8.4 p -106.21 134.87 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.455 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.512 ' CB ' ' O ' ' B' ' 3' ' ' VAL . . . 75.93 -153.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.489 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' B' ' 4' ' ' ALA . 1.3 m -169.65 124.21 0.8 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.417 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -119.84 -143.84 0.36 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.18 -0.95 . . . . 0.0 109.228 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.565 ' HB3' ' CG ' ' B' ' 34' ' ' HIS . 0.8 OUTLIER -158.85 120.94 3.52 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.233 -0.917 . . . . 0.0 109.658 -179.992 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' B' ' 10' ' ' GLN . 0.1 OUTLIER -133.98 159.19 41.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.379 -0.825 . . . . 0.0 108.99 179.707 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.465 ' HB3' ' OE2' ' B' ' 39' ' ' GLU . 58.8 m -44.63 101.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.34 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.506 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 22.1 mm100 -62.55 -9.94 10.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.889 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.448 ' SG ' ' HG2' ' B' ' 39' ' ' GLU . 39.6 m -138.87 68.03 1.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 109.836 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.3 OUTLIER -45.28 -45.63 12.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 108.883 179.609 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . 0.417 ' OE1' ' N ' ' B' ' 14' ' ' THR . 0.5 OUTLIER -118.03 116.87 27.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 108.928 179.643 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.417 ' N ' ' OE1' ' B' ' 13' ' ' GLN . 0.6 OUTLIER -90.24 171.1 9.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -0.924 . . . . 0.0 110.042 -179.456 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.478 ' CD1' ' O ' ' B' ' 51' ' ' CYS . 1.0 OUTLIER -119.86 143.66 47.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.45 -0.781 . . . . 0.0 109.013 179.764 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.9 OUTLIER -44.58 -38.29 4.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 -179.962 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.514 ' HA2' ' CD2' ' B' ' 52' ' ' LEU . . . 138.26 156.52 7.14 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.537 ' CD1' HD23 ' B' ' 52' ' ' LEU . 0.2 OUTLIER -125.84 156.04 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -1.084 . . . . 0.0 109.316 179.579 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.584 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -42.8 154.03 0.31 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 109.31 179.797 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 33.6 Cg_endo -76.38 -5.0 15.74 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.377 2.051 . . . . 0.0 109.862 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -81.74 -22.2 37.44 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.532 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 35.6 m-20 -98.54 59.94 1.31 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.217 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.47 ' CD1' ' O ' ' B' ' 22' ' ' ASN . 2.6 mm -143.78 167.54 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.963 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.549 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -160.24 -35.1 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.273 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.549 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.4 p -133.46 176.77 8.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.009 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.507 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 54.0 t -151.31 92.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.897 -1.127 . . . . 0.0 109.86 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.455 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 5.1 t-20 -94.1 110.62 22.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.249 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.45 HG11 HG21 ' B' ' 40' ' ' VAL . 1.9 t -121.76 100.16 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.605 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.506 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 9.6 ptpt -98.05 106.66 18.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 109.401 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.463 ' O ' ' O ' ' B' ' 29' ' ' LYS . 1.1 p -45.9 170.57 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.399 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.525 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 35.9 Cg_endo -77.79 132.21 11.76 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.594 2.196 . . . . 0.0 110.499 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.32 -142.7 4.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.2 8.1 3.39 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.524 2.15 . . . . 0.0 110.873 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.565 ' CG ' ' HB3' ' B' ' 7' ' ' LEU . 6.6 p-80 -124.44 -18.66 5.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.006 -1.059 . . . . 0.0 109.757 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.464 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -160.22 96.59 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -0.948 . . . . 0.0 109.303 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -55.19 -29.12 57.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.941 . . . . 0.0 109.651 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.61 125.41 35.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.486 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.505 HG21 ' N ' ' B' ' 39' ' ' GLU . 32.4 m -46.41 152.74 0.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.424 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.505 ' N ' HG21 ' B' ' 38' ' ' THR . 0.0 OUTLIER -129.32 121.59 27.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.193 -0.942 . . . . 0.0 109.733 -179.929 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.518 ' CG1' HD12 ' B' ' 63' ' ' ILE . 16.2 t -108.17 150.36 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.24 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.456 HG13 ' O ' ' B' ' 40' ' ' VAL . 14.5 mt -143.19 143.12 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.438 ' N ' HG21 ' B' ' 41' ' ' ILE . . . -131.03 123.03 27.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 108.862 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.527 ' HB ' ' CB ' ' B' ' 25' ' ' SER . 41.8 m -89.31 103.24 15.88 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.943 -1.098 . . . . 0.0 109.182 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.532 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 72.5 mt -42.46 165.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.538 -0.726 . . . . 0.0 109.582 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.4 ptpt -87.26 16.38 5.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 109.555 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.523 ' OD1' ' CB ' ' B' ' 44' ' ' LEU . 19.0 p-10 -117.33 6.17 12.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.619 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.47 14.61 43.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.41 ' C ' ' HG2' ' B' ' 49' ' ' LYS . 9.7 mtp180 -111.43 174.26 5.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -1.207 . . . . 0.0 109.495 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.41 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 6.7 mttt -138.24 156.81 47.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.33 120.52 7.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.821 . . . . 0.0 109.02 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.478 ' O ' ' CD1' ' B' ' 15' ' ' LEU . 20.5 m -79.37 140.62 37.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.074 -1.016 . . . . 0.0 109.122 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.537 HD23 ' CD1' ' B' ' 18' ' ' ILE . 10.2 mt -124.51 168.96 12.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.549 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 7.1 t30 -105.57 127.39 28.62 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.795 . . . . 0.0 109.185 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.468 ' HA ' HG13 ' B' ' 59' ' ' VAL . 33.9 Cg_endo -75.74 2.27 7.17 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.208 1.939 . . . . 0.0 110.657 -179.563 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . 0.479 ' HB1' ' ND2' ' B' ' 53' ' ' ASN . . . -85.98 -19.1 30.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 0.0 109.074 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.473 ' OG ' HG23 ' B' ' 58' ' ' ILE . 0.4 OUTLIER -90.29 162.76 33.7 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.503 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.73 -33.0 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.755 2.303 . . . . 0.0 111.006 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.516 HG21 ' N ' ' B' ' 59' ' ' VAL . 15.9 tt -70.59 -40.16 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.109 -0.994 . . . . 0.0 109.51 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.549 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 24.5 t -62.07 -48.17 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.378 -0.827 . . . . 0.0 108.913 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -60.92 -29.7 69.76 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.525 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -81.81 -19.65 40.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 179.804 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.514 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 16.4 mt -72.76 -38.88 58.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' B' ' 63' ' ' ILE . 1.5 mp -75.16 -61.91 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -47.86 25.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.38 -0.825 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' B' ' 66' ' ' MET . 21.9 tptt -51.85 -57.38 9.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.163 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.507 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -44.39 -48.48 9.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.173 179.783 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.527 ' CD1' HG21 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -48.77 -54.63 14.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 179.899 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' B' ' 69' ' ' SER . 18.5 t30 -56.27 -32.7 64.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 0.0 109.498 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' B' ' 70' ' ' ASP . 1.1 p -44.07 -59.23 2.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 109.468 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' B' ' 69' ' ' SER . 0.2 OUTLIER 77.58 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -0.841 . . . . 0.0 109.586 179.906 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . 0.453 ' HG2' ' HG3' ' A' ' 31' ' ' PRO . 4.9 mtmt -155.43 -46.6 0.08 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.201 -0.937 . . . . 0.0 109.494 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -148.2 148.57 30.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.435 179.967 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 m -120.0 -29.39 4.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.917 . . . . 0.0 109.486 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.17 169.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.88 . . . . 0.0 109.468 179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.526 ' O ' ' CG2' ' A' ' 5' ' ' THR . . . 178.12 140.26 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.427 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 4' ' ' ALA . 13.6 t 41.96 32.45 0.29 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.454 -0.779 . . . . 0.0 109.673 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -132.54 74.3 1.57 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.416 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.526 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -116.62 98.18 6.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.933 . . . . 0.0 109.607 -179.972 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.6 OUTLIER -83.98 154.67 23.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -0.947 . . . . 0.0 108.991 179.586 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.512 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 7.2 m -44.38 126.17 5.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.078 -1.014 . . . . 0.0 109.414 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.503 ' NE2' ' HG2' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -41.08 -38.38 1.02 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.515 -0.741 . . . . 0.0 109.736 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.446 ' SG ' HG13 ' A' ' 41' ' ' ILE . 72.3 m -136.56 78.21 1.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.695 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.512 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.87 -46.77 11.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.083 179.646 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -117.6 124.94 49.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.357 -0.839 . . . . 0.0 108.995 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 169.47 8.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 109.992 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 51' ' ' CYS . 4.8 mt -113.86 -167.42 1.2 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.523 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.4 mt-30 -88.92 -48.06 7.72 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 0.0 109.348 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.477 ' HA2' HD23 ' A' ' 52' ' ' LEU . . . 154.2 161.57 10.54 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' A' ' 18' ' ' ILE . 0.1 OUTLIER -142.98 149.67 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.378 -1.072 . . . . 0.0 109.311 179.666 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.573 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.94 152.08 0.38 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 109.535 -179.865 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.573 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -77.18 -2.65 12.88 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.584 2.189 . . . . 0.0 110.177 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.513 ' NZ ' ' HA ' ' A' ' 72' ' ' SER . 3.9 mmtt -90.19 -24.55 20.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.113 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 6.1 m-20 -85.43 -5.88 59.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.323 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.517 ' CD1' HG21 ' A' ' 62' ' ' ILE . 9.4 mt -104.93 152.7 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.255 -0.903 . . . . 0.0 110.043 -179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.578 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -124.98 -28.44 3.46 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.441 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.578 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.9 OUTLIER -137.33 174.08 10.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.072 179.473 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.523 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 21.4 t -149.74 119.64 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.985 . . . . 0.0 109.788 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.46 ' O ' HD13 ' A' ' 41' ' ' ILE . 4.8 t-20 -112.85 112.7 24.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 109.338 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.33 109.89 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.489 -179.955 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.567 ' CE ' ' NE2' ' A' ' 34' ' ' HIS . 7.4 tttt -107.68 107.79 18.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.445 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.433 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.1 p -50.66 168.42 0.23 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.41 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 35.8 Cg_endo -77.88 134.68 13.52 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.582 2.188 . . . . 0.0 110.422 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.8 -142.04 4.45 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.09 7.79 3.5 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.553 2.169 . . . . 0.0 110.88 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.567 ' NE2' ' CE ' ' A' ' 29' ' ' LYS . 8.0 p-80 -126.34 -7.55 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.079 -1.013 . . . . 0.0 109.628 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.446 ' SG ' ' OE2' ' A' ' 39' ' ' GLU . 4.2 t -160.3 146.47 15.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.288 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.3 0.84 23.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 37' ' ' GLN . 3.8 mp0 -126.88 124.91 40.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.004 . . . . 0.0 109.474 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.6 m -45.8 144.58 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 0.0 109.349 179.847 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HB2' ' HB2' ' A' ' 10' ' ' GLN . 4.6 mm-40 -122.47 107.24 11.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.664 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.45 ' O ' HG13 ' A' ' 41' ' ' ILE . 38.5 t -91.89 150.39 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.135 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 27' ' ' ASN . 3.1 mt -139.87 154.67 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.11 -0.994 . . . . 0.0 109.802 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.481 ' HB3' ' CG2' ' A' ' 23' ' ' ILE . . . -138.57 118.07 12.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.155 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.534 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.9 m -89.16 97.83 11.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.907 -1.121 . . . . 0.0 108.912 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 90.8 mt -44.0 166.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.488 -0.758 . . . . 0.0 109.66 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -81.58 8.06 10.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.699 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.517 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.01 24.68 12.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.225 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.16 3.93 71.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.517 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 6.9 mtt180 -93.2 166.56 12.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.146 -1.208 . . . . 0.0 109.454 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.4 155.6 49.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 0.0 109.433 -179.957 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.35 118.33 6.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.194 179.995 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.463 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 7.0 m -79.51 138.33 37.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.125 -0.984 . . . . 0.0 108.868 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.569 ' CD2' ' CD1' ' A' ' 18' ' ' ILE . 9.8 mt -124.0 168.61 12.6 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.55 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 65.5 t30 -101.49 121.38 51.67 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.47 -0.769 . . . . 0.0 109.446 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.494 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.7 Cg_endo -74.67 -2.25 12.2 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.163 1.909 . . . . 0.0 110.488 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.8 -17.38 41.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.304 -0.873 . . . . 0.0 108.849 179.342 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.469 ' OG ' HG21 ' A' ' 58' ' ' ILE . 0.8 OUTLIER -90.27 163.08 32.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.443 179.919 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 35.9 Cg_endo -77.74 -35.32 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.638 2.226 . . . . 0.0 111.113 -179.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.542 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 16.1 tt -67.9 -47.41 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.979 -1.076 . . . . 0.0 109.236 -179.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.55 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 32.7 t -55.04 -48.61 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.195 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.494 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 12.0 mttt -57.36 -31.32 65.63 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.525 ' CE ' ' OE2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -75.67 -27.59 58.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.655 -0.653 . . . . 0.0 109.342 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -67.33 -43.25 88.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.404 -0.81 . . . . 0.0 108.832 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.555 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.1 mp -69.53 -65.28 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.833 . . . . 0.0 109.721 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' OE2' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -49.01 -35.32 15.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.131 -0.98 . . . . 0.0 109.643 -179.703 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.465 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 21.3 mmtm -63.38 -54.0 43.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.09 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.523 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -49.06 -46.53 44.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.314 -0.866 . . . . 0.0 109.146 179.599 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.55 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 1.0 OUTLIER -56.87 -47.56 80.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.509 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.53 31.36 2.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.437 ' O ' ' CG ' ' A' ' 70' ' ' ASP . 56.8 p -90.93 -40.53 11.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.138 -0.976 . . . . 0.0 109.372 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 70' ' ' ASP . 6.4 p-10 40.68 83.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.533 -0.73 . . . . 0.0 109.771 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 70' ' ' ASP . 12.5 mtmt 44.07 -148.99 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.54 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.513 ' HA ' ' NZ ' ' A' ' 21' ' ' LYS . 4.3 m -90.37 -42.63 10.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.538 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.473 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.4 m -119.97 -29.42 4.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.89 . . . . 0.0 109.458 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 2.0 t -68.04 169.75 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.501 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . 0.525 ' O ' ' CG2' ' B' ' 5' ' ' THR . . . 178.06 140.29 0.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.457 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' B' ' 4' ' ' ALA . 13.5 t 42.01 32.37 0.29 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.429 -0.794 . . . . 0.0 109.642 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -132.47 74.25 1.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 109.475 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.523 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -116.55 98.14 6.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.594 -179.905 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.6 OUTLIER -83.96 154.74 23.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.295 -0.878 . . . . 0.0 109.019 179.579 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.523 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 7.0 m -44.44 126.18 5.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.955 . . . . 0.0 109.374 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.504 ' NE2' ' HG2' ' B' ' 29' ' ' LYS . 0.9 OUTLIER -41.02 -38.39 0.99 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.829 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.443 ' SG ' HG13 ' B' ' 41' ' ' ILE . 72.5 m -136.58 78.26 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.736 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.523 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.0 -46.74 11.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.059 179.71 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -117.57 125.06 50.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 108.968 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.99 169.42 8.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.215 -0.928 . . . . 0.0 109.992 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' B' ' 51' ' ' CYS . 4.9 mt -113.89 -167.41 1.2 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.526 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.4 mt-30 -88.86 -48.17 7.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.126 -0.984 . . . . 0.0 109.299 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.483 ' HA2' HD23 ' B' ' 52' ' ' LEU . . . 154.26 161.55 10.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -143.0 149.79 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.357 -1.084 . . . . 0.0 109.267 179.589 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.57 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -42.98 152.12 0.38 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.356 -0.84 . . . . 0.0 109.468 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.57 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -77.28 -2.67 12.88 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.498 2.132 . . . . 0.0 110.092 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.501 ' NZ ' ' HA ' ' B' ' 72' ' ' SER . 3.9 mmtt -90.06 -24.61 21.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -0.847 . . . . 0.0 109.178 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.529 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 6.1 m-20 -85.33 -5.96 59.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.296 -0.878 . . . . 0.0 109.364 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.5 ' CD1' HG21 ' B' ' 62' ' ' ILE . 9.2 mt -104.89 152.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 110.089 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.576 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -124.9 -28.46 3.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.479 -0.763 . . . . 0.0 109.084 179.355 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.576 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.9 OUTLIER -137.24 174.2 10.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.902 . . . . 0.0 109.076 179.436 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.522 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 21.4 t -149.86 119.66 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.045 -1.034 . . . . 0.0 109.707 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.454 ' O ' HD13 ' B' ' 41' ' ' ILE . 4.8 t-20 -112.89 112.71 24.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.344 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -116.31 109.9 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 109.403 -179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.573 ' CE ' ' NE2' ' B' ' 34' ' ' HIS . 7.4 tttt -107.62 107.8 18.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.869 . . . . 0.0 109.444 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.416 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.1 p -50.7 168.48 0.23 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 36.0 Cg_endo -77.89 134.65 13.49 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.666 2.244 . . . . 0.0 110.424 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.81 -142.01 4.44 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.1 7.75 3.52 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.651 2.234 . . . . 0.0 110.816 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.573 ' NE2' ' CE ' ' B' ' 29' ' ' LYS . 8.0 p-80 -126.35 -7.59 6.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 109.608 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.444 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 4.2 t -160.23 146.52 15.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.287 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.29 0.76 23.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.151 -0.968 . . . . 0.0 109.706 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.42 ' CD ' ' N ' ' B' ' 37' ' ' GLN . 3.9 mp0 -126.88 125.01 40.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.129 -0.982 . . . . 0.0 109.506 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 23.8 m -45.78 144.58 1.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 109.307 179.875 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' B' ' 10' ' ' GLN . 4.6 mm-40 -122.48 107.24 11.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 109.624 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.447 ' O ' HG13 ' B' ' 41' ' ' ILE . 38.6 t -91.84 150.35 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.199 179.772 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.454 HD13 ' O ' ' B' ' 27' ' ' ASN . 3.1 mt -139.89 154.79 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.785 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.479 ' HB3' ' CG2' ' B' ' 23' ' ' ILE . . . -138.61 118.02 12.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 109.117 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 1.8 m -89.18 97.74 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.036 -1.04 . . . . 0.0 108.966 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 90.8 mt -43.95 166.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.456 -0.778 . . . . 0.0 109.617 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.469 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -81.64 8.12 10.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 109.664 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.02 24.64 12.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 109.227 179.726 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.1 4.01 71.21 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.511 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 6.9 mtt180 -93.23 166.51 12.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.164 -1.197 . . . . 0.0 109.499 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.38 155.7 49.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.427 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.4 118.39 6.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 109.143 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 6.9 m -79.56 138.31 37.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.124 -0.985 . . . . 0.0 108.83 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.562 ' CD2' ' CD1' ' B' ' 18' ' ' ILE . 9.7 mt -123.95 168.58 12.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.129 -0.982 . . . . 0.0 109.581 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.548 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 65.5 t30 -101.56 121.5 51.12 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.44 -0.787 . . . . 0.0 109.458 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.489 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.2 Cg_endo -74.79 -2.18 12.14 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.182 1.921 . . . . 0.0 110.462 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.85 -17.45 40.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.911 . . . . 0.0 108.763 179.385 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.474 ' OG ' HG21 ' B' ' 58' ' ' ILE . 0.8 OUTLIER -90.25 163.15 32.53 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.442 -0.786 . . . . 0.0 109.433 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.459 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.74 -35.47 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.781 2.321 . . . . 0.0 111.082 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.557 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 16.2 tt -67.83 -47.56 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.001 -1.062 . . . . 0.0 109.189 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.557 ' N ' ' CG2' ' B' ' 58' ' ' ILE . 33.1 t -54.97 -48.71 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.135 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.489 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 12.0 mttt -57.21 -31.37 65.4 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.22 -0.925 . . . . 0.0 108.514 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.514 ' CE ' ' OE2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -75.67 -27.6 58.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.317 179.947 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -67.44 -43.26 87.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.55 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.1 mp -69.56 -65.31 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.679 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.514 ' OE2' ' CE ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -49.04 -35.3 15.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 109.538 -179.62 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.464 ' HB3' ' CB ' ' B' ' 20' ' ' PRO . 21.3 mmtm -63.35 -54.02 43.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.069 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.522 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 1.0 OUTLIER -49.2 -46.27 45.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 0.0 109.222 179.664 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.555 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -56.96 -47.56 80.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.436 -0.79 . . . . 0.0 109.453 179.871 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.49 31.32 2.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.947 . . . . 0.0 109.572 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.428 ' O ' ' C ' ' B' ' 70' ' ' ASP . 56.9 p -90.95 -40.64 11.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.364 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' B' ' 70' ' ' ASP . 6.4 p-10 40.82 83.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.549 -0.719 . . . . 0.0 109.781 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt 44.27 -149.01 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.501 ' HA ' ' NZ ' ' B' ' 21' ' ' LYS . 4.3 m -90.35 -42.68 10.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.524 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.423 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 1' ' ' ALA . 6.1 t 61.5 136.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.322 -0.861 . . . . 0.0 109.476 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.97 68.22 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.335 -0.853 . . . . 0.0 109.427 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.06 111.72 18.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 109.469 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.443 HG21 ' N ' ' A' ' 6' ' ' GLU . 9.5 t -101.79 -32.07 10.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.438 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' N ' HG21 ' A' ' 5' ' ' THR . 0.6 OUTLIER -153.63 27.57 0.49 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 -179.97 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.541 HD21 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -132.28 106.01 7.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.278 -0.888 . . . . 0.0 109.601 -179.933 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 9' ' ' CYS . 1.7 mtm180 -107.51 155.96 19.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.333 -0.854 . . . . 0.0 108.986 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.527 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 9.6 m -44.48 107.99 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.392 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.46 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 47.0 mm-40 -49.87 -21.21 1.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.453 ' SG ' HG13 ' A' ' 41' ' ' ILE . 83.1 m -141.47 71.43 1.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.598 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.29 -44.58 8.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.219 179.727 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.54 121.12 37.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.418 -0.801 . . . . 0.0 109.228 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.02 160.53 14.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.854 . . . . 0.0 109.807 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.461 HD13 ' O ' ' A' ' 51' ' ' CYS . 4.5 mt -103.69 142.78 33.75 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 15' ' ' LEU . 1.4 tt0 -44.75 -26.59 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.124 -0.985 . . . . 0.0 109.125 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.523 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 154.86 -178.91 31.31 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.439 HG21 HD12 ' A' ' 62' ' ' ILE . 4.6 tp -155.72 170.62 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.501 -1.0 . . . . 0.0 108.925 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.574 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.6 t-80 -60.0 143.71 87.59 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.068 -1.02 . . . . 0.0 108.973 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -77.26 -24.64 9.22 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.443 2.095 . . . . 0.0 110.267 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.473 ' O ' ' HE2' ' A' ' 45' ' ' LYS . 13.2 mttm -90.52 -13.74 34.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.81 . . . . 0.0 109.175 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.571 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 92.4 m-20 -80.18 -15.34 57.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.528 HD11 ' CG2' ' A' ' 62' ' ' ILE . 6.9 mt -90.0 162.46 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.415 -0.803 . . . . 0.0 110.696 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -128.61 -39.65 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.198 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.459 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 1.5 p -126.86 172.09 10.7 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.304 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.448 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 78.4 t -143.97 93.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.993 -1.067 . . . . 0.0 109.716 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.458 ' O ' HD13 ' A' ' 41' ' ' ILE . 3.4 t-20 -86.85 108.72 18.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.319 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -104.66 94.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.937 . . . . 0.0 109.545 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HE2' ' HG3' ' A' ' 10' ' ' GLN . 3.6 tppt? -90.6 92.58 8.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.443 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.51 ' HB3' ' CE ' ' B' ' 66' ' ' MET . 1.0 OUTLIER -45.99 170.96 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.488 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.6 Cg_endo -77.76 140.08 18.27 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.644 2.229 . . . . 0.0 110.458 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.91 -142.44 3.66 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.82 39.22 0.81 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.689 2.259 . . . . 0.0 110.782 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.541 ' CD2' HD21 ' A' ' 7' ' ' LEU . 6.0 p-80 -158.67 -38.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.012 -1.055 . . . . 0.0 109.301 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -138.01 102.18 4.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.277 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' A' ' 31' ' ' PRO . . . -62.99 -29.16 70.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.699 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.71 125.73 34.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.512 HG21 ' N ' ' A' ' 39' ' ' GLU . 73.5 m -48.54 148.81 1.87 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.269 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.512 ' N ' HG21 ' A' ' 38' ' ' THR . 21.5 mm-40 -125.07 123.46 39.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.628 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 16.8 t -107.55 145.53 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.266 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.458 HD13 ' O ' ' A' ' 27' ' ' ASN . 3.6 mp -134.88 144.29 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.518 ' CB ' HG21 ' A' ' 23' ' ' ILE . . . -131.27 117.71 19.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.301 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 3.4 m -89.29 95.83 10.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.949 -1.094 . . . . 0.0 108.896 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 85.1 mt -42.16 163.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.548 -0.72 . . . . 0.0 109.962 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HB3' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -81.01 10.77 4.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.838 . . . . 0.0 109.872 179.905 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.477 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -110.71 14.0 22.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.13 -0.982 . . . . 0.0 109.225 179.61 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.07 15.82 68.8 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.477 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 8.9 mtp-105 -108.04 175.63 5.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -1.142 . . . . 0.0 109.414 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.439 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -143.29 152.47 41.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.21 122.23 8.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.856 . . . . 0.0 108.898 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.461 ' O ' HD13 ' A' ' 15' ' ' LEU . 23.0 m -79.76 143.16 34.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 0.0 109.277 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.544 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 18.7 mt -128.19 168.03 16.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 109.081 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' A' ' 59' ' ' VAL . 2.5 t-20 -104.87 127.72 28.23 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 109.47 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.527 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.8 Cg_endo -75.46 -11.56 20.66 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.33 2.02 . . . . 0.0 110.49 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.12 -17.41 61.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.102 -0.999 . . . . 0.0 108.969 179.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.466 ' OG ' HG21 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -90.27 162.15 35.44 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 179.941 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.411 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.08 -35.08 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.702 2.268 . . . . 0.0 111.098 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.523 ' CG2' ' HA3' ' A' ' 17' ' ' GLY . 2.9 tt -68.24 -45.15 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.065 -1.022 . . . . 0.0 109.397 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.553 ' CB ' ' O ' ' A' ' 53' ' ' ASN . 40.3 t -59.04 -45.87 92.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 18.2 mttt -60.08 -29.39 68.54 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 2.5 mmpt? -79.55 -23.54 42.75 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 20.5 mt -70.85 -37.91 70.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.642 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.584 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -74.69 -56.74 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.475 -0.765 . . . . 0.0 109.296 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.519 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -59.36 -28.12 66.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.962 . . . . 0.0 109.226 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -70.61 -52.06 23.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 108.914 179.611 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.519 ' CE ' ' HB3' ' B' ' 30' ' ' SER . 0.4 OUTLIER -49.58 -44.37 46.88 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.276 -0.89 . . . . 0.0 108.949 179.473 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.578 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -55.08 -59.17 5.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.547 -0.72 . . . . 0.0 109.566 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -79.89 5.33 14.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.725 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.467 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 85.6 p -55.43 -55.85 26.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.393 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 72' ' ' SER . 80.0 m-20 -72.94 -9.92 59.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.507 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 70' ' ' ASP . 4.2 mtpt 43.28 -94.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.657 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -166.08 -73.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.984 . . . . 0.0 109.464 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.472 179.987 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.46 ' O ' ' O ' ' B' ' 1' ' ' ALA . 6.1 t 61.46 136.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -148.92 68.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.473 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.06 111.61 18.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 0.0 109.489 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 5' ' ' THR . . . . . 0.438 HG21 ' N ' ' B' ' 6' ' ' GLU . 9.4 t -101.61 -32.09 10.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 109.536 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.438 ' N ' HG21 ' B' ' 5' ' ' THR . 0.6 OUTLIER -153.64 27.64 0.49 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 179.977 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.539 HD21 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -132.36 106.06 7.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.217 -0.927 . . . . 0.0 109.614 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -107.46 155.97 19.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.392 -0.817 . . . . 0.0 109.013 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.516 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 9.3 m -44.55 108.02 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.333 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.437 ' HG3' ' HE2' ' B' ' 29' ' ' LYS . 47.1 mm-40 -49.85 -21.13 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.713 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.453 ' SG ' HG13 ' B' ' 41' ' ' ILE . 82.6 m -141.59 71.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.062 -1.024 . . . . 0.0 109.652 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.516 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.25 -44.55 8.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.232 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.55 121.11 37.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.252 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.96 160.44 14.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.807 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.463 HD13 ' O ' ' B' ' 51' ' ' CYS . 4.4 mt -103.65 142.76 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' B' ' 15' ' ' LEU . 1.4 tt0 -44.73 -26.56 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.157 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.519 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 154.8 -178.92 31.26 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.647 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.431 HG21 HD12 ' B' ' 62' ' ' ILE . 4.6 tp -155.7 170.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.467 -1.019 . . . . 0.0 108.963 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.581 ' CB ' ' ND2' ' B' ' 22' ' ' ASN . 1.6 t-80 -59.98 143.71 87.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 108.993 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.26 -24.69 9.17 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.51 2.14 . . . . 0.0 110.318 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.46 ' O ' ' HE2' ' B' ' 45' ' ' LYS . 13.2 mttm -90.42 -13.81 34.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 109.235 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.581 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 92.5 m-20 -80.12 -15.45 57.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.526 HG21 ' CB ' ' B' ' 42' ' ' ALA . 6.9 mt -90.08 162.43 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.43 -0.794 . . . . 0.0 110.668 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.2 OUTLIER -128.61 -39.65 1.63 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.273 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 1.5 p -126.79 172.07 10.68 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.321 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' B' ' 41' ' ' ILE . 77.8 t -144.05 93.6 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.004 -1.06 . . . . 0.0 109.703 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.454 ' HB3' HD11 ' B' ' 41' ' ' ILE . 3.4 t-20 -86.85 108.77 18.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.32 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.8 t -104.63 94.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.2 -0.938 . . . . 0.0 109.609 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' B' ' 30' ' ' SER . 3.6 tppt? -90.67 92.64 8.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.423 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.519 ' HB3' ' CE ' ' A' ' 66' ' ' MET . 1.0 OUTLIER -46.11 171.03 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.0 109.483 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.9 Cg_endo -77.86 140.11 18.08 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.574 2.183 . . . . 0.0 110.473 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.9 -142.49 3.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.74 39.16 0.8 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.666 2.244 . . . . 0.0 110.893 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.539 ' CD2' HD21 ' B' ' 7' ' ' LEU . 6.0 p-80 -158.7 -38.52 0.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.07 -1.019 . . . . 0.0 109.32 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -138.14 102.21 4.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.231 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.454 ' O ' ' HB3' ' B' ' 31' ' ' PRO . . . -62.92 -29.23 70.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.706 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.68 125.67 34.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.954 . . . . 0.0 109.561 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.505 HG21 ' N ' ' B' ' 39' ' ' GLU . 71.8 m -48.53 148.77 1.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.917 . . . . 0.0 109.34 179.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . 0.505 ' N ' HG21 ' B' ' 38' ' ' THR . 21.5 mm-40 -125.05 123.4 39.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.613 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 16.7 t -107.44 145.58 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.89 . . . . 0.0 109.337 179.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 3.6 mp -134.92 144.33 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.182 -0.949 . . . . 0.0 109.605 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.526 ' CB ' HG21 ' B' ' 23' ' ' ILE . . . -131.37 117.73 19.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.292 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 3.4 m -89.36 95.88 10.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.894 -1.129 . . . . 0.0 108.949 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 85.1 mt -42.07 163.63 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.529 -0.732 . . . . 0.0 109.926 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.504 ' HB3' ' NZ ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -81.02 10.83 4.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.377 -0.827 . . . . 0.0 109.838 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -110.77 13.96 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.142 179.678 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.08 15.79 68.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.474 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 8.9 mtp-105 -108.05 175.57 5.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -1.135 . . . . 0.0 109.484 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.438 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 0.3 OUTLIER -143.23 152.46 41.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.891 . . . . 0.0 109.438 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.18 122.2 8.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.244 -0.91 . . . . 0.0 108.983 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.463 ' O ' HD13 ' B' ' 15' ' ' LEU . 23.0 m -79.77 143.19 34.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.166 -0.959 . . . . 0.0 109.308 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.536 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 18.7 mt -128.24 167.97 16.13 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 109.013 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.553 ' O ' ' CB ' ' B' ' 59' ' ' VAL . 2.6 t-20 -104.96 127.81 27.98 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.425 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.526 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.9 Cg_endo -75.5 -11.59 20.58 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.349 2.033 . . . . 0.0 110.45 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.07 -17.36 61.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 109.09 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.475 ' OG ' HG21 ' B' ' 58' ' ' ILE . 0.6 OUTLIER -90.29 162.16 35.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 109.504 179.916 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.401 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -78.1 -35.12 1.41 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.762 2.308 . . . . 0.0 111.086 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.525 ' CG2' ' N ' ' B' ' 59' ' ' VAL . 2.9 tt -68.19 -45.19 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.065 -1.022 . . . . 0.0 109.424 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.553 ' CB ' ' O ' ' B' ' 53' ' ' ASN . 40.5 t -58.9 -45.96 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.056 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 18.2 mttt -60.06 -29.47 68.57 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' B' ' 65' ' ' LYS . 2.5 mmpt? -79.53 -23.44 42.87 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 20.5 mt -70.94 -37.81 69.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.578 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -74.68 -56.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.322 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.518 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.3 OUTLIER -59.35 -28.06 66.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.329 179.838 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.518 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 0.0 OUTLIER -70.64 -52.09 23.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 108.909 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.51 ' CE ' ' HB3' ' A' ' 30' ' ' SER . 0.5 OUTLIER -49.59 -44.37 46.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.009 179.422 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.584 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -55.02 -59.19 5.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.65 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -79.87 5.34 13.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.927 . . . . 0.0 109.76 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' B' ' 66' ' ' MET . 85.5 p -55.42 -55.83 27.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' B' ' 72' ' ' SER . 79.9 m-20 -72.86 -10.12 59.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt 43.35 -94.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.326 -0.859 . . . . 0.0 109.614 -179.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 72' ' ' SER . . . . . 0.526 ' N ' ' O ' ' B' ' 70' ' ' ASP . 1.0 OUTLIER -166.03 -73.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.476 179.977 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.495 -179.983 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.315 0.579 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.9 t -114.86 -48.29 2.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.2 m -112.64 168.66 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.552 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.22 134.25 14.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 m -157.74 115.66 3.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 109.459 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.456 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.7 tp10 -128.59 -144.12 0.28 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.264 -0.897 . . . . 0.0 109.187 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.569 HD21 ' CD2' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -159.96 121.07 3.11 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.884 . . . . 0.0 109.585 179.996 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 9' ' ' CYS . 4.4 mtm180 -134.52 159.68 40.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.368 -0.832 . . . . 0.0 108.984 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.456 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 18.7 m -44.57 105.23 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.12 -0.988 . . . . 0.0 109.297 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.466 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 19.1 mm-40 -64.68 -8.06 13.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.816 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.453 ' SG ' HG13 ' A' ' 41' ' ' ILE . 73.8 m -144.66 71.66 1.31 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.066 -1.021 . . . . 0.0 109.711 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.456 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 52.4 mt -46.29 -42.49 14.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.187 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -119.76 122.09 40.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.114 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -101.21 158.73 15.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.834 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.459 ' HB2' HD22 ' A' ' 52' ' ' LEU . 3.5 mt -102.85 139.92 37.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -43.96 -26.89 0.31 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.222 179.943 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . 0.46 ' HA2' HG21 ' A' ' 59' ' ' VAL . . . 157.98 -179.89 33.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.458 HG23 HD12 ' A' ' 52' ' ' LEU . 4.6 tp -154.98 170.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.548 -0.972 . . . . 0.0 108.801 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.58 ' CB ' ' ND2' ' A' ' 22' ' ' ASN . 3.4 t-80 -59.19 141.97 86.43 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.985 -1.072 . . . . 0.0 109.055 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.3 Cg_endo -77.59 -23.62 9.63 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.499 2.133 . . . . 0.0 110.273 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 9.5 mmtp -90.25 -15.09 32.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.434 -0.791 . . . . 0.0 109.129 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.58 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 84.8 m-20 -78.94 -27.76 43.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -0.788 . . . . 0.0 109.377 179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.525 HG23 ' N ' ' A' ' 24' ' ' GLN . 6.5 mt -77.44 163.7 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.828 0.823 . . . . 0.0 110.697 -179.014 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.525 ' N ' HG23 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -129.62 -41.26 1.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.109 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.456 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 10.9 p -124.97 166.69 15.88 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.075 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.455 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 50.8 t -145.2 98.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.051 -1.03 . . . . 0.0 109.772 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.465 ' HB3' HD11 ' A' ' 41' ' ' ILE . 49.8 t-20 -84.35 133.23 34.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.189 -0.944 . . . . 0.0 109.383 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' B' ' 26' ' ' VAL . 2.2 t -118.08 82.34 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.982 . . . . 0.0 109.516 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HD3' ' HG3' ' A' ' 10' ' ' GLN . 20.9 mtpt -87.32 103.62 15.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.524 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.462 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.1 p -57.63 163.8 3.49 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 109.334 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.44 132.21 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.598 2.199 . . . . 0.0 110.473 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.73 -141.13 3.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.06 7.61 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.663 2.242 . . . . 0.0 110.852 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.569 ' CD2' HD21 ' A' ' 7' ' ' LEU . 6.4 p-80 -124.88 -14.82 6.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.059 -1.026 . . . . 0.0 109.775 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.38 125.56 3.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -0.996 . . . . 0.0 109.363 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' O ' ' CD ' ' A' ' 37' ' ' GLN . . . -87.19 17.49 4.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.617 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . 0.42 ' CD ' ' O ' ' A' ' 36' ' ' ALA . 9.6 mm-40 -143.36 125.77 15.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.924 . . . . 0.0 109.524 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' B' ' 70' ' ' ASP . 3.2 m -44.32 157.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 109.313 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -132.64 107.1 8.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 109.576 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.517 ' CG1' HD12 ' A' ' 63' ' ' ILE . 1.7 t -101.98 93.64 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.907 . . . . 0.0 109.269 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.465 HD11 ' HB3' ' A' ' 27' ' ' ASN . 3.4 mp -82.18 150.41 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.724 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.521 ' CB ' HG12 ' A' ' 23' ' ' ILE . . . -132.65 114.91 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 108.994 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 4.3 m -89.22 98.16 11.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.879 -1.138 . . . . 0.0 108.992 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 93.1 mt -41.14 163.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.305 0.574 . . . . 0.0 109.931 -179.715 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -82.06 11.09 5.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 0.0 109.921 -179.785 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ASN . . . . . 0.472 ' OD1' ' HB2' ' A' ' 44' ' ' LEU . 23.4 p-10 -112.56 8.09 19.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.076 -1.015 . . . . 0.0 109.419 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.59 1.66 63.82 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.414 ' C ' ' HG2' ' A' ' 49' ' ' LYS . 19.4 mtt180 -96.57 165.63 12.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -1.194 . . . . 0.0 109.545 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 2.2 mttt -133.02 153.16 51.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.466 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.3 123.39 8.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 108.908 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 35.6 m -79.62 140.94 36.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.072 -1.017 . . . . 0.0 109.305 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.54 ' HB3' ' CG2' ' A' ' 59' ' ' VAL . 16.0 mt -125.37 168.24 13.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.379 -0.826 . . . . 0.0 109.224 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.533 ' O ' ' CG2' ' A' ' 59' ' ' VAL . 1.6 m-20 -106.28 124.84 34.53 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.434 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.458 ' HG3' ' HB ' ' A' ' 38' ' ' THR . 33.5 Cg_endo -75.26 -7.01 18.57 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.359 2.039 . . . . 0.0 110.327 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 -17.52 50.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.227 -0.921 . . . . 0.0 108.963 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.465 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 163.7 30.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.413 -0.804 . . . . 0.0 109.321 179.866 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.434 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.45 -36.55 1.23 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.589 2.193 . . . . 0.0 110.678 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.452 HG21 HD13 ' A' ' 62' ' ' ILE . 52.4 mt -61.47 -48.07 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.539 -179.879 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.54 ' CG2' ' HB3' ' A' ' 52' ' ' LEU . 76.6 t -62.25 -50.0 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.353 -0.842 . . . . 0.0 109.615 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' A' ' 56' ' ' SER . 6.0 mttt -51.24 -30.72 18.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.122 -0.986 . . . . 0.0 108.722 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.475 ' HA ' ' CG ' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -78.45 -34.54 47.67 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' HA ' ' A' ' 59' ' ' VAL . 14.2 mt -59.68 -38.34 75.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.551 -0.718 . . . . 0.0 109.28 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.589 ' CG2' ' CD1' ' B' ' 67' ' ' LEU . 2.2 mp -74.52 -62.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.475 ' CG ' ' HA ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -53.14 -20.09 3.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 109.394 -179.931 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -79.64 -40.24 29.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.913 . . . . 0.0 109.026 179.729 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.449 ' SD ' ' OG ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -65.19 -45.79 83.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 108.995 179.613 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.591 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -43.5 -50.28 7.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.527 -0.733 . . . . 0.0 109.487 179.822 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -76.81 -27.07 55.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.845 . . . . 0.0 109.614 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.449 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p -76.25 0.78 17.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 109.676 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' O ' ' OG1' ' B' ' 38' ' ' THR . 14.1 p-10 -44.35 -35.76 2.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.45 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -114.58 109.74 18.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.9 t -149.23 -56.22 0.19 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.452 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.489 -179.966 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.284 0.564 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 34.9 t -114.86 -48.22 2.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 25.7 m -112.75 168.63 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.47 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.2 134.38 14.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.49 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 17.6 m -157.85 115.71 3.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 6' ' ' GLU . . . . . 0.454 ' O ' ' HG ' ' B' ' 7' ' ' LEU . 1.7 tp10 -128.71 -144.07 0.28 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.241 -0.912 . . . . 0.0 109.153 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 7' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' B' ' 34' ' ' HIS . 1.0 OUTLIER -159.95 121.04 3.11 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.233 -0.917 . . . . 0.0 109.654 -179.967 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' B' ' 9' ' ' CYS . 4.4 mtm180 -134.46 159.6 40.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.392 -0.818 . . . . 0.0 109.043 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . 0.466 ' HB2' HD21 ' B' ' 12' ' ' LEU . 18.5 m -44.62 105.3 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.957 . . . . 0.0 109.217 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 10' ' ' GLN . . . . . 0.446 ' HG3' ' HD3' ' B' ' 29' ' ' LYS . 19.0 mm-40 -64.77 -8.0 13.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 0.0 109.78 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 11' ' ' CYS . . . . . 0.456 ' SG ' HG13 ' B' ' 41' ' ' ILE . 73.6 m -144.69 71.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.082 -1.011 . . . . 0.0 109.657 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' B' ' 9' ' ' CYS . 52.6 mt -46.29 -42.54 14.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.17 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -119.73 122.06 40.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 109.123 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 14' ' ' THR . . . . . 0.45 ' OG1' ' OD1' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -101.22 158.65 15.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.816 -179.692 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' B' ' 51' ' ' CYS . 3.5 mt -102.79 139.93 37.72 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 16' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.6 OUTLIER -43.96 -26.95 0.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.176 179.969 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 17' ' ' GLY . . . . . 0.442 ' HA2' HG21 ' B' ' 59' ' ' VAL . . . 158.03 -179.89 33.41 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.464 HG21 HD12 ' B' ' 62' ' ' ILE . 4.5 tp -155.03 170.9 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.571 -0.958 . . . . 0.0 108.745 -179.578 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.58 ' CB ' ' ND2' ' B' ' 22' ' ' ASN . 3.4 t-80 -59.14 142.03 86.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.028 -1.045 . . . . 0.0 109.109 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 20' ' ' PRO . . . . . 0.567 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.1 Cg_endo -77.73 -23.53 9.52 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.517 2.145 . . . . 0.0 110.238 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.526 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 9.5 mmtp -90.29 -15.0 32.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.404 -0.81 . . . . 0.0 109.139 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 22' ' ' ASN . . . . . 0.58 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 84.8 m-20 -78.99 -27.7 43.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.431 -0.793 . . . . 0.0 109.403 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.519 HG23 ' N ' ' B' ' 24' ' ' GLN . 6.5 mt -77.45 163.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.751 0.786 . . . . 0.0 110.743 -179.029 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 24' ' ' GLN . . . . . 0.522 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.2 OUTLIER -129.65 -41.25 1.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.07 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 25' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 11.0 p -124.92 166.72 15.79 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 26' ' ' VAL . . . . . 0.464 ' HB ' ' HB ' ' A' ' 28' ' ' VAL . 51.3 t -145.26 98.78 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.998 -1.064 . . . . 0.0 109.779 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 27' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 50.0 t-20 -84.4 133.21 34.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 28' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 25' ' ' SER . 2.2 t -118.02 82.25 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.142 -0.974 . . . . 0.0 109.591 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 29' ' ' LYS . . . . . 0.446 ' HD3' ' HG3' ' B' ' 10' ' ' GLN . 20.9 mtpt -87.36 103.64 15.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 30' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.1 p -57.56 163.85 3.37 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.342 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.44 132.21 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.581 2.187 . . . . 0.0 110.436 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.74 -141.01 3.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.18 7.69 3.58 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.592 2.194 . . . . 0.0 110.84 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 34' ' ' HIS . . . . . 0.566 ' CD2' HD21 ' B' ' 7' ' ' LEU . 6.4 p-80 -124.92 -14.74 6.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.007 -1.058 . . . . 0.0 109.761 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.36 125.62 3.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.97 . . . . 0.0 109.332 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 36' ' ' ALA . . . . . 0.42 ' O ' ' CD ' ' B' ' 37' ' ' GLN . . . -87.23 17.55 4.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.626 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 37' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' B' ' 38' ' ' THR . 9.7 mm-40 -143.42 125.74 15.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.504 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 38' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 70' ' ' ASP . 3.2 m -44.32 157.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 0.0 109.309 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -132.61 107.01 8.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.571 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.528 ' CG1' HD12 ' B' ' 63' ' ' ILE . 1.7 t -101.86 93.57 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.202 -0.936 . . . . 0.0 109.335 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 41' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 3.5 mp -82.19 150.42 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.726 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 42' ' ' ALA . . . . . 0.512 ' CB ' HG12 ' B' ' 23' ' ' ILE . . . -132.68 114.9 14.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.852 . . . . 0.0 109.004 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 43' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 4.4 m -89.23 98.2 11.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.856 -1.152 . . . . 0.0 108.996 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 44' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' B' ' 22' ' ' ASN . 93.1 mt -41.16 163.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.686 -0.634 . . . . 0.0 109.877 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -82.09 11.04 5.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.921 -179.818 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 46' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' B' ' 44' ' ' LEU . 23.4 p-10 -112.44 7.98 19.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.034 -1.042 . . . . 0.0 109.535 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.56 1.84 63.76 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 48' ' ' ARG . . . . . 0.404 ' C ' ' HG2' ' B' ' 49' ' ' LYS . 19.4 mtt180 -96.66 165.67 12.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -1.226 . . . . 0.0 109.535 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.404 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 2.2 mttt -132.99 153.2 51.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.481 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.27 123.4 8.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 108.91 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 51' ' ' CYS . . . . . 0.458 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 35.7 m -79.6 140.93 36.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.035 -1.041 . . . . 0.0 109.299 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 52' ' ' LEU . . . . . 0.535 ' HB3' ' CG2' ' B' ' 59' ' ' VAL . 15.9 mt -125.41 168.3 13.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.296 -0.877 . . . . 0.0 109.227 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.529 ' O ' ' CG2' ' B' ' 59' ' ' VAL . 1.6 m-20 -106.41 124.87 34.38 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.407 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 54' ' ' PRO . . . . . 0.459 ' HB3' HG23 ' B' ' 40' ' ' VAL . 34.1 Cg_endo -75.22 -6.92 18.49 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.308 2.005 . . . . 0.0 110.422 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.94 -17.58 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 108.915 179.398 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 56' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -90.02 163.76 30.78 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.356 -0.84 . . . . 0.0 109.323 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 57' ' ' PRO . . . . . 0.443 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.57 -36.46 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.633 2.222 . . . . 0.0 110.667 -179.897 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 58' ' ' ILE . . . . . 0.454 HG21 HD13 ' B' ' 62' ' ' ILE . 52.6 mt -61.42 -48.14 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.652 179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 59' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' B' ' 52' ' ' LEU . 76.6 t -62.19 -50.05 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.83 . . . . 0.0 109.617 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 60' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' B' ' 56' ' ' SER . 6.0 mttt -51.2 -30.75 18.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.084 -1.01 . . . . 0.0 108.735 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.487 ' HA ' ' CG ' ' B' ' 64' ' ' GLU . 0.0 OUTLIER -78.45 -34.51 47.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.856 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' B' ' 59' ' ' VAL . 14.2 mt -59.7 -38.43 75.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.543 -0.723 . . . . 0.0 109.229 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 63' ' ' ILE . . . . . 0.591 ' CG2' ' CD1' ' A' ' 67' ' ' LEU . 2.2 mp -74.5 -62.29 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.64 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 64' ' ' GLU . . . . . 0.487 ' CG ' ' HA ' ' B' ' 61' ' ' LYS . 0.2 OUTLIER -53.14 -20.1 3.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.413 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -79.64 -40.14 29.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.868 . . . . 0.0 109.031 179.749 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 66' ' ' MET . . . . . 0.446 ' SD ' ' OG ' ' B' ' 69' ' ' SER . 0.6 OUTLIER -65.16 -45.87 83.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.841 . . . . 0.0 108.994 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 67' ' ' LEU . . . . . 0.589 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -43.42 -50.34 6.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.476 -0.765 . . . . 0.0 109.46 179.858 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -76.8 -27.09 55.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.833 . . . . 0.0 109.558 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 69' ' ' SER . . . . . 0.446 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.2 p -76.22 0.76 17.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.316 -0.865 . . . . 0.0 109.707 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 38' ' ' THR . 14.2 p-10 -44.28 -35.86 2.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.416 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -114.57 109.75 18.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.437 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 40.9 t -149.24 -56.3 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.463 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.459 -179.996 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.64 ' HB2' HD22 ' A' ' 12' ' ' LEU . 97.2 m . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -42.66 -26.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 109.763 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.474 ' SG ' HG13 ' A' ' 41' ' ' ILE . 97.1 m -122.22 66.17 0.93 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.996 . . . . 0.0 109.799 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.85 -38.9 4.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.967 . . . . 0.0 108.735 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.527 ' O ' HG23 ' A' ' 14' ' ' THR . 1.0 OUTLIER -118.42 -173.3 2.44 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.355 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -160.15 158.06 29.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.04 -1.038 . . . . 0.0 109.935 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.523 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.5 mt -116.93 142.76 46.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.474 -0.766 . . . . 0.0 109.043 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -44.04 -33.3 1.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 109.362 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.859 ' O ' HG23 ' A' ' 18' ' ' ILE . . . 147.34 -166.47 28.59 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.933 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -171.53 163.45 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.44 -1.035 . . . . 0.0 109.076 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.567 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -57.39 149.74 47.39 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.204 -0.935 . . . . 0.0 109.234 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.654 ' HA ' HD12 ' A' ' 23' ' ' ILE . 34.8 Cg_endo -77.25 -4.34 14.66 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.516 2.144 . . . . 0.0 110.19 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.18 -24.02 21.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.362 -0.836 . . . . 0.0 109.197 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.0 m-20 -84.01 -15.87 46.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -0.855 . . . . 0.0 109.213 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.976 HG23 ' HB1' ' A' ' 42' ' ' ALA . 17.3 mt -89.32 169.04 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.434 -0.791 . . . . 0.0 110.245 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.579 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -137.49 -39.98 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.433 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 5.9 p -128.2 173.36 10.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.458 -0.776 . . . . 0.0 109.029 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.589 HG23 ' HG3' ' A' ' 66' ' ' MET . 47.7 t -142.22 95.5 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.58 ' O ' HD12 ' A' ' 41' ' ' ILE . 5.1 t-20 -93.06 111.58 23.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.925 . . . . 0.0 109.417 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.443 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -109.35 97.69 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.404 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' B' ' 25' ' ' SER . 1.9 ttmt -90.59 110.28 21.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.2 p -63.68 167.72 6.8 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.355 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.6 Cg_endo -77.61 145.62 23.41 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.603 2.202 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.95 -140.05 2.97 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.452 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 36.1 Cg_endo -77.87 10.71 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.596 2.197 . . . . 0.0 111.023 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.506 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 3.3 p-80 -127.76 -32.91 2.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.559 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -145.45 115.89 7.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 109.265 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.92 6.97 11.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.694 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 1.6 mp0 -120.71 124.62 45.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 m -46.76 156.85 0.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 109.317 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 7.1 mm-40 -141.37 107.56 5.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.933 . . . . 0.0 109.627 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.656 HG11 HD11 ' A' ' 63' ' ' ILE . 41.2 t -90.56 150.4 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.225 -0.922 . . . . 0.0 109.272 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.58 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.4 mt -140.29 147.79 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.71 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.976 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -135.39 120.05 18.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.404 -0.81 . . . . 0.0 109.162 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 8.6 m -89.3 100.95 13.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.94 -1.1 . . . . 0.0 109.01 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 84.5 mt -46.08 172.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.47 -0.769 . . . . 0.0 109.732 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -87.93 10.47 18.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.215 -0.928 . . . . 0.0 109.179 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -114.04 27.52 9.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.325 -0.86 . . . . 0.0 109.134 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.13 11.14 70.2 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.501 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 3.8 mtp180 -100.18 165.91 11.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -1.157 . . . . 0.0 109.443 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.83 154.06 50.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.214 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.523 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.18 123.7 9.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.213 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.7 m -79.49 144.96 33.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.956 . . . . 0.0 109.169 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.995 HD13 HD13 ' A' ' 62' ' ' ILE . 15.4 mt -121.99 167.54 12.97 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.447 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.653 ' O ' HG21 ' A' ' 59' ' ' VAL . 5.7 t30 -97.14 118.08 65.06 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.467 -0.771 . . . . 0.0 109.201 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 33.1 Cg_endo -74.24 -0.35 9.51 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.175 1.917 . . . . 0.0 110.376 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.28 -14.08 27.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.325 -0.859 . . . . 0.0 108.906 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.11 162.61 34.56 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.392 -0.818 . . . . 0.0 109.391 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.06 -36.17 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.694 2.263 . . . . 0.0 110.659 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.3 mt -66.41 -36.39 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 109.661 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.002 ' HA ' HD12 ' A' ' 62' ' ' ILE . 37.7 t -67.95 -51.36 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.258 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.1 OUTLIER -54.3 -30.23 50.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 108.992 179.503 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.529 ' HB3' ' NZ ' ' A' ' 65' ' ' LYS . 9.6 mmmm -81.98 -28.85 32.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 109.108 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.002 HD12 ' HA ' ' A' ' 59' ' ' VAL . 11.9 mt -59.61 -38.1 73.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.937 HG22 HD11 ' B' ' 67' ' ' LEU . 1.7 mp -76.15 -61.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -43.02 -28.73 0.29 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.817 . . . . 0.0 109.646 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.529 ' NZ ' ' HB3' ' A' ' 61' ' ' LYS . 2.0 mtmt -74.74 -60.24 2.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.589 ' HG3' HG23 ' A' ' 26' ' ' VAL . 1.4 mmm -44.17 -47.78 9.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 109.272 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.943 HD11 HG22 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -43.65 -51.26 7.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.452 -0.78 . . . . 0.0 109.353 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 69' ' ' SER . 11.9 t30 -66.41 -34.82 78.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.495 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 68' ' ' ASN . 1.2 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.562 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.658 ' HB2' HD22 ' B' ' 12' ' ' LEU . 96.6 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.422 ' C ' ' O ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -42.75 -26.4 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.796 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.457 ' SG ' HG13 ' B' ' 41' ' ' ILE . 97.4 m -122.18 66.25 0.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.786 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.658 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.83 -38.95 4.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.147 -0.971 . . . . 0.0 108.753 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLN . . . . . 0.529 ' O ' HG23 ' B' ' 14' ' ' THR . 1.1 mp0 -118.49 -173.25 2.43 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.534 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.4 OUTLIER -160.17 158.08 29.49 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.994 -1.066 . . . . 0.0 109.896 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.531 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.6 mt -116.96 142.77 46.52 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.4 OUTLIER -44.04 -33.36 1.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.363 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.858 ' O ' HG23 ' B' ' 18' ' ' ILE . . . 147.45 -166.49 28.63 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.941 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -171.51 163.44 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.454 -1.027 . . . . 0.0 109.07 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.564 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -57.43 149.73 47.95 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.186 -0.946 . . . . 0.0 109.237 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.645 ' HA ' HD12 ' B' ' 23' ' ' ILE . 35.0 Cg_endo -77.15 -4.36 14.73 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.477 2.118 . . . . 0.0 110.231 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.21 -23.89 21.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.413 -0.804 . . . . 0.0 109.177 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.0 m-20 -84.05 -15.84 46.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.227 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.98 HG23 ' HB1' ' B' ' 42' ' ' ALA . 17.0 mt -89.4 169.12 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 110.25 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.581 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.0 OUTLIER -137.58 -39.94 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.439 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 6.0 p -128.18 173.4 10.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.423 -0.798 . . . . 0.0 108.971 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.59 HG23 ' HG3' ' B' ' 66' ' ' MET . 47.5 t -142.31 95.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.961 . . . . 0.0 109.646 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.572 ' O ' HD12 ' B' ' 41' ' ' ILE . 5.1 t-20 -93.03 111.49 23.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.869 . . . . 0.0 109.428 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.438 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -109.24 97.73 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.421 ' HA ' ' HB2' ' A' ' 25' ' ' SER . 1.9 ttmt -90.65 110.38 21.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 109.504 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.2 p -63.61 167.7 6.72 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.346 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 36.0 Cg_endo -77.66 145.57 23.22 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.556 2.171 . . . . 0.0 110.432 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.89 -140.03 2.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.447 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.1 Cg_endo -77.87 10.74 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.602 2.201 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.515 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 3.2 p-80 -127.8 -32.83 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 109.532 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -145.48 115.89 7.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.03 7.07 11.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.695 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' B' ' 39' ' ' GLU . 1.6 mp0 -120.79 124.6 45.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.123 -0.986 . . . . 0.0 109.473 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 1.6 m -46.74 156.83 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.319 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' B' ' 39' ' ' GLU . 7.1 mm-40 -141.36 107.63 5.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.038 -1.039 . . . . 0.0 109.685 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.631 HG11 HD11 ' B' ' 63' ' ' ILE . 41.4 t -90.56 150.47 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.183 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.572 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.4 mt -140.3 147.85 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.154 -0.967 . . . . 0.0 109.709 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.98 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -135.48 120.03 18.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.115 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 8.6 m -89.26 100.83 13.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.934 -1.104 . . . . 0.0 109.038 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 84.5 mt -45.99 172.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.427 -0.795 . . . . 0.0 109.814 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -87.92 10.63 18.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.144 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -114.11 27.53 9.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.055 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.05 11.22 69.97 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.516 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 3.8 mtp180 -100.22 165.94 11.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -1.158 . . . . 0.0 109.471 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.82 154.08 50.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.176 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.531 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.21 123.65 9.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.26 -0.9 . . . . 0.0 109.297 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 7.7 m -79.49 144.87 33.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.103 -0.998 . . . . 0.0 109.17 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 1.059 HD13 HD13 ' B' ' 62' ' ' ILE . 15.3 mt -121.88 167.48 12.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.654 ' O ' HG21 ' B' ' 59' ' ' VAL . 5.6 t30 -97.04 118.04 65.19 Favored Pre-proline 0 C--N 1.299 -1.608 0 O-C-N 121.426 -0.797 . . . . 0.0 109.227 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.33 -0.28 9.47 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.224 1.949 . . . . 0.0 110.344 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.31 -14.1 27.35 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.311 -0.868 . . . . 0.0 108.916 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.09 162.73 34.26 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.368 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -78.22 -36.13 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.591 2.194 . . . . 0.0 110.626 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 65.5 mt -66.29 -36.46 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.139 -0.975 . . . . 0.0 109.709 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 1.034 ' HA ' HD12 ' B' ' 62' ' ' ILE . 37.8 t -67.89 -51.35 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.266 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' B' ' 56' ' ' SER . 0.1 OUTLIER -54.39 -30.21 51.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.322 -0.861 . . . . 0.0 108.941 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.533 ' HB3' ' NZ ' ' B' ' 65' ' ' LYS . 9.6 mmmm -81.97 -28.82 32.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.126 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 1.059 HD13 HD13 ' B' ' 52' ' ' LEU . 11.9 mt -59.61 -38.14 74.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.943 HG22 HD11 ' A' ' 67' ' ' LEU . 1.7 mp -76.16 -61.57 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -43.09 -28.73 0.3 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.4 -0.813 . . . . 0.0 109.617 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.533 ' NZ ' ' HB3' ' B' ' 61' ' ' LYS . 2.0 mtmt -74.71 -60.27 2.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.337 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.59 ' HG3' HG23 ' B' ' 26' ' ' VAL . 1.4 mmm -44.09 -47.87 8.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.873 . . . . 0.0 109.257 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.937 HD11 HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -43.63 -51.19 7.13 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.401 -0.812 . . . . 0.0 109.408 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' B' ' 69' ' ' SER . 11.9 t30 -66.48 -34.77 78.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.4 -0.813 . . . . 0.0 109.516 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.42 ' C ' ' O ' ' B' ' 68' ' ' ASN . 1.2 p . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 109.502 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.877 ' HB2' HD22 ' A' ' 12' ' ' LEU . 20.1 m . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -42.28 -26.91 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.815 . . . . 0.0 109.853 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 39' ' ' GLU . 72.4 m -124.17 63.3 1.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.769 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.877 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.71 -39.69 5.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.117 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -123.26 126.47 46.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 109.061 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -103.12 162.86 12.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.118 -0.989 . . . . 0.0 109.935 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.501 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 6.2 mt -115.44 140.96 48.67 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.477 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.7 tt0 -44.34 -26.52 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.306 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.838 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 138.32 -171.34 23.47 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.721 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.4 pp -161.48 162.74 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -1.117 . . . . 0.0 109.399 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.601 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -56.36 153.97 17.95 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 109.274 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.601 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -76.9 -7.39 17.39 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.438 2.092 . . . . 0.0 109.971 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.512 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 3.1 mttm -80.91 -23.32 39.01 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.843 ' O ' HD13 ' A' ' 23' ' ' ILE . 25.0 m-20 -98.35 59.47 1.33 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.843 HD13 ' O ' ' A' ' 22' ' ' ASN . 2.7 mm -142.49 169.93 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.181 -0.95 . . . . 0.0 110.044 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -160.18 -40.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.434 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.5 p -133.53 -173.79 3.32 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 25' ' ' SER . 50.8 t -159.62 97.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.037 -1.04 . . . . 0.0 109.74 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.472 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 3.7 t-20 -94.62 111.42 23.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.396 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.74 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -117.35 103.48 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -107.05 108.43 19.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.43 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.586 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.1 p -50.97 168.68 0.24 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.8 Cg_endo -77.99 131.64 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.523 2.149 . . . . 0.0 110.508 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.04 -143.35 5.39 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.57 5.18 4.94 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.594 2.196 . . . . 0.0 110.643 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.405 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 14.1 p-80 -124.39 -10.89 7.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.647 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 4.0 t -160.2 104.51 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.316 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.92 -3.59 23.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.653 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 4.6 mm-40 -114.52 124.67 52.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 30' ' ' SER . 14.1 m -49.43 148.18 2.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.331 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.465 ' OE2' ' CA ' ' A' ' 9' ' ' CYS . 0.8 OUTLIER -131.22 107.12 8.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 109.743 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.74 HG22 HG13 ' A' ' 28' ' ' VAL . 30.8 t -91.75 156.12 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.245 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.482 HG13 ' SG ' ' A' ' 51' ' ' CYS . 2.1 mp -143.44 144.79 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.799 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -129.45 124.13 33.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.361 -0.837 . . . . 0.0 109.12 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 23.0 m -89.4 101.76 14.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.075 -1.016 . . . . 0.0 109.207 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 22' ' ' ASN . 84.5 mt -43.59 164.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 109.266 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 11.3 ptpt -85.76 13.36 7.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.465 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -112.56 11.04 19.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.174 179.506 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.39 21.17 45.68 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.638 ' HB2' HD12 ' A' ' 44' ' ' LEU . 95.6 mtt-85 -116.11 171.43 7.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -1.156 . . . . 0.0 109.468 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -137.45 153.76 50.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.477 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.501 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.22 125.36 10.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.413 -0.804 . . . . 0.0 109.029 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.482 ' SG ' HG13 ' A' ' 41' ' ' ILE . 13.9 m -79.57 140.59 37.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.006 . . . . 0.0 109.045 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.874 ' HB3' HG22 ' A' ' 59' ' ' VAL . 11.9 mt -122.25 167.81 12.77 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.655 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.4 t-20 -101.29 121.4 51.91 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.474 -0.766 . . . . 0.0 109.199 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.92 -7.1 18.91 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.324 2.016 . . . . 0.0 110.321 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.17 -14.83 49.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 108.95 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.06 162.76 34.27 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.48 -0.763 . . . . 0.0 109.369 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.73 -37.5 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.733 2.289 . . . . 0.0 110.584 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 52.2 mt -61.88 -52.94 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.081 -1.012 . . . . 0.0 109.019 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.874 HG22 ' HB3' ' A' ' 52' ' ' LEU . 56.1 t -53.28 -51.74 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.549 -0.719 . . . . 0.0 109.723 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -50.18 -33.16 18.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.077 -1.014 . . . . 0.0 108.958 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.535 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 3.2 mmpt? -75.74 -34.71 60.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 0.0 109.458 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -60.2 -41.69 87.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.088 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.677 ' N ' HD12 ' A' ' 63' ' ' ILE . 2.2 mp -70.42 -62.32 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.864 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.468 ' OE2' ' HA ' ' A' ' 61' ' ' LYS . 5.9 pt-20 -57.6 -16.57 10.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.047 -1.033 . . . . 0.0 109.439 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.508 ' HG2' ' HB3' ' A' ' 20' ' ' PRO . 5.7 tptm -81.65 -40.66 22.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 108.664 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.532 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -61.97 -44.81 95.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.645 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -43.38 -51.8 6.26 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.551 -0.718 . . . . 0.0 109.308 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.28 -50.73 72.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.392 -0.818 . . . . 0.0 109.497 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.527 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.873 ' HB2' HD22 ' B' ' 12' ' ' LEU . 20.1 m . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -42.18 -27.0 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.466 -0.771 . . . . 0.0 109.884 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.437 ' HB2' ' HB3' ' B' ' 39' ' ' GLU . 72.6 m -124.22 63.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 109.688 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.873 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.72 -39.78 5.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 0.0 109.062 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -123.19 126.49 47.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 109.085 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.417 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -103.14 162.88 12.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.195 -0.941 . . . . 0.0 110.015 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.506 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 6.3 mt -115.48 140.93 48.71 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.486 ' O ' HG23 ' B' ' 59' ' ' VAL . 2.7 tt0 -44.27 -26.57 0.33 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.837 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 138.35 -171.27 23.52 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.725 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.4 pp -161.53 162.74 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.34 -1.094 . . . . 0.0 109.379 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -56.28 153.89 17.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.346 -0.846 . . . . 0.0 109.322 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -76.88 -7.35 17.4 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.451 2.1 . . . . 0.0 109.963 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.519 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 3.1 mttm -80.9 -23.37 39.02 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.821 ' O ' HD13 ' B' ' 23' ' ' ILE . 25.0 m-20 -98.37 59.46 1.33 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.821 HD13 ' O ' ' B' ' 22' ' ' ASN . 2.6 mm -142.47 169.97 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.216 -0.927 . . . . 0.0 110.042 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.3 OUTLIER -160.16 -40.43 0.05 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.633 ' O ' HG23 ' B' ' 26' ' ' VAL . 1.5 p -133.55 -173.83 3.34 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.633 HG23 ' O ' ' B' ' 25' ' ' SER . 51.0 t -159.58 97.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.963 -1.086 . . . . 0.0 109.773 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.49 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 3.7 t-20 -94.67 111.38 23.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.412 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.745 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -117.3 103.52 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.464 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -107.12 108.48 19.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.388 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.587 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -51.05 168.64 0.24 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.8 Cg_endo -77.97 131.63 11.17 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.594 2.196 . . . . 0.0 110.459 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.01 -143.29 5.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.61 5.22 4.94 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.598 2.199 . . . . 0.0 110.64 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -124.38 -10.96 7.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 109.584 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 4.0 t -160.18 104.54 1.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 109.347 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.87 -3.64 23.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.716 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' B' ' 39' ' ' GLU . 4.6 mm-40 -114.48 124.7 52.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.096 -1.003 . . . . 0.0 109.522 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.587 HG23 ' HA ' ' B' ' 30' ' ' SER . 14.3 m -49.44 148.22 2.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.308 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.479 ' OE2' ' CA ' ' B' ' 9' ' ' CYS . 0.9 OUTLIER -131.24 107.29 8.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.669 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.745 HG22 HG13 ' B' ' 28' ' ' VAL . 31.2 t -91.9 156.22 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.213 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' B' ' 27' ' ' ASN . 2.1 mp -143.54 144.78 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.152 -0.968 . . . . 0.0 109.778 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.535 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -129.49 124.29 33.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.044 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 23.0 m -89.45 101.76 14.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.934 -1.104 . . . . 0.0 109.156 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.775 HD23 ' O ' ' B' ' 22' ' ' ASN . 84.9 mt -43.61 164.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.5 -0.75 . . . . 0.0 109.245 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 11.3 ptpt -85.74 13.35 7.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.482 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -112.52 11.05 19.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.888 . . . . 0.0 109.256 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.36 21.21 45.68 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.628 ' HB2' HD12 ' B' ' 44' ' ' LEU . 95.5 mtt-85 -116.19 171.49 7.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -137.51 153.7 49.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.425 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.506 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.22 125.32 9.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.303 -0.873 . . . . 0.0 109.081 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' B' ' 41' ' ' ILE . 13.8 m -79.54 140.59 37.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.029 -1.045 . . . . 0.0 109.109 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.873 ' HB3' HG22 ' B' ' 59' ' ' VAL . 11.9 mt -122.19 167.78 12.79 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.344 -0.847 . . . . 0.0 109.409 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.654 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.4 t-20 -101.32 121.37 51.96 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.195 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.96 -6.92 18.7 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.262 1.975 . . . . 0.0 110.321 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.28 -14.84 48.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.22 -0.925 . . . . 0.0 108.946 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.02 162.7 34.56 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.468 -0.77 . . . . 0.0 109.406 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.77 -37.4 0.9 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.613 2.209 . . . . 0.0 110.65 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.523 ' O ' HD13 ' B' ' 62' ' ' ILE . 52.3 mt -61.86 -53.01 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.963 . . . . 0.0 109.004 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.873 HG22 ' HB3' ' B' ' 52' ' ' LEU . 55.9 t -53.2 -51.73 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.55 -0.719 . . . . 0.0 109.796 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' B' ' 56' ' ' SER . 0.2 OUTLIER -50.24 -33.17 18.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.256 -0.902 . . . . 0.0 108.899 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.536 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 3.2 mmpt? -75.58 -34.92 60.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.468 -0.77 . . . . 0.0 109.477 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.523 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -60.1 -41.73 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.31 -0.869 . . . . 0.0 109.077 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.682 ' N ' HD12 ' B' ' 63' ' ' ILE . 2.2 mp -70.39 -62.32 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.888 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.47 ' OE2' ' HA ' ' B' ' 61' ' ' LYS . 5.9 pt-20 -57.54 -16.61 10.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.063 -1.023 . . . . 0.0 109.437 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' B' ' 20' ' ' PRO . 5.7 tptm -81.61 -40.79 22.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.275 -0.891 . . . . 0.0 108.644 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.537 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -61.85 -44.88 95.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.398 -0.814 . . . . 0.0 108.85 179.386 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.664 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -43.36 -51.76 6.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.511 -0.743 . . . . 0.0 109.34 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.37 -50.66 72.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.495 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.22 -0.925 . . . . 0.0 109.509 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.491 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.525 ' HG3' ' CB ' ' A' ' 29' ' ' LYS . 7.1 mm-40 -42.88 -26.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.475 ' SG ' HG13 ' A' ' 41' ' ' ILE . 60.3 m -148.74 72.63 1.19 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.085 -1.009 . . . . 0.0 109.903 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.491 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.87 -46.05 15.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 108.799 179.505 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -116.17 121.69 42.83 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -98.26 166.18 11.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 110.056 -179.384 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.513 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.1 mt -115.02 146.01 41.7 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.716 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -44.05 -42.76 6.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.413 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.98 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 147.36 -167.5 28.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.952 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -169.5 163.43 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.396 -1.061 . . . . 0.0 109.252 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.58 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -55.74 151.14 23.85 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.263 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.58 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.44 -2.31 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.551 2.167 . . . . 0.0 110.175 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -90.23 -24.79 20.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.43 -0.794 . . . . 0.0 109.136 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.7 m-20 -83.47 -9.59 58.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.391 -0.818 . . . . 0.0 109.288 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.952 HD11 ' CD1' ' A' ' 18' ' ' ILE . 7.9 mt -101.97 165.81 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.882 . . . . 0.0 110.436 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.578 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -139.07 -31.67 0.7 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.578 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.3 p -128.68 168.66 15.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 108.84 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.519 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 56.1 t -141.18 105.65 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.026 -1.046 . . . . 0.0 109.857 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.731 ' O ' HD12 ' A' ' 41' ' ' ILE . 5.2 t-20 -105.79 111.67 24.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -0.941 . . . . 0.0 109.457 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -116.05 103.44 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.537 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.525 ' CB ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -95.96 105.94 18.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.905 . . . . 0.0 109.395 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.462 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.1 p -51.92 167.87 0.31 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.401 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.52 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 35.7 Cg_endo -78.01 131.95 11.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.566 2.177 . . . . 0.0 110.514 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.47 -143.32 4.82 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.55 4.93 5.11 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.57 2.18 . . . . 0.0 110.636 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.4 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 14.6 p-80 -123.95 -10.6 7.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 0.0 109.595 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.5 t -160.08 124.13 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 109.269 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -80.74 -38.03 29.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.868 . . . . 0.0 109.658 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.435 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 2.0 mp0 -86.73 140.21 29.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.619 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.462 HG23 ' HA ' ' A' ' 30' ' ' SER . 50.6 m -60.79 153.88 23.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.465 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 2.5 mp0 -130.33 107.06 8.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 109.688 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.798 HG22 HG13 ' A' ' 28' ' ' VAL . 38.9 t -89.59 154.13 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.84 . . . . 0.0 109.148 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.731 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.1 mp -141.99 153.08 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.109 -0.994 . . . . 0.0 109.782 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.939 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -140.45 121.55 14.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.823 . . . . 0.0 109.063 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.528 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 3.1 m -89.17 103.94 16.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.887 -1.133 . . . . 0.0 108.798 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 79.7 mt -48.75 177.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.541 -0.724 . . . . 0.0 109.742 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -90.03 8.53 32.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 109.187 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.486 ' ND2' ' HD2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -113.79 28.97 8.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.81 11.77 66.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.486 ' HD2' ' ND2' ' A' ' 46' ' ' ASN . 57.9 mtt180 -98.77 168.83 9.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -1.154 . . . . 0.0 109.434 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 16.3 mttt -140.24 151.25 45.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -0.869 . . . . 0.0 109.242 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.22 123.42 8.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.286 -0.884 . . . . 0.0 109.08 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.483 ' SG ' HG13 ' A' ' 41' ' ' ILE . 15.3 m -79.56 144.69 33.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.082 -1.011 . . . . 0.0 109.258 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.98 HD22 ' HA2' ' A' ' 17' ' ' GLY . 15.2 mt -121.33 167.59 12.59 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.278 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.642 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.8 t-20 -100.18 121.1 54.84 Favored Pre-proline 0 C--N 1.298 -1.668 0 O-C-N 121.385 -0.822 . . . . 0.0 109.103 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.03 -9.27 20.66 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.137 1.891 . . . . 0.0 110.271 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.96 -14.8 57.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 108.804 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -89.97 159.87 41.88 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.404 -0.81 . . . . 0.0 109.376 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.68 -34.36 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.667 2.245 . . . . 0.0 110.722 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.599 ' O ' HD13 ' A' ' 62' ' ' ILE . 12.5 tt -66.65 -46.76 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 109.11 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 52' ' ' LEU . 38.6 t -57.08 -48.62 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 109.048 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 1.1 mttp -55.14 -31.28 61.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.492 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -76.28 -30.62 57.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.615 -0.678 . . . . 0.0 109.297 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -65.16 -44.51 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.352 -0.842 . . . . 0.0 109.015 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.912 HG22 HD11 ' B' ' 67' ' ' LEU . 2.2 mp -67.53 -61.66 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.613 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.507 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -52.61 -27.94 19.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.633 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.55 ' CD ' ' HG3' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -71.48 -40.91 69.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.187 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.519 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -63.36 -46.9 84.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.838 . . . . 0.0 109.185 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.946 HD11 HG22 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.58 -51.12 9.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.522 -0.736 . . . . 0.0 109.455 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -71.97 -29.08 63.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.878 . . . . 0.0 109.546 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.452 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.478 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.352 0.596 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.526 ' HG3' ' CB ' ' B' ' 29' ' ' LYS . 7.1 mm-40 -42.9 -26.26 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.853 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' B' ' 41' ' ' ILE . 60.2 m -148.68 72.6 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.083 -1.011 . . . . 0.0 109.953 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.478 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.8 -46.04 15.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.935 . . . . 0.0 108.773 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -116.19 121.59 42.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.414 -0.804 . . . . 0.0 108.896 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.5 OUTLIER -98.25 166.15 11.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.146 -0.972 . . . . 0.0 110.068 -179.347 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.504 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.1 mt -115.0 146.09 41.6 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.715 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.7 OUTLIER -44.18 -42.66 6.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.386 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 1.051 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 147.31 -167.56 28.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.967 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -169.44 163.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.509 -0.995 . . . . 0.0 109.272 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.594 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -55.72 151.1 23.76 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.267 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.9 Cg_endo -77.4 -2.3 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.515 2.143 . . . . 0.0 110.224 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HD2' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -90.25 -24.83 20.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.159 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.7 m-20 -83.37 -9.58 58.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.295 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.967 HD11 ' CD1' ' B' ' 18' ' ' ILE . 8.0 mt -102.02 165.83 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 110.438 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.581 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -139.05 -31.79 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.297 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.581 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.3 p -128.62 168.56 15.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 108.85 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.513 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 55.7 t -141.13 105.78 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.145 -0.972 . . . . 0.0 109.77 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.711 ' O ' HD12 ' B' ' 41' ' ' ILE . 5.2 t-20 -105.9 111.72 24.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.762 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -116.09 103.42 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.938 . . . . 0.0 109.525 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.526 ' CB ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -96.05 105.89 17.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.408 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.46 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -51.88 167.92 0.31 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.518 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 36.2 Cg_endo -78.03 131.99 11.34 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.599 2.199 . . . . 0.0 110.51 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.57 -143.39 4.82 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.6 5.07 5.03 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.5 2.133 . . . . 0.0 110.581 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -123.93 -10.71 7.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.565 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 3.5 t -160.07 124.1 3.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -80.64 -38.09 29.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.75 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.428 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 2.0 mp0 -86.71 140.17 30.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.46 HG23 ' HA ' ' B' ' 30' ' ' SER . 50.6 m -60.72 153.93 22.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.456 ' HB3' ' SG ' ' B' ' 11' ' ' CYS . 2.5 mp0 -130.37 107.08 8.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 109.631 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.762 HG22 HG13 ' B' ' 28' ' ' VAL . 39.1 t -89.68 154.2 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.102 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.711 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.1 mp -142.03 153.07 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.125 -0.984 . . . . 0.0 109.842 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.946 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -140.45 121.57 14.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 108.972 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 3.1 m -89.18 103.87 16.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.871 -1.143 . . . . 0.0 108.856 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 80.1 mt -48.71 177.03 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.489 -0.757 . . . . 0.0 109.747 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -90.03 8.63 31.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.248 -0.907 . . . . 0.0 109.156 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.495 ' ND2' ' HD2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -113.86 29.05 8.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.876 . . . . 0.0 109.139 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.85 11.73 66.69 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.495 ' HD2' ' ND2' ' B' ' 46' ' ' ASN . 57.8 mtt180 -98.78 168.8 9.91 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 109.466 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.439 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 16.3 mttt -140.22 151.36 45.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 109.219 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.504 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.31 123.38 8.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.039 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.48 ' SG ' HG13 ' B' ' 41' ' ' ILE . 15.3 m -79.56 144.7 33.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.252 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 1.051 HD22 ' HA2' ' B' ' 17' ' ' GLY . 15.3 mt -121.38 167.5 12.7 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.913 . . . . 0.0 109.222 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.641 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.8 t-20 -100.12 121.13 54.82 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.169 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.95 -9.39 20.82 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.214 1.943 . . . . 0.0 110.292 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.89 -14.77 57.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 108.851 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.494 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -90.01 159.88 41.74 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.0 109.304 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.71 -34.22 1.96 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.675 2.25 . . . . 0.0 110.727 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.607 ' O ' HD13 ' B' ' 62' ' ' ILE . 12.6 tt -66.76 -46.75 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.994 . . . . 0.0 109.083 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' B' ' 52' ' ' LEU . 38.4 t -57.11 -48.58 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.363 -0.835 . . . . 0.0 109.059 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' B' ' 56' ' ' SER . 1.1 mttp -55.18 -31.28 61.27 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' B' ' 65' ' ' LYS . 0.9 OUTLIER -76.3 -30.56 57.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.566 -0.709 . . . . 0.0 109.329 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.607 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -65.07 -44.69 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 109.009 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.946 HG22 HD11 ' A' ' 67' ' ' LEU . 2.2 mp -67.41 -61.7 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.629 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.511 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.2 OUTLIER -52.61 -28.01 19.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 109.579 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.547 ' CD ' ' HG3' ' B' ' 20' ' ' PRO . 0.0 OUTLIER -71.47 -40.85 70.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.114 -0.991 . . . . 0.0 109.225 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.513 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -63.36 -46.94 84.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.207 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.912 HD11 HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.63 -51.08 9.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.323 -0.861 . . . . 0.0 109.451 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -71.94 -29.13 63.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 109.536 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.429 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.929 ' HB2' HD22 ' A' ' 12' ' ' LEU . 10.4 m . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.55 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 10.3 mm100 -43.01 -26.44 0.14 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.735 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' A' ' 41' ' ' ILE . 96.8 m -125.61 63.16 1.2 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.82 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.929 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.09 -38.28 4.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.051 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -125.29 131.54 53.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.408 -0.808 . . . . 0.0 108.962 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -108.42 163.18 13.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.098 -1.001 . . . . 0.0 109.995 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.535 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.3 mt -120.78 146.04 46.93 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.73 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.9 tt0 -44.26 -40.68 5.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.41 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.861 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 150.12 -168.11 30.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 1.013 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -168.49 163.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.487 -1.007 . . . . 0.0 109.213 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.541 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -57.89 150.63 48.15 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.92 . . . . 0.0 109.434 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HG3' ' CD ' ' A' ' 65' ' ' LYS . 34.9 Cg_endo -77.44 -2.78 12.97 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.571 2.18 . . . . 0.0 110.202 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.24 -24.85 20.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 109.069 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.524 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 3.4 m-20 -83.31 -5.53 59.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 109.354 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.013 HD11 ' CD1' ' A' ' 18' ' ' ILE . 7.0 mt -107.07 145.57 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 110.103 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.544 ' HG3' ' N ' ' A' ' 25' ' ' SER . 1.0 OUTLIER -117.78 -26.19 6.6 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -143.53 172.24 13.07 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 25' ' ' SER . 50.6 t -159.52 137.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.943 -1.098 . . . . 0.0 109.98 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 43.3 t30 -112.47 169.21 9.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.203 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 t -151.27 92.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.543 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.55 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 0.6 OUTLIER -100.19 116.12 31.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.559 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.24 167.49 9.99 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 109.355 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.529 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.6 Cg_endo -78.0 131.33 10.94 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.677 2.251 . . . . 0.0 110.483 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.62 -144.1 4.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.95 6.9 3.89 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.593 2.196 . . . . 0.0 110.736 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.408 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 12.4 p-80 -125.09 -7.3 7.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.141 -0.975 . . . . 0.0 109.551 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.0 t -160.04 116.34 2.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.963 . . . . 0.0 109.418 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.12 45.79 1.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.556 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.529 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 6.1 pt20 -174.47 139.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.462 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 m -57.58 151.32 17.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.334 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.455 ' OE2' ' HG2' ' A' ' 29' ' ' LYS . 6.4 pt-20 -138.05 114.97 10.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.616 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.81 154.02 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 109.222 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.535 ' O ' HG13 ' A' ' 26' ' ' VAL . 4.2 mt -138.39 154.28 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.729 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.813 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -137.24 118.77 14.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 43' ' ' THR . 1.2 m -89.17 96.4 10.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.962 -1.086 . . . . 0.0 108.63 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 89.4 mt -43.18 167.36 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.572 -0.705 . . . . 0.0 109.881 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -80.67 7.59 9.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.645 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.98 23.42 13.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 109.299 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.33 7.41 82.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -95.54 167.64 11.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -1.202 . . . . 0.0 109.497 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HD3' ' OG1' ' A' ' 43' ' ' THR . 18.5 mttt -138.75 151.36 47.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.535 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.3 122.19 8.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.29 -0.881 . . . . 0.0 109.114 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.481 ' SG ' HG12 ' A' ' 41' ' ' ILE . 4.4 m -79.64 142.16 35.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.065 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.861 HD22 ' HA2' ' A' ' 17' ' ' GLY . 12.7 mt -120.03 167.44 12.18 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.292 -0.88 . . . . 0.0 109.492 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.658 ' O ' HG21 ' A' ' 59' ' ' VAL . 5.5 t30 -97.2 115.75 65.81 Favored Pre-proline 0 C--N 1.299 -1.627 0 O-C-N 121.434 -0.791 . . . . 0.0 109.226 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.488 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 33.3 Cg_endo -74.17 0.17 8.8 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.275 1.984 . . . . 0.0 110.433 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.05 -13.85 24.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -0.887 . . . . 0.0 108.944 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 164.61 27.25 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.423 -0.798 . . . . 0.0 109.407 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.9 -37.63 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.676 2.251 . . . . 0.0 110.568 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 10.0 mt -61.4 -51.88 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 109.058 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.861 HG22 ' HB3' ' A' ' 52' ' ' LEU . 54.4 t -54.56 -54.3 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.739 . . . . 0.0 109.744 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 56' ' ' SER . 5.1 mttt -47.5 -33.71 6.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 108.971 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -74.61 -38.56 62.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.494 -0.754 . . . . 0.0 109.328 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -58.13 -41.96 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.429 -0.794 . . . . 0.0 109.146 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.122 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -70.12 -67.87 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.762 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG2' ' HA ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -44.02 -28.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.663 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.548 ' CD ' ' HG3' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -72.88 -59.93 2.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.183 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.414 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.8 OUTLIER -44.12 -44.42 7.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.388 -0.82 . . . . 0.0 109.183 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.114 HD11 ' CG2' ' B' ' 63' ' ' ILE . 1.3 mt -55.16 -58.68 6.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.705 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -80.86 6.85 11.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.734 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 65' ' ' LYS . 10.0 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.465 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.89 ' HB2' HD22 ' B' ' 12' ' ' LEU . 10.3 m . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.553 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 10.2 mm100 -43.01 -26.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.72 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.468 ' SG ' HG13 ' B' ' 41' ' ' ILE . 95.9 m -125.64 63.29 1.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.981 . . . . 0.0 109.784 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.89 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.18 -38.35 5.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -125.2 131.57 53.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.818 . . . . 0.0 108.966 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.496 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -108.43 163.17 13.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.12 -0.988 . . . . 0.0 110.025 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.542 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.3 mt -120.74 146.0 46.93 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.72 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.9 tt0 -44.29 -40.64 5.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.974 . . . . 0.0 109.42 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.838 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 150.09 -168.08 30.1 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.995 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -168.52 163.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.454 -1.027 . . . . 0.0 109.255 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.547 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -57.81 150.45 48.15 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.251 -0.906 . . . . 0.0 109.401 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.549 ' HG3' ' CD ' ' B' ' 65' ' ' LYS . 35.3 Cg_endo -77.32 -2.79 13.0 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.59 2.194 . . . . 0.0 110.231 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.465 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.21 -24.88 20.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.383 -0.823 . . . . 0.0 109.057 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 3.4 m-20 -83.33 -5.56 59.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.463 -0.773 . . . . 0.0 109.217 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.995 HD11 ' CD1' ' B' ' 18' ' ' ILE . 7.1 mt -107.13 145.46 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.878 . . . . 0.0 110.112 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.545 ' HG3' ' N ' ' B' ' 25' ' ' SER . 1.0 OUTLIER -117.71 -26.09 6.66 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.63 ' O ' HG23 ' B' ' 26' ' ' VAL . 0.0 OUTLIER -143.57 172.22 13.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.419 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.63 HG23 ' O ' ' B' ' 25' ' ' SER . 50.4 t -159.49 137.58 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.969 -1.082 . . . . 0.0 109.993 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 43.2 t30 -112.48 169.26 9.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.293 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 t -151.32 92.97 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.436 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.553 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 0.6 OUTLIER -100.26 116.19 31.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.27 167.45 10.14 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.413 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.537 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.7 Cg_endo -77.98 131.3 10.93 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.632 2.222 . . . . 0.0 110.494 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.58 -144.1 4.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.93 6.87 3.91 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.552 2.168 . . . . 0.0 110.763 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.413 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 12.3 p-80 -125.01 -7.37 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.046 -1.034 . . . . 0.0 109.505 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.9 t -160.07 116.25 2.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.355 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.01 45.76 1.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.64 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.537 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 6.1 pt20 -174.54 139.47 0.57 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -0.956 . . . . 0.0 109.549 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 1.3 m -57.6 151.34 17.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.862 . . . . 0.0 109.338 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.453 ' HB2' ' SG ' ' B' ' 11' ' ' CYS . 6.4 pt-20 -138.02 114.94 10.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.611 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.86 154.0 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.153 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.528 ' O ' HG13 ' B' ' 26' ' ' VAL . 4.2 mt -138.36 154.21 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.746 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.813 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -137.19 118.77 14.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.221 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.606 ' O ' HG22 ' B' ' 43' ' ' THR . 1.2 m -89.17 96.41 10.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.027 -1.046 . . . . 0.0 108.63 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.6 mt -43.22 167.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.581 -0.699 . . . . 0.0 109.895 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -80.67 7.68 9.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 109.652 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.11 23.46 13.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.95 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.29 7.44 82.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.513 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 0.7 OUTLIER -95.54 167.66 11.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -1.177 . . . . 0.0 109.507 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.443 ' HD3' ' OG1' ' B' ' 43' ' ' THR . 18.4 mttt -138.71 151.31 47.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.902 . . . . 0.0 109.511 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.542 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.26 122.27 8.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.117 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.476 ' SG ' HG12 ' B' ' 41' ' ' ILE . 4.4 m -79.7 142.26 35.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 109.125 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.849 ' HB3' HG22 ' B' ' 59' ' ' VAL . 12.8 mt -120.19 167.41 12.28 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.285 -0.884 . . . . 0.0 109.356 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.654 ' N ' HG21 ' B' ' 59' ' ' VAL . 5.5 t30 -97.14 115.73 65.81 Favored Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 109.278 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.471 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.4 Cg_endo -74.18 0.14 8.84 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.265 1.976 . . . . 0.0 110.46 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.03 -13.85 24.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.267 -0.896 . . . . 0.0 108.918 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' B' ' 53' ' ' ASN . 0.0 OUTLIER -90.09 164.52 27.68 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 109.403 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.79 -37.74 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.668 2.245 . . . . 0.0 110.508 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' B' ' 62' ' ' ILE . 10.0 mt -61.42 -51.89 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 0.0 109.026 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.849 HG22 ' HB3' ' B' ' 52' ' ' LEU . 54.8 t -54.45 -54.42 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.542 -0.724 . . . . 0.0 109.745 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 5.1 mttt -47.44 -33.65 6.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 109.078 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.479 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -74.6 -38.61 62.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 0.0 109.372 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -58.05 -41.99 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.825 . . . . 0.0 109.168 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 1.114 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -70.1 -67.86 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.766 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -44.01 -28.31 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 109.747 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.549 ' CD ' ' HG3' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -72.81 -59.95 2.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 0.0 109.237 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.425 ' C ' ' O ' ' B' ' 65' ' ' LYS . 0.8 OUTLIER -44.05 -44.43 7.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.155 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.122 HD11 ' CG2' ' A' ' 63' ' ' ILE . 1.3 mt -55.21 -58.63 6.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.52 -0.738 . . . . 0.0 109.701 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -80.9 6.94 11.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 109.749 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' B' ' 65' ' ' LYS . 10.0 p . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.122 -0.986 . . . . 0.0 109.402 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.432 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 19.7 m . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.342 0.592 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.528 ' CG ' ' HE3' ' A' ' 29' ' ' LYS . 22.5 mm-40 -49.78 -21.66 1.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.715 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' OE1' ' A' ' 39' ' ' GLU . 49.9 m -144.98 67.43 1.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 0.0 109.909 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 12' ' ' LEU . 14.5 mt -45.12 -45.53 11.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 108.817 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.09 119.41 35.76 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -94.52 167.14 11.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 110.101 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.517 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.4 mt -114.38 144.99 42.4 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.585 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.4 tt0 -44.29 -39.06 4.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.176 -0.952 . . . . 0.0 109.41 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.988 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 144.99 -164.72 27.85 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.941 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -170.82 163.74 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.488 -1.007 . . . . 0.0 109.094 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.524 ' ND1' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -53.54 149.48 15.11 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 109.354 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.533 ' HA ' HD12 ' A' ' 23' ' ' ILE . 35.0 Cg_endo -77.19 -3.98 14.3 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.53 2.153 . . . . 0.0 110.176 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HE2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.25 -24.38 20.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.376 -0.828 . . . . 0.0 109.089 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.523 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 2.5 m-20 -82.87 -6.47 59.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 109.258 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.941 HD11 ' CD1' ' A' ' 18' ' ' ILE . 8.5 mt -104.94 148.89 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.574 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -120.54 -27.27 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.574 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -137.69 168.51 19.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.092 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.585 HG23 ' HG3' ' A' ' 66' ' ' MET . 90.5 t -140.87 114.46 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.011 . . . . 0.0 109.776 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.629 ' O ' HD12 ' A' ' 41' ' ' ILE . 3.8 t-20 -109.62 110.65 21.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 109.348 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.716 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -110.1 105.54 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 109.516 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HE3' ' CG ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -98.51 114.71 27.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.402 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.98 167.82 5.54 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.464 ' HB3' ' C ' ' A' ' 36' ' ' ALA . 36.2 Cg_endo -78.13 151.44 26.93 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.615 2.21 . . . . 0.0 110.44 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.84 -141.3 3.14 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.538 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 36.3 Cg_endo -77.89 10.96 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.649 2.233 . . . . 0.0 111.008 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.718 ' N ' ' CD2' ' A' ' 34' ' ' HIS . 2.1 p80 -128.27 -34.48 2.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.058 -1.026 . . . . 0.0 109.441 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.9 t -145.39 88.03 1.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.287 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.464 ' C ' ' HB3' ' A' ' 31' ' ' PRO . . . -52.59 -19.93 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.706 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.462 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 33.8 mm-40 -92.85 131.93 37.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 3.6 m -54.79 161.3 1.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.33 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.488 ' HB2' ' CG ' ' A' ' 29' ' ' LYS . 22.5 mm-40 -145.33 107.53 4.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 0.0 109.635 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.716 HG22 HG13 ' A' ' 28' ' ' VAL . 43.1 t -91.77 152.84 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.326 -0.859 . . . . 0.0 109.311 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 27' ' ' ASN . 2.7 mp -140.34 155.42 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.949 . . . . 0.0 109.709 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.777 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -140.9 117.99 11.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 109.103 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.537 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.4 m -89.22 97.66 11.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.892 -1.13 . . . . 0.0 108.787 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 87.1 mt -43.53 162.8 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.464 -0.772 . . . . 0.0 109.583 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.72 ' HZ2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -79.1 7.17 7.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.805 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.502 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -108.85 16.87 22.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.132 -0.98 . . . . 0.0 109.198 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.57 -0.8 89.45 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.502 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 13.7 mtt180 -89.68 162.97 15.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -1.201 . . . . 0.0 109.426 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.3 mptt -134.5 151.06 50.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.24 123.93 9.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 109.033 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 22.9 m -79.47 143.99 34.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.078 -1.014 . . . . 0.0 109.189 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.993 HD13 HD13 ' A' ' 62' ' ' ILE . 15.2 mt -121.19 167.69 12.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -0.856 . . . . 0.0 109.437 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.648 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.8 t-20 -100.84 123.48 45.36 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.413 -0.804 . . . . 0.0 109.177 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.19 -7.04 18.64 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.219 1.946 . . . . 0.0 110.398 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.45 -13.1 55.47 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 108.961 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -90.06 161.65 37.4 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.374 -0.829 . . . . 0.0 109.429 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.92 -35.66 1.33 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.648 2.232 . . . . 0.0 110.574 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.601 HG23 ' N ' ' A' ' 59' ' ' VAL . 16.8 tt -67.31 -45.74 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.426 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.0 ' HA ' HD12 ' A' ' 62' ' ' ILE . 42.7 t -58.62 -46.82 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.413 -0.804 . . . . 0.0 109.369 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 1.3 mmpt? -59.47 -29.48 67.85 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -79.72 -23.84 42.08 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.0 HD12 ' HA ' ' A' ' 59' ' ' VAL . 22.7 mt -70.58 -37.76 70.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.689 HD11 HG11 ' A' ' 40' ' ' VAL . 2.2 mp -74.75 -56.48 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 0.0 109.321 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER -59.35 -27.87 66.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.296 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 1.7 tptt -71.78 -50.68 27.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.058 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.585 ' HG3' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -51.85 -45.78 64.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 109.081 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.639 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -44.27 -52.15 7.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.335 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.9 OUTLIER -62.14 -38.1 87.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.393 -0.817 . . . . 0.0 109.456 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.429 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 2.5 p . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.444 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 19.4 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.372 0.605 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.517 ' CG ' ' HE3' ' B' ' 29' ' ' LYS . 22.5 mm-40 -49.75 -21.66 1.16 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.757 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.467 ' HB2' ' OE1' ' B' ' 39' ' ' GLU . 50.8 m -145.01 67.51 1.24 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.126 -0.984 . . . . 0.0 109.893 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 14.5 mt -45.12 -45.57 11.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -0.972 . . . . 0.0 108.854 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' B' ' 13' ' ' GLN . 0.0 OUTLIER -116.06 119.44 35.85 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.6 OUTLIER -94.55 167.1 11.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.242 -0.911 . . . . 0.0 110.098 -179.365 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.509 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.4 mt -114.36 144.97 42.42 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.578 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.4 tt0 -44.27 -39.09 4.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 109.395 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 1.051 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 144.95 -164.62 27.85 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.944 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -170.82 163.7 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.442 -1.034 . . . . 0.0 109.145 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.523 ' ND1' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -53.53 149.46 15.13 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.326 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.532 ' HA ' HD12 ' B' ' 23' ' ' ILE . 34.7 Cg_endo -77.29 -3.89 14.17 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.586 2.191 . . . . 0.0 110.189 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.45 ' O ' ' CD ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.3 -24.31 20.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.151 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 2.5 m-20 -82.87 -6.42 59.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.332 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.944 HD11 ' CD1' ' B' ' 18' ' ' ILE . 8.4 mt -104.95 148.88 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 110.269 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.556 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -120.55 -27.31 5.17 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.237 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.556 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -137.64 168.47 19.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.141 179.337 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.608 HG23 ' HG3' ' B' ' 66' ' ' MET . 91.3 t -140.81 114.43 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.802 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.625 ' O ' HD12 ' B' ' 41' ' ' ILE . 3.8 t-20 -109.6 110.63 21.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.295 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.696 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -110.03 105.62 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.275 -0.89 . . . . 0.0 109.592 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -98.6 114.67 27.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.387 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.95 167.89 5.4 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.423 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.462 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 36.2 Cg_endo -78.16 151.47 26.85 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.518 2.146 . . . . 0.0 110.456 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.82 -141.34 3.15 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.543 ' HD2' ' CD2' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -77.92 10.98 2.41 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.603 2.202 . . . . 0.0 110.993 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.701 ' N ' ' CD2' ' B' ' 34' ' ' HIS . 2.1 p80 -128.27 -34.44 2.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.016 -1.052 . . . . 0.0 109.474 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 2.0 t -145.43 88.07 1.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.296 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -52.6 -20.0 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.708 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.453 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 33.5 mm-40 -92.8 131.9 37.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.457 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 3.6 m -54.74 161.33 1.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.396 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.497 ' HB2' ' CG ' ' B' ' 29' ' ' LYS . 22.5 mm-40 -145.35 107.58 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.696 HG22 HG13 ' B' ' 28' ' ' VAL . 42.9 t -91.8 152.8 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 109.299 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.625 HD12 ' O ' ' B' ' 27' ' ' ASN . 2.7 mp -140.31 155.35 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.719 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.775 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -140.88 118.05 11.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.093 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.55 HG22 ' O ' ' B' ' 43' ' ' THR . 1.5 m -89.13 97.55 11.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.92 -1.113 . . . . 0.0 108.817 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 86.9 mt -43.45 162.8 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.479 -0.763 . . . . 0.0 109.661 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.629 ' HZ2' ' HB3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -79.15 7.29 7.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 109.83 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -108.88 16.76 22.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.134 -0.979 . . . . 0.0 109.121 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.68 -0.87 89.4 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.506 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 13.7 mtt180 -89.64 162.95 15.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.082 -1.246 . . . . 0.0 109.445 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 1.3 mptt -134.46 151.06 50.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 109.435 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.21 123.91 9.18 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 109.057 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' B' ' 41' ' ' ILE . 22.8 m -79.49 143.93 34.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.063 -1.023 . . . . 0.0 109.169 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 1.051 HD22 ' HA2' ' B' ' 17' ' ' GLY . 15.2 mt -121.14 167.61 12.47 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.647 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.7 t-20 -100.79 123.55 45.2 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.13 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.24 -7.05 18.62 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.225 1.95 . . . . 0.0 110.4 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.5 -13.13 55.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.229 -0.919 . . . . 0.0 108.868 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.3 OUTLIER -90.06 161.66 37.39 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.99 -35.53 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.609 2.206 . . . . 0.0 110.504 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.596 HG23 ' N ' ' B' ' 59' ' ' VAL . 16.8 tt -67.33 -45.79 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.417 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 1.009 ' HA ' HD12 ' B' ' 62' ' ' ILE . 42.5 t -58.72 -46.72 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.812 . . . . 0.0 109.333 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 1.3 mmpt? -59.47 -29.59 67.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.48 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -79.63 -23.89 42.29 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 1.009 HD12 ' HA ' ' B' ' 59' ' ' VAL . 23.0 mt -70.52 -37.8 71.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.56 -0.712 . . . . 0.0 109.079 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.665 HD11 HG11 ' B' ' 40' ' ' VAL . 2.2 mp -74.67 -56.49 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.427 -0.795 . . . . 0.0 109.398 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.4 OUTLIER -59.32 -27.86 66.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.294 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.512 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 1.6 tptt -71.79 -50.71 27.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.047 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.608 ' HG3' HG23 ' B' ' 26' ' ' VAL . 0.4 OUTLIER -51.82 -45.68 64.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.282 -0.886 . . . . 0.0 109.114 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.652 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -44.27 -52.35 7.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.314 -0.867 . . . . 0.0 109.258 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' B' ' 69' ' ' SER . 0.9 OUTLIER -61.95 -38.12 87.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.529 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.45 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 2.5 p . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.73 ' HB2' HD22 ' A' ' 12' ' ' LEU . 50.7 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.506 ' OE1' ' NZ ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.59 -26.79 0.13 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.347 -0.846 . . . . 0.0 109.761 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' CYS . 72.0 m -118.25 58.33 0.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.73 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.2 -37.91 3.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.234 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.37 123.86 41.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.383 -0.823 . . . . 0.0 109.11 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -100.05 161.1 13.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.536 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.2 mt -115.07 141.16 48.38 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.1 tt0 -44.12 -26.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.271 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 1.053 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 139.41 -162.68 26.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.852 HG23 ' O ' ' A' ' 17' ' ' GLY . 1.3 pp -171.0 163.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.466 -1.02 . . . . 0.0 109.267 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -58.12 154.27 31.1 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 0.0 109.201 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -76.99 -9.31 17.99 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.415 2.077 . . . . 0.0 109.927 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.501 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 35.5 mttm -77.34 -27.85 52.85 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.931 ' O ' HD13 ' A' ' 23' ' ' ILE . 22.9 m-20 -93.33 59.29 2.97 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.931 HD13 ' O ' ' A' ' 22' ' ' ASN . 1.5 mm -147.17 169.01 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 110.028 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.754 ' HG2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -160.38 -36.0 0.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.607 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.7 p -134.83 -175.17 3.81 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 25' ' ' SER . 50.7 t -158.82 98.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.946 -1.096 . . . . 0.0 109.867 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.484 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 3.5 t-20 -91.33 110.74 22.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.218 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.475 HG13 HG13 ' A' ' 40' ' ' VAL . 1.7 t -114.32 104.11 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.478 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.681 ' HZ3' ' HB3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -108.19 110.45 22.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.4 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -55.04 168.88 0.47 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.365 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.525 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.4 Cg_endo -78.13 131.95 11.21 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.556 2.171 . . . . 0.0 110.5 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.08 -143.55 5.42 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.86 5.86 4.6 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.519 2.146 . . . . 0.0 110.709 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.418 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 12.2 p-80 -124.28 -12.66 7.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.979 . . . . 0.0 109.623 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 2.7 t -160.22 98.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.214 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.98 -8.48 30.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 109.651 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.455 ' OE1' ' CA ' ' A' ' 37' ' ' GLN . 6.5 mm-40 -106.0 125.44 51.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.415 ' C ' ' HG2' ' A' ' 39' ' ' GLU . 25.9 m -49.7 152.61 1.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.417 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HG2' ' C ' ' A' ' 38' ' ' THR . 2.2 mt-10 -137.66 107.32 6.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.984 . . . . 0.0 109.791 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.922 HG11 HD11 ' A' ' 63' ' ' ILE . 3.8 t -93.8 157.73 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.12 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.548 ' CD1' ' HE2' ' A' ' 29' ' ' LYS . 1.9 mp -144.28 143.8 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 109.835 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.624 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -126.88 125.25 41.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 109.016 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.754 HG22 ' HG2' ' A' ' 24' ' ' GLN . 25.8 m -89.65 104.71 17.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.031 -1.043 . . . . 0.0 109.051 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 22' ' ' ASN . 80.1 mt -47.35 164.92 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.223 -0.923 . . . . 0.0 109.155 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 13.4 ptpt -84.93 12.97 6.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.148 -0.97 . . . . 0.0 109.566 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -111.2 10.68 21.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.888 . . . . 0.0 109.181 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.04 20.81 48.44 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.566 ' HB2' HD12 ' A' ' 44' ' ' LEU . 9.4 mtt180 -115.95 173.68 6.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -1.148 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 4.2 mttt -139.71 154.66 47.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.536 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.17 125.45 10.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.097 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.48 ' SG ' HG13 ' A' ' 41' ' ' ILE . 16.8 m -79.51 144.52 33.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 0.0 109.192 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.053 HD22 ' HA2' ' A' ' 17' ' ' GLY . 15.1 mt -122.53 168.34 12.26 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.663 ' O ' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -98.04 120.96 58.79 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.368 -0.833 . . . . 0.0 109.112 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.83 -6.79 18.61 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.196 1.931 . . . . 0.0 110.284 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.3 -14.25 53.42 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.257 -0.902 . . . . 0.0 108.833 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 1.1 p -90.05 158.3 44.47 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.474 -0.766 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.479 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.0 Cg_endo -77.14 -32.27 3.24 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.614 2.209 . . . . 0.0 110.509 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.591 HG23 ' N ' ' A' ' 59' ' ' VAL . 9.0 tt -69.2 -45.16 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.112 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.029 ' HA ' HD12 ' A' ' 62' ' ' ILE . 25.2 t -57.45 -46.2 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.522 -0.736 . . . . 0.0 109.248 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -61.08 -30.32 70.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.524 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 3.4 mmpt? -79.05 -20.58 48.53 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.029 HD12 ' HA ' ' A' ' 59' ' ' VAL . 26.7 mt -75.51 -37.34 37.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.578 -0.701 . . . . 0.0 109.181 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.922 HD11 HG11 ' A' ' 40' ' ' VAL . 2.2 mp -74.28 -50.33 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 8.7 pt-20 -66.12 -35.95 81.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 109.328 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.53 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 32.9 mttm -61.38 -40.44 94.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 108.945 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.53 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -61.1 -45.33 95.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.087 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.885 HD11 HG22 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -49.59 -54.88 15.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 109.69 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.2 -16.18 60.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.895 . . . . 0.0 109.724 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 28.4 p . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 109.468 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.729 ' HB2' HD22 ' B' ' 12' ' ' LEU . 50.9 m . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.517 ' OE1' ' NZ ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -42.59 -26.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.359 -0.838 . . . . 0.0 109.722 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' B' ' 9' ' ' CYS . 72.1 m -118.28 58.38 0.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.729 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.13 -37.99 3.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 109.256 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.32 123.91 41.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.1 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.552 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.4 OUTLIER -100.13 161.12 13.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.535 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.2 mt -115.17 141.15 48.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.461 -0.775 . . . . 0.0 108.952 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.522 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 3.1 tt0 -44.08 -26.73 0.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.35 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 1.003 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 139.36 -162.67 26.1 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.854 HG23 ' O ' ' B' ' 17' ' ' GLY . 1.3 pp -170.96 163.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.404 -1.056 . . . . 0.0 109.217 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.592 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -58.16 154.21 31.77 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.25 -0.907 . . . . 0.0 109.27 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.592 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.9 Cg_endo -76.88 -9.31 18.15 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.449 2.099 . . . . 0.0 109.924 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.495 ' O ' ' NZ ' ' B' ' 45' ' ' LYS . 35.4 mttm -77.38 -27.87 52.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.952 ' O ' HD13 ' B' ' 23' ' ' ILE . 23.0 m-20 -93.38 59.38 2.97 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.952 HD13 ' O ' ' B' ' 22' ' ' ASN . 1.4 mm -147.23 168.93 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.141 -0.974 . . . . 0.0 110.047 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.75 ' HG2' HG22 ' B' ' 43' ' ' THR . 0.0 OUTLIER -160.38 -35.98 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.987 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.606 ' O ' HG23 ' B' ' 26' ' ' VAL . 1.7 p -134.82 -175.19 3.82 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 25' ' ' SER . 50.4 t -158.81 98.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.96 -1.087 . . . . 0.0 109.79 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.487 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 3.6 t-20 -91.48 110.76 22.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.235 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.483 HG13 HG13 ' B' ' 40' ' ' VAL . 1.7 t -114.35 104.09 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.492 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.615 ' HZ3' ' HB3' ' B' ' 29' ' ' LYS . 0.9 OUTLIER -108.16 110.41 22.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.401 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.0 OUTLIER -54.96 168.84 0.47 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 109.414 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 36.0 Cg_endo -78.0 131.8 11.25 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.67 2.247 . . . . 0.0 110.507 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.01 -143.58 5.43 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.72 5.68 4.66 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.642 2.228 . . . . 0.0 110.68 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.405 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 12.1 p-80 -124.3 -12.68 7.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.181 -0.949 . . . . 0.0 109.585 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 2.7 t -160.18 98.88 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.25 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.9 -8.59 30.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.631 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.451 ' HA ' ' OE1' ' B' ' 37' ' ' GLN . 6.4 mm-40 -105.85 125.42 50.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.591 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.43 ' C ' ' HG2' ' B' ' 39' ' ' GLU . 26.0 m -49.79 152.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.868 . . . . 0.0 109.341 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.43 ' HG2' ' C ' ' B' ' 38' ' ' THR . 2.1 mt-10 -137.58 107.36 6.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.724 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.913 HG11 HD11 ' B' ' 63' ' ' ILE . 3.8 t -93.85 157.64 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.115 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.554 ' CD1' ' HE2' ' B' ' 29' ' ' LYS . 1.9 mp -144.24 143.8 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.96 . . . . 0.0 109.81 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.619 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -126.93 125.18 41.1 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.75 HG22 ' HG2' ' B' ' 24' ' ' GLN . 26.2 m -89.53 104.73 17.26 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.981 -1.074 . . . . 0.0 109.05 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.788 HD23 ' O ' ' B' ' 22' ' ' ASN . 80.8 mt -47.44 164.98 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.354 -0.841 . . . . 0.0 109.123 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' B' ' 21' ' ' LYS . 13.4 ptpt -84.98 13.11 6.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.594 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -111.28 10.68 21.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.878 . . . . 0.0 109.064 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.03 20.73 48.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.566 ' HB2' HD12 ' B' ' 44' ' ' LEU . 9.4 mtt180 -115.96 173.72 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -1.128 . . . . 0.0 109.394 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.441 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 4.2 mttt -139.67 154.69 47.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.423 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.535 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.19 125.34 10.02 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.276 -0.89 . . . . 0.0 109.175 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.477 ' SG ' HG13 ' B' ' 41' ' ' ILE . 17.1 m -79.45 144.47 34.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.957 . . . . 0.0 109.152 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 1.003 HD22 ' HA2' ' B' ' 17' ' ' GLY . 15.0 mt -122.52 168.33 12.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.891 . . . . 0.0 109.35 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.668 ' O ' HG21 ' B' ' 59' ' ' VAL . 0.1 OUTLIER -98.01 120.91 58.94 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.37 -0.831 . . . . 0.0 109.093 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.83 -6.68 18.46 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.126 1.884 . . . . 0.0 110.35 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.35 -14.21 53.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 0.0 108.826 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 1.1 p -90.05 158.26 44.5 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.383 -0.823 . . . . 0.0 109.402 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.488 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 35.5 Cg_endo -77.06 -32.29 3.28 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.676 2.25 . . . . 0.0 110.522 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.602 HG23 ' N ' ' B' ' 59' ' ' VAL . 9.1 tt -69.23 -45.16 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 0.0 109.113 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 1.028 ' HA ' HD12 ' B' ' 62' ' ' ILE . 25.2 t -57.55 -46.1 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.474 -0.766 . . . . 0.0 109.163 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' B' ' 56' ' ' SER . 0.0 OUTLIER -61.17 -30.28 70.31 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.532 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 3.4 mmpt? -78.96 -20.77 48.38 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 1.028 HD12 ' HA ' ' B' ' 59' ' ' VAL . 26.7 mt -75.38 -37.34 38.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.641 -0.662 . . . . 0.0 109.267 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.913 HD11 HG11 ' B' ' 40' ' ' VAL . 2.2 mp -74.29 -50.34 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.624 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.538 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 8.7 pt-20 -66.09 -35.93 81.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.998 -1.064 . . . . 0.0 109.353 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.538 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 32.8 mttm -61.42 -40.53 94.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 108.939 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.518 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.2 OUTLIER -61.0 -45.3 95.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.149 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.91 HD11 HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -49.64 -54.78 16.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 109.698 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.32 -16.19 60.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.687 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 28.3 p . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.537 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.761 ' HB2' HD22 ' A' ' 12' ' ' LEU . 68.7 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.539 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.52 -26.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.874 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 39' ' ' GLU . 83.0 m -116.8 58.71 0.76 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 109.71 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.761 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.82 -37.14 3.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.178 -0.951 . . . . 0.0 109.147 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -127.28 127.72 44.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.374 -0.829 . . . . 0.0 109.059 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -101.94 165.37 11.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.217 -0.927 . . . . 0.0 109.953 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.566 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 6.9 mt -124.21 143.42 50.53 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.3 tt0 -44.17 -40.89 5.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -0.946 . . . . 0.0 109.402 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 1.032 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 140.41 166.67 10.76 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.893 HD11 ' CG1' ' A' ' 23' ' ' ILE . 1.9 pp -139.31 162.8 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.549 -0.971 . . . . 0.0 109.083 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.734 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -46.49 151.61 0.99 Allowed Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 109.204 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.568 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -76.91 -4.87 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.502 2.135 . . . . 0.0 110.083 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.44 -23.41 21.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.331 -0.855 . . . . 0.0 109.237 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.523 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 4.8 m-20 -82.52 -4.7 57.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 0.0 109.44 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.893 ' CG1' HD11 ' A' ' 18' ' ' ILE . 9.0 mt -105.61 155.3 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 110.304 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.6 OUTLIER -127.27 -29.19 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.32 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.582 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -135.11 171.12 14.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.029 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.54 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 46.4 t -143.78 101.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.959 . . . . 0.0 109.733 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.525 ' O ' HD12 ' A' ' 41' ' ' ILE . 3.8 t-20 -95.71 110.4 22.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.364 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.402 HG13 HG22 ' A' ' 40' ' ' VAL . 1.9 t -107.0 100.72 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.504 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.539 ' CD ' ' HB2' ' A' ' 10' ' ' GLN . 10.2 ptmt -95.54 109.41 21.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.44 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.455 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -61.88 171.52 1.45 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.4 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.3 Cg_endo -77.54 144.57 22.67 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.611 2.207 . . . . 0.0 110.444 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.89 -141.3 3.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.9 39.96 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.746 2.297 . . . . 0.0 110.759 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.48 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 6.4 p-80 -159.41 -38.82 0.06 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.082 -1.011 . . . . 0.0 109.13 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -141.14 99.0 3.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.865 . . . . 0.0 109.146 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.87 -11.85 42.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 0.0 109.679 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 37' ' ' GLN . 4.0 mm-40 -98.92 124.4 43.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.457 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.459 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 9.4 m -47.72 157.85 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.252 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 29' ' ' LYS . 7.3 mm-40 -145.57 107.29 4.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 109.702 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.9 HG11 HD11 ' A' ' 63' ' ' ILE . 6.5 t -89.74 156.23 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.154 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 27' ' ' ASN . 2.6 mp -141.09 148.43 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.145 -0.972 . . . . 0.0 109.838 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.756 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -133.04 118.18 18.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.007 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.532 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 2.1 m -89.12 98.91 12.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.931 -1.106 . . . . 0.0 108.885 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 88.9 mt -44.41 166.6 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.504 -0.747 . . . . 0.0 109.593 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.4 ptpt -81.88 8.21 10.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.639 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.15 25.04 11.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.216 -0.928 . . . . 0.0 109.242 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.18 2.64 67.23 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.511 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 5.8 mtt180 -92.1 164.32 13.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.193 -1.181 . . . . 0.0 109.436 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.6 mptt -135.92 153.13 51.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.174 -0.954 . . . . 0.0 109.393 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.566 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.29 122.45 8.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.065 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.4 m -79.46 143.07 35.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.102 -0.999 . . . . 0.0 109.036 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.054 HD13 HD13 ' A' ' 62' ' ' ILE . 14.2 mt -119.74 167.59 11.91 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.29 -0.881 . . . . 0.0 109.611 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.676 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.4 t-20 -97.64 119.0 63.52 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.518 -0.739 . . . . 0.0 109.172 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.11 -0.0 9.0 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.136 1.891 . . . . 0.0 110.443 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.79 -13.07 25.97 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.296 -0.877 . . . . 0.0 108.835 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.11 165.35 24.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.389 -0.82 . . . . 0.0 109.399 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.502 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.17 -42.18 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.707 2.271 . . . . 0.0 110.816 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.1 mt -61.52 -39.71 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.734 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.988 ' HA ' HD12 ' A' ' 62' ' ' ILE . 47.5 t -64.42 -49.46 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.794 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 8.7 mttm -53.73 -32.33 51.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.071 -1.018 . . . . 0.0 108.706 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -78.06 -29.93 49.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.55 -0.719 . . . . 0.0 109.268 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.054 HD13 HD13 ' A' ' 52' ' ' LEU . 15.2 mt -64.43 -38.55 82.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.219 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.948 ' CG2' HD11 ' B' ' 67' ' ' LEU . 1.4 mp -76.01 -64.65 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.858 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -49.65 -55.22 14.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 109.449 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 61' ' ' LYS . 42.8 tptt -46.62 -55.79 7.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.128 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.54 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -44.38 -43.19 7.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 0.0 109.169 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.955 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -55.83 -55.27 34.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.419 -0.8 . . . . 0.0 109.579 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.28 10.31 17.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 109.679 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 91.2 p . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.495 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.754 ' HB2' HD22 ' B' ' 12' ' ' LEU . 68.6 m . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.534 ' HB2' ' CD ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -42.67 -26.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.436 -0.79 . . . . 0.0 109.761 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' B' ' 39' ' ' GLU . 82.9 m -116.85 58.77 0.76 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.729 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.754 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.18 3.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -127.31 127.64 44.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.016 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.506 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -101.88 165.42 11.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.968 . . . . 0.0 109.958 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.554 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 6.9 mt -124.2 143.43 50.52 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.488 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.3 tt0 -44.22 -40.97 5.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.28 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.987 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 140.45 166.72 10.78 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.911 HD11 ' CG1' ' B' ' 23' ' ' ILE . 1.9 pp -139.37 162.82 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.496 -1.002 . . . . 0.0 109.034 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.744 ' O ' HD12 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -46.49 151.61 0.99 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.982 . . . . 0.0 109.134 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.554 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -76.91 -4.84 15.37 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.475 2.117 . . . . 0.0 110.008 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.473 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.47 -23.28 21.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.389 -0.819 . . . . 0.0 109.229 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 4.8 m-20 -82.61 -4.69 58.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.911 ' CG1' HD11 ' B' ' 18' ' ' ILE . 8.9 mt -105.59 155.35 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.569 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.6 OUTLIER -127.36 -29.14 2.73 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.569 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -135.11 171.06 14.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 109.055 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.536 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 46.2 t -143.73 101.82 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.047 -1.033 . . . . 0.0 109.752 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.518 ' O ' HD12 ' B' ' 41' ' ' ILE . 3.9 t-20 -95.65 110.4 22.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.321 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.406 HG13 HG22 ' B' ' 40' ' ' VAL . 1.9 t -107.01 100.71 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.481 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.534 ' CD ' ' HB2' ' B' ' 10' ' ' GLN . 10.1 ptmt -95.57 109.52 21.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 109.441 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.451 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -61.99 171.49 1.5 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 109.447 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.8 Cg_endo -77.43 144.6 22.96 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.615 2.21 . . . . 0.0 110.455 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.84 -141.25 3.29 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.9 39.94 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.684 2.256 . . . . 0.0 110.826 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.482 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 6.5 p-80 -159.37 -38.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.073 -1.017 . . . . 0.0 109.202 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -141.21 99.02 3.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 109.154 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.9 -11.93 43.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.7 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.456 ' HA ' ' OE1' ' B' ' 37' ' ' GLN . 4.0 mm-40 -98.77 124.45 43.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.519 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.454 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 9.4 m -47.78 157.89 0.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.313 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' B' ' 38' ' ' THR . 7.3 mm-40 -145.58 107.27 4.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.732 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.903 HG11 HD11 ' B' ' 63' ' ' ILE . 6.3 t -89.72 156.2 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.846 . . . . 0.0 109.182 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.518 HD12 ' O ' ' B' ' 27' ' ' ASN . 2.6 mp -141.07 148.47 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.777 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.76 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -133.09 118.19 18.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.057 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.518 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 2.1 m -89.08 98.82 11.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.909 -1.12 . . . . 0.0 108.896 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.1 mt -44.4 166.5 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.523 -0.736 . . . . 0.0 109.697 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.4 ptpt -81.73 8.09 10.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 109.692 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.07 25.01 11.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.26 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.28 2.55 67.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.508 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 5.8 mtt180 -92.01 164.28 13.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -1.204 . . . . 0.0 109.436 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 1.6 mptt -135.86 153.2 51.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.382 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.554 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.39 122.36 8.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.835 . . . . 0.0 109.075 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 5.4 m -79.4 142.96 35.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.021 . . . . 0.0 109.08 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 1.131 HD13 HD13 ' B' ' 62' ' ' ILE . 14.0 mt -119.65 167.63 11.84 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.262 -0.899 . . . . 0.0 109.678 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.669 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.4 t-20 -97.62 118.99 63.56 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.506 -0.746 . . . . 0.0 109.182 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -74.26 0.14 8.89 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.07 1.846 . . . . 0.0 110.339 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.72 -13.16 26.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 108.867 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.1 165.4 24.23 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.835 . . . . 0.0 109.419 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.501 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.5 Cg_endo -78.1 -42.23 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.742 2.295 . . . . 0.0 110.831 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 47.2 mt -61.61 -39.62 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.189 -0.944 . . . . 0.0 109.706 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 1.037 ' HA ' HD12 ' B' ' 62' ' ' ILE . 47.6 t -64.43 -49.48 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.347 -0.845 . . . . 0.0 109.832 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' B' ' 64' ' ' GLU . 8.7 mttm -53.77 -32.28 51.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 108.741 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -78.04 -29.89 49.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.615 -0.678 . . . . 0.0 109.285 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 1.131 HD13 HD13 ' B' ' 52' ' ' LEU . 15.0 mt -64.6 -38.43 82.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 109.138 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.955 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.4 mp -75.99 -64.79 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 109.786 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -49.61 -55.2 14.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.01 -1.057 . . . . 0.0 109.449 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' B' ' 61' ' ' LYS . 42.9 tptt -46.57 -55.81 7.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.135 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.536 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.0 OUTLIER -44.43 -43.2 7.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.948 . . . . 0.0 109.116 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.948 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -55.72 -55.39 32.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.434 -0.791 . . . . 0.0 109.63 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.2 10.35 17.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 0.0 109.623 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 90.6 p . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.459 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.71 ' HB2' HD22 ' A' ' 12' ' ' LEU . 67.1 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.466 ' HG2' ' HB3' ' A' ' 29' ' ' LYS . 2.5 mp0 -40.66 -40.01 1.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.587 -0.695 . . . . 0.0 109.857 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.459 ' SG ' HG13 ' A' ' 41' ' ' ILE . 82.5 m -132.09 80.49 1.91 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 109.878 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.71 HD22 ' HB2' ' A' ' 9' ' ' CYS . 3.9 mm? -49.2 -45.35 44.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 108.993 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -116.89 122.71 45.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.429 -0.794 . . . . 0.0 108.923 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.12 166.83 10.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.952 . . . . 0.0 110.006 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.493 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 6.0 mt -115.27 146.21 41.7 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.562 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.8 OUTLIER -44.74 -35.65 2.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.109 -0.994 . . . . 0.0 109.38 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.754 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 146.37 -176.98 25.01 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.759 HD13 HD11 ' A' ' 23' ' ' ILE . 1.7 pp -157.04 162.39 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -1.06 . . . . 0.0 109.372 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.6 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -59.24 156.21 30.25 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 0.0 109.343 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -77.04 -13.3 17.36 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.501 2.134 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.533 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 22.0 mttt -74.17 -30.86 62.45 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.969 ' O ' HD13 ' A' ' 23' ' ' ILE . 26.5 m-20 -89.59 58.41 4.32 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.969 HD13 ' O ' ' A' ' 22' ' ' ASN . 1.5 mm -145.63 169.16 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -0.974 . . . . 0.0 110.098 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.748 ' HG2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -160.18 -35.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.621 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.0 p -136.37 -172.59 3.18 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 25' ' ' SER . 52.1 t -159.24 115.16 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.891 -1.131 . . . . 0.0 109.97 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.508 ' O ' HD12 ' A' ' 41' ' ' ILE . 3.9 t-20 -109.11 110.76 22.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 109.111 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.536 HG13 HG22 ' A' ' 40' ' ' VAL . 2.1 t -120.71 109.8 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.3 -0.875 . . . . 0.0 109.729 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -108.87 102.03 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.37 -0.831 . . . . 0.0 109.309 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.464 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -48.81 171.31 0.1 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 36.0 Cg_endo -78.03 140.87 18.32 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.586 2.191 . . . . 0.0 110.462 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.48 -141.49 3.68 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.45 8.82 3.13 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.544 2.163 . . . . 0.0 110.878 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.491 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 4.4 p-80 -125.53 -21.33 4.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.047 -1.033 . . . . 0.0 109.807 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' OE1' ' A' ' 37' ' ' GLN . 2.1 t -160.02 122.44 3.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.012 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.42 16.2 4.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.637 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 2.0 mp0 -124.13 124.83 43.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.9 m -54.88 137.54 45.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.406 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 39' ' ' GLU . 1.7 mp0 -118.77 107.02 13.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 109.683 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.711 HG11 HD11 ' A' ' 63' ' ' ILE . 13.5 t -95.12 146.94 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.244 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.514 ' CG1' ' SG ' ' A' ' 51' ' ' CYS . 2.1 mp -138.23 152.58 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.874 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.756 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -136.62 125.25 23.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.411 -0.805 . . . . 0.0 109.041 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.748 HG22 ' HG2' ' A' ' 24' ' ' GLN . 33.4 m -89.51 106.86 18.73 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.008 -1.058 . . . . 0.0 109.093 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.847 HD23 ' O ' ' A' ' 22' ' ' ASN . 71.9 mt -49.03 166.11 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.183 -0.948 . . . . 0.0 109.114 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.533 ' CD ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -84.27 11.04 8.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.057 -1.027 . . . . 0.0 109.533 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -111.12 19.26 18.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.325 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 14.61 80.1 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.599 ' HB2' HD12 ' A' ' 44' ' ' LEU . 49.1 mtt180 -109.15 175.23 5.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -1.173 . . . . 0.0 109.502 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -145.15 155.25 43.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.48 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.1 124.99 9.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.365 -0.834 . . . . 0.0 109.116 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.514 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 12.0 m -79.55 140.35 37.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.091 -1.006 . . . . 0.0 109.267 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.862 ' HB3' HG22 ' A' ' 59' ' ' VAL . 11.4 mt -122.93 168.67 12.01 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.253 -0.904 . . . . 0.0 109.266 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.65 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.2 t30 -104.68 124.79 35.77 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 109.276 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.11 -13.48 21.18 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.165 1.91 . . . . 0.0 110.531 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.549 ' HB3' HD22 ' A' ' 53' ' ' ASN . . . -73.55 -16.65 61.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.261 -0.899 . . . . 0.0 108.875 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -90.16 161.16 38.51 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.453 -0.779 . . . . 0.0 109.419 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -78.12 -37.17 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.679 2.253 . . . . 0.0 111.044 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.58 ' O ' HD13 ' A' ' 62' ' ' ILE . 17.6 tt -64.73 -47.2 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.06 -1.025 . . . . 0.0 109.13 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.862 HG22 ' HB3' ' A' ' 52' ' ' LEU . 39.5 t -56.68 -48.23 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.509 -0.745 . . . . 0.0 109.163 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 56' ' ' SER . 4.6 mmtt -54.21 -31.18 52.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.508 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 9.6 mmmm -78.3 -30.66 48.49 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.35 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.602 HG22 HD12 ' A' ' 63' ' ' ILE . 1.7 mp -58.0 -43.59 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.833 ' CG2' HD11 ' B' ' 67' ' ' LEU . 1.6 mp -68.7 -61.76 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -42.6 -29.03 0.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.344 -0.847 . . . . 0.0 109.584 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 66' ' ' MET . 0.7 OUTLIER -74.32 -60.57 2.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.858 . . . . 0.0 109.271 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.537 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 1.2 mmm -44.05 -48.37 8.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.825 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -43.64 -51.21 7.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 0.0 109.342 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.97 -37.04 86.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.467 -0.771 . . . . 0.0 109.497 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.846 . . . . 0.0 109.465 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.705 ' HB2' HD22 ' B' ' 12' ' ' LEU . 67.4 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.471 ' HG2' ' HB3' ' B' ' 29' ' ' LYS . 2.5 mp0 -40.74 -40.03 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.549 -0.719 . . . . 0.0 109.899 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.46 ' SG ' HG13 ' B' ' 41' ' ' ILE . 83.2 m -132.0 80.63 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.854 . . . . 0.0 109.882 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.705 HD22 ' HB2' ' B' ' 9' ' ' CYS . 3.9 mm? -49.38 -45.33 45.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.104 -0.998 . . . . 0.0 108.921 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -116.92 122.78 45.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.417 -0.802 . . . . 0.0 108.911 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.18 166.78 10.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.999 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.482 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 6.0 mt -115.2 146.18 41.67 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.563 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.8 OUTLIER -44.67 -35.67 2.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.142 -0.973 . . . . 0.0 109.438 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.766 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 146.32 -177.02 24.94 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.795 HD13 HD11 ' B' ' 23' ' ' ILE . 1.7 pp -157.01 162.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -1.105 . . . . 0.0 109.428 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.608 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -59.25 156.24 30.22 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.291 -0.881 . . . . 0.0 109.233 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.608 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.06 -13.19 17.37 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.467 2.112 . . . . 0.0 109.961 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.525 ' O ' ' CD ' ' B' ' 45' ' ' LYS . 22.1 mttt -74.17 -30.85 62.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.96 ' O ' HD13 ' B' ' 23' ' ' ILE . 26.4 m-20 -89.65 58.41 4.29 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.96 HD13 ' O ' ' B' ' 22' ' ' ASN . 1.5 mm -145.65 169.21 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.072 -1.018 . . . . 0.0 110.135 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.737 ' HG2' HG22 ' B' ' 43' ' ' THR . 0.0 OUTLIER -160.16 -35.68 0.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.614 ' O ' HG23 ' B' ' 26' ' ' VAL . 3.0 p -136.37 -172.64 3.19 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.614 HG23 ' O ' ' B' ' 25' ' ' SER . 52.0 t -159.2 115.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.915 -1.115 . . . . 0.0 109.984 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.514 ' O ' HD12 ' B' ' 41' ' ' ILE . 3.9 t-20 -109.09 110.71 22.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.111 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.549 HG13 HG22 ' B' ' 40' ' ' VAL . 2.1 t -120.74 109.81 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.661 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.471 ' HB3' ' HG2' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -108.78 102.04 11.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.282 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.451 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.0 OUTLIER -48.84 171.29 0.1 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.377 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 36.3 Cg_endo -77.98 140.87 18.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.641 2.227 . . . . 0.0 110.497 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.57 -141.46 3.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.47 8.82 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.563 2.175 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.471 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 4.4 p-80 -125.56 -21.32 4.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.053 -1.03 . . . . 0.0 109.775 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.445 ' SG ' ' OE1' ' B' ' 37' ' ' GLN . 2.1 t -160.03 122.59 3.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.092 -1.005 . . . . 0.0 109.333 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' B' ' 31' ' ' PRO . . . -86.57 16.28 4.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.603 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.455 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 2.0 mp0 -124.17 124.87 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 109.474 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 15.3 m -54.78 137.58 44.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.939 . . . . 0.0 109.413 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.472 ' OE1' ' N ' ' B' ' 39' ' ' GLU . 1.7 mp0 -118.85 107.06 13.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.94 . . . . 0.0 109.632 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.724 HG11 HD11 ' B' ' 63' ' ' ILE . 13.5 t -95.14 146.91 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.515 ' CG1' ' SG ' ' B' ' 51' ' ' CYS . 2.1 mp -138.2 152.63 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.089 -1.007 . . . . 0.0 109.899 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.753 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -136.6 125.29 23.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.085 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.737 HG22 ' HG2' ' B' ' 24' ' ' GLN . 33.8 m -89.6 106.87 18.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.973 -1.08 . . . . 0.0 109.071 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.826 HD23 ' O ' ' B' ' 22' ' ' ASN . 72.8 mt -49.07 166.17 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.151 -0.968 . . . . 0.0 109.013 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -84.34 11.03 9.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 0.0 109.442 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -111.12 19.3 18.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.345 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.63 80.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.577 ' HB2' HD12 ' B' ' 44' ' ' LEU . 49.2 mtt180 -109.16 175.24 5.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -1.209 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -145.19 155.33 43.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.425 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.482 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.14 124.98 9.83 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.391 -0.818 . . . . 0.0 109.112 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.515 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 12.0 m -79.64 140.3 37.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.166 -0.959 . . . . 0.0 109.244 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.827 ' HB3' HG22 ' B' ' 59' ' ' VAL . 11.4 mt -122.91 168.69 11.98 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.259 -0.901 . . . . 0.0 109.229 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.652 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.2 t30 -104.78 124.86 35.48 Favored Pre-proline 0 C--N 1.299 -1.601 0 O-C-N 121.344 -0.847 . . . . 0.0 109.171 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.06 -13.58 21.25 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.263 1.975 . . . . 0.0 110.452 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.526 ' HB3' HD22 ' B' ' 53' ' ' ASN . . . -73.53 -16.68 61.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 108.804 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.493 ' HG ' HG22 ' B' ' 58' ' ' ILE . 0.7 OUTLIER -90.2 161.13 38.46 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.342 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.5 Cg_endo -78.07 -37.19 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.703 2.269 . . . . 0.0 111.08 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.593 ' O ' HD13 ' B' ' 62' ' ' ILE . 17.5 tt -64.69 -47.26 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.053 -1.029 . . . . 0.0 109.162 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.827 HG22 ' HB3' ' B' ' 52' ' ' LEU . 39.4 t -56.75 -48.28 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' B' ' 56' ' ' SER . 4.6 mmtt -54.15 -31.24 51.93 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.51 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 9.7 mmmm -78.27 -30.64 48.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.498 -0.751 . . . . 0.0 109.302 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.604 HG22 HD12 ' B' ' 63' ' ' ILE . 1.7 mp -58.08 -43.57 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.825 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.6 mp -68.72 -61.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -42.7 -28.99 0.27 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.347 -0.845 . . . . 0.0 109.583 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' B' ' 66' ' ' MET . 0.7 OUTLIER -74.38 -60.47 2.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.942 . . . . 0.0 109.276 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.531 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 1.2 mmm -44.16 -48.28 9.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.83 . . . . 0.0 109.207 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.833 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -43.75 -51.16 7.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.379 -0.825 . . . . 0.0 109.317 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -64.91 -37.09 86.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.523 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.499 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.956 ' HB2' HD22 ' A' ' 12' ' ' LEU . 7.7 m . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -42.25 -27.25 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.415 -0.803 . . . . 0.0 109.797 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.446 ' SG ' HG13 ' A' ' 41' ' ' ILE . 98.7 m -131.26 67.18 1.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.185 -0.947 . . . . 0.0 109.616 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.956 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.43 -40.44 5.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.228 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -121.43 126.44 49.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.405 -0.81 . . . . 0.0 109.173 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -106.52 160.51 15.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.469 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.1 mt -110.38 140.64 44.39 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.519 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.2 tt0 -44.07 -26.62 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.371 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.782 ' O ' HG23 ' A' ' 18' ' ' ILE . . . 151.78 -165.88 30.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.782 HG23 ' O ' ' A' ' 17' ' ' GLY . 1.2 pp -169.14 162.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -1.064 . . . . 0.0 109.842 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.629 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.7 t60 -56.83 149.07 45.09 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.629 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -80.37 -15.99 10.99 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.318 2.012 . . . . 0.0 108.922 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.53 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 5.7 mttm -77.99 -22.8 48.83 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.962 ' O ' HD13 ' A' ' 23' ' ' ILE . 17.9 m-20 -94.25 57.85 2.39 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.962 HD13 ' O ' ' A' ' 22' ' ' ASN . 2.4 mm -143.27 169.97 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.044 -1.035 . . . . 0.0 110.129 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -160.09 -40.47 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.528 ' CB ' ' HB ' ' A' ' 43' ' ' THR . 2.2 p -133.18 174.98 9.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.531 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 50.4 t -156.48 122.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.952 -1.092 . . . . 0.0 109.759 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.495 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 56.0 t30 -104.77 155.97 18.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.486 ' HB ' ' HB ' ' B' ' 26' ' ' VAL . 2.9 t -145.59 76.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.527 ' HE3' ' NE2' ' A' ' 34' ' ' HIS . 11.0 tptt -87.36 100.4 12.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.3 p -51.65 166.34 0.38 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 109.41 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.527 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.9 Cg_endo -78.15 131.75 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.594 2.196 . . . . 0.0 110.537 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.54 -144.34 4.91 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.19 7.77 3.54 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.59 2.194 . . . . 0.0 110.767 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.527 ' NE2' ' HE3' ' A' ' 29' ' ' LYS . 11.5 p-80 -125.98 -6.91 6.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.089 -1.007 . . . . 0.0 109.616 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.6 t -160.04 116.97 2.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.41 45.83 1.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.508 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.527 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 4.3 pt20 -172.55 139.14 0.93 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.53 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.435 ' HB ' ' CG ' ' A' ' 54' ' ' PRO . 2.4 m -57.52 144.06 38.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 109.373 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -124.77 107.64 11.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.592 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.986 HG11 HD11 ' A' ' 63' ' ' ILE . 44.2 t -100.39 150.02 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.867 . . . . 0.0 109.297 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.504 HG22 ' N ' ' A' ' 42' ' ' ALA . 2.5 mp -136.06 159.66 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.848 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.656 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -141.73 121.53 13.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.803 . . . . 0.0 109.11 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.528 ' HB ' ' CB ' ' A' ' 25' ' ' SER . 16.4 m -89.53 101.27 13.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.973 -1.079 . . . . 0.0 109.17 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.775 HD23 ' O ' ' A' ' 22' ' ' ASN . 73.7 mt -44.56 165.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.323 -0.861 . . . . 0.0 109.02 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.53 ' CD ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -83.64 9.93 10.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 109.494 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -109.99 16.88 21.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.364 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.83 18.54 67.6 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.595 ' HB2' HD12 ' A' ' 44' ' ' LEU . 1.7 mtp180 -111.89 169.43 8.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -1.134 . . . . 0.0 109.502 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -136.18 153.65 51.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.943 . . . . 0.0 109.478 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.27 123.36 8.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.113 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.435 ' SG ' HG13 ' A' ' 41' ' ' ILE . 11.8 m -79.51 143.19 35.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.096 -1.002 . . . . 0.0 109.14 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.864 ' HB3' HG22 ' A' ' 59' ' ' VAL . 14.0 mt -123.63 168.12 13.07 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.372 -0.83 . . . . 0.0 109.305 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.657 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.9 t-20 -100.48 122.39 49.89 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.151 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.506 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.6 Cg_endo -75.14 -10.2 20.89 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.205 1.937 . . . . 0.0 110.283 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.08 -14.76 58.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.273 -0.892 . . . . 0.0 108.969 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -89.96 159.53 42.62 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.435 -0.791 . . . . 0.0 109.426 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.44 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.7 -33.49 2.27 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.578 2.185 . . . . 0.0 110.671 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.591 HG23 ' N ' ' A' ' 59' ' ' VAL . 16.8 tt -68.07 -46.96 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.015 . . . . 0.0 109.232 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.864 HG22 ' HB3' ' A' ' 52' ' ' LEU . 37.3 t -56.23 -48.78 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.414 -0.804 . . . . 0.0 109.076 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.506 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 14.9 mttt -56.32 -31.51 63.78 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -74.52 -29.93 61.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.604 -0.685 . . . . 0.0 109.284 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -68.88 -43.59 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.012 HG22 HD11 ' B' ' 67' ' ' LEU . 2.2 mp -65.17 -65.86 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.523 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -48.04 -42.73 29.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 109.593 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -55.58 -49.24 73.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 109.3 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.531 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -53.48 -47.47 69.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.265 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.98 HD11 HG22 ' B' ' 63' ' ' ILE . 0.2 OUTLIER -46.89 -52.48 14.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.462 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' SER . 13.4 t-20 -63.52 -31.73 72.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.466 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 68' ' ' ASN . 5.9 p . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 109.509 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.935 ' HB2' HD22 ' B' ' 12' ' ' LEU . 7.8 m . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -42.16 -27.3 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.833 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.452 ' SG ' HG13 ' B' ' 41' ' ' ILE . 98.9 m -131.27 67.15 1.52 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.598 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.935 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.37 -40.59 5.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.164 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -121.34 126.54 49.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.167 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.531 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -106.56 160.59 15.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.841 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.473 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.0 mt -110.38 140.58 44.45 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.461 -0.774 . . . . 0.0 108.928 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.528 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.2 tt0 -44.04 -26.59 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.119 -0.988 . . . . 0.0 109.422 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.766 ' O ' HG23 ' B' ' 18' ' ' ILE . . . 151.76 -165.86 30.69 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.766 HG23 ' O ' ' B' ' 17' ' ' GLY . 1.2 pp -169.13 162.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -1.068 . . . . 0.0 109.837 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.612 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 1.7 t60 -56.89 149.05 45.83 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.612 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.6 Cg_endo -80.32 -16.03 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.383 2.055 . . . . 0.0 108.915 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.537 ' O ' ' CD ' ' B' ' 45' ' ' LYS . 5.7 mttm -78.04 -22.71 48.77 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.969 ' O ' HD13 ' B' ' 23' ' ' ILE . 17.8 m-20 -94.34 57.96 2.38 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.969 HD13 ' O ' ' B' ' 22' ' ' ASN . 2.3 mm -143.31 169.98 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.093 -1.004 . . . . 0.0 110.157 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.0 OUTLIER -160.11 -40.62 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.524 ' CB ' ' HB ' ' B' ' 43' ' ' THR . 2.1 p -133.13 174.93 9.85 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.535 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 50.4 t -156.38 122.5 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.939 -1.101 . . . . 0.0 109.759 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.488 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 55.6 t30 -104.71 155.9 18.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.244 -0.91 . . . . 0.0 109.357 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 2.9 t -145.52 76.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.516 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.518 ' HE3' ' NE2' ' B' ' 34' ' ' HIS . 11.0 tptt -87.32 100.49 12.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.3 p -51.75 166.29 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.533 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.8 Cg_endo -78.05 131.71 11.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.648 2.232 . . . . 0.0 110.524 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.5 -144.41 4.93 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.11 7.74 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.649 2.233 . . . . 0.0 110.819 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.518 ' NE2' ' HE3' ' B' ' 29' ' ' LYS . 11.4 p-80 -125.98 -6.86 6.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.993 . . . . 0.0 109.67 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.7 t -160.15 116.93 2.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.415 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.4 45.73 1.22 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.576 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.533 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 4.2 pt20 -172.48 139.17 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 109.55 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.437 ' HB ' ' CG ' ' B' ' 54' ' ' PRO . 2.4 m -57.46 144.12 37.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -124.84 107.59 11.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.554 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.98 HG11 HD11 ' B' ' 63' ' ' ILE . 44.3 t -100.39 150.05 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.281 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.491 HG22 ' N ' ' B' ' 42' ' ' ALA . 2.5 mp -136.03 159.63 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.121 -0.987 . . . . 0.0 109.87 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.648 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -141.69 121.47 13.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.822 . . . . 0.0 109.135 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 16.4 m -89.43 101.32 14.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.024 -1.047 . . . . 0.0 109.23 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.783 HD23 ' O ' ' B' ' 22' ' ' ASN . 73.8 mt -44.56 165.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 109.058 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.537 ' CD ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -83.66 9.88 10.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.161 -0.962 . . . . 0.0 109.434 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -109.91 16.79 21.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.92 18.46 67.58 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.587 ' HB2' HD12 ' B' ' 44' ' ' LEU . 1.7 mtp180 -111.82 169.29 8.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -1.173 . . . . 0.0 109.512 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.429 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 0.3 OUTLIER -136.04 153.61 51.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 109.592 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.473 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.21 123.31 8.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 109.072 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.433 ' SG ' HG13 ' B' ' 41' ' ' ILE . 12.0 m -79.45 143.21 35.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.091 -1.006 . . . . 0.0 109.239 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.858 ' HB3' HG22 ' B' ' 59' ' ' VAL . 14.0 mt -123.7 168.07 13.16 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.222 -0.924 . . . . 0.0 109.344 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.663 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.9 t-20 -100.52 122.31 50.08 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.182 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.51 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.6 Cg_endo -74.99 -10.17 21.1 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.143 1.895 . . . . 0.0 110.388 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.1 -14.74 58.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -0.919 . . . . 0.0 108.892 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.3 OUTLIER -90.01 159.55 42.44 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.409 -0.807 . . . . 0.0 109.421 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.451 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.71 -33.43 2.29 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.622 2.215 . . . . 0.0 110.652 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.608 ' O ' HD13 ' B' ' 62' ' ' ILE . 16.9 tt -68.2 -46.88 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.099 -1.0 . . . . 0.0 109.151 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.858 HG22 ' HB3' ' B' ' 52' ' ' LEU . 37.1 t -56.3 -48.69 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 109.072 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.51 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 14.9 mttt -56.44 -31.43 63.93 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.471 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -74.63 -29.85 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.604 -0.685 . . . . 0.0 109.266 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.608 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -68.89 -43.67 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.98 HG22 HD11 ' A' ' 67' ' ' LEU . 2.1 mp -65.17 -65.89 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.499 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -47.99 -42.82 28.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 109.549 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -55.52 -49.24 73.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.308 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.535 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -53.49 -47.39 69.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.299 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.012 HD11 HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -46.9 -52.47 14.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.454 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' B' ' 69' ' ' SER . 13.4 t-20 -63.53 -31.75 73.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.41 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.402 ' C ' ' O ' ' B' ' 68' ' ' ASN . 5.8 p . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.497 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.829 ' HB2' HD22 ' A' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' A' ' 9' ' ' CYS . 13.7 mm-40 -42.16 -27.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -0.818 . . . . 0.0 109.798 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.472 ' SG ' HG13 ' A' ' 41' ' ' ILE . 79.1 m -136.55 81.06 1.86 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 109.716 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.829 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -53.93 -41.44 67.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.16 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -118.5 117.93 30.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.16 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.78 163.18 12.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.792 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.516 ' HB2' HD23 ' A' ' 52' ' ' LEU . 4.4 mt -106.18 137.2 44.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.83 . . . . 0.0 108.963 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -44.49 -41.39 6.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.979 . . . . 0.0 109.366 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 177.54 168.84 37.82 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.734 ' H ' HD11 ' A' ' 62' ' ' ILE . 8.0 tp -153.67 158.37 3.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.473 -1.016 . . . . 0.0 108.772 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.576 ' CB ' ' ND2' ' A' ' 22' ' ' ASN . 2.6 t-80 -45.04 139.89 3.77 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.226 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.7 Cg_endo -77.77 -25.44 7.78 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.491 2.127 . . . . 0.0 110.292 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -90.12 -14.83 32.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 0.0 108.987 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.576 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 51.7 m-20 -70.33 -11.61 61.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.325 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.879 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 3.1 mt -105.44 149.01 9.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.263 -0.898 . . . . 0.0 110.611 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.514 ' HG3' ' N ' ' A' ' 25' ' ' SER . 1.3 pp0? -115.61 -27.69 7.03 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.514 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -136.1 160.72 37.79 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.523 ' O ' HG23 ' B' ' 28' ' ' VAL . 2.0 t -146.16 101.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.941 -1.1 . . . . 0.0 109.932 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 29.1 t30 -79.96 116.73 20.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.198 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.52 HG23 ' O ' ' B' ' 26' ' ' VAL . 1.8 t -98.23 84.68 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -0.923 . . . . 0.0 109.49 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER -89.59 93.91 9.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.364 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.09 167.26 0.25 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.376 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.5 Cg_endo -77.96 131.84 11.32 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.619 2.213 . . . . 0.0 110.38 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.22 -145.97 6.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.96 5.48 4.93 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.628 2.219 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -121.81 -16.83 7.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.614 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 9.1 t -160.12 96.88 1.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.33 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.76 -10.57 28.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.595 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.445 ' OE1' ' SG ' ' A' ' 9' ' ' CYS . 2.0 mp0 -96.24 125.26 40.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.57 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.478 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 3.8 m -50.68 150.7 2.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.944 . . . . 0.0 109.385 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 35' ' ' CYS . 3.3 mp0 -129.39 107.7 9.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.959 . . . . 0.0 109.571 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.723 HG11 HD11 ' A' ' 63' ' ' ILE . 1.7 t -102.59 95.34 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.257 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.536 HD12 ' N ' ' A' ' 41' ' ' ILE . 5.2 mp -86.03 140.73 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.742 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.879 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -124.14 119.14 28.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.202 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 43' ' ' THR . 1.0 OUTLIER -89.17 100.07 12.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.02 -1.05 . . . . 0.0 108.459 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 48' ' ' ARG . 72.5 mt -41.49 165.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.541 0.686 . . . . 0.0 110.073 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.5 ptpt -80.36 6.96 10.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.539 -0.726 . . . . 0.0 109.686 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -111.95 8.54 20.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.406 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.35 -6.11 71.42 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.523 ' HB2' HD12 ' A' ' 44' ' ' LEU . 7.3 mtt180 -84.46 170.52 13.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.13 -1.218 . . . . 0.0 109.537 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 10.0 mttt -133.86 153.73 51.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.22 118.12 6.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.037 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.467 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 19.4 m -79.57 139.02 37.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.129 -0.982 . . . . 0.0 109.166 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.968 HD13 HD13 ' A' ' 62' ' ' ILE . 11.3 mt -126.9 168.25 14.74 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.15 -0.969 . . . . 0.0 109.329 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.651 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.8 t30 -108.26 129.16 24.42 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.554 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.478 ' HG3' ' HB ' ' A' ' 38' ' ' THR . 34.4 Cg_endo -76.1 4.45 5.3 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.407 2.071 . . . . 0.0 110.747 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.38 -21.31 27.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.249 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.06 163.97 29.86 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.843 . . . . 0.0 109.466 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.84 -29.1 4.61 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.654 2.236 . . . . 0.0 110.143 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.541 ' CG2' ' HA3' ' A' ' 17' ' ' GLY . 8.6 mm -68.18 -47.33 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.004 ' HA ' HD12 ' A' ' 62' ' ' ILE . 51.1 t -62.38 -48.61 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 109.675 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 56' ' ' SER . 2.8 mmpt? -56.91 -30.52 64.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.93 . . . . 0.0 108.809 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.533 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -81.66 -24.69 36.15 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.004 HD12 ' HA ' ' A' ' 59' ' ' VAL . 16.0 mt -67.97 -38.25 79.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.25 -0.906 . . . . 0.0 108.592 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.091 ' CG2' HD11 ' B' ' 67' ' ' LEU . 1.5 mp -76.36 -63.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.383 -0.823 . . . . 0.0 109.117 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -43.92 -50.84 7.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.253 -0.904 . . . . 0.0 109.428 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 66' ' ' MET . 4.4 tmtm? -52.03 -57.58 9.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.211 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.483 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -44.12 -46.2 8.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 109.127 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.098 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -55.59 -49.54 72.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.452 -0.78 . . . . 0.0 109.527 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -96.26 33.91 1.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.474 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.473 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.829 ' HB2' HD22 ' B' ' 12' ' ' LEU . 1.7 m . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' B' ' 9' ' ' CYS . 13.6 mm-40 -42.14 -27.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.796 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' B' ' 41' ' ' ILE . 78.4 m -136.61 81.1 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 109.595 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.829 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.3 OUTLIER -53.94 -41.47 67.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.202 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -118.39 117.97 30.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.283 -0.886 . . . . 0.0 109.146 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.85 163.09 12.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.825 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.515 ' HB2' HD23 ' B' ' 52' ' ' LEU . 4.3 mt -106.0 137.17 44.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.321 -0.862 . . . . 0.0 108.995 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.0 OUTLIER -44.56 -41.28 6.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 109.4 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.531 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 177.5 168.8 37.73 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.716 ' H ' HD11 ' B' ' 62' ' ' ILE . 8.0 tp -153.64 158.39 3.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.493 -1.004 . . . . 0.0 108.784 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.576 ' CB ' ' ND2' ' B' ' 22' ' ' ASN . 2.6 t-80 -45.05 139.86 3.8 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.02 -1.05 . . . . 0.0 109.156 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.481 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.1 Cg_endo -77.8 -25.36 7.8 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.501 2.134 . . . . 0.0 110.256 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.463 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.2 OUTLIER -90.18 -14.84 32.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.405 -0.81 . . . . 0.0 108.974 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.576 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 52.0 m-20 -70.29 -11.61 61.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.451 -0.781 . . . . 0.0 109.318 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.888 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 3.0 mt -105.41 148.99 9.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.238 -0.914 . . . . 0.0 110.584 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.516 ' HG3' ' N ' ' B' ' 25' ' ' SER . 1.3 pp0? -115.63 -27.75 7.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.516 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -136.04 160.81 37.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 28' ' ' VAL . 2.0 t -146.24 101.5 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.03 -1.044 . . . . 0.0 109.917 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 29.0 t30 -79.88 116.79 20.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.247 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 26' ' ' VAL . 1.8 t -98.24 84.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER -89.58 93.87 9.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.214 -0.929 . . . . 0.0 109.396 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.02 167.21 0.25 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.266 -0.896 . . . . 0.0 109.399 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.9 Cg_endo -77.91 131.87 11.4 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.56 2.173 . . . . 0.0 110.455 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.22 -146.12 6.05 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -76.87 5.47 4.88 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.623 2.216 . . . . 0.0 110.654 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -121.86 -16.75 7.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.951 . . . . 0.0 109.555 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 9.1 t -160.14 96.92 1.23 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 109.353 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.77 -10.56 28.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.638 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.446 ' OE1' ' SG ' ' B' ' 9' ' ' CYS . 2.0 mp0 -96.28 125.21 40.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.494 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.476 ' HB ' ' HG3' ' B' ' 54' ' ' PRO . 3.8 m -50.62 150.67 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 109.375 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.472 ' OE2' ' HB3' ' B' ' 35' ' ' CYS . 3.3 mp0 -129.4 107.81 9.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.603 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.734 HG11 HD11 ' B' ' 63' ' ' ILE . 1.7 t -102.61 95.26 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.288 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.538 ' N ' HD12 ' B' ' 41' ' ' ILE . 5.2 mp -86.02 140.72 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.888 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -124.16 119.13 28.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.845 . . . . 0.0 109.226 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.617 ' O ' HG22 ' B' ' 43' ' ' THR . 1.0 OUTLIER -89.13 100.08 12.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.035 -1.041 . . . . 0.0 108.437 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' B' ' 48' ' ' ARG . 72.1 mt -41.48 165.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.573 0.702 . . . . 0.0 110.031 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.463 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.5 ptpt -80.49 7.04 10.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.472 -0.767 . . . . 0.0 109.647 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -111.91 8.48 20.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.473 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.01 71.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.547 ' HB2' HD12 ' B' ' 44' ' ' LEU . 7.3 mtt180 -84.6 170.56 13.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.239 . . . . 0.0 109.513 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.42 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 9.9 mttt -133.84 153.81 51.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 109.507 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.34 118.11 6.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 108.971 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 19.6 m -79.56 138.95 37.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.169 -0.957 . . . . 0.0 109.237 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.988 HD13 HD13 ' B' ' 62' ' ' ILE . 11.3 mt -126.84 168.3 14.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.638 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.8 t30 -108.26 129.32 24.21 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.521 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.476 ' HG3' ' HB ' ' B' ' 38' ' ' THR . 34.6 Cg_endo -76.27 4.52 5.32 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.342 2.028 . . . . 0.0 110.755 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.43 -21.27 27.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.162 -0.962 . . . . 0.0 109.231 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -90.12 163.93 29.87 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.477 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.74 -29.18 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.683 2.255 . . . . 0.0 110.171 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.531 ' CG2' ' HA3' ' B' ' 17' ' ' GLY . 8.6 mm -68.1 -47.28 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.442 -0.786 . . . . 0.0 109.264 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.996 ' HA ' HD12 ' B' ' 62' ' ' ILE . 50.7 t -62.49 -48.46 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.328 -0.858 . . . . 0.0 109.731 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' B' ' 56' ' ' SER . 2.8 mmpt? -56.96 -30.54 64.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -0.929 . . . . 0.0 108.797 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -81.6 -24.68 36.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.524 -0.735 . . . . 0.0 109.247 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.996 HD12 ' HA ' ' B' ' 59' ' ' VAL . 16.1 mt -67.93 -38.23 79.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 1.098 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.5 mp -76.33 -63.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.505 -0.747 . . . . 0.0 109.097 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -43.93 -50.84 7.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.289 -0.882 . . . . 0.0 109.444 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' B' ' 66' ' ' MET . 4.4 tmtm? -52.14 -57.45 9.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.269 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.486 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.4 OUTLIER -44.1 -46.2 8.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.149 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.091 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -55.67 -49.54 72.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 0.0 109.484 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -96.2 33.87 1.68 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 179.951 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 11' ' ' CYS . 72.8 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.533 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 30.2 mm-40 -43.16 -26.09 0.15 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.714 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.46 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 19.4 m -145.19 75.12 1.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.633 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -44.66 -50.72 9.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.168 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 7.8 pt20 -108.95 103.25 12.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.157 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.439 ' HB ' ' C ' ' A' ' 52' ' ' LEU . 1.1 p -79.89 144.93 32.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.668 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.584 ' HB2' HD23 ' A' ' 52' ' ' LEU . 22.3 mt -78.6 -174.06 3.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 109.336 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.62 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -84.23 -40.76 17.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 0.0 109.502 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.874 ' O ' HG23 ' A' ' 18' ' ' ILE . . . 155.61 -172.07 33.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.874 HG23 ' O ' ' A' ' 17' ' ' GLY . 1.3 pp -172.11 164.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -1.056 . . . . 0.0 109.213 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.49 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -58.92 150.14 61.8 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.319 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.675 ' HA ' HD12 ' A' ' 23' ' ' ILE . 35.3 Cg_endo -77.14 -4.47 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.512 2.141 . . . . 0.0 110.176 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.459 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -90.35 -23.49 21.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.385 -0.822 . . . . 0.0 109.198 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.3 m-20 -85.18 -18.99 32.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.305 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.964 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 22.0 mt -83.38 169.22 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.441 -0.787 . . . . 0.0 110.07 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.574 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -139.37 -40.93 0.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.468 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 1.7 p -124.9 177.31 6.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.838 . . . . 0.0 108.892 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.571 HG23 ' HG3' ' A' ' 66' ' ' MET . 47.7 t -146.8 100.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.018 -1.051 . . . . 0.0 109.698 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.666 ' O ' HD12 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -100.05 111.15 23.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.266 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.863 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -120.98 102.3 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.533 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -103.94 117.22 33.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.919 . . . . 0.0 109.397 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.444 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -57.31 171.68 0.46 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.153 -0.967 . . . . 0.0 109.284 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.516 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.8 Cg_endo -77.83 153.07 29.23 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.693 2.262 . . . . 0.0 110.456 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.98 -140.56 2.9 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.561 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 36.4 Cg_endo -78.28 12.14 2.17 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.654 2.236 . . . . 0.0 110.982 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.561 ' CE1' ' HD2' ' A' ' 33' ' ' PRO . 1.9 p-80 -127.49 -32.71 2.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.988 -1.07 . . . . 0.0 109.53 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.31 121.4 12.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.381 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.8 44.41 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.933 . . . . 0.0 109.625 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.516 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 5.2 pt20 -169.98 139.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.54 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.6 m -55.91 141.39 39.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.93 107.54 10.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.95 HG11 HD11 ' A' ' 63' ' ' ILE . 47.7 t -95.1 149.24 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.21 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.666 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.4 mp -142.0 151.13 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.863 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.964 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -135.13 123.08 22.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 108.886 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 7.4 m -89.77 100.18 13.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.089 . . . . 0.0 109.375 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 60.7 mt -42.43 164.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 0.0 109.606 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 13.0 ptpt -82.83 9.78 9.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -113.91 19.55 16.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.457 ' O ' ' HD2' ' A' ' 49' ' ' LYS . . . 87.6 -17.64 43.23 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.462 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 42.8 mtt180 -77.3 163.19 26.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -1.116 . . . . 0.0 109.416 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -144.01 122.65 12.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.148 -0.97 . . . . 0.0 109.541 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.562 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -116.18 127.94 55.21 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.24 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.507 ' O ' HD23 ' A' ' 52' ' ' LEU . 92.2 m -79.65 155.34 28.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.062 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.032 HD13 HD13 ' A' ' 62' ' ' ILE . 12.8 mt -135.19 170.98 15.08 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.141 -0.974 . . . . 0.0 109.702 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.663 ' O ' HG21 ' A' ' 59' ' ' VAL . 15.3 p-10 -105.39 127.6 28.26 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.78 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -75.08 -4.66 15.71 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.087 1.858 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 -19.29 53.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 108.778 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 159.39 42.5 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.349 -0.844 . . . . 0.0 109.022 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.92 -32.25 3.44 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.582 2.188 . . . . 0.0 110.778 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.623 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -69.53 -44.66 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 109.168 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.059 ' HA ' HD12 ' A' ' 62' ' ' ILE . 31.4 t -58.0 -46.94 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.834 . . . . 0.0 109.152 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 56' ' ' SER . 9.6 mtmt -60.51 -30.49 69.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.492 ' CE ' ' CD ' ' A' ' 64' ' ' GLU . 4.9 mmpt? -76.67 -23.56 53.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.059 HD12 ' HA ' ' A' ' 59' ' ' VAL . 19.0 mt -71.39 -37.16 63.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.95 HD11 HG11 ' A' ' 40' ' ' VAL . 2.3 mp -73.21 -58.14 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.492 ' CD ' ' CE ' ' A' ' 61' ' ' LYS . 5.7 pt-20 -59.2 -52.19 66.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.045 -1.034 . . . . 0.0 109.652 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 6.5 mtpp -46.35 -52.43 12.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.112 -0.992 . . . . 0.0 109.132 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.571 ' HG3' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -49.38 -46.41 47.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.214 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.615 HD11 ' HB ' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -45.93 -52.08 12.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.432 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -64.39 -33.59 76.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.843 . . . . 0.0 109.531 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.427 ' O ' ' N ' ' B' ' 11' ' ' CYS . 71.8 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.526 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 30.2 mm-40 -43.22 -26.07 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 0.0 109.704 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.454 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 19.9 m -145.18 75.09 1.43 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.983 . . . . 0.0 109.601 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.509 HD13 ' O ' ' B' ' 12' ' ' LEU . 0.2 OUTLIER -44.61 -50.72 9.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 109.238 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 13' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' B' ' 13' ' ' GLN . 7.8 pt20 -108.95 103.25 12.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.831 . . . . 0.0 109.144 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.433 ' HB ' ' C ' ' B' ' 52' ' ' LEU . 1.0 OUTLIER -79.9 144.89 33.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.608 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.565 ' HB2' HD23 ' B' ' 52' ' ' LEU . 22.2 mt -78.46 -174.07 3.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.854 . . . . 0.0 109.33 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.625 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.0 OUTLIER -84.33 -40.74 17.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.176 -0.952 . . . . 0.0 109.474 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.872 ' O ' HG23 ' B' ' 18' ' ' ILE . . . 155.66 -172.04 33.71 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.872 HG23 ' O ' ' B' ' 17' ' ' GLY . 1.3 pp -172.2 163.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -1.013 . . . . 0.0 109.161 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.508 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -58.91 150.19 61.55 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.299 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.669 ' HA ' HD12 ' B' ' 23' ' ' ILE . 35.3 Cg_endo -77.14 -4.47 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.55 2.167 . . . . 0.0 110.173 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -90.3 -23.61 21.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.3 m-20 -85.16 -18.88 32.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.24 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.979 HG23 ' HB1' ' B' ' 42' ' ' ALA . 21.8 mt -83.43 169.22 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.389 -0.819 . . . . 0.0 110.066 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.583 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.4 OUTLIER -139.35 -41.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.458 ' CB ' ' HB ' ' B' ' 43' ' ' THR . 1.7 p -124.88 177.26 6.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.451 -0.781 . . . . 0.0 108.899 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.564 HG23 ' HG3' ' B' ' 66' ' ' MET . 48.2 t -146.76 100.46 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.647 ' O ' HD12 ' B' ' 41' ' ' ILE . 0.1 OUTLIER -100.09 111.18 23.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 109.217 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.831 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -120.97 102.37 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.526 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 0.2 OUTLIER -103.95 117.16 33.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.401 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.447 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.0 OUTLIER -57.18 171.63 0.45 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.306 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.522 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.8 Cg_endo -77.83 153.09 29.24 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.623 2.215 . . . . 0.0 110.435 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.98 -140.64 2.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.552 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -78.33 12.34 2.12 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.513 2.142 . . . . 0.0 111.006 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.552 ' CE1' ' HD2' ' B' ' 33' ' ' PRO . 1.9 p-80 -127.6 -32.63 2.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.013 -1.054 . . . . 0.0 109.509 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.34 121.34 12.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.393 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.78 44.52 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.701 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.522 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 5.2 pt20 -170.08 139.3 1.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.494 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 2.7 m -55.98 141.28 40.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.78 107.54 10.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.659 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.939 HG11 HD11 ' B' ' 63' ' ' ILE . 47.7 t -95.2 149.31 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.204 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.647 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.4 mp -141.96 151.17 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.875 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.979 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -135.14 122.92 22.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 108.962 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 7.4 m -89.66 100.16 13.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.955 -1.09 . . . . 0.0 109.392 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' B' ' 22' ' ' ASN . 60.4 mt -42.49 164.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.63 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.459 ' HA ' ' HB2' ' B' ' 24' ' ' GLN . 12.9 ptpt -82.79 9.8 9.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.708 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -113.94 19.62 16.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.23 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 47' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' B' ' 49' ' ' LYS . . . 87.62 -17.77 42.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.468 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 42.7 mtt180 -77.25 163.06 26.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -1.151 . . . . 0.0 109.405 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.463 ' HD2' ' O ' ' B' ' 47' ' ' GLY . 0.0 OUTLIER -143.97 122.67 12.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.546 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.553 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -116.19 127.94 55.2 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.445 -0.784 . . . . 0.0 109.33 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.494 ' O ' HD23 ' B' ' 52' ' ' LEU . 91.2 m -79.66 155.32 28.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.047 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 1.053 HD13 HD13 ' B' ' 62' ' ' ILE . 12.8 mt -135.18 170.92 15.18 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.152 -0.968 . . . . 0.0 109.744 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.666 ' O ' HG21 ' B' ' 59' ' ' VAL . 15.4 p-10 -105.34 127.54 28.38 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.845 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.04 -4.57 15.6 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.111 1.874 . . . . 0.0 110.308 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.45 -19.25 53.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.923 . . . . 0.0 108.761 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -90.01 159.42 42.72 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.109 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.04 -32.25 3.31 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.578 2.185 . . . . 0.0 110.792 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.641 ' O ' HD13 ' B' ' 58' ' ' ILE . 0.1 OUTLIER -69.45 -44.72 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.102 -0.999 . . . . 0.0 109.153 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 1.011 ' HA ' HD12 ' B' ' 62' ' ' ILE . 32.1 t -57.97 -46.94 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 109.177 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' B' ' 56' ' ' SER . 9.6 mtmt -60.49 -30.55 69.78 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' B' ' 61' ' ' LYS . 4.9 mmpt? -76.64 -23.61 53.32 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 1.053 HD13 HD13 ' B' ' 52' ' ' LEU . 19.2 mt -71.25 -37.25 65.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.939 HD11 HG11 ' B' ' 40' ' ' VAL . 2.3 mp -73.23 -58.09 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.876 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.487 ' CD ' ' CE ' ' B' ' 61' ' ' LYS . 5.6 pt-20 -59.33 -52.09 67.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.013 -1.054 . . . . 0.0 109.614 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 6.5 mtpp -46.39 -52.41 13.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 109.056 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.564 ' HG3' HG23 ' B' ' 26' ' ' VAL . 0.2 OUTLIER -49.41 -46.35 47.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.282 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.614 HD11 ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -45.96 -52.05 12.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 0.0 109.41 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' B' ' 69' ' ' SER . 2.4 t30 -64.41 -33.6 76.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.855 . . . . 0.0 109.52 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 68' ' ' ASN . 4.9 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.46 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.954 ' HB2' HD22 ' A' ' 12' ' ' LEU . 93.2 m . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.505 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -42.76 -26.21 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.865 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.521 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 78.1 m -130.85 72.25 1.49 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.642 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.954 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.55 -44.3 8.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.937 . . . . 0.0 109.214 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.32 117.5 33.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.283 -0.886 . . . . 0.0 109.198 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.426 ' OG1' ' CG ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -103.09 156.43 17.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.697 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.566 HD12 HD23 ' A' ' 52' ' ' LEU . 5.5 mt -98.08 135.76 39.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.293 -0.879 . . . . 0.0 109.004 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 15' ' ' LEU . 1.1 tt0 -44.09 -26.79 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.952 . . . . 0.0 109.252 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 156.25 149.32 5.32 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.659 HG22 ' CD2' ' A' ' 52' ' ' LEU . 6.9 tt -128.34 149.97 33.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.375 -1.073 . . . . 0.0 108.883 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.466 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -43.64 146.37 0.98 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.257 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.466 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.2 Cg_endo -76.61 -13.03 18.32 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.435 2.09 . . . . 0.0 109.996 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.532 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 7.6 mttp -78.95 -15.42 58.32 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 1.011 ' O ' HD13 ' A' ' 23' ' ' ILE . 86.5 m-20 -100.43 54.75 0.89 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.011 HD13 ' O ' ' A' ' 22' ' ' ASN . 0.7 OUTLIER -146.08 163.33 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.039 -1.038 . . . . 0.0 110.35 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.749 ' HG2' HG22 ' A' ' 43' ' ' THR . 0.4 OUTLIER -153.02 -36.21 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.9 p -128.47 179.5 5.62 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 25' ' ' SER . 51.0 t -160.14 115.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.897 -1.127 . . . . 0.0 109.891 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 20.3 t-20 -104.87 153.3 21.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.951 . . . . 0.0 109.117 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' B' ' 25' ' ' SER . 2.6 t -143.67 91.82 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HD2' ' NE2' ' A' ' 10' ' ' GLN . 4.2 mttm -95.3 93.45 7.28 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 0.0 109.524 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 4.3 p -44.71 164.26 0.18 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 0.0 109.303 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.7 Cg_endo -77.78 131.87 11.54 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.648 2.232 . . . . 0.0 110.502 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.27 -138.48 3.28 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.22 7.98 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.562 2.175 . . . . 0.0 110.778 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.488 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 4.9 p-80 -126.86 -16.74 5.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.017 . . . . 0.0 109.883 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -160.17 125.23 3.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.024 -1.047 . . . . 0.0 109.229 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' O ' ' CD ' ' A' ' 37' ' ' GLN . . . -87.42 18.95 3.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.719 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.511 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 13.6 mm-40 -143.35 125.06 14.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.497 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 30' ' ' SER . 17.5 m -50.29 140.55 13.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.505 ' OE1' ' N ' ' A' ' 10' ' ' GLN . 8.5 mt-10 -117.66 106.83 13.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.654 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.809 HG21 ' HB3' ' A' ' 54' ' ' PRO . 1.7 t -98.47 106.71 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 109.186 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.521 ' CG1' ' SG ' ' A' ' 11' ' ' CYS . 2.9 mp -94.74 157.31 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.224 -0.923 . . . . 0.0 109.83 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.972 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -136.47 125.88 25.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.798 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.749 HG22 ' HG2' ' A' ' 24' ' ' GLN . 22.4 m -89.66 105.52 17.85 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.026 -1.046 . . . . 0.0 109.111 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.962 HD23 ' O ' ' A' ' 22' ' ' ASN . 82.9 mt -43.79 168.7 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.322 -0.861 . . . . 0.0 109.597 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.532 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.3 ptpt -90.16 17.52 6.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 109.35 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.517 ' OD1' ' CB ' ' A' ' 44' ' ' LEU . 19.6 p-10 -119.49 7.21 11.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.402 -0.812 . . . . 0.0 109.143 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.28 -17.9 54.91 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.744 ' HB2' HD12 ' A' ' 44' ' ' LEU . 8.8 mtt85 -83.73 171.97 12.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -1.185 . . . . 0.0 109.169 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.519 ' CD ' ' OG1' ' A' ' 43' ' ' THR . 9.9 mtmt -144.49 125.21 14.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 109.553 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.24 131.14 55.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.891 . . . . 0.0 109.132 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.464 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 61.7 m -79.74 140.21 37.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.186 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.859 ' HB3' HG22 ' A' ' 59' ' ' VAL . 12.5 mt -129.41 168.64 16.01 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.218 -0.926 . . . . 0.0 109.441 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.66 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.8 m-20 -111.02 130.85 22.53 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.333 -0.854 . . . . 0.0 109.62 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.809 ' HB3' HG21 ' A' ' 40' ' ' VAL . 33.8 Cg_endo -75.26 -14.54 20.55 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.217 1.945 . . . . 0.0 110.21 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.91 -19.13 61.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.875 . . . . 0.0 108.879 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.03 163.16 33.06 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.493 -0.754 . . . . 0.0 109.206 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.14 -41.78 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.665 2.243 . . . . 0.0 110.635 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.542 ' CG2' ' HA3' ' A' ' 17' ' ' GLY . 11.7 mm -54.48 -55.48 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.154 -0.966 . . . . 0.0 109.411 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.859 HG22 ' HB3' ' A' ' 52' ' ' LEU . 89.1 t -54.48 -53.7 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.755 . . . . 0.0 110.053 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -45.81 -31.72 2.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.046 -1.034 . . . . 0.0 108.941 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.531 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -79.5 -38.32 34.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.52 -0.738 . . . . 0.0 109.6 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.8 mp -55.4 -41.88 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.164 -0.96 . . . . 0.0 108.811 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.044 HG22 HD11 ' B' ' 67' ' ' LEU . 2.1 mp -72.11 -65.78 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.353 -0.842 . . . . 0.0 109.49 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -42.23 -27.28 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.445 -0.784 . . . . 0.0 109.67 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -73.86 -49.31 25.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 108.93 179.708 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.475 ' HA ' ' HB3' ' A' ' 69' ' ' SER . 0.4 OUTLIER -55.14 -45.57 75.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.368 -0.832 . . . . 0.0 109.018 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.028 HD11 ' CG2' ' B' ' 63' ' ' ILE . 3.7 mt -53.56 -60.09 3.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.52 -0.738 . . . . 0.0 109.598 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -73.51 -3.98 31.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.632 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 4.1 p . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 109.393 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.936 ' HB2' HD22 ' B' ' 12' ' ' LEU . 94.5 m . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.509 ' N ' ' OE1' ' B' ' 39' ' ' GLU . 0.1 OUTLIER -42.77 -26.23 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.839 . . . . 0.0 109.866 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.517 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 78.2 m -130.78 72.2 1.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.621 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.936 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.55 -44.29 8.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.932 . . . . 0.0 109.147 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.32 117.5 33.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.29 -0.881 . . . . 0.0 109.275 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.426 ' OG1' ' CG ' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -103.09 156.44 17.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.865 . . . . 0.0 109.641 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.551 HD12 HD23 ' B' ' 52' ' ' LEU . 5.6 mt -98.04 135.77 39.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.79 . . . . 0.0 109.05 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' B' ' 15' ' ' LEU . 1.1 tt0 -44.07 -26.78 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 109.313 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.538 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 156.21 149.23 5.3 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.65 HG22 ' CD2' ' B' ' 52' ' ' LEU . 6.9 tt -128.25 150.03 33.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.511 -0.994 . . . . 0.0 108.803 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.469 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -43.74 146.41 1.01 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.945 . . . . 0.0 109.289 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.4 Cg_endo -76.6 -13.03 18.34 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.424 2.083 . . . . 0.0 109.991 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.534 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 7.6 mttp -78.93 -15.42 58.33 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 1.026 ' O ' HD13 ' B' ' 23' ' ' ILE . 86.5 m-20 -100.46 54.8 0.88 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 1.026 HD13 ' O ' ' B' ' 22' ' ' ASN . 0.7 OUTLIER -146.11 163.41 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.032 -1.042 . . . . 0.0 110.337 -179.359 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.735 ' HG2' HG22 ' B' ' 43' ' ' THR . 0.4 OUTLIER -153.08 -36.26 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.835 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.656 ' O ' HG23 ' B' ' 26' ' ' VAL . 5.0 p -128.41 179.52 5.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.656 HG23 ' O ' ' B' ' 25' ' ' SER . 51.4 t -160.11 115.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.786 -1.196 . . . . 0.0 109.99 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 20.4 t-20 -104.83 153.31 21.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 109.097 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' SER . 2.6 t -143.71 91.83 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 109.654 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.446 ' HD2' ' NE2' ' B' ' 10' ' ' GLN . 4.3 mttm -95.3 93.43 7.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 4.3 p -44.7 164.21 0.18 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.843 . . . . 0.0 109.301 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.506 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.7 Cg_endo -77.77 131.96 11.6 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.592 2.195 . . . . 0.0 110.527 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.26 -138.5 3.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.27 8.09 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.498 2.132 . . . . 0.0 110.782 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.484 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 5.0 p-80 -126.92 -16.79 5.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.063 -1.023 . . . . 0.0 109.849 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -160.12 125.21 3.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.075 -1.016 . . . . 0.0 109.278 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.419 ' O ' ' CD ' ' B' ' 37' ' ' GLN . . . -87.41 18.9 3.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.674 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.506 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 13.4 mm-40 -143.31 124.97 14.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.961 . . . . 0.0 109.558 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.434 HG23 ' HA ' ' B' ' 30' ' ' SER . 17.5 m -50.26 140.65 12.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.937 . . . . 0.0 109.255 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' B' ' 10' ' ' GLN . 8.5 mt-10 -117.76 106.81 13.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 109.619 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.802 HG21 ' HB3' ' B' ' 54' ' ' PRO . 1.7 t -98.5 106.76 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.166 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.517 ' CG1' ' SG ' ' B' ' 11' ' ' CYS . 2.9 mp -94.77 157.29 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.872 . . . . 0.0 109.803 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.964 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -136.38 125.85 25.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 108.866 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.735 HG22 ' HG2' ' B' ' 24' ' ' GLN . 22.4 m -89.68 105.57 17.89 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.958 -1.089 . . . . 0.0 109.151 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.934 HD23 ' O ' ' B' ' 22' ' ' ASN . 82.4 mt -43.83 168.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.312 -0.868 . . . . 0.0 109.583 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.534 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.2 ptpt -90.15 17.49 6.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.525 ' OD1' ' CB ' ' B' ' 44' ' ' LEU . 19.5 p-10 -119.42 7.23 11.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.22 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.3 -17.97 54.73 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.742 ' HB2' HD12 ' B' ' 44' ' ' LEU . 8.8 mtt85 -83.73 171.95 12.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 109.15 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.519 ' CD ' ' OG1' ' B' ' 43' ' ' THR . 10.0 mtmt -144.42 125.21 14.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.509 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.27 131.18 55.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.163 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 61.7 m -79.83 140.2 36.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -0.979 . . . . 0.0 109.186 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.868 ' HB3' HG22 ' B' ' 59' ' ' VAL . 12.5 mt -129.41 168.63 16.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.218 -0.926 . . . . 0.0 109.378 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.657 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.8 m-20 -110.94 130.91 22.45 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.587 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.802 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.7 Cg_endo -75.31 -14.56 20.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.312 2.008 . . . . 0.0 110.248 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.99 -19.11 61.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 108.829 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -89.91 163.09 33.61 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.152 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.16 -41.76 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.59 2.193 . . . . 0.0 110.632 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.538 ' CG2' ' HA3' ' B' ' 17' ' ' GLY . 11.7 mm -54.46 -55.54 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.351 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.868 HG22 ' HB3' ' B' ' 52' ' ' LEU . 90.0 t -54.46 -53.67 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.528 -0.732 . . . . 0.0 110.054 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 0.4 OUTLIER -45.86 -31.66 2.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.028 -1.045 . . . . 0.0 108.966 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.529 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -79.57 -38.27 34.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 109.647 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.8 mp -55.32 -41.85 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 108.856 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 1.028 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.1 mp -72.17 -65.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -42.14 -27.26 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -73.82 -49.37 25.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 108.947 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.481 ' HA ' ' HB3' ' B' ' 69' ' ' SER . 0.4 OUTLIER -55.18 -45.53 75.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.415 -0.803 . . . . 0.0 109.002 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.044 HD11 HG22 ' A' ' 63' ' ' ILE . 3.7 mt -53.67 -60.07 3.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.734 . . . . 0.0 109.52 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -73.51 -3.93 30.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.686 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 4.1 p . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 109.455 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.49 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.503 ' HG3' ' CB ' ' A' ' 29' ' ' LYS . 56.6 mm-40 -42.08 -27.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.791 . . . . 0.0 109.842 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.468 ' SG ' HG13 ' A' ' 41' ' ' ILE . 81.1 m -146.04 72.04 1.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.162 -0.961 . . . . 0.0 109.61 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -44.07 -45.65 8.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.068 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -110.13 120.87 43.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.414 -0.804 . . . . 0.0 109.072 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.99 161.43 14.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.236 -0.915 . . . . 0.0 109.986 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.666 ' HB2' HD23 ' A' ' 52' ' ' LEU . 3.1 mt -108.66 143.08 38.21 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.607 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.4 tt0 -44.9 -26.54 0.42 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.061 -1.025 . . . . 0.0 109.065 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.592 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 152.37 177.65 26.25 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.656 HG22 HD11 ' A' ' 52' ' ' LEU . 6.4 tp -148.56 159.99 6.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.42 -1.047 . . . . 0.0 109.071 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.589 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.5 t-80 -50.2 144.23 11.63 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.243 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.589 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.37 -22.66 10.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.504 2.136 . . . . 0.0 110.264 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.456 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.27 -15.2 31.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -0.871 . . . . 0.0 109.108 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 9.5 m120 -79.55 -11.89 59.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.317 -0.865 . . . . 0.0 109.455 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.894 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 4.3 mt -101.0 155.55 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.308 -0.87 . . . . 0.0 110.422 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.533 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -124.5 -30.04 3.41 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.533 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -132.02 169.05 16.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 108.855 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.739 HG23 ' HG3' ' A' ' 66' ' ' MET . 49.9 t -139.45 111.2 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 109.801 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.712 ' O ' HD12 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -106.15 110.99 23.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.158 179.611 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -113.8 106.36 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.655 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.503 ' CB ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -97.25 94.81 7.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.222 -0.924 . . . . 0.0 109.319 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.1 p -45.2 169.25 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.479 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 36' ' ' ALA . 35.6 Cg_endo -77.84 132.15 11.67 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.582 2.188 . . . . 0.0 110.408 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.84 -140.29 4.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.06 41.61 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.718 2.278 . . . . 0.0 110.708 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.438 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 9.7 p-80 -161.93 -38.1 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.053 -1.029 . . . . 0.0 109.244 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 6.2 t -135.82 112.78 10.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.285 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 31' ' ' PRO . . . -71.45 -32.06 67.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 109.646 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.437 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 6.2 mm100 -87.63 130.51 34.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.586 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.458 HG23 ' HA ' ' A' ' 30' ' ' SER . 63.2 m -53.31 142.97 19.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.38 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.484 ' CB ' ' HB2' ' A' ' 10' ' ' GLN . 30.6 mm-40 -117.46 107.33 14.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.568 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 54' ' ' PRO . 9.5 t -92.48 148.32 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.5 mp -140.6 153.87 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 0.0 109.7 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.894 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -137.5 121.93 18.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.418 -0.801 . . . . 0.0 109.215 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 43' ' ' THR . 1.2 m -89.29 98.99 12.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.998 -1.064 . . . . 0.0 108.783 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.489 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 73.7 mt -41.78 165.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.434 0.635 . . . . 0.0 109.919 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 13.9 ptpt -81.22 7.87 10.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.811 . . . . 0.0 109.745 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -111.25 16.27 21.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.391 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.49 3.75 88.24 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.462 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 2.4 mtp-105 -94.04 174.95 6.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -1.158 . . . . 0.0 109.562 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -141.24 152.96 44.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.29 120.45 7.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 108.889 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 33.0 m -79.7 140.35 37.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.488 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.885 ' HB3' HG22 ' A' ' 59' ' ' VAL . 14.7 mt -126.36 166.94 16.24 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.38 -0.825 . . . . 0.0 108.899 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.661 ' O ' HG21 ' A' ' 59' ' ' VAL . 5.1 t30 -101.52 123.94 42.61 Favored Pre-proline 0 C--N 1.299 -1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.386 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.65 ' HB3' HG21 ' A' ' 40' ' ' VAL . 33.8 Cg_endo -75.03 -9.89 20.93 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.152 1.901 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.43 -14.14 57.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 108.862 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -89.69 162.22 36.75 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.325 179.824 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.0 Cg_endo -77.56 -39.93 0.48 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.63 2.22 . . . . 0.0 110.626 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 32.4 mt -61.13 -51.86 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.973 . . . . 0.0 109.17 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.885 HG22 ' HB3' ' A' ' 52' ' ' LEU . 54.4 t -53.48 -52.03 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.511 -0.743 . . . . 0.0 109.762 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 6.9 mmtt -50.14 -33.22 18.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.077 -1.015 . . . . 0.0 108.813 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 57' ' ' PRO . 2.5 mmpt? -74.36 -36.02 63.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.448 -0.783 . . . . 0.0 109.26 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.705 HG23 ' CD1' ' A' ' 23' ' ' ILE . 1.7 mp -61.53 -41.14 89.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.419 -0.801 . . . . 0.0 109.079 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.1 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -69.68 -68.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 0.0 109.766 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -43.82 -33.75 1.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 0.0 109.6 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 69' ' ' SER . 10.7 mmtm -66.07 -59.12 4.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.169 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.739 ' HG3' HG23 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -44.4 -45.7 9.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.051 179.627 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.105 HD11 ' CG2' ' B' ' 63' ' ' ILE . 1.9 mt -56.88 -56.38 22.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.501 -0.749 . . . . 0.0 109.4 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -85.91 13.64 7.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 65' ' ' LYS . 93.7 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.484 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.511 ' HG3' ' CB ' ' B' ' 29' ' ' LYS . 56.7 mm-40 -41.91 -27.53 0.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.46 -0.775 . . . . 0.0 109.829 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.47 ' SG ' HG13 ' B' ' 41' ' ' ILE . 80.7 m -145.98 72.04 1.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.661 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.3 OUTLIER -44.12 -45.57 8.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.092 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -110.1 121.0 44.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 109.047 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.06 161.46 14.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.221 -0.925 . . . . 0.0 109.897 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.669 ' HB2' HD23 ' B' ' 52' ' ' LEU . 3.1 mt -108.76 143.19 38.24 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.608 ' O ' HG23 ' B' ' 59' ' ' VAL . 2.4 tt0 -44.95 -26.46 0.42 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.994 . . . . 0.0 109.116 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.595 ' CA ' HD22 ' B' ' 52' ' ' LEU . . . 152.3 177.66 26.2 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.661 HG22 HD11 ' B' ' 52' ' ' LEU . 6.4 tp -148.51 160.06 6.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.434 -1.039 . . . . 0.0 109.029 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.594 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 1.5 t-80 -50.29 144.22 11.93 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.086 -1.009 . . . . 0.0 109.141 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -77.46 -22.53 10.73 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.483 2.122 . . . . 0.0 110.237 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.464 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.23 -15.36 31.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.36 -0.837 . . . . 0.0 109.096 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 9.5 m120 -79.52 -11.87 59.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.897 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 4.3 mt -101.01 155.55 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 110.406 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.552 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -124.58 -30.0 3.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.325 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.552 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -132.02 169.04 16.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 108.912 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.749 HG23 ' HG3' ' B' ' 66' ' ' MET . 50.3 t -139.46 111.3 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.013 . . . . 0.0 109.836 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.722 ' O ' HD12 ' B' ' 41' ' ' ILE . 0.1 OUTLIER -106.14 110.93 23.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.149 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.8 t -113.77 106.37 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.696 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.511 ' CB ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -97.25 94.74 7.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.44 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.468 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -45.13 169.23 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.452 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.8 Cg_endo -77.77 132.17 11.75 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.562 2.175 . . . . 0.0 110.46 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.85 -140.35 4.02 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.12 41.68 1.17 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.69 2.26 . . . . 0.0 110.679 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.446 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 9.6 p-80 -161.9 -38.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.142 -0.974 . . . . 0.0 109.324 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 6.3 t -135.82 112.81 10.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.276 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' B' ' 31' ' ' PRO . . . -71.56 -32.03 67.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.611 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.426 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 6.3 mm100 -87.68 130.65 34.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.486 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.468 HG23 ' HA ' ' B' ' 30' ' ' SER . 62.4 m -53.47 143.06 20.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.353 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' B' ' 10' ' ' GLN . 30.4 mm-40 -117.47 107.38 14.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.635 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' B' ' 54' ' ' PRO . 9.7 t -92.51 148.35 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.894 . . . . 0.0 109.267 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.722 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.5 mp -140.65 153.83 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.961 . . . . 0.0 109.679 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.897 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -137.42 121.97 18.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.356 -0.84 . . . . 0.0 109.186 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.559 HG22 ' O ' ' B' ' 43' ' ' THR . 1.2 m -89.31 99.01 12.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.976 -1.077 . . . . 0.0 108.78 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 73.9 mt -41.82 164.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.565 -0.709 . . . . 0.0 109.981 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.464 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 13.9 ptpt -81.18 7.89 10.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 0.0 109.775 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -111.25 16.16 21.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.384 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.5 3.78 88.21 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.478 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 2.4 mtp-105 -94.05 174.93 6.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.5 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -141.23 152.89 44.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 0.0 109.501 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.22 120.43 7.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 108.959 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.431 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 33.0 m -79.66 140.24 37.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.125 -0.984 . . . . 0.0 109.46 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.891 ' HB3' HG22 ' B' ' 59' ' ' VAL . 14.7 mt -126.29 166.99 16.1 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.4 -0.812 . . . . 0.0 108.924 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.65 ' O ' HG21 ' B' ' 59' ' ' VAL . 5.1 t30 -101.49 123.94 42.67 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.632 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.8 Cg_endo -75.02 -9.99 20.98 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.177 1.918 . . . . 0.0 110.244 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.29 -14.18 57.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.268 -0.895 . . . . 0.0 108.944 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -89.65 162.15 37.04 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.432 -0.793 . . . . 0.0 109.323 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.448 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 35.9 Cg_endo -77.53 -39.87 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.636 2.224 . . . . 0.0 110.658 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' B' ' 62' ' ' ILE . 32.4 mt -61.14 -51.87 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 109.118 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.891 HG22 ' HB3' ' B' ' 52' ' ' LEU . 54.5 t -53.53 -52.03 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.509 -0.744 . . . . 0.0 109.746 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' B' ' 56' ' ' SER . 6.9 mmtt -50.13 -33.18 17.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 108.844 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' B' ' 57' ' ' PRO . 2.5 mmpt? -74.34 -36.08 63.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.6 -0.688 . . . . 0.0 109.303 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.702 HG23 ' CD1' ' B' ' 23' ' ' ILE . 1.7 mp -61.5 -41.13 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.38 -0.825 . . . . 0.0 109.048 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 1.105 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -69.76 -69.0 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.643 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -43.67 -33.71 1.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.137 -0.977 . . . . 0.0 109.671 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' B' ' 69' ' ' SER . 10.7 mmtm -66.14 -59.22 3.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.102 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.749 ' HG3' HG23 ' B' ' 26' ' ' VAL . 0.6 OUTLIER -44.37 -45.68 8.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.832 . . . . 0.0 109.097 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.1 HD11 ' CG2' ' A' ' 63' ' ' ILE . 1.9 mt -56.88 -56.27 23.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.394 -0.816 . . . . 0.0 109.48 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -85.95 13.5 7.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.506 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.482 ' N ' ' O ' ' B' ' 65' ' ' LYS . 93.0 p . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.507 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.94 ' HB2' HD22 ' A' ' 12' ' ' LEU . 18.0 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.5 ' HB2' ' HD2' ' A' ' 29' ' ' LYS . 21.4 mm-40 -42.68 -26.53 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.365 -0.835 . . . . 0.0 109.773 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.471 ' HB2' ' HG2' ' A' ' 39' ' ' GLU . 73.5 m -122.38 58.33 1.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.962 . . . . 0.0 109.777 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.94 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.64 4.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 108.839 179.64 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -123.94 123.56 40.67 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -97.99 172.87 7.35 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.185 -0.947 . . . . 0.0 110.243 -179.273 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.494 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 4.5 mt -128.85 143.11 50.81 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.614 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.7 tt0 -44.4 -44.73 8.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 1.014 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 142.28 161.42 8.76 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.78 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -130.76 156.54 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -1.093 . . . . 0.0 109.137 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.588 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -43.23 150.82 0.46 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.321 -0.862 . . . . 0.0 109.291 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -76.54 -0.51 10.52 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.472 2.115 . . . . 0.0 110.12 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER -90.03 -27.12 19.93 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.265 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.57 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 8.9 m-20 -84.97 6.0 26.9 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.714 HG23 ' HB1' ' A' ' 42' ' ' ALA . 2.5 mm -94.26 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.936 . . . . 0.0 110.552 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.618 ' H ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -154.54 -41.5 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.261 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.476 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 1.3 p -135.73 174.59 10.44 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.535 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 52.7 t -150.3 89.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.949 -1.094 . . . . 0.0 109.962 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 3.2 t-20 -79.67 105.49 11.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.23 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -98.49 91.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.547 ' HE3' ' CD1' ' A' ' 41' ' ' ILE . 1.3 ptpm? -98.23 112.5 24.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.366 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.421 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -63.99 171.2 2.65 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.253 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.547 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.8 Cg_endo -77.98 130.91 10.67 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.626 2.218 . . . . 0.0 110.412 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.11 -144.56 5.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.87 5.48 4.88 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.546 2.164 . . . . 0.0 110.545 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -123.14 -11.54 8.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 0.0 109.595 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' OE2' ' A' ' 39' ' ' GLU . 7.9 t -160.14 118.8 2.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.382 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.68 29.56 1.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.559 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.547 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 17.8 mm-40 -141.93 127.97 19.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.522 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -53.37 152.29 4.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.335 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 11' ' ' CYS . 2.4 mp0 -138.32 112.0 8.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.681 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.896 HG11 HD11 ' A' ' 63' ' ' ILE . 1.6 t -103.64 90.59 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.227 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.547 ' CD1' ' HE3' ' A' ' 29' ' ' LYS . 3.5 mt -79.9 144.01 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.961 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.714 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -124.13 120.48 32.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.418 -0.801 . . . . 0.0 108.864 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 24' ' ' GLN . 9.0 m -89.22 101.21 13.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.92 -1.113 . . . . 0.0 109.071 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.57 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 81.4 mt -46.28 167.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.366 -0.834 . . . . 0.0 109.573 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HA ' ' HG3' ' A' ' 24' ' ' GLN . 14.6 ptpt -83.79 9.95 10.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -111.37 16.71 20.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.93 . . . . 0.0 109.372 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.89 6.92 87.94 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HB2' HD12 ' A' ' 44' ' ' LEU . 45.8 mtt-85 -99.37 168.81 9.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -1.151 . . . . 0.0 109.429 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -135.63 155.95 49.63 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.494 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.4 120.16 7.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 109.178 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.408 ' SG ' HG12 ' A' ' 41' ' ' ILE . 11.1 m -79.15 138.95 38.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.027 -1.045 . . . . 0.0 108.537 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.014 HD22 ' HA2' ' A' ' 17' ' ' GLY . 11.6 mt -119.55 167.47 11.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.647 ' O ' HG21 ' A' ' 59' ' ' VAL . 4.7 t-20 -98.76 119.72 60.52 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.72 -3.92 14.63 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.052 1.834 . . . . 0.0 110.269 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.27 -13.0 42.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 108.823 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -89.91 161.24 38.97 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.839 . . . . 0.0 109.371 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.475 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.71 -35.52 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.7 2.266 . . . . 0.0 110.714 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.546 HG23 ' N ' ' A' ' 59' ' ' VAL . 9.2 tt -67.73 -44.3 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 109.296 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.004 ' HA ' HD12 ' A' ' 62' ' ' ILE . 31.2 t -58.57 -47.1 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.533 -0.729 . . . . 0.0 109.161 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 8.9 mttt -59.22 -30.32 68.16 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -79.36 -23.54 43.29 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.004 HD12 ' HA ' ' A' ' 59' ' ' VAL . 16.5 mt -71.22 -38.1 68.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.535 -0.728 . . . . 0.0 109.056 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.989 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -73.84 -55.86 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 109.284 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -59.9 -28.34 67.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.95 . . . . 0.0 109.35 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.513 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -70.08 -43.28 71.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 108.978 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.535 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -60.24 -46.04 91.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.085 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.013 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.7 OUTLIER -48.72 -54.71 13.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.45 -0.781 . . . . 0.0 109.511 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' SER . 17.1 t-20 -68.11 -23.25 64.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 109.614 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.428 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 9.9 p . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.509 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.947 ' HB2' HD22 ' B' ' 12' ' ' LEU . 17.9 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.488 ' HB2' ' HD2' ' B' ' 29' ' ' LYS . 21.3 mm-40 -42.63 -26.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.356 -0.84 . . . . 0.0 109.78 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.468 ' HB2' ' HG2' ' B' ' 39' ' ' GLU . 73.6 m -122.39 58.35 1.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.947 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.63 4.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 108.925 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -123.95 123.63 40.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.437 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -98.04 172.82 7.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.232 -0.917 . . . . 0.0 110.212 -179.259 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.486 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 4.5 mt -128.77 143.14 50.84 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.614 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.7 tt0 -44.32 -44.88 8.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.096 -1.003 . . . . 0.0 109.1 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 1.017 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 142.29 161.37 8.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.808 HD13 ' N ' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -130.67 156.58 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.373 -1.075 . . . . 0.0 109.171 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.589 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -43.38 150.82 0.48 Allowed Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.258 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.589 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.5 Cg_endo -76.43 -0.59 10.57 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.434 2.089 . . . . 0.0 110.181 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.445 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -89.98 -27.21 19.93 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.574 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 9.0 m-20 -84.84 5.91 26.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.705 HG23 ' HB1' ' B' ' 42' ' ' ALA . 2.5 mm -94.14 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.869 . . . . 0.0 110.506 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.613 ' H ' HG22 ' B' ' 23' ' ' ILE . 0.5 OUTLIER -154.59 -41.51 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.195 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.467 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 1.3 p -135.71 174.63 10.41 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.534 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 52.9 t -150.23 89.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.924 -1.11 . . . . 0.0 109.941 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 3.2 t-20 -79.78 105.38 11.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.192 -0.942 . . . . 0.0 109.242 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.9 t -98.49 91.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.54 ' HE3' ' CD1' ' B' ' 41' ' ' ILE . 1.3 ptpm? -98.21 112.46 24.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 109.373 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.425 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.0 OUTLIER -63.8 171.09 2.59 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.327 -0.858 . . . . 0.0 109.381 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.544 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.1 Cg_endo -77.97 130.87 10.67 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.606 2.204 . . . . 0.0 110.478 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.02 -144.6 5.77 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.81 5.45 4.87 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.553 2.169 . . . . 0.0 110.586 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -123.18 -11.47 7.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.559 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 7.8 t -160.18 118.73 2.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.68 29.47 1.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.584 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.544 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 17.9 mm-40 -141.89 128.01 19.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.208 -0.933 . . . . 0.0 109.566 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -53.27 152.33 4.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.896 . . . . 0.0 109.396 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' B' ' 11' ' ' CYS . 2.4 mp0 -138.39 111.9 8.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -0.961 . . . . 0.0 109.695 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.901 HG11 HD11 ' B' ' 63' ' ' ILE . 1.6 t -103.59 90.64 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.163 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.54 ' CD1' ' HE3' ' B' ' 29' ' ' LYS . 3.5 mt -79.94 144.0 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.897 . . . . 0.0 109.957 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.705 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -124.16 120.49 32.46 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' B' ' 24' ' ' GLN . 9.1 m -89.21 101.26 13.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.908 -1.12 . . . . 0.0 109.128 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.574 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 81.3 mt -46.33 167.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.388 -0.82 . . . . 0.0 109.587 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.452 ' HA ' ' HG3' ' B' ' 24' ' ' GLN . 14.6 ptpt -83.88 10.05 10.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -111.37 16.69 20.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.349 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.86 7.02 87.85 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.52 ' HB2' HD12 ' B' ' 44' ' ' LEU . 45.8 mtt-85 -99.45 168.85 9.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -1.163 . . . . 0.0 109.432 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.522 ' N ' ' HD2' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -135.63 155.99 49.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.486 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.41 120.21 7.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.337 -0.852 . . . . 0.0 109.118 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.41 ' SG ' HG12 ' B' ' 41' ' ' ILE . 11.1 m -79.14 138.9 38.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.042 -1.037 . . . . 0.0 108.579 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 1.017 HD22 ' HA2' ' B' ' 17' ' ' GLY . 11.5 mt -119.41 167.49 11.88 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.236 -0.915 . . . . 0.0 109.856 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.647 ' O ' HG21 ' B' ' 59' ' ' VAL . 4.7 t-20 -98.84 119.7 60.45 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.55 -0.719 . . . . 0.0 109.061 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.64 -3.92 14.62 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.05 1.834 . . . . 0.0 110.319 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.34 -12.86 42.22 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.317 -0.864 . . . . 0.0 108.901 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 1.0 OUTLIER -90.0 161.23 38.73 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.299 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.0 Cg_endo -77.77 -35.54 1.44 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.649 2.232 . . . . 0.0 110.697 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.56 HG23 ' N ' ' B' ' 59' ' ' VAL . 9.2 tt -67.69 -44.31 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.31 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 1.008 ' HA ' HD12 ' B' ' 62' ' ' ILE . 31.6 t -58.54 -47.05 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.466 -0.771 . . . . 0.0 109.178 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' B' ' 56' ' ' SER . 8.9 mttt -59.21 -30.36 68.17 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.496 ' O ' ' CG ' ' B' ' 65' ' ' LYS . 0.0 OUTLIER -79.28 -23.59 43.49 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 1.008 HD12 ' HA ' ' B' ' 59' ' ' VAL . 16.4 mt -71.24 -38.06 68.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.506 -0.746 . . . . 0.0 109.081 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 1.013 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -73.82 -55.85 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.366 -0.833 . . . . 0.0 109.336 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.3 OUTLIER -59.85 -28.39 67.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 109.379 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.515 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 0.1 OUTLIER -70.08 -43.21 71.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.002 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.534 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.6 OUTLIER -60.35 -45.91 91.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 109.072 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.989 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -48.78 -54.73 13.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.445 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' B' ' 69' ' ' SER . 17.2 t-20 -68.15 -23.28 64.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.428 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 9.9 p . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.525 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.493 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -45.53 -24.84 0.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.423 ' SG ' HG13 ' A' ' 41' ' ' ILE . 60.8 m -148.7 71.16 1.14 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.082 -1.011 . . . . 0.0 109.822 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.493 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.04 -45.87 11.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 108.948 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -115.27 119.69 37.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.443 -0.786 . . . . 0.0 108.961 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -97.45 163.51 12.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.193 -0.942 . . . . 0.0 110.011 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.544 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.4 mt -115.17 146.26 41.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.487 -0.758 . . . . 0.0 108.981 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.77 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.9 tt0 -44.22 -46.91 9.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.339 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 1.033 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 156.03 -164.82 32.49 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.802 HG23 ' O ' ' A' ' 17' ' ' GLY . 1.2 pp -170.26 162.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.436 -1.038 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.623 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 13.0 t60 -44.8 144.58 1.83 Allowed Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.623 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.6 Cg_endo -77.76 -13.93 15.91 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.29 1.994 . . . . 0.0 109.889 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.516 ' CE ' ' HG2' ' A' ' 20' ' ' PRO . 1.9 mmpt? -90.86 -19.87 22.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.401 -0.812 . . . . 0.0 108.861 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 5.2 m-20 -78.61 -12.96 60.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.237 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.941 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 12.0 mt -91.93 165.89 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.981 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.543 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -131.88 -41.96 1.02 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.8 p -125.11 173.49 8.69 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.539 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 48.3 t -144.33 95.53 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.01 -1.056 . . . . 0.0 109.694 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.673 ' O ' HD12 ' A' ' 41' ' ' ILE . 5.3 t-20 -96.83 112.4 24.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.406 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.833 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -115.6 102.65 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 109.597 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -94.35 110.92 22.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.394 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.67 165.36 0.73 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.421 ' HB3' ' C ' ' A' ' 37' ' ' GLN . 35.8 Cg_endo -78.12 136.43 14.57 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.61 2.207 . . . . 0.0 110.419 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.67 -145.3 4.59 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.19 7.41 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.633 2.222 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.413 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 11.5 p-80 -124.32 -7.73 7.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.628 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.9 t -160.1 117.35 2.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 109.449 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.15 45.71 1.2 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.594 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.463 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 1.6 pt20 -171.11 140.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.474 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.467 ' HB ' ' CG ' ' A' ' 54' ' ' PRO . 1.4 m -60.64 145.19 50.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 109.368 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.463 ' OE2' ' O ' ' A' ' 37' ' ' GLN . 0.7 OUTLIER -127.3 107.4 9.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.582 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.833 HG22 HG13 ' A' ' 28' ' ' VAL . 32.0 t -93.09 151.82 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.207 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 27' ' ' ASN . 2.5 mp -140.19 146.61 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.067 -1.021 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.941 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -133.87 119.16 18.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.416 -0.802 . . . . 0.0 109.08 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 6.8 m -89.39 97.51 11.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.944 -1.098 . . . . 0.0 109.131 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 87.0 mt -43.13 166.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.477 -0.765 . . . . 0.0 109.731 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.8 ptpt -82.56 9.84 8.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 109.704 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.514 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -113.69 27.69 9.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.143 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.29 6.21 64.68 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.514 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 40.5 mtt180 -96.23 160.99 14.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -1.188 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.57 150.23 48.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.177 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.544 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.21 124.73 9.64 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.213 -0.929 . . . . 0.0 109.191 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.48 ' SG ' HG13 ' A' ' 41' ' ' ILE . 15.7 m -79.51 148.08 31.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.104 -0.997 . . . . 0.0 109.225 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.033 HD22 ' HA2' ' A' ' 17' ' ' GLY . 15.7 mt -122.76 167.22 13.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.271 -0.893 . . . . 0.0 109.329 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.648 ' O ' HG21 ' A' ' 59' ' ' VAL . 3.0 t-20 -98.86 119.45 61.0 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.152 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.467 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 32.9 Cg_endo -74.87 -6.12 17.71 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.137 1.891 . . . . 0.0 110.23 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.95 -14.69 46.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 108.886 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -90.0 160.7 40.02 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.398 -0.813 . . . . 0.0 109.355 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.8 -34.39 1.84 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.627 2.218 . . . . 0.0 110.686 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.586 ' O ' HD13 ' A' ' 62' ' ' ILE . 2.7 tt -66.5 -46.67 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.138 -0.976 . . . . 0.0 109.09 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.859 HG22 ' HB3' ' A' ' 52' ' ' LEU . 38.1 t -57.02 -48.2 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.403 -0.81 . . . . 0.0 109.023 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.1 OUTLIER -55.23 -31.28 61.36 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 2.8 mmpt? -76.23 -30.62 57.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -65.48 -44.65 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.346 -0.846 . . . . 0.0 108.936 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.95 HG22 HD11 ' B' ' 67' ' ' LEU . 2.2 mp -66.82 -61.78 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.489 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -52.67 -27.7 18.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.481 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 13.9 mttt -71.43 -43.03 67.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.197 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.539 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -61.8 -47.13 86.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.31 -0.869 . . . . 0.0 109.185 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.949 HD11 HG22 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.75 -50.89 9.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -69.32 -31.32 69.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.498 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.406 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.3 p . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.474 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -45.55 -24.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 109.698 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.429 ' O ' ' C ' ' B' ' 12' ' ' LEU . 60.7 m -148.7 71.11 1.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.086 -1.009 . . . . 0.0 109.884 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.474 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.94 -45.94 10.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.007 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -115.24 119.61 36.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.461 -0.775 . . . . 0.0 108.954 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.538 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.6 OUTLIER -97.31 163.6 12.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 110.014 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.532 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.4 mt -115.27 146.2 41.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.479 -0.763 . . . . 0.0 108.949 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.788 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.9 tt0 -44.16 -46.88 9.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 1.051 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 155.99 -164.94 32.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.802 HG23 ' O ' ' B' ' 17' ' ' GLY . 1.2 pp -170.19 162.77 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.399 -1.059 . . . . 0.0 109.503 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.614 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 12.8 t60 -44.75 144.6 1.8 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.614 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -77.78 -13.99 15.85 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.347 2.031 . . . . 0.0 109.87 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.507 ' CE ' ' HG2' ' B' ' 20' ' ' PRO . 1.9 mmpt? -90.77 -19.96 22.91 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.487 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 5.1 m-20 -78.63 -12.92 60.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 0.0 109.234 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.95 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 12.0 mt -91.96 165.91 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.276 -0.89 . . . . 0.0 109.982 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.555 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.1 OUTLIER -131.92 -41.87 1.02 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.496 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 3.7 p -125.25 173.45 8.79 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.533 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 48.7 t -144.26 95.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.077 -1.014 . . . . 0.0 109.728 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.679 ' O ' HD12 ' B' ' 41' ' ' ILE . 5.3 t-20 -96.95 112.39 24.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 0.0 109.392 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.814 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -115.64 102.62 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.56 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -94.34 110.93 22.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.7 165.34 0.74 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.457 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.409 ' HB3' ' C ' ' B' ' 37' ' ' GLN . 35.7 Cg_endo -78.04 136.45 14.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.629 2.219 . . . . 0.0 110.451 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.66 -145.24 4.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.22 7.41 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.738 2.292 . . . . 0.0 110.746 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.415 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 11.7 p-80 -124.43 -7.66 7.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.9 t -160.13 117.29 2.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.357 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.18 45.72 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.476 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.448 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 1.6 pt20 -171.14 140.93 1.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 109.528 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.473 ' HB ' ' CG ' ' B' ' 54' ' ' PRO . 1.4 m -60.58 145.09 50.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.448 ' OE2' ' O ' ' B' ' 37' ' ' GLN . 0.7 OUTLIER -127.23 107.32 9.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.814 HG22 HG13 ' B' ' 28' ' ' VAL . 31.5 t -92.99 151.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.257 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.679 HD12 ' O ' ' B' ' 27' ' ' ASN . 2.6 mp -140.15 146.57 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.788 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.95 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -133.91 119.16 18.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 109.073 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 6.7 m -89.32 97.49 11.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.924 -1.11 . . . . 0.0 109.17 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 86.9 mt -43.13 166.14 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.507 -0.746 . . . . 0.0 109.673 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.481 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.8 ptpt -82.56 9.95 8.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -0.823 . . . . 0.0 109.676 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -113.77 27.75 9.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.324 -0.86 . . . . 0.0 109.152 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.3 6.16 64.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.51 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 40.6 mtt180 -96.23 161.03 14.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.171 -1.193 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.506 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.62 150.25 48.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.154 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.532 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.21 124.71 9.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.35 -0.844 . . . . 0.0 109.137 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.483 ' SG ' HG13 ' B' ' 41' ' ' ILE . 15.6 m -79.49 148.08 31.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.124 -0.985 . . . . 0.0 109.184 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 1.051 HD22 ' HA2' ' B' ' 17' ' ' GLY . 15.9 mt -122.88 167.2 13.85 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.651 ' O ' HG21 ' B' ' 59' ' ' VAL . 3.0 t-20 -98.82 119.38 61.23 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.163 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.473 ' CG ' ' HB ' ' B' ' 38' ' ' THR . 33.4 Cg_endo -74.66 -6.31 18.04 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.182 1.921 . . . . 0.0 110.304 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.93 -14.68 46.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.36 -0.838 . . . . 0.0 108.846 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -90.02 160.75 39.89 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.288 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.85 -34.35 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.582 2.188 . . . . 0.0 110.709 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.598 ' O ' HD13 ' B' ' 62' ' ' ILE . 2.7 tt -66.49 -46.65 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.108 -0.995 . . . . 0.0 109.136 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.865 HG22 ' HB3' ' B' ' 52' ' ' LEU . 38.1 t -57.1 -48.08 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.017 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.1 OUTLIER -55.28 -31.3 61.49 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.467 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 2.8 mmpt? -76.16 -30.6 58.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.591 -0.693 . . . . 0.0 109.391 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.598 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -65.46 -44.7 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.353 -0.842 . . . . 0.0 108.987 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.949 HG22 HD11 ' A' ' 67' ' ' LEU . 2.2 mp -66.69 -61.8 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.1 OUTLIER -52.73 -27.72 18.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.462 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.512 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 13.9 mttt -71.38 -43.0 67.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 109.236 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.533 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -61.81 -47.11 86.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.378 -0.826 . . . . 0.0 109.248 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.95 HD11 HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.7 -50.91 9.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.504 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -69.32 -31.28 69.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.486 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.918 . . . . 0.0 109.523 179.991 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.441 ' HB3' ' OE2' ' A' ' 39' ' ' GLU . 17.2 m . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.667 ' HB3' HD11 ' A' ' 41' ' ' ILE . 45.2 mm-40 -40.69 -39.89 1.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.482 -0.761 . . . . 0.0 109.756 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.481 ' O ' HG23 ' A' ' 14' ' ' THR . 1.7 m -165.85 70.19 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.4 -0.812 . . . . 0.0 109.506 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.965 ' O ' HD13 ' A' ' 12' ' ' LEU . 1.5 tm? -44.22 -34.46 1.89 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.342 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -93.6 81.4 4.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.244 -0.91 . . . . 0.0 109.099 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 11' ' ' CYS . 10.1 p -87.78 158.65 18.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.291 -0.881 . . . . 0.0 109.91 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HB2' HD23 ' A' ' 52' ' ' LEU . 2.4 mt -100.24 144.25 29.48 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.455 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.9 tt0 -45.41 -25.91 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.074 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.532 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 154.09 171.54 21.19 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.844 HG22 HD11 ' A' ' 52' ' ' LEU . 7.7 tp -145.32 151.96 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.336 -1.096 . . . . 0.0 109.166 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.507 ' ND1' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.92 146.98 1.82 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.935 . . . . 0.0 109.303 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.507 ' HD2' ' ND1' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.15 -13.85 16.95 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.549 2.166 . . . . 0.0 110.04 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.526 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -80.92 -16.34 53.84 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.234 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.989 ' O ' HD23 ' A' ' 44' ' ' LEU . 80.1 m-20 -101.34 55.59 0.83 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.459 -0.776 . . . . 0.0 108.988 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.974 HG23 ' HB1' ' A' ' 42' ' ' ALA . 1.8 mm -139.79 170.83 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.133 -0.979 . . . . 0.0 110.041 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -160.06 -40.72 0.05 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.525 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.8 p -131.13 -177.97 4.62 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 25' ' ' SER . 51.9 t -157.22 111.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.025 -1.047 . . . . 0.0 109.748 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.424 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 18.6 t-20 -94.87 124.61 39.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -0.85 . . . . 0.0 109.358 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.46 ' HB ' ' HB ' ' B' ' 26' ' ' VAL . 1.9 t -119.91 89.7 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.196 -0.94 . . . . 0.0 109.53 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 104.22 15.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.279 -0.888 . . . . 0.0 109.547 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.2 p -54.31 168.42 0.46 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.445 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 35.9 Cg_endo -78.01 133.15 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.664 2.242 . . . . 0.0 110.434 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.85 -141.05 3.8 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.55 10.25 2.59 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.531 2.154 . . . . 0.0 110.992 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.499 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 3.7 p-80 -127.16 -10.21 5.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.023 -1.048 . . . . 0.0 109.813 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' OE1' ' A' ' 39' ' ' GLU . 1.8 t -160.27 121.4 3.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.002 . . . . 0.0 109.372 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.72 44.16 1.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.577 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.441 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 5.8 pt20 -172.36 139.76 1.04 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 m -56.49 142.28 39.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.452 ' OE1' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -127.62 122.59 33.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.899 . . . . 0.0 109.623 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.844 HG11 HD11 ' A' ' 63' ' ' ILE . 74.6 t -114.48 151.44 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.371 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.667 HD11 ' HB3' ' A' ' 10' ' ' GLN . 3.3 mp -141.82 155.18 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.607 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.974 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -134.21 126.63 30.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.397 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.635 HG23 ' HG3' ' A' ' 49' ' ' LYS . 51.9 m -89.81 105.87 18.09 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.111 -0.993 . . . . 0.0 109.089 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.989 HD23 ' O ' ' A' ' 22' ' ' ASN . 77.1 mt -41.73 164.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.464 -0.772 . . . . 0.0 109.587 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.4 ptpt -87.44 17.81 4.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.748 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 1.1 p-10 -120.46 -3.53 9.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.97 . . . . 0.0 109.349 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.4 -25.31 8.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.845 ' HB2' HD12 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -79.34 172.9 13.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -1.172 . . . . 0.0 109.255 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.635 ' HG3' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -147.24 125.55 12.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.66 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.74 124.77 51.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.422 -0.799 . . . . 0.0 108.847 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.44 ' SG ' HG12 ' A' ' 41' ' ' ILE . 83.9 m -79.55 140.99 37.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.947 . . . . 0.0 109.317 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.844 HD11 HG22 ' A' ' 18' ' ' ILE . 14.3 mt -127.78 168.25 15.39 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 108.975 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.609 ' O ' HG21 ' A' ' 59' ' ' VAL . 6.7 t30 -106.12 132.95 20.46 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.321 -0.862 . . . . 0.0 109.125 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HG3' HG23 ' A' ' 40' ' ' VAL . 33.9 Cg_endo -75.62 -25.23 11.12 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.12 1.88 . . . . 0.0 110.298 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.87 -16.15 26.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.212 -0.93 . . . . 0.0 108.843 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 37.1 p -88.66 158.18 48.43 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.433 -0.792 . . . . 0.0 109.395 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.427 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.86 -38.74 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.695 2.263 . . . . 0.0 110.744 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.599 HG23 ' N ' ' A' ' 59' ' ' VAL . 5.9 tt -66.04 -46.63 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.974 . . . . 0.0 109.235 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.785 HG22 ' HB3' ' A' ' 52' ' ' LEU . 40.3 t -56.81 -48.46 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.494 -0.753 . . . . 0.0 109.241 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -55.45 -31.42 61.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HE2' ' OE2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -74.89 -31.25 61.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.614 -0.679 . . . . 0.0 109.226 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -67.0 -42.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.401 -0.812 . . . . 0.0 108.848 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.043 HG22 HD11 ' B' ' 67' ' ' LEU . 2.1 mp -65.87 -66.64 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -46.23 -39.32 9.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 0.0 109.496 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.479 ' HG3' ' OE1' ' A' ' 64' ' ' GLU . 12.2 mttm -59.08 -50.9 72.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.209 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.45 -48.1 62.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 109.216 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.047 HD11 HG22 ' B' ' 63' ' ' ILE . 0.2 OUTLIER -47.02 -51.8 16.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.387 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 69' ' ' SER . 11.7 t30 -58.46 -38.47 77.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' ASN . 4.2 p . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.448 ' O ' ' C ' ' B' ' 10' ' ' GLN . 17.4 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.655 ' HB3' HD11 ' B' ' 41' ' ' ILE . 45.1 mm-40 -40.52 -39.97 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.56 -0.712 . . . . 0.0 109.767 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.495 ' O ' HG23 ' B' ' 14' ' ' THR . 1.7 m -165.85 70.24 0.13 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.97 ' O ' HD13 ' B' ' 12' ' ' LEU . 1.5 tm? -44.3 -34.46 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.266 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -93.63 81.53 4.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.266 -0.897 . . . . 0.0 109.118 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.495 HG23 ' O ' ' B' ' 11' ' ' CYS . 10.2 p -87.88 158.63 18.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.332 -0.855 . . . . 0.0 109.859 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.57 ' HB2' HD23 ' B' ' 52' ' ' LEU . 2.4 mt -100.18 144.26 29.41 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.464 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.9 tt0 -45.44 -25.88 0.48 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.043 -1.036 . . . . 0.0 109.063 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.532 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 154.1 171.55 21.2 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.836 HG22 HD11 ' B' ' 52' ' ' LEU . 7.7 tp -145.3 151.91 14.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.405 -1.056 . . . . 0.0 109.247 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.507 ' ND1' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -45.9 147.01 1.79 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.507 ' HD2' ' ND1' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.17 -13.94 16.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.622 2.215 . . . . 0.0 109.963 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -80.9 -16.39 53.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.972 ' O ' HD23 ' B' ' 44' ' ' LEU . 80.1 m-20 -101.31 55.64 0.84 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.448 -0.782 . . . . 0.0 108.935 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.998 HG23 ' HB1' ' B' ' 42' ' ' ALA . 1.8 mm -139.78 170.78 14.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.091 -1.005 . . . . 0.0 109.947 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.1 OUTLIER -159.99 -40.7 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.548 ' O ' HG23 ' B' ' 26' ' ' VAL . 4.8 p -131.14 -177.99 4.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 25' ' ' SER . 51.5 t -157.16 111.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.981 -1.075 . . . . 0.0 109.771 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.434 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 18.8 t-20 -94.89 124.7 39.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.882 . . . . 0.0 109.281 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 1.9 t -119.99 89.83 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.47 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.23 104.28 15.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.2 p -54.53 168.43 0.48 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.381 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 35.6 Cg_endo -77.93 133.11 12.22 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.609 2.206 . . . . 0.0 110.414 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.79 -141.04 3.8 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.66 10.35 2.58 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.541 2.16 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.499 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 3.7 p-80 -127.16 -10.26 5.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.981 -1.074 . . . . 0.0 109.855 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 1.8 t -160.3 121.37 3.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.357 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.69 44.1 1.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.588 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.446 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 5.9 pt20 -172.24 139.86 1.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.515 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 1.5 m -56.69 142.33 40.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.451 ' OE2' ' SG ' ' B' ' 35' ' ' CYS . 0.0 OUTLIER -127.53 122.59 33.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.869 HG11 HD11 ' B' ' 63' ' ' ILE . 76.9 t -114.55 151.46 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.321 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' B' ' 10' ' ' GLN . 3.3 mp -141.79 155.25 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.643 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.998 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -134.33 126.56 29.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -0.866 . . . . 0.0 109.335 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.634 HG23 ' HG3' ' B' ' 49' ' ' LYS . 52.2 m -89.9 105.96 18.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 109.089 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.972 HD23 ' O ' ' B' ' 22' ' ' ASN . 77.0 mt -41.71 164.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.467 -0.771 . . . . 0.0 109.667 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.4 ptpt -87.33 17.76 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.877 . . . . 0.0 109.865 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.477 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 1.1 p-10 -120.42 -3.54 9.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.386 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.52 -25.49 8.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.874 ' HB2' HD12 ' B' ' 44' ' ' LEU . 0.3 OUTLIER -79.31 172.95 13.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -1.186 . . . . 0.0 109.273 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.634 ' HG3' HG23 ' B' ' 43' ' ' THR . 0.0 OUTLIER -147.27 125.46 12.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.657 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.68 124.76 51.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.395 -0.816 . . . . 0.0 108.915 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.448 ' SG ' HG12 ' B' ' 41' ' ' ILE . 84.3 m -79.49 141.07 37.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.15 -0.969 . . . . 0.0 109.289 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.836 HD11 HG22 ' B' ' 18' ' ' ILE . 14.2 mt -127.89 168.16 15.59 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.418 -0.802 . . . . 0.0 109.001 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.626 ' O ' HG21 ' B' ' 59' ' ' VAL . 6.7 t30 -106.01 132.84 20.55 Favored Pre-proline 0 C--N 1.299 -1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.205 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.463 ' HG3' HG23 ' B' ' 40' ' ' VAL . 33.7 Cg_endo -75.59 -25.22 11.18 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.09 1.86 . . . . 0.0 110.324 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.83 -16.16 26.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.274 -0.891 . . . . 0.0 108.792 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 36.9 p -88.68 158.21 48.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.478 -0.764 . . . . 0.0 109.297 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -77.88 -38.7 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.666 2.244 . . . . 0.0 110.741 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.593 HG23 ' N ' ' B' ' 59' ' ' VAL . 5.8 tt -66.05 -46.61 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.096 -1.003 . . . . 0.0 109.248 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.795 HG22 ' HB3' ' B' ' 52' ' ' LEU . 40.0 t -56.87 -48.52 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.407 -0.808 . . . . 0.0 109.174 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.5 OUTLIER -55.48 -31.29 61.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' B' ' 57' ' ' PRO . 0.1 OUTLIER -74.95 -31.23 61.44 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.583 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -67.04 -42.96 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 1.047 HG22 HD11 ' A' ' 67' ' ' LEU . 2.1 mp -65.83 -66.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.356 -0.84 . . . . 0.0 109.466 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -46.36 -39.26 10.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.942 . . . . 0.0 109.43 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.477 ' HG3' ' OE1' ' B' ' 64' ' ' GLU . 12.2 mttm -59.1 -50.88 72.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 109.269 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 66' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.44 -48.07 62.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 0.0 109.219 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.043 HD11 HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -46.97 -51.9 15.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' B' ' 69' ' ' SER . 11.8 t30 -58.42 -38.54 77.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.405 ' C ' ' O ' ' B' ' 68' ' ' ASN . 4.1 p . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 109.466 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.418 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 43.8 m . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.503 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 75.8 mm-40 -53.04 -18.48 2.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 12' ' ' LEU . 53.0 m -135.63 65.96 1.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.076 -1.015 . . . . 0.0 109.889 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -44.7 -44.86 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 108.895 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.41 119.44 34.6 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.31 168.55 11.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.186 -0.946 . . . . 0.0 110.09 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.519 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 6.8 mt -119.13 145.5 45.92 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.835 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -43.99 -46.63 8.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.254 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 1.011 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 151.39 -170.88 30.99 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.92 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.4 pp -164.95 162.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -1.028 . . . . 0.0 109.33 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.584 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -53.97 150.69 14.05 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.22 -0.925 . . . . 0.0 109.328 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.5 Cg_endo -77.44 -3.89 14.12 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.598 2.199 . . . . 0.0 110.29 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 3.1 pttm -90.21 -24.19 21.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.865 . . . . 0.0 109.207 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.519 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 3.1 m-20 -83.19 -7.31 59.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.385 -0.822 . . . . 0.0 109.268 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.927 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 6.8 mt -104.26 162.12 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.874 . . . . 0.0 110.1 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.566 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -135.12 -31.36 1.0 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.526 -0.734 . . . . 0.0 109.177 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.566 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.1 p -132.82 175.14 9.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 0.0 108.854 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.638 HG23 ' HG3' ' A' ' 66' ' ' MET . 46.6 t -149.69 115.77 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.045 -1.034 . . . . 0.0 109.922 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.563 ' O ' HD12 ' A' ' 41' ' ' ILE . 4.1 t-20 -111.85 110.76 21.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.147 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.849 HG22 HG13 ' A' ' 40' ' ' VAL . 3.1 t -117.12 113.65 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.709 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -105.74 114.76 29.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.251 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -55.23 167.29 0.71 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.544 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.3 Cg_endo -77.53 140.25 18.89 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.607 2.205 . . . . 0.0 110.378 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.92 -139.6 3.03 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.66 38.73 0.76 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.594 2.196 . . . . 0.0 110.903 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.493 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 3.9 p-80 -154.99 -38.73 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.031 . . . . 0.0 109.375 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.415 ' SG ' ' CD ' ' A' ' 39' ' ' GLU . 1.8 t -133.58 124.77 27.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.23 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.53 42.43 0.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.736 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.453 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -170.76 148.48 2.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.153 -0.967 . . . . 0.0 109.631 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 m -63.49 144.94 56.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.325 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 37' ' ' GLN . 0.5 OUTLIER -126.64 110.27 13.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 109.628 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.849 HG13 HG22 ' A' ' 28' ' ' VAL . 3.3 t -97.53 144.84 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.273 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.563 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.6 mt -132.4 153.08 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.58 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.927 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -137.69 120.21 16.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.174 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 2.3 m -89.23 102.69 15.35 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.973 -1.08 . . . . 0.0 108.737 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 88.6 mt -49.22 164.59 0.07 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.432 -0.792 . . . . 0.0 109.549 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -79.12 6.78 8.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 109.978 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.526 ' ND2' ' HD2' ' A' ' 48' ' ' ARG . 41.7 p30 -109.36 20.72 17.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.124 -0.985 . . . . 0.0 109.363 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.87 14.08 82.73 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HD2' ' ND2' ' A' ' 46' ' ' ASN . 1.6 mtp-105 -103.56 171.64 7.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -1.151 . . . . 0.0 109.452 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -141.9 151.19 42.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.519 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.25 123.03 8.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.294 -0.879 . . . . 0.0 109.074 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.414 ' SG ' HG12 ' A' ' 41' ' ' ILE . 15.6 m -79.77 141.1 36.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.011 HD22 ' HA2' ' A' ' 17' ' ' GLY . 12.3 mt -119.6 167.82 11.63 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.321 -0.862 . . . . 0.0 109.195 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.653 ' O ' HG21 ' A' ' 59' ' ' VAL . 7.9 t30 -98.15 119.34 62.17 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.337 -0.852 . . . . 0.0 108.983 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.48 ' HB3' HG21 ' A' ' 40' ' ' VAL . 33.3 Cg_endo -75.2 -6.76 18.31 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.103 1.869 . . . . 0.0 110.327 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.75 -14.66 47.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 108.865 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -90.07 162.12 36.06 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.317 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.501 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 36.7 Cg_endo -78.29 -37.72 0.7 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.644 2.229 . . . . 0.0 110.944 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.611 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -63.26 -48.13 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.073 -1.017 . . . . 0.0 108.917 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.853 HG22 ' HB3' ' A' ' 52' ' ' LEU . 37.2 t -55.75 -48.48 77.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -51.33 -33.62 30.02 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.298 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -72.94 -36.37 67.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.549 -0.719 . . . . 0.0 109.261 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 58' ' ' ILE . 1.3 mp -57.91 -44.05 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.878 . . . . 0.0 109.051 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.117 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.1 mp -69.76 -68.95 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.874 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG2' ' HA ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -43.43 -27.82 0.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -0.957 . . . . 0.0 109.584 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.476 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 10.3 mmtt -72.49 -58.66 3.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 108.931 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.638 ' HG3' HG23 ' A' ' 26' ' ' VAL . 1.1 tmm? -44.62 -45.72 9.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 108.911 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.124 HD11 ' CG2' ' B' ' 63' ' ' ILE . 2.5 mt -55.38 -49.29 72.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 109.409 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.06 33.9 1.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.574 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.465 -179.978 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.411 ' HA ' ' OE2' ' B' ' 39' ' ' GLU . 43.1 m . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.499 ' HB2' ' CD ' ' B' ' 29' ' ' LYS . 75.9 mm-40 -53.01 -18.45 2.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.699 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' B' ' 12' ' ' LEU . 54.3 m -135.62 66.0 1.52 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 109.779 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.2 OUTLIER -44.81 -44.85 9.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.895 . . . . 0.0 108.881 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.38 119.46 34.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.43 168.6 10.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.303 -0.873 . . . . 0.0 110.037 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.509 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 6.9 mt -119.19 145.55 45.93 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.836 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.0 OUTLIER -43.97 -46.62 8.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 109.342 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 1.012 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 151.36 -170.91 30.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.932 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.4 pp -164.86 162.96 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -1.023 . . . . 0.0 109.303 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.595 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -53.99 150.79 13.85 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 109.314 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.2 Cg_endo -77.55 -3.9 14.08 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.554 2.17 . . . . 0.0 110.251 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 3.1 pttm -90.2 -24.19 21.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 0.0 109.128 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 3.1 m-20 -83.21 -7.35 59.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.932 HD11 ' CD1' ' B' ' 18' ' ' ILE . 6.8 mt -104.13 162.1 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.566 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.9 OUTLIER -135.1 -31.3 1.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.504 -0.748 . . . . 0.0 109.231 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.566 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.1 p -132.87 175.1 9.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 108.828 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.64 HG23 ' HG3' ' B' ' 66' ' ' MET . 46.4 t -149.66 115.82 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.042 -1.036 . . . . 0.0 109.919 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.568 ' O ' HD12 ' B' ' 41' ' ' ILE . 4.1 t-20 -111.84 110.79 21.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.2 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.856 HG22 HG13 ' B' ' 40' ' ' VAL . 3.1 t -117.14 113.67 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.766 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' B' ' 29' ' ' LYS . 0.4 OUTLIER -105.77 114.75 29.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.249 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.403 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.0 OUTLIER -55.18 167.38 0.69 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.87 . . . . 0.0 109.461 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.435 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.0 Cg_endo -77.54 140.16 18.79 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.606 2.204 . . . . 0.0 110.435 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.84 -139.56 3.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.74 38.76 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.587 2.191 . . . . 0.0 110.91 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.507 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 3.8 p-80 -154.95 -38.86 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.026 -1.046 . . . . 0.0 109.359 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.41 ' SG ' ' CD ' ' B' ' 39' ' ' GLU . 1.8 t -133.52 124.75 27.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.54 42.47 0.96 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.876 . . . . 0.0 109.709 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.446 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 0.1 OUTLIER -170.74 148.46 2.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.12 -0.988 . . . . 0.0 109.618 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 1.4 m -63.53 144.98 56.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.331 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.446 ' OE1' ' O ' ' B' ' 37' ' ' GLN . 0.5 OUTLIER -126.69 110.27 12.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 0.0 109.604 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.856 HG13 HG22 ' B' ' 28' ' ' VAL . 3.4 t -97.53 144.78 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.206 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.568 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.6 mt -132.41 153.08 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.586 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.931 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -137.61 120.26 16.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.208 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.527 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 2.3 m -89.28 102.63 15.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.999 -1.063 . . . . 0.0 108.709 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 88.8 mt -49.12 164.5 0.07 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.416 -0.802 . . . . 0.0 109.651 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -79.04 6.77 8.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 -179.67 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.535 ' ND2' ' HD2' ' B' ' 48' ' ' ARG . 42.0 p30 -109.4 20.7 17.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.982 . . . . 0.0 109.415 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.93 14.0 82.8 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.535 ' HD2' ' ND2' ' B' ' 46' ' ' ASN . 1.6 mtp-105 -103.51 171.66 7.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -1.173 . . . . 0.0 109.499 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -141.95 151.18 42.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 109.367 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.23 123.0 8.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 109.078 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.411 ' SG ' HG12 ' B' ' 41' ' ' ILE . 15.5 m -79.83 141.16 36.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.161 -0.962 . . . . 0.0 109.262 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 1.012 HD22 ' HA2' ' B' ' 17' ' ' GLY . 12.3 mt -119.56 167.85 11.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.161 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.644 ' O ' HG21 ' B' ' 59' ' ' VAL . 7.8 t30 -98.13 119.2 62.5 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.057 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.481 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.8 Cg_endo -75.11 -6.79 18.42 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.07 1.847 . . . . 0.0 110.317 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.77 -14.51 47.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 108.882 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -90.17 162.22 35.51 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.83 . . . . 0.0 109.293 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.502 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -78.41 -37.68 0.68 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.612 2.208 . . . . 0.0 110.852 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.62 ' O ' HD13 ' B' ' 58' ' ' ILE . 0.2 OUTLIER -63.32 -48.02 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.045 -1.034 . . . . 0.0 108.975 -179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.873 HG22 ' HB3' ' B' ' 52' ' ' LEU . 37.5 t -55.71 -48.61 77.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.504 -0.747 . . . . 0.0 109.044 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.3 OUTLIER -51.28 -33.65 29.49 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.322 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.502 ' HD2' ' O ' ' B' ' 57' ' ' PRO . 0.1 OUTLIER -72.82 -36.43 67.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.488 -0.758 . . . . 0.0 109.304 179.6 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' B' ' 58' ' ' ILE . 1.3 mp -57.89 -44.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.018 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 1.124 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.1 mp -69.85 -68.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 109.829 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -43.51 -27.78 0.31 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -0.965 . . . . 0.0 109.549 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.474 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 10.4 mmtt -72.5 -58.64 3.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 108.973 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.64 ' HG3' HG23 ' B' ' 26' ' ' VAL . 1.1 tmm? -44.66 -45.64 9.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 108.914 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.117 HD11 ' CG2' ' A' ' 63' ' ' ILE . 2.5 mt -55.44 -49.2 73.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.518 -0.739 . . . . 0.0 109.411 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.12 33.85 1.86 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.499 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 4.7 m . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -61.37 -12.66 15.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.765 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' A' ' 41' ' ' ILE . 70.8 m -135.2 60.71 1.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.119 -0.988 . . . . 0.0 109.873 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.52 -38.33 6.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 108.815 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -124.87 123.05 39.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.28 173.93 7.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 110.092 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.47 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 4.6 mt -129.53 145.81 51.42 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.644 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.3 tt0 -44.94 -45.67 10.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.078 -1.014 . . . . 0.0 109.202 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 1.037 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 139.87 156.14 6.82 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.772 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -129.19 157.53 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -1.095 . . . . 0.0 109.254 179.57 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.605 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.95 151.92 0.39 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 109.38 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.4 Cg_endo -76.66 -1.71 11.85 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.473 2.115 . . . . 0.0 110.156 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.458 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 2.2 mtmm -90.26 -25.51 20.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.806 . . . . 0.0 109.0 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 4.6 m-20 -82.37 -5.69 58.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.417 -0.802 . . . . 0.0 109.26 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.806 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 9.3 mt -107.52 145.36 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.27 -0.894 . . . . 0.0 110.114 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.555 ' HG3' ' N ' ' A' ' 25' ' ' SER . 1.0 OUTLIER -117.49 -26.48 6.63 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.413 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.555 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -139.68 162.99 33.77 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.568 HG11 HG13 ' A' ' 63' ' ' ILE . 52.8 t -146.86 99.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.945 -1.097 . . . . 0.0 109.891 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 13.0 t30 -80.07 113.43 18.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.284 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.466 ' O ' ' CE ' ' B' ' 66' ' ' MET . 1.8 t -97.17 90.53 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.51 ' HE3' ' NE2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -94.94 105.68 17.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.475 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.453 ' HA ' HG23 ' A' ' 38' ' ' THR . 0.9 OUTLIER -59.65 167.13 2.7 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 109.43 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 36.1 Cg_endo -78.11 145.85 22.28 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.527 2.151 . . . . 0.0 110.418 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.14 -142.85 3.63 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.6 10.09 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.685 2.256 . . . . 0.0 111.013 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.51 ' NE2' ' HE3' ' A' ' 29' ' ' LYS . 4.8 p-80 -126.8 -32.58 2.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.056 . . . . 0.0 109.45 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -147.31 88.74 1.73 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.207 -0.933 . . . . 0.0 109.264 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -54.07 -18.85 4.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.33 -0.856 . . . . 0.0 109.699 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.452 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 1.5 mp0 -92.84 124.78 37.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 0.0 109.516 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.509 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 2.7 m -49.5 162.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.292 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 37' ' ' GLN . 1.3 mp0 -142.78 108.98 5.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 109.663 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.092 ' CG1' HD11 ' A' ' 63' ' ' ILE . 57.3 t -100.62 95.12 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 109.147 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.478 HG13 ' SG ' ' A' ' 51' ' ' CYS . 2.6 mp -84.59 139.62 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.958 . . . . 0.0 109.831 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.806 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -121.25 118.36 29.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 109.133 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.616 HG22 ' O ' ' A' ' 43' ' ' THR . 1.1 m -89.07 97.36 11.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.972 -1.08 . . . . 0.0 108.668 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 90.8 mt -43.44 167.77 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.567 -0.708 . . . . 0.0 109.906 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.458 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.1 ptpt -81.29 7.96 10.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.841 . . . . 0.0 109.581 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.47 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.7 13.28 21.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.272 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.99 -1.6 86.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.47 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 2.1 mtt-85 -87.88 168.07 13.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -1.182 . . . . 0.0 109.392 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 2.0 mttt -134.26 155.17 50.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.913 . . . . 0.0 109.428 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.34 117.73 6.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.193 -0.942 . . . . 0.0 109.186 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.478 ' SG ' HG13 ' A' ' 41' ' ' ILE . 8.7 m -79.39 139.05 37.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.151 -0.968 . . . . 0.0 108.853 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.037 HD22 ' HA2' ' A' ' 17' ' ' GLY . 8.7 mt -121.16 167.85 12.22 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.148 -0.97 . . . . 0.0 109.588 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.677 ' O ' HG21 ' A' ' 59' ' ' VAL . 7.1 t-20 -100.47 119.25 59.33 Favored Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.401 -0.812 . . . . 0.0 109.215 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HG3' ' HB ' ' A' ' 38' ' ' THR . 32.7 Cg_endo -74.18 0.82 7.97 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.157 1.905 . . . . 0.0 110.595 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.555 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -90.54 -15.69 30.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 108.904 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -90.28 164.21 28.36 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.455 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.78 -37.94 0.78 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.687 2.258 . . . . 0.0 111.061 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.638 ' O ' HD13 ' A' ' 62' ' ' ILE . 16.0 tt -65.43 -46.87 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.991 -1.068 . . . . 0.0 109.124 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.877 HG22 ' HB3' ' A' ' 52' ' ' LEU . 34.0 t -55.37 -46.85 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.434 -0.792 . . . . 0.0 109.25 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 54' ' ' PRO . 18.1 mttt -57.74 -30.75 65.82 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.511 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -79.37 -24.81 42.41 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.511 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.6 mp -65.85 -43.59 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.092 HD11 ' CG1' ' A' ' 40' ' ' VAL . 1.6 mp -69.61 -62.94 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.547 -0.721 . . . . 0.0 109.214 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.707 ' OE2' HD13 ' B' ' 67' ' ' LEU . 1.3 mp0 -41.76 -48.5 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.793 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.54 ' CE ' ' HG3' ' A' ' 20' ' ' PRO . 2.8 mmtm -53.75 -59.27 4.83 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.372 -0.83 . . . . 0.0 109.342 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.465 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 1.4 mmm -43.52 -45.78 6.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.297 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.079 HD11 ' CG2' ' B' ' 63' ' ' ILE . 3.1 mt -55.67 -57.72 10.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.46 -0.775 . . . . 0.0 109.738 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -81.13 7.37 11.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.799 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 66' ' ' MET . 7.8 p . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 109.384 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.527 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 4.6 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.355 0.597 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -61.32 -12.7 14.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.709 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.467 ' SG ' HG13 ' B' ' 41' ' ' ILE . 71.0 m -135.25 60.78 1.68 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.913 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.56 -38.2 6.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.107 -0.995 . . . . 0.0 108.912 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -124.95 122.98 38.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 108.843 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.27 173.98 7.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 0.0 110.153 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.467 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 4.5 mt -129.51 145.82 51.41 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.651 ' O ' HG23 ' B' ' 59' ' ' VAL . 2.2 tt0 -44.92 -45.65 10.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.249 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 1.003 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 139.84 156.18 6.84 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.761 HD13 ' N ' ' B' ' 18' ' ' ILE . 0.2 OUTLIER -129.25 157.56 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -1.091 . . . . 0.0 109.21 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.6 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -43.0 152.01 0.39 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 0.0 109.39 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -76.75 -1.73 11.89 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.442 2.095 . . . . 0.0 110.19 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 2.2 mtmm -90.19 -25.6 20.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.273 -0.892 . . . . 0.0 108.997 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 4.7 m-20 -82.33 -5.67 58.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.413 -0.804 . . . . 0.0 109.318 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.807 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 9.3 mt -107.43 145.39 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 110.089 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.551 ' HG3' ' N ' ' B' ' 25' ' ' SER . 1.0 OUTLIER -117.5 -26.46 6.63 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.269 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.551 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -139.6 163.02 33.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.567 HG11 HG13 ' B' ' 63' ' ' ILE . 52.5 t -146.86 99.38 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.081 -1.012 . . . . 0.0 109.931 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 13.2 t30 -80.01 113.43 18.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.253 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.455 ' O ' ' CE ' ' A' ' 66' ' ' MET . 1.8 t -97.15 90.48 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.515 ' HE3' ' NE2' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -94.92 105.67 17.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.548 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.447 ' HA ' HG23 ' B' ' 38' ' ' THR . 0.9 OUTLIER -59.59 167.14 2.64 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 109.422 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 36.3 Cg_endo -78.03 145.8 22.44 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.659 2.239 . . . . 0.0 110.419 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.19 -142.88 3.64 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.46 9.82 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.695 2.263 . . . . 0.0 110.983 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.515 ' NE2' ' HE3' ' B' ' 29' ' ' LYS . 4.6 p-80 -126.68 -32.44 2.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 109.42 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -147.38 88.7 1.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.213 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -54.03 -18.94 4.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.705 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.456 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 1.5 mp0 -92.67 124.62 36.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.13 -0.981 . . . . 0.0 109.596 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.494 ' HB ' ' HG3' ' B' ' 54' ' ' PRO . 2.7 m -49.47 162.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.238 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' B' ' 37' ' ' GLN . 1.3 mp0 -142.74 108.91 5.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.117 -0.989 . . . . 0.0 109.706 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 1.095 ' CG1' HD11 ' B' ' 63' ' ' ILE . 57.4 t -100.56 95.12 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.247 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.467 HG13 ' SG ' ' B' ' 11' ' ' CYS . 2.6 mp -84.57 139.63 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.892 . . . . 0.0 109.875 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.807 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -121.24 118.46 29.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.619 ' O ' HG22 ' B' ' 43' ' ' THR . 1.1 m -89.18 97.38 11.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.955 -1.091 . . . . 0.0 108.665 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 90.9 mt -43.49 167.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.61 -0.681 . . . . 0.0 109.878 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.1 ptpt -81.34 7.95 10.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.49 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -111.72 13.38 21.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.288 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.0 -1.66 86.81 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.49 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 2.1 mtt-85 -87.78 168.11 13.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -1.221 . . . . 0.0 109.436 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 2.0 mttt -134.3 155.24 50.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.467 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.37 117.75 6.06 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.348 -0.845 . . . . 0.0 109.17 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.466 ' SG ' HG13 ' B' ' 41' ' ' ILE . 8.6 m -79.45 139.02 37.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 0.0 108.852 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 1.003 HD22 ' HA2' ' B' ' 17' ' ' GLY . 8.7 mt -121.1 167.85 12.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.17 -0.956 . . . . 0.0 109.629 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.67 ' O ' HG21 ' B' ' 59' ' ' VAL . 7.1 t-20 -100.45 119.31 59.22 Favored Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 121.51 -0.744 . . . . 0.0 109.201 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.494 ' HG3' ' HB ' ' B' ' 38' ' ' THR . 32.9 Cg_endo -74.25 0.86 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.077 1.851 . . . . 0.0 110.582 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.565 ' HB3' ' OD1' ' B' ' 53' ' ' ASN . . . -90.64 -15.64 30.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 108.863 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.9 OUTLIER -90.18 164.21 28.59 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 109.498 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.77 -38.0 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.673 2.249 . . . . 0.0 111.055 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.635 ' O ' HD13 ' B' ' 62' ' ' ILE . 16.0 tt -65.4 -46.9 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.065 . . . . 0.0 109.112 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.892 HG22 ' HB3' ' B' ' 52' ' ' LEU . 33.6 t -55.41 -46.82 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.412 -0.805 . . . . 0.0 109.221 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' B' ' 54' ' ' PRO . 18.1 mttt -57.64 -30.86 65.73 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.534 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.7 OUTLIER -79.33 -24.86 42.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.515 -0.741 . . . . 0.0 109.457 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.635 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.6 mp -65.86 -43.58 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 1.095 HD11 ' CG1' ' B' ' 40' ' ' VAL . 1.6 mp -69.6 -63.02 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 109.104 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.709 ' OE2' HD13 ' A' ' 67' ' ' LEU . 1.3 mp0 -41.73 -48.48 4.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.423 -0.798 . . . . 0.0 109.826 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.531 ' CE ' ' HG3' ' B' ' 20' ' ' PRO . 2.8 mmtm -53.69 -59.42 4.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.88 . . . . 0.0 109.233 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 28' ' ' VAL . 1.4 mmm -43.44 -45.77 6.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.37 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.089 HD11 ' CG2' ' A' ' 63' ' ' ILE . 3.1 mt -55.69 -57.68 10.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.516 -0.74 . . . . 0.0 109.753 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -81.07 7.24 11.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 109.804 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' B' ' 66' ' ' MET . 7.6 p . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.168 -0.958 . . . . 0.0 109.443 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.947 ' HB2' HD22 ' A' ' 12' ' ' LEU . 4.5 m . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.532 ' NE2' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -43.08 -26.83 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.382 -0.824 . . . . 0.0 109.578 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.469 ' SG ' HG13 ' A' ' 41' ' ' ILE . 56.4 m -127.14 65.11 1.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.48 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.947 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -43.76 -37.17 2.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.901 . . . . 0.0 109.027 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 14' ' ' THR . 15.1 pt20 -121.65 -174.98 2.99 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -160.09 151.44 19.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.143 -0.973 . . . . 0.0 109.778 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.527 HD12 ' HB1' ' A' ' 50' ' ' ALA . 7.2 mt -114.0 144.61 42.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 0.0 108.923 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.53 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.1 tt0 -44.05 -26.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 109.293 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 1.067 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 142.41 -164.03 27.04 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.835 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -170.37 162.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.376 -1.073 . . . . 0.0 109.534 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.631 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 3.3 t60 -44.84 146.61 1.29 Allowed Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.631 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.6 Cg_endo -79.1 -17.01 12.11 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.366 2.044 . . . . 0.0 109.524 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 7.7 mmtm -90.4 -19.35 24.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 16.7 m-20 -78.2 -14.62 59.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -0.841 . . . . 0.0 109.033 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.948 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 11.0 mt -91.66 168.05 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.513 -0.742 . . . . 0.0 110.1 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.583 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -135.59 -40.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.459 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 6.4 p -123.58 172.57 8.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.532 ' CG1' HG13 ' A' ' 63' ' ' ILE . 97.3 t -144.25 88.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.741 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 4.0 t-20 -84.77 108.41 17.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.36 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.884 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -108.6 91.77 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 109.439 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HD2' ' NE2' ' A' ' 10' ' ' GLN . 0.7 OUTLIER -92.39 128.15 38.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.857 . . . . 0.0 109.521 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.439 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -76.91 171.62 11.9 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.513 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 36.1 Cg_endo -78.03 132.4 11.62 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.606 2.204 . . . . 0.0 110.465 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.46 -144.23 5.0 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.85 11.94 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.711 2.274 . . . . 0.0 111.041 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.483 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 5.9 p-80 -128.99 -33.5 1.98 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.558 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -129.42 116.99 19.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.3 45.8 1.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.513 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -173.09 141.07 0.93 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 m -58.24 153.51 15.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 15.4 pt-20 -142.12 107.9 5.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.572 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.007 HG11 HD11 ' A' ' 63' ' ' ILE . 55.5 t -90.77 153.45 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.374 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' A' ' 27' ' ' ASN . 3.6 mt -140.67 144.68 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.626 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.948 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -131.71 119.95 22.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.119 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 7.9 m -89.45 97.98 11.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.996 -1.065 . . . . 0.0 109.09 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 85.4 mt -43.75 163.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.448 -0.783 . . . . 0.0 109.736 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -80.05 9.12 5.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 109.931 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.58 27.52 9.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.217 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.3 9.42 72.68 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.512 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 3.4 mtt180 -99.6 163.21 12.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.207 -1.172 . . . . 0.0 109.53 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -137.68 151.83 48.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.339 -0.851 . . . . 0.0 109.257 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.527 ' HB1' HD12 ' A' ' 15' ' ' LEU . . . -150.15 127.99 11.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.6 m -79.6 151.83 30.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.055 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.067 HD22 ' HA2' ' A' ' 17' ' ' GLY . 19.3 mt -127.07 166.72 17.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.315 -0.866 . . . . 0.0 109.326 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.629 ' O ' HG21 ' A' ' 59' ' ' VAL . 8.4 t30 -93.53 115.87 65.67 Favored Pre-proline 0 C--N 1.299 -1.594 0 O-C-N 121.404 -0.81 . . . . 0.0 109.079 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.54 -1.21 10.75 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.106 1.871 . . . . 0.0 110.413 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.2 -12.12 36.28 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.367 -0.833 . . . . 0.0 108.835 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -90.13 160.91 39.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.443 -0.786 . . . . 0.0 109.428 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.511 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 35.6 Cg_endo -77.5 -31.16 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.661 2.241 . . . . 0.0 110.547 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 59' ' ' VAL . 4.1 tt -72.35 -45.16 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.083 -1.011 . . . . 0.0 109.288 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.045 ' HA ' HD12 ' A' ' 62' ' ' ILE . 19.7 t -56.96 -48.53 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.511 -0.743 . . . . 0.0 109.294 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -61.09 -32.06 71.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.186 -0.946 . . . . 0.0 108.552 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.545 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -77.41 -19.14 56.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.528 -0.733 . . . . 0.0 109.161 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.045 HD12 ' HA ' ' A' ' 59' ' ' VAL . 16.2 mt -75.16 -38.84 42.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.007 HD11 HG11 ' A' ' 40' ' ' VAL . 1.9 mp -72.68 -55.98 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.908 . . . . 0.0 109.069 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.532 ' CG ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -58.79 -38.39 78.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.283 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 61' ' ' LYS . 8.2 tttp -59.57 -40.94 89.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -0.874 . . . . 0.0 109.173 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.523 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -61.47 -46.55 89.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.45 -0.782 . . . . 0.0 109.211 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.606 ' CD1' HG22 ' B' ' 63' ' ' ILE . 0.2 OUTLIER -44.11 -51.65 7.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.835 . . . . 0.0 109.395 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.67 -30.32 66.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 0.0 109.623 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.448 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.923 ' HB2' HD22 ' B' ' 12' ' ' LEU . 4.5 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.532 ' NE2' ' HD2' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -43.0 -26.79 0.15 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.402 -0.811 . . . . 0.0 109.586 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' B' ' 41' ' ' ILE . 56.3 m -127.18 65.02 1.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.275 -0.89 . . . . 0.0 109.447 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.923 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -43.75 -37.11 2.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.019 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 13' ' ' GLN . . . . . 0.499 ' O ' HG23 ' B' ' 14' ' ' THR . 15.0 pt20 -121.67 -174.97 2.99 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.379 -0.826 . . . . 0.0 108.843 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.678 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -160.1 151.45 19.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.073 -1.017 . . . . 0.0 109.789 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.536 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.2 mt -114.05 144.63 42.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.436 -0.79 . . . . 0.0 108.874 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.524 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.1 tt0 -44.03 -26.8 0.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.353 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 1.028 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 142.46 -163.95 27.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.837 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -170.42 162.66 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.419 -1.048 . . . . 0.0 109.451 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.624 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 3.4 t60 -44.95 146.67 1.3 Allowed Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.624 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -79.15 -16.98 12.06 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.327 2.018 . . . . 0.0 109.452 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 7.7 mmtm -90.42 -19.38 23.99 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 16.7 m-20 -78.25 -14.57 59.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.845 . . . . 0.0 109.002 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.946 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 10.9 mt -91.68 168.01 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 110.129 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.593 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.0 OUTLIER -135.55 -40.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.459 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 6.4 p -123.54 172.51 8.7 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.533 ' CG1' HG13 ' B' ' 63' ' ' ILE . 97.2 t -144.23 88.1 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.719 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.499 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.0 t-20 -84.77 108.36 17.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.393 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.872 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -108.58 91.85 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.532 ' HD2' ' NE2' ' B' ' 10' ' ' GLN . 0.7 OUTLIER -92.51 128.1 38.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.925 . . . . 0.0 109.463 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.443 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -76.8 171.59 11.93 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 109.466 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.509 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.0 Cg_endo -78.02 132.44 11.66 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.658 2.239 . . . . 0.0 110.391 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.54 -144.23 5.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.95 12.01 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.693 2.262 . . . . 0.0 111.051 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.479 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 5.8 p-80 -129.0 -33.46 1.98 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 109.614 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -129.4 116.95 19.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.31 45.92 1.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.512 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.509 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -173.19 141.01 0.91 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 2.2 m -58.14 153.55 14.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.871 . . . . 0.0 109.503 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.457 ' HB2' ' SG ' ' B' ' 11' ' ' CYS . 15.3 pt-20 -142.19 107.92 5.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 1.044 HG11 HD11 ' B' ' 63' ' ' ILE . 55.7 t -90.85 153.36 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 0.0 109.34 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' B' ' 27' ' ' ASN . 3.6 mt -140.54 144.77 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 109.646 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.946 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -131.77 119.92 21.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.869 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 7.9 m -89.41 97.92 11.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.015 -1.053 . . . . 0.0 109.095 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 85.5 mt -43.77 163.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.343 -0.848 . . . . 0.0 109.738 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -80.0 9.01 5.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.354 -0.841 . . . . 0.0 109.857 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.46 27.43 9.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 0.0 109.215 179.739 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.33 9.43 72.81 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.513 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 3.4 mtt180 -99.56 163.2 12.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -1.174 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.529 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.2 OUTLIER -137.7 151.89 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.219 179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.536 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.23 127.98 11.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.288 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.58 151.86 30.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 109.077 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 1.028 HD22 ' HA2' ' B' ' 17' ' ' GLY . 19.3 mt -127.15 166.65 17.27 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.275 -0.891 . . . . 0.0 109.326 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.636 ' O ' HG21 ' B' ' 59' ' ' VAL . 8.4 t30 -93.43 115.91 65.72 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 109.106 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.54 -1.24 10.79 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.11 1.873 . . . . 0.0 110.401 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.13 -12.18 36.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 108.867 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 1.0 OUTLIER -90.11 160.94 39.23 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.415 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.505 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.1 Cg_endo -77.42 -31.27 3.56 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.584 2.189 . . . . 0.0 110.588 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.606 HG23 ' N ' ' B' ' 59' ' ' VAL . 4.1 tt -72.28 -45.16 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.032 -1.043 . . . . 0.0 109.37 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 1.0 ' HA ' HD12 ' B' ' 62' ' ' ILE . 19.6 t -56.88 -48.58 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.435 -0.791 . . . . 0.0 109.3 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -61.14 -31.99 71.7 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.147 -0.97 . . . . 0.0 108.536 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -77.51 -19.1 56.35 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 1.0 HD12 ' HA ' ' B' ' 59' ' ' VAL . 16.3 mt -75.23 -38.74 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 1.044 HD11 HG11 ' B' ' 40' ' ' VAL . 1.9 mp -72.75 -56.04 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 108.975 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.533 ' CG ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -58.77 -38.42 78.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.3 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' B' ' 61' ' ' LYS . 8.2 tttp -59.45 -41.07 88.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.157 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.53 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -61.37 -46.6 89.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 109.22 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.606 ' CD1' HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -44.0 -51.73 7.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.451 -0.781 . . . . 0.0 109.396 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.64 -30.33 66.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.352 -0.842 . . . . 0.0 109.571 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.457 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.0 m . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.552 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -47.98 -22.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.753 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.421 ' O ' ' C ' ' A' ' 12' ' ' LEU . 63.0 m -126.45 65.2 1.25 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.9 . . . . 0.0 109.872 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -44.59 -43.74 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 108.866 179.459 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -122.97 124.86 44.12 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -96.44 167.36 11.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 0.0 110.014 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.542 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.5 mt -118.92 146.27 45.08 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.617 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -44.21 -41.28 5.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.281 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.991 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 147.51 -164.33 28.75 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.952 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -171.11 163.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -1.041 . . . . 0.0 109.197 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.584 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -54.64 149.57 21.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.371 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -77.23 -4.11 14.43 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.502 2.135 . . . . 0.0 110.213 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.486 ' HG2' ' HB3' ' A' ' 19' ' ' HIS . 8.4 pttt -90.29 -24.03 21.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.118 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.521 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 2.6 m-20 -82.92 -5.5 59.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.282 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.952 HD11 ' CD1' ' A' ' 18' ' ' ILE . 9.2 mt -105.99 145.96 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -119.13 -25.42 6.18 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.553 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -143.0 -179.51 6.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 109.122 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 25' ' ' SER . 47.0 t -156.76 155.6 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.994 -1.066 . . . . 0.0 109.911 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -138.71 114.14 9.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.405 -0.809 . . . . 0.0 109.266 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.47 108.47 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.471 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.552 ' CD ' ' HB2' ' A' ' 10' ' ' GLN . 4.2 ptmm? -113.39 108.33 17.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.893 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.414 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.0 OUTLIER -59.83 163.94 6.66 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.377 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.51 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.8 Cg_endo -77.58 152.39 29.59 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.628 2.219 . . . . 0.0 110.336 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.25 -137.06 2.12 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.516 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 35.9 Cg_endo -77.56 8.17 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.515 2.144 . . . . 0.0 110.758 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.516 ' CE1' ' HD2' ' A' ' 33' ' ' PRO . 2.5 p-80 -125.6 -24.34 3.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.023 -1.048 . . . . 0.0 109.733 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.51 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 1.8 t -160.06 107.31 1.63 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.049 -1.032 . . . . 0.0 109.305 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.7 -5.59 26.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.895 . . . . 0.0 109.69 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.445 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 2.2 mp0 -109.17 124.74 51.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.521 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.414 HG23 ' HA ' ' A' ' 30' ' ' SER . 1.7 m -48.26 158.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.293 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.515 ' HG3' ' NZ ' ' A' ' 29' ' ' LYS . 25.7 mm-40 -139.93 107.36 5.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.65 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.715 HG11 HD11 ' A' ' 63' ' ' ILE . 10.3 t -92.52 151.99 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 109.179 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 3.2 mt -140.19 156.13 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.113 -0.992 . . . . 0.0 109.883 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.759 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -142.65 117.87 10.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 109.015 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 43' ' ' THR . 1.2 m -89.11 96.03 10.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.982 -1.074 . . . . 0.0 108.736 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 89.6 mt -42.32 165.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.586 -0.696 . . . . 0.0 109.891 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -79.52 7.22 8.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.842 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.41 24.0 13.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.139 -0.976 . . . . 0.0 109.22 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.36 -0.11 65.01 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.516 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 72.5 mtt85 -88.57 162.27 16.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -1.195 . . . . 0.0 109.397 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.4 mptt -135.55 151.23 50.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.167 -0.958 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.542 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.25 123.43 8.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.349 -0.844 . . . . 0.0 109.05 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 10.0 m -79.59 142.54 35.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.057 -1.027 . . . . 0.0 109.079 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.133 HD13 HD13 ' A' ' 62' ' ' ILE . 14.3 mt -120.43 167.74 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.243 -0.911 . . . . 0.0 109.62 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.673 ' O ' HG21 ' A' ' 59' ' ' VAL . 7.5 t30 -99.57 122.62 50.86 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.484 -0.76 . . . . 0.0 109.047 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.455 ' O ' ' HE2' ' A' ' 60' ' ' LYS . 33.2 Cg_endo -75.11 -3.53 14.06 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.079 1.852 . . . . 0.0 110.354 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.59 -12.4 42.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.913 . . . . 0.0 108.919 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -89.98 163.09 33.45 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.438 -0.789 . . . . 0.0 109.394 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.68 -38.98 0.57 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.696 2.264 . . . . 0.0 110.784 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.589 HG23 ' N ' ' A' ' 59' ' ' VAL . 20.6 tt -65.16 -45.92 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.346 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.052 ' HA ' HD12 ' A' ' 62' ' ' ILE . 44.7 t -57.42 -45.6 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -0.82 . . . . 0.0 109.333 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 56' ' ' SER . 7.4 mttt -59.68 -29.53 68.14 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 7.0 mmmm -79.53 -23.61 42.75 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.133 HD13 HD13 ' A' ' 52' ' ' LEU . 29.2 mt -72.1 -36.63 57.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.54 -0.725 . . . . 0.0 109.303 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.715 HD11 HG11 ' A' ' 40' ' ' VAL . 2.2 mp -75.87 -51.14 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.752 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.482 ' OE2' ' HE3' ' A' ' 61' ' ' LYS . 9.4 pt-20 -65.8 -29.0 69.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.035 -1.04 . . . . 0.0 109.347 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 4.4 mmtt -69.47 -46.11 67.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.871 . . . . 0.0 108.994 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.409 ' O ' ' C ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -56.12 -45.29 79.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.438 -0.789 . . . . 0.0 109.076 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.591 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.62 -51.85 8.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.421 -0.8 . . . . 0.0 109.478 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 69' ' ' SER . 6.8 t-20 -64.86 -37.29 87.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.403 -0.81 . . . . 0.0 109.476 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ASN . 1.1 p . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 89.0 m . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.539 ' HB2' ' CD ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -48.03 -22.78 0.66 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.742 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' B' ' 12' ' ' LEU . 63.3 m -126.42 65.22 1.24 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.825 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.2 OUTLIER -44.63 -43.79 8.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 108.818 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -122.86 124.88 44.28 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.477 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -96.45 167.43 11.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.236 -0.915 . . . . 0.0 109.968 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.529 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.5 mt -119.04 146.21 45.24 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.597 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.2 OUTLIER -44.08 -41.31 5.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.372 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 1.024 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 147.53 -164.21 28.75 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.975 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -171.19 163.64 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.473 -1.016 . . . . 0.0 109.166 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.59 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -54.54 149.58 20.63 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.183 -0.948 . . . . 0.0 109.326 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.0 Cg_endo -77.22 -4.15 14.47 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.489 2.126 . . . . 0.0 110.257 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' B' ' 19' ' ' HIS . 8.4 pttt -90.26 -24.05 21.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.352 -0.843 . . . . 0.0 109.136 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 2.5 m-20 -82.92 -5.43 59.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 109.259 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.975 HD11 ' CD1' ' B' ' 18' ' ' ILE . 9.1 mt -105.98 145.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.55 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.9 OUTLIER -119.12 -25.44 6.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.55 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -142.98 -179.45 6.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.431 -0.793 . . . . 0.0 108.98 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 25' ' ' SER . 46.9 t -156.79 155.61 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.101 -0.999 . . . . 0.0 109.901 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' B' ' 41' ' ' ILE . 0.1 OUTLIER -138.72 114.23 9.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.364 -0.835 . . . . 0.0 109.21 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.58 108.52 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.473 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.539 ' CD ' ' HB2' ' B' ' 10' ' ' GLN . 4.2 ptmm? -113.38 108.35 17.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.433 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.402 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.0 OUTLIER -59.8 163.92 6.63 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.521 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.6 Cg_endo -77.64 152.45 29.42 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.56 2.173 . . . . 0.0 110.357 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.24 -136.97 2.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.519 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -77.58 8.01 3.56 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.536 2.157 . . . . 0.0 110.79 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.519 ' CE1' ' HD2' ' B' ' 33' ' ' PRO . 2.4 p-80 -125.53 -24.25 3.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.983 . . . . 0.0 109.734 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.521 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 1.8 t -160.13 107.39 1.62 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.963 . . . . 0.0 109.249 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.7 -5.67 26.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.29 -0.881 . . . . 0.0 109.717 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.45 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 2.2 mp0 -109.1 124.8 51.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.154 -0.967 . . . . 0.0 109.527 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.424 ' O ' ' CD ' ' B' ' 39' ' ' GLU . 1.7 m -48.33 158.38 0.27 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.938 . . . . 0.0 109.282 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.513 ' HG3' ' NZ ' ' B' ' 29' ' ' LYS . 25.7 mm-40 -139.92 107.32 5.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 109.716 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.721 HG11 HD11 ' B' ' 63' ' ' ILE . 10.5 t -92.56 151.95 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.18 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' B' ' 51' ' ' CYS . 3.2 mt -140.25 156.22 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.78 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.759 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -142.6 117.98 10.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 109.047 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.61 HG22 ' O ' ' B' ' 43' ' ' THR . 1.2 m -89.19 96.05 10.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.875 -1.141 . . . . 0.0 108.729 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.4 mt -42.27 165.71 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.614 -0.679 . . . . 0.0 109.917 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -79.63 7.23 8.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.452 -0.78 . . . . 0.0 109.804 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.49 24.06 12.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.249 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.31 0.06 65.33 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.512 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 72.3 mtt85 -88.67 162.22 16.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -1.157 . . . . 0.0 109.33 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.523 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 1.4 mptt -135.53 151.35 50.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.89 . . . . 0.0 109.39 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.529 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.29 123.37 8.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.254 -0.904 . . . . 0.0 109.143 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' B' ' 41' ' ' ILE . 10.1 m -79.54 142.59 35.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 109.091 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 1.067 HD13 HD13 ' B' ' 62' ' ' ILE . 14.4 mt -120.45 167.72 12.07 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.561 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.674 ' O ' HG21 ' B' ' 59' ' ' VAL . 7.5 t30 -99.55 122.5 51.28 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.453 -0.779 . . . . 0.0 109.108 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.441 ' O ' ' HE2' ' B' ' 60' ' ' LYS . 33.4 Cg_endo -75.0 -3.6 14.16 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.185 1.923 . . . . 0.0 110.385 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.59 -12.24 43.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 108.993 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.4 OUTLIER -90.06 163.06 33.37 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 109.382 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.63 -39.04 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.636 2.224 . . . . 0.0 110.746 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.6 HG23 ' N ' ' B' ' 59' ' ' VAL . 20.6 tt -65.2 -45.87 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 1.056 ' HA ' HD12 ' B' ' 62' ' ' ILE . 44.2 t -57.48 -45.65 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.847 . . . . 0.0 109.304 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' B' ' 56' ' ' SER . 7.4 mttt -59.57 -29.57 68.03 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' B' ' 65' ' ' LYS . 7.0 mmmm -79.5 -23.66 42.8 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 1.067 HD13 HD13 ' B' ' 52' ' ' LEU . 29.4 mt -72.08 -36.6 57.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.57 -0.706 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.721 HD11 HG11 ' B' ' 40' ' ' VAL . 2.2 mp -75.86 -51.13 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.797 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.48 ' OE2' ' HE3' ' B' ' 61' ' ' LYS . 9.4 pt-20 -65.81 -29.0 69.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.023 -1.048 . . . . 0.0 109.303 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 4.4 mmtt -69.42 -46.19 67.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 108.943 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.442 ' SD ' ' OG ' ' B' ' 69' ' ' SER . 0.3 OUTLIER -56.13 -45.22 79.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.379 -0.826 . . . . 0.0 109.051 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.73 -51.85 8.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.423 -0.798 . . . . 0.0 109.418 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' B' ' 69' ' ' SER . 6.9 t-20 -64.84 -37.25 87.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.486 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.442 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.1 p . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.453 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.885 ' HB2' HD22 ' A' ' 12' ' ' LEU . 8.7 m . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.538 ' HG3' ' CD ' ' A' ' 29' ' ' LYS . 64.3 mm-40 -43.78 -24.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.827 . . . . 0.0 110.015 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.472 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 66.4 m -139.83 77.9 1.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.026 -1.047 . . . . 0.0 109.974 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.885 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -50.51 -43.95 55.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 108.89 179.498 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.53 121.81 41.98 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.49 170.49 8.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.144 -0.972 . . . . 0.0 110.009 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.975 HD12 ' O ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -127.54 148.84 50.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.803 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.6 tt0 -44.43 -54.69 5.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 1.039 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 149.04 168.53 14.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.848 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -136.34 161.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -1.097 . . . . 0.0 109.374 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.619 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -43.26 147.74 0.7 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.795 . . . . 0.0 109.048 179.533 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.619 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 33.6 Cg_endo -75.59 -3.01 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.213 1.942 . . . . 0.0 110.009 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.44 -25.22 20.46 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.367 -0.833 . . . . 0.0 108.909 179.26 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 5.2 m-20 -81.92 -4.88 57.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.435 -0.79 . . . . 0.0 109.334 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.61 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 13.6 mt -107.0 149.6 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 0.0 110.294 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.571 ' HG3' ' N ' ' A' ' 25' ' ' SER . 1.0 OUTLIER -120.93 -28.1 4.87 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.248 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.571 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -135.93 169.17 18.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.105 179.323 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 25' ' ' SER . 48.9 t -156.66 126.27 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.718 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 55.5 t30 -108.49 157.93 18.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.339 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.07 95.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.493 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.538 ' CD ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -100.54 126.99 47.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.577 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.492 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.2 p -75.85 160.99 77.54 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.346 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.496 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.2 Cg_endo -77.15 145.61 24.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.509 2.14 . . . . 0.0 110.425 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.39 -133.64 1.55 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.97 41.46 1.12 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.719 2.279 . . . . 0.0 110.781 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.455 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 9.1 p-80 -162.11 -38.01 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.073 -1.017 . . . . 0.0 109.28 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 2.7 t -145.71 101.18 3.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.176 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.17 -12.46 20.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.725 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.459 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 1.9 mp0 -106.92 129.39 54.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.526 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.492 HG23 ' HA ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -48.49 162.82 0.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.192 -0.942 . . . . 0.0 109.292 179.887 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' A' ' 11' ' ' CYS . 2.6 mp0 -136.95 114.44 11.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.643 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.844 HG11 HD11 ' A' ' 63' ' ' ILE . 19.5 t -104.86 144.57 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.16 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 2.6 mp -133.34 152.35 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.61 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -137.6 116.49 12.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.866 . . . . 0.0 109.173 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.534 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.8 m -89.12 97.51 11.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.956 -1.09 . . . . 0.0 108.785 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 93.1 mt -44.72 166.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.522 -0.736 . . . . 0.0 109.6 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.2 ptpt -81.61 8.46 9.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.28 19.92 17.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.204 179.742 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 4.54 89.6 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.516 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 5.8 mtt180 -94.55 168.39 10.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -1.194 . . . . 0.0 109.508 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.93 156.72 48.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 179.808 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.4 120.03 7.0 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.308 -0.87 . . . . 0.0 109.098 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.975 ' O ' HD12 ' A' ' 15' ' ' LEU . 8.0 m -79.74 139.08 37.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.077 -1.014 . . . . 0.0 108.948 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.039 HD22 ' HA2' ' A' ' 17' ' ' GLY . 10.4 mt -123.39 168.32 12.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.204 -0.935 . . . . 0.0 109.68 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.615 ' O ' HG21 ' A' ' 59' ' ' VAL . 28.9 t-20 -101.65 119.89 55.94 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.5 -0.75 . . . . 0.0 109.334 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.444 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 33.6 Cg_endo -74.84 1.39 7.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.127 1.885 . . . . 0.0 110.542 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.53 -17.36 30.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.219 -0.926 . . . . 0.0 108.964 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -90.16 164.06 29.26 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 109.456 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.29 -33.31 1.98 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.731 2.287 . . . . 0.0 110.671 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.615 ' O ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -67.26 -48.33 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.104 -0.998 . . . . 0.0 108.99 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.852 HG22 ' HB3' ' A' ' 52' ' ' LEU . 33.7 t -57.38 -48.73 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 108.983 179.353 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 56' ' ' SER . 4.9 mmmt -53.6 -32.2 50.15 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.535 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 3.1 mmpt? -73.64 -34.03 64.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.505 -0.747 . . . . 0.0 109.193 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.615 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.5 mp -59.9 -44.68 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.807 . . . . 0.0 108.921 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.904 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -66.66 -62.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -0.869 . . . . 0.0 109.897 -179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 60' ' ' LYS . 5.6 pt-20 -58.35 -15.81 12.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.992 -1.067 . . . . 0.0 109.517 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 7.8 mmtt -83.32 -36.18 24.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 108.795 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.464 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -68.99 -44.83 72.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.402 -0.811 . . . . 0.0 108.946 179.429 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.908 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -43.63 -50.74 7.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.328 179.68 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -72.84 -36.74 67.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.464 ' OG ' ' HA ' ' A' ' 66' ' ' MET . 25.2 p . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.452 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.928 ' HB2' HD22 ' B' ' 12' ' ' LEU . 8.8 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.532 ' HG3' ' CD ' ' B' ' 29' ' ' LYS . 64.3 mm-40 -43.78 -24.92 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.336 -0.853 . . . . 0.0 109.998 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.469 ' HB2' ' HG3' ' B' ' 39' ' ' GLU . 66.3 m -139.8 77.97 1.64 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.072 -1.018 . . . . 0.0 109.986 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.928 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -50.53 -43.85 56.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 108.922 179.474 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.57 121.83 42.01 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.527 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.49 170.53 8.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 110.053 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.985 HD12 ' O ' ' B' ' 51' ' ' CYS . 0.3 OUTLIER -127.61 148.74 50.37 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.754 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.784 ' O ' HG23 ' B' ' 59' ' ' VAL . 2.6 tt0 -44.36 -54.74 5.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.97 . . . . 0.0 109.451 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 1.041 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 149.1 168.59 14.88 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.829 HD13 ' N ' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -136.39 161.65 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -1.072 . . . . 0.0 109.359 179.746 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.607 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.5 OUTLIER -43.34 147.85 0.71 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.394 -0.816 . . . . 0.0 109.005 179.561 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.607 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 33.1 Cg_endo -75.61 -3.08 13.39 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.264 1.976 . . . . 0.0 109.941 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.49 -25.26 20.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.825 . . . . 0.0 108.807 179.383 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.53 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 5.3 m-20 -81.77 -4.96 57.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.444 -0.785 . . . . 0.0 109.398 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.605 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 13.7 mt -107.05 149.62 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 110.213 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.576 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -120.92 -28.03 4.88 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.267 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.576 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -136.05 169.1 18.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.33 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 25' ' ' SER . 48.7 t -156.56 126.27 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 109.752 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 55.6 t30 -108.47 157.99 17.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.329 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.13 95.42 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.532 ' CD ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -100.51 127.03 46.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.591 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.478 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.2 p -75.87 160.99 77.47 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.332 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.495 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.4 Cg_endo -77.11 145.55 24.67 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.575 2.183 . . . . 0.0 110.456 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.4 -133.63 1.54 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.0 41.53 1.14 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.595 2.197 . . . . 0.0 110.807 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.46 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 9.0 p-80 -162.09 -38.05 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.046 . . . . 0.0 109.269 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.495 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 2.7 t -145.7 101.31 3.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 0.0 109.131 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.28 -12.39 20.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.903 . . . . 0.0 109.737 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 1.9 mp0 -106.89 129.36 54.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -0.942 . . . . 0.0 109.503 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.478 HG23 ' HA ' ' B' ' 30' ' ' SER . 0.6 OUTLIER -48.44 162.83 0.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 109.227 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' B' ' 11' ' ' CYS . 2.6 mp0 -136.94 114.42 10.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.687 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.809 HG11 HD11 ' B' ' 63' ' ' ILE . 19.1 t -104.85 144.47 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.851 . . . . 0.0 109.184 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 2.6 mp -133.24 152.37 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.81 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.605 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -137.62 116.43 12.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -0.888 . . . . 0.0 109.179 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.532 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 1.8 m -89.11 97.52 11.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.922 -1.111 . . . . 0.0 108.737 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 93.1 mt -44.62 166.75 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.556 -0.715 . . . . 0.0 109.628 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.2 ptpt -81.6 8.5 9.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.632 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -111.3 19.87 17.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.96 . . . . 0.0 109.228 179.71 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 4.59 89.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 5.8 mtt180 -94.59 168.35 10.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.162 -1.199 . . . . 0.0 109.55 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.89 156.74 48.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.82 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.39 120.08 7.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.335 -0.853 . . . . 0.0 109.052 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.985 ' O ' HD12 ' B' ' 15' ' ' LEU . 8.0 m -79.74 139.11 37.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 108.972 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 1.041 HD22 ' HA2' ' B' ' 17' ' ' GLY . 10.5 mt -123.47 168.36 12.67 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.149 -0.97 . . . . 0.0 109.67 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.611 ' O ' HG21 ' B' ' 59' ' ' VAL . 29.1 t-20 -101.68 119.89 55.89 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 109.332 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.449 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.2 Cg_endo -74.84 1.3 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.183 1.922 . . . . 0.0 110.518 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.48 -17.31 30.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.912 . . . . 0.0 108.977 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.4 OUTLIER -90.2 164.01 29.3 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.82 . . . . 0.0 109.383 179.915 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.32 -33.22 1.99 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.624 2.216 . . . . 0.0 110.694 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.608 ' O ' HD13 ' B' ' 62' ' ' ILE . 0.2 OUTLIER -67.21 -48.33 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.105 -0.997 . . . . 0.0 108.995 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.859 HG22 ' HB3' ' B' ' 52' ' ' LEU . 33.8 t -57.42 -48.72 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.414 -0.804 . . . . 0.0 108.981 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' B' ' 56' ' ' SER . 4.9 mmmt -53.63 -32.19 50.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.539 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 3.1 mmpt? -73.57 -34.19 65.01 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.608 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.5 mp -59.74 -44.79 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 108.955 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.908 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -66.72 -62.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 109.876 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.473 ' OE2' ' HA ' ' B' ' 61' ' ' LYS . 5.6 pt-20 -58.28 -15.85 11.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.99 . . . . 0.0 109.576 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 7.7 mmtt -83.29 -36.21 24.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 108.791 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.47 ' HA ' ' OG ' ' B' ' 69' ' ' SER . 0.2 OUTLIER -69.0 -44.79 72.1 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.484 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.904 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -43.68 -50.67 7.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.381 -0.824 . . . . 0.0 109.373 179.701 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -72.81 -36.73 67.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.884 . . . . 0.0 109.482 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' B' ' 66' ' ' MET . 25.6 p . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.381 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.44 ' HB3' ' OE2' ' A' ' 39' ' ' GLU . 58.4 m . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.537 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 22.1 mm100 -62.5 -10.01 10.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.891 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.462 ' SG ' ' HG2' ' A' ' 39' ' ' GLU . 39.7 m -138.83 67.93 1.39 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.005 -1.06 . . . . 0.0 109.851 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -45.13 -45.63 11.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.147 -0.97 . . . . 0.0 108.998 179.54 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.426 ' OE1' ' N ' ' A' ' 14' ' ' THR . 0.5 OUTLIER -118.14 116.9 27.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.463 -0.773 . . . . 0.0 108.95 179.541 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.426 ' N ' ' OE1' ' A' ' 13' ' ' GLN . 0.6 OUTLIER -90.24 171.08 9.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 110.048 -179.442 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 51' ' ' CYS . 1.0 OUTLIER -119.81 143.66 47.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.478 -0.763 . . . . 0.0 109.09 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.524 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -44.65 -38.27 4.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.084 -1.01 . . . . 0.0 109.287 -179.909 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 1.074 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 138.26 156.51 7.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.805 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -125.8 156.11 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -1.082 . . . . 0.0 109.332 179.592 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.616 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.94 153.99 0.31 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.852 . . . . 0.0 109.298 179.82 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.616 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.1 Cg_endo -76.27 -5.03 15.81 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.417 2.078 . . . . 0.0 109.943 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -81.73 -22.28 37.42 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.047 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.906 ' O ' HD23 ' A' ' 44' ' ' LEU . 35.4 m-20 -98.58 60.03 1.3 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.895 HD13 ' O ' ' A' ' 22' ' ' ASN . 2.6 mm -143.78 167.5 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.937 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.754 ' HG2' HG22 ' A' ' 43' ' ' THR . 0.1 OUTLIER -160.18 -35.15 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.566 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.5 p -133.51 176.72 8.29 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.173 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.507 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 54.6 t -151.29 92.11 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.976 -1.078 . . . . 0.0 109.868 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.493 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 5.1 t-20 -94.03 110.63 22.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.219 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.581 HG13 HG22 ' A' ' 40' ' ' VAL . 1.9 t -121.77 100.15 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.584 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.537 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 9.6 ptpt -98.09 106.67 19.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.352 -0.843 . . . . 0.0 109.363 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.591 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.1 p -45.87 170.54 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.398 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 35.6 Cg_endo -77.89 132.28 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.568 2.179 . . . . 0.0 110.407 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.33 -142.7 4.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.21 8.12 3.38 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.584 2.189 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.451 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 6.6 p-80 -124.44 -18.75 5.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 109.73 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -160.22 96.62 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 109.255 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -55.17 -29.16 57.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.55 125.33 35.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.591 HG23 ' HA ' ' A' ' 30' ' ' SER . 32.5 m -46.43 152.75 0.41 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -129.31 121.67 27.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.65 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.687 HG11 HD11 ' A' ' 63' ' ' ILE . 16.2 t -108.14 150.34 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.22 179.693 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 27' ' ' ASN . 14.4 mt -143.15 143.12 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.015 . . . . 0.0 109.846 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.684 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -130.99 123.02 27.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 108.932 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.754 HG22 ' HG2' ' A' ' 24' ' ' GLN . 40.5 m -89.39 103.26 15.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.967 -1.083 . . . . 0.0 109.097 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.906 HD23 ' O ' ' A' ' 22' ' ' ASN . 73.1 mt -42.48 165.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.502 -0.749 . . . . 0.0 109.59 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.4 ptpt -87.27 16.44 5.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 44' ' ' LEU . 19.0 p-10 -117.27 6.02 12.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 109.399 179.635 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.53 14.46 44.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.674 ' HB2' HD12 ' A' ' 44' ' ' LEU . 9.8 mtp180 -111.32 174.23 5.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -1.203 . . . . 0.0 109.553 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.434 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 6.8 mttt -138.26 156.69 47.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.25 120.48 7.29 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.331 -0.855 . . . . 0.0 109.058 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.866 ' O ' HD12 ' A' ' 15' ' ' LEU . 20.6 m -79.31 140.59 37.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.12 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 1.074 HD22 ' HA2' ' A' ' 17' ' ' GLY . 10.2 mt -124.51 168.97 12.35 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.234 -0.916 . . . . 0.0 109.597 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.681 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.7 t-20 -105.61 127.39 28.61 Favored Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.381 -0.824 . . . . 0.0 109.255 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.71 2.21 7.22 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.236 1.957 . . . . 0.0 110.648 -179.503 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.429 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -86.0 -19.03 30.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.033 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.512 ' OG ' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -90.22 162.7 34.04 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 109.526 179.95 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.76 -32.98 2.44 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.722 2.281 . . . . 0.0 111.002 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.512 HG22 ' OG ' ' A' ' 56' ' ' SER . 15.8 tt -70.54 -40.26 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.057 -1.027 . . . . 0.0 109.539 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 1.006 ' HA ' HD12 ' A' ' 62' ' ' ILE . 24.6 t -61.96 -48.19 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.343 -0.848 . . . . 0.0 108.951 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -60.9 -29.63 69.69 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.541 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -81.92 -19.7 40.24 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.867 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 1.006 HD12 ' HA ' ' A' ' 59' ' ' VAL . 16.4 mt -72.71 -38.86 59.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.936 HG22 HD11 ' B' ' 67' ' ' LEU . 1.5 mp -75.27 -61.84 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.313 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.33 -47.82 25.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.342 -0.849 . . . . 0.0 109.294 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 21.8 tptt -52.0 -57.3 9.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.185 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.507 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -44.36 -48.45 9.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.2 179.747 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.899 HD11 HG22 ' B' ' 63' ' ' ILE . 0.4 OUTLIER -48.81 -54.66 14.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.49 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' SER . 18.5 t30 -56.14 -32.82 64.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.484 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 68' ' ' ASN . 1.1 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.471 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.448 ' HB3' ' OE2' ' B' ' 39' ' ' GLU . 58.8 m . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.529 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 22.1 mm100 -62.55 -9.94 10.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.889 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.461 ' SG ' ' HG2' ' B' ' 39' ' ' GLU . 39.6 m -138.87 68.03 1.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 109.836 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.3 OUTLIER -45.28 -45.63 12.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 108.883 179.609 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 13' ' ' GLN . . . . . 0.417 ' OE1' ' N ' ' B' ' 14' ' ' THR . 0.5 OUTLIER -118.03 116.87 27.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 108.928 179.643 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.417 ' N ' ' OE1' ' B' ' 13' ' ' GLN . 0.6 OUTLIER -90.24 171.1 9.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -0.924 . . . . 0.0 110.042 -179.456 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.836 HD12 ' O ' ' B' ' 51' ' ' CYS . 1.0 OUTLIER -119.86 143.66 47.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.45 -0.781 . . . . 0.0 109.013 179.764 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.52 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.9 OUTLIER -44.58 -38.29 4.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 -179.962 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 1.02 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 138.26 156.52 7.14 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.805 ' H ' HD13 ' B' ' 18' ' ' ILE . 0.2 OUTLIER -125.84 156.04 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -1.084 . . . . 0.0 109.316 179.579 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.609 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -42.8 154.03 0.31 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 109.31 179.797 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.609 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 33.6 Cg_endo -76.38 -5.0 15.74 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.377 2.051 . . . . 0.0 109.862 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -81.74 -22.2 37.44 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.997 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.902 ' O ' HD23 ' B' ' 44' ' ' LEU . 35.6 m-20 -98.54 59.94 1.31 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.217 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.881 HD13 ' O ' ' B' ' 22' ' ' ASN . 2.6 mm -143.78 167.54 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.963 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.746 ' HG2' HG22 ' B' ' 43' ' ' THR . 0.1 OUTLIER -160.24 -35.1 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.273 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.545 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.4 p -133.46 176.77 8.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.009 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.511 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 54.0 t -151.31 92.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.897 -1.127 . . . . 0.0 109.86 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.485 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 5.1 t-20 -94.1 110.62 22.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.249 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.595 HG13 HG22 ' B' ' 40' ' ' VAL . 1.9 t -121.76 100.16 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.605 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.529 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 9.6 ptpt -98.05 106.66 18.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 109.401 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.588 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -45.9 170.57 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.399 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.525 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 35.9 Cg_endo -77.79 132.21 11.76 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.594 2.196 . . . . 0.0 110.499 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.32 -142.7 4.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.2 8.1 3.39 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.524 2.15 . . . . 0.0 110.873 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.453 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 6.6 p-80 -124.44 -18.66 5.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.006 -1.059 . . . . 0.0 109.757 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -160.22 96.59 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -0.948 . . . . 0.0 109.303 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -55.19 -29.12 57.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.941 . . . . 0.0 109.651 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.61 125.41 35.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.486 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.588 HG23 ' HA ' ' B' ' 30' ' ' SER . 32.4 m -46.41 152.74 0.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.424 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.461 ' HG2' ' SG ' ' B' ' 11' ' ' CYS . 0.0 OUTLIER -129.32 121.59 27.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.193 -0.942 . . . . 0.0 109.733 -179.929 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.688 HG11 HD11 ' B' ' 63' ' ' ILE . 16.2 t -108.17 150.36 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.24 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' B' ' 27' ' ' ASN . 14.5 mt -143.19 143.12 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.673 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -131.03 123.03 27.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 108.862 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.746 HG22 ' HG2' ' B' ' 24' ' ' GLN . 41.8 m -89.31 103.24 15.88 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.943 -1.098 . . . . 0.0 109.182 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.902 HD23 ' O ' ' B' ' 22' ' ' ASN . 72.5 mt -42.46 165.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.538 -0.726 . . . . 0.0 109.582 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.4 ptpt -87.26 16.38 5.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 109.555 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.523 ' OD1' ' CB ' ' B' ' 44' ' ' LEU . 19.0 p-10 -117.33 6.17 12.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.619 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.47 14.61 43.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.696 ' HB2' HD12 ' B' ' 44' ' ' LEU . 9.7 mtp180 -111.43 174.26 5.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -1.207 . . . . 0.0 109.495 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.42 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 6.7 mttt -138.24 156.81 47.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.33 120.52 7.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.821 . . . . 0.0 109.02 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.836 ' O ' HD12 ' B' ' 15' ' ' LEU . 20.5 m -79.37 140.62 37.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.074 -1.016 . . . . 0.0 109.122 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 1.032 HD13 HD13 ' B' ' 62' ' ' ILE . 10.2 mt -124.51 168.96 12.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.69 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.7 t-20 -105.57 127.39 28.62 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.795 . . . . 0.0 109.185 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.74 2.27 7.17 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.208 1.939 . . . . 0.0 110.657 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.443 ' HB3' ' OD1' ' B' ' 53' ' ' ASN . . . -85.98 -19.1 30.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 0.0 109.074 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.505 ' OG ' HG22 ' B' ' 58' ' ' ILE . 0.4 OUTLIER -90.29 162.76 33.7 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.503 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.73 -33.0 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.755 2.303 . . . . 0.0 111.006 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.505 HG22 ' OG ' ' B' ' 56' ' ' SER . 15.9 tt -70.59 -40.16 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.109 -0.994 . . . . 0.0 109.51 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 1.026 ' HA ' HD12 ' B' ' 62' ' ' ILE . 24.5 t -62.07 -48.17 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.378 -0.827 . . . . 0.0 108.913 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -60.92 -29.7 69.76 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.535 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -81.81 -19.65 40.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 179.804 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 1.032 HD13 HD13 ' B' ' 52' ' ' LEU . 16.4 mt -72.76 -38.88 58.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.899 HG22 HD11 ' A' ' 67' ' ' LEU . 1.5 mp -75.16 -61.91 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -47.86 25.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.38 -0.825 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' B' ' 66' ' ' MET . 21.9 tptt -51.85 -57.38 9.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.163 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.511 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -44.39 -48.48 9.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.173 179.783 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.936 HD11 HG22 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -48.77 -54.63 14.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 179.899 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 68' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' B' ' 69' ' ' SER . 18.5 t30 -56.27 -32.7 64.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 0.0 109.498 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.429 ' C ' ' O ' ' B' ' 68' ' ' ASN . 1.1 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 109.468 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.986 ' HB2' HD22 ' A' ' 12' ' ' LEU . 7.2 m . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 39' ' ' GLU . 5.3 mp0 -41.08 -38.38 1.02 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.515 -0.741 . . . . 0.0 109.736 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' A' ' 41' ' ' ILE . 72.3 m -136.56 78.21 1.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.695 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.986 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.87 -46.77 11.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.083 179.646 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -117.6 124.94 49.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.357 -0.839 . . . . 0.0 108.995 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 169.47 8.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 109.992 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 51' ' ' CYS . 4.8 mt -113.86 -167.42 1.2 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.759 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.4 mt-30 -88.92 -48.06 7.72 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 0.0 109.348 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.523 ' C ' HD13 ' A' ' 18' ' ' ILE . . . 154.2 161.57 10.54 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.853 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -142.98 149.67 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.378 -1.072 . . . . 0.0 109.311 179.666 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.597 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.94 152.08 0.38 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 109.535 -179.865 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -77.18 -2.65 12.88 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.584 2.189 . . . . 0.0 110.177 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 3.9 mmtt -90.19 -24.55 20.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.113 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 6.1 m-20 -85.43 -5.88 59.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.323 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.798 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 9.4 mt -104.93 152.7 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.255 -0.903 . . . . 0.0 110.043 -179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.576 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -124.98 -28.44 3.46 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.441 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.576 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.9 OUTLIER -137.33 174.08 10.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.072 179.473 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.55 HG11 HG13 ' A' ' 63' ' ' ILE . 21.4 t -149.74 119.64 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.985 . . . . 0.0 109.788 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.629 ' O ' HD12 ' A' ' 41' ' ' ILE . 4.8 t-20 -112.85 112.7 24.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 109.338 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.841 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -116.33 109.89 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.489 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.567 ' CE ' ' NE2' ' A' ' 34' ' ' HIS . 7.4 tttt -107.68 107.79 18.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.445 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.436 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.1 p -50.66 168.42 0.23 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.41 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 35.8 Cg_endo -77.88 134.68 13.52 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.582 2.188 . . . . 0.0 110.422 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.8 -142.04 4.45 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.09 7.79 3.5 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.553 2.169 . . . . 0.0 110.88 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.567 ' NE2' ' CE ' ' A' ' 29' ' ' LYS . 8.0 p-80 -126.34 -7.55 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.079 -1.013 . . . . 0.0 109.628 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.446 ' SG ' ' OE2' ' A' ' 39' ' ' GLU . 4.2 t -160.3 146.47 15.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.288 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.3 0.84 23.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 37' ' ' GLN . 3.8 mp0 -126.88 124.91 40.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.004 . . . . 0.0 109.474 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.436 HG23 ' HA ' ' A' ' 30' ' ' SER . 23.6 m -45.8 144.58 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 0.0 109.349 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 10' ' ' GLN . 4.6 mm-40 -122.47 107.24 11.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.664 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.866 HG11 HD11 ' A' ' 63' ' ' ILE . 38.5 t -91.89 150.39 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.135 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.1 mt -139.87 154.67 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.11 -0.994 . . . . 0.0 109.802 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.798 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -138.57 118.07 12.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.155 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.534 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.9 m -89.16 97.83 11.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.907 -1.121 . . . . 0.0 108.912 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 90.8 mt -44.0 166.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.488 -0.758 . . . . 0.0 109.66 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -81.58 8.06 10.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.699 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.01 24.68 12.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.225 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.16 3.93 71.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 6.9 mtt180 -93.2 166.56 12.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.146 -1.208 . . . . 0.0 109.454 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.4 155.6 49.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 0.0 109.433 -179.957 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.35 118.33 6.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.194 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.466 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 7.0 m -79.51 138.33 37.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.125 -0.984 . . . . 0.0 108.868 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.876 ' HB3' HG22 ' A' ' 59' ' ' VAL . 9.8 mt -124.0 168.61 12.6 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.632 ' O ' HG21 ' A' ' 59' ' ' VAL . 65.5 t30 -101.49 121.38 51.67 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.47 -0.769 . . . . 0.0 109.446 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.494 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.7 Cg_endo -74.67 -2.25 12.2 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.163 1.909 . . . . 0.0 110.488 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.58 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -83.8 -17.38 41.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.304 -0.873 . . . . 0.0 108.849 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -90.27 163.08 32.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.443 179.919 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.475 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 35.9 Cg_endo -77.74 -35.32 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.638 2.226 . . . . 0.0 111.113 -179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.626 ' O ' HD13 ' A' ' 62' ' ' ILE . 16.1 tt -67.9 -47.41 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.979 -1.076 . . . . 0.0 109.236 -179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.876 HG22 ' HB3' ' A' ' 52' ' ' LEU . 32.7 t -55.04 -48.61 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.195 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 12.0 mttt -57.36 -31.32 65.63 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.525 ' CE ' ' OE2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -75.67 -27.59 58.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.655 -0.653 . . . . 0.0 109.342 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.65 HG23 ' CD1' ' A' ' 23' ' ' ILE . 1.7 mp -67.33 -43.25 88.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.404 -0.81 . . . . 0.0 108.832 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.042 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.1 mp -69.53 -65.28 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.833 . . . . 0.0 109.721 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' OE2' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -49.01 -35.32 15.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.131 -0.98 . . . . 0.0 109.643 -179.703 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.484 ' HB3' ' CB ' ' A' ' 20' ' ' PRO . 21.3 mmtm -63.38 -54.0 43.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.09 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.529 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -49.06 -46.53 44.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.314 -0.866 . . . . 0.0 109.146 179.599 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.053 HD11 ' CG2' ' B' ' 63' ' ' ILE . 1.0 OUTLIER -56.87 -47.56 80.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.509 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.53 31.36 2.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.138 -0.976 . . . . 0.0 109.372 179.919 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 1.002 ' HB2' HD22 ' B' ' 12' ' ' LEU . 7.0 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.493 ' HB2' ' HB2' ' B' ' 39' ' ' GLU . 5.3 mp0 -41.02 -38.39 0.99 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.829 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.464 ' SG ' HG13 ' B' ' 41' ' ' ILE . 72.5 m -136.58 78.26 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.736 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 1.002 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.0 -46.74 11.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.059 179.71 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -117.57 125.06 50.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 108.968 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.99 169.42 8.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.215 -0.928 . . . . 0.0 109.992 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 51' ' ' CYS . 4.9 mt -113.89 -167.41 1.2 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.755 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.4 mt-30 -88.86 -48.17 7.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.126 -0.984 . . . . 0.0 109.299 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.51 ' C ' HD13 ' B' ' 18' ' ' ILE . . . 154.26 161.55 10.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.843 HD13 ' N ' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -143.0 149.79 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.357 -1.084 . . . . 0.0 109.267 179.589 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.592 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -42.98 152.12 0.38 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.356 -0.84 . . . . 0.0 109.468 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.592 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -77.28 -2.67 12.88 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.498 2.132 . . . . 0.0 110.092 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.467 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 3.9 mmtt -90.06 -24.61 21.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -0.847 . . . . 0.0 109.178 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.529 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 6.1 m-20 -85.33 -5.96 59.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.296 -0.878 . . . . 0.0 109.364 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.8 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 9.2 mt -104.89 152.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 110.089 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.572 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -124.9 -28.46 3.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.479 -0.763 . . . . 0.0 109.084 179.355 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.572 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.9 OUTLIER -137.24 174.2 10.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.902 . . . . 0.0 109.076 179.436 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.541 HG11 HG13 ' B' ' 63' ' ' ILE . 21.4 t -149.86 119.66 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.045 -1.034 . . . . 0.0 109.707 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.633 ' O ' HD12 ' B' ' 41' ' ' ILE . 4.8 t-20 -112.89 112.71 24.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.344 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.847 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -116.31 109.9 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 109.403 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.573 ' CE ' ' NE2' ' B' ' 34' ' ' HIS . 7.4 tttt -107.62 107.8 18.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.869 . . . . 0.0 109.444 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.447 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -50.7 168.48 0.23 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 36.0 Cg_endo -77.89 134.65 13.49 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.666 2.244 . . . . 0.0 110.424 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.81 -142.01 4.44 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.1 7.75 3.52 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.651 2.234 . . . . 0.0 110.816 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.573 ' NE2' ' CE ' ' B' ' 29' ' ' LYS . 8.0 p-80 -126.35 -7.59 6.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 109.608 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.444 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 4.2 t -160.23 146.52 15.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.287 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.29 0.76 23.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.151 -0.968 . . . . 0.0 109.706 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.42 ' CD ' ' N ' ' B' ' 37' ' ' GLN . 3.9 mp0 -126.88 125.01 40.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.129 -0.982 . . . . 0.0 109.506 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.447 HG23 ' HA ' ' B' ' 30' ' ' SER . 23.8 m -45.78 144.58 1.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 109.307 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' B' ' 10' ' ' GLN . 4.6 mm-40 -122.48 107.24 11.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 109.624 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.847 HG22 HG13 ' B' ' 28' ' ' VAL . 38.6 t -91.84 150.35 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.199 179.772 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.633 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.1 mt -139.89 154.79 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.785 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.8 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -138.61 118.02 12.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 109.117 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 1.8 m -89.18 97.74 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.036 -1.04 . . . . 0.0 108.966 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 90.8 mt -43.95 166.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.456 -0.778 . . . . 0.0 109.617 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.467 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -81.64 8.12 10.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 109.664 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.02 24.64 12.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 109.227 179.726 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.1 4.01 71.21 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 6.9 mtt180 -93.23 166.51 12.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.164 -1.197 . . . . 0.0 109.499 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.38 155.7 49.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.427 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 50' ' ' ALA . . . . . 0.413 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.4 118.39 6.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 109.143 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 6.9 m -79.56 138.31 37.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.124 -0.985 . . . . 0.0 108.83 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.84 ' HB3' HG22 ' B' ' 59' ' ' VAL . 9.7 mt -123.95 168.58 12.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.129 -0.982 . . . . 0.0 109.581 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.63 ' O ' HG21 ' B' ' 59' ' ' VAL . 65.5 t30 -101.56 121.5 51.12 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.44 -0.787 . . . . 0.0 109.458 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.491 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.2 Cg_endo -74.79 -2.18 12.14 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.182 1.921 . . . . 0.0 110.462 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 55' ' ' ALA . . . . . 0.569 ' HB3' ' ND2' ' B' ' 53' ' ' ASN . . . -83.85 -17.45 40.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.911 . . . . 0.0 108.763 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.8 OUTLIER -90.25 163.15 32.53 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.442 -0.786 . . . . 0.0 109.433 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.74 -35.47 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.781 2.321 . . . . 0.0 111.082 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.62 ' O ' HD13 ' B' ' 62' ' ' ILE . 16.2 tt -67.83 -47.56 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.001 -1.062 . . . . 0.0 109.189 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 0.84 HG22 ' HB3' ' B' ' 52' ' ' LEU . 33.1 t -54.97 -48.71 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.135 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 12.0 mttt -57.21 -31.37 65.4 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.22 -0.925 . . . . 0.0 108.514 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.514 ' CE ' ' OE2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -75.67 -27.6 58.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.317 179.947 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 0.65 HG23 ' CD1' ' B' ' 23' ' ' ILE . 1.7 mp -67.44 -43.26 87.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 1.053 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.1 mp -69.56 -65.31 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.679 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.514 ' OE2' ' CE ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -49.04 -35.3 15.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 109.538 -179.62 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.486 ' HB3' ' CB ' ' B' ' 20' ' ' PRO . 21.3 mmtm -63.35 -54.02 43.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.069 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.526 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 1.0 OUTLIER -49.2 -46.27 45.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 0.0 109.222 179.664 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 1.042 HD11 ' CG2' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -56.96 -47.56 80.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.436 -0.79 . . . . 0.0 109.453 179.871 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.49 31.32 2.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.947 . . . . 0.0 109.572 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 56.9 p . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.364 -179.992 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 9.6 m . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.501 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 47.0 mm-40 -49.87 -21.21 1.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.468 ' SG ' HG13 ' A' ' 41' ' ' ILE . 83.1 m -141.47 71.43 1.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.598 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.544 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.29 -44.58 8.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.219 179.727 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.54 121.12 37.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.418 -0.801 . . . . 0.0 109.228 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.02 160.53 14.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.854 . . . . 0.0 109.807 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.6 ' HB2' HD23 ' A' ' 52' ' ' LEU . 4.5 mt -103.69 142.78 33.75 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.613 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 15' ' ' LEU . 1.4 tt0 -44.75 -26.59 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.124 -0.985 . . . . 0.0 109.125 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 154.86 -178.91 31.31 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.644 ' H ' HD11 ' A' ' 62' ' ' ILE . 4.6 tp -155.72 170.62 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.501 -1.0 . . . . 0.0 108.925 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.59 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.6 t-80 -60.0 143.71 87.59 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.068 -1.02 . . . . 0.0 108.973 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -77.26 -24.64 9.22 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.443 2.095 . . . . 0.0 110.267 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' HE2' ' A' ' 45' ' ' LYS . 13.2 mttm -90.52 -13.74 34.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.81 . . . . 0.0 109.175 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 8.0 m120 -80.18 -15.34 57.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.921 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 6.9 mt -90.0 162.46 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.415 -0.803 . . . . 0.0 110.696 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -128.61 -39.65 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.198 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 1.5 p -126.86 172.09 10.7 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.304 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 78.4 t -143.97 93.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.993 -1.067 . . . . 0.0 109.716 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.481 ' O ' HD12 ' A' ' 41' ' ' ILE . 3.4 t-20 -86.85 108.72 18.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.319 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -104.66 94.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.937 . . . . 0.0 109.545 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HE2' ' HG3' ' A' ' 10' ' ' GLN . 3.6 tppt? -90.6 92.58 8.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.443 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.521 ' HB3' ' CE ' ' B' ' 66' ' ' MET . 1.0 OUTLIER -45.99 170.96 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.488 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HB3' ' O ' ' A' ' 36' ' ' ALA . 35.6 Cg_endo -77.76 140.08 18.27 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.644 2.229 . . . . 0.0 110.458 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.91 -142.44 3.66 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.82 39.22 0.81 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.689 2.259 . . . . 0.0 110.782 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.482 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 6.0 p-80 -158.67 -38.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.012 -1.055 . . . . 0.0 109.301 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -138.01 102.18 4.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.277 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 31' ' ' PRO . . . -62.99 -29.16 70.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.699 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.71 125.73 34.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' ' 30' ' ' SER . 73.5 m -48.54 148.81 1.87 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.269 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.45 ' OE1' ' HB2' ' A' ' 11' ' ' CYS . 21.5 mm-40 -125.07 123.46 39.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.628 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.605 HG11 HD11 ' A' ' 63' ' ' ILE . 16.8 t -107.55 145.53 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.266 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.481 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.6 mp -134.88 144.29 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.921 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -131.27 117.71 19.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.301 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 3.4 m -89.29 95.83 10.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.949 -1.094 . . . . 0.0 108.896 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 85.1 mt -42.16 163.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.548 -0.72 . . . . 0.0 109.962 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.52 ' HB3' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -81.01 10.77 4.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.838 . . . . 0.0 109.872 179.905 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.494 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -110.71 14.0 22.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.13 -0.982 . . . . 0.0 109.225 179.61 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.07 15.82 68.8 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.471 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 8.9 mtp-105 -108.04 175.63 5.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -1.142 . . . . 0.0 109.414 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.439 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -143.29 152.47 41.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.21 122.23 8.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.856 . . . . 0.0 108.898 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.455 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 23.0 m -79.76 143.16 34.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 0.0 109.277 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.945 HD13 HD13 ' A' ' 62' ' ' ILE . 18.7 mt -128.19 168.03 16.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 109.081 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.641 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.5 t-20 -104.87 127.72 28.23 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 109.47 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.527 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.8 Cg_endo -75.46 -11.56 20.66 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.33 2.02 . . . . 0.0 110.49 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.12 -17.41 61.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.102 -0.999 . . . . 0.0 108.969 179.618 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -90.27 162.15 35.44 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 179.941 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.08 -35.08 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.702 2.268 . . . . 0.0 111.098 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.548 HG23 ' N ' ' A' ' 59' ' ' VAL . 2.9 tt -68.24 -45.15 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.065 -1.022 . . . . 0.0 109.397 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.999 ' HA ' HD12 ' A' ' 62' ' ' ILE . 40.3 t -59.04 -45.87 92.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 18.2 mttt -60.08 -29.39 68.54 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 2.5 mmpt? -79.55 -23.54 42.75 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.999 HD12 ' HA ' ' A' ' 59' ' ' VAL . 20.5 mt -70.85 -37.91 70.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.642 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.92 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -74.69 -56.74 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.475 -0.765 . . . . 0.0 109.296 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -59.36 -28.12 66.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.962 . . . . 0.0 109.226 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.514 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -70.61 -52.06 23.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 108.914 179.611 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.528 ' CE ' ' HB3' ' B' ' 30' ' ' SER . 0.4 OUTLIER -49.58 -44.37 46.88 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.276 -0.89 . . . . 0.0 108.949 179.473 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.929 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -55.08 -59.17 5.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.547 -0.72 . . . . 0.0 109.566 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -79.89 5.33 14.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.725 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 85.6 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.393 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.534 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 9.3 m . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.479 ' HG3' ' HE2' ' B' ' 29' ' ' LYS . 47.1 mm-40 -49.85 -21.13 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.713 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.468 ' SG ' HG13 ' B' ' 41' ' ' ILE . 82.6 m -141.59 71.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.062 -1.024 . . . . 0.0 109.652 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.25 -44.55 8.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.232 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.55 121.11 37.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.252 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.96 160.44 14.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.807 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.59 ' HB2' HD23 ' B' ' 52' ' ' LEU . 4.4 mt -103.65 142.76 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' B' ' 15' ' ' LEU . 1.4 tt0 -44.73 -26.56 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.157 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.538 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 154.8 -178.92 31.26 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.647 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.631 ' H ' HD11 ' B' ' 62' ' ' ILE . 4.6 tp -155.7 170.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.467 -1.019 . . . . 0.0 108.963 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.585 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 1.6 t-80 -59.98 143.71 87.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 108.993 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.585 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.26 -24.69 9.17 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.51 2.14 . . . . 0.0 110.318 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HE2' ' B' ' 45' ' ' LYS . 13.2 mttm -90.42 -13.81 34.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 109.235 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.581 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 92.5 m-20 -80.12 -15.45 57.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.928 HG23 ' HB1' ' B' ' 42' ' ' ALA . 6.9 mt -90.08 162.43 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.43 -0.794 . . . . 0.0 110.668 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.2 OUTLIER -128.61 -39.65 1.63 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.273 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 1.5 p -126.79 172.07 10.68 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.321 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' B' ' 41' ' ' ILE . 77.8 t -144.05 93.6 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.004 -1.06 . . . . 0.0 109.703 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.475 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 3.4 t-20 -86.85 108.77 18.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.32 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.8 t -104.63 94.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.2 -0.938 . . . . 0.0 109.609 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.479 ' HE2' ' HG3' ' B' ' 10' ' ' GLN . 3.6 tppt? -90.67 92.64 8.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.423 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.528 ' HB3' ' CE ' ' A' ' 66' ' ' MET . 1.0 OUTLIER -46.11 171.03 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.0 109.483 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 31' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' B' ' 36' ' ' ALA . 35.9 Cg_endo -77.86 140.11 18.08 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.574 2.183 . . . . 0.0 110.473 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.9 -142.49 3.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.74 39.16 0.8 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.666 2.244 . . . . 0.0 110.893 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.479 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 6.0 p-80 -158.7 -38.52 0.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.07 -1.019 . . . . 0.0 109.32 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 35' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -138.14 102.21 4.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.231 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' B' ' 31' ' ' PRO . . . -62.92 -29.23 70.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.706 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.68 125.67 34.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.954 . . . . 0.0 109.561 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.439 HG23 ' HA ' ' B' ' 30' ' ' SER . 71.8 m -48.53 148.77 1.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.917 . . . . 0.0 109.34 179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 39' ' ' GLU . . . . . 0.441 ' OE1' ' HB2' ' B' ' 11' ' ' CYS . 21.5 mm-40 -125.05 123.4 39.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.613 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.628 HG11 HD11 ' B' ' 63' ' ' ILE . 16.7 t -107.44 145.58 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.89 . . . . 0.0 109.337 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' B' ' 27' ' ' ASN . 3.6 mp -134.92 144.33 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.182 -0.949 . . . . 0.0 109.605 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.928 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -131.37 117.73 19.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.292 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 3.4 m -89.36 95.88 10.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.894 -1.129 . . . . 0.0 108.949 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 85.1 mt -42.07 163.63 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.529 -0.732 . . . . 0.0 109.926 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.509 ' HB3' ' NZ ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -81.02 10.83 4.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.377 -0.827 . . . . 0.0 109.838 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -110.77 13.96 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.142 179.678 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.08 15.79 68.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.467 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 8.9 mtp-105 -108.05 175.57 5.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -1.135 . . . . 0.0 109.484 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.438 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 0.3 OUTLIER -143.23 152.46 41.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.891 . . . . 0.0 109.438 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.18 122.2 8.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.244 -0.91 . . . . 0.0 108.983 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.452 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 23.0 m -79.77 143.19 34.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.166 -0.959 . . . . 0.0 109.308 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.967 HD13 HD13 ' B' ' 62' ' ' ILE . 18.7 mt -128.24 167.97 16.13 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 109.013 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.637 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.6 t-20 -104.96 127.81 27.98 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.425 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.526 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.9 Cg_endo -75.5 -11.59 20.58 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.349 2.033 . . . . 0.0 110.45 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.07 -17.36 61.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 109.09 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.6 OUTLIER -90.29 162.16 35.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 109.504 179.916 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -78.1 -35.12 1.41 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.762 2.308 . . . . 0.0 111.086 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 58' ' ' ILE . . . . . 0.566 HG23 ' N ' ' B' ' 59' ' ' VAL . 2.9 tt -68.19 -45.19 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.065 -1.022 . . . . 0.0 109.424 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 1.018 ' HA ' HD12 ' B' ' 62' ' ' ILE . 40.5 t -58.9 -45.96 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.056 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 18.2 mttt -60.06 -29.47 68.57 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' B' ' 65' ' ' LYS . 2.5 mmpt? -79.53 -23.44 42.87 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' B' ' 59' ' ' VAL . 20.5 mt -70.94 -37.81 69.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 0.929 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -74.68 -56.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.322 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.3 OUTLIER -59.35 -28.06 66.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.329 179.838 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.515 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 0.0 OUTLIER -70.64 -52.09 23.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 108.909 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.521 ' CE ' ' HB3' ' A' ' 30' ' ' SER . 0.5 OUTLIER -49.59 -44.37 46.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.009 179.422 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.92 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -55.02 -59.19 5.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.65 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -79.87 5.34 13.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.927 . . . . 0.0 109.76 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 85.5 p . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.448 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.498 ' HB2' HD23 ' A' ' 12' ' ' LEU . 18.7 m . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.498 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 14.4 mm100 -64.68 -8.06 13.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.816 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' A' ' 41' ' ' ILE . 73.8 m -144.66 71.66 1.31 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.066 -1.021 . . . . 0.0 109.711 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.498 HD23 ' HB2' ' A' ' 9' ' ' CYS . 52.4 mt -46.29 -42.49 14.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.187 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -119.76 122.09 40.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.114 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -101.21 158.73 15.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.834 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.527 ' HB2' HD23 ' A' ' 52' ' ' LEU . 3.5 mt -102.85 139.92 37.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -43.96 -26.89 0.31 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.222 179.943 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 15' ' ' LEU . . . 157.98 -179.89 33.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.797 ' H ' HD11 ' A' ' 62' ' ' ILE . 4.6 tp -154.98 170.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.548 -0.972 . . . . 0.0 108.801 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.574 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 3.4 t-80 -59.19 141.97 86.43 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.985 -1.072 . . . . 0.0 109.055 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.3 Cg_endo -77.59 -23.62 9.63 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.499 2.133 . . . . 0.0 110.273 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 9.5 mmtp -90.25 -15.09 32.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.434 -0.791 . . . . 0.0 109.129 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 7.2 m120 -78.94 -27.76 43.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -0.788 . . . . 0.0 109.377 179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.804 HG12 ' HB1' ' A' ' 42' ' ' ALA . 6.5 mt -77.44 163.7 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.828 0.823 . . . . 0.0 110.697 -179.014 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.555 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -129.62 -41.26 1.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.109 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 10.9 p -124.97 166.69 15.88 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.075 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.738 ' O ' HG23 ' B' ' 28' ' ' VAL . 50.8 t -145.2 98.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.051 -1.03 . . . . 0.0 109.772 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 49.8 t-20 -84.35 133.23 34.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.189 -0.944 . . . . 0.0 109.383 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.739 HG23 ' O ' ' B' ' 26' ' ' VAL . 2.2 t -118.08 82.34 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.982 . . . . 0.0 109.516 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HD3' ' HG3' ' A' ' 10' ' ' GLN . 20.9 mtpt -87.32 103.62 15.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.524 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.1 p -57.63 163.8 3.49 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 109.334 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.44 132.21 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.598 2.199 . . . . 0.0 110.473 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.73 -141.13 3.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.06 7.61 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.663 2.242 . . . . 0.0 110.852 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.466 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 6.4 p-80 -124.88 -14.82 6.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.059 -1.026 . . . . 0.0 109.775 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.38 125.56 3.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -0.996 . . . . 0.0 109.363 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.42 ' O ' ' CD ' ' A' ' 37' ' ' GLN . . . -87.19 17.49 4.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.617 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' GLN . . . . . 0.42 ' CD ' ' O ' ' A' ' 36' ' ' ALA . 9.6 mm-40 -143.36 125.77 15.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.924 . . . . 0.0 109.524 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.502 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 3.2 m -44.32 157.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 109.313 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -132.64 107.1 8.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 109.576 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 1.006 HG11 HD11 ' A' ' 63' ' ' ILE . 1.7 t -101.98 93.64 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.907 . . . . 0.0 109.269 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.471 HG13 ' SG ' ' A' ' 11' ' ' CYS . 3.4 mp -82.18 150.41 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.724 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.804 ' HB1' HG12 ' A' ' 23' ' ' ILE . . . -132.65 114.91 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 108.994 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 4.3 m -89.22 98.16 11.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.879 -1.138 . . . . 0.0 108.992 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 93.1 mt -41.14 163.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.305 0.574 . . . . 0.0 109.931 -179.715 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -82.06 11.09 5.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 0.0 109.921 -179.785 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' A' ' 44' ' ' LEU . 23.4 p-10 -112.56 8.09 19.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.076 -1.015 . . . . 0.0 109.419 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.59 1.66 63.82 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.784 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.463 ' HB2' HD12 ' A' ' 44' ' ' LEU . 19.4 mtt180 -96.57 165.63 12.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -1.194 . . . . 0.0 109.545 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 2.2 mttt -133.02 153.16 51.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.466 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.3 123.39 8.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 108.908 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 35.6 m -79.62 140.94 36.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.072 -1.017 . . . . 0.0 109.305 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.958 HD13 HD13 ' A' ' 62' ' ' ILE . 16.0 mt -125.37 168.24 13.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.379 -0.826 . . . . 0.0 109.224 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.621 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.6 m-20 -106.28 124.84 34.53 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.434 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HG3' ' HB ' ' A' ' 38' ' ' THR . 33.5 Cg_endo -75.26 -7.01 18.57 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.359 2.039 . . . . 0.0 110.327 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 -17.52 50.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.227 -0.921 . . . . 0.0 108.963 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 163.7 30.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.413 -0.804 . . . . 0.0 109.321 179.866 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.443 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.45 -36.55 1.23 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.589 2.193 . . . . 0.0 110.678 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.4 mt -61.47 -48.07 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.539 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.986 ' HA ' HD12 ' A' ' 62' ' ' ILE . 76.6 t -62.25 -50.0 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.353 -0.842 . . . . 0.0 109.615 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 56' ' ' SER . 6.0 mttt -51.24 -30.72 18.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.122 -0.986 . . . . 0.0 108.722 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.483 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -78.45 -34.54 47.67 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.986 HD12 ' HA ' ' A' ' 59' ' ' VAL . 14.2 mt -59.68 -38.34 75.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.551 -0.718 . . . . 0.0 109.28 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 1.006 HD11 HG11 ' A' ' 40' ' ' VAL . 2.2 mp -74.52 -62.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.483 ' HG2' ' HA ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -53.14 -20.09 3.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 109.394 -179.931 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -79.64 -40.24 29.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.913 . . . . 0.0 109.026 179.729 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.449 ' SD ' ' OG ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -65.19 -45.79 83.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 108.995 179.613 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.697 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -43.5 -50.28 7.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.527 -0.733 . . . . 0.0 109.487 179.822 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -76.81 -27.07 55.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.845 . . . . 0.0 109.614 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.449 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 109.676 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 9' ' ' CYS . . . . . 0.518 ' HB2' HD23 ' B' ' 12' ' ' LEU . 18.5 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 10' ' ' GLN . . . . . 0.483 ' HG3' ' HD3' ' B' ' 29' ' ' LYS . 14.4 mm100 -64.77 -8.0 13.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 0.0 109.78 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 11' ' ' CYS . . . . . 0.473 ' SG ' HG13 ' B' ' 41' ' ' ILE . 73.6 m -144.69 71.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.082 -1.011 . . . . 0.0 109.657 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' B' ' 9' ' ' CYS . 52.6 mt -46.29 -42.54 14.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.17 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -119.73 122.06 40.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 109.123 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 14' ' ' THR . . . . . 0.439 ' OG1' ' OD1' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -101.22 158.65 15.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.816 -179.692 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.531 ' HB2' HD23 ' B' ' 52' ' ' LEU . 3.5 mt -102.79 139.93 37.72 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 16' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.6 OUTLIER -43.96 -26.95 0.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.176 179.969 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 17' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' B' ' 15' ' ' LEU . . . 158.03 -179.89 33.41 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.779 ' H ' HD11 ' B' ' 62' ' ' ILE . 4.5 tp -155.03 170.9 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.571 -0.958 . . . . 0.0 108.745 -179.578 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.577 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 3.4 t-80 -59.14 142.03 86.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.028 -1.045 . . . . 0.0 109.109 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 20' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.1 Cg_endo -77.73 -23.53 9.52 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.517 2.145 . . . . 0.0 110.238 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.526 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 9.5 mmtp -90.29 -15.0 32.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.404 -0.81 . . . . 0.0 109.139 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 22' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 7.2 m120 -78.99 -27.7 43.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.431 -0.793 . . . . 0.0 109.403 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.801 HG12 ' HB1' ' B' ' 42' ' ' ALA . 6.5 mt -77.45 163.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.751 0.786 . . . . 0.0 110.743 -179.029 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 24' ' ' GLN . . . . . 0.549 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.2 OUTLIER -129.65 -41.25 1.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.07 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 25' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 11.0 p -124.92 166.72 15.79 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 26' ' ' VAL . . . . . 0.739 ' O ' HG23 ' A' ' 28' ' ' VAL . 51.3 t -145.26 98.78 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.998 -1.064 . . . . 0.0 109.779 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 27' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 50.0 t-20 -84.4 133.21 34.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 28' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.2 t -118.02 82.25 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.142 -0.974 . . . . 0.0 109.591 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 29' ' ' LYS . . . . . 0.483 ' HD3' ' HG3' ' B' ' 10' ' ' GLN . 20.9 mtpt -87.36 103.64 15.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 30' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.1 p -57.56 163.85 3.37 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.342 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.44 132.21 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.581 2.187 . . . . 0.0 110.436 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.74 -141.01 3.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.18 7.69 3.58 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.592 2.194 . . . . 0.0 110.84 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 34' ' ' HIS . . . . . 0.464 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 6.4 p-80 -124.92 -14.74 6.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.007 -1.058 . . . . 0.0 109.761 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.36 125.62 3.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.97 . . . . 0.0 109.332 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 36' ' ' ALA . . . . . 0.42 ' O ' ' CD ' ' B' ' 37' ' ' GLN . . . -87.23 17.55 4.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.626 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 37' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' B' ' 38' ' ' THR . 9.7 mm-40 -143.42 125.74 15.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.504 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 38' ' ' THR . . . . . 0.494 ' HB ' ' HG3' ' B' ' 54' ' ' PRO . 3.2 m -44.32 157.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 0.0 109.309 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -132.61 107.01 8.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.571 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 1.015 HG11 HD11 ' B' ' 63' ' ' ILE . 1.7 t -101.86 93.57 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.202 -0.936 . . . . 0.0 109.335 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 41' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 3.5 mp -82.19 150.42 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.726 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 42' ' ' ALA . . . . . 0.801 ' HB1' HG12 ' B' ' 23' ' ' ILE . . . -132.68 114.9 14.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.852 . . . . 0.0 109.004 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 43' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 4.4 m -89.23 98.2 11.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.856 -1.152 . . . . 0.0 108.996 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 44' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 93.1 mt -41.16 163.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.686 -0.634 . . . . 0.0 109.877 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 45' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -82.09 11.04 5.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.921 -179.818 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 46' ' ' ASN . . . . . 0.494 ' OD1' ' HB2' ' B' ' 44' ' ' LEU . 23.4 p-10 -112.44 7.98 19.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.034 -1.042 . . . . 0.0 109.535 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.56 1.84 63.76 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 48' ' ' ARG . . . . . 0.485 ' HB2' HD12 ' B' ' 44' ' ' LEU . 19.4 mtt180 -96.66 165.67 12.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -1.226 . . . . 0.0 109.535 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.414 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 2.2 mttt -132.99 153.2 51.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.481 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.27 123.4 8.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 108.91 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 51' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 35.7 m -79.6 140.93 36.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.035 -1.041 . . . . 0.0 109.299 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 52' ' ' LEU . . . . . 0.966 HD13 HD13 ' B' ' 62' ' ' ILE . 15.9 mt -125.41 168.3 13.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.296 -0.877 . . . . 0.0 109.227 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 53' ' ' ASN . . . . . 0.614 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.6 m-20 -106.41 124.87 34.38 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.407 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 54' ' ' PRO . . . . . 0.494 ' HG3' ' HB ' ' B' ' 38' ' ' THR . 34.1 Cg_endo -75.22 -6.92 18.49 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.308 2.005 . . . . 0.0 110.422 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.94 -17.58 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 108.915 179.398 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 56' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -90.02 163.76 30.78 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.356 -0.84 . . . . 0.0 109.323 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 57' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.57 -36.46 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.633 2.222 . . . . 0.0 110.667 -179.897 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.42 -48.14 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.652 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 59' ' ' VAL . . . . . 1.034 ' HA ' HD12 ' B' ' 62' ' ' ILE . 76.6 t -62.19 -50.05 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.83 . . . . 0.0 109.617 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 60' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' B' ' 56' ' ' SER . 6.0 mttt -51.2 -30.75 18.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.084 -1.01 . . . . 0.0 108.735 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 61' ' ' LYS . . . . . 0.491 ' HA ' ' CG ' ' B' ' 64' ' ' GLU . 0.0 OUTLIER -78.45 -34.51 47.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.856 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 62' ' ' ILE . . . . . 1.034 HD12 ' HA ' ' B' ' 59' ' ' VAL . 14.2 mt -59.7 -38.43 75.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.543 -0.723 . . . . 0.0 109.229 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 63' ' ' ILE . . . . . 1.015 HD11 HG11 ' B' ' 40' ' ' VAL . 2.2 mp -74.5 -62.29 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.64 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 64' ' ' GLU . . . . . 0.491 ' CG ' ' HA ' ' B' ' 61' ' ' LYS . 0.2 OUTLIER -53.14 -20.1 3.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.413 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -79.64 -40.14 29.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.868 . . . . 0.0 109.031 179.749 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 66' ' ' MET . . . . . 0.446 ' SD ' ' OG ' ' B' ' 69' ' ' SER . 0.6 OUTLIER -65.16 -45.87 83.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.841 . . . . 0.0 108.994 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 67' ' ' LEU . . . . . 0.692 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -43.42 -50.34 6.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.476 -0.765 . . . . 0.0 109.46 179.858 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -76.8 -27.09 55.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.833 . . . . 0.0 109.558 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 69' ' ' SER . . . . . 0.446 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.316 -0.865 . . . . 0.0 109.707 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.279 0.561 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 t -176.01 90.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.506 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 3' ' ' VAL . 12.0 p -169.88 114.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.467 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.653 ' O ' HG22 ' A' ' 5' ' ' THR . . . -177.62 81.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.865 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 4' ' ' ALA . 13.7 t 41.88 33.45 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.424 -0.798 . . . . 0.0 109.667 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -117.74 63.47 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.534 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.664 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -124.5 101.53 7.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.183 -0.948 . . . . 0.0 109.582 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 10' ' ' GLN . 22.4 mtp180 -104.72 152.84 22.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 109.045 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.64 ' HB2' HD22 ' A' ' 12' ' ' LEU . 97.2 m -44.24 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.127 -0.983 . . . . 0.0 109.373 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -42.66 -26.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 109.763 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.474 ' SG ' HG13 ' A' ' 41' ' ' ILE . 97.1 m -122.22 66.17 0.93 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.996 . . . . 0.0 109.799 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.85 -38.9 4.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.967 . . . . 0.0 108.735 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.527 ' O ' HG23 ' A' ' 14' ' ' THR . 1.0 OUTLIER -118.42 -173.3 2.44 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.355 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -160.15 158.06 29.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.04 -1.038 . . . . 0.0 109.935 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.523 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.5 mt -116.93 142.76 46.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.474 -0.766 . . . . 0.0 109.043 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -44.04 -33.3 1.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 109.362 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.859 ' O ' HG23 ' A' ' 18' ' ' ILE . . . 147.34 -166.47 28.59 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.933 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -171.53 163.45 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.44 -1.035 . . . . 0.0 109.076 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.567 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -57.39 149.74 47.39 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.204 -0.935 . . . . 0.0 109.234 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.654 ' HA ' HD12 ' A' ' 23' ' ' ILE . 34.8 Cg_endo -77.25 -4.34 14.66 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.516 2.144 . . . . 0.0 110.19 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.18 -24.02 21.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.362 -0.836 . . . . 0.0 109.197 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.0 m-20 -84.01 -15.87 46.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -0.855 . . . . 0.0 109.213 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.976 HG23 ' HB1' ' A' ' 42' ' ' ALA . 17.3 mt -89.32 169.04 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.434 -0.791 . . . . 0.0 110.245 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.579 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -137.49 -39.98 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.433 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 5.9 p -128.2 173.36 10.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.458 -0.776 . . . . 0.0 109.029 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.589 HG23 ' HG3' ' A' ' 66' ' ' MET . 47.7 t -142.22 95.5 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.58 ' O ' HD12 ' A' ' 41' ' ' ILE . 5.1 t-20 -93.06 111.58 23.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.925 . . . . 0.0 109.417 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.443 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -109.35 97.69 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.404 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.417 ' HA ' ' HB2' ' B' ' 25' ' ' SER . 1.9 ttmt -90.59 110.28 21.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.2 p -63.68 167.72 6.8 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.355 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.6 Cg_endo -77.61 145.62 23.41 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.603 2.202 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.95 -140.05 2.97 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.452 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 36.1 Cg_endo -77.87 10.71 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.596 2.197 . . . . 0.0 111.023 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.664 ' CD2' HD22 ' A' ' 7' ' ' LEU . 3.3 p-80 -127.76 -32.91 2.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.559 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -145.45 115.89 7.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 109.265 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.92 6.97 11.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.694 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 1.6 mp0 -120.71 124.62 45.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.466 HG21 ' HB3' ' B' ' 70' ' ' ASP . 1.6 m -46.76 156.85 0.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 109.317 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 7.1 mm-40 -141.37 107.56 5.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.933 . . . . 0.0 109.627 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.656 HG11 HD11 ' A' ' 63' ' ' ILE . 41.2 t -90.56 150.4 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.225 -0.922 . . . . 0.0 109.272 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.58 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.4 mt -140.29 147.79 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.71 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.976 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -135.39 120.05 18.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.404 -0.81 . . . . 0.0 109.162 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 8.6 m -89.3 100.95 13.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.94 -1.1 . . . . 0.0 109.01 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 84.5 mt -46.08 172.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.47 -0.769 . . . . 0.0 109.732 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -87.93 10.47 18.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.215 -0.928 . . . . 0.0 109.179 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -114.04 27.52 9.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.325 -0.86 . . . . 0.0 109.134 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.13 11.14 70.2 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.501 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 3.8 mtp180 -100.18 165.91 11.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -1.157 . . . . 0.0 109.443 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.83 154.06 50.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.214 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.523 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.18 123.7 9.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.213 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.7 m -79.49 144.96 33.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.956 . . . . 0.0 109.169 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.995 HD13 HD13 ' A' ' 62' ' ' ILE . 15.4 mt -121.99 167.54 12.97 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.447 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.653 ' O ' HG21 ' A' ' 59' ' ' VAL . 5.7 t30 -97.14 118.08 65.06 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.467 -0.771 . . . . 0.0 109.201 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 33.1 Cg_endo -74.24 -0.35 9.51 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.175 1.917 . . . . 0.0 110.376 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.28 -14.08 27.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.325 -0.859 . . . . 0.0 108.906 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.11 162.61 34.56 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.392 -0.818 . . . . 0.0 109.391 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.06 -36.17 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.694 2.263 . . . . 0.0 110.659 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.3 mt -66.41 -36.39 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 109.661 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.002 ' HA ' HD12 ' A' ' 62' ' ' ILE . 37.7 t -67.95 -51.36 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.258 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.505 ' NZ ' ' O ' ' B' ' 70' ' ' ASP . 0.1 OUTLIER -54.3 -30.23 50.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 108.992 179.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.529 ' HB3' ' NZ ' ' A' ' 65' ' ' LYS . 9.6 mmmm -81.98 -28.85 32.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 109.108 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.002 HD12 ' HA ' ' A' ' 59' ' ' VAL . 11.9 mt -59.61 -38.1 73.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.937 HG22 HD11 ' B' ' 67' ' ' LEU . 1.7 mp -76.15 -61.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -43.02 -28.73 0.29 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.817 . . . . 0.0 109.646 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.529 ' NZ ' ' HB3' ' A' ' 61' ' ' LYS . 2.0 mtmt -74.74 -60.24 2.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.589 ' HG3' HG23 ' A' ' 26' ' ' VAL . 1.4 mmm -44.17 -47.78 9.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 109.272 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.943 HD11 HG22 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -43.65 -51.26 7.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.452 -0.78 . . . . 0.0 109.353 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 69' ' ' SER . 11.9 t30 -66.41 -34.82 78.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.495 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 68' ' ' ASN . 1.2 p -43.85 -26.88 0.29 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.562 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.505 ' O ' ' NZ ' ' B' ' 60' ' ' LYS . 0.3 OUTLIER -112.14 67.46 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.295 -0.878 . . . . 0.0 109.555 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -120.08 82.92 1.97 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 109.532 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 73' ' ' ASN . 0.2 OUTLIER 60.73 170.58 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.485 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 72' ' ' SER . 2.9 p30 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.382 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.9 t -176.14 90.09 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.455 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.681 HG13 ' O ' ' B' ' 3' ' ' VAL . 12.0 p -169.9 114.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.47 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.663 ' O ' HG22 ' B' ' 5' ' ' THR . . . -177.61 80.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.0 109.498 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.663 HG22 ' O ' ' B' ' 4' ' ' ALA . 13.7 t 41.92 33.51 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.461 -0.775 . . . . 0.0 109.657 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -117.83 63.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 0.0 109.553 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.671 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -124.47 101.56 7.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.211 -0.93 . . . . 0.0 109.578 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' B' ' 10' ' ' GLN . 22.4 mtp180 -104.75 152.76 22.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.315 -0.865 . . . . 0.0 109.03 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.658 ' HB2' HD22 ' B' ' 12' ' ' LEU . 96.6 m -44.15 96.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.359 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' B' ' 8' ' ' ARG . 0.0 OUTLIER -42.75 -26.4 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.796 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.457 ' SG ' HG13 ' B' ' 41' ' ' ILE . 97.4 m -122.18 66.25 0.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.786 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.658 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.83 -38.95 4.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.147 -0.971 . . . . 0.0 108.753 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLN . . . . . 0.529 ' O ' HG23 ' B' ' 14' ' ' THR . 1.1 mp0 -118.49 -173.25 2.43 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.534 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.4 OUTLIER -160.17 158.08 29.49 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.994 -1.066 . . . . 0.0 109.896 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.531 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.6 mt -116.96 142.77 46.52 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.4 OUTLIER -44.04 -33.36 1.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.363 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.858 ' O ' HG23 ' B' ' 18' ' ' ILE . . . 147.45 -166.49 28.63 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.941 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -171.51 163.44 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.454 -1.027 . . . . 0.0 109.07 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.564 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -57.43 149.73 47.95 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.186 -0.946 . . . . 0.0 109.237 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.645 ' HA ' HD12 ' B' ' 23' ' ' ILE . 35.0 Cg_endo -77.15 -4.36 14.73 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.477 2.118 . . . . 0.0 110.231 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.21 -23.89 21.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.413 -0.804 . . . . 0.0 109.177 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.0 m-20 -84.05 -15.84 46.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.227 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.98 HG23 ' HB1' ' B' ' 42' ' ' ALA . 17.0 mt -89.4 169.12 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 110.25 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.581 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.0 OUTLIER -137.58 -39.94 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.439 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 6.0 p -128.18 173.4 10.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.423 -0.798 . . . . 0.0 108.971 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.59 HG23 ' HG3' ' B' ' 66' ' ' MET . 47.5 t -142.31 95.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.961 . . . . 0.0 109.646 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.572 ' O ' HD12 ' B' ' 41' ' ' ILE . 5.1 t-20 -93.03 111.49 23.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.869 . . . . 0.0 109.428 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.438 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -109.24 97.73 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.421 ' HA ' ' HB2' ' A' ' 25' ' ' SER . 1.9 ttmt -90.65 110.38 21.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 109.504 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.2 p -63.61 167.7 6.72 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.346 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 36.0 Cg_endo -77.66 145.57 23.22 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.556 2.171 . . . . 0.0 110.432 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.89 -140.03 2.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.447 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.1 Cg_endo -77.87 10.74 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.602 2.201 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.671 ' CD2' HD22 ' B' ' 7' ' ' LEU . 3.2 p-80 -127.8 -32.83 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 109.532 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -145.48 115.89 7.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.03 7.07 11.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.695 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' B' ' 39' ' ' GLU . 1.6 mp0 -120.79 124.6 45.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.123 -0.986 . . . . 0.0 109.473 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.458 HG21 ' HB3' ' A' ' 70' ' ' ASP . 1.6 m -46.74 156.83 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.319 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' B' ' 39' ' ' GLU . 7.1 mm-40 -141.36 107.63 5.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.038 -1.039 . . . . 0.0 109.685 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.631 HG11 HD11 ' B' ' 63' ' ' ILE . 41.4 t -90.56 150.47 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.183 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.572 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.4 mt -140.3 147.85 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.154 -0.967 . . . . 0.0 109.709 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.98 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -135.48 120.03 18.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.115 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 8.6 m -89.26 100.83 13.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.934 -1.104 . . . . 0.0 109.038 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 84.5 mt -45.99 172.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.427 -0.795 . . . . 0.0 109.814 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -87.92 10.63 18.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.144 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -114.11 27.53 9.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.055 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.05 11.22 69.97 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.516 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 3.8 mtp180 -100.22 165.94 11.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -1.158 . . . . 0.0 109.471 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.82 154.08 50.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.176 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.531 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.21 123.65 9.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.26 -0.9 . . . . 0.0 109.297 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 7.7 m -79.49 144.87 33.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.103 -0.998 . . . . 0.0 109.17 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 1.059 HD13 HD13 ' B' ' 62' ' ' ILE . 15.3 mt -121.88 167.48 12.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.654 ' O ' HG21 ' B' ' 59' ' ' VAL . 5.6 t30 -97.04 118.04 65.19 Favored Pre-proline 0 C--N 1.299 -1.608 0 O-C-N 121.426 -0.797 . . . . 0.0 109.227 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.33 -0.28 9.47 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.224 1.949 . . . . 0.0 110.344 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.31 -14.1 27.35 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.311 -0.868 . . . . 0.0 108.916 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.09 162.73 34.26 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.368 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -78.22 -36.13 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.591 2.194 . . . . 0.0 110.626 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 65.5 mt -66.29 -36.46 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.139 -0.975 . . . . 0.0 109.709 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 1.034 ' HA ' HD12 ' B' ' 62' ' ' ILE . 37.8 t -67.89 -51.35 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.266 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.505 ' NZ ' ' O ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -54.39 -30.21 51.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.322 -0.861 . . . . 0.0 108.941 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.533 ' HB3' ' NZ ' ' B' ' 65' ' ' LYS . 9.6 mmmm -81.97 -28.82 32.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.126 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 1.059 HD13 HD13 ' B' ' 52' ' ' LEU . 11.9 mt -59.61 -38.14 74.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.943 HG22 HD11 ' A' ' 67' ' ' LEU . 1.7 mp -76.16 -61.57 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -43.09 -28.73 0.3 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.4 -0.813 . . . . 0.0 109.617 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.533 ' NZ ' ' HB3' ' B' ' 61' ' ' LYS . 2.0 mtmt -74.71 -60.27 2.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.337 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.59 ' HG3' HG23 ' B' ' 26' ' ' VAL . 1.4 mmm -44.09 -47.87 8.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.873 . . . . 0.0 109.257 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.937 HD11 HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -43.63 -51.19 7.13 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.401 -0.812 . . . . 0.0 109.408 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' B' ' 69' ' ' SER . 11.9 t30 -66.48 -34.77 78.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.4 -0.813 . . . . 0.0 109.516 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.42 ' C ' ' O ' ' B' ' 68' ' ' ASN . 1.2 p -43.85 -26.92 0.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 109.502 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.505 ' O ' ' NZ ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -112.06 67.55 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 109.512 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -120.17 82.87 1.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.446 ' O ' ' CB ' ' B' ' 73' ' ' ASN . 0.2 OUTLIER 60.75 170.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.138 -0.976 . . . . 0.0 109.426 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 73' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' B' ' 72' ' ' SER . 2.9 p30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.662 ' O ' HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER 70.38 161.78 0.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 2' ' ' SER . 7.6 p 41.95 33.51 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.444 -0.785 . . . . 0.0 109.624 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.58 103.37 11.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.445 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.89 92.29 3.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.458 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.98 122.89 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.466 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.552 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -117.12 98.42 6.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.309 -0.869 . . . . 0.0 109.594 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 9' ' ' CYS . 6.5 mtm180 -90.97 152.23 20.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.056 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.877 ' HB2' HD22 ' A' ' 12' ' ' LEU . 20.1 m -44.05 106.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.964 . . . . 0.0 109.359 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -42.28 -26.91 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.815 . . . . 0.0 109.853 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 39' ' ' GLU . 72.4 m -124.17 63.3 1.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.769 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.877 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.71 -39.69 5.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.117 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -123.26 126.47 46.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 109.061 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -103.12 162.86 12.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.118 -0.989 . . . . 0.0 109.935 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.501 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 6.2 mt -115.44 140.96 48.67 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.477 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.7 tt0 -44.34 -26.52 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.306 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.838 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 138.32 -171.34 23.47 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.721 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.4 pp -161.48 162.74 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -1.117 . . . . 0.0 109.399 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.601 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -56.36 153.97 17.95 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 109.274 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.601 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -76.9 -7.39 17.39 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.438 2.092 . . . . 0.0 109.971 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.512 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 3.1 mttm -80.91 -23.32 39.01 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.843 ' O ' HD13 ' A' ' 23' ' ' ILE . 25.0 m-20 -98.35 59.47 1.33 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.843 HD13 ' O ' ' A' ' 22' ' ' ASN . 2.7 mm -142.49 169.93 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.181 -0.95 . . . . 0.0 110.044 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -160.18 -40.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.434 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.5 p -133.53 -173.79 3.32 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 25' ' ' SER . 50.8 t -159.62 97.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.037 -1.04 . . . . 0.0 109.74 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.472 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 3.7 t-20 -94.62 111.42 23.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.396 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.74 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -117.35 103.48 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -107.05 108.43 19.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.43 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.586 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.1 p -50.97 168.68 0.24 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.8 Cg_endo -77.99 131.64 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.523 2.149 . . . . 0.0 110.508 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.04 -143.35 5.39 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.57 5.18 4.94 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.594 2.196 . . . . 0.0 110.643 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.552 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 14.1 p-80 -124.39 -10.89 7.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.647 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 4.0 t -160.2 104.51 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.316 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.92 -3.59 23.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.653 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 4.6 mm-40 -114.52 124.67 52.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 30' ' ' SER . 14.1 m -49.43 148.18 2.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.331 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.465 ' OE2' ' CA ' ' A' ' 9' ' ' CYS . 0.8 OUTLIER -131.22 107.12 8.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 109.743 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.74 HG22 HG13 ' A' ' 28' ' ' VAL . 30.8 t -91.75 156.12 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.245 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.482 HG13 ' SG ' ' A' ' 51' ' ' CYS . 2.1 mp -143.44 144.79 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.799 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -129.45 124.13 33.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.361 -0.837 . . . . 0.0 109.12 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 23.0 m -89.4 101.76 14.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.075 -1.016 . . . . 0.0 109.207 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 22' ' ' ASN . 84.5 mt -43.59 164.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 109.266 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 11.3 ptpt -85.76 13.36 7.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.465 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -112.56 11.04 19.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.174 179.506 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.39 21.17 45.68 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.638 ' HB2' HD12 ' A' ' 44' ' ' LEU . 95.6 mtt-85 -116.11 171.43 7.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -1.156 . . . . 0.0 109.468 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -137.45 153.76 50.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.477 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.501 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.22 125.36 10.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.413 -0.804 . . . . 0.0 109.029 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.482 ' SG ' HG13 ' A' ' 41' ' ' ILE . 13.9 m -79.57 140.59 37.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.006 . . . . 0.0 109.045 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.874 ' HB3' HG22 ' A' ' 59' ' ' VAL . 11.9 mt -122.25 167.81 12.77 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.655 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.4 t-20 -101.29 121.4 51.91 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.474 -0.766 . . . . 0.0 109.199 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.92 -7.1 18.91 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.324 2.016 . . . . 0.0 110.321 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.17 -14.83 49.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 108.95 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.06 162.76 34.27 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.48 -0.763 . . . . 0.0 109.369 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.73 -37.5 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.733 2.289 . . . . 0.0 110.584 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 52.2 mt -61.88 -52.94 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.081 -1.012 . . . . 0.0 109.019 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.874 HG22 ' HB3' ' A' ' 52' ' ' LEU . 56.1 t -53.28 -51.74 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.549 -0.719 . . . . 0.0 109.723 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -50.18 -33.16 18.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.077 -1.014 . . . . 0.0 108.958 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.535 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 3.2 mmpt? -75.74 -34.71 60.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 0.0 109.458 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -60.2 -41.69 87.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.088 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.677 ' N ' HD12 ' A' ' 63' ' ' ILE . 2.2 mp -70.42 -62.32 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.864 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.468 ' OE2' ' HA ' ' A' ' 61' ' ' LYS . 5.9 pt-20 -57.6 -16.57 10.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.047 -1.033 . . . . 0.0 109.439 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.508 ' HG2' ' HB3' ' A' ' 20' ' ' PRO . 5.7 tptm -81.65 -40.66 22.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 108.664 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.532 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -61.97 -44.81 95.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.645 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -43.38 -51.8 6.26 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.551 -0.718 . . . . 0.0 109.308 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.28 -50.73 72.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.392 -0.818 . . . . 0.0 109.497 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -47.98 -25.68 1.47 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.521 ' CG ' HG21 ' B' ' 38' ' ' THR . 20.6 m-20 -103.43 61.52 0.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -109.08 -64.21 1.27 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.233 -0.917 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 m -135.63 -43.4 0.68 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.523 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.499 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.414 ' O ' ' CB ' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.652 ' O ' HG12 ' B' ' 3' ' ' VAL . 0.2 OUTLIER 70.2 161.87 0.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.481 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.652 HG12 ' O ' ' B' ' 2' ' ' SER . 7.8 p 41.84 33.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.389 -0.819 . . . . 0.0 109.629 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.65 103.32 11.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.424 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.8 92.3 3.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 0.0 109.507 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.96 122.93 0.07 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.163 -0.961 . . . . 0.0 109.498 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.542 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -117.09 98.41 6.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.632 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 9' ' ' CYS . 6.5 mtm180 -90.93 152.25 20.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.354 -0.841 . . . . 0.0 109.08 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.873 ' HB2' HD22 ' B' ' 12' ' ' LEU . 20.1 m -44.04 106.29 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.967 . . . . 0.0 109.403 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -42.18 -27.0 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.466 -0.771 . . . . 0.0 109.884 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.437 ' HB2' ' HB3' ' B' ' 39' ' ' GLU . 72.6 m -124.22 63.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 109.688 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.873 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.72 -39.78 5.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 0.0 109.062 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -123.19 126.49 47.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 109.085 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.417 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -103.14 162.88 12.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.195 -0.941 . . . . 0.0 110.015 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.506 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 6.3 mt -115.48 140.93 48.71 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.486 ' O ' HG23 ' B' ' 59' ' ' VAL . 2.7 tt0 -44.27 -26.57 0.33 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.837 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 138.35 -171.27 23.52 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.725 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.4 pp -161.53 162.74 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.34 -1.094 . . . . 0.0 109.379 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -56.28 153.89 17.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.346 -0.846 . . . . 0.0 109.322 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -76.88 -7.35 17.4 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.451 2.1 . . . . 0.0 109.963 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.519 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 3.1 mttm -80.9 -23.37 39.02 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.821 ' O ' HD13 ' B' ' 23' ' ' ILE . 25.0 m-20 -98.37 59.46 1.33 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.821 HD13 ' O ' ' B' ' 22' ' ' ASN . 2.6 mm -142.47 169.97 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.216 -0.927 . . . . 0.0 110.042 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.3 OUTLIER -160.16 -40.43 0.05 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.633 ' O ' HG23 ' B' ' 26' ' ' VAL . 1.5 p -133.55 -173.83 3.34 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.633 HG23 ' O ' ' B' ' 25' ' ' SER . 51.0 t -159.58 97.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.963 -1.086 . . . . 0.0 109.773 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.49 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 3.7 t-20 -94.67 111.38 23.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.412 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.745 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -117.3 103.52 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.464 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -107.12 108.48 19.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.388 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.587 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -51.05 168.64 0.24 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.8 Cg_endo -77.97 131.63 11.17 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.594 2.196 . . . . 0.0 110.459 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.01 -143.29 5.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.61 5.22 4.94 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.598 2.199 . . . . 0.0 110.64 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.542 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 14.1 p-80 -124.38 -10.96 7.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 109.584 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 4.0 t -160.18 104.54 1.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 109.347 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.87 -3.64 23.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.716 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' B' ' 39' ' ' GLU . 4.6 mm-40 -114.48 124.7 52.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.096 -1.003 . . . . 0.0 109.522 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.587 HG23 ' HA ' ' B' ' 30' ' ' SER . 14.3 m -49.44 148.22 2.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.308 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.479 ' OE2' ' CA ' ' B' ' 9' ' ' CYS . 0.9 OUTLIER -131.24 107.29 8.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.669 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.745 HG22 HG13 ' B' ' 28' ' ' VAL . 31.2 t -91.9 156.22 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.213 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' B' ' 27' ' ' ASN . 2.1 mp -143.54 144.78 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.152 -0.968 . . . . 0.0 109.778 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.535 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -129.49 124.29 33.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.044 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 23.0 m -89.45 101.76 14.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.934 -1.104 . . . . 0.0 109.156 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.775 HD23 ' O ' ' B' ' 22' ' ' ASN . 84.9 mt -43.61 164.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.5 -0.75 . . . . 0.0 109.245 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 11.3 ptpt -85.74 13.35 7.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.482 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -112.52 11.05 19.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.888 . . . . 0.0 109.256 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.36 21.21 45.68 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.628 ' HB2' HD12 ' B' ' 44' ' ' LEU . 95.5 mtt-85 -116.19 171.49 7.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -137.51 153.7 49.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.425 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.506 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.22 125.32 9.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.303 -0.873 . . . . 0.0 109.081 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' B' ' 41' ' ' ILE . 13.8 m -79.54 140.59 37.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.029 -1.045 . . . . 0.0 109.109 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.873 ' HB3' HG22 ' B' ' 59' ' ' VAL . 11.9 mt -122.19 167.78 12.79 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.344 -0.847 . . . . 0.0 109.409 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.654 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.4 t-20 -101.32 121.37 51.96 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.195 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.96 -6.92 18.7 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.262 1.975 . . . . 0.0 110.321 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.28 -14.84 48.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.22 -0.925 . . . . 0.0 108.946 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.02 162.7 34.56 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.468 -0.77 . . . . 0.0 109.406 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.77 -37.4 0.9 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.613 2.209 . . . . 0.0 110.65 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.523 ' O ' HD13 ' B' ' 62' ' ' ILE . 52.3 mt -61.86 -53.01 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.963 . . . . 0.0 109.004 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.873 HG22 ' HB3' ' B' ' 52' ' ' LEU . 55.9 t -53.2 -51.73 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.55 -0.719 . . . . 0.0 109.796 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' B' ' 56' ' ' SER . 0.2 OUTLIER -50.24 -33.17 18.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.256 -0.902 . . . . 0.0 108.899 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.536 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 3.2 mmpt? -75.58 -34.92 60.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.468 -0.77 . . . . 0.0 109.477 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.523 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -60.1 -41.73 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.31 -0.869 . . . . 0.0 109.077 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.682 ' N ' HD12 ' B' ' 63' ' ' ILE . 2.2 mp -70.39 -62.32 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.888 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.47 ' OE2' ' HA ' ' B' ' 61' ' ' LYS . 5.9 pt-20 -57.54 -16.61 10.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.063 -1.023 . . . . 0.0 109.437 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' B' ' 20' ' ' PRO . 5.7 tptm -81.61 -40.79 22.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.275 -0.891 . . . . 0.0 108.644 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.537 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -61.85 -44.88 95.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.398 -0.814 . . . . 0.0 108.85 179.386 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.664 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -43.36 -51.76 6.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.511 -0.743 . . . . 0.0 109.34 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.37 -50.66 72.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.495 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -48.01 -25.56 1.44 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.22 -0.925 . . . . 0.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.513 ' CG ' HG21 ' A' ' 38' ' ' THR . 20.9 m-20 -103.55 61.52 0.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.437 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -109.05 -64.22 1.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.451 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 75.6 m -135.67 -43.49 0.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.478 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.432 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -97.34 -34.84 10.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.446 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 12.1 t -137.29 -63.47 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.87 . . . . 0.0 109.497 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 3' ' ' VAL . . . 62.11 78.7 0.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.446 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -92.44 76.84 5.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.309 -0.869 . . . . 0.0 109.476 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 5' ' ' THR . 1.6 mt-10 -160.65 96.52 1.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.449 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.663 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -125.8 101.89 7.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 109.554 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 9' ' ' CYS . 27.2 mtt180 -96.56 155.06 16.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.112 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.491 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m -44.02 113.31 0.51 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 0.0 109.406 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.525 ' HG3' ' CB ' ' A' ' 29' ' ' LYS . 7.1 mm-40 -42.88 -26.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.475 ' SG ' HG13 ' A' ' 41' ' ' ILE . 60.3 m -148.74 72.63 1.19 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.085 -1.009 . . . . 0.0 109.903 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.491 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.87 -46.05 15.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 108.799 179.505 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -116.17 121.69 42.83 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -98.26 166.18 11.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 110.056 -179.384 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.513 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.1 mt -115.02 146.01 41.7 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.716 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -44.05 -42.76 6.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.413 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.98 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 147.36 -167.5 28.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.952 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -169.5 163.43 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.396 -1.061 . . . . 0.0 109.252 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.58 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -55.74 151.14 23.85 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.263 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.58 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.44 -2.31 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.551 2.167 . . . . 0.0 110.175 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -90.23 -24.79 20.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.43 -0.794 . . . . 0.0 109.136 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.7 m-20 -83.47 -9.59 58.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.391 -0.818 . . . . 0.0 109.288 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.952 HD11 ' CD1' ' A' ' 18' ' ' ILE . 7.9 mt -101.97 165.81 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.882 . . . . 0.0 110.436 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.578 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -139.07 -31.67 0.7 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.578 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.3 p -128.68 168.66 15.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 108.84 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.519 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 56.1 t -141.18 105.65 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.026 -1.046 . . . . 0.0 109.857 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.731 ' O ' HD12 ' A' ' 41' ' ' ILE . 5.2 t-20 -105.79 111.67 24.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -0.941 . . . . 0.0 109.457 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -116.05 103.44 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.537 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.525 ' CB ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -95.96 105.94 18.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.905 . . . . 0.0 109.395 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.462 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.1 p -51.92 167.87 0.31 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.401 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.52 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 35.7 Cg_endo -78.01 131.95 11.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.566 2.177 . . . . 0.0 110.514 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.47 -143.32 4.82 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.55 4.93 5.11 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.57 2.18 . . . . 0.0 110.636 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.663 ' CD2' HD22 ' A' ' 7' ' ' LEU . 14.6 p-80 -123.95 -10.6 7.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 0.0 109.595 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.5 t -160.08 124.13 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 109.269 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -80.74 -38.03 29.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.868 . . . . 0.0 109.658 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.435 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 2.0 mp0 -86.73 140.21 29.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.619 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.462 HG23 ' HA ' ' A' ' 30' ' ' SER . 50.6 m -60.79 153.88 23.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.465 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 2.5 mp0 -130.33 107.06 8.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 109.688 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.798 HG22 HG13 ' A' ' 28' ' ' VAL . 38.9 t -89.59 154.13 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.84 . . . . 0.0 109.148 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.731 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.1 mp -141.99 153.08 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.109 -0.994 . . . . 0.0 109.782 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.939 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -140.45 121.55 14.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.823 . . . . 0.0 109.063 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.528 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 3.1 m -89.17 103.94 16.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.887 -1.133 . . . . 0.0 108.798 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 79.7 mt -48.75 177.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.541 -0.724 . . . . 0.0 109.742 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -90.03 8.53 32.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 109.187 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.486 ' ND2' ' HD2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -113.79 28.97 8.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.81 11.77 66.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.486 ' HD2' ' ND2' ' A' ' 46' ' ' ASN . 57.9 mtt180 -98.77 168.83 9.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -1.154 . . . . 0.0 109.434 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 16.3 mttt -140.24 151.25 45.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -0.869 . . . . 0.0 109.242 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.22 123.42 8.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.286 -0.884 . . . . 0.0 109.08 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.483 ' SG ' HG13 ' A' ' 41' ' ' ILE . 15.3 m -79.56 144.69 33.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.082 -1.011 . . . . 0.0 109.258 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.98 HD22 ' HA2' ' A' ' 17' ' ' GLY . 15.2 mt -121.33 167.59 12.59 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.278 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.642 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.8 t-20 -100.18 121.1 54.84 Favored Pre-proline 0 C--N 1.298 -1.668 0 O-C-N 121.385 -0.822 . . . . 0.0 109.103 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.03 -9.27 20.66 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.137 1.891 . . . . 0.0 110.271 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.96 -14.8 57.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 108.804 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -89.97 159.87 41.88 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.404 -0.81 . . . . 0.0 109.376 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.68 -34.36 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.667 2.245 . . . . 0.0 110.722 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.599 ' O ' HD13 ' A' ' 62' ' ' ILE . 12.5 tt -66.65 -46.76 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 109.11 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 52' ' ' LEU . 38.6 t -57.08 -48.62 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 109.048 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 1.1 mttp -55.14 -31.28 61.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.492 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -76.28 -30.62 57.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.615 -0.678 . . . . 0.0 109.297 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -65.16 -44.51 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.352 -0.842 . . . . 0.0 109.015 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.912 HG22 HD11 ' B' ' 67' ' ' LEU . 2.2 mp -67.53 -61.66 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.613 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.507 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -52.61 -27.94 19.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.633 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.55 ' CD ' ' HG3' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -71.48 -40.91 69.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.187 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.519 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -63.36 -46.9 84.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.838 . . . . 0.0 109.185 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.946 HD11 HG22 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.58 -51.12 9.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.522 -0.736 . . . . 0.0 109.455 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -71.97 -29.08 63.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.878 . . . . 0.0 109.546 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.452 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p -63.83 -18.4 64.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' OD2' ' HA ' ' A' ' 67' ' ' LEU . 2.6 p30 -101.47 46.61 0.93 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.403 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -86.45 -35.58 19.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.4 t -157.3 -61.16 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.855 . . . . 0.0 109.474 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.8 t30 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.503 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -97.21 -35.0 10.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 109.436 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' B' ' 4' ' ' ALA . 12.0 t -137.25 -63.55 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.523 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' B' ' 3' ' ' VAL . . . 62.2 78.69 0.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.441 ' O ' ' HG3' ' B' ' 6' ' ' GLU . 0.6 OUTLIER -92.43 76.9 5.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.496 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' B' ' 5' ' ' THR . 1.6 mt-10 -160.68 96.52 1.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.435 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.656 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -125.84 101.92 7.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 0.0 109.593 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' B' ' 9' ' ' CYS . 27.4 mtt180 -96.64 155.09 16.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.281 -0.887 . . . . 0.0 109.073 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.478 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 1.8 m -44.02 113.35 0.51 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.398 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.526 ' HG3' ' CB ' ' B' ' 29' ' ' LYS . 7.1 mm-40 -42.9 -26.26 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.853 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' B' ' 41' ' ' ILE . 60.2 m -148.68 72.6 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.083 -1.011 . . . . 0.0 109.953 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.478 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.8 -46.04 15.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.935 . . . . 0.0 108.773 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -116.19 121.59 42.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.414 -0.804 . . . . 0.0 108.896 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.5 OUTLIER -98.25 166.15 11.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.146 -0.972 . . . . 0.0 110.068 -179.347 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.504 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.1 mt -115.0 146.09 41.6 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.715 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.7 OUTLIER -44.18 -42.66 6.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.386 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 1.051 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 147.31 -167.56 28.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.967 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -169.44 163.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.509 -0.995 . . . . 0.0 109.272 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.594 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -55.72 151.1 23.76 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.267 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.9 Cg_endo -77.4 -2.3 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.515 2.143 . . . . 0.0 110.224 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HD2' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -90.25 -24.83 20.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.159 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.7 m-20 -83.37 -9.58 58.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.295 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.967 HD11 ' CD1' ' B' ' 18' ' ' ILE . 8.0 mt -102.02 165.83 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 110.438 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.581 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -139.05 -31.79 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.297 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.581 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.3 p -128.62 168.56 15.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 108.85 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.513 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 55.7 t -141.13 105.78 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.145 -0.972 . . . . 0.0 109.77 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.711 ' O ' HD12 ' B' ' 41' ' ' ILE . 5.2 t-20 -105.9 111.72 24.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.762 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -116.09 103.42 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.938 . . . . 0.0 109.525 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.526 ' CB ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -96.05 105.89 17.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.408 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.46 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -51.88 167.92 0.31 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.518 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 36.2 Cg_endo -78.03 131.99 11.34 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.599 2.199 . . . . 0.0 110.51 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.57 -143.39 4.82 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.6 5.07 5.03 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.5 2.133 . . . . 0.0 110.581 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.656 ' CD2' HD22 ' B' ' 7' ' ' LEU . 14.5 p-80 -123.93 -10.71 7.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.565 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 3.5 t -160.07 124.1 3.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -80.64 -38.09 29.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.75 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.428 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 2.0 mp0 -86.71 140.17 30.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.46 HG23 ' HA ' ' B' ' 30' ' ' SER . 50.6 m -60.72 153.93 22.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.456 ' HB3' ' SG ' ' B' ' 11' ' ' CYS . 2.5 mp0 -130.37 107.08 8.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 109.631 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.762 HG22 HG13 ' B' ' 28' ' ' VAL . 39.1 t -89.68 154.2 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.102 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.711 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.1 mp -142.03 153.07 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.125 -0.984 . . . . 0.0 109.842 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.946 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -140.45 121.57 14.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 108.972 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 3.1 m -89.18 103.87 16.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.871 -1.143 . . . . 0.0 108.856 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 80.1 mt -48.71 177.03 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.489 -0.757 . . . . 0.0 109.747 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -90.03 8.63 31.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.248 -0.907 . . . . 0.0 109.156 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.495 ' ND2' ' HD2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -113.86 29.05 8.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.876 . . . . 0.0 109.139 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.85 11.73 66.69 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.495 ' HD2' ' ND2' ' B' ' 46' ' ' ASN . 57.8 mtt180 -98.78 168.8 9.91 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 109.466 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.439 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 16.3 mttt -140.22 151.36 45.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 109.219 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.504 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.31 123.38 8.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.039 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.48 ' SG ' HG13 ' B' ' 41' ' ' ILE . 15.3 m -79.56 144.7 33.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.252 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 1.051 HD22 ' HA2' ' B' ' 17' ' ' GLY . 15.3 mt -121.38 167.5 12.7 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.913 . . . . 0.0 109.222 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.641 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.8 t-20 -100.12 121.13 54.82 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.169 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.95 -9.39 20.82 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.214 1.943 . . . . 0.0 110.292 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.89 -14.77 57.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 108.851 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.494 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -90.01 159.88 41.74 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.0 109.304 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.71 -34.22 1.96 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.675 2.25 . . . . 0.0 110.727 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.607 ' O ' HD13 ' B' ' 62' ' ' ILE . 12.6 tt -66.76 -46.75 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.994 . . . . 0.0 109.083 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' B' ' 52' ' ' LEU . 38.4 t -57.11 -48.58 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.363 -0.835 . . . . 0.0 109.059 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' B' ' 56' ' ' SER . 1.1 mttp -55.18 -31.28 61.27 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' B' ' 65' ' ' LYS . 0.9 OUTLIER -76.3 -30.56 57.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.566 -0.709 . . . . 0.0 109.329 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.607 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -65.07 -44.69 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 109.009 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.946 HG22 HD11 ' A' ' 67' ' ' LEU . 2.2 mp -67.41 -61.7 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.629 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.511 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.2 OUTLIER -52.61 -28.01 19.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 109.579 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.547 ' CD ' ' HG3' ' B' ' 20' ' ' PRO . 0.0 OUTLIER -71.47 -40.85 70.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.114 -0.991 . . . . 0.0 109.225 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.513 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -63.36 -46.94 84.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.207 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.912 HD11 HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.63 -51.08 9.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.323 -0.861 . . . . 0.0 109.451 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -71.94 -29.13 63.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 109.536 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.429 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.2 p -63.85 -18.38 64.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.46 ' OD2' ' HA ' ' B' ' 67' ' ' LEU . 2.6 p30 -101.39 46.56 0.93 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.299 -0.876 . . . . 0.0 109.505 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -86.42 -35.54 19.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.527 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 34.3 t -157.39 -61.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 51.9 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.464 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.3 p -156.54 129.61 7.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.908 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.0 m -140.14 130.45 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.449 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.46 157.52 40.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.48 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.407 ' C ' ' HG3' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -103.2 9.67 38.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.932 . . . . 0.0 109.52 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HG3' ' C ' ' A' ' 5' ' ' THR . 1.2 mp0 -134.96 106.01 6.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 109.403 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.548 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -116.45 98.24 6.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.0 109.511 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.5 OUTLIER -90.28 151.52 21.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.34 -0.85 . . . . 0.0 109.071 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.929 ' HB2' HD22 ' A' ' 12' ' ' LEU . 10.4 m -43.99 108.38 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.401 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.55 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 10.3 mm100 -43.01 -26.44 0.14 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.735 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' A' ' 41' ' ' ILE . 96.8 m -125.61 63.16 1.2 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.82 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.929 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.09 -38.28 4.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.051 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -125.29 131.54 53.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.408 -0.808 . . . . 0.0 108.962 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -108.42 163.18 13.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.098 -1.001 . . . . 0.0 109.995 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.535 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.3 mt -120.78 146.04 46.93 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.73 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.9 tt0 -44.26 -40.68 5.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.41 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.861 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 150.12 -168.11 30.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 1.013 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -168.49 163.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.487 -1.007 . . . . 0.0 109.213 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.541 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -57.89 150.63 48.15 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.92 . . . . 0.0 109.434 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HG3' ' CD ' ' A' ' 65' ' ' LYS . 34.9 Cg_endo -77.44 -2.78 12.97 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.571 2.18 . . . . 0.0 110.202 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.24 -24.85 20.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 109.069 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.524 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 3.4 m-20 -83.31 -5.53 59.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 109.354 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.013 HD11 ' CD1' ' A' ' 18' ' ' ILE . 7.0 mt -107.07 145.57 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 110.103 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.544 ' HG3' ' N ' ' A' ' 25' ' ' SER . 1.0 OUTLIER -117.78 -26.19 6.6 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -143.53 172.24 13.07 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 25' ' ' SER . 50.6 t -159.52 137.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.943 -1.098 . . . . 0.0 109.98 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 43.3 t30 -112.47 169.21 9.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.203 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 t -151.27 92.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.543 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.55 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 0.6 OUTLIER -100.19 116.12 31.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.559 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.24 167.49 9.99 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 109.355 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.529 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.6 Cg_endo -78.0 131.33 10.94 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.677 2.251 . . . . 0.0 110.483 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.62 -144.1 4.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.95 6.9 3.89 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.593 2.196 . . . . 0.0 110.736 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.548 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 12.4 p-80 -125.09 -7.3 7.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.141 -0.975 . . . . 0.0 109.551 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.0 t -160.04 116.34 2.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.963 . . . . 0.0 109.418 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.12 45.79 1.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.556 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.529 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 6.1 pt20 -174.47 139.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.462 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' B' ' 70' ' ' ASP . 1.3 m -57.58 151.32 17.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.334 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.455 ' OE2' ' HG2' ' A' ' 29' ' ' LYS . 6.4 pt-20 -138.05 114.97 10.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.616 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.81 154.02 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 109.222 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.535 ' O ' HG13 ' A' ' 26' ' ' VAL . 4.2 mt -138.39 154.28 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.729 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.813 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -137.24 118.77 14.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 43' ' ' THR . 1.2 m -89.17 96.4 10.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.962 -1.086 . . . . 0.0 108.63 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 89.4 mt -43.18 167.36 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.572 -0.705 . . . . 0.0 109.881 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -80.67 7.59 9.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.645 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.98 23.42 13.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 109.299 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.33 7.41 82.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -95.54 167.64 11.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -1.202 . . . . 0.0 109.497 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HD3' ' OG1' ' A' ' 43' ' ' THR . 18.5 mttt -138.75 151.36 47.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.535 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.3 122.19 8.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.29 -0.881 . . . . 0.0 109.114 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.481 ' SG ' HG12 ' A' ' 41' ' ' ILE . 4.4 m -79.64 142.16 35.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.065 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.861 HD22 ' HA2' ' A' ' 17' ' ' GLY . 12.7 mt -120.03 167.44 12.18 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.292 -0.88 . . . . 0.0 109.492 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.658 ' O ' HG21 ' A' ' 59' ' ' VAL . 5.5 t30 -97.2 115.75 65.81 Favored Pre-proline 0 C--N 1.299 -1.627 0 O-C-N 121.434 -0.791 . . . . 0.0 109.226 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.488 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 33.3 Cg_endo -74.17 0.17 8.8 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.275 1.984 . . . . 0.0 110.433 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.05 -13.85 24.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -0.887 . . . . 0.0 108.944 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 164.61 27.25 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.423 -0.798 . . . . 0.0 109.407 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.9 -37.63 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.676 2.251 . . . . 0.0 110.568 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 10.0 mt -61.4 -51.88 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 109.058 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.861 HG22 ' HB3' ' A' ' 52' ' ' LEU . 54.4 t -54.56 -54.3 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.739 . . . . 0.0 109.744 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 56' ' ' SER . 5.1 mttt -47.5 -33.71 6.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 108.971 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -74.61 -38.56 62.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.494 -0.754 . . . . 0.0 109.328 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -58.13 -41.96 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.429 -0.794 . . . . 0.0 109.146 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.122 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -70.12 -67.87 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.762 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG2' ' HA ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -44.02 -28.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.663 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.548 ' CD ' ' HG3' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -72.88 -59.93 2.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.183 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.414 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.8 OUTLIER -44.12 -44.42 7.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.388 -0.82 . . . . 0.0 109.183 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.114 HD11 ' CG2' ' B' ' 63' ' ' ILE . 1.3 mt -55.16 -58.68 6.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.705 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -80.86 6.85 11.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.734 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 65' ' ' LYS . 10.0 p -94.24 -10.21 33.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.465 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' O ' ' CG ' ' A' ' 71' ' ' LYS . 0.6 OUTLIER -107.79 27.58 9.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 0.0 109.472 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' A' ' 70' ' ' ASP . 18.3 pttm 41.78 -161.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.492 -0.755 . . . . 0.0 109.663 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.98 -63.19 0.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.459 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.502 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 53.4 p -156.56 129.58 7.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.448 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.1 130.45 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.462 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.52 157.4 41.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.417 ' C ' ' HG3' ' B' ' 6' ' ' GLU . 0.2 OUTLIER -103.1 9.68 38.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.417 ' HG3' ' C ' ' B' ' 5' ' ' THR . 1.2 mp0 -134.92 106.0 6.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.444 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.55 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -116.41 98.21 6.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.554 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.5 OUTLIER -90.15 151.56 21.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.31 -0.869 . . . . 0.0 109.142 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.89 ' HB2' HD22 ' B' ' 12' ' ' LEU . 10.3 m -44.15 108.44 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.898 . . . . 0.0 109.359 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.553 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 10.2 mm100 -43.01 -26.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.72 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.468 ' SG ' HG13 ' B' ' 41' ' ' ILE . 95.9 m -125.64 63.29 1.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.981 . . . . 0.0 109.784 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.89 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.18 -38.35 5.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -125.2 131.57 53.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.818 . . . . 0.0 108.966 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.496 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -108.43 163.17 13.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.12 -0.988 . . . . 0.0 110.025 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.542 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.3 mt -120.74 146.0 46.93 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.72 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.9 tt0 -44.29 -40.64 5.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.974 . . . . 0.0 109.42 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.838 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 150.09 -168.08 30.1 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.995 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -168.52 163.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.454 -1.027 . . . . 0.0 109.255 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.547 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -57.81 150.45 48.15 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.251 -0.906 . . . . 0.0 109.401 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.549 ' HG3' ' CD ' ' B' ' 65' ' ' LYS . 35.3 Cg_endo -77.32 -2.79 13.0 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.59 2.194 . . . . 0.0 110.231 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.465 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.21 -24.88 20.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.383 -0.823 . . . . 0.0 109.057 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 3.4 m-20 -83.33 -5.56 59.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.463 -0.773 . . . . 0.0 109.217 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.995 HD11 ' CD1' ' B' ' 18' ' ' ILE . 7.1 mt -107.13 145.46 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.878 . . . . 0.0 110.112 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.545 ' HG3' ' N ' ' B' ' 25' ' ' SER . 1.0 OUTLIER -117.71 -26.09 6.66 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.63 ' O ' HG23 ' B' ' 26' ' ' VAL . 0.0 OUTLIER -143.57 172.22 13.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.419 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.63 HG23 ' O ' ' B' ' 25' ' ' SER . 50.4 t -159.49 137.58 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.969 -1.082 . . . . 0.0 109.993 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 43.2 t30 -112.48 169.26 9.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.293 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 t -151.32 92.97 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.436 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.553 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 0.6 OUTLIER -100.26 116.19 31.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.27 167.45 10.14 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.413 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.537 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.7 Cg_endo -77.98 131.3 10.93 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.632 2.222 . . . . 0.0 110.494 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.58 -144.1 4.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.93 6.87 3.91 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.552 2.168 . . . . 0.0 110.763 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.55 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 12.3 p-80 -125.01 -7.37 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.046 -1.034 . . . . 0.0 109.505 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.9 t -160.07 116.25 2.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.355 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.01 45.76 1.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.64 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.537 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 6.1 pt20 -174.54 139.47 0.57 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -0.956 . . . . 0.0 109.549 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 70' ' ' ASP . 1.3 m -57.6 151.34 17.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.862 . . . . 0.0 109.338 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.453 ' HB2' ' SG ' ' B' ' 11' ' ' CYS . 6.4 pt-20 -138.02 114.94 10.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.611 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.86 154.0 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.153 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.528 ' O ' HG13 ' B' ' 26' ' ' VAL . 4.2 mt -138.36 154.21 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.746 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.813 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -137.19 118.77 14.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.221 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.606 HG22 ' O ' ' B' ' 43' ' ' THR . 1.2 m -89.17 96.41 10.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.027 -1.046 . . . . 0.0 108.63 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.6 mt -43.22 167.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.581 -0.699 . . . . 0.0 109.895 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -80.67 7.68 9.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 109.652 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.11 23.46 13.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.95 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.29 7.44 82.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.513 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 0.7 OUTLIER -95.54 167.66 11.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -1.177 . . . . 0.0 109.507 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.443 ' HD3' ' OG1' ' B' ' 43' ' ' THR . 18.4 mttt -138.71 151.31 47.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.902 . . . . 0.0 109.511 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.542 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.26 122.27 8.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.117 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.476 ' SG ' HG12 ' B' ' 41' ' ' ILE . 4.4 m -79.7 142.26 35.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 109.125 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.849 ' HB3' HG22 ' B' ' 59' ' ' VAL . 12.8 mt -120.19 167.41 12.28 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.285 -0.884 . . . . 0.0 109.356 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.654 ' N ' HG21 ' B' ' 59' ' ' VAL . 5.5 t30 -97.14 115.73 65.81 Favored Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 109.278 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.471 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.4 Cg_endo -74.18 0.14 8.84 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.265 1.976 . . . . 0.0 110.46 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.03 -13.85 24.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.267 -0.896 . . . . 0.0 108.918 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' B' ' 53' ' ' ASN . 0.0 OUTLIER -90.09 164.52 27.68 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 109.403 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.79 -37.74 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.668 2.245 . . . . 0.0 110.508 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' B' ' 62' ' ' ILE . 10.0 mt -61.42 -51.89 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 0.0 109.026 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.849 HG22 ' HB3' ' B' ' 52' ' ' LEU . 54.8 t -54.45 -54.42 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.542 -0.724 . . . . 0.0 109.745 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 5.1 mttt -47.44 -33.65 6.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 109.078 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.479 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -74.6 -38.61 62.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 0.0 109.372 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -58.05 -41.99 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.825 . . . . 0.0 109.168 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 1.114 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -70.1 -67.86 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.766 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -44.01 -28.31 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 109.747 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.549 ' CD ' ' HG3' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -72.81 -59.95 2.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 0.0 109.237 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.425 ' C ' ' O ' ' B' ' 65' ' ' LYS . 0.8 OUTLIER -44.05 -44.43 7.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.155 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.122 HD11 ' CG2' ' A' ' 63' ' ' ILE . 1.3 mt -55.21 -58.63 6.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.52 -0.738 . . . . 0.0 109.701 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -80.9 6.94 11.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 109.749 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' B' ' 65' ' ' LYS . 10.0 p -94.34 -10.22 33.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.122 -0.986 . . . . 0.0 109.402 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.523 ' O ' ' CG ' ' B' ' 71' ' ' LYS . 0.6 OUTLIER -107.8 27.54 9.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.46 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 70' ' ' ASP . 18.3 pttm 41.77 -161.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.452 -0.78 . . . . 0.0 109.666 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.96 -63.17 0.41 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.216 -0.928 . . . . 0.0 109.484 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.493 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -120.4 119.08 32.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 0.0 109.439 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.99 136.65 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.36 101.01 0.51 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.468 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.1 m -143.79 -39.48 0.3 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 109.457 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -162.46 120.62 2.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.31 -0.869 . . . . 0.0 109.484 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.532 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -121.36 99.81 6.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 9' ' ' CYS . 8.9 mtm180 -97.89 153.43 18.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.24 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.432 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 19.7 m -44.18 107.94 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.414 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.528 ' CG ' ' HE3' ' A' ' 29' ' ' LYS . 22.5 mm-40 -49.78 -21.66 1.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.715 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' OE1' ' A' ' 39' ' ' GLU . 49.9 m -144.98 67.43 1.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 0.0 109.909 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 12' ' ' LEU . 14.5 mt -45.12 -45.53 11.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 108.817 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.09 119.41 35.76 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -94.52 167.14 11.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 110.101 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.517 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.4 mt -114.38 144.99 42.4 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.585 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.4 tt0 -44.29 -39.06 4.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.176 -0.952 . . . . 0.0 109.41 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.988 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 144.99 -164.72 27.85 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.941 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -170.82 163.74 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.488 -1.007 . . . . 0.0 109.094 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.524 ' ND1' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -53.54 149.48 15.11 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 109.354 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.533 ' HA ' HD12 ' A' ' 23' ' ' ILE . 35.0 Cg_endo -77.19 -3.98 14.3 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.53 2.153 . . . . 0.0 110.176 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HE2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.25 -24.38 20.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.376 -0.828 . . . . 0.0 109.089 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.523 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 2.5 m-20 -82.87 -6.47 59.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 109.258 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.941 HD11 ' CD1' ' A' ' 18' ' ' ILE . 8.5 mt -104.94 148.89 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.574 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -120.54 -27.27 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.574 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -137.69 168.51 19.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.092 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.585 HG23 ' HG3' ' A' ' 66' ' ' MET . 90.5 t -140.87 114.46 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.011 . . . . 0.0 109.776 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.629 ' O ' HD12 ' A' ' 41' ' ' ILE . 3.8 t-20 -109.62 110.65 21.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 109.348 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.716 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -110.1 105.54 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 109.516 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HE3' ' CG ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -98.51 114.71 27.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.402 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.98 167.82 5.54 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.464 ' HB3' ' C ' ' A' ' 36' ' ' ALA . 36.2 Cg_endo -78.13 151.44 26.93 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.615 2.21 . . . . 0.0 110.44 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.84 -141.3 3.14 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.538 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 36.3 Cg_endo -77.89 10.96 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.649 2.233 . . . . 0.0 111.008 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.718 ' N ' ' CD2' ' A' ' 34' ' ' HIS . 2.1 p80 -128.27 -34.48 2.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.058 -1.026 . . . . 0.0 109.441 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.9 t -145.39 88.03 1.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.287 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.464 ' C ' ' HB3' ' A' ' 31' ' ' PRO . . . -52.59 -19.93 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.706 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.462 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 33.8 mm-40 -92.85 131.93 37.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.471 HG21 ' OD1' ' B' ' 70' ' ' ASP . 3.6 m -54.79 161.3 1.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.33 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.488 ' HB2' ' CG ' ' A' ' 29' ' ' LYS . 22.5 mm-40 -145.33 107.53 4.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 0.0 109.635 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.716 HG22 HG13 ' A' ' 28' ' ' VAL . 43.1 t -91.77 152.84 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.326 -0.859 . . . . 0.0 109.311 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 27' ' ' ASN . 2.7 mp -140.34 155.42 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.949 . . . . 0.0 109.709 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.777 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -140.9 117.99 11.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 109.103 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.537 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.4 m -89.22 97.66 11.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.892 -1.13 . . . . 0.0 108.787 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 87.1 mt -43.53 162.8 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.464 -0.772 . . . . 0.0 109.583 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.72 ' HZ2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -79.1 7.17 7.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.805 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.502 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -108.85 16.87 22.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.132 -0.98 . . . . 0.0 109.198 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.57 -0.8 89.45 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.502 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 13.7 mtt180 -89.68 162.97 15.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -1.201 . . . . 0.0 109.426 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.3 mptt -134.5 151.06 50.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.24 123.93 9.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 109.033 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 22.9 m -79.47 143.99 34.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.078 -1.014 . . . . 0.0 109.189 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.993 HD13 HD13 ' A' ' 62' ' ' ILE . 15.2 mt -121.19 167.69 12.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -0.856 . . . . 0.0 109.437 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.648 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.8 t-20 -100.84 123.48 45.36 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.413 -0.804 . . . . 0.0 109.177 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.19 -7.04 18.64 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.219 1.946 . . . . 0.0 110.398 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.45 -13.1 55.47 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 108.961 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -90.06 161.65 37.4 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.374 -0.829 . . . . 0.0 109.429 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.92 -35.66 1.33 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.648 2.232 . . . . 0.0 110.574 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.601 HG23 ' N ' ' A' ' 59' ' ' VAL . 16.8 tt -67.31 -45.74 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.426 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.0 ' HA ' HD12 ' A' ' 62' ' ' ILE . 42.7 t -58.62 -46.82 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.413 -0.804 . . . . 0.0 109.369 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 1.3 mmpt? -59.47 -29.48 67.85 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -79.72 -23.84 42.08 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.0 HD12 ' HA ' ' A' ' 59' ' ' VAL . 22.7 mt -70.58 -37.76 70.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.689 HD11 HG11 ' A' ' 40' ' ' VAL . 2.2 mp -74.75 -56.48 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 0.0 109.321 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER -59.35 -27.87 66.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.296 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 1.7 tptt -71.78 -50.68 27.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.058 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.585 ' HG3' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -51.85 -45.78 64.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 109.081 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.639 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -44.27 -52.15 7.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.335 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.9 OUTLIER -62.14 -38.1 87.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.393 -0.817 . . . . 0.0 109.456 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.429 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 2.5 p -44.69 -30.56 0.96 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.457 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.472 ' OD1' HG21 ' B' ' 38' ' ' THR . 27.9 m-20 -59.87 -89.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.491 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.74 175.01 14.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.9 p -85.64 -156.65 0.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.439 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.485 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -120.31 119.15 32.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.462 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.02 136.71 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.498 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.44 101.06 0.5 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 109.458 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 40.3 m -143.81 -39.44 0.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.461 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -162.52 120.57 2.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.438 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.538 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -121.33 99.95 6.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.537 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' B' ' 9' ' ' CYS . 8.9 mtm180 -97.96 153.36 18.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.183 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.444 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 19.4 m -44.16 107.9 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 109.39 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.517 ' CG ' ' HE3' ' B' ' 29' ' ' LYS . 22.5 mm-40 -49.75 -21.66 1.16 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.757 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.467 ' HB2' ' OE1' ' B' ' 39' ' ' GLU . 50.8 m -145.01 67.51 1.24 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.126 -0.984 . . . . 0.0 109.893 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 14.5 mt -45.12 -45.57 11.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -0.972 . . . . 0.0 108.854 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' B' ' 13' ' ' GLN . 0.0 OUTLIER -116.06 119.44 35.85 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.6 OUTLIER -94.55 167.1 11.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.242 -0.911 . . . . 0.0 110.098 -179.365 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.509 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.4 mt -114.36 144.97 42.42 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.578 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.4 tt0 -44.27 -39.09 4.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 109.395 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 1.051 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 144.95 -164.62 27.85 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.944 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -170.82 163.7 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.442 -1.034 . . . . 0.0 109.145 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.523 ' ND1' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -53.53 149.46 15.13 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.326 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.532 ' HA ' HD12 ' B' ' 23' ' ' ILE . 34.7 Cg_endo -77.29 -3.89 14.17 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.586 2.191 . . . . 0.0 110.189 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.45 ' O ' ' CD ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.3 -24.31 20.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.151 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 2.5 m-20 -82.87 -6.42 59.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.332 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.944 HD11 ' CD1' ' B' ' 18' ' ' ILE . 8.4 mt -104.95 148.88 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 110.269 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.556 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -120.55 -27.31 5.17 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.237 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.556 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -137.64 168.47 19.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.141 179.337 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.608 HG23 ' HG3' ' B' ' 66' ' ' MET . 91.3 t -140.81 114.43 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.802 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.625 ' O ' HD12 ' B' ' 41' ' ' ILE . 3.8 t-20 -109.6 110.63 21.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.295 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.696 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -110.03 105.62 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.275 -0.89 . . . . 0.0 109.592 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -98.6 114.67 27.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.387 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.95 167.89 5.4 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.423 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.462 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 36.2 Cg_endo -78.16 151.47 26.85 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.518 2.146 . . . . 0.0 110.456 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.82 -141.34 3.15 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.543 ' HD2' ' CD2' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -77.92 10.98 2.41 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.603 2.202 . . . . 0.0 110.993 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.701 ' N ' ' CD2' ' B' ' 34' ' ' HIS . 2.1 p80 -128.27 -34.44 2.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.016 -1.052 . . . . 0.0 109.474 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 2.0 t -145.43 88.07 1.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.296 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -52.6 -20.0 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.708 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.453 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 33.5 mm-40 -92.8 131.9 37.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.472 HG21 ' OD1' ' A' ' 70' ' ' ASP . 3.6 m -54.74 161.33 1.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.396 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.497 ' HB2' ' CG ' ' B' ' 29' ' ' LYS . 22.5 mm-40 -145.35 107.58 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.696 HG22 HG13 ' B' ' 28' ' ' VAL . 42.9 t -91.8 152.8 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 109.299 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.625 HD12 ' O ' ' B' ' 27' ' ' ASN . 2.7 mp -140.31 155.35 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.719 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.775 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -140.88 118.05 11.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.093 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.55 HG22 ' O ' ' B' ' 43' ' ' THR . 1.5 m -89.13 97.55 11.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.92 -1.113 . . . . 0.0 108.817 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 86.9 mt -43.45 162.8 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.479 -0.763 . . . . 0.0 109.661 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.629 ' HZ2' ' HB3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -79.15 7.29 7.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 109.83 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -108.88 16.76 22.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.134 -0.979 . . . . 0.0 109.121 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.68 -0.87 89.4 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.506 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 13.7 mtt180 -89.64 162.95 15.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.082 -1.246 . . . . 0.0 109.445 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 1.3 mptt -134.46 151.06 50.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 109.435 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.21 123.91 9.18 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 109.057 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' B' ' 41' ' ' ILE . 22.8 m -79.49 143.93 34.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.063 -1.023 . . . . 0.0 109.169 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 1.051 HD22 ' HA2' ' B' ' 17' ' ' GLY . 15.2 mt -121.14 167.61 12.47 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.647 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.7 t-20 -100.79 123.55 45.2 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.13 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.24 -7.05 18.62 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.225 1.95 . . . . 0.0 110.4 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.5 -13.13 55.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.229 -0.919 . . . . 0.0 108.868 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.3 OUTLIER -90.06 161.66 37.39 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.99 -35.53 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.609 2.206 . . . . 0.0 110.504 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.596 HG23 ' N ' ' B' ' 59' ' ' VAL . 16.8 tt -67.33 -45.79 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.417 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 1.009 ' HA ' HD12 ' B' ' 62' ' ' ILE . 42.5 t -58.72 -46.72 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.812 . . . . 0.0 109.333 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 1.3 mmpt? -59.47 -29.59 67.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.48 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -79.63 -23.89 42.29 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 1.009 HD12 ' HA ' ' B' ' 59' ' ' VAL . 23.0 mt -70.52 -37.8 71.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.56 -0.712 . . . . 0.0 109.079 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.665 HD11 HG11 ' B' ' 40' ' ' VAL . 2.2 mp -74.67 -56.49 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.427 -0.795 . . . . 0.0 109.398 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.4 OUTLIER -59.32 -27.86 66.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.294 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.512 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 1.6 tptt -71.79 -50.71 27.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.047 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.608 ' HG3' HG23 ' B' ' 26' ' ' VAL . 0.4 OUTLIER -51.82 -45.68 64.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.282 -0.886 . . . . 0.0 109.114 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.652 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -44.27 -52.35 7.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.314 -0.867 . . . . 0.0 109.258 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' B' ' 69' ' ' SER . 0.9 OUTLIER -61.95 -38.12 87.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.529 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.45 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 2.5 p -44.62 -30.65 0.95 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.471 ' OD1' HG21 ' A' ' 38' ' ' THR . 28.0 m-20 -59.81 -89.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.44 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.75 175.06 14.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.0 109.409 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 13.8 p -85.59 -156.67 0.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.494 179.992 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -149.67 -66.47 0.21 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.446 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.619 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 30.7 m -138.12 128.21 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.298 -0.876 . . . . 0.0 109.478 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 3' ' ' VAL . . . 70.79 144.06 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.09 85.31 2.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.88 . . . . 0.0 109.437 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -152.57 111.37 3.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.437 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.553 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -117.72 98.79 6.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.873 . . . . 0.0 109.586 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 9' ' ' CYS . 29.9 mtt180 -92.83 150.52 20.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.32 -0.863 . . . . 0.0 109.022 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.73 ' HB2' HD22 ' A' ' 12' ' ' LEU . 50.7 m -43.99 102.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 109.351 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.506 ' OE1' ' NZ ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.59 -26.79 0.13 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.347 -0.846 . . . . 0.0 109.761 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' CYS . 72.0 m -118.25 58.33 0.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.73 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.2 -37.91 3.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.234 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.37 123.86 41.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.383 -0.823 . . . . 0.0 109.11 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -100.05 161.1 13.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.536 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.2 mt -115.07 141.16 48.38 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.1 tt0 -44.12 -26.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.271 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 1.053 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 139.41 -162.68 26.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.852 HG23 ' O ' ' A' ' 17' ' ' GLY . 1.3 pp -171.0 163.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.466 -1.02 . . . . 0.0 109.267 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -58.12 154.27 31.1 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 0.0 109.201 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -76.99 -9.31 17.99 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.415 2.077 . . . . 0.0 109.927 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.501 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 35.5 mttm -77.34 -27.85 52.85 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.931 ' O ' HD13 ' A' ' 23' ' ' ILE . 22.9 m-20 -93.33 59.29 2.97 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.931 HD13 ' O ' ' A' ' 22' ' ' ASN . 1.5 mm -147.17 169.01 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 110.028 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.754 ' HG2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -160.38 -36.0 0.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.607 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.7 p -134.83 -175.17 3.81 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 25' ' ' SER . 50.7 t -158.82 98.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.946 -1.096 . . . . 0.0 109.867 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.484 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 3.5 t-20 -91.33 110.74 22.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.218 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.475 HG13 HG13 ' A' ' 40' ' ' VAL . 1.7 t -114.32 104.11 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.478 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.681 ' HZ3' ' HB3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -108.19 110.45 22.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.4 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -55.04 168.88 0.47 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.365 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.525 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.4 Cg_endo -78.13 131.95 11.21 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.556 2.171 . . . . 0.0 110.5 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.08 -143.55 5.42 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.86 5.86 4.6 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.519 2.146 . . . . 0.0 110.709 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.553 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 12.2 p-80 -124.28 -12.66 7.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.979 . . . . 0.0 109.623 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 2.7 t -160.22 98.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.214 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.98 -8.48 30.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 109.651 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.455 ' OE1' ' CA ' ' A' ' 37' ' ' GLN . 6.5 mm-40 -106.0 125.44 51.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.415 ' C ' ' HG2' ' A' ' 39' ' ' GLU . 25.9 m -49.7 152.61 1.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.417 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HG2' ' C ' ' A' ' 38' ' ' THR . 2.2 mt-10 -137.66 107.32 6.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.984 . . . . 0.0 109.791 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.922 HG11 HD11 ' A' ' 63' ' ' ILE . 3.8 t -93.8 157.73 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.12 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.548 ' CD1' ' HE2' ' A' ' 29' ' ' LYS . 1.9 mp -144.28 143.8 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 109.835 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.624 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -126.88 125.25 41.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 109.016 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.754 HG22 ' HG2' ' A' ' 24' ' ' GLN . 25.8 m -89.65 104.71 17.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.031 -1.043 . . . . 0.0 109.051 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 22' ' ' ASN . 80.1 mt -47.35 164.92 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.223 -0.923 . . . . 0.0 109.155 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 13.4 ptpt -84.93 12.97 6.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.148 -0.97 . . . . 0.0 109.566 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -111.2 10.68 21.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.888 . . . . 0.0 109.181 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.04 20.81 48.44 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.566 ' HB2' HD12 ' A' ' 44' ' ' LEU . 9.4 mtt180 -115.95 173.68 6.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -1.148 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 4.2 mttt -139.71 154.66 47.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.536 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.17 125.45 10.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.097 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.48 ' SG ' HG13 ' A' ' 41' ' ' ILE . 16.8 m -79.51 144.52 33.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 0.0 109.192 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.053 HD22 ' HA2' ' A' ' 17' ' ' GLY . 15.1 mt -122.53 168.34 12.26 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.663 ' O ' HG21 ' A' ' 59' ' ' VAL . 0.1 OUTLIER -98.04 120.96 58.79 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.368 -0.833 . . . . 0.0 109.112 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.83 -6.79 18.61 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.196 1.931 . . . . 0.0 110.284 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.3 -14.25 53.42 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.257 -0.902 . . . . 0.0 108.833 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 1.1 p -90.05 158.3 44.47 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.474 -0.766 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.479 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.0 Cg_endo -77.14 -32.27 3.24 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.614 2.209 . . . . 0.0 110.509 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.591 HG23 ' N ' ' A' ' 59' ' ' VAL . 9.0 tt -69.2 -45.16 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.112 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.029 ' HA ' HD12 ' A' ' 62' ' ' ILE . 25.2 t -57.45 -46.2 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.522 -0.736 . . . . 0.0 109.248 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -61.08 -30.32 70.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.524 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 3.4 mmpt? -79.05 -20.58 48.53 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.029 HD12 ' HA ' ' A' ' 59' ' ' VAL . 26.7 mt -75.51 -37.34 37.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.578 -0.701 . . . . 0.0 109.181 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.922 HD11 HG11 ' A' ' 40' ' ' VAL . 2.2 mp -74.28 -50.33 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 8.7 pt-20 -66.12 -35.95 81.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 109.328 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.53 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 32.9 mttm -61.38 -40.44 94.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 108.945 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.53 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -61.1 -45.33 95.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.087 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.885 HD11 HG22 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -49.59 -54.88 15.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 109.69 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.2 -16.18 60.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.895 . . . . 0.0 109.724 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 28.4 p -46.67 -55.48 7.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 109.468 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 32.4 t70 59.01 102.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 0.0 109.403 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HG2' ' N ' ' A' ' 72' ' ' SER . 20.5 tttt 61.37 -88.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.489 ' N ' ' HG2' ' A' ' 71' ' ' LYS . 7.9 t -166.23 -59.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.41 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.072 -0.965 . . . . 0.0 109.465 -179.901 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m -149.66 -66.38 0.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.354 -0.841 . . . . 0.0 109.475 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.611 ' O ' ' HB3' ' B' ' 4' ' ' ALA . 31.1 m -138.19 128.22 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.885 . . . . 0.0 109.476 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' B' ' 3' ' ' VAL . . . 70.84 144.0 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.515 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.11 85.31 2.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.915 . . . . 0.0 109.436 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -152.58 111.4 3.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.553 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -117.74 98.82 6.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.254 -0.904 . . . . 0.0 109.614 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.432 ' O ' ' C ' ' B' ' 9' ' ' CYS . 29.7 mtt180 -92.78 150.49 20.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.067 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.729 ' HB2' HD22 ' B' ' 12' ' ' LEU . 50.9 m -43.92 102.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 109.374 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.517 ' OE1' ' NZ ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -42.59 -26.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.359 -0.838 . . . . 0.0 109.722 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' B' ' 9' ' ' CYS . 72.1 m -118.28 58.38 0.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.729 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.13 -37.99 3.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 109.256 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.32 123.91 41.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.1 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.552 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.4 OUTLIER -100.13 161.12 13.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.535 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.2 mt -115.17 141.15 48.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.461 -0.775 . . . . 0.0 108.952 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.522 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 3.1 tt0 -44.08 -26.73 0.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.35 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 1.003 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 139.36 -162.67 26.1 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.854 HG23 ' O ' ' B' ' 17' ' ' GLY . 1.3 pp -170.96 163.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.404 -1.056 . . . . 0.0 109.217 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.592 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -58.16 154.21 31.77 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.25 -0.907 . . . . 0.0 109.27 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.592 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.9 Cg_endo -76.88 -9.31 18.15 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.449 2.099 . . . . 0.0 109.924 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.495 ' O ' ' NZ ' ' B' ' 45' ' ' LYS . 35.4 mttm -77.38 -27.87 52.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.952 ' O ' HD13 ' B' ' 23' ' ' ILE . 23.0 m-20 -93.38 59.38 2.97 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.952 HD13 ' O ' ' B' ' 22' ' ' ASN . 1.4 mm -147.23 168.93 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.141 -0.974 . . . . 0.0 110.047 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.75 ' HG2' HG22 ' B' ' 43' ' ' THR . 0.0 OUTLIER -160.38 -35.98 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.606 ' O ' HG23 ' B' ' 26' ' ' VAL . 1.7 p -134.82 -175.19 3.82 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 25' ' ' SER . 50.4 t -158.81 98.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.96 -1.087 . . . . 0.0 109.79 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.487 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 3.6 t-20 -91.48 110.76 22.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.235 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.483 HG13 HG13 ' B' ' 40' ' ' VAL . 1.7 t -114.35 104.09 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.492 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.615 ' HZ3' ' HB3' ' B' ' 29' ' ' LYS . 0.9 OUTLIER -108.16 110.41 22.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.401 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.0 OUTLIER -54.96 168.84 0.47 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 109.414 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 36.0 Cg_endo -78.0 131.8 11.25 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.67 2.247 . . . . 0.0 110.507 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.01 -143.58 5.43 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.72 5.68 4.66 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.642 2.228 . . . . 0.0 110.68 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.553 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 12.1 p-80 -124.3 -12.68 7.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.181 -0.949 . . . . 0.0 109.585 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 2.7 t -160.18 98.88 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.25 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.9 -8.59 30.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.631 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.451 ' HA ' ' OE1' ' B' ' 37' ' ' GLN . 6.4 mm-40 -105.85 125.42 50.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.591 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.43 ' C ' ' HG2' ' B' ' 39' ' ' GLU . 26.0 m -49.79 152.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.868 . . . . 0.0 109.341 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.43 ' HG2' ' C ' ' B' ' 38' ' ' THR . 2.1 mt-10 -137.58 107.36 6.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.724 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.913 HG11 HD11 ' B' ' 63' ' ' ILE . 3.8 t -93.85 157.64 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.115 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.554 ' CD1' ' HE2' ' B' ' 29' ' ' LYS . 1.9 mp -144.24 143.8 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.96 . . . . 0.0 109.81 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.619 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -126.93 125.18 41.1 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.75 HG22 ' HG2' ' B' ' 24' ' ' GLN . 26.2 m -89.53 104.73 17.26 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.981 -1.074 . . . . 0.0 109.05 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.788 HD23 ' O ' ' B' ' 22' ' ' ASN . 80.8 mt -47.44 164.98 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.354 -0.841 . . . . 0.0 109.123 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' B' ' 21' ' ' LYS . 13.4 ptpt -84.98 13.11 6.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.594 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -111.28 10.68 21.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.878 . . . . 0.0 109.064 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.03 20.73 48.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.566 ' HB2' HD12 ' B' ' 44' ' ' LEU . 9.4 mtt180 -115.96 173.72 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -1.128 . . . . 0.0 109.394 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.441 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 4.2 mttt -139.67 154.69 47.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.423 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.535 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.19 125.34 10.02 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.276 -0.89 . . . . 0.0 109.175 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.477 ' SG ' HG13 ' B' ' 41' ' ' ILE . 17.1 m -79.45 144.47 34.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.957 . . . . 0.0 109.152 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 1.003 HD22 ' HA2' ' B' ' 17' ' ' GLY . 15.0 mt -122.52 168.33 12.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.891 . . . . 0.0 109.35 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.668 ' O ' HG21 ' B' ' 59' ' ' VAL . 0.1 OUTLIER -98.01 120.91 58.94 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.37 -0.831 . . . . 0.0 109.093 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.83 -6.68 18.46 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.126 1.884 . . . . 0.0 110.35 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.35 -14.21 53.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 0.0 108.826 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 1.1 p -90.05 158.26 44.5 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.383 -0.823 . . . . 0.0 109.402 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.488 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 35.5 Cg_endo -77.06 -32.29 3.28 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.676 2.25 . . . . 0.0 110.522 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.602 HG23 ' N ' ' B' ' 59' ' ' VAL . 9.1 tt -69.23 -45.16 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 0.0 109.113 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 1.028 ' HA ' HD12 ' B' ' 62' ' ' ILE . 25.2 t -57.55 -46.1 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.474 -0.766 . . . . 0.0 109.163 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' B' ' 56' ' ' SER . 0.0 OUTLIER -61.17 -30.28 70.31 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.532 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 3.4 mmpt? -78.96 -20.77 48.38 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 1.028 HD12 ' HA ' ' B' ' 59' ' ' VAL . 26.7 mt -75.38 -37.34 38.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.641 -0.662 . . . . 0.0 109.267 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.913 HD11 HG11 ' B' ' 40' ' ' VAL . 2.2 mp -74.29 -50.34 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.624 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.538 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 8.7 pt-20 -66.09 -35.93 81.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.998 -1.064 . . . . 0.0 109.353 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.538 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 32.8 mttm -61.42 -40.53 94.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 108.939 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.518 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.2 OUTLIER -61.0 -45.3 95.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.149 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.91 HD11 HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -49.64 -54.78 16.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 109.698 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.32 -16.19 60.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.687 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 28.3 p -46.52 -55.59 7.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.537 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' B' ' 71' ' ' LYS . 32.3 t70 59.06 102.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.41 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' B' ' 72' ' ' SER . 20.4 tttt 61.35 -88.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.449 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.504 ' N ' ' HG2' ' B' ' 71' ' ' LYS . 7.9 t -166.27 -59.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.512 179.973 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 68.41 -86.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.476 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 4' ' ' ALA . 2.1 m -144.63 49.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.482 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 3' ' ' VAL . . . -44.05 165.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.474 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.2 69.68 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.186 -0.946 . . . . 0.0 109.475 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.85 80.89 2.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.563 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -119.28 99.71 6.87 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.329 -0.857 . . . . 0.0 109.61 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -96.14 149.83 21.19 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.325 -0.859 . . . . 0.0 108.994 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.761 ' HB2' HD22 ' A' ' 12' ' ' LEU . 68.7 m -44.01 98.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.139 -0.976 . . . . 0.0 109.411 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.539 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.52 -26.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.874 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 39' ' ' GLU . 83.0 m -116.8 58.71 0.76 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 109.71 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.761 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.82 -37.14 3.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.178 -0.951 . . . . 0.0 109.147 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -127.28 127.72 44.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.374 -0.829 . . . . 0.0 109.059 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -101.94 165.37 11.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.217 -0.927 . . . . 0.0 109.953 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.566 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 6.9 mt -124.21 143.42 50.53 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.3 tt0 -44.17 -40.89 5.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -0.946 . . . . 0.0 109.402 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 1.032 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 140.41 166.67 10.76 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.893 HD11 ' CG1' ' A' ' 23' ' ' ILE . 1.9 pp -139.31 162.8 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.549 -0.971 . . . . 0.0 109.083 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.734 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -46.49 151.61 0.99 Allowed Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 109.204 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.568 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -76.91 -4.87 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.502 2.135 . . . . 0.0 110.083 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.44 -23.41 21.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.331 -0.855 . . . . 0.0 109.237 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.523 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 4.8 m-20 -82.52 -4.7 57.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 0.0 109.44 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.893 ' CG1' HD11 ' A' ' 18' ' ' ILE . 9.0 mt -105.61 155.3 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 110.304 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.6 OUTLIER -127.27 -29.19 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.32 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.582 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -135.11 171.12 14.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.029 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.54 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 46.4 t -143.78 101.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.959 . . . . 0.0 109.733 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.525 ' O ' HD12 ' A' ' 41' ' ' ILE . 3.8 t-20 -95.71 110.4 22.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.364 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.402 HG13 HG22 ' A' ' 40' ' ' VAL . 1.9 t -107.0 100.72 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.504 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.539 ' CD ' ' HB2' ' A' ' 10' ' ' GLN . 10.2 ptmt -95.54 109.41 21.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.44 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.455 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -61.88 171.52 1.45 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.4 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.545 ' HG2' ' CB ' ' B' ' 71' ' ' LYS . 35.3 Cg_endo -77.54 144.57 22.67 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.611 2.207 . . . . 0.0 110.444 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.89 -141.3 3.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.9 39.96 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.746 2.297 . . . . 0.0 110.759 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.563 ' CD2' HD22 ' A' ' 7' ' ' LEU . 6.4 p-80 -159.41 -38.82 0.06 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.082 -1.011 . . . . 0.0 109.13 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -141.14 99.0 3.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.865 . . . . 0.0 109.146 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.87 -11.85 42.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 0.0 109.679 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 37' ' ' GLN . 4.0 mm-40 -98.92 124.4 43.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.457 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.459 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 9.4 m -47.72 157.85 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.252 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 29' ' ' LYS . 7.3 mm-40 -145.57 107.29 4.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 109.702 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.9 HG11 HD11 ' A' ' 63' ' ' ILE . 6.5 t -89.74 156.23 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.154 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 27' ' ' ASN . 2.6 mp -141.09 148.43 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.145 -0.972 . . . . 0.0 109.838 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.756 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -133.04 118.18 18.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.007 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.532 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 2.1 m -89.12 98.91 12.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.931 -1.106 . . . . 0.0 108.885 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 88.9 mt -44.41 166.6 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.504 -0.747 . . . . 0.0 109.593 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.4 ptpt -81.88 8.21 10.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.639 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.15 25.04 11.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.216 -0.928 . . . . 0.0 109.242 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.18 2.64 67.23 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.511 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 5.8 mtt180 -92.1 164.32 13.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.193 -1.181 . . . . 0.0 109.436 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.6 mptt -135.92 153.13 51.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.174 -0.954 . . . . 0.0 109.393 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.566 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.29 122.45 8.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.065 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.4 m -79.46 143.07 35.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.102 -0.999 . . . . 0.0 109.036 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.054 HD13 HD13 ' A' ' 62' ' ' ILE . 14.2 mt -119.74 167.59 11.91 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.29 -0.881 . . . . 0.0 109.611 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.676 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.4 t-20 -97.64 119.0 63.52 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.518 -0.739 . . . . 0.0 109.172 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.11 -0.0 9.0 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.136 1.891 . . . . 0.0 110.443 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.79 -13.07 25.97 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.296 -0.877 . . . . 0.0 108.835 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.11 165.35 24.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.389 -0.82 . . . . 0.0 109.399 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.502 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.17 -42.18 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.707 2.271 . . . . 0.0 110.816 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.1 mt -61.52 -39.71 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.734 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.988 ' HA ' HD12 ' A' ' 62' ' ' ILE . 47.5 t -64.42 -49.46 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.794 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 8.7 mttm -53.73 -32.33 51.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.071 -1.018 . . . . 0.0 108.706 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -78.06 -29.93 49.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.55 -0.719 . . . . 0.0 109.268 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.054 HD13 HD13 ' A' ' 52' ' ' LEU . 15.2 mt -64.43 -38.55 82.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.219 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.948 ' CG2' HD11 ' B' ' 67' ' ' LEU . 1.4 mp -76.01 -64.65 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.858 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -49.65 -55.22 14.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 109.449 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 61' ' ' LYS . 42.8 tptt -46.62 -55.79 7.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.128 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.54 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -44.38 -43.19 7.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 0.0 109.169 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.955 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -55.83 -55.27 34.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.419 -0.8 . . . . 0.0 109.579 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.28 10.31 17.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 109.679 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 91.2 p -63.19 -40.32 97.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' A' ' 71' ' ' LYS . 2.9 m-20 59.74 66.68 0.96 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.546 ' CB ' ' HG2' ' B' ' 31' ' ' PRO . 13.9 ptpt 41.8 -163.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.49 -0.756 . . . . 0.0 109.659 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.45 ' O ' ' OXT' ' A' ' 73' ' ' ASN . 4.3 t -113.1 76.05 0.95 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 109.457 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' OXT' ' O ' ' A' ' 72' ' ' SER . 4.3 t30 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.503 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.293 0.568 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' B' ' 1' ' ' ALA . 0.6 OUTLIER 68.3 -86.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.445 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' B' ' 4' ' ' ALA . 2.2 m -144.61 49.77 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.547 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' B' ' 3' ' ' VAL . . . -44.09 165.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 109.372 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.19 69.74 0.19 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.84 80.87 2.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.42 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.559 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -119.2 99.6 6.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.204 -0.935 . . . . 0.0 109.694 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -96.05 149.86 21.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.007 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.754 ' HB2' HD22 ' B' ' 12' ' ' LEU . 68.6 m -43.97 98.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.893 . . . . 0.0 109.335 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.534 ' HB2' ' CD ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -42.67 -26.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.436 -0.79 . . . . 0.0 109.761 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' B' ' 39' ' ' GLU . 82.9 m -116.85 58.77 0.76 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.729 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.754 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.18 3.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -127.31 127.64 44.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.016 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.506 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -101.88 165.42 11.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.968 . . . . 0.0 109.958 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.554 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 6.9 mt -124.2 143.43 50.52 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.488 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.3 tt0 -44.22 -40.97 5.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.28 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.987 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 140.45 166.72 10.78 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.911 HD11 ' CG1' ' B' ' 23' ' ' ILE . 1.9 pp -139.37 162.82 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.496 -1.002 . . . . 0.0 109.034 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.744 ' O ' HD12 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -46.49 151.61 0.99 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.982 . . . . 0.0 109.134 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.554 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -76.91 -4.84 15.37 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.475 2.117 . . . . 0.0 110.008 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.473 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.47 -23.28 21.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.389 -0.819 . . . . 0.0 109.229 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 4.8 m-20 -82.61 -4.69 58.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.911 ' CG1' HD11 ' B' ' 18' ' ' ILE . 8.9 mt -105.59 155.35 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.569 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.6 OUTLIER -127.36 -29.14 2.73 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.569 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -135.11 171.06 14.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 109.055 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.536 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 46.2 t -143.73 101.82 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.047 -1.033 . . . . 0.0 109.752 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.518 ' O ' HD12 ' B' ' 41' ' ' ILE . 3.9 t-20 -95.65 110.4 22.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.321 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.406 HG13 HG22 ' B' ' 40' ' ' VAL . 1.9 t -107.01 100.71 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.481 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.534 ' CD ' ' HB2' ' B' ' 10' ' ' GLN . 10.1 ptmt -95.57 109.52 21.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 109.441 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.451 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -61.99 171.49 1.5 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 109.447 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.546 ' HG2' ' CB ' ' A' ' 71' ' ' LYS . 35.8 Cg_endo -77.43 144.6 22.96 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.615 2.21 . . . . 0.0 110.455 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.84 -141.25 3.29 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.9 39.94 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.684 2.256 . . . . 0.0 110.826 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.559 ' CD2' HD22 ' B' ' 7' ' ' LEU . 6.5 p-80 -159.37 -38.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.073 -1.017 . . . . 0.0 109.202 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -141.21 99.02 3.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 109.154 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.9 -11.93 43.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.7 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.456 ' HA ' ' OE1' ' B' ' 37' ' ' GLN . 4.0 mm-40 -98.77 124.45 43.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.519 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.454 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 9.4 m -47.78 157.89 0.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.313 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' B' ' 38' ' ' THR . 7.3 mm-40 -145.58 107.27 4.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.732 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.903 HG11 HD11 ' B' ' 63' ' ' ILE . 6.3 t -89.72 156.2 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.846 . . . . 0.0 109.182 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.518 HD12 ' O ' ' B' ' 27' ' ' ASN . 2.6 mp -141.07 148.47 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.777 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.76 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -133.09 118.19 18.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.057 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.518 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 2.1 m -89.08 98.82 11.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.909 -1.12 . . . . 0.0 108.896 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.1 mt -44.4 166.5 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.523 -0.736 . . . . 0.0 109.697 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.4 ptpt -81.73 8.09 10.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 109.692 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.07 25.01 11.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.26 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.28 2.55 67.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.508 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 5.8 mtt180 -92.01 164.28 13.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -1.204 . . . . 0.0 109.436 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 1.6 mptt -135.86 153.2 51.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.382 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.554 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.39 122.36 8.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.835 . . . . 0.0 109.075 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 5.4 m -79.4 142.96 35.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.021 . . . . 0.0 109.08 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 1.131 HD13 HD13 ' B' ' 62' ' ' ILE . 14.0 mt -119.65 167.63 11.84 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.262 -0.899 . . . . 0.0 109.678 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.669 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.4 t-20 -97.62 118.99 63.56 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.506 -0.746 . . . . 0.0 109.182 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -74.26 0.14 8.89 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.07 1.846 . . . . 0.0 110.339 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -94.72 -13.16 26.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 108.867 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.1 165.4 24.23 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.835 . . . . 0.0 109.419 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.501 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.5 Cg_endo -78.1 -42.23 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.742 2.295 . . . . 0.0 110.831 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 47.2 mt -61.61 -39.62 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.189 -0.944 . . . . 0.0 109.706 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 1.037 ' HA ' HD12 ' B' ' 62' ' ' ILE . 47.6 t -64.43 -49.48 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.347 -0.845 . . . . 0.0 109.832 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' B' ' 64' ' ' GLU . 8.7 mttm -53.77 -32.28 51.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 108.741 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -78.04 -29.89 49.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.615 -0.678 . . . . 0.0 109.285 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 1.131 HD13 HD13 ' B' ' 52' ' ' LEU . 15.0 mt -64.6 -38.43 82.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 109.138 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.955 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.4 mp -75.99 -64.79 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 109.786 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -49.61 -55.2 14.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.01 -1.057 . . . . 0.0 109.449 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' B' ' 61' ' ' LYS . 42.9 tptt -46.57 -55.81 7.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.135 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.536 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.0 OUTLIER -44.43 -43.2 7.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.948 . . . . 0.0 109.116 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.948 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -55.72 -55.39 32.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.434 -0.791 . . . . 0.0 109.63 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.2 10.35 17.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 0.0 109.623 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 90.6 p -63.29 -40.31 96.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.459 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.528 ' O ' ' CG ' ' B' ' 71' ' ' LYS . 2.8 m-20 59.67 66.74 0.96 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.94 . . . . 0.0 109.496 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.545 ' CB ' ' HG2' ' A' ' 31' ' ' PRO . 13.9 ptpt 41.78 -163.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.435 -0.791 . . . . 0.0 109.696 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.448 ' O ' ' OXT' ' B' ' 73' ' ' ASN . 4.3 t -113.13 76.13 0.96 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.456 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' ASN . . . . . 0.448 ' OXT' ' O ' ' B' ' 72' ' ' SER . 4.3 t30 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.439 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.71 172.86 6.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 3' ' ' VAL . 10.8 p -151.36 17.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.199 -0.938 . . . . 0.0 109.468 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 3' ' ' VAL . . . 69.5 -158.11 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.483 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -158.24 117.05 3.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.433 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 5' ' ' THR . 8.5 tt0 179.97 76.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.615 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -117.14 98.52 6.5 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.175 -0.953 . . . . 0.0 109.645 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -88.42 153.33 21.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.022 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.71 ' HB2' HD22 ' A' ' 12' ' ' LEU . 67.1 m -44.31 118.83 1.63 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 109.403 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.466 ' HG2' ' HB3' ' A' ' 29' ' ' LYS . 2.5 mp0 -40.66 -40.01 1.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.587 -0.695 . . . . 0.0 109.857 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.459 ' SG ' HG13 ' A' ' 41' ' ' ILE . 82.5 m -132.09 80.49 1.91 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 109.878 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.71 HD22 ' HB2' ' A' ' 9' ' ' CYS . 3.9 mm? -49.2 -45.35 44.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 108.993 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -116.89 122.71 45.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.429 -0.794 . . . . 0.0 108.923 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.12 166.83 10.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.952 . . . . 0.0 110.006 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.493 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 6.0 mt -115.27 146.21 41.7 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.562 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.8 OUTLIER -44.74 -35.65 2.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.109 -0.994 . . . . 0.0 109.38 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.754 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 146.37 -176.98 25.01 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.759 HD13 HD11 ' A' ' 23' ' ' ILE . 1.7 pp -157.04 162.39 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -1.06 . . . . 0.0 109.372 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.6 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -59.24 156.21 30.25 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 0.0 109.343 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -77.04 -13.3 17.36 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.501 2.134 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.533 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 22.0 mttt -74.17 -30.86 62.45 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.969 ' O ' HD13 ' A' ' 23' ' ' ILE . 26.5 m-20 -89.59 58.41 4.32 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.969 HD13 ' O ' ' A' ' 22' ' ' ASN . 1.5 mm -145.63 169.16 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -0.974 . . . . 0.0 110.098 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.748 ' HG2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -160.18 -35.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.621 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.0 p -136.37 -172.59 3.18 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 25' ' ' SER . 52.1 t -159.24 115.16 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.891 -1.131 . . . . 0.0 109.97 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.508 ' O ' HD12 ' A' ' 41' ' ' ILE . 3.9 t-20 -109.11 110.76 22.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 109.111 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.536 HG13 HG22 ' A' ' 40' ' ' VAL . 2.1 t -120.71 109.8 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.3 -0.875 . . . . 0.0 109.729 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' HB3' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -108.87 102.03 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.37 -0.831 . . . . 0.0 109.309 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.464 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -48.81 171.31 0.1 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 36.0 Cg_endo -78.03 140.87 18.32 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.586 2.191 . . . . 0.0 110.462 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.48 -141.49 3.68 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.45 8.82 3.13 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.544 2.163 . . . . 0.0 110.878 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.615 ' CD2' HD22 ' A' ' 7' ' ' LEU . 4.4 p-80 -125.53 -21.33 4.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.047 -1.033 . . . . 0.0 109.807 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' OE1' ' A' ' 37' ' ' GLN . 2.1 t -160.02 122.44 3.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.012 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.42 16.2 4.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.637 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 2.0 mp0 -124.13 124.83 43.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.842 HG21 ' HB3' ' B' ' 70' ' ' ASP . 15.9 m -54.88 137.54 45.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.406 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 39' ' ' GLU . 1.7 mp0 -118.77 107.02 13.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 109.683 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.711 HG11 HD11 ' A' ' 63' ' ' ILE . 13.5 t -95.12 146.94 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.244 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.514 ' CG1' ' SG ' ' A' ' 51' ' ' CYS . 2.1 mp -138.23 152.58 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.874 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.756 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -136.62 125.25 23.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.411 -0.805 . . . . 0.0 109.041 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.748 HG22 ' HG2' ' A' ' 24' ' ' GLN . 33.4 m -89.51 106.86 18.73 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.008 -1.058 . . . . 0.0 109.093 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.847 HD23 ' O ' ' A' ' 22' ' ' ASN . 71.9 mt -49.03 166.11 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.183 -0.948 . . . . 0.0 109.114 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.533 ' CD ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -84.27 11.04 8.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.057 -1.027 . . . . 0.0 109.533 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -111.12 19.26 18.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.325 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 14.61 80.1 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.599 ' HB2' HD12 ' A' ' 44' ' ' LEU . 49.1 mtt180 -109.15 175.23 5.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -1.173 . . . . 0.0 109.502 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -145.15 155.25 43.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.48 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.1 124.99 9.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.365 -0.834 . . . . 0.0 109.116 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.514 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 12.0 m -79.55 140.35 37.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.091 -1.006 . . . . 0.0 109.267 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.862 ' HB3' HG22 ' A' ' 59' ' ' VAL . 11.4 mt -122.93 168.67 12.01 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.253 -0.904 . . . . 0.0 109.266 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.65 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.2 t30 -104.68 124.79 35.77 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 109.276 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.11 -13.48 21.18 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.165 1.91 . . . . 0.0 110.531 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.549 ' HB3' HD22 ' A' ' 53' ' ' ASN . . . -73.55 -16.65 61.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.261 -0.899 . . . . 0.0 108.875 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -90.16 161.16 38.51 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.453 -0.779 . . . . 0.0 109.419 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -78.12 -37.17 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.679 2.253 . . . . 0.0 111.044 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.58 ' O ' HD13 ' A' ' 62' ' ' ILE . 17.6 tt -64.73 -47.2 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.06 -1.025 . . . . 0.0 109.13 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.862 HG22 ' HB3' ' A' ' 52' ' ' LEU . 39.5 t -56.68 -48.23 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.509 -0.745 . . . . 0.0 109.163 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 56' ' ' SER . 4.6 mmtt -54.21 -31.18 52.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.508 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 9.6 mmmm -78.3 -30.66 48.49 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.35 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.602 HG22 HD12 ' A' ' 63' ' ' ILE . 1.7 mp -58.0 -43.59 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.833 ' CG2' HD11 ' B' ' 67' ' ' LEU . 1.6 mp -68.7 -61.76 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -42.6 -29.03 0.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.344 -0.847 . . . . 0.0 109.584 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 66' ' ' MET . 0.7 OUTLIER -74.32 -60.57 2.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.858 . . . . 0.0 109.271 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.537 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 1.2 mmm -44.05 -48.37 8.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.825 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -43.64 -51.21 7.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 0.0 109.342 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.97 -37.04 86.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.467 -0.771 . . . . 0.0 109.497 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -46.71 -32.0 3.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.846 . . . . 0.0 109.465 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.837 ' HB3' HG21 ' B' ' 38' ' ' THR . 3.4 p30 -99.25 88.17 3.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.134 -0.979 . . . . 0.0 109.448 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.426 ' HG2' ' N ' ' A' ' 72' ' ' SER . 10.5 tttt -118.7 152.44 36.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.526 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.426 ' N ' ' HG2' ' A' ' 71' ' ' LYS . 0.4 OUTLIER -168.01 71.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.411 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.55 ' O ' ' ND2' ' A' ' 73' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.126 -0.984 . . . . 0.0 109.5 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.7 172.87 6.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 109.463 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.597 ' O ' HG22 ' B' ' 3' ' ' VAL . 10.8 p -151.37 17.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.482 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' B' ' 3' ' ' VAL . . . 69.41 -158.09 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' B' ' 6' ' ' GLU . 0.0 OUTLIER -158.22 116.93 3.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.502 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' B' ' 5' ' ' THR . 8.5 tt0 -179.97 76.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.44 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.618 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -117.16 98.53 6.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.205 -0.934 . . . . 0.0 109.649 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -88.4 153.32 21.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.004 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.705 ' HB2' HD22 ' B' ' 12' ' ' LEU . 67.4 m -44.3 118.88 1.64 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.49 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.471 ' HG2' ' HB3' ' B' ' 29' ' ' LYS . 2.5 mp0 -40.74 -40.03 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.549 -0.719 . . . . 0.0 109.899 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.46 ' SG ' HG13 ' B' ' 41' ' ' ILE . 83.2 m -132.0 80.63 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.854 . . . . 0.0 109.882 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.705 HD22 ' HB2' ' B' ' 9' ' ' CYS . 3.9 mm? -49.38 -45.33 45.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.104 -0.998 . . . . 0.0 108.921 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -116.92 122.78 45.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.417 -0.802 . . . . 0.0 108.911 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.18 166.78 10.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.999 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.482 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 6.0 mt -115.2 146.18 41.67 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.563 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.8 OUTLIER -44.67 -35.67 2.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.142 -0.973 . . . . 0.0 109.438 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.766 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 146.32 -177.02 24.94 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.795 HD13 HD11 ' B' ' 23' ' ' ILE . 1.7 pp -157.01 162.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -1.105 . . . . 0.0 109.428 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.608 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -59.25 156.24 30.22 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.291 -0.881 . . . . 0.0 109.233 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.608 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.06 -13.19 17.37 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.467 2.112 . . . . 0.0 109.961 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.525 ' O ' ' CD ' ' B' ' 45' ' ' LYS . 22.1 mttt -74.17 -30.85 62.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.96 ' O ' HD13 ' B' ' 23' ' ' ILE . 26.4 m-20 -89.65 58.41 4.29 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.96 HD13 ' O ' ' B' ' 22' ' ' ASN . 1.5 mm -145.65 169.21 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.072 -1.018 . . . . 0.0 110.135 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.737 ' HG2' HG22 ' B' ' 43' ' ' THR . 0.0 OUTLIER -160.16 -35.68 0.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.614 ' O ' HG23 ' B' ' 26' ' ' VAL . 3.0 p -136.37 -172.64 3.19 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.614 HG23 ' O ' ' B' ' 25' ' ' SER . 52.0 t -159.2 115.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.915 -1.115 . . . . 0.0 109.984 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.514 ' O ' HD12 ' B' ' 41' ' ' ILE . 3.9 t-20 -109.09 110.71 22.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.111 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.549 HG13 HG22 ' B' ' 40' ' ' VAL . 2.1 t -120.74 109.81 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.661 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.471 ' HB3' ' HG2' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -108.78 102.04 11.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.282 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.451 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.0 OUTLIER -48.84 171.29 0.1 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.377 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 36.3 Cg_endo -77.98 140.87 18.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.641 2.227 . . . . 0.0 110.497 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.57 -141.46 3.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.47 8.82 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.563 2.175 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.618 ' CD2' HD22 ' B' ' 7' ' ' LEU . 4.4 p-80 -125.56 -21.32 4.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.053 -1.03 . . . . 0.0 109.775 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.445 ' SG ' ' OE1' ' B' ' 37' ' ' GLN . 2.1 t -160.03 122.59 3.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.092 -1.005 . . . . 0.0 109.333 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' B' ' 31' ' ' PRO . . . -86.57 16.28 4.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.603 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.455 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 2.0 mp0 -124.17 124.87 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 109.474 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.837 HG21 ' HB3' ' A' ' 70' ' ' ASP . 15.3 m -54.78 137.58 44.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.939 . . . . 0.0 109.413 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.472 ' OE1' ' N ' ' B' ' 39' ' ' GLU . 1.7 mp0 -118.85 107.06 13.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.94 . . . . 0.0 109.632 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.724 HG11 HD11 ' B' ' 63' ' ' ILE . 13.5 t -95.14 146.91 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.515 ' CG1' ' SG ' ' B' ' 51' ' ' CYS . 2.1 mp -138.2 152.63 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.089 -1.007 . . . . 0.0 109.899 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.753 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -136.6 125.29 23.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.085 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.737 HG22 ' HG2' ' B' ' 24' ' ' GLN . 33.8 m -89.6 106.87 18.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.973 -1.08 . . . . 0.0 109.071 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.826 HD23 ' O ' ' B' ' 22' ' ' ASN . 72.8 mt -49.07 166.17 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.151 -0.968 . . . . 0.0 109.013 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -84.34 11.03 9.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 0.0 109.442 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -111.12 19.3 18.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.345 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.63 80.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.577 ' HB2' HD12 ' B' ' 44' ' ' LEU . 49.2 mtt180 -109.16 175.24 5.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -1.209 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -145.19 155.33 43.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.425 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.482 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.14 124.98 9.83 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.391 -0.818 . . . . 0.0 109.112 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.515 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 12.0 m -79.64 140.3 37.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.166 -0.959 . . . . 0.0 109.244 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.827 ' HB3' HG22 ' B' ' 59' ' ' VAL . 11.4 mt -122.91 168.69 11.98 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.259 -0.901 . . . . 0.0 109.229 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.652 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.2 t30 -104.78 124.86 35.48 Favored Pre-proline 0 C--N 1.299 -1.601 0 O-C-N 121.344 -0.847 . . . . 0.0 109.171 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.06 -13.58 21.25 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.263 1.975 . . . . 0.0 110.452 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.526 ' HB3' HD22 ' B' ' 53' ' ' ASN . . . -73.53 -16.68 61.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 108.804 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.493 ' HG ' HG22 ' B' ' 58' ' ' ILE . 0.7 OUTLIER -90.2 161.13 38.46 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.342 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.5 Cg_endo -78.07 -37.19 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.703 2.269 . . . . 0.0 111.08 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.593 ' O ' HD13 ' B' ' 62' ' ' ILE . 17.5 tt -64.69 -47.26 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.053 -1.029 . . . . 0.0 109.162 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.827 HG22 ' HB3' ' B' ' 52' ' ' LEU . 39.4 t -56.75 -48.28 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' B' ' 56' ' ' SER . 4.6 mmtt -54.15 -31.24 51.93 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.51 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 9.7 mmmm -78.27 -30.64 48.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.498 -0.751 . . . . 0.0 109.302 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.604 HG22 HD12 ' B' ' 63' ' ' ILE . 1.7 mp -58.08 -43.57 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.825 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.6 mp -68.72 -61.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -42.7 -28.99 0.27 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.347 -0.845 . . . . 0.0 109.583 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' B' ' 66' ' ' MET . 0.7 OUTLIER -74.38 -60.47 2.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.942 . . . . 0.0 109.276 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.531 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 1.2 mmm -44.16 -48.28 9.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.83 . . . . 0.0 109.207 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.833 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -43.75 -51.16 7.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.379 -0.825 . . . . 0.0 109.317 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 28.1 t30 -64.91 -37.09 86.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.523 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -46.74 -31.93 3.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.499 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.842 ' HB3' HG21 ' A' ' 38' ' ' THR . 3.4 p30 -99.29 88.18 3.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.424 ' HG2' ' N ' ' B' ' 72' ' ' SER . 10.4 tttt -118.7 152.51 35.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.476 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.424 ' N ' ' HG2' ' B' ' 71' ' ' LYS . 0.4 OUTLIER -168.01 71.95 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 73' ' ' ASN . . . . . 0.553 ' O ' ' ND2' ' B' ' 73' ' ' ASN . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.066 -0.968 . . . . 0.0 109.455 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -154.82 114.33 3.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.922 . . . . 0.0 109.47 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 4' ' ' ALA . 48.7 t 58.58 -89.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.53 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.606 ' N ' HG12 ' A' ' 3' ' ' VAL . . . -151.15 88.49 1.45 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.905 . . . . 0.0 109.415 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.2 p -87.09 -24.03 24.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.47 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.89 91.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.551 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -118.41 98.86 6.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 0.0 109.533 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 9' ' ' CYS . 1.8 mpp_? -91.16 151.64 20.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.282 -0.886 . . . . 0.0 109.141 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.956 ' HB2' HD22 ' A' ' 12' ' ' LEU . 7.7 m -44.06 109.97 0.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.176 -0.952 . . . . 0.0 109.361 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -42.25 -27.25 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.415 -0.803 . . . . 0.0 109.797 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.446 ' SG ' HG13 ' A' ' 41' ' ' ILE . 98.7 m -131.26 67.18 1.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.185 -0.947 . . . . 0.0 109.616 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.956 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.43 -40.44 5.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.228 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -121.43 126.44 49.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.405 -0.81 . . . . 0.0 109.173 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -106.52 160.51 15.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.469 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.1 mt -110.38 140.64 44.39 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.519 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.2 tt0 -44.07 -26.62 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.371 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.782 ' O ' HG23 ' A' ' 18' ' ' ILE . . . 151.78 -165.88 30.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.782 HG23 ' O ' ' A' ' 17' ' ' GLY . 1.2 pp -169.14 162.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -1.064 . . . . 0.0 109.842 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.629 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.7 t60 -56.83 149.07 45.09 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.629 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -80.37 -15.99 10.99 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.318 2.012 . . . . 0.0 108.922 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.53 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 5.7 mttm -77.99 -22.8 48.83 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.962 ' O ' HD13 ' A' ' 23' ' ' ILE . 17.9 m-20 -94.25 57.85 2.39 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.962 HD13 ' O ' ' A' ' 22' ' ' ASN . 2.4 mm -143.27 169.97 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.044 -1.035 . . . . 0.0 110.129 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -160.09 -40.47 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.528 ' CB ' ' HB ' ' A' ' 43' ' ' THR . 2.2 p -133.18 174.98 9.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.531 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 50.4 t -156.48 122.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.952 -1.092 . . . . 0.0 109.759 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.495 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 56.0 t30 -104.77 155.97 18.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.486 ' HB ' ' HB ' ' B' ' 26' ' ' VAL . 2.9 t -145.59 76.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.527 ' HE3' ' NE2' ' A' ' 34' ' ' HIS . 11.0 tptt -87.36 100.4 12.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.3 p -51.65 166.34 0.38 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 109.41 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.527 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.9 Cg_endo -78.15 131.75 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.594 2.196 . . . . 0.0 110.537 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.54 -144.34 4.91 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.19 7.77 3.54 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.59 2.194 . . . . 0.0 110.767 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.551 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 11.5 p-80 -125.98 -6.91 6.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.089 -1.007 . . . . 0.0 109.616 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.6 t -160.04 116.97 2.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.41 45.83 1.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.508 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.527 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 4.3 pt20 -172.55 139.14 0.93 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.53 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.435 ' HB ' ' CG ' ' A' ' 54' ' ' PRO . 2.4 m -57.52 144.06 38.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 109.373 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -124.77 107.64 11.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.592 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.986 HG11 HD11 ' A' ' 63' ' ' ILE . 44.2 t -100.39 150.02 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.867 . . . . 0.0 109.297 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.504 HG22 ' N ' ' A' ' 42' ' ' ALA . 2.5 mp -136.06 159.66 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.848 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.656 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -141.73 121.53 13.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.803 . . . . 0.0 109.11 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.528 ' HB ' ' CB ' ' A' ' 25' ' ' SER . 16.4 m -89.53 101.27 13.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.973 -1.079 . . . . 0.0 109.17 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.775 HD23 ' O ' ' A' ' 22' ' ' ASN . 73.7 mt -44.56 165.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.323 -0.861 . . . . 0.0 109.02 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.53 ' CD ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -83.64 9.93 10.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 109.494 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -109.99 16.88 21.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.364 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.83 18.54 67.6 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.595 ' HB2' HD12 ' A' ' 44' ' ' LEU . 1.7 mtp180 -111.89 169.43 8.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -1.134 . . . . 0.0 109.502 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -136.18 153.65 51.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.943 . . . . 0.0 109.478 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.27 123.36 8.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.113 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.435 ' SG ' HG13 ' A' ' 41' ' ' ILE . 11.8 m -79.51 143.19 35.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.096 -1.002 . . . . 0.0 109.14 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.864 ' HB3' HG22 ' A' ' 59' ' ' VAL . 14.0 mt -123.63 168.12 13.07 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.372 -0.83 . . . . 0.0 109.305 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.657 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.9 t-20 -100.48 122.39 49.89 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.151 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.506 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.6 Cg_endo -75.14 -10.2 20.89 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.205 1.937 . . . . 0.0 110.283 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.08 -14.76 58.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.273 -0.892 . . . . 0.0 108.969 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -89.96 159.53 42.62 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.435 -0.791 . . . . 0.0 109.426 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.44 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.7 -33.49 2.27 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.578 2.185 . . . . 0.0 110.671 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.591 HG23 ' N ' ' A' ' 59' ' ' VAL . 16.8 tt -68.07 -46.96 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.015 . . . . 0.0 109.232 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.864 HG22 ' HB3' ' A' ' 52' ' ' LEU . 37.3 t -56.23 -48.78 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.414 -0.804 . . . . 0.0 109.076 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.506 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 14.9 mttt -56.32 -31.51 63.78 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.472 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -74.52 -29.93 61.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.604 -0.685 . . . . 0.0 109.284 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -68.88 -43.59 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.012 HG22 HD11 ' B' ' 67' ' ' LEU . 2.2 mp -65.17 -65.86 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.523 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -48.04 -42.73 29.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 109.593 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -55.58 -49.24 73.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 109.3 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.531 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -53.48 -47.47 69.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.265 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.98 HD11 HG22 ' B' ' 63' ' ' ILE . 0.2 OUTLIER -46.89 -52.48 14.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.462 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' SER . 13.4 t-20 -63.52 -31.73 72.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.466 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 68' ' ' ASN . 5.9 p -43.94 -34.59 1.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 109.509 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -54.77 -59.51 4.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.877 . . . . 0.0 109.489 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -97.14 -160.25 0.79 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 109.474 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.0 t -164.21 -66.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.47 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.427 ' O ' ' N ' ' B' ' 4' ' ' ALA . 0.7 OUTLIER -154.78 114.29 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.459 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.619 HG12 ' N ' ' B' ' 4' ' ' ALA . 48.7 t 58.61 -89.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.619 ' N ' HG12 ' B' ' 3' ' ' VAL . . . -151.1 88.37 1.45 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.486 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 35.6 p -86.94 -24.24 24.84 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.8 91.61 0.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.417 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.549 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -118.35 98.97 6.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.215 -0.928 . . . . 0.0 109.621 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' B' ' 9' ' ' CYS . 1.8 mpp_? -91.26 151.69 20.81 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.262 -0.899 . . . . 0.0 109.125 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.935 ' HB2' HD22 ' B' ' 12' ' ' LEU . 7.8 m -44.01 109.89 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.352 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -42.16 -27.3 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.833 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.452 ' SG ' HG13 ' B' ' 41' ' ' ILE . 98.9 m -131.27 67.15 1.52 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.598 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.935 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.37 -40.59 5.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.164 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -121.34 126.54 49.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.167 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.531 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -106.56 160.59 15.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.841 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.473 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.0 mt -110.38 140.58 44.45 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.461 -0.774 . . . . 0.0 108.928 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.528 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.2 tt0 -44.04 -26.59 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.119 -0.988 . . . . 0.0 109.422 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.766 ' O ' HG23 ' B' ' 18' ' ' ILE . . . 151.76 -165.86 30.69 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.766 HG23 ' O ' ' B' ' 17' ' ' GLY . 1.2 pp -169.13 162.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -1.068 . . . . 0.0 109.837 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.612 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 1.7 t60 -56.89 149.05 45.83 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.612 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.6 Cg_endo -80.32 -16.03 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.383 2.055 . . . . 0.0 108.915 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.537 ' O ' ' CD ' ' B' ' 45' ' ' LYS . 5.7 mttm -78.04 -22.71 48.77 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.969 ' O ' HD13 ' B' ' 23' ' ' ILE . 17.8 m-20 -94.34 57.96 2.38 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.969 HD13 ' O ' ' B' ' 22' ' ' ASN . 2.3 mm -143.31 169.98 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.093 -1.004 . . . . 0.0 110.157 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.0 OUTLIER -160.11 -40.62 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.524 ' CB ' ' HB ' ' B' ' 43' ' ' THR . 2.1 p -133.13 174.93 9.85 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.535 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 50.4 t -156.38 122.5 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.939 -1.101 . . . . 0.0 109.759 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.488 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 55.6 t30 -104.71 155.9 18.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.244 -0.91 . . . . 0.0 109.357 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 2.9 t -145.52 76.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.516 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.518 ' HE3' ' NE2' ' B' ' 34' ' ' HIS . 11.0 tptt -87.32 100.49 12.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.3 p -51.75 166.29 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.533 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.8 Cg_endo -78.05 131.71 11.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.648 2.232 . . . . 0.0 110.524 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.5 -144.41 4.93 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.11 7.74 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.649 2.233 . . . . 0.0 110.819 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.549 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 11.4 p-80 -125.98 -6.86 6.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.993 . . . . 0.0 109.67 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.7 t -160.15 116.93 2.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.415 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.4 45.73 1.22 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.576 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.533 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 4.2 pt20 -172.48 139.17 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 109.55 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.437 ' HB ' ' CG ' ' B' ' 54' ' ' PRO . 2.4 m -57.46 144.12 37.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -124.84 107.59 11.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.554 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.98 HG11 HD11 ' B' ' 63' ' ' ILE . 44.3 t -100.39 150.05 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.281 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.491 HG22 ' N ' ' B' ' 42' ' ' ALA . 2.5 mp -136.03 159.63 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.121 -0.987 . . . . 0.0 109.87 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.648 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -141.69 121.47 13.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.822 . . . . 0.0 109.135 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 16.4 m -89.43 101.32 14.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.024 -1.047 . . . . 0.0 109.23 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.783 HD23 ' O ' ' B' ' 22' ' ' ASN . 73.8 mt -44.56 165.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 109.058 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.537 ' CD ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -83.66 9.88 10.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.161 -0.962 . . . . 0.0 109.434 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -109.91 16.79 21.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.92 18.46 67.58 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.587 ' HB2' HD12 ' B' ' 44' ' ' LEU . 1.7 mtp180 -111.82 169.29 8.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -1.173 . . . . 0.0 109.512 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.429 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 0.3 OUTLIER -136.04 153.61 51.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 109.592 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.473 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.21 123.31 8.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 109.072 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.433 ' SG ' HG13 ' B' ' 41' ' ' ILE . 12.0 m -79.45 143.21 35.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.091 -1.006 . . . . 0.0 109.239 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.858 ' HB3' HG22 ' B' ' 59' ' ' VAL . 14.0 mt -123.7 168.07 13.16 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.222 -0.924 . . . . 0.0 109.344 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.663 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.9 t-20 -100.52 122.31 50.08 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.182 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.51 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.6 Cg_endo -74.99 -10.17 21.1 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.143 1.895 . . . . 0.0 110.388 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.1 -14.74 58.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -0.919 . . . . 0.0 108.892 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.3 OUTLIER -90.01 159.55 42.44 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.409 -0.807 . . . . 0.0 109.421 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.451 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.71 -33.43 2.29 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.622 2.215 . . . . 0.0 110.652 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.608 ' O ' HD13 ' B' ' 62' ' ' ILE . 16.9 tt -68.2 -46.88 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.099 -1.0 . . . . 0.0 109.151 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.858 HG22 ' HB3' ' B' ' 52' ' ' LEU . 37.1 t -56.3 -48.69 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 109.072 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.51 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 14.9 mttt -56.44 -31.43 63.93 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.471 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -74.63 -29.85 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.604 -0.685 . . . . 0.0 109.266 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.608 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -68.89 -43.67 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.98 HG22 HD11 ' A' ' 67' ' ' LEU . 2.1 mp -65.17 -65.89 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.499 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -47.99 -42.82 28.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 109.549 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -55.52 -49.24 73.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.308 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.535 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -53.49 -47.39 69.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.299 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.012 HD11 HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -46.9 -52.47 14.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.454 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' B' ' 69' ' ' SER . 13.4 t-20 -63.53 -31.75 73.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.41 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.402 ' C ' ' O ' ' B' ' 68' ' ' ASN . 5.8 p -43.91 -34.66 1.72 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.497 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -54.78 -59.52 4.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.457 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -97.2 -160.23 0.79 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.244 -0.91 . . . . 0.0 109.5 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.1 t -164.18 -66.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.443 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 61.93 128.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.47 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.727 ' O ' HG13 ' A' ' 3' ' ' VAL . 9.9 p -146.36 77.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.6 ' C ' HG22 ' A' ' 5' ' ' THR . . . -109.24 145.52 35.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.6 HG22 ' C ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER 164.9 133.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.184 -0.947 . . . . 0.0 109.501 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -88.83 84.31 6.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.539 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -115.89 98.07 6.45 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.274 -0.891 . . . . 0.0 109.594 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -87.43 157.68 19.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.091 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.829 ' HB2' HD22 ' A' ' 12' ' ' LEU . 1.8 m -44.06 114.72 0.71 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -0.983 . . . . 0.0 109.464 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' A' ' 9' ' ' CYS . 13.7 mm-40 -42.16 -27.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -0.818 . . . . 0.0 109.798 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.472 ' SG ' HG13 ' A' ' 41' ' ' ILE . 79.1 m -136.55 81.06 1.86 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 109.716 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.829 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -53.93 -41.44 67.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.16 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -118.5 117.93 30.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.16 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.78 163.18 12.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.792 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.516 ' HB2' HD23 ' A' ' 52' ' ' LEU . 4.4 mt -106.18 137.2 44.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.83 . . . . 0.0 108.963 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -44.49 -41.39 6.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.979 . . . . 0.0 109.366 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 177.54 168.84 37.82 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.734 ' H ' HD11 ' A' ' 62' ' ' ILE . 8.0 tp -153.67 158.37 3.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.473 -1.016 . . . . 0.0 108.772 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.576 ' CB ' ' ND2' ' A' ' 22' ' ' ASN . 2.6 t-80 -45.04 139.89 3.77 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.226 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.7 Cg_endo -77.77 -25.44 7.78 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.491 2.127 . . . . 0.0 110.292 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -90.12 -14.83 32.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 0.0 108.987 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.576 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 51.7 m-20 -70.33 -11.61 61.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.325 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.879 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 3.1 mt -105.44 149.01 9.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.263 -0.898 . . . . 0.0 110.611 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.514 ' HG3' ' N ' ' A' ' 25' ' ' SER . 1.3 pp0? -115.61 -27.69 7.03 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.514 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -136.1 160.72 37.79 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.523 ' O ' HG23 ' B' ' 28' ' ' VAL . 2.0 t -146.16 101.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.941 -1.1 . . . . 0.0 109.932 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 29.1 t30 -79.96 116.73 20.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.198 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.52 HG23 ' O ' ' B' ' 26' ' ' VAL . 1.8 t -98.23 84.68 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -0.923 . . . . 0.0 109.49 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER -89.59 93.91 9.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.364 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.09 167.26 0.25 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.376 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.5 Cg_endo -77.96 131.84 11.32 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.619 2.213 . . . . 0.0 110.38 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.22 -145.97 6.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.96 5.48 4.93 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.628 2.219 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.539 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 18.2 p-80 -121.81 -16.83 7.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.614 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 9.1 t -160.12 96.88 1.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.33 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.76 -10.57 28.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.595 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.445 ' OE1' ' SG ' ' A' ' 9' ' ' CYS . 2.0 mp0 -96.24 125.26 40.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.57 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.478 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 3.8 m -50.68 150.7 2.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.944 . . . . 0.0 109.385 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 35' ' ' CYS . 3.3 mp0 -129.39 107.7 9.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.959 . . . . 0.0 109.571 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.723 HG11 HD11 ' A' ' 63' ' ' ILE . 1.7 t -102.59 95.34 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.257 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.536 HD12 ' N ' ' A' ' 41' ' ' ILE . 5.2 mp -86.03 140.73 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.742 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.879 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -124.14 119.14 28.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.202 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 43' ' ' THR . 1.0 OUTLIER -89.17 100.07 12.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.02 -1.05 . . . . 0.0 108.459 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 48' ' ' ARG . 72.5 mt -41.49 165.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.541 0.686 . . . . 0.0 110.073 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.5 ptpt -80.36 6.96 10.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.539 -0.726 . . . . 0.0 109.686 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -111.95 8.54 20.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.406 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.35 -6.11 71.42 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.523 ' HB2' HD12 ' A' ' 44' ' ' LEU . 7.3 mtt180 -84.46 170.52 13.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.13 -1.218 . . . . 0.0 109.537 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 10.0 mttt -133.86 153.73 51.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.22 118.12 6.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.037 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.467 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 19.4 m -79.57 139.02 37.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.129 -0.982 . . . . 0.0 109.166 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.968 HD13 HD13 ' A' ' 62' ' ' ILE . 11.3 mt -126.9 168.25 14.74 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.15 -0.969 . . . . 0.0 109.329 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.651 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.8 t30 -108.26 129.16 24.42 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.554 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.478 ' HG3' ' HB ' ' A' ' 38' ' ' THR . 34.4 Cg_endo -76.1 4.45 5.3 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.407 2.071 . . . . 0.0 110.747 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.38 -21.31 27.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.249 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.06 163.97 29.86 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.843 . . . . 0.0 109.466 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.84 -29.1 4.61 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.654 2.236 . . . . 0.0 110.143 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.541 ' CG2' ' HA3' ' A' ' 17' ' ' GLY . 8.6 mm -68.18 -47.33 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.004 ' HA ' HD12 ' A' ' 62' ' ' ILE . 51.1 t -62.38 -48.61 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 109.675 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 56' ' ' SER . 2.8 mmpt? -56.91 -30.52 64.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.93 . . . . 0.0 108.809 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.533 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -81.66 -24.69 36.15 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.004 HD12 ' HA ' ' A' ' 59' ' ' VAL . 16.0 mt -67.97 -38.25 79.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.25 -0.906 . . . . 0.0 108.592 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.091 ' CG2' HD11 ' B' ' 67' ' ' LEU . 1.5 mp -76.36 -63.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.383 -0.823 . . . . 0.0 109.117 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -43.92 -50.84 7.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.253 -0.904 . . . . 0.0 109.428 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 66' ' ' MET . 4.4 tmtm? -52.03 -57.58 9.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.211 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.483 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -44.12 -46.2 8.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 109.127 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.098 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -55.59 -49.54 72.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.452 -0.78 . . . . 0.0 109.527 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -96.26 33.91 1.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.474 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.8 p -95.43 -38.27 10.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.473 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -80.45 76.26 7.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.433 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 72' ' ' SER . 9.9 ttpt -116.89 -58.28 2.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 0.0 109.447 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 71' ' ' LYS . 1.9 t 73.79 178.87 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.445 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.439 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.444 ' O ' ' O ' ' B' ' 1' ' ' ALA . 0.6 OUTLIER 61.91 128.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.407 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.737 HG13 ' O ' ' B' ' 3' ' ' VAL . 9.8 p -146.33 77.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.501 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.598 ' C ' HG22 ' B' ' 5' ' ' THR . . . -109.27 145.54 35.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 109.404 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.598 HG22 ' C ' ' B' ' 4' ' ' ALA . 0.1 OUTLIER 164.9 133.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 0.0 109.421 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' B' ' 6' ' ' GLU . 0.4 OUTLIER -88.82 84.16 6.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 109.521 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.546 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -115.82 98.05 6.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.197 -0.939 . . . . 0.0 109.585 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -87.42 157.65 19.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 109.139 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.829 ' HB2' HD22 ' B' ' 12' ' ' LEU . 1.7 m -44.07 114.74 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 109.436 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' B' ' 9' ' ' CYS . 13.6 mm-40 -42.14 -27.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.796 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' B' ' 41' ' ' ILE . 78.4 m -136.61 81.1 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 109.595 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.829 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.3 OUTLIER -53.94 -41.47 67.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.202 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -118.39 117.97 30.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.283 -0.886 . . . . 0.0 109.146 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -99.85 163.09 12.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.825 -179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.515 ' HB2' HD23 ' B' ' 52' ' ' LEU . 4.3 mt -106.0 137.17 44.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.321 -0.862 . . . . 0.0 108.995 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.0 OUTLIER -44.56 -41.28 6.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 109.4 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.531 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 177.5 168.8 37.73 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.716 ' H ' HD11 ' B' ' 62' ' ' ILE . 8.0 tp -153.64 158.39 3.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.493 -1.004 . . . . 0.0 108.784 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.576 ' CB ' ' ND2' ' B' ' 22' ' ' ASN . 2.6 t-80 -45.05 139.86 3.8 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.02 -1.05 . . . . 0.0 109.156 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.481 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.1 Cg_endo -77.8 -25.36 7.8 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.501 2.134 . . . . 0.0 110.256 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.463 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.2 OUTLIER -90.18 -14.84 32.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.405 -0.81 . . . . 0.0 108.974 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.576 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 52.0 m-20 -70.29 -11.61 61.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.451 -0.781 . . . . 0.0 109.318 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.888 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 3.0 mt -105.41 148.99 9.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.238 -0.914 . . . . 0.0 110.584 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.516 ' HG3' ' N ' ' B' ' 25' ' ' SER . 1.3 pp0? -115.63 -27.75 7.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.516 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -136.04 160.81 37.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 28' ' ' VAL . 2.0 t -146.24 101.5 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.03 -1.044 . . . . 0.0 109.917 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 29.0 t30 -79.88 116.79 20.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.247 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 26' ' ' VAL . 1.8 t -98.24 84.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER -89.58 93.87 9.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.214 -0.929 . . . . 0.0 109.396 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.02 167.21 0.25 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.266 -0.896 . . . . 0.0 109.399 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.9 Cg_endo -77.91 131.87 11.4 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.56 2.173 . . . . 0.0 110.455 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.22 -146.12 6.05 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -76.87 5.47 4.88 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.623 2.216 . . . . 0.0 110.654 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.546 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 18.1 p-80 -121.86 -16.75 7.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.951 . . . . 0.0 109.555 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 9.1 t -160.14 96.92 1.23 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 109.353 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.77 -10.56 28.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.638 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.446 ' OE1' ' SG ' ' B' ' 9' ' ' CYS . 2.0 mp0 -96.28 125.21 40.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.494 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.476 ' HB ' ' HG3' ' B' ' 54' ' ' PRO . 3.8 m -50.62 150.67 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 109.375 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.472 ' OE2' ' HB3' ' B' ' 35' ' ' CYS . 3.3 mp0 -129.4 107.81 9.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.603 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.734 HG11 HD11 ' B' ' 63' ' ' ILE . 1.7 t -102.61 95.26 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.288 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.538 ' N ' HD12 ' B' ' 41' ' ' ILE . 5.2 mp -86.02 140.72 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.888 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -124.16 119.13 28.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.845 . . . . 0.0 109.226 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.617 ' O ' HG22 ' B' ' 43' ' ' THR . 1.0 OUTLIER -89.13 100.08 12.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.035 -1.041 . . . . 0.0 108.437 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' B' ' 48' ' ' ARG . 72.1 mt -41.48 165.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.573 0.702 . . . . 0.0 110.031 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.463 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.5 ptpt -80.49 7.04 10.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.472 -0.767 . . . . 0.0 109.647 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -111.91 8.48 20.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.473 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.01 71.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.547 ' HB2' HD12 ' B' ' 44' ' ' LEU . 7.3 mtt180 -84.6 170.56 13.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.239 . . . . 0.0 109.513 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.42 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 9.9 mttt -133.84 153.81 51.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 109.507 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.34 118.11 6.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 108.971 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 19.6 m -79.56 138.95 37.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.169 -0.957 . . . . 0.0 109.237 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.988 HD13 HD13 ' B' ' 62' ' ' ILE . 11.3 mt -126.84 168.3 14.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.638 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.8 t30 -108.26 129.32 24.21 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.521 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.476 ' HG3' ' HB ' ' B' ' 38' ' ' THR . 34.6 Cg_endo -76.27 4.52 5.32 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.342 2.028 . . . . 0.0 110.755 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.43 -21.27 27.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.162 -0.962 . . . . 0.0 109.231 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -90.12 163.93 29.87 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.477 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.74 -29.18 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.683 2.255 . . . . 0.0 110.171 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.531 ' CG2' ' HA3' ' B' ' 17' ' ' GLY . 8.6 mm -68.1 -47.28 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.442 -0.786 . . . . 0.0 109.264 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.996 ' HA ' HD12 ' B' ' 62' ' ' ILE . 50.7 t -62.49 -48.46 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.328 -0.858 . . . . 0.0 109.731 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' B' ' 56' ' ' SER . 2.8 mmpt? -56.96 -30.54 64.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -0.929 . . . . 0.0 108.797 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -81.6 -24.68 36.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.524 -0.735 . . . . 0.0 109.247 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.996 HD12 ' HA ' ' B' ' 59' ' ' VAL . 16.1 mt -67.93 -38.23 79.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 1.098 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.5 mp -76.33 -63.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.505 -0.747 . . . . 0.0 109.097 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -43.93 -50.84 7.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.289 -0.882 . . . . 0.0 109.444 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' B' ' 66' ' ' MET . 4.4 tmtm? -52.14 -57.45 9.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.269 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.486 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.4 OUTLIER -44.1 -46.2 8.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.149 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.091 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -55.67 -49.54 72.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 0.0 109.484 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -96.2 33.87 1.68 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p -95.44 -38.2 10.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -80.54 76.22 7.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.922 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' B' ' 72' ' ' SER . 9.8 ttpt -116.85 -58.31 2.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 109.428 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' B' ' 71' ' ' LYS . 1.9 t 73.72 178.87 0.22 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.496 -179.992 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 t 57.48 69.79 0.71 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.51 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 3' ' ' VAL . 8.8 p -173.12 106.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.456 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 5' ' ' THR . . . -105.8 149.83 26.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.485 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.524 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER 75.84 129.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -129.61 -144.01 0.27 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.331 -0.855 . . . . 0.0 109.102 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.591 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -125.08 102.92 7.72 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.18 -0.95 . . . . 0.0 109.408 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 10' ' ' GLN . 24.0 mtp85 -109.58 154.48 22.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.251 -0.906 . . . . 0.0 109.14 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.433 ' C ' ' O ' ' A' ' 8' ' ' ARG . 72.8 m -44.32 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.363 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.533 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 30.2 mm-40 -43.16 -26.09 0.15 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.714 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.46 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 19.4 m -145.19 75.12 1.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.633 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -44.66 -50.72 9.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.168 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 7.8 pt20 -108.95 103.25 12.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.157 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.439 ' HB ' ' C ' ' A' ' 52' ' ' LEU . 1.1 p -79.89 144.93 32.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.668 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.584 ' HB2' HD23 ' A' ' 52' ' ' LEU . 22.3 mt -78.6 -174.06 3.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 109.336 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.62 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -84.23 -40.76 17.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 0.0 109.502 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.874 ' O ' HG23 ' A' ' 18' ' ' ILE . . . 155.61 -172.07 33.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.874 HG23 ' O ' ' A' ' 17' ' ' GLY . 1.3 pp -172.11 164.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -1.056 . . . . 0.0 109.213 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.49 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -58.92 150.14 61.8 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.319 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.675 ' HA ' HD12 ' A' ' 23' ' ' ILE . 35.3 Cg_endo -77.14 -4.47 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.512 2.141 . . . . 0.0 110.176 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.459 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -90.35 -23.49 21.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.385 -0.822 . . . . 0.0 109.198 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.3 m-20 -85.18 -18.99 32.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.305 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.964 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 22.0 mt -83.38 169.22 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.441 -0.787 . . . . 0.0 110.07 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.574 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -139.37 -40.93 0.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.468 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 1.7 p -124.9 177.31 6.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.838 . . . . 0.0 108.892 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.571 HG23 ' HG3' ' A' ' 66' ' ' MET . 47.7 t -146.8 100.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.018 -1.051 . . . . 0.0 109.698 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.666 ' O ' HD12 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -100.05 111.15 23.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.266 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.863 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -120.98 102.3 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.533 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -103.94 117.22 33.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.919 . . . . 0.0 109.397 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.444 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -57.31 171.68 0.46 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.153 -0.967 . . . . 0.0 109.284 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.516 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.8 Cg_endo -77.83 153.07 29.23 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.693 2.262 . . . . 0.0 110.456 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.98 -140.56 2.9 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.561 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 36.4 Cg_endo -78.28 12.14 2.17 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.654 2.236 . . . . 0.0 110.982 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.591 ' CD2' HD22 ' A' ' 7' ' ' LEU . 1.9 p-80 -127.49 -32.71 2.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.988 -1.07 . . . . 0.0 109.53 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.31 121.4 12.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.381 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.8 44.41 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.933 . . . . 0.0 109.625 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.516 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 5.2 pt20 -169.98 139.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.54 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.514 HG21 ' CG ' ' B' ' 70' ' ' ASP . 2.6 m -55.91 141.39 39.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.93 107.54 10.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.95 HG11 HD11 ' A' ' 63' ' ' ILE . 47.7 t -95.1 149.24 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.21 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.666 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.4 mp -142.0 151.13 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.863 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.964 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -135.13 123.08 22.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 108.886 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 7.4 m -89.77 100.18 13.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.089 . . . . 0.0 109.375 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 60.7 mt -42.43 164.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 0.0 109.606 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 13.0 ptpt -82.83 9.78 9.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -113.91 19.55 16.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.457 ' O ' ' HD2' ' A' ' 49' ' ' LYS . . . 87.6 -17.64 43.23 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.462 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 42.8 mtt180 -77.3 163.19 26.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -1.116 . . . . 0.0 109.416 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -144.01 122.65 12.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.148 -0.97 . . . . 0.0 109.541 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.562 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -116.18 127.94 55.21 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.24 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.507 ' O ' HD23 ' A' ' 52' ' ' LEU . 92.2 m -79.65 155.34 28.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.062 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.032 HD13 HD13 ' A' ' 62' ' ' ILE . 12.8 mt -135.19 170.98 15.08 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.141 -0.974 . . . . 0.0 109.702 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.663 ' O ' HG21 ' A' ' 59' ' ' VAL . 15.3 p-10 -105.39 127.6 28.26 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.78 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -75.08 -4.66 15.71 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.087 1.858 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 -19.29 53.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 108.778 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 159.39 42.5 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.349 -0.844 . . . . 0.0 109.022 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.92 -32.25 3.44 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.582 2.188 . . . . 0.0 110.778 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.623 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -69.53 -44.66 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 109.168 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.059 ' HA ' HD12 ' A' ' 62' ' ' ILE . 31.4 t -58.0 -46.94 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.834 . . . . 0.0 109.152 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 56' ' ' SER . 9.6 mtmt -60.51 -30.49 69.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.492 ' CE ' ' CD ' ' A' ' 64' ' ' GLU . 4.9 mmpt? -76.67 -23.56 53.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.059 HD12 ' HA ' ' A' ' 59' ' ' VAL . 19.0 mt -71.39 -37.16 63.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.95 HD11 HG11 ' A' ' 40' ' ' VAL . 2.3 mp -73.21 -58.14 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.492 ' CD ' ' CE ' ' A' ' 61' ' ' LYS . 5.7 pt-20 -59.2 -52.19 66.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.045 -1.034 . . . . 0.0 109.652 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 6.5 mtpp -46.35 -52.43 12.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.112 -0.992 . . . . 0.0 109.132 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.571 ' HG3' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -49.38 -46.41 47.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.214 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.615 HD11 ' HB ' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -45.93 -52.08 12.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.432 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -64.39 -33.59 76.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.843 . . . . 0.0 109.531 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 p -44.11 -27.88 0.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' CG ' HG21 ' B' ' 38' ' ' THR . 1.0 OUTLIER -113.76 61.86 0.65 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.531 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -78.85 -71.52 0.43 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.446 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -112.3 155.38 24.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.453 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 40.8 t30 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.416 -179.992 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.3 t 57.58 69.71 0.72 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.696 HG13 ' O ' ' B' ' 3' ' ' VAL . 8.7 p -173.09 106.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.92 . . . . 0.0 109.461 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' B' ' 5' ' ' THR . . . -105.79 149.82 26.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.408 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' B' ' 4' ' ' ALA . 0.8 OUTLIER 75.75 129.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.494 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -129.67 -144.04 0.27 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.25 -0.906 . . . . 0.0 109.128 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.584 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -125.06 102.9 7.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.134 -0.979 . . . . 0.0 109.475 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.472 ' O ' ' N ' ' B' ' 10' ' ' GLN . 23.9 mtp85 -109.6 154.49 22.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.088 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.427 ' O ' ' N ' ' B' ' 11' ' ' CYS . 71.8 m -44.32 98.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.26 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.526 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 30.2 mm-40 -43.22 -26.07 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 0.0 109.704 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.454 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 19.9 m -145.18 75.09 1.43 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.983 . . . . 0.0 109.601 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.509 HD13 ' O ' ' B' ' 12' ' ' LEU . 0.2 OUTLIER -44.61 -50.72 9.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 109.238 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 13' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' B' ' 13' ' ' GLN . 7.8 pt20 -108.95 103.25 12.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.831 . . . . 0.0 109.144 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.433 ' HB ' ' C ' ' B' ' 52' ' ' LEU . 1.0 OUTLIER -79.9 144.89 33.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.608 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.565 ' HB2' HD23 ' B' ' 52' ' ' LEU . 22.2 mt -78.46 -174.07 3.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.854 . . . . 0.0 109.33 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.625 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.0 OUTLIER -84.33 -40.74 17.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.176 -0.952 . . . . 0.0 109.474 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.872 ' O ' HG23 ' B' ' 18' ' ' ILE . . . 155.66 -172.04 33.71 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.872 HG23 ' O ' ' B' ' 17' ' ' GLY . 1.3 pp -172.2 163.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -1.013 . . . . 0.0 109.161 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.508 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -58.91 150.19 61.55 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.299 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.669 ' HA ' HD12 ' B' ' 23' ' ' ILE . 35.3 Cg_endo -77.14 -4.47 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.55 2.167 . . . . 0.0 110.173 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -90.3 -23.61 21.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.3 m-20 -85.16 -18.88 32.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.24 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.979 HG23 ' HB1' ' B' ' 42' ' ' ALA . 21.8 mt -83.43 169.22 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.389 -0.819 . . . . 0.0 110.066 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.583 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.4 OUTLIER -139.35 -41.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.458 ' CB ' ' HB ' ' B' ' 43' ' ' THR . 1.7 p -124.88 177.26 6.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.451 -0.781 . . . . 0.0 108.899 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.564 HG23 ' HG3' ' B' ' 66' ' ' MET . 48.2 t -146.76 100.46 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.647 ' O ' HD12 ' B' ' 41' ' ' ILE . 0.1 OUTLIER -100.09 111.18 23.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 109.217 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.831 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -120.97 102.37 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.526 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 0.2 OUTLIER -103.95 117.16 33.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.401 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.447 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.0 OUTLIER -57.18 171.63 0.45 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.306 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.522 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.8 Cg_endo -77.83 153.09 29.24 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.623 2.215 . . . . 0.0 110.435 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.98 -140.64 2.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.552 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -78.33 12.34 2.12 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.513 2.142 . . . . 0.0 111.006 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.584 ' CD2' HD22 ' B' ' 7' ' ' LEU . 1.9 p-80 -127.6 -32.63 2.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.013 -1.054 . . . . 0.0 109.509 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.34 121.34 12.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.393 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.78 44.52 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.701 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.522 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 5.2 pt20 -170.08 139.3 1.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.494 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.52 HG21 ' CG ' ' A' ' 70' ' ' ASP . 2.7 m -55.98 141.28 40.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.78 107.54 10.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.659 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.939 HG11 HD11 ' B' ' 63' ' ' ILE . 47.7 t -95.2 149.31 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.204 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.647 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.4 mp -141.96 151.17 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.875 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.979 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -135.14 122.92 22.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 108.962 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 7.4 m -89.66 100.16 13.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.955 -1.09 . . . . 0.0 109.392 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' B' ' 22' ' ' ASN . 60.4 mt -42.49 164.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.63 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.459 ' HA ' ' HB2' ' B' ' 24' ' ' GLN . 12.9 ptpt -82.79 9.8 9.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.708 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -113.94 19.62 16.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.23 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 47' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' B' ' 49' ' ' LYS . . . 87.62 -17.77 42.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.468 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 42.7 mtt180 -77.25 163.06 26.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -1.151 . . . . 0.0 109.405 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.463 ' HD2' ' O ' ' B' ' 47' ' ' GLY . 0.0 OUTLIER -143.97 122.67 12.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.546 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.553 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -116.19 127.94 55.2 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.445 -0.784 . . . . 0.0 109.33 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.494 ' O ' HD23 ' B' ' 52' ' ' LEU . 91.2 m -79.66 155.32 28.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.047 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 1.053 HD13 HD13 ' B' ' 62' ' ' ILE . 12.8 mt -135.18 170.92 15.18 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.152 -0.968 . . . . 0.0 109.744 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.666 ' O ' HG21 ' B' ' 59' ' ' VAL . 15.4 p-10 -105.34 127.54 28.38 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.845 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.04 -4.57 15.6 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.111 1.874 . . . . 0.0 110.308 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.45 -19.25 53.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.923 . . . . 0.0 108.761 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -90.01 159.42 42.72 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.109 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.04 -32.25 3.31 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.578 2.185 . . . . 0.0 110.792 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.641 ' O ' HD13 ' B' ' 58' ' ' ILE . 0.1 OUTLIER -69.45 -44.72 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.102 -0.999 . . . . 0.0 109.153 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 1.011 ' HA ' HD12 ' B' ' 62' ' ' ILE . 32.1 t -57.97 -46.94 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 109.177 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' B' ' 56' ' ' SER . 9.6 mtmt -60.49 -30.55 69.78 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' B' ' 61' ' ' LYS . 4.9 mmpt? -76.64 -23.61 53.32 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 1.053 HD13 HD13 ' B' ' 52' ' ' LEU . 19.2 mt -71.25 -37.25 65.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.939 HD11 HG11 ' B' ' 40' ' ' VAL . 2.3 mp -73.23 -58.09 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.876 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.487 ' CD ' ' CE ' ' B' ' 61' ' ' LYS . 5.6 pt-20 -59.33 -52.09 67.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.013 -1.054 . . . . 0.0 109.614 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 6.5 mtpp -46.39 -52.41 13.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 109.056 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.564 ' HG3' HG23 ' B' ' 26' ' ' VAL . 0.2 OUTLIER -49.41 -46.35 47.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.282 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.614 HD11 ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -45.96 -52.05 12.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 0.0 109.41 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' B' ' 69' ' ' SER . 2.4 t30 -64.41 -33.6 76.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.855 . . . . 0.0 109.52 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 68' ' ' ASN . 4.9 p -44.14 -27.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.514 ' CG ' HG21 ' A' ' 38' ' ' THR . 1.0 OUTLIER -113.87 61.81 0.66 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.551 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -78.87 -71.4 0.44 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.547 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -112.35 155.36 24.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 0.0 109.448 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 40.9 t30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.453 -179.961 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m 50.59 -165.55 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.448 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.5 m -107.02 149.72 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.508 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 46.01 65.16 1.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -146.63 49.41 1.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.33 70.23 8.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -0.938 . . . . 0.0 109.427 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.631 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -146.62 115.03 6.71 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -130.1 161.2 31.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.365 -0.834 . . . . 0.0 108.923 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.954 ' HB2' HD22 ' A' ' 12' ' ' LEU . 93.2 m -48.84 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.938 . . . . 0.0 109.367 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -42.76 -26.21 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.865 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.521 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 78.1 m -130.85 72.25 1.49 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.642 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.954 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.55 -44.3 8.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.937 . . . . 0.0 109.214 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.32 117.5 33.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.283 -0.886 . . . . 0.0 109.198 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.426 ' OG1' ' CG ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -103.09 156.43 17.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.697 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.566 HD12 HD23 ' A' ' 52' ' ' LEU . 5.5 mt -98.08 135.76 39.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.293 -0.879 . . . . 0.0 109.004 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 15' ' ' LEU . 1.1 tt0 -44.09 -26.79 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.952 . . . . 0.0 109.252 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 156.25 149.32 5.32 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.659 HG22 ' CD2' ' A' ' 52' ' ' LEU . 6.9 tt -128.34 149.97 33.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.375 -1.073 . . . . 0.0 108.883 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.466 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -43.64 146.37 0.98 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.257 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.466 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.2 Cg_endo -76.61 -13.03 18.32 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.435 2.09 . . . . 0.0 109.996 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.532 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 7.6 mttp -78.95 -15.42 58.32 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 1.011 ' O ' HD13 ' A' ' 23' ' ' ILE . 86.5 m-20 -100.43 54.75 0.89 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.011 HD13 ' O ' ' A' ' 22' ' ' ASN . 0.7 OUTLIER -146.08 163.33 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.039 -1.038 . . . . 0.0 110.35 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.749 ' HG2' HG22 ' A' ' 43' ' ' THR . 0.4 OUTLIER -153.02 -36.21 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.9 p -128.47 179.5 5.62 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 25' ' ' SER . 51.0 t -160.14 115.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.897 -1.127 . . . . 0.0 109.891 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 20.3 t-20 -104.87 153.3 21.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.951 . . . . 0.0 109.117 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' B' ' 25' ' ' SER . 2.6 t -143.67 91.82 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HD2' ' NE2' ' A' ' 10' ' ' GLN . 4.2 mttm -95.3 93.45 7.28 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 0.0 109.524 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 4.3 p -44.71 164.26 0.18 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 0.0 109.303 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.517 ' CG ' ' O ' ' B' ' 71' ' ' LYS . 35.7 Cg_endo -77.78 131.87 11.54 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.648 2.232 . . . . 0.0 110.502 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.27 -138.48 3.28 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.22 7.98 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.562 2.175 . . . . 0.0 110.778 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.631 ' CD2' HD22 ' A' ' 7' ' ' LEU . 4.9 p-80 -126.86 -16.74 5.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.017 . . . . 0.0 109.883 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -160.17 125.23 3.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.024 -1.047 . . . . 0.0 109.229 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' O ' ' CD ' ' A' ' 37' ' ' GLN . . . -87.42 18.95 3.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.719 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.511 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 13.6 mm-40 -143.35 125.06 14.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.497 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 30' ' ' SER . 17.5 m -50.29 140.55 13.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.505 ' OE1' ' N ' ' A' ' 10' ' ' GLN . 8.5 mt-10 -117.66 106.83 13.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.654 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.809 HG21 ' HB3' ' A' ' 54' ' ' PRO . 1.7 t -98.47 106.71 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 109.186 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.521 ' CG1' ' SG ' ' A' ' 11' ' ' CYS . 2.9 mp -94.74 157.31 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.224 -0.923 . . . . 0.0 109.83 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.972 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -136.47 125.88 25.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.798 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.749 HG22 ' HG2' ' A' ' 24' ' ' GLN . 22.4 m -89.66 105.52 17.85 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.026 -1.046 . . . . 0.0 109.111 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.962 HD23 ' O ' ' A' ' 22' ' ' ASN . 82.9 mt -43.79 168.7 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.322 -0.861 . . . . 0.0 109.597 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.532 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.3 ptpt -90.16 17.52 6.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 109.35 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.517 ' OD1' ' CB ' ' A' ' 44' ' ' LEU . 19.6 p-10 -119.49 7.21 11.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.402 -0.812 . . . . 0.0 109.143 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.28 -17.9 54.91 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.744 ' HB2' HD12 ' A' ' 44' ' ' LEU . 8.8 mtt85 -83.73 171.97 12.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -1.185 . . . . 0.0 109.169 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' CD ' ' OG1' ' A' ' 43' ' ' THR . 9.9 mtmt -144.49 125.21 14.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 109.553 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.24 131.14 55.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.891 . . . . 0.0 109.132 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.464 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 61.7 m -79.74 140.21 37.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.186 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.859 ' HB3' HG22 ' A' ' 59' ' ' VAL . 12.5 mt -129.41 168.64 16.01 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.218 -0.926 . . . . 0.0 109.441 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.66 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.8 m-20 -111.02 130.85 22.53 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.333 -0.854 . . . . 0.0 109.62 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.809 ' HB3' HG21 ' A' ' 40' ' ' VAL . 33.8 Cg_endo -75.26 -14.54 20.55 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.217 1.945 . . . . 0.0 110.21 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.91 -19.13 61.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.875 . . . . 0.0 108.879 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.03 163.16 33.06 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.493 -0.754 . . . . 0.0 109.206 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.14 -41.78 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.665 2.243 . . . . 0.0 110.635 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.542 ' CG2' ' HA3' ' A' ' 17' ' ' GLY . 11.7 mm -54.48 -55.48 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.154 -0.966 . . . . 0.0 109.411 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.859 HG22 ' HB3' ' A' ' 52' ' ' LEU . 89.1 t -54.48 -53.7 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.755 . . . . 0.0 110.053 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -45.81 -31.72 2.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.046 -1.034 . . . . 0.0 108.941 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.531 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -79.5 -38.32 34.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.52 -0.738 . . . . 0.0 109.6 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.8 mp -55.4 -41.88 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.164 -0.96 . . . . 0.0 108.811 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.044 HG22 HD11 ' B' ' 67' ' ' LEU . 2.1 mp -72.11 -65.78 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.353 -0.842 . . . . 0.0 109.49 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -42.23 -27.28 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.445 -0.784 . . . . 0.0 109.67 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -73.86 -49.31 25.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 108.93 179.708 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.475 ' HA ' ' HB3' ' A' ' 69' ' ' SER . 0.4 OUTLIER -55.14 -45.57 75.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.368 -0.832 . . . . 0.0 109.018 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.028 HD11 ' CG2' ' B' ' 63' ' ' ILE . 3.7 mt -53.56 -60.09 3.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.52 -0.738 . . . . 0.0 109.598 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -73.51 -3.98 31.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.632 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 4.1 p -49.59 -57.1 7.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 109.393 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' N ' ' OG ' ' A' ' 69' ' ' SER . 0.7 OUTLIER 62.8 12.47 5.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.236 -0.915 . . . . 0.0 109.51 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.526 ' O ' ' CG ' ' B' ' 31' ' ' PRO . 2.3 mttt -58.94 122.65 14.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.405 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 73' ' ' ASN . 30.0 t -170.99 -90.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 109.461 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 72' ' ' SER . 8.6 t-20 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.934 -1.031 . . . . 0.0 109.477 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.8 m 50.59 -165.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 28.4 m -107.06 149.71 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.496 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 45.97 65.21 1.22 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.498 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -146.66 49.44 1.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.903 . . . . 0.0 109.441 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.39 70.23 8.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.455 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.627 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.4 OUTLIER -146.65 115.02 6.69 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.28 -0.888 . . . . 0.0 109.608 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' B' ' 10' ' ' GLN . 0.1 OUTLIER -130.0 161.19 31.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 0.0 108.917 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.936 ' HB2' HD22 ' B' ' 12' ' ' LEU . 94.5 m -48.86 92.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.334 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' B' ' 8' ' ' ARG . 0.1 OUTLIER -42.77 -26.23 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.839 . . . . 0.0 109.866 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.517 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 78.2 m -130.78 72.2 1.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.621 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.936 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.55 -44.29 8.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.932 . . . . 0.0 109.147 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.32 117.5 33.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.29 -0.881 . . . . 0.0 109.275 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.426 ' OG1' ' CG ' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -103.09 156.44 17.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.865 . . . . 0.0 109.641 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.551 HD12 HD23 ' B' ' 52' ' ' LEU . 5.6 mt -98.04 135.77 39.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.79 . . . . 0.0 109.05 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' B' ' 15' ' ' LEU . 1.1 tt0 -44.07 -26.78 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 109.313 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.538 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 156.21 149.23 5.3 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.65 HG22 ' CD2' ' B' ' 52' ' ' LEU . 6.9 tt -128.25 150.03 33.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.511 -0.994 . . . . 0.0 108.803 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.469 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -43.74 146.41 1.01 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.945 . . . . 0.0 109.289 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.4 Cg_endo -76.6 -13.03 18.34 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.424 2.083 . . . . 0.0 109.991 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.534 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 7.6 mttp -78.93 -15.42 58.33 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 1.026 ' O ' HD13 ' B' ' 23' ' ' ILE . 86.5 m-20 -100.46 54.8 0.88 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 1.026 HD13 ' O ' ' B' ' 22' ' ' ASN . 0.7 OUTLIER -146.11 163.41 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.032 -1.042 . . . . 0.0 110.337 -179.359 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.735 ' HG2' HG22 ' B' ' 43' ' ' THR . 0.4 OUTLIER -153.08 -36.26 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.835 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.656 ' O ' HG23 ' B' ' 26' ' ' VAL . 5.0 p -128.41 179.52 5.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.656 HG23 ' O ' ' B' ' 25' ' ' SER . 51.4 t -160.11 115.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.786 -1.196 . . . . 0.0 109.99 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 20.4 t-20 -104.83 153.31 21.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 109.097 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' SER . 2.6 t -143.71 91.83 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 109.654 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.446 ' HD2' ' NE2' ' B' ' 10' ' ' GLN . 4.3 mttm -95.3 93.43 7.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 4.3 p -44.7 164.21 0.18 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.843 . . . . 0.0 109.301 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.526 ' CG ' ' O ' ' A' ' 71' ' ' LYS . 35.7 Cg_endo -77.77 131.96 11.6 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.592 2.195 . . . . 0.0 110.527 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.26 -138.5 3.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.27 8.09 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.498 2.132 . . . . 0.0 110.782 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.627 ' CD2' HD22 ' B' ' 7' ' ' LEU . 5.0 p-80 -126.92 -16.79 5.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.063 -1.023 . . . . 0.0 109.849 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -160.12 125.21 3.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.075 -1.016 . . . . 0.0 109.278 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.419 ' O ' ' CD ' ' B' ' 37' ' ' GLN . . . -87.41 18.9 3.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.674 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.506 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 13.4 mm-40 -143.31 124.97 14.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.961 . . . . 0.0 109.558 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.434 HG23 ' HA ' ' B' ' 30' ' ' SER . 17.5 m -50.26 140.65 12.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.937 . . . . 0.0 109.255 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' B' ' 10' ' ' GLN . 8.5 mt-10 -117.76 106.81 13.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 109.619 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.802 HG21 ' HB3' ' B' ' 54' ' ' PRO . 1.7 t -98.5 106.76 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.166 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.517 ' CG1' ' SG ' ' B' ' 11' ' ' CYS . 2.9 mp -94.77 157.29 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.872 . . . . 0.0 109.803 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.964 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -136.38 125.85 25.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 108.866 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.735 HG22 ' HG2' ' B' ' 24' ' ' GLN . 22.4 m -89.68 105.57 17.89 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.958 -1.089 . . . . 0.0 109.151 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.934 HD23 ' O ' ' B' ' 22' ' ' ASN . 82.4 mt -43.83 168.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.312 -0.868 . . . . 0.0 109.583 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.534 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.2 ptpt -90.15 17.49 6.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.525 ' OD1' ' CB ' ' B' ' 44' ' ' LEU . 19.5 p-10 -119.42 7.23 11.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.22 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.3 -17.97 54.73 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.742 ' HB2' HD12 ' B' ' 44' ' ' LEU . 8.8 mtt85 -83.73 171.95 12.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 109.15 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.519 ' CD ' ' OG1' ' B' ' 43' ' ' THR . 10.0 mtmt -144.42 125.21 14.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.509 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.27 131.18 55.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.163 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 61.7 m -79.83 140.2 36.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -0.979 . . . . 0.0 109.186 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.868 ' HB3' HG22 ' B' ' 59' ' ' VAL . 12.5 mt -129.41 168.63 16.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.218 -0.926 . . . . 0.0 109.378 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.657 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.8 m-20 -110.94 130.91 22.45 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.587 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.802 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.7 Cg_endo -75.31 -14.56 20.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.312 2.008 . . . . 0.0 110.248 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.99 -19.11 61.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 108.829 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -89.91 163.09 33.61 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.152 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.16 -41.76 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.59 2.193 . . . . 0.0 110.632 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.538 ' CG2' ' HA3' ' B' ' 17' ' ' GLY . 11.7 mm -54.46 -55.54 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.351 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.868 HG22 ' HB3' ' B' ' 52' ' ' LEU . 90.0 t -54.46 -53.67 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.528 -0.732 . . . . 0.0 110.054 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 0.4 OUTLIER -45.86 -31.66 2.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.028 -1.045 . . . . 0.0 108.966 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.529 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -79.57 -38.27 34.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 109.647 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.8 mp -55.32 -41.85 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 108.856 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 1.028 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.1 mp -72.17 -65.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -42.14 -27.26 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -73.82 -49.37 25.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 108.947 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.481 ' HA ' ' HB3' ' B' ' 69' ' ' SER . 0.4 OUTLIER -55.18 -45.53 75.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.415 -0.803 . . . . 0.0 109.002 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.044 HD11 HG22 ' A' ' 63' ' ' ILE . 3.7 mt -53.67 -60.07 3.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.734 . . . . 0.0 109.52 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -73.51 -3.93 30.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.686 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 4.1 p -49.64 -57.07 7.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 109.455 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.477 ' N ' ' OG ' ' B' ' 69' ' ' SER . 0.7 OUTLIER 62.83 12.51 5.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.868 . . . . 0.0 109.416 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 2.3 mttt -58.96 122.67 14.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.282 -0.886 . . . . 0.0 109.503 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' B' ' 73' ' ' ASN . 30.2 t -170.93 -90.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 73' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' B' ' 72' ' ' SER . 8.6 t-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.474 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.9 -41.26 23.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 109.497 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.12 137.79 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.926 . . . . 0.0 109.426 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -132.53 -179.75 5.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.29 -0.881 . . . . 0.0 109.488 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 5' ' ' THR . 32.4 m -118.86 61.81 0.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.5 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.52 39.05 1.02 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.42 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.538 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -115.6 98.25 6.6 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.219 -0.925 . . . . 0.0 109.532 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -83.49 154.51 23.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.132 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.49 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m -43.88 121.73 2.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 109.394 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.503 ' HG3' ' CB ' ' A' ' 29' ' ' LYS . 56.6 mm-40 -42.08 -27.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.791 . . . . 0.0 109.842 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.468 ' SG ' HG13 ' A' ' 41' ' ' ILE . 81.1 m -146.04 72.04 1.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.162 -0.961 . . . . 0.0 109.61 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -44.07 -45.65 8.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.068 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -110.13 120.87 43.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.414 -0.804 . . . . 0.0 109.072 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.99 161.43 14.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.236 -0.915 . . . . 0.0 109.986 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.666 ' HB2' HD23 ' A' ' 52' ' ' LEU . 3.1 mt -108.66 143.08 38.21 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.607 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.4 tt0 -44.9 -26.54 0.42 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.061 -1.025 . . . . 0.0 109.065 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.592 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 152.37 177.65 26.25 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.656 HG22 HD11 ' A' ' 52' ' ' LEU . 6.4 tp -148.56 159.99 6.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.42 -1.047 . . . . 0.0 109.071 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.589 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.5 t-80 -50.2 144.23 11.63 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.243 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.589 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.37 -22.66 10.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.504 2.136 . . . . 0.0 110.264 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.456 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.27 -15.2 31.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -0.871 . . . . 0.0 109.108 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.475 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 9.5 m120 -79.55 -11.89 59.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.317 -0.865 . . . . 0.0 109.455 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.894 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 4.3 mt -101.0 155.55 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.308 -0.87 . . . . 0.0 110.422 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.533 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -124.5 -30.04 3.41 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.533 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -132.02 169.05 16.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 108.855 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.739 HG23 ' HG3' ' A' ' 66' ' ' MET . 49.9 t -139.45 111.2 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 109.801 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.712 ' O ' HD12 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -106.15 110.99 23.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.158 179.611 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -113.8 106.36 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.655 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.503 ' CB ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -97.25 94.81 7.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.222 -0.924 . . . . 0.0 109.319 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.1 p -45.2 169.25 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.479 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 36' ' ' ALA . 35.6 Cg_endo -77.84 132.15 11.67 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.582 2.188 . . . . 0.0 110.408 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.84 -140.29 4.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.06 41.61 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.718 2.278 . . . . 0.0 110.708 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 9.7 p-80 -161.93 -38.1 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.053 -1.029 . . . . 0.0 109.244 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 6.2 t -135.82 112.78 10.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.285 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 31' ' ' PRO . . . -71.45 -32.06 67.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 109.646 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.437 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 6.2 mm100 -87.63 130.51 34.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.586 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.458 HG23 ' HA ' ' A' ' 30' ' ' SER . 63.2 m -53.31 142.97 19.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.38 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.484 ' CB ' ' HB2' ' A' ' 10' ' ' GLN . 30.6 mm-40 -117.46 107.33 14.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.568 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 54' ' ' PRO . 9.5 t -92.48 148.32 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.5 mp -140.6 153.87 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 0.0 109.7 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.894 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -137.5 121.93 18.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.418 -0.801 . . . . 0.0 109.215 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 43' ' ' THR . 1.2 m -89.29 98.99 12.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.998 -1.064 . . . . 0.0 108.783 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.489 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 73.7 mt -41.78 165.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.434 0.635 . . . . 0.0 109.919 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 13.9 ptpt -81.22 7.87 10.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.811 . . . . 0.0 109.745 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -111.25 16.27 21.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.391 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.49 3.75 88.24 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.462 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 2.4 mtp-105 -94.04 174.95 6.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -1.158 . . . . 0.0 109.562 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -141.24 152.96 44.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.29 120.45 7.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 108.889 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 33.0 m -79.7 140.35 37.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.488 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.885 ' HB3' HG22 ' A' ' 59' ' ' VAL . 14.7 mt -126.36 166.94 16.24 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.38 -0.825 . . . . 0.0 108.899 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.661 ' O ' HG21 ' A' ' 59' ' ' VAL . 5.1 t30 -101.52 123.94 42.61 Favored Pre-proline 0 C--N 1.299 -1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.386 -179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.65 ' HB3' HG21 ' A' ' 40' ' ' VAL . 33.8 Cg_endo -75.03 -9.89 20.93 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.152 1.901 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.43 -14.14 57.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 108.862 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -89.69 162.22 36.75 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.325 179.824 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.0 Cg_endo -77.56 -39.93 0.48 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.63 2.22 . . . . 0.0 110.626 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 32.4 mt -61.13 -51.86 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.973 . . . . 0.0 109.17 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.885 HG22 ' HB3' ' A' ' 52' ' ' LEU . 54.4 t -53.48 -52.03 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.511 -0.743 . . . . 0.0 109.762 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 6.9 mmtt -50.14 -33.22 18.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.077 -1.015 . . . . 0.0 108.813 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 57' ' ' PRO . 2.5 mmpt? -74.36 -36.02 63.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.448 -0.783 . . . . 0.0 109.26 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.705 HG23 ' CD1' ' A' ' 23' ' ' ILE . 1.7 mp -61.53 -41.14 89.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.419 -0.801 . . . . 0.0 109.079 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.1 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -69.68 -68.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 0.0 109.766 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -43.82 -33.75 1.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 0.0 109.6 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 69' ' ' SER . 10.7 mmtm -66.07 -59.12 4.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.169 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.739 ' HG3' HG23 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -44.4 -45.7 9.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.051 179.627 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.105 HD11 ' CG2' ' B' ' 63' ' ' ILE . 1.9 mt -56.88 -56.38 22.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.501 -0.749 . . . . 0.0 109.4 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 5.2 t30 -85.91 13.64 7.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 65' ' ' LYS . 93.7 p -64.63 -49.6 70.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' A' ' 70' ' ' ASP . 6.4 p-10 40.86 83.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.509 -0.744 . . . . 0.0 109.715 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 76.17 6.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.509 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.78 -18.34 13.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.471 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.6 t30 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.507 179.939 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.293 0.568 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -41.26 23.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.51 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.01 137.76 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -132.61 -179.75 5.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.718 HG22 ' O ' ' B' ' 5' ' ' THR . 31.7 m -118.84 61.91 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.62 39.21 1.03 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.492 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.543 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -115.61 98.2 6.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.233 -0.917 . . . . 0.0 109.54 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -83.43 154.57 23.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.34 -0.85 . . . . 0.0 109.188 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.484 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 1.8 m -43.94 121.64 2.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.447 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.511 ' HG3' ' CB ' ' B' ' 29' ' ' LYS . 56.7 mm-40 -41.91 -27.53 0.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.46 -0.775 . . . . 0.0 109.829 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.47 ' SG ' HG13 ' B' ' 41' ' ' ILE . 80.7 m -145.98 72.04 1.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.661 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.3 OUTLIER -44.12 -45.57 8.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.092 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -110.1 121.0 44.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 109.047 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.06 161.46 14.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.221 -0.925 . . . . 0.0 109.897 -179.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.669 ' HB2' HD23 ' B' ' 52' ' ' LEU . 3.1 mt -108.76 143.19 38.24 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.608 ' O ' HG23 ' B' ' 59' ' ' VAL . 2.4 tt0 -44.95 -26.46 0.42 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.994 . . . . 0.0 109.116 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.595 ' CA ' HD22 ' B' ' 52' ' ' LEU . . . 152.3 177.66 26.2 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.661 HG22 HD11 ' B' ' 52' ' ' LEU . 6.4 tp -148.51 160.06 6.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.434 -1.039 . . . . 0.0 109.029 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.594 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 1.5 t-80 -50.29 144.22 11.93 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.086 -1.009 . . . . 0.0 109.141 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -77.46 -22.53 10.73 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.483 2.122 . . . . 0.0 110.237 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.464 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.23 -15.36 31.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.36 -0.837 . . . . 0.0 109.096 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 9.5 m120 -79.52 -11.87 59.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.897 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 4.3 mt -101.01 155.55 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 110.406 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.552 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -124.58 -30.0 3.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.325 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.552 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -132.02 169.04 16.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 108.912 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.749 HG23 ' HG3' ' B' ' 66' ' ' MET . 50.3 t -139.46 111.3 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.013 . . . . 0.0 109.836 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.722 ' O ' HD12 ' B' ' 41' ' ' ILE . 0.1 OUTLIER -106.14 110.93 23.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.149 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.8 t -113.77 106.37 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.696 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.511 ' CB ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -97.25 94.74 7.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.44 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.468 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -45.13 169.23 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.452 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.8 Cg_endo -77.77 132.17 11.75 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.562 2.175 . . . . 0.0 110.46 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.85 -140.35 4.02 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.12 41.68 1.17 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.69 2.26 . . . . 0.0 110.679 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.543 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 9.6 p-80 -161.9 -38.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.142 -0.974 . . . . 0.0 109.324 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 6.3 t -135.82 112.81 10.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.276 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' B' ' 31' ' ' PRO . . . -71.56 -32.03 67.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.611 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.426 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 6.3 mm100 -87.68 130.65 34.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.486 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.468 HG23 ' HA ' ' B' ' 30' ' ' SER . 62.4 m -53.47 143.06 20.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.353 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' B' ' 10' ' ' GLN . 30.4 mm-40 -117.47 107.38 14.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.635 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' B' ' 54' ' ' PRO . 9.7 t -92.51 148.35 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.894 . . . . 0.0 109.267 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.722 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.5 mp -140.65 153.83 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.961 . . . . 0.0 109.679 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.897 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -137.42 121.97 18.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.356 -0.84 . . . . 0.0 109.186 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.559 HG22 ' O ' ' B' ' 43' ' ' THR . 1.2 m -89.31 99.01 12.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.976 -1.077 . . . . 0.0 108.78 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 73.9 mt -41.82 164.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.565 -0.709 . . . . 0.0 109.981 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.464 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 13.9 ptpt -81.18 7.89 10.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 0.0 109.775 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -111.25 16.16 21.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.384 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.5 3.78 88.21 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.478 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 2.4 mtp-105 -94.05 174.93 6.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.5 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -141.23 152.89 44.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 0.0 109.501 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.22 120.43 7.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 108.959 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.431 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 33.0 m -79.66 140.24 37.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.125 -0.984 . . . . 0.0 109.46 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.891 ' HB3' HG22 ' B' ' 59' ' ' VAL . 14.7 mt -126.29 166.99 16.1 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.4 -0.812 . . . . 0.0 108.924 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.65 ' O ' HG21 ' B' ' 59' ' ' VAL . 5.1 t30 -101.49 123.94 42.67 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 -179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.632 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.8 Cg_endo -75.02 -9.99 20.98 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.177 1.918 . . . . 0.0 110.244 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.29 -14.18 57.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.268 -0.895 . . . . 0.0 108.944 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -89.65 162.15 37.04 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.432 -0.793 . . . . 0.0 109.323 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.448 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 35.9 Cg_endo -77.53 -39.87 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.636 2.224 . . . . 0.0 110.658 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' B' ' 62' ' ' ILE . 32.4 mt -61.14 -51.87 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 109.118 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.891 HG22 ' HB3' ' B' ' 52' ' ' LEU . 54.5 t -53.53 -52.03 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.509 -0.744 . . . . 0.0 109.746 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' B' ' 56' ' ' SER . 6.9 mmtt -50.13 -33.18 17.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 108.844 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' B' ' 57' ' ' PRO . 2.5 mmpt? -74.34 -36.08 63.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.6 -0.688 . . . . 0.0 109.303 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.702 HG23 ' CD1' ' B' ' 23' ' ' ILE . 1.7 mp -61.5 -41.13 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.38 -0.825 . . . . 0.0 109.048 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 1.105 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -69.76 -69.0 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.643 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -43.67 -33.71 1.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.137 -0.977 . . . . 0.0 109.671 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' B' ' 69' ' ' SER . 10.7 mmtm -66.14 -59.22 3.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.102 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.749 ' HG3' HG23 ' B' ' 26' ' ' VAL . 0.6 OUTLIER -44.37 -45.68 8.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.832 . . . . 0.0 109.097 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.1 HD11 ' CG2' ' A' ' 63' ' ' ILE . 1.9 mt -56.88 -56.27 23.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.394 -0.816 . . . . 0.0 109.48 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.445 ' O ' ' OD1' ' B' ' 70' ' ' ASP . 5.2 t30 -85.95 13.5 7.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.506 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.482 ' N ' ' O ' ' B' ' 65' ' ' LYS . 93.0 p -64.53 -49.54 70.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.507 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.461 ' OD2' ' O ' ' B' ' 70' ' ' ASP . 6.4 p-10 40.76 83.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.51 -0.744 . . . . 0.0 109.793 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 76.08 6.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.117 -0.989 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.71 -18.31 13.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 15.8 t30 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.502 179.939 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.847 ' O ' HG13 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -44.21 102.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 0.0 109.42 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.847 HG13 ' O ' ' A' ' 1' ' ' ALA . 30.9 m -105.34 134.06 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 0.0 109.468 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.57 75.42 1.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 109.368 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.04 117.86 3.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 0.0 109.529 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -173.81 126.45 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.551 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -112.0 96.96 6.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.509 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -87.98 155.11 20.0 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.337 -0.852 . . . . 0.0 109.099 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.94 ' HB2' HD22 ' A' ' 12' ' ' LEU . 18.0 m -44.11 106.29 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 109.374 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.5 ' HB2' ' HD2' ' A' ' 29' ' ' LYS . 21.4 mm-40 -42.68 -26.53 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.365 -0.835 . . . . 0.0 109.773 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.471 ' HB2' ' HG2' ' A' ' 39' ' ' GLU . 73.5 m -122.38 58.33 1.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.962 . . . . 0.0 109.777 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.94 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.64 4.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 108.839 179.64 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -123.94 123.56 40.67 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -97.99 172.87 7.35 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.185 -0.947 . . . . 0.0 110.243 -179.273 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.494 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 4.5 mt -128.85 143.11 50.81 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.614 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.7 tt0 -44.4 -44.73 8.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 1.014 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 142.28 161.42 8.76 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.78 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -130.76 156.54 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -1.093 . . . . 0.0 109.137 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.588 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -43.23 150.82 0.46 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.321 -0.862 . . . . 0.0 109.291 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -76.54 -0.51 10.52 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.472 2.115 . . . . 0.0 110.12 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER -90.03 -27.12 19.93 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.265 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.57 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 8.9 m-20 -84.97 6.0 26.9 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.714 HG23 ' HB1' ' A' ' 42' ' ' ALA . 2.5 mm -94.26 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.936 . . . . 0.0 110.552 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.618 ' H ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -154.54 -41.5 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.261 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.476 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 1.3 p -135.73 174.59 10.44 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.535 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 52.7 t -150.3 89.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.949 -1.094 . . . . 0.0 109.962 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 3.2 t-20 -79.67 105.49 11.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.23 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -98.49 91.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.547 ' HE3' ' CD1' ' A' ' 41' ' ' ILE . 1.3 ptpm? -98.23 112.5 24.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.366 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.421 ' OG ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -63.99 171.2 2.65 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.253 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.547 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.8 Cg_endo -77.98 130.91 10.67 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.626 2.218 . . . . 0.0 110.412 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.11 -144.56 5.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.87 5.48 4.88 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.546 2.164 . . . . 0.0 110.545 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.551 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 17.5 p-80 -123.14 -11.54 8.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 0.0 109.595 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' OE2' ' A' ' 39' ' ' GLU . 7.9 t -160.14 118.8 2.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.382 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.68 29.56 1.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.559 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.547 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 17.8 mm-40 -141.93 127.97 19.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.522 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -53.37 152.29 4.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.335 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 11' ' ' CYS . 2.4 mp0 -138.32 112.0 8.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.681 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.896 HG11 HD11 ' A' ' 63' ' ' ILE . 1.6 t -103.64 90.59 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.227 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.547 ' CD1' ' HE3' ' A' ' 29' ' ' LYS . 3.5 mt -79.9 144.01 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.961 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.714 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -124.13 120.48 32.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.418 -0.801 . . . . 0.0 108.864 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 24' ' ' GLN . 9.0 m -89.22 101.21 13.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.92 -1.113 . . . . 0.0 109.071 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.57 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 81.4 mt -46.28 167.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.366 -0.834 . . . . 0.0 109.573 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HA ' ' HG3' ' A' ' 24' ' ' GLN . 14.6 ptpt -83.79 9.95 10.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -111.37 16.71 20.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.93 . . . . 0.0 109.372 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.89 6.92 87.94 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HB2' HD12 ' A' ' 44' ' ' LEU . 45.8 mtt-85 -99.37 168.81 9.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -1.151 . . . . 0.0 109.429 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -135.63 155.95 49.63 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.494 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.4 120.16 7.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 109.178 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.408 ' SG ' HG12 ' A' ' 41' ' ' ILE . 11.1 m -79.15 138.95 38.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.027 -1.045 . . . . 0.0 108.537 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.014 HD22 ' HA2' ' A' ' 17' ' ' GLY . 11.6 mt -119.55 167.47 11.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.647 ' O ' HG21 ' A' ' 59' ' ' VAL . 4.7 t-20 -98.76 119.72 60.52 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.72 -3.92 14.63 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.052 1.834 . . . . 0.0 110.269 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.27 -13.0 42.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 108.823 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -89.91 161.24 38.97 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.839 . . . . 0.0 109.371 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.475 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.71 -35.52 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.7 2.266 . . . . 0.0 110.714 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.546 HG23 ' N ' ' A' ' 59' ' ' VAL . 9.2 tt -67.73 -44.3 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 109.296 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.004 ' HA ' HD12 ' A' ' 62' ' ' ILE . 31.2 t -58.57 -47.1 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.533 -0.729 . . . . 0.0 109.161 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 8.9 mttt -59.22 -30.32 68.16 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -79.36 -23.54 43.29 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.004 HD12 ' HA ' ' A' ' 59' ' ' VAL . 16.5 mt -71.22 -38.1 68.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.535 -0.728 . . . . 0.0 109.056 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.989 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -73.84 -55.86 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 109.284 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -59.9 -28.34 67.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.95 . . . . 0.0 109.35 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.513 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -70.08 -43.28 71.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 108.978 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.535 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -60.24 -46.04 91.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.085 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.013 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.7 OUTLIER -48.72 -54.71 13.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.45 -0.781 . . . . 0.0 109.511 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' SER . 17.1 t-20 -68.11 -23.25 64.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 109.614 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 70' ' ' ASP . 9.9 p -43.58 -45.71 6.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.509 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 69' ' ' SER . 15.5 t70 43.89 92.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.437 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt 69.39 150.69 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.891 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 24.4 m -115.7 155.6 27.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.535 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.3 m-80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.466 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.842 ' O ' HG13 ' B' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.418 ' C ' ' O ' ' B' ' 1' ' ' ALA . 0.9 OUTLIER -44.23 102.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.371 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.842 HG13 ' O ' ' B' ' 1' ' ' ALA . 30.7 m -105.3 134.02 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.479 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.56 75.44 1.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.02 117.96 3.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.936 . . . . 0.0 109.48 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -173.9 126.32 0.37 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.554 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -111.84 96.89 6.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.3 -0.875 . . . . 0.0 109.606 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' B' ' 9' ' ' CYS . 17.7 mmt180 -87.96 155.21 19.95 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.299 -0.876 . . . . 0.0 109.094 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.947 ' HB2' HD22 ' B' ' 12' ' ' LEU . 17.9 m -44.25 106.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 109.34 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.488 ' HB2' ' HD2' ' B' ' 29' ' ' LYS . 21.3 mm-40 -42.63 -26.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.356 -0.84 . . . . 0.0 109.78 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.468 ' HB2' ' HG2' ' B' ' 39' ' ' GLU . 73.6 m -122.39 58.35 1.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.947 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.63 4.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 108.925 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -123.95 123.63 40.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.437 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -98.04 172.82 7.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.232 -0.917 . . . . 0.0 110.212 -179.259 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.486 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 4.5 mt -128.77 143.14 50.84 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.614 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.7 tt0 -44.32 -44.88 8.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.096 -1.003 . . . . 0.0 109.1 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 1.017 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 142.29 161.37 8.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.808 HD13 ' N ' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -130.67 156.58 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.373 -1.075 . . . . 0.0 109.171 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.589 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -43.38 150.82 0.48 Allowed Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.258 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.589 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.5 Cg_endo -76.43 -0.59 10.57 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.434 2.089 . . . . 0.0 110.181 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.445 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -89.98 -27.21 19.93 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.574 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 9.0 m-20 -84.84 5.91 26.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.705 HG23 ' HB1' ' B' ' 42' ' ' ALA . 2.5 mm -94.14 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.869 . . . . 0.0 110.506 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.613 ' H ' HG22 ' B' ' 23' ' ' ILE . 0.5 OUTLIER -154.59 -41.51 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.195 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.467 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 1.3 p -135.71 174.63 10.41 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.534 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 52.9 t -150.23 89.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.924 -1.11 . . . . 0.0 109.941 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 3.2 t-20 -79.78 105.38 11.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.192 -0.942 . . . . 0.0 109.242 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.9 t -98.49 91.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.54 ' HE3' ' CD1' ' B' ' 41' ' ' ILE . 1.3 ptpm? -98.21 112.46 24.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 109.373 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.425 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.0 OUTLIER -63.8 171.09 2.59 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.327 -0.858 . . . . 0.0 109.381 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.544 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.1 Cg_endo -77.97 130.87 10.67 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.606 2.204 . . . . 0.0 110.478 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.02 -144.6 5.77 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.81 5.45 4.87 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.553 2.169 . . . . 0.0 110.586 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.554 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 17.4 p-80 -123.18 -11.47 7.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.559 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 7.8 t -160.18 118.73 2.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.68 29.47 1.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.584 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.544 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 17.9 mm-40 -141.89 128.01 19.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.208 -0.933 . . . . 0.0 109.566 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -53.27 152.33 4.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.896 . . . . 0.0 109.396 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' B' ' 11' ' ' CYS . 2.4 mp0 -138.39 111.9 8.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -0.961 . . . . 0.0 109.695 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.901 HG11 HD11 ' B' ' 63' ' ' ILE . 1.6 t -103.59 90.64 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.163 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.54 ' CD1' ' HE3' ' B' ' 29' ' ' LYS . 3.5 mt -79.94 144.0 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.897 . . . . 0.0 109.957 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.705 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -124.16 120.49 32.46 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' B' ' 24' ' ' GLN . 9.1 m -89.21 101.26 13.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.908 -1.12 . . . . 0.0 109.128 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.574 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 81.3 mt -46.33 167.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.388 -0.82 . . . . 0.0 109.587 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.452 ' HA ' ' HG3' ' B' ' 24' ' ' GLN . 14.6 ptpt -83.88 10.05 10.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -111.37 16.69 20.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.349 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.86 7.02 87.85 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.52 ' HB2' HD12 ' B' ' 44' ' ' LEU . 45.8 mtt-85 -99.45 168.85 9.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -1.163 . . . . 0.0 109.432 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -135.63 155.99 49.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.486 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.41 120.21 7.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.337 -0.852 . . . . 0.0 109.118 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.41 ' SG ' HG12 ' B' ' 41' ' ' ILE . 11.1 m -79.14 138.9 38.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.042 -1.037 . . . . 0.0 108.579 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 1.017 HD22 ' HA2' ' B' ' 17' ' ' GLY . 11.5 mt -119.41 167.49 11.88 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.236 -0.915 . . . . 0.0 109.856 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.647 ' O ' HG21 ' B' ' 59' ' ' VAL . 4.7 t-20 -98.84 119.7 60.45 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.55 -0.719 . . . . 0.0 109.061 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.64 -3.92 14.62 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.05 1.834 . . . . 0.0 110.319 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.34 -12.86 42.22 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.317 -0.864 . . . . 0.0 108.901 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 1.0 OUTLIER -90.0 161.23 38.73 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.299 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.0 Cg_endo -77.77 -35.54 1.44 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.649 2.232 . . . . 0.0 110.697 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.56 HG23 ' N ' ' B' ' 59' ' ' VAL . 9.2 tt -67.69 -44.31 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.31 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 1.008 ' HA ' HD12 ' B' ' 62' ' ' ILE . 31.6 t -58.54 -47.05 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.466 -0.771 . . . . 0.0 109.178 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' B' ' 56' ' ' SER . 8.9 mttt -59.21 -30.36 68.17 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.496 ' O ' ' CG ' ' B' ' 65' ' ' LYS . 0.0 OUTLIER -79.28 -23.59 43.49 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 1.008 HD12 ' HA ' ' B' ' 59' ' ' VAL . 16.4 mt -71.24 -38.06 68.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.506 -0.746 . . . . 0.0 109.081 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 1.013 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -73.82 -55.85 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.366 -0.833 . . . . 0.0 109.336 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.3 OUTLIER -59.85 -28.39 67.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 109.379 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.515 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 0.1 OUTLIER -70.08 -43.21 71.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.002 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.534 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.6 OUTLIER -60.35 -45.91 91.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 109.072 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.989 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -48.78 -54.73 13.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.445 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' B' ' 69' ' ' SER . 17.2 t-20 -68.15 -23.28 64.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.459 ' O ' ' O ' ' B' ' 70' ' ' ASP . 9.9 p -43.5 -45.82 6.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' B' ' 69' ' ' SER . 15.3 t70 44.0 92.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' B' ' 70' ' ' ASP . 11.1 ttmt 69.46 150.8 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.403 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' B' ' 73' ' ' ASN . 24.3 m -115.79 155.69 27.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.925 . . . . 0.0 109.492 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 73' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' B' ' 72' ' ' SER . 2.3 m-80 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.444 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 m -153.95 25.57 0.49 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 109.462 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 3' ' ' VAL . 11.6 p -156.51 78.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 3' ' ' VAL . . . 174.35 -148.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.486 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.527 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 0.2 OUTLIER 76.27 91.3 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 0.0 109.56 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -131.56 67.65 1.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 0.0 109.387 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.662 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -122.28 100.31 6.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.264 -0.897 . . . . 0.0 109.615 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.4 OUTLIER -92.36 151.87 20.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.925 . . . . 0.0 109.201 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.493 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m -44.09 114.39 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.14 -0.975 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -45.53 -24.84 0.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.423 ' SG ' HG13 ' A' ' 41' ' ' ILE . 60.8 m -148.7 71.16 1.14 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.082 -1.011 . . . . 0.0 109.822 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.493 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.04 -45.87 11.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 108.948 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -115.27 119.69 37.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.443 -0.786 . . . . 0.0 108.961 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -97.45 163.51 12.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.193 -0.942 . . . . 0.0 110.011 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.544 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.4 mt -115.17 146.26 41.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.487 -0.758 . . . . 0.0 108.981 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.77 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.9 tt0 -44.22 -46.91 9.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.339 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 1.033 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 156.03 -164.82 32.49 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.802 HG23 ' O ' ' A' ' 17' ' ' GLY . 1.2 pp -170.26 162.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.436 -1.038 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.623 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 13.0 t60 -44.8 144.58 1.83 Allowed Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.623 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.6 Cg_endo -77.76 -13.93 15.91 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.29 1.994 . . . . 0.0 109.889 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.516 ' CE ' ' HG2' ' A' ' 20' ' ' PRO . 1.9 mmpt? -90.86 -19.87 22.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.401 -0.812 . . . . 0.0 108.861 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 5.2 m-20 -78.61 -12.96 60.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.237 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.941 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 12.0 mt -91.93 165.89 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.981 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.543 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -131.88 -41.96 1.02 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.8 p -125.11 173.49 8.69 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.539 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 48.3 t -144.33 95.53 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.01 -1.056 . . . . 0.0 109.694 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.673 ' O ' HD12 ' A' ' 41' ' ' ILE . 5.3 t-20 -96.83 112.4 24.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.406 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.833 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -115.6 102.65 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 109.597 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -94.35 110.92 22.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.394 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.67 165.36 0.73 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.504 ' CG ' ' HA ' ' B' ' 71' ' ' LYS . 35.8 Cg_endo -78.12 136.43 14.57 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.61 2.207 . . . . 0.0 110.419 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.67 -145.3 4.59 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.19 7.41 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.633 2.222 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.662 ' CD2' HD22 ' A' ' 7' ' ' LEU . 11.5 p-80 -124.32 -7.73 7.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.628 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.9 t -160.1 117.35 2.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 109.449 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.15 45.71 1.2 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.594 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.463 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 1.6 pt20 -171.11 140.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.474 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.467 ' HB ' ' CG ' ' A' ' 54' ' ' PRO . 1.4 m -60.64 145.19 50.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 109.368 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.463 ' OE2' ' O ' ' A' ' 37' ' ' GLN . 0.7 OUTLIER -127.3 107.4 9.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.582 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.833 HG22 HG13 ' A' ' 28' ' ' VAL . 32.0 t -93.09 151.82 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.207 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 27' ' ' ASN . 2.5 mp -140.19 146.61 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.067 -1.021 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.941 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -133.87 119.16 18.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.416 -0.802 . . . . 0.0 109.08 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 6.8 m -89.39 97.51 11.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.944 -1.098 . . . . 0.0 109.131 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 87.0 mt -43.13 166.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.477 -0.765 . . . . 0.0 109.731 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.8 ptpt -82.56 9.84 8.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 109.704 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.514 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -113.69 27.69 9.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.143 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.29 6.21 64.68 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.514 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 40.5 mtt180 -96.23 160.99 14.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -1.188 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.57 150.23 48.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.177 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.544 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.21 124.73 9.64 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.213 -0.929 . . . . 0.0 109.191 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.48 ' SG ' HG13 ' A' ' 41' ' ' ILE . 15.7 m -79.51 148.08 31.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.104 -0.997 . . . . 0.0 109.225 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.033 HD22 ' HA2' ' A' ' 17' ' ' GLY . 15.7 mt -122.76 167.22 13.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.271 -0.893 . . . . 0.0 109.329 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.648 ' O ' HG21 ' A' ' 59' ' ' VAL . 3.0 t-20 -98.86 119.45 61.0 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.152 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.467 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 32.9 Cg_endo -74.87 -6.12 17.71 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.137 1.891 . . . . 0.0 110.23 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.95 -14.69 46.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 108.886 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -90.0 160.7 40.02 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.398 -0.813 . . . . 0.0 109.355 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.8 -34.39 1.84 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.627 2.218 . . . . 0.0 110.686 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.586 ' O ' HD13 ' A' ' 62' ' ' ILE . 2.7 tt -66.5 -46.67 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.138 -0.976 . . . . 0.0 109.09 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.859 HG22 ' HB3' ' A' ' 52' ' ' LEU . 38.1 t -57.02 -48.2 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.403 -0.81 . . . . 0.0 109.023 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.1 OUTLIER -55.23 -31.28 61.36 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 2.8 mmpt? -76.23 -30.62 57.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -65.48 -44.65 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.346 -0.846 . . . . 0.0 108.936 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.95 HG22 HD11 ' B' ' 67' ' ' LEU . 2.2 mp -66.82 -61.78 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.489 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -52.67 -27.7 18.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.481 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 13.9 mttt -71.43 -43.03 67.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.197 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.539 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -61.8 -47.13 86.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.31 -0.869 . . . . 0.0 109.185 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.949 HD11 HG22 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.75 -50.89 9.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.462 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 18.0 t-20 -69.32 -31.32 69.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.498 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 70' ' ' ASP . 1.3 p -48.82 -58.78 4.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.508 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' N ' ' OG ' ' A' ' 69' ' ' SER . 1.2 m-20 64.25 -85.37 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.542 -0.724 . . . . 0.0 109.557 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HA ' ' CG ' ' B' ' 31' ' ' PRO . 3.8 tttt -80.98 -31.11 34.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.405 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.8 t 57.46 16.88 3.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.863 . . . . 0.0 109.48 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.491 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.295 0.569 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.0 m -153.89 25.53 0.5 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.763 HG13 ' O ' ' B' ' 3' ' ' VAL . 11.6 p -156.46 78.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.935 . . . . 0.0 109.387 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' B' ' 3' ' ' VAL . . . 174.31 -148.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.442 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.516 ' CB ' ' O ' ' B' ' 4' ' ' ALA . 0.2 OUTLIER 76.39 91.31 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.466 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -131.56 67.63 1.51 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 109.414 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.649 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -122.34 100.44 6.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.305 -0.872 . . . . 0.0 109.577 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.4 OUTLIER -92.41 151.83 20.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.245 -0.909 . . . . 0.0 109.215 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.474 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 1.8 m -44.04 114.37 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -45.55 -24.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 109.698 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.429 ' O ' ' C ' ' B' ' 12' ' ' LEU . 60.7 m -148.7 71.11 1.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.086 -1.009 . . . . 0.0 109.884 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.474 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.94 -45.94 10.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.007 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -115.24 119.61 36.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.461 -0.775 . . . . 0.0 108.954 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.538 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.6 OUTLIER -97.31 163.6 12.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 110.014 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.532 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.4 mt -115.27 146.2 41.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.479 -0.763 . . . . 0.0 108.949 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.788 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.9 tt0 -44.16 -46.88 9.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 1.051 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 155.99 -164.94 32.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.802 HG23 ' O ' ' B' ' 17' ' ' GLY . 1.2 pp -170.19 162.77 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.399 -1.059 . . . . 0.0 109.503 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.614 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 12.8 t60 -44.75 144.6 1.8 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.614 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -77.78 -13.99 15.85 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.347 2.031 . . . . 0.0 109.87 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.507 ' CE ' ' HG2' ' B' ' 20' ' ' PRO . 1.9 mmpt? -90.77 -19.96 22.91 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.487 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 5.1 m-20 -78.63 -12.92 60.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 0.0 109.234 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.95 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 12.0 mt -91.96 165.91 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.276 -0.89 . . . . 0.0 109.982 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.555 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.1 OUTLIER -131.92 -41.87 1.02 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.496 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 3.7 p -125.25 173.45 8.79 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.533 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 48.7 t -144.26 95.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.077 -1.014 . . . . 0.0 109.728 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.679 ' O ' HD12 ' B' ' 41' ' ' ILE . 5.3 t-20 -96.95 112.39 24.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 0.0 109.392 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.814 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -115.64 102.62 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.56 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -94.34 110.93 22.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.7 165.34 0.74 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.457 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.509 ' CG ' ' HA ' ' A' ' 71' ' ' LYS . 35.7 Cg_endo -78.04 136.45 14.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.629 2.219 . . . . 0.0 110.451 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.66 -145.24 4.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.22 7.41 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.738 2.292 . . . . 0.0 110.746 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.649 ' CD2' HD22 ' B' ' 7' ' ' LEU . 11.7 p-80 -124.43 -7.66 7.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.9 t -160.13 117.29 2.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.357 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.18 45.72 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.476 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.448 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 1.6 pt20 -171.14 140.93 1.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 109.528 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.473 ' HB ' ' CG ' ' B' ' 54' ' ' PRO . 1.4 m -60.58 145.09 50.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.448 ' OE2' ' O ' ' B' ' 37' ' ' GLN . 0.7 OUTLIER -127.23 107.32 9.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.814 HG22 HG13 ' B' ' 28' ' ' VAL . 31.5 t -92.99 151.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.257 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.679 HD12 ' O ' ' B' ' 27' ' ' ASN . 2.6 mp -140.15 146.57 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.788 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.95 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -133.91 119.16 18.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 109.073 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 6.7 m -89.32 97.49 11.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.924 -1.11 . . . . 0.0 109.17 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 86.9 mt -43.13 166.14 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.507 -0.746 . . . . 0.0 109.673 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.481 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.8 ptpt -82.56 9.95 8.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -0.823 . . . . 0.0 109.676 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -113.77 27.75 9.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.324 -0.86 . . . . 0.0 109.152 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.3 6.16 64.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.51 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 40.6 mtt180 -96.23 161.03 14.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.171 -1.193 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.506 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.62 150.25 48.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.154 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.532 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.21 124.71 9.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.35 -0.844 . . . . 0.0 109.137 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.483 ' SG ' HG13 ' B' ' 41' ' ' ILE . 15.6 m -79.49 148.08 31.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.124 -0.985 . . . . 0.0 109.184 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 1.051 HD22 ' HA2' ' B' ' 17' ' ' GLY . 15.9 mt -122.88 167.2 13.85 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.651 ' O ' HG21 ' B' ' 59' ' ' VAL . 3.0 t-20 -98.82 119.38 61.23 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.163 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.473 ' CG ' ' HB ' ' B' ' 38' ' ' THR . 33.4 Cg_endo -74.66 -6.31 18.04 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.182 1.921 . . . . 0.0 110.304 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.93 -14.68 46.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.36 -0.838 . . . . 0.0 108.846 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -90.02 160.75 39.89 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.288 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.85 -34.35 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.582 2.188 . . . . 0.0 110.709 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.598 ' O ' HD13 ' B' ' 62' ' ' ILE . 2.7 tt -66.49 -46.65 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.108 -0.995 . . . . 0.0 109.136 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.865 HG22 ' HB3' ' B' ' 52' ' ' LEU . 38.1 t -57.1 -48.08 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.017 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.1 OUTLIER -55.28 -31.3 61.49 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.467 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 2.8 mmpt? -76.16 -30.6 58.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.591 -0.693 . . . . 0.0 109.391 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.598 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -65.46 -44.7 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.353 -0.842 . . . . 0.0 108.987 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.949 HG22 HD11 ' A' ' 67' ' ' LEU . 2.2 mp -66.69 -61.8 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.1 OUTLIER -52.73 -27.72 18.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.462 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.512 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 13.9 mttt -71.38 -43.0 67.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 109.236 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.533 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -61.81 -47.11 86.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.378 -0.826 . . . . 0.0 109.248 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.95 HD11 HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.7 -50.91 9.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.504 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' B' ' 70' ' ' ASP . 17.8 t-20 -69.32 -31.28 69.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.486 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' B' ' 70' ' ' ASP . 1.3 p -48.82 -58.82 4.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.918 . . . . 0.0 109.523 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.506 ' N ' ' OG ' ' B' ' 69' ' ' SER . 1.2 m-20 64.23 -85.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.523 -0.736 . . . . 0.0 109.62 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.504 ' HA ' ' CG ' ' A' ' 31' ' ' PRO . 3.8 tttt -80.97 -31.06 34.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 25.6 t 57.39 16.96 3.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 109.478 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.478 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m 49.6 23.66 1.0 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.424 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 1' ' ' ALA . 47.4 t -105.78 134.59 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.534 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -176.31 144.11 0.54 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.0 m -158.05 116.48 3.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.516 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -105.71 91.58 3.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.367 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.528 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -118.43 99.76 7.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.235 -0.916 . . . . 0.0 109.637 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 9' ' ' CYS . 16.6 mtp180 -91.52 155.42 18.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.267 -0.896 . . . . 0.0 108.885 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.441 ' HB3' ' OE2' ' A' ' 39' ' ' GLU . 17.2 m -44.28 125.5 4.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.204 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.667 ' HB3' HD11 ' A' ' 41' ' ' ILE . 45.2 mm-40 -40.69 -39.89 1.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.482 -0.761 . . . . 0.0 109.756 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.481 ' O ' HG23 ' A' ' 14' ' ' THR . 1.7 m -165.85 70.19 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.4 -0.812 . . . . 0.0 109.506 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.965 HD13 ' O ' ' A' ' 12' ' ' LEU . 1.5 tm? -44.22 -34.46 1.89 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.342 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -93.6 81.4 4.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.244 -0.91 . . . . 0.0 109.099 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.481 HG23 ' O ' ' A' ' 11' ' ' CYS . 10.1 p -87.78 158.65 18.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.291 -0.881 . . . . 0.0 109.91 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HB2' HD23 ' A' ' 52' ' ' LEU . 2.4 mt -100.24 144.25 29.48 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.455 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.9 tt0 -45.41 -25.91 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.074 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.532 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 154.09 171.54 21.19 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.844 HG22 HD11 ' A' ' 52' ' ' LEU . 7.7 tp -145.32 151.96 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.336 -1.096 . . . . 0.0 109.166 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.507 ' ND1' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.92 146.98 1.82 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.935 . . . . 0.0 109.303 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.507 ' HD2' ' ND1' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.15 -13.85 16.95 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.549 2.166 . . . . 0.0 110.04 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.526 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -80.92 -16.34 53.84 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.234 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.989 ' O ' HD23 ' A' ' 44' ' ' LEU . 80.1 m-20 -101.34 55.59 0.83 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.459 -0.776 . . . . 0.0 108.988 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.974 HG23 ' HB1' ' A' ' 42' ' ' ALA . 1.8 mm -139.79 170.83 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.133 -0.979 . . . . 0.0 110.041 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -160.06 -40.72 0.05 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.525 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.8 p -131.13 -177.97 4.62 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 25' ' ' SER . 51.9 t -157.22 111.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.025 -1.047 . . . . 0.0 109.748 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.424 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 18.6 t-20 -94.87 124.61 39.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -0.85 . . . . 0.0 109.358 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.46 ' HB ' ' HB ' ' B' ' 26' ' ' VAL . 1.9 t -119.91 89.7 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.196 -0.94 . . . . 0.0 109.53 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 104.22 15.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.279 -0.888 . . . . 0.0 109.547 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.2 p -54.31 168.42 0.46 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.445 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 35.9 Cg_endo -78.01 133.15 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.664 2.242 . . . . 0.0 110.434 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.85 -141.05 3.8 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.55 10.25 2.59 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.531 2.154 . . . . 0.0 110.992 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.528 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 3.7 p-80 -127.16 -10.21 5.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.023 -1.048 . . . . 0.0 109.813 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' OE1' ' A' ' 39' ' ' GLU . 1.8 t -160.27 121.4 3.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.002 . . . . 0.0 109.372 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.72 44.16 1.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.577 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.441 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 5.8 pt20 -172.36 139.76 1.04 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.531 HG21 ' CG ' ' B' ' 70' ' ' ASP . 1.5 m -56.49 142.28 39.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.399 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.452 ' OE1' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -127.62 122.59 33.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.899 . . . . 0.0 109.623 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.844 HG11 HD11 ' A' ' 63' ' ' ILE . 74.6 t -114.48 151.44 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.371 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.667 HD11 ' HB3' ' A' ' 10' ' ' GLN . 3.3 mp -141.82 155.18 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.607 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.974 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -134.21 126.63 30.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.397 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.635 HG23 ' HG3' ' A' ' 49' ' ' LYS . 51.9 m -89.81 105.87 18.09 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.111 -0.993 . . . . 0.0 109.089 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.989 HD23 ' O ' ' A' ' 22' ' ' ASN . 77.1 mt -41.73 164.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.464 -0.772 . . . . 0.0 109.587 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.4 ptpt -87.44 17.81 4.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.748 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 1.1 p-10 -120.46 -3.53 9.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.97 . . . . 0.0 109.349 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.4 -25.31 8.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.845 ' HB2' HD12 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -79.34 172.9 13.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -1.172 . . . . 0.0 109.255 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.635 ' HG3' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -147.24 125.55 12.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.66 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.74 124.77 51.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.422 -0.799 . . . . 0.0 108.847 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.44 ' SG ' HG12 ' A' ' 41' ' ' ILE . 83.9 m -79.55 140.99 37.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.947 . . . . 0.0 109.317 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.844 HD11 HG22 ' A' ' 18' ' ' ILE . 14.3 mt -127.78 168.25 15.39 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 108.975 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.609 ' O ' HG21 ' A' ' 59' ' ' VAL . 6.7 t30 -106.12 132.95 20.46 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.321 -0.862 . . . . 0.0 109.125 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HG3' HG23 ' A' ' 40' ' ' VAL . 33.9 Cg_endo -75.62 -25.23 11.12 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.12 1.88 . . . . 0.0 110.298 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.87 -16.15 26.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.212 -0.93 . . . . 0.0 108.843 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 37.1 p -88.66 158.18 48.43 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.433 -0.792 . . . . 0.0 109.395 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.427 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.86 -38.74 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.695 2.263 . . . . 0.0 110.744 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.599 HG23 ' N ' ' A' ' 59' ' ' VAL . 5.9 tt -66.04 -46.63 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.974 . . . . 0.0 109.235 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.785 HG22 ' HB3' ' A' ' 52' ' ' LEU . 40.3 t -56.81 -48.46 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.494 -0.753 . . . . 0.0 109.241 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -55.45 -31.42 61.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HE2' ' OE2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -74.89 -31.25 61.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.614 -0.679 . . . . 0.0 109.226 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -67.0 -42.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.401 -0.812 . . . . 0.0 108.848 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.043 HG22 HD11 ' B' ' 67' ' ' LEU . 2.1 mp -65.87 -66.64 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -46.23 -39.32 9.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 0.0 109.496 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.479 ' HG3' ' OE1' ' A' ' 64' ' ' GLU . 12.2 mttm -59.08 -50.9 72.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.209 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.45 -48.1 62.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 109.216 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.047 HD11 HG22 ' B' ' 63' ' ' ILE . 0.2 OUTLIER -47.02 -51.8 16.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.387 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.47 ' HA ' ' HB2' ' A' ' 71' ' ' LYS . 11.7 t30 -58.46 -38.47 77.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' ASN . 4.2 p -44.19 -33.07 1.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.535 ' CG ' HG21 ' B' ' 38' ' ' THR . 0.2 OUTLIER -126.4 53.94 1.61 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.464 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 68' ' ' ASN . 0.7 OUTLIER -100.28 117.81 35.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 109.484 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.438 ' O ' ' OXT' ' A' ' 73' ' ' ASN . 0.4 OUTLIER -131.38 118.88 20.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.438 ' OXT' ' O ' ' A' ' 72' ' ' SER . 16.0 p-10 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.473 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.529 ' O ' HG23 ' B' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 18.8 m 49.58 23.59 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.529 HG23 ' O ' ' B' ' 1' ' ' ALA . 47.7 t -105.82 134.59 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.171 -0.955 . . . . 0.0 109.499 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -176.27 144.12 0.54 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.124 -0.985 . . . . 0.0 109.447 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -158.11 116.5 3.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.29 -0.881 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -105.68 91.52 3.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.425 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.526 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -118.38 99.75 7.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.3 -0.875 . . . . 0.0 109.612 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' B' ' 9' ' ' CYS . 16.7 mtp180 -91.54 155.32 18.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 108.857 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.448 ' O ' ' C ' ' B' ' 10' ' ' GLN . 17.4 m -44.09 125.36 4.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -0.957 . . . . 0.0 109.294 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.655 ' HB3' HD11 ' B' ' 41' ' ' ILE . 45.1 mm-40 -40.52 -39.97 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.56 -0.712 . . . . 0.0 109.767 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.495 ' O ' HG23 ' B' ' 14' ' ' THR . 1.7 m -165.85 70.24 0.13 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.97 HD13 ' O ' ' B' ' 12' ' ' LEU . 1.5 tm? -44.3 -34.46 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.266 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -93.63 81.53 4.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.266 -0.897 . . . . 0.0 109.118 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.495 HG23 ' O ' ' B' ' 11' ' ' CYS . 10.2 p -87.88 158.63 18.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.332 -0.855 . . . . 0.0 109.859 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.57 ' HB2' HD23 ' B' ' 52' ' ' LEU . 2.4 mt -100.18 144.26 29.41 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.464 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.9 tt0 -45.44 -25.88 0.48 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.043 -1.036 . . . . 0.0 109.063 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.532 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 154.1 171.55 21.2 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.836 HG22 HD11 ' B' ' 52' ' ' LEU . 7.7 tp -145.3 151.91 14.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.405 -1.056 . . . . 0.0 109.247 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.507 ' ND1' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -45.9 147.01 1.79 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.507 ' HD2' ' ND1' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.17 -13.94 16.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.622 2.215 . . . . 0.0 109.963 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -80.9 -16.39 53.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.972 ' O ' HD23 ' B' ' 44' ' ' LEU . 80.1 m-20 -101.31 55.64 0.84 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.448 -0.782 . . . . 0.0 108.935 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.998 HG23 ' HB1' ' B' ' 42' ' ' ALA . 1.8 mm -139.78 170.78 14.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.091 -1.005 . . . . 0.0 109.947 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.1 OUTLIER -159.99 -40.7 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.548 ' O ' HG23 ' B' ' 26' ' ' VAL . 4.8 p -131.14 -177.99 4.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 25' ' ' SER . 51.5 t -157.16 111.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.981 -1.075 . . . . 0.0 109.771 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.434 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 18.8 t-20 -94.89 124.7 39.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.882 . . . . 0.0 109.281 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 1.9 t -119.99 89.83 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.47 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.23 104.28 15.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.2 p -54.53 168.43 0.48 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.381 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 35.6 Cg_endo -77.93 133.11 12.22 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.609 2.206 . . . . 0.0 110.414 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.79 -141.04 3.8 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.66 10.35 2.58 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.541 2.16 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.526 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 3.7 p-80 -127.16 -10.26 5.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.981 -1.074 . . . . 0.0 109.855 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 1.8 t -160.3 121.37 3.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.357 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.69 44.1 1.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.588 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.446 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 5.9 pt20 -172.24 139.86 1.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.515 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.535 HG21 ' CG ' ' A' ' 70' ' ' ASP . 1.5 m -56.69 142.33 40.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.451 ' OE2' ' SG ' ' B' ' 35' ' ' CYS . 0.0 OUTLIER -127.53 122.59 33.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.869 HG11 HD11 ' B' ' 63' ' ' ILE . 76.9 t -114.55 151.46 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.321 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' B' ' 10' ' ' GLN . 3.3 mp -141.79 155.25 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.643 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.998 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -134.33 126.56 29.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -0.866 . . . . 0.0 109.335 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.634 HG23 ' HG3' ' B' ' 49' ' ' LYS . 52.2 m -89.9 105.96 18.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 109.089 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.972 HD23 ' O ' ' B' ' 22' ' ' ASN . 77.0 mt -41.71 164.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.467 -0.771 . . . . 0.0 109.667 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.4 ptpt -87.33 17.76 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.877 . . . . 0.0 109.865 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.477 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 1.1 p-10 -120.42 -3.54 9.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.386 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.52 -25.49 8.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.874 ' HB2' HD12 ' B' ' 44' ' ' LEU . 0.3 OUTLIER -79.31 172.95 13.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -1.186 . . . . 0.0 109.273 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.634 ' HG3' HG23 ' B' ' 43' ' ' THR . 0.0 OUTLIER -147.27 125.46 12.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.657 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.68 124.76 51.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.395 -0.816 . . . . 0.0 108.915 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.448 ' SG ' HG12 ' B' ' 41' ' ' ILE . 84.3 m -79.49 141.07 37.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.15 -0.969 . . . . 0.0 109.289 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.836 HD11 HG22 ' B' ' 18' ' ' ILE . 14.2 mt -127.89 168.16 15.59 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.418 -0.802 . . . . 0.0 109.001 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.626 ' O ' HG21 ' B' ' 59' ' ' VAL . 6.7 t30 -106.01 132.84 20.55 Favored Pre-proline 0 C--N 1.299 -1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.205 -179.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.463 ' HG3' HG23 ' B' ' 40' ' ' VAL . 33.7 Cg_endo -75.59 -25.22 11.18 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.09 1.86 . . . . 0.0 110.324 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.83 -16.16 26.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.274 -0.891 . . . . 0.0 108.792 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 36.9 p -88.68 158.21 48.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.478 -0.764 . . . . 0.0 109.297 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -77.88 -38.7 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.666 2.244 . . . . 0.0 110.741 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.593 HG23 ' N ' ' B' ' 59' ' ' VAL . 5.8 tt -66.05 -46.61 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.096 -1.003 . . . . 0.0 109.248 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.795 HG22 ' HB3' ' B' ' 52' ' ' LEU . 40.0 t -56.87 -48.52 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.407 -0.808 . . . . 0.0 109.174 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.5 OUTLIER -55.48 -31.29 61.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' B' ' 57' ' ' PRO . 0.1 OUTLIER -74.95 -31.23 61.44 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.583 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -67.04 -42.96 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 1.047 HG22 HD11 ' A' ' 67' ' ' LEU . 2.1 mp -65.83 -66.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.356 -0.84 . . . . 0.0 109.466 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -46.36 -39.26 10.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.942 . . . . 0.0 109.43 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.477 ' HG3' ' OE1' ' B' ' 64' ' ' GLU . 12.2 mttm -59.1 -50.88 72.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 109.269 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 66' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.44 -48.07 62.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 0.0 109.219 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.043 HD11 HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -46.97 -51.9 15.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.473 ' HA ' ' HB2' ' B' ' 71' ' ' LYS . 11.8 t30 -58.42 -38.54 77.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.405 ' C ' ' O ' ' B' ' 68' ' ' ASN . 4.1 p -44.0 -33.22 1.35 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 109.466 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.531 ' CG ' HG21 ' A' ' 38' ' ' THR . 0.2 OUTLIER -126.28 53.92 1.6 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.473 ' HB2' ' HA ' ' B' ' 68' ' ' ASN . 0.7 OUTLIER -100.38 117.66 35.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.481 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.424 ' O ' ' OXT' ' B' ' 73' ' ' ASN . 0.4 OUTLIER -131.32 118.89 20.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.915 . . . . 0.0 109.523 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 73' ' ' ASN . . . . . 0.424 ' OXT' ' O ' ' B' ' 72' ' ' SER . 15.9 p-10 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.53 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 t -159.7 161.79 34.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.471 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.691 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 1.9 t -107.91 -25.65 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.936 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 3' ' ' VAL . . . 75.27 -152.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.486 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 4' ' ' ALA . 13.5 t 42.21 27.39 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.836 . . . . 0.0 109.726 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -155.54 26.88 0.39 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.94 . . . . 0.0 109.405 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.606 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -136.65 109.47 7.58 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.31 -0.868 . . . . 0.0 109.591 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -115.62 156.22 26.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.075 179.606 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 8' ' ' ARG . 43.8 m -44.52 102.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.248 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.503 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 75.8 mm-40 -53.04 -18.48 2.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 12' ' ' LEU . 53.0 m -135.63 65.96 1.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.076 -1.015 . . . . 0.0 109.889 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -44.7 -44.86 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 108.895 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.41 119.44 34.6 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.31 168.55 11.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.186 -0.946 . . . . 0.0 110.09 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.519 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 6.8 mt -119.13 145.5 45.92 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.835 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -43.99 -46.63 8.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.254 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 1.011 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 151.39 -170.88 30.99 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.92 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.4 pp -164.95 162.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -1.028 . . . . 0.0 109.33 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.584 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -53.97 150.69 14.05 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.22 -0.925 . . . . 0.0 109.328 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.5 Cg_endo -77.44 -3.89 14.12 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.598 2.199 . . . . 0.0 110.29 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 3.1 pttm -90.21 -24.19 21.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.865 . . . . 0.0 109.207 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.519 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 3.1 m-20 -83.19 -7.31 59.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.385 -0.822 . . . . 0.0 109.268 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.927 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 6.8 mt -104.26 162.12 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.874 . . . . 0.0 110.1 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.566 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -135.12 -31.36 1.0 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.526 -0.734 . . . . 0.0 109.177 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.566 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.1 p -132.82 175.14 9.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 0.0 108.854 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.638 HG23 ' HG3' ' A' ' 66' ' ' MET . 46.6 t -149.69 115.77 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.045 -1.034 . . . . 0.0 109.922 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.563 ' O ' HD12 ' A' ' 41' ' ' ILE . 4.1 t-20 -111.85 110.76 21.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.147 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.849 HG22 HG13 ' A' ' 40' ' ' VAL . 3.1 t -117.12 113.65 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.709 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -105.74 114.76 29.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.251 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -55.23 167.29 0.71 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.544 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.3 Cg_endo -77.53 140.25 18.89 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.607 2.205 . . . . 0.0 110.378 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.92 -139.6 3.03 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.66 38.73 0.76 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.594 2.196 . . . . 0.0 110.903 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.606 ' CD2' HD22 ' A' ' 7' ' ' LEU . 3.9 p-80 -154.99 -38.73 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.031 . . . . 0.0 109.375 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.415 ' SG ' ' CD ' ' A' ' 39' ' ' GLU . 1.8 t -133.58 124.77 27.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.23 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.53 42.43 0.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.736 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.453 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 0.1 OUTLIER -170.76 148.48 2.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.153 -0.967 . . . . 0.0 109.631 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 m -63.49 144.94 56.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.325 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 37' ' ' GLN . 0.5 OUTLIER -126.64 110.27 13.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 109.628 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.849 HG13 HG22 ' A' ' 28' ' ' VAL . 3.3 t -97.53 144.84 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.273 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.563 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.6 mt -132.4 153.08 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.58 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.927 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -137.69 120.21 16.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.174 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 2.3 m -89.23 102.69 15.35 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.973 -1.08 . . . . 0.0 108.737 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 88.6 mt -49.22 164.59 0.07 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.432 -0.792 . . . . 0.0 109.549 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -79.12 6.78 8.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 109.978 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.526 ' ND2' ' HD2' ' A' ' 48' ' ' ARG . 41.7 p30 -109.36 20.72 17.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.124 -0.985 . . . . 0.0 109.363 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.87 14.08 82.73 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HD2' ' ND2' ' A' ' 46' ' ' ASN . 1.6 mtp-105 -103.56 171.64 7.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -1.151 . . . . 0.0 109.452 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -141.9 151.19 42.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.519 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.25 123.03 8.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.294 -0.879 . . . . 0.0 109.074 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.414 ' SG ' HG12 ' A' ' 41' ' ' ILE . 15.6 m -79.77 141.1 36.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.011 HD22 ' HA2' ' A' ' 17' ' ' GLY . 12.3 mt -119.6 167.82 11.63 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.321 -0.862 . . . . 0.0 109.195 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.653 ' O ' HG21 ' A' ' 59' ' ' VAL . 7.9 t30 -98.15 119.34 62.17 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.337 -0.852 . . . . 0.0 108.983 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.48 ' HB3' HG21 ' A' ' 40' ' ' VAL . 33.3 Cg_endo -75.2 -6.76 18.31 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.103 1.869 . . . . 0.0 110.327 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.75 -14.66 47.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 108.865 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -90.07 162.12 36.06 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.317 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.501 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 36.7 Cg_endo -78.29 -37.72 0.7 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.644 2.229 . . . . 0.0 110.944 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.611 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -63.26 -48.13 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.073 -1.017 . . . . 0.0 108.917 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.853 HG22 ' HB3' ' A' ' 52' ' ' LEU . 37.2 t -55.75 -48.48 77.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -51.33 -33.62 30.02 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.298 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -72.94 -36.37 67.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.549 -0.719 . . . . 0.0 109.261 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 58' ' ' ILE . 1.3 mp -57.91 -44.05 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.878 . . . . 0.0 109.051 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.117 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.1 mp -69.76 -68.95 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.874 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG2' ' HA ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -43.43 -27.82 0.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -0.957 . . . . 0.0 109.584 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.476 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 10.3 mmtt -72.49 -58.66 3.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 108.931 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.638 ' HG3' HG23 ' A' ' 26' ' ' VAL . 1.1 tmm? -44.62 -45.72 9.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 108.911 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.124 HD11 ' CG2' ' B' ' 63' ' ' ILE . 2.5 mt -55.38 -49.29 72.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 109.409 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.06 33.9 1.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.574 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 p -105.04 -25.28 12.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.55 34.38 0.82 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.455 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 47.36 -149.41 0.14 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 47.7 -167.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 109.492 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.41 ' OXT' ' HD2' ' B' ' 60' ' ' LYS . 21.3 m-80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.7 t -159.6 161.79 35.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.345 -0.847 . . . . 0.0 109.449 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.688 ' O ' ' HB3' ' B' ' 4' ' ' ALA . 1.9 t -107.95 -25.66 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.472 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' B' ' 3' ' ' VAL . . . 75.4 -152.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.871 . . . . 0.0 109.507 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.653 HG22 ' O ' ' B' ' 4' ' ' ALA . 13.5 t 42.12 27.44 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 0.0 109.789 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' B' ' 4' ' ' ALA . 0.0 OUTLIER -155.58 26.91 0.39 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 109.455 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.605 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -136.63 109.53 7.63 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.251 -0.906 . . . . 0.0 109.536 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -115.62 156.28 26.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 108.97 179.638 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.411 ' HA ' ' OE2' ' B' ' 39' ' ' GLU . 43.1 m -44.66 102.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.97 . . . . 0.0 109.322 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.499 ' HB2' ' CD ' ' B' ' 29' ' ' LYS . 75.9 mm-40 -53.01 -18.45 2.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.699 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' B' ' 12' ' ' LEU . 54.3 m -135.62 66.0 1.52 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 109.779 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.2 OUTLIER -44.81 -44.85 9.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.895 . . . . 0.0 108.881 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.38 119.46 34.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -93.43 168.6 10.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.303 -0.873 . . . . 0.0 110.037 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.509 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 6.9 mt -119.19 145.55 45.93 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.836 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.0 OUTLIER -43.97 -46.62 8.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 109.342 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 1.012 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 151.36 -170.91 30.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.932 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.4 pp -164.86 162.96 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -1.023 . . . . 0.0 109.303 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.595 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -53.99 150.79 13.85 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 109.314 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.2 Cg_endo -77.55 -3.9 14.08 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.554 2.17 . . . . 0.0 110.251 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 3.1 pttm -90.2 -24.19 21.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 0.0 109.128 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 3.1 m-20 -83.21 -7.35 59.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.932 HD11 ' CD1' ' B' ' 18' ' ' ILE . 6.8 mt -104.13 162.1 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.566 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.9 OUTLIER -135.1 -31.3 1.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.504 -0.748 . . . . 0.0 109.231 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.566 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.1 p -132.87 175.1 9.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 108.828 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.64 HG23 ' HG3' ' B' ' 66' ' ' MET . 46.4 t -149.66 115.82 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.042 -1.036 . . . . 0.0 109.919 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.568 ' O ' HD12 ' B' ' 41' ' ' ILE . 4.1 t-20 -111.84 110.79 21.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.2 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.856 HG22 HG13 ' B' ' 40' ' ' VAL . 3.1 t -117.14 113.67 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.766 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' B' ' 29' ' ' LYS . 0.4 OUTLIER -105.77 114.75 29.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.249 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.403 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.0 OUTLIER -55.18 167.38 0.69 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.87 . . . . 0.0 109.461 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.435 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.0 Cg_endo -77.54 140.16 18.79 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.606 2.204 . . . . 0.0 110.435 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.84 -139.56 3.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.74 38.76 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.587 2.191 . . . . 0.0 110.91 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.605 ' CD2' HD22 ' B' ' 7' ' ' LEU . 3.8 p-80 -154.95 -38.86 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.026 -1.046 . . . . 0.0 109.359 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.41 ' SG ' ' CD ' ' B' ' 39' ' ' GLU . 1.8 t -133.52 124.75 27.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.54 42.47 0.96 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.876 . . . . 0.0 109.709 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.446 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 0.1 OUTLIER -170.74 148.46 2.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.12 -0.988 . . . . 0.0 109.618 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 1.4 m -63.53 144.98 56.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.331 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.446 ' OE1' ' O ' ' B' ' 37' ' ' GLN . 0.5 OUTLIER -126.69 110.27 12.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 0.0 109.604 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.856 HG13 HG22 ' B' ' 28' ' ' VAL . 3.4 t -97.53 144.78 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.206 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.568 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.6 mt -132.41 153.08 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.586 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.931 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -137.61 120.26 16.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.208 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.527 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 2.3 m -89.28 102.63 15.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.999 -1.063 . . . . 0.0 108.709 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 88.8 mt -49.12 164.5 0.07 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.416 -0.802 . . . . 0.0 109.651 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -79.04 6.77 8.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 -179.67 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.535 ' ND2' ' HD2' ' B' ' 48' ' ' ARG . 42.0 p30 -109.4 20.7 17.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.982 . . . . 0.0 109.415 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.93 14.0 82.8 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.535 ' HD2' ' ND2' ' B' ' 46' ' ' ASN . 1.6 mtp-105 -103.51 171.66 7.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -1.173 . . . . 0.0 109.499 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -141.95 151.18 42.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 109.367 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.23 123.0 8.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 109.078 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.411 ' SG ' HG12 ' B' ' 41' ' ' ILE . 15.5 m -79.83 141.16 36.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.161 -0.962 . . . . 0.0 109.262 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 1.012 HD22 ' HA2' ' B' ' 17' ' ' GLY . 12.3 mt -119.56 167.85 11.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.161 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.644 ' O ' HG21 ' B' ' 59' ' ' VAL . 7.8 t30 -98.13 119.2 62.5 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.057 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.481 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.8 Cg_endo -75.11 -6.79 18.42 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.07 1.847 . . . . 0.0 110.317 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.77 -14.51 47.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 108.882 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -90.17 162.22 35.51 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.83 . . . . 0.0 109.293 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.502 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -78.41 -37.68 0.68 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.612 2.208 . . . . 0.0 110.852 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.62 ' O ' HD13 ' B' ' 58' ' ' ILE . 0.2 OUTLIER -63.32 -48.02 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.045 -1.034 . . . . 0.0 108.975 -179.837 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.873 HG22 ' HB3' ' B' ' 52' ' ' LEU . 37.5 t -55.71 -48.61 77.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.504 -0.747 . . . . 0.0 109.044 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.3 OUTLIER -51.28 -33.65 29.49 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.322 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.502 ' HD2' ' O ' ' B' ' 57' ' ' PRO . 0.1 OUTLIER -72.82 -36.43 67.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.488 -0.758 . . . . 0.0 109.304 179.6 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' B' ' 58' ' ' ILE . 1.3 mp -57.89 -44.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.018 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 1.124 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.1 mp -69.85 -68.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 109.829 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -43.51 -27.78 0.31 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -0.965 . . . . 0.0 109.549 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.474 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 10.4 mmtt -72.5 -58.64 3.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 108.973 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.64 ' HG3' HG23 ' B' ' 26' ' ' VAL . 1.1 tmm? -44.66 -45.64 9.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 108.914 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.117 HD11 ' CG2' ' A' ' 63' ' ' ILE . 2.5 mt -55.44 -49.2 73.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.518 -0.739 . . . . 0.0 109.411 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.12 33.85 1.86 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.499 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.0 p -104.96 -25.28 12.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -89.52 34.31 0.82 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 47.37 -149.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.449 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 47.71 -167.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.15 -0.969 . . . . 0.0 109.453 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 73' ' ' ASN . . . . . 0.423 ' OXT' ' HD2' ' A' ' 60' ' ' LYS . 21.4 m-80 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.506 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.09 -83.2 0.52 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.452 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.619 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 1.8 t -115.14 36.84 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 3' ' ' VAL . . . 71.55 147.46 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.9 m -147.39 -41.89 0.18 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.468 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -143.97 108.08 4.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.334 -0.854 . . . . 0.0 109.449 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.579 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -118.78 99.4 6.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.253 -0.904 . . . . 0.0 109.52 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.432 ' O ' ' C ' ' A' ' 9' ' ' CYS . 19.2 mtt180 -94.19 152.23 18.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.213 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 4.7 m -44.16 113.25 0.5 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -61.37 -12.66 15.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.765 -179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' A' ' 41' ' ' ILE . 70.8 m -135.2 60.71 1.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.119 -0.988 . . . . 0.0 109.873 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.52 -38.33 6.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 108.815 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -124.87 123.05 39.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.28 173.93 7.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 110.092 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.47 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 4.6 mt -129.53 145.81 51.42 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.644 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.3 tt0 -44.94 -45.67 10.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.078 -1.014 . . . . 0.0 109.202 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 1.037 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 139.87 156.14 6.82 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.772 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -129.19 157.53 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -1.095 . . . . 0.0 109.254 179.57 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.605 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.95 151.92 0.39 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 109.38 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.4 Cg_endo -76.66 -1.71 11.85 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.473 2.115 . . . . 0.0 110.156 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.458 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 2.2 mtmm -90.26 -25.51 20.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.806 . . . . 0.0 109.0 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 4.6 m-20 -82.37 -5.69 58.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.417 -0.802 . . . . 0.0 109.26 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.806 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 9.3 mt -107.52 145.36 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.27 -0.894 . . . . 0.0 110.114 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.555 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -117.49 -26.48 6.63 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.413 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.555 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -139.68 162.99 33.77 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.568 HG11 HG13 ' A' ' 63' ' ' ILE . 52.8 t -146.86 99.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.945 -1.097 . . . . 0.0 109.891 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 13.0 t30 -80.07 113.43 18.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.284 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.466 ' O ' ' CE ' ' B' ' 66' ' ' MET . 1.8 t -97.17 90.53 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.51 ' HE3' ' NE2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -94.94 105.68 17.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.475 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.453 ' HA ' HG23 ' A' ' 38' ' ' THR . 0.9 OUTLIER -59.65 167.13 2.7 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 109.43 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 36.1 Cg_endo -78.11 145.85 22.28 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.527 2.151 . . . . 0.0 110.418 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.14 -142.85 3.63 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.6 10.09 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.685 2.256 . . . . 0.0 111.013 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.579 ' CD2' HD22 ' A' ' 7' ' ' LEU . 4.8 p-80 -126.8 -32.58 2.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.056 . . . . 0.0 109.45 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -147.31 88.74 1.73 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.207 -0.933 . . . . 0.0 109.264 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -54.07 -18.85 4.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.33 -0.856 . . . . 0.0 109.699 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.452 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 1.5 mp0 -92.84 124.78 37.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 0.0 109.516 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.509 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 2.7 m -49.5 162.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.292 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 37' ' ' GLN . 1.3 mp0 -142.78 108.98 5.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 109.663 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.092 ' CG1' HD11 ' A' ' 63' ' ' ILE . 57.3 t -100.62 95.12 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 109.147 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.478 HG13 ' SG ' ' A' ' 51' ' ' CYS . 2.6 mp -84.59 139.62 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.958 . . . . 0.0 109.831 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.806 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -121.25 118.36 29.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 109.133 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.616 HG22 ' O ' ' A' ' 43' ' ' THR . 1.1 m -89.07 97.36 11.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.972 -1.08 . . . . 0.0 108.668 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 90.8 mt -43.44 167.77 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.567 -0.708 . . . . 0.0 109.906 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.458 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.1 ptpt -81.29 7.96 10.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.841 . . . . 0.0 109.581 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.47 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.7 13.28 21.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.272 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.99 -1.6 86.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.47 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 2.1 mtt-85 -87.88 168.07 13.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -1.182 . . . . 0.0 109.392 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 2.0 mttt -134.26 155.17 50.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.913 . . . . 0.0 109.428 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.34 117.73 6.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.193 -0.942 . . . . 0.0 109.186 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.478 ' SG ' HG13 ' A' ' 41' ' ' ILE . 8.7 m -79.39 139.05 37.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.151 -0.968 . . . . 0.0 108.853 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.037 HD22 ' HA2' ' A' ' 17' ' ' GLY . 8.7 mt -121.16 167.85 12.22 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.148 -0.97 . . . . 0.0 109.588 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.677 ' O ' HG21 ' A' ' 59' ' ' VAL . 7.1 t-20 -100.47 119.25 59.33 Favored Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.401 -0.812 . . . . 0.0 109.215 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HG3' ' HB ' ' A' ' 38' ' ' THR . 32.7 Cg_endo -74.18 0.82 7.97 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.157 1.905 . . . . 0.0 110.595 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.555 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -90.54 -15.69 30.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 108.904 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -90.28 164.21 28.36 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.455 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.78 -37.94 0.78 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.687 2.258 . . . . 0.0 111.061 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.638 ' O ' HD13 ' A' ' 62' ' ' ILE . 16.0 tt -65.43 -46.87 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.991 -1.068 . . . . 0.0 109.124 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.877 HG22 ' HB3' ' A' ' 52' ' ' LEU . 34.0 t -55.37 -46.85 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.434 -0.792 . . . . 0.0 109.25 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 54' ' ' PRO . 18.1 mttt -57.74 -30.75 65.82 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.511 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -79.37 -24.81 42.41 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.511 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.6 mp -65.85 -43.59 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.092 HD11 ' CG1' ' A' ' 40' ' ' VAL . 1.6 mp -69.61 -62.94 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.547 -0.721 . . . . 0.0 109.214 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.707 ' OE2' HD13 ' B' ' 67' ' ' LEU . 1.3 mp0 -41.76 -48.5 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.793 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.54 ' CE ' ' HG3' ' A' ' 20' ' ' PRO . 2.8 mmtm -53.75 -59.27 4.83 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.372 -0.83 . . . . 0.0 109.342 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.465 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 1.4 mmm -43.52 -45.78 6.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.297 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.079 HD11 ' CG2' ' B' ' 63' ' ' ILE . 3.1 mt -55.67 -57.72 10.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.46 -0.775 . . . . 0.0 109.738 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.566 ' ND2' ' HD3' ' A' ' 71' ' ' LYS . 0.9 OUTLIER -81.13 7.37 11.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.799 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 66' ' ' MET . 7.8 p -101.82 -12.34 18.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 109.384 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.468 ' HB2' ' OG1' ' B' ' 38' ' ' THR . 2.0 p30 -103.88 -12.9 16.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.566 ' HD3' ' ND2' ' A' ' 68' ' ' ASN . 15.4 pttt -76.3 -160.19 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.452 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 73' ' ' ASN . 62.2 p -82.96 107.8 15.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.488 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 72' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.494 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.08 -83.18 0.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.482 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.635 ' O ' ' HB3' ' B' ' 4' ' ' ALA . 1.8 t -115.17 36.84 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.478 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' B' ' 3' ' ' VAL . . . 71.63 147.42 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.477 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 21.1 m -147.37 -41.86 0.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.504 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -144.05 108.01 4.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.897 . . . . 0.0 109.494 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.58 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -118.77 99.36 6.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.266 -0.897 . . . . 0.0 109.496 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 9' ' ' CYS . 19.2 mtt180 -94.16 152.24 18.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.849 . . . . 0.0 109.228 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.527 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 4.6 m -44.18 113.21 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 109.393 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 15.9 mm-40 -61.32 -12.7 14.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.709 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.467 ' SG ' HG13 ' B' ' 41' ' ' ILE . 71.0 m -135.25 60.78 1.68 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.913 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.56 -38.2 6.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.107 -0.995 . . . . 0.0 108.912 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -124.95 122.98 38.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 108.843 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.27 173.98 7.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 0.0 110.153 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.467 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 4.5 mt -129.51 145.82 51.41 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.651 ' O ' HG23 ' B' ' 59' ' ' VAL . 2.2 tt0 -44.92 -45.65 10.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.249 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 1.003 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 139.84 156.18 6.84 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.761 HD13 ' N ' ' B' ' 18' ' ' ILE . 0.2 OUTLIER -129.25 157.56 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -1.091 . . . . 0.0 109.21 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.6 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -43.0 152.01 0.39 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 0.0 109.39 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -76.75 -1.73 11.89 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.442 2.095 . . . . 0.0 110.19 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 2.2 mtmm -90.19 -25.6 20.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.273 -0.892 . . . . 0.0 108.997 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 4.7 m-20 -82.33 -5.67 58.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.413 -0.804 . . . . 0.0 109.318 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.807 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 9.3 mt -107.43 145.39 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 110.089 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.551 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -117.5 -26.46 6.63 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.269 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.551 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -139.6 163.02 33.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.567 HG11 HG13 ' B' ' 63' ' ' ILE . 52.5 t -146.86 99.38 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.081 -1.012 . . . . 0.0 109.931 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 13.2 t30 -80.01 113.43 18.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.253 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.455 ' O ' ' CE ' ' A' ' 66' ' ' MET . 1.8 t -97.15 90.48 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.515 ' HE3' ' NE2' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -94.92 105.67 17.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.548 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.447 ' HA ' HG23 ' B' ' 38' ' ' THR . 0.9 OUTLIER -59.59 167.14 2.64 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 109.422 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 36.3 Cg_endo -78.03 145.8 22.44 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.659 2.239 . . . . 0.0 110.419 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.19 -142.88 3.64 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.46 9.82 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.695 2.263 . . . . 0.0 110.983 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.58 ' CD2' HD22 ' B' ' 7' ' ' LEU . 4.6 p-80 -126.68 -32.44 2.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 109.42 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -147.38 88.7 1.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.213 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -54.03 -18.94 4.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.705 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.456 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 1.5 mp0 -92.67 124.62 36.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.13 -0.981 . . . . 0.0 109.596 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.494 ' HB ' ' HG3' ' B' ' 54' ' ' PRO . 2.7 m -49.47 162.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.238 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' B' ' 37' ' ' GLN . 1.3 mp0 -142.74 108.91 5.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.117 -0.989 . . . . 0.0 109.706 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 1.095 ' CG1' HD11 ' B' ' 63' ' ' ILE . 57.4 t -100.56 95.12 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.247 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.467 HG13 ' SG ' ' B' ' 11' ' ' CYS . 2.6 mp -84.57 139.63 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.892 . . . . 0.0 109.875 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.807 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -121.24 118.46 29.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.619 HG22 ' O ' ' B' ' 43' ' ' THR . 1.1 m -89.18 97.38 11.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.955 -1.091 . . . . 0.0 108.665 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 90.9 mt -43.49 167.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.61 -0.681 . . . . 0.0 109.878 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.1 ptpt -81.34 7.95 10.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.49 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -111.72 13.38 21.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.288 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.0 -1.66 86.81 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.49 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 2.1 mtt-85 -87.78 168.11 13.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -1.221 . . . . 0.0 109.436 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 2.0 mttt -134.3 155.24 50.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.467 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.37 117.75 6.06 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.348 -0.845 . . . . 0.0 109.17 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.466 ' SG ' HG13 ' B' ' 41' ' ' ILE . 8.6 m -79.45 139.02 37.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 0.0 108.852 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 1.003 HD22 ' HA2' ' B' ' 17' ' ' GLY . 8.7 mt -121.1 167.85 12.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.17 -0.956 . . . . 0.0 109.629 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.67 ' O ' HG21 ' B' ' 59' ' ' VAL . 7.1 t-20 -100.45 119.31 59.22 Favored Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 121.51 -0.744 . . . . 0.0 109.201 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.494 ' HG3' ' HB ' ' B' ' 38' ' ' THR . 32.9 Cg_endo -74.25 0.86 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.077 1.851 . . . . 0.0 110.582 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.565 ' HB3' ' OD1' ' B' ' 53' ' ' ASN . . . -90.64 -15.64 30.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 108.863 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.452 ' OG ' HG22 ' B' ' 58' ' ' ILE . 0.9 OUTLIER -90.18 164.21 28.59 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 109.498 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.77 -38.0 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.673 2.249 . . . . 0.0 111.055 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.635 ' O ' HD13 ' B' ' 62' ' ' ILE . 16.0 tt -65.4 -46.9 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.065 . . . . 0.0 109.112 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.892 HG22 ' HB3' ' B' ' 52' ' ' LEU . 33.6 t -55.41 -46.82 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.412 -0.805 . . . . 0.0 109.221 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' B' ' 54' ' ' PRO . 18.1 mttt -57.64 -30.86 65.73 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.534 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.7 OUTLIER -79.33 -24.86 42.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.515 -0.741 . . . . 0.0 109.457 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.635 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.6 mp -65.86 -43.58 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 1.095 HD11 ' CG1' ' B' ' 40' ' ' VAL . 1.6 mp -69.6 -63.02 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 109.104 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.709 ' OE2' HD13 ' A' ' 67' ' ' LEU . 1.3 mp0 -41.73 -48.48 4.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.423 -0.798 . . . . 0.0 109.826 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.531 ' CE ' ' HG3' ' B' ' 20' ' ' PRO . 2.8 mmtm -53.69 -59.42 4.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.88 . . . . 0.0 109.233 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 28' ' ' VAL . 1.4 mmm -43.44 -45.77 6.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.37 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.089 HD11 ' CG2' ' A' ' 63' ' ' ILE . 3.1 mt -55.69 -57.68 10.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.516 -0.74 . . . . 0.0 109.753 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.572 ' ND2' ' HD3' ' B' ' 71' ' ' LYS . 0.9 OUTLIER -81.07 7.24 11.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 109.804 -179.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' B' ' 66' ' ' MET . 7.6 p -101.76 -12.39 18.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.168 -0.958 . . . . 0.0 109.443 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.459 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 2.0 p30 -103.85 -12.89 16.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.445 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.572 ' HD3' ' ND2' ' B' ' 68' ' ' ASN . 15.4 pttt -76.28 -160.26 0.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 109.472 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' B' ' 73' ' ' ASN . 62.3 p -82.93 107.8 15.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.463 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 73' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' B' ' 72' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.321 0.582 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.57 10.66 11.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.188 -0.945 . . . . 0.0 109.49 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.02 70.12 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.476 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.79 -149.28 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 0.0 109.516 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.1 p -127.89 73.21 1.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 109.488 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.09 41.96 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.543 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -116.97 98.1 6.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.231 -0.918 . . . . 0.0 109.534 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.1 OUTLIER -80.49 145.66 31.75 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.331 -0.856 . . . . 0.0 109.076 179.771 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.947 ' HB2' HD22 ' A' ' 12' ' ' LEU . 4.5 m -44.01 110.32 0.2 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.386 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.532 ' NE2' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -43.08 -26.83 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.382 -0.824 . . . . 0.0 109.578 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.469 ' SG ' HG13 ' A' ' 41' ' ' ILE . 56.4 m -127.14 65.11 1.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.48 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.947 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -43.76 -37.17 2.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.901 . . . . 0.0 109.027 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 14' ' ' THR . 15.1 pt20 -121.65 -174.98 2.99 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -160.09 151.44 19.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.143 -0.973 . . . . 0.0 109.778 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.527 HD12 ' HB1' ' A' ' 50' ' ' ALA . 7.2 mt -114.0 144.61 42.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 0.0 108.923 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.53 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.1 tt0 -44.05 -26.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 109.293 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 1.067 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 142.41 -164.03 27.04 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.835 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -170.37 162.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.376 -1.073 . . . . 0.0 109.534 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.631 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 3.3 t60 -44.84 146.61 1.29 Allowed Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.631 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.6 Cg_endo -79.1 -17.01 12.11 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.366 2.044 . . . . 0.0 109.524 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 7.7 mmtm -90.4 -19.35 24.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 16.7 m-20 -78.2 -14.62 59.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -0.841 . . . . 0.0 109.033 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.948 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 11.0 mt -91.66 168.05 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.513 -0.742 . . . . 0.0 110.1 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.583 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -135.59 -40.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.459 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 6.4 p -123.58 172.57 8.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.532 ' CG1' HG13 ' A' ' 63' ' ' ILE . 97.3 t -144.25 88.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.741 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 4.0 t-20 -84.77 108.41 17.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.36 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.884 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -108.6 91.77 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 109.439 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.532 ' HD2' ' NE2' ' A' ' 10' ' ' GLN . 0.7 OUTLIER -92.39 128.15 38.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.857 . . . . 0.0 109.521 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.439 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -76.91 171.62 11.9 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.513 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 36.1 Cg_endo -78.03 132.4 11.62 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.606 2.204 . . . . 0.0 110.465 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.46 -144.23 5.0 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.85 11.94 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.711 2.274 . . . . 0.0 111.041 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.543 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 5.9 p-80 -128.99 -33.5 1.98 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.558 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -129.42 116.99 19.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.3 45.8 1.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.513 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -173.09 141.07 0.93 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 m -58.24 153.51 15.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 15.4 pt-20 -142.12 107.9 5.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.572 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.007 HG11 HD11 ' A' ' 63' ' ' ILE . 55.5 t -90.77 153.45 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.374 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' A' ' 27' ' ' ASN . 3.6 mt -140.67 144.68 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.626 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.948 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -131.71 119.95 22.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.119 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 7.9 m -89.45 97.98 11.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.996 -1.065 . . . . 0.0 109.09 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 85.4 mt -43.75 163.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.448 -0.783 . . . . 0.0 109.736 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -80.05 9.12 5.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 109.931 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.58 27.52 9.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.217 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.3 9.42 72.68 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.512 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 3.4 mtt180 -99.6 163.21 12.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.207 -1.172 . . . . 0.0 109.53 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -137.68 151.83 48.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.339 -0.851 . . . . 0.0 109.257 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.527 ' HB1' HD12 ' A' ' 15' ' ' LEU . . . -150.15 127.99 11.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.6 m -79.6 151.83 30.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.055 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.067 HD22 ' HA2' ' A' ' 17' ' ' GLY . 19.3 mt -127.07 166.72 17.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.315 -0.866 . . . . 0.0 109.326 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.629 ' O ' HG21 ' A' ' 59' ' ' VAL . 8.4 t30 -93.53 115.87 65.67 Favored Pre-proline 0 C--N 1.299 -1.594 0 O-C-N 121.404 -0.81 . . . . 0.0 109.079 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.54 -1.21 10.75 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.106 1.871 . . . . 0.0 110.413 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.2 -12.12 36.28 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.367 -0.833 . . . . 0.0 108.835 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -90.13 160.91 39.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.443 -0.786 . . . . 0.0 109.428 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.511 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 35.6 Cg_endo -77.5 -31.16 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.661 2.241 . . . . 0.0 110.547 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 59' ' ' VAL . 4.1 tt -72.35 -45.16 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.083 -1.011 . . . . 0.0 109.288 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.045 ' HA ' HD12 ' A' ' 62' ' ' ILE . 19.7 t -56.96 -48.53 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.511 -0.743 . . . . 0.0 109.294 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -61.09 -32.06 71.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.186 -0.946 . . . . 0.0 108.552 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.545 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -77.41 -19.14 56.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.528 -0.733 . . . . 0.0 109.161 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.045 HD12 ' HA ' ' A' ' 59' ' ' VAL . 16.2 mt -75.16 -38.84 42.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.007 HD11 HG11 ' A' ' 40' ' ' VAL . 1.9 mp -72.68 -55.98 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.908 . . . . 0.0 109.069 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.532 ' CG ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -58.79 -38.39 78.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.283 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 61' ' ' LYS . 8.2 tttp -59.57 -40.94 89.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -0.874 . . . . 0.0 109.173 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.523 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -61.47 -46.55 89.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.45 -0.782 . . . . 0.0 109.211 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.606 ' CD1' HG22 ' B' ' 63' ' ' ILE . 0.2 OUTLIER -44.11 -51.65 7.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.835 . . . . 0.0 109.395 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.67 -30.32 66.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 0.0 109.623 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.448 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p -56.95 -19.49 18.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.497 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -83.29 -83.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.453 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -154.64 127.26 8.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.527 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.6 t -73.85 -82.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.513 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.911 -1.042 . . . . 0.0 109.448 -179.988 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.61 10.65 11.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.36 -0.838 . . . . 0.0 109.494 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.1 70.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.89 -149.27 0.44 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 18.9 p -127.91 73.21 1.45 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.422 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.1 41.96 1.0 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.902 . . . . 0.0 109.515 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.549 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -116.89 97.95 6.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.915 . . . . 0.0 109.547 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.1 OUTLIER -80.37 145.56 31.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.165 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.923 ' HB2' HD22 ' B' ' 12' ' ' LEU . 4.5 m -43.98 110.21 0.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.532 ' NE2' ' HD2' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -43.0 -26.79 0.15 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.402 -0.811 . . . . 0.0 109.586 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' B' ' 41' ' ' ILE . 56.3 m -127.18 65.02 1.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.275 -0.89 . . . . 0.0 109.447 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.923 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -43.75 -37.11 2.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.019 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 13' ' ' GLN . . . . . 0.499 ' O ' HG23 ' B' ' 14' ' ' THR . 15.0 pt20 -121.67 -174.97 2.99 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.379 -0.826 . . . . 0.0 108.843 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.678 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -160.1 151.45 19.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.073 -1.017 . . . . 0.0 109.789 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.536 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.2 mt -114.05 144.63 42.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.436 -0.79 . . . . 0.0 108.874 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.524 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.1 tt0 -44.03 -26.8 0.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.353 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 1.028 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 142.46 -163.95 27.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.837 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -170.42 162.66 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.419 -1.048 . . . . 0.0 109.451 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.624 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 3.4 t60 -44.95 146.67 1.3 Allowed Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.624 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -79.15 -16.98 12.06 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.327 2.018 . . . . 0.0 109.452 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 7.7 mmtm -90.42 -19.38 23.99 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 16.7 m-20 -78.25 -14.57 59.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.845 . . . . 0.0 109.002 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.946 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 10.9 mt -91.68 168.01 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 110.129 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.593 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.0 OUTLIER -135.55 -40.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.459 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 6.4 p -123.54 172.51 8.7 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.533 ' CG1' HG13 ' B' ' 63' ' ' ILE . 97.2 t -144.23 88.1 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.719 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.499 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.0 t-20 -84.77 108.36 17.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.393 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.872 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -108.58 91.85 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.532 ' HD2' ' NE2' ' B' ' 10' ' ' GLN . 0.7 OUTLIER -92.51 128.1 38.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.925 . . . . 0.0 109.463 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.443 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -76.8 171.59 11.93 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 109.466 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.509 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.0 Cg_endo -78.02 132.44 11.66 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.658 2.239 . . . . 0.0 110.391 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.54 -144.23 5.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.95 12.01 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.693 2.262 . . . . 0.0 111.051 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.549 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 5.8 p-80 -129.0 -33.46 1.98 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 109.614 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -129.4 116.95 19.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.31 45.92 1.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.512 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.509 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -173.19 141.01 0.91 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 2.2 m -58.14 153.55 14.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.871 . . . . 0.0 109.503 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.457 ' HB2' ' SG ' ' B' ' 11' ' ' CYS . 15.3 pt-20 -142.19 107.92 5.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 1.044 HG11 HD11 ' B' ' 63' ' ' ILE . 55.7 t -90.85 153.36 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 0.0 109.34 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' B' ' 27' ' ' ASN . 3.6 mt -140.54 144.77 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 109.646 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.946 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -131.77 119.92 21.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.869 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 7.9 m -89.41 97.92 11.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.015 -1.053 . . . . 0.0 109.095 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 85.5 mt -43.77 163.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.343 -0.848 . . . . 0.0 109.738 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -80.0 9.01 5.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.354 -0.841 . . . . 0.0 109.857 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.46 27.43 9.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 0.0 109.215 179.739 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.33 9.43 72.81 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.513 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 3.4 mtt180 -99.56 163.2 12.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -1.174 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.529 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.2 OUTLIER -137.7 151.89 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.219 179.804 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.536 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.23 127.98 11.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.288 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.58 151.86 30.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 109.077 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 1.028 HD22 ' HA2' ' B' ' 17' ' ' GLY . 19.3 mt -127.15 166.65 17.27 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.275 -0.891 . . . . 0.0 109.326 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.636 ' O ' HG21 ' B' ' 59' ' ' VAL . 8.4 t30 -93.43 115.91 65.72 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 109.106 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.54 -1.24 10.79 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.11 1.873 . . . . 0.0 110.401 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.13 -12.18 36.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 108.867 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 1.0 OUTLIER -90.11 160.94 39.23 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.415 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.505 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.1 Cg_endo -77.42 -31.27 3.56 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.584 2.189 . . . . 0.0 110.588 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.606 HG23 ' N ' ' B' ' 59' ' ' VAL . 4.1 tt -72.28 -45.16 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.032 -1.043 . . . . 0.0 109.37 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 1.0 ' HA ' HD12 ' B' ' 62' ' ' ILE . 19.6 t -56.88 -48.58 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.435 -0.791 . . . . 0.0 109.3 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -61.14 -31.99 71.7 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.147 -0.97 . . . . 0.0 108.536 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -77.51 -19.1 56.35 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 1.0 HD12 ' HA ' ' B' ' 59' ' ' VAL . 16.3 mt -75.23 -38.74 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 1.044 HD11 HG11 ' B' ' 40' ' ' VAL . 1.9 mp -72.75 -56.04 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 108.975 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.533 ' CG ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -58.77 -38.42 78.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.3 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' B' ' 61' ' ' LYS . 8.2 tttp -59.45 -41.07 88.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.157 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.53 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -61.37 -46.6 89.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 109.22 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.606 ' CD1' HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -44.0 -51.73 7.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.451 -0.781 . . . . 0.0 109.396 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.64 -30.33 66.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.352 -0.842 . . . . 0.0 109.571 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -57.01 -19.5 18.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.457 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -83.28 -83.63 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.536 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -154.71 127.29 8.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.501 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.6 t -73.86 -82.55 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.493 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.9 -1.048 . . . . 0.0 109.464 179.988 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.662 ' O ' HG12 ' A' ' 3' ' ' VAL . 38.4 p -83.02 -154.69 0.14 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.401 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 2' ' ' SER . 7.9 p 41.84 27.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.379 -0.826 . . . . 0.0 109.712 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 2' ' ' SER . . . -160.67 160.48 31.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.359 -0.838 . . . . 0.0 109.412 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -167.31 26.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.884 . . . . 0.0 109.517 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -128.59 -145.33 0.3 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.222 -0.923 . . . . 0.0 109.176 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.596 ' HB3' ' CG ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -164.74 123.15 1.74 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -112.18 149.74 31.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 108.909 179.564 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 8' ' ' ARG . 89.0 m -44.5 95.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 109.385 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.552 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -47.98 -22.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.753 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.421 ' O ' ' C ' ' A' ' 12' ' ' LEU . 63.0 m -126.45 65.2 1.25 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.9 . . . . 0.0 109.872 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -44.59 -43.74 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 108.866 179.459 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -122.97 124.86 44.12 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -96.44 167.36 11.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 0.0 110.014 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.542 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.5 mt -118.92 146.27 45.08 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.617 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -44.21 -41.28 5.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.281 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.991 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 147.51 -164.33 28.75 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.952 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -171.11 163.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -1.041 . . . . 0.0 109.197 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.584 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -54.64 149.57 21.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.371 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -77.23 -4.11 14.43 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.502 2.135 . . . . 0.0 110.213 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.486 ' HG2' ' HB3' ' A' ' 19' ' ' HIS . 8.4 pttt -90.29 -24.03 21.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.118 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.521 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 2.6 m-20 -82.92 -5.5 59.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.282 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.952 HD11 ' CD1' ' A' ' 18' ' ' ILE . 9.2 mt -105.99 145.96 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -119.13 -25.42 6.18 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.553 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -143.0 -179.51 6.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 109.122 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 25' ' ' SER . 47.0 t -156.76 155.6 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.994 -1.066 . . . . 0.0 109.911 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . 0.1 OUTLIER -138.71 114.14 9.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.405 -0.809 . . . . 0.0 109.266 179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.47 108.47 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.471 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' CD ' ' HB2' ' A' ' 10' ' ' GLN . 4.2 ptmm? -113.39 108.33 17.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.893 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.414 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.0 OUTLIER -59.83 163.94 6.66 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.377 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.51 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.8 Cg_endo -77.58 152.39 29.59 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.628 2.219 . . . . 0.0 110.336 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.25 -137.06 2.12 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.516 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 35.9 Cg_endo -77.56 8.17 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.515 2.144 . . . . 0.0 110.758 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.596 ' CG ' ' HB3' ' A' ' 7' ' ' LEU . 2.5 p-80 -125.6 -24.34 3.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.023 -1.048 . . . . 0.0 109.733 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.51 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 1.8 t -160.06 107.31 1.63 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.049 -1.032 . . . . 0.0 109.305 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.7 -5.59 26.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.895 . . . . 0.0 109.69 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.445 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 2.2 mp0 -109.17 124.74 51.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.521 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.73 HG21 ' CB ' ' B' ' 70' ' ' ASP . 1.7 m -48.26 158.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.293 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.515 ' HG3' ' NZ ' ' A' ' 29' ' ' LYS . 25.7 mm-40 -139.93 107.36 5.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.65 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.715 HG11 HD11 ' A' ' 63' ' ' ILE . 10.3 t -92.52 151.99 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 109.179 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 3.2 mt -140.19 156.13 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.113 -0.992 . . . . 0.0 109.883 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.759 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -142.65 117.87 10.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 109.015 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 43' ' ' THR . 1.2 m -89.11 96.03 10.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.982 -1.074 . . . . 0.0 108.736 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 89.6 mt -42.32 165.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.586 -0.696 . . . . 0.0 109.891 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -79.52 7.22 8.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.842 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.41 24.0 13.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.139 -0.976 . . . . 0.0 109.22 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.36 -0.11 65.01 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.516 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 72.5 mtt85 -88.57 162.27 16.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -1.195 . . . . 0.0 109.397 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.4 mptt -135.55 151.23 50.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.167 -0.958 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.542 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.25 123.43 8.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.349 -0.844 . . . . 0.0 109.05 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 10.0 m -79.59 142.54 35.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.057 -1.027 . . . . 0.0 109.079 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.133 HD13 HD13 ' A' ' 62' ' ' ILE . 14.3 mt -120.43 167.74 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.243 -0.911 . . . . 0.0 109.62 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.673 ' O ' HG21 ' A' ' 59' ' ' VAL . 7.5 t30 -99.57 122.62 50.86 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.484 -0.76 . . . . 0.0 109.047 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' O ' ' HE2' ' A' ' 60' ' ' LYS . 33.2 Cg_endo -75.11 -3.53 14.06 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.079 1.852 . . . . 0.0 110.354 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.59 -12.4 42.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.913 . . . . 0.0 108.919 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -89.98 163.09 33.45 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.438 -0.789 . . . . 0.0 109.394 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.68 -38.98 0.57 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.696 2.264 . . . . 0.0 110.784 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.589 HG23 ' N ' ' A' ' 59' ' ' VAL . 20.6 tt -65.16 -45.92 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.346 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.052 ' HA ' HD12 ' A' ' 62' ' ' ILE . 44.7 t -57.42 -45.6 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -0.82 . . . . 0.0 109.333 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 56' ' ' SER . 7.4 mttt -59.68 -29.53 68.14 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 7.0 mmmm -79.53 -23.61 42.75 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.133 HD13 HD13 ' A' ' 52' ' ' LEU . 29.2 mt -72.1 -36.63 57.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.54 -0.725 . . . . 0.0 109.303 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.715 HD11 HG11 ' A' ' 40' ' ' VAL . 2.2 mp -75.87 -51.14 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.752 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.482 ' OE2' ' HE3' ' A' ' 61' ' ' LYS . 9.4 pt-20 -65.8 -29.0 69.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.035 -1.04 . . . . 0.0 109.347 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 4.4 mmtt -69.47 -46.11 67.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.871 . . . . 0.0 108.994 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.409 ' O ' ' C ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -56.12 -45.29 79.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.438 -0.789 . . . . 0.0 109.076 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.591 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.62 -51.85 8.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.421 -0.8 . . . . 0.0 109.478 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 69' ' ' SER . 6.8 t-20 -64.86 -37.29 87.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.403 -0.81 . . . . 0.0 109.476 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ASN . 1.1 p -44.14 -26.59 0.32 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.745 ' CB ' HG21 ' B' ' 38' ' ' THR . 1.6 p30 -111.88 82.51 1.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.476 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -127.94 86.44 2.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.476 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.06 157.75 15.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.444 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.484 179.976 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.655 ' O ' HG12 ' B' ' 3' ' ' VAL . 38.8 p -83.02 -154.69 0.14 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.434 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.655 HG12 ' O ' ' B' ' 2' ' ' SER . 7.9 p 41.85 27.89 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.437 -0.789 . . . . 0.0 109.668 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' B' ' 2' ' ' SER . . . -160.75 160.44 31.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -167.21 26.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 109.534 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.474 ' O ' ' HG ' ' B' ' 7' ' ' LEU . 0.9 OUTLIER -128.51 -145.34 0.3 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.207 -0.933 . . . . 0.0 109.175 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.593 ' HB3' ' CG ' ' B' ' 34' ' ' HIS . 1.0 OUTLIER -164.68 123.22 1.76 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.283 -0.886 . . . . 0.0 109.619 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -112.24 149.78 31.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 108.898 179.572 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.429 ' C ' ' O ' ' B' ' 8' ' ' ARG . 89.0 m -44.45 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.149 -0.969 . . . . 0.0 109.339 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.539 ' HB2' ' CD ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -48.03 -22.78 0.66 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.742 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' B' ' 12' ' ' LEU . 63.3 m -126.42 65.22 1.24 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.825 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.2 OUTLIER -44.63 -43.79 8.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 108.818 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -122.86 124.88 44.28 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.477 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -96.45 167.43 11.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.236 -0.915 . . . . 0.0 109.968 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.529 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.5 mt -119.04 146.21 45.24 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.597 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.2 OUTLIER -44.08 -41.31 5.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.372 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 1.024 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 147.53 -164.21 28.75 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.975 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -171.19 163.64 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.473 -1.016 . . . . 0.0 109.166 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.59 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -54.54 149.58 20.63 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.183 -0.948 . . . . 0.0 109.326 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.0 Cg_endo -77.22 -4.15 14.47 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.489 2.126 . . . . 0.0 110.257 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' B' ' 19' ' ' HIS . 8.4 pttt -90.26 -24.05 21.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.352 -0.843 . . . . 0.0 109.136 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 2.5 m-20 -82.92 -5.43 59.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 109.259 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.975 HD11 ' CD1' ' B' ' 18' ' ' ILE . 9.1 mt -105.98 145.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.55 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.9 OUTLIER -119.12 -25.44 6.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.55 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -142.98 -179.45 6.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.431 -0.793 . . . . 0.0 108.98 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 25' ' ' SER . 46.9 t -156.79 155.61 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.101 -0.999 . . . . 0.0 109.901 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' B' ' 41' ' ' ILE . 0.1 OUTLIER -138.72 114.23 9.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.364 -0.835 . . . . 0.0 109.21 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.58 108.52 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.473 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.539 ' CD ' ' HB2' ' B' ' 10' ' ' GLN . 4.2 ptmm? -113.38 108.35 17.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.433 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.402 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.0 OUTLIER -59.8 163.92 6.63 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.521 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.6 Cg_endo -77.64 152.45 29.42 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.56 2.173 . . . . 0.0 110.357 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.24 -136.97 2.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.519 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -77.58 8.01 3.56 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.536 2.157 . . . . 0.0 110.79 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.593 ' CG ' ' HB3' ' B' ' 7' ' ' LEU . 2.4 p-80 -125.53 -24.25 3.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.983 . . . . 0.0 109.734 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.521 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 1.8 t -160.13 107.39 1.62 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.963 . . . . 0.0 109.249 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.7 -5.67 26.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.29 -0.881 . . . . 0.0 109.717 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.45 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 2.2 mp0 -109.1 124.8 51.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.154 -0.967 . . . . 0.0 109.527 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.745 HG21 ' CB ' ' A' ' 70' ' ' ASP . 1.7 m -48.33 158.38 0.27 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.938 . . . . 0.0 109.282 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.513 ' HG3' ' NZ ' ' B' ' 29' ' ' LYS . 25.7 mm-40 -139.92 107.32 5.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 109.716 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.721 HG11 HD11 ' B' ' 63' ' ' ILE . 10.5 t -92.56 151.95 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.18 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' B' ' 51' ' ' CYS . 3.2 mt -140.25 156.22 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.78 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.759 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -142.6 117.98 10.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 109.047 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.61 HG22 ' O ' ' B' ' 43' ' ' THR . 1.2 m -89.19 96.05 10.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.875 -1.141 . . . . 0.0 108.729 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.4 mt -42.27 165.71 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.614 -0.679 . . . . 0.0 109.917 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -79.63 7.23 8.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.452 -0.78 . . . . 0.0 109.804 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.49 24.06 12.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.249 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.31 0.06 65.33 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.512 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 72.3 mtt85 -88.67 162.22 16.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -1.157 . . . . 0.0 109.33 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.523 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 1.4 mptt -135.53 151.35 50.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.89 . . . . 0.0 109.39 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.529 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.29 123.37 8.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.254 -0.904 . . . . 0.0 109.143 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' B' ' 41' ' ' ILE . 10.1 m -79.54 142.59 35.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 109.091 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 1.067 HD13 HD13 ' B' ' 62' ' ' ILE . 14.4 mt -120.45 167.72 12.07 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.561 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.674 ' O ' HG21 ' B' ' 59' ' ' VAL . 7.5 t30 -99.55 122.5 51.28 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.453 -0.779 . . . . 0.0 109.108 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.441 ' O ' ' HE2' ' B' ' 60' ' ' LYS . 33.4 Cg_endo -75.0 -3.6 14.16 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.185 1.923 . . . . 0.0 110.385 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.59 -12.24 43.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 108.993 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.4 OUTLIER -90.06 163.06 33.37 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 109.382 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.63 -39.04 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.636 2.224 . . . . 0.0 110.746 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.6 HG23 ' N ' ' B' ' 59' ' ' VAL . 20.6 tt -65.2 -45.87 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 1.056 ' HA ' HD12 ' B' ' 62' ' ' ILE . 44.2 t -57.48 -45.65 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.847 . . . . 0.0 109.304 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' B' ' 56' ' ' SER . 7.4 mttt -59.57 -29.57 68.03 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' B' ' 65' ' ' LYS . 7.0 mmmm -79.5 -23.66 42.8 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 1.067 HD13 HD13 ' B' ' 52' ' ' LEU . 29.4 mt -72.08 -36.6 57.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.57 -0.706 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.721 HD11 HG11 ' B' ' 40' ' ' VAL . 2.2 mp -75.86 -51.13 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.797 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.48 ' OE2' ' HE3' ' B' ' 61' ' ' LYS . 9.4 pt-20 -65.81 -29.0 69.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.023 -1.048 . . . . 0.0 109.303 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 4.4 mmtt -69.42 -46.19 67.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 108.943 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.442 ' SD ' ' OG ' ' B' ' 69' ' ' SER . 0.3 OUTLIER -56.13 -45.22 79.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.379 -0.826 . . . . 0.0 109.051 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.73 -51.85 8.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.423 -0.798 . . . . 0.0 109.418 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' B' ' 69' ' ' SER . 6.9 t-20 -64.84 -37.25 87.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.486 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.442 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.1 p -44.17 -26.66 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.453 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.73 ' CB ' HG21 ' A' ' 38' ' ' THR . 1.6 p30 -111.83 82.52 1.63 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.893 . . . . 0.0 109.434 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -127.95 86.47 2.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.849 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.09 157.72 15.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.527 179.93 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.88 29.63 7.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.494 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.707 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 1.1 m -116.75 -0.58 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 3' ' ' VAL . . . 76.16 83.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.508 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 t -106.52 30.71 5.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.83 129.66 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 109.29 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -116.17 98.22 6.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.162 -0.961 . . . . 0.0 109.582 -179.983 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -95.32 154.34 17.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.275 -0.891 . . . . 0.0 109.003 179.609 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.885 ' HB2' HD22 ' A' ' 12' ' ' LEU . 8.7 m -44.17 107.56 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.258 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.538 ' HG3' ' CD ' ' A' ' 29' ' ' LYS . 64.3 mm-40 -43.78 -24.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.827 . . . . 0.0 110.015 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.472 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 66.4 m -139.83 77.9 1.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.026 -1.047 . . . . 0.0 109.974 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.885 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -50.51 -43.95 55.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 108.89 179.498 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.53 121.81 41.98 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.49 170.49 8.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.144 -0.972 . . . . 0.0 110.009 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.975 HD12 ' O ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -127.54 148.84 50.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.803 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.6 tt0 -44.43 -54.69 5.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 1.039 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 149.04 168.53 14.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.848 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -136.34 161.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -1.097 . . . . 0.0 109.374 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.619 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -43.26 147.74 0.7 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.795 . . . . 0.0 109.048 179.533 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.619 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 33.6 Cg_endo -75.59 -3.01 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.213 1.942 . . . . 0.0 110.009 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.44 -25.22 20.46 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.367 -0.833 . . . . 0.0 108.909 179.26 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 5.2 m-20 -81.92 -4.88 57.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.435 -0.79 . . . . 0.0 109.334 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.61 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 13.6 mt -107.0 149.6 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 0.0 110.294 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.571 ' HG3' ' N ' ' A' ' 25' ' ' SER . 1.0 OUTLIER -120.93 -28.1 4.87 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.248 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.571 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -135.93 169.17 18.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.105 179.323 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 25' ' ' SER . 48.9 t -156.66 126.27 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.718 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 55.5 t30 -108.49 157.93 18.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.339 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.07 95.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.493 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.538 ' CD ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -100.54 126.99 47.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.577 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.492 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.2 p -75.85 160.99 77.54 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.346 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.496 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.2 Cg_endo -77.15 145.61 24.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.509 2.14 . . . . 0.0 110.425 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.39 -133.64 1.55 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.97 41.46 1.12 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.719 2.279 . . . . 0.0 110.781 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 9.1 p-80 -162.11 -38.01 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.073 -1.017 . . . . 0.0 109.28 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 2.7 t -145.71 101.18 3.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.176 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.17 -12.46 20.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.725 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.459 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 1.9 mp0 -106.92 129.39 54.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.526 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.848 HG21 ' HB2' ' B' ' 70' ' ' ASP . 0.6 OUTLIER -48.49 162.82 0.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.192 -0.942 . . . . 0.0 109.292 179.887 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' A' ' 11' ' ' CYS . 2.6 mp0 -136.95 114.44 11.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.643 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.844 HG11 HD11 ' A' ' 63' ' ' ILE . 19.5 t -104.86 144.57 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.16 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 2.6 mp -133.34 152.35 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.61 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -137.6 116.49 12.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.866 . . . . 0.0 109.173 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.534 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.8 m -89.12 97.51 11.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.956 -1.09 . . . . 0.0 108.785 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 93.1 mt -44.72 166.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.522 -0.736 . . . . 0.0 109.6 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.2 ptpt -81.61 8.46 9.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.28 19.92 17.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.204 179.742 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 4.54 89.6 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.516 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 5.8 mtt180 -94.55 168.39 10.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -1.194 . . . . 0.0 109.508 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.93 156.72 48.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 179.808 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.4 120.03 7.0 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.308 -0.87 . . . . 0.0 109.098 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.975 ' O ' HD12 ' A' ' 15' ' ' LEU . 8.0 m -79.74 139.08 37.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.077 -1.014 . . . . 0.0 108.948 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.039 HD22 ' HA2' ' A' ' 17' ' ' GLY . 10.4 mt -123.39 168.32 12.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.204 -0.935 . . . . 0.0 109.68 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.615 ' O ' HG21 ' A' ' 59' ' ' VAL . 28.9 t-20 -101.65 119.89 55.94 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.5 -0.75 . . . . 0.0 109.334 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.444 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 33.6 Cg_endo -74.84 1.39 7.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.127 1.885 . . . . 0.0 110.542 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.53 -17.36 30.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.219 -0.926 . . . . 0.0 108.964 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -90.16 164.06 29.26 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 109.456 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.29 -33.31 1.98 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.731 2.287 . . . . 0.0 110.671 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.615 ' O ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -67.26 -48.33 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.104 -0.998 . . . . 0.0 108.99 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.852 HG22 ' HB3' ' A' ' 52' ' ' LEU . 33.7 t -57.38 -48.73 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 108.983 179.353 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 56' ' ' SER . 4.9 mmmt -53.6 -32.2 50.15 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.535 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 3.1 mmpt? -73.64 -34.03 64.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.505 -0.747 . . . . 0.0 109.193 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.615 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.5 mp -59.9 -44.68 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.807 . . . . 0.0 108.921 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.904 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -66.66 -62.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -0.869 . . . . 0.0 109.897 -179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 60' ' ' LYS . 5.6 pt-20 -58.35 -15.81 12.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.992 -1.067 . . . . 0.0 109.517 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 7.8 mmtt -83.32 -36.18 24.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 108.795 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.464 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -68.99 -44.83 72.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.402 -0.811 . . . . 0.0 108.946 179.429 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.908 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -43.63 -50.74 7.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.328 179.68 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -72.84 -36.74 67.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.464 ' OG ' ' HA ' ' A' ' 66' ' ' MET . 25.2 p -88.26 39.33 0.9 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.452 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.822 ' HB2' HG21 ' B' ' 38' ' ' THR . 5.0 p-10 -91.67 -13.67 31.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.86 . . . . 0.0 109.468 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' C ' ' OG ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -145.0 44.3 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.493 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 0.3 OUTLIER 65.32 103.36 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.266 -0.896 . . . . 0.0 109.459 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 72' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.91 29.69 7.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.529 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.709 ' O ' ' HB3' ' B' ' 4' ' ' ALA . 1.1 m -116.84 -0.58 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.544 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' B' ' 3' ' ' VAL . . . 76.13 83.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.134 -0.979 . . . . 0.0 109.54 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.1 t -106.58 30.67 5.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.92 129.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 109.353 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -116.06 98.3 6.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.127 -0.983 . . . . 0.0 109.608 179.972 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -95.37 154.33 17.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.356 -0.84 . . . . 0.0 108.959 179.607 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.928 ' HB2' HD22 ' B' ' 12' ' ' LEU . 8.8 m -44.17 107.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 109.325 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.532 ' HG3' ' CD ' ' B' ' 29' ' ' LYS . 64.3 mm-40 -43.78 -24.92 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.336 -0.853 . . . . 0.0 109.998 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.469 ' HB2' ' HG3' ' B' ' 39' ' ' GLU . 66.3 m -139.8 77.97 1.64 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.072 -1.018 . . . . 0.0 109.986 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.928 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -50.53 -43.85 56.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 108.922 179.474 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.57 121.83 42.01 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.527 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.49 170.53 8.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 110.053 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.985 HD12 ' O ' ' B' ' 51' ' ' CYS . 0.3 OUTLIER -127.61 148.74 50.37 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.754 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.784 ' O ' HG23 ' B' ' 59' ' ' VAL . 2.6 tt0 -44.36 -54.74 5.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.97 . . . . 0.0 109.451 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 1.041 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 149.1 168.59 14.88 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.829 HD13 ' N ' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -136.39 161.65 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -1.072 . . . . 0.0 109.359 179.746 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.607 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.5 OUTLIER -43.34 147.85 0.71 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.394 -0.816 . . . . 0.0 109.005 179.561 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.607 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 33.1 Cg_endo -75.61 -3.08 13.39 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.264 1.976 . . . . 0.0 109.941 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.49 -25.26 20.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.825 . . . . 0.0 108.807 179.383 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.53 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 5.3 m-20 -81.77 -4.96 57.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.444 -0.785 . . . . 0.0 109.398 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.605 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 13.7 mt -107.05 149.62 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 110.213 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.576 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -120.92 -28.03 4.88 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.267 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.576 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -136.05 169.1 18.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.33 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 25' ' ' SER . 48.7 t -156.56 126.27 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 109.752 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 55.6 t30 -108.47 157.99 17.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.329 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.13 95.42 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.532 ' CD ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -100.51 127.03 46.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.591 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.478 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.2 p -75.87 160.99 77.47 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.332 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.495 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.4 Cg_endo -77.11 145.55 24.67 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.575 2.183 . . . . 0.0 110.456 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.4 -133.63 1.54 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.0 41.53 1.14 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.595 2.197 . . . . 0.0 110.807 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' B' ' 7' ' ' LEU . 9.0 p-80 -162.09 -38.05 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.046 . . . . 0.0 109.269 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.495 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 2.7 t -145.7 101.31 3.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 0.0 109.131 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.28 -12.39 20.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.903 . . . . 0.0 109.737 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 1.9 mp0 -106.89 129.36 54.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -0.942 . . . . 0.0 109.503 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.822 HG21 ' HB2' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -48.44 162.83 0.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 109.227 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' B' ' 11' ' ' CYS . 2.6 mp0 -136.94 114.42 10.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.687 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.809 HG11 HD11 ' B' ' 63' ' ' ILE . 19.1 t -104.85 144.47 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.851 . . . . 0.0 109.184 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 2.6 mp -133.24 152.37 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.81 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.605 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -137.62 116.43 12.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -0.888 . . . . 0.0 109.179 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.532 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 1.8 m -89.11 97.52 11.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.922 -1.111 . . . . 0.0 108.737 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 93.1 mt -44.62 166.75 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.556 -0.715 . . . . 0.0 109.628 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.2 ptpt -81.6 8.5 9.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.632 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -111.3 19.87 17.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.96 . . . . 0.0 109.228 179.71 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 4.59 89.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 5.8 mtt180 -94.59 168.35 10.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.162 -1.199 . . . . 0.0 109.55 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.89 156.74 48.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.82 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.39 120.08 7.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.335 -0.853 . . . . 0.0 109.052 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.985 ' O ' HD12 ' B' ' 15' ' ' LEU . 8.0 m -79.74 139.11 37.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 108.972 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 1.041 HD22 ' HA2' ' B' ' 17' ' ' GLY . 10.5 mt -123.47 168.36 12.67 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.149 -0.97 . . . . 0.0 109.67 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.611 ' O ' HG21 ' B' ' 59' ' ' VAL . 29.1 t-20 -101.68 119.89 55.89 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 109.332 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.449 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.2 Cg_endo -74.84 1.3 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.183 1.922 . . . . 0.0 110.518 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.48 -17.31 30.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.912 . . . . 0.0 108.977 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.4 OUTLIER -90.2 164.01 29.3 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.82 . . . . 0.0 109.383 179.915 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.32 -33.22 1.99 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.624 2.216 . . . . 0.0 110.694 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.608 ' O ' HD13 ' B' ' 62' ' ' ILE . 0.2 OUTLIER -67.21 -48.33 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.105 -0.997 . . . . 0.0 108.995 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.859 HG22 ' HB3' ' B' ' 52' ' ' LEU . 33.8 t -57.42 -48.72 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.414 -0.804 . . . . 0.0 108.981 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' B' ' 56' ' ' SER . 4.9 mmmt -53.63 -32.19 50.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.539 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 3.1 mmpt? -73.57 -34.19 65.01 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.608 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.5 mp -59.74 -44.79 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 108.955 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.908 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -66.72 -62.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 109.876 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.473 ' OE2' ' HA ' ' B' ' 61' ' ' LYS . 5.6 pt-20 -58.28 -15.85 11.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.99 . . . . 0.0 109.576 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 7.7 mmtt -83.29 -36.21 24.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 108.791 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.47 ' HA ' ' OG ' ' B' ' 69' ' ' SER . 0.2 OUTLIER -69.0 -44.79 72.1 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.484 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.904 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -43.68 -50.67 7.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.381 -0.824 . . . . 0.0 109.373 179.701 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -72.81 -36.73 67.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.884 . . . . 0.0 109.482 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' B' ' 66' ' ' MET . 25.6 p -88.31 39.28 0.9 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.381 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.848 ' HB2' HG21 ' A' ' 38' ' ' THR . 4.9 p-10 -91.59 -13.69 31.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.411 ' C ' ' OG ' ' B' ' 72' ' ' SER . 0.0 OUTLIER -145.04 44.39 1.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.399 -179.974 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' B' ' 73' ' ' ASN . 0.3 OUTLIER 65.23 103.42 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.467 -179.992 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 73' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' B' ' 72' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.482 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -178.26 57.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.516 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.703 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 8.4 p -106.17 134.85 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -0.899 . . . . 0.0 109.456 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 3' ' ' VAL . . . 75.92 -153.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.552 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 4' ' ' ALA . 1.3 m -169.63 124.2 0.8 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.419 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.421 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 3.2 tt0 -119.92 -143.82 0.36 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.257 -0.902 . . . . 0.0 109.199 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.681 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -158.89 120.87 3.49 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.669 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -133.98 159.1 41.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.4 -0.813 . . . . 0.0 109.001 179.789 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.44 ' HB3' ' OE2' ' A' ' 39' ' ' GLU . 58.4 m -44.55 101.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.944 . . . . 0.0 109.289 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.537 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 22.1 mm100 -62.5 -10.01 10.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.891 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.462 ' SG ' ' HG2' ' A' ' 39' ' ' GLU . 39.7 m -138.83 67.93 1.39 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.005 -1.06 . . . . 0.0 109.851 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -45.13 -45.63 11.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.147 -0.97 . . . . 0.0 108.998 179.54 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.426 ' OE1' ' N ' ' A' ' 14' ' ' THR . 0.5 OUTLIER -118.14 116.9 27.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.463 -0.773 . . . . 0.0 108.95 179.541 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.426 ' N ' ' OE1' ' A' ' 13' ' ' GLN . 0.6 OUTLIER -90.24 171.08 9.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 110.048 -179.442 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 51' ' ' CYS . 1.0 OUTLIER -119.81 143.66 47.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.478 -0.763 . . . . 0.0 109.09 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.524 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -44.65 -38.27 4.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.084 -1.01 . . . . 0.0 109.287 -179.909 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 1.074 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 138.26 156.51 7.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.805 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -125.8 156.11 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -1.082 . . . . 0.0 109.332 179.592 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.616 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.94 153.99 0.31 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.852 . . . . 0.0 109.298 179.82 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.616 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.1 Cg_endo -76.27 -5.03 15.81 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.417 2.078 . . . . 0.0 109.943 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -81.73 -22.28 37.42 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.047 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.906 ' O ' HD23 ' A' ' 44' ' ' LEU . 35.4 m-20 -98.58 60.03 1.3 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.895 HD13 ' O ' ' A' ' 22' ' ' ASN . 2.6 mm -143.78 167.5 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.937 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.754 ' HG2' HG22 ' A' ' 43' ' ' THR . 0.1 OUTLIER -160.18 -35.15 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.566 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.5 p -133.51 176.72 8.29 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.173 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.507 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 54.6 t -151.29 92.11 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.976 -1.078 . . . . 0.0 109.868 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.493 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 5.1 t-20 -94.03 110.63 22.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.219 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.581 HG13 HG22 ' A' ' 40' ' ' VAL . 1.9 t -121.77 100.15 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.584 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.537 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 9.6 ptpt -98.09 106.67 19.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.352 -0.843 . . . . 0.0 109.363 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.591 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.1 p -45.87 170.54 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.398 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 35.6 Cg_endo -77.89 132.28 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.568 2.179 . . . . 0.0 110.407 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.33 -142.7 4.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.21 8.12 3.38 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.584 2.189 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.681 ' CD2' HD22 ' A' ' 7' ' ' LEU . 6.6 p-80 -124.44 -18.75 5.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 109.73 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -160.22 96.62 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 109.255 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -55.17 -29.16 57.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.55 125.33 35.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.591 HG23 ' HA ' ' A' ' 30' ' ' SER . 32.5 m -46.43 152.75 0.41 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -129.31 121.67 27.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.65 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.687 HG11 HD11 ' A' ' 63' ' ' ILE . 16.2 t -108.14 150.34 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.22 179.693 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 27' ' ' ASN . 14.4 mt -143.15 143.12 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.015 . . . . 0.0 109.846 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.684 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -130.99 123.02 27.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 108.932 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.754 HG22 ' HG2' ' A' ' 24' ' ' GLN . 40.5 m -89.39 103.26 15.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.967 -1.083 . . . . 0.0 109.097 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.906 HD23 ' O ' ' A' ' 22' ' ' ASN . 73.1 mt -42.48 165.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.502 -0.749 . . . . 0.0 109.59 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.4 ptpt -87.27 16.44 5.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 44' ' ' LEU . 19.0 p-10 -117.27 6.02 12.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 109.399 179.635 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.53 14.46 44.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.674 ' HB2' HD12 ' A' ' 44' ' ' LEU . 9.8 mtp180 -111.32 174.23 5.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -1.203 . . . . 0.0 109.553 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.434 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 6.8 mttt -138.26 156.69 47.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.25 120.48 7.29 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.331 -0.855 . . . . 0.0 109.058 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.866 ' O ' HD12 ' A' ' 15' ' ' LEU . 20.6 m -79.31 140.59 37.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.12 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 1.074 HD22 ' HA2' ' A' ' 17' ' ' GLY . 10.2 mt -124.51 168.97 12.35 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.234 -0.916 . . . . 0.0 109.597 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.681 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.7 t-20 -105.61 127.39 28.61 Favored Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.381 -0.824 . . . . 0.0 109.255 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.71 2.21 7.22 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.236 1.957 . . . . 0.0 110.648 -179.503 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.429 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -86.0 -19.03 30.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.033 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.512 ' OG ' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -90.22 162.7 34.04 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 109.526 179.95 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.76 -32.98 2.44 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.722 2.281 . . . . 0.0 111.002 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.512 HG22 ' OG ' ' A' ' 56' ' ' SER . 15.8 tt -70.54 -40.26 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.057 -1.027 . . . . 0.0 109.539 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 1.006 ' HA ' HD12 ' A' ' 62' ' ' ILE . 24.6 t -61.96 -48.19 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.343 -0.848 . . . . 0.0 108.951 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -60.9 -29.63 69.69 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.541 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -81.92 -19.7 40.24 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.867 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 1.006 HD12 ' HA ' ' A' ' 59' ' ' VAL . 16.4 mt -72.71 -38.86 59.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.936 HG22 HD11 ' B' ' 67' ' ' LEU . 1.5 mp -75.27 -61.84 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.313 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.33 -47.82 25.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.342 -0.849 . . . . 0.0 109.294 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 21.8 tptt -52.0 -57.3 9.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.185 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.507 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -44.36 -48.45 9.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.2 179.747 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.899 HD11 HG22 ' B' ' 63' ' ' ILE . 0.4 OUTLIER -48.81 -54.66 14.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.49 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' SER . 18.5 t30 -56.14 -32.82 64.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.484 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 1.1 p -43.9 -59.39 2.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.471 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.2 OUTLIER 77.66 -77.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.855 . . . . 0.0 109.565 179.99 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.516 ' HG2' ' HG3' ' B' ' 31' ' ' PRO . 4.9 mtmt -155.43 -46.66 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -0.955 . . . . 0.0 109.478 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -148.1 148.56 30.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.339 -0.85 . . . . 0.0 109.47 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.415 179.997 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -178.21 58.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.412 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.705 ' O ' ' HB3' ' B' ' 4' ' ' ALA . 8.4 p -106.21 134.87 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.455 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' B' ' 3' ' ' VAL . . . 75.93 -153.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.489 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' B' ' 4' ' ' ALA . 1.3 m -169.65 124.21 0.8 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.417 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.404 ' O ' ' HG ' ' B' ' 7' ' ' LEU . 3.2 tt0 -119.84 -143.84 0.36 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.18 -0.95 . . . . 0.0 109.228 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.685 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.8 OUTLIER -158.85 120.94 3.52 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.233 -0.917 . . . . 0.0 109.658 -179.992 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' B' ' 10' ' ' GLN . 0.1 OUTLIER -133.98 159.19 41.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.379 -0.825 . . . . 0.0 108.99 179.707 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.448 ' HB3' ' OE2' ' B' ' 39' ' ' GLU . 58.8 m -44.63 101.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.34 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.529 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 22.1 mm100 -62.55 -9.94 10.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.889 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.461 ' SG ' ' HG2' ' B' ' 39' ' ' GLU . 39.6 m -138.87 68.03 1.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 109.836 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.3 OUTLIER -45.28 -45.63 12.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 108.883 179.609 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 13' ' ' GLN . . . . . 0.417 ' OE1' ' N ' ' B' ' 14' ' ' THR . 0.5 OUTLIER -118.03 116.87 27.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 108.928 179.643 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.417 ' N ' ' OE1' ' B' ' 13' ' ' GLN . 0.6 OUTLIER -90.24 171.1 9.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -0.924 . . . . 0.0 110.042 -179.456 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.836 HD12 ' O ' ' B' ' 51' ' ' CYS . 1.0 OUTLIER -119.86 143.66 47.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.45 -0.781 . . . . 0.0 109.013 179.764 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.52 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.9 OUTLIER -44.58 -38.29 4.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 -179.962 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 1.02 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 138.26 156.52 7.14 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.805 ' H ' HD13 ' B' ' 18' ' ' ILE . 0.2 OUTLIER -125.84 156.04 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -1.084 . . . . 0.0 109.316 179.579 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.609 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -42.8 154.03 0.31 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 109.31 179.797 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.609 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 33.6 Cg_endo -76.38 -5.0 15.74 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.377 2.051 . . . . 0.0 109.862 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -81.74 -22.2 37.44 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.997 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.902 ' O ' HD23 ' B' ' 44' ' ' LEU . 35.6 m-20 -98.54 59.94 1.31 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.217 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.881 HD13 ' O ' ' B' ' 22' ' ' ASN . 2.6 mm -143.78 167.54 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.963 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.746 ' HG2' HG22 ' B' ' 43' ' ' THR . 0.1 OUTLIER -160.24 -35.1 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.273 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.545 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.4 p -133.46 176.77 8.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.009 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.511 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 54.0 t -151.31 92.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.897 -1.127 . . . . 0.0 109.86 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.485 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 5.1 t-20 -94.1 110.62 22.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.249 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.595 HG13 HG22 ' B' ' 40' ' ' VAL . 1.9 t -121.76 100.16 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.605 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.529 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 9.6 ptpt -98.05 106.66 18.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 109.401 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.588 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -45.9 170.57 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.399 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.525 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 35.9 Cg_endo -77.79 132.21 11.76 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.594 2.196 . . . . 0.0 110.499 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.32 -142.7 4.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.2 8.1 3.39 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.524 2.15 . . . . 0.0 110.873 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.685 ' CD2' HD22 ' B' ' 7' ' ' LEU . 6.6 p-80 -124.44 -18.66 5.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.006 -1.059 . . . . 0.0 109.757 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -160.22 96.59 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -0.948 . . . . 0.0 109.303 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -55.19 -29.12 57.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.941 . . . . 0.0 109.651 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.61 125.41 35.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.486 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.588 HG23 ' HA ' ' B' ' 30' ' ' SER . 32.4 m -46.41 152.74 0.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.424 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.461 ' HG2' ' SG ' ' B' ' 11' ' ' CYS . 0.0 OUTLIER -129.32 121.59 27.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.193 -0.942 . . . . 0.0 109.733 -179.929 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.688 HG11 HD11 ' B' ' 63' ' ' ILE . 16.2 t -108.17 150.36 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.24 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' B' ' 27' ' ' ASN . 14.5 mt -143.19 143.12 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.673 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -131.03 123.03 27.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 108.862 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.746 HG22 ' HG2' ' B' ' 24' ' ' GLN . 41.8 m -89.31 103.24 15.88 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.943 -1.098 . . . . 0.0 109.182 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.902 HD23 ' O ' ' B' ' 22' ' ' ASN . 72.5 mt -42.46 165.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.538 -0.726 . . . . 0.0 109.582 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.4 ptpt -87.26 16.38 5.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 109.555 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.523 ' OD1' ' CB ' ' B' ' 44' ' ' LEU . 19.0 p-10 -117.33 6.17 12.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.619 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.47 14.61 43.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.696 ' HB2' HD12 ' B' ' 44' ' ' LEU . 9.7 mtp180 -111.43 174.26 5.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -1.207 . . . . 0.0 109.495 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.42 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 6.7 mttt -138.24 156.81 47.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.33 120.52 7.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.821 . . . . 0.0 109.02 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.836 ' O ' HD12 ' B' ' 15' ' ' LEU . 20.5 m -79.37 140.62 37.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.074 -1.016 . . . . 0.0 109.122 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 1.032 HD13 HD13 ' B' ' 62' ' ' ILE . 10.2 mt -124.51 168.96 12.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.69 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.7 t-20 -105.57 127.39 28.62 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.795 . . . . 0.0 109.185 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.74 2.27 7.17 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.208 1.939 . . . . 0.0 110.657 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.443 ' HB3' ' OD1' ' B' ' 53' ' ' ASN . . . -85.98 -19.1 30.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 0.0 109.074 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.505 ' OG ' HG22 ' B' ' 58' ' ' ILE . 0.4 OUTLIER -90.29 162.76 33.7 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.503 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.73 -33.0 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.755 2.303 . . . . 0.0 111.006 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.505 HG22 ' OG ' ' B' ' 56' ' ' SER . 15.9 tt -70.59 -40.16 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.109 -0.994 . . . . 0.0 109.51 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 1.026 ' HA ' HD12 ' B' ' 62' ' ' ILE . 24.5 t -62.07 -48.17 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.378 -0.827 . . . . 0.0 108.913 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -60.92 -29.7 69.76 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.535 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -81.81 -19.65 40.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 179.804 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 1.032 HD13 HD13 ' B' ' 52' ' ' LEU . 16.4 mt -72.76 -38.88 58.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.899 HG22 HD11 ' A' ' 67' ' ' LEU . 1.5 mp -75.16 -61.91 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -47.86 25.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.38 -0.825 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' B' ' 66' ' ' MET . 21.9 tptt -51.85 -57.38 9.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.163 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.511 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -44.39 -48.48 9.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.173 179.783 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.936 HD11 HG22 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -48.77 -54.63 14.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 179.899 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' B' ' 69' ' ' SER . 18.5 t30 -56.27 -32.7 64.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 0.0 109.498 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' B' ' 70' ' ' ASP . 1.1 p -44.07 -59.23 2.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 109.468 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' B' ' 69' ' ' SER . 0.2 OUTLIER 77.58 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -0.841 . . . . 0.0 109.586 179.906 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.512 ' HG2' ' HG3' ' A' ' 31' ' ' PRO . 4.9 mtmt -155.43 -46.6 0.08 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.201 -0.937 . . . . 0.0 109.494 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -148.2 148.57 30.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.435 179.967 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 m -120.0 -29.39 4.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.917 . . . . 0.0 109.486 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 2.0 t -68.17 169.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.88 . . . . 0.0 109.468 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.655 ' O ' HG22 ' A' ' 5' ' ' THR . . . 178.12 140.26 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.427 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 4' ' ' ALA . 13.6 t 41.96 32.45 0.29 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.454 -0.779 . . . . 0.0 109.673 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -132.54 74.3 1.57 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.416 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.546 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -116.62 98.18 6.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.933 . . . . 0.0 109.607 -179.972 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.6 OUTLIER -83.98 154.67 23.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -0.947 . . . . 0.0 108.991 179.586 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.986 ' HB2' HD22 ' A' ' 12' ' ' LEU . 7.2 m -44.38 126.17 5.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.078 -1.014 . . . . 0.0 109.414 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 39' ' ' GLU . 5.3 mp0 -41.08 -38.38 1.02 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.515 -0.741 . . . . 0.0 109.736 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' A' ' 41' ' ' ILE . 72.3 m -136.56 78.21 1.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.695 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.986 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.87 -46.77 11.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.083 179.646 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -117.6 124.94 49.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.357 -0.839 . . . . 0.0 108.995 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 169.47 8.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 109.992 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 51' ' ' CYS . 4.8 mt -113.86 -167.42 1.2 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.759 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.4 mt-30 -88.92 -48.06 7.72 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 0.0 109.348 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.523 ' C ' HD13 ' A' ' 18' ' ' ILE . . . 154.2 161.57 10.54 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.853 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -142.98 149.67 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.378 -1.072 . . . . 0.0 109.311 179.666 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.597 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.94 152.08 0.38 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 109.535 -179.865 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -77.18 -2.65 12.88 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.584 2.189 . . . . 0.0 110.177 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.522 ' NZ ' ' HA ' ' A' ' 72' ' ' SER . 3.9 mmtt -90.19 -24.55 20.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.113 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 6.1 m-20 -85.43 -5.88 59.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.323 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.798 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 9.4 mt -104.93 152.7 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.255 -0.903 . . . . 0.0 110.043 -179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.576 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -124.98 -28.44 3.46 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.441 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.576 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.9 OUTLIER -137.33 174.08 10.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.072 179.473 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.55 HG11 HG13 ' A' ' 63' ' ' ILE . 21.4 t -149.74 119.64 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.985 . . . . 0.0 109.788 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.629 ' O ' HD12 ' A' ' 41' ' ' ILE . 4.8 t-20 -112.85 112.7 24.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 109.338 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.841 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -116.33 109.89 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.489 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.567 ' CE ' ' NE2' ' A' ' 34' ' ' HIS . 7.4 tttt -107.68 107.79 18.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.445 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.436 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.1 p -50.66 168.42 0.23 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.41 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 35.8 Cg_endo -77.88 134.68 13.52 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.582 2.188 . . . . 0.0 110.422 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.8 -142.04 4.45 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.09 7.79 3.5 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.553 2.169 . . . . 0.0 110.88 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.567 ' NE2' ' CE ' ' A' ' 29' ' ' LYS . 8.0 p-80 -126.34 -7.55 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.079 -1.013 . . . . 0.0 109.628 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.446 ' SG ' ' OE2' ' A' ' 39' ' ' GLU . 4.2 t -160.3 146.47 15.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.288 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.3 0.84 23.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 37' ' ' GLN . 3.8 mp0 -126.88 124.91 40.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.004 . . . . 0.0 109.474 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.436 HG23 ' HA ' ' A' ' 30' ' ' SER . 23.6 m -45.8 144.58 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 0.0 109.349 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 10' ' ' GLN . 4.6 mm-40 -122.47 107.24 11.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.664 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.866 HG11 HD11 ' A' ' 63' ' ' ILE . 38.5 t -91.89 150.39 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.135 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.1 mt -139.87 154.67 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.11 -0.994 . . . . 0.0 109.802 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.798 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -138.57 118.07 12.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.155 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.534 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.9 m -89.16 97.83 11.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.907 -1.121 . . . . 0.0 108.912 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 90.8 mt -44.0 166.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.488 -0.758 . . . . 0.0 109.66 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -81.58 8.06 10.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.699 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.01 24.68 12.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.225 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.16 3.93 71.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 6.9 mtt180 -93.2 166.56 12.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.146 -1.208 . . . . 0.0 109.454 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.4 155.6 49.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 0.0 109.433 -179.957 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.35 118.33 6.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.194 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.466 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 7.0 m -79.51 138.33 37.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.125 -0.984 . . . . 0.0 108.868 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.876 ' HB3' HG22 ' A' ' 59' ' ' VAL . 9.8 mt -124.0 168.61 12.6 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.632 ' O ' HG21 ' A' ' 59' ' ' VAL . 65.5 t30 -101.49 121.38 51.67 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.47 -0.769 . . . . 0.0 109.446 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.494 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.7 Cg_endo -74.67 -2.25 12.2 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.163 1.909 . . . . 0.0 110.488 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.58 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -83.8 -17.38 41.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.304 -0.873 . . . . 0.0 108.849 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -90.27 163.08 32.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.443 179.919 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.475 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 35.9 Cg_endo -77.74 -35.32 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.638 2.226 . . . . 0.0 111.113 -179.68 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.626 ' O ' HD13 ' A' ' 62' ' ' ILE . 16.1 tt -67.9 -47.41 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.979 -1.076 . . . . 0.0 109.236 -179.807 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.876 HG22 ' HB3' ' A' ' 52' ' ' LEU . 32.7 t -55.04 -48.61 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.195 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 12.0 mttt -57.36 -31.32 65.63 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.525 ' CE ' ' OE2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -75.67 -27.59 58.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.655 -0.653 . . . . 0.0 109.342 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.65 HG23 ' CD1' ' A' ' 23' ' ' ILE . 1.7 mp -67.33 -43.25 88.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.404 -0.81 . . . . 0.0 108.832 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.042 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.1 mp -69.53 -65.28 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.833 . . . . 0.0 109.721 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' OE2' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -49.01 -35.32 15.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.131 -0.98 . . . . 0.0 109.643 -179.703 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.484 ' HB3' ' CB ' ' A' ' 20' ' ' PRO . 21.3 mmtm -63.38 -54.0 43.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.09 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.529 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -49.06 -46.53 44.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.314 -0.866 . . . . 0.0 109.146 179.599 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.053 HD11 ' CG2' ' B' ' 63' ' ' ILE . 1.0 OUTLIER -56.87 -47.56 80.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.509 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.53 31.36 2.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.437 ' O ' ' CG ' ' A' ' 70' ' ' ASP . 56.8 p -90.93 -40.53 11.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.138 -0.976 . . . . 0.0 109.372 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 70' ' ' ASP . 6.4 p-10 40.68 83.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.533 -0.73 . . . . 0.0 109.771 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 70' ' ' ASP . 12.5 mtmt 44.07 -148.99 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.54 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.522 ' HA ' ' NZ ' ' A' ' 21' ' ' LYS . 4.3 m -90.37 -42.63 10.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.538 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.473 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.4 m -119.97 -29.42 4.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.89 . . . . 0.0 109.458 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' B' ' 4' ' ' ALA . 2.0 t -68.04 169.75 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.501 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 4' ' ' ALA . . . . . 0.654 ' O ' HG22 ' B' ' 5' ' ' THR . . . 178.06 140.29 0.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.457 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 5' ' ' THR . . . . . 0.654 HG22 ' O ' ' B' ' 4' ' ' ALA . 13.5 t 42.01 32.37 0.29 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.429 -0.794 . . . . 0.0 109.642 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -132.47 74.25 1.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 109.475 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.546 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -116.55 98.14 6.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.594 -179.905 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.6 OUTLIER -83.96 154.74 23.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.295 -0.878 . . . . 0.0 109.019 179.579 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 1.002 ' HB2' HD22 ' B' ' 12' ' ' LEU . 7.0 m -44.44 126.18 5.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.955 . . . . 0.0 109.374 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.493 ' HB2' ' HB2' ' B' ' 39' ' ' GLU . 5.3 mp0 -41.02 -38.39 0.99 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.829 -179.975 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.464 ' SG ' HG13 ' B' ' 41' ' ' ILE . 72.5 m -136.58 78.26 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.736 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 1.002 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.0 -46.74 11.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.059 179.71 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -117.57 125.06 50.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 108.968 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.99 169.42 8.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.215 -0.928 . . . . 0.0 109.992 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 51' ' ' CYS . 4.9 mt -113.89 -167.41 1.2 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.755 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.4 mt-30 -88.86 -48.17 7.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.126 -0.984 . . . . 0.0 109.299 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.51 ' C ' HD13 ' B' ' 18' ' ' ILE . . . 154.26 161.55 10.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.843 HD13 ' N ' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -143.0 149.79 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.357 -1.084 . . . . 0.0 109.267 179.589 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.592 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -42.98 152.12 0.38 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.356 -0.84 . . . . 0.0 109.468 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.592 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -77.28 -2.67 12.88 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.498 2.132 . . . . 0.0 110.092 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.51 ' NZ ' ' HA ' ' B' ' 72' ' ' SER . 3.9 mmtt -90.06 -24.61 21.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -0.847 . . . . 0.0 109.178 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.529 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 6.1 m-20 -85.33 -5.96 59.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.296 -0.878 . . . . 0.0 109.364 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.8 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 9.2 mt -104.89 152.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 110.089 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.572 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -124.9 -28.46 3.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.479 -0.763 . . . . 0.0 109.084 179.355 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.572 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.9 OUTLIER -137.24 174.2 10.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.902 . . . . 0.0 109.076 179.436 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.541 HG11 HG13 ' B' ' 63' ' ' ILE . 21.4 t -149.86 119.66 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.045 -1.034 . . . . 0.0 109.707 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.633 ' O ' HD12 ' B' ' 41' ' ' ILE . 4.8 t-20 -112.89 112.71 24.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.344 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.847 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -116.31 109.9 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 109.403 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.573 ' CE ' ' NE2' ' B' ' 34' ' ' HIS . 7.4 tttt -107.62 107.8 18.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.869 . . . . 0.0 109.444 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.447 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -50.7 168.48 0.23 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 36.0 Cg_endo -77.89 134.65 13.49 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.666 2.244 . . . . 0.0 110.424 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.81 -142.01 4.44 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.1 7.75 3.52 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.651 2.234 . . . . 0.0 110.816 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.573 ' NE2' ' CE ' ' B' ' 29' ' ' LYS . 8.0 p-80 -126.35 -7.59 6.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 109.608 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.444 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 4.2 t -160.23 146.52 15.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.287 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.29 0.76 23.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.151 -0.968 . . . . 0.0 109.706 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.42 ' CD ' ' N ' ' B' ' 37' ' ' GLN . 3.9 mp0 -126.88 125.01 40.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.129 -0.982 . . . . 0.0 109.506 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.447 HG23 ' HA ' ' B' ' 30' ' ' SER . 23.8 m -45.78 144.58 1.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 109.307 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' B' ' 10' ' ' GLN . 4.6 mm-40 -122.48 107.24 11.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 109.624 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.847 HG22 HG13 ' B' ' 28' ' ' VAL . 38.6 t -91.84 150.35 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.199 179.772 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.633 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.1 mt -139.89 154.79 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.785 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.8 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -138.61 118.02 12.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 109.117 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 1.8 m -89.18 97.74 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.036 -1.04 . . . . 0.0 108.966 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 90.8 mt -43.95 166.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.456 -0.778 . . . . 0.0 109.617 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.467 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -81.64 8.12 10.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 109.664 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.02 24.64 12.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 109.227 179.726 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.1 4.01 71.21 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 6.9 mtt180 -93.23 166.51 12.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.164 -1.197 . . . . 0.0 109.499 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.38 155.7 49.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.427 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 50' ' ' ALA . . . . . 0.413 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.4 118.39 6.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 109.143 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 6.9 m -79.56 138.31 37.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.124 -0.985 . . . . 0.0 108.83 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.84 ' HB3' HG22 ' B' ' 59' ' ' VAL . 9.7 mt -123.95 168.58 12.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.129 -0.982 . . . . 0.0 109.581 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.63 ' O ' HG21 ' B' ' 59' ' ' VAL . 65.5 t30 -101.56 121.5 51.12 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.44 -0.787 . . . . 0.0 109.458 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.491 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.2 Cg_endo -74.79 -2.18 12.14 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.182 1.921 . . . . 0.0 110.462 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 55' ' ' ALA . . . . . 0.569 ' HB3' ' ND2' ' B' ' 53' ' ' ASN . . . -83.85 -17.45 40.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.911 . . . . 0.0 108.763 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.8 OUTLIER -90.25 163.15 32.53 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.442 -0.786 . . . . 0.0 109.433 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.74 -35.47 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.781 2.321 . . . . 0.0 111.082 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.62 ' O ' HD13 ' B' ' 62' ' ' ILE . 16.2 tt -67.83 -47.56 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.001 -1.062 . . . . 0.0 109.189 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 0.84 HG22 ' HB3' ' B' ' 52' ' ' LEU . 33.1 t -54.97 -48.71 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.135 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 12.0 mttt -57.21 -31.37 65.4 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.22 -0.925 . . . . 0.0 108.514 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.514 ' CE ' ' OE2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -75.67 -27.6 58.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.317 179.947 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 0.65 HG23 ' CD1' ' B' ' 23' ' ' ILE . 1.7 mp -67.44 -43.26 87.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 1.053 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.1 mp -69.56 -65.31 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.679 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.514 ' OE2' ' CE ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -49.04 -35.3 15.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 109.538 -179.62 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.486 ' HB3' ' CB ' ' B' ' 20' ' ' PRO . 21.3 mmtm -63.35 -54.02 43.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.069 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.526 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 1.0 OUTLIER -49.2 -46.27 45.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 0.0 109.222 179.664 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 1.042 HD11 ' CG2' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -56.96 -47.56 80.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.436 -0.79 . . . . 0.0 109.453 179.871 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.49 31.32 2.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.947 . . . . 0.0 109.572 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.428 ' O ' ' C ' ' B' ' 70' ' ' ASP . 56.9 p -90.95 -40.64 11.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.364 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' B' ' 70' ' ' ASP . 6.4 p-10 40.82 83.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.549 -0.719 . . . . 0.0 109.781 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt 44.27 -149.01 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.51 ' HA ' ' NZ ' ' B' ' 21' ' ' LYS . 4.3 m -90.35 -42.68 10.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.524 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.423 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 1' ' ' ALA . 6.1 t 61.5 136.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.322 -0.861 . . . . 0.0 109.476 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 3' ' ' VAL . 7.3 p -148.97 68.22 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.335 -0.853 . . . . 0.0 109.427 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.06 111.72 18.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 109.469 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.5 t -101.79 -32.07 10.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.438 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.63 27.57 0.49 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.667 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -132.28 106.01 7.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.278 -0.888 . . . . 0.0 109.601 -179.933 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 9' ' ' CYS . 1.7 mtm180 -107.51 155.96 19.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.333 -0.854 . . . . 0.0 108.986 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 9.6 m -44.48 107.99 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.392 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.501 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 47.0 mm-40 -49.87 -21.21 1.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.468 ' SG ' HG13 ' A' ' 41' ' ' ILE . 83.1 m -141.47 71.43 1.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.598 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.544 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.29 -44.58 8.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.219 179.727 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.54 121.12 37.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.418 -0.801 . . . . 0.0 109.228 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.02 160.53 14.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.854 . . . . 0.0 109.807 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.6 ' HB2' HD23 ' A' ' 52' ' ' LEU . 4.5 mt -103.69 142.78 33.75 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.613 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 15' ' ' LEU . 1.4 tt0 -44.75 -26.59 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.124 -0.985 . . . . 0.0 109.125 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 154.86 -178.91 31.31 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.644 ' H ' HD11 ' A' ' 62' ' ' ILE . 4.6 tp -155.72 170.62 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.501 -1.0 . . . . 0.0 108.925 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.59 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.6 t-80 -60.0 143.71 87.59 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.068 -1.02 . . . . 0.0 108.973 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -77.26 -24.64 9.22 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.443 2.095 . . . . 0.0 110.267 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' HE2' ' A' ' 45' ' ' LYS . 13.2 mttm -90.52 -13.74 34.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.81 . . . . 0.0 109.175 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 8.0 m120 -80.18 -15.34 57.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.921 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 6.9 mt -90.0 162.46 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.415 -0.803 . . . . 0.0 110.696 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -128.61 -39.65 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.198 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 1.5 p -126.86 172.09 10.7 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.304 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 78.4 t -143.97 93.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.993 -1.067 . . . . 0.0 109.716 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.481 ' O ' HD12 ' A' ' 41' ' ' ILE . 3.4 t-20 -86.85 108.72 18.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.319 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -104.66 94.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.937 . . . . 0.0 109.545 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HE2' ' HG3' ' A' ' 10' ' ' GLN . 3.6 tppt? -90.6 92.58 8.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.443 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.521 ' HB3' ' CE ' ' B' ' 66' ' ' MET . 1.0 OUTLIER -45.99 170.96 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.488 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HB3' ' O ' ' A' ' 36' ' ' ALA . 35.6 Cg_endo -77.76 140.08 18.27 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.644 2.229 . . . . 0.0 110.458 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.91 -142.44 3.66 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.82 39.22 0.81 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.689 2.259 . . . . 0.0 110.782 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.667 ' CD2' HD22 ' A' ' 7' ' ' LEU . 6.0 p-80 -158.67 -38.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.012 -1.055 . . . . 0.0 109.301 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -138.01 102.18 4.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.277 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 31' ' ' PRO . . . -62.99 -29.16 70.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.699 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.71 125.73 34.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' ' 30' ' ' SER . 73.5 m -48.54 148.81 1.87 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.269 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.45 ' OE1' ' HB2' ' A' ' 11' ' ' CYS . 21.5 mm-40 -125.07 123.46 39.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.628 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.605 HG11 HD11 ' A' ' 63' ' ' ILE . 16.8 t -107.55 145.53 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.266 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.481 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.6 mp -134.88 144.29 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.921 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -131.27 117.71 19.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.301 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 3.4 m -89.29 95.83 10.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.949 -1.094 . . . . 0.0 108.896 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 85.1 mt -42.16 163.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.548 -0.72 . . . . 0.0 109.962 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.52 ' HB3' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -81.01 10.77 4.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.838 . . . . 0.0 109.872 179.905 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.494 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -110.71 14.0 22.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.13 -0.982 . . . . 0.0 109.225 179.61 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.07 15.82 68.8 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.471 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 8.9 mtp-105 -108.04 175.63 5.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -1.142 . . . . 0.0 109.414 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.439 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -143.29 152.47 41.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.21 122.23 8.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.856 . . . . 0.0 108.898 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.455 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 23.0 m -79.76 143.16 34.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 0.0 109.277 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.945 HD13 HD13 ' A' ' 62' ' ' ILE . 18.7 mt -128.19 168.03 16.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 109.081 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.641 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.5 t-20 -104.87 127.72 28.23 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 109.47 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.527 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.8 Cg_endo -75.46 -11.56 20.66 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.33 2.02 . . . . 0.0 110.49 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.12 -17.41 61.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.102 -0.999 . . . . 0.0 108.969 179.618 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -90.27 162.15 35.44 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 179.941 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.08 -35.08 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.702 2.268 . . . . 0.0 111.098 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.548 HG23 ' N ' ' A' ' 59' ' ' VAL . 2.9 tt -68.24 -45.15 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.065 -1.022 . . . . 0.0 109.397 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.999 ' HA ' HD12 ' A' ' 62' ' ' ILE . 40.3 t -59.04 -45.87 92.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 18.2 mttt -60.08 -29.39 68.54 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 2.5 mmpt? -79.55 -23.54 42.75 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.999 HD12 ' HA ' ' A' ' 59' ' ' VAL . 20.5 mt -70.85 -37.91 70.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.642 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.92 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -74.69 -56.74 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.475 -0.765 . . . . 0.0 109.296 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -59.36 -28.12 66.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.962 . . . . 0.0 109.226 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.514 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -70.61 -52.06 23.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 108.914 179.611 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.528 ' CE ' ' HB3' ' B' ' 30' ' ' SER . 0.4 OUTLIER -49.58 -44.37 46.88 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.276 -0.89 . . . . 0.0 108.949 179.473 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.929 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -55.08 -59.17 5.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.547 -0.72 . . . . 0.0 109.566 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -79.89 5.33 14.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.725 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 85.6 p -55.43 -55.85 26.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.393 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 72' ' ' SER . 80.0 m-20 -72.94 -9.92 59.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.507 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 70' ' ' ASP . 4.2 mtpt 43.28 -94.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.657 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -166.08 -73.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.984 . . . . 0.0 109.464 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.472 179.987 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 1' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.46 ' O ' ' O ' ' B' ' 1' ' ' ALA . 6.1 t 61.46 136.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.618 HG13 ' O ' ' B' ' 3' ' ' VAL . 7.3 p -148.92 68.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.06 111.61 18.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 0.0 109.489 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -101.61 -32.09 10.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 109.536 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.64 27.64 0.49 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.659 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -132.36 106.06 7.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.217 -0.927 . . . . 0.0 109.614 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -107.46 155.97 19.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.392 -0.817 . . . . 0.0 109.013 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.534 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 9.3 m -44.55 108.02 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.333 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.479 ' HG3' ' HE2' ' B' ' 29' ' ' LYS . 47.1 mm-40 -49.85 -21.13 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.713 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.468 ' SG ' HG13 ' B' ' 41' ' ' ILE . 82.6 m -141.59 71.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.062 -1.024 . . . . 0.0 109.652 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.25 -44.55 8.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.232 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.55 121.11 37.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.252 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.96 160.44 14.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.807 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.59 ' HB2' HD23 ' B' ' 52' ' ' LEU . 4.4 mt -103.65 142.76 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' B' ' 15' ' ' LEU . 1.4 tt0 -44.73 -26.56 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.157 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.538 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 154.8 -178.92 31.26 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.647 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.631 ' H ' HD11 ' B' ' 62' ' ' ILE . 4.6 tp -155.7 170.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.467 -1.019 . . . . 0.0 108.963 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.585 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 1.6 t-80 -59.98 143.71 87.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 108.993 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.585 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.26 -24.69 9.17 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.51 2.14 . . . . 0.0 110.318 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HE2' ' B' ' 45' ' ' LYS . 13.2 mttm -90.42 -13.81 34.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 109.235 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.581 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 92.5 m-20 -80.12 -15.45 57.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.928 HG23 ' HB1' ' B' ' 42' ' ' ALA . 6.9 mt -90.08 162.43 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.43 -0.794 . . . . 0.0 110.668 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.2 OUTLIER -128.61 -39.65 1.63 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.273 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 1.5 p -126.79 172.07 10.68 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.321 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' B' ' 41' ' ' ILE . 77.8 t -144.05 93.6 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.004 -1.06 . . . . 0.0 109.703 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.475 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 3.4 t-20 -86.85 108.77 18.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.32 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.8 t -104.63 94.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.2 -0.938 . . . . 0.0 109.609 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.479 ' HE2' ' HG3' ' B' ' 10' ' ' GLN . 3.6 tppt? -90.67 92.64 8.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.423 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.528 ' HB3' ' CE ' ' A' ' 66' ' ' MET . 1.0 OUTLIER -46.11 171.03 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.0 109.483 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 31' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' B' ' 36' ' ' ALA . 35.9 Cg_endo -77.86 140.11 18.08 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.574 2.183 . . . . 0.0 110.473 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.9 -142.49 3.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.74 39.16 0.8 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.666 2.244 . . . . 0.0 110.893 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.659 ' CD2' HD22 ' B' ' 7' ' ' LEU . 6.0 p-80 -158.7 -38.52 0.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.07 -1.019 . . . . 0.0 109.32 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 35' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -138.14 102.21 4.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.231 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' B' ' 31' ' ' PRO . . . -62.92 -29.23 70.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.706 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.68 125.67 34.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.954 . . . . 0.0 109.561 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.439 HG23 ' HA ' ' B' ' 30' ' ' SER . 71.8 m -48.53 148.77 1.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.917 . . . . 0.0 109.34 179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 39' ' ' GLU . . . . . 0.441 ' OE1' ' HB2' ' B' ' 11' ' ' CYS . 21.5 mm-40 -125.05 123.4 39.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.613 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.628 HG11 HD11 ' B' ' 63' ' ' ILE . 16.7 t -107.44 145.58 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.89 . . . . 0.0 109.337 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' B' ' 27' ' ' ASN . 3.6 mp -134.92 144.33 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.182 -0.949 . . . . 0.0 109.605 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.928 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -131.37 117.73 19.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.292 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 3.4 m -89.36 95.88 10.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.894 -1.129 . . . . 0.0 108.949 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 85.1 mt -42.07 163.63 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.529 -0.732 . . . . 0.0 109.926 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.509 ' HB3' ' NZ ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -81.02 10.83 4.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.377 -0.827 . . . . 0.0 109.838 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -110.77 13.96 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.142 179.678 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.08 15.79 68.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.467 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 8.9 mtp-105 -108.05 175.57 5.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -1.135 . . . . 0.0 109.484 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.438 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 0.3 OUTLIER -143.23 152.46 41.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.891 . . . . 0.0 109.438 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.18 122.2 8.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.244 -0.91 . . . . 0.0 108.983 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.452 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 23.0 m -79.77 143.19 34.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.166 -0.959 . . . . 0.0 109.308 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.967 HD13 HD13 ' B' ' 62' ' ' ILE . 18.7 mt -128.24 167.97 16.13 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 109.013 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.637 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.6 t-20 -104.96 127.81 27.98 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.425 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.526 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.9 Cg_endo -75.5 -11.59 20.58 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.349 2.033 . . . . 0.0 110.45 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.07 -17.36 61.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 109.09 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.6 OUTLIER -90.29 162.16 35.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 109.504 179.916 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -78.1 -35.12 1.41 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.762 2.308 . . . . 0.0 111.086 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 58' ' ' ILE . . . . . 0.566 HG23 ' N ' ' B' ' 59' ' ' VAL . 2.9 tt -68.19 -45.19 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.065 -1.022 . . . . 0.0 109.424 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 1.018 ' HA ' HD12 ' B' ' 62' ' ' ILE . 40.5 t -58.9 -45.96 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.056 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 18.2 mttt -60.06 -29.47 68.57 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' B' ' 65' ' ' LYS . 2.5 mmpt? -79.53 -23.44 42.87 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' B' ' 59' ' ' VAL . 20.5 mt -70.94 -37.81 69.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 0.929 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -74.68 -56.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.322 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.3 OUTLIER -59.35 -28.06 66.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.329 179.838 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.515 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 0.0 OUTLIER -70.64 -52.09 23.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 108.909 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.521 ' CE ' ' HB3' ' A' ' 30' ' ' SER . 0.5 OUTLIER -49.59 -44.37 46.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.009 179.422 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.92 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -55.02 -59.19 5.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.65 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 68' ' ' ASN . . . . . 0.401 ' O ' ' HG3' ' B' ' 71' ' ' LYS . 4.3 t-20 -79.87 5.34 13.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.927 . . . . 0.0 109.76 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 85.5 p -55.42 -55.83 27.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' B' ' 72' ' ' SER . 79.9 m-20 -72.86 -10.12 59.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 71' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' B' ' 68' ' ' ASN . 4.3 mtpt 43.35 -94.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.326 -0.859 . . . . 0.0 109.614 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 72' ' ' SER . . . . . 0.526 ' N ' ' O ' ' B' ' 70' ' ' ASP . 1.0 OUTLIER -166.03 -73.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.476 179.977 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.495 -179.983 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.315 0.579 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.9 t -114.86 -48.29 2.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.2 m -112.64 168.66 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.552 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.22 134.25 14.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 m -157.74 115.66 3.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 109.459 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.7 tp10 -128.59 -144.12 0.28 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.264 -0.897 . . . . 0.0 109.187 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.711 HD22 ' CD2' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -159.96 121.07 3.11 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.884 . . . . 0.0 109.585 179.996 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 9' ' ' CYS . 4.4 mtm180 -134.52 159.68 40.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.368 -0.832 . . . . 0.0 108.984 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.498 ' HB2' HD23 ' A' ' 12' ' ' LEU . 18.7 m -44.57 105.23 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.12 -0.988 . . . . 0.0 109.297 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.498 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 14.4 mm100 -64.68 -8.06 13.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.816 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' A' ' 41' ' ' ILE . 73.8 m -144.66 71.66 1.31 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.066 -1.021 . . . . 0.0 109.711 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.498 HD23 ' HB2' ' A' ' 9' ' ' CYS . 52.4 mt -46.29 -42.49 14.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.187 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -119.76 122.09 40.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.114 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -101.21 158.73 15.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.834 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.527 ' HB2' HD23 ' A' ' 52' ' ' LEU . 3.5 mt -102.85 139.92 37.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -43.96 -26.89 0.31 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.222 179.943 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 15' ' ' LEU . . . 157.98 -179.89 33.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.797 ' H ' HD11 ' A' ' 62' ' ' ILE . 4.6 tp -154.98 170.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.548 -0.972 . . . . 0.0 108.801 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.574 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 3.4 t-80 -59.19 141.97 86.43 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.985 -1.072 . . . . 0.0 109.055 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.3 Cg_endo -77.59 -23.62 9.63 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.499 2.133 . . . . 0.0 110.273 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 9.5 mmtp -90.25 -15.09 32.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.434 -0.791 . . . . 0.0 109.129 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.502 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 7.2 m120 -78.94 -27.76 43.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -0.788 . . . . 0.0 109.377 179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.804 HG12 ' HB1' ' A' ' 42' ' ' ALA . 6.5 mt -77.44 163.7 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.828 0.823 . . . . 0.0 110.697 -179.014 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.555 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -129.62 -41.26 1.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.109 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 10.9 p -124.97 166.69 15.88 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.075 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.738 ' O ' HG23 ' B' ' 28' ' ' VAL . 50.8 t -145.2 98.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.051 -1.03 . . . . 0.0 109.772 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 49.8 t-20 -84.35 133.23 34.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.189 -0.944 . . . . 0.0 109.383 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.739 HG23 ' O ' ' B' ' 26' ' ' VAL . 2.2 t -118.08 82.34 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.982 . . . . 0.0 109.516 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HD3' ' HG3' ' A' ' 10' ' ' GLN . 20.9 mtpt -87.32 103.62 15.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.524 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.1 p -57.63 163.8 3.49 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 109.334 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.44 132.21 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.598 2.199 . . . . 0.0 110.473 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.73 -141.13 3.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.06 7.61 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.663 2.242 . . . . 0.0 110.852 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.711 ' CD2' HD22 ' A' ' 7' ' ' LEU . 6.4 p-80 -124.88 -14.82 6.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.059 -1.026 . . . . 0.0 109.775 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.38 125.56 3.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -0.996 . . . . 0.0 109.363 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' O ' ' CD ' ' A' ' 37' ' ' GLN . . . -87.19 17.49 4.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.617 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' GLN . . . . . 0.42 ' CD ' ' O ' ' A' ' 36' ' ' ALA . 9.6 mm-40 -143.36 125.77 15.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.924 . . . . 0.0 109.524 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.502 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 3.2 m -44.32 157.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 109.313 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -132.64 107.1 8.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 109.576 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 1.006 HG11 HD11 ' A' ' 63' ' ' ILE . 1.7 t -101.98 93.64 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.907 . . . . 0.0 109.269 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.471 HG13 ' SG ' ' A' ' 11' ' ' CYS . 3.4 mp -82.18 150.41 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.724 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.804 ' HB1' HG12 ' A' ' 23' ' ' ILE . . . -132.65 114.91 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 108.994 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 4.3 m -89.22 98.16 11.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.879 -1.138 . . . . 0.0 108.992 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 93.1 mt -41.14 163.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.305 0.574 . . . . 0.0 109.931 -179.715 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -82.06 11.09 5.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 0.0 109.921 -179.785 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' A' ' 44' ' ' LEU . 23.4 p-10 -112.56 8.09 19.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.076 -1.015 . . . . 0.0 109.419 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.59 1.66 63.82 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.784 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.463 ' HB2' HD12 ' A' ' 44' ' ' LEU . 19.4 mtt180 -96.57 165.63 12.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -1.194 . . . . 0.0 109.545 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 2.2 mttt -133.02 153.16 51.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.466 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.3 123.39 8.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 108.908 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 35.6 m -79.62 140.94 36.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.072 -1.017 . . . . 0.0 109.305 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.958 HD13 HD13 ' A' ' 62' ' ' ILE . 16.0 mt -125.37 168.24 13.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.379 -0.826 . . . . 0.0 109.224 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.621 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.6 m-20 -106.28 124.84 34.53 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.434 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HG3' ' HB ' ' A' ' 38' ' ' THR . 33.5 Cg_endo -75.26 -7.01 18.57 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.359 2.039 . . . . 0.0 110.327 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 -17.52 50.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.227 -0.921 . . . . 0.0 108.963 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 163.7 30.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.413 -0.804 . . . . 0.0 109.321 179.866 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.443 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.45 -36.55 1.23 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.589 2.193 . . . . 0.0 110.678 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.4 mt -61.47 -48.07 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.539 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.986 ' HA ' HD12 ' A' ' 62' ' ' ILE . 76.6 t -62.25 -50.0 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.353 -0.842 . . . . 0.0 109.615 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 56' ' ' SER . 6.0 mttt -51.24 -30.72 18.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.122 -0.986 . . . . 0.0 108.722 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.483 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -78.45 -34.54 47.67 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.986 HD12 ' HA ' ' A' ' 59' ' ' VAL . 14.2 mt -59.68 -38.34 75.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.551 -0.718 . . . . 0.0 109.28 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 1.006 HD11 HG11 ' A' ' 40' ' ' VAL . 2.2 mp -74.52 -62.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.483 ' HG2' ' HA ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -53.14 -20.09 3.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 109.394 -179.931 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -79.64 -40.24 29.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.913 . . . . 0.0 109.026 179.729 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.449 ' SD ' ' OG ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -65.19 -45.79 83.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 108.995 179.613 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.697 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -43.5 -50.28 7.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.527 -0.733 . . . . 0.0 109.487 179.822 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -76.81 -27.07 55.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.845 . . . . 0.0 109.614 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.449 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p -76.25 0.78 17.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 109.676 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' O ' ' OG1' ' B' ' 38' ' ' THR . 14.1 p-10 -44.35 -35.76 2.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.45 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -114.58 109.74 18.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.9 t -149.23 -56.22 0.19 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.452 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.489 -179.966 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.284 0.564 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 34.9 t -114.86 -48.22 2.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 25.7 m -112.75 168.63 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.47 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.2 134.38 14.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.49 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 17.6 m -157.85 115.71 3.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 6' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' B' ' 7' ' ' LEU . 1.7 tp10 -128.71 -144.07 0.28 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.241 -0.912 . . . . 0.0 109.153 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 7' ' ' LEU . . . . . 0.698 HD22 ' CD2' ' B' ' 34' ' ' HIS . 1.0 OUTLIER -159.95 121.04 3.11 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.233 -0.917 . . . . 0.0 109.654 -179.967 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' B' ' 9' ' ' CYS . 4.4 mtm180 -134.46 159.6 40.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.392 -0.818 . . . . 0.0 109.043 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 9' ' ' CYS . . . . . 0.518 ' HB2' HD23 ' B' ' 12' ' ' LEU . 18.5 m -44.62 105.3 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.957 . . . . 0.0 109.217 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 10' ' ' GLN . . . . . 0.483 ' HG3' ' HD3' ' B' ' 29' ' ' LYS . 14.4 mm100 -64.77 -8.0 13.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 0.0 109.78 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 11' ' ' CYS . . . . . 0.473 ' SG ' HG13 ' B' ' 41' ' ' ILE . 73.6 m -144.69 71.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.082 -1.011 . . . . 0.0 109.657 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' B' ' 9' ' ' CYS . 52.6 mt -46.29 -42.54 14.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.17 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -119.73 122.06 40.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 109.123 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 14' ' ' THR . . . . . 0.439 ' OG1' ' OD1' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -101.22 158.65 15.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.816 -179.692 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.531 ' HB2' HD23 ' B' ' 52' ' ' LEU . 3.5 mt -102.79 139.93 37.72 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 16' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.6 OUTLIER -43.96 -26.95 0.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.176 179.969 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 17' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' B' ' 15' ' ' LEU . . . 158.03 -179.89 33.41 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.779 ' H ' HD11 ' B' ' 62' ' ' ILE . 4.5 tp -155.03 170.9 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.571 -0.958 . . . . 0.0 108.745 -179.578 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.577 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 3.4 t-80 -59.14 142.03 86.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.028 -1.045 . . . . 0.0 109.109 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 20' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.1 Cg_endo -77.73 -23.53 9.52 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.517 2.145 . . . . 0.0 110.238 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.526 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 9.5 mmtp -90.29 -15.0 32.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.404 -0.81 . . . . 0.0 109.139 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 22' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 7.2 m120 -78.99 -27.7 43.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.431 -0.793 . . . . 0.0 109.403 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.801 HG12 ' HB1' ' B' ' 42' ' ' ALA . 6.5 mt -77.45 163.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.751 0.786 . . . . 0.0 110.743 -179.029 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 24' ' ' GLN . . . . . 0.549 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.2 OUTLIER -129.65 -41.25 1.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.07 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 25' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 11.0 p -124.92 166.72 15.79 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 26' ' ' VAL . . . . . 0.739 ' O ' HG23 ' A' ' 28' ' ' VAL . 51.3 t -145.26 98.78 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.998 -1.064 . . . . 0.0 109.779 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 27' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 50.0 t-20 -84.4 133.21 34.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 28' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.2 t -118.02 82.25 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.142 -0.974 . . . . 0.0 109.591 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 29' ' ' LYS . . . . . 0.483 ' HD3' ' HG3' ' B' ' 10' ' ' GLN . 20.9 mtpt -87.36 103.64 15.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 30' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.1 p -57.56 163.85 3.37 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.342 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.44 132.21 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.581 2.187 . . . . 0.0 110.436 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.74 -141.01 3.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.18 7.69 3.58 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.592 2.194 . . . . 0.0 110.84 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 34' ' ' HIS . . . . . 0.698 ' CD2' HD22 ' B' ' 7' ' ' LEU . 6.4 p-80 -124.92 -14.74 6.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.007 -1.058 . . . . 0.0 109.761 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.36 125.62 3.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.97 . . . . 0.0 109.332 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 36' ' ' ALA . . . . . 0.42 ' O ' ' CD ' ' B' ' 37' ' ' GLN . . . -87.23 17.55 4.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.626 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 37' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' B' ' 38' ' ' THR . 9.7 mm-40 -143.42 125.74 15.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.504 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 38' ' ' THR . . . . . 0.494 ' HB ' ' HG3' ' B' ' 54' ' ' PRO . 3.2 m -44.32 157.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 0.0 109.309 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -132.61 107.01 8.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.571 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 1.015 HG11 HD11 ' B' ' 63' ' ' ILE . 1.7 t -101.86 93.57 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.202 -0.936 . . . . 0.0 109.335 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 41' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 3.5 mp -82.19 150.42 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.726 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 42' ' ' ALA . . . . . 0.801 ' HB1' HG12 ' B' ' 23' ' ' ILE . . . -132.68 114.9 14.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.852 . . . . 0.0 109.004 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 43' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 4.4 m -89.23 98.2 11.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.856 -1.152 . . . . 0.0 108.996 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 44' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 93.1 mt -41.16 163.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.686 -0.634 . . . . 0.0 109.877 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 45' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -82.09 11.04 5.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.921 -179.818 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 46' ' ' ASN . . . . . 0.494 ' OD1' ' HB2' ' B' ' 44' ' ' LEU . 23.4 p-10 -112.44 7.98 19.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.034 -1.042 . . . . 0.0 109.535 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.56 1.84 63.76 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 48' ' ' ARG . . . . . 0.485 ' HB2' HD12 ' B' ' 44' ' ' LEU . 19.4 mtt180 -96.66 165.67 12.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -1.226 . . . . 0.0 109.535 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.414 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 2.2 mttt -132.99 153.2 51.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.481 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.27 123.4 8.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 108.91 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 51' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 35.7 m -79.6 140.93 36.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.035 -1.041 . . . . 0.0 109.299 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 52' ' ' LEU . . . . . 0.966 HD13 HD13 ' B' ' 62' ' ' ILE . 15.9 mt -125.41 168.3 13.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.296 -0.877 . . . . 0.0 109.227 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.614 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.6 m-20 -106.41 124.87 34.38 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.407 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 54' ' ' PRO . . . . . 0.494 ' HG3' ' HB ' ' B' ' 38' ' ' THR . 34.1 Cg_endo -75.22 -6.92 18.49 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.308 2.005 . . . . 0.0 110.422 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.94 -17.58 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 108.915 179.398 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 56' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -90.02 163.76 30.78 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.356 -0.84 . . . . 0.0 109.323 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 57' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.57 -36.46 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.633 2.222 . . . . 0.0 110.667 -179.897 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.42 -48.14 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.652 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 59' ' ' VAL . . . . . 1.034 ' HA ' HD12 ' B' ' 62' ' ' ILE . 76.6 t -62.19 -50.05 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.83 . . . . 0.0 109.617 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 60' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' B' ' 56' ' ' SER . 6.0 mttt -51.2 -30.75 18.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.084 -1.01 . . . . 0.0 108.735 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.491 ' HA ' ' CG ' ' B' ' 64' ' ' GLU . 0.0 OUTLIER -78.45 -34.51 47.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.856 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 62' ' ' ILE . . . . . 1.034 HD12 ' HA ' ' B' ' 59' ' ' VAL . 14.2 mt -59.7 -38.43 75.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.543 -0.723 . . . . 0.0 109.229 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 63' ' ' ILE . . . . . 1.015 HD11 HG11 ' B' ' 40' ' ' VAL . 2.2 mp -74.5 -62.29 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.64 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 64' ' ' GLU . . . . . 0.491 ' CG ' ' HA ' ' B' ' 61' ' ' LYS . 0.2 OUTLIER -53.14 -20.1 3.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.413 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -79.64 -40.14 29.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.868 . . . . 0.0 109.031 179.749 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 66' ' ' MET . . . . . 0.446 ' SD ' ' OG ' ' B' ' 69' ' ' SER . 0.6 OUTLIER -65.16 -45.87 83.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.841 . . . . 0.0 108.994 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 67' ' ' LEU . . . . . 0.692 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -43.42 -50.34 6.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.476 -0.765 . . . . 0.0 109.46 179.858 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -76.8 -27.09 55.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.833 . . . . 0.0 109.558 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 69' ' ' SER . . . . . 0.446 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.2 p -76.22 0.76 17.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.316 -0.865 . . . . 0.0 109.707 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 38' ' ' THR . 14.2 p-10 -44.28 -35.86 2.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.416 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -114.57 109.75 18.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.437 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 40.9 t -149.24 -56.3 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.463 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.459 -179.996 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.64 ' HB2' HD22 ' A' ' 12' ' ' LEU . 97.2 m . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.373 -0.602 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.521 ' NE2' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.66 -26.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 109.763 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.474 ' SG ' HG13 ' A' ' 41' ' ' ILE . 97.1 m -122.22 66.17 0.93 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.996 . . . . 0.0 109.799 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.85 -38.9 4.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.967 . . . . 0.0 108.735 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.527 ' O ' HG23 ' A' ' 14' ' ' THR . 0.7 OUTLIER -118.42 -173.3 2.44 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -160.15 158.06 29.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.04 -1.038 . . . . 0.0 109.935 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.523 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.5 mt -116.93 142.76 46.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.474 -0.766 . . . . 0.0 109.043 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -44.04 -33.3 1.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 109.362 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.859 ' O ' HG23 ' A' ' 18' ' ' ILE . . . 147.34 -166.47 28.59 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.933 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -171.53 163.45 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.44 -1.035 . . . . 0.0 109.076 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.567 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -57.39 149.74 47.39 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.204 -0.935 . . . . 0.0 109.234 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.654 ' HA ' HD12 ' A' ' 23' ' ' ILE . 34.8 Cg_endo -77.25 -4.34 14.66 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.516 2.144 . . . . 0.0 110.19 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.18 -24.02 21.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.362 -0.836 . . . . 0.0 109.197 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.0 m-20 -84.01 -15.87 46.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -0.855 . . . . 0.0 109.213 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.976 HG23 ' HB1' ' A' ' 42' ' ' ALA . 17.3 mt -89.32 169.04 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.434 -0.791 . . . . 0.0 110.245 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.579 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -137.49 -39.98 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.433 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 5.9 p -128.2 173.36 10.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.458 -0.776 . . . . 0.0 109.029 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.589 HG23 ' HG3' ' A' ' 66' ' ' MET . 47.7 t -142.22 95.5 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.58 ' O ' HD12 ' A' ' 41' ' ' ILE . 5.1 t-20 -93.06 111.58 23.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.925 . . . . 0.0 109.417 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.443 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -109.35 97.69 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.404 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.521 ' HD2' ' NE2' ' A' ' 10' ' ' GLN . 1.9 ttmt -90.59 110.28 21.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.2 p -63.68 167.72 6.8 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.355 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.6 Cg_endo -77.61 145.62 23.41 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.603 2.202 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.95 -140.05 2.97 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.452 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 36.1 Cg_endo -77.87 10.71 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.596 2.197 . . . . 0.0 111.023 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.506 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 3.3 p-80 -127.76 -32.91 2.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.559 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -145.45 115.89 7.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 109.265 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.92 6.97 11.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.694 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 1.6 mp0 -120.71 124.62 45.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.6 m -46.76 156.85 0.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 109.317 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 7.1 mm-40 -141.37 107.56 5.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.933 . . . . 0.0 109.627 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.656 HG11 HD11 ' A' ' 63' ' ' ILE . 41.2 t -90.56 150.4 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.225 -0.922 . . . . 0.0 109.272 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.58 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.4 mt -140.29 147.79 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.71 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.976 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -135.39 120.05 18.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.404 -0.81 . . . . 0.0 109.162 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 8.6 m -89.3 100.95 13.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.94 -1.1 . . . . 0.0 109.01 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 84.5 mt -46.08 172.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.47 -0.769 . . . . 0.0 109.732 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -87.93 10.47 18.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.215 -0.928 . . . . 0.0 109.179 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -114.04 27.52 9.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.325 -0.86 . . . . 0.0 109.134 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.13 11.14 70.2 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.501 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 3.8 mtp180 -100.18 165.91 11.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -1.157 . . . . 0.0 109.443 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.83 154.06 50.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.214 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.523 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.18 123.7 9.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.213 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.7 m -79.49 144.96 33.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.956 . . . . 0.0 109.169 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.995 HD13 HD13 ' A' ' 62' ' ' ILE . 15.4 mt -121.99 167.54 12.97 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.447 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.653 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -97.14 118.08 65.06 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.467 -0.771 . . . . 0.0 109.201 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 33.1 Cg_endo -74.24 -0.35 9.51 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.175 1.917 . . . . 0.0 110.376 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.28 -14.08 27.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.325 -0.859 . . . . 0.0 108.906 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.11 162.61 34.56 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.392 -0.818 . . . . 0.0 109.391 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.06 -36.17 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.694 2.263 . . . . 0.0 110.659 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.3 mt -66.41 -36.39 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 109.661 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.002 ' HA ' HD12 ' A' ' 62' ' ' ILE . 37.7 t -67.95 -51.36 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.258 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.1 OUTLIER -54.3 -30.23 50.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 108.992 179.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.529 ' HB3' ' NZ ' ' A' ' 65' ' ' LYS . 9.6 mmmm -81.98 -28.85 32.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 109.108 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.002 HD12 ' HA ' ' A' ' 59' ' ' VAL . 11.9 mt -59.61 -38.1 73.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.937 HG22 HD11 ' B' ' 67' ' ' LEU . 1.7 mp -76.15 -61.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -43.02 -28.73 0.29 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.817 . . . . 0.0 109.646 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.529 ' NZ ' ' HB3' ' A' ' 61' ' ' LYS . 2.0 mtmt -74.74 -60.24 2.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.589 ' HG3' HG23 ' A' ' 26' ' ' VAL . 1.4 mmm -44.17 -47.78 9.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 109.272 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.943 HD11 HG22 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -43.65 -51.26 7.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.452 -0.78 . . . . 0.0 109.353 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 69' ' ' SER . 11.9 t30 -66.41 -34.82 78.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.495 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 68' ' ' ASN . 1.2 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.562 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.658 ' HB2' HD22 ' B' ' 12' ' ' LEU . 96.6 m . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.526 ' NE2' ' HD2' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -42.75 -26.4 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.796 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.457 ' SG ' HG13 ' B' ' 41' ' ' ILE . 97.4 m -122.18 66.25 0.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.786 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.658 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.83 -38.95 4.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.147 -0.971 . . . . 0.0 108.753 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . 0.529 ' O ' HG23 ' B' ' 14' ' ' THR . 0.7 OUTLIER -118.49 -173.25 2.43 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.534 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.4 OUTLIER -160.17 158.08 29.49 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.994 -1.066 . . . . 0.0 109.896 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.531 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.6 mt -116.96 142.77 46.52 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.4 OUTLIER -44.04 -33.36 1.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.363 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.858 ' O ' HG23 ' B' ' 18' ' ' ILE . . . 147.45 -166.49 28.63 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.941 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -171.51 163.44 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.454 -1.027 . . . . 0.0 109.07 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.564 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -57.43 149.73 47.95 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.186 -0.946 . . . . 0.0 109.237 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.645 ' HA ' HD12 ' B' ' 23' ' ' ILE . 35.0 Cg_endo -77.15 -4.36 14.73 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.477 2.118 . . . . 0.0 110.231 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.21 -23.89 21.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.413 -0.804 . . . . 0.0 109.177 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.0 m-20 -84.05 -15.84 46.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.227 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.98 HG23 ' HB1' ' B' ' 42' ' ' ALA . 17.0 mt -89.4 169.12 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 110.25 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.581 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.0 OUTLIER -137.58 -39.94 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.439 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 6.0 p -128.18 173.4 10.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.423 -0.798 . . . . 0.0 108.971 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.59 HG23 ' HG3' ' B' ' 66' ' ' MET . 47.5 t -142.31 95.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.961 . . . . 0.0 109.646 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.572 ' O ' HD12 ' B' ' 41' ' ' ILE . 5.1 t-20 -93.03 111.49 23.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.869 . . . . 0.0 109.428 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.438 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -109.24 97.73 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.526 ' HD2' ' NE2' ' B' ' 10' ' ' GLN . 1.9 ttmt -90.65 110.38 21.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 109.504 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.2 p -63.61 167.7 6.72 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.346 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 36.0 Cg_endo -77.66 145.57 23.22 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.556 2.171 . . . . 0.0 110.432 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.89 -140.03 2.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.447 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.1 Cg_endo -77.87 10.74 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.602 2.201 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.515 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 3.2 p-80 -127.8 -32.83 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 109.532 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -145.48 115.89 7.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.03 7.07 11.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.695 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' B' ' 39' ' ' GLU . 1.6 mp0 -120.79 124.6 45.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.123 -0.986 . . . . 0.0 109.473 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 1.6 m -46.74 156.83 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.319 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' B' ' 39' ' ' GLU . 7.1 mm-40 -141.36 107.63 5.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.038 -1.039 . . . . 0.0 109.685 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.631 HG11 HD11 ' B' ' 63' ' ' ILE . 41.4 t -90.56 150.47 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.183 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.572 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.4 mt -140.3 147.85 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.154 -0.967 . . . . 0.0 109.709 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.98 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -135.48 120.03 18.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.115 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 8.6 m -89.26 100.83 13.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.934 -1.104 . . . . 0.0 109.038 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 84.5 mt -45.99 172.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.427 -0.795 . . . . 0.0 109.814 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -87.92 10.63 18.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.144 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -114.11 27.53 9.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.055 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.05 11.22 69.97 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.516 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 3.8 mtp180 -100.22 165.94 11.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -1.158 . . . . 0.0 109.471 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.82 154.08 50.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.176 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.531 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.21 123.65 9.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.26 -0.9 . . . . 0.0 109.297 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 7.7 m -79.49 144.87 33.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.103 -0.998 . . . . 0.0 109.17 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 1.059 HD13 HD13 ' B' ' 62' ' ' ILE . 15.3 mt -121.88 167.48 12.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.654 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.0 OUTLIER -97.04 118.04 65.19 Favored Pre-proline 0 C--N 1.299 -1.608 0 O-C-N 121.426 -0.797 . . . . 0.0 109.227 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.33 -0.28 9.47 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.224 1.949 . . . . 0.0 110.344 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.31 -14.1 27.35 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.311 -0.868 . . . . 0.0 108.916 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.09 162.73 34.26 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.368 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -78.22 -36.13 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.591 2.194 . . . . 0.0 110.626 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 65.5 mt -66.29 -36.46 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.139 -0.975 . . . . 0.0 109.709 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 1.034 ' HA ' HD12 ' B' ' 62' ' ' ILE . 37.8 t -67.89 -51.35 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.266 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' B' ' 56' ' ' SER . 0.1 OUTLIER -54.39 -30.21 51.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.322 -0.861 . . . . 0.0 108.941 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.533 ' HB3' ' NZ ' ' B' ' 65' ' ' LYS . 9.6 mmmm -81.97 -28.82 32.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.126 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 1.059 HD13 HD13 ' B' ' 52' ' ' LEU . 11.9 mt -59.61 -38.14 74.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.943 HG22 HD11 ' A' ' 67' ' ' LEU . 1.7 mp -76.16 -61.57 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -43.09 -28.73 0.3 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.4 -0.813 . . . . 0.0 109.617 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.533 ' NZ ' ' HB3' ' B' ' 61' ' ' LYS . 2.0 mtmt -74.71 -60.27 2.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.337 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.59 ' HG3' HG23 ' B' ' 26' ' ' VAL . 1.4 mmm -44.09 -47.87 8.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.873 . . . . 0.0 109.257 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.937 HD11 HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -43.63 -51.19 7.13 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.401 -0.812 . . . . 0.0 109.408 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' B' ' 69' ' ' SER . 11.9 t30 -66.48 -34.77 78.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.4 -0.813 . . . . 0.0 109.516 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.42 ' C ' ' O ' ' B' ' 68' ' ' ASN . 1.2 p . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 109.502 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.877 ' HB2' HD22 ' A' ' 12' ' ' LEU . 20.1 m . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -42.28 -26.91 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.815 . . . . 0.0 109.853 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 39' ' ' GLU . 72.4 m -124.17 63.3 1.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.769 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.877 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.71 -39.69 5.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.117 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -123.26 126.47 46.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 109.061 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -103.12 162.86 12.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.118 -0.989 . . . . 0.0 109.935 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.501 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 6.2 mt -115.44 140.96 48.67 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.477 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.7 tt0 -44.34 -26.52 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.306 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.838 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 138.32 -171.34 23.47 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.721 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.4 pp -161.48 162.74 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -1.117 . . . . 0.0 109.399 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.601 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -56.36 153.97 17.95 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 109.274 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.601 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -76.9 -7.39 17.39 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.438 2.092 . . . . 0.0 109.971 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.512 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 3.1 mttm -80.91 -23.32 39.01 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.843 ' O ' HD13 ' A' ' 23' ' ' ILE . 25.0 m-20 -98.35 59.47 1.33 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.843 HD13 ' O ' ' A' ' 22' ' ' ASN . 2.7 mm -142.49 169.93 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.181 -0.95 . . . . 0.0 110.044 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -160.18 -40.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.5 p -133.53 -173.79 3.32 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 25' ' ' SER . 50.8 t -159.62 97.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.037 -1.04 . . . . 0.0 109.74 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.472 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 3.7 t-20 -94.62 111.42 23.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.396 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.74 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -117.35 103.48 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -107.05 108.43 19.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.43 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.586 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.1 p -50.97 168.68 0.24 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.8 Cg_endo -77.99 131.64 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.523 2.149 . . . . 0.0 110.508 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.04 -143.35 5.39 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.57 5.18 4.94 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.594 2.196 . . . . 0.0 110.643 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.405 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 14.1 p-80 -124.39 -10.89 7.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.647 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 4.0 t -160.2 104.51 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.316 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.92 -3.59 23.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.653 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 4.6 mm-40 -114.52 124.67 52.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 30' ' ' SER . 14.1 m -49.43 148.18 2.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.331 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.465 ' OE2' ' CA ' ' A' ' 9' ' ' CYS . 0.8 OUTLIER -131.22 107.12 8.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 109.743 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.74 HG22 HG13 ' A' ' 28' ' ' VAL . 30.8 t -91.75 156.12 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.245 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.482 HG13 ' SG ' ' A' ' 51' ' ' CYS . 2.1 mp -143.44 144.79 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.799 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -129.45 124.13 33.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.361 -0.837 . . . . 0.0 109.12 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 23.0 m -89.4 101.76 14.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.075 -1.016 . . . . 0.0 109.207 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 22' ' ' ASN . 84.5 mt -43.59 164.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 109.266 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 11.3 ptpt -85.76 13.36 7.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.465 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -112.56 11.04 19.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.174 179.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.39 21.17 45.68 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.638 ' HB2' HD12 ' A' ' 44' ' ' LEU . 95.6 mtt-85 -116.11 171.43 7.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -1.156 . . . . 0.0 109.468 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -137.45 153.76 50.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.477 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.501 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.22 125.36 10.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.413 -0.804 . . . . 0.0 109.029 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.482 ' SG ' HG13 ' A' ' 41' ' ' ILE . 13.9 m -79.57 140.59 37.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.006 . . . . 0.0 109.045 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.874 ' HB3' HG22 ' A' ' 59' ' ' VAL . 11.9 mt -122.25 167.81 12.77 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.655 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.4 t-20 -101.29 121.4 51.91 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.474 -0.766 . . . . 0.0 109.199 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.92 -7.1 18.91 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.324 2.016 . . . . 0.0 110.321 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.17 -14.83 49.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 108.95 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.06 162.76 34.27 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.48 -0.763 . . . . 0.0 109.369 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.73 -37.5 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.733 2.289 . . . . 0.0 110.584 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 52.2 mt -61.88 -52.94 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.081 -1.012 . . . . 0.0 109.019 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.874 HG22 ' HB3' ' A' ' 52' ' ' LEU . 56.1 t -53.28 -51.74 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.549 -0.719 . . . . 0.0 109.723 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -50.18 -33.16 18.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.077 -1.014 . . . . 0.0 108.958 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.535 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 3.2 mmpt? -75.74 -34.71 60.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 0.0 109.458 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -60.2 -41.69 87.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.088 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.677 ' N ' HD12 ' A' ' 63' ' ' ILE . 2.2 mp -70.42 -62.32 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.864 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.468 ' OE2' ' HA ' ' A' ' 61' ' ' LYS . 5.9 pt-20 -57.6 -16.57 10.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.047 -1.033 . . . . 0.0 109.439 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.508 ' HG2' ' HB3' ' A' ' 20' ' ' PRO . 5.7 tptm -81.65 -40.66 22.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 108.664 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.532 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -61.97 -44.81 95.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.645 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -43.38 -51.8 6.26 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.551 -0.718 . . . . 0.0 109.308 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.28 -50.73 72.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.392 -0.818 . . . . 0.0 109.497 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.527 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.873 ' HB2' HD22 ' B' ' 12' ' ' LEU . 20.1 m . . . . . 0 N--CA 1.489 1.49 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -42.18 -27.0 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.466 -0.771 . . . . 0.0 109.884 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.437 ' HB2' ' HB3' ' B' ' 39' ' ' GLU . 72.6 m -124.22 63.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 109.688 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.873 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.72 -39.78 5.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 0.0 109.062 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -123.19 126.49 47.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 109.085 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.417 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -103.14 162.88 12.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.195 -0.941 . . . . 0.0 110.015 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.506 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 6.3 mt -115.48 140.93 48.71 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.486 ' O ' HG23 ' B' ' 59' ' ' VAL . 2.7 tt0 -44.27 -26.57 0.33 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.837 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 138.35 -171.27 23.52 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.725 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.4 pp -161.53 162.74 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.34 -1.094 . . . . 0.0 109.379 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -56.28 153.89 17.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.346 -0.846 . . . . 0.0 109.322 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -76.88 -7.35 17.4 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.451 2.1 . . . . 0.0 109.963 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.519 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 3.1 mttm -80.9 -23.37 39.02 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.821 ' O ' HD13 ' B' ' 23' ' ' ILE . 25.0 m-20 -98.37 59.46 1.33 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.821 HD13 ' O ' ' B' ' 22' ' ' ASN . 2.6 mm -142.47 169.97 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.216 -0.927 . . . . 0.0 110.042 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.3 OUTLIER -160.16 -40.43 0.05 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.633 ' O ' HG23 ' B' ' 26' ' ' VAL . 1.5 p -133.55 -173.83 3.34 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.633 HG23 ' O ' ' B' ' 25' ' ' SER . 51.0 t -159.58 97.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.963 -1.086 . . . . 0.0 109.773 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.49 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 3.7 t-20 -94.67 111.38 23.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.412 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.745 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -117.3 103.52 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.464 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -107.12 108.48 19.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.388 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.587 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -51.05 168.64 0.24 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.8 Cg_endo -77.97 131.63 11.17 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.594 2.196 . . . . 0.0 110.459 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.01 -143.29 5.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.61 5.22 4.94 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.598 2.199 . . . . 0.0 110.64 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 14.1 p-80 -124.38 -10.96 7.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 109.584 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 4.0 t -160.18 104.54 1.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 109.347 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.87 -3.64 23.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.716 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' B' ' 39' ' ' GLU . 4.6 mm-40 -114.48 124.7 52.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.096 -1.003 . . . . 0.0 109.522 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.587 HG23 ' HA ' ' B' ' 30' ' ' SER . 14.3 m -49.44 148.22 2.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.308 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.479 ' OE2' ' CA ' ' B' ' 9' ' ' CYS . 0.9 OUTLIER -131.24 107.29 8.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.669 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.745 HG22 HG13 ' B' ' 28' ' ' VAL . 31.2 t -91.9 156.22 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.213 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' B' ' 27' ' ' ASN . 2.1 mp -143.54 144.78 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.152 -0.968 . . . . 0.0 109.778 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.535 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -129.49 124.29 33.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.044 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 23.0 m -89.45 101.76 14.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.934 -1.104 . . . . 0.0 109.156 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.775 HD23 ' O ' ' B' ' 22' ' ' ASN . 84.9 mt -43.61 164.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.5 -0.75 . . . . 0.0 109.245 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 11.3 ptpt -85.74 13.35 7.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.482 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -112.52 11.05 19.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.888 . . . . 0.0 109.256 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.36 21.21 45.68 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.628 ' HB2' HD12 ' B' ' 44' ' ' LEU . 95.5 mtt-85 -116.19 171.49 7.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -137.51 153.7 49.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.425 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.506 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.22 125.32 9.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.303 -0.873 . . . . 0.0 109.081 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' B' ' 41' ' ' ILE . 13.8 m -79.54 140.59 37.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.029 -1.045 . . . . 0.0 109.109 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.873 ' HB3' HG22 ' B' ' 59' ' ' VAL . 11.9 mt -122.19 167.78 12.79 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.344 -0.847 . . . . 0.0 109.409 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.654 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.4 t-20 -101.32 121.37 51.96 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.195 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.96 -6.92 18.7 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.262 1.975 . . . . 0.0 110.321 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.28 -14.84 48.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.22 -0.925 . . . . 0.0 108.946 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.02 162.7 34.56 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.468 -0.77 . . . . 0.0 109.406 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.77 -37.4 0.9 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.613 2.209 . . . . 0.0 110.65 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.523 ' O ' HD13 ' B' ' 62' ' ' ILE . 52.3 mt -61.86 -53.01 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.963 . . . . 0.0 109.004 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.873 HG22 ' HB3' ' B' ' 52' ' ' LEU . 55.9 t -53.2 -51.73 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.55 -0.719 . . . . 0.0 109.796 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' B' ' 56' ' ' SER . 0.2 OUTLIER -50.24 -33.17 18.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.256 -0.902 . . . . 0.0 108.899 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.536 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 3.2 mmpt? -75.58 -34.92 60.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.468 -0.77 . . . . 0.0 109.477 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.523 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -60.1 -41.73 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.31 -0.869 . . . . 0.0 109.077 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.682 ' N ' HD12 ' B' ' 63' ' ' ILE . 2.2 mp -70.39 -62.32 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.888 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.47 ' OE2' ' HA ' ' B' ' 61' ' ' LYS . 5.9 pt-20 -57.54 -16.61 10.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.063 -1.023 . . . . 0.0 109.437 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' B' ' 20' ' ' PRO . 5.7 tptm -81.61 -40.79 22.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.275 -0.891 . . . . 0.0 108.644 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.537 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -61.85 -44.88 95.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.398 -0.814 . . . . 0.0 108.85 179.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.664 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -43.36 -51.76 6.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.511 -0.743 . . . . 0.0 109.34 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.37 -50.66 72.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.495 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.22 -0.925 . . . . 0.0 109.509 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.491 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.525 ' HG3' ' CB ' ' A' ' 29' ' ' LYS . 7.1 mm-40 -42.88 -26.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.475 ' SG ' HG13 ' A' ' 41' ' ' ILE . 60.3 m -148.74 72.63 1.19 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.085 -1.009 . . . . 0.0 109.903 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.491 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.87 -46.05 15.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 108.799 179.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -116.17 121.69 42.83 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -98.26 166.18 11.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 110.056 -179.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.513 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.1 mt -115.02 146.01 41.7 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.716 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -44.05 -42.76 6.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.413 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.98 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 147.36 -167.5 28.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.952 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -169.5 163.43 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.396 -1.061 . . . . 0.0 109.252 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.58 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -55.74 151.14 23.85 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.263 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.58 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.44 -2.31 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.551 2.167 . . . . 0.0 110.175 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -90.23 -24.79 20.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.43 -0.794 . . . . 0.0 109.136 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.7 m-20 -83.47 -9.59 58.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.391 -0.818 . . . . 0.0 109.288 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.952 HD11 ' CD1' ' A' ' 18' ' ' ILE . 7.9 mt -101.97 165.81 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.882 . . . . 0.0 110.436 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.578 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -139.07 -31.67 0.7 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.578 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.3 p -128.68 168.66 15.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 108.84 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.519 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 56.1 t -141.18 105.65 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.026 -1.046 . . . . 0.0 109.857 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.731 ' O ' HD12 ' A' ' 41' ' ' ILE . 5.2 t-20 -105.79 111.67 24.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -0.941 . . . . 0.0 109.457 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -116.05 103.44 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.537 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.525 ' CB ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -95.96 105.94 18.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.905 . . . . 0.0 109.395 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.462 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.1 p -51.92 167.87 0.31 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.401 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.52 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 35.7 Cg_endo -78.01 131.95 11.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.566 2.177 . . . . 0.0 110.514 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.47 -143.32 4.82 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.55 4.93 5.11 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.57 2.18 . . . . 0.0 110.636 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.4 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 14.6 p-80 -123.95 -10.6 7.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 0.0 109.595 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.5 t -160.08 124.13 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 109.269 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -80.74 -38.03 29.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.868 . . . . 0.0 109.658 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.435 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 2.0 mp0 -86.73 140.21 29.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.619 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.462 HG23 ' HA ' ' A' ' 30' ' ' SER . 50.6 m -60.79 153.88 23.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.465 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 2.5 mp0 -130.33 107.06 8.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 109.688 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.798 HG22 HG13 ' A' ' 28' ' ' VAL . 38.9 t -89.59 154.13 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.84 . . . . 0.0 109.148 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.731 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.1 mp -141.99 153.08 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.109 -0.994 . . . . 0.0 109.782 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.939 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -140.45 121.55 14.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.823 . . . . 0.0 109.063 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.528 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 3.1 m -89.17 103.94 16.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.887 -1.133 . . . . 0.0 108.798 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 79.7 mt -48.75 177.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.541 -0.724 . . . . 0.0 109.742 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -90.03 8.53 32.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 109.187 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.486 ' ND2' ' HD2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -113.79 28.97 8.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.81 11.77 66.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.486 ' HD2' ' ND2' ' A' ' 46' ' ' ASN . 57.9 mtt180 -98.77 168.83 9.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -1.154 . . . . 0.0 109.434 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 16.3 mttt -140.24 151.25 45.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -0.869 . . . . 0.0 109.242 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.22 123.42 8.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.286 -0.884 . . . . 0.0 109.08 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.483 ' SG ' HG13 ' A' ' 41' ' ' ILE . 15.3 m -79.56 144.69 33.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.082 -1.011 . . . . 0.0 109.258 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.98 HD22 ' HA2' ' A' ' 17' ' ' GLY . 15.2 mt -121.33 167.59 12.59 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.278 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.642 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.8 t-20 -100.18 121.1 54.84 Favored Pre-proline 0 C--N 1.298 -1.668 0 O-C-N 121.385 -0.822 . . . . 0.0 109.103 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.03 -9.27 20.66 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.137 1.891 . . . . 0.0 110.271 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.96 -14.8 57.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 108.804 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -89.97 159.87 41.88 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.404 -0.81 . . . . 0.0 109.376 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.68 -34.36 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.667 2.245 . . . . 0.0 110.722 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.599 ' O ' HD13 ' A' ' 62' ' ' ILE . 12.5 tt -66.65 -46.76 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 109.11 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 52' ' ' LEU . 38.6 t -57.08 -48.62 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 109.048 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 1.1 mttp -55.14 -31.28 61.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.492 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -76.28 -30.62 57.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.615 -0.678 . . . . 0.0 109.297 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -65.16 -44.51 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.352 -0.842 . . . . 0.0 109.015 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.912 HG22 HD11 ' B' ' 67' ' ' LEU . 2.2 mp -67.53 -61.66 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.613 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.507 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -52.61 -27.94 19.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.633 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.55 ' CD ' ' HG3' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -71.48 -40.91 69.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.187 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.519 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -63.36 -46.9 84.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.838 . . . . 0.0 109.185 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.946 HD11 HG22 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.58 -51.12 9.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.522 -0.736 . . . . 0.0 109.455 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -71.97 -29.08 63.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.878 . . . . 0.0 109.546 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.452 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.478 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.352 0.596 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.526 ' HG3' ' CB ' ' B' ' 29' ' ' LYS . 7.1 mm-40 -42.9 -26.26 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.853 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' B' ' 41' ' ' ILE . 60.2 m -148.68 72.6 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.083 -1.011 . . . . 0.0 109.953 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.478 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.8 -46.04 15.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.935 . . . . 0.0 108.773 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -116.19 121.59 42.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.414 -0.804 . . . . 0.0 108.896 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.5 OUTLIER -98.25 166.15 11.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.146 -0.972 . . . . 0.0 110.068 -179.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.504 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.1 mt -115.0 146.09 41.6 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.715 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.7 OUTLIER -44.18 -42.66 6.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.386 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 1.051 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 147.31 -167.56 28.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.967 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -169.44 163.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.509 -0.995 . . . . 0.0 109.272 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.594 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -55.72 151.1 23.76 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.267 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.9 Cg_endo -77.4 -2.3 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.515 2.143 . . . . 0.0 110.224 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HD2' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -90.25 -24.83 20.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.159 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.7 m-20 -83.37 -9.58 58.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.295 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.967 HD11 ' CD1' ' B' ' 18' ' ' ILE . 8.0 mt -102.02 165.83 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 110.438 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.581 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -139.05 -31.79 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.581 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.3 p -128.62 168.56 15.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 108.85 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.513 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 55.7 t -141.13 105.78 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.145 -0.972 . . . . 0.0 109.77 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.711 ' O ' HD12 ' B' ' 41' ' ' ILE . 5.2 t-20 -105.9 111.72 24.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.762 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -116.09 103.42 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.938 . . . . 0.0 109.525 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.526 ' CB ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -96.05 105.89 17.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.408 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.46 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -51.88 167.92 0.31 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.518 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 36.2 Cg_endo -78.03 131.99 11.34 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.599 2.199 . . . . 0.0 110.51 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.57 -143.39 4.82 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.6 5.07 5.03 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.5 2.133 . . . . 0.0 110.581 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 14.5 p-80 -123.93 -10.71 7.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.565 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 3.5 t -160.07 124.1 3.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -80.64 -38.09 29.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.75 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.428 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 2.0 mp0 -86.71 140.17 30.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.46 HG23 ' HA ' ' B' ' 30' ' ' SER . 50.6 m -60.72 153.93 22.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.456 ' HB3' ' SG ' ' B' ' 11' ' ' CYS . 2.5 mp0 -130.37 107.08 8.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 109.631 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.762 HG22 HG13 ' B' ' 28' ' ' VAL . 39.1 t -89.68 154.2 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.102 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.711 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.1 mp -142.03 153.07 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.125 -0.984 . . . . 0.0 109.842 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.946 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -140.45 121.57 14.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 108.972 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 3.1 m -89.18 103.87 16.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.871 -1.143 . . . . 0.0 108.856 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 80.1 mt -48.71 177.03 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.489 -0.757 . . . . 0.0 109.747 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -90.03 8.63 31.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.248 -0.907 . . . . 0.0 109.156 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.495 ' ND2' ' HD2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -113.86 29.05 8.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.876 . . . . 0.0 109.139 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.85 11.73 66.69 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.495 ' HD2' ' ND2' ' B' ' 46' ' ' ASN . 57.8 mtt180 -98.78 168.8 9.91 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 109.466 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.439 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 16.3 mttt -140.22 151.36 45.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 109.219 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.504 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.31 123.38 8.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.039 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.48 ' SG ' HG13 ' B' ' 41' ' ' ILE . 15.3 m -79.56 144.7 33.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.252 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 1.051 HD22 ' HA2' ' B' ' 17' ' ' GLY . 15.3 mt -121.38 167.5 12.7 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.913 . . . . 0.0 109.222 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.641 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.8 t-20 -100.12 121.13 54.82 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.169 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.95 -9.39 20.82 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.214 1.943 . . . . 0.0 110.292 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.89 -14.77 57.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 108.851 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.494 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -90.01 159.88 41.74 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.0 109.304 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.71 -34.22 1.96 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.675 2.25 . . . . 0.0 110.727 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.607 ' O ' HD13 ' B' ' 62' ' ' ILE . 12.6 tt -66.76 -46.75 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.994 . . . . 0.0 109.083 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' B' ' 52' ' ' LEU . 38.4 t -57.11 -48.58 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.363 -0.835 . . . . 0.0 109.059 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' B' ' 56' ' ' SER . 1.1 mttp -55.18 -31.28 61.27 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' B' ' 65' ' ' LYS . 0.9 OUTLIER -76.3 -30.56 57.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.566 -0.709 . . . . 0.0 109.329 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.607 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -65.07 -44.69 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 109.009 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.946 HG22 HD11 ' A' ' 67' ' ' LEU . 2.2 mp -67.41 -61.7 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.629 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.511 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.2 OUTLIER -52.61 -28.01 19.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 109.579 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.547 ' CD ' ' HG3' ' B' ' 20' ' ' PRO . 0.0 OUTLIER -71.47 -40.85 70.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.114 -0.991 . . . . 0.0 109.225 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.513 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -63.36 -46.94 84.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.207 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.912 HD11 HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.63 -51.08 9.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.323 -0.861 . . . . 0.0 109.451 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -71.94 -29.13 63.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 109.536 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.429 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.929 ' HB2' HD22 ' A' ' 12' ' ' LEU . 10.4 m . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.55 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 16.0 mm-40 -43.01 -26.44 0.14 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.735 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' A' ' 41' ' ' ILE . 96.8 m -125.61 63.16 1.2 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.82 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.929 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.09 -38.28 4.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.051 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -125.29 131.54 53.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.408 -0.808 . . . . 0.0 108.962 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -108.42 163.18 13.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.098 -1.001 . . . . 0.0 109.995 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.535 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.3 mt -120.78 146.04 46.93 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.73 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.9 tt0 -44.26 -40.68 5.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.41 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.861 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 150.12 -168.11 30.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 1.013 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -168.49 163.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.487 -1.007 . . . . 0.0 109.213 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.541 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -57.89 150.63 48.15 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.92 . . . . 0.0 109.434 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HG3' ' CD ' ' A' ' 65' ' ' LYS . 34.9 Cg_endo -77.44 -2.78 12.97 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.571 2.18 . . . . 0.0 110.202 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.24 -24.85 20.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 109.069 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.524 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 3.4 m-20 -83.31 -5.53 59.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 109.354 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.013 HD11 ' CD1' ' A' ' 18' ' ' ILE . 7.0 mt -107.07 145.57 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 110.103 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.544 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -117.78 -26.19 6.6 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -143.53 172.24 13.07 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 25' ' ' SER . 50.6 t -159.52 137.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.943 -1.098 . . . . 0.0 109.98 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 43.3 t30 -112.47 169.21 9.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.203 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 t -151.27 92.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.543 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.55 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 0.6 OUTLIER -100.19 116.12 31.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.559 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.24 167.49 9.99 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 109.355 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.529 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.6 Cg_endo -78.0 131.33 10.94 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.677 2.251 . . . . 0.0 110.483 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.62 -144.1 4.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.95 6.9 3.89 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.593 2.196 . . . . 0.0 110.736 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.408 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 12.4 p-80 -125.09 -7.3 7.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.141 -0.975 . . . . 0.0 109.551 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.0 t -160.04 116.34 2.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.963 . . . . 0.0 109.418 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.12 45.79 1.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.556 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.529 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 6.1 pt20 -174.47 139.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.462 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.3 m -57.58 151.32 17.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.334 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.455 ' OE2' ' HG2' ' A' ' 29' ' ' LYS . 6.4 pt-20 -138.05 114.97 10.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.616 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.81 154.02 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 109.222 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.535 ' O ' HG13 ' A' ' 26' ' ' VAL . 4.2 mt -138.39 154.28 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.729 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.813 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -137.24 118.77 14.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 43' ' ' THR . 1.2 m -89.17 96.4 10.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.962 -1.086 . . . . 0.0 108.63 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 89.4 mt -43.18 167.36 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.572 -0.705 . . . . 0.0 109.881 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -80.67 7.59 9.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.645 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.98 23.42 13.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 109.299 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.33 7.41 82.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -95.54 167.64 11.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -1.202 . . . . 0.0 109.497 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HD3' ' OG1' ' A' ' 43' ' ' THR . 18.5 mttt -138.75 151.36 47.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.535 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.3 122.19 8.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.29 -0.881 . . . . 0.0 109.114 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.481 ' SG ' HG12 ' A' ' 41' ' ' ILE . 4.4 m -79.64 142.16 35.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.065 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.861 HD22 ' HA2' ' A' ' 17' ' ' GLY . 12.7 mt -120.03 167.44 12.18 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.292 -0.88 . . . . 0.0 109.492 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.658 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -97.2 115.75 65.81 Favored Pre-proline 0 C--N 1.299 -1.627 0 O-C-N 121.434 -0.791 . . . . 0.0 109.226 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.488 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 33.3 Cg_endo -74.17 0.17 8.8 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.275 1.984 . . . . 0.0 110.433 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.05 -13.85 24.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -0.887 . . . . 0.0 108.944 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 164.61 27.25 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.423 -0.798 . . . . 0.0 109.407 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.9 -37.63 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.676 2.251 . . . . 0.0 110.568 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 10.0 mt -61.4 -51.88 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 109.058 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.861 HG22 ' HB3' ' A' ' 52' ' ' LEU . 54.4 t -54.56 -54.3 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.739 . . . . 0.0 109.744 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 56' ' ' SER . 5.1 mttt -47.5 -33.71 6.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 108.971 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -74.61 -38.56 62.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.494 -0.754 . . . . 0.0 109.328 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -58.13 -41.96 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.429 -0.794 . . . . 0.0 109.146 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.122 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -70.12 -67.87 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.762 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG2' ' HA ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -44.02 -28.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.663 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.548 ' CD ' ' HG3' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -72.88 -59.93 2.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.183 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.414 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.8 OUTLIER -44.12 -44.42 7.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.388 -0.82 . . . . 0.0 109.183 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.114 HD11 ' CG2' ' B' ' 63' ' ' ILE . 1.3 mt -55.16 -58.68 6.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.705 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -80.86 6.85 11.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.734 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 65' ' ' LYS . 10.0 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.465 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.89 ' HB2' HD22 ' B' ' 12' ' ' LEU . 10.3 m . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.553 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 15.8 mm-40 -43.01 -26.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.72 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.468 ' SG ' HG13 ' B' ' 41' ' ' ILE . 95.9 m -125.64 63.29 1.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.981 . . . . 0.0 109.784 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.89 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.18 -38.35 5.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -125.2 131.57 53.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.818 . . . . 0.0 108.966 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.496 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -108.43 163.17 13.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.12 -0.988 . . . . 0.0 110.025 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.542 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.3 mt -120.74 146.0 46.93 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.72 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.9 tt0 -44.29 -40.64 5.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.974 . . . . 0.0 109.42 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.838 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 150.09 -168.08 30.1 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.995 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -168.52 163.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.454 -1.027 . . . . 0.0 109.255 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.547 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -57.81 150.45 48.15 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.251 -0.906 . . . . 0.0 109.401 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.549 ' HG3' ' CD ' ' B' ' 65' ' ' LYS . 35.3 Cg_endo -77.32 -2.79 13.0 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.59 2.194 . . . . 0.0 110.231 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.465 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.21 -24.88 20.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.383 -0.823 . . . . 0.0 109.057 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 3.4 m-20 -83.33 -5.56 59.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.463 -0.773 . . . . 0.0 109.217 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.995 HD11 ' CD1' ' B' ' 18' ' ' ILE . 7.1 mt -107.13 145.46 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.878 . . . . 0.0 110.112 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.545 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -117.71 -26.09 6.66 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.63 ' O ' HG23 ' B' ' 26' ' ' VAL . 0.0 OUTLIER -143.57 172.22 13.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.63 HG23 ' O ' ' B' ' 25' ' ' SER . 50.4 t -159.49 137.58 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.969 -1.082 . . . . 0.0 109.993 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 43.2 t30 -112.48 169.26 9.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.293 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 t -151.32 92.97 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.436 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.553 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 0.6 OUTLIER -100.26 116.19 31.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.27 167.45 10.14 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.413 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.537 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.7 Cg_endo -77.98 131.3 10.93 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.632 2.222 . . . . 0.0 110.494 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.58 -144.1 4.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.93 6.87 3.91 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.552 2.168 . . . . 0.0 110.763 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.413 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 12.3 p-80 -125.01 -7.37 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.046 -1.034 . . . . 0.0 109.505 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.9 t -160.07 116.25 2.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.355 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.01 45.76 1.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.64 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.537 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 6.1 pt20 -174.54 139.47 0.57 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -0.956 . . . . 0.0 109.549 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 1.3 m -57.6 151.34 17.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.862 . . . . 0.0 109.338 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.453 ' HB2' ' SG ' ' B' ' 11' ' ' CYS . 6.4 pt-20 -138.02 114.94 10.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.611 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.86 154.0 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.153 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.528 ' O ' HG13 ' B' ' 26' ' ' VAL . 4.2 mt -138.36 154.21 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.746 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.813 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -137.19 118.77 14.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.221 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.606 HG22 ' O ' ' B' ' 43' ' ' THR . 1.2 m -89.17 96.41 10.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.027 -1.046 . . . . 0.0 108.63 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.6 mt -43.22 167.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.581 -0.699 . . . . 0.0 109.895 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -80.67 7.68 9.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 109.652 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.11 23.46 13.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.95 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.29 7.44 82.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.513 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 0.7 OUTLIER -95.54 167.66 11.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -1.177 . . . . 0.0 109.507 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.443 ' HD3' ' OG1' ' B' ' 43' ' ' THR . 18.4 mttt -138.71 151.31 47.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.902 . . . . 0.0 109.511 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.542 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.26 122.27 8.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.117 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.476 ' SG ' HG12 ' B' ' 41' ' ' ILE . 4.4 m -79.7 142.26 35.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 109.125 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.849 ' HB3' HG22 ' B' ' 59' ' ' VAL . 12.8 mt -120.19 167.41 12.28 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.285 -0.884 . . . . 0.0 109.356 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.654 ' N ' HG21 ' B' ' 59' ' ' VAL . 1.0 OUTLIER -97.14 115.73 65.81 Favored Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 109.278 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.471 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.4 Cg_endo -74.18 0.14 8.84 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.265 1.976 . . . . 0.0 110.46 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.03 -13.85 24.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.267 -0.896 . . . . 0.0 108.918 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' B' ' 53' ' ' ASN . 0.0 OUTLIER -90.09 164.52 27.68 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 109.403 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.79 -37.74 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.668 2.245 . . . . 0.0 110.508 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' B' ' 62' ' ' ILE . 10.0 mt -61.42 -51.89 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 0.0 109.026 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.849 HG22 ' HB3' ' B' ' 52' ' ' LEU . 54.8 t -54.45 -54.42 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.542 -0.724 . . . . 0.0 109.745 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 5.1 mttt -47.44 -33.65 6.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 109.078 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.479 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -74.6 -38.61 62.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 0.0 109.372 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -58.05 -41.99 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.825 . . . . 0.0 109.168 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 1.114 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -70.1 -67.86 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.766 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -44.01 -28.31 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 109.747 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.549 ' CD ' ' HG3' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -72.81 -59.95 2.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 0.0 109.237 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.425 ' C ' ' O ' ' B' ' 65' ' ' LYS . 0.8 OUTLIER -44.05 -44.43 7.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.155 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.122 HD11 ' CG2' ' A' ' 63' ' ' ILE . 1.3 mt -55.21 -58.63 6.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.52 -0.738 . . . . 0.0 109.701 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -80.9 6.94 11.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 109.749 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' B' ' 65' ' ' LYS . 10.0 p . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.122 -0.986 . . . . 0.0 109.402 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.432 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 19.7 m . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 121.342 0.592 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.528 ' CG ' ' HE3' ' A' ' 29' ' ' LYS . 22.5 mm-40 -49.78 -21.66 1.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.715 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' OE1' ' A' ' 39' ' ' GLU . 49.9 m -144.98 67.43 1.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 0.0 109.909 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 12' ' ' LEU . 14.5 mt -45.12 -45.53 11.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 108.817 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.09 119.41 35.76 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -94.52 167.14 11.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 110.101 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.517 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.4 mt -114.38 144.99 42.4 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.585 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.4 tt0 -44.29 -39.06 4.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.176 -0.952 . . . . 0.0 109.41 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.988 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 144.99 -164.72 27.85 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.941 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -170.82 163.74 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.488 -1.007 . . . . 0.0 109.094 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.524 ' ND1' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -53.54 149.48 15.11 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 109.354 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.533 ' HA ' HD12 ' A' ' 23' ' ' ILE . 35.0 Cg_endo -77.19 -3.98 14.3 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.53 2.153 . . . . 0.0 110.176 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HE2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.25 -24.38 20.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.376 -0.828 . . . . 0.0 109.089 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.523 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 2.5 m-20 -82.87 -6.47 59.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 109.258 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.941 HD11 ' CD1' ' A' ' 18' ' ' ILE . 8.5 mt -104.94 148.89 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.574 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -120.54 -27.27 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.574 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -137.69 168.51 19.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.092 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.585 HG23 ' HG3' ' A' ' 66' ' ' MET . 90.5 t -140.87 114.46 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.011 . . . . 0.0 109.776 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.629 ' O ' HD12 ' A' ' 41' ' ' ILE . 3.8 t-20 -109.62 110.65 21.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 109.348 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.716 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -110.1 105.54 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 109.516 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HE3' ' CG ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -98.51 114.71 27.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.402 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.98 167.82 5.54 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.464 ' HB3' ' C ' ' A' ' 36' ' ' ALA . 36.2 Cg_endo -78.13 151.44 26.93 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.615 2.21 . . . . 0.0 110.44 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.84 -141.3 3.14 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.469 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 36.3 Cg_endo -77.89 10.96 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.649 2.233 . . . . 0.0 111.008 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.506 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 3.6 p-80 -128.27 -34.48 2.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.058 -1.026 . . . . 0.0 109.441 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.9 t -145.39 88.03 1.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.287 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.464 ' C ' ' HB3' ' A' ' 31' ' ' PRO . . . -52.59 -19.93 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.706 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.462 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 33.8 mm-40 -92.85 131.93 37.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.458 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 3.6 m -54.79 161.3 1.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.33 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.488 ' HB2' ' CG ' ' A' ' 29' ' ' LYS . 22.5 mm-40 -145.33 107.53 4.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 0.0 109.635 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.716 HG22 HG13 ' A' ' 28' ' ' VAL . 43.1 t -91.77 152.84 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.326 -0.859 . . . . 0.0 109.311 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 27' ' ' ASN . 2.7 mp -140.34 155.42 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.949 . . . . 0.0 109.709 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.777 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -140.9 117.99 11.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 109.103 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.537 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.4 m -89.22 97.66 11.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.892 -1.13 . . . . 0.0 108.787 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 87.1 mt -43.53 162.8 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.464 -0.772 . . . . 0.0 109.583 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.72 ' HZ2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -79.1 7.17 7.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.805 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.502 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -108.85 16.87 22.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.132 -0.98 . . . . 0.0 109.198 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.57 -0.8 89.45 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.502 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 13.7 mtt180 -89.68 162.97 15.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -1.201 . . . . 0.0 109.426 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.3 mptt -134.5 151.06 50.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.24 123.93 9.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 109.033 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 22.9 m -79.47 143.99 34.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.078 -1.014 . . . . 0.0 109.189 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.993 HD13 HD13 ' A' ' 62' ' ' ILE . 15.2 mt -121.19 167.69 12.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -0.856 . . . . 0.0 109.437 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.648 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.8 t-20 -100.84 123.48 45.36 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.413 -0.804 . . . . 0.0 109.177 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.19 -7.04 18.64 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.219 1.946 . . . . 0.0 110.398 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.45 -13.1 55.47 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 108.961 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -90.06 161.65 37.4 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.374 -0.829 . . . . 0.0 109.429 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.92 -35.66 1.33 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.648 2.232 . . . . 0.0 110.574 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.601 HG23 ' N ' ' A' ' 59' ' ' VAL . 16.8 tt -67.31 -45.74 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.426 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.0 ' HA ' HD12 ' A' ' 62' ' ' ILE . 42.7 t -58.62 -46.82 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.413 -0.804 . . . . 0.0 109.369 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 1.3 mmpt? -59.47 -29.48 67.85 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -79.72 -23.84 42.08 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.0 HD12 ' HA ' ' A' ' 59' ' ' VAL . 22.7 mt -70.58 -37.76 70.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.689 HD11 HG11 ' A' ' 40' ' ' VAL . 2.2 mp -74.75 -56.48 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 0.0 109.321 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER -59.35 -27.87 66.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.296 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 1.7 tptt -71.78 -50.68 27.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.058 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.585 ' HG3' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -51.85 -45.78 64.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 109.081 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.639 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -44.27 -52.15 7.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.335 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.9 OUTLIER -62.14 -38.1 87.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.393 -0.817 . . . . 0.0 109.456 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.429 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 2.5 p . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.457 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.444 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 19.4 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.372 0.605 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.517 ' CG ' ' HE3' ' B' ' 29' ' ' LYS . 22.5 mm-40 -49.75 -21.66 1.16 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.757 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.467 ' HB2' ' OE1' ' B' ' 39' ' ' GLU . 50.8 m -145.01 67.51 1.24 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.126 -0.984 . . . . 0.0 109.893 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 14.5 mt -45.12 -45.57 11.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -0.972 . . . . 0.0 108.854 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' B' ' 13' ' ' GLN . 0.0 OUTLIER -116.06 119.44 35.85 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.6 OUTLIER -94.55 167.1 11.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.242 -0.911 . . . . 0.0 110.098 -179.365 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.509 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.4 mt -114.36 144.97 42.42 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.578 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.4 tt0 -44.27 -39.09 4.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 109.395 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 1.051 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 144.95 -164.62 27.85 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.944 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -170.82 163.7 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.442 -1.034 . . . . 0.0 109.145 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.523 ' ND1' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -53.53 149.46 15.13 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.326 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.532 ' HA ' HD12 ' B' ' 23' ' ' ILE . 34.7 Cg_endo -77.29 -3.89 14.17 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.586 2.191 . . . . 0.0 110.189 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.45 ' O ' ' CD ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.3 -24.31 20.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.151 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 2.5 m-20 -82.87 -6.42 59.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.332 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.944 HD11 ' CD1' ' B' ' 18' ' ' ILE . 8.4 mt -104.95 148.88 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 110.269 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.556 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -120.55 -27.31 5.17 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.237 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.556 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -137.64 168.47 19.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.141 179.337 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.608 HG23 ' HG3' ' B' ' 66' ' ' MET . 91.3 t -140.81 114.43 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.802 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.625 ' O ' HD12 ' B' ' 41' ' ' ILE . 3.8 t-20 -109.6 110.63 21.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.295 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.696 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -110.03 105.62 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.275 -0.89 . . . . 0.0 109.592 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -98.6 114.67 27.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.387 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.95 167.89 5.4 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.423 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.462 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 36.2 Cg_endo -78.16 151.47 26.85 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.518 2.146 . . . . 0.0 110.456 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.82 -141.34 3.15 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.461 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -77.92 10.98 2.41 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.603 2.202 . . . . 0.0 110.993 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.512 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 3.7 p-80 -128.27 -34.44 2.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.016 -1.052 . . . . 0.0 109.474 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 2.0 t -145.43 88.07 1.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.296 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -52.6 -20.0 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.708 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.453 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 33.5 mm-40 -92.8 131.9 37.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.457 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 3.6 m -54.74 161.33 1.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.396 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.497 ' HB2' ' CG ' ' B' ' 29' ' ' LYS . 22.5 mm-40 -145.35 107.58 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.696 HG22 HG13 ' B' ' 28' ' ' VAL . 42.9 t -91.8 152.8 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 109.299 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.625 HD12 ' O ' ' B' ' 27' ' ' ASN . 2.7 mp -140.31 155.35 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.719 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.775 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -140.88 118.05 11.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.093 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.55 HG22 ' O ' ' B' ' 43' ' ' THR . 1.5 m -89.13 97.55 11.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.92 -1.113 . . . . 0.0 108.817 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 86.9 mt -43.45 162.8 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.479 -0.763 . . . . 0.0 109.661 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.629 ' HZ2' ' HB3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -79.15 7.29 7.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 109.83 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -108.88 16.76 22.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.134 -0.979 . . . . 0.0 109.121 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.68 -0.87 89.4 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.506 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 13.7 mtt180 -89.64 162.95 15.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.082 -1.246 . . . . 0.0 109.445 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 1.3 mptt -134.46 151.06 50.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 109.435 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.21 123.91 9.18 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 109.057 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' B' ' 41' ' ' ILE . 22.8 m -79.49 143.93 34.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.063 -1.023 . . . . 0.0 109.169 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 1.051 HD22 ' HA2' ' B' ' 17' ' ' GLY . 15.2 mt -121.14 167.61 12.47 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.647 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.7 t-20 -100.79 123.55 45.2 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.13 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.24 -7.05 18.62 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.225 1.95 . . . . 0.0 110.4 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.5 -13.13 55.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.229 -0.919 . . . . 0.0 108.868 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.3 OUTLIER -90.06 161.66 37.39 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.99 -35.53 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.609 2.206 . . . . 0.0 110.504 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.596 HG23 ' N ' ' B' ' 59' ' ' VAL . 16.8 tt -67.33 -45.79 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.417 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 1.009 ' HA ' HD12 ' B' ' 62' ' ' ILE . 42.5 t -58.72 -46.72 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.812 . . . . 0.0 109.333 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 1.3 mmpt? -59.47 -29.59 67.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.48 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -79.63 -23.89 42.29 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 1.009 HD12 ' HA ' ' B' ' 59' ' ' VAL . 23.0 mt -70.52 -37.8 71.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.56 -0.712 . . . . 0.0 109.079 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.665 HD11 HG11 ' B' ' 40' ' ' VAL . 2.2 mp -74.67 -56.49 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.427 -0.795 . . . . 0.0 109.398 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.4 OUTLIER -59.32 -27.86 66.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.294 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.512 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 1.6 tptt -71.79 -50.71 27.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.047 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.608 ' HG3' HG23 ' B' ' 26' ' ' VAL . 0.4 OUTLIER -51.82 -45.68 64.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.282 -0.886 . . . . 0.0 109.114 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.652 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -44.27 -52.35 7.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.314 -0.867 . . . . 0.0 109.258 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' B' ' 69' ' ' SER . 0.9 OUTLIER -61.95 -38.12 87.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.529 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.45 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 2.5 p . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.73 ' HB2' HD22 ' A' ' 12' ' ' LEU . 50.7 m . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.506 ' OE1' ' NZ ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.59 -26.79 0.13 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.347 -0.846 . . . . 0.0 109.761 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' CYS . 72.0 m -118.25 58.33 0.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.73 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.2 -37.91 3.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.234 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.37 123.86 41.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.383 -0.823 . . . . 0.0 109.11 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -100.05 161.1 13.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.536 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.2 mt -115.07 141.16 48.38 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.1 tt0 -44.12 -26.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.271 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 1.053 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 139.41 -162.68 26.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.852 HG23 ' O ' ' A' ' 17' ' ' GLY . 1.3 pp -171.0 163.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.466 -1.02 . . . . 0.0 109.267 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -58.12 154.27 31.1 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 0.0 109.201 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -76.99 -9.31 17.99 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.415 2.077 . . . . 0.0 109.927 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.501 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 35.5 mttm -77.34 -27.85 52.85 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.931 ' O ' HD13 ' A' ' 23' ' ' ILE . 22.9 m-20 -93.33 59.29 2.97 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.931 HD13 ' O ' ' A' ' 22' ' ' ASN . 1.5 mm -147.17 169.01 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 110.028 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.754 ' HG2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -160.38 -36.0 0.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.607 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.7 p -134.83 -175.17 3.81 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 25' ' ' SER . 50.7 t -158.82 98.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.946 -1.096 . . . . 0.0 109.867 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.484 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 3.5 t-20 -91.33 110.74 22.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.218 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.475 HG13 HG13 ' A' ' 40' ' ' VAL . 1.7 t -114.32 104.11 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.478 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.681 ' HZ3' ' HB3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -108.19 110.45 22.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.4 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -55.04 168.88 0.47 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.365 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.525 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.4 Cg_endo -78.13 131.95 11.21 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.556 2.171 . . . . 0.0 110.5 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.08 -143.55 5.42 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.86 5.86 4.6 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.519 2.146 . . . . 0.0 110.709 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.418 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 12.2 p-80 -124.28 -12.66 7.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.979 . . . . 0.0 109.623 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 2.7 t -160.22 98.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.214 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.98 -8.48 30.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 109.651 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.455 ' OE1' ' CA ' ' A' ' 37' ' ' GLN . 6.5 mm-40 -106.0 125.44 51.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.415 ' C ' ' HG2' ' A' ' 39' ' ' GLU . 25.9 m -49.7 152.61 1.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.417 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HG2' ' C ' ' A' ' 38' ' ' THR . 2.2 mt-10 -137.66 107.32 6.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.984 . . . . 0.0 109.791 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.922 HG11 HD11 ' A' ' 63' ' ' ILE . 3.8 t -93.8 157.73 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.12 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.548 ' CD1' ' HE2' ' A' ' 29' ' ' LYS . 1.9 mp -144.28 143.8 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 109.835 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.624 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -126.88 125.25 41.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 109.016 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.754 HG22 ' HG2' ' A' ' 24' ' ' GLN . 25.8 m -89.65 104.71 17.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.031 -1.043 . . . . 0.0 109.051 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 22' ' ' ASN . 80.1 mt -47.35 164.92 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.223 -0.923 . . . . 0.0 109.155 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 13.4 ptpt -84.93 12.97 6.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.148 -0.97 . . . . 0.0 109.566 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -111.2 10.68 21.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.888 . . . . 0.0 109.181 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.04 20.81 48.44 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.566 ' HB2' HD12 ' A' ' 44' ' ' LEU . 9.4 mtt180 -115.95 173.68 6.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -1.148 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 4.2 mttt -139.71 154.66 47.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.536 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.17 125.45 10.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.097 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.48 ' SG ' HG13 ' A' ' 41' ' ' ILE . 16.8 m -79.51 144.52 33.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 0.0 109.192 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.053 HD22 ' HA2' ' A' ' 17' ' ' GLY . 15.1 mt -122.53 168.34 12.26 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.663 ' O ' HG21 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -98.04 120.96 58.79 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.368 -0.833 . . . . 0.0 109.112 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.83 -6.79 18.61 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.196 1.931 . . . . 0.0 110.284 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.3 -14.25 53.42 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.257 -0.902 . . . . 0.0 108.833 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 1.1 p -90.05 158.3 44.47 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.474 -0.766 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.479 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.0 Cg_endo -77.14 -32.27 3.24 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.614 2.209 . . . . 0.0 110.509 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.591 HG23 ' N ' ' A' ' 59' ' ' VAL . 9.0 tt -69.2 -45.16 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.112 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.029 ' HA ' HD12 ' A' ' 62' ' ' ILE . 25.2 t -57.45 -46.2 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.522 -0.736 . . . . 0.0 109.248 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -61.08 -30.32 70.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.524 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 3.4 mmpt? -79.05 -20.58 48.53 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.029 HD12 ' HA ' ' A' ' 59' ' ' VAL . 26.7 mt -75.51 -37.34 37.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.578 -0.701 . . . . 0.0 109.181 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.922 HD11 HG11 ' A' ' 40' ' ' VAL . 2.2 mp -74.28 -50.33 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 8.7 pt-20 -66.12 -35.95 81.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 109.328 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.53 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 32.9 mttm -61.38 -40.44 94.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 108.945 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.53 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -61.1 -45.33 95.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.087 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.885 HD11 HG22 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -49.59 -54.88 15.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 109.69 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.2 -16.18 60.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.895 . . . . 0.0 109.724 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 28.4 p . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 109.468 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.729 ' HB2' HD22 ' B' ' 12' ' ' LEU . 50.9 m . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.517 ' OE1' ' NZ ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -42.59 -26.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.359 -0.838 . . . . 0.0 109.722 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' B' ' 9' ' ' CYS . 72.1 m -118.28 58.38 0.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.729 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.13 -37.99 3.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 109.256 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.32 123.91 41.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.1 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.552 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.4 OUTLIER -100.13 161.12 13.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.535 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.2 mt -115.17 141.15 48.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.461 -0.775 . . . . 0.0 108.952 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.522 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 3.1 tt0 -44.08 -26.73 0.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.35 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 1.003 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 139.36 -162.67 26.1 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.854 HG23 ' O ' ' B' ' 17' ' ' GLY . 1.3 pp -170.96 163.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.404 -1.056 . . . . 0.0 109.217 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.592 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -58.16 154.21 31.77 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.25 -0.907 . . . . 0.0 109.27 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.592 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.9 Cg_endo -76.88 -9.31 18.15 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.449 2.099 . . . . 0.0 109.924 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.495 ' O ' ' NZ ' ' B' ' 45' ' ' LYS . 35.4 mttm -77.38 -27.87 52.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.952 ' O ' HD13 ' B' ' 23' ' ' ILE . 23.0 m-20 -93.38 59.38 2.97 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.952 HD13 ' O ' ' B' ' 22' ' ' ASN . 1.4 mm -147.23 168.93 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.141 -0.974 . . . . 0.0 110.047 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.75 ' HG2' HG22 ' B' ' 43' ' ' THR . 0.0 OUTLIER -160.38 -35.98 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.606 ' O ' HG23 ' B' ' 26' ' ' VAL . 1.7 p -134.82 -175.19 3.82 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 25' ' ' SER . 50.4 t -158.81 98.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.96 -1.087 . . . . 0.0 109.79 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.487 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 3.6 t-20 -91.48 110.76 22.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.235 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.483 HG13 HG13 ' B' ' 40' ' ' VAL . 1.7 t -114.35 104.09 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.492 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.615 ' HZ3' ' HB3' ' B' ' 29' ' ' LYS . 0.9 OUTLIER -108.16 110.41 22.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.401 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.0 OUTLIER -54.96 168.84 0.47 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 109.414 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 36.0 Cg_endo -78.0 131.8 11.25 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.67 2.247 . . . . 0.0 110.507 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.01 -143.58 5.43 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.72 5.68 4.66 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.642 2.228 . . . . 0.0 110.68 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.405 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 12.1 p-80 -124.3 -12.68 7.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.181 -0.949 . . . . 0.0 109.585 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 2.7 t -160.18 98.88 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.25 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.9 -8.59 30.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.631 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.451 ' HA ' ' OE1' ' B' ' 37' ' ' GLN . 6.4 mm-40 -105.85 125.42 50.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.591 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.43 ' C ' ' HG2' ' B' ' 39' ' ' GLU . 26.0 m -49.79 152.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.868 . . . . 0.0 109.341 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.43 ' HG2' ' C ' ' B' ' 38' ' ' THR . 2.1 mt-10 -137.58 107.36 6.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.724 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.913 HG11 HD11 ' B' ' 63' ' ' ILE . 3.8 t -93.85 157.64 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.115 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.554 ' CD1' ' HE2' ' B' ' 29' ' ' LYS . 1.9 mp -144.24 143.8 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.96 . . . . 0.0 109.81 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.619 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -126.93 125.18 41.1 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.75 HG22 ' HG2' ' B' ' 24' ' ' GLN . 26.2 m -89.53 104.73 17.26 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.981 -1.074 . . . . 0.0 109.05 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.788 HD23 ' O ' ' B' ' 22' ' ' ASN . 80.8 mt -47.44 164.98 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.354 -0.841 . . . . 0.0 109.123 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' B' ' 21' ' ' LYS . 13.4 ptpt -84.98 13.11 6.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.594 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -111.28 10.68 21.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.878 . . . . 0.0 109.064 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.03 20.73 48.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.566 ' HB2' HD12 ' B' ' 44' ' ' LEU . 9.4 mtt180 -115.96 173.72 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -1.128 . . . . 0.0 109.394 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.441 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 4.2 mttt -139.67 154.69 47.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.423 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.535 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.19 125.34 10.02 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.276 -0.89 . . . . 0.0 109.175 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.477 ' SG ' HG13 ' B' ' 41' ' ' ILE . 17.1 m -79.45 144.47 34.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.957 . . . . 0.0 109.152 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 1.003 HD22 ' HA2' ' B' ' 17' ' ' GLY . 15.0 mt -122.52 168.33 12.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.891 . . . . 0.0 109.35 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.668 ' O ' HG21 ' B' ' 59' ' ' VAL . 0.9 OUTLIER -98.01 120.91 58.94 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.37 -0.831 . . . . 0.0 109.093 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.83 -6.68 18.46 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.126 1.884 . . . . 0.0 110.35 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.35 -14.21 53.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 0.0 108.826 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 1.1 p -90.05 158.26 44.5 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.383 -0.823 . . . . 0.0 109.402 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.488 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 35.5 Cg_endo -77.06 -32.29 3.28 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.676 2.25 . . . . 0.0 110.522 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.602 HG23 ' N ' ' B' ' 59' ' ' VAL . 9.1 tt -69.23 -45.16 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 0.0 109.113 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 1.028 ' HA ' HD12 ' B' ' 62' ' ' ILE . 25.2 t -57.55 -46.1 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.474 -0.766 . . . . 0.0 109.163 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' B' ' 56' ' ' SER . 0.0 OUTLIER -61.17 -30.28 70.31 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.532 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 3.4 mmpt? -78.96 -20.77 48.38 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 1.028 HD12 ' HA ' ' B' ' 59' ' ' VAL . 26.7 mt -75.38 -37.34 38.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.641 -0.662 . . . . 0.0 109.267 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.913 HD11 HG11 ' B' ' 40' ' ' VAL . 2.2 mp -74.29 -50.34 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.624 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.538 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 8.7 pt-20 -66.09 -35.93 81.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.998 -1.064 . . . . 0.0 109.353 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.538 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 32.8 mttm -61.42 -40.53 94.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 108.939 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.518 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.2 OUTLIER -61.0 -45.3 95.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.149 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.91 HD11 HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -49.64 -54.78 16.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 109.698 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.32 -16.19 60.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.687 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 28.3 p . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.537 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.761 ' HB2' HD22 ' A' ' 12' ' ' LEU . 68.7 m . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.539 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.52 -26.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.874 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 39' ' ' GLU . 83.0 m -116.8 58.71 0.76 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 109.71 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.761 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.82 -37.14 3.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.178 -0.951 . . . . 0.0 109.147 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -127.28 127.72 44.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.374 -0.829 . . . . 0.0 109.059 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -101.94 165.37 11.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.217 -0.927 . . . . 0.0 109.953 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.566 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 6.9 mt -124.21 143.42 50.53 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.3 tt0 -44.17 -40.89 5.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -0.946 . . . . 0.0 109.402 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 1.032 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 140.41 166.67 10.76 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.893 HD11 ' CG1' ' A' ' 23' ' ' ILE . 1.9 pp -139.31 162.8 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.549 -0.971 . . . . 0.0 109.083 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.734 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -46.49 151.61 0.99 Allowed Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 109.204 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.568 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -76.91 -4.87 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.502 2.135 . . . . 0.0 110.083 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.44 -23.41 21.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.331 -0.855 . . . . 0.0 109.237 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.523 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 4.8 m-20 -82.52 -4.7 57.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 0.0 109.44 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.893 ' CG1' HD11 ' A' ' 18' ' ' ILE . 9.0 mt -105.61 155.3 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 110.304 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -127.27 -29.19 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.32 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.582 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -135.11 171.12 14.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.029 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.54 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 46.4 t -143.78 101.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.959 . . . . 0.0 109.733 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.525 ' O ' HD12 ' A' ' 41' ' ' ILE . 3.8 t-20 -95.71 110.4 22.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.364 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.402 HG13 HG22 ' A' ' 40' ' ' VAL . 1.9 t -107.0 100.72 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.504 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.539 ' CD ' ' HB2' ' A' ' 10' ' ' GLN . 10.2 ptmt -95.54 109.41 21.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.44 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.455 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -61.88 171.52 1.45 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.4 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.457 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.3 Cg_endo -77.54 144.57 22.67 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.611 2.207 . . . . 0.0 110.444 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.89 -141.3 3.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.9 39.96 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.746 2.297 . . . . 0.0 110.759 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.48 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 6.4 p-80 -159.41 -38.82 0.06 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.082 -1.011 . . . . 0.0 109.13 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -141.14 99.0 3.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.865 . . . . 0.0 109.146 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.87 -11.85 42.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 0.0 109.679 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 37' ' ' GLN . 4.0 mm-40 -98.92 124.4 43.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.457 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.459 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 9.4 m -47.72 157.85 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.252 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 29' ' ' LYS . 7.3 mm-40 -145.57 107.29 4.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 109.702 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.9 HG11 HD11 ' A' ' 63' ' ' ILE . 6.5 t -89.74 156.23 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.154 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 27' ' ' ASN . 2.6 mp -141.09 148.43 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.145 -0.972 . . . . 0.0 109.838 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.756 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -133.04 118.18 18.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.007 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.532 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 2.1 m -89.12 98.91 12.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.931 -1.106 . . . . 0.0 108.885 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 88.9 mt -44.41 166.6 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.504 -0.747 . . . . 0.0 109.593 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.4 ptpt -81.88 8.21 10.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.639 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.15 25.04 11.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.216 -0.928 . . . . 0.0 109.242 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.18 2.64 67.23 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.511 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 5.8 mtt180 -92.1 164.32 13.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.193 -1.181 . . . . 0.0 109.436 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.6 mptt -135.92 153.13 51.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.174 -0.954 . . . . 0.0 109.393 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.566 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.29 122.45 8.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.065 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.4 m -79.46 143.07 35.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.102 -0.999 . . . . 0.0 109.036 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.054 HD13 HD13 ' A' ' 62' ' ' ILE . 14.2 mt -119.74 167.59 11.91 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.29 -0.881 . . . . 0.0 109.611 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.676 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.1 t30 -97.64 119.0 63.52 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.518 -0.739 . . . . 0.0 109.172 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.11 -0.0 9.0 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.136 1.891 . . . . 0.0 110.443 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.562 ' HB3' HD22 ' A' ' 53' ' ' ASN . . . -94.79 -13.07 25.97 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.296 -0.877 . . . . 0.0 108.835 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.11 165.35 24.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.389 -0.82 . . . . 0.0 109.399 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.502 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.17 -42.18 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.707 2.271 . . . . 0.0 110.816 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.1 mt -61.52 -39.71 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.734 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.988 ' HA ' HD12 ' A' ' 62' ' ' ILE . 47.5 t -64.42 -49.46 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.794 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 8.7 mttm -53.73 -32.33 51.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.071 -1.018 . . . . 0.0 108.706 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -78.06 -29.93 49.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.55 -0.719 . . . . 0.0 109.268 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.054 HD13 HD13 ' A' ' 52' ' ' LEU . 15.2 mt -64.43 -38.55 82.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.219 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.948 ' CG2' HD11 ' B' ' 67' ' ' LEU . 1.4 mp -76.01 -64.65 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.858 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -49.65 -55.22 14.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 109.449 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 61' ' ' LYS . 42.8 tptt -46.62 -55.79 7.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.128 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.54 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -44.38 -43.19 7.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 0.0 109.169 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.955 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -55.83 -55.27 34.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.419 -0.8 . . . . 0.0 109.579 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.28 10.31 17.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 109.679 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 91.2 p . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.495 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.754 ' HB2' HD22 ' B' ' 12' ' ' LEU . 68.6 m . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.534 ' HB2' ' CD ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -42.67 -26.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.436 -0.79 . . . . 0.0 109.761 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' B' ' 39' ' ' GLU . 82.9 m -116.85 58.77 0.76 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.729 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.754 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.18 3.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -127.31 127.64 44.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.016 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.506 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -101.88 165.42 11.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.968 . . . . 0.0 109.958 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.554 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 6.9 mt -124.2 143.43 50.52 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.488 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.3 tt0 -44.22 -40.97 5.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.28 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.987 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 140.45 166.72 10.78 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.911 HD11 ' CG1' ' B' ' 23' ' ' ILE . 1.9 pp -139.37 162.82 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.496 -1.002 . . . . 0.0 109.034 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.744 ' O ' HD12 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -46.49 151.61 0.99 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.982 . . . . 0.0 109.134 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.554 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -76.91 -4.84 15.37 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.475 2.117 . . . . 0.0 110.008 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.473 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.47 -23.28 21.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.389 -0.819 . . . . 0.0 109.229 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 4.8 m-20 -82.61 -4.69 58.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.911 ' CG1' HD11 ' B' ' 18' ' ' ILE . 8.9 mt -105.59 155.35 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.569 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -127.36 -29.14 2.73 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.569 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -135.11 171.06 14.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 109.055 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.536 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 46.2 t -143.73 101.82 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.047 -1.033 . . . . 0.0 109.752 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.518 ' O ' HD12 ' B' ' 41' ' ' ILE . 3.9 t-20 -95.65 110.4 22.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.321 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.406 HG13 HG22 ' B' ' 40' ' ' VAL . 1.9 t -107.01 100.71 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.481 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.534 ' CD ' ' HB2' ' B' ' 10' ' ' GLN . 10.1 ptmt -95.57 109.52 21.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 109.441 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.451 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -61.99 171.49 1.5 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 109.447 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.8 Cg_endo -77.43 144.6 22.96 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.615 2.21 . . . . 0.0 110.455 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.84 -141.25 3.29 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.9 39.94 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.684 2.256 . . . . 0.0 110.826 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.482 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 6.5 p-80 -159.37 -38.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.073 -1.017 . . . . 0.0 109.202 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -141.21 99.02 3.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 109.154 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.9 -11.93 43.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.7 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.456 ' HA ' ' OE1' ' B' ' 37' ' ' GLN . 4.0 mm-40 -98.77 124.45 43.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.519 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.454 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 9.4 m -47.78 157.89 0.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.313 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' B' ' 38' ' ' THR . 7.3 mm-40 -145.58 107.27 4.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.732 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.903 HG11 HD11 ' B' ' 63' ' ' ILE . 6.3 t -89.72 156.2 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.846 . . . . 0.0 109.182 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.518 HD12 ' O ' ' B' ' 27' ' ' ASN . 2.6 mp -141.07 148.47 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.777 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.76 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -133.09 118.19 18.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.057 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.518 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 2.1 m -89.08 98.82 11.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.909 -1.12 . . . . 0.0 108.896 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.1 mt -44.4 166.5 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.523 -0.736 . . . . 0.0 109.697 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.4 ptpt -81.73 8.09 10.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 109.692 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.07 25.01 11.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.26 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.28 2.55 67.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.508 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 5.8 mtt180 -92.01 164.28 13.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -1.204 . . . . 0.0 109.436 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 1.6 mptt -135.86 153.2 51.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.382 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.554 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.39 122.36 8.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.835 . . . . 0.0 109.075 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 5.4 m -79.4 142.96 35.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.021 . . . . 0.0 109.08 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 1.131 HD13 HD13 ' B' ' 62' ' ' ILE . 14.0 mt -119.65 167.63 11.84 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.262 -0.899 . . . . 0.0 109.678 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.669 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.1 t30 -97.62 118.99 63.56 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.506 -0.746 . . . . 0.0 109.182 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -74.26 0.14 8.89 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.07 1.846 . . . . 0.0 110.339 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.569 ' HB3' HD22 ' B' ' 53' ' ' ASN . . . -94.72 -13.16 26.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 108.867 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.1 165.4 24.23 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.835 . . . . 0.0 109.419 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.501 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.5 Cg_endo -78.1 -42.23 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.742 2.295 . . . . 0.0 110.831 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 47.2 mt -61.61 -39.62 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.189 -0.944 . . . . 0.0 109.706 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 1.037 ' HA ' HD12 ' B' ' 62' ' ' ILE . 47.6 t -64.43 -49.48 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.347 -0.845 . . . . 0.0 109.832 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' B' ' 64' ' ' GLU . 8.7 mttm -53.77 -32.28 51.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 108.741 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -78.04 -29.89 49.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.615 -0.678 . . . . 0.0 109.285 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 1.131 HD13 HD13 ' B' ' 52' ' ' LEU . 15.0 mt -64.6 -38.43 82.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 109.138 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.955 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.4 mp -75.99 -64.79 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 109.786 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -49.61 -55.2 14.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.01 -1.057 . . . . 0.0 109.449 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' B' ' 61' ' ' LYS . 42.9 tptt -46.57 -55.81 7.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.135 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.536 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.0 OUTLIER -44.43 -43.2 7.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.948 . . . . 0.0 109.116 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.948 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -55.72 -55.39 32.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.434 -0.791 . . . . 0.0 109.63 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.2 10.35 17.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 0.0 109.623 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 90.6 p . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.459 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.71 ' HB2' HD22 ' A' ' 12' ' ' LEU . 67.1 m . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.531 ' NE2' ' HD3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -40.66 -40.01 1.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.587 -0.695 . . . . 0.0 109.857 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.459 ' SG ' HG13 ' A' ' 41' ' ' ILE . 82.5 m -132.09 80.49 1.91 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 109.878 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.71 HD22 ' HB2' ' A' ' 9' ' ' CYS . 3.9 mm? -49.2 -45.35 44.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 108.993 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -116.89 122.71 45.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.429 -0.794 . . . . 0.0 108.923 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.12 166.83 10.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.952 . . . . 0.0 110.006 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.493 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 6.0 mt -115.27 146.21 41.7 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.562 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.8 OUTLIER -44.74 -35.65 2.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.109 -0.994 . . . . 0.0 109.38 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.754 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 146.37 -176.98 25.01 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.759 HD13 HD11 ' A' ' 23' ' ' ILE . 1.7 pp -157.04 162.39 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -1.06 . . . . 0.0 109.372 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.6 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -59.24 156.21 30.25 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 0.0 109.343 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -77.04 -13.3 17.36 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.501 2.134 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.533 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 22.0 mttt -74.17 -30.86 62.45 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.969 ' O ' HD13 ' A' ' 23' ' ' ILE . 26.5 m-20 -89.59 58.41 4.32 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.969 HD13 ' O ' ' A' ' 22' ' ' ASN . 1.5 mm -145.63 169.16 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -0.974 . . . . 0.0 110.098 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.748 ' HG2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -160.18 -35.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.621 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.0 p -136.37 -172.59 3.18 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 25' ' ' SER . 52.1 t -159.24 115.16 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.891 -1.131 . . . . 0.0 109.97 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.508 ' O ' HD12 ' A' ' 41' ' ' ILE . 3.9 t-20 -109.11 110.76 22.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 109.111 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.536 HG13 HG22 ' A' ' 40' ' ' VAL . 2.1 t -120.71 109.8 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.3 -0.875 . . . . 0.0 109.729 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.531 ' HD3' ' NE2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -108.87 102.03 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.37 -0.831 . . . . 0.0 109.309 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.464 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -48.81 171.31 0.1 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 36.0 Cg_endo -78.03 140.87 18.32 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.586 2.191 . . . . 0.0 110.462 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.48 -141.49 3.68 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.45 8.82 3.13 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.544 2.163 . . . . 0.0 110.878 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.491 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 4.4 p-80 -125.53 -21.33 4.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.047 -1.033 . . . . 0.0 109.807 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' OE1' ' A' ' 37' ' ' GLN . 2.1 t -160.02 122.44 3.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.012 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.42 16.2 4.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.637 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 2.0 mp0 -124.13 124.83 43.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 15.9 m -54.88 137.54 45.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.406 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 39' ' ' GLU . 1.7 mp0 -118.77 107.02 13.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 109.683 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.711 HG11 HD11 ' A' ' 63' ' ' ILE . 13.5 t -95.12 146.94 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.244 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.514 ' CG1' ' SG ' ' A' ' 51' ' ' CYS . 2.1 mp -138.23 152.58 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.874 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.756 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -136.62 125.25 23.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.411 -0.805 . . . . 0.0 109.041 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.748 HG22 ' HG2' ' A' ' 24' ' ' GLN . 33.4 m -89.51 106.86 18.73 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.008 -1.058 . . . . 0.0 109.093 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.847 HD23 ' O ' ' A' ' 22' ' ' ASN . 71.9 mt -49.03 166.11 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.183 -0.948 . . . . 0.0 109.114 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.533 ' CD ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -84.27 11.04 8.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.057 -1.027 . . . . 0.0 109.533 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -111.12 19.26 18.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.325 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 14.61 80.1 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.599 ' HB2' HD12 ' A' ' 44' ' ' LEU . 49.1 mtt180 -109.15 175.23 5.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -1.173 . . . . 0.0 109.502 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -145.15 155.25 43.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.48 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.1 124.99 9.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.365 -0.834 . . . . 0.0 109.116 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.514 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 12.0 m -79.55 140.35 37.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.091 -1.006 . . . . 0.0 109.267 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.862 ' HB3' HG22 ' A' ' 59' ' ' VAL . 11.4 mt -122.93 168.67 12.01 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.253 -0.904 . . . . 0.0 109.266 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.65 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.2 t30 -104.68 124.79 35.77 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 109.276 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.11 -13.48 21.18 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.165 1.91 . . . . 0.0 110.531 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.549 ' HB3' HD22 ' A' ' 53' ' ' ASN . . . -73.55 -16.65 61.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.261 -0.899 . . . . 0.0 108.875 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -90.16 161.16 38.51 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.453 -0.779 . . . . 0.0 109.419 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -78.12 -37.17 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.679 2.253 . . . . 0.0 111.044 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.58 ' O ' HD13 ' A' ' 62' ' ' ILE . 17.6 tt -64.73 -47.2 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.06 -1.025 . . . . 0.0 109.13 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.862 HG22 ' HB3' ' A' ' 52' ' ' LEU . 39.5 t -56.68 -48.23 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.509 -0.745 . . . . 0.0 109.163 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 56' ' ' SER . 4.6 mmtt -54.21 -31.18 52.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.508 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 9.6 mmmm -78.3 -30.66 48.49 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.35 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.602 HG22 HD12 ' A' ' 63' ' ' ILE . 1.7 mp -58.0 -43.59 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.833 ' CG2' HD11 ' B' ' 67' ' ' LEU . 1.6 mp -68.7 -61.76 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -42.6 -29.03 0.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.344 -0.847 . . . . 0.0 109.584 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 66' ' ' MET . 0.7 OUTLIER -74.32 -60.57 2.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.858 . . . . 0.0 109.271 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.537 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 1.2 mmm -44.05 -48.37 8.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.825 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -43.64 -51.21 7.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 0.0 109.342 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.97 -37.04 86.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.467 -0.771 . . . . 0.0 109.497 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.846 . . . . 0.0 109.465 179.975 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.705 ' HB2' HD22 ' B' ' 12' ' ' LEU . 67.4 m . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.528 ' NE2' ' HD3' ' B' ' 29' ' ' LYS . 0.9 OUTLIER -40.74 -40.03 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.549 -0.719 . . . . 0.0 109.899 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.46 ' SG ' HG13 ' B' ' 41' ' ' ILE . 83.2 m -132.0 80.63 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.854 . . . . 0.0 109.882 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.705 HD22 ' HB2' ' B' ' 9' ' ' CYS . 3.9 mm? -49.38 -45.33 45.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.104 -0.998 . . . . 0.0 108.921 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -116.92 122.78 45.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.417 -0.802 . . . . 0.0 108.911 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.18 166.78 10.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.999 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.482 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 6.0 mt -115.2 146.18 41.67 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.563 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.8 OUTLIER -44.67 -35.67 2.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.142 -0.973 . . . . 0.0 109.438 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.766 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 146.32 -177.02 24.94 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.795 HD13 HD11 ' B' ' 23' ' ' ILE . 1.7 pp -157.01 162.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -1.105 . . . . 0.0 109.428 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.608 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -59.25 156.24 30.22 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.291 -0.881 . . . . 0.0 109.233 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.608 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.06 -13.19 17.37 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.467 2.112 . . . . 0.0 109.961 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.525 ' O ' ' CD ' ' B' ' 45' ' ' LYS . 22.1 mttt -74.17 -30.85 62.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.96 ' O ' HD13 ' B' ' 23' ' ' ILE . 26.4 m-20 -89.65 58.41 4.29 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.96 HD13 ' O ' ' B' ' 22' ' ' ASN . 1.5 mm -145.65 169.21 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.072 -1.018 . . . . 0.0 110.135 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.737 ' HG2' HG22 ' B' ' 43' ' ' THR . 0.0 OUTLIER -160.16 -35.68 0.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.614 ' O ' HG23 ' B' ' 26' ' ' VAL . 3.0 p -136.37 -172.64 3.19 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.614 HG23 ' O ' ' B' ' 25' ' ' SER . 52.0 t -159.2 115.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.915 -1.115 . . . . 0.0 109.984 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.514 ' O ' HD12 ' B' ' 41' ' ' ILE . 3.9 t-20 -109.09 110.71 22.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.111 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.549 HG13 HG22 ' B' ' 40' ' ' VAL . 2.1 t -120.74 109.81 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.661 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.528 ' HD3' ' NE2' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -108.78 102.04 11.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.282 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.451 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.0 OUTLIER -48.84 171.29 0.1 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.377 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 36.3 Cg_endo -77.98 140.87 18.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.641 2.227 . . . . 0.0 110.497 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.57 -141.46 3.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.47 8.82 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.563 2.175 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.471 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 4.4 p-80 -125.56 -21.32 4.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.053 -1.03 . . . . 0.0 109.775 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.445 ' SG ' ' OE1' ' B' ' 37' ' ' GLN . 2.1 t -160.03 122.59 3.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.092 -1.005 . . . . 0.0 109.333 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' B' ' 31' ' ' PRO . . . -86.57 16.28 4.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.603 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.455 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 2.0 mp0 -124.17 124.87 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 109.474 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 15.3 m -54.78 137.58 44.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.939 . . . . 0.0 109.413 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.472 ' OE1' ' N ' ' B' ' 39' ' ' GLU . 1.7 mp0 -118.85 107.06 13.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.94 . . . . 0.0 109.632 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.724 HG11 HD11 ' B' ' 63' ' ' ILE . 13.5 t -95.14 146.91 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.515 ' CG1' ' SG ' ' B' ' 51' ' ' CYS . 2.1 mp -138.2 152.63 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.089 -1.007 . . . . 0.0 109.899 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.753 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -136.6 125.29 23.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.085 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.737 HG22 ' HG2' ' B' ' 24' ' ' GLN . 33.8 m -89.6 106.87 18.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.973 -1.08 . . . . 0.0 109.071 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.826 HD23 ' O ' ' B' ' 22' ' ' ASN . 72.8 mt -49.07 166.17 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.151 -0.968 . . . . 0.0 109.013 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -84.34 11.03 9.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 0.0 109.442 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -111.12 19.3 18.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.345 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.63 80.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.577 ' HB2' HD12 ' B' ' 44' ' ' LEU . 49.2 mtt180 -109.16 175.24 5.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -1.209 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -145.19 155.33 43.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.425 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.482 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.14 124.98 9.83 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.391 -0.818 . . . . 0.0 109.112 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.515 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 12.0 m -79.64 140.3 37.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.166 -0.959 . . . . 0.0 109.244 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.827 ' HB3' HG22 ' B' ' 59' ' ' VAL . 11.4 mt -122.91 168.69 11.98 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.259 -0.901 . . . . 0.0 109.229 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.652 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.2 t30 -104.78 124.86 35.48 Favored Pre-proline 0 C--N 1.299 -1.601 0 O-C-N 121.344 -0.847 . . . . 0.0 109.171 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.06 -13.58 21.25 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.263 1.975 . . . . 0.0 110.452 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.526 ' HB3' HD22 ' B' ' 53' ' ' ASN . . . -73.53 -16.68 61.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 108.804 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.493 ' HG ' HG22 ' B' ' 58' ' ' ILE . 0.7 OUTLIER -90.2 161.13 38.46 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.342 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.5 Cg_endo -78.07 -37.19 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.703 2.269 . . . . 0.0 111.08 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.593 ' O ' HD13 ' B' ' 62' ' ' ILE . 17.5 tt -64.69 -47.26 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.053 -1.029 . . . . 0.0 109.162 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.827 HG22 ' HB3' ' B' ' 52' ' ' LEU . 39.4 t -56.75 -48.28 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' B' ' 56' ' ' SER . 4.6 mmtt -54.15 -31.24 51.93 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.51 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 9.7 mmmm -78.27 -30.64 48.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.498 -0.751 . . . . 0.0 109.302 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.604 HG22 HD12 ' B' ' 63' ' ' ILE . 1.7 mp -58.08 -43.57 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.825 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.6 mp -68.72 -61.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -42.7 -28.99 0.27 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.347 -0.845 . . . . 0.0 109.583 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' B' ' 66' ' ' MET . 0.7 OUTLIER -74.38 -60.47 2.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.942 . . . . 0.0 109.276 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.531 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 1.2 mmm -44.16 -48.28 9.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.83 . . . . 0.0 109.207 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.833 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -43.75 -51.16 7.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.379 -0.825 . . . . 0.0 109.317 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.91 -37.09 86.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.523 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.499 -179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.956 ' HB2' HD22 ' A' ' 12' ' ' LEU . 7.7 m . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -42.25 -27.25 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.415 -0.803 . . . . 0.0 109.797 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.446 ' SG ' HG13 ' A' ' 41' ' ' ILE . 98.7 m -131.26 67.18 1.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.185 -0.947 . . . . 0.0 109.616 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.956 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.43 -40.44 5.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.228 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -121.43 126.44 49.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.405 -0.81 . . . . 0.0 109.173 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -106.52 160.51 15.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.469 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.1 mt -110.38 140.64 44.39 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.519 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.2 tt0 -44.07 -26.62 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.371 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.782 ' O ' HG23 ' A' ' 18' ' ' ILE . . . 151.78 -165.88 30.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.782 HG23 ' O ' ' A' ' 17' ' ' GLY . 1.2 pp -169.14 162.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -1.064 . . . . 0.0 109.842 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.629 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.7 t60 -56.83 149.07 45.09 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.629 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -80.37 -15.99 10.99 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.318 2.012 . . . . 0.0 108.922 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.53 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 5.7 mttm -77.99 -22.8 48.83 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.962 ' O ' HD13 ' A' ' 23' ' ' ILE . 17.9 m-20 -94.25 57.85 2.39 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.962 HD13 ' O ' ' A' ' 22' ' ' ASN . 2.4 mm -143.27 169.97 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.044 -1.035 . . . . 0.0 110.129 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -160.09 -40.47 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.528 ' CB ' ' HB ' ' A' ' 43' ' ' THR . 2.2 p -133.18 174.98 9.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.531 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 50.4 t -156.48 122.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.952 -1.092 . . . . 0.0 109.759 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.495 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 56.0 t30 -104.77 155.97 18.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.486 ' HB ' ' HB ' ' B' ' 26' ' ' VAL . 2.9 t -145.59 76.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.527 ' HE3' ' NE2' ' A' ' 34' ' ' HIS . 11.0 tptt -87.36 100.4 12.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.3 p -51.65 166.34 0.38 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 109.41 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.527 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.9 Cg_endo -78.15 131.75 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.594 2.196 . . . . 0.0 110.537 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.54 -144.34 4.91 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.19 7.77 3.54 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.59 2.194 . . . . 0.0 110.767 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.527 ' NE2' ' HE3' ' A' ' 29' ' ' LYS . 11.5 p-80 -125.98 -6.91 6.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.089 -1.007 . . . . 0.0 109.616 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.6 t -160.04 116.97 2.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.41 45.83 1.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.508 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.527 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 4.3 pt20 -172.55 139.14 0.93 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.53 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.435 ' HB ' ' CG ' ' A' ' 54' ' ' PRO . 2.4 m -57.52 144.06 38.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 109.373 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -124.77 107.64 11.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.592 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.986 HG11 HD11 ' A' ' 63' ' ' ILE . 44.2 t -100.39 150.02 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.867 . . . . 0.0 109.297 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.504 HG22 ' N ' ' A' ' 42' ' ' ALA . 2.5 mp -136.06 159.66 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.848 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.656 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -141.73 121.53 13.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.803 . . . . 0.0 109.11 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.528 ' HB ' ' CB ' ' A' ' 25' ' ' SER . 16.4 m -89.53 101.27 13.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.973 -1.079 . . . . 0.0 109.17 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.775 HD23 ' O ' ' A' ' 22' ' ' ASN . 73.7 mt -44.56 165.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.323 -0.861 . . . . 0.0 109.02 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.53 ' CD ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -83.64 9.93 10.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 109.494 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -109.99 16.88 21.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.364 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.83 18.54 67.6 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.595 ' HB2' HD12 ' A' ' 44' ' ' LEU . 1.7 mtp180 -111.89 169.43 8.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -1.134 . . . . 0.0 109.502 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -136.18 153.65 51.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.943 . . . . 0.0 109.478 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.27 123.36 8.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.113 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.435 ' SG ' HG13 ' A' ' 41' ' ' ILE . 11.8 m -79.51 143.19 35.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.096 -1.002 . . . . 0.0 109.14 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.864 ' HB3' HG22 ' A' ' 59' ' ' VAL . 14.0 mt -123.63 168.12 13.07 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.372 -0.83 . . . . 0.0 109.305 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.657 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.9 t-20 -100.48 122.39 49.89 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.151 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.506 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.6 Cg_endo -75.14 -10.2 20.89 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.205 1.937 . . . . 0.0 110.283 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.08 -14.76 58.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.273 -0.892 . . . . 0.0 108.969 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -89.96 159.53 42.62 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.435 -0.791 . . . . 0.0 109.426 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.44 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.7 -33.49 2.27 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.578 2.185 . . . . 0.0 110.671 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.591 HG23 ' N ' ' A' ' 59' ' ' VAL . 16.8 tt -68.07 -46.96 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.015 . . . . 0.0 109.232 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.864 HG22 ' HB3' ' A' ' 52' ' ' LEU . 37.3 t -56.23 -48.78 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.414 -0.804 . . . . 0.0 109.076 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.506 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 14.9 mttt -56.32 -31.51 63.78 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -74.52 -29.93 61.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.604 -0.685 . . . . 0.0 109.284 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -68.88 -43.59 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.012 HG22 HD11 ' B' ' 67' ' ' LEU . 2.2 mp -65.17 -65.86 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.523 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -48.04 -42.73 29.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 109.593 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -55.58 -49.24 73.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 109.3 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.531 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -53.48 -47.47 69.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.265 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.98 HD11 HG22 ' B' ' 63' ' ' ILE . 0.2 OUTLIER -46.89 -52.48 14.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.462 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' SER . 13.4 t-20 -63.52 -31.73 72.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.466 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 68' ' ' ASN . 5.9 p . . . . . 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 109.509 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.935 ' HB2' HD22 ' B' ' 12' ' ' LEU . 7.8 m . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -42.16 -27.3 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.833 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.452 ' SG ' HG13 ' B' ' 41' ' ' ILE . 98.9 m -131.27 67.15 1.52 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.598 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.935 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.37 -40.59 5.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.164 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -121.34 126.54 49.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.167 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.531 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -106.56 160.59 15.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.841 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.473 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.0 mt -110.38 140.58 44.45 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.461 -0.774 . . . . 0.0 108.928 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.528 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.2 tt0 -44.04 -26.59 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.119 -0.988 . . . . 0.0 109.422 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.766 ' O ' HG23 ' B' ' 18' ' ' ILE . . . 151.76 -165.86 30.69 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.766 HG23 ' O ' ' B' ' 17' ' ' GLY . 1.2 pp -169.13 162.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -1.068 . . . . 0.0 109.837 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.612 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 1.7 t60 -56.89 149.05 45.83 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.612 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.6 Cg_endo -80.32 -16.03 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.383 2.055 . . . . 0.0 108.915 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.537 ' O ' ' CD ' ' B' ' 45' ' ' LYS . 5.7 mttm -78.04 -22.71 48.77 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.969 ' O ' HD13 ' B' ' 23' ' ' ILE . 17.8 m-20 -94.34 57.96 2.38 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.969 HD13 ' O ' ' B' ' 22' ' ' ASN . 2.3 mm -143.31 169.98 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.093 -1.004 . . . . 0.0 110.157 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.0 OUTLIER -160.11 -40.62 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.524 ' CB ' ' HB ' ' B' ' 43' ' ' THR . 2.1 p -133.13 174.93 9.85 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.535 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 50.4 t -156.38 122.5 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.939 -1.101 . . . . 0.0 109.759 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.488 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 55.6 t30 -104.71 155.9 18.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.244 -0.91 . . . . 0.0 109.357 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 2.9 t -145.52 76.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.516 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.518 ' HE3' ' NE2' ' B' ' 34' ' ' HIS . 11.0 tptt -87.32 100.49 12.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.3 p -51.75 166.29 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.533 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.8 Cg_endo -78.05 131.71 11.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.648 2.232 . . . . 0.0 110.524 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.5 -144.41 4.93 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.11 7.74 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.649 2.233 . . . . 0.0 110.819 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.518 ' NE2' ' HE3' ' B' ' 29' ' ' LYS . 11.4 p-80 -125.98 -6.86 6.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.993 . . . . 0.0 109.67 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.7 t -160.15 116.93 2.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.415 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.4 45.73 1.22 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.576 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.533 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 4.2 pt20 -172.48 139.17 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 109.55 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.437 ' HB ' ' CG ' ' B' ' 54' ' ' PRO . 2.4 m -57.46 144.12 37.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -124.84 107.59 11.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.554 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.98 HG11 HD11 ' B' ' 63' ' ' ILE . 44.3 t -100.39 150.05 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.281 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.491 HG22 ' N ' ' B' ' 42' ' ' ALA . 2.5 mp -136.03 159.63 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.121 -0.987 . . . . 0.0 109.87 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.648 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -141.69 121.47 13.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.822 . . . . 0.0 109.135 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 16.4 m -89.43 101.32 14.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.024 -1.047 . . . . 0.0 109.23 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.783 HD23 ' O ' ' B' ' 22' ' ' ASN . 73.8 mt -44.56 165.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 109.058 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.537 ' CD ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -83.66 9.88 10.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.161 -0.962 . . . . 0.0 109.434 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -109.91 16.79 21.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.92 18.46 67.58 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.587 ' HB2' HD12 ' B' ' 44' ' ' LEU . 1.7 mtp180 -111.82 169.29 8.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -1.173 . . . . 0.0 109.512 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.429 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 0.3 OUTLIER -136.04 153.61 51.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 109.592 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.473 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.21 123.31 8.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 109.072 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.433 ' SG ' HG13 ' B' ' 41' ' ' ILE . 12.0 m -79.45 143.21 35.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.091 -1.006 . . . . 0.0 109.239 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.858 ' HB3' HG22 ' B' ' 59' ' ' VAL . 14.0 mt -123.7 168.07 13.16 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.222 -0.924 . . . . 0.0 109.344 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.663 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.9 t-20 -100.52 122.31 50.08 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.182 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.51 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.6 Cg_endo -74.99 -10.17 21.1 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.143 1.895 . . . . 0.0 110.388 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.1 -14.74 58.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -0.919 . . . . 0.0 108.892 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.3 OUTLIER -90.01 159.55 42.44 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.409 -0.807 . . . . 0.0 109.421 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.451 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.71 -33.43 2.29 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.622 2.215 . . . . 0.0 110.652 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.608 ' O ' HD13 ' B' ' 62' ' ' ILE . 16.9 tt -68.2 -46.88 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.099 -1.0 . . . . 0.0 109.151 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.858 HG22 ' HB3' ' B' ' 52' ' ' LEU . 37.1 t -56.3 -48.69 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 109.072 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.51 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 14.9 mttt -56.44 -31.43 63.93 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.471 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -74.63 -29.85 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.604 -0.685 . . . . 0.0 109.266 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.608 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -68.89 -43.67 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.98 HG22 HD11 ' A' ' 67' ' ' LEU . 2.1 mp -65.17 -65.89 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.499 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -47.99 -42.82 28.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 109.549 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -55.52 -49.24 73.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.308 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.535 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -53.49 -47.39 69.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.299 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.012 HD11 HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -46.9 -52.47 14.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.454 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' B' ' 69' ' ' SER . 13.4 t-20 -63.53 -31.75 73.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.41 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.402 ' C ' ' O ' ' B' ' 68' ' ' ASN . 5.8 p . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.497 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.829 ' HB2' HD22 ' A' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' A' ' 9' ' ' CYS . 13.7 mm-40 -42.16 -27.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -0.818 . . . . 0.0 109.798 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.472 ' SG ' HG13 ' A' ' 41' ' ' ILE . 79.1 m -136.55 81.06 1.86 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 109.716 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.829 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -53.93 -41.44 67.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.16 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -118.5 117.93 30.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.16 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.598 HG21 HD22 ' A' ' 53' ' ' ASN . 0.6 OUTLIER -99.78 163.18 12.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.792 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.516 ' HB2' HD23 ' A' ' 52' ' ' LEU . 4.4 mt -106.18 137.2 44.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.83 . . . . 0.0 108.963 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -44.49 -41.39 6.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.979 . . . . 0.0 109.366 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.541 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 177.54 168.84 37.82 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.734 ' H ' HD11 ' A' ' 62' ' ' ILE . 8.0 tp -153.67 158.37 3.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.473 -1.016 . . . . 0.0 108.772 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.576 ' CB ' ' ND2' ' A' ' 22' ' ' ASN . 2.6 t-80 -45.04 139.89 3.77 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.226 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.7 Cg_endo -77.77 -25.44 7.78 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.491 2.127 . . . . 0.0 110.292 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -90.12 -14.83 32.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 0.0 108.987 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.576 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 51.7 m-20 -70.33 -11.61 61.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.325 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.879 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 3.1 mt -105.44 149.01 9.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.263 -0.898 . . . . 0.0 110.611 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.514 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -115.61 -27.69 7.03 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.514 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -136.1 160.72 37.79 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.523 ' O ' HG23 ' B' ' 28' ' ' VAL . 2.0 t -146.16 101.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.941 -1.1 . . . . 0.0 109.932 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 29.1 t30 -79.96 116.73 20.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.198 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.52 HG23 ' O ' ' B' ' 26' ' ' VAL . 1.8 t -98.23 84.68 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -0.923 . . . . 0.0 109.49 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER -89.59 93.91 9.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.364 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.09 167.26 0.25 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.376 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.5 Cg_endo -77.96 131.84 11.32 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.619 2.213 . . . . 0.0 110.38 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.22 -145.97 6.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.96 5.48 4.93 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.628 2.219 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -121.81 -16.83 7.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.614 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 9.1 t -160.12 96.88 1.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.33 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.76 -10.57 28.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.595 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.445 ' OE1' ' SG ' ' A' ' 9' ' ' CYS . 2.0 mp0 -96.24 125.26 40.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.57 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.478 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 3.8 m -50.68 150.7 2.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.944 . . . . 0.0 109.385 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 35' ' ' CYS . 3.3 mp0 -129.39 107.7 9.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.959 . . . . 0.0 109.571 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.723 HG11 HD11 ' A' ' 63' ' ' ILE . 1.7 t -102.59 95.34 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.257 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.536 HD12 ' N ' ' A' ' 41' ' ' ILE . 5.2 mp -86.03 140.73 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.742 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.879 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -124.14 119.14 28.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.202 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 43' ' ' THR . 1.0 OUTLIER -89.17 100.07 12.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.02 -1.05 . . . . 0.0 108.459 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 48' ' ' ARG . 72.5 mt -41.49 165.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.541 0.686 . . . . 0.0 110.073 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.5 ptpt -80.36 6.96 10.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.539 -0.726 . . . . 0.0 109.686 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -111.95 8.54 20.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.406 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.35 -6.11 71.42 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.523 ' HB2' HD12 ' A' ' 44' ' ' LEU . 7.3 mtt180 -84.46 170.52 13.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.13 -1.218 . . . . 0.0 109.537 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 10.0 mttt -133.86 153.73 51.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.22 118.12 6.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.037 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.467 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 19.4 m -79.57 139.02 37.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.129 -0.982 . . . . 0.0 109.166 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.968 HD13 HD13 ' A' ' 62' ' ' ILE . 11.3 mt -126.9 168.25 14.74 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.15 -0.969 . . . . 0.0 109.329 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.651 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.1 t-20 -108.26 129.16 24.42 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.554 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.478 ' HG3' ' HB ' ' A' ' 38' ' ' THR . 34.4 Cg_endo -76.1 4.45 5.3 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.407 2.071 . . . . 0.0 110.747 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.38 -21.31 27.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.249 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.06 163.97 29.86 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.843 . . . . 0.0 109.466 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.84 -29.1 4.61 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.654 2.236 . . . . 0.0 110.143 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.541 ' CG2' ' HA3' ' A' ' 17' ' ' GLY . 8.6 mm -68.18 -47.33 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.004 ' HA ' HD12 ' A' ' 62' ' ' ILE . 51.1 t -62.38 -48.61 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 109.675 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 56' ' ' SER . 2.8 mmpt? -56.91 -30.52 64.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.93 . . . . 0.0 108.809 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.533 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -81.66 -24.69 36.15 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.004 HD12 ' HA ' ' A' ' 59' ' ' VAL . 16.0 mt -67.97 -38.25 79.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.25 -0.906 . . . . 0.0 108.592 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.091 ' CG2' HD11 ' B' ' 67' ' ' LEU . 1.5 mp -76.36 -63.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.383 -0.823 . . . . 0.0 109.117 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -43.92 -50.84 7.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.253 -0.904 . . . . 0.0 109.428 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 66' ' ' MET . 4.4 tmtm? -52.03 -57.58 9.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.211 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.483 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -44.12 -46.2 8.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 109.127 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.098 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -55.59 -49.54 72.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.452 -0.78 . . . . 0.0 109.527 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -96.26 33.91 1.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.474 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.473 179.952 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.829 ' HB2' HD22 ' B' ' 12' ' ' LEU . 1.7 m . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' B' ' 9' ' ' CYS . 13.6 mm-40 -42.14 -27.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.796 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' B' ' 41' ' ' ILE . 78.4 m -136.61 81.1 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 109.595 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.829 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.3 OUTLIER -53.94 -41.47 67.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.202 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -118.39 117.97 30.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.283 -0.886 . . . . 0.0 109.146 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.59 HG21 HD22 ' B' ' 53' ' ' ASN . 0.6 OUTLIER -99.85 163.09 12.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.825 -179.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.515 ' HB2' HD23 ' B' ' 52' ' ' LEU . 4.3 mt -106.0 137.17 44.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.321 -0.862 . . . . 0.0 108.995 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.0 OUTLIER -44.56 -41.28 6.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 109.4 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.531 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 177.5 168.8 37.73 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.716 ' H ' HD11 ' B' ' 62' ' ' ILE . 8.0 tp -153.64 158.39 3.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.493 -1.004 . . . . 0.0 108.784 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.576 ' CB ' ' ND2' ' B' ' 22' ' ' ASN . 2.6 t-80 -45.05 139.86 3.8 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.02 -1.05 . . . . 0.0 109.156 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.481 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.1 Cg_endo -77.8 -25.36 7.8 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.501 2.134 . . . . 0.0 110.256 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.463 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.2 OUTLIER -90.18 -14.84 32.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.405 -0.81 . . . . 0.0 108.974 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.576 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 52.0 m-20 -70.29 -11.61 61.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.451 -0.781 . . . . 0.0 109.318 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.888 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 3.0 mt -105.41 148.99 9.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.238 -0.914 . . . . 0.0 110.584 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.516 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -115.63 -27.75 7.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.516 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -136.04 160.81 37.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 28' ' ' VAL . 2.0 t -146.24 101.5 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.03 -1.044 . . . . 0.0 109.917 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 29.0 t30 -79.88 116.79 20.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.247 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 26' ' ' VAL . 1.8 t -98.24 84.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER -89.58 93.87 9.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.214 -0.929 . . . . 0.0 109.396 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.02 167.21 0.25 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.266 -0.896 . . . . 0.0 109.399 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.9 Cg_endo -77.91 131.87 11.4 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.56 2.173 . . . . 0.0 110.455 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.22 -146.12 6.05 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -76.87 5.47 4.88 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.623 2.216 . . . . 0.0 110.654 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 18.1 p-80 -121.86 -16.75 7.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.951 . . . . 0.0 109.555 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 9.1 t -160.14 96.92 1.23 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 109.353 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.77 -10.56 28.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.638 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.446 ' OE1' ' SG ' ' B' ' 9' ' ' CYS . 2.0 mp0 -96.28 125.21 40.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.494 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.476 ' HB ' ' HG3' ' B' ' 54' ' ' PRO . 3.8 m -50.62 150.67 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 109.375 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.472 ' OE2' ' HB3' ' B' ' 35' ' ' CYS . 3.3 mp0 -129.4 107.81 9.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.603 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.734 HG11 HD11 ' B' ' 63' ' ' ILE . 1.7 t -102.61 95.26 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.288 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.538 ' N ' HD12 ' B' ' 41' ' ' ILE . 5.2 mp -86.02 140.72 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.888 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -124.16 119.13 28.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.845 . . . . 0.0 109.226 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.617 ' O ' HG22 ' B' ' 43' ' ' THR . 1.0 OUTLIER -89.13 100.08 12.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.035 -1.041 . . . . 0.0 108.437 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' B' ' 48' ' ' ARG . 72.1 mt -41.48 165.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.573 0.702 . . . . 0.0 110.031 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.463 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.5 ptpt -80.49 7.04 10.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.472 -0.767 . . . . 0.0 109.647 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -111.91 8.48 20.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.473 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.01 71.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.547 ' HB2' HD12 ' B' ' 44' ' ' LEU . 7.3 mtt180 -84.6 170.56 13.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.239 . . . . 0.0 109.513 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.42 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 9.9 mttt -133.84 153.81 51.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 109.507 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.34 118.11 6.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 108.971 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 19.6 m -79.56 138.95 37.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.169 -0.957 . . . . 0.0 109.237 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.988 HD13 HD13 ' B' ' 62' ' ' ILE . 11.3 mt -126.84 168.3 14.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.638 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.1 t-20 -108.26 129.32 24.21 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.521 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.476 ' HG3' ' HB ' ' B' ' 38' ' ' THR . 34.6 Cg_endo -76.27 4.52 5.32 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.342 2.028 . . . . 0.0 110.755 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.43 -21.27 27.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.162 -0.962 . . . . 0.0 109.231 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -90.12 163.93 29.87 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.477 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.74 -29.18 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.683 2.255 . . . . 0.0 110.171 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.531 ' CG2' ' HA3' ' B' ' 17' ' ' GLY . 8.6 mm -68.1 -47.28 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.442 -0.786 . . . . 0.0 109.264 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.996 ' HA ' HD12 ' B' ' 62' ' ' ILE . 50.7 t -62.49 -48.46 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.328 -0.858 . . . . 0.0 109.731 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' B' ' 56' ' ' SER . 2.8 mmpt? -56.96 -30.54 64.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -0.929 . . . . 0.0 108.797 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -81.6 -24.68 36.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.524 -0.735 . . . . 0.0 109.247 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.996 HD12 ' HA ' ' B' ' 59' ' ' VAL . 16.1 mt -67.93 -38.23 79.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 1.098 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.5 mp -76.33 -63.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.505 -0.747 . . . . 0.0 109.097 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -43.93 -50.84 7.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.289 -0.882 . . . . 0.0 109.444 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' B' ' 66' ' ' MET . 4.4 tmtm? -52.14 -57.45 9.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.269 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.486 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.4 OUTLIER -44.1 -46.2 8.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.149 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.091 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -55.67 -49.54 72.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 0.0 109.484 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -96.2 33.87 1.68 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 179.951 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.428 ' O ' ' N ' ' A' ' 11' ' ' CYS . 72.8 m . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.533 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 30.2 mm-40 -43.16 -26.09 0.15 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.714 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.46 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 19.4 m -145.19 75.12 1.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.633 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -44.66 -50.72 9.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.168 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 7.8 pt20 -108.95 103.25 12.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.157 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.439 ' HB ' ' C ' ' A' ' 52' ' ' LEU . 1.1 p -79.89 144.93 32.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.668 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.584 ' HB2' HD23 ' A' ' 52' ' ' LEU . 22.3 mt -78.6 -174.06 3.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 109.336 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.62 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -84.23 -40.76 17.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 0.0 109.502 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.874 ' O ' HG23 ' A' ' 18' ' ' ILE . . . 155.61 -172.07 33.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.874 HG23 ' O ' ' A' ' 17' ' ' GLY . 1.3 pp -172.11 164.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -1.056 . . . . 0.0 109.213 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.49 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -58.92 150.14 61.8 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.319 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.675 ' HA ' HD12 ' A' ' 23' ' ' ILE . 35.3 Cg_endo -77.14 -4.47 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.512 2.141 . . . . 0.0 110.176 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.459 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -90.35 -23.49 21.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.385 -0.822 . . . . 0.0 109.198 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.3 m-20 -85.18 -18.99 32.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.305 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.964 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 22.0 mt -83.38 169.22 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.441 -0.787 . . . . 0.0 110.07 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.574 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -139.37 -40.93 0.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.468 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 1.7 p -124.9 177.31 6.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.838 . . . . 0.0 108.892 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.571 HG23 ' HG3' ' A' ' 66' ' ' MET . 47.7 t -146.8 100.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.018 -1.051 . . . . 0.0 109.698 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.666 ' O ' HD12 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -100.05 111.15 23.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.266 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.863 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -120.98 102.3 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.533 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -103.94 117.22 33.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.919 . . . . 0.0 109.397 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.444 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -57.31 171.68 0.46 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.153 -0.967 . . . . 0.0 109.284 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.516 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.8 Cg_endo -77.83 153.07 29.23 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.693 2.262 . . . . 0.0 110.456 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.98 -140.56 2.9 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.561 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 36.4 Cg_endo -78.28 12.14 2.17 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.654 2.236 . . . . 0.0 110.982 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.561 ' CE1' ' HD2' ' A' ' 33' ' ' PRO . 1.9 p-80 -127.49 -32.71 2.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.988 -1.07 . . . . 0.0 109.53 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.31 121.4 12.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.381 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.8 44.41 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.933 . . . . 0.0 109.625 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.516 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 5.2 pt20 -169.98 139.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.54 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.6 m -55.91 141.39 39.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.93 107.54 10.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.95 HG11 HD11 ' A' ' 63' ' ' ILE . 47.7 t -95.1 149.24 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.21 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.666 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.4 mp -142.0 151.13 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.863 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.964 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -135.13 123.08 22.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 108.886 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 7.4 m -89.77 100.18 13.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.089 . . . . 0.0 109.375 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 60.7 mt -42.43 164.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 0.0 109.606 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 13.0 ptpt -82.83 9.78 9.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -113.91 19.55 16.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.457 ' O ' ' HD2' ' A' ' 49' ' ' LYS . . . 87.6 -17.64 43.23 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.462 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 42.8 mtt180 -77.3 163.19 26.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -1.116 . . . . 0.0 109.416 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -144.01 122.65 12.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.148 -0.97 . . . . 0.0 109.541 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.562 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -116.18 127.94 55.21 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.24 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.507 ' O ' HD23 ' A' ' 52' ' ' LEU . 92.2 m -79.65 155.34 28.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.062 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.032 HD13 HD13 ' A' ' 62' ' ' ILE . 12.8 mt -135.19 170.98 15.08 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.141 -0.974 . . . . 0.0 109.702 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.663 ' O ' HG21 ' A' ' 59' ' ' VAL . 15.3 p-10 -105.39 127.6 28.26 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.78 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -75.08 -4.66 15.71 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.087 1.858 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 -19.29 53.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 108.778 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 159.39 42.5 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.349 -0.844 . . . . 0.0 109.022 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.92 -32.25 3.44 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.582 2.188 . . . . 0.0 110.778 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.623 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -69.53 -44.66 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 109.168 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.059 ' HA ' HD12 ' A' ' 62' ' ' ILE . 31.4 t -58.0 -46.94 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.834 . . . . 0.0 109.152 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 56' ' ' SER . 9.6 mtmt -60.51 -30.49 69.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.492 ' CE ' ' CD ' ' A' ' 64' ' ' GLU . 4.9 mmpt? -76.67 -23.56 53.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.059 HD12 ' HA ' ' A' ' 59' ' ' VAL . 19.0 mt -71.39 -37.16 63.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.95 HD11 HG11 ' A' ' 40' ' ' VAL . 2.3 mp -73.21 -58.14 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.492 ' CD ' ' CE ' ' A' ' 61' ' ' LYS . 5.7 pt-20 -59.2 -52.19 66.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.045 -1.034 . . . . 0.0 109.652 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 6.5 mtpp -46.35 -52.43 12.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.112 -0.992 . . . . 0.0 109.132 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.571 ' HG3' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -49.38 -46.41 47.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.214 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.615 HD11 ' HB ' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -45.93 -52.08 12.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.432 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -64.39 -33.59 76.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.843 . . . . 0.0 109.531 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 p . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 -179.987 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.427 ' O ' ' N ' ' B' ' 11' ' ' CYS . 71.8 m . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.526 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 30.2 mm-40 -43.22 -26.07 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 0.0 109.704 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.454 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 19.9 m -145.18 75.09 1.43 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.983 . . . . 0.0 109.601 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.509 HD13 ' O ' ' B' ' 12' ' ' LEU . 0.2 OUTLIER -44.61 -50.72 9.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 109.238 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' B' ' 13' ' ' GLN . 7.8 pt20 -108.95 103.25 12.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.831 . . . . 0.0 109.144 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.433 ' HB ' ' C ' ' B' ' 52' ' ' LEU . 1.0 OUTLIER -79.9 144.89 33.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.608 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.565 ' HB2' HD23 ' B' ' 52' ' ' LEU . 22.2 mt -78.46 -174.07 3.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.854 . . . . 0.0 109.33 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.625 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.0 OUTLIER -84.33 -40.74 17.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.176 -0.952 . . . . 0.0 109.474 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.872 ' O ' HG23 ' B' ' 18' ' ' ILE . . . 155.66 -172.04 33.71 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.872 HG23 ' O ' ' B' ' 17' ' ' GLY . 1.3 pp -172.2 163.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -1.013 . . . . 0.0 109.161 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.508 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -58.91 150.19 61.55 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.299 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.669 ' HA ' HD12 ' B' ' 23' ' ' ILE . 35.3 Cg_endo -77.14 -4.47 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.55 2.167 . . . . 0.0 110.173 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -90.3 -23.61 21.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.3 m-20 -85.16 -18.88 32.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.24 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.979 HG23 ' HB1' ' B' ' 42' ' ' ALA . 21.8 mt -83.43 169.22 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.389 -0.819 . . . . 0.0 110.066 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.583 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.4 OUTLIER -139.35 -41.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.458 ' CB ' ' HB ' ' B' ' 43' ' ' THR . 1.7 p -124.88 177.26 6.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.451 -0.781 . . . . 0.0 108.899 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.564 HG23 ' HG3' ' B' ' 66' ' ' MET . 48.2 t -146.76 100.46 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.647 ' O ' HD12 ' B' ' 41' ' ' ILE . 0.1 OUTLIER -100.09 111.18 23.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 109.217 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.831 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -120.97 102.37 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.526 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 0.2 OUTLIER -103.95 117.16 33.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.401 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.447 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.0 OUTLIER -57.18 171.63 0.45 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.306 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.522 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.8 Cg_endo -77.83 153.09 29.24 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.623 2.215 . . . . 0.0 110.435 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.98 -140.64 2.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.552 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -78.33 12.34 2.12 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.513 2.142 . . . . 0.0 111.006 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.552 ' CE1' ' HD2' ' B' ' 33' ' ' PRO . 1.9 p-80 -127.6 -32.63 2.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.013 -1.054 . . . . 0.0 109.509 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.34 121.34 12.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.393 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.78 44.52 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.701 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.522 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 5.2 pt20 -170.08 139.3 1.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.494 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 2.7 m -55.98 141.28 40.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.78 107.54 10.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.659 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.939 HG11 HD11 ' B' ' 63' ' ' ILE . 47.7 t -95.2 149.31 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.204 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.647 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.4 mp -141.96 151.17 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.875 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.979 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -135.14 122.92 22.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 108.962 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 7.4 m -89.66 100.16 13.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.955 -1.09 . . . . 0.0 109.392 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' B' ' 22' ' ' ASN . 60.4 mt -42.49 164.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.63 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.459 ' HA ' ' HB2' ' B' ' 24' ' ' GLN . 12.9 ptpt -82.79 9.8 9.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.708 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -113.94 19.62 16.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.23 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' B' ' 49' ' ' LYS . . . 87.62 -17.77 42.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.468 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 42.7 mtt180 -77.25 163.06 26.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -1.151 . . . . 0.0 109.405 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.463 ' HD2' ' O ' ' B' ' 47' ' ' GLY . 0.0 OUTLIER -143.97 122.67 12.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.546 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.553 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -116.19 127.94 55.2 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.445 -0.784 . . . . 0.0 109.33 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.494 ' O ' HD23 ' B' ' 52' ' ' LEU . 91.2 m -79.66 155.32 28.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.047 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 1.053 HD13 HD13 ' B' ' 62' ' ' ILE . 12.8 mt -135.18 170.92 15.18 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.152 -0.968 . . . . 0.0 109.744 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.666 ' O ' HG21 ' B' ' 59' ' ' VAL . 15.4 p-10 -105.34 127.54 28.38 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.845 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.04 -4.57 15.6 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.111 1.874 . . . . 0.0 110.308 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.45 -19.25 53.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.923 . . . . 0.0 108.761 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -90.01 159.42 42.72 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.109 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.04 -32.25 3.31 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.578 2.185 . . . . 0.0 110.792 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.641 ' O ' HD13 ' B' ' 58' ' ' ILE . 0.1 OUTLIER -69.45 -44.72 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.102 -0.999 . . . . 0.0 109.153 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 1.011 ' HA ' HD12 ' B' ' 62' ' ' ILE . 32.1 t -57.97 -46.94 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 109.177 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' B' ' 56' ' ' SER . 9.6 mtmt -60.49 -30.55 69.78 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' B' ' 61' ' ' LYS . 4.9 mmpt? -76.64 -23.61 53.32 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 1.053 HD13 HD13 ' B' ' 52' ' ' LEU . 19.2 mt -71.25 -37.25 65.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.939 HD11 HG11 ' B' ' 40' ' ' VAL . 2.3 mp -73.23 -58.09 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.876 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.487 ' CD ' ' CE ' ' B' ' 61' ' ' LYS . 5.6 pt-20 -59.33 -52.09 67.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.013 -1.054 . . . . 0.0 109.614 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 6.5 mtpp -46.39 -52.41 13.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 109.056 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.564 ' HG3' HG23 ' B' ' 26' ' ' VAL . 0.2 OUTLIER -49.41 -46.35 47.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.282 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.614 HD11 ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -45.96 -52.05 12.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 0.0 109.41 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' B' ' 69' ' ' SER . 2.4 t30 -64.41 -33.6 76.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.855 . . . . 0.0 109.52 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 68' ' ' ASN . 4.9 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.46 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.954 ' HB2' HD22 ' A' ' 12' ' ' LEU . 93.2 m . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.505 ' N ' ' OE1' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -42.76 -26.21 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.865 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.521 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 78.1 m -130.85 72.25 1.49 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.642 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.954 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.55 -44.3 8.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.937 . . . . 0.0 109.214 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.32 117.5 33.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.283 -0.886 . . . . 0.0 109.198 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.426 ' OG1' ' CG ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -103.09 156.43 17.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.697 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.566 HD12 HD23 ' A' ' 52' ' ' LEU . 5.5 mt -98.08 135.76 39.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.293 -0.879 . . . . 0.0 109.004 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 15' ' ' LEU . 1.1 tt0 -44.09 -26.79 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.952 . . . . 0.0 109.252 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 156.25 149.32 5.32 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.659 HG22 ' CD2' ' A' ' 52' ' ' LEU . 6.9 tt -128.34 149.97 33.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.375 -1.073 . . . . 0.0 108.883 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.466 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -43.64 146.37 0.98 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.257 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.466 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.2 Cg_endo -76.61 -13.03 18.32 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.435 2.09 . . . . 0.0 109.996 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.532 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 7.6 mttp -78.95 -15.42 58.32 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 1.011 ' O ' HD13 ' A' ' 23' ' ' ILE . 86.5 m-20 -100.43 54.75 0.89 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.011 HD13 ' O ' ' A' ' 22' ' ' ASN . 0.7 OUTLIER -146.08 163.33 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.039 -1.038 . . . . 0.0 110.35 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.749 ' HG2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -153.02 -36.21 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.9 p -128.47 179.5 5.62 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 25' ' ' SER . 51.0 t -160.14 115.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.897 -1.127 . . . . 0.0 109.891 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 20.3 t-20 -104.87 153.3 21.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.951 . . . . 0.0 109.117 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' B' ' 25' ' ' SER . 2.6 t -143.67 91.82 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HD2' ' NE2' ' A' ' 10' ' ' GLN . 4.2 mttm -95.3 93.45 7.28 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 0.0 109.524 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 4.3 p -44.71 164.26 0.18 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 0.0 109.303 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.511 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.7 Cg_endo -77.78 131.87 11.54 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.648 2.232 . . . . 0.0 110.502 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.27 -138.48 3.28 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.22 7.98 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.562 2.175 . . . . 0.0 110.778 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.488 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 4.9 p-80 -126.86 -16.74 5.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.017 . . . . 0.0 109.883 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -160.17 125.23 3.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.024 -1.047 . . . . 0.0 109.229 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.419 ' O ' ' CD ' ' A' ' 37' ' ' GLN . . . -87.42 18.95 3.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.719 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.511 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 13.6 mm-40 -143.35 125.06 14.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.497 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 30' ' ' SER . 17.5 m -50.29 140.55 13.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.505 ' OE1' ' N ' ' A' ' 10' ' ' GLN . 8.5 mt-10 -117.66 106.83 13.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.654 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.809 HG21 ' HB3' ' A' ' 54' ' ' PRO . 1.7 t -98.47 106.71 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 109.186 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.521 ' CG1' ' SG ' ' A' ' 11' ' ' CYS . 2.9 mp -94.74 157.31 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.224 -0.923 . . . . 0.0 109.83 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.972 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -136.47 125.88 25.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.798 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.749 HG22 ' HG2' ' A' ' 24' ' ' GLN . 22.4 m -89.66 105.52 17.85 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.026 -1.046 . . . . 0.0 109.111 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.962 HD23 ' O ' ' A' ' 22' ' ' ASN . 82.9 mt -43.79 168.7 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.322 -0.861 . . . . 0.0 109.597 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.532 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.3 ptpt -90.16 17.52 6.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 109.35 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.517 ' OD1' ' CB ' ' A' ' 44' ' ' LEU . 19.6 p-10 -119.49 7.21 11.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.402 -0.812 . . . . 0.0 109.143 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.28 -17.9 54.91 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.744 ' HB2' HD12 ' A' ' 44' ' ' LEU . 8.8 mtt85 -83.73 171.97 12.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -1.185 . . . . 0.0 109.169 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.519 ' CD ' ' OG1' ' A' ' 43' ' ' THR . 9.9 mtmt -144.49 125.21 14.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 109.553 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.24 131.14 55.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.891 . . . . 0.0 109.132 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.464 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 61.7 m -79.74 140.21 37.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.186 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.859 ' HB3' HG22 ' A' ' 59' ' ' VAL . 12.5 mt -129.41 168.64 16.01 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.218 -0.926 . . . . 0.0 109.441 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.66 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.8 m-20 -111.02 130.85 22.53 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.333 -0.854 . . . . 0.0 109.62 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.809 ' HB3' HG21 ' A' ' 40' ' ' VAL . 33.8 Cg_endo -75.26 -14.54 20.55 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.217 1.945 . . . . 0.0 110.21 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.91 -19.13 61.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.875 . . . . 0.0 108.879 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.03 163.16 33.06 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.493 -0.754 . . . . 0.0 109.206 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.14 -41.78 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.665 2.243 . . . . 0.0 110.635 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.542 ' CG2' ' HA3' ' A' ' 17' ' ' GLY . 11.7 mm -54.48 -55.48 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.154 -0.966 . . . . 0.0 109.411 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.859 HG22 ' HB3' ' A' ' 52' ' ' LEU . 89.1 t -54.48 -53.7 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.755 . . . . 0.0 110.053 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -45.81 -31.72 2.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.046 -1.034 . . . . 0.0 108.941 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.531 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -79.5 -38.32 34.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.52 -0.738 . . . . 0.0 109.6 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.8 mp -55.4 -41.88 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.164 -0.96 . . . . 0.0 108.811 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.044 HG22 HD11 ' B' ' 67' ' ' LEU . 2.1 mp -72.11 -65.78 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.353 -0.842 . . . . 0.0 109.49 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -42.23 -27.28 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.445 -0.784 . . . . 0.0 109.67 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -73.86 -49.31 25.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 108.93 179.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.475 ' HA ' ' HB3' ' A' ' 69' ' ' SER . 0.4 OUTLIER -55.14 -45.57 75.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.368 -0.832 . . . . 0.0 109.018 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.028 HD11 ' CG2' ' B' ' 63' ' ' ILE . 3.7 mt -53.56 -60.09 3.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.52 -0.738 . . . . 0.0 109.598 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -73.51 -3.98 31.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.632 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 4.1 p . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 109.393 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.936 ' HB2' HD22 ' B' ' 12' ' ' LEU . 94.5 m . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.509 ' N ' ' OE1' ' B' ' 39' ' ' GLU . 0.1 OUTLIER -42.77 -26.23 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.839 . . . . 0.0 109.866 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.517 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 78.2 m -130.78 72.2 1.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.621 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.936 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.55 -44.29 8.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.932 . . . . 0.0 109.147 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.32 117.5 33.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.29 -0.881 . . . . 0.0 109.275 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.426 ' OG1' ' CG ' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -103.09 156.44 17.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.865 . . . . 0.0 109.641 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.551 HD12 HD23 ' B' ' 52' ' ' LEU . 5.6 mt -98.04 135.77 39.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.79 . . . . 0.0 109.05 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' B' ' 15' ' ' LEU . 1.1 tt0 -44.07 -26.78 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 109.313 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.538 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 156.21 149.23 5.3 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.65 HG22 ' CD2' ' B' ' 52' ' ' LEU . 6.9 tt -128.25 150.03 33.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.511 -0.994 . . . . 0.0 108.803 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.469 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -43.74 146.41 1.01 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.945 . . . . 0.0 109.289 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.4 Cg_endo -76.6 -13.03 18.34 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.424 2.083 . . . . 0.0 109.991 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.534 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 7.6 mttp -78.93 -15.42 58.33 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 1.026 ' O ' HD13 ' B' ' 23' ' ' ILE . 86.5 m-20 -100.46 54.8 0.88 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 1.026 HD13 ' O ' ' B' ' 22' ' ' ASN . 0.7 OUTLIER -146.11 163.41 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.032 -1.042 . . . . 0.0 110.337 -179.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.735 ' HG2' HG22 ' B' ' 43' ' ' THR . 0.0 OUTLIER -153.08 -36.26 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.656 ' O ' HG23 ' B' ' 26' ' ' VAL . 5.0 p -128.41 179.52 5.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.656 HG23 ' O ' ' B' ' 25' ' ' SER . 51.4 t -160.11 115.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.786 -1.196 . . . . 0.0 109.99 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 20.4 t-20 -104.83 153.31 21.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 109.097 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' SER . 2.6 t -143.71 91.83 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 109.654 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.446 ' HD2' ' NE2' ' B' ' 10' ' ' GLN . 4.3 mttm -95.3 93.43 7.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 4.3 p -44.7 164.21 0.18 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.843 . . . . 0.0 109.301 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.506 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.7 Cg_endo -77.77 131.96 11.6 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.592 2.195 . . . . 0.0 110.527 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.26 -138.5 3.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.27 8.09 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.498 2.132 . . . . 0.0 110.782 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.484 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 5.0 p-80 -126.92 -16.79 5.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.063 -1.023 . . . . 0.0 109.849 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -160.12 125.21 3.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.075 -1.016 . . . . 0.0 109.278 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.419 ' O ' ' CD ' ' B' ' 37' ' ' GLN . . . -87.41 18.9 3.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.674 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.506 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 13.4 mm-40 -143.31 124.97 14.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.961 . . . . 0.0 109.558 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.434 HG23 ' HA ' ' B' ' 30' ' ' SER . 17.5 m -50.26 140.65 12.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.937 . . . . 0.0 109.255 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' B' ' 10' ' ' GLN . 8.5 mt-10 -117.76 106.81 13.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 109.619 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.802 HG21 ' HB3' ' B' ' 54' ' ' PRO . 1.7 t -98.5 106.76 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.166 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.517 ' CG1' ' SG ' ' B' ' 11' ' ' CYS . 2.9 mp -94.77 157.29 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.872 . . . . 0.0 109.803 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.964 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -136.38 125.85 25.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 108.866 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.735 HG22 ' HG2' ' B' ' 24' ' ' GLN . 22.4 m -89.68 105.57 17.89 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.958 -1.089 . . . . 0.0 109.151 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.934 HD23 ' O ' ' B' ' 22' ' ' ASN . 82.4 mt -43.83 168.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.312 -0.868 . . . . 0.0 109.583 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.534 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.2 ptpt -90.15 17.49 6.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.525 ' OD1' ' CB ' ' B' ' 44' ' ' LEU . 19.5 p-10 -119.42 7.23 11.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.22 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.3 -17.97 54.73 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.742 ' HB2' HD12 ' B' ' 44' ' ' LEU . 8.8 mtt85 -83.73 171.95 12.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 109.15 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.519 ' CD ' ' OG1' ' B' ' 43' ' ' THR . 10.0 mtmt -144.42 125.21 14.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.509 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.27 131.18 55.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.163 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 61.7 m -79.83 140.2 36.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -0.979 . . . . 0.0 109.186 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.868 ' HB3' HG22 ' B' ' 59' ' ' VAL . 12.5 mt -129.41 168.63 16.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.218 -0.926 . . . . 0.0 109.378 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.657 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.8 m-20 -110.94 130.91 22.45 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.587 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.802 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.7 Cg_endo -75.31 -14.56 20.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.312 2.008 . . . . 0.0 110.248 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.99 -19.11 61.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 108.829 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -89.91 163.09 33.61 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.152 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.16 -41.76 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.59 2.193 . . . . 0.0 110.632 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.538 ' CG2' ' HA3' ' B' ' 17' ' ' GLY . 11.7 mm -54.46 -55.54 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.351 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.868 HG22 ' HB3' ' B' ' 52' ' ' LEU . 90.0 t -54.46 -53.67 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.528 -0.732 . . . . 0.0 110.054 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 0.4 OUTLIER -45.86 -31.66 2.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.028 -1.045 . . . . 0.0 108.966 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.529 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -79.57 -38.27 34.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 109.647 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.8 mp -55.32 -41.85 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 108.856 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 1.028 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.1 mp -72.17 -65.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -42.14 -27.26 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -73.82 -49.37 25.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 108.947 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.481 ' HA ' ' HB3' ' B' ' 69' ' ' SER . 0.4 OUTLIER -55.18 -45.53 75.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.415 -0.803 . . . . 0.0 109.002 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.044 HD11 HG22 ' A' ' 63' ' ' ILE . 3.7 mt -53.67 -60.07 3.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.734 . . . . 0.0 109.52 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -73.51 -3.93 30.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.686 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 4.1 p . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 109.455 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.49 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.503 ' HG3' ' CB ' ' A' ' 29' ' ' LYS . 56.6 mm-40 -42.08 -27.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.791 . . . . 0.0 109.842 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.468 ' SG ' HG13 ' A' ' 41' ' ' ILE . 81.1 m -146.04 72.04 1.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.162 -0.961 . . . . 0.0 109.61 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -44.07 -45.65 8.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.068 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -110.13 120.87 43.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.414 -0.804 . . . . 0.0 109.072 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.66 HG21 HD22 ' A' ' 53' ' ' ASN . 0.5 OUTLIER -105.99 161.43 14.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.236 -0.915 . . . . 0.0 109.986 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.666 ' HB2' HD23 ' A' ' 52' ' ' LEU . 3.1 mt -108.66 143.08 38.21 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.607 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.4 tt0 -44.9 -26.54 0.42 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.061 -1.025 . . . . 0.0 109.065 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.592 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 152.37 177.65 26.25 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.656 HG22 HD11 ' A' ' 52' ' ' LEU . 6.4 tp -148.56 159.99 6.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.42 -1.047 . . . . 0.0 109.071 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.589 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.5 t-80 -50.2 144.23 11.63 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.243 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.589 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.37 -22.66 10.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.504 2.136 . . . . 0.0 110.264 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.456 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.27 -15.2 31.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -0.871 . . . . 0.0 109.108 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.569 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 95.0 m-20 -79.55 -11.89 59.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.317 -0.865 . . . . 0.0 109.455 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.894 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 4.3 mt -101.0 155.55 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.308 -0.87 . . . . 0.0 110.422 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.533 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -124.5 -30.04 3.41 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.533 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -132.02 169.05 16.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 108.855 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.739 HG23 ' HG3' ' A' ' 66' ' ' MET . 49.9 t -139.45 111.2 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 109.801 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.712 ' O ' HD12 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -106.15 110.99 23.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.158 179.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -113.8 106.36 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.655 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.503 ' CB ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -97.25 94.81 7.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.222 -0.924 . . . . 0.0 109.319 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.1 p -45.2 169.25 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.479 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 36' ' ' ALA . 35.6 Cg_endo -77.84 132.15 11.67 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.582 2.188 . . . . 0.0 110.408 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.84 -140.29 4.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.06 41.61 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.718 2.278 . . . . 0.0 110.708 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.438 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 9.7 p-80 -161.93 -38.1 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.053 -1.029 . . . . 0.0 109.244 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 6.2 t -135.82 112.78 10.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.285 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 31' ' ' PRO . . . -71.45 -32.06 67.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 109.646 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.437 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 2.5 mm-40 -87.63 130.51 34.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.586 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.458 HG23 ' HA ' ' A' ' 30' ' ' SER . 63.2 m -53.31 142.97 19.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.38 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.484 ' CB ' ' HB2' ' A' ' 10' ' ' GLN . 30.6 mm-40 -117.46 107.33 14.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.568 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 54' ' ' PRO . 9.5 t -92.48 148.32 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.5 mp -140.6 153.87 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 0.0 109.7 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.894 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -137.5 121.93 18.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.418 -0.801 . . . . 0.0 109.215 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 43' ' ' THR . 1.2 m -89.29 98.99 12.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.998 -1.064 . . . . 0.0 108.783 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.489 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 73.7 mt -41.78 165.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.434 0.635 . . . . 0.0 109.919 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 13.9 ptpt -81.22 7.87 10.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.811 . . . . 0.0 109.745 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -111.25 16.27 21.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.391 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.49 3.75 88.24 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.462 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 2.4 mtp-105 -94.04 174.95 6.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -1.158 . . . . 0.0 109.562 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -141.24 152.96 44.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.29 120.45 7.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 108.889 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 33.0 m -79.7 140.35 37.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.488 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.885 ' HB3' HG22 ' A' ' 59' ' ' VAL . 14.7 mt -126.36 166.94 16.24 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.38 -0.825 . . . . 0.0 108.899 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.661 ' O ' HG21 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -101.52 123.94 42.61 Favored Pre-proline 0 C--N 1.299 -1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.386 -179.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.65 ' HB3' HG21 ' A' ' 40' ' ' VAL . 33.8 Cg_endo -75.03 -9.89 20.93 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.152 1.901 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.43 -14.14 57.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 108.862 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -89.69 162.22 36.75 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.325 179.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.0 Cg_endo -77.56 -39.93 0.48 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.63 2.22 . . . . 0.0 110.626 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 32.4 mt -61.13 -51.86 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.973 . . . . 0.0 109.17 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.885 HG22 ' HB3' ' A' ' 52' ' ' LEU . 54.4 t -53.48 -52.03 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.511 -0.743 . . . . 0.0 109.762 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 6.9 mmtt -50.14 -33.22 18.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.077 -1.015 . . . . 0.0 108.813 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 57' ' ' PRO . 2.5 mmpt? -74.36 -36.02 63.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.448 -0.783 . . . . 0.0 109.26 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.705 HG23 ' CD1' ' A' ' 23' ' ' ILE . 1.7 mp -61.53 -41.14 89.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.419 -0.801 . . . . 0.0 109.079 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.1 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -69.68 -68.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 0.0 109.766 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -43.82 -33.75 1.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 0.0 109.6 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 69' ' ' SER . 10.7 mmtm -66.07 -59.12 4.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.169 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.739 ' HG3' HG23 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -44.4 -45.7 9.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.051 179.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.105 HD11 ' CG2' ' B' ' 63' ' ' ILE . 1.9 mt -56.88 -56.38 22.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.501 -0.749 . . . . 0.0 109.4 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -85.91 13.64 7.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 65' ' ' LYS . 93.7 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.484 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.511 ' HG3' ' CB ' ' B' ' 29' ' ' LYS . 56.7 mm-40 -41.91 -27.53 0.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.46 -0.775 . . . . 0.0 109.829 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.47 ' SG ' HG13 ' B' ' 41' ' ' ILE . 80.7 m -145.98 72.04 1.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.661 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.3 OUTLIER -44.12 -45.57 8.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.092 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -110.1 121.0 44.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 109.047 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.657 HG21 HD22 ' B' ' 53' ' ' ASN . 0.5 OUTLIER -106.06 161.46 14.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.221 -0.925 . . . . 0.0 109.897 -179.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.669 ' HB2' HD23 ' B' ' 52' ' ' LEU . 3.1 mt -108.76 143.19 38.24 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.608 ' O ' HG23 ' B' ' 59' ' ' VAL . 2.4 tt0 -44.95 -26.46 0.42 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.994 . . . . 0.0 109.116 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.595 ' CA ' HD22 ' B' ' 52' ' ' LEU . . . 152.3 177.66 26.2 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.661 HG22 HD11 ' B' ' 52' ' ' LEU . 6.4 tp -148.51 160.06 6.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.434 -1.039 . . . . 0.0 109.029 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.594 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 1.5 t-80 -50.29 144.22 11.93 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.086 -1.009 . . . . 0.0 109.141 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -77.46 -22.53 10.73 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.483 2.122 . . . . 0.0 110.237 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.464 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.23 -15.36 31.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.36 -0.837 . . . . 0.0 109.096 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.579 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 95.0 m-20 -79.52 -11.87 59.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.897 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 4.3 mt -101.01 155.55 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 110.406 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.552 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -124.58 -30.0 3.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.325 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.552 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -132.02 169.04 16.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 108.912 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.749 HG23 ' HG3' ' B' ' 66' ' ' MET . 50.3 t -139.46 111.3 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.013 . . . . 0.0 109.836 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.722 ' O ' HD12 ' B' ' 41' ' ' ILE . 0.1 OUTLIER -106.14 110.93 23.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.149 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.8 t -113.77 106.37 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.696 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.511 ' CB ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -97.25 94.74 7.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.44 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.468 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -45.13 169.23 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.452 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.8 Cg_endo -77.77 132.17 11.75 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.562 2.175 . . . . 0.0 110.46 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.85 -140.35 4.02 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.12 41.68 1.17 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.69 2.26 . . . . 0.0 110.679 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.446 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 9.6 p-80 -161.9 -38.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.142 -0.974 . . . . 0.0 109.324 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 6.3 t -135.82 112.81 10.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.276 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' B' ' 31' ' ' PRO . . . -71.56 -32.03 67.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.611 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.426 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 2.5 mm-40 -87.68 130.65 34.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.486 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.468 HG23 ' HA ' ' B' ' 30' ' ' SER . 62.4 m -53.47 143.06 20.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.353 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' B' ' 10' ' ' GLN . 30.4 mm-40 -117.47 107.38 14.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.635 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' B' ' 54' ' ' PRO . 9.7 t -92.51 148.35 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.894 . . . . 0.0 109.267 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.722 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.5 mp -140.65 153.83 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.961 . . . . 0.0 109.679 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.897 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -137.42 121.97 18.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.356 -0.84 . . . . 0.0 109.186 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.559 HG22 ' O ' ' B' ' 43' ' ' THR . 1.2 m -89.31 99.01 12.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.976 -1.077 . . . . 0.0 108.78 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 73.9 mt -41.82 164.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.565 -0.709 . . . . 0.0 109.981 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.464 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 13.9 ptpt -81.18 7.89 10.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 0.0 109.775 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -111.25 16.16 21.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.384 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.5 3.78 88.21 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.478 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 2.4 mtp-105 -94.05 174.93 6.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.5 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -141.23 152.89 44.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 0.0 109.501 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.22 120.43 7.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 108.959 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.431 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 33.0 m -79.66 140.24 37.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.125 -0.984 . . . . 0.0 109.46 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.891 ' HB3' HG22 ' B' ' 59' ' ' VAL . 14.7 mt -126.29 166.99 16.1 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.4 -0.812 . . . . 0.0 108.924 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.657 HD22 HG21 ' B' ' 14' ' ' THR . 0.7 OUTLIER -101.49 123.94 42.67 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.632 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.8 Cg_endo -75.02 -9.99 20.98 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.177 1.918 . . . . 0.0 110.244 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.29 -14.18 57.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.268 -0.895 . . . . 0.0 108.944 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -89.65 162.15 37.04 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.432 -0.793 . . . . 0.0 109.323 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.448 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 35.9 Cg_endo -77.53 -39.87 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.636 2.224 . . . . 0.0 110.658 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' B' ' 62' ' ' ILE . 32.4 mt -61.14 -51.87 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 109.118 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.891 HG22 ' HB3' ' B' ' 52' ' ' LEU . 54.5 t -53.53 -52.03 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.509 -0.744 . . . . 0.0 109.746 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' B' ' 56' ' ' SER . 6.9 mmtt -50.13 -33.18 17.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 108.844 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' B' ' 57' ' ' PRO . 2.5 mmpt? -74.34 -36.08 63.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.6 -0.688 . . . . 0.0 109.303 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.702 HG23 ' CD1' ' B' ' 23' ' ' ILE . 1.7 mp -61.5 -41.13 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.38 -0.825 . . . . 0.0 109.048 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 1.105 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -69.76 -69.0 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.643 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -43.67 -33.71 1.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.137 -0.977 . . . . 0.0 109.671 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' B' ' 69' ' ' SER . 10.7 mmtm -66.14 -59.22 3.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.102 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.749 ' HG3' HG23 ' B' ' 26' ' ' VAL . 0.6 OUTLIER -44.37 -45.68 8.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.832 . . . . 0.0 109.097 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.1 HD11 ' CG2' ' A' ' 63' ' ' ILE . 1.9 mt -56.88 -56.27 23.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.394 -0.816 . . . . 0.0 109.48 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -85.95 13.5 7.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.506 -179.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.482 ' N ' ' O ' ' B' ' 65' ' ' LYS . 93.0 p . . . . . 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.507 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.94 ' HB2' HD22 ' A' ' 12' ' ' LEU . 18.0 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.5 ' HB2' ' HD2' ' A' ' 29' ' ' LYS . 21.4 mm-40 -42.68 -26.53 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.365 -0.835 . . . . 0.0 109.773 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.471 ' HB2' ' HG2' ' A' ' 39' ' ' GLU . 73.5 m -122.38 58.33 1.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.962 . . . . 0.0 109.777 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.94 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.64 4.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 108.839 179.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -123.94 123.56 40.67 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -97.99 172.87 7.35 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.185 -0.947 . . . . 0.0 110.243 -179.273 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.494 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 4.5 mt -128.85 143.11 50.81 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.614 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.7 tt0 -44.4 -44.73 8.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 1.014 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 142.28 161.42 8.76 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.78 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -130.76 156.54 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -1.093 . . . . 0.0 109.137 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.588 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -43.23 150.82 0.46 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.321 -0.862 . . . . 0.0 109.291 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -76.54 -0.51 10.52 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.472 2.115 . . . . 0.0 110.12 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER -90.03 -27.12 19.93 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.265 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.57 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 8.9 m-20 -84.97 6.0 26.9 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.714 HG23 ' HB1' ' A' ' 42' ' ' ALA . 2.5 mm -94.26 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.936 . . . . 0.0 110.552 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.618 ' H ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -154.54 -41.5 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.476 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 1.3 p -135.73 174.59 10.44 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.535 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 52.7 t -150.3 89.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.949 -1.094 . . . . 0.0 109.962 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 3.2 t-20 -79.67 105.49 11.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.23 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -98.49 91.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.547 ' HE3' ' CD1' ' A' ' 41' ' ' ILE . 1.3 ptpm? -98.23 112.5 24.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.366 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.421 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -63.99 171.2 2.65 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.253 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.547 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.8 Cg_endo -77.98 130.91 10.67 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.626 2.218 . . . . 0.0 110.412 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.11 -144.56 5.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.87 5.48 4.88 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.546 2.164 . . . . 0.0 110.545 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 17.5 p-80 -123.14 -11.54 8.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 0.0 109.595 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' OE2' ' A' ' 39' ' ' GLU . 7.9 t -160.14 118.8 2.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.382 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.68 29.56 1.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.559 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.547 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 17.8 mm-40 -141.93 127.97 19.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.522 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -53.37 152.29 4.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.335 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 11' ' ' CYS . 2.4 mp0 -138.32 112.0 8.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.681 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.896 HG11 HD11 ' A' ' 63' ' ' ILE . 1.6 t -103.64 90.59 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.227 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.547 ' CD1' ' HE3' ' A' ' 29' ' ' LYS . 3.5 mt -79.9 144.01 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.961 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.714 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -124.13 120.48 32.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.418 -0.801 . . . . 0.0 108.864 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 24' ' ' GLN . 9.0 m -89.22 101.21 13.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.92 -1.113 . . . . 0.0 109.071 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.57 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 81.4 mt -46.28 167.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.366 -0.834 . . . . 0.0 109.573 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HA ' ' HG3' ' A' ' 24' ' ' GLN . 14.6 ptpt -83.79 9.95 10.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -111.37 16.71 20.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.93 . . . . 0.0 109.372 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.89 6.92 87.94 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HB2' HD12 ' A' ' 44' ' ' LEU . 45.8 mtt-85 -99.37 168.81 9.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -1.151 . . . . 0.0 109.429 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -135.63 155.95 49.63 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.494 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.4 120.16 7.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 109.178 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.408 ' SG ' HG12 ' A' ' 41' ' ' ILE . 11.1 m -79.15 138.95 38.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.027 -1.045 . . . . 0.0 108.537 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.014 HD22 ' HA2' ' A' ' 17' ' ' GLY . 11.6 mt -119.55 167.47 11.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.647 ' O ' HG21 ' A' ' 59' ' ' VAL . 4.7 t-20 -98.76 119.72 60.52 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.72 -3.92 14.63 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.052 1.834 . . . . 0.0 110.269 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.27 -13.0 42.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 108.823 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -89.91 161.24 38.97 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.839 . . . . 0.0 109.371 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.475 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.71 -35.52 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.7 2.266 . . . . 0.0 110.714 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.546 HG23 ' N ' ' A' ' 59' ' ' VAL . 9.2 tt -67.73 -44.3 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 109.296 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.004 ' HA ' HD12 ' A' ' 62' ' ' ILE . 31.2 t -58.57 -47.1 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.533 -0.729 . . . . 0.0 109.161 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 8.9 mttt -59.22 -30.32 68.16 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -79.36 -23.54 43.29 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.004 HD12 ' HA ' ' A' ' 59' ' ' VAL . 16.5 mt -71.22 -38.1 68.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.535 -0.728 . . . . 0.0 109.056 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.989 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -73.84 -55.86 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 109.284 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -59.9 -28.34 67.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.95 . . . . 0.0 109.35 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.513 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -70.08 -43.28 71.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 108.978 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.535 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -60.24 -46.04 91.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.085 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.013 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.7 OUTLIER -48.72 -54.71 13.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.45 -0.781 . . . . 0.0 109.511 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' SER . 17.1 t-20 -68.11 -23.25 64.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 109.614 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.428 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 9.9 p . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.509 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.947 ' HB2' HD22 ' B' ' 12' ' ' LEU . 17.9 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.488 ' HB2' ' HD2' ' B' ' 29' ' ' LYS . 21.3 mm-40 -42.63 -26.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.356 -0.84 . . . . 0.0 109.78 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.468 ' HB2' ' HG2' ' B' ' 39' ' ' GLU . 73.6 m -122.39 58.35 1.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.947 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.63 4.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 108.925 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -123.95 123.63 40.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.437 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -98.04 172.82 7.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.232 -0.917 . . . . 0.0 110.212 -179.259 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.486 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 4.5 mt -128.77 143.14 50.84 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.614 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.7 tt0 -44.32 -44.88 8.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.096 -1.003 . . . . 0.0 109.1 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 1.017 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 142.29 161.37 8.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.808 HD13 ' N ' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -130.67 156.58 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.373 -1.075 . . . . 0.0 109.171 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.589 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -43.38 150.82 0.48 Allowed Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.258 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.589 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.5 Cg_endo -76.43 -0.59 10.57 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.434 2.089 . . . . 0.0 110.181 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.445 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -89.98 -27.21 19.93 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.574 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 9.0 m-20 -84.84 5.91 26.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.705 HG23 ' HB1' ' B' ' 42' ' ' ALA . 2.5 mm -94.14 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.869 . . . . 0.0 110.506 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.613 ' H ' HG22 ' B' ' 23' ' ' ILE . 0.5 OUTLIER -154.59 -41.51 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.467 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 1.3 p -135.71 174.63 10.41 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.534 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 52.9 t -150.23 89.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.924 -1.11 . . . . 0.0 109.941 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 3.2 t-20 -79.78 105.38 11.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.192 -0.942 . . . . 0.0 109.242 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.9 t -98.49 91.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.54 ' HE3' ' CD1' ' B' ' 41' ' ' ILE . 1.3 ptpm? -98.21 112.46 24.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 109.373 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.425 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.0 OUTLIER -63.8 171.09 2.59 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.327 -0.858 . . . . 0.0 109.381 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.544 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.1 Cg_endo -77.97 130.87 10.67 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.606 2.204 . . . . 0.0 110.478 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.02 -144.6 5.77 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.81 5.45 4.87 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.553 2.169 . . . . 0.0 110.586 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -123.18 -11.47 7.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.559 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 7.8 t -160.18 118.73 2.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.68 29.47 1.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.584 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.544 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 17.9 mm-40 -141.89 128.01 19.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.208 -0.933 . . . . 0.0 109.566 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -53.27 152.33 4.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.896 . . . . 0.0 109.396 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' B' ' 11' ' ' CYS . 2.4 mp0 -138.39 111.9 8.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -0.961 . . . . 0.0 109.695 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.901 HG11 HD11 ' B' ' 63' ' ' ILE . 1.6 t -103.59 90.64 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.163 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.54 ' CD1' ' HE3' ' B' ' 29' ' ' LYS . 3.5 mt -79.94 144.0 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.897 . . . . 0.0 109.957 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.705 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -124.16 120.49 32.46 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' B' ' 24' ' ' GLN . 9.1 m -89.21 101.26 13.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.908 -1.12 . . . . 0.0 109.128 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.574 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 81.3 mt -46.33 167.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.388 -0.82 . . . . 0.0 109.587 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.452 ' HA ' ' HG3' ' B' ' 24' ' ' GLN . 14.6 ptpt -83.88 10.05 10.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -111.37 16.69 20.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.349 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.86 7.02 87.85 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.52 ' HB2' HD12 ' B' ' 44' ' ' LEU . 45.8 mtt-85 -99.45 168.85 9.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -1.163 . . . . 0.0 109.432 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.522 ' N ' ' HD2' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -135.63 155.99 49.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.486 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.41 120.21 7.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.337 -0.852 . . . . 0.0 109.118 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.41 ' SG ' HG12 ' B' ' 41' ' ' ILE . 11.1 m -79.14 138.9 38.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.042 -1.037 . . . . 0.0 108.579 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 1.017 HD22 ' HA2' ' B' ' 17' ' ' GLY . 11.5 mt -119.41 167.49 11.88 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.236 -0.915 . . . . 0.0 109.856 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.647 ' O ' HG21 ' B' ' 59' ' ' VAL . 4.7 t-20 -98.84 119.7 60.45 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.55 -0.719 . . . . 0.0 109.061 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.64 -3.92 14.62 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.05 1.834 . . . . 0.0 110.319 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.34 -12.86 42.22 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.317 -0.864 . . . . 0.0 108.901 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 1.0 OUTLIER -90.0 161.23 38.73 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.299 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.0 Cg_endo -77.77 -35.54 1.44 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.649 2.232 . . . . 0.0 110.697 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.56 HG23 ' N ' ' B' ' 59' ' ' VAL . 9.2 tt -67.69 -44.31 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.31 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 1.008 ' HA ' HD12 ' B' ' 62' ' ' ILE . 31.6 t -58.54 -47.05 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.466 -0.771 . . . . 0.0 109.178 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' B' ' 56' ' ' SER . 8.9 mttt -59.21 -30.36 68.17 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.496 ' O ' ' CG ' ' B' ' 65' ' ' LYS . 0.0 OUTLIER -79.28 -23.59 43.49 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 1.008 HD12 ' HA ' ' B' ' 59' ' ' VAL . 16.4 mt -71.24 -38.06 68.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.506 -0.746 . . . . 0.0 109.081 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 1.013 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -73.82 -55.85 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.366 -0.833 . . . . 0.0 109.336 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.3 OUTLIER -59.85 -28.39 67.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 109.379 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.515 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 0.1 OUTLIER -70.08 -43.21 71.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.002 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.534 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.6 OUTLIER -60.35 -45.91 91.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 109.072 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.989 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -48.78 -54.73 13.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.445 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' B' ' 69' ' ' SER . 17.2 t-20 -68.15 -23.28 64.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.428 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 9.9 p . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.525 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.493 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -45.53 -24.84 0.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.423 ' SG ' HG13 ' A' ' 41' ' ' ILE . 60.8 m -148.7 71.16 1.14 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.082 -1.011 . . . . 0.0 109.822 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.493 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.04 -45.87 11.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 108.948 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -115.27 119.69 37.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.443 -0.786 . . . . 0.0 108.961 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -97.45 163.51 12.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.193 -0.942 . . . . 0.0 110.011 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.544 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.4 mt -115.17 146.26 41.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.487 -0.758 . . . . 0.0 108.981 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.77 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.9 tt0 -44.22 -46.91 9.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.339 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 1.033 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 156.03 -164.82 32.49 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.802 HG23 ' O ' ' A' ' 17' ' ' GLY . 1.2 pp -170.26 162.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.436 -1.038 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.623 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 13.0 t60 -44.8 144.58 1.83 Allowed Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.623 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.6 Cg_endo -77.76 -13.93 15.91 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.29 1.994 . . . . 0.0 109.889 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.516 ' CE ' ' HG2' ' A' ' 20' ' ' PRO . 1.9 mmpt? -90.86 -19.87 22.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.401 -0.812 . . . . 0.0 108.861 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 5.2 m-20 -78.61 -12.96 60.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.237 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.941 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 12.0 mt -91.93 165.89 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.981 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.543 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -131.88 -41.96 1.02 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.8 p -125.11 173.49 8.69 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.539 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 48.3 t -144.33 95.53 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.01 -1.056 . . . . 0.0 109.694 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.673 ' O ' HD12 ' A' ' 41' ' ' ILE . 5.3 t-20 -96.83 112.4 24.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.406 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.833 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -115.6 102.65 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 109.597 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -94.35 110.92 22.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.394 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.67 165.36 0.73 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.421 ' HB3' ' C ' ' A' ' 37' ' ' GLN . 35.8 Cg_endo -78.12 136.43 14.57 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.61 2.207 . . . . 0.0 110.419 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.67 -145.3 4.59 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.19 7.41 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.633 2.222 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.413 ' ND1' ' N ' ' A' ' 34' ' ' HIS . 11.5 p-80 -124.32 -7.73 7.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.628 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.9 t -160.1 117.35 2.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 109.449 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.15 45.71 1.2 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.594 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.463 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 1.6 pt20 -171.11 140.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.474 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.467 ' HB ' ' CG ' ' A' ' 54' ' ' PRO . 1.4 m -60.64 145.19 50.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 109.368 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.463 ' OE2' ' O ' ' A' ' 37' ' ' GLN . 0.7 OUTLIER -127.3 107.4 9.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.582 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.833 HG22 HG13 ' A' ' 28' ' ' VAL . 32.0 t -93.09 151.82 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.207 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 27' ' ' ASN . 2.5 mp -140.19 146.61 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.067 -1.021 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.941 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -133.87 119.16 18.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.416 -0.802 . . . . 0.0 109.08 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 6.8 m -89.39 97.51 11.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.944 -1.098 . . . . 0.0 109.131 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 87.0 mt -43.13 166.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.477 -0.765 . . . . 0.0 109.731 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.8 ptpt -82.56 9.84 8.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 109.704 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.514 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -113.69 27.69 9.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.143 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.29 6.21 64.68 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.514 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 40.5 mtt180 -96.23 160.99 14.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -1.188 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.57 150.23 48.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.177 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.544 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.21 124.73 9.64 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.213 -0.929 . . . . 0.0 109.191 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.48 ' SG ' HG13 ' A' ' 41' ' ' ILE . 15.7 m -79.51 148.08 31.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.104 -0.997 . . . . 0.0 109.225 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.033 HD22 ' HA2' ' A' ' 17' ' ' GLY . 15.7 mt -122.76 167.22 13.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.271 -0.893 . . . . 0.0 109.329 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.648 ' O ' HG21 ' A' ' 59' ' ' VAL . 3.0 t-20 -98.86 119.45 61.0 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.152 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.467 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 32.9 Cg_endo -74.87 -6.12 17.71 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.137 1.891 . . . . 0.0 110.23 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.95 -14.69 46.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 108.886 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -90.0 160.7 40.02 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.398 -0.813 . . . . 0.0 109.355 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.8 -34.39 1.84 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.627 2.218 . . . . 0.0 110.686 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.586 ' O ' HD13 ' A' ' 62' ' ' ILE . 2.7 tt -66.5 -46.67 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.138 -0.976 . . . . 0.0 109.09 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.859 HG22 ' HB3' ' A' ' 52' ' ' LEU . 38.1 t -57.02 -48.2 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.403 -0.81 . . . . 0.0 109.023 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.1 OUTLIER -55.23 -31.28 61.36 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 2.8 mmpt? -76.23 -30.62 57.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -65.48 -44.65 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.346 -0.846 . . . . 0.0 108.936 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.95 HG22 HD11 ' B' ' 67' ' ' LEU . 2.2 mp -66.82 -61.78 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.489 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -52.67 -27.7 18.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.481 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 13.9 mttt -71.43 -43.03 67.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.197 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.539 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -61.8 -47.13 86.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.31 -0.869 . . . . 0.0 109.185 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.949 HD11 HG22 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.75 -50.89 9.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -69.32 -31.32 69.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.498 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.406 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 1.3 p . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.508 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.474 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 1.8 m . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -45.55 -24.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 109.698 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.429 ' O ' ' C ' ' B' ' 12' ' ' LEU . 60.7 m -148.7 71.11 1.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.086 -1.009 . . . . 0.0 109.884 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.474 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.94 -45.94 10.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.007 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -115.24 119.61 36.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.461 -0.775 . . . . 0.0 108.954 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.538 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.6 OUTLIER -97.31 163.6 12.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 110.014 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.532 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.4 mt -115.27 146.2 41.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.479 -0.763 . . . . 0.0 108.949 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.788 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.9 tt0 -44.16 -46.88 9.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 1.051 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 155.99 -164.94 32.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.802 HG23 ' O ' ' B' ' 17' ' ' GLY . 1.2 pp -170.19 162.77 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.399 -1.059 . . . . 0.0 109.503 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.614 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 12.8 t60 -44.75 144.6 1.8 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.614 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -77.78 -13.99 15.85 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.347 2.031 . . . . 0.0 109.87 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.507 ' CE ' ' HG2' ' B' ' 20' ' ' PRO . 1.9 mmpt? -90.77 -19.96 22.91 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.487 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 5.1 m-20 -78.63 -12.92 60.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 0.0 109.234 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.95 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 12.0 mt -91.96 165.91 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.276 -0.89 . . . . 0.0 109.982 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.555 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.0 OUTLIER -131.92 -41.87 1.02 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 3.7 p -125.25 173.45 8.79 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.533 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 48.7 t -144.26 95.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.077 -1.014 . . . . 0.0 109.728 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.679 ' O ' HD12 ' B' ' 41' ' ' ILE . 5.3 t-20 -96.95 112.39 24.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 0.0 109.392 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.814 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -115.64 102.62 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.56 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -94.34 110.93 22.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.7 165.34 0.74 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.457 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.409 ' HB3' ' C ' ' B' ' 37' ' ' GLN . 35.7 Cg_endo -78.04 136.45 14.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.629 2.219 . . . . 0.0 110.451 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.66 -145.24 4.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.22 7.41 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.738 2.292 . . . . 0.0 110.746 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.415 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 11.7 p-80 -124.43 -7.66 7.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.9 t -160.13 117.29 2.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.357 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.18 45.72 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.476 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.448 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 1.6 pt20 -171.14 140.93 1.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 109.528 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.473 ' HB ' ' CG ' ' B' ' 54' ' ' PRO . 1.4 m -60.58 145.09 50.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.448 ' OE2' ' O ' ' B' ' 37' ' ' GLN . 0.7 OUTLIER -127.23 107.32 9.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.814 HG22 HG13 ' B' ' 28' ' ' VAL . 31.5 t -92.99 151.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.257 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.679 HD12 ' O ' ' B' ' 27' ' ' ASN . 2.6 mp -140.15 146.57 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.788 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.95 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -133.91 119.16 18.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 109.073 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 6.7 m -89.32 97.49 11.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.924 -1.11 . . . . 0.0 109.17 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 86.9 mt -43.13 166.14 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.507 -0.746 . . . . 0.0 109.673 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.481 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.8 ptpt -82.56 9.95 8.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -0.823 . . . . 0.0 109.676 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -113.77 27.75 9.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.324 -0.86 . . . . 0.0 109.152 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.3 6.16 64.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.51 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 40.6 mtt180 -96.23 161.03 14.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.171 -1.193 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.506 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.62 150.25 48.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.154 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.532 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.21 124.71 9.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.35 -0.844 . . . . 0.0 109.137 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.483 ' SG ' HG13 ' B' ' 41' ' ' ILE . 15.6 m -79.49 148.08 31.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.124 -0.985 . . . . 0.0 109.184 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 1.051 HD22 ' HA2' ' B' ' 17' ' ' GLY . 15.9 mt -122.88 167.2 13.85 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.651 ' O ' HG21 ' B' ' 59' ' ' VAL . 3.0 t-20 -98.82 119.38 61.23 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.163 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.473 ' CG ' ' HB ' ' B' ' 38' ' ' THR . 33.4 Cg_endo -74.66 -6.31 18.04 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.182 1.921 . . . . 0.0 110.304 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.93 -14.68 46.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.36 -0.838 . . . . 0.0 108.846 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -90.02 160.75 39.89 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.288 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.85 -34.35 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.582 2.188 . . . . 0.0 110.709 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.598 ' O ' HD13 ' B' ' 62' ' ' ILE . 2.7 tt -66.49 -46.65 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.108 -0.995 . . . . 0.0 109.136 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.865 HG22 ' HB3' ' B' ' 52' ' ' LEU . 38.1 t -57.1 -48.08 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.017 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.1 OUTLIER -55.28 -31.3 61.49 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.467 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 2.8 mmpt? -76.16 -30.6 58.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.591 -0.693 . . . . 0.0 109.391 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.598 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -65.46 -44.7 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.353 -0.842 . . . . 0.0 108.987 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.949 HG22 HD11 ' A' ' 67' ' ' LEU . 2.2 mp -66.69 -61.8 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.1 OUTLIER -52.73 -27.72 18.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.462 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.512 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 13.9 mttt -71.38 -43.0 67.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 109.236 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.533 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -61.81 -47.11 86.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.378 -0.826 . . . . 0.0 109.248 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.95 HD11 HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.7 -50.91 9.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.504 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 17.8 t-20 -69.32 -31.28 69.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.486 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.918 . . . . 0.0 109.523 179.991 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.441 ' HB3' ' OE2' ' A' ' 39' ' ' GLU . 17.2 m . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.667 ' HB3' HD11 ' A' ' 41' ' ' ILE . 45.2 mm-40 -40.69 -39.89 1.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.482 -0.761 . . . . 0.0 109.756 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.481 ' O ' HG23 ' A' ' 14' ' ' THR . 1.7 m -165.85 70.19 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.4 -0.812 . . . . 0.0 109.506 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.965 HD13 ' O ' ' A' ' 12' ' ' LEU . 1.5 tm? -44.22 -34.46 1.89 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.342 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -93.6 81.4 4.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.244 -0.91 . . . . 0.0 109.099 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.666 HG21 HD22 ' A' ' 53' ' ' ASN . 10.1 p -87.78 158.65 18.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.291 -0.881 . . . . 0.0 109.91 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HB2' HD23 ' A' ' 52' ' ' LEU . 2.4 mt -100.24 144.25 29.48 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.455 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.9 tt0 -45.41 -25.91 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.074 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.532 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 154.09 171.54 21.19 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.844 HG22 HD11 ' A' ' 52' ' ' LEU . 7.7 tp -145.32 151.96 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.336 -1.096 . . . . 0.0 109.166 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.507 ' ND1' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.92 146.98 1.82 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.935 . . . . 0.0 109.303 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.507 ' HD2' ' ND1' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.15 -13.85 16.95 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.549 2.166 . . . . 0.0 110.04 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.526 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -80.92 -16.34 53.84 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.234 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.989 ' O ' HD23 ' A' ' 44' ' ' LEU . 80.1 m-20 -101.34 55.59 0.83 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.459 -0.776 . . . . 0.0 108.988 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.974 HG23 ' HB1' ' A' ' 42' ' ' ALA . 1.8 mm -139.79 170.83 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.133 -0.979 . . . . 0.0 110.041 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -160.06 -40.72 0.05 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.8 p -131.13 -177.97 4.62 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 25' ' ' SER . 51.9 t -157.22 111.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.025 -1.047 . . . . 0.0 109.748 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.424 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 18.6 t-20 -94.87 124.61 39.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -0.85 . . . . 0.0 109.358 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.46 ' HB ' ' HB ' ' B' ' 26' ' ' VAL . 1.9 t -119.91 89.7 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.196 -0.94 . . . . 0.0 109.53 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 104.22 15.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.279 -0.888 . . . . 0.0 109.547 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.2 p -54.31 168.42 0.46 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.445 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 35.9 Cg_endo -78.01 133.15 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.664 2.242 . . . . 0.0 110.434 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.85 -141.05 3.8 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.55 10.25 2.59 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.531 2.154 . . . . 0.0 110.992 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.499 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 3.7 p-80 -127.16 -10.21 5.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.023 -1.048 . . . . 0.0 109.813 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' OE1' ' A' ' 39' ' ' GLU . 1.8 t -160.27 121.4 3.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.002 . . . . 0.0 109.372 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.72 44.16 1.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.577 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.441 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 5.8 pt20 -172.36 139.76 1.04 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.5 m -56.49 142.28 39.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.399 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.452 ' OE1' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -127.62 122.59 33.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.899 . . . . 0.0 109.623 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.844 HG11 HD11 ' A' ' 63' ' ' ILE . 74.6 t -114.48 151.44 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.371 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.667 HD11 ' HB3' ' A' ' 10' ' ' GLN . 3.3 mp -141.82 155.18 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.607 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.974 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -134.21 126.63 30.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.397 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.635 HG23 ' HG3' ' A' ' 49' ' ' LYS . 51.9 m -89.81 105.87 18.09 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.111 -0.993 . . . . 0.0 109.089 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.989 HD23 ' O ' ' A' ' 22' ' ' ASN . 77.1 mt -41.73 164.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.464 -0.772 . . . . 0.0 109.587 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.4 ptpt -87.44 17.81 4.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.748 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 1.1 p-10 -120.46 -3.53 9.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.97 . . . . 0.0 109.349 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.4 -25.31 8.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.845 ' HB2' HD12 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -79.34 172.9 13.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -1.172 . . . . 0.0 109.255 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.635 ' HG3' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -147.24 125.55 12.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.66 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.74 124.77 51.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.422 -0.799 . . . . 0.0 108.847 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.44 ' SG ' HG12 ' A' ' 41' ' ' ILE . 83.9 m -79.55 140.99 37.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.947 . . . . 0.0 109.317 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.844 HD11 HG22 ' A' ' 18' ' ' ILE . 14.3 mt -127.78 168.25 15.39 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 108.975 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.666 HD22 HG21 ' A' ' 14' ' ' THR . 0.8 OUTLIER -106.12 132.95 20.46 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.321 -0.862 . . . . 0.0 109.125 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HG3' HG23 ' A' ' 40' ' ' VAL . 33.9 Cg_endo -75.62 -25.23 11.12 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.12 1.88 . . . . 0.0 110.298 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.87 -16.15 26.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.212 -0.93 . . . . 0.0 108.843 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 37.1 p -88.66 158.18 48.43 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.433 -0.792 . . . . 0.0 109.395 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.427 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.86 -38.74 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.695 2.263 . . . . 0.0 110.744 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.599 HG23 ' N ' ' A' ' 59' ' ' VAL . 5.9 tt -66.04 -46.63 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.974 . . . . 0.0 109.235 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.785 HG22 ' HB3' ' A' ' 52' ' ' LEU . 40.3 t -56.81 -48.46 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.494 -0.753 . . . . 0.0 109.241 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -55.45 -31.42 61.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HE2' ' OE2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -74.89 -31.25 61.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.614 -0.679 . . . . 0.0 109.226 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -67.0 -42.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.401 -0.812 . . . . 0.0 108.848 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.043 HG22 HD11 ' B' ' 67' ' ' LEU . 2.1 mp -65.87 -66.64 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -46.23 -39.32 9.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 0.0 109.496 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.479 ' HG3' ' OE1' ' A' ' 64' ' ' GLU . 12.2 mttm -59.08 -50.9 72.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.209 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.45 -48.1 62.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 109.216 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.047 HD11 HG22 ' B' ' 63' ' ' ILE . 0.2 OUTLIER -47.02 -51.8 16.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.387 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.422 ' O ' ' C ' ' A' ' 69' ' ' SER . 11.7 t30 -58.46 -38.47 77.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' ASN . 4.2 p . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.448 ' O ' ' C ' ' B' ' 10' ' ' GLN . 17.4 m . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.655 ' HB3' HD11 ' B' ' 41' ' ' ILE . 45.1 mm-40 -40.52 -39.97 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.56 -0.712 . . . . 0.0 109.767 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.495 ' O ' HG23 ' B' ' 14' ' ' THR . 1.7 m -165.85 70.24 0.13 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.97 HD13 ' O ' ' B' ' 12' ' ' LEU . 1.5 tm? -44.3 -34.46 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.266 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -93.63 81.53 4.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.266 -0.897 . . . . 0.0 109.118 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.647 HG21 HD22 ' B' ' 53' ' ' ASN . 10.2 p -87.88 158.63 18.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.332 -0.855 . . . . 0.0 109.859 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.57 ' HB2' HD23 ' B' ' 52' ' ' LEU . 2.4 mt -100.18 144.26 29.41 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.464 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.9 tt0 -45.44 -25.88 0.48 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.043 -1.036 . . . . 0.0 109.063 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.532 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 154.1 171.55 21.2 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.836 HG22 HD11 ' B' ' 52' ' ' LEU . 7.7 tp -145.3 151.91 14.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.405 -1.056 . . . . 0.0 109.247 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.507 ' ND1' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -45.9 147.01 1.79 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.507 ' HD2' ' ND1' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.17 -13.94 16.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.622 2.215 . . . . 0.0 109.963 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -80.9 -16.39 53.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.972 ' O ' HD23 ' B' ' 44' ' ' LEU . 80.1 m-20 -101.31 55.64 0.84 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.448 -0.782 . . . . 0.0 108.935 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.998 HG23 ' HB1' ' B' ' 42' ' ' ALA . 1.8 mm -139.78 170.78 14.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.091 -1.005 . . . . 0.0 109.947 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.1 OUTLIER -159.99 -40.7 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.548 ' O ' HG23 ' B' ' 26' ' ' VAL . 4.8 p -131.14 -177.99 4.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 25' ' ' SER . 51.5 t -157.16 111.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.981 -1.075 . . . . 0.0 109.771 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.434 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 18.8 t-20 -94.89 124.7 39.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.882 . . . . 0.0 109.281 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 1.9 t -119.99 89.83 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.47 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.23 104.28 15.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.2 p -54.53 168.43 0.48 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.381 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 35.6 Cg_endo -77.93 133.11 12.22 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.609 2.206 . . . . 0.0 110.414 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.79 -141.04 3.8 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.66 10.35 2.58 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.541 2.16 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.499 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 3.7 p-80 -127.16 -10.26 5.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.981 -1.074 . . . . 0.0 109.855 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 1.8 t -160.3 121.37 3.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.357 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.69 44.1 1.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.588 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.446 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 5.9 pt20 -172.24 139.86 1.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.515 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 1.5 m -56.69 142.33 40.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.451 ' OE2' ' SG ' ' B' ' 35' ' ' CYS . 0.0 OUTLIER -127.53 122.59 33.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.869 HG11 HD11 ' B' ' 63' ' ' ILE . 76.9 t -114.55 151.46 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.321 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' B' ' 10' ' ' GLN . 3.3 mp -141.79 155.25 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.643 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.998 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -134.33 126.56 29.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -0.866 . . . . 0.0 109.335 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.634 HG23 ' HG3' ' B' ' 49' ' ' LYS . 52.2 m -89.9 105.96 18.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 109.089 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.972 HD23 ' O ' ' B' ' 22' ' ' ASN . 77.0 mt -41.71 164.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.467 -0.771 . . . . 0.0 109.667 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.4 ptpt -87.33 17.76 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.877 . . . . 0.0 109.865 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.477 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 1.1 p-10 -120.42 -3.54 9.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.386 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.52 -25.49 8.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.874 ' HB2' HD12 ' B' ' 44' ' ' LEU . 0.3 OUTLIER -79.31 172.95 13.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -1.186 . . . . 0.0 109.273 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.634 ' HG3' HG23 ' B' ' 43' ' ' THR . 0.0 OUTLIER -147.27 125.46 12.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.657 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.68 124.76 51.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.395 -0.816 . . . . 0.0 108.915 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.448 ' SG ' HG12 ' B' ' 41' ' ' ILE . 84.3 m -79.49 141.07 37.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.15 -0.969 . . . . 0.0 109.289 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.836 HD11 HG22 ' B' ' 18' ' ' ILE . 14.2 mt -127.89 168.16 15.59 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.418 -0.802 . . . . 0.0 109.001 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.647 HD22 HG21 ' B' ' 14' ' ' THR . 0.8 OUTLIER -106.01 132.84 20.55 Favored Pre-proline 0 C--N 1.299 -1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.205 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.463 ' HG3' HG23 ' B' ' 40' ' ' VAL . 33.7 Cg_endo -75.59 -25.22 11.18 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.09 1.86 . . . . 0.0 110.324 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.83 -16.16 26.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.274 -0.891 . . . . 0.0 108.792 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 36.9 p -88.68 158.21 48.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.478 -0.764 . . . . 0.0 109.297 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -77.88 -38.7 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.666 2.244 . . . . 0.0 110.741 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.593 HG23 ' N ' ' B' ' 59' ' ' VAL . 5.8 tt -66.05 -46.61 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.096 -1.003 . . . . 0.0 109.248 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.795 HG22 ' HB3' ' B' ' 52' ' ' LEU . 40.0 t -56.87 -48.52 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.407 -0.808 . . . . 0.0 109.174 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.5 OUTLIER -55.48 -31.29 61.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' B' ' 57' ' ' PRO . 0.1 OUTLIER -74.95 -31.23 61.44 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.583 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -67.04 -42.96 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 1.047 HG22 HD11 ' A' ' 67' ' ' LEU . 2.1 mp -65.83 -66.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.356 -0.84 . . . . 0.0 109.466 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -46.36 -39.26 10.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.942 . . . . 0.0 109.43 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.477 ' HG3' ' OE1' ' B' ' 64' ' ' GLU . 12.2 mttm -59.1 -50.88 72.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 109.269 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.44 -48.07 62.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 0.0 109.219 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.043 HD11 HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -46.97 -51.9 15.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' B' ' 69' ' ' SER . 11.8 t30 -58.42 -38.54 77.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.405 ' C ' ' O ' ' B' ' 68' ' ' ASN . 4.1 p . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 109.466 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.418 ' HA ' ' OE2' ' A' ' 39' ' ' GLU . 43.8 m . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.503 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 75.8 mm-40 -53.04 -18.48 2.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 12' ' ' LEU . 53.0 m -135.63 65.96 1.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.076 -1.015 . . . . 0.0 109.889 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -44.7 -44.86 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 108.895 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.41 119.44 34.6 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.461 HG21 HD22 ' A' ' 53' ' ' ASN . 0.5 OUTLIER -93.31 168.55 11.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.186 -0.946 . . . . 0.0 110.09 -179.385 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.519 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 6.8 mt -119.13 145.5 45.92 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.835 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -43.99 -46.63 8.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.254 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 1.011 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 151.39 -170.88 30.99 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.92 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.4 pp -164.95 162.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -1.028 . . . . 0.0 109.33 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.584 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -53.97 150.69 14.05 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.22 -0.925 . . . . 0.0 109.328 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.5 Cg_endo -77.44 -3.89 14.12 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.598 2.199 . . . . 0.0 110.29 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 3.1 pttm -90.21 -24.19 21.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.865 . . . . 0.0 109.207 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.519 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 3.1 m-20 -83.19 -7.31 59.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.385 -0.822 . . . . 0.0 109.268 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.927 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 6.8 mt -104.26 162.12 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.874 . . . . 0.0 110.1 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.566 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -135.12 -31.36 1.0 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.526 -0.734 . . . . 0.0 109.177 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.566 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.1 p -132.82 175.14 9.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 0.0 108.854 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.638 HG23 ' HG3' ' A' ' 66' ' ' MET . 46.6 t -149.69 115.77 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.045 -1.034 . . . . 0.0 109.922 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.563 ' O ' HD12 ' A' ' 41' ' ' ILE . 4.1 t-20 -111.85 110.76 21.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.147 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.849 HG22 HG13 ' A' ' 40' ' ' VAL . 3.1 t -117.12 113.65 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.709 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -105.74 114.76 29.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.251 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -55.23 167.29 0.71 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.544 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.3 Cg_endo -77.53 140.25 18.89 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.607 2.205 . . . . 0.0 110.378 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.92 -139.6 3.03 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.66 38.73 0.76 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.594 2.196 . . . . 0.0 110.903 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.493 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 3.9 p-80 -154.99 -38.73 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.031 . . . . 0.0 109.375 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.415 ' SG ' ' CD ' ' A' ' 39' ' ' GLU . 1.8 t -133.58 124.77 27.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.23 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.53 42.43 0.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.736 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.453 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -170.76 148.48 2.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.153 -0.967 . . . . 0.0 109.631 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 m -63.49 144.94 56.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.325 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 37' ' ' GLN . 0.5 OUTLIER -126.64 110.27 13.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 109.628 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.849 HG13 HG22 ' A' ' 28' ' ' VAL . 3.3 t -97.53 144.84 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.273 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.563 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.6 mt -132.4 153.08 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.58 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.927 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -137.69 120.21 16.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.174 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 2.3 m -89.23 102.69 15.35 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.973 -1.08 . . . . 0.0 108.737 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 88.6 mt -49.22 164.59 0.07 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.432 -0.792 . . . . 0.0 109.549 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -79.12 6.78 8.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 109.978 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.526 ' ND2' ' HD2' ' A' ' 48' ' ' ARG . 41.7 p30 -109.36 20.72 17.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.124 -0.985 . . . . 0.0 109.363 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.87 14.08 82.73 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HD2' ' ND2' ' A' ' 46' ' ' ASN . 1.6 mtp-105 -103.56 171.64 7.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -1.151 . . . . 0.0 109.452 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -141.9 151.19 42.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.519 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.25 123.03 8.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.294 -0.879 . . . . 0.0 109.074 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.414 ' SG ' HG12 ' A' ' 41' ' ' ILE . 15.6 m -79.77 141.1 36.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.011 HD22 ' HA2' ' A' ' 17' ' ' GLY . 12.3 mt -119.6 167.82 11.63 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.321 -0.862 . . . . 0.0 109.195 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.653 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -98.15 119.34 62.17 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.337 -0.852 . . . . 0.0 108.983 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.48 ' HB3' HG21 ' A' ' 40' ' ' VAL . 33.3 Cg_endo -75.2 -6.76 18.31 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.103 1.869 . . . . 0.0 110.327 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.75 -14.66 47.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 108.865 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -90.07 162.12 36.06 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.317 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.501 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 36.7 Cg_endo -78.29 -37.72 0.7 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.644 2.229 . . . . 0.0 110.944 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.611 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -63.26 -48.13 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.073 -1.017 . . . . 0.0 108.917 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.853 HG22 ' HB3' ' A' ' 52' ' ' LEU . 37.2 t -55.75 -48.48 77.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -51.33 -33.62 30.02 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -72.94 -36.37 67.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.549 -0.719 . . . . 0.0 109.261 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 58' ' ' ILE . 1.3 mp -57.91 -44.05 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.878 . . . . 0.0 109.051 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.117 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.1 mp -69.76 -68.95 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.874 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG2' ' HA ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -43.43 -27.82 0.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -0.957 . . . . 0.0 109.584 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.476 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 10.3 mmtt -72.49 -58.66 3.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 108.931 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.638 ' HG3' HG23 ' A' ' 26' ' ' VAL . 1.1 tmm? -44.62 -45.72 9.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 108.911 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.124 HD11 ' CG2' ' B' ' 63' ' ' ILE . 2.5 mt -55.38 -49.29 72.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 109.409 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.06 33.9 1.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.574 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 p . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.465 -179.978 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.411 ' HA ' ' OE2' ' B' ' 39' ' ' GLU . 43.1 m . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.499 ' HB2' ' CD ' ' B' ' 29' ' ' LYS . 75.9 mm-40 -53.01 -18.45 2.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.699 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' B' ' 12' ' ' LEU . 54.3 m -135.62 66.0 1.52 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 109.779 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.2 OUTLIER -44.81 -44.85 9.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.895 . . . . 0.0 108.881 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.38 119.46 34.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.473 HG21 HD22 ' B' ' 53' ' ' ASN . 0.5 OUTLIER -93.43 168.6 10.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.303 -0.873 . . . . 0.0 110.037 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.509 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 6.9 mt -119.19 145.55 45.93 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.836 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.0 OUTLIER -43.97 -46.62 8.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 109.342 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 1.012 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 151.36 -170.91 30.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.932 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.4 pp -164.86 162.96 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -1.023 . . . . 0.0 109.303 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.595 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -53.99 150.79 13.85 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 109.314 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.2 Cg_endo -77.55 -3.9 14.08 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.554 2.17 . . . . 0.0 110.251 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 3.1 pttm -90.2 -24.19 21.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 0.0 109.128 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 3.1 m-20 -83.21 -7.35 59.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.932 HD11 ' CD1' ' B' ' 18' ' ' ILE . 6.8 mt -104.13 162.1 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.566 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -135.1 -31.3 1.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.504 -0.748 . . . . 0.0 109.231 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.566 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.1 p -132.87 175.1 9.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 108.828 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.64 HG23 ' HG3' ' B' ' 66' ' ' MET . 46.4 t -149.66 115.82 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.042 -1.036 . . . . 0.0 109.919 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.568 ' O ' HD12 ' B' ' 41' ' ' ILE . 4.1 t-20 -111.84 110.79 21.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.2 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.856 HG22 HG13 ' B' ' 40' ' ' VAL . 3.1 t -117.14 113.67 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.766 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' B' ' 29' ' ' LYS . 0.4 OUTLIER -105.77 114.75 29.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.249 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.403 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.0 OUTLIER -55.18 167.38 0.69 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.87 . . . . 0.0 109.461 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.435 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.0 Cg_endo -77.54 140.16 18.79 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.606 2.204 . . . . 0.0 110.435 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.84 -139.56 3.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.74 38.76 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.587 2.191 . . . . 0.0 110.91 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.507 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 3.8 p-80 -154.95 -38.86 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.026 -1.046 . . . . 0.0 109.359 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.41 ' SG ' ' CD ' ' B' ' 39' ' ' GLU . 1.8 t -133.52 124.75 27.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.54 42.47 0.96 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.876 . . . . 0.0 109.709 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.446 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 0.0 OUTLIER -170.74 148.46 2.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.12 -0.988 . . . . 0.0 109.618 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 1.4 m -63.53 144.98 56.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.331 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.446 ' OE1' ' O ' ' B' ' 37' ' ' GLN . 0.5 OUTLIER -126.69 110.27 12.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 0.0 109.604 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.856 HG13 HG22 ' B' ' 28' ' ' VAL . 3.4 t -97.53 144.78 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.206 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.568 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.6 mt -132.41 153.08 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.586 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.931 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -137.61 120.26 16.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.208 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.527 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 2.3 m -89.28 102.63 15.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.999 -1.063 . . . . 0.0 108.709 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 88.8 mt -49.12 164.5 0.07 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.416 -0.802 . . . . 0.0 109.651 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -79.04 6.77 8.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 -179.67 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.535 ' ND2' ' HD2' ' B' ' 48' ' ' ARG . 42.0 p30 -109.4 20.7 17.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.982 . . . . 0.0 109.415 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.93 14.0 82.8 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.535 ' HD2' ' ND2' ' B' ' 46' ' ' ASN . 1.6 mtp-105 -103.51 171.66 7.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -1.173 . . . . 0.0 109.499 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -141.95 151.18 42.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 109.367 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.23 123.0 8.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 109.078 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.411 ' SG ' HG12 ' B' ' 41' ' ' ILE . 15.5 m -79.83 141.16 36.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.161 -0.962 . . . . 0.0 109.262 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 1.012 HD22 ' HA2' ' B' ' 17' ' ' GLY . 12.3 mt -119.56 167.85 11.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.161 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.644 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.0 OUTLIER -98.13 119.2 62.5 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.057 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.481 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.8 Cg_endo -75.11 -6.79 18.42 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.07 1.847 . . . . 0.0 110.317 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.77 -14.51 47.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 108.882 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -90.17 162.22 35.51 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.83 . . . . 0.0 109.293 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.502 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -78.41 -37.68 0.68 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.612 2.208 . . . . 0.0 110.852 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.62 ' O ' HD13 ' B' ' 58' ' ' ILE . 0.2 OUTLIER -63.32 -48.02 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.045 -1.034 . . . . 0.0 108.975 -179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.873 HG22 ' HB3' ' B' ' 52' ' ' LEU . 37.5 t -55.71 -48.61 77.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.504 -0.747 . . . . 0.0 109.044 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.3 OUTLIER -51.28 -33.65 29.49 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.322 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.502 ' HD2' ' O ' ' B' ' 57' ' ' PRO . 0.1 OUTLIER -72.82 -36.43 67.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.488 -0.758 . . . . 0.0 109.304 179.6 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' B' ' 58' ' ' ILE . 1.3 mp -57.89 -44.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.018 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 1.124 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.1 mp -69.85 -68.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 109.829 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -43.51 -27.78 0.31 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -0.965 . . . . 0.0 109.549 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.474 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 10.4 mmtt -72.5 -58.64 3.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 108.973 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.64 ' HG3' HG23 ' B' ' 26' ' ' VAL . 1.1 tmm? -44.66 -45.64 9.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 108.914 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.117 HD11 ' CG2' ' A' ' 63' ' ' ILE . 2.5 mt -55.44 -49.2 73.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.518 -0.739 . . . . 0.0 109.411 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.12 33.85 1.86 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.499 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.997 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 4.7 m . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -12.66 15.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.765 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' A' ' 41' ' ' ILE . 70.8 m -135.2 60.71 1.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.119 -0.988 . . . . 0.0 109.873 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.52 -38.33 6.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 108.815 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -124.87 123.05 39.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.28 173.93 7.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 110.092 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.47 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 4.6 mt -129.53 145.81 51.42 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.644 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.3 tt0 -44.94 -45.67 10.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.078 -1.014 . . . . 0.0 109.202 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 1.037 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 139.87 156.14 6.82 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.772 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -129.19 157.53 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -1.095 . . . . 0.0 109.254 179.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.605 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.95 151.92 0.39 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 109.38 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.4 Cg_endo -76.66 -1.71 11.85 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.473 2.115 . . . . 0.0 110.156 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.458 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 2.2 mtmm -90.26 -25.51 20.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.806 . . . . 0.0 109.0 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 4.6 m-20 -82.37 -5.69 58.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.417 -0.802 . . . . 0.0 109.26 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.806 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 9.3 mt -107.52 145.36 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.27 -0.894 . . . . 0.0 110.114 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.555 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -117.49 -26.48 6.63 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.555 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -139.68 162.99 33.77 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.568 HG11 HG13 ' A' ' 63' ' ' ILE . 52.8 t -146.86 99.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.945 -1.097 . . . . 0.0 109.891 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 13.0 t30 -80.07 113.43 18.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.284 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.466 ' O ' ' CE ' ' B' ' 66' ' ' MET . 1.8 t -97.17 90.53 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.51 ' HE3' ' NE2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -94.94 105.68 17.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.475 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.453 ' HA ' HG23 ' A' ' 38' ' ' THR . 0.9 OUTLIER -59.65 167.13 2.7 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 109.43 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 36.1 Cg_endo -78.11 145.85 22.28 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.527 2.151 . . . . 0.0 110.418 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.14 -142.85 3.63 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.6 10.09 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.685 2.256 . . . . 0.0 111.013 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.51 ' NE2' ' HE3' ' A' ' 29' ' ' LYS . 4.8 p-80 -126.8 -32.58 2.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.056 . . . . 0.0 109.45 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -147.31 88.74 1.73 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.207 -0.933 . . . . 0.0 109.264 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -54.07 -18.85 4.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.33 -0.856 . . . . 0.0 109.699 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.452 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 1.5 mp0 -92.84 124.78 37.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 0.0 109.516 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.509 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 2.7 m -49.5 162.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.292 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 37' ' ' GLN . 1.3 mp0 -142.78 108.98 5.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 109.663 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.092 ' CG1' HD11 ' A' ' 63' ' ' ILE . 57.3 t -100.62 95.12 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 109.147 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.478 HG13 ' SG ' ' A' ' 51' ' ' CYS . 2.6 mp -84.59 139.62 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.958 . . . . 0.0 109.831 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.806 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -121.25 118.36 29.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 109.133 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.616 HG22 ' O ' ' A' ' 43' ' ' THR . 1.1 m -89.07 97.36 11.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.972 -1.08 . . . . 0.0 108.668 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 90.8 mt -43.44 167.77 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.567 -0.708 . . . . 0.0 109.906 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.458 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.1 ptpt -81.29 7.96 10.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.841 . . . . 0.0 109.581 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.47 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.7 13.28 21.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.272 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.99 -1.6 86.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.47 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 2.1 mtt-85 -87.88 168.07 13.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -1.182 . . . . 0.0 109.392 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 2.0 mttt -134.26 155.17 50.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.913 . . . . 0.0 109.428 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.34 117.73 6.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.193 -0.942 . . . . 0.0 109.186 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.478 ' SG ' HG13 ' A' ' 41' ' ' ILE . 8.7 m -79.39 139.05 37.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.151 -0.968 . . . . 0.0 108.853 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.037 HD22 ' HA2' ' A' ' 17' ' ' GLY . 8.7 mt -121.16 167.85 12.22 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.148 -0.97 . . . . 0.0 109.588 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.677 ' O ' HG21 ' A' ' 59' ' ' VAL . 7.1 t-20 -100.47 119.25 59.33 Favored Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.401 -0.812 . . . . 0.0 109.215 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HG3' ' HB ' ' A' ' 38' ' ' THR . 32.7 Cg_endo -74.18 0.82 7.97 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.157 1.905 . . . . 0.0 110.595 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.555 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -90.54 -15.69 30.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 108.904 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -90.28 164.21 28.36 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.455 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.78 -37.94 0.78 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.687 2.258 . . . . 0.0 111.061 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.638 ' O ' HD13 ' A' ' 62' ' ' ILE . 16.0 tt -65.43 -46.87 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.991 -1.068 . . . . 0.0 109.124 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.877 HG22 ' HB3' ' A' ' 52' ' ' LEU . 34.0 t -55.37 -46.85 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.434 -0.792 . . . . 0.0 109.25 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 54' ' ' PRO . 18.1 mttt -57.74 -30.75 65.82 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.511 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -79.37 -24.81 42.41 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.511 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.6 mp -65.85 -43.59 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.092 HD11 ' CG1' ' A' ' 40' ' ' VAL . 1.6 mp -69.61 -62.94 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.547 -0.721 . . . . 0.0 109.214 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.707 ' OE2' HD13 ' B' ' 67' ' ' LEU . 1.3 mp0 -41.76 -48.5 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.793 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.54 ' CE ' ' HG3' ' A' ' 20' ' ' PRO . 2.8 mmtm -53.75 -59.27 4.83 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.372 -0.83 . . . . 0.0 109.342 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.465 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 1.4 mmm -43.52 -45.78 6.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.297 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.079 HD11 ' CG2' ' B' ' 63' ' ' ILE . 3.1 mt -55.67 -57.72 10.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.46 -0.775 . . . . 0.0 109.738 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -81.13 7.37 11.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.799 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 66' ' ' MET . 7.8 p . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 109.384 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.527 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 4.6 m . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.355 0.597 . . . . 0.0 109.393 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -12.7 14.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.709 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.467 ' SG ' HG13 ' B' ' 41' ' ' ILE . 71.0 m -135.25 60.78 1.68 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.913 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.56 -38.2 6.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.107 -0.995 . . . . 0.0 108.912 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -124.95 122.98 38.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 108.843 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.27 173.98 7.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 0.0 110.153 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.467 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 4.5 mt -129.51 145.82 51.41 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.651 ' O ' HG23 ' B' ' 59' ' ' VAL . 2.2 tt0 -44.92 -45.65 10.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.249 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 1.003 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 139.84 156.18 6.84 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.761 HD13 ' N ' ' B' ' 18' ' ' ILE . 0.2 OUTLIER -129.25 157.56 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -1.091 . . . . 0.0 109.21 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.6 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -43.0 152.01 0.39 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 0.0 109.39 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -76.75 -1.73 11.89 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.442 2.095 . . . . 0.0 110.19 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 2.2 mtmm -90.19 -25.6 20.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.273 -0.892 . . . . 0.0 108.997 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 4.7 m-20 -82.33 -5.67 58.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.413 -0.804 . . . . 0.0 109.318 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.807 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 9.3 mt -107.43 145.39 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 110.089 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.551 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -117.5 -26.46 6.63 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.269 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.551 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -139.6 163.02 33.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.567 HG11 HG13 ' B' ' 63' ' ' ILE . 52.5 t -146.86 99.38 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.081 -1.012 . . . . 0.0 109.931 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 13.2 t30 -80.01 113.43 18.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.253 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.455 ' O ' ' CE ' ' A' ' 66' ' ' MET . 1.8 t -97.15 90.48 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.515 ' HE3' ' NE2' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -94.92 105.67 17.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.548 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.447 ' HA ' HG23 ' B' ' 38' ' ' THR . 0.9 OUTLIER -59.59 167.14 2.64 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 109.422 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 36.3 Cg_endo -78.03 145.8 22.44 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.659 2.239 . . . . 0.0 110.419 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.19 -142.88 3.64 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.46 9.82 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.695 2.263 . . . . 0.0 110.983 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.515 ' NE2' ' HE3' ' B' ' 29' ' ' LYS . 4.6 p-80 -126.68 -32.44 2.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 109.42 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -147.38 88.7 1.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.213 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -54.03 -18.94 4.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.705 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.456 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 1.5 mp0 -92.67 124.62 36.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.13 -0.981 . . . . 0.0 109.596 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.494 ' HB ' ' HG3' ' B' ' 54' ' ' PRO . 2.7 m -49.47 162.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.238 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' B' ' 37' ' ' GLN . 1.3 mp0 -142.74 108.91 5.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.117 -0.989 . . . . 0.0 109.706 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 1.095 ' CG1' HD11 ' B' ' 63' ' ' ILE . 57.4 t -100.56 95.12 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.247 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.467 HG13 ' SG ' ' B' ' 11' ' ' CYS . 2.6 mp -84.57 139.63 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.892 . . . . 0.0 109.875 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.807 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -121.24 118.46 29.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.619 ' O ' HG22 ' B' ' 43' ' ' THR . 1.1 m -89.18 97.38 11.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.955 -1.091 . . . . 0.0 108.665 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 90.9 mt -43.49 167.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.61 -0.681 . . . . 0.0 109.878 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.1 ptpt -81.34 7.95 10.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.49 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -111.72 13.38 21.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.288 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.0 -1.66 86.81 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.49 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 2.1 mtt-85 -87.78 168.11 13.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -1.221 . . . . 0.0 109.436 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 2.0 mttt -134.3 155.24 50.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.467 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.37 117.75 6.06 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.348 -0.845 . . . . 0.0 109.17 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.466 ' SG ' HG13 ' B' ' 41' ' ' ILE . 8.6 m -79.45 139.02 37.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 0.0 108.852 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 1.003 HD22 ' HA2' ' B' ' 17' ' ' GLY . 8.7 mt -121.1 167.85 12.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.17 -0.956 . . . . 0.0 109.629 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.67 ' O ' HG21 ' B' ' 59' ' ' VAL . 7.1 t-20 -100.45 119.31 59.22 Favored Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 121.51 -0.744 . . . . 0.0 109.201 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.494 ' HG3' ' HB ' ' B' ' 38' ' ' THR . 32.9 Cg_endo -74.25 0.86 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.077 1.851 . . . . 0.0 110.582 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.565 ' HB3' ' OD1' ' B' ' 53' ' ' ASN . . . -90.64 -15.64 30.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 108.863 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.452 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.9 OUTLIER -90.18 164.21 28.59 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 109.498 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.77 -38.0 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.673 2.249 . . . . 0.0 111.055 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.635 ' O ' HD13 ' B' ' 62' ' ' ILE . 16.0 tt -65.4 -46.9 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.065 . . . . 0.0 109.112 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.892 HG22 ' HB3' ' B' ' 52' ' ' LEU . 33.6 t -55.41 -46.82 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.412 -0.805 . . . . 0.0 109.221 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' B' ' 54' ' ' PRO . 18.1 mttt -57.64 -30.86 65.73 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.534 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.7 OUTLIER -79.33 -24.86 42.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.515 -0.741 . . . . 0.0 109.457 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.635 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.6 mp -65.86 -43.58 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 1.095 HD11 ' CG1' ' B' ' 40' ' ' VAL . 1.6 mp -69.6 -63.02 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 109.104 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.709 ' OE2' HD13 ' A' ' 67' ' ' LEU . 1.3 mp0 -41.73 -48.48 4.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.423 -0.798 . . . . 0.0 109.826 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.531 ' CE ' ' HG3' ' B' ' 20' ' ' PRO . 2.8 mmtm -53.69 -59.42 4.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.88 . . . . 0.0 109.233 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 28' ' ' VAL . 1.4 mmm -43.44 -45.77 6.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.37 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.089 HD11 ' CG2' ' A' ' 63' ' ' ILE . 3.1 mt -55.69 -57.68 10.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.516 -0.74 . . . . 0.0 109.753 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.2 t30 -81.07 7.24 11.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 109.804 -179.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' B' ' 66' ' ' MET . 7.6 p . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.168 -0.958 . . . . 0.0 109.443 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.947 ' HB2' HD22 ' A' ' 12' ' ' LEU . 4.5 m . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.539 ' NE2' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -43.08 -26.83 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.382 -0.824 . . . . 0.0 109.578 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.469 ' SG ' HG13 ' A' ' 41' ' ' ILE . 56.4 m -127.14 65.11 1.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.48 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.947 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -43.76 -37.17 2.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.901 . . . . 0.0 109.027 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 14' ' ' THR . 15.1 pt20 -121.65 -174.98 2.99 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -160.09 151.44 19.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.143 -0.973 . . . . 0.0 109.778 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.527 HD12 ' HB1' ' A' ' 50' ' ' ALA . 7.2 mt -114.0 144.61 42.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 0.0 108.923 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.53 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.1 tt0 -44.05 -26.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 109.293 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 1.067 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 142.41 -164.03 27.04 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.835 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -170.37 162.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.376 -1.073 . . . . 0.0 109.534 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.631 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 3.3 t60 -44.84 146.61 1.29 Allowed Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.631 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.6 Cg_endo -79.1 -17.01 12.11 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.366 2.044 . . . . 0.0 109.524 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 7.7 mmtm -90.4 -19.35 24.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 16.7 m-20 -78.2 -14.62 59.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -0.841 . . . . 0.0 109.033 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.948 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 11.0 mt -91.66 168.05 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.513 -0.742 . . . . 0.0 110.1 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.583 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -135.59 -40.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.459 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 6.4 p -123.58 172.57 8.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.532 ' CG1' HG13 ' A' ' 63' ' ' ILE . 97.3 t -144.25 88.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.741 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 4.0 t-20 -84.77 108.41 17.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.36 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.884 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -108.6 91.77 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 109.439 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HD2' ' NE2' ' A' ' 10' ' ' GLN . 0.7 OUTLIER -92.39 128.15 38.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.857 . . . . 0.0 109.521 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.439 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -76.91 171.62 11.9 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.513 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 36.1 Cg_endo -78.03 132.4 11.62 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.606 2.204 . . . . 0.0 110.465 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.46 -144.23 5.0 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.85 11.94 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.711 2.274 . . . . 0.0 111.041 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.483 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 5.9 p-80 -128.99 -33.5 1.98 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.558 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -129.42 116.99 19.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.3 45.8 1.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.513 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -173.09 141.07 0.93 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 m -58.24 153.51 15.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 15.4 pt-20 -142.12 107.9 5.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.572 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.007 HG11 HD11 ' A' ' 63' ' ' ILE . 55.5 t -90.77 153.45 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.374 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' A' ' 27' ' ' ASN . 3.6 mt -140.67 144.68 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.626 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.948 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -131.71 119.95 22.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.119 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 7.9 m -89.45 97.98 11.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.996 -1.065 . . . . 0.0 109.09 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 85.4 mt -43.75 163.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.448 -0.783 . . . . 0.0 109.736 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -80.05 9.12 5.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 109.931 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.58 27.52 9.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.217 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.3 9.42 72.68 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.512 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 3.4 mtt180 -99.6 163.21 12.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.207 -1.172 . . . . 0.0 109.53 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -137.68 151.83 48.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.339 -0.851 . . . . 0.0 109.257 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.527 ' HB1' HD12 ' A' ' 15' ' ' LEU . . . -150.15 127.99 11.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.6 m -79.6 151.83 30.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.055 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.067 HD22 ' HA2' ' A' ' 17' ' ' GLY . 19.3 mt -127.07 166.72 17.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.315 -0.866 . . . . 0.0 109.326 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.629 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.1 t-20 -93.53 115.87 65.67 Favored Pre-proline 0 C--N 1.299 -1.594 0 O-C-N 121.404 -0.81 . . . . 0.0 109.079 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.54 -1.21 10.75 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.106 1.871 . . . . 0.0 110.413 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.2 -12.12 36.28 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.367 -0.833 . . . . 0.0 108.835 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -90.13 160.91 39.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.443 -0.786 . . . . 0.0 109.428 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.511 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 35.6 Cg_endo -77.5 -31.16 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.661 2.241 . . . . 0.0 110.547 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 59' ' ' VAL . 4.1 tt -72.35 -45.16 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.083 -1.011 . . . . 0.0 109.288 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.045 ' HA ' HD12 ' A' ' 62' ' ' ILE . 19.7 t -56.96 -48.53 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.511 -0.743 . . . . 0.0 109.294 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -61.09 -32.06 71.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.186 -0.946 . . . . 0.0 108.552 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.545 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -77.41 -19.14 56.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.528 -0.733 . . . . 0.0 109.161 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.045 HD12 ' HA ' ' A' ' 59' ' ' VAL . 16.2 mt -75.16 -38.84 42.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.007 HD11 HG11 ' A' ' 40' ' ' VAL . 1.9 mp -72.68 -55.98 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.908 . . . . 0.0 109.069 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.532 ' CG ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -58.79 -38.39 78.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.283 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 61' ' ' LYS . 8.2 tttp -59.57 -40.94 89.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -0.874 . . . . 0.0 109.173 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.523 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -61.47 -46.55 89.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.45 -0.782 . . . . 0.0 109.211 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.606 ' CD1' HG22 ' B' ' 63' ' ' ILE . 0.2 OUTLIER -44.11 -51.65 7.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.835 . . . . 0.0 109.395 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.67 -30.32 66.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 0.0 109.623 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.448 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.497 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.923 ' HB2' HD22 ' B' ' 12' ' ' LEU . 4.5 m . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.539 ' NE2' ' HD2' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -43.0 -26.79 0.15 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.402 -0.811 . . . . 0.0 109.586 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' B' ' 41' ' ' ILE . 56.3 m -127.18 65.02 1.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.275 -0.89 . . . . 0.0 109.447 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.923 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -43.75 -37.11 2.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.019 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . 0.499 ' O ' HG23 ' B' ' 14' ' ' THR . 15.0 pt20 -121.67 -174.97 2.99 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.379 -0.826 . . . . 0.0 108.843 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.678 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -160.1 151.45 19.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.073 -1.017 . . . . 0.0 109.789 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.536 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.2 mt -114.05 144.63 42.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.436 -0.79 . . . . 0.0 108.874 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.524 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.1 tt0 -44.03 -26.8 0.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.353 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 1.028 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 142.46 -163.95 27.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.837 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -170.42 162.66 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.419 -1.048 . . . . 0.0 109.451 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.624 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 3.4 t60 -44.95 146.67 1.3 Allowed Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.624 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -79.15 -16.98 12.06 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.327 2.018 . . . . 0.0 109.452 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 7.7 mmtm -90.42 -19.38 23.99 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 16.7 m-20 -78.25 -14.57 59.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.845 . . . . 0.0 109.002 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.946 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 10.9 mt -91.68 168.01 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 110.129 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.593 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.1 OUTLIER -135.55 -40.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.459 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 6.4 p -123.54 172.51 8.7 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.533 ' CG1' HG13 ' B' ' 63' ' ' ILE . 97.2 t -144.23 88.1 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.719 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.499 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.0 t-20 -84.77 108.36 17.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.393 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.872 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -108.58 91.85 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.539 ' HD2' ' NE2' ' B' ' 10' ' ' GLN . 0.7 OUTLIER -92.51 128.1 38.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.925 . . . . 0.0 109.463 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.443 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -76.8 171.59 11.93 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 109.466 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.509 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.0 Cg_endo -78.02 132.44 11.66 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.658 2.239 . . . . 0.0 110.391 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.54 -144.23 5.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.95 12.01 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.693 2.262 . . . . 0.0 111.051 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.479 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 5.8 p-80 -129.0 -33.46 1.98 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 109.614 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -129.4 116.95 19.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.31 45.92 1.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.512 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.509 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -173.19 141.01 0.91 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 2.2 m -58.14 153.55 14.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.871 . . . . 0.0 109.503 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.457 ' HB2' ' SG ' ' B' ' 11' ' ' CYS . 15.3 pt-20 -142.19 107.92 5.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 1.044 HG11 HD11 ' B' ' 63' ' ' ILE . 55.7 t -90.85 153.36 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 0.0 109.34 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' B' ' 27' ' ' ASN . 3.6 mt -140.54 144.77 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 109.646 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.946 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -131.77 119.92 21.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.869 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 7.9 m -89.41 97.92 11.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.015 -1.053 . . . . 0.0 109.095 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 85.5 mt -43.77 163.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.343 -0.848 . . . . 0.0 109.738 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -80.0 9.01 5.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.354 -0.841 . . . . 0.0 109.857 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.46 27.43 9.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 0.0 109.215 179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.33 9.43 72.81 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.513 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 3.4 mtt180 -99.56 163.2 12.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -1.174 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.529 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.2 OUTLIER -137.7 151.89 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.219 179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.536 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.23 127.98 11.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.288 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.58 151.86 30.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 109.077 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 1.028 HD22 ' HA2' ' B' ' 17' ' ' GLY . 19.3 mt -127.15 166.65 17.27 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.275 -0.891 . . . . 0.0 109.326 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.636 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.2 t-20 -93.43 115.91 65.72 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 109.106 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.54 -1.24 10.79 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.11 1.873 . . . . 0.0 110.401 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.13 -12.18 36.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 108.867 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 1.0 OUTLIER -90.11 160.94 39.23 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.415 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.505 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.1 Cg_endo -77.42 -31.27 3.56 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.584 2.189 . . . . 0.0 110.588 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.606 HG23 ' N ' ' B' ' 59' ' ' VAL . 4.1 tt -72.28 -45.16 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.032 -1.043 . . . . 0.0 109.37 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 1.0 ' HA ' HD12 ' B' ' 62' ' ' ILE . 19.6 t -56.88 -48.58 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.435 -0.791 . . . . 0.0 109.3 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -61.14 -31.99 71.7 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.147 -0.97 . . . . 0.0 108.536 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -77.51 -19.1 56.35 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 1.0 HD12 ' HA ' ' B' ' 59' ' ' VAL . 16.3 mt -75.23 -38.74 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 1.044 HD11 HG11 ' B' ' 40' ' ' VAL . 1.9 mp -72.75 -56.04 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 108.975 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.533 ' CG ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -58.77 -38.42 78.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.3 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' B' ' 61' ' ' LYS . 8.2 tttp -59.45 -41.07 88.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.157 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.53 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -61.37 -46.6 89.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 109.22 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.606 ' CD1' HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -44.0 -51.73 7.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.451 -0.781 . . . . 0.0 109.396 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.64 -30.33 66.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.352 -0.842 . . . . 0.0 109.571 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.457 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 89.0 m . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.552 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -47.98 -22.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.753 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.421 ' O ' ' C ' ' A' ' 12' ' ' LEU . 63.0 m -126.45 65.2 1.25 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.9 . . . . 0.0 109.872 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -44.59 -43.74 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 108.866 179.459 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -122.97 124.86 44.12 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -96.44 167.36 11.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 0.0 110.014 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.542 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.5 mt -118.92 146.27 45.08 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.617 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -44.21 -41.28 5.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.281 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.991 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 147.51 -164.33 28.75 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.952 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -171.11 163.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -1.041 . . . . 0.0 109.197 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.584 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -54.64 149.57 21.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.371 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -77.23 -4.11 14.43 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.502 2.135 . . . . 0.0 110.213 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.486 ' HG2' ' HB3' ' A' ' 19' ' ' HIS . 8.4 pttt -90.29 -24.03 21.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.118 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.521 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 2.6 m-20 -82.92 -5.5 59.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.282 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.952 HD11 ' CD1' ' A' ' 18' ' ' ILE . 9.2 mt -105.99 145.96 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -119.13 -25.42 6.18 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.553 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -143.0 -179.51 6.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 109.122 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 25' ' ' SER . 47.0 t -156.76 155.6 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.994 -1.066 . . . . 0.0 109.911 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . 2.6 t-20 -138.71 114.14 9.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.405 -0.809 . . . . 0.0 109.266 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.47 108.47 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.471 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.552 ' CD ' ' HB2' ' A' ' 10' ' ' GLN . 4.2 ptmm? -113.39 108.33 17.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.893 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.414 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.0 OUTLIER -59.83 163.94 6.66 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.377 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.51 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.8 Cg_endo -77.58 152.39 29.59 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.628 2.219 . . . . 0.0 110.336 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.25 -137.06 2.12 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.516 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 35.9 Cg_endo -77.56 8.17 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.515 2.144 . . . . 0.0 110.758 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.516 ' CE1' ' HD2' ' A' ' 33' ' ' PRO . 2.5 p-80 -125.6 -24.34 3.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.023 -1.048 . . . . 0.0 109.733 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.51 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 1.8 t -160.06 107.31 1.63 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.049 -1.032 . . . . 0.0 109.305 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.7 -5.59 26.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.895 . . . . 0.0 109.69 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.445 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 2.2 mp0 -109.17 124.74 51.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.521 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.414 HG23 ' HA ' ' A' ' 30' ' ' SER . 1.7 m -48.26 158.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.293 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.515 ' HG3' ' NZ ' ' A' ' 29' ' ' LYS . 25.7 mm-40 -139.93 107.36 5.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.65 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.715 HG11 HD11 ' A' ' 63' ' ' ILE . 10.3 t -92.52 151.99 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 109.179 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 3.2 mt -140.19 156.13 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.113 -0.992 . . . . 0.0 109.883 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.759 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -142.65 117.87 10.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 109.015 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 43' ' ' THR . 1.2 m -89.11 96.03 10.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.982 -1.074 . . . . 0.0 108.736 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 89.6 mt -42.32 165.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.586 -0.696 . . . . 0.0 109.891 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -79.52 7.22 8.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.842 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.41 24.0 13.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.139 -0.976 . . . . 0.0 109.22 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.36 -0.11 65.01 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.516 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 72.5 mtt85 -88.57 162.27 16.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -1.195 . . . . 0.0 109.397 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.4 mptt -135.55 151.23 50.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.167 -0.958 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.542 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.25 123.43 8.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.349 -0.844 . . . . 0.0 109.05 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 10.0 m -79.59 142.54 35.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.057 -1.027 . . . . 0.0 109.079 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.133 HD13 HD13 ' A' ' 62' ' ' ILE . 14.3 mt -120.43 167.74 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.243 -0.911 . . . . 0.0 109.62 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.673 ' O ' HG21 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -99.57 122.62 50.86 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.484 -0.76 . . . . 0.0 109.047 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.455 ' O ' ' HE2' ' A' ' 60' ' ' LYS . 33.2 Cg_endo -75.11 -3.53 14.06 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.079 1.852 . . . . 0.0 110.354 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.59 -12.4 42.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.913 . . . . 0.0 108.919 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -89.98 163.09 33.45 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.438 -0.789 . . . . 0.0 109.394 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.68 -38.98 0.57 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.696 2.264 . . . . 0.0 110.784 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.589 HG23 ' N ' ' A' ' 59' ' ' VAL . 20.6 tt -65.16 -45.92 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.346 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.052 ' HA ' HD12 ' A' ' 62' ' ' ILE . 44.7 t -57.42 -45.6 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -0.82 . . . . 0.0 109.333 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 56' ' ' SER . 7.4 mttt -59.68 -29.53 68.14 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 7.0 mmmm -79.53 -23.61 42.75 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.133 HD13 HD13 ' A' ' 52' ' ' LEU . 29.2 mt -72.1 -36.63 57.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.54 -0.725 . . . . 0.0 109.303 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.715 HD11 HG11 ' A' ' 40' ' ' VAL . 2.2 mp -75.87 -51.14 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.752 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.482 ' OE2' ' HE3' ' A' ' 61' ' ' LYS . 9.4 pt-20 -65.8 -29.0 69.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.035 -1.04 . . . . 0.0 109.347 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 4.4 mmtt -69.47 -46.11 67.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.871 . . . . 0.0 108.994 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.409 ' O ' ' C ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -56.12 -45.29 79.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.438 -0.789 . . . . 0.0 109.076 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.591 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.62 -51.85 8.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.421 -0.8 . . . . 0.0 109.478 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 69' ' ' SER . 6.8 t-20 -64.86 -37.29 87.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.403 -0.81 . . . . 0.0 109.476 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ASN . 1.1 p . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 89.0 m . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.539 ' HB2' ' CD ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -48.03 -22.78 0.66 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.742 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' B' ' 12' ' ' LEU . 63.3 m -126.42 65.22 1.24 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.825 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.2 OUTLIER -44.63 -43.79 8.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 108.818 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -122.86 124.88 44.28 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.477 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -96.45 167.43 11.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.236 -0.915 . . . . 0.0 109.968 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.529 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.5 mt -119.04 146.21 45.24 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.597 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.2 OUTLIER -44.08 -41.31 5.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.372 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 1.024 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 147.53 -164.21 28.75 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.975 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -171.19 163.64 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.473 -1.016 . . . . 0.0 109.166 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.59 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -54.54 149.58 20.63 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.183 -0.948 . . . . 0.0 109.326 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.0 Cg_endo -77.22 -4.15 14.47 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.489 2.126 . . . . 0.0 110.257 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' B' ' 19' ' ' HIS . 8.4 pttt -90.26 -24.05 21.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.352 -0.843 . . . . 0.0 109.136 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 2.5 m-20 -82.92 -5.43 59.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 109.259 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.975 HD11 ' CD1' ' B' ' 18' ' ' ILE . 9.1 mt -105.98 145.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.55 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -119.12 -25.44 6.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.55 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -142.98 -179.45 6.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.431 -0.793 . . . . 0.0 108.98 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 25' ' ' SER . 46.9 t -156.79 155.61 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.101 -0.999 . . . . 0.0 109.901 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' B' ' 41' ' ' ILE . 2.5 t-20 -138.72 114.23 9.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.364 -0.835 . . . . 0.0 109.21 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.58 108.52 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.473 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.539 ' CD ' ' HB2' ' B' ' 10' ' ' GLN . 4.2 ptmm? -113.38 108.35 17.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.433 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.402 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.0 OUTLIER -59.8 163.92 6.63 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.521 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.6 Cg_endo -77.64 152.45 29.42 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.56 2.173 . . . . 0.0 110.357 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.24 -136.97 2.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.519 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -77.58 8.01 3.56 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.536 2.157 . . . . 0.0 110.79 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.519 ' CE1' ' HD2' ' B' ' 33' ' ' PRO . 2.4 p-80 -125.53 -24.25 3.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.983 . . . . 0.0 109.734 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.521 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 1.8 t -160.13 107.39 1.62 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.963 . . . . 0.0 109.249 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.7 -5.67 26.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.29 -0.881 . . . . 0.0 109.717 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.45 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 2.2 mp0 -109.1 124.8 51.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.154 -0.967 . . . . 0.0 109.527 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.424 ' O ' ' CD ' ' B' ' 39' ' ' GLU . 1.7 m -48.33 158.38 0.27 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.938 . . . . 0.0 109.282 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.513 ' HG3' ' NZ ' ' B' ' 29' ' ' LYS . 25.7 mm-40 -139.92 107.32 5.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 109.716 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.721 HG11 HD11 ' B' ' 63' ' ' ILE . 10.5 t -92.56 151.95 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.18 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' B' ' 51' ' ' CYS . 3.2 mt -140.25 156.22 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.78 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.759 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -142.6 117.98 10.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 109.047 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.61 HG22 ' O ' ' B' ' 43' ' ' THR . 1.2 m -89.19 96.05 10.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.875 -1.141 . . . . 0.0 108.729 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.4 mt -42.27 165.71 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.614 -0.679 . . . . 0.0 109.917 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -79.63 7.23 8.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.452 -0.78 . . . . 0.0 109.804 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.49 24.06 12.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.249 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.31 0.06 65.33 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.512 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 72.3 mtt85 -88.67 162.22 16.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -1.157 . . . . 0.0 109.33 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.523 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 1.4 mptt -135.53 151.35 50.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.89 . . . . 0.0 109.39 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.529 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.29 123.37 8.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.254 -0.904 . . . . 0.0 109.143 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' B' ' 41' ' ' ILE . 10.1 m -79.54 142.59 35.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 109.091 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 1.067 HD13 HD13 ' B' ' 62' ' ' ILE . 14.4 mt -120.45 167.72 12.07 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.561 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.674 ' O ' HG21 ' B' ' 59' ' ' VAL . 0.9 OUTLIER -99.55 122.5 51.28 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.453 -0.779 . . . . 0.0 109.108 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.441 ' O ' ' HE2' ' B' ' 60' ' ' LYS . 33.4 Cg_endo -75.0 -3.6 14.16 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.185 1.923 . . . . 0.0 110.385 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.59 -12.24 43.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 108.993 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.4 OUTLIER -90.06 163.06 33.37 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 109.382 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.63 -39.04 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.636 2.224 . . . . 0.0 110.746 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.6 HG23 ' N ' ' B' ' 59' ' ' VAL . 20.6 tt -65.2 -45.87 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 1.056 ' HA ' HD12 ' B' ' 62' ' ' ILE . 44.2 t -57.48 -45.65 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.847 . . . . 0.0 109.304 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' B' ' 56' ' ' SER . 7.4 mttt -59.57 -29.57 68.03 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' B' ' 65' ' ' LYS . 7.0 mmmm -79.5 -23.66 42.8 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 1.067 HD13 HD13 ' B' ' 52' ' ' LEU . 29.4 mt -72.08 -36.6 57.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.57 -0.706 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.721 HD11 HG11 ' B' ' 40' ' ' VAL . 2.2 mp -75.86 -51.13 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.797 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.48 ' OE2' ' HE3' ' B' ' 61' ' ' LYS . 9.4 pt-20 -65.81 -29.0 69.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.023 -1.048 . . . . 0.0 109.303 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 4.4 mmtt -69.42 -46.19 67.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 108.943 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.442 ' SD ' ' OG ' ' B' ' 69' ' ' SER . 0.3 OUTLIER -56.13 -45.22 79.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.379 -0.826 . . . . 0.0 109.051 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.73 -51.85 8.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.423 -0.798 . . . . 0.0 109.418 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' B' ' 69' ' ' SER . 6.9 t-20 -64.84 -37.25 87.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.486 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.442 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.1 p . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.453 -179.986 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.885 ' HB2' HD22 ' A' ' 12' ' ' LEU . 8.7 m . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.538 ' HG3' ' CD ' ' A' ' 29' ' ' LYS . 13.8 mm100 -43.78 -24.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.827 . . . . 0.0 110.015 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.472 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 66.4 m -139.83 77.9 1.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.026 -1.047 . . . . 0.0 109.974 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.885 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -50.51 -43.95 55.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 108.89 179.498 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.53 121.81 41.98 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.49 170.49 8.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.144 -0.972 . . . . 0.0 110.009 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.975 HD12 ' O ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -127.54 148.84 50.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.803 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.6 tt0 -44.43 -54.69 5.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 1.039 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 149.04 168.53 14.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.848 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -136.34 161.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -1.097 . . . . 0.0 109.374 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.619 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -43.26 147.74 0.7 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.795 . . . . 0.0 109.048 179.533 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.619 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 33.6 Cg_endo -75.59 -3.01 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.213 1.942 . . . . 0.0 110.009 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.44 -25.22 20.46 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.367 -0.833 . . . . 0.0 108.909 179.26 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 5.2 m-20 -81.92 -4.88 57.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.435 -0.79 . . . . 0.0 109.334 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.61 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 13.6 mt -107.0 149.6 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 0.0 110.294 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.571 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -120.93 -28.1 4.87 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.248 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.571 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -135.93 169.17 18.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.105 179.323 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 25' ' ' SER . 48.9 t -156.66 126.27 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.718 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 55.5 t30 -108.49 157.93 18.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.339 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.07 95.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.493 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.538 ' CD ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -100.54 126.99 47.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.577 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.492 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.2 p -75.85 160.99 77.54 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.346 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.496 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.2 Cg_endo -77.15 145.61 24.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.509 2.14 . . . . 0.0 110.425 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.39 -133.64 1.55 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.97 41.46 1.12 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.719 2.279 . . . . 0.0 110.781 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.455 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 9.1 p-80 -162.11 -38.01 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.073 -1.017 . . . . 0.0 109.28 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 2.7 t -145.71 101.18 3.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.176 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.17 -12.46 20.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.725 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.459 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 1.9 mp0 -106.92 129.39 54.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.526 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.492 HG23 ' HA ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -48.49 162.82 0.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.192 -0.942 . . . . 0.0 109.292 179.887 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' A' ' 11' ' ' CYS . 2.6 mp0 -136.95 114.44 11.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.643 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.844 HG11 HD11 ' A' ' 63' ' ' ILE . 19.5 t -104.86 144.57 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.16 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 2.6 mp -133.34 152.35 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.61 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -137.6 116.49 12.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.866 . . . . 0.0 109.173 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.534 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.8 m -89.12 97.51 11.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.956 -1.09 . . . . 0.0 108.785 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 93.1 mt -44.72 166.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.522 -0.736 . . . . 0.0 109.6 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.2 ptpt -81.61 8.46 9.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.28 19.92 17.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.204 179.742 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 4.54 89.6 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.516 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 5.8 mtt180 -94.55 168.39 10.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -1.194 . . . . 0.0 109.508 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.93 156.72 48.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 179.808 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.4 120.03 7.0 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.308 -0.87 . . . . 0.0 109.098 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.975 ' O ' HD12 ' A' ' 15' ' ' LEU . 8.0 m -79.74 139.08 37.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.077 -1.014 . . . . 0.0 108.948 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.039 HD22 ' HA2' ' A' ' 17' ' ' GLY . 10.4 mt -123.39 168.32 12.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.204 -0.935 . . . . 0.0 109.68 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.615 ' O ' HG21 ' A' ' 59' ' ' VAL . 28.9 t-20 -101.65 119.89 55.94 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.5 -0.75 . . . . 0.0 109.334 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.444 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 33.6 Cg_endo -74.84 1.39 7.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.127 1.885 . . . . 0.0 110.542 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.53 -17.36 30.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.219 -0.926 . . . . 0.0 108.964 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -90.16 164.06 29.26 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 109.456 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.29 -33.31 1.98 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.731 2.287 . . . . 0.0 110.671 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.615 ' O ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -67.26 -48.33 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.104 -0.998 . . . . 0.0 108.99 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.852 HG22 ' HB3' ' A' ' 52' ' ' LEU . 33.7 t -57.38 -48.73 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 108.983 179.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 56' ' ' SER . 4.9 mmmt -53.6 -32.2 50.15 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.535 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 3.1 mmpt? -73.64 -34.03 64.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.505 -0.747 . . . . 0.0 109.193 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.615 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.5 mp -59.9 -44.68 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.807 . . . . 0.0 108.921 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.904 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -66.66 -62.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -0.869 . . . . 0.0 109.897 -179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 60' ' ' LYS . 5.6 pt-20 -58.35 -15.81 12.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.992 -1.067 . . . . 0.0 109.517 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 7.8 mmtt -83.32 -36.18 24.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 108.795 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.464 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -68.99 -44.83 72.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.402 -0.811 . . . . 0.0 108.946 179.429 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.908 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -43.63 -50.74 7.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.328 179.68 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -72.84 -36.74 67.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.464 ' OG ' ' HA ' ' A' ' 66' ' ' MET . 25.2 p . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.452 179.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.928 ' HB2' HD22 ' B' ' 12' ' ' LEU . 8.8 m . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.532 ' HG3' ' CD ' ' B' ' 29' ' ' LYS . 13.8 mm100 -43.78 -24.92 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.336 -0.853 . . . . 0.0 109.998 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.469 ' HB2' ' HG3' ' B' ' 39' ' ' GLU . 66.3 m -139.8 77.97 1.64 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.072 -1.018 . . . . 0.0 109.986 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.928 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -50.53 -43.85 56.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 108.922 179.474 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.57 121.83 42.01 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.49 170.53 8.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 110.053 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.985 HD12 ' O ' ' B' ' 51' ' ' CYS . 0.3 OUTLIER -127.61 148.74 50.37 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.754 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.784 ' O ' HG23 ' B' ' 59' ' ' VAL . 2.6 tt0 -44.36 -54.74 5.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.97 . . . . 0.0 109.451 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 1.041 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 149.1 168.59 14.88 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.829 HD13 ' N ' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -136.39 161.65 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -1.072 . . . . 0.0 109.359 179.746 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.607 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.5 OUTLIER -43.34 147.85 0.71 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.394 -0.816 . . . . 0.0 109.005 179.561 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.607 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 33.1 Cg_endo -75.61 -3.08 13.39 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.264 1.976 . . . . 0.0 109.941 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.49 -25.26 20.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.825 . . . . 0.0 108.807 179.383 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.53 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 5.3 m-20 -81.77 -4.96 57.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.444 -0.785 . . . . 0.0 109.398 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.605 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 13.7 mt -107.05 149.62 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 110.213 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.576 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -120.92 -28.03 4.88 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.267 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.576 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -136.05 169.1 18.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.33 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 25' ' ' SER . 48.7 t -156.56 126.27 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 109.752 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 55.6 t30 -108.47 157.99 17.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.329 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.13 95.42 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.532 ' CD ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -100.51 127.03 46.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.591 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.478 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.2 p -75.87 160.99 77.47 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.332 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.495 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.4 Cg_endo -77.11 145.55 24.67 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.575 2.183 . . . . 0.0 110.456 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.4 -133.63 1.54 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.0 41.53 1.14 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.595 2.197 . . . . 0.0 110.807 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.46 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 9.0 p-80 -162.09 -38.05 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.046 . . . . 0.0 109.269 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.495 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 2.7 t -145.7 101.31 3.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 0.0 109.131 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.28 -12.39 20.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.903 . . . . 0.0 109.737 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 1.9 mp0 -106.89 129.36 54.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -0.942 . . . . 0.0 109.503 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.478 HG23 ' HA ' ' B' ' 30' ' ' SER . 0.6 OUTLIER -48.44 162.83 0.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 109.227 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' B' ' 11' ' ' CYS . 2.6 mp0 -136.94 114.42 10.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.687 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.809 HG11 HD11 ' B' ' 63' ' ' ILE . 19.1 t -104.85 144.47 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.851 . . . . 0.0 109.184 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 2.6 mp -133.24 152.37 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.81 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.605 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -137.62 116.43 12.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -0.888 . . . . 0.0 109.179 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.532 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 1.8 m -89.11 97.52 11.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.922 -1.111 . . . . 0.0 108.737 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 93.1 mt -44.62 166.75 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.556 -0.715 . . . . 0.0 109.628 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.2 ptpt -81.6 8.5 9.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.632 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -111.3 19.87 17.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.96 . . . . 0.0 109.228 179.71 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 4.59 89.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 5.8 mtt180 -94.59 168.35 10.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.162 -1.199 . . . . 0.0 109.55 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.89 156.74 48.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.82 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.39 120.08 7.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.335 -0.853 . . . . 0.0 109.052 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.985 ' O ' HD12 ' B' ' 15' ' ' LEU . 8.0 m -79.74 139.11 37.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 108.972 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 1.041 HD22 ' HA2' ' B' ' 17' ' ' GLY . 10.5 mt -123.47 168.36 12.67 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.149 -0.97 . . . . 0.0 109.67 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.611 ' O ' HG21 ' B' ' 59' ' ' VAL . 29.1 t-20 -101.68 119.89 55.89 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 109.332 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.449 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.2 Cg_endo -74.84 1.3 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.183 1.922 . . . . 0.0 110.518 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.48 -17.31 30.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.912 . . . . 0.0 108.977 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.4 OUTLIER -90.2 164.01 29.3 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.82 . . . . 0.0 109.383 179.915 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.32 -33.22 1.99 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.624 2.216 . . . . 0.0 110.694 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.608 ' O ' HD13 ' B' ' 62' ' ' ILE . 0.2 OUTLIER -67.21 -48.33 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.105 -0.997 . . . . 0.0 108.995 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.859 HG22 ' HB3' ' B' ' 52' ' ' LEU . 33.8 t -57.42 -48.72 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.414 -0.804 . . . . 0.0 108.981 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' B' ' 56' ' ' SER . 4.9 mmmt -53.63 -32.19 50.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.539 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 3.1 mmpt? -73.57 -34.19 65.01 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.608 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.5 mp -59.74 -44.79 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 108.955 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.908 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -66.72 -62.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 109.876 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.473 ' OE2' ' HA ' ' B' ' 61' ' ' LYS . 5.6 pt-20 -58.28 -15.85 11.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.99 . . . . 0.0 109.576 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 7.7 mmtt -83.29 -36.21 24.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 108.791 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.47 ' HA ' ' OG ' ' B' ' 69' ' ' SER . 0.2 OUTLIER -69.0 -44.79 72.1 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.484 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.904 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -43.68 -50.67 7.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.381 -0.824 . . . . 0.0 109.373 179.701 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -72.81 -36.73 67.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.884 . . . . 0.0 109.482 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' B' ' 66' ' ' MET . 25.6 p . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.381 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.44 ' HB3' ' OE2' ' A' ' 39' ' ' GLU . 58.4 m . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.537 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 22.1 mm100 -62.5 -10.01 10.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.891 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.462 ' SG ' ' HG2' ' A' ' 39' ' ' GLU . 39.7 m -138.83 67.93 1.39 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.005 -1.06 . . . . 0.0 109.851 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -45.13 -45.63 11.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.147 -0.97 . . . . 0.0 108.998 179.54 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.426 ' OE1' ' N ' ' A' ' 14' ' ' THR . 0.5 OUTLIER -118.14 116.9 27.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.463 -0.773 . . . . 0.0 108.95 179.541 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.426 ' N ' ' OE1' ' A' ' 13' ' ' GLN . 0.6 OUTLIER -90.24 171.08 9.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 110.048 -179.442 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 51' ' ' CYS . 1.0 OUTLIER -119.81 143.66 47.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.478 -0.763 . . . . 0.0 109.09 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.524 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -44.65 -38.27 4.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.084 -1.01 . . . . 0.0 109.287 -179.909 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 1.074 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 138.26 156.51 7.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.805 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -125.8 156.11 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -1.082 . . . . 0.0 109.332 179.592 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.616 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.94 153.99 0.31 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.852 . . . . 0.0 109.298 179.82 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.616 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.1 Cg_endo -76.27 -5.03 15.81 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.417 2.078 . . . . 0.0 109.943 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -81.73 -22.28 37.42 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.047 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.906 ' O ' HD23 ' A' ' 44' ' ' LEU . 35.4 m-20 -98.58 60.03 1.3 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.895 HD13 ' O ' ' A' ' 22' ' ' ASN . 2.6 mm -143.78 167.5 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.937 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.754 ' HG2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -160.18 -35.15 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.566 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.5 p -133.51 176.72 8.29 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.173 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.507 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 54.6 t -151.29 92.11 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.976 -1.078 . . . . 0.0 109.868 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.493 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 5.1 t-20 -94.03 110.63 22.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.219 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.581 HG13 HG22 ' A' ' 40' ' ' VAL . 1.9 t -121.77 100.15 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.584 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.537 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 9.6 ptpt -98.09 106.67 19.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.352 -0.843 . . . . 0.0 109.363 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.591 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.1 p -45.87 170.54 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.398 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 35.6 Cg_endo -77.89 132.28 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.568 2.179 . . . . 0.0 110.407 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.33 -142.7 4.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.21 8.12 3.38 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.584 2.189 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.451 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 6.6 p-80 -124.44 -18.75 5.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 109.73 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -160.22 96.62 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 109.255 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -55.17 -29.16 57.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.55 125.33 35.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.591 HG23 ' HA ' ' A' ' 30' ' ' SER . 32.5 m -46.43 152.75 0.41 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -129.31 121.67 27.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.65 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.687 HG11 HD11 ' A' ' 63' ' ' ILE . 16.2 t -108.14 150.34 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.22 179.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 27' ' ' ASN . 14.4 mt -143.15 143.12 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.015 . . . . 0.0 109.846 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.684 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -130.99 123.02 27.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 108.932 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.754 HG22 ' HG2' ' A' ' 24' ' ' GLN . 40.5 m -89.39 103.26 15.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.967 -1.083 . . . . 0.0 109.097 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.906 HD23 ' O ' ' A' ' 22' ' ' ASN . 73.1 mt -42.48 165.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.502 -0.749 . . . . 0.0 109.59 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.4 ptpt -87.27 16.44 5.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 44' ' ' LEU . 19.0 p-10 -117.27 6.02 12.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 109.399 179.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.53 14.46 44.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.674 ' HB2' HD12 ' A' ' 44' ' ' LEU . 9.8 mtp180 -111.32 174.23 5.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -1.203 . . . . 0.0 109.553 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.434 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 6.8 mttt -138.26 156.69 47.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.25 120.48 7.29 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.331 -0.855 . . . . 0.0 109.058 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.866 ' O ' HD12 ' A' ' 15' ' ' LEU . 20.6 m -79.31 140.59 37.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.12 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 1.074 HD22 ' HA2' ' A' ' 17' ' ' GLY . 10.2 mt -124.51 168.97 12.35 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.234 -0.916 . . . . 0.0 109.597 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.75 HD22 ' HB3' ' A' ' 55' ' ' ALA . 7.1 t30 -105.61 127.39 28.61 Favored Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.381 -0.824 . . . . 0.0 109.255 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.71 2.21 7.22 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.236 1.957 . . . . 0.0 110.648 -179.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.75 ' HB3' HD22 ' A' ' 53' ' ' ASN . . . -86.0 -19.03 30.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.033 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.512 ' OG ' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -90.22 162.7 34.04 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 109.526 179.95 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.76 -32.98 2.44 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.722 2.281 . . . . 0.0 111.002 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.512 HG22 ' OG ' ' A' ' 56' ' ' SER . 15.8 tt -70.54 -40.26 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.057 -1.027 . . . . 0.0 109.539 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 1.006 ' HA ' HD12 ' A' ' 62' ' ' ILE . 24.6 t -61.96 -48.19 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.343 -0.848 . . . . 0.0 108.951 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -60.9 -29.63 69.69 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.541 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -81.92 -19.7 40.24 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.867 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 1.006 HD12 ' HA ' ' A' ' 59' ' ' VAL . 16.4 mt -72.71 -38.86 59.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.936 HG22 HD11 ' B' ' 67' ' ' LEU . 1.5 mp -75.27 -61.84 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.33 -47.82 25.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.342 -0.849 . . . . 0.0 109.294 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 21.8 tptt -52.0 -57.3 9.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.185 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.507 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -44.36 -48.45 9.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.2 179.747 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.899 HD11 HG22 ' B' ' 63' ' ' ILE . 0.4 OUTLIER -48.81 -54.66 14.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.49 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' SER . 18.5 t30 -56.14 -32.82 64.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.484 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.42 ' C ' ' O ' ' A' ' 68' ' ' ASN . 1.1 p . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.471 -179.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.448 ' HB3' ' OE2' ' B' ' 39' ' ' GLU . 58.8 m . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.529 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 22.1 mm100 -62.55 -9.94 10.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.889 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.461 ' SG ' ' HG2' ' B' ' 39' ' ' GLU . 39.6 m -138.87 68.03 1.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 109.836 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.3 OUTLIER -45.28 -45.63 12.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 108.883 179.609 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . 0.417 ' OE1' ' N ' ' B' ' 14' ' ' THR . 0.5 OUTLIER -118.03 116.87 27.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 108.928 179.643 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.417 ' N ' ' OE1' ' B' ' 13' ' ' GLN . 0.6 OUTLIER -90.24 171.1 9.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -0.924 . . . . 0.0 110.042 -179.456 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.836 HD12 ' O ' ' B' ' 51' ' ' CYS . 1.0 OUTLIER -119.86 143.66 47.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.45 -0.781 . . . . 0.0 109.013 179.764 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.52 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.9 OUTLIER -44.58 -38.29 4.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 -179.962 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 1.02 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 138.26 156.52 7.14 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.805 ' H ' HD13 ' B' ' 18' ' ' ILE . 0.2 OUTLIER -125.84 156.04 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -1.084 . . . . 0.0 109.316 179.579 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.609 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -42.8 154.03 0.31 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 109.31 179.797 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.609 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 33.6 Cg_endo -76.38 -5.0 15.74 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.377 2.051 . . . . 0.0 109.862 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -81.74 -22.2 37.44 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.902 ' O ' HD23 ' B' ' 44' ' ' LEU . 35.6 m-20 -98.54 59.94 1.31 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.217 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.881 HD13 ' O ' ' B' ' 22' ' ' ASN . 2.6 mm -143.78 167.54 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.963 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.746 ' HG2' HG22 ' B' ' 43' ' ' THR . 0.0 OUTLIER -160.24 -35.1 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.273 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.545 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.4 p -133.46 176.77 8.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.009 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.511 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 54.0 t -151.31 92.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.897 -1.127 . . . . 0.0 109.86 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.485 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 5.1 t-20 -94.1 110.62 22.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.249 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.595 HG13 HG22 ' B' ' 40' ' ' VAL . 1.9 t -121.76 100.16 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.605 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.529 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 9.6 ptpt -98.05 106.66 18.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 109.401 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.588 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -45.9 170.57 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.399 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.525 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 35.9 Cg_endo -77.79 132.21 11.76 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.594 2.196 . . . . 0.0 110.499 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.32 -142.7 4.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.2 8.1 3.39 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.524 2.15 . . . . 0.0 110.873 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.453 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 6.6 p-80 -124.44 -18.66 5.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.006 -1.059 . . . . 0.0 109.757 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -160.22 96.59 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -0.948 . . . . 0.0 109.303 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -55.19 -29.12 57.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.941 . . . . 0.0 109.651 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.61 125.41 35.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.486 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.588 HG23 ' HA ' ' B' ' 30' ' ' SER . 32.4 m -46.41 152.74 0.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.424 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.461 ' HG2' ' SG ' ' B' ' 11' ' ' CYS . 0.0 OUTLIER -129.32 121.59 27.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.193 -0.942 . . . . 0.0 109.733 -179.929 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.688 HG11 HD11 ' B' ' 63' ' ' ILE . 16.2 t -108.17 150.36 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.24 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' B' ' 27' ' ' ASN . 14.5 mt -143.19 143.12 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.673 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -131.03 123.03 27.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 108.862 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.746 HG22 ' HG2' ' B' ' 24' ' ' GLN . 41.8 m -89.31 103.24 15.88 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.943 -1.098 . . . . 0.0 109.182 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.902 HD23 ' O ' ' B' ' 22' ' ' ASN . 72.5 mt -42.46 165.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.538 -0.726 . . . . 0.0 109.582 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.4 ptpt -87.26 16.38 5.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 109.555 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.523 ' OD1' ' CB ' ' B' ' 44' ' ' LEU . 19.0 p-10 -117.33 6.17 12.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.47 14.61 43.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.696 ' HB2' HD12 ' B' ' 44' ' ' LEU . 9.7 mtp180 -111.43 174.26 5.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -1.207 . . . . 0.0 109.495 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.42 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 6.7 mttt -138.24 156.81 47.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.33 120.52 7.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.821 . . . . 0.0 109.02 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.836 ' O ' HD12 ' B' ' 15' ' ' LEU . 20.5 m -79.37 140.62 37.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.074 -1.016 . . . . 0.0 109.122 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 1.032 HD13 HD13 ' B' ' 62' ' ' ILE . 10.2 mt -124.51 168.96 12.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.736 HD22 ' HB3' ' B' ' 55' ' ' ALA . 7.1 t30 -105.57 127.39 28.62 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.795 . . . . 0.0 109.185 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.74 2.27 7.17 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.208 1.939 . . . . 0.0 110.657 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.736 ' HB3' HD22 ' B' ' 53' ' ' ASN . . . -85.98 -19.1 30.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 0.0 109.074 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.505 ' OG ' HG22 ' B' ' 58' ' ' ILE . 0.4 OUTLIER -90.29 162.76 33.7 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.503 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.73 -33.0 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.755 2.303 . . . . 0.0 111.006 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.505 HG22 ' OG ' ' B' ' 56' ' ' SER . 15.9 tt -70.59 -40.16 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.109 -0.994 . . . . 0.0 109.51 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 1.026 ' HA ' HD12 ' B' ' 62' ' ' ILE . 24.5 t -62.07 -48.17 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.378 -0.827 . . . . 0.0 108.913 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -60.92 -29.7 69.76 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.535 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -81.81 -19.65 40.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 179.804 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 1.032 HD13 HD13 ' B' ' 52' ' ' LEU . 16.4 mt -72.76 -38.88 58.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.899 HG22 HD11 ' A' ' 67' ' ' LEU . 1.5 mp -75.16 -61.91 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -47.86 25.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.38 -0.825 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' B' ' 66' ' ' MET . 21.9 tptt -51.85 -57.38 9.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.163 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.511 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -44.39 -48.48 9.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.173 179.783 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.936 HD11 HG22 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -48.77 -54.63 14.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 179.899 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' B' ' 69' ' ' SER . 18.5 t30 -56.27 -32.7 64.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 0.0 109.498 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.429 ' C ' ' O ' ' B' ' 68' ' ' ASN . 1.1 p . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 109.468 -179.97 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.986 ' HB2' HD22 ' A' ' 12' ' ' LEU . 7.2 m . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 39' ' ' GLU . 0.9 OUTLIER -41.08 -38.38 1.02 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.515 -0.741 . . . . 0.0 109.736 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' A' ' 41' ' ' ILE . 72.3 m -136.56 78.21 1.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.695 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.986 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.87 -46.77 11.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.083 179.646 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -117.6 124.94 49.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.357 -0.839 . . . . 0.0 108.995 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 169.47 8.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 109.992 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 51' ' ' CYS . 4.8 mt -113.86 -167.42 1.2 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.759 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.4 mt-30 -88.92 -48.06 7.72 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 0.0 109.348 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.523 ' C ' HD13 ' A' ' 18' ' ' ILE . . . 154.2 161.57 10.54 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.853 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -142.98 149.67 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.378 -1.072 . . . . 0.0 109.311 179.666 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.597 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.94 152.08 0.38 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 109.535 -179.865 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -77.18 -2.65 12.88 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.584 2.189 . . . . 0.0 110.177 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 3.9 mmtt -90.19 -24.55 20.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.113 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 6.1 m-20 -85.43 -5.88 59.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.323 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.798 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 9.4 mt -104.93 152.7 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.255 -0.903 . . . . 0.0 110.043 -179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.576 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -124.98 -28.44 3.46 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.441 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.576 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.9 OUTLIER -137.33 174.08 10.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.072 179.473 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.55 HG11 HG13 ' A' ' 63' ' ' ILE . 21.4 t -149.74 119.64 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.985 . . . . 0.0 109.788 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.629 ' O ' HD12 ' A' ' 41' ' ' ILE . 4.8 t-20 -112.85 112.7 24.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 109.338 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.841 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -116.33 109.89 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.489 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.567 ' CE ' ' NE2' ' A' ' 34' ' ' HIS . 7.4 tttt -107.68 107.79 18.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.445 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.436 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.1 p -50.66 168.42 0.23 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.41 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 35.8 Cg_endo -77.88 134.68 13.52 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.582 2.188 . . . . 0.0 110.422 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.8 -142.04 4.45 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.09 7.79 3.5 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.553 2.169 . . . . 0.0 110.88 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.567 ' NE2' ' CE ' ' A' ' 29' ' ' LYS . 8.0 p-80 -126.34 -7.55 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.079 -1.013 . . . . 0.0 109.628 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.446 ' SG ' ' OE2' ' A' ' 39' ' ' GLU . 4.2 t -160.3 146.47 15.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.288 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.3 0.84 23.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 37' ' ' GLN . 3.8 mp0 -126.88 124.91 40.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.004 . . . . 0.0 109.474 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.436 HG23 ' HA ' ' A' ' 30' ' ' SER . 23.6 m -45.8 144.58 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 0.0 109.349 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 10' ' ' GLN . 4.6 mm-40 -122.47 107.24 11.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.664 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.866 HG11 HD11 ' A' ' 63' ' ' ILE . 38.5 t -91.89 150.39 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.135 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.1 mt -139.87 154.67 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.11 -0.994 . . . . 0.0 109.802 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.798 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -138.57 118.07 12.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.155 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.534 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.9 m -89.16 97.83 11.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.907 -1.121 . . . . 0.0 108.912 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 90.8 mt -44.0 166.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.488 -0.758 . . . . 0.0 109.66 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -81.58 8.06 10.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.699 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.01 24.68 12.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.225 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.16 3.93 71.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 6.9 mtt180 -93.2 166.56 12.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.146 -1.208 . . . . 0.0 109.454 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.4 155.6 49.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 0.0 109.433 -179.957 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.425 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.35 118.33 6.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.194 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.466 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 7.0 m -79.51 138.33 37.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.125 -0.984 . . . . 0.0 108.868 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.876 ' HB3' HG22 ' A' ' 59' ' ' VAL . 9.8 mt -124.0 168.61 12.6 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.632 ' O ' HG21 ' A' ' 59' ' ' VAL . 65.5 t30 -101.49 121.38 51.67 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.47 -0.769 . . . . 0.0 109.446 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.494 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.7 Cg_endo -74.67 -2.25 12.2 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.163 1.909 . . . . 0.0 110.488 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.58 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -83.8 -17.38 41.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.304 -0.873 . . . . 0.0 108.849 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -90.27 163.08 32.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.443 179.919 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.475 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 35.9 Cg_endo -77.74 -35.32 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.638 2.226 . . . . 0.0 111.113 -179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.626 ' O ' HD13 ' A' ' 62' ' ' ILE . 16.1 tt -67.9 -47.41 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.979 -1.076 . . . . 0.0 109.236 -179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.876 HG22 ' HB3' ' A' ' 52' ' ' LEU . 32.7 t -55.04 -48.61 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.195 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 12.0 mttt -57.36 -31.32 65.63 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.525 ' CE ' ' OE2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -75.67 -27.59 58.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.655 -0.653 . . . . 0.0 109.342 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.65 HG23 ' CD1' ' A' ' 23' ' ' ILE . 1.7 mp -67.33 -43.25 88.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.404 -0.81 . . . . 0.0 108.832 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.042 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.1 mp -69.53 -65.28 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.833 . . . . 0.0 109.721 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.525 ' OE2' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -49.01 -35.32 15.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.131 -0.98 . . . . 0.0 109.643 -179.703 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.484 ' HB3' ' CB ' ' A' ' 20' ' ' PRO . 21.3 mmtm -63.38 -54.0 43.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.09 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.529 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -49.06 -46.53 44.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.314 -0.866 . . . . 0.0 109.146 179.599 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.053 HD11 ' CG2' ' B' ' 63' ' ' ILE . 1.0 OUTLIER -56.87 -47.56 80.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.509 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.53 31.36 2.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 56.8 p . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.138 -0.976 . . . . 0.0 109.372 179.919 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 1.002 ' HB2' HD22 ' B' ' 12' ' ' LEU . 7.0 m . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.499 ' NE2' ' HG2' ' B' ' 29' ' ' LYS . 0.9 OUTLIER -41.02 -38.39 0.99 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.829 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.464 ' SG ' HG13 ' B' ' 41' ' ' ILE . 72.5 m -136.58 78.26 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.736 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 1.002 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.0 -46.74 11.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.059 179.71 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -117.57 125.06 50.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 108.968 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.99 169.42 8.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.215 -0.928 . . . . 0.0 109.992 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 51' ' ' CYS . 4.9 mt -113.89 -167.41 1.2 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.755 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.4 mt-30 -88.86 -48.17 7.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.126 -0.984 . . . . 0.0 109.299 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.51 ' C ' HD13 ' B' ' 18' ' ' ILE . . . 154.26 161.55 10.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.843 HD13 ' N ' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -143.0 149.79 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.357 -1.084 . . . . 0.0 109.267 179.589 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.592 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -42.98 152.12 0.38 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.356 -0.84 . . . . 0.0 109.468 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.592 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -77.28 -2.67 12.88 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.498 2.132 . . . . 0.0 110.092 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.467 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 3.9 mmtt -90.06 -24.61 21.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -0.847 . . . . 0.0 109.178 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.529 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 6.1 m-20 -85.33 -5.96 59.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.296 -0.878 . . . . 0.0 109.364 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.8 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 9.2 mt -104.89 152.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 110.089 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.572 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -124.9 -28.46 3.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.479 -0.763 . . . . 0.0 109.084 179.355 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.572 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.9 OUTLIER -137.24 174.2 10.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.902 . . . . 0.0 109.076 179.436 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.541 HG11 HG13 ' B' ' 63' ' ' ILE . 21.4 t -149.86 119.66 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.045 -1.034 . . . . 0.0 109.707 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.633 ' O ' HD12 ' B' ' 41' ' ' ILE . 4.8 t-20 -112.89 112.71 24.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.344 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.847 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -116.31 109.9 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 109.403 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.573 ' CE ' ' NE2' ' B' ' 34' ' ' HIS . 7.4 tttt -107.62 107.8 18.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.869 . . . . 0.0 109.444 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.447 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -50.7 168.48 0.23 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 36.0 Cg_endo -77.89 134.65 13.49 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.666 2.244 . . . . 0.0 110.424 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.81 -142.01 4.44 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.1 7.75 3.52 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.651 2.234 . . . . 0.0 110.816 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.573 ' NE2' ' CE ' ' B' ' 29' ' ' LYS . 8.0 p-80 -126.35 -7.59 6.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 109.608 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.444 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 4.2 t -160.23 146.52 15.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.287 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.29 0.76 23.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.151 -0.968 . . . . 0.0 109.706 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.42 ' CD ' ' N ' ' B' ' 37' ' ' GLN . 3.9 mp0 -126.88 125.01 40.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.129 -0.982 . . . . 0.0 109.506 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.447 HG23 ' HA ' ' B' ' 30' ' ' SER . 23.8 m -45.78 144.58 1.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 109.307 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' B' ' 10' ' ' GLN . 4.6 mm-40 -122.48 107.24 11.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 109.624 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.847 HG22 HG13 ' B' ' 28' ' ' VAL . 38.6 t -91.84 150.35 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.199 179.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.633 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.1 mt -139.89 154.79 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.785 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.8 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -138.61 118.02 12.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 109.117 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 1.8 m -89.18 97.74 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.036 -1.04 . . . . 0.0 108.966 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 90.8 mt -43.95 166.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.456 -0.778 . . . . 0.0 109.617 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.467 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -81.64 8.12 10.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 109.664 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.02 24.64 12.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 109.227 179.726 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.1 4.01 71.21 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 6.9 mtt180 -93.23 166.51 12.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.164 -1.197 . . . . 0.0 109.499 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.38 155.7 49.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.427 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . 0.413 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.4 118.39 6.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 109.143 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 6.9 m -79.56 138.31 37.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.124 -0.985 . . . . 0.0 108.83 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.84 ' HB3' HG22 ' B' ' 59' ' ' VAL . 9.7 mt -123.95 168.58 12.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.129 -0.982 . . . . 0.0 109.581 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.63 ' O ' HG21 ' B' ' 59' ' ' VAL . 65.5 t30 -101.56 121.5 51.12 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.44 -0.787 . . . . 0.0 109.458 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.491 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.2 Cg_endo -74.79 -2.18 12.14 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.182 1.921 . . . . 0.0 110.462 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . 0.569 ' HB3' ' ND2' ' B' ' 53' ' ' ASN . . . -83.85 -17.45 40.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.911 . . . . 0.0 108.763 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.8 OUTLIER -90.25 163.15 32.53 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.442 -0.786 . . . . 0.0 109.433 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.74 -35.47 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.781 2.321 . . . . 0.0 111.082 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.62 ' O ' HD13 ' B' ' 62' ' ' ILE . 16.2 tt -67.83 -47.56 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.001 -1.062 . . . . 0.0 109.189 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 0.84 HG22 ' HB3' ' B' ' 52' ' ' LEU . 33.1 t -54.97 -48.71 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.135 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 12.0 mttt -57.21 -31.37 65.4 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.22 -0.925 . . . . 0.0 108.514 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.514 ' CE ' ' OE2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -75.67 -27.6 58.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.317 179.947 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 0.65 HG23 ' CD1' ' B' ' 23' ' ' ILE . 1.7 mp -67.44 -43.26 87.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 1.053 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.1 mp -69.56 -65.31 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.679 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.514 ' OE2' ' CE ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -49.04 -35.3 15.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 109.538 -179.62 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.486 ' HB3' ' CB ' ' B' ' 20' ' ' PRO . 21.3 mmtm -63.35 -54.02 43.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.069 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.526 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 1.0 OUTLIER -49.2 -46.27 45.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 0.0 109.222 179.664 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 1.042 HD11 ' CG2' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -56.96 -47.56 80.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.436 -0.79 . . . . 0.0 109.453 179.871 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.49 31.32 2.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.947 . . . . 0.0 109.572 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 56.9 p . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.364 -179.992 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 9.6 m . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.392 -0.596 . . . . 0.0 109.392 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.501 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 47.0 mm-40 -49.87 -21.21 1.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.468 ' SG ' HG13 ' A' ' 41' ' ' ILE . 83.1 m -141.47 71.43 1.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.598 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.544 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.29 -44.58 8.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.219 179.727 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.54 121.12 37.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.418 -0.801 . . . . 0.0 109.228 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.02 160.53 14.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.854 . . . . 0.0 109.807 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.6 ' HB2' HD23 ' A' ' 52' ' ' LEU . 4.5 mt -103.69 142.78 33.75 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 15' ' ' LEU . 1.4 tt0 -44.75 -26.59 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.124 -0.985 . . . . 0.0 109.125 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 154.86 -178.91 31.31 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.644 ' H ' HD11 ' A' ' 62' ' ' ILE . 4.6 tp -155.72 170.62 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.501 -1.0 . . . . 0.0 108.925 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.59 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.6 t-80 -60.0 143.71 87.59 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.068 -1.02 . . . . 0.0 108.973 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -77.26 -24.64 9.22 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.443 2.095 . . . . 0.0 110.267 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' HE2' ' A' ' 45' ' ' LYS . 13.2 mttm -90.52 -13.74 34.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.81 . . . . 0.0 109.175 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.571 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 92.4 m-20 -80.18 -15.34 57.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.921 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 6.9 mt -90.0 162.46 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.415 -0.803 . . . . 0.0 110.696 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -128.61 -39.65 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.198 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 1.5 p -126.86 172.09 10.7 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.304 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 78.4 t -143.97 93.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.993 -1.067 . . . . 0.0 109.716 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.481 ' O ' HD12 ' A' ' 41' ' ' ILE . 3.4 t-20 -86.85 108.72 18.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.319 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -104.66 94.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.937 . . . . 0.0 109.545 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HE2' ' HG3' ' A' ' 10' ' ' GLN . 3.6 tppt? -90.6 92.58 8.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.443 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.521 ' HB3' ' CE ' ' B' ' 66' ' ' MET . 1.0 OUTLIER -45.99 170.96 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.488 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HB3' ' O ' ' A' ' 36' ' ' ALA . 35.6 Cg_endo -77.76 140.08 18.27 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.644 2.229 . . . . 0.0 110.458 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.91 -142.44 3.66 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.82 39.22 0.81 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.689 2.259 . . . . 0.0 110.782 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.482 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 6.0 p-80 -158.67 -38.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.012 -1.055 . . . . 0.0 109.301 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -138.01 102.18 4.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.277 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 31' ' ' PRO . . . -62.99 -29.16 70.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.699 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.71 125.73 34.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' ' 30' ' ' SER . 73.5 m -48.54 148.81 1.87 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.269 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.45 ' OE1' ' HB2' ' A' ' 11' ' ' CYS . 21.5 mm-40 -125.07 123.46 39.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.628 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.605 HG11 HD11 ' A' ' 63' ' ' ILE . 16.8 t -107.55 145.53 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.266 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.481 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.6 mp -134.88 144.29 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.921 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -131.27 117.71 19.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.301 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 3.4 m -89.29 95.83 10.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.949 -1.094 . . . . 0.0 108.896 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 85.1 mt -42.16 163.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.548 -0.72 . . . . 0.0 109.962 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.52 ' HB3' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -81.01 10.77 4.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.838 . . . . 0.0 109.872 179.905 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.494 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -110.71 14.0 22.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.13 -0.982 . . . . 0.0 109.225 179.61 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.07 15.82 68.8 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.471 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 8.9 mtp-105 -108.04 175.63 5.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -1.142 . . . . 0.0 109.414 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.439 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -143.29 152.47 41.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.21 122.23 8.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.856 . . . . 0.0 108.898 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.455 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 23.0 m -79.76 143.16 34.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 0.0 109.277 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.945 HD13 HD13 ' A' ' 62' ' ' ILE . 18.7 mt -128.19 168.03 16.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 109.081 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.641 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.5 t-20 -104.87 127.72 28.23 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 109.47 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.527 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.8 Cg_endo -75.46 -11.56 20.66 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.33 2.02 . . . . 0.0 110.49 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.12 -17.41 61.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.102 -0.999 . . . . 0.0 108.969 179.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -90.27 162.15 35.44 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 179.941 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.08 -35.08 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.702 2.268 . . . . 0.0 111.098 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.548 HG23 ' N ' ' A' ' 59' ' ' VAL . 2.9 tt -68.24 -45.15 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.065 -1.022 . . . . 0.0 109.397 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.999 ' HA ' HD12 ' A' ' 62' ' ' ILE . 40.3 t -59.04 -45.87 92.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 18.2 mttt -60.08 -29.39 68.54 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 2.5 mmpt? -79.55 -23.54 42.75 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.999 HD12 ' HA ' ' A' ' 59' ' ' VAL . 20.5 mt -70.85 -37.91 70.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.92 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -74.69 -56.74 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.475 -0.765 . . . . 0.0 109.296 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -59.36 -28.12 66.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.962 . . . . 0.0 109.226 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.514 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -70.61 -52.06 23.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 108.914 179.611 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.528 ' CE ' ' HB3' ' B' ' 30' ' ' SER . 0.4 OUTLIER -49.58 -44.37 46.88 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.276 -0.89 . . . . 0.0 108.949 179.473 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.929 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -55.08 -59.17 5.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.547 -0.72 . . . . 0.0 109.566 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -79.89 5.33 14.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.725 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 85.6 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.393 -179.996 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.534 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 9.3 m . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.479 ' HG3' ' HE2' ' B' ' 29' ' ' LYS . 47.1 mm-40 -49.85 -21.13 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.713 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.468 ' SG ' HG13 ' B' ' 41' ' ' ILE . 82.6 m -141.59 71.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.062 -1.024 . . . . 0.0 109.652 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.25 -44.55 8.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.232 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.55 121.11 37.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.252 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.96 160.44 14.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.807 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.59 ' HB2' HD23 ' B' ' 52' ' ' LEU . 4.4 mt -103.65 142.76 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' B' ' 15' ' ' LEU . 1.4 tt0 -44.73 -26.56 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.157 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.538 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 154.8 -178.92 31.26 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.631 ' H ' HD11 ' B' ' 62' ' ' ILE . 4.6 tp -155.7 170.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.467 -1.019 . . . . 0.0 108.963 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.585 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 1.6 t-80 -59.98 143.71 87.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 108.993 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.585 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.26 -24.69 9.17 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.51 2.14 . . . . 0.0 110.318 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HE2' ' B' ' 45' ' ' LYS . 13.2 mttm -90.42 -13.81 34.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 109.235 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.581 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 92.5 m-20 -80.12 -15.45 57.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.928 HG23 ' HB1' ' B' ' 42' ' ' ALA . 6.9 mt -90.08 162.43 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.43 -0.794 . . . . 0.0 110.668 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.2 OUTLIER -128.61 -39.65 1.63 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.273 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 1.5 p -126.79 172.07 10.68 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.321 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' B' ' 41' ' ' ILE . 77.8 t -144.05 93.6 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.004 -1.06 . . . . 0.0 109.703 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.475 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 3.4 t-20 -86.85 108.77 18.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.32 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.8 t -104.63 94.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.2 -0.938 . . . . 0.0 109.609 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.479 ' HE2' ' HG3' ' B' ' 10' ' ' GLN . 3.6 tppt? -90.67 92.64 8.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.423 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.528 ' HB3' ' CE ' ' A' ' 66' ' ' MET . 1.0 OUTLIER -46.11 171.03 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.0 109.483 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' B' ' 36' ' ' ALA . 35.9 Cg_endo -77.86 140.11 18.08 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.574 2.183 . . . . 0.0 110.473 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.9 -142.49 3.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.74 39.16 0.8 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.666 2.244 . . . . 0.0 110.893 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.479 ' N ' ' ND1' ' B' ' 34' ' ' HIS . 6.0 p-80 -158.7 -38.52 0.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.07 -1.019 . . . . 0.0 109.32 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -138.14 102.21 4.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.231 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' B' ' 31' ' ' PRO . . . -62.92 -29.23 70.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.706 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.68 125.67 34.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.954 . . . . 0.0 109.561 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.439 HG23 ' HA ' ' B' ' 30' ' ' SER . 71.8 m -48.53 148.77 1.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.917 . . . . 0.0 109.34 179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . 0.441 ' OE1' ' HB2' ' B' ' 11' ' ' CYS . 21.5 mm-40 -125.05 123.4 39.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.613 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.628 HG11 HD11 ' B' ' 63' ' ' ILE . 16.7 t -107.44 145.58 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.89 . . . . 0.0 109.337 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' B' ' 27' ' ' ASN . 3.6 mp -134.92 144.33 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.182 -0.949 . . . . 0.0 109.605 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.928 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -131.37 117.73 19.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.292 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 3.4 m -89.36 95.88 10.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.894 -1.129 . . . . 0.0 108.949 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 85.1 mt -42.07 163.63 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.529 -0.732 . . . . 0.0 109.926 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.509 ' HB3' ' NZ ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -81.02 10.83 4.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.377 -0.827 . . . . 0.0 109.838 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -110.77 13.96 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.142 179.678 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.08 15.79 68.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.467 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 8.9 mtp-105 -108.05 175.57 5.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -1.135 . . . . 0.0 109.484 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.438 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 0.3 OUTLIER -143.23 152.46 41.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.891 . . . . 0.0 109.438 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.18 122.2 8.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.244 -0.91 . . . . 0.0 108.983 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.452 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 23.0 m -79.77 143.19 34.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.166 -0.959 . . . . 0.0 109.308 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.967 HD13 HD13 ' B' ' 62' ' ' ILE . 18.7 mt -128.24 167.97 16.13 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 109.013 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.637 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.6 t-20 -104.96 127.81 27.98 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.425 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.526 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.9 Cg_endo -75.5 -11.59 20.58 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.349 2.033 . . . . 0.0 110.45 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.07 -17.36 61.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 109.09 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.6 OUTLIER -90.29 162.16 35.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 109.504 179.916 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -78.1 -35.12 1.41 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.762 2.308 . . . . 0.0 111.086 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . 0.566 HG23 ' N ' ' B' ' 59' ' ' VAL . 2.9 tt -68.19 -45.19 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.065 -1.022 . . . . 0.0 109.424 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 1.018 ' HA ' HD12 ' B' ' 62' ' ' ILE . 40.5 t -58.9 -45.96 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.056 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 18.2 mttt -60.06 -29.47 68.57 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' B' ' 65' ' ' LYS . 2.5 mmpt? -79.53 -23.44 42.87 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' B' ' 59' ' ' VAL . 20.5 mt -70.94 -37.81 69.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 0.929 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -74.68 -56.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.322 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.3 OUTLIER -59.35 -28.06 66.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.329 179.838 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.515 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 0.0 OUTLIER -70.64 -52.09 23.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 108.909 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.521 ' CE ' ' HB3' ' A' ' 30' ' ' SER . 0.5 OUTLIER -49.59 -44.37 46.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.009 179.422 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.92 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -55.02 -59.19 5.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.65 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -79.87 5.34 13.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.927 . . . . 0.0 109.76 -179.808 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 85.5 p . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.448 179.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.498 ' HB2' HD23 ' A' ' 12' ' ' LEU . 18.7 m . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.498 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 19.1 mm-40 -64.68 -8.06 13.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.816 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' A' ' 41' ' ' ILE . 73.8 m -144.66 71.66 1.31 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.066 -1.021 . . . . 0.0 109.711 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.498 HD23 ' HB2' ' A' ' 9' ' ' CYS . 52.4 mt -46.29 -42.49 14.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.187 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -119.76 122.09 40.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.114 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -101.21 158.73 15.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.834 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.527 ' HB2' HD23 ' A' ' 52' ' ' LEU . 3.5 mt -102.85 139.92 37.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -43.96 -26.89 0.31 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.222 179.943 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 15' ' ' LEU . . . 157.98 -179.89 33.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.797 ' H ' HD11 ' A' ' 62' ' ' ILE . 4.6 tp -154.98 170.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.548 -0.972 . . . . 0.0 108.801 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.58 ' CB ' ' ND2' ' A' ' 22' ' ' ASN . 3.4 t-80 -59.19 141.97 86.43 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.985 -1.072 . . . . 0.0 109.055 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.3 Cg_endo -77.59 -23.62 9.63 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.499 2.133 . . . . 0.0 110.273 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 9.5 mmtp -90.25 -15.09 32.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.434 -0.791 . . . . 0.0 109.129 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.58 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 84.8 m-20 -78.94 -27.76 43.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -0.788 . . . . 0.0 109.377 179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.804 HG12 ' HB1' ' A' ' 42' ' ' ALA . 6.5 mt -77.44 163.7 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.828 0.823 . . . . 0.0 110.697 -179.014 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.555 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -129.62 -41.26 1.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.109 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 10.9 p -124.97 166.69 15.88 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.075 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.738 ' O ' HG23 ' B' ' 28' ' ' VAL . 50.8 t -145.2 98.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.051 -1.03 . . . . 0.0 109.772 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 49.8 t-20 -84.35 133.23 34.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.189 -0.944 . . . . 0.0 109.383 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.739 HG23 ' O ' ' B' ' 26' ' ' VAL . 2.2 t -118.08 82.34 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.982 . . . . 0.0 109.516 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HD3' ' HG3' ' A' ' 10' ' ' GLN . 20.9 mtpt -87.32 103.62 15.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.524 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.1 p -57.63 163.8 3.49 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 109.334 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.44 132.21 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.598 2.199 . . . . 0.0 110.473 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.73 -141.13 3.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.06 7.61 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.663 2.242 . . . . 0.0 110.852 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.466 ' N ' ' ND1' ' A' ' 34' ' ' HIS . 6.4 p-80 -124.88 -14.82 6.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.059 -1.026 . . . . 0.0 109.775 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.38 125.56 3.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -0.996 . . . . 0.0 109.363 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.42 ' O ' ' CD ' ' A' ' 37' ' ' GLN . . . -87.19 17.49 4.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.617 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . 0.42 ' CD ' ' O ' ' A' ' 36' ' ' ALA . 9.6 mm-40 -143.36 125.77 15.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.924 . . . . 0.0 109.524 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.502 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 3.2 m -44.32 157.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 109.313 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -132.64 107.1 8.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 109.576 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 1.006 HG11 HD11 ' A' ' 63' ' ' ILE . 1.7 t -101.98 93.64 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.907 . . . . 0.0 109.269 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.471 HG13 ' SG ' ' A' ' 11' ' ' CYS . 3.4 mp -82.18 150.41 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.724 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.804 ' HB1' HG12 ' A' ' 23' ' ' ILE . . . -132.65 114.91 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 108.994 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 4.3 m -89.22 98.16 11.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.879 -1.138 . . . . 0.0 108.992 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 93.1 mt -41.14 163.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.305 0.574 . . . . 0.0 109.931 -179.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -82.06 11.09 5.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 0.0 109.921 -179.785 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' A' ' 44' ' ' LEU . 23.4 p-10 -112.56 8.09 19.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.076 -1.015 . . . . 0.0 109.419 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.59 1.66 63.82 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.463 ' HB2' HD12 ' A' ' 44' ' ' LEU . 19.4 mtt180 -96.57 165.63 12.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -1.194 . . . . 0.0 109.545 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 2.2 mttt -133.02 153.16 51.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.466 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.3 123.39 8.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 108.908 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 35.6 m -79.62 140.94 36.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.072 -1.017 . . . . 0.0 109.305 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.958 HD13 HD13 ' A' ' 62' ' ' ILE . 16.0 mt -125.37 168.24 13.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.379 -0.826 . . . . 0.0 109.224 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.621 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.6 m-20 -106.28 124.84 34.53 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.434 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HG3' ' HB ' ' A' ' 38' ' ' THR . 33.5 Cg_endo -75.26 -7.01 18.57 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.359 2.039 . . . . 0.0 110.327 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 -17.52 50.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.227 -0.921 . . . . 0.0 108.963 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 163.7 30.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.413 -0.804 . . . . 0.0 109.321 179.866 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.443 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.45 -36.55 1.23 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.589 2.193 . . . . 0.0 110.678 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.4 mt -61.47 -48.07 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.539 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.986 ' HA ' HD12 ' A' ' 62' ' ' ILE . 76.6 t -62.25 -50.0 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.353 -0.842 . . . . 0.0 109.615 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 56' ' ' SER . 6.0 mttt -51.24 -30.72 18.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.122 -0.986 . . . . 0.0 108.722 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.483 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -78.45 -34.54 47.67 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.986 HD12 ' HA ' ' A' ' 59' ' ' VAL . 14.2 mt -59.68 -38.34 75.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.551 -0.718 . . . . 0.0 109.28 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 1.006 HD11 HG11 ' A' ' 40' ' ' VAL . 2.2 mp -74.52 -62.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.483 ' HG2' ' HA ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -53.14 -20.09 3.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 109.394 -179.931 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -79.64 -40.24 29.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.913 . . . . 0.0 109.026 179.729 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.449 ' SD ' ' OG ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -65.19 -45.79 83.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 108.995 179.613 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.697 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -43.5 -50.28 7.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.527 -0.733 . . . . 0.0 109.487 179.822 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -76.81 -27.07 55.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.845 . . . . 0.0 109.614 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.449 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 109.676 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . 0.518 ' HB2' HD23 ' B' ' 12' ' ' LEU . 18.5 m . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 10' ' ' GLN . . . . . 0.483 ' HG3' ' HD3' ' B' ' 29' ' ' LYS . 19.0 mm-40 -64.77 -8.0 13.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 0.0 109.78 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 11' ' ' CYS . . . . . 0.473 ' SG ' HG13 ' B' ' 41' ' ' ILE . 73.6 m -144.69 71.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.082 -1.011 . . . . 0.0 109.657 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' B' ' 9' ' ' CYS . 52.6 mt -46.29 -42.54 14.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.17 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -119.73 122.06 40.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 109.123 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 14' ' ' THR . . . . . 0.439 ' OG1' ' OD1' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -101.22 158.65 15.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.816 -179.692 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.531 ' HB2' HD23 ' B' ' 52' ' ' LEU . 3.5 mt -102.79 139.93 37.72 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 16' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.6 OUTLIER -43.96 -26.95 0.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.176 179.969 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 17' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' B' ' 15' ' ' LEU . . . 158.03 -179.89 33.41 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.779 ' H ' HD11 ' B' ' 62' ' ' ILE . 4.5 tp -155.03 170.9 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.571 -0.958 . . . . 0.0 108.745 -179.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.58 ' CB ' ' ND2' ' B' ' 22' ' ' ASN . 3.4 t-80 -59.14 142.03 86.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.028 -1.045 . . . . 0.0 109.109 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 20' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.1 Cg_endo -77.73 -23.53 9.52 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.517 2.145 . . . . 0.0 110.238 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.526 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 9.5 mmtp -90.29 -15.0 32.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.404 -0.81 . . . . 0.0 109.139 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 22' ' ' ASN . . . . . 0.58 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 84.8 m-20 -78.99 -27.7 43.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.431 -0.793 . . . . 0.0 109.403 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.801 HG12 ' HB1' ' B' ' 42' ' ' ALA . 6.5 mt -77.45 163.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.751 0.786 . . . . 0.0 110.743 -179.029 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 24' ' ' GLN . . . . . 0.549 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.2 OUTLIER -129.65 -41.25 1.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.07 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 25' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 11.0 p -124.92 166.72 15.79 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 26' ' ' VAL . . . . . 0.739 ' O ' HG23 ' A' ' 28' ' ' VAL . 51.3 t -145.26 98.78 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.998 -1.064 . . . . 0.0 109.779 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 27' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 50.0 t-20 -84.4 133.21 34.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 28' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.2 t -118.02 82.25 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.142 -0.974 . . . . 0.0 109.591 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 29' ' ' LYS . . . . . 0.483 ' HD3' ' HG3' ' B' ' 10' ' ' GLN . 20.9 mtpt -87.36 103.64 15.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 30' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.1 p -57.56 163.85 3.37 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.342 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.44 132.21 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.581 2.187 . . . . 0.0 110.436 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.74 -141.01 3.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.18 7.69 3.58 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.592 2.194 . . . . 0.0 110.84 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 34' ' ' HIS . . . . . 0.464 ' ND1' ' N ' ' B' ' 34' ' ' HIS . 6.4 p-80 -124.92 -14.74 6.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.007 -1.058 . . . . 0.0 109.761 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.36 125.62 3.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.97 . . . . 0.0 109.332 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 36' ' ' ALA . . . . . 0.42 ' O ' ' CD ' ' B' ' 37' ' ' GLN . . . -87.23 17.55 4.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.626 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 37' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' B' ' 38' ' ' THR . 9.7 mm-40 -143.42 125.74 15.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.504 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 38' ' ' THR . . . . . 0.494 ' HB ' ' HG3' ' B' ' 54' ' ' PRO . 3.2 m -44.32 157.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 0.0 109.309 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -132.61 107.01 8.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.571 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 1.015 HG11 HD11 ' B' ' 63' ' ' ILE . 1.7 t -101.86 93.57 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.202 -0.936 . . . . 0.0 109.335 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 41' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 3.5 mp -82.19 150.42 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.726 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 42' ' ' ALA . . . . . 0.801 ' HB1' HG12 ' B' ' 23' ' ' ILE . . . -132.68 114.9 14.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.852 . . . . 0.0 109.004 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 43' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 4.4 m -89.23 98.2 11.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.856 -1.152 . . . . 0.0 108.996 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 44' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 93.1 mt -41.16 163.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.686 -0.634 . . . . 0.0 109.877 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 45' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -82.09 11.04 5.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.921 -179.818 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 46' ' ' ASN . . . . . 0.494 ' OD1' ' HB2' ' B' ' 44' ' ' LEU . 23.4 p-10 -112.44 7.98 19.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.034 -1.042 . . . . 0.0 109.535 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.56 1.84 63.76 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 48' ' ' ARG . . . . . 0.485 ' HB2' HD12 ' B' ' 44' ' ' LEU . 19.4 mtt180 -96.66 165.67 12.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -1.226 . . . . 0.0 109.535 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.414 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 2.2 mttt -132.99 153.2 51.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.481 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.27 123.4 8.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 108.91 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 51' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 35.7 m -79.6 140.93 36.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.035 -1.041 . . . . 0.0 109.299 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 52' ' ' LEU . . . . . 0.966 HD13 HD13 ' B' ' 62' ' ' ILE . 15.9 mt -125.41 168.3 13.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.296 -0.877 . . . . 0.0 109.227 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 53' ' ' ASN . . . . . 0.614 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.6 m-20 -106.41 124.87 34.38 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.407 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 54' ' ' PRO . . . . . 0.494 ' HG3' ' HB ' ' B' ' 38' ' ' THR . 34.1 Cg_endo -75.22 -6.92 18.49 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.308 2.005 . . . . 0.0 110.422 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.94 -17.58 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 108.915 179.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 56' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -90.02 163.76 30.78 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.356 -0.84 . . . . 0.0 109.323 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 57' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.57 -36.46 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.633 2.222 . . . . 0.0 110.667 -179.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.42 -48.14 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.652 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 59' ' ' VAL . . . . . 1.034 ' HA ' HD12 ' B' ' 62' ' ' ILE . 76.6 t -62.19 -50.05 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.83 . . . . 0.0 109.617 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 60' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' B' ' 56' ' ' SER . 6.0 mttt -51.2 -30.75 18.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.084 -1.01 . . . . 0.0 108.735 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 61' ' ' LYS . . . . . 0.491 ' HA ' ' CG ' ' B' ' 64' ' ' GLU . 0.0 OUTLIER -78.45 -34.51 47.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.856 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . 1.034 HD12 ' HA ' ' B' ' 59' ' ' VAL . 14.2 mt -59.7 -38.43 75.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.543 -0.723 . . . . 0.0 109.229 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 63' ' ' ILE . . . . . 1.015 HD11 HG11 ' B' ' 40' ' ' VAL . 2.2 mp -74.5 -62.29 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.64 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 64' ' ' GLU . . . . . 0.491 ' CG ' ' HA ' ' B' ' 61' ' ' LYS . 0.2 OUTLIER -53.14 -20.1 3.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.413 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -79.64 -40.14 29.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.868 . . . . 0.0 109.031 179.749 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 66' ' ' MET . . . . . 0.446 ' SD ' ' OG ' ' B' ' 69' ' ' SER . 0.6 OUTLIER -65.16 -45.87 83.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.841 . . . . 0.0 108.994 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 67' ' ' LEU . . . . . 0.692 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -43.42 -50.34 6.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.476 -0.765 . . . . 0.0 109.46 179.858 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -76.8 -27.09 55.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.833 . . . . 0.0 109.558 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 69' ' ' SER . . . . . 0.446 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.2 p . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.316 -0.865 . . . . 0.0 109.707 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 121.279 0.561 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.9 t -176.01 90.18 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.169 -0.957 . . . . 0.0 109.506 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 3' ' ' VAL . 12.0 p -169.88 114.4 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.467 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.653 ' O ' HG22 ' A' ' 5' ' ' THR . . . -177.62 81.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.317 -0.865 . . . . 0.0 109.496 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.653 HG22 ' O ' ' A' ' 4' ' ' ALA . 13.7 t 41.88 33.45 0.35 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.424 -0.798 . . . . 0.0 109.667 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -117.74 63.47 0.75 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.534 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.664 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -124.5 101.53 7.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.183 -0.948 . . . . 0.0 109.582 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.508 ' O ' ' N ' ' A' ' 10' ' ' GLN . 22.4 mtp180 -104.72 152.84 22.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.342 -0.849 . . . . 0.0 109.045 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.64 ' HB2' HD22 ' A' ' 12' ' ' LEU . 97.2 m -44.24 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.127 -0.983 . . . . 0.0 109.373 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.521 ' NE2' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.66 -26.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.399 -0.813 . . . . 0.0 109.763 -179.861 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.474 ' SG ' HG13 ' A' ' 41' ' ' ILE . 97.1 m -122.22 66.17 0.93 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.106 -0.996 . . . . 0.0 109.799 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.64 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.85 -38.9 4.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.152 -0.967 . . . . 0.0 108.735 179.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.527 ' O ' HG23 ' A' ' 14' ' ' THR . 0.7 OUTLIER -118.42 -173.3 2.44 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -160.15 158.06 29.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.04 -1.038 . . . . 0.0 109.935 179.911 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.523 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.5 mt -116.93 142.76 46.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.474 -0.766 . . . . 0.0 109.043 179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.4 OUTLIER -44.04 -33.3 1.4 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.184 -0.948 . . . . 0.0 109.362 -179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.859 ' O ' HG23 ' A' ' 18' ' ' ILE . . . 147.34 -166.47 28.59 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.933 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -171.53 163.45 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.44 -1.035 . . . . 0.0 109.076 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.567 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -57.39 149.74 47.39 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.204 -0.935 . . . . 0.0 109.234 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.654 ' HA ' HD12 ' A' ' 23' ' ' ILE . 34.8 Cg_endo -77.25 -4.34 14.66 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.516 2.144 . . . . 0.0 110.19 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.445 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.18 -24.02 21.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.362 -0.836 . . . . 0.0 109.197 179.673 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.508 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.0 m-20 -84.01 -15.87 46.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -0.855 . . . . 0.0 109.213 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.976 HG23 ' HB1' ' A' ' 42' ' ' ALA . 17.3 mt -89.32 169.04 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.434 -0.791 . . . . 0.0 110.245 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.579 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -137.49 -39.98 0.57 Allowed 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.433 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 5.9 p -128.2 173.36 10.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.458 -0.776 . . . . 0.0 109.029 179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.589 HG23 ' HG3' ' A' ' 66' ' ' MET . 47.7 t -142.22 95.5 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.12 -0.988 . . . . 0.0 109.705 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.58 ' O ' HD12 ' A' ' 41' ' ' ILE . 5.1 t-20 -93.06 111.58 23.25 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.221 -0.925 . . . . 0.0 109.417 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.443 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -109.35 97.69 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.878 . . . . 0.0 109.404 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.521 ' HD2' ' NE2' ' A' ' 10' ' ' GLN . 1.9 ttmt -90.59 110.28 21.43 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.2 p -63.68 167.72 6.8 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.191 -0.943 . . . . 0.0 109.355 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.47 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.6 Cg_endo -77.61 145.62 23.41 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.603 2.202 . . . . 0.0 110.446 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.95 -140.05 2.97 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.452 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 36.1 Cg_endo -77.87 10.71 2.5 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.596 2.197 . . . . 0.0 111.023 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.664 ' CD2' HD22 ' A' ' 7' ' ' LEU . 3.3 p-80 -127.76 -32.91 2.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.559 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -145.45 115.89 7.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.218 -0.926 . . . . 0.0 109.265 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -80.92 6.97 11.71 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.218 -0.926 . . . . 0.0 109.694 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.428 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 1.6 mp0 -120.71 124.62 45.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 109.48 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.466 HG21 ' HB3' ' B' ' 70' ' ' ASP . 1.6 m -46.76 156.85 0.17 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.317 -0.864 . . . . 0.0 109.317 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.455 ' HA ' ' OE1' ' A' ' 39' ' ' GLU . 7.1 mm-40 -141.37 107.56 5.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.933 . . . . 0.0 109.627 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.656 HG11 HD11 ' A' ' 63' ' ' ILE . 41.2 t -90.56 150.4 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.225 -0.922 . . . . 0.0 109.272 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.58 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.4 mt -140.29 147.79 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.71 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.976 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -135.39 120.05 18.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.404 -0.81 . . . . 0.0 109.162 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.524 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 8.6 m -89.3 100.95 13.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.94 -1.1 . . . . 0.0 109.01 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.508 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 84.5 mt -46.08 172.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.47 -0.769 . . . . 0.0 109.732 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -87.93 10.47 18.69 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.215 -0.928 . . . . 0.0 109.179 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -114.04 27.52 9.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.325 -0.86 . . . . 0.0 109.134 179.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.13 11.14 70.2 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.501 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 3.8 mtp180 -100.18 165.91 11.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.232 -1.157 . . . . 0.0 109.443 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.83 154.06 50.62 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.305 -0.872 . . . . 0.0 109.214 179.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.523 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.18 123.7 9.08 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.266 -0.896 . . . . 0.0 109.213 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 7.7 m -79.49 144.96 33.51 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.171 -0.956 . . . . 0.0 109.169 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.995 HD13 HD13 ' A' ' 62' ' ' ILE . 15.4 mt -121.99 167.54 12.97 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.305 -0.872 . . . . 0.0 109.447 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.653 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -97.14 118.08 65.06 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.467 -0.771 . . . . 0.0 109.201 -179.95 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.4 ' HB3' ' CG2' ' A' ' 40' ' ' VAL . 33.1 Cg_endo -74.24 -0.35 9.51 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.175 1.917 . . . . 0.0 110.376 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.28 -14.08 27.43 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.325 -0.859 . . . . 0.0 108.906 179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.466 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.11 162.61 34.56 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.392 -0.818 . . . . 0.0 109.391 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.06 -36.17 1.13 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.694 2.263 . . . . 0.0 110.659 -179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 65.3 mt -66.41 -36.39 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 109.661 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.002 ' HA ' HD12 ' A' ' 62' ' ' ILE . 37.7 t -67.95 -51.36 50.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 0.0 109.258 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.505 ' NZ ' ' O ' ' B' ' 70' ' ' ASP . 0.1 OUTLIER -54.3 -30.23 50.19 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 108.992 179.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.529 ' HB3' ' NZ ' ' A' ' 65' ' ' LYS . 9.6 mmmm -81.98 -28.85 32.42 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 0.0 109.108 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.002 HD12 ' HA ' ' A' ' 59' ' ' VAL . 11.9 mt -59.61 -38.1 73.89 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.937 HG22 HD11 ' B' ' 67' ' ' LEU . 1.7 mp -76.15 -61.62 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.404 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -43.02 -28.73 0.29 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.817 . . . . 0.0 109.646 179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.529 ' NZ ' ' HB3' ' A' ' 61' ' ' LYS . 2.0 mtmt -74.74 -60.24 2.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.277 -0.889 . . . . 0.0 109.321 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.589 ' HG3' HG23 ' A' ' 26' ' ' VAL . 1.4 mmm -44.17 -47.78 9.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.313 -0.867 . . . . 0.0 109.272 179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.943 HD11 HG22 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -43.65 -51.26 7.14 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.452 -0.78 . . . . 0.0 109.353 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' A' ' 69' ' ' SER . 11.9 t30 -66.41 -34.82 78.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.301 -0.874 . . . . 0.0 109.495 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.416 ' C ' ' O ' ' A' ' 68' ' ' ASN . 1.2 p -43.85 -26.88 0.29 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.562 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.505 ' O ' ' NZ ' ' B' ' 60' ' ' LYS . 0.3 OUTLIER -112.14 67.46 0.65 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.295 -0.878 . . . . 0.0 109.555 179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -120.08 82.92 1.97 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 109.532 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.438 ' O ' ' CB ' ' A' ' 73' ' ' ASN . 0.2 OUTLIER 60.73 170.58 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.269 -0.894 . . . . 0.0 109.485 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' A' ' 72' ' ' SER . 2.9 p30 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 118.03 -0.986 . . . . 0.0 109.382 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.9 t -176.14 90.09 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.275 -0.891 . . . . 0.0 109.455 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.681 HG13 ' O ' ' B' ' 3' ' ' VAL . 12.0 p -169.9 114.38 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.47 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.663 ' O ' HG22 ' B' ' 5' ' ' THR . . . -177.61 80.97 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.266 -0.896 . . . . 0.0 109.498 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.663 HG22 ' O ' ' B' ' 4' ' ' ALA . 13.7 t 41.92 33.51 0.36 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.461 -0.775 . . . . 0.0 109.657 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 1.3 pt-20 -117.83 63.43 0.75 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 0.0 109.553 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.671 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -124.47 101.56 7.21 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.211 -0.93 . . . . 0.0 109.578 -179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.501 ' O ' ' N ' ' B' ' 10' ' ' GLN . 22.4 mtp180 -104.75 152.76 22.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.315 -0.865 . . . . 0.0 109.03 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.658 ' HB2' HD22 ' B' ' 12' ' ' LEU . 96.6 m -44.15 96.57 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.235 -0.916 . . . . 0.0 109.359 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.526 ' NE2' ' HD2' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -42.75 -26.4 0.13 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.4 -0.813 . . . . 0.0 109.796 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.457 ' SG ' HG13 ' B' ' 41' ' ' ILE . 97.4 m -122.18 66.25 0.93 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.148 -0.97 . . . . 0.0 109.786 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.658 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.83 -38.95 4.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.147 -0.971 . . . . 0.0 108.753 179.577 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . 0.529 ' O ' HG23 ' B' ' 14' ' ' THR . 0.7 OUTLIER -118.49 -173.25 2.43 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.534 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.4 OUTLIER -160.17 158.08 29.49 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.994 -1.066 . . . . 0.0 109.896 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.531 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.6 mt -116.96 142.77 46.52 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.4 OUTLIER -44.04 -33.36 1.42 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.224 -0.922 . . . . 0.0 109.363 -179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.858 ' O ' HG23 ' B' ' 18' ' ' ILE . . . 147.45 -166.49 28.63 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.941 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -171.51 163.44 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.454 -1.027 . . . . 0.0 109.07 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.564 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -57.43 149.73 47.95 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.186 -0.946 . . . . 0.0 109.237 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.645 ' HA ' HD12 ' B' ' 23' ' ' ILE . 35.0 Cg_endo -77.15 -4.36 14.73 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.477 2.118 . . . . 0.0 110.231 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.441 ' O ' ' HD2' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.21 -23.89 21.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.413 -0.804 . . . . 0.0 109.177 179.709 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.506 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.0 m-20 -84.05 -15.84 46.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.227 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.98 HG23 ' HB1' ' B' ' 42' ' ' ALA . 17.0 mt -89.4 169.12 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 110.25 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.581 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.0 OUTLIER -137.58 -39.94 0.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.494 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.439 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 6.0 p -128.18 173.4 10.14 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.423 -0.798 . . . . 0.0 108.971 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.59 HG23 ' HG3' ' B' ' 66' ' ' MET . 47.5 t -142.31 95.44 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.163 -0.961 . . . . 0.0 109.646 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.572 ' O ' HD12 ' B' ' 41' ' ' ILE . 5.1 t-20 -93.03 111.49 23.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.309 -0.869 . . . . 0.0 109.428 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.438 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -109.24 97.73 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.526 ' HD2' ' NE2' ' B' ' 10' ' ' GLN . 1.9 ttmt -90.65 110.38 21.54 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.869 . . . . 0.0 109.504 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.2 p -63.61 167.7 6.72 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.269 -0.894 . . . . 0.0 109.346 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.476 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 36.0 Cg_endo -77.66 145.57 23.22 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.556 2.171 . . . . 0.0 110.432 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -153.89 -140.03 2.97 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.447 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.1 Cg_endo -77.87 10.74 2.49 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.602 2.201 . . . . 0.0 110.943 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.671 ' CD2' HD22 ' B' ' 7' ' ' LEU . 3.2 p-80 -127.8 -32.83 2.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 109.532 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -145.48 115.89 7.57 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 0.0 109.242 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -81.03 7.07 11.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 0.0 109.695 -179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' B' ' 39' ' ' GLU . 1.6 mp0 -120.79 124.6 45.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.123 -0.986 . . . . 0.0 109.473 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.458 HG21 ' HB3' ' A' ' 70' ' ' ASP . 1.6 m -46.74 156.83 0.17 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.305 -0.872 . . . . 0.0 109.319 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.458 ' HA ' ' OE1' ' B' ' 39' ' ' GLU . 7.1 mm-40 -141.36 107.63 5.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.038 -1.039 . . . . 0.0 109.685 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.631 HG11 HD11 ' B' ' 63' ' ' ILE . 41.4 t -90.56 150.47 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.183 179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.572 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.4 mt -140.3 147.85 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.154 -0.967 . . . . 0.0 109.709 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.98 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -135.48 120.03 18.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.36 -0.838 . . . . 0.0 109.115 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 8.6 m -89.26 100.83 13.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.934 -1.104 . . . . 0.0 109.038 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.507 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 84.5 mt -45.99 172.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.427 -0.795 . . . . 0.0 109.814 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -87.92 10.63 18.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.225 -0.922 . . . . 0.0 109.144 179.826 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -114.11 27.53 9.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.055 179.598 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 71.05 11.22 69.97 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.516 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 3.8 mtp180 -100.22 165.94 11.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.231 -1.158 . . . . 0.0 109.471 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.517 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.82 154.08 50.62 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.0 109.176 179.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.531 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.21 123.65 9.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.26 -0.9 . . . . 0.0 109.297 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 7.7 m -79.49 144.87 33.6 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.103 -0.998 . . . . 0.0 109.17 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 1.059 HD13 HD13 ' B' ' 62' ' ' ILE . 15.3 mt -121.88 167.48 12.99 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.26 -0.9 . . . . 0.0 109.532 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.654 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.0 OUTLIER -97.04 118.04 65.19 Favored Pre-proline 0 C--N 1.299 -1.608 0 O-C-N 121.426 -0.797 . . . . 0.0 109.227 180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.33 -0.28 9.47 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.224 1.949 . . . . 0.0 110.344 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -93.31 -14.1 27.35 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.311 -0.868 . . . . 0.0 108.916 179.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.09 162.73 34.26 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.368 179.876 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -78.22 -36.13 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.591 2.194 . . . . 0.0 110.626 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 65.5 mt -66.29 -36.46 77.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.139 -0.975 . . . . 0.0 109.709 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 1.034 ' HA ' HD12 ' B' ' 62' ' ' ILE . 37.8 t -67.89 -51.35 50.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.266 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.505 ' NZ ' ' O ' ' A' ' 70' ' ' ASP . 0.1 OUTLIER -54.39 -30.21 51.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.322 -0.861 . . . . 0.0 108.941 179.547 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.533 ' HB3' ' NZ ' ' B' ' 65' ' ' LYS . 9.6 mmmm -81.97 -28.82 32.46 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.369 -0.832 . . . . 0.0 109.126 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 1.059 HD13 HD13 ' B' ' 52' ' ' LEU . 11.9 mt -59.61 -38.14 74.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.943 HG22 HD11 ' A' ' 67' ' ' LEU . 1.7 mp -76.16 -61.57 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -43.09 -28.73 0.3 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.4 -0.813 . . . . 0.0 109.617 179.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.533 ' NZ ' ' HB3' ' B' ' 61' ' ' LYS . 2.0 mtmt -74.71 -60.27 2.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.231 -0.918 . . . . 0.0 109.337 179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.59 ' HG3' HG23 ' B' ' 26' ' ' VAL . 1.4 mmm -44.09 -47.87 8.93 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.302 -0.873 . . . . 0.0 109.257 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.937 HD11 HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -43.63 -51.19 7.13 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.401 -0.812 . . . . 0.0 109.408 179.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' B' ' 69' ' ' SER . 11.9 t30 -66.48 -34.77 78.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.4 -0.813 . . . . 0.0 109.516 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.42 ' C ' ' O ' ' B' ' 68' ' ' ASN . 1.2 p -43.85 -26.92 0.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.247 -0.908 . . . . 0.0 109.502 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.505 ' O ' ' NZ ' ' A' ' 60' ' ' LYS . 0.3 OUTLIER -112.06 67.55 0.65 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.211 -0.93 . . . . 0.0 109.512 179.979 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -120.17 82.87 1.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.287 -0.883 . . . . 0.0 109.437 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.446 ' O ' ' CB ' ' B' ' 73' ' ' ASN . 0.2 OUTLIER 60.75 170.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.138 -0.976 . . . . 0.0 109.426 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' B' ' 72' ' ' SER . 2.9 p30 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.485 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.413 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.662 ' O ' HG12 ' A' ' 3' ' ' VAL . 0.2 OUTLIER 70.38 161.78 0.23 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.424 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 2' ' ' SER . 7.6 p 41.95 33.51 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.444 -0.785 . . . . 0.0 109.624 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.58 103.37 11.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.271 -0.893 . . . . 0.0 109.445 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.89 92.29 3.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.458 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.98 122.89 0.07 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.302 -0.874 . . . . 0.0 109.466 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.552 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -117.12 98.42 6.45 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.309 -0.869 . . . . 0.0 109.594 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.43 ' O ' ' C ' ' A' ' 9' ' ' CYS . 6.5 mtm180 -90.97 152.23 20.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.355 -0.841 . . . . 0.0 109.056 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.877 ' HB2' HD22 ' A' ' 12' ' ' LEU . 20.1 m -44.05 106.34 0.07 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.157 -0.964 . . . . 0.0 109.359 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.415 ' C ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -42.28 -26.91 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.397 -0.815 . . . . 0.0 109.853 -179.851 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 39' ' ' GLU . 72.4 m -124.17 63.3 1.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.18 -0.95 . . . . 0.0 109.769 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.877 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.71 -39.69 5.35 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.287 -0.883 . . . . 0.0 109.117 179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -123.26 126.47 46.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.453 -0.779 . . . . 0.0 109.061 179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.42 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -103.12 162.86 12.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.118 -0.989 . . . . 0.0 109.935 -179.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.501 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 6.2 mt -115.44 140.96 48.67 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.477 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.7 tt0 -44.34 -26.52 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.306 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.838 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 138.32 -171.34 23.47 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.721 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.4 pp -161.48 162.74 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -1.117 . . . . 0.0 109.399 179.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.601 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -56.36 153.97 17.95 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.272 -0.893 . . . . 0.0 109.274 179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.601 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -76.9 -7.39 17.39 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.438 2.092 . . . . 0.0 109.971 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.512 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 3.1 mttm -80.91 -23.32 39.01 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.843 ' O ' HD13 ' A' ' 23' ' ' ILE . 25.0 m-20 -98.35 59.47 1.33 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.843 HD13 ' O ' ' A' ' 22' ' ' ASN . 2.7 mm -142.49 169.93 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.181 -0.95 . . . . 0.0 110.044 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -160.18 -40.45 0.05 Allowed 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.635 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.5 p -133.53 -173.79 3.32 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 179.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 25' ' ' SER . 50.8 t -159.62 97.57 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.037 -1.04 . . . . 0.0 109.74 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.472 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 3.7 t-20 -94.62 111.42 23.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.243 -0.911 . . . . 0.0 109.396 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.74 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -117.35 103.48 14.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.237 -0.914 . . . . 0.0 109.517 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -107.05 108.43 19.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.314 -0.866 . . . . 0.0 109.43 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.586 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.1 p -50.97 168.68 0.24 Allowed Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.8 Cg_endo -77.99 131.64 11.15 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.523 2.149 . . . . 0.0 110.508 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.04 -143.35 5.39 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -76.57 5.18 4.94 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.594 2.196 . . . . 0.0 110.643 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.552 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 14.1 p-80 -124.39 -10.89 7.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.193 -0.942 . . . . 0.0 109.647 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.523 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 4.0 t -160.2 104.51 1.48 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -0.929 . . . . 0.0 109.316 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.92 -3.59 23.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.921 . . . . 0.0 109.653 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 4.6 mm-40 -114.52 124.67 52.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.194 -0.941 . . . . 0.0 109.523 180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.586 HG23 ' HA ' ' A' ' 30' ' ' SER . 14.1 m -49.43 148.18 2.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.0 109.331 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.465 ' OE2' ' CA ' ' A' ' 9' ' ' CYS . 0.8 OUTLIER -131.22 107.12 8.77 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 0.0 109.743 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.74 HG22 HG13 ' A' ' 28' ' ' VAL . 30.8 t -91.75 156.12 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.245 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.482 HG13 ' SG ' ' A' ' 51' ' ' CYS . 2.1 mp -143.44 144.79 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.165 -0.959 . . . . 0.0 109.799 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.531 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -129.45 124.13 33.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.361 -0.837 . . . . 0.0 109.12 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 23.0 m -89.4 101.76 14.43 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.075 -1.016 . . . . 0.0 109.207 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 22' ' ' ASN . 84.5 mt -43.59 164.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.46 -0.775 . . . . 0.0 109.266 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 11.3 ptpt -85.76 13.36 7.34 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.254 -0.904 . . . . 0.0 109.465 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -112.56 11.04 19.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 109.174 179.506 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.39 21.17 45.68 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.638 ' HB2' HD12 ' A' ' 44' ' ' LEU . 95.6 mtt-85 -116.11 171.43 7.8 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.235 -1.156 . . . . 0.0 109.468 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -137.45 153.76 50.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -0.93 . . . . 0.0 109.477 179.966 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.501 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.22 125.36 10.01 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.413 -0.804 . . . . 0.0 109.029 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.482 ' SG ' HG13 ' A' ' 41' ' ' ILE . 13.9 m -79.57 140.59 37.14 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.006 . . . . 0.0 109.045 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.874 ' HB3' HG22 ' A' ' 59' ' ' VAL . 11.9 mt -122.25 167.81 12.77 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.249 -0.907 . . . . 0.0 109.379 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.655 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.4 t-20 -101.29 121.4 51.91 Favored Pre-proline 0 C--N 1.3 -1.582 0 O-C-N 121.474 -0.766 . . . . 0.0 109.199 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -74.92 -7.1 18.91 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.324 2.016 . . . . 0.0 110.321 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.17 -14.83 49.13 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.242 -0.911 . . . . 0.0 108.95 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.06 162.76 34.27 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.48 -0.763 . . . . 0.0 109.369 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.73 -37.5 0.89 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.733 2.289 . . . . 0.0 110.584 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 52.2 mt -61.88 -52.94 54.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.081 -1.012 . . . . 0.0 109.019 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.874 HG22 ' HB3' ' A' ' 52' ' ' LEU . 56.1 t -53.28 -51.74 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.549 -0.719 . . . . 0.0 109.723 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -50.18 -33.16 18.29 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.077 -1.014 . . . . 0.0 108.958 179.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.535 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 3.2 mmpt? -75.74 -34.71 60.31 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.468 -0.77 . . . . 0.0 109.458 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -60.2 -41.69 87.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.292 -0.88 . . . . 0.0 109.088 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.677 ' N ' HD12 ' A' ' 63' ' ' ILE . 2.2 mp -70.42 -62.32 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.185 -0.947 . . . . 0.0 109.864 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.468 ' OE2' ' HA ' ' A' ' 61' ' ' LYS . 5.9 pt-20 -57.6 -16.57 10.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.047 -1.033 . . . . 0.0 109.439 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.508 ' HG2' ' HB3' ' A' ' 20' ' ' PRO . 5.7 tptm -81.65 -40.66 22.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.2 -0.937 . . . . 0.0 108.664 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.532 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -61.97 -44.81 95.98 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.645 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -43.38 -51.8 6.26 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.551 -0.718 . . . . 0.0 109.308 179.724 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.28 -50.73 72.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.392 -0.818 . . . . 0.0 109.497 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -47.98 -25.68 1.47 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.527 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.521 ' CG ' HG21 ' B' ' 38' ' ' THR . 20.6 m-20 -103.43 61.52 0.77 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.238 -0.914 . . . . 0.0 109.485 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -109.08 -64.21 1.27 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.233 -0.917 . . . . 0.0 109.497 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 75.4 m -135.63 -43.4 0.68 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.523 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.945 -1.026 . . . . 0.0 109.499 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.414 ' O ' ' CB ' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.652 ' O ' HG12 ' B' ' 3' ' ' VAL . 0.2 OUTLIER 70.2 161.87 0.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.188 -0.945 . . . . 0.0 109.481 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.652 HG12 ' O ' ' B' ' 2' ' ' SER . 7.8 p 41.84 33.61 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.389 -0.819 . . . . 0.0 109.629 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -110.65 103.32 11.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.424 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.8 92.3 3.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 0.0 109.507 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -179.96 122.93 0.07 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.163 -0.961 . . . . 0.0 109.498 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.542 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -117.09 98.41 6.45 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.305 -0.872 . . . . 0.0 109.632 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 9' ' ' CYS . 6.5 mtm180 -90.93 152.25 20.79 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.354 -0.841 . . . . 0.0 109.08 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.873 ' HB2' HD22 ' B' ' 12' ' ' LEU . 20.1 m -44.04 106.29 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.152 -0.967 . . . . 0.0 109.403 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -42.18 -27.0 0.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.466 -0.771 . . . . 0.0 109.884 -179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.437 ' HB2' ' HB3' ' B' ' 39' ' ' GLU . 72.6 m -124.22 63.38 1.08 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.21 -0.931 . . . . 0.0 109.688 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.873 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.72 -39.78 5.45 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 0.0 109.062 179.782 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 mm-40 -123.19 126.49 47.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.348 -0.845 . . . . 0.0 109.085 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.417 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -103.14 162.88 12.59 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.195 -0.941 . . . . 0.0 110.015 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.506 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 6.3 mt -115.48 140.93 48.71 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.486 ' O ' HG23 ' B' ' 59' ' ' VAL . 2.7 tt0 -44.27 -26.57 0.33 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.165 -0.959 . . . . 0.0 109.376 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.837 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 138.35 -171.27 23.52 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.725 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.4 pp -161.53 162.74 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.34 -1.094 . . . . 0.0 109.379 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -56.28 153.89 17.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.346 -0.846 . . . . 0.0 109.322 179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -76.88 -7.35 17.4 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.451 2.1 . . . . 0.0 109.963 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.519 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 3.1 mttm -80.9 -23.37 39.02 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.821 ' O ' HD13 ' B' ' 23' ' ' ILE . 25.0 m-20 -98.37 59.46 1.33 Allowed 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.821 HD13 ' O ' ' B' ' 22' ' ' ASN . 2.6 mm -142.47 169.97 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.216 -0.927 . . . . 0.0 110.042 -179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.3 OUTLIER -160.16 -40.43 0.05 Allowed 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.633 ' O ' HG23 ' B' ' 26' ' ' VAL . 1.5 p -133.55 -173.83 3.34 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.633 HG23 ' O ' ' B' ' 25' ' ' SER . 51.0 t -159.58 97.58 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.963 -1.086 . . . . 0.0 109.773 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.49 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 3.7 t-20 -94.67 111.38 23.15 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.191 -0.943 . . . . 0.0 109.412 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.745 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -117.3 103.52 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.279 -0.888 . . . . 0.0 109.464 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 11.9 tttp -107.12 108.48 19.97 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.388 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.587 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -51.05 168.64 0.24 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.8 Cg_endo -77.97 131.63 11.17 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.594 2.196 . . . . 0.0 110.459 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.01 -143.29 5.38 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -76.61 5.22 4.94 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.598 2.199 . . . . 0.0 110.64 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.542 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 14.1 p-80 -124.38 -10.96 7.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.226 -0.921 . . . . 0.0 109.584 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 4.0 t -160.18 104.54 1.48 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.158 -0.964 . . . . 0.0 109.347 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -71.87 -3.64 23.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.265 -0.897 . . . . 0.0 109.716 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' B' ' 39' ' ' GLU . 4.6 mm-40 -114.48 124.7 52.57 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.096 -1.003 . . . . 0.0 109.522 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.587 HG23 ' HA ' ' B' ' 30' ' ' SER . 14.3 m -49.44 148.22 2.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.279 -0.888 . . . . 0.0 109.308 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.479 ' OE2' ' CA ' ' B' ' 9' ' ' CYS . 0.9 OUTLIER -131.24 107.29 8.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.669 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.745 HG22 HG13 ' B' ' 28' ' ' VAL . 31.2 t -91.9 156.22 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.213 179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' B' ' 27' ' ' ASN . 2.1 mp -143.54 144.78 23.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.152 -0.968 . . . . 0.0 109.778 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.535 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -129.49 124.29 33.61 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.381 -0.824 . . . . 0.0 109.044 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.527 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 23.0 m -89.45 101.76 14.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.934 -1.104 . . . . 0.0 109.156 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.775 HD23 ' O ' ' B' ' 22' ' ' ASN . 84.9 mt -43.61 164.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.5 -0.75 . . . . 0.0 109.245 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 11.3 ptpt -85.74 13.35 7.32 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.0 109.489 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.482 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -112.52 11.05 19.69 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.888 . . . . 0.0 109.256 179.489 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.36 21.21 45.68 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.628 ' HB2' HD12 ' B' ' 44' ' ' LEU . 95.5 mtt-85 -116.19 171.49 7.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -1.178 . . . . 0.0 109.43 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -137.51 153.7 49.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.23 -0.919 . . . . 0.0 109.425 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.506 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.22 125.32 9.99 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.303 -0.873 . . . . 0.0 109.081 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' B' ' 41' ' ' ILE . 13.8 m -79.54 140.59 37.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.029 -1.045 . . . . 0.0 109.109 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.873 ' HB3' HG22 ' B' ' 59' ' ' VAL . 11.9 mt -122.19 167.78 12.79 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.344 -0.847 . . . . 0.0 109.409 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.654 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.4 t-20 -101.32 121.37 51.96 Favored Pre-proline 0 C--N 1.299 -1.598 0 O-C-N 121.396 -0.815 . . . . 0.0 109.195 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.96 -6.92 18.7 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.262 1.975 . . . . 0.0 110.321 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.28 -14.84 48.71 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.22 -0.925 . . . . 0.0 108.946 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.48 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.02 162.7 34.56 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.468 -0.77 . . . . 0.0 109.406 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.77 -37.4 0.9 Allowed 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.613 2.209 . . . . 0.0 110.65 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.523 ' O ' HD13 ' B' ' 62' ' ' ILE . 52.3 mt -61.86 -53.01 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.16 -0.963 . . . . 0.0 109.004 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.873 HG22 ' HB3' ' B' ' 52' ' ' LEU . 55.9 t -53.2 -51.73 37.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.55 -0.719 . . . . 0.0 109.796 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.48 ' HG3' ' O ' ' B' ' 56' ' ' SER . 0.2 OUTLIER -50.24 -33.17 18.71 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.256 -0.902 . . . . 0.0 108.899 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.536 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 3.2 mmpt? -75.58 -34.92 60.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.468 -0.77 . . . . 0.0 109.477 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.523 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -60.1 -41.73 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.31 -0.869 . . . . 0.0 109.077 179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.682 ' N ' HD12 ' B' ' 63' ' ' ILE . 2.2 mp -70.39 -62.32 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.303 -0.873 . . . . 0.0 109.888 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.47 ' OE2' ' HA ' ' B' ' 61' ' ' LYS . 5.9 pt-20 -57.54 -16.61 10.52 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.063 -1.023 . . . . 0.0 109.437 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' B' ' 20' ' ' PRO . 5.7 tptm -81.61 -40.79 22.46 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.275 -0.891 . . . . 0.0 108.644 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.537 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -61.85 -44.88 95.93 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.398 -0.814 . . . . 0.0 108.85 179.386 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.664 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -43.36 -51.76 6.25 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.511 -0.743 . . . . 0.0 109.34 179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -58.37 -50.66 72.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.382 -0.824 . . . . 0.0 109.495 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -48.01 -25.56 1.44 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.22 -0.925 . . . . 0.0 109.509 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.513 ' CG ' HG21 ' A' ' 38' ' ' THR . 20.9 m-20 -103.55 61.52 0.76 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.437 179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 1.5 ttpt -109.05 -64.22 1.27 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.893 . . . . 0.0 109.451 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 75.6 m -135.67 -43.49 0.67 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.478 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 117.963 -1.017 . . . . 0.0 109.432 -179.979 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.8 p -97.34 -34.84 10.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.446 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.451 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 12.1 t -137.29 -63.47 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.307 -0.87 . . . . 0.0 109.497 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 3' ' ' VAL . . . 62.11 78.7 0.28 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 109.477 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.446 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 0.7 OUTLIER -92.44 76.84 5.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.309 -0.869 . . . . 0.0 109.476 -179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 5' ' ' THR . 1.6 mt-10 -160.65 96.52 1.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.449 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.663 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -125.8 101.89 7.06 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.239 -0.913 . . . . 0.0 109.554 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 9' ' ' CYS . 27.2 mtt180 -96.56 155.06 16.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.112 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.491 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m -44.02 113.31 0.51 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.213 -0.929 . . . . 0.0 109.406 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.525 ' HG3' ' CB ' ' A' ' 29' ' ' LYS . 7.1 mm-40 -42.88 -26.23 0.13 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.301 -0.874 . . . . 0.0 109.891 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.475 ' SG ' HG13 ' A' ' 41' ' ' ILE . 60.3 m -148.74 72.63 1.19 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.085 -1.009 . . . . 0.0 109.903 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.491 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.87 -46.05 15.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.127 -0.983 . . . . 0.0 108.799 179.505 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -116.17 121.69 42.83 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 179.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.5 OUTLIER -98.26 166.18 11.51 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.24 -0.912 . . . . 0.0 110.056 -179.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.513 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.1 mt -115.02 146.01 41.7 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.716 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -44.05 -42.76 6.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.213 -0.929 . . . . 0.0 109.413 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.98 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 147.36 -167.5 28.51 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.032 -1.227 . . . . 0.0 110.032 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.952 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -169.5 163.43 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.396 -1.061 . . . . 0.0 109.252 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.58 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -55.74 151.14 23.85 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.285 -0.885 . . . . 0.0 109.263 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.58 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.44 -2.31 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.551 2.167 . . . . 0.0 110.175 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HD2' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -90.23 -24.79 20.88 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.43 -0.794 . . . . 0.0 109.136 179.719 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.512 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.7 m-20 -83.47 -9.59 58.9 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.391 -0.818 . . . . 0.0 109.288 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.952 HD11 ' CD1' ' A' ' 18' ' ' ILE . 7.9 mt -101.97 165.81 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.288 -0.882 . . . . 0.0 110.436 -179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.578 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -139.07 -31.67 0.7 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.578 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.3 p -128.68 168.66 15.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.072 -1.017 . . . . 0.0 108.84 179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.519 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 56.1 t -141.18 105.65 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.026 -1.046 . . . . 0.0 109.857 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.731 ' O ' HD12 ' A' ' 41' ' ' ILE . 5.2 t-20 -105.79 111.67 24.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -0.941 . . . . 0.0 109.457 179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.798 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -116.05 103.44 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.265 -0.897 . . . . 0.0 109.537 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.525 ' CB ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -95.96 105.94 18.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.905 . . . . 0.0 109.395 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.462 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.1 p -51.92 167.87 0.31 Allowed Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.232 -0.918 . . . . 0.0 109.401 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.52 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 35.7 Cg_endo -78.01 131.95 11.34 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.566 2.177 . . . . 0.0 110.514 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.47 -143.32 4.82 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -76.55 4.93 5.11 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.57 2.18 . . . . 0.0 110.636 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.663 ' CD2' HD22 ' A' ' 7' ' ' LEU . 14.6 p-80 -123.95 -10.6 7.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.145 -0.972 . . . . 0.0 109.595 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.5 t -160.08 124.13 3.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.183 -0.948 . . . . 0.0 109.269 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.52 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -80.74 -38.03 29.42 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.312 -0.868 . . . . 0.0 109.658 -179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.435 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 2.0 mp0 -86.73 140.21 29.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.619 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.462 HG23 ' HA ' ' A' ' 30' ' ' SER . 50.6 m -60.79 153.88 23.28 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.271 -0.893 . . . . 0.0 109.282 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.465 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 2.5 mp0 -130.33 107.06 8.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.167 -0.958 . . . . 0.0 109.688 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.798 HG22 HG13 ' A' ' 28' ' ' VAL . 38.9 t -89.59 154.13 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.357 -0.84 . . . . 0.0 109.148 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.731 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.1 mp -141.99 153.08 18.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.109 -0.994 . . . . 0.0 109.782 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.939 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -140.45 121.55 14.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.823 . . . . 0.0 109.063 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.528 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 3.1 m -89.17 103.94 16.52 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.887 -1.133 . . . . 0.0 108.798 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.512 ' HA ' ' O ' ' A' ' 22' ' ' ASN . 79.7 mt -48.75 177.06 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.541 -0.724 . . . . 0.0 109.742 -179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -90.03 8.53 32.07 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 0.0 109.187 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.486 ' ND2' ' HD2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -113.79 28.97 8.35 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.251 -0.906 . . . . 0.0 109.127 179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.81 11.77 66.63 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.584 -1.407 . . . . 0.0 109.584 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.486 ' HD2' ' ND2' ' A' ' 46' ' ' ASN . 57.9 mtt180 -98.77 168.83 9.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -1.154 . . . . 0.0 109.434 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.431 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 16.3 mttt -140.24 151.25 45.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.31 -0.869 . . . . 0.0 109.242 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.513 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.22 123.42 8.89 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.286 -0.884 . . . . 0.0 109.08 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.483 ' SG ' HG13 ' A' ' 41' ' ' ILE . 15.3 m -79.56 144.69 33.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.082 -1.011 . . . . 0.0 109.258 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.98 HD22 ' HA2' ' A' ' 17' ' ' GLY . 15.2 mt -121.33 167.59 12.59 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.343 -0.848 . . . . 0.0 109.278 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.642 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.8 t-20 -100.18 121.1 54.84 Favored Pre-proline 0 C--N 1.298 -1.668 0 O-C-N 121.385 -0.822 . . . . 0.0 109.103 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -75.03 -9.27 20.66 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.137 1.891 . . . . 0.0 110.271 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.96 -14.8 57.63 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.269 -0.894 . . . . 0.0 108.804 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -89.97 159.87 41.88 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.404 -0.81 . . . . 0.0 109.376 179.797 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.433 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.68 -34.36 1.91 Allowed 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.667 2.245 . . . . 0.0 110.722 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.599 ' O ' HD13 ' A' ' 62' ' ' ILE . 12.5 tt -66.65 -46.76 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.134 -0.979 . . . . 0.0 109.11 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.847 HG22 ' HB3' ' A' ' 52' ' ' LEU . 38.6 t -57.08 -48.62 81.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 109.048 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 1.1 mttp -55.14 -31.28 61.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.492 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.9 OUTLIER -76.28 -30.62 57.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.615 -0.678 . . . . 0.0 109.297 179.94 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.599 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -65.16 -44.51 95.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.352 -0.842 . . . . 0.0 109.015 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.912 HG22 HD11 ' B' ' 67' ' ' LEU . 2.2 mp -67.53 -61.66 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.294 -0.879 . . . . 0.0 109.613 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.507 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -52.61 -27.94 19.16 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 0.0 109.633 -179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.55 ' CD ' ' HG3' ' A' ' 20' ' ' PRO . 0.0 OUTLIER -71.48 -40.91 69.94 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.189 -0.944 . . . . 0.0 109.187 179.764 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.519 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -63.36 -46.9 84.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.36 -0.838 . . . . 0.0 109.185 179.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.946 HD11 HG22 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.58 -51.12 9.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.522 -0.736 . . . . 0.0 109.455 179.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -71.97 -29.08 63.88 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.296 -0.878 . . . . 0.0 109.546 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.452 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p -63.83 -18.4 64.09 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' OD2' ' HA ' ' A' ' 67' ' ' LEU . 2.6 p30 -101.47 46.61 0.93 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.279 -0.888 . . . . 0.0 109.403 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 5.9 ttmt -86.45 -35.58 19.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 34.4 t -157.3 -61.16 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.333 -0.855 . . . . 0.0 109.474 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 51.8 t30 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.503 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.9 p -97.21 -35.0 10.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.282 -0.886 . . . . 0.0 109.436 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.448 ' O ' ' HB3' ' B' ' 4' ' ' ALA . 12.0 t -137.25 -63.55 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.235 -0.916 . . . . 0.0 109.523 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' B' ' 3' ' ' VAL . . . 62.2 78.69 0.28 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.21 -0.931 . . . . 0.0 109.452 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.441 ' O ' ' HG3' ' B' ' 6' ' ' GLU . 0.6 OUTLIER -92.43 76.9 5.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.292 -0.88 . . . . 0.0 109.496 179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' B' ' 5' ' ' THR . 1.6 mt-10 -160.68 96.52 1.15 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.435 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.656 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -125.84 101.92 7.06 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.236 -0.915 . . . . 0.0 109.593 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.407 ' O ' ' C ' ' B' ' 9' ' ' CYS . 27.4 mtt180 -96.64 155.09 16.92 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.281 -0.887 . . . . 0.0 109.073 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.478 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 1.8 m -44.02 113.35 0.51 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.183 -0.948 . . . . 0.0 109.398 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.526 ' HG3' ' CB ' ' B' ' 29' ' ' LYS . 7.1 mm-40 -42.9 -26.26 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.312 -0.867 . . . . 0.0 109.853 -179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' B' ' 41' ' ' ILE . 60.2 m -148.68 72.6 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.083 -1.011 . . . . 0.0 109.953 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.478 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.8 -46.04 15.17 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.205 -0.935 . . . . 0.0 108.773 179.477 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -116.19 121.59 42.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.414 -0.804 . . . . 0.0 108.896 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.5 OUTLIER -98.25 166.15 11.53 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.146 -0.972 . . . . 0.0 110.068 -179.347 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.504 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.1 mt -115.0 146.09 41.6 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.715 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.7 OUTLIER -44.18 -42.66 6.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.151 -0.968 . . . . 0.0 109.386 -179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 1.051 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 147.31 -167.56 28.48 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.967 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -169.44 163.44 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.509 -0.995 . . . . 0.0 109.272 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.594 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -55.72 151.1 23.76 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.267 -179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.9 Cg_endo -77.4 -2.3 12.49 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.515 2.143 . . . . 0.0 110.224 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.444 ' O ' ' HD2' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -90.25 -24.83 20.84 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.34 -0.85 . . . . 0.0 109.159 179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.7 m-20 -83.37 -9.58 58.96 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.354 -0.841 . . . . 0.0 109.295 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.967 HD11 ' CD1' ' B' ' 18' ' ' ILE . 8.0 mt -102.02 165.83 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.298 -0.876 . . . . 0.0 110.438 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.581 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -139.05 -31.79 0.69 Allowed 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.297 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.581 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.3 p -128.62 168.56 15.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.102 -0.999 . . . . 0.0 108.85 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.513 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 55.7 t -141.13 105.78 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.145 -0.972 . . . . 0.0 109.77 -179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.711 ' O ' HD12 ' B' ' 41' ' ' ILE . 5.2 t-20 -105.9 111.72 24.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.265 -0.897 . . . . 0.0 109.393 179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.762 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -116.09 103.42 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.198 -0.938 . . . . 0.0 109.525 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.526 ' CB ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -96.05 105.89 17.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.21 -0.931 . . . . 0.0 109.408 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.46 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -51.88 167.92 0.31 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.236 -0.915 . . . . 0.0 109.389 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.518 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 36.2 Cg_endo -78.03 131.99 11.34 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.599 2.199 . . . . 0.0 110.51 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.57 -143.39 4.82 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.381 -1.487 . . . . 0.0 109.381 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -76.6 5.07 5.03 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.5 2.133 . . . . 0.0 110.581 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.656 ' CD2' HD22 ' B' ' 7' ' ' LEU . 14.5 p-80 -123.93 -10.71 7.69 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.191 -0.943 . . . . 0.0 109.565 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 3.5 t -160.07 124.1 3.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.518 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -80.64 -38.09 29.81 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.75 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.428 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 2.0 mp0 -86.71 140.17 30.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 109.664 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.46 HG23 ' HA ' ' B' ' 30' ' ' SER . 50.6 m -60.72 153.93 22.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 109.261 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.456 ' HB3' ' SG ' ' B' ' 11' ' ' CYS . 2.5 mp0 -130.37 107.08 8.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.214 -0.929 . . . . 0.0 109.631 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.762 HG22 HG13 ' B' ' 28' ' ' VAL . 39.1 t -89.68 154.2 3.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.102 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.711 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.1 mp -142.03 153.07 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.125 -0.984 . . . . 0.0 109.842 -179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.946 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -140.45 121.57 14.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.436 -0.79 . . . . 0.0 108.972 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 3.1 m -89.18 103.87 16.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.871 -1.143 . . . . 0.0 108.856 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 80.1 mt -48.71 177.03 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.489 -0.757 . . . . 0.0 109.747 -179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.444 ' HD2' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -90.03 8.63 31.6 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.248 -0.907 . . . . 0.0 109.156 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.495 ' ND2' ' HD2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -113.86 29.05 8.29 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.299 -0.876 . . . . 0.0 109.139 179.641 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.85 11.73 66.69 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.495 ' HD2' ' ND2' ' B' ' 46' ' ' ASN . 57.8 mtt180 -98.78 168.8 9.91 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.272 -1.134 . . . . 0.0 109.466 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.439 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 16.3 mttt -140.22 151.36 45.12 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.28 -0.887 . . . . 0.0 109.219 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.504 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.31 123.38 8.81 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.257 -0.902 . . . . 0.0 109.039 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.48 ' SG ' HG13 ' B' ' 41' ' ' ILE . 15.3 m -79.56 144.7 33.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.252 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 1.051 HD22 ' HA2' ' B' ' 17' ' ' GLY . 15.3 mt -121.38 167.5 12.7 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.24 -0.913 . . . . 0.0 109.222 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.641 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.8 t-20 -100.12 121.13 54.82 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.169 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -74.95 -9.39 20.82 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.214 1.943 . . . . 0.0 110.292 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.89 -14.77 57.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.285 -0.885 . . . . 0.0 108.851 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.494 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -90.01 159.88 41.74 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.411 -0.806 . . . . 0.0 109.304 179.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.424 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.71 -34.22 1.96 Allowed 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.675 2.25 . . . . 0.0 110.727 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.607 ' O ' HD13 ' B' ' 62' ' ' ILE . 12.6 tt -66.76 -46.75 84.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.109 -0.994 . . . . 0.0 109.083 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.875 HG22 ' HB3' ' B' ' 52' ' ' LEU . 38.4 t -57.11 -48.58 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.363 -0.835 . . . . 0.0 109.059 179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' B' ' 56' ' ' SER . 1.1 mttp -55.18 -31.28 61.27 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' B' ' 65' ' ' LYS . 0.9 OUTLIER -76.3 -30.56 57.8 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.566 -0.709 . . . . 0.0 109.329 179.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.607 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -65.07 -44.69 95.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.356 -0.84 . . . . 0.0 109.009 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.946 HG22 HD11 ' A' ' 67' ' ' LEU . 2.2 mp -67.41 -61.7 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.26 -0.9 . . . . 0.0 109.629 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.511 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.2 OUTLIER -52.61 -28.01 19.41 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.179 -0.951 . . . . 0.0 109.579 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.547 ' CD ' ' HG3' ' B' ' 20' ' ' PRO . 0.0 OUTLIER -71.47 -40.85 70.0 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.114 -0.991 . . . . 0.0 109.225 179.821 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.513 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -63.36 -46.94 84.24 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.343 -0.848 . . . . 0.0 109.207 179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.912 HD11 HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.63 -51.08 9.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.323 -0.861 . . . . 0.0 109.451 179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -71.94 -29.13 63.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.326 -0.859 . . . . 0.0 109.536 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.429 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.2 p -63.85 -18.38 64.09 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.515 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.46 ' OD2' ' HA ' ' B' ' 67' ' ' LEU . 2.6 p30 -101.39 46.56 0.93 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.299 -0.876 . . . . 0.0 109.505 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -86.42 -35.54 19.65 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.245 -0.909 . . . . 0.0 109.527 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 34.3 t -157.39 -61.18 0.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.442 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 51.9 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.464 -179.998 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.3 p -156.54 129.61 7.93 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -0.908 . . . . 0.0 109.472 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 19.0 m -140.14 130.45 29.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.324 -0.86 . . . . 0.0 109.449 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.46 157.52 40.89 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.48 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.407 ' C ' ' HG3' ' A' ' 6' ' ' GLU . 0.2 OUTLIER -103.2 9.67 38.12 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.21 -0.932 . . . . 0.0 109.52 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.407 ' HG3' ' C ' ' A' ' 5' ' ' THR . 1.2 mp0 -134.96 106.01 6.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.184 -0.947 . . . . 0.0 109.403 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.548 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -116.45 98.24 6.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.188 -0.945 . . . . 0.0 109.511 -179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.5 OUTLIER -90.28 151.52 21.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.34 -0.85 . . . . 0.0 109.071 179.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.929 ' HB2' HD22 ' A' ' 12' ' ' LEU . 10.4 m -43.99 108.38 0.11 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.129 -0.982 . . . . 0.0 109.401 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.55 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 16.0 mm-40 -43.01 -26.44 0.14 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.735 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' A' ' 41' ' ' ILE . 96.8 m -125.61 63.16 1.2 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.209 -0.932 . . . . 0.0 109.82 -179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.929 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.09 -38.28 4.91 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.236 -0.915 . . . . 0.0 109.051 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -125.29 131.54 53.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.408 -0.808 . . . . 0.0 108.962 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.493 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.2 OUTLIER -108.42 163.18 13.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.098 -1.001 . . . . 0.0 109.995 -179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.535 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.3 mt -120.78 146.04 46.93 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.73 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.9 tt0 -44.26 -40.68 5.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.0 109.41 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.861 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 150.12 -168.11 30.12 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 1.013 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -168.49 163.59 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.487 -1.007 . . . . 0.0 109.213 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.541 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -57.89 150.63 48.15 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.227 -0.92 . . . . 0.0 109.434 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.548 ' HG3' ' CD ' ' A' ' 65' ' ' LYS . 34.9 Cg_endo -77.44 -2.78 12.97 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.571 2.18 . . . . 0.0 110.202 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.24 -24.85 20.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.338 -0.851 . . . . 0.0 109.069 179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.524 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 3.4 m-20 -83.31 -5.53 59.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.326 -0.859 . . . . 0.0 109.354 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.013 HD11 ' CD1' ' A' ' 18' ' ' ILE . 7.0 mt -107.07 145.57 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 110.103 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.544 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -117.78 -26.19 6.6 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.624 ' O ' HG23 ' A' ' 26' ' ' VAL . 0.0 OUTLIER -143.53 172.24 13.07 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.496 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.624 HG23 ' O ' ' A' ' 25' ' ' SER . 50.6 t -159.52 137.59 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.943 -1.098 . . . . 0.0 109.98 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 43.3 t30 -112.47 169.21 9.04 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.346 -0.846 . . . . 0.0 109.203 179.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 t -151.27 92.84 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.23 -0.919 . . . . 0.0 109.543 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.55 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 0.6 OUTLIER -100.19 116.12 31.46 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.249 -0.907 . . . . 0.0 109.559 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.24 167.49 9.99 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 109.355 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.529 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.6 Cg_endo -78.0 131.33 10.94 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.677 2.251 . . . . 0.0 110.483 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.62 -144.1 4.76 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.95 6.9 3.89 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.593 2.196 . . . . 0.0 110.736 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.548 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 12.4 p-80 -125.09 -7.3 7.15 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.141 -0.975 . . . . 0.0 109.551 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.0 t -160.04 116.34 2.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.16 -0.963 . . . . 0.0 109.418 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.12 45.79 1.21 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.556 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.529 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 6.1 pt20 -174.47 139.57 0.58 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.259 -0.901 . . . . 0.0 109.462 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' B' ' 70' ' ' ASP . 1.3 m -57.58 151.32 17.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.232 -0.918 . . . . 0.0 109.334 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.455 ' OE2' ' HG2' ' A' ' 29' ' ' LYS . 6.4 pt-20 -138.05 114.97 10.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.14 -0.975 . . . . 0.0 109.616 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.81 154.02 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 109.222 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.535 ' O ' HG13 ' A' ' 26' ' ' VAL . 4.2 mt -138.39 154.28 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.205 -0.934 . . . . 0.0 109.729 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.813 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -137.24 118.77 14.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 109.246 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.592 HG22 ' O ' ' A' ' 43' ' ' THR . 1.2 m -89.17 96.4 10.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.962 -1.086 . . . . 0.0 108.63 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 89.4 mt -43.18 167.36 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.572 -0.705 . . . . 0.0 109.881 -179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -80.67 7.59 9.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.645 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.98 23.42 13.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 109.299 179.747 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.33 7.41 82.41 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 0.7 OUTLIER -95.54 167.64 11.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.156 -1.202 . . . . 0.0 109.497 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.44 ' HD3' ' OG1' ' A' ' 43' ' ' THR . 18.5 mttt -138.75 151.36 47.04 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.462 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.535 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.3 122.19 8.17 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.29 -0.881 . . . . 0.0 109.114 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.481 ' SG ' HG12 ' A' ' 41' ' ' ILE . 4.4 m -79.64 142.16 35.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.135 -0.978 . . . . 0.0 109.065 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.861 HD22 ' HA2' ' A' ' 17' ' ' GLY . 12.7 mt -120.03 167.44 12.18 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.292 -0.88 . . . . 0.0 109.492 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.658 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -97.2 115.75 65.81 Favored Pre-proline 0 C--N 1.299 -1.627 0 O-C-N 121.434 -0.791 . . . . 0.0 109.226 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.488 ' O ' ' HE3' ' A' ' 60' ' ' LYS . 33.3 Cg_endo -74.17 0.17 8.8 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.275 1.984 . . . . 0.0 110.433 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.05 -13.85 24.81 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.281 -0.887 . . . . 0.0 108.944 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 164.61 27.25 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.423 -0.798 . . . . 0.0 109.407 179.938 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.9 -37.63 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.676 2.251 . . . . 0.0 110.568 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 10.0 mt -61.4 -51.88 67.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.143 -0.973 . . . . 0.0 109.058 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.861 HG22 ' HB3' ' A' ' 52' ' ' LEU . 54.4 t -54.56 -54.3 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.518 -0.739 . . . . 0.0 109.744 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.495 ' HG3' ' O ' ' A' ' 56' ' ' SER . 5.1 mttt -47.5 -33.71 6.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.092 -1.005 . . . . 0.0 108.971 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -74.61 -38.56 62.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.494 -0.754 . . . . 0.0 109.328 179.929 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -58.13 -41.96 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.429 -0.794 . . . . 0.0 109.146 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.122 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -70.12 -67.87 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 0.0 109.762 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG2' ' HA ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -44.02 -28.27 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 0.0 109.663 -179.63 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.548 ' CD ' ' HG3' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -72.88 -59.93 2.47 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.183 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.414 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.8 OUTLIER -44.12 -44.42 7.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.388 -0.82 . . . . 0.0 109.183 179.638 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.114 HD11 ' CG2' ' B' ' 63' ' ' ILE . 1.3 mt -55.16 -58.68 6.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.516 -0.74 . . . . 0.0 109.705 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -80.86 6.85 11.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 0.0 109.734 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 65' ' ' LYS . 10.0 p -94.24 -10.21 33.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.223 -0.923 . . . . 0.0 109.465 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' O ' ' CG ' ' A' ' 71' ' ' LYS . 0.6 OUTLIER -107.79 27.58 9.05 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.299 -0.875 . . . . 0.0 109.472 -179.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' A' ' 70' ' ' ASP . 18.3 pttm 41.78 -161.58 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.492 -0.755 . . . . 0.0 109.663 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.98 -63.19 0.41 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.333 -0.854 . . . . 0.0 109.459 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.502 -179.999 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 53.4 p -156.56 129.58 7.91 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.448 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 19.1 m -140.1 130.45 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.315 -0.865 . . . . 0.0 109.462 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.52 157.4 41.28 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.265 -0.897 . . . . 0.0 109.484 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.417 ' C ' ' HG3' ' B' ' 6' ' ' GLU . 0.2 OUTLIER -103.1 9.68 38.33 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.296 -0.878 . . . . 0.0 109.515 179.973 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.417 ' HG3' ' C ' ' B' ' 5' ' ' THR . 1.2 mp0 -134.92 106.0 6.65 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.282 -0.886 . . . . 0.0 109.444 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.55 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -116.41 98.21 6.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.26 -0.9 . . . . 0.0 109.554 179.986 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.5 OUTLIER -90.15 151.56 21.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.31 -0.869 . . . . 0.0 109.142 179.616 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.89 ' HB2' HD22 ' B' ' 12' ' ' LEU . 10.3 m -44.15 108.44 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.898 . . . . 0.0 109.359 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.553 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 15.8 mm-40 -43.01 -26.46 0.14 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.313 -0.867 . . . . 0.0 109.72 -179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.468 ' SG ' HG13 ' B' ' 41' ' ' ILE . 95.9 m -125.64 63.29 1.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.131 -0.981 . . . . 0.0 109.784 -179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.89 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.18 -38.35 5.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -125.2 131.57 53.15 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.818 . . . . 0.0 108.966 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.496 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.2 OUTLIER -108.43 163.17 13.45 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.12 -0.988 . . . . 0.0 110.025 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.542 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.3 mt -120.74 146.0 46.93 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.72 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.9 tt0 -44.29 -40.64 5.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.974 . . . . 0.0 109.42 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.838 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 150.09 -168.08 30.1 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.995 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -168.52 163.52 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.454 -1.027 . . . . 0.0 109.255 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.547 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -57.81 150.45 48.15 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.251 -0.906 . . . . 0.0 109.401 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.549 ' HG3' ' CD ' ' B' ' 65' ' ' LYS . 35.3 Cg_endo -77.32 -2.79 13.0 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.59 2.194 . . . . 0.0 110.231 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.465 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.21 -24.88 20.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.383 -0.823 . . . . 0.0 109.057 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 3.4 m-20 -83.33 -5.56 59.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.463 -0.773 . . . . 0.0 109.217 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.995 HD11 ' CD1' ' B' ' 18' ' ' ILE . 7.1 mt -107.13 145.46 14.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.296 -0.878 . . . . 0.0 110.112 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.545 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -117.71 -26.09 6.66 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.176 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.63 ' O ' HG23 ' B' ' 26' ' ' VAL . 0.0 OUTLIER -143.57 172.22 13.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.419 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.63 HG23 ' O ' ' B' ' 25' ' ' SER . 50.4 t -159.49 137.58 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 120.969 -1.082 . . . . 0.0 109.993 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.489 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 43.2 t30 -112.48 169.26 9.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.29 -0.881 . . . . 0.0 109.293 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 t -151.32 92.97 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.226 -0.921 . . . . 0.0 109.436 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.553 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 0.6 OUTLIER -100.26 116.19 31.67 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.276 -0.89 . . . . 0.0 109.52 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.27 167.45 10.14 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 109.413 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.537 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.7 Cg_endo -77.98 131.3 10.93 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.632 2.222 . . . . 0.0 110.494 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.58 -144.1 4.76 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.93 6.87 3.91 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.552 2.168 . . . . 0.0 110.763 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.55 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 12.3 p-80 -125.01 -7.37 7.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.046 -1.034 . . . . 0.0 109.505 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.9 t -160.07 116.25 2.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.355 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.01 45.76 1.2 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.266 -0.896 . . . . 0.0 109.64 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.537 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 6.1 pt20 -174.54 139.47 0.57 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.17 -0.956 . . . . 0.0 109.549 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.48 ' OG1' ' HB3' ' A' ' 70' ' ' ASP . 1.3 m -57.6 151.34 17.26 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.322 -0.862 . . . . 0.0 109.338 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.453 ' HB2' ' SG ' ' B' ' 11' ' ' CYS . 6.4 pt-20 -138.02 114.94 10.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.175 -0.953 . . . . 0.0 109.611 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 22.0 t -100.86 154.0 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -0.859 . . . . 0.0 109.153 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.528 ' O ' HG13 ' B' ' 26' ' ' VAL . 4.2 mt -138.36 154.21 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.746 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.813 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -137.19 118.77 14.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.221 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.606 HG22 ' O ' ' B' ' 43' ' ' THR . 1.2 m -89.17 96.41 10.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.027 -1.046 . . . . 0.0 108.63 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.6 mt -43.22 167.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.581 -0.699 . . . . 0.0 109.895 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.465 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -80.67 7.68 9.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.318 -0.864 . . . . 0.0 109.652 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.11 23.46 13.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.95 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.29 7.44 82.36 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.513 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 0.7 OUTLIER -95.54 167.66 11.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.199 -1.177 . . . . 0.0 109.507 179.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.443 ' HD3' ' OG1' ' B' ' 43' ' ' THR . 18.4 mttt -138.71 151.31 47.04 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.258 -0.902 . . . . 0.0 109.511 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.542 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.26 122.27 8.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.367 -0.833 . . . . 0.0 109.117 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.476 ' SG ' HG12 ' B' ' 41' ' ' ILE . 4.4 m -79.7 142.26 35.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.162 -0.961 . . . . 0.0 109.125 179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.849 ' HB3' HG22 ' B' ' 59' ' ' VAL . 12.8 mt -120.19 167.41 12.28 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.285 -0.884 . . . . 0.0 109.356 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.654 ' N ' HG21 ' B' ' 59' ' ' VAL . 1.0 OUTLIER -97.14 115.73 65.81 Favored Pre-proline 0 C--N 1.299 -1.619 0 O-C-N 121.356 -0.84 . . . . 0.0 109.278 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.471 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.4 Cg_endo -74.18 0.14 8.84 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.265 1.976 . . . . 0.0 110.46 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.03 -13.85 24.84 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.267 -0.896 . . . . 0.0 108.918 179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.485 ' OG ' ' HB3' ' B' ' 53' ' ' ASN . 0.0 OUTLIER -90.09 164.52 27.68 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.404 -0.81 . . . . 0.0 109.403 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.79 -37.74 0.82 Allowed 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.668 2.245 . . . . 0.0 110.508 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' B' ' 62' ' ' ILE . 10.0 mt -61.42 -51.89 67.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.206 -0.934 . . . . 0.0 109.026 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.849 HG22 ' HB3' ' B' ' 52' ' ' LEU . 54.8 t -54.45 -54.42 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.542 -0.724 . . . . 0.0 109.745 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.481 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 5.1 mttt -47.44 -33.65 6.34 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.166 -0.959 . . . . 0.0 109.078 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.479 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -74.6 -38.61 62.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 0.0 109.372 179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -58.05 -41.99 81.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.379 -0.825 . . . . 0.0 109.168 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 1.114 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -70.1 -67.86 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.322 -0.861 . . . . 0.0 109.766 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -44.01 -28.31 0.46 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 109.747 -179.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.549 ' CD ' ' HG3' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -72.81 -59.95 2.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.182 -0.949 . . . . 0.0 109.237 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.425 ' C ' ' O ' ' B' ' 65' ' ' LYS . 0.8 OUTLIER -44.05 -44.43 7.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.329 -0.857 . . . . 0.0 109.155 179.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.122 HD11 ' CG2' ' A' ' 63' ' ' ILE . 1.3 mt -55.21 -58.63 6.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.52 -0.738 . . . . 0.0 109.701 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -80.9 6.94 11.76 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.357 -0.839 . . . . 0.0 109.749 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.44 ' HB3' ' O ' ' B' ' 65' ' ' LYS . 10.0 p -94.34 -10.22 33.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.122 -0.986 . . . . 0.0 109.402 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.523 ' O ' ' CG ' ' B' ' 71' ' ' LYS . 0.6 OUTLIER -107.8 27.54 9.1 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.46 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 70' ' ' ASP . 18.3 pttm 41.77 -161.62 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.452 -0.78 . . . . 0.0 109.666 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.96 -63.17 0.41 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.216 -0.928 . . . . 0.0 109.484 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.493 179.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -120.4 119.08 32.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.283 -0.885 . . . . 0.0 109.439 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.99 136.65 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.282 -0.886 . . . . 0.0 109.486 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.36 101.01 0.51 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.189 -0.944 . . . . 0.0 109.468 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.1 m -143.79 -39.48 0.3 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.858 . . . . 0.0 109.457 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -162.46 120.62 2.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.31 -0.869 . . . . 0.0 109.484 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.664 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -121.36 99.81 6.69 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.235 -0.915 . . . . 0.0 109.501 -179.868 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' A' ' 9' ' ' CYS . 8.9 mtm180 -97.89 153.43 18.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -0.908 . . . . 0.0 109.24 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.432 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 19.7 m -44.18 107.94 0.1 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.414 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.528 ' CG ' ' HE3' ' A' ' 29' ' ' LYS . 22.5 mm-40 -49.78 -21.66 1.18 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.715 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.464 ' HB2' ' OE1' ' A' ' 39' ' ' GLU . 49.9 m -144.98 67.43 1.24 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 0.0 109.909 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 12' ' ' LEU . 14.5 mt -45.12 -45.53 11.29 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 108.817 179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.09 119.41 35.76 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -94.52 167.14 11.68 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.275 -0.89 . . . . 0.0 110.101 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.517 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.4 mt -114.38 144.99 42.4 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.585 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.4 tt0 -44.29 -39.06 4.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.176 -0.952 . . . . 0.0 109.41 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.988 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 144.99 -164.72 27.85 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.941 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -170.82 163.74 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.488 -1.007 . . . . 0.0 109.094 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.524 ' ND1' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -53.54 149.48 15.11 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.273 -0.892 . . . . 0.0 109.354 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.533 ' HA ' HD12 ' A' ' 23' ' ' ILE . 35.0 Cg_endo -77.19 -3.98 14.3 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.53 2.153 . . . . 0.0 110.176 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' ' HE2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.25 -24.38 20.96 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.376 -0.828 . . . . 0.0 109.089 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.523 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 2.5 m-20 -82.87 -6.47 59.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.407 -0.808 . . . . 0.0 109.258 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.941 HD11 ' CD1' ' A' ' 18' ' ' ILE . 8.5 mt -104.94 148.89 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.278 -0.889 . . . . 0.0 110.235 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.574 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -120.54 -27.27 5.18 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.279 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.574 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -137.69 168.51 19.54 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.207 -0.933 . . . . 0.0 109.092 179.344 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.585 HG23 ' HG3' ' A' ' 66' ' ' MET . 90.5 t -140.87 114.46 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.083 -1.011 . . . . 0.0 109.776 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.629 ' O ' HD12 ' A' ' 41' ' ' ILE . 3.8 t-20 -109.62 110.65 21.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.168 -0.957 . . . . 0.0 109.348 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.716 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -110.1 105.54 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.189 -0.945 . . . . 0.0 109.516 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.528 ' HE3' ' CG ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -98.51 114.71 27.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.402 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.98 167.82 5.54 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.266 -0.896 . . . . 0.0 109.436 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.464 ' HB3' ' C ' ' A' ' 36' ' ' ALA . 36.2 Cg_endo -78.13 151.44 26.93 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.615 2.21 . . . . 0.0 110.44 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.84 -141.3 3.14 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.469 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 36.3 Cg_endo -77.89 10.96 2.41 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.649 2.233 . . . . 0.0 111.008 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.664 ' CD2' HD22 ' A' ' 7' ' ' LEU . 3.6 p-80 -128.27 -34.48 2.07 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.058 -1.026 . . . . 0.0 109.441 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.9 t -145.39 88.03 1.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.287 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.464 ' C ' ' HB3' ' A' ' 31' ' ' PRO . . . -52.59 -19.93 2.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.271 -0.893 . . . . 0.0 109.706 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.462 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 33.8 mm-40 -92.85 131.93 37.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.206 -0.934 . . . . 0.0 109.554 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.471 HG21 ' OD1' ' B' ' 70' ' ' ASP . 3.6 m -54.79 161.3 1.6 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.33 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.488 ' HB2' ' CG ' ' A' ' 29' ' ' LYS . 22.5 mm-40 -145.33 107.53 4.36 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 0.0 109.635 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.716 HG22 HG13 ' A' ' 28' ' ' VAL . 43.1 t -91.77 152.84 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.326 -0.859 . . . . 0.0 109.311 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 27' ' ' ASN . 2.7 mp -140.34 155.42 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.949 . . . . 0.0 109.709 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.777 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -140.9 117.99 11.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.383 -0.823 . . . . 0.0 109.103 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.537 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.4 m -89.22 97.66 11.32 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.892 -1.13 . . . . 0.0 108.787 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 87.1 mt -43.53 162.8 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.464 -0.772 . . . . 0.0 109.583 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.72 ' HZ2' ' HB3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -79.1 7.17 7.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.272 -0.892 . . . . 0.0 109.805 -179.827 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.502 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -108.85 16.87 22.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.132 -0.98 . . . . 0.0 109.198 179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.57 -0.8 89.45 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.502 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 13.7 mtt180 -89.68 162.97 15.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.158 -1.201 . . . . 0.0 109.426 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.3 mptt -134.5 151.06 50.89 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.41 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.517 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.24 123.93 9.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.349 -0.844 . . . . 0.0 109.033 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.475 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 22.9 m -79.47 143.99 34.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.078 -1.014 . . . . 0.0 109.189 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.993 HD13 HD13 ' A' ' 62' ' ' ILE . 15.2 mt -121.19 167.69 12.41 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.331 -0.856 . . . . 0.0 109.437 -179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.648 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.8 t-20 -100.84 123.48 45.36 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.413 -0.804 . . . . 0.0 109.177 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -75.19 -7.04 18.64 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.219 1.946 . . . . 0.0 110.398 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.45 -13.1 55.47 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.222 -0.924 . . . . 0.0 108.961 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -90.06 161.65 37.4 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.374 -0.829 . . . . 0.0 109.429 179.931 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.92 -35.66 1.33 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.648 2.232 . . . . 0.0 110.574 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.601 HG23 ' N ' ' A' ' 59' ' ' VAL . 16.8 tt -67.31 -45.74 85.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.426 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.0 ' HA ' HD12 ' A' ' 62' ' ' ILE . 42.7 t -58.62 -46.82 90.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.413 -0.804 . . . . 0.0 109.369 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 1.3 mmpt? -59.47 -29.48 67.85 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -79.72 -23.84 42.08 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.0 HD12 ' HA ' ' A' ' 59' ' ' VAL . 22.7 mt -70.58 -37.76 70.94 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.689 HD11 HG11 ' A' ' 40' ' ' VAL . 2.2 mp -74.75 -56.48 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.457 -0.777 . . . . 0.0 109.321 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER -59.35 -27.87 66.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.296 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 1.7 tptt -71.78 -50.68 27.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.278 -0.889 . . . . 0.0 109.058 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.585 ' HG3' HG23 ' A' ' 26' ' ' VAL . 0.4 OUTLIER -51.85 -45.78 64.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 109.081 179.635 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.639 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.2 OUTLIER -44.27 -52.15 7.76 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.404 -0.81 . . . . 0.0 109.335 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.405 ' O ' ' C ' ' A' ' 69' ' ' SER . 0.9 OUTLIER -62.14 -38.1 87.68 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.393 -0.817 . . . . 0.0 109.456 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.429 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 2.5 p -44.69 -30.56 0.96 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.457 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.472 ' OD1' HG21 ' B' ' 38' ' ' THR . 27.9 m-20 -59.87 -89.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.191 -0.943 . . . . 0.0 109.491 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.74 175.01 14.25 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -0.933 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 13.9 p -85.64 -156.65 0.28 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.288 -0.883 . . . . 0.0 109.439 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 118.005 -0.997 . . . . 0.0 109.485 -179.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 69.6 m -120.31 119.15 32.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.462 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 7.4 p -78.02 136.71 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.498 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -167.44 101.06 0.5 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.217 -0.927 . . . . 0.0 109.458 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 40.3 m -143.81 -39.44 0.3 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.461 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -162.52 120.57 2.12 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.224 -0.922 . . . . 0.0 109.438 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.665 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -121.33 99.95 6.77 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.537 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' B' ' 9' ' ' CYS . 8.9 mtm180 -97.96 153.36 18.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.377 -0.827 . . . . 0.0 109.183 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.444 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 19.4 m -44.16 107.9 0.1 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.0 109.39 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.517 ' CG ' ' HE3' ' B' ' 29' ' ' LYS . 22.5 mm-40 -49.75 -21.66 1.16 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.757 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.467 ' HB2' ' OE1' ' B' ' 39' ' ' GLU . 50.8 m -145.01 67.51 1.24 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.126 -0.984 . . . . 0.0 109.893 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.444 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 14.5 mt -45.12 -45.57 11.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.144 -0.972 . . . . 0.0 108.854 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . 0.409 ' OE1' ' HA ' ' B' ' 13' ' ' GLN . 0.0 OUTLIER -116.06 119.44 35.85 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.464 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' B' ' 52' ' ' LEU . 0.6 OUTLIER -94.55 167.1 11.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.242 -0.911 . . . . 0.0 110.098 -179.365 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.509 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.4 mt -114.36 144.97 42.42 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.578 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.4 tt0 -44.27 -39.09 4.25 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.154 -0.966 . . . . 0.0 109.395 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 1.051 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 144.95 -164.62 27.85 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.944 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -170.82 163.7 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.442 -1.034 . . . . 0.0 109.145 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.523 ' ND1' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -53.53 149.46 15.13 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.326 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.532 ' HA ' HD12 ' B' ' 23' ' ' ILE . 34.7 Cg_endo -77.29 -3.89 14.17 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.586 2.191 . . . . 0.0 110.189 179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.45 ' O ' ' CD ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.3 -24.31 20.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.399 -0.813 . . . . 0.0 109.151 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 2.5 m-20 -82.87 -6.42 59.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.374 -0.829 . . . . 0.0 109.332 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.944 HD11 ' CD1' ' B' ' 18' ' ' ILE . 8.4 mt -104.95 148.88 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.206 -0.934 . . . . 0.0 110.269 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.556 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -120.55 -27.31 5.17 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.237 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.556 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -137.64 168.47 19.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.298 -0.876 . . . . 0.0 109.141 179.337 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.608 HG23 ' HG3' ' B' ' 66' ' ' MET . 91.3 t -140.81 114.43 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 109.802 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.625 ' O ' HD12 ' B' ' 41' ' ' ILE . 3.8 t-20 -109.6 110.63 21.76 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 109.295 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.696 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -110.03 105.62 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.275 -0.89 . . . . 0.0 109.592 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -98.6 114.67 27.21 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.387 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -62.95 167.89 5.4 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.228 -0.92 . . . . 0.0 109.423 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.462 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 36.2 Cg_endo -78.16 151.47 26.85 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.518 2.146 . . . . 0.0 110.456 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.82 -141.34 3.15 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.39 -1.484 . . . . 0.0 109.39 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.461 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -77.92 10.98 2.41 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.603 2.202 . . . . 0.0 110.993 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.665 ' CD2' HD22 ' B' ' 7' ' ' LEU . 3.7 p-80 -128.27 -34.44 2.07 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.016 -1.052 . . . . 0.0 109.474 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.461 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 2.0 t -145.43 88.07 1.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.276 -0.89 . . . . 0.0 109.296 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.462 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -52.6 -20.0 2.72 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.311 -0.868 . . . . 0.0 109.708 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.453 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 33.5 mm-40 -92.8 131.9 37.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.472 HG21 ' OD1' ' A' ' 70' ' ' ASP . 3.6 m -54.74 161.33 1.57 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -0.899 . . . . 0.0 109.396 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.497 ' HB2' ' CG ' ' B' ' 29' ' ' LYS . 22.5 mm-40 -145.35 107.58 4.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.596 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.696 HG22 HG13 ' B' ' 28' ' ' VAL . 42.9 t -91.8 152.8 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.346 -0.846 . . . . 0.0 109.299 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.625 HD12 ' O ' ' B' ' 27' ' ' ASN . 2.7 mp -140.31 155.35 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.189 -0.944 . . . . 0.0 109.719 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.775 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -140.88 118.05 11.29 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.34 -0.85 . . . . 0.0 109.093 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.55 HG22 ' O ' ' B' ' 43' ' ' THR . 1.5 m -89.13 97.55 11.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.92 -1.113 . . . . 0.0 108.817 179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 86.9 mt -43.45 162.8 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.479 -0.763 . . . . 0.0 109.661 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.629 ' HZ2' ' HB3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -79.15 7.29 7.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 109.83 -179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -108.88 16.76 22.45 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.134 -0.979 . . . . 0.0 109.121 179.666 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.68 -0.87 89.4 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.506 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 13.7 mtt180 -89.64 162.95 15.36 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.082 -1.246 . . . . 0.0 109.445 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 1.3 mptt -134.46 151.06 50.92 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.228 -0.92 . . . . 0.0 109.435 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.21 123.91 9.18 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.338 -0.851 . . . . 0.0 109.057 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' B' ' 41' ' ' ILE . 22.8 m -79.49 143.93 34.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.063 -1.023 . . . . 0.0 109.169 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 1.051 HD22 ' HA2' ' B' ' 17' ' ' GLY . 15.2 mt -121.14 167.61 12.47 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.465 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.647 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.7 t-20 -100.79 123.55 45.2 Favored Pre-proline 0 C--N 1.299 -1.596 0 O-C-N 121.42 -0.8 . . . . 0.0 109.13 -179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.24 -7.05 18.62 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.225 1.95 . . . . 0.0 110.4 -179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.5 -13.13 55.28 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.229 -0.919 . . . . 0.0 108.868 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.3 OUTLIER -90.06 161.66 37.39 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.313 -0.867 . . . . 0.0 109.43 179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.455 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.99 -35.53 1.34 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.609 2.206 . . . . 0.0 110.504 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.596 HG23 ' N ' ' B' ' 59' ' ' VAL . 16.8 tt -67.33 -45.79 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.417 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 1.009 ' HA ' HD12 ' B' ' 62' ' ' ILE . 42.5 t -58.72 -46.72 90.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.812 . . . . 0.0 109.333 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.483 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 1.3 mmpt? -59.47 -29.59 67.93 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.48 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -79.63 -23.89 42.29 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 1.009 HD12 ' HA ' ' B' ' 59' ' ' VAL . 23.0 mt -70.52 -37.8 71.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.56 -0.712 . . . . 0.0 109.079 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.665 HD11 HG11 ' B' ' 40' ' ' VAL . 2.2 mp -74.67 -56.49 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.427 -0.795 . . . . 0.0 109.398 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.4 OUTLIER -59.32 -27.86 66.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.222 -0.924 . . . . 0.0 109.294 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.512 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 1.6 tptt -71.79 -50.71 27.43 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.238 -0.914 . . . . 0.0 109.047 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.608 ' HG3' HG23 ' B' ' 26' ' ' VAL . 0.4 OUTLIER -51.82 -45.68 64.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.282 -0.886 . . . . 0.0 109.114 179.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.652 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -44.27 -52.35 7.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.314 -0.867 . . . . 0.0 109.258 179.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' B' ' 69' ' ' SER . 0.9 OUTLIER -61.95 -38.12 87.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.353 -0.842 . . . . 0.0 109.529 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.45 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 2.5 p -44.62 -30.65 0.95 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.89 . . . . 0.0 109.461 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.471 ' OD1' HG21 ' A' ' 38' ' ' THR . 28.0 m-20 -59.81 -89.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.295 -0.878 . . . . 0.0 109.44 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.75 175.06 14.19 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.245 -0.909 . . . . 0.0 109.409 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 13.8 p -85.59 -156.67 0.28 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.219 -0.926 . . . . 0.0 109.466 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p30 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.494 179.992 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.3 m -149.67 -66.47 0.21 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 109.446 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.619 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 30.7 m -138.12 128.21 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.298 -0.876 . . . . 0.0 109.478 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 3' ' ' VAL . . . 70.79 144.06 0.06 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.256 -0.902 . . . . 0.0 109.499 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.09 85.31 2.02 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.293 -0.88 . . . . 0.0 109.437 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -152.57 111.37 3.78 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.365 -0.834 . . . . 0.0 109.437 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.553 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -117.72 98.79 6.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.873 . . . . 0.0 109.586 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 9' ' ' CYS . 29.9 mtt180 -92.83 150.52 20.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.32 -0.863 . . . . 0.0 109.022 179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.73 ' HB2' HD22 ' A' ' 12' ' ' LEU . 50.7 m -43.99 102.48 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.208 -0.933 . . . . 0.0 109.351 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.506 ' OE1' ' NZ ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.59 -26.79 0.13 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.347 -0.846 . . . . 0.0 109.761 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.432 ' N ' ' O ' ' A' ' 9' ' ' CYS . 72.0 m -118.25 58.33 0.82 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.223 -0.923 . . . . 0.0 109.604 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.73 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.2 -37.91 3.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.308 -0.87 . . . . 0.0 109.234 179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.37 123.86 41.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.383 -0.823 . . . . 0.0 109.11 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.552 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.4 OUTLIER -100.05 161.1 13.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.283 -0.886 . . . . 0.0 109.884 -179.617 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.536 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.2 mt -115.07 141.16 48.38 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.525 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 3.1 tt0 -44.12 -26.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.202 -0.936 . . . . 0.0 109.271 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 1.053 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 139.41 -162.68 26.12 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.864 -1.295 . . . . 0.0 109.864 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.852 HG23 ' O ' ' A' ' 17' ' ' GLY . 1.3 pp -171.0 163.17 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.466 -1.02 . . . . 0.0 109.267 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.599 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -58.12 154.27 31.1 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.221 -0.924 . . . . 0.0 109.201 179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.599 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -76.99 -9.31 17.99 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.415 2.077 . . . . 0.0 109.927 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.501 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 35.5 mttm -77.34 -27.85 52.85 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.931 ' O ' HD13 ' A' ' 23' ' ' ILE . 22.9 m-20 -93.33 59.29 2.97 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.931 HD13 ' O ' ' A' ' 22' ' ' ASN . 1.5 mm -147.17 169.01 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.923 . . . . 0.0 110.028 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.754 ' HG2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -160.38 -36.0 0.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.0 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.607 ' O ' HG23 ' A' ' 26' ' ' VAL . 1.7 p -134.83 -175.17 3.81 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.607 HG23 ' O ' ' A' ' 25' ' ' SER . 50.7 t -158.82 98.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.946 -1.096 . . . . 0.0 109.867 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.484 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 3.5 t-20 -91.33 110.74 22.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.916 . . . . 0.0 109.218 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.475 HG13 HG13 ' A' ' 40' ' ' VAL . 1.7 t -114.32 104.11 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.478 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.681 ' HZ3' ' HB3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -108.19 110.45 22.08 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.948 . . . . 0.0 109.448 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.4 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -55.04 168.88 0.47 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.297 -0.877 . . . . 0.0 109.365 -179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.525 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.4 Cg_endo -78.13 131.95 11.21 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.556 2.171 . . . . 0.0 110.5 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.08 -143.55 5.42 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.439 -1.465 . . . . 0.0 109.439 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.86 5.86 4.6 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.519 2.146 . . . . 0.0 110.709 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.553 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 12.2 p-80 -124.28 -12.66 7.32 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.979 . . . . 0.0 109.623 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 2.7 t -160.22 98.9 1.31 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.19 -0.944 . . . . 0.0 109.214 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.98 -8.48 30.17 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.272 -0.893 . . . . 0.0 109.651 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.455 ' OE1' ' CA ' ' A' ' 37' ' ' GLN . 6.5 mm-40 -106.0 125.44 51.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.415 ' C ' ' HG2' ' A' ' 39' ' ' GLU . 25.9 m -49.7 152.61 1.42 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.312 -0.868 . . . . 0.0 109.417 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.415 ' HG2' ' C ' ' A' ' 38' ' ' THR . 2.2 mt-10 -137.66 107.32 6.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.125 -0.984 . . . . 0.0 109.791 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.922 HG11 HD11 ' A' ' 63' ' ' ILE . 3.8 t -93.8 157.73 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.251 -0.905 . . . . 0.0 109.12 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.548 ' CD1' ' HE2' ' A' ' 29' ' ' LYS . 1.9 mp -144.28 143.8 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.189 -0.945 . . . . 0.0 109.835 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.624 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -126.88 125.25 41.29 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.392 -0.818 . . . . 0.0 109.016 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.754 HG22 ' HG2' ' A' ' 24' ' ' GLN . 25.8 m -89.65 104.71 17.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.031 -1.043 . . . . 0.0 109.051 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.783 HD23 ' O ' ' A' ' 22' ' ' ASN . 80.1 mt -47.35 164.92 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.223 -0.923 . . . . 0.0 109.155 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.506 ' HA ' ' HB3' ' A' ' 24' ' ' GLN . 13.4 ptpt -84.93 12.97 6.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.148 -0.97 . . . . 0.0 109.566 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -111.2 10.68 21.83 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.278 -0.888 . . . . 0.0 109.181 179.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.04 20.81 48.44 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.566 ' HB2' HD12 ' A' ' 44' ' ' LEU . 9.4 mtt180 -115.95 173.68 6.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -1.148 . . . . 0.0 109.414 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.424 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 4.2 mttt -139.71 154.66 47.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.271 -0.893 . . . . 0.0 109.454 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.536 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.17 125.45 10.1 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.367 -0.833 . . . . 0.0 109.097 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.48 ' SG ' HG13 ' A' ' 41' ' ' ILE . 16.8 m -79.51 144.52 33.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 0.0 109.192 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.053 HD22 ' HA2' ' A' ' 17' ' ' GLY . 15.1 mt -122.53 168.34 12.26 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.246 -0.909 . . . . 0.0 109.433 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.663 ' O ' HG21 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -98.04 120.96 58.79 Favored Pre-proline 0 C--N 1.301 -1.517 0 O-C-N 121.368 -0.833 . . . . 0.0 109.112 -179.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.83 -6.79 18.61 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.196 1.931 . . . . 0.0 110.284 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.3 -14.25 53.42 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.257 -0.902 . . . . 0.0 108.833 179.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 1.1 p -90.05 158.3 44.47 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.474 -0.766 . . . . 0.0 109.385 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.479 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.0 Cg_endo -77.14 -32.27 3.24 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.614 2.209 . . . . 0.0 110.509 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.591 HG23 ' N ' ' A' ' 59' ' ' VAL . 9.0 tt -69.2 -45.16 79.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -0.924 . . . . 0.0 109.112 179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.029 ' HA ' HD12 ' A' ' 62' ' ' ILE . 25.2 t -57.45 -46.2 85.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.522 -0.736 . . . . 0.0 109.248 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.0 OUTLIER -61.08 -30.32 70.28 Favored 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.362 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.524 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 3.4 mmpt? -79.05 -20.58 48.53 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.029 HD12 ' HA ' ' A' ' 59' ' ' VAL . 26.7 mt -75.51 -37.34 37.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.578 -0.701 . . . . 0.0 109.181 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.922 HD11 HG11 ' A' ' 40' ' ' VAL . 2.2 mp -74.28 -50.33 28.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.317 -0.864 . . . . 0.0 109.63 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 8.7 pt-20 -66.12 -35.95 81.85 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.013 -1.054 . . . . 0.0 109.328 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.53 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 32.9 mttm -61.38 -40.44 94.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.263 -0.898 . . . . 0.0 108.945 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.53 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.2 OUTLIER -61.1 -45.33 95.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.495 -0.753 . . . . 0.0 109.087 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.885 HD11 HG22 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -49.59 -54.88 15.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.508 -0.745 . . . . 0.0 109.69 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.2 -16.18 60.98 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.895 . . . . 0.0 109.724 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 28.4 p -46.67 -55.48 7.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.211 -0.93 . . . . 0.0 109.468 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 71' ' ' LYS . 32.4 t70 59.01 102.35 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.219 -0.926 . . . . 0.0 109.403 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HG2' ' N ' ' A' ' 72' ' ' SER . 20.5 tttt 61.37 -88.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.444 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.489 ' N ' ' HG2' ' A' ' 71' ' ' LYS . 7.9 t -166.23 -59.25 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 0.0 109.41 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 118.072 -0.965 . . . . 0.0 109.465 -179.901 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.2 m -149.66 -66.38 0.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.354 -0.841 . . . . 0.0 109.475 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.611 ' O ' ' HB3' ' B' ' 4' ' ' ALA . 31.1 m -138.19 128.22 34.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.285 -0.885 . . . . 0.0 109.476 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.611 ' HB3' ' O ' ' B' ' 3' ' ' VAL . . . 70.84 144.0 0.06 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.234 -0.916 . . . . 0.0 109.515 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.11 85.31 2.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.237 -0.915 . . . . 0.0 109.436 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -152.58 111.4 3.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.208 -0.933 . . . . 0.0 109.51 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.553 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -117.74 98.82 6.56 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.254 -0.904 . . . . 0.0 109.614 -179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.432 ' O ' ' C ' ' B' ' 9' ' ' CYS . 29.7 mtt180 -92.78 150.49 20.61 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.261 -0.899 . . . . 0.0 109.067 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.729 ' HB2' HD22 ' B' ' 12' ' ' LEU . 50.9 m -43.92 102.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 109.374 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.517 ' OE1' ' NZ ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -42.59 -26.83 0.13 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.359 -0.838 . . . . 0.0 109.722 -179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.43 ' N ' ' O ' ' B' ' 9' ' ' CYS . 72.1 m -118.28 58.38 0.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.178 -0.951 . . . . 0.0 109.578 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.729 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.13 -37.99 3.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 109.256 179.816 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -124.32 123.91 41.24 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.299 -0.876 . . . . 0.0 109.1 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.552 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.4 OUTLIER -100.13 161.12 13.81 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.225 -0.922 . . . . 0.0 109.897 -179.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.535 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.2 mt -115.17 141.15 48.4 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.461 -0.775 . . . . 0.0 108.952 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.522 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 3.1 tt0 -44.08 -26.73 0.32 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.35 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 1.003 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 139.36 -162.67 26.1 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.861 -1.295 . . . . 0.0 109.861 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.854 HG23 ' O ' ' B' ' 17' ' ' GLY . 1.3 pp -170.96 163.19 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.404 -1.056 . . . . 0.0 109.217 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.592 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -58.16 154.21 31.77 Favored Pre-proline 0 N--CA 1.488 1.473 0 O-C-N 121.25 -0.907 . . . . 0.0 109.27 179.849 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.592 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.9 Cg_endo -76.88 -9.31 18.15 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.449 2.099 . . . . 0.0 109.924 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.495 ' O ' ' NZ ' ' B' ' 45' ' ' LYS . 35.4 mttm -77.38 -27.87 52.66 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.952 ' O ' HD13 ' B' ' 23' ' ' ILE . 23.0 m-20 -93.38 59.38 2.97 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.952 HD13 ' O ' ' B' ' 22' ' ' ASN . 1.4 mm -147.23 168.93 4.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.141 -0.974 . . . . 0.0 110.047 -179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.75 ' HG2' HG22 ' B' ' 43' ' ' THR . 0.0 OUTLIER -160.38 -35.98 0.05 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.606 ' O ' HG23 ' B' ' 26' ' ' VAL . 1.7 p -134.82 -175.19 3.82 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 25' ' ' SER . 50.4 t -158.81 98.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.96 -1.087 . . . . 0.0 109.79 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.487 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 3.6 t-20 -91.48 110.76 22.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.289 -0.882 . . . . 0.0 109.235 179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.483 HG13 HG13 ' B' ' 40' ' ' VAL . 1.7 t -114.35 104.09 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.159 -0.963 . . . . 0.0 109.492 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.615 ' HZ3' ' HB3' ' B' ' 29' ' ' LYS . 0.9 OUTLIER -108.16 110.41 22.05 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.465 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.401 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.0 OUTLIER -54.96 168.84 0.47 Allowed Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.254 -0.904 . . . . 0.0 109.414 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.516 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 36.0 Cg_endo -78.0 131.8 11.25 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.67 2.247 . . . . 0.0 110.507 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -130.01 -143.58 5.43 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -76.72 5.68 4.66 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.642 2.228 . . . . 0.0 110.68 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.553 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 12.1 p-80 -124.3 -12.68 7.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.181 -0.949 . . . . 0.0 109.585 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.516 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 2.7 t -160.18 98.88 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.25 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.9 -8.59 30.37 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.23 -0.919 . . . . 0.0 109.631 -179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.451 ' HA ' ' OE1' ' B' ' 37' ' ' GLN . 6.4 mm-40 -105.85 125.42 50.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 109.591 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.43 ' C ' ' HG2' ' B' ' 39' ' ' GLU . 26.0 m -49.79 152.53 1.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.312 -0.868 . . . . 0.0 109.341 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.43 ' HG2' ' C ' ' B' ' 38' ' ' THR . 2.1 mt-10 -137.58 107.36 6.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.226 -0.921 . . . . 0.0 109.724 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.913 HG11 HD11 ' B' ' 63' ' ' ILE . 3.8 t -93.85 157.64 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.115 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.554 ' CD1' ' HE2' ' B' ' 29' ' ' LYS . 1.9 mp -144.24 143.8 23.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.163 -0.96 . . . . 0.0 109.81 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.619 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -126.93 125.18 41.1 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.649 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.75 HG22 ' HG2' ' B' ' 24' ' ' GLN . 26.2 m -89.53 104.73 17.26 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.981 -1.074 . . . . 0.0 109.05 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.788 HD23 ' O ' ' B' ' 22' ' ' ASN . 80.8 mt -47.44 164.98 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.354 -0.841 . . . . 0.0 109.123 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.495 ' NZ ' ' O ' ' B' ' 21' ' ' LYS . 13.4 ptpt -84.98 13.11 6.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.594 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -111.28 10.68 21.69 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.294 -0.878 . . . . 0.0 109.064 179.477 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.03 20.73 48.74 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.566 ' HB2' HD12 ' B' ' 44' ' ' LEU . 9.4 mtt180 -115.96 173.72 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -1.128 . . . . 0.0 109.394 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.441 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 4.2 mttt -139.67 154.69 47.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.262 -0.899 . . . . 0.0 109.423 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.535 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.19 125.34 10.02 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.276 -0.89 . . . . 0.0 109.175 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.477 ' SG ' HG13 ' B' ' 41' ' ' ILE . 17.1 m -79.45 144.47 34.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.957 . . . . 0.0 109.152 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 1.003 HD22 ' HA2' ' B' ' 17' ' ' GLY . 15.0 mt -122.52 168.33 12.26 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.891 . . . . 0.0 109.35 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.668 ' O ' HG21 ' B' ' 59' ' ' VAL . 0.9 OUTLIER -98.01 120.91 58.94 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.37 -0.831 . . . . 0.0 109.093 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -74.83 -6.68 18.46 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.126 1.884 . . . . 0.0 110.35 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.35 -14.21 53.36 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.347 -0.846 . . . . 0.0 108.826 179.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 1.1 p -90.05 158.26 44.5 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.383 -0.823 . . . . 0.0 109.402 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.488 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 35.5 Cg_endo -77.06 -32.29 3.28 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.676 2.25 . . . . 0.0 110.522 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.602 HG23 ' N ' ' B' ' 59' ' ' VAL . 9.1 tt -69.23 -45.16 79.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.17 -0.956 . . . . 0.0 109.113 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 1.028 ' HA ' HD12 ' B' ' 62' ' ' ILE . 25.2 t -57.55 -46.1 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.474 -0.766 . . . . 0.0 109.163 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' B' ' 56' ' ' SER . 0.0 OUTLIER -61.17 -30.28 70.31 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 179.332 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.532 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 3.4 mmpt? -78.96 -20.77 48.38 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 1.028 HD12 ' HA ' ' B' ' 59' ' ' VAL . 26.7 mt -75.38 -37.34 38.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.641 -0.662 . . . . 0.0 109.267 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.913 HD11 HG11 ' B' ' 40' ' ' VAL . 2.2 mp -74.29 -50.34 27.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.386 -0.821 . . . . 0.0 109.624 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.538 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 8.7 pt-20 -66.09 -35.93 81.83 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.998 -1.064 . . . . 0.0 109.353 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.538 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 32.8 mttm -61.42 -40.53 94.78 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 108.939 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.518 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.2 OUTLIER -61.0 -45.3 95.4 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.338 -0.851 . . . . 0.0 109.149 179.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.91 HD11 HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -49.64 -54.78 16.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.393 -0.817 . . . . 0.0 109.698 179.973 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -74.32 -16.19 60.93 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.687 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 28.3 p -46.52 -55.59 7.3 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -0.917 . . . . 0.0 109.537 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' B' ' 71' ' ' LYS . 32.3 t70 59.06 102.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.41 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' B' ' 72' ' ' SER . 20.4 tttt 61.35 -88.66 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.449 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.504 ' N ' ' HG2' ' B' ' 71' ' ' LYS . 7.9 t -166.27 -59.24 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.512 179.973 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 68.41 -86.11 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.249 -0.907 . . . . 0.0 109.476 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.421 ' O ' ' C ' ' A' ' 4' ' ' ALA . 2.1 m -144.63 49.89 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.279 -0.888 . . . . 0.0 109.482 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.421 ' C ' ' O ' ' A' ' 3' ' ' VAL . . . -44.05 165.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.255 -0.903 . . . . 0.0 109.474 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.2 69.68 0.19 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.186 -0.946 . . . . 0.0 109.475 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.85 80.89 2.76 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 109.369 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.563 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -119.28 99.71 6.87 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.329 -0.857 . . . . 0.0 109.61 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -96.14 149.83 21.19 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.325 -0.859 . . . . 0.0 108.994 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.761 ' HB2' HD22 ' A' ' 12' ' ' LEU . 68.7 m -44.01 98.68 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.139 -0.976 . . . . 0.0 109.411 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.539 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -42.52 -26.52 0.12 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 0.0 109.874 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.448 ' SG ' ' HB3' ' A' ' 39' ' ' GLU . 83.0 m -116.8 58.71 0.76 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.239 -0.913 . . . . 0.0 109.71 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.761 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.82 -37.14 3.62 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.178 -0.951 . . . . 0.0 109.147 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mm-40 -127.28 127.72 44.82 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.374 -0.829 . . . . 0.0 109.059 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.512 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -101.94 165.37 11.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.217 -0.927 . . . . 0.0 109.953 -179.585 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.566 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 6.9 mt -124.21 143.42 50.53 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.3 tt0 -44.17 -40.89 5.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.187 -0.946 . . . . 0.0 109.402 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 1.032 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 140.41 166.67 10.76 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.893 HD11 ' CG1' ' A' ' 23' ' ' ILE . 1.9 pp -139.31 162.8 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.549 -0.971 . . . . 0.0 109.083 179.687 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.734 ' O ' HD12 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -46.49 151.61 0.99 Allowed Pre-proline 0 C--N 1.302 -1.474 0 O-C-N 121.251 -0.906 . . . . 0.0 109.204 179.963 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.568 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -76.91 -4.87 15.4 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.502 2.135 . . . . 0.0 110.083 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.44 -23.41 21.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.331 -0.855 . . . . 0.0 109.237 179.76 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.523 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 4.8 m-20 -82.52 -4.7 57.98 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.385 -0.822 . . . . 0.0 109.44 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.893 ' CG1' HD11 ' A' ' 18' ' ' ILE . 9.0 mt -105.61 155.3 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.201 -0.937 . . . . 0.0 110.304 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -127.27 -29.19 2.75 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.32 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.582 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -135.11 171.12 14.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.257 -0.902 . . . . 0.0 109.029 179.414 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.54 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 46.4 t -143.78 101.85 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.959 . . . . 0.0 109.733 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.525 ' O ' HD12 ' A' ' 41' ' ' ILE . 3.8 t-20 -95.71 110.4 22.54 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.243 -0.91 . . . . 0.0 109.364 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.402 HG13 HG22 ' A' ' 40' ' ' VAL . 1.9 t -107.0 100.72 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.3 -0.875 . . . . 0.0 109.504 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.539 ' CD ' ' HB2' ' A' ' 10' ' ' GLN . 10.2 ptmt -95.54 109.41 21.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.222 -0.924 . . . . 0.0 109.44 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.455 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -61.88 171.52 1.45 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.262 -0.899 . . . . 0.0 109.4 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.545 ' HG2' ' CB ' ' B' ' 71' ' ' LYS . 35.3 Cg_endo -77.54 144.57 22.67 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.611 2.207 . . . . 0.0 110.444 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.89 -141.3 3.29 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.9 39.96 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.746 2.297 . . . . 0.0 110.759 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.563 ' CD2' HD22 ' A' ' 7' ' ' LEU . 6.4 p-80 -159.41 -38.82 0.06 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.082 -1.011 . . . . 0.0 109.13 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -141.14 99.0 3.49 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.315 -0.865 . . . . 0.0 109.146 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.87 -11.85 42.16 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 0.0 109.679 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.46 ' OE1' ' HA ' ' A' ' 37' ' ' GLN . 4.0 mm-40 -98.92 124.4 43.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.958 . . . . 0.0 109.457 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.459 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 9.4 m -47.72 157.85 0.23 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.31 -0.869 . . . . 0.0 109.252 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.471 ' HB2' ' HG3' ' A' ' 29' ' ' LYS . 7.3 mm-40 -145.57 107.29 4.27 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.116 -0.99 . . . . 0.0 109.702 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.9 HG11 HD11 ' A' ' 63' ' ' ILE . 6.5 t -89.74 156.23 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.282 -0.886 . . . . 0.0 109.154 179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.525 HD12 ' O ' ' A' ' 27' ' ' ASN . 2.6 mp -141.09 148.43 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.145 -0.972 . . . . 0.0 109.838 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.756 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -133.04 118.18 18.48 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 0.0 109.007 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.532 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 2.1 m -89.12 98.91 12.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.931 -1.106 . . . . 0.0 108.885 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 88.9 mt -44.41 166.6 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.504 -0.747 . . . . 0.0 109.593 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.4 ptpt -81.88 8.21 10.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.639 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.511 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.15 25.04 11.95 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.216 -0.928 . . . . 0.0 109.242 179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.18 2.64 67.23 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.511 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 5.8 mtt180 -92.1 164.32 13.63 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.193 -1.181 . . . . 0.0 109.436 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.6 mptt -135.92 153.13 51.53 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.174 -0.954 . . . . 0.0 109.393 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.566 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.29 122.45 8.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.333 -0.854 . . . . 0.0 109.065 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 5.4 m -79.46 143.07 35.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.102 -0.999 . . . . 0.0 109.036 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.054 HD13 HD13 ' A' ' 62' ' ' ILE . 14.2 mt -119.74 167.59 11.91 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.29 -0.881 . . . . 0.0 109.611 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.676 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.1 t30 -97.64 119.0 63.52 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.518 -0.739 . . . . 0.0 109.172 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -74.11 -0.0 9.0 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.136 1.891 . . . . 0.0 110.443 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.562 ' HB3' HD22 ' A' ' 53' ' ' ASN . . . -94.79 -13.07 25.97 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.296 -0.877 . . . . 0.0 108.835 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.442 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.1 OUTLIER -90.11 165.35 24.41 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.389 -0.82 . . . . 0.0 109.399 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.502 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.17 -42.18 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.707 2.271 . . . . 0.0 110.816 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.1 mt -61.52 -39.71 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.151 -0.968 . . . . 0.0 109.734 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.988 ' HA ' HD12 ' A' ' 62' ' ' ILE . 47.5 t -64.42 -49.46 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.277 -0.889 . . . . 0.0 109.794 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.513 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 8.7 mttm -53.73 -32.33 51.71 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.071 -1.018 . . . . 0.0 108.706 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.508 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -78.06 -29.93 49.5 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.55 -0.719 . . . . 0.0 109.268 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.054 HD13 HD13 ' A' ' 52' ' ' LEU . 15.2 mt -64.43 -38.55 82.88 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.307 -0.871 . . . . 0.0 109.219 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.948 ' CG2' HD11 ' B' ' 67' ' ' LEU . 1.4 mp -76.01 -64.65 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.3 -0.875 . . . . 0.0 109.858 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.513 ' CG ' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -49.65 -55.22 14.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.102 -0.999 . . . . 0.0 109.449 -179.694 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' A' ' 61' ' ' LYS . 42.8 tptt -46.62 -55.79 7.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.175 -0.953 . . . . 0.0 109.128 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.54 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -44.38 -43.19 7.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.274 -0.891 . . . . 0.0 109.169 179.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.955 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -55.83 -55.27 34.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.419 -0.8 . . . . 0.0 109.579 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.28 10.31 17.54 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.887 . . . . 0.0 109.679 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 91.2 p -63.19 -40.32 97.16 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.283 -0.886 . . . . 0.0 109.495 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' A' ' 71' ' ' LYS . 2.9 m-20 59.74 66.68 0.96 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.281 -0.887 . . . . 0.0 109.474 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.546 ' CB ' ' HG2' ' B' ' 31' ' ' PRO . 13.9 ptpt 41.8 -163.9 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.49 -0.756 . . . . 0.0 109.659 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.45 ' O ' ' OXT' ' A' ' 73' ' ' ASN . 4.3 t -113.1 76.05 0.95 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.927 . . . . 0.0 109.457 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.45 ' OXT' ' O ' ' A' ' 72' ' ' SER . 4.3 t30 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.503 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.293 0.568 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' B' ' 1' ' ' ALA . 0.6 OUTLIER 68.3 -86.04 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.445 -179.977 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.415 ' O ' ' C ' ' B' ' 4' ' ' ALA . 2.2 m -144.61 49.77 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.237 -0.914 . . . . 0.0 109.547 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.415 ' C ' ' O ' ' B' ' 3' ' ' VAL . . . -44.09 165.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.237 -0.914 . . . . 0.0 109.372 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -164.19 69.74 0.19 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.84 80.87 2.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.42 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.559 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -119.2 99.6 6.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.204 -0.935 . . . . 0.0 109.694 -179.884 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.468 ' O ' ' N ' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -96.05 149.86 21.12 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.007 179.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.754 ' HB2' HD22 ' B' ' 12' ' ' LEU . 68.6 m -43.97 98.73 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.272 -0.893 . . . . 0.0 109.335 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.534 ' HB2' ' CD ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -42.67 -26.44 0.12 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.436 -0.79 . . . . 0.0 109.761 -179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.452 ' SG ' ' HB3' ' B' ' 39' ' ' GLU . 82.9 m -116.85 58.77 0.76 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.267 -0.896 . . . . 0.0 109.729 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.754 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.18 3.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 9.7 mm-40 -127.31 127.64 44.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.329 -0.857 . . . . 0.0 109.016 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.506 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -101.88 165.42 11.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.15 -0.968 . . . . 0.0 109.958 -179.595 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.554 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 6.9 mt -124.2 143.43 50.52 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.488 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.3 tt0 -44.22 -40.97 5.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.28 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.987 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 140.45 166.72 10.78 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.911 HD11 ' CG1' ' B' ' 23' ' ' ILE . 1.9 pp -139.37 162.82 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.496 -1.002 . . . . 0.0 109.034 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.744 ' O ' HD12 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -46.49 151.61 0.99 Allowed Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.128 -0.982 . . . . 0.0 109.134 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.554 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -76.91 -4.84 15.37 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.475 2.117 . . . . 0.0 110.008 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.473 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.47 -23.28 21.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.389 -0.819 . . . . 0.0 109.229 179.762 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 4.8 m-20 -82.61 -4.69 58.08 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.33 -0.856 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.911 ' CG1' HD11 ' B' ' 18' ' ' ILE . 8.9 mt -105.59 155.35 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 110.283 -179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.569 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -127.36 -29.14 2.73 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 179.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.569 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -135.11 171.06 14.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.161 -0.962 . . . . 0.0 109.055 179.374 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.536 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 46.2 t -143.73 101.82 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.047 -1.033 . . . . 0.0 109.752 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.518 ' O ' HD12 ' B' ' 41' ' ' ILE . 3.9 t-20 -95.65 110.4 22.52 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.297 -0.877 . . . . 0.0 109.321 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.406 HG13 HG22 ' B' ' 40' ' ' VAL . 1.9 t -107.01 100.71 11.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.216 -0.928 . . . . 0.0 109.481 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.534 ' CD ' ' HB2' ' B' ' 10' ' ' GLN . 10.1 ptmt -95.57 109.52 21.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.185 -0.947 . . . . 0.0 109.441 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.451 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -61.99 171.49 1.5 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.315 -0.865 . . . . 0.0 109.447 -180.0 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.546 ' HG2' ' CB ' ' A' ' 71' ' ' LYS . 35.8 Cg_endo -77.43 144.6 22.96 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.615 2.21 . . . . 0.0 110.455 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -151.84 -141.25 3.29 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.9 39.94 0.9 Allowed 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.684 2.256 . . . . 0.0 110.826 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.559 ' CD2' HD22 ' B' ' 7' ' ' LEU . 6.5 p-80 -159.37 -38.8 0.06 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.073 -1.017 . . . . 0.0 109.202 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -141.21 99.02 3.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.351 -0.843 . . . . 0.0 109.154 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.9 -11.93 43.43 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.27 -0.894 . . . . 0.0 109.7 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.456 ' HA ' ' OE1' ' B' ' 37' ' ' GLN . 4.0 mm-40 -98.77 124.45 43.65 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.224 -0.923 . . . . 0.0 109.519 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.454 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 9.4 m -47.78 157.89 0.24 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.268 -0.895 . . . . 0.0 109.313 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.454 ' OE1' ' O ' ' B' ' 38' ' ' THR . 7.3 mm-40 -145.58 107.27 4.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.732 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.903 HG11 HD11 ' B' ' 63' ' ' ILE . 6.3 t -89.72 156.2 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.346 -0.846 . . . . 0.0 109.182 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.518 HD12 ' O ' ' B' ' 27' ' ' ASN . 2.6 mp -141.07 148.47 21.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.144 -0.973 . . . . 0.0 109.777 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.76 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -133.09 118.19 18.44 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.383 -0.823 . . . . 0.0 109.057 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.518 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 2.1 m -89.08 98.82 11.98 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.909 -1.12 . . . . 0.0 108.896 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.1 mt -44.4 166.5 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.523 -0.736 . . . . 0.0 109.697 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.4 ptpt -81.73 8.09 10.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.318 -0.864 . . . . 0.0 109.692 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.07 25.01 11.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.231 -0.918 . . . . 0.0 109.26 179.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.28 2.55 67.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.508 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 5.8 mtt180 -92.01 164.28 13.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.153 -1.204 . . . . 0.0 109.436 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 1.6 mptt -135.86 153.2 51.55 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.229 -0.919 . . . . 0.0 109.382 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.554 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.39 122.36 8.21 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.365 -0.835 . . . . 0.0 109.075 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 5.4 m -79.4 142.96 35.5 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.021 . . . . 0.0 109.08 179.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 1.131 HD13 HD13 ' B' ' 62' ' ' ILE . 14.0 mt -119.65 167.63 11.84 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.262 -0.899 . . . . 0.0 109.678 -179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.669 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.1 t30 -97.62 118.99 63.56 Favored Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.506 -0.746 . . . . 0.0 109.182 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -74.26 0.14 8.89 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.07 1.846 . . . . 0.0 110.339 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.569 ' HB3' HD22 ' B' ' 53' ' ' ASN . . . -94.72 -13.16 26.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.34 -0.85 . . . . 0.0 108.867 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.1 OUTLIER -90.1 165.4 24.23 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.363 -0.835 . . . . 0.0 109.419 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.501 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.5 Cg_endo -78.1 -42.23 0.25 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.742 2.295 . . . . 0.0 110.831 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 47.2 mt -61.61 -39.62 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.189 -0.944 . . . . 0.0 109.706 -179.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 1.037 ' HA ' HD12 ' B' ' 62' ' ' ILE . 47.6 t -64.43 -49.48 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.347 -0.845 . . . . 0.0 109.832 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.524 ' O ' ' CG ' ' B' ' 64' ' ' GLU . 8.7 mttm -53.77 -32.28 51.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.115 -0.991 . . . . 0.0 108.741 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -78.04 -29.89 49.58 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.615 -0.678 . . . . 0.0 109.285 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 1.131 HD13 HD13 ' B' ' 52' ' ' LEU . 15.0 mt -64.6 -38.43 82.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.309 -0.869 . . . . 0.0 109.138 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.955 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.4 mp -75.99 -64.79 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.339 -0.851 . . . . 0.0 109.786 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.524 ' CG ' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -49.61 -55.2 14.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.01 -1.057 . . . . 0.0 109.449 -179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.486 ' HB3' ' O ' ' B' ' 61' ' ' LYS . 42.9 tptt -46.57 -55.81 7.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.207 -0.933 . . . . 0.0 109.135 179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.536 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.0 OUTLIER -44.43 -43.2 7.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.184 -0.948 . . . . 0.0 109.116 179.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.948 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -55.72 -55.39 32.88 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.434 -0.791 . . . . 0.0 109.63 179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -87.2 10.35 17.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.227 -0.921 . . . . 0.0 109.623 -179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.47 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 90.6 p -63.29 -40.31 96.99 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 109.459 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.528 ' O ' ' CG ' ' B' ' 71' ' ' LYS . 2.8 m-20 59.67 66.74 0.96 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.94 . . . . 0.0 109.496 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.545 ' CB ' ' HG2' ' A' ' 31' ' ' PRO . 13.9 ptpt 41.78 -163.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.435 -0.791 . . . . 0.0 109.696 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.448 ' O ' ' OXT' ' B' ' 73' ' ' ASN . 4.3 t -113.13 76.13 0.96 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.285 -0.884 . . . . 0.0 109.456 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . 0.448 ' OXT' ' O ' ' B' ' 72' ' ' SER . 4.3 t30 . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.439 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.71 172.86 6.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.258 -0.901 . . . . 0.0 109.485 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.593 ' O ' HG22 ' A' ' 3' ' ' VAL . 10.8 p -151.36 17.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.199 -0.938 . . . . 0.0 109.468 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.583 ' HB3' ' O ' ' A' ' 3' ' ' VAL . . . 69.5 -158.11 0.16 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.263 -0.898 . . . . 0.0 109.483 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.401 ' O ' ' HB2' ' A' ' 6' ' ' GLU . 0.0 OUTLIER -158.24 117.05 3.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.0 109.433 179.985 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 5' ' ' THR . 8.5 tt0 179.97 76.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.237 -0.914 . . . . 0.0 109.449 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.615 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -117.14 98.52 6.5 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.175 -0.953 . . . . 0.0 109.645 -179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -88.42 153.33 21.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.288 -0.883 . . . . 0.0 109.022 179.641 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.71 ' HB2' HD22 ' A' ' 12' ' ' LEU . 67.1 m -44.31 118.83 1.63 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 109.403 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.531 ' NE2' ' HD3' ' A' ' 29' ' ' LYS . 0.9 OUTLIER -40.66 -40.01 1.19 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.587 -0.695 . . . . 0.0 109.857 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.459 ' SG ' HG13 ' A' ' 41' ' ' ILE . 82.5 m -132.09 80.49 1.91 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.354 -0.841 . . . . 0.0 109.878 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.71 HD22 ' HB2' ' A' ' 9' ' ' CYS . 3.9 mm? -49.2 -45.35 44.18 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 108.993 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -116.89 122.71 45.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.429 -0.794 . . . . 0.0 108.923 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.12 166.83 10.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.952 . . . . 0.0 110.006 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.493 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 6.0 mt -115.27 146.21 41.7 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.562 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.8 OUTLIER -44.74 -35.65 2.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.109 -0.994 . . . . 0.0 109.38 -179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.754 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 146.37 -176.98 25.01 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.759 HD13 HD11 ' A' ' 23' ' ' ILE . 1.7 pp -157.04 162.39 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.399 -1.06 . . . . 0.0 109.372 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.6 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -59.24 156.21 30.25 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 0.0 109.343 179.817 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -77.04 -13.3 17.36 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.501 2.134 . . . . 0.0 109.852 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.533 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 22.0 mttt -74.17 -30.86 62.45 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.969 ' O ' HD13 ' A' ' 23' ' ' ILE . 26.5 m-20 -89.59 58.41 4.32 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.969 HD13 ' O ' ' A' ' 22' ' ' ASN . 1.5 mm -145.63 169.16 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.141 -0.974 . . . . 0.0 110.098 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.748 ' HG2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -160.18 -35.66 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.621 ' O ' HG23 ' A' ' 26' ' ' VAL . 3.0 p -136.37 -172.59 3.18 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.621 HG23 ' O ' ' A' ' 25' ' ' SER . 52.1 t -159.24 115.16 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.891 -1.131 . . . . 0.0 109.97 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.508 ' O ' HD12 ' A' ' 41' ' ' ILE . 3.9 t-20 -109.11 110.76 22.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.281 -0.887 . . . . 0.0 109.111 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.536 HG13 HG22 ' A' ' 40' ' ' VAL . 2.1 t -120.71 109.8 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.3 -0.875 . . . . 0.0 109.729 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.531 ' HD3' ' NE2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -108.87 102.03 11.08 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.37 -0.831 . . . . 0.0 109.309 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.464 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -48.81 171.31 0.1 Allowed Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 -179.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 36.0 Cg_endo -78.03 140.87 18.32 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 C-N-CA 122.586 2.191 . . . . 0.0 110.462 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.48 -141.49 3.68 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.45 8.82 3.13 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.544 2.163 . . . . 0.0 110.878 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.615 ' CD2' HD22 ' A' ' 7' ' ' LEU . 4.4 p-80 -125.53 -21.33 4.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.047 -1.033 . . . . 0.0 109.807 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' OE1' ' A' ' 37' ' ' GLN . 2.1 t -160.02 122.44 3.36 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.012 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -86.42 16.2 4.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.313 -0.867 . . . . 0.0 109.637 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 2.0 mp0 -124.13 124.83 43.35 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -0.918 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.842 HG21 ' HB3' ' B' ' 70' ' ' ASP . 15.9 m -54.88 137.54 45.11 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.24 -0.912 . . . . 0.0 109.406 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.47 ' OE1' ' N ' ' A' ' 39' ' ' GLU . 1.7 mp0 -118.77 107.02 13.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.213 -0.93 . . . . 0.0 109.683 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.711 HG11 HD11 ' A' ' 63' ' ' ILE . 13.5 t -95.12 146.94 6.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 109.244 179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.514 ' CG1' ' SG ' ' A' ' 51' ' ' CYS . 2.1 mp -138.23 152.58 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.874 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.756 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -136.62 125.25 23.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.411 -0.805 . . . . 0.0 109.041 179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.748 HG22 ' HG2' ' A' ' 24' ' ' GLN . 33.4 m -89.51 106.86 18.73 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.008 -1.058 . . . . 0.0 109.093 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.847 HD23 ' O ' ' A' ' 22' ' ' ASN . 71.9 mt -49.03 166.11 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.183 -0.948 . . . . 0.0 109.114 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.533 ' CD ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -84.27 11.04 8.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.057 -1.027 . . . . 0.0 109.533 179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -111.12 19.26 18.59 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.325 179.844 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.26 14.61 80.1 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.599 ' HB2' HD12 ' A' ' 44' ' ' LEU . 49.1 mtt180 -109.15 175.23 5.53 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.205 -1.173 . . . . 0.0 109.502 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 48' ' ' ARG . 0.0 OUTLIER -145.15 155.25 43.18 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.319 -0.863 . . . . 0.0 109.48 -179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.493 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.1 124.99 9.87 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.365 -0.834 . . . . 0.0 109.116 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.514 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 12.0 m -79.55 140.35 37.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.091 -1.006 . . . . 0.0 109.267 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.862 ' HB3' HG22 ' A' ' 59' ' ' VAL . 11.4 mt -122.93 168.67 12.01 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.253 -0.904 . . . . 0.0 109.266 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.65 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.2 t30 -104.68 124.79 35.77 Favored Pre-proline 0 C--N 1.299 -1.599 0 O-C-N 121.397 -0.814 . . . . 0.0 109.276 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.8 Cg_endo -75.11 -13.48 21.18 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.165 1.91 . . . . 0.0 110.531 -179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.549 ' HB3' HD22 ' A' ' 53' ' ' ASN . . . -73.55 -16.65 61.26 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.261 -0.899 . . . . 0.0 108.875 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.7 OUTLIER -90.16 161.16 38.51 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.453 -0.779 . . . . 0.0 109.419 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -78.12 -37.17 0.85 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.679 2.253 . . . . 0.0 111.044 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.58 ' O ' HD13 ' A' ' 62' ' ' ILE . 17.6 tt -64.73 -47.2 89.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.06 -1.025 . . . . 0.0 109.13 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.862 HG22 ' HB3' ' A' ' 52' ' ' LEU . 39.5 t -56.68 -48.23 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.509 -0.745 . . . . 0.0 109.163 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 56' ' ' SER . 4.6 mmtt -54.21 -31.18 52.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.508 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 9.6 mmmm -78.3 -30.66 48.49 Favored 'General case' 0 N--CA 1.491 1.58 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.35 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.602 HG22 HD12 ' A' ' 63' ' ' ILE . 1.7 mp -58.0 -43.59 85.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 179.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.833 ' CG2' HD11 ' B' ' 67' ' ' LEU . 1.6 mp -68.7 -61.76 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.43 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -42.6 -29.03 0.26 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.344 -0.847 . . . . 0.0 109.584 179.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' A' ' 66' ' ' MET . 0.7 OUTLIER -74.32 -60.57 2.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.858 . . . . 0.0 109.271 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.537 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 1.2 mmm -44.05 -48.37 8.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.385 -0.822 . . . . 0.0 109.245 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.825 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -43.64 -51.21 7.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.315 -0.866 . . . . 0.0 109.342 179.824 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.97 -37.04 86.34 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.467 -0.771 . . . . 0.0 109.497 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -46.71 -32.0 3.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.347 -0.846 . . . . 0.0 109.465 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.837 ' HB3' HG21 ' B' ' 38' ' ' THR . 3.4 p30 -99.25 88.17 3.85 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.134 -0.979 . . . . 0.0 109.448 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.426 ' HG2' ' N ' ' A' ' 72' ' ' SER . 10.5 tttt -118.7 152.44 36.13 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.221 -0.924 . . . . 0.0 109.526 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.426 ' N ' ' HG2' ' A' ' 71' ' ' LYS . 0.4 OUTLIER -168.01 71.95 0.1 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.212 -0.93 . . . . 0.0 109.411 -179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.413 ' O ' ' OD1' ' A' ' 73' ' ' ASN . 12.9 p30 . . . . . 0 N--CA 1.489 1.508 0 O-C-N 121.126 -0.984 . . . . 0.0 109.5 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -104.7 172.87 6.56 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.286 -0.884 . . . . 0.0 109.463 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.597 ' O ' HG22 ' B' ' 3' ' ' VAL . 10.8 p -151.37 17.75 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.482 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' B' ' 3' ' ' VAL . . . 69.41 -158.09 0.17 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.493 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.407 ' O ' ' HB2' ' B' ' 6' ' ' GLU . 0.0 OUTLIER -158.22 116.93 3.09 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 0.0 109.502 -179.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.407 ' HB2' ' O ' ' B' ' 5' ' ' THR . 8.5 tt0 -179.97 76.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 109.44 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.618 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -117.16 98.53 6.5 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.205 -0.934 . . . . 0.0 109.649 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -88.4 153.32 21.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.004 179.59 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.705 ' HB2' HD22 ' B' ' 12' ' ' LEU . 67.4 m -44.3 118.88 1.64 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.196 -0.94 . . . . 0.0 109.49 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.528 ' NE2' ' HD3' ' B' ' 29' ' ' LYS . 0.9 OUTLIER -40.74 -40.03 1.23 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.549 -0.719 . . . . 0.0 109.899 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.46 ' SG ' HG13 ' B' ' 41' ' ' ILE . 83.2 m -132.0 80.63 1.92 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.333 -0.854 . . . . 0.0 109.882 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.705 HD22 ' HB2' ' B' ' 9' ' ' CYS . 3.9 mm? -49.38 -45.33 45.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.104 -0.998 . . . . 0.0 108.921 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -116.92 122.78 45.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.417 -0.802 . . . . 0.0 108.911 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -102.18 166.78 10.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.226 -0.921 . . . . 0.0 109.999 -179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.482 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 6.0 mt -115.2 146.18 41.67 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.563 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.8 OUTLIER -44.67 -35.67 2.74 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.142 -0.973 . . . . 0.0 109.438 179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.766 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 146.32 -177.02 24.94 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.795 HD13 HD11 ' B' ' 23' ' ' ILE . 1.7 pp -157.01 162.38 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.322 -1.105 . . . . 0.0 109.428 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.608 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -59.25 156.24 30.22 Favored Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.291 -0.881 . . . . 0.0 109.233 179.868 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.608 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.06 -13.19 17.37 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.467 2.112 . . . . 0.0 109.961 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.525 ' O ' ' CD ' ' B' ' 45' ' ' LYS . 22.1 mttt -74.17 -30.85 62.43 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.96 ' O ' HD13 ' B' ' 23' ' ' ILE . 26.4 m-20 -89.65 58.41 4.29 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.96 HD13 ' O ' ' B' ' 22' ' ' ASN . 1.5 mm -145.65 169.21 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.072 -1.018 . . . . 0.0 110.135 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.737 ' HG2' HG22 ' B' ' 43' ' ' THR . 0.0 OUTLIER -160.16 -35.68 0.05 Allowed 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.115 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.614 ' O ' HG23 ' B' ' 26' ' ' VAL . 3.0 p -136.37 -172.64 3.19 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.614 HG23 ' O ' ' B' ' 25' ' ' SER . 52.0 t -159.2 115.21 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.915 -1.115 . . . . 0.0 109.984 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.514 ' O ' HD12 ' B' ' 41' ' ' ILE . 3.9 t-20 -109.09 110.71 22.04 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.361 -0.837 . . . . 0.0 109.111 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.549 HG13 HG22 ' B' ' 40' ' ' VAL . 2.1 t -120.74 109.81 26.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.176 -0.952 . . . . 0.0 109.661 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.528 ' HD3' ' NE2' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -108.78 102.04 11.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.189 -0.944 . . . . 0.0 109.282 179.733 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.451 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.0 OUTLIER -48.84 171.29 0.1 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.193 -0.942 . . . . 0.0 109.377 -179.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.451 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 36.3 Cg_endo -77.98 140.87 18.45 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.641 2.227 . . . . 0.0 110.497 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.57 -141.46 3.66 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.47 8.82 3.13 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.563 2.175 . . . . 0.0 110.865 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.618 ' CD2' HD22 ' B' ' 7' ' ' LEU . 4.4 p-80 -125.56 -21.32 4.51 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.053 -1.03 . . . . 0.0 109.775 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.445 ' SG ' ' OE1' ' B' ' 37' ' ' GLN . 2.1 t -160.03 122.59 3.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.092 -1.005 . . . . 0.0 109.333 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.404 ' HA ' ' HB2' ' B' ' 31' ' ' PRO . . . -86.57 16.28 4.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.603 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.455 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 2.0 mp0 -124.17 124.87 43.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 0.0 109.474 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.837 HG21 ' HB3' ' A' ' 70' ' ' ASP . 15.3 m -54.78 137.58 44.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.197 -0.939 . . . . 0.0 109.413 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.472 ' OE1' ' N ' ' B' ' 39' ' ' GLU . 1.7 mp0 -118.85 107.06 13.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.195 -0.94 . . . . 0.0 109.632 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.724 HG11 HD11 ' B' ' 63' ' ' ILE . 13.5 t -95.14 146.91 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.23 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.515 ' CG1' ' SG ' ' B' ' 51' ' ' CYS . 2.1 mp -138.2 152.63 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.089 -1.007 . . . . 0.0 109.899 -179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.753 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -136.6 125.29 23.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.085 179.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.737 HG22 ' HG2' ' B' ' 24' ' ' GLN . 33.8 m -89.6 106.87 18.74 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 120.973 -1.08 . . . . 0.0 109.071 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.826 HD23 ' O ' ' B' ' 22' ' ' ASN . 72.8 mt -49.07 166.17 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.151 -0.968 . . . . 0.0 109.013 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.525 ' CD ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -84.34 11.03 9.12 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.042 -1.036 . . . . 0.0 109.442 179.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -111.12 19.3 18.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.267 -0.896 . . . . 0.0 109.345 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.28 14.63 80.04 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.577 ' HB2' HD12 ' B' ' 44' ' ' LEU . 49.2 mtt180 -109.16 175.24 5.53 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -1.209 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' B' ' 48' ' ' ARG . 0.0 OUTLIER -145.19 155.33 43.21 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 109.425 179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.482 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.14 124.98 9.83 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.391 -0.818 . . . . 0.0 109.112 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.515 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 12.0 m -79.64 140.3 37.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.166 -0.959 . . . . 0.0 109.244 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.827 ' HB3' HG22 ' B' ' 59' ' ' VAL . 11.4 mt -122.91 168.69 11.98 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.259 -0.901 . . . . 0.0 109.229 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.652 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.2 t30 -104.78 124.86 35.48 Favored Pre-proline 0 C--N 1.299 -1.601 0 O-C-N 121.344 -0.847 . . . . 0.0 109.171 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -75.06 -13.58 21.25 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.263 1.975 . . . . 0.0 110.452 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.526 ' HB3' HD22 ' B' ' 53' ' ' ASN . . . -73.53 -16.68 61.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.209 -0.932 . . . . 0.0 108.804 179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.493 ' HG ' HG22 ' B' ' 58' ' ' ILE . 0.7 OUTLIER -90.2 161.13 38.46 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.388 -0.82 . . . . 0.0 109.342 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.404 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.5 Cg_endo -78.07 -37.19 0.86 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.703 2.269 . . . . 0.0 111.08 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.593 ' O ' HD13 ' B' ' 62' ' ' ILE . 17.5 tt -64.69 -47.26 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.053 -1.029 . . . . 0.0 109.162 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.827 HG22 ' HB3' ' B' ' 52' ' ' LEU . 39.4 t -56.75 -48.28 81.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' B' ' 56' ' ' SER . 4.6 mmtt -54.15 -31.24 51.93 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.51 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 9.7 mmmm -78.27 -30.64 48.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.498 -0.751 . . . . 0.0 109.302 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.604 HG22 HD12 ' B' ' 63' ' ' ILE . 1.7 mp -58.08 -43.57 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.123 -1.066 . . . . 0.0 108.123 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.825 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.6 mp -68.72 -61.63 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -42.7 -28.99 0.27 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.347 -0.845 . . . . 0.0 109.583 179.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.423 ' O ' ' C ' ' B' ' 66' ' ' MET . 0.7 OUTLIER -74.38 -60.47 2.26 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.192 -0.942 . . . . 0.0 109.276 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.531 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 1.2 mmm -44.16 -48.28 9.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.371 -0.83 . . . . 0.0 109.207 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.833 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -43.75 -51.16 7.42 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.379 -0.825 . . . . 0.0 109.317 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -64.91 -37.09 86.47 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.3 -0.875 . . . . 0.0 109.523 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -46.74 -31.93 3.29 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.499 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.842 ' HB3' HG21 ' A' ' 38' ' ' THR . 3.4 p30 -99.29 88.18 3.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 0.0 109.457 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.424 ' HG2' ' N ' ' B' ' 72' ' ' SER . 10.4 tttt -118.7 152.51 35.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.476 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.424 ' N ' ' HG2' ' B' ' 71' ' ' LYS . 0.4 OUTLIER -168.01 71.95 0.1 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.245 -0.909 . . . . 0.0 109.512 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . 0.403 ' O ' ' OD1' ' B' ' 73' ' ' ASN . 13.0 p30 . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 118.066 -0.968 . . . . 0.0 109.455 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.424 ' O ' ' N ' ' A' ' 4' ' ' ALA . 0.7 OUTLIER -154.82 114.33 3.71 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.922 . . . . 0.0 109.47 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.606 HG12 ' N ' ' A' ' 4' ' ' ALA . 48.7 t 58.58 -89.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.53 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.606 ' N ' HG12 ' A' ' 3' ' ' VAL . . . -151.15 88.49 1.45 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.905 . . . . 0.0 109.415 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 35.2 p -87.09 -24.03 24.7 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.296 -0.878 . . . . 0.0 109.47 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.89 91.63 0.26 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.474 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.551 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -118.41 98.86 6.48 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.251 -0.905 . . . . 0.0 109.533 -179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 9' ' ' CYS . 1.8 mpp_? -91.16 151.64 20.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.282 -0.886 . . . . 0.0 109.141 179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.956 ' HB2' HD22 ' A' ' 12' ' ' LEU . 7.7 m -44.06 109.97 0.18 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.176 -0.952 . . . . 0.0 109.361 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.439 ' C ' ' O ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -42.25 -27.25 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.415 -0.803 . . . . 0.0 109.797 -179.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.446 ' SG ' HG13 ' A' ' 41' ' ' ILE . 98.7 m -131.26 67.18 1.52 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.185 -0.947 . . . . 0.0 109.616 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.956 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.43 -40.44 5.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.272 -0.893 . . . . 0.0 109.228 179.835 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -121.43 126.44 49.34 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.405 -0.81 . . . . 0.0 109.173 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -106.52 160.51 15.37 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.214 -0.929 . . . . 0.0 109.926 -179.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.469 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.1 mt -110.38 140.64 44.39 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.519 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.2 tt0 -44.07 -26.62 0.31 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -0.889 . . . . 0.0 109.371 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.782 ' O ' HG23 ' A' ' 18' ' ' ILE . . . 151.78 -165.88 30.71 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.782 HG23 ' O ' ' A' ' 17' ' ' GLY . 1.2 pp -169.14 162.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -1.064 . . . . 0.0 109.842 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.629 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.7 t60 -56.83 149.07 45.09 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.629 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -80.37 -15.99 10.99 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.318 2.012 . . . . 0.0 108.922 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.53 ' O ' ' CD ' ' A' ' 45' ' ' LYS . 5.7 mttm -77.99 -22.8 48.83 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.962 ' O ' HD13 ' A' ' 23' ' ' ILE . 17.9 m-20 -94.25 57.85 2.39 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 179.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.962 HD13 ' O ' ' A' ' 22' ' ' ASN . 2.4 mm -143.27 169.97 10.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.044 -1.035 . . . . 0.0 110.129 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER -160.09 -40.47 0.05 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.528 ' CB ' ' HB ' ' A' ' 43' ' ' THR . 2.2 p -133.18 174.98 9.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.531 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 50.4 t -156.48 122.55 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 120.952 -1.092 . . . . 0.0 109.759 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.495 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 56.0 t30 -104.77 155.97 18.41 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.276 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.486 ' HB ' ' HB ' ' B' ' 26' ' ' VAL . 2.9 t -145.59 76.41 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.959 . . . . 0.0 109.513 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.527 ' HE3' ' NE2' ' A' ' 34' ' ' HIS . 11.0 tptt -87.36 100.4 12.7 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.886 . . . . 0.0 109.479 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.3 p -51.65 166.34 0.38 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.248 -0.908 . . . . 0.0 109.41 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.527 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.9 Cg_endo -78.15 131.75 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.594 2.196 . . . . 0.0 110.537 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.54 -144.34 4.91 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.19 7.77 3.54 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.59 2.194 . . . . 0.0 110.767 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.551 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 11.5 p-80 -125.98 -6.91 6.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.089 -1.007 . . . . 0.0 109.616 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 2.6 t -160.04 116.97 2.52 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.169 -0.957 . . . . 0.0 109.424 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.41 45.83 1.23 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.344 -0.848 . . . . 0.0 109.508 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.527 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 4.3 pt20 -172.55 139.14 0.93 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.53 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.435 ' HB ' ' CG ' ' A' ' 54' ' ' PRO . 2.4 m -57.52 144.06 38.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.265 -0.897 . . . . 0.0 109.373 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -124.77 107.64 11.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.272 -0.892 . . . . 0.0 109.592 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.986 HG11 HD11 ' A' ' 63' ' ' ILE . 44.2 t -100.39 150.02 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.867 . . . . 0.0 109.297 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.504 HG22 ' N ' ' A' ' 42' ' ' ALA . 2.5 mp -136.06 159.66 38.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.196 -0.94 . . . . 0.0 109.848 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.656 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -141.73 121.53 13.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.414 -0.803 . . . . 0.0 109.11 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.528 ' HB ' ' CB ' ' A' ' 25' ' ' SER . 16.4 m -89.53 101.27 13.95 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.973 -1.079 . . . . 0.0 109.17 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.775 HD23 ' O ' ' A' ' 22' ' ' ASN . 73.7 mt -44.56 165.3 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.323 -0.861 . . . . 0.0 109.02 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.53 ' CD ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -83.64 9.93 10.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.119 -0.988 . . . . 0.0 109.494 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -109.99 16.88 21.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.183 -0.948 . . . . 0.0 109.364 179.938 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.83 18.54 67.6 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.595 ' HB2' HD12 ' A' ' 44' ' ' LEU . 1.7 mtp180 -111.89 169.43 8.84 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.271 -1.134 . . . . 0.0 109.502 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.428 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 0.3 OUTLIER -136.18 153.65 51.19 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.192 -0.943 . . . . 0.0 109.478 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.27 123.36 8.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.113 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.435 ' SG ' HG13 ' A' ' 41' ' ' ILE . 11.8 m -79.51 143.19 35.11 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.096 -1.002 . . . . 0.0 109.14 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.864 ' HB3' HG22 ' A' ' 59' ' ' VAL . 14.0 mt -123.63 168.12 13.07 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.372 -0.83 . . . . 0.0 109.305 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.657 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.9 t-20 -100.48 122.39 49.89 Favored Pre-proline 0 C--N 1.3 -1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.151 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.506 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.6 Cg_endo -75.14 -10.2 20.89 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.205 1.937 . . . . 0.0 110.283 -179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.08 -14.76 58.95 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.273 -0.892 . . . . 0.0 108.969 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.3 OUTLIER -89.96 159.53 42.62 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.435 -0.791 . . . . 0.0 109.426 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.44 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.7 -33.49 2.27 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.578 2.185 . . . . 0.0 110.671 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.591 HG23 ' N ' ' A' ' 59' ' ' VAL . 16.8 tt -68.07 -46.96 80.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.075 -1.015 . . . . 0.0 109.232 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.864 HG22 ' HB3' ' A' ' 52' ' ' LEU . 37.3 t -56.23 -48.78 78.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.414 -0.804 . . . . 0.0 109.076 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.506 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 14.9 mttt -56.32 -31.51 63.78 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.472 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -74.52 -29.93 61.59 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.604 -0.685 . . . . 0.0 109.284 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.589 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -68.88 -43.59 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.012 HG22 HD11 ' B' ' 67' ' ' LEU . 2.2 mp -65.17 -65.86 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.346 -0.846 . . . . 0.0 109.523 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.486 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -48.04 -42.73 29.12 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.121 -0.987 . . . . 0.0 109.593 -179.765 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.449 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -55.58 -49.24 73.28 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.225 -0.922 . . . . 0.0 109.3 179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.531 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -53.48 -47.47 69.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.387 -0.82 . . . . 0.0 109.265 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.98 HD11 HG22 ' B' ' 63' ' ' ILE . 0.2 OUTLIER -46.89 -52.48 14.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.413 -0.804 . . . . 0.0 109.462 179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' A' ' 69' ' ' SER . 13.4 t-20 -63.52 -31.73 72.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.274 -0.891 . . . . 0.0 109.466 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 68' ' ' ASN . 5.9 p -43.94 -34.59 1.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.306 -0.871 . . . . 0.0 109.509 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -54.77 -59.51 4.62 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.296 -0.877 . . . . 0.0 109.489 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -97.14 -160.25 0.79 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.933 . . . . 0.0 109.474 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.0 t -164.21 -66.14 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.298 -0.876 . . . . 0.0 109.429 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.47 -179.957 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.427 ' O ' ' N ' ' B' ' 4' ' ' ALA . 0.7 OUTLIER -154.78 114.29 3.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.911 . . . . 0.0 109.459 -179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.619 HG12 ' N ' ' B' ' 4' ' ' ALA . 48.7 t 58.61 -89.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.494 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.619 ' N ' HG12 ' B' ' 3' ' ' VAL . . . -151.1 88.37 1.45 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.486 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 35.6 p -86.94 -24.24 24.84 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.232 -0.918 . . . . 0.0 109.468 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.8 91.61 0.27 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.417 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.549 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -118.35 98.97 6.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.215 -0.928 . . . . 0.0 109.621 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.423 ' O ' ' C ' ' B' ' 9' ' ' CYS . 1.8 mpp_? -91.26 151.69 20.81 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.262 -0.899 . . . . 0.0 109.125 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.935 ' HB2' HD22 ' B' ' 12' ' ' LEU . 7.8 m -44.01 109.89 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.352 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.431 ' C ' ' O ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -42.16 -27.3 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.456 -0.778 . . . . 0.0 109.833 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.452 ' SG ' HG13 ' B' ' 41' ' ' ILE . 98.9 m -131.27 67.15 1.52 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.598 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.935 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.37 -40.59 5.49 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.164 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 -121.34 126.54 49.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.337 -0.852 . . . . 0.0 109.167 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.531 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -106.56 160.59 15.32 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.248 -0.908 . . . . 0.0 109.841 -179.613 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.473 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.0 mt -110.38 140.58 44.45 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.461 -0.774 . . . . 0.0 108.928 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.528 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.2 tt0 -44.04 -26.59 0.3 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.119 -0.988 . . . . 0.0 109.422 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.766 ' O ' HG23 ' B' ' 18' ' ' ILE . . . 151.76 -165.86 30.69 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.789 -1.325 . . . . 0.0 109.789 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.766 HG23 ' O ' ' B' ' 17' ' ' GLY . 1.2 pp -169.13 162.34 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.385 -1.068 . . . . 0.0 109.837 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.612 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 1.7 t60 -56.89 149.05 45.83 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.612 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.6 Cg_endo -80.32 -16.03 11.05 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.383 2.055 . . . . 0.0 108.915 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.537 ' O ' ' CD ' ' B' ' 45' ' ' LYS . 5.7 mttm -78.04 -22.71 48.77 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.969 ' O ' HD13 ' B' ' 23' ' ' ILE . 17.8 m-20 -94.34 57.96 2.38 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 178.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.969 HD13 ' O ' ' B' ' 22' ' ' ASN . 2.3 mm -143.31 169.98 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.093 -1.004 . . . . 0.0 110.157 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.0 OUTLIER -160.11 -40.62 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 179.46 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.524 ' CB ' ' HB ' ' B' ' 43' ' ' THR . 2.1 p -133.13 174.93 9.85 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.535 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 50.4 t -156.38 122.5 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.939 -1.101 . . . . 0.0 109.759 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.488 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 55.6 t30 -104.71 155.9 18.46 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.244 -0.91 . . . . 0.0 109.357 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.477 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 2.9 t -145.52 76.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.23 -0.919 . . . . 0.0 109.516 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.518 ' HE3' ' NE2' ' B' ' 34' ' ' HIS . 11.0 tptt -87.32 100.49 12.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.287 -0.883 . . . . 0.0 109.448 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.455 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.3 p -51.75 166.29 0.39 Allowed Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.533 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.8 Cg_endo -78.05 131.71 11.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.648 2.232 . . . . 0.0 110.524 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.5 -144.41 4.93 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.11 7.74 3.53 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.649 2.233 . . . . 0.0 110.819 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.549 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 11.4 p-80 -125.98 -6.86 6.65 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.112 -0.993 . . . . 0.0 109.67 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 2.7 t -160.15 116.93 2.48 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.179 -0.95 . . . . 0.0 109.415 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.4 45.73 1.22 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.576 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.533 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 4.2 pt20 -172.48 139.17 0.95 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.892 . . . . 0.0 109.55 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.437 ' HB ' ' CG ' ' B' ' 54' ' ' PRO . 2.4 m -57.46 144.12 37.86 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.258 -0.901 . . . . 0.0 109.427 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -124.84 107.59 11.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.266 -0.896 . . . . 0.0 109.554 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.98 HG11 HD11 ' B' ' 63' ' ' ILE . 44.3 t -100.39 150.05 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.32 -0.862 . . . . 0.0 109.281 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.491 HG22 ' N ' ' B' ' 42' ' ' ALA . 2.5 mp -136.03 159.63 38.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.121 -0.987 . . . . 0.0 109.87 -179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.648 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -141.69 121.47 13.5 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.386 -0.822 . . . . 0.0 109.135 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 16.4 m -89.43 101.32 14.0 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.024 -1.047 . . . . 0.0 109.23 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.783 HD23 ' O ' ' B' ' 22' ' ' ASN . 73.8 mt -44.56 165.34 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.336 -0.853 . . . . 0.0 109.058 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.537 ' CD ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -83.66 9.88 10.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.161 -0.962 . . . . 0.0 109.434 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -109.91 16.79 21.73 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.188 -0.945 . . . . 0.0 109.385 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.92 18.46 67.58 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.587 ' HB2' HD12 ' B' ' 44' ' ' LEU . 1.7 mtp180 -111.82 169.29 8.93 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.205 -1.173 . . . . 0.0 109.512 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.429 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 0.3 OUTLIER -136.04 153.61 51.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.212 -0.93 . . . . 0.0 109.592 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.473 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.21 123.31 8.84 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 109.072 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.433 ' SG ' HG13 ' B' ' 41' ' ' ILE . 12.0 m -79.45 143.21 35.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.091 -1.006 . . . . 0.0 109.239 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.858 ' HB3' HG22 ' B' ' 59' ' ' VAL . 14.0 mt -123.7 168.07 13.16 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.222 -0.924 . . . . 0.0 109.344 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.663 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.9 t-20 -100.52 122.31 50.08 Favored Pre-proline 0 C--N 1.3 -1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.182 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.51 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.6 Cg_endo -74.99 -10.17 21.1 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 C-N-CA 122.143 1.895 . . . . 0.0 110.388 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -79.1 -14.74 58.95 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.229 -0.919 . . . . 0.0 108.892 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.3 OUTLIER -90.01 159.55 42.44 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.409 -0.807 . . . . 0.0 109.421 179.844 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.451 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.71 -33.43 2.29 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.622 2.215 . . . . 0.0 110.652 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.608 ' O ' HD13 ' B' ' 62' ' ' ILE . 16.9 tt -68.2 -46.88 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.099 -1.0 . . . . 0.0 109.151 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.858 HG22 ' HB3' ' B' ' 52' ' ' LEU . 37.1 t -56.3 -48.69 79.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.363 -0.836 . . . . 0.0 109.072 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.51 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 14.9 mttt -56.44 -31.43 63.93 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.471 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -74.63 -29.85 61.43 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.604 -0.685 . . . . 0.0 109.266 179.762 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.608 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -68.89 -43.67 82.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.98 HG22 HD11 ' A' ' 67' ' ' LEU . 2.1 mp -65.17 -65.89 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.306 -0.871 . . . . 0.0 109.499 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -47.99 -42.82 28.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.194 -0.941 . . . . 0.0 109.549 -179.775 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -55.52 -49.24 73.13 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.225 -0.922 . . . . 0.0 109.308 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.535 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -53.49 -47.39 69.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.245 -0.909 . . . . 0.0 109.299 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.012 HD11 HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -46.9 -52.47 14.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.308 -0.87 . . . . 0.0 109.454 179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' B' ' 69' ' ' SER . 13.4 t-20 -63.53 -31.75 73.0 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.229 -0.919 . . . . 0.0 109.41 -179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.402 ' C ' ' O ' ' B' ' 68' ' ' ASN . 5.8 p -43.91 -34.66 1.72 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 109.497 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 41.3 t0 -54.78 -59.52 4.62 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.327 -0.858 . . . . 0.0 109.457 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 19.1 tttt -97.2 -160.23 0.79 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.244 -0.91 . . . . 0.0 109.5 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.1 t -164.18 -66.08 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.283 -0.885 . . . . 0.0 109.514 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 118.073 -0.965 . . . . 0.0 109.443 -179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.434 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.434 ' O ' ' O ' ' A' ' 1' ' ' ALA . 0.6 OUTLIER 61.93 128.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.281 -0.887 . . . . 0.0 109.47 179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.727 ' O ' HG13 ' A' ' 3' ' ' VAL . 9.9 p -146.36 77.27 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.196 -0.94 . . . . 0.0 109.482 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.6 ' C ' HG22 ' A' ' 5' ' ' THR . . . -109.24 145.52 35.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.6 HG22 ' C ' ' A' ' 4' ' ' ALA . 0.1 OUTLIER 164.9 133.29 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.184 -0.947 . . . . 0.0 109.501 179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 6' ' ' GLU . 0.4 OUTLIER -88.83 84.31 6.67 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.261 -0.899 . . . . 0.0 109.508 -179.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.539 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -115.89 98.07 6.45 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.274 -0.891 . . . . 0.0 109.594 -179.944 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -87.43 157.68 19.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.271 -0.893 . . . . 0.0 109.091 179.748 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.829 ' HB2' HD22 ' A' ' 12' ' ' LEU . 1.8 m -44.06 114.72 0.71 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -0.983 . . . . 0.0 109.464 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' A' ' 9' ' ' CYS . 13.7 mm-40 -42.16 -27.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -0.818 . . . . 0.0 109.798 -179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.472 ' SG ' HG13 ' A' ' 41' ' ' ILE . 79.1 m -136.55 81.06 1.86 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.213 -0.929 . . . . 0.0 109.716 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.829 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -53.93 -41.44 67.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.231 -0.918 . . . . 0.0 109.16 179.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -118.5 117.93 30.33 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.16 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.598 HG21 HD22 ' A' ' 53' ' ' ASN . 0.6 OUTLIER -99.78 163.18 12.58 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.218 -0.926 . . . . 0.0 109.792 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.516 ' HB2' HD23 ' A' ' 52' ' ' LEU . 4.4 mt -106.18 137.2 44.53 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.371 -0.83 . . . . 0.0 108.963 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.423 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -44.49 -41.39 6.32 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.133 -0.979 . . . . 0.0 109.366 -179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.541 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 177.54 168.84 37.82 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.799 -1.32 . . . . 0.0 109.799 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.734 ' H ' HD11 ' A' ' 62' ' ' ILE . 8.0 tp -153.67 158.37 3.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.473 -1.016 . . . . 0.0 108.772 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.576 ' CB ' ' ND2' ' A' ' 22' ' ' ASN . 2.6 t-80 -45.04 139.89 3.77 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 0.0 109.226 179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.489 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.7 Cg_endo -77.77 -25.44 7.78 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.491 2.127 . . . . 0.0 110.292 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.2 OUTLIER -90.12 -14.83 32.84 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.337 -0.852 . . . . 0.0 108.987 179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.576 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 51.7 m-20 -70.33 -11.61 61.02 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.351 -0.843 . . . . 0.0 109.325 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.879 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 3.1 mt -105.44 149.01 9.19 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 O-C-N 121.263 -0.898 . . . . 0.0 110.611 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.514 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -115.61 -27.69 7.03 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.514 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -136.1 160.72 37.79 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.331 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.523 ' O ' HG23 ' B' ' 28' ' ' VAL . 2.0 t -146.16 101.61 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 120.941 -1.1 . . . . 0.0 109.932 -179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 29.1 t30 -79.96 116.73 20.26 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -0.897 . . . . 0.0 109.198 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.52 HG23 ' O ' ' B' ' 26' ' ' VAL . 1.8 t -98.23 84.68 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.224 -0.923 . . . . 0.0 109.49 -179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HA ' ' HB3' ' B' ' 25' ' ' SER . 0.0 OUTLIER -89.59 93.91 9.66 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.261 -0.899 . . . . 0.0 109.364 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.09 167.26 0.25 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.216 -0.928 . . . . 0.0 109.376 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 35' ' ' CYS . 35.5 Cg_endo -77.96 131.84 11.32 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.619 2.213 . . . . 0.0 110.38 -179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.22 -145.97 6.02 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.472 -1.451 . . . . 0.0 109.472 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.96 5.48 4.93 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.628 2.219 . . . . 0.0 110.626 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.539 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 18.2 p-80 -121.81 -16.83 7.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.187 -0.946 . . . . 0.0 109.614 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.477 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 9.1 t -160.12 96.88 1.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.33 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.76 -10.57 28.6 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.335 -0.853 . . . . 0.0 109.595 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.445 ' OE1' ' SG ' ' A' ' 9' ' ' CYS . 2.0 mp0 -96.24 125.26 40.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.176 -0.953 . . . . 0.0 109.57 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.478 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 3.8 m -50.68 150.7 2.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.189 -0.944 . . . . 0.0 109.385 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.469 ' OE2' ' HB3' ' A' ' 35' ' ' CYS . 3.3 mp0 -129.39 107.7 9.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.959 . . . . 0.0 109.571 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.723 HG11 HD11 ' A' ' 63' ' ' ILE . 1.7 t -102.59 95.34 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -0.904 . . . . 0.0 109.257 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.536 HD12 ' N ' ' A' ' 41' ' ' ILE . 5.2 mp -86.03 140.73 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.742 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.879 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -124.14 119.14 28.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.286 -0.884 . . . . 0.0 109.202 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.631 HG22 ' O ' ' A' ' 43' ' ' THR . 1.0 OUTLIER -89.17 100.07 12.93 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.02 -1.05 . . . . 0.0 108.459 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.523 HD12 ' HB2' ' A' ' 48' ' ' ARG . 72.5 mt -41.49 165.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 121.541 0.686 . . . . 0.0 110.073 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.5 ptpt -80.36 6.96 10.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.539 -0.726 . . . . 0.0 109.686 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -111.95 8.54 20.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -0.951 . . . . 0.0 109.406 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.35 -6.11 71.42 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.523 ' HB2' HD12 ' A' ' 44' ' ' LEU . 7.3 mtt180 -84.46 170.52 13.43 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.13 -1.218 . . . . 0.0 109.537 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 10.0 mttt -133.86 153.73 51.54 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.56 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.22 118.12 6.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.037 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.467 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 19.4 m -79.57 139.02 37.64 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.129 -0.982 . . . . 0.0 109.166 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.968 HD13 HD13 ' A' ' 62' ' ' ILE . 11.3 mt -126.9 168.25 14.74 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.15 -0.969 . . . . 0.0 109.329 179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.651 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.1 t-20 -108.26 129.16 24.42 Favored Pre-proline 0 C--N 1.3 -1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.554 -179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.478 ' HG3' ' HB ' ' A' ' 38' ' ' THR . 34.4 Cg_endo -76.1 4.45 5.3 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.407 2.071 . . . . 0.0 110.747 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.38 -21.31 27.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.249 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.473 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.06 163.97 29.86 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.352 -0.843 . . . . 0.0 109.466 179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.84 -29.1 4.61 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.654 2.236 . . . . 0.0 110.143 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.541 ' CG2' ' HA3' ' A' ' 17' ' ' GLY . 8.6 mm -68.18 -47.33 78.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.363 -0.836 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.004 ' HA ' HD12 ' A' ' 62' ' ' ILE . 51.1 t -62.38 -48.61 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.385 -0.822 . . . . 0.0 109.675 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 56' ' ' SER . 2.8 mmpt? -56.91 -30.52 64.02 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.213 -0.93 . . . . 0.0 108.809 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.533 ' HA ' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -81.66 -24.69 36.15 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.004 HD12 ' HA ' ' A' ' 59' ' ' VAL . 16.0 mt -67.97 -38.25 79.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.25 -0.906 . . . . 0.0 108.592 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.091 ' CG2' HD11 ' B' ' 67' ' ' LEU . 1.5 mp -76.36 -63.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.383 -0.823 . . . . 0.0 109.117 179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.406 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -43.92 -50.84 7.96 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.253 -0.904 . . . . 0.0 109.428 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' O ' ' C ' ' A' ' 66' ' ' MET . 4.4 tmtm? -52.03 -57.58 9.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.323 -0.861 . . . . 0.0 109.211 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.483 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.4 OUTLIER -44.12 -46.2 8.56 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.291 -0.88 . . . . 0.0 109.127 179.786 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.098 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -55.59 -49.54 72.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.452 -0.78 . . . . 0.0 109.527 179.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -96.26 33.91 1.68 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.474 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.8 p -95.43 -38.27 10.55 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.473 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -80.45 76.26 7.28 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.433 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.488 ' O ' ' CB ' ' A' ' 72' ' ' SER . 9.9 ttpt -116.89 -58.28 2.09 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.88 . . . . 0.0 109.447 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.488 ' CB ' ' O ' ' A' ' 71' ' ' LYS . 1.9 t 73.79 178.87 0.22 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.18 -0.95 . . . . 0.0 109.445 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.49 1.541 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.439 -179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.444 ' O ' ' O ' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.444 ' O ' ' O ' ' B' ' 1' ' ' ALA . 0.6 OUTLIER 61.91 128.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.407 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.737 HG13 ' O ' ' B' ' 3' ' ' VAL . 9.8 p -146.33 77.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.238 -0.914 . . . . 0.0 109.501 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.598 ' C ' HG22 ' B' ' 5' ' ' THR . . . -109.27 145.54 35.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.292 -0.88 . . . . 0.0 109.404 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.598 HG22 ' C ' ' B' ' 4' ' ' ALA . 0.1 OUTLIER 164.9 133.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 0.0 109.421 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' B' ' 6' ' ' GLU . 0.4 OUTLIER -88.82 84.16 6.67 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.177 -0.952 . . . . 0.0 109.521 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.546 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -115.82 98.05 6.45 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.197 -0.939 . . . . 0.0 109.585 -179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -87.42 157.65 19.18 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 109.139 179.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.829 ' HB2' HD22 ' B' ' 12' ' ' LEU . 1.7 m -44.07 114.74 0.71 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.221 -0.924 . . . . 0.0 109.436 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.425 ' C ' ' O ' ' B' ' 9' ' ' CYS . 13.6 mm-40 -42.14 -27.11 0.12 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.337 -0.852 . . . . 0.0 109.796 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' B' ' 41' ' ' ILE . 78.4 m -136.61 81.1 1.86 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.201 -0.937 . . . . 0.0 109.595 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.829 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.3 OUTLIER -53.94 -41.47 67.8 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.202 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -118.39 117.97 30.49 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.283 -0.886 . . . . 0.0 109.146 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.59 HG21 HD22 ' B' ' 53' ' ' ASN . 0.6 OUTLIER -99.85 163.09 12.61 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.244 -0.91 . . . . 0.0 109.825 -179.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.515 ' HB2' HD23 ' B' ' 52' ' ' LEU . 4.3 mt -106.0 137.17 44.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.321 -0.862 . . . . 0.0 108.995 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.0 OUTLIER -44.56 -41.28 6.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.219 -0.926 . . . . 0.0 109.4 -179.984 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.531 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 177.5 168.8 37.73 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.716 ' H ' HD11 ' B' ' 62' ' ' ILE . 8.0 tp -153.64 158.39 3.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.493 -1.004 . . . . 0.0 108.784 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.576 ' CB ' ' ND2' ' B' ' 22' ' ' ASN . 2.6 t-80 -45.05 139.86 3.8 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.02 -1.05 . . . . 0.0 109.156 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.481 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.1 Cg_endo -77.8 -25.36 7.8 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.501 2.134 . . . . 0.0 110.256 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.463 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.2 OUTLIER -90.18 -14.84 32.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.405 -0.81 . . . . 0.0 108.974 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.576 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 52.0 m-20 -70.29 -11.61 61.02 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.451 -0.781 . . . . 0.0 109.318 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.888 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 3.0 mt -105.41 148.99 9.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.238 -0.914 . . . . 0.0 110.584 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.516 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -115.63 -27.75 7.0 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.516 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -136.04 160.81 37.48 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.52 ' O ' HG23 ' A' ' 28' ' ' VAL . 2.0 t -146.24 101.5 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.03 -1.044 . . . . 0.0 109.917 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 29.0 t30 -79.88 116.79 20.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.343 -0.848 . . . . 0.0 109.247 179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.523 HG23 ' O ' ' A' ' 26' ' ' VAL . 1.8 t -98.24 84.71 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.535 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.467 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 0.0 OUTLIER -89.58 93.87 9.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.214 -0.929 . . . . 0.0 109.396 179.968 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -50.02 167.21 0.25 Allowed Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.266 -0.896 . . . . 0.0 109.399 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.9 Cg_endo -77.91 131.87 11.4 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.56 2.173 . . . . 0.0 110.455 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.22 -146.12 6.05 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.441 -1.463 . . . . 0.0 109.441 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -76.87 5.47 4.88 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.623 2.216 . . . . 0.0 110.654 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.546 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 18.1 p-80 -121.86 -16.75 7.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.179 -0.951 . . . . 0.0 109.555 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.48 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 9.1 t -160.14 96.92 1.23 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.32 -0.862 . . . . 0.0 109.353 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.77 -10.56 28.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.177 -0.952 . . . . 0.0 109.638 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.446 ' OE1' ' SG ' ' B' ' 9' ' ' CYS . 2.0 mp0 -96.28 125.21 40.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.24 -0.912 . . . . 0.0 109.494 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.476 ' HB ' ' HG3' ' B' ' 54' ' ' PRO . 3.8 m -50.62 150.67 2.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.297 -0.877 . . . . 0.0 109.375 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.472 ' OE2' ' HB3' ' B' ' 35' ' ' CYS . 3.3 mp0 -129.4 107.81 9.8 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.191 -0.943 . . . . 0.0 109.603 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.734 HG11 HD11 ' B' ' 63' ' ' ILE . 1.7 t -102.61 95.26 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.927 . . . . 0.0 109.288 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.538 ' N ' HD12 ' B' ' 41' ' ' ILE . 5.2 mp -86.02 140.72 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.736 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.888 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -124.16 119.13 28.51 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.347 -0.845 . . . . 0.0 109.226 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.617 ' O ' HG22 ' B' ' 43' ' ' THR . 1.0 OUTLIER -89.13 100.08 12.93 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.035 -1.041 . . . . 0.0 108.437 179.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.547 HD12 ' HB2' ' B' ' 48' ' ' ARG . 72.1 mt -41.48 165.66 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 121.573 0.702 . . . . 0.0 110.031 -179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.463 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.5 ptpt -80.49 7.04 10.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.472 -0.767 . . . . 0.0 109.647 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -111.91 8.48 20.37 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.473 179.758 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.36 -6.01 71.32 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.547 ' HB2' HD12 ' B' ' 44' ' ' LEU . 7.3 mtt180 -84.6 170.56 13.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.094 -1.239 . . . . 0.0 109.513 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.42 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 9.9 mttt -133.84 153.81 51.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.314 -0.866 . . . . 0.0 109.507 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.34 118.11 6.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 108.971 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 19.6 m -79.56 138.95 37.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.169 -0.957 . . . . 0.0 109.237 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.988 HD13 HD13 ' B' ' 62' ' ' ILE . 11.3 mt -126.84 168.3 14.65 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.324 -0.86 . . . . 0.0 109.36 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.638 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.1 t-20 -108.26 129.32 24.21 Favored Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.335 -0.853 . . . . 0.0 109.521 -179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.476 ' HG3' ' HB ' ' B' ' 38' ' ' THR . 34.6 Cg_endo -76.27 4.52 5.32 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.342 2.028 . . . . 0.0 110.755 -179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.43 -21.27 27.19 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.162 -0.962 . . . . 0.0 109.231 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.482 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -90.12 163.93 29.87 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.477 179.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.74 -29.18 4.65 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.683 2.255 . . . . 0.0 110.171 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.531 ' CG2' ' HA3' ' B' ' 17' ' ' GLY . 8.6 mm -68.1 -47.28 79.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.442 -0.786 . . . . 0.0 109.264 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.996 ' HA ' HD12 ' B' ' 62' ' ' ILE . 50.7 t -62.49 -48.46 88.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.328 -0.858 . . . . 0.0 109.731 -179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' B' ' 56' ' ' SER . 2.8 mmpt? -56.96 -30.54 64.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.214 -0.929 . . . . 0.0 108.797 179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.528 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -81.6 -24.68 36.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.524 -0.735 . . . . 0.0 109.247 179.937 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.996 HD12 ' HA ' ' B' ' 59' ' ' VAL . 16.1 mt -67.93 -38.23 79.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 1.098 ' CG2' HD11 ' A' ' 67' ' ' LEU . 1.5 mp -76.33 -63.98 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.505 -0.747 . . . . 0.0 109.097 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -43.93 -50.84 7.98 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.289 -0.882 . . . . 0.0 109.444 179.916 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.426 ' O ' ' C ' ' B' ' 66' ' ' MET . 4.4 tmtm? -52.14 -57.45 9.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.379 -0.826 . . . . 0.0 109.269 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.486 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.4 OUTLIER -44.1 -46.2 8.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -0.905 . . . . 0.0 109.149 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.091 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.5 OUTLIER -55.67 -49.54 72.65 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.486 -0.759 . . . . 0.0 109.484 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -96.2 33.87 1.68 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.51 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 24.7 p -95.44 -38.2 10.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.478 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -80.54 76.22 7.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.224 -0.922 . . . . 0.0 109.461 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.474 ' O ' ' CB ' ' B' ' 72' ' ' SER . 9.8 ttpt -116.85 -58.31 2.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.268 -0.895 . . . . 0.0 109.428 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.474 ' CB ' ' O ' ' B' ' 71' ' ' LYS . 1.9 t 73.72 178.87 0.22 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.212 -0.93 . . . . 0.0 109.479 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.496 -179.992 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 t 57.48 69.79 0.71 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.301 -0.874 . . . . 0.0 109.51 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.678 HG13 ' O ' ' A' ' 3' ' ' VAL . 8.8 p -173.12 106.85 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.456 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.524 ' O ' ' CB ' ' A' ' 5' ' ' THR . . . -105.8 149.83 26.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.485 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.524 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 0.8 OUTLIER 75.84 129.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.256 -0.903 . . . . 0.0 109.465 -179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -129.61 -144.01 0.27 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.331 -0.855 . . . . 0.0 109.102 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.591 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -125.08 102.92 7.72 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.18 -0.95 . . . . 0.0 109.408 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.473 ' O ' ' N ' ' A' ' 10' ' ' GLN . 24.0 mtp85 -109.58 154.48 22.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.251 -0.906 . . . . 0.0 109.14 179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.433 ' C ' ' O ' ' A' ' 8' ' ' ARG . 72.8 m -44.32 98.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.363 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.533 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 30.2 mm-40 -43.16 -26.09 0.15 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.302 -0.874 . . . . 0.0 109.714 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.46 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 19.4 m -145.19 75.12 1.43 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.166 -0.959 . . . . 0.0 109.633 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.5 HD13 ' O ' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -44.66 -50.72 9.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 0.0 109.168 179.808 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.459 ' O ' ' HG3' ' A' ' 13' ' ' GLN . 7.8 pt20 -108.95 103.25 12.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.249 -0.907 . . . . 0.0 109.157 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.439 ' HB ' ' C ' ' A' ' 52' ' ' LEU . 1.1 p -79.89 144.93 32.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.196 -0.94 . . . . 0.0 109.668 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.584 ' HB2' HD23 ' A' ' 52' ' ' LEU . 22.3 mt -78.6 -174.06 3.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.351 -0.843 . . . . 0.0 109.336 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.62 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -84.23 -40.76 17.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.179 -0.951 . . . . 0.0 109.502 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.874 ' O ' HG23 ' A' ' 18' ' ' ILE . . . 155.61 -172.07 33.68 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.874 HG23 ' O ' ' A' ' 17' ' ' GLY . 1.3 pp -172.11 164.03 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.405 -1.056 . . . . 0.0 109.213 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.49 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -58.92 150.14 61.8 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.255 -0.903 . . . . 0.0 109.319 179.853 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.675 ' HA ' HD12 ' A' ' 23' ' ' ILE . 35.3 Cg_endo -77.14 -4.47 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.512 2.141 . . . . 0.0 110.176 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.459 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -90.35 -23.49 21.1 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.385 -0.822 . . . . 0.0 109.198 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 3.3 m-20 -85.18 -18.99 32.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.305 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.964 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 22.0 mt -83.38 169.22 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.441 -0.787 . . . . 0.0 110.07 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.574 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -139.37 -40.93 0.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.638 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.468 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 1.7 p -124.9 177.31 6.1 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.838 . . . . 0.0 108.892 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.571 HG23 ' HG3' ' A' ' 66' ' ' MET . 47.7 t -146.8 100.48 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.018 -1.051 . . . . 0.0 109.698 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.666 ' O ' HD12 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -100.05 111.15 23.45 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.266 179.654 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.863 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -120.98 102.3 12.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 0.0 109.496 -179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.533 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 0.2 OUTLIER -103.94 117.22 33.79 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.229 -0.919 . . . . 0.0 109.397 179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.444 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -57.31 171.68 0.46 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.153 -0.967 . . . . 0.0 109.284 -179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.516 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.8 Cg_endo -77.83 153.07 29.23 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.693 2.262 . . . . 0.0 110.456 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.98 -140.56 2.9 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.561 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 36.4 Cg_endo -78.28 12.14 2.17 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.654 2.236 . . . . 0.0 110.982 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.591 ' CD2' HD22 ' A' ' 7' ' ' LEU . 1.9 p-80 -127.49 -32.71 2.39 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.988 -1.07 . . . . 0.0 109.53 179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.31 121.4 12.93 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.924 . . . . 0.0 109.381 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.8 44.41 1.06 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.208 -0.933 . . . . 0.0 109.625 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.516 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 5.2 pt20 -169.98 139.32 1.85 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.203 -0.936 . . . . 0.0 109.54 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.514 HG21 ' CG ' ' B' ' 70' ' ' ASP . 2.6 m -55.91 141.39 39.45 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.295 -0.878 . . . . 0.0 109.394 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.93 107.54 10.17 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.198 -0.939 . . . . 0.0 109.596 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.95 HG11 HD11 ' A' ' 63' ' ' ILE . 47.7 t -95.1 149.24 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.258 -0.901 . . . . 0.0 109.21 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.666 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.4 mp -142.0 151.13 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.863 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.964 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -135.13 123.08 22.59 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.415 -0.803 . . . . 0.0 108.886 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 7.4 m -89.77 100.18 13.04 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.957 -1.089 . . . . 0.0 109.375 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 60.7 mt -42.43 164.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.334 -0.854 . . . . 0.0 109.606 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 13.0 ptpt -82.83 9.78 9.12 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.235 -0.916 . . . . 0.0 109.693 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.7 OUTLIER -113.91 19.55 16.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.217 -0.927 . . . . 0.0 109.249 179.805 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.457 ' O ' ' HD2' ' A' ' 49' ' ' LYS . . . 87.6 -17.64 43.23 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.462 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 42.8 mtt180 -77.3 163.19 26.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -1.116 . . . . 0.0 109.416 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.457 ' HD2' ' O ' ' A' ' 47' ' ' GLY . 0.0 OUTLIER -144.01 122.65 12.54 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.148 -0.97 . . . . 0.0 109.541 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.562 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -116.18 127.94 55.21 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.481 -0.762 . . . . 0.0 109.24 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.507 ' O ' HD23 ' A' ' 52' ' ' LEU . 92.2 m -79.65 155.34 28.11 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.238 -0.914 . . . . 0.0 109.062 179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.032 HD13 HD13 ' A' ' 62' ' ' ILE . 12.8 mt -135.19 170.98 15.08 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.141 -0.974 . . . . 0.0 109.702 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.663 ' O ' HG21 ' A' ' 59' ' ' VAL . 15.3 p-10 -105.39 127.6 28.26 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.343 -0.848 . . . . 0.0 109.78 -179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -75.08 -4.66 15.71 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.087 1.858 . . . . 0.0 110.224 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.32 -19.29 53.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.332 -0.855 . . . . 0.0 108.778 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 159.39 42.5 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.349 -0.844 . . . . 0.0 109.022 179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -76.92 -32.25 3.44 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.582 2.188 . . . . 0.0 110.778 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.623 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.1 OUTLIER -69.53 -44.66 79.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.072 -1.018 . . . . 0.0 109.168 -179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.059 ' HA ' HD12 ' A' ' 62' ' ' ILE . 31.4 t -58.0 -46.94 87.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.834 . . . . 0.0 109.152 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.503 ' HG3' ' O ' ' A' ' 56' ' ' SER . 9.6 mtmt -60.51 -30.49 69.76 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.492 ' CE ' ' CD ' ' A' ' 64' ' ' GLU . 4.9 mmpt? -76.67 -23.56 53.23 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.059 HD12 ' HA ' ' A' ' 59' ' ' VAL . 19.0 mt -71.39 -37.16 63.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.95 HD11 HG11 ' A' ' 40' ' ' VAL . 2.3 mp -73.21 -58.14 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.337 -0.852 . . . . 0.0 109.901 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.492 ' CD ' ' CE ' ' A' ' 61' ' ' LYS . 5.7 pt-20 -59.2 -52.19 66.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.045 -1.034 . . . . 0.0 109.652 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 6.5 mtpp -46.35 -52.43 12.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.112 -0.992 . . . . 0.0 109.132 179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.571 ' HG3' HG23 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -49.38 -46.41 47.21 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.301 -0.874 . . . . 0.0 109.214 179.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.615 HD11 ' HB ' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -45.93 -52.08 12.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.432 179.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.4 t30 -64.39 -33.59 76.22 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.352 -0.843 . . . . 0.0 109.531 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 p -44.11 -27.88 0.44 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.447 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.52 ' CG ' HG21 ' B' ' 38' ' ' THR . 1.0 OUTLIER -113.76 61.86 0.65 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.217 -0.927 . . . . 0.0 109.531 179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 26.1 tttt -78.85 -71.52 0.43 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.446 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -112.3 155.38 24.18 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.453 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 40.8 t30 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.974 -1.012 . . . . 0.0 109.416 -179.992 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 3.3 t 57.58 69.71 0.72 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.29 -0.881 . . . . 0.0 109.48 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.696 HG13 ' O ' ' B' ' 3' ' ' VAL . 8.7 p -173.09 106.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.92 . . . . 0.0 109.461 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.482 ' O ' ' CB ' ' B' ' 5' ' ' THR . . . -105.79 149.82 26.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.26 -0.9 . . . . 0.0 109.408 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' B' ' 4' ' ' ALA . 0.8 OUTLIER 75.75 129.46 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 0.0 109.494 179.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -129.67 -144.04 0.27 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.25 -0.906 . . . . 0.0 109.128 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.584 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -125.06 102.9 7.72 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.134 -0.979 . . . . 0.0 109.475 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.472 ' O ' ' N ' ' B' ' 10' ' ' GLN . 23.9 mtp85 -109.6 154.49 22.71 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.298 -0.876 . . . . 0.0 109.088 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.427 ' O ' ' N ' ' B' ' 11' ' ' CYS . 71.8 m -44.32 98.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -0.961 . . . . 0.0 109.26 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.526 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 30.2 mm-40 -43.22 -26.07 0.15 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.434 -0.791 . . . . 0.0 109.704 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.454 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 19.9 m -145.18 75.09 1.43 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.128 -0.983 . . . . 0.0 109.601 -179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.509 HD13 ' O ' ' B' ' 12' ' ' LEU . 0.2 OUTLIER -44.61 -50.72 9.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.232 -0.917 . . . . 0.0 109.238 179.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' B' ' 13' ' ' GLN . 7.8 pt20 -108.95 103.25 12.26 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.37 -0.831 . . . . 0.0 109.144 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.433 ' HB ' ' C ' ' B' ' 52' ' ' LEU . 1.0 OUTLIER -79.9 144.89 33.0 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.184 -0.948 . . . . 0.0 109.608 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.565 ' HB2' HD23 ' B' ' 52' ' ' LEU . 22.2 mt -78.46 -174.07 3.63 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.333 -0.854 . . . . 0.0 109.33 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.625 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.0 OUTLIER -84.33 -40.74 17.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.176 -0.952 . . . . 0.0 109.474 -179.987 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.872 ' O ' HG23 ' B' ' 18' ' ' ILE . . . 155.66 -172.04 33.71 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 110.025 -1.23 . . . . 0.0 110.025 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.872 HG23 ' O ' ' B' ' 17' ' ' GLY . 1.3 pp -172.2 163.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.478 -1.013 . . . . 0.0 109.161 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.508 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -58.91 150.19 61.55 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.258 -0.901 . . . . 0.0 109.299 179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.669 ' HA ' HD12 ' B' ' 23' ' ' ILE . 35.3 Cg_endo -77.14 -4.47 14.85 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.55 2.167 . . . . 0.0 110.173 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.454 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -90.3 -23.61 21.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.385 -0.822 . . . . 0.0 109.206 179.845 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.488 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 3.3 m-20 -85.16 -18.88 32.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.24 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.979 HG23 ' HB1' ' B' ' 42' ' ' ALA . 21.8 mt -83.43 169.22 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.389 -0.819 . . . . 0.0 110.066 -179.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.583 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.4 OUTLIER -139.35 -41.03 0.46 Allowed 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 179.678 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.458 ' CB ' ' HB ' ' B' ' 43' ' ' THR . 1.7 p -124.88 177.26 6.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.451 -0.781 . . . . 0.0 108.899 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.564 HG23 ' HG3' ' B' ' 66' ' ' MET . 48.2 t -146.76 100.46 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.647 ' O ' HD12 ' B' ' 41' ' ' ILE . 0.1 OUTLIER -100.09 111.18 23.48 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.32 -0.863 . . . . 0.0 109.217 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.831 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -120.97 102.37 12.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 0.0 109.537 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.526 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 0.2 OUTLIER -103.95 117.16 33.65 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.401 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.447 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.0 OUTLIER -57.18 171.63 0.45 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.284 -0.885 . . . . 0.0 109.306 -179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.522 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 35.8 Cg_endo -77.83 153.09 29.24 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.623 2.215 . . . . 0.0 110.435 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -162.98 -140.64 2.92 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.552 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -78.33 12.34 2.12 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.513 2.142 . . . . 0.0 111.006 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.584 ' CD2' HD22 ' B' ' 7' ' ' LEU . 1.9 p-80 -127.6 -32.63 2.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.013 -1.054 . . . . 0.0 109.509 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.34 121.34 12.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 109.393 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -84.78 44.52 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.252 -0.905 . . . . 0.0 109.701 -179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.522 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 5.2 pt20 -170.08 139.3 1.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.177 -0.952 . . . . 0.0 109.494 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.52 HG21 ' CG ' ' A' ' 70' ' ' ASP . 2.7 m -55.98 141.28 40.3 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.0 109.36 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.78 107.54 10.23 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.659 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.939 HG11 HD11 ' B' ' 63' ' ' ILE . 47.7 t -95.2 149.31 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.316 -0.865 . . . . 0.0 109.204 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.647 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.4 mp -141.96 151.17 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.14 -0.975 . . . . 0.0 109.875 -179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.979 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -135.14 122.92 22.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.379 -0.826 . . . . 0.0 108.962 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 7.4 m -89.66 100.16 13.02 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.955 -1.09 . . . . 0.0 109.392 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.488 ' HA ' ' O ' ' B' ' 22' ' ' ASN . 60.4 mt -42.49 164.13 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.388 -0.82 . . . . 0.0 109.63 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.459 ' HA ' ' HB2' ' B' ' 24' ' ' GLN . 12.9 ptpt -82.79 9.8 9.01 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.708 -179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.478 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.7 OUTLIER -113.94 19.62 16.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.212 -0.93 . . . . 0.0 109.23 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' B' ' 49' ' ' LYS . . . 87.62 -17.77 42.56 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.468 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 42.7 mtt180 -77.25 163.06 26.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -1.151 . . . . 0.0 109.405 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.463 ' HD2' ' O ' ' B' ' 47' ' ' GLY . 0.0 OUTLIER -143.97 122.67 12.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.185 -0.947 . . . . 0.0 109.546 179.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.553 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -116.19 127.94 55.2 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.445 -0.784 . . . . 0.0 109.33 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.494 ' O ' HD23 ' B' ' 52' ' ' LEU . 91.2 m -79.66 155.32 28.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.926 . . . . 0.0 109.047 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 1.053 HD13 HD13 ' B' ' 62' ' ' ILE . 12.8 mt -135.18 170.92 15.18 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.152 -0.968 . . . . 0.0 109.744 -179.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.666 ' O ' HG21 ' B' ' 59' ' ' VAL . 15.4 p-10 -105.34 127.54 28.38 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.338 -0.851 . . . . 0.0 109.845 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -75.04 -4.57 15.6 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.111 1.874 . . . . 0.0 110.308 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.45 -19.25 53.54 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.224 -0.923 . . . . 0.0 108.761 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -90.01 159.42 42.72 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.109 179.665 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.04 -32.25 3.31 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.578 2.185 . . . . 0.0 110.792 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.641 ' O ' HD13 ' B' ' 58' ' ' ILE . 0.1 OUTLIER -69.45 -44.72 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.102 -0.999 . . . . 0.0 109.153 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 1.011 ' HA ' HD12 ' B' ' 62' ' ' ILE . 32.1 t -57.97 -46.94 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.455 -0.778 . . . . 0.0 109.177 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' B' ' 56' ' ' SER . 9.6 mtmt -60.49 -30.55 69.78 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 179.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.496 ' HE2' ' HA ' ' B' ' 61' ' ' LYS . 4.9 mmpt? -76.64 -23.61 53.32 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 1.053 HD13 HD13 ' B' ' 52' ' ' LEU . 19.2 mt -71.25 -37.25 65.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.939 HD11 HG11 ' B' ' 40' ' ' VAL . 2.3 mp -73.23 -58.09 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.449 -0.782 . . . . 0.0 109.876 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.487 ' CD ' ' CE ' ' B' ' 61' ' ' LYS . 5.6 pt-20 -59.33 -52.09 67.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.013 -1.054 . . . . 0.0 109.614 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.482 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 6.5 mtpp -46.39 -52.41 13.01 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.159 -0.963 . . . . 0.0 109.056 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.564 ' HG3' HG23 ' B' ' 26' ' ' VAL . 0.2 OUTLIER -49.41 -46.35 47.41 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.318 -0.864 . . . . 0.0 109.282 179.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.614 HD11 ' HB ' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -45.96 -52.05 12.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 0.0 109.41 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.419 ' O ' ' C ' ' B' ' 69' ' ' SER . 2.4 t30 -64.41 -33.6 76.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.331 -0.855 . . . . 0.0 109.52 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.419 ' C ' ' O ' ' B' ' 68' ' ' ASN . 4.9 p -44.14 -27.76 0.43 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 0.0 109.46 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.514 ' CG ' HG21 ' A' ' 38' ' ' THR . 1.0 OUTLIER -113.87 61.81 0.66 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.551 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 26.0 tttt -78.87 -71.4 0.44 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.547 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 1.5 m -112.35 155.36 24.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.253 -0.905 . . . . 0.0 109.448 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 40.9 t30 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.453 -179.961 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.9 m 50.59 -165.55 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.257 -0.902 . . . . 0.0 109.448 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.5 m -107.02 149.72 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.222 -0.924 . . . . 0.0 109.508 179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 46.01 65.16 1.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.488 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -146.63 49.41 1.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.221 -0.924 . . . . 0.0 109.469 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.33 70.23 8.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -0.938 . . . . 0.0 109.427 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.631 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.5 OUTLIER -146.62 115.03 6.71 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -130.1 161.2 31.59 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.365 -0.834 . . . . 0.0 108.923 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.954 ' HB2' HD22 ' A' ' 12' ' ' LEU . 93.2 m -48.84 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.938 . . . . 0.0 109.367 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -42.76 -26.21 0.12 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.0 109.865 -179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.521 ' SG ' ' CG1' ' A' ' 41' ' ' ILE . 78.1 m -130.85 72.25 1.49 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.116 -0.99 . . . . 0.0 109.642 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.954 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.55 -44.3 8.66 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.937 . . . . 0.0 109.214 179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.32 117.5 33.29 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.283 -0.886 . . . . 0.0 109.198 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.426 ' OG1' ' CG ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -103.09 156.43 17.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.265 -0.897 . . . . 0.0 109.697 -179.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.566 HD12 HD23 ' A' ' 52' ' ' LEU . 5.5 mt -98.08 135.76 39.3 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.293 -0.879 . . . . 0.0 109.004 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' A' ' 15' ' ' LEU . 1.1 tt0 -44.09 -26.79 0.32 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -0.952 . . . . 0.0 109.252 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 156.25 149.32 5.32 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.659 HG22 ' CD2' ' A' ' 52' ' ' LEU . 6.9 tt -128.34 149.97 33.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.375 -1.073 . . . . 0.0 108.883 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.466 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -43.64 146.37 0.98 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.241 -0.912 . . . . 0.0 109.257 -179.951 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.466 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.2 Cg_endo -76.61 -13.03 18.32 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.435 2.09 . . . . 0.0 109.996 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.532 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 7.6 mttp -78.95 -15.42 58.32 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 1.011 ' O ' HD13 ' A' ' 23' ' ' ILE . 86.5 m-20 -100.43 54.75 0.89 Allowed 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.011 HD13 ' O ' ' A' ' 22' ' ' ASN . 0.7 OUTLIER -146.08 163.33 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.039 -1.038 . . . . 0.0 110.35 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.749 ' HG2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -153.02 -36.21 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.656 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.9 p -128.47 179.5 5.62 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 178.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.656 HG23 ' O ' ' A' ' 25' ' ' SER . 51.0 t -160.14 115.29 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 120.897 -1.127 . . . . 0.0 109.891 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 20.3 t-20 -104.87 153.3 21.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.179 -0.951 . . . . 0.0 109.117 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' B' ' 25' ' ' SER . 2.6 t -143.67 91.82 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.158 -0.964 . . . . 0.0 109.625 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.456 ' HD2' ' NE2' ' A' ' 10' ' ' GLN . 4.2 mttm -95.3 93.45 7.28 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.214 -0.929 . . . . 0.0 109.524 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 4.3 p -44.71 164.26 0.18 Allowed Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.388 -0.82 . . . . 0.0 109.303 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.517 ' CG ' ' O ' ' B' ' 71' ' ' LYS . 35.7 Cg_endo -77.78 131.87 11.54 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.648 2.232 . . . . 0.0 110.502 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.27 -138.48 3.28 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.22 7.98 3.46 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.562 2.175 . . . . 0.0 110.778 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.631 ' CD2' HD22 ' A' ' 7' ' ' LEU . 4.9 p-80 -126.86 -16.74 5.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.017 . . . . 0.0 109.883 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -160.17 125.23 3.91 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.024 -1.047 . . . . 0.0 109.229 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.419 ' O ' ' CD ' ' A' ' 37' ' ' GLN . . . -87.42 18.95 3.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.208 -0.933 . . . . 0.0 109.719 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.511 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 13.6 mm-40 -143.35 125.06 14.97 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -0.902 . . . . 0.0 109.497 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.428 HG23 ' HA ' ' A' ' 30' ' ' SER . 17.5 m -50.29 140.55 13.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.283 -0.886 . . . . 0.0 109.308 179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.505 ' OE1' ' N ' ' A' ' 10' ' ' GLN . 8.5 mt-10 -117.66 106.83 13.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.208 -0.932 . . . . 0.0 109.654 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.809 HG21 ' HB3' ' A' ' 54' ' ' PRO . 1.7 t -98.47 106.71 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -0.908 . . . . 0.0 109.186 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.521 ' CG1' ' SG ' ' A' ' 11' ' ' CYS . 2.9 mp -94.74 157.31 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.224 -0.923 . . . . 0.0 109.83 -179.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.972 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -136.47 125.88 25.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 108.798 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.749 HG22 ' HG2' ' A' ' 24' ' ' GLN . 22.4 m -89.66 105.52 17.85 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.026 -1.046 . . . . 0.0 109.111 -179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.962 HD23 ' O ' ' A' ' 22' ' ' ASN . 82.9 mt -43.79 168.7 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.322 -0.861 . . . . 0.0 109.597 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.532 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.3 ptpt -90.16 17.52 6.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.297 -0.877 . . . . 0.0 109.35 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.517 ' OD1' ' CB ' ' A' ' 44' ' ' LEU . 19.6 p-10 -119.49 7.21 11.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.402 -0.812 . . . . 0.0 109.143 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.28 -17.9 54.91 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.744 ' HB2' HD12 ' A' ' 44' ' ' LEU . 8.8 mtt85 -83.73 171.97 12.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -1.185 . . . . 0.0 109.169 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.519 ' CD ' ' OG1' ' A' ' 43' ' ' THR . 9.9 mtmt -144.49 125.21 14.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.255 -0.903 . . . . 0.0 109.553 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.24 131.14 55.35 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.275 -0.891 . . . . 0.0 109.132 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.464 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 61.7 m -79.74 140.21 37.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.124 -0.985 . . . . 0.0 109.186 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.859 ' HB3' HG22 ' A' ' 59' ' ' VAL . 12.5 mt -129.41 168.64 16.01 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.218 -0.926 . . . . 0.0 109.441 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.66 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.8 m-20 -111.02 130.85 22.53 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.333 -0.854 . . . . 0.0 109.62 -179.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.809 ' HB3' HG21 ' A' ' 40' ' ' VAL . 33.8 Cg_endo -75.26 -14.54 20.55 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.217 1.945 . . . . 0.0 110.21 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.91 -19.13 61.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.875 . . . . 0.0 108.879 179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.499 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.03 163.16 33.06 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.493 -0.754 . . . . 0.0 109.206 179.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.14 -41.78 0.34 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.665 2.243 . . . . 0.0 110.635 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.542 ' CG2' ' HA3' ' A' ' 17' ' ' GLY . 11.7 mm -54.48 -55.48 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.154 -0.966 . . . . 0.0 109.411 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.859 HG22 ' HB3' ' A' ' 52' ' ' LEU . 89.1 t -54.48 -53.7 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.491 -0.755 . . . . 0.0 110.053 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.524 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 0.4 OUTLIER -45.81 -31.72 2.22 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.046 -1.034 . . . . 0.0 108.941 179.772 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.531 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -79.5 -38.32 34.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.52 -0.738 . . . . 0.0 109.6 -179.803 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.527 ' CD1' ' O ' ' A' ' 58' ' ' ILE . 1.8 mp -55.4 -41.88 64.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.164 -0.96 . . . . 0.0 108.811 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.044 HG22 HD11 ' B' ' 67' ' ' LEU . 2.1 mp -72.11 -65.78 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.353 -0.842 . . . . 0.0 109.49 179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.428 ' C ' ' O ' ' A' ' 63' ' ' ILE . 0.0 OUTLIER -42.23 -27.28 0.13 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.445 -0.784 . . . . 0.0 109.67 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -73.86 -49.31 25.6 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 0.0 108.93 179.708 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.475 ' HA ' ' HB3' ' A' ' 69' ' ' SER . 0.4 OUTLIER -55.14 -45.57 75.64 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.368 -0.832 . . . . 0.0 109.018 179.519 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.028 HD11 ' CG2' ' B' ' 63' ' ' ILE . 3.7 mt -53.56 -60.09 3.75 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.52 -0.738 . . . . 0.0 109.598 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -73.51 -3.98 31.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.333 -0.854 . . . . 0.0 109.632 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.475 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 4.1 p -49.59 -57.1 7.77 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.124 -0.985 . . . . 0.0 109.393 179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' N ' ' OG ' ' A' ' 69' ' ' SER . 0.7 OUTLIER 62.8 12.47 5.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.236 -0.915 . . . . 0.0 109.51 179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.526 ' O ' ' CG ' ' B' ' 31' ' ' PRO . 2.3 mttt -58.94 122.65 14.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.247 -0.908 . . . . 0.0 109.405 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 73' ' ' ASN . 30.0 t -170.99 -90.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.922 . . . . 0.0 109.461 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 72' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 117.934 -1.031 . . . . 0.0 109.477 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.8 m 50.59 -165.57 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 28.4 m -107.06 149.71 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.288 -0.883 . . . . 0.0 109.496 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . 45.97 65.21 1.22 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.181 -0.949 . . . . 0.0 109.498 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -146.66 49.44 1.15 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -0.903 . . . . 0.0 109.441 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.39 70.23 8.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.956 . . . . 0.0 109.455 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.627 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.4 OUTLIER -146.65 115.02 6.69 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.28 -0.888 . . . . 0.0 109.608 179.998 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.53 ' O ' ' N ' ' B' ' 10' ' ' GLN . 0.1 OUTLIER -130.0 161.19 31.51 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.417 -0.802 . . . . 0.0 108.917 179.717 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.936 ' HB2' HD22 ' B' ' 12' ' ' LEU . 94.5 m -48.86 92.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.334 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.53 ' N ' ' O ' ' B' ' 8' ' ' ARG . 0.1 OUTLIER -42.77 -26.23 0.12 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.839 . . . . 0.0 109.866 -179.916 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.517 ' SG ' ' CG1' ' B' ' 41' ' ' ILE . 78.2 m -130.78 72.2 1.49 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.212 -0.93 . . . . 0.0 109.621 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.936 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.55 -44.29 8.64 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.208 -0.932 . . . . 0.0 109.147 179.839 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.32 117.5 33.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.29 -0.881 . . . . 0.0 109.275 179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.426 ' OG1' ' CG ' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -103.09 156.44 17.68 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.317 -0.865 . . . . 0.0 109.641 -179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.551 HD12 HD23 ' B' ' 52' ' ' LEU . 5.6 mt -98.04 135.77 39.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.437 -0.79 . . . . 0.0 109.05 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.421 ' C ' ' O ' ' B' ' 15' ' ' LEU . 1.1 tt0 -44.07 -26.78 0.32 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.248 -0.908 . . . . 0.0 109.313 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.538 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 156.21 149.23 5.3 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.65 HG22 ' CD2' ' B' ' 52' ' ' LEU . 6.9 tt -128.25 150.03 33.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.511 -0.994 . . . . 0.0 108.803 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.469 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -43.74 146.41 1.01 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.945 . . . . 0.0 109.289 179.961 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.469 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.4 Cg_endo -76.6 -13.03 18.34 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.424 2.083 . . . . 0.0 109.991 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.534 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 7.6 mttp -78.93 -15.42 58.33 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 179.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 1.026 ' O ' HD13 ' B' ' 23' ' ' ILE . 86.5 m-20 -100.46 54.8 0.88 Allowed 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 1.026 HD13 ' O ' ' B' ' 22' ' ' ASN . 0.7 OUTLIER -146.11 163.41 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.032 -1.042 . . . . 0.0 110.337 -179.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.735 ' HG2' HG22 ' B' ' 43' ' ' THR . 0.0 OUTLIER -153.08 -36.26 0.11 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.835 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.656 ' O ' HG23 ' B' ' 26' ' ' VAL . 5.0 p -128.41 179.52 5.6 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.656 HG23 ' O ' ' B' ' 25' ' ' SER . 51.4 t -160.11 115.24 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.786 -1.196 . . . . 0.0 109.99 -179.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.472 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 20.4 t-20 -104.83 153.31 21.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.213 -0.929 . . . . 0.0 109.097 179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' SER . 2.6 t -143.71 91.83 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.102 -0.999 . . . . 0.0 109.654 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.446 ' HD2' ' NE2' ' B' ' 10' ' ' GLN . 4.3 mttm -95.3 93.43 7.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.253 -0.904 . . . . 0.0 109.533 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.466 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 4.3 p -44.7 164.21 0.18 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.352 -0.843 . . . . 0.0 109.301 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.526 ' CG ' ' O ' ' A' ' 71' ' ' LYS . 35.7 Cg_endo -77.77 131.96 11.6 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.592 2.195 . . . . 0.0 110.527 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -145.26 -138.5 3.28 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.27 8.09 3.42 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.498 2.132 . . . . 0.0 110.782 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.627 ' CD2' HD22 ' B' ' 7' ' ' LEU . 5.0 p-80 -126.92 -16.79 5.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.063 -1.023 . . . . 0.0 109.849 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -160.12 125.21 3.93 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.075 -1.016 . . . . 0.0 109.278 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.419 ' O ' ' CD ' ' B' ' 37' ' ' GLN . . . -87.41 18.9 3.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.232 -0.918 . . . . 0.0 109.674 -179.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.506 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 13.4 mm-40 -143.31 124.97 14.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.163 -0.961 . . . . 0.0 109.558 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.434 HG23 ' HA ' ' B' ' 30' ' ' SER . 17.5 m -50.26 140.65 12.8 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.2 -0.937 . . . . 0.0 109.255 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.509 ' OE1' ' N ' ' B' ' 10' ' ' GLN . 8.5 mt-10 -117.76 106.81 13.43 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.179 -0.95 . . . . 0.0 109.619 -179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.802 HG21 ' HB3' ' B' ' 54' ' ' PRO . 1.7 t -98.5 106.76 19.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.266 -0.896 . . . . 0.0 109.166 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.517 ' CG1' ' SG ' ' B' ' 11' ' ' CYS . 2.9 mp -94.77 157.29 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.304 -0.872 . . . . 0.0 109.803 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.964 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -136.38 125.85 25.13 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.369 -0.832 . . . . 0.0 108.866 179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.735 HG22 ' HG2' ' B' ' 24' ' ' GLN . 22.4 m -89.68 105.57 17.89 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 120.958 -1.089 . . . . 0.0 109.151 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.934 HD23 ' O ' ' B' ' 22' ' ' ASN . 82.4 mt -43.83 168.66 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.312 -0.868 . . . . 0.0 109.583 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.534 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.2 ptpt -90.15 17.49 6.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.266 -0.896 . . . . 0.0 109.359 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.525 ' OD1' ' CB ' ' B' ' 44' ' ' LEU . 19.5 p-10 -119.42 7.23 11.16 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.22 179.494 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 101.3 -17.97 54.73 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.742 ' HB2' HD12 ' B' ' 44' ' ' LEU . 8.8 mtt85 -83.73 171.95 12.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.214 -1.168 . . . . 0.0 109.15 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.519 ' CD ' ' OG1' ' B' ' 43' ' ' THR . 10.0 mtmt -144.42 125.21 14.22 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.901 . . . . 0.0 109.509 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.27 131.18 55.31 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.351 -0.843 . . . . 0.0 109.163 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.456 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 61.7 m -79.83 140.2 36.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.133 -0.979 . . . . 0.0 109.186 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.868 ' HB3' HG22 ' B' ' 59' ' ' VAL . 12.5 mt -129.41 168.63 16.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.218 -0.926 . . . . 0.0 109.378 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.657 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.8 m-20 -110.94 130.91 22.45 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.345 -0.847 . . . . 0.0 109.587 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.802 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.7 Cg_endo -75.31 -14.56 20.46 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.312 2.008 . . . . 0.0 110.248 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -71.99 -19.11 61.92 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.342 -0.849 . . . . 0.0 108.829 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -89.91 163.09 33.61 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.369 -0.832 . . . . 0.0 109.152 179.731 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.16 -41.76 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.59 2.193 . . . . 0.0 110.632 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.538 ' CG2' ' HA3' ' B' ' 17' ' ' GLY . 11.7 mm -54.46 -55.54 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.18 -0.95 . . . . 0.0 109.351 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.868 HG22 ' HB3' ' B' ' 52' ' ' LEU . 90.0 t -54.46 -53.67 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.528 -0.732 . . . . 0.0 110.054 -179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 0.4 OUTLIER -45.86 -31.66 2.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.028 -1.045 . . . . 0.0 108.966 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.529 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -79.57 -38.27 34.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.474 -0.766 . . . . 0.0 109.647 -179.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.526 ' CD1' ' O ' ' B' ' 58' ' ' ILE . 1.8 mp -55.32 -41.85 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.272 -0.892 . . . . 0.0 108.856 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 1.028 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.1 mp -72.17 -65.88 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.268 -0.895 . . . . 0.0 109.396 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' B' ' 63' ' ' ILE . 0.0 OUTLIER -42.14 -27.26 0.13 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -0.816 . . . . 0.0 109.756 -179.887 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -73.82 -49.37 25.55 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.0 108.947 179.662 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.481 ' HA ' ' HB3' ' B' ' 69' ' ' SER . 0.4 OUTLIER -55.18 -45.53 75.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.415 -0.803 . . . . 0.0 109.002 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.044 HD11 HG22 ' A' ' 63' ' ' ILE . 3.7 mt -53.67 -60.07 3.78 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.526 -0.734 . . . . 0.0 109.52 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -73.51 -3.93 30.73 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.303 -0.873 . . . . 0.0 109.686 -179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.481 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 4.1 p -49.64 -57.07 7.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.172 -0.955 . . . . 0.0 109.455 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.477 ' N ' ' OG ' ' B' ' 69' ' ' SER . 0.7 OUTLIER 62.83 12.51 5.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.312 -0.868 . . . . 0.0 109.416 179.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 31' ' ' PRO . 2.3 mttt -58.96 122.67 14.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.282 -0.886 . . . . 0.0 109.503 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.495 ' O ' ' CB ' ' B' ' 73' ' ' ASN . 30.2 t -170.93 -90.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' B' ' 72' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 117.94 -1.029 . . . . 0.0 109.474 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.9 -41.26 23.32 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.2 -0.937 . . . . 0.0 109.497 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.12 137.79 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.219 -0.926 . . . . 0.0 109.426 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -132.53 -179.75 5.64 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.29 -0.881 . . . . 0.0 109.488 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.711 HG22 ' O ' ' A' ' 5' ' ' THR . 32.4 m -118.86 61.81 0.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.5 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.52 39.05 1.02 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.256 -0.903 . . . . 0.0 109.42 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.538 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -115.6 98.25 6.6 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.219 -0.925 . . . . 0.0 109.532 179.964 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -83.49 154.51 23.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.273 -0.892 . . . . 0.0 109.132 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.49 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m -43.88 121.73 2.53 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 0.0 109.394 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.503 ' HG3' ' CB ' ' A' ' 29' ' ' LYS . 56.6 mm-40 -42.08 -27.39 0.13 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.434 -0.791 . . . . 0.0 109.842 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.468 ' SG ' HG13 ' A' ' 41' ' ' ILE . 81.1 m -146.04 72.04 1.28 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.162 -0.961 . . . . 0.0 109.61 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.49 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.3 OUTLIER -44.07 -45.65 8.16 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.068 179.693 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -110.13 120.87 43.82 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.414 -0.804 . . . . 0.0 109.072 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.66 HG21 HD22 ' A' ' 53' ' ' ASN . 0.5 OUTLIER -105.99 161.43 14.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.236 -0.915 . . . . 0.0 109.986 -179.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.666 ' HB2' HD23 ' A' ' 52' ' ' LEU . 3.1 mt -108.66 143.08 38.21 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 179.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.607 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.4 tt0 -44.9 -26.54 0.42 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.061 -1.025 . . . . 0.0 109.065 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.592 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 152.37 177.65 26.25 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.656 HG22 HD11 ' A' ' 52' ' ' LEU . 6.4 tp -148.56 159.99 6.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.42 -1.047 . . . . 0.0 109.071 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.589 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.5 t-80 -50.2 144.23 11.63 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.124 -0.985 . . . . 0.0 109.243 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.589 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.37 -22.66 10.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.504 2.136 . . . . 0.0 110.264 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.456 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.27 -15.2 31.75 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -0.871 . . . . 0.0 109.108 179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.569 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 95.0 m-20 -79.55 -11.89 59.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.317 -0.865 . . . . 0.0 109.455 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.894 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 4.3 mt -101.0 155.55 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.308 -0.87 . . . . 0.0 110.422 -179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.533 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -124.5 -30.04 3.41 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.315 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.533 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -132.02 169.05 16.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 108.855 179.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.739 HG23 ' HG3' ' A' ' 66' ' ' MET . 49.9 t -139.45 111.2 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.103 -0.998 . . . . 0.0 109.801 -179.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.712 ' O ' HD12 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -106.15 110.99 23.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.348 -0.845 . . . . 0.0 109.158 179.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -113.8 106.36 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.655 -179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.503 ' CB ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -97.25 94.81 7.31 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.222 -0.924 . . . . 0.0 109.319 179.814 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.468 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.1 p -45.2 169.25 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.209 -0.932 . . . . 0.0 109.479 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 36' ' ' ALA . 35.6 Cg_endo -77.84 132.15 11.67 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.582 2.188 . . . . 0.0 110.408 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.84 -140.29 4.01 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -80.06 41.61 1.16 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.718 2.278 . . . . 0.0 110.708 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.538 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 9.7 p-80 -161.93 -38.1 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.053 -1.029 . . . . 0.0 109.244 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 6.2 t -135.82 112.78 10.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.285 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.474 ' O ' ' HB3' ' A' ' 31' ' ' PRO . . . -71.45 -32.06 67.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.342 -0.849 . . . . 0.0 109.646 -179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.437 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 2.5 mm-40 -87.63 130.51 34.75 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.256 -0.903 . . . . 0.0 109.586 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.458 HG23 ' HA ' ' A' ' 30' ' ' SER . 63.2 m -53.31 142.97 19.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.243 -0.911 . . . . 0.0 109.38 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.484 ' CB ' ' HB2' ' A' ' 10' ' ' GLN . 30.6 mm-40 -117.46 107.33 14.19 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.568 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.65 HG21 ' HB3' ' A' ' 54' ' ' PRO . 9.5 t -92.48 148.32 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.308 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.712 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.5 mp -140.6 153.87 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.145 -0.972 . . . . 0.0 109.7 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.894 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -137.5 121.93 18.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.418 -0.801 . . . . 0.0 109.215 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.543 HG22 ' O ' ' A' ' 43' ' ' THR . 1.2 m -89.29 98.99 12.08 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.998 -1.064 . . . . 0.0 108.783 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.489 ' HB3' ' OD1' ' A' ' 46' ' ' ASN . 73.7 mt -41.78 165.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 121.434 0.635 . . . . 0.0 109.919 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 13.9 ptpt -81.22 7.87 10.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.402 -0.811 . . . . 0.0 109.745 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -111.25 16.27 21.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.186 -0.946 . . . . 0.0 109.391 179.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.49 3.75 88.24 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.462 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 2.4 mtp-105 -94.04 174.95 6.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -1.158 . . . . 0.0 109.562 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.515 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -141.24 152.96 44.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 -179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.29 120.45 7.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.33 -0.856 . . . . 0.0 108.889 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.424 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 33.0 m -79.7 140.35 37.03 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.488 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.885 ' HB3' HG22 ' A' ' 59' ' ' VAL . 14.7 mt -126.36 166.94 16.24 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.38 -0.825 . . . . 0.0 108.899 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.661 ' O ' HG21 ' A' ' 59' ' ' VAL . 0.7 OUTLIER -101.52 123.94 42.61 Favored Pre-proline 0 C--N 1.299 -1.624 0 O-C-N 121.294 -0.879 . . . . 0.0 109.386 -179.607 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.65 ' HB3' HG21 ' A' ' 40' ' ' VAL . 33.8 Cg_endo -75.03 -9.89 20.93 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.152 1.901 . . . . 0.0 110.302 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.43 -14.14 57.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.249 -0.907 . . . . 0.0 108.862 179.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -89.69 162.22 36.75 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.426 -0.796 . . . . 0.0 109.325 179.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.0 Cg_endo -77.56 -39.93 0.48 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.63 2.22 . . . . 0.0 110.626 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.529 ' O ' ' CD1' ' A' ' 62' ' ' ILE . 32.4 mt -61.13 -51.86 68.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.144 -0.973 . . . . 0.0 109.17 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.885 HG22 ' HB3' ' A' ' 52' ' ' LEU . 54.4 t -53.48 -52.03 36.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.511 -0.743 . . . . 0.0 109.762 179.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 6.9 mmtt -50.14 -33.22 18.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.077 -1.015 . . . . 0.0 108.813 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.447 ' HG2' ' O ' ' A' ' 57' ' ' PRO . 2.5 mmpt? -74.36 -36.02 63.56 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.448 -0.783 . . . . 0.0 109.26 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.705 HG23 ' CD1' ' A' ' 23' ' ' ILE . 1.7 mp -61.53 -41.14 89.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.419 -0.801 . . . . 0.0 109.079 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.1 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -69.68 -68.94 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.34 -0.85 . . . . 0.0 109.766 -179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -43.82 -33.75 1.4 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.23 -0.919 . . . . 0.0 109.6 -179.688 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' O ' ' N ' ' A' ' 69' ' ' SER . 10.7 mmtm -66.07 -59.12 4.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.24 -0.912 . . . . 0.0 109.169 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.739 ' HG3' HG23 ' A' ' 26' ' ' VAL . 0.6 OUTLIER -44.4 -45.7 9.09 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.377 -0.827 . . . . 0.0 109.051 179.627 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.105 HD11 ' CG2' ' B' ' 63' ' ' ILE . 1.9 mt -56.88 -56.38 22.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.501 -0.749 . . . . 0.0 109.4 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.452 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 5.2 t30 -85.91 13.64 7.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 65' ' ' LYS . 93.7 p -64.63 -49.6 70.44 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.426 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.458 ' OD2' ' O ' ' A' ' 70' ' ' ASP . 6.4 p-10 40.86 83.95 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.509 -0.744 . . . . 0.0 109.715 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.06 76.17 6.8 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.193 -0.942 . . . . 0.0 109.509 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.78 -18.34 13.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.471 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 15.6 t30 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.959 -1.02 . . . . 0.0 109.507 179.939 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.293 0.568 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -80.93 -41.26 23.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.51 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 11.7 p -78.01 137.76 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.262 -0.899 . . . . 0.0 109.487 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -132.61 -179.75 5.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.304 -0.872 . . . . 0.0 109.437 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.718 HG22 ' O ' ' B' ' 5' ' ' THR . 31.7 m -118.84 61.91 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.62 39.21 1.03 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.282 -0.886 . . . . 0.0 109.492 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.543 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -115.61 98.2 6.57 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.233 -0.917 . . . . 0.0 109.54 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -83.43 154.57 23.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.34 -0.85 . . . . 0.0 109.188 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.484 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 1.8 m -43.94 121.64 2.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.447 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.511 ' HG3' ' CB ' ' B' ' 29' ' ' LYS . 56.7 mm-40 -41.91 -27.53 0.12 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.46 -0.775 . . . . 0.0 109.829 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.47 ' SG ' HG13 ' B' ' 41' ' ' ILE . 80.7 m -145.98 72.04 1.28 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.661 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.484 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.3 OUTLIER -44.12 -45.57 8.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.29 -0.881 . . . . 0.0 109.092 179.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -110.1 121.0 44.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.407 -0.808 . . . . 0.0 109.047 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.657 HG21 HD22 ' B' ' 53' ' ' ASN . 0.5 OUTLIER -106.06 161.46 14.46 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.221 -0.925 . . . . 0.0 109.897 -179.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.669 ' HB2' HD23 ' B' ' 52' ' ' LEU . 3.1 mt -108.76 143.19 38.24 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.608 ' O ' HG23 ' B' ' 59' ' ' VAL . 2.4 tt0 -44.95 -26.46 0.42 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.109 -0.994 . . . . 0.0 109.116 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.595 ' CA ' HD22 ' B' ' 52' ' ' LEU . . . 152.3 177.66 26.2 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.661 HG22 HD11 ' B' ' 52' ' ' LEU . 6.4 tp -148.51 160.06 6.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.434 -1.039 . . . . 0.0 109.029 -179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.594 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 1.5 t-80 -50.29 144.22 11.93 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.086 -1.009 . . . . 0.0 109.141 179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -77.46 -22.53 10.73 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.483 2.122 . . . . 0.0 110.237 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.464 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.23 -15.36 31.52 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.36 -0.837 . . . . 0.0 109.096 179.714 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.579 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 95.0 m-20 -79.52 -11.87 59.88 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.361 -0.837 . . . . 0.0 109.421 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.897 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 4.3 mt -101.01 155.55 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.319 -0.863 . . . . 0.0 110.406 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.552 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -124.58 -30.0 3.4 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.325 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.552 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -132.02 169.04 16.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.314 -0.866 . . . . 0.0 108.912 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.749 HG23 ' HG3' ' B' ' 66' ' ' MET . 50.3 t -139.46 111.3 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.08 -1.013 . . . . 0.0 109.836 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.722 ' O ' HD12 ' B' ' 41' ' ' ILE . 0.1 OUTLIER -106.14 110.93 23.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.335 -0.853 . . . . 0.0 109.149 179.634 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.8 t -113.77 106.37 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.272 -0.892 . . . . 0.0 109.696 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.511 ' CB ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -97.25 94.74 7.27 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.305 -0.872 . . . . 0.0 109.44 179.776 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.468 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -45.13 169.23 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.212 -0.93 . . . . 0.0 109.452 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 35.8 Cg_endo -77.77 132.17 11.75 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.562 2.175 . . . . 0.0 110.46 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -137.85 -140.35 4.02 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.12 41.68 1.17 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.69 2.26 . . . . 0.0 110.679 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.543 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 9.6 p-80 -161.9 -38.04 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.142 -0.974 . . . . 0.0 109.324 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.474 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 6.3 t -135.82 112.81 10.34 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.276 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.473 ' O ' ' HB3' ' B' ' 31' ' ' PRO . . . -71.56 -32.03 67.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.251 -0.906 . . . . 0.0 109.611 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.426 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 2.5 mm-40 -87.68 130.65 34.73 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.212 -0.93 . . . . 0.0 109.486 -179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.468 HG23 ' HA ' ' B' ' 30' ' ' SER . 62.4 m -53.47 143.06 20.35 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.353 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' B' ' 10' ' ' GLN . 30.4 mm-40 -117.47 107.38 14.24 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.635 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.632 HG21 ' HB3' ' B' ' 54' ' ' PRO . 9.7 t -92.51 148.35 4.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.894 . . . . 0.0 109.267 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.722 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.5 mp -140.65 153.83 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.163 -0.961 . . . . 0.0 109.679 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.897 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -137.42 121.97 18.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.356 -0.84 . . . . 0.0 109.186 179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.559 HG22 ' O ' ' B' ' 43' ' ' THR . 1.2 m -89.31 99.01 12.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.976 -1.077 . . . . 0.0 108.78 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 73.9 mt -41.82 164.99 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.565 -0.709 . . . . 0.0 109.981 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.464 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 13.9 ptpt -81.18 7.89 10.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.377 -0.827 . . . . 0.0 109.775 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.491 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -111.25 16.16 21.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.199 -0.938 . . . . 0.0 109.384 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.5 3.78 88.21 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.478 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 2.4 mtp-105 -94.05 174.93 6.91 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.231 -1.158 . . . . 0.0 109.5 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.516 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -141.23 152.89 44.94 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.872 . . . . 0.0 109.501 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.22 120.43 7.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.3 -0.875 . . . . 0.0 108.959 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.431 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 33.0 m -79.66 140.24 37.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.125 -0.984 . . . . 0.0 109.46 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.891 ' HB3' HG22 ' B' ' 59' ' ' VAL . 14.7 mt -126.29 166.99 16.1 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.4 -0.812 . . . . 0.0 108.924 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.657 HD22 HG21 ' B' ' 14' ' ' THR . 0.7 OUTLIER -101.49 123.94 42.67 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.407 -0.808 . . . . 0.0 109.412 -179.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.632 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.8 Cg_endo -75.02 -9.99 20.98 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.177 1.918 . . . . 0.0 110.244 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.29 -14.18 57.64 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.268 -0.895 . . . . 0.0 108.944 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -89.65 162.15 37.04 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.432 -0.793 . . . . 0.0 109.323 179.876 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.448 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 35.9 Cg_endo -77.53 -39.87 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.636 2.224 . . . . 0.0 110.658 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' B' ' 62' ' ' ILE . 32.4 mt -61.14 -51.87 68.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.931 . . . . 0.0 109.118 179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.891 HG22 ' HB3' ' B' ' 52' ' ' LEU . 54.5 t -53.53 -52.03 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.509 -0.744 . . . . 0.0 109.746 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' B' ' 56' ' ' SER . 6.9 mmtt -50.13 -33.18 17.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.129 -0.982 . . . . 0.0 108.844 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.448 ' HG2' ' O ' ' B' ' 57' ' ' PRO . 2.5 mmpt? -74.34 -36.08 63.61 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.6 -0.688 . . . . 0.0 109.303 179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.702 HG23 ' CD1' ' B' ' 23' ' ' ILE . 1.7 mp -61.5 -41.13 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.38 -0.825 . . . . 0.0 109.048 179.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 1.105 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -69.76 -69.0 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.335 -0.853 . . . . 0.0 109.643 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.487 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -43.67 -33.71 1.29 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.137 -0.977 . . . . 0.0 109.671 -179.687 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.482 ' O ' ' N ' ' B' ' 69' ' ' SER . 10.7 mmtm -66.14 -59.22 3.98 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.206 -0.934 . . . . 0.0 109.102 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.749 ' HG3' HG23 ' B' ' 26' ' ' VAL . 0.6 OUTLIER -44.37 -45.68 8.99 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.832 . . . . 0.0 109.097 179.661 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.1 HD11 ' CG2' ' A' ' 63' ' ' ILE . 1.9 mt -56.88 -56.27 23.77 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.394 -0.816 . . . . 0.0 109.48 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.445 ' O ' ' OD1' ' B' ' 70' ' ' ASP . 5.2 t30 -85.95 13.5 7.45 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.193 -0.942 . . . . 0.0 109.506 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.482 ' N ' ' O ' ' B' ' 65' ' ' LYS . 93.0 p -64.53 -49.54 70.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 109.507 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.461 ' OD2' ' O ' ' B' ' 70' ' ' ASP . 6.4 p-10 40.76 83.95 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.51 -0.744 . . . . 0.0 109.793 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.0 76.08 6.72 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.117 -0.989 . . . . 0.0 109.486 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.71 -18.31 13.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.494 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 15.8 t30 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.502 179.939 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.847 ' O ' HG13 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.415 ' C ' ' O ' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -44.21 102.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 0.0 109.42 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.847 HG13 ' O ' ' A' ' 1' ' ' ALA . 30.9 m -105.34 134.06 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 0.0 109.468 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.57 75.42 1.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.934 . . . . 0.0 109.368 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.04 117.86 3.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.9 . . . . 0.0 109.529 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -173.81 126.45 0.38 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.551 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -112.0 96.96 6.35 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.509 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -87.98 155.11 20.0 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.337 -0.852 . . . . 0.0 109.099 179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.94 ' HB2' HD22 ' A' ' 12' ' ' LEU . 18.0 m -44.11 106.29 0.07 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.187 -0.946 . . . . 0.0 109.374 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.5 ' HB2' ' HD2' ' A' ' 29' ' ' LYS . 21.4 mm-40 -42.68 -26.53 0.13 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.365 -0.835 . . . . 0.0 109.773 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.471 ' HB2' ' HG2' ' A' ' 39' ' ' GLU . 73.5 m -122.38 58.33 1.06 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.962 . . . . 0.0 109.777 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.94 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.64 4.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 108.839 179.64 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -123.94 123.56 40.67 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.438 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -97.99 172.87 7.35 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.185 -0.947 . . . . 0.0 110.243 -179.273 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.494 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 4.5 mt -128.85 143.11 50.81 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.614 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.7 tt0 -44.4 -44.73 8.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.116 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 1.014 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 142.28 161.42 8.76 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.78 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -130.76 156.54 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.342 -1.093 . . . . 0.0 109.137 179.477 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.588 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -43.23 150.82 0.46 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.321 -0.862 . . . . 0.0 109.291 179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.588 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.3 Cg_endo -76.54 -0.51 10.52 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.472 2.115 . . . . 0.0 110.12 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.448 ' HG3' ' N ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER -90.03 -27.12 19.93 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 179.265 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.57 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 8.9 m-20 -84.97 6.0 26.9 Favored 'General case' 0 N--CA 1.487 1.381 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.714 HG23 ' HB1' ' A' ' 42' ' ' ALA . 2.5 mm -94.26 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.202 -0.936 . . . . 0.0 110.552 -179.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.618 ' H ' HG22 ' A' ' 23' ' ' ILE . 0.5 OUTLIER -154.54 -41.5 0.09 Allowed 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.261 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.476 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 1.3 p -135.73 174.59 10.44 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.535 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 52.7 t -150.3 89.54 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.949 -1.094 . . . . 0.0 109.962 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 3.2 t-20 -79.67 105.49 11.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.183 -0.948 . . . . 0.0 109.23 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -98.49 91.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.572 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.547 ' HE3' ' CD1' ' A' ' 41' ' ' ILE . 1.3 ptpm? -98.23 112.5 24.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.937 . . . . 0.0 109.366 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.421 ' OG ' ' HD2' ' A' ' 31' ' ' PRO . 0.0 OUTLIER -63.99 171.2 2.65 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.253 -179.907 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.547 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.8 Cg_endo -77.98 130.91 10.67 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.626 2.218 . . . . 0.0 110.412 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.11 -144.56 5.74 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -76.87 5.48 4.88 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.546 2.164 . . . . 0.0 110.545 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.551 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 17.5 p-80 -123.14 -11.54 8.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.158 -0.964 . . . . 0.0 109.595 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' OE2' ' A' ' 39' ' ' GLU . 7.9 t -160.14 118.8 2.69 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.931 . . . . 0.0 109.382 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.68 29.56 1.14 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -0.897 . . . . 0.0 109.559 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.547 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 17.8 mm-40 -141.93 127.97 19.59 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.522 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -53.37 152.29 4.81 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.901 . . . . 0.0 109.335 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.471 ' HG2' ' HB2' ' A' ' 11' ' ' CYS . 2.4 mp0 -138.32 112.0 8.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 109.681 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.896 HG11 HD11 ' A' ' 63' ' ' ILE . 1.6 t -103.64 90.59 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.227 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.547 ' CD1' ' HE3' ' A' ' 29' ' ' LYS . 3.5 mt -79.9 144.01 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.298 -0.876 . . . . 0.0 109.961 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.714 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -124.13 120.48 32.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.418 -0.801 . . . . 0.0 108.864 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.478 ' O ' ' HB3' ' A' ' 24' ' ' GLN . 9.0 m -89.22 101.21 13.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.92 -1.113 . . . . 0.0 109.071 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.57 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 81.4 mt -46.28 167.39 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.366 -0.834 . . . . 0.0 109.573 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.469 ' HA ' ' HG3' ' A' ' 24' ' ' GLN . 14.6 ptpt -83.79 9.95 10.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 109.493 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.7 OUTLIER -111.37 16.71 20.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.213 -0.93 . . . . 0.0 109.372 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.89 6.92 87.94 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HB2' HD12 ' A' ' 44' ' ' LEU . 45.8 mtt-85 -99.37 168.81 9.77 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.244 -1.151 . . . . 0.0 109.429 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.52 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -135.63 155.95 49.63 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.246 -0.909 . . . . 0.0 109.499 179.905 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.494 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.4 120.16 7.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.369 -0.832 . . . . 0.0 109.178 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.408 ' SG ' HG12 ' A' ' 41' ' ' ILE . 11.1 m -79.15 138.95 38.11 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.027 -1.045 . . . . 0.0 108.537 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.014 HD22 ' HA2' ' A' ' 17' ' ' GLY . 11.6 mt -119.55 167.47 11.95 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.294 -0.879 . . . . 0.0 109.886 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.647 ' O ' HG21 ' A' ' 59' ' ' VAL . 4.7 t-20 -98.76 119.72 60.52 Favored Pre-proline 0 C--N 1.298 -1.646 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -74.72 -3.92 14.63 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.052 1.834 . . . . 0.0 110.269 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.27 -13.0 42.02 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.329 -0.857 . . . . 0.0 108.823 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 1.0 OUTLIER -89.91 161.24 38.97 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.357 -0.839 . . . . 0.0 109.371 179.899 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.475 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.71 -35.52 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.7 2.266 . . . . 0.0 110.714 -179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.546 HG23 ' N ' ' A' ' 59' ' ' VAL . 9.2 tt -67.73 -44.3 85.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.103 -0.998 . . . . 0.0 109.296 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.004 ' HA ' HD12 ' A' ' 62' ' ' ILE . 31.2 t -58.57 -47.1 89.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.533 -0.729 . . . . 0.0 109.161 179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 8.9 mttt -59.22 -30.32 68.16 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.422 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.502 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -79.36 -23.54 43.29 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.004 HD12 ' HA ' ' A' ' 59' ' ' VAL . 16.5 mt -71.22 -38.1 68.96 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.535 -0.728 . . . . 0.0 109.056 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.989 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -73.84 -55.86 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.41 -0.806 . . . . 0.0 109.284 179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.513 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -59.9 -28.34 67.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.95 . . . . 0.0 109.35 179.945 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.513 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -70.08 -43.28 71.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 108.978 179.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.535 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -60.24 -46.04 91.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.332 -0.855 . . . . 0.0 109.085 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.013 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.7 OUTLIER -48.72 -54.71 13.81 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.45 -0.781 . . . . 0.0 109.511 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' SER . 17.1 t-20 -68.11 -23.25 64.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.296 -0.877 . . . . 0.0 109.614 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 70' ' ' ASP . 9.9 p -43.58 -45.71 6.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.509 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 69' ' ' SER . 15.5 t70 43.89 92.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.28 -0.888 . . . . 0.0 109.437 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.2 ttmt 69.39 150.69 0.08 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.275 -0.891 . . . . 0.0 109.455 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.422 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 24.4 m -115.7 155.6 27.44 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.286 -0.884 . . . . 0.0 109.535 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 72' ' ' SER . 2.3 m-80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.466 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.842 ' O ' HG13 ' B' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.418 ' C ' ' O ' ' B' ' 1' ' ' ALA . 0.9 OUTLIER -44.23 102.37 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.308 -0.87 . . . . 0.0 109.371 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.842 HG13 ' O ' ' B' ' 1' ' ' ALA . 30.7 m -105.3 134.02 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.479 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.56 75.44 1.44 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.255 -0.903 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.02 117.96 3.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.203 -0.936 . . . . 0.0 109.48 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -173.9 126.32 0.37 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.229 -0.919 . . . . 0.0 109.454 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.554 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -111.84 96.89 6.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.3 -0.875 . . . . 0.0 109.606 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.429 ' O ' ' C ' ' B' ' 9' ' ' CYS . 17.7 mmt180 -87.96 155.21 19.95 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.299 -0.876 . . . . 0.0 109.094 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.947 ' HB2' HD22 ' B' ' 12' ' ' LEU . 17.9 m -44.25 106.27 0.07 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.18 -0.95 . . . . 0.0 109.34 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.488 ' HB2' ' HD2' ' B' ' 29' ' ' LYS . 21.3 mm-40 -42.63 -26.55 0.13 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.356 -0.84 . . . . 0.0 109.78 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.468 ' HB2' ' HG2' ' B' ' 39' ' ' GLU . 73.6 m -122.39 58.35 1.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.788 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.947 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.88 -37.63 4.04 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.188 -0.945 . . . . 0.0 108.925 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -123.95 123.63 40.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.437 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -98.04 172.82 7.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.232 -0.917 . . . . 0.0 110.212 -179.259 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.486 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 4.5 mt -128.77 143.14 50.84 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.614 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.7 tt0 -44.32 -44.88 8.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.096 -1.003 . . . . 0.0 109.1 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 1.017 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 142.29 161.37 8.74 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 110.081 -1.208 . . . . 0.0 110.081 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.808 HD13 ' N ' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -130.67 156.58 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.373 -1.075 . . . . 0.0 109.171 179.517 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.589 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -43.38 150.82 0.48 Allowed Pre-proline 0 N--CA 1.488 1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.258 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.589 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.5 Cg_endo -76.43 -0.59 10.57 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.434 2.089 . . . . 0.0 110.181 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.445 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -89.98 -27.21 19.93 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 179.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.574 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 9.0 m-20 -84.84 5.91 26.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.705 HG23 ' HB1' ' B' ' 42' ' ' ALA . 2.5 mm -94.14 175.61 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.309 -0.869 . . . . 0.0 110.506 -179.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.613 ' H ' HG22 ' B' ' 23' ' ' ILE . 0.5 OUTLIER -154.59 -41.51 0.09 Allowed 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.195 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.467 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 1.3 p -135.71 174.63 10.41 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.534 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 52.9 t -150.23 89.76 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.924 -1.11 . . . . 0.0 109.941 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.483 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 3.2 t-20 -79.78 105.38 11.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.192 -0.942 . . . . 0.0 109.242 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.9 t -98.49 91.34 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 -179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.54 ' HE3' ' CD1' ' B' ' 41' ' ' ILE . 1.3 ptpm? -98.21 112.46 24.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.268 -0.895 . . . . 0.0 109.373 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.425 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.0 OUTLIER -63.8 171.09 2.59 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.327 -0.858 . . . . 0.0 109.381 179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.544 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.1 Cg_endo -77.97 130.87 10.67 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.606 2.204 . . . . 0.0 110.478 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -129.02 -144.6 5.77 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -76.81 5.45 4.87 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.553 2.169 . . . . 0.0 110.586 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.554 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 17.4 p-80 -123.18 -11.47 7.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.559 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.45 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 7.8 t -160.18 118.73 2.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.399 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -89.68 29.47 1.15 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.232 -0.917 . . . . 0.0 109.584 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.544 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 17.9 mm-40 -141.89 128.01 19.67 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.208 -0.933 . . . . 0.0 109.566 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 10.1 m -53.27 152.33 4.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.896 . . . . 0.0 109.396 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.468 ' HG2' ' HB2' ' B' ' 11' ' ' CYS . 2.4 mp0 -138.39 111.9 8.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -0.961 . . . . 0.0 109.695 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.901 HG11 HD11 ' B' ' 63' ' ' ILE . 1.6 t -103.59 90.64 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.163 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.54 ' CD1' ' HE3' ' B' ' 29' ' ' LYS . 3.5 mt -79.94 144.0 11.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.897 . . . . 0.0 109.957 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.705 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -124.16 120.49 32.46 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' B' ' 24' ' ' GLN . 9.1 m -89.21 101.26 13.92 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.908 -1.12 . . . . 0.0 109.128 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.574 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 81.3 mt -46.33 167.41 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.388 -0.82 . . . . 0.0 109.587 -179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.452 ' HA ' ' HG3' ' B' ' 24' ' ' GLN . 14.6 ptpt -83.88 10.05 10.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.45 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.7 OUTLIER -111.37 16.69 20.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.236 -0.915 . . . . 0.0 109.349 179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 82.86 7.02 87.85 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.52 ' HB2' HD12 ' B' ' 44' ' ' LEU . 45.8 mtt-85 -99.45 168.85 9.73 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.223 -1.163 . . . . 0.0 109.432 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -135.63 155.99 49.56 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.236 -0.915 . . . . 0.0 109.452 179.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.486 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.41 120.21 7.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.337 -0.852 . . . . 0.0 109.118 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.41 ' SG ' HG12 ' B' ' 41' ' ' ILE . 11.1 m -79.14 138.9 38.09 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.042 -1.037 . . . . 0.0 108.579 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 1.017 HD22 ' HA2' ' B' ' 17' ' ' GLY . 11.5 mt -119.41 167.49 11.88 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.236 -0.915 . . . . 0.0 109.856 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.647 ' O ' HG21 ' B' ' 59' ' ' VAL . 4.7 t-20 -98.84 119.7 60.45 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.55 -0.719 . . . . 0.0 109.061 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.64 -3.92 14.62 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.05 1.834 . . . . 0.0 110.319 -179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.34 -12.86 42.22 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.317 -0.864 . . . . 0.0 108.901 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.484 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 1.0 OUTLIER -90.0 161.23 38.73 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.436 -0.79 . . . . 0.0 109.299 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.0 Cg_endo -77.77 -35.54 1.44 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.649 2.232 . . . . 0.0 110.697 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.56 HG23 ' N ' ' B' ' 59' ' ' VAL . 9.2 tt -67.69 -44.31 86.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 0.0 109.31 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 1.008 ' HA ' HD12 ' B' ' 62' ' ' ILE . 31.6 t -58.54 -47.05 89.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.466 -0.771 . . . . 0.0 109.178 179.838 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' B' ' 56' ' ' SER . 8.9 mttt -59.21 -30.36 68.17 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.496 ' O ' ' CG ' ' B' ' 65' ' ' LYS . 0.0 OUTLIER -79.28 -23.59 43.49 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 1.008 HD12 ' HA ' ' B' ' 59' ' ' VAL . 16.4 mt -71.24 -38.06 68.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.506 -0.746 . . . . 0.0 109.081 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 1.013 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -73.82 -55.85 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.366 -0.833 . . . . 0.0 109.336 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.3 OUTLIER -59.85 -28.39 67.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.159 -0.963 . . . . 0.0 109.379 179.896 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.515 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 0.1 OUTLIER -70.08 -43.21 71.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.002 179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.534 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.6 OUTLIER -60.35 -45.91 91.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 0.0 109.072 179.615 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.989 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -48.78 -54.73 13.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.492 -0.755 . . . . 0.0 109.445 179.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.425 ' O ' ' C ' ' B' ' 69' ' ' SER . 17.2 t-20 -68.15 -23.28 64.86 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 0.0 109.536 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.459 ' O ' ' O ' ' B' ' 70' ' ' ASP . 9.9 p -43.5 -45.82 6.65 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.525 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.459 ' O ' ' O ' ' B' ' 69' ' ' SER . 15.3 t70 44.0 92.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.416 ' CB ' ' O ' ' B' ' 70' ' ' ASP . 11.1 ttmt 69.46 150.8 0.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 109.403 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' B' ' 73' ' ' ASN . 24.3 m -115.79 155.69 27.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.219 -0.925 . . . . 0.0 109.492 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' B' ' 72' ' ' SER . 2.3 m-80 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.444 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 m -153.95 25.57 0.49 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 109.462 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.764 HG13 ' O ' ' A' ' 3' ' ' VAL . 11.6 p -156.51 78.48 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.529 ' HB2' ' O ' ' A' ' 3' ' ' VAL . . . 174.35 -148.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.223 -0.923 . . . . 0.0 109.486 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.527 ' CB ' ' O ' ' A' ' 4' ' ' ALA . 0.2 OUTLIER 76.27 91.3 0.07 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.203 -0.936 . . . . 0.0 109.56 179.985 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -131.56 67.65 1.51 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.278 -0.889 . . . . 0.0 109.387 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.662 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -122.28 100.31 6.88 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.264 -0.897 . . . . 0.0 109.615 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.431 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.4 OUTLIER -92.36 151.87 20.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.219 -0.925 . . . . 0.0 109.201 179.771 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.493 ' HB2' ' HG ' ' A' ' 12' ' ' LEU . 1.8 m -44.09 114.39 0.66 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.14 -0.975 . . . . 0.0 109.454 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.4 mm-40 -45.53 -24.84 0.37 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.764 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.423 ' SG ' HG13 ' A' ' 41' ' ' ILE . 60.8 m -148.7 71.16 1.14 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.082 -1.011 . . . . 0.0 109.822 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.493 ' HG ' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.04 -45.87 11.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.156 -0.965 . . . . 0.0 108.948 179.646 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -115.27 119.69 37.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.443 -0.786 . . . . 0.0 108.961 179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -97.45 163.51 12.84 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.193 -0.942 . . . . 0.0 110.011 -179.465 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.544 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.4 mt -115.17 146.26 41.57 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.487 -0.758 . . . . 0.0 108.981 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.77 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.9 tt0 -44.22 -46.91 9.19 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.222 -0.924 . . . . 0.0 109.339 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 1.033 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 156.03 -164.82 32.49 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.802 HG23 ' O ' ' A' ' 17' ' ' GLY . 1.2 pp -170.26 162.75 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.436 -1.038 . . . . 0.0 109.472 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.623 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 13.0 t60 -44.8 144.58 1.83 Allowed Pre-proline 0 C--N 1.302 -1.499 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.623 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.6 Cg_endo -77.76 -13.93 15.91 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.29 1.994 . . . . 0.0 109.889 -179.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.516 ' CE ' ' HG2' ' A' ' 20' ' ' PRO . 1.9 mmpt? -90.86 -19.87 22.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.401 -0.812 . . . . 0.0 108.861 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.492 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 5.2 m-20 -78.61 -12.96 60.04 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.301 -0.875 . . . . 0.0 109.237 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.941 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 12.0 mt -91.93 165.89 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.981 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.543 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -131.88 -41.96 1.02 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.437 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.8 p -125.11 173.49 8.69 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.539 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 48.3 t -144.33 95.53 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.01 -1.056 . . . . 0.0 109.694 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.673 ' O ' HD12 ' A' ' 41' ' ' ILE . 5.3 t-20 -96.83 112.4 24.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.406 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.833 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -115.6 102.65 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.233 -0.917 . . . . 0.0 109.597 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -94.35 110.92 22.65 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.278 -0.889 . . . . 0.0 109.394 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.67 165.36 0.73 Allowed Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.25 -0.906 . . . . 0.0 109.439 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.504 ' CG ' ' HA ' ' B' ' 71' ' ' LYS . 35.8 Cg_endo -78.12 136.43 14.57 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.61 2.207 . . . . 0.0 110.419 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.67 -145.3 4.59 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.19 7.41 3.71 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.633 2.222 . . . . 0.0 110.849 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.662 ' CD2' HD22 ' A' ' 7' ' ' LEU . 11.5 p-80 -124.32 -7.73 7.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.13 -0.981 . . . . 0.0 109.628 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.9 t -160.1 117.35 2.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.0 109.449 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.15 45.71 1.2 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.932 . . . . 0.0 109.594 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.463 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 1.6 pt20 -171.11 140.99 1.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 0.0 109.474 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.467 ' HB ' ' CG ' ' A' ' 54' ' ' PRO . 1.4 m -60.64 145.19 50.0 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.0 109.368 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.463 ' OE2' ' O ' ' A' ' 37' ' ' GLN . 0.7 OUTLIER -127.3 107.4 9.95 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.273 -0.892 . . . . 0.0 109.582 -179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.833 HG22 HG13 ' A' ' 28' ' ' VAL . 32.0 t -93.09 151.82 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.324 -0.86 . . . . 0.0 109.207 179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.673 HD12 ' O ' ' A' ' 27' ' ' ASN . 2.5 mp -140.19 146.61 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.067 -1.021 . . . . 0.0 109.741 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.941 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -133.87 119.16 18.8 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.416 -0.802 . . . . 0.0 109.08 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.523 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 6.8 m -89.39 97.51 11.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.944 -1.098 . . . . 0.0 109.131 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 87.0 mt -43.13 166.2 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.477 -0.765 . . . . 0.0 109.731 -179.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.8 ptpt -82.56 9.84 8.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.402 -0.811 . . . . 0.0 109.704 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.514 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -113.69 27.69 9.35 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.253 -0.904 . . . . 0.0 109.143 179.707 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.29 6.21 64.68 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.514 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 40.5 mtt180 -96.23 160.99 14.14 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.181 -1.188 . . . . 0.0 109.463 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.509 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.57 150.23 48.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.225 -0.922 . . . . 0.0 109.177 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.544 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.21 124.73 9.64 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.213 -0.929 . . . . 0.0 109.191 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.48 ' SG ' HG13 ' A' ' 41' ' ' ILE . 15.7 m -79.51 148.08 31.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.104 -0.997 . . . . 0.0 109.225 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.033 HD22 ' HA2' ' A' ' 17' ' ' GLY . 15.7 mt -122.76 167.22 13.76 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.271 -0.893 . . . . 0.0 109.329 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.648 ' O ' HG21 ' A' ' 59' ' ' VAL . 3.0 t-20 -98.86 119.45 61.0 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 121.332 -0.855 . . . . 0.0 109.152 180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.467 ' CG ' ' HB ' ' A' ' 38' ' ' THR . 32.9 Cg_endo -74.87 -6.12 17.71 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 C-N-CA 122.137 1.891 . . . . 0.0 110.23 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.95 -14.69 46.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 108.886 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.486 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.2 OUTLIER -90.0 160.7 40.02 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.398 -0.813 . . . . 0.0 109.355 179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.8 -34.39 1.84 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.627 2.218 . . . . 0.0 110.686 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.586 ' O ' HD13 ' A' ' 62' ' ' ILE . 2.7 tt -66.5 -46.67 85.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.138 -0.976 . . . . 0.0 109.09 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.859 HG22 ' HB3' ' A' ' 52' ' ' LEU . 38.1 t -57.02 -48.2 82.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.403 -0.81 . . . . 0.0 109.023 179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.486 ' HG3' ' O ' ' A' ' 56' ' ' SER . 0.1 OUTLIER -55.23 -31.28 61.36 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.491 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 2.8 mmpt? -76.23 -30.62 57.99 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.556 -0.715 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.586 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -65.48 -44.65 94.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.346 -0.846 . . . . 0.0 108.936 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.95 HG22 HD11 ' B' ' 67' ' ' LEU . 2.2 mp -66.82 -61.78 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.489 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.508 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -52.67 -27.7 18.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.157 -0.964 . . . . 0.0 109.481 -179.936 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.508 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 13.9 mttt -71.43 -43.03 67.49 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.197 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.539 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -61.8 -47.13 86.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.31 -0.869 . . . . 0.0 109.185 179.744 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.949 HD11 HG22 ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.75 -50.89 9.85 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.326 -0.859 . . . . 0.0 109.433 179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.462 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 18.0 t-20 -69.32 -31.32 69.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.498 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.491 ' OG ' ' N ' ' A' ' 70' ' ' ASP . 1.3 p -48.82 -58.78 4.28 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.234 -0.916 . . . . 0.0 109.508 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' N ' ' OG ' ' A' ' 69' ' ' SER . 1.2 m-20 64.25 -85.37 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.542 -0.724 . . . . 0.0 109.557 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HA ' ' CG ' ' B' ' 31' ' ' PRO . 3.8 tttt -80.98 -31.11 34.9 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.925 . . . . 0.0 109.405 -179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 25.8 t 57.46 16.88 3.5 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.863 . . . . 0.0 109.48 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.491 -179.965 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.295 0.569 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 5.0 m -153.89 25.53 0.5 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.203 -0.936 . . . . 0.0 109.491 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.763 HG13 ' O ' ' B' ' 3' ' ' VAL . 11.6 p -156.46 78.47 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.203 -0.935 . . . . 0.0 109.387 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' B' ' 3' ' ' VAL . . . 174.31 -148.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.214 -0.929 . . . . 0.0 109.442 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.516 ' CB ' ' O ' ' B' ' 4' ' ' ALA . 0.2 OUTLIER 76.39 91.31 0.07 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.466 -179.994 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -131.56 67.63 1.51 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.204 -0.935 . . . . 0.0 109.414 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.649 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -122.34 100.44 6.95 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.305 -0.872 . . . . 0.0 109.577 -179.928 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.412 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.4 OUTLIER -92.41 151.83 20.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.245 -0.909 . . . . 0.0 109.215 179.802 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.474 ' HB2' ' HG ' ' B' ' 12' ' ' LEU . 1.8 m -44.04 114.37 0.66 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.49 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 60.5 mm-40 -45.55 -24.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.305 -0.872 . . . . 0.0 109.698 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.429 ' O ' ' C ' ' B' ' 12' ' ' LEU . 60.7 m -148.7 71.11 1.14 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.086 -1.009 . . . . 0.0 109.884 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.474 ' HG ' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.94 -45.94 10.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.007 179.662 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -115.24 119.61 36.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.461 -0.775 . . . . 0.0 108.954 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.538 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.6 OUTLIER -97.31 163.6 12.82 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.253 -0.904 . . . . 0.0 110.014 -179.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.532 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.4 mt -115.27 146.2 41.71 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.479 -0.763 . . . . 0.0 108.949 179.625 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.788 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.9 tt0 -44.16 -46.88 9.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.151 -0.968 . . . . 0.0 109.344 -179.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 1.051 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 155.99 -164.94 32.52 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.802 HG23 ' O ' ' B' ' 17' ' ' GLY . 1.2 pp -170.19 162.77 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.399 -1.059 . . . . 0.0 109.503 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.614 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 12.8 t60 -44.75 144.6 1.8 Allowed Pre-proline 0 N--CA 1.487 1.422 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.614 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -77.78 -13.99 15.85 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.347 2.031 . . . . 0.0 109.87 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.507 ' CE ' ' HG2' ' B' ' 20' ' ' PRO . 1.9 mmpt? -90.77 -19.96 22.91 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.487 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 5.1 m-20 -78.63 -12.92 60.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.321 -0.862 . . . . 0.0 109.234 179.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.95 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 12.0 mt -91.96 165.91 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.276 -0.89 . . . . 0.0 109.982 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.555 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.0 OUTLIER -131.92 -41.87 1.02 Allowed 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . . . . . . . . . 3.7 p -125.25 173.45 8.79 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.533 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 48.7 t -144.26 95.61 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.077 -1.014 . . . . 0.0 109.728 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.679 ' O ' HD12 ' B' ' 41' ' ' ILE . 5.3 t-20 -96.95 112.39 24.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.245 -0.91 . . . . 0.0 109.392 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.814 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -115.64 102.62 14.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 109.56 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 6.0 tttt -94.34 110.93 22.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -53.7 165.34 0.74 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.168 -0.958 . . . . 0.0 109.457 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.509 ' CG ' ' HA ' ' A' ' 71' ' ' LYS . 35.7 Cg_endo -78.04 136.45 14.71 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.629 2.219 . . . . 0.0 110.451 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -140.66 -145.24 4.58 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.22 7.41 3.72 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.738 2.292 . . . . 0.0 110.746 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.649 ' CD2' HD22 ' B' ' 7' ' ' LEU . 11.7 p-80 -124.43 -7.66 7.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.189 -0.944 . . . . 0.0 109.54 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.9 t -160.13 117.29 2.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.188 -0.945 . . . . 0.0 109.357 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.18 45.72 1.21 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.232 -0.918 . . . . 0.0 109.476 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.448 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 1.6 pt20 -171.14 140.93 1.57 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.254 -0.903 . . . . 0.0 109.528 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.473 ' HB ' ' CG ' ' B' ' 54' ' ' PRO . 1.4 m -60.58 145.09 50.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.423 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.448 ' OE2' ' O ' ' B' ' 37' ' ' GLN . 0.7 OUTLIER -127.23 107.32 9.9 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.151 -0.968 . . . . 0.0 109.596 -179.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.814 HG22 HG13 ' B' ' 28' ' ' VAL . 31.5 t -92.99 151.83 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.261 -0.899 . . . . 0.0 109.257 179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.679 HD12 ' O ' ' B' ' 27' ' ' ASN . 2.6 mp -140.15 146.57 24.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.788 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.95 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -133.91 119.16 18.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.402 -0.811 . . . . 0.0 109.073 179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 6.7 m -89.32 97.49 11.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.924 -1.11 . . . . 0.0 109.17 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.501 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 86.9 mt -43.13 166.14 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.507 -0.746 . . . . 0.0 109.673 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.481 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.8 ptpt -82.56 9.95 8.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.383 -0.823 . . . . 0.0 109.676 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -113.77 27.75 9.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.324 -0.86 . . . . 0.0 109.152 179.627 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.3 6.16 64.6 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.51 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 40.6 mtt180 -96.23 161.03 14.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.171 -1.193 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.506 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.62 150.25 48.43 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.324 -0.86 . . . . 0.0 109.154 179.847 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.532 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.21 124.71 9.63 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.35 -0.844 . . . . 0.0 109.137 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.483 ' SG ' HG13 ' B' ' 41' ' ' ILE . 15.6 m -79.49 148.08 31.99 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.124 -0.985 . . . . 0.0 109.184 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 1.051 HD22 ' HA2' ' B' ' 17' ' ' GLY . 15.9 mt -122.88 167.2 13.85 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.298 -0.876 . . . . 0.0 109.229 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.651 ' O ' HG21 ' B' ' 59' ' ' VAL . 3.0 t-20 -98.82 119.38 61.23 Favored Pre-proline 0 C--N 1.299 -1.591 0 O-C-N 121.352 -0.842 . . . . 0.0 109.163 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.473 ' CG ' ' HB ' ' B' ' 38' ' ' THR . 33.4 Cg_endo -74.66 -6.31 18.04 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 C-N-CA 122.182 1.921 . . . . 0.0 110.304 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.93 -14.68 46.9 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.36 -0.838 . . . . 0.0 108.846 179.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -90.02 160.75 39.89 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.288 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.85 -34.35 1.83 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.582 2.188 . . . . 0.0 110.709 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.598 ' O ' HD13 ' B' ' 62' ' ' ILE . 2.7 tt -66.49 -46.65 85.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.108 -0.995 . . . . 0.0 109.136 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.865 HG22 ' HB3' ' B' ' 52' ' ' LEU . 38.1 t -57.1 -48.08 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.375 -0.828 . . . . 0.0 109.017 179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.1 OUTLIER -55.28 -31.3 61.49 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.467 ' HA ' ' HG2' ' B' ' 64' ' ' GLU . 2.8 mmpt? -76.16 -30.6 58.16 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.591 -0.693 . . . . 0.0 109.391 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.598 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -65.46 -44.7 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.353 -0.842 . . . . 0.0 108.987 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.949 HG22 HD11 ' A' ' 67' ' ' LEU . 2.2 mp -66.69 -61.8 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.326 -0.859 . . . . 0.0 109.533 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.1 OUTLIER -52.73 -27.72 18.93 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.967 . . . . 0.0 109.462 -179.894 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.512 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 13.9 mttt -71.38 -43.0 67.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.19 -0.944 . . . . 0.0 109.236 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.533 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -61.81 -47.11 86.58 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.378 -0.826 . . . . 0.0 109.248 179.715 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.95 HD11 HG22 ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.7 -50.91 9.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.345 -0.847 . . . . 0.0 109.504 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.453 ' O ' ' OD1' ' B' ' 70' ' ' ASP . 17.8 t-20 -69.32 -31.28 69.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.319 -0.863 . . . . 0.0 109.486 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.506 ' OG ' ' N ' ' B' ' 70' ' ' ASP . 1.3 p -48.82 -58.82 4.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.918 . . . . 0.0 109.523 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.506 ' N ' ' OG ' ' B' ' 69' ' ' SER . 1.2 m-20 64.23 -85.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.523 -0.736 . . . . 0.0 109.62 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.504 ' HA ' ' CG ' ' A' ' 31' ' ' PRO . 3.8 tttt -80.97 -31.06 34.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.488 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 25.6 t 57.39 16.96 3.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 109.478 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.478 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.54 ' O ' HG23 ' A' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.7 m 49.6 23.66 1.0 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.424 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 1' ' ' ALA . 47.4 t -105.78 134.59 46.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.247 -0.908 . . . . 0.0 109.534 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -176.31 144.11 0.54 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.274 -0.891 . . . . 0.0 109.522 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 87.0 m -158.05 116.48 3.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.274 -0.891 . . . . 0.0 109.516 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -105.71 91.58 3.81 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 0.0 109.367 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.528 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -118.43 99.76 7.03 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.235 -0.916 . . . . 0.0 109.637 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 9' ' ' CYS . 16.6 mtp180 -91.52 155.42 18.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.267 -0.896 . . . . 0.0 108.885 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.441 ' HB3' ' OE2' ' A' ' 39' ' ' GLU . 17.2 m -44.28 125.5 4.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.204 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.667 ' HB3' HD11 ' A' ' 41' ' ' ILE . 45.2 mm-40 -40.69 -39.89 1.18 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.482 -0.761 . . . . 0.0 109.756 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.481 ' O ' HG23 ' A' ' 14' ' ' THR . 1.7 m -165.85 70.19 0.13 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.4 -0.812 . . . . 0.0 109.506 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.965 HD13 ' O ' ' A' ' 12' ' ' LEU . 1.5 tm? -44.22 -34.46 1.89 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.308 -0.87 . . . . 0.0 109.342 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 15.6 tt0 -93.6 81.4 4.32 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.244 -0.91 . . . . 0.0 109.099 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.666 HG21 HD22 ' A' ' 53' ' ' ASN . 10.1 p -87.78 158.65 18.72 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.291 -0.881 . . . . 0.0 109.91 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.555 ' HB2' HD23 ' A' ' 52' ' ' LEU . 2.4 mt -100.24 144.25 29.48 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.455 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.9 tt0 -45.41 -25.91 0.48 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.121 -0.987 . . . . 0.0 109.074 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.532 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 154.09 171.54 21.19 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.844 HG22 HD11 ' A' ' 52' ' ' LEU . 7.7 tp -145.32 151.96 14.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.336 -1.096 . . . . 0.0 109.166 -179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.507 ' ND1' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -45.92 146.98 1.82 Allowed Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.935 . . . . 0.0 109.303 -179.959 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.507 ' HD2' ' ND1' ' A' ' 19' ' ' HIS . 35.0 Cg_endo -77.15 -13.85 16.95 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.549 2.166 . . . . 0.0 110.04 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.526 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -80.92 -16.34 53.84 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.234 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.989 ' O ' HD23 ' A' ' 44' ' ' LEU . 80.1 m-20 -101.34 55.59 0.83 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.459 -0.776 . . . . 0.0 108.988 179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.974 HG23 ' HB1' ' A' ' 42' ' ' ALA . 1.8 mm -139.79 170.83 14.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.133 -0.979 . . . . 0.0 110.041 -179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.527 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.1 OUTLIER -160.06 -40.72 0.05 Allowed 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 179.525 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.546 ' O ' HG23 ' A' ' 26' ' ' VAL . 4.8 p -131.13 -177.97 4.62 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 25' ' ' SER . 51.9 t -157.22 111.03 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.025 -1.047 . . . . 0.0 109.748 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.424 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 18.6 t-20 -94.87 124.61 39.01 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.341 -0.85 . . . . 0.0 109.358 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.46 ' HB ' ' HB ' ' B' ' 26' ' ' VAL . 1.9 t -119.91 89.7 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.196 -0.94 . . . . 0.0 109.53 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.18 104.22 15.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.279 -0.888 . . . . 0.0 109.547 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.461 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.2 p -54.31 168.42 0.46 Allowed Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.241 -0.912 . . . . 0.0 109.445 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.461 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 35.9 Cg_endo -78.01 133.15 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.664 2.242 . . . . 0.0 110.434 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.85 -141.05 3.8 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.399 -1.48 . . . . 0.0 109.399 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.55 10.25 2.59 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.531 2.154 . . . . 0.0 110.992 179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.528 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 3.7 p-80 -127.16 -10.21 5.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.023 -1.048 . . . . 0.0 109.813 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.452 ' SG ' ' OE1' ' A' ' 39' ' ' GLU . 1.8 t -160.27 121.4 3.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.096 -1.002 . . . . 0.0 109.372 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.72 44.16 1.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.26 -0.9 . . . . 0.0 109.577 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.441 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 5.8 pt20 -172.36 139.76 1.04 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.249 -0.907 . . . . 0.0 109.517 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.531 HG21 ' CG ' ' B' ' 70' ' ' ASP . 1.5 m -56.49 142.28 39.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.292 -0.88 . . . . 0.0 109.399 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.452 ' OE1' ' SG ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -127.62 122.59 33.5 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.261 -0.899 . . . . 0.0 109.623 -179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.844 HG11 HD11 ' A' ' 63' ' ' ILE . 74.6 t -114.48 151.44 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.392 -0.818 . . . . 0.0 109.371 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.667 HD11 ' HB3' ' A' ' 10' ' ' GLN . 3.3 mp -141.82 155.18 19.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.607 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.974 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -134.21 126.63 30.27 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 109.397 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.635 HG23 ' HG3' ' A' ' 49' ' ' LYS . 51.9 m -89.81 105.87 18.09 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.111 -0.993 . . . . 0.0 109.089 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.989 HD23 ' O ' ' A' ' 22' ' ' ASN . 77.1 mt -41.73 164.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.464 -0.772 . . . . 0.0 109.587 -179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.4 ptpt -87.44 17.81 4.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 0.0 109.748 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.492 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 1.1 p-10 -120.46 -3.53 9.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.149 -0.97 . . . . 0.0 109.349 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.4 -25.31 8.72 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.845 ' HB2' HD12 ' A' ' 44' ' ' LEU . 0.3 OUTLIER -79.34 172.9 13.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.208 -1.172 . . . . 0.0 109.255 179.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.635 ' HG3' HG23 ' A' ' 43' ' ' THR . 0.0 OUTLIER -147.24 125.55 12.28 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.223 -0.923 . . . . 0.0 109.66 -179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.74 124.77 51.82 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.422 -0.799 . . . . 0.0 108.847 179.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.44 ' SG ' HG12 ' A' ' 41' ' ' ILE . 83.9 m -79.55 140.99 37.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.184 -0.947 . . . . 0.0 109.317 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.844 HD11 HG22 ' A' ' 18' ' ' ILE . 14.3 mt -127.78 168.25 15.39 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.387 -0.821 . . . . 0.0 108.975 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.666 HD22 HG21 ' A' ' 14' ' ' THR . 0.8 OUTLIER -106.12 132.95 20.46 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.321 -0.862 . . . . 0.0 109.125 -179.644 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.463 ' HG3' HG23 ' A' ' 40' ' ' VAL . 33.9 Cg_endo -75.62 -25.23 11.12 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.12 1.88 . . . . 0.0 110.298 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.87 -16.15 26.76 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.212 -0.93 . . . . 0.0 108.843 179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 37.1 p -88.66 158.18 48.43 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.433 -0.792 . . . . 0.0 109.395 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.427 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.86 -38.74 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.695 2.263 . . . . 0.0 110.744 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.599 HG23 ' N ' ' A' ' 59' ' ' VAL . 5.9 tt -66.04 -46.63 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.141 -0.974 . . . . 0.0 109.235 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.785 HG22 ' HB3' ' A' ' 52' ' ' LEU . 40.3 t -56.81 -48.46 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.494 -0.753 . . . . 0.0 109.241 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.49 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.5 OUTLIER -55.45 -31.42 61.93 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HE2' ' OE2' ' A' ' 64' ' ' GLU . 0.1 OUTLIER -74.89 -31.25 61.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.614 -0.679 . . . . 0.0 109.226 179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.563 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.7 mp -67.0 -42.97 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.401 -0.812 . . . . 0.0 108.848 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.043 HG22 HD11 ' B' ' 67' ' ' LEU . 2.1 mp -65.87 -66.64 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.349 -0.844 . . . . 0.0 109.468 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.49 ' HG2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -46.23 -39.32 9.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.168 -0.957 . . . . 0.0 109.496 -179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.479 ' HG3' ' OE1' ' A' ' 64' ' ' GLU . 12.2 mttm -59.08 -50.9 72.32 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.258 -0.901 . . . . 0.0 109.209 179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.45 -48.1 62.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.266 -0.896 . . . . 0.0 109.216 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.047 HD11 HG22 ' B' ' 63' ' ' ILE . 0.2 OUTLIER -47.02 -51.8 16.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.387 179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.47 ' HA ' ' HB2' ' A' ' 71' ' ' LYS . 11.7 t30 -58.46 -38.47 77.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.499 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.422 ' C ' ' O ' ' A' ' 68' ' ' ASN . 4.2 p -44.19 -33.07 1.42 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 0.0 109.436 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.535 ' CG ' HG21 ' B' ' 38' ' ' THR . 0.2 OUTLIER -126.4 53.94 1.61 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.464 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.47 ' HB2' ' HA ' ' A' ' 68' ' ' ASN . 0.7 OUTLIER -100.28 117.81 35.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.269 -0.894 . . . . 0.0 109.484 179.934 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.438 ' O ' ' OXT' ' A' ' 73' ' ' ASN . 0.4 OUTLIER -131.38 118.88 20.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.251 -0.906 . . . . 0.0 109.494 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.438 ' OXT' ' O ' ' A' ' 72' ' ' SER . 16.0 p-10 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.006 -0.997 . . . . 0.0 109.473 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.529 ' O ' HG23 ' B' ' 3' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 18.8 m 49.58 23.59 0.97 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.294 -0.879 . . . . 0.0 109.525 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.529 HG23 ' O ' ' B' ' 1' ' ' ALA . 47.7 t -105.82 134.59 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.171 -0.955 . . . . 0.0 109.499 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -176.27 144.12 0.54 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.124 -0.985 . . . . 0.0 109.447 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 86.6 m -158.11 116.5 3.07 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.29 -0.881 . . . . 0.0 109.487 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -105.68 91.52 3.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.425 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.526 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -118.38 99.75 7.03 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.3 -0.875 . . . . 0.0 109.612 -179.951 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.411 ' O ' ' C ' ' B' ' 9' ' ' CYS . 16.7 mtp180 -91.54 155.32 18.47 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.28 -0.887 . . . . 0.0 108.857 179.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.448 ' O ' ' C ' ' B' ' 10' ' ' GLN . 17.4 m -44.09 125.36 4.38 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.168 -0.957 . . . . 0.0 109.294 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.655 ' HB3' HD11 ' B' ' 41' ' ' ILE . 45.1 mm-40 -40.52 -39.97 1.14 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.56 -0.712 . . . . 0.0 109.767 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.495 ' O ' HG23 ' B' ' 14' ' ' THR . 1.7 m -165.85 70.24 0.13 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.289 -0.882 . . . . 0.0 109.454 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.97 HD13 ' O ' ' B' ' 12' ' ' LEU . 1.5 tm? -44.3 -34.46 1.95 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.214 -0.929 . . . . 0.0 109.266 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -93.63 81.53 4.31 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.266 -0.897 . . . . 0.0 109.118 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.647 HG21 HD22 ' B' ' 53' ' ' ASN . 10.2 p -87.88 158.63 18.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.332 -0.855 . . . . 0.0 109.859 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.57 ' HB2' HD23 ' B' ' 52' ' ' LEU . 2.4 mt -100.18 144.26 29.41 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.464 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.9 tt0 -45.44 -25.88 0.48 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.043 -1.036 . . . . 0.0 109.063 179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.532 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 154.1 171.55 21.2 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.836 HG22 HD11 ' B' ' 52' ' ' LEU . 7.7 tp -145.3 151.91 14.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.405 -1.056 . . . . 0.0 109.247 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.507 ' ND1' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -45.9 147.01 1.79 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.257 -0.902 . . . . 0.0 109.329 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.507 ' HD2' ' ND1' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.17 -13.94 16.87 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.622 2.215 . . . . 0.0 109.963 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -80.9 -16.39 53.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.972 ' O ' HD23 ' B' ' 44' ' ' LEU . 80.1 m-20 -101.31 55.64 0.84 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.448 -0.782 . . . . 0.0 108.935 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.998 HG23 ' HB1' ' B' ' 42' ' ' ALA . 1.8 mm -139.78 170.78 14.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.091 -1.005 . . . . 0.0 109.947 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.516 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.1 OUTLIER -159.99 -40.7 0.05 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.367 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.548 ' O ' HG23 ' B' ' 26' ' ' VAL . 4.8 p -131.14 -177.99 4.63 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.548 HG23 ' O ' ' B' ' 25' ' ' SER . 51.5 t -157.16 111.02 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.981 -1.075 . . . . 0.0 109.771 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.434 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 18.8 t-20 -94.89 124.7 39.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.29 -0.882 . . . . 0.0 109.281 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.461 ' HB ' ' HB ' ' A' ' 26' ' ' VAL . 1.9 t -119.99 89.83 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.47 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.23 104.28 15.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.421 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.2 p -54.53 168.43 0.48 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.289 -0.882 . . . . 0.0 109.381 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.448 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 35.6 Cg_endo -77.93 133.11 12.22 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.609 2.206 . . . . 0.0 110.414 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -142.79 -141.04 3.8 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.66 10.35 2.58 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.541 2.16 . . . . 0.0 110.993 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.526 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 3.7 p-80 -127.16 -10.26 5.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.981 -1.074 . . . . 0.0 109.855 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.451 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 1.8 t -160.3 121.37 3.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.357 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.69 44.1 1.08 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.195 -0.941 . . . . 0.0 109.588 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.446 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 5.9 pt20 -172.24 139.86 1.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.227 -0.921 . . . . 0.0 109.515 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.535 HG21 ' CG ' ' A' ' 70' ' ' ASP . 1.5 m -56.69 142.33 40.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.451 ' OE2' ' SG ' ' B' ' 35' ' ' CYS . 0.0 OUTLIER -127.53 122.59 33.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.641 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.869 HG11 HD11 ' B' ' 63' ' ' ILE . 76.9 t -114.55 151.46 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.31 -0.869 . . . . 0.0 109.321 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' B' ' 10' ' ' GLN . 3.3 mp -141.79 155.25 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 0.0 109.643 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.998 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -134.33 126.56 29.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.314 -0.866 . . . . 0.0 109.335 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.634 HG23 ' HG3' ' B' ' 49' ' ' LYS . 52.2 m -89.9 105.96 18.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.071 -1.018 . . . . 0.0 109.089 179.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.972 HD23 ' O ' ' B' ' 22' ' ' ASN . 77.0 mt -41.71 164.45 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.467 -0.771 . . . . 0.0 109.667 -179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.4 ptpt -87.33 17.76 4.22 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.296 -0.877 . . . . 0.0 109.865 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.477 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 1.1 p-10 -120.42 -3.54 9.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.206 -0.934 . . . . 0.0 109.386 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 117.52 -25.49 8.58 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.874 ' HB2' HD12 ' B' ' 44' ' ' LEU . 0.3 OUTLIER -79.31 172.95 13.09 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -1.186 . . . . 0.0 109.273 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.634 ' HG3' HG23 ' B' ' 43' ' ' THR . 0.0 OUTLIER -147.27 125.46 12.19 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.265 -0.897 . . . . 0.0 109.657 -179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -109.68 124.76 51.75 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.395 -0.816 . . . . 0.0 108.915 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.448 ' SG ' HG12 ' B' ' 41' ' ' ILE . 84.3 m -79.49 141.07 37.06 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.15 -0.969 . . . . 0.0 109.289 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.836 HD11 HG22 ' B' ' 18' ' ' ILE . 14.2 mt -127.89 168.16 15.59 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.418 -0.802 . . . . 0.0 109.001 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.647 HD22 HG21 ' B' ' 14' ' ' THR . 0.8 OUTLIER -106.01 132.84 20.55 Favored Pre-proline 0 C--N 1.299 -1.626 0 O-C-N 121.324 -0.86 . . . . 0.0 109.205 -179.609 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.463 ' HG3' HG23 ' B' ' 40' ' ' VAL . 33.7 Cg_endo -75.59 -25.22 11.18 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.09 1.86 . . . . 0.0 110.324 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -59.83 -16.16 26.42 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.274 -0.891 . . . . 0.0 108.792 179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 36.9 p -88.68 158.21 48.33 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.478 -0.764 . . . . 0.0 109.297 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.438 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -77.88 -38.7 0.6 Allowed 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.666 2.244 . . . . 0.0 110.741 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.593 HG23 ' N ' ' B' ' 59' ' ' VAL . 5.8 tt -66.05 -46.61 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.096 -1.003 . . . . 0.0 109.248 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.795 HG22 ' HB3' ' B' ' 52' ' ' LEU . 40.0 t -56.87 -48.52 81.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.407 -0.808 . . . . 0.0 109.174 179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.494 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.5 OUTLIER -55.48 -31.29 61.87 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 179.358 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' B' ' 57' ' ' PRO . 0.1 OUTLIER -74.95 -31.23 61.44 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.711 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.583 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.7 mp -67.04 -42.96 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 1.047 HG22 HD11 ' A' ' 67' ' ' LEU . 2.1 mp -65.83 -66.57 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.356 -0.84 . . . . 0.0 109.466 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -46.36 -39.26 10.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.942 . . . . 0.0 109.43 -179.731 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.477 ' HG3' ' OE1' ' B' ' 64' ' ' GLU . 12.2 mttm -59.1 -50.88 72.39 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 109.269 179.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -51.44 -48.07 62.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.357 -0.839 . . . . 0.0 109.219 179.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.043 HD11 HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -46.97 -51.9 15.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.299 -0.876 . . . . 0.0 109.412 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.473 ' HA ' ' HB2' ' B' ' 71' ' ' LYS . 11.8 t30 -58.42 -38.54 77.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.511 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.405 ' C ' ' O ' ' B' ' 68' ' ' ASN . 4.1 p -44.0 -33.22 1.35 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.214 -0.929 . . . . 0.0 109.466 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.531 ' CG ' HG21 ' A' ' 38' ' ' THR . 0.2 OUTLIER -126.28 53.92 1.6 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.473 ' HB2' ' HA ' ' B' ' 68' ' ' ASN . 0.7 OUTLIER -100.38 117.66 35.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.298 -0.876 . . . . 0.0 109.481 -179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.424 ' O ' ' OXT' ' B' ' 73' ' ' ASN . 0.4 OUTLIER -131.32 118.89 20.96 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.235 -0.915 . . . . 0.0 109.523 179.983 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . 0.424 ' OXT' ' O ' ' B' ' 72' ' ' SER . 15.9 p-10 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.53 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 t -159.7 161.79 34.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.471 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.691 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 1.9 t -107.91 -25.65 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.203 -0.936 . . . . 0.0 109.468 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' A' ' 3' ' ' VAL . . . 75.27 -152.29 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 0.0 109.486 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 4' ' ' ALA . 13.5 t 42.21 27.39 0.08 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.362 -0.836 . . . . 0.0 109.726 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.522 ' CG ' ' O ' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -155.54 26.88 0.39 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.94 . . . . 0.0 109.405 179.886 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.606 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -136.65 109.47 7.58 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.31 -0.868 . . . . 0.0 109.591 -179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -115.62 156.22 26.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.075 179.606 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.424 ' C ' ' O ' ' A' ' 8' ' ' ARG . 43.8 m -44.52 102.34 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.248 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.503 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 75.8 mm-40 -53.04 -18.48 2.08 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.655 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.418 ' O ' ' C ' ' A' ' 12' ' ' LEU . 53.0 m -135.63 65.96 1.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.076 -1.015 . . . . 0.0 109.889 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.418 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -44.7 -44.86 9.47 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.263 -0.898 . . . . 0.0 108.895 179.565 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.41 119.44 34.6 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.461 HG21 HD22 ' A' ' 53' ' ' ASN . 0.5 OUTLIER -93.31 168.55 11.0 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.186 -0.946 . . . . 0.0 110.09 -179.385 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.519 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 6.8 mt -119.13 145.5 45.92 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.835 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -43.99 -46.63 8.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.162 -0.961 . . . . 0.0 109.254 -179.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 1.011 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 151.39 -170.88 30.99 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.901 -1.279 . . . . 0.0 109.901 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.92 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.4 pp -164.95 162.9 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.452 -1.028 . . . . 0.0 109.33 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.584 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -53.97 150.69 14.05 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.22 -0.925 . . . . 0.0 109.328 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.5 Cg_endo -77.44 -3.89 14.12 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.598 2.199 . . . . 0.0 110.29 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 3.1 pttm -90.21 -24.19 21.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.317 -0.865 . . . . 0.0 109.207 179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.519 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 3.1 m-20 -83.19 -7.31 59.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.385 -0.822 . . . . 0.0 109.268 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.927 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 6.8 mt -104.26 162.12 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.301 -0.874 . . . . 0.0 110.1 -179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.566 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -135.12 -31.36 1.0 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.526 -0.734 . . . . 0.0 109.177 179.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.566 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.1 p -132.82 175.14 9.6 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.108 -0.995 . . . . 0.0 108.854 179.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.638 HG23 ' HG3' ' A' ' 66' ' ' MET . 46.6 t -149.69 115.77 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.045 -1.034 . . . . 0.0 109.922 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.563 ' O ' HD12 ' A' ' 41' ' ' ILE . 4.1 t-20 -111.85 110.76 21.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.147 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.849 HG22 HG13 ' A' ' 40' ' ' VAL . 3.1 t -117.12 113.65 43.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.709 -179.714 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.522 ' CG ' ' O ' ' A' ' 29' ' ' LYS . 0.4 OUTLIER -105.74 114.76 29.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.0 109.251 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.407 ' HB2' ' HD2' ' A' ' 31' ' ' PRO . 1.0 OUTLIER -55.23 167.29 0.71 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.218 -0.926 . . . . 0.0 109.544 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.442 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 35.3 Cg_endo -77.53 140.25 18.89 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.607 2.205 . . . . 0.0 110.378 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.92 -139.6 3.03 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.327 -1.509 . . . . 0.0 109.327 -179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -79.66 38.73 0.76 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.594 2.196 . . . . 0.0 110.903 179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.606 ' CD2' HD22 ' A' ' 7' ' ' LEU . 3.9 p-80 -154.99 -38.73 0.09 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.05 -1.031 . . . . 0.0 109.375 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.415 ' SG ' ' CD ' ' A' ' 39' ' ' GLU . 1.8 t -133.58 124.77 27.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.235 -0.916 . . . . 0.0 109.23 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.53 42.43 0.96 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.358 -0.839 . . . . 0.0 109.736 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.453 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 0.0 OUTLIER -170.76 148.48 2.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.153 -0.967 . . . . 0.0 109.631 -179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 1.4 m -63.49 144.94 56.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.325 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.453 ' OE1' ' O ' ' A' ' 37' ' ' GLN . 0.5 OUTLIER -126.64 110.27 13.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.156 -0.965 . . . . 0.0 109.628 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.849 HG13 HG22 ' A' ' 28' ' ' VAL . 3.3 t -97.53 144.84 10.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.31 -0.869 . . . . 0.0 109.273 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.563 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.6 mt -132.4 153.08 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.169 -0.957 . . . . 0.0 109.58 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.927 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -137.69 120.21 16.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -0.873 . . . . 0.0 109.174 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.525 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 2.3 m -89.23 102.69 15.35 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.973 -1.08 . . . . 0.0 108.737 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 88.6 mt -49.22 164.59 0.07 Allowed 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.432 -0.792 . . . . 0.0 109.549 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -79.12 6.78 8.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.288 -0.882 . . . . 0.0 109.978 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.526 ' ND2' ' HD2' ' A' ' 48' ' ' ARG . 41.7 p30 -109.36 20.72 17.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.124 -0.985 . . . . 0.0 109.363 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.87 14.08 82.73 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HD2' ' ND2' ' A' ' 46' ' ' ASN . 1.6 mtp-105 -103.56 171.64 7.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.244 -1.151 . . . . 0.0 109.452 179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.468 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -141.9 151.19 42.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.357 179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.519 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.25 123.03 8.66 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.294 -0.879 . . . . 0.0 109.074 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.414 ' SG ' HG12 ' A' ' 41' ' ' ILE . 15.6 m -79.77 141.1 36.61 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.198 -0.939 . . . . 0.0 109.329 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.011 HD22 ' HA2' ' A' ' 17' ' ' GLY . 12.3 mt -119.6 167.82 11.63 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.321 -0.862 . . . . 0.0 109.195 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.653 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -98.15 119.34 62.17 Favored Pre-proline 0 C--N 1.299 -1.593 0 O-C-N 121.337 -0.852 . . . . 0.0 108.983 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.48 ' HB3' HG21 ' A' ' 40' ' ' VAL . 33.3 Cg_endo -75.2 -6.76 18.31 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.103 1.869 . . . . 0.0 110.327 -179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.75 -14.66 47.6 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.253 -0.904 . . . . 0.0 108.865 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.413 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -90.07 162.12 36.06 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.412 -0.805 . . . . 0.0 109.317 179.905 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.501 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 36.7 Cg_endo -78.29 -37.72 0.7 Allowed 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.644 2.229 . . . . 0.0 110.944 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.611 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -63.26 -48.13 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.073 -1.017 . . . . 0.0 108.917 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.853 HG22 ' HB3' ' A' ' 52' ' ' LEU . 37.2 t -55.75 -48.48 77.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.477 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.3 OUTLIER -51.33 -33.62 30.02 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.298 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -72.94 -36.37 67.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.549 -0.719 . . . . 0.0 109.261 179.626 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.585 ' CD1' ' CD1' ' A' ' 58' ' ' ILE . 1.3 mp -57.91 -44.05 85.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.296 -0.878 . . . . 0.0 109.051 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.117 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.1 mp -69.76 -68.95 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.882 . . . . 0.0 109.874 -179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.491 ' HG2' ' HA ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -43.43 -27.82 0.3 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.169 -0.957 . . . . 0.0 109.584 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.476 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 10.3 mmtt -72.49 -58.66 3.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.179 -0.951 . . . . 0.0 108.931 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.638 ' HG3' HG23 ' A' ' 26' ' ' VAL . 1.1 tmm? -44.62 -45.72 9.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.335 -0.853 . . . . 0.0 108.911 179.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.124 HD11 ' CG2' ' B' ' 63' ' ' ILE . 2.5 mt -55.38 -49.29 72.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.546 -0.721 . . . . 0.0 109.409 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.06 33.9 1.84 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.256 -0.902 . . . . 0.0 109.574 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 p -105.04 -25.28 12.6 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.465 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -89.55 34.38 0.82 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.276 -0.89 . . . . 0.0 109.455 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 47.36 -149.41 0.14 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.0 109.447 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 47.7 -167.3 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.297 -0.877 . . . . 0.0 109.492 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.41 ' OXT' ' HD2' ' B' ' 60' ' ' LYS . 21.3 m-80 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.505 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 2.7 t -159.6 161.79 35.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.345 -0.847 . . . . 0.0 109.449 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.688 ' O ' ' HB3' ' B' ' 4' ' ' ALA . 1.9 t -107.95 -25.66 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.472 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.688 ' HB3' ' O ' ' B' ' 3' ' ' VAL . . . 75.4 -152.34 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.871 . . . . 0.0 109.507 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.653 HG22 ' O ' ' B' ' 4' ' ' ALA . 13.5 t 42.12 27.44 0.08 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 0.0 109.789 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.523 ' CG ' ' O ' ' B' ' 4' ' ' ALA . 0.0 OUTLIER -155.58 26.91 0.39 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.179 -0.951 . . . . 0.0 109.455 179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.605 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -136.63 109.53 7.63 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.251 -0.906 . . . . 0.0 109.536 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.409 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -115.62 156.28 26.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 108.97 179.638 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.411 ' HA ' ' OE2' ' B' ' 39' ' ' GLU . 43.1 m -44.66 102.35 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.149 -0.97 . . . . 0.0 109.322 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.499 ' HB2' ' CD ' ' B' ' 29' ' ' LYS . 75.9 mm-40 -53.01 -18.45 2.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.249 -0.907 . . . . 0.0 109.699 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.435 ' O ' ' C ' ' B' ' 12' ' ' LEU . 54.3 m -135.62 66.0 1.52 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.091 -1.006 . . . . 0.0 109.779 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.435 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.2 OUTLIER -44.81 -44.85 9.74 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.895 . . . . 0.0 108.881 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -118.38 119.46 34.68 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.473 HG21 HD22 ' B' ' 53' ' ' ASN . 0.5 OUTLIER -93.43 168.6 10.95 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.303 -0.873 . . . . 0.0 110.037 -179.297 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.509 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 6.9 mt -119.19 145.55 45.93 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.836 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.0 OUTLIER -43.97 -46.62 8.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.214 -0.929 . . . . 0.0 109.342 -179.89 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 1.012 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 151.36 -170.91 30.97 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.896 -1.282 . . . . 0.0 109.896 179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.932 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.4 pp -164.86 162.96 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.461 -1.023 . . . . 0.0 109.303 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.595 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -53.99 150.79 13.85 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.205 -0.935 . . . . 0.0 109.314 179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.2 Cg_endo -77.55 -3.9 14.08 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.554 2.17 . . . . 0.0 110.251 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 3.1 pttm -90.2 -24.19 21.07 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.316 -0.865 . . . . 0.0 109.128 179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.526 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 3.1 m-20 -83.21 -7.35 59.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.357 -0.84 . . . . 0.0 109.279 179.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.932 HD11 ' CD1' ' B' ' 18' ' ' ILE . 6.8 mt -104.13 162.1 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.237 -0.914 . . . . 0.0 110.152 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.566 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -135.1 -31.3 1.0 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.504 -0.748 . . . . 0.0 109.231 179.296 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.566 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.1 p -132.87 175.1 9.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.144 -0.973 . . . . 0.0 108.828 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.64 HG23 ' HG3' ' B' ' 66' ' ' MET . 46.4 t -149.66 115.82 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.042 -1.036 . . . . 0.0 109.919 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.568 ' O ' HD12 ' B' ' 41' ' ' ILE . 4.1 t-20 -111.84 110.79 21.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.303 -0.873 . . . . 0.0 109.2 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.856 HG22 HG13 ' B' ' 40' ' ' VAL . 3.1 t -117.14 113.67 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.0 109.766 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' B' ' 29' ' ' LYS . 0.4 OUTLIER -105.77 114.75 29.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 0.0 109.249 179.734 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.403 ' HB2' ' HD2' ' B' ' 31' ' ' PRO . 1.0 OUTLIER -55.18 167.38 0.69 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.309 -0.87 . . . . 0.0 109.461 -179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.435 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.0 Cg_endo -77.54 140.16 18.79 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.606 2.204 . . . . 0.0 110.435 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.84 -139.56 3.03 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.318 -1.513 . . . . 0.0 109.318 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -79.74 38.76 0.76 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.587 2.191 . . . . 0.0 110.91 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.605 ' CD2' HD22 ' B' ' 7' ' ' LEU . 3.8 p-80 -154.95 -38.86 0.09 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.026 -1.046 . . . . 0.0 109.359 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.41 ' SG ' ' CD ' ' B' ' 39' ' ' GLU . 1.8 t -133.52 124.75 27.52 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.231 -0.918 . . . . 0.0 109.244 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.54 42.47 0.96 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.876 . . . . 0.0 109.709 -179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.446 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 0.0 OUTLIER -170.74 148.46 2.95 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.12 -0.988 . . . . 0.0 109.618 -179.88 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 1.4 m -63.53 144.98 56.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.348 -0.845 . . . . 0.0 109.331 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.446 ' OE1' ' O ' ' B' ' 37' ' ' GLN . 0.5 OUTLIER -126.69 110.27 12.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.251 -0.905 . . . . 0.0 109.604 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.856 HG13 HG22 ' B' ' 28' ' ' VAL . 3.4 t -97.53 144.78 10.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.218 -0.926 . . . . 0.0 109.206 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.568 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.6 mt -132.41 153.08 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.586 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.931 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -137.61 120.26 16.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.271 -0.893 . . . . 0.0 109.208 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.527 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 2.3 m -89.28 102.63 15.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.999 -1.063 . . . . 0.0 108.709 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 88.8 mt -49.12 164.5 0.07 Allowed 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.416 -0.802 . . . . 0.0 109.651 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -79.04 6.77 8.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.37 -0.831 . . . . 0.0 109.983 -179.67 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.535 ' ND2' ' HD2' ' B' ' 48' ' ' ARG . 42.0 p30 -109.4 20.7 17.94 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.13 -0.982 . . . . 0.0 109.415 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.93 14.0 82.8 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.535 ' HD2' ' ND2' ' B' ' 46' ' ' ASN . 1.6 mtp-105 -103.51 171.66 7.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.205 -1.173 . . . . 0.0 109.499 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.467 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -141.95 151.18 42.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.327 -0.858 . . . . 0.0 109.367 179.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.509 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.23 123.0 8.65 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.284 -0.885 . . . . 0.0 109.078 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.411 ' SG ' HG12 ' B' ' 41' ' ' ILE . 15.5 m -79.83 141.16 36.45 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.161 -0.962 . . . . 0.0 109.262 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 1.012 HD22 ' HA2' ' B' ' 17' ' ' GLY . 12.3 mt -119.56 167.85 11.58 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.378 -0.826 . . . . 0.0 109.161 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.644 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.0 OUTLIER -98.13 119.2 62.5 Favored Pre-proline 0 C--N 1.299 -1.616 0 O-C-N 121.391 -0.818 . . . . 0.0 109.057 179.893 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.481 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.8 Cg_endo -75.11 -6.79 18.42 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.07 1.847 . . . . 0.0 110.317 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -84.77 -14.51 47.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.337 -0.852 . . . . 0.0 108.882 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -90.17 162.22 35.51 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.373 -0.83 . . . . 0.0 109.293 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.502 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -78.41 -37.68 0.68 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.612 2.208 . . . . 0.0 110.852 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.62 ' O ' HD13 ' B' ' 58' ' ' ILE . 0.2 OUTLIER -63.32 -48.02 89.3 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.045 -1.034 . . . . 0.0 108.975 -179.837 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.873 HG22 ' HB3' ' B' ' 52' ' ' LEU . 37.5 t -55.71 -48.61 77.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.504 -0.747 . . . . 0.0 109.044 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.3 OUTLIER -51.28 -33.65 29.49 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.322 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.502 ' HD2' ' O ' ' B' ' 57' ' ' PRO . 0.1 OUTLIER -72.82 -36.43 67.52 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.488 -0.758 . . . . 0.0 109.304 179.6 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.591 ' CD1' ' CD1' ' B' ' 58' ' ' ILE . 1.3 mp -57.89 -44.01 85.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.43 -0.794 . . . . 0.0 109.018 179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 1.124 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.1 mp -69.85 -68.89 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.358 -0.839 . . . . 0.0 109.829 -179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.485 ' HG2' ' O ' ' B' ' 60' ' ' LYS . 0.2 OUTLIER -43.51 -27.78 0.31 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.157 -0.965 . . . . 0.0 109.549 -179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.474 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 10.4 mmtt -72.5 -58.64 3.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 108.973 179.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.64 ' HG3' HG23 ' B' ' 26' ' ' VAL . 1.1 tmm? -44.66 -45.64 9.79 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.353 -0.842 . . . . 0.0 108.914 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.117 HD11 ' CG2' ' A' ' 63' ' ' ILE . 2.5 mt -55.44 -49.2 73.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.518 -0.739 . . . . 0.0 109.411 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -97.12 33.85 1.86 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.266 -0.896 . . . . 0.0 109.499 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 14.0 p -104.96 -25.28 12.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.252 -0.905 . . . . 0.0 109.433 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -89.52 34.31 0.82 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -0.896 . . . . 0.0 109.424 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 47.37 -149.43 0.14 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.319 -0.863 . . . . 0.0 109.449 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 47.71 -167.31 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.15 -0.969 . . . . 0.0 109.453 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . 0.423 ' OXT' ' HD2' ' A' ' 60' ' ' LYS . 21.4 m-80 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.506 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.09 -83.2 0.52 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.218 -0.926 . . . . 0.0 109.452 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.619 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 1.8 t -115.14 36.84 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 3' ' ' VAL . . . 71.55 147.46 0.08 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 20.9 m -147.39 -41.89 0.18 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.468 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -143.97 108.08 4.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.334 -0.854 . . . . 0.0 109.449 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.579 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -118.78 99.4 6.74 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.253 -0.904 . . . . 0.0 109.52 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.432 ' O ' ' C ' ' A' ' 9' ' ' CYS . 19.2 mtt180 -94.19 152.23 18.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.213 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 4.7 m -44.16 113.25 0.5 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.37 -12.66 15.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.369 -0.832 . . . . 0.0 109.765 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.461 ' SG ' HG13 ' A' ' 41' ' ' ILE . 70.8 m -135.2 60.71 1.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.119 -0.988 . . . . 0.0 109.873 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.525 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -45.52 -38.33 6.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.18 -0.95 . . . . 0.0 108.815 179.593 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -124.87 123.05 39.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.28 173.93 7.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 110.092 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.47 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 4.6 mt -129.53 145.81 51.42 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.644 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.3 tt0 -44.94 -45.67 10.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.078 -1.014 . . . . 0.0 109.202 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 1.037 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 139.87 156.14 6.82 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.772 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -129.19 157.53 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.338 -1.095 . . . . 0.0 109.254 179.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.605 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.95 151.92 0.39 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 109.38 179.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.4 Cg_endo -76.66 -1.71 11.85 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.473 2.115 . . . . 0.0 110.156 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.458 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 2.2 mtmm -90.26 -25.51 20.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.806 . . . . 0.0 109.0 179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 4.6 m-20 -82.37 -5.69 58.79 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.417 -0.802 . . . . 0.0 109.26 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.806 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 9.3 mt -107.52 145.36 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.27 -0.894 . . . . 0.0 110.114 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.555 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -117.49 -26.48 6.63 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.413 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.555 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -139.68 162.99 33.77 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.568 HG11 HG13 ' A' ' 63' ' ' ILE . 52.8 t -146.86 99.49 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.945 -1.097 . . . . 0.0 109.891 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 13.0 t30 -80.07 113.43 18.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.286 -0.884 . . . . 0.0 109.284 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.466 ' O ' ' CE ' ' B' ' 66' ' ' MET . 1.8 t -97.17 90.53 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.898 . . . . 0.0 109.432 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.51 ' HE3' ' NE2' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -94.94 105.68 17.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.264 -0.897 . . . . 0.0 109.475 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.453 ' HA ' HG23 ' A' ' 38' ' ' THR . 0.9 OUTLIER -59.65 167.13 2.7 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.352 -0.843 . . . . 0.0 109.43 179.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.472 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 36.1 Cg_endo -78.11 145.85 22.28 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.527 2.151 . . . . 0.0 110.418 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.14 -142.85 3.63 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.6 10.09 2.67 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.685 2.256 . . . . 0.0 111.013 179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.579 ' CD2' HD22 ' A' ' 7' ' ' LEU . 4.8 p-80 -126.8 -32.58 2.57 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.011 -1.056 . . . . 0.0 109.45 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -147.31 88.74 1.73 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.207 -0.933 . . . . 0.0 109.264 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.472 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -54.07 -18.85 4.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.33 -0.856 . . . . 0.0 109.699 -179.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.452 ' O ' ' OE1' ' A' ' 39' ' ' GLU . 1.5 mp0 -92.84 124.78 37.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.137 -0.977 . . . . 0.0 109.516 -179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.509 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 2.7 m -49.5 162.04 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.238 -0.914 . . . . 0.0 109.292 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.452 ' OE1' ' O ' ' A' ' 37' ' ' GLN . 1.3 mp0 -142.78 108.98 5.24 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.924 . . . . 0.0 109.663 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.092 ' CG1' HD11 ' A' ' 63' ' ' ILE . 57.3 t -100.62 95.12 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.278 -0.889 . . . . 0.0 109.147 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.478 HG13 ' SG ' ' A' ' 51' ' ' CYS . 2.6 mp -84.59 139.62 17.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.168 -0.958 . . . . 0.0 109.831 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.806 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -121.25 118.36 29.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -0.851 . . . . 0.0 109.133 179.641 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.616 HG22 ' O ' ' A' ' 43' ' ' THR . 1.1 m -89.07 97.36 11.16 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.972 -1.08 . . . . 0.0 108.668 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 90.8 mt -43.44 167.77 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.567 -0.708 . . . . 0.0 109.906 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.458 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.1 ptpt -81.29 7.96 10.21 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.841 . . . . 0.0 109.581 -179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.47 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.7 13.28 21.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.272 179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 86.99 -1.6 86.8 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.47 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 2.1 mtt-85 -87.88 168.07 13.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.191 -1.182 . . . . 0.0 109.392 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.418 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 2.0 mttt -134.26 155.17 50.66 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.913 . . . . 0.0 109.428 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.34 117.73 6.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.193 -0.942 . . . . 0.0 109.186 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.478 ' SG ' HG13 ' A' ' 41' ' ' ILE . 8.7 m -79.39 139.05 37.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.151 -0.968 . . . . 0.0 108.853 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.037 HD22 ' HA2' ' A' ' 17' ' ' GLY . 8.7 mt -121.16 167.85 12.22 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.148 -0.97 . . . . 0.0 109.588 -179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.677 ' O ' HG21 ' A' ' 59' ' ' VAL . 7.1 t-20 -100.47 119.25 59.33 Favored Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.401 -0.812 . . . . 0.0 109.215 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HG3' ' HB ' ' A' ' 38' ' ' THR . 32.7 Cg_endo -74.18 0.82 7.97 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.157 1.905 . . . . 0.0 110.595 -179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.555 ' HB3' ' OD1' ' A' ' 53' ' ' ASN . . . -90.54 -15.69 30.2 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.278 -0.889 . . . . 0.0 108.904 179.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.454 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.9 OUTLIER -90.28 164.21 28.36 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.313 -0.867 . . . . 0.0 109.455 -179.96 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.468 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.3 Cg_endo -77.78 -37.94 0.78 Allowed 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.687 2.258 . . . . 0.0 111.061 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.638 ' O ' HD13 ' A' ' 62' ' ' ILE . 16.0 tt -65.43 -46.87 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 120.991 -1.068 . . . . 0.0 109.124 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.877 HG22 ' HB3' ' A' ' 52' ' ' LEU . 34.0 t -55.37 -46.85 78.55 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.434 -0.792 . . . . 0.0 109.25 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 54' ' ' PRO . 18.1 mttt -57.74 -30.75 65.82 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.511 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -79.37 -24.81 42.41 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.048 -0.661 . . . . 0.0 109.511 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.638 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.6 mp -65.85 -43.59 93.11 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.092 HD11 ' CG1' ' A' ' 40' ' ' VAL . 1.6 mp -69.61 -62.94 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.547 -0.721 . . . . 0.0 109.214 179.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.707 ' OE2' HD13 ' B' ' 67' ' ' LEU . 1.3 mp0 -41.76 -48.5 4.27 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.437 -0.789 . . . . 0.0 109.793 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.54 ' CE ' ' HG3' ' A' ' 20' ' ' PRO . 2.8 mmtm -53.75 -59.27 4.83 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.372 -0.83 . . . . 0.0 109.342 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.465 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 1.4 mmm -43.52 -45.78 6.67 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.358 -0.839 . . . . 0.0 109.297 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.079 HD11 ' CG2' ' B' ' 63' ' ' ILE . 3.1 mt -55.67 -57.72 10.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.46 -0.775 . . . . 0.0 109.738 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.421 ' OD1' ' HD3' ' A' ' 71' ' ' LYS . 2.3 t30 -81.13 7.37 11.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.261 -0.899 . . . . 0.0 109.799 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 66' ' ' MET . 7.8 p -101.82 -12.34 18.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.217 -0.927 . . . . 0.0 109.384 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.468 ' HB2' ' OG1' ' B' ' 38' ' ' THR . 2.0 p30 -103.88 -12.9 16.6 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 109.506 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.421 ' HD3' ' OD1' ' A' ' 68' ' ' ASN . 15.4 pttt -76.3 -160.19 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.452 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' A' ' 73' ' ' ASN . 62.2 p -82.96 107.8 15.82 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.237 -0.914 . . . . 0.0 109.488 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' A' ' 72' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.482 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.494 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.08 -83.18 0.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.288 -0.883 . . . . 0.0 109.482 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.635 ' O ' ' HB3' ' B' ' 4' ' ' ALA . 1.8 t -115.17 36.84 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.261 -0.899 . . . . 0.0 109.478 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.635 ' HB3' ' O ' ' B' ' 3' ' ' VAL . . . 71.63 147.42 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.279 -0.888 . . . . 0.0 109.477 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 21.1 m -147.37 -41.86 0.18 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.504 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -144.05 108.01 4.72 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.264 -0.897 . . . . 0.0 109.494 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.58 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -118.77 99.36 6.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.266 -0.897 . . . . 0.0 109.496 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.427 ' O ' ' C ' ' B' ' 9' ' ' CYS . 19.2 mtt180 -94.16 152.24 18.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.341 -0.849 . . . . 0.0 109.228 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.527 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 4.6 m -44.18 113.21 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -0.943 . . . . 0.0 109.393 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -12.7 14.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.709 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.467 ' SG ' HG13 ' B' ' 41' ' ' ILE . 71.0 m -135.25 60.78 1.68 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.958 . . . . 0.0 109.913 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.56 -38.2 6.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.107 -0.995 . . . . 0.0 108.912 179.524 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -124.95 122.98 38.89 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.374 -0.829 . . . . 0.0 108.843 179.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -96.27 173.98 7.12 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.213 -0.929 . . . . 0.0 110.153 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.467 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 4.5 mt -129.51 145.82 51.41 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.651 ' O ' HG23 ' B' ' 59' ' ' VAL . 2.2 tt0 -44.92 -45.65 10.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.159 -0.963 . . . . 0.0 109.249 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 1.003 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 139.84 156.18 6.84 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.989 -1.245 . . . . 0.0 109.989 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.761 HD13 ' N ' ' B' ' 18' ' ' ILE . 0.2 OUTLIER -129.25 157.56 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.345 -1.091 . . . . 0.0 109.21 179.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.6 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -43.0 152.01 0.39 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 0.0 109.39 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.7 Cg_endo -76.75 -1.73 11.89 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.442 2.095 . . . . 0.0 110.19 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.462 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 2.2 mtmm -90.19 -25.6 20.55 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.273 -0.892 . . . . 0.0 108.997 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 4.7 m-20 -82.33 -5.67 58.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.413 -0.804 . . . . 0.0 109.318 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.807 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 9.3 mt -107.43 145.39 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -0.877 . . . . 0.0 110.089 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.551 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -117.5 -26.46 6.63 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.269 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.551 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -139.6 163.02 33.66 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.567 HG11 HG13 ' B' ' 63' ' ' ILE . 52.5 t -146.86 99.38 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.081 -1.012 . . . . 0.0 109.931 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 13.2 t30 -80.01 113.43 18.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.224 -0.922 . . . . 0.0 109.253 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.455 ' O ' ' CE ' ' A' ' 66' ' ' MET . 1.8 t -97.15 90.48 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.515 ' HE3' ' NE2' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -94.92 105.67 17.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.548 179.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.447 ' HA ' HG23 ' B' ' 38' ' ' THR . 0.9 OUTLIER -59.59 167.14 2.64 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.308 -0.87 . . . . 0.0 109.422 179.966 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' B' ' 35' ' ' CYS . 36.3 Cg_endo -78.03 145.8 22.44 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.659 2.239 . . . . 0.0 110.419 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -150.19 -142.88 3.64 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.46 9.82 2.73 Favored 'Trans proline' 0 C--N 1.31 -1.447 0 C-N-CA 122.695 2.263 . . . . 0.0 110.983 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.58 ' CD2' HD22 ' B' ' 7' ' ' LEU . 4.6 p-80 -126.68 -32.44 2.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.1 -1.0 . . . . 0.0 109.42 179.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.471 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -147.38 88.7 1.73 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 109.213 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -54.03 -18.94 4.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 0.0 109.705 -179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.456 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 1.5 mp0 -92.67 124.62 36.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.13 -0.981 . . . . 0.0 109.596 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.494 ' HB ' ' HG3' ' B' ' 54' ' ' PRO . 2.7 m -49.47 162.0 0.17 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.912 . . . . 0.0 109.238 179.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.456 ' OE1' ' O ' ' B' ' 37' ' ' GLN . 1.3 mp0 -142.74 108.91 5.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.117 -0.989 . . . . 0.0 109.706 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 1.095 ' CG1' HD11 ' B' ' 63' ' ' ILE . 57.4 t -100.56 95.12 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -0.912 . . . . 0.0 109.247 179.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.467 HG13 ' SG ' ' B' ' 11' ' ' CYS . 2.6 mp -84.57 139.63 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -0.892 . . . . 0.0 109.875 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.807 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -121.24 118.46 29.65 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.404 -0.81 . . . . 0.0 109.134 179.638 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.619 HG22 ' O ' ' B' ' 43' ' ' THR . 1.1 m -89.18 97.38 11.17 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.955 -1.091 . . . . 0.0 108.665 -179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 90.9 mt -43.49 167.83 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.61 -0.681 . . . . 0.0 109.878 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.1 ptpt -81.34 7.95 10.34 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.362 -0.836 . . . . 0.0 109.599 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.49 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -111.72 13.38 21.12 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -0.93 . . . . 0.0 109.288 179.812 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.0 -1.66 86.81 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.49 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 2.1 mtt-85 -87.78 168.11 13.23 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.125 -1.221 . . . . 0.0 109.436 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 2.0 mttt -134.3 155.24 50.56 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.463 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.467 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.37 117.75 6.06 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.348 -0.845 . . . . 0.0 109.17 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.466 ' SG ' HG13 ' B' ' 41' ' ' ILE . 8.6 m -79.45 139.02 37.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 0.0 108.852 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 1.003 HD22 ' HA2' ' B' ' 17' ' ' GLY . 8.7 mt -121.1 167.85 12.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.17 -0.956 . . . . 0.0 109.629 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.67 ' O ' HG21 ' B' ' 59' ' ' VAL . 7.1 t-20 -100.45 119.31 59.22 Favored Pre-proline 0 C--N 1.298 -1.631 0 O-C-N 121.51 -0.744 . . . . 0.0 109.201 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.494 ' HG3' ' HB ' ' B' ' 38' ' ' THR . 32.9 Cg_endo -74.25 0.86 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.077 1.851 . . . . 0.0 110.582 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.565 ' HB3' ' OD1' ' B' ' 53' ' ' ASN . . . -90.64 -15.64 30.08 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.212 -0.93 . . . . 0.0 108.863 179.258 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.452 ' OG ' HG22 ' B' ' 58' ' ' ILE . 0.9 OUTLIER -90.18 164.21 28.59 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.46 -0.775 . . . . 0.0 109.498 179.938 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.462 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.77 -38.0 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.673 2.249 . . . . 0.0 111.055 -179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.635 ' O ' HD13 ' B' ' 62' ' ' ILE . 16.0 tt -65.4 -46.9 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 120.997 -1.065 . . . . 0.0 109.112 -179.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.892 HG22 ' HB3' ' B' ' 52' ' ' LEU . 33.6 t -55.41 -46.82 78.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.412 -0.805 . . . . 0.0 109.221 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.484 ' HE2' ' O ' ' B' ' 54' ' ' PRO . 18.1 mttt -57.64 -30.86 65.73 Favored 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.534 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.7 OUTLIER -79.33 -24.86 42.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.515 -0.741 . . . . 0.0 109.457 -179.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.635 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.6 mp -65.86 -43.58 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 1.095 HD11 ' CG1' ' B' ' 40' ' ' VAL . 1.6 mp -69.6 -63.02 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.549 -0.72 . . . . 0.0 109.104 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.709 ' OE2' HD13 ' A' ' 67' ' ' LEU . 1.3 mp0 -41.73 -48.48 4.22 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.423 -0.798 . . . . 0.0 109.826 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.531 ' CE ' ' HG3' ' B' ' 20' ' ' PRO . 2.8 mmtm -53.69 -59.42 4.63 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.88 . . . . 0.0 109.233 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.466 ' CE ' ' O ' ' A' ' 28' ' ' VAL . 1.4 mmm -43.44 -45.77 6.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.336 -0.853 . . . . 0.0 109.37 179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.089 HD11 ' CG2' ' A' ' 63' ' ' ILE . 3.1 mt -55.69 -57.68 10.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.516 -0.74 . . . . 0.0 109.753 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.426 ' ND2' ' HE2' ' B' ' 71' ' ' LYS . 2.2 t30 -81.07 7.24 11.39 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.187 -0.946 . . . . 0.0 109.804 -179.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.461 ' OG ' ' HA ' ' B' ' 66' ' ' MET . 7.6 p -101.76 -12.39 18.37 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.168 -0.958 . . . . 0.0 109.443 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.459 ' HB2' ' OG1' ' A' ' 38' ' ' THR . 2.0 p30 -103.85 -12.89 16.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.232 -0.917 . . . . 0.0 109.445 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.426 ' HE2' ' ND2' ' B' ' 68' ' ' ASN . 15.4 pttt -76.28 -160.26 0.14 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.3 -0.875 . . . . 0.0 109.472 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.421 ' O ' ' CB ' ' B' ' 73' ' ' ASN . 62.3 p -82.93 107.8 15.79 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 0.0 109.463 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . 0.421 ' CB ' ' O ' ' B' ' 72' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.521 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.321 0.582 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.57 10.66 11.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.188 -0.945 . . . . 0.0 109.49 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.02 70.12 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.476 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.79 -149.28 0.44 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 0.0 109.516 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 19.1 p -127.89 73.21 1.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.208 -0.933 . . . . 0.0 109.488 179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.09 41.96 1.0 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.473 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.543 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -116.97 98.1 6.3 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.231 -0.918 . . . . 0.0 109.534 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.1 OUTLIER -80.49 145.66 31.75 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.331 -0.856 . . . . 0.0 109.076 179.771 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.947 ' HB2' HD22 ' A' ' 12' ' ' LEU . 4.5 m -44.01 110.32 0.2 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.386 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.539 ' NE2' ' HD2' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -43.08 -26.83 0.17 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.382 -0.824 . . . . 0.0 109.578 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.469 ' SG ' HG13 ' A' ' 41' ' ' ILE . 56.4 m -127.14 65.11 1.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.48 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.947 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -43.76 -37.17 2.58 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.258 -0.901 . . . . 0.0 109.027 179.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.497 ' O ' HG23 ' A' ' 14' ' ' THR . 15.1 pt20 -121.65 -174.98 2.99 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.676 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -160.09 151.44 19.58 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.143 -0.973 . . . . 0.0 109.778 179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.527 HD12 ' HB1' ' A' ' 50' ' ' ALA . 7.2 mt -114.0 144.61 42.81 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 0.0 108.923 179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.53 ' O ' ' CG2' ' A' ' 58' ' ' ILE . 1.1 tt0 -44.05 -26.79 0.32 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 0.0 109.293 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 1.067 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 142.41 -164.03 27.04 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.891 -1.284 . . . . 0.0 109.891 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.835 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -170.37 162.61 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.376 -1.073 . . . . 0.0 109.534 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.631 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 3.3 t60 -44.84 146.61 1.29 Allowed Pre-proline 0 C--N 1.303 -1.438 0 N-CA-C 108.801 -0.815 . . . . 0.0 108.801 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.631 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.6 Cg_endo -79.1 -17.01 12.11 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.366 2.044 . . . . 0.0 109.524 -179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 7.7 mmtm -90.4 -19.35 24.04 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.511 ' O ' ' HA ' ' A' ' 44' ' ' LEU . 16.7 m-20 -78.2 -14.62 59.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.354 -0.841 . . . . 0.0 109.033 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.948 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 11.0 mt -91.66 168.05 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.513 -0.742 . . . . 0.0 110.1 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.583 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -135.59 -40.79 0.7 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.471 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.459 ' OG ' ' HB ' ' A' ' 43' ' ' THR . 6.4 p -123.58 172.57 8.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.532 ' CG1' HG13 ' A' ' 63' ' ' ILE . 97.3 t -144.25 88.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.0 109.741 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.481 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 4.0 t-20 -84.77 108.41 17.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.36 179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.884 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -108.6 91.77 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.281 -0.887 . . . . 0.0 109.439 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.539 ' HD2' ' NE2' ' A' ' 10' ' ' GLN . 0.7 OUTLIER -92.39 128.15 38.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.33 -0.857 . . . . 0.0 109.521 179.944 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.439 ' CB ' ' HD2' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -76.91 171.62 11.9 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 109.445 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.513 ' HB3' ' N ' ' A' ' 37' ' ' GLN . 36.1 Cg_endo -78.03 132.4 11.62 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.606 2.204 . . . . 0.0 110.465 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.46 -144.23 5.0 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.85 11.94 2.11 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.711 2.274 . . . . 0.0 111.041 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.543 ' CB ' ' HB3' ' A' ' 7' ' ' LEU . 5.9 p-80 -128.99 -33.5 1.98 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.036 -1.04 . . . . 0.0 109.558 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -129.42 116.99 19.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.191 -0.943 . . . . 0.0 109.402 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.3 45.8 1.22 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 109.465 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.513 ' N ' ' HB3' ' A' ' 31' ' ' PRO . 0.9 OUTLIER -173.09 141.07 0.93 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.223 -0.923 . . . . 0.0 109.467 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 2.3 m -58.24 153.51 15.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.271 -0.893 . . . . 0.0 109.433 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.464 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 15.4 pt-20 -142.12 107.9 5.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -0.894 . . . . 0.0 109.572 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.007 HG11 HD11 ' A' ' 63' ' ' ILE . 55.5 t -90.77 153.45 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.241 -0.912 . . . . 0.0 109.374 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.477 ' HB ' ' HB3' ' A' ' 27' ' ' ASN . 3.6 mt -140.67 144.68 26.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.182 -0.949 . . . . 0.0 109.626 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.948 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -131.71 119.95 22.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.373 -0.83 . . . . 0.0 109.119 179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 7.9 m -89.45 97.98 11.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.996 -1.065 . . . . 0.0 109.09 -179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 85.4 mt -43.75 163.5 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.448 -0.783 . . . . 0.0 109.736 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -80.05 9.12 5.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.0 109.931 -179.757 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.58 27.52 9.57 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.086 -1.009 . . . . 0.0 109.217 179.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.3 9.42 72.68 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.512 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 3.4 mtt180 -99.6 163.21 12.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.207 -1.172 . . . . 0.0 109.53 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.54 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.2 OUTLIER -137.68 151.83 48.65 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.339 -0.851 . . . . 0.0 109.257 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.527 ' HB1' HD12 ' A' ' 15' ' ' LEU . . . -150.15 127.99 11.76 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.256 -0.903 . . . . 0.0 109.395 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . . . . . . . . . 4.6 m -79.6 151.83 30.4 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.236 -0.915 . . . . 0.0 109.055 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.067 HD22 ' HA2' ' A' ' 17' ' ' GLY . 19.3 mt -127.07 166.72 17.07 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.315 -0.866 . . . . 0.0 109.326 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.629 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.1 t-20 -93.53 115.87 65.67 Favored Pre-proline 0 C--N 1.299 -1.594 0 O-C-N 121.404 -0.81 . . . . 0.0 109.079 179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.54 -1.21 10.75 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.106 1.871 . . . . 0.0 110.413 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.2 -12.12 36.28 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.367 -0.833 . . . . 0.0 108.835 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -90.13 160.91 39.21 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.443 -0.786 . . . . 0.0 109.428 179.954 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.511 ' O ' ' HD2' ' A' ' 61' ' ' LYS . 35.6 Cg_endo -77.5 -31.16 3.56 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.661 2.241 . . . . 0.0 110.547 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 59' ' ' VAL . 4.1 tt -72.35 -45.16 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.083 -1.011 . . . . 0.0 109.288 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.045 ' HA ' HD12 ' A' ' 62' ' ' ILE . 19.7 t -56.96 -48.53 81.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.511 -0.743 . . . . 0.0 109.294 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.487 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 0.2 OUTLIER -61.09 -32.06 71.73 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.186 -0.946 . . . . 0.0 108.552 179.613 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.545 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -77.41 -19.14 56.57 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.528 -0.733 . . . . 0.0 109.161 179.878 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.045 HD12 ' HA ' ' A' ' 59' ' ' VAL . 16.2 mt -75.16 -38.84 42.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.007 HD11 HG11 ' A' ' 40' ' ' VAL . 1.9 mp -72.68 -55.98 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.908 . . . . 0.0 109.069 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.532 ' CG ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -58.79 -38.39 78.46 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.185 -0.947 . . . . 0.0 109.283 179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 61' ' ' LYS . 8.2 tttp -59.57 -40.94 89.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.302 -0.874 . . . . 0.0 109.173 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.523 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.3 OUTLIER -61.47 -46.55 89.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.45 -0.782 . . . . 0.0 109.211 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.606 ' CD1' HG22 ' B' ' 63' ' ' ILE . 0.2 OUTLIER -44.11 -51.65 7.84 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.365 -0.835 . . . . 0.0 109.395 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.67 -30.32 66.89 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.269 -0.894 . . . . 0.0 109.623 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.448 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p -56.95 -19.49 18.33 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.294 -0.879 . . . . 0.0 109.497 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -83.29 -83.72 0.14 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.254 -0.904 . . . . 0.0 109.453 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 18.1 tptt -154.64 127.26 8.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.233 -0.917 . . . . 0.0 109.527 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.6 t -73.85 -82.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.513 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.911 -1.042 . . . . 0.0 109.448 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.61 10.65 11.81 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.36 -0.838 . . . . 0.0 109.494 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 1.8 t -103.1 70.18 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 109.456 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -108.89 -149.27 0.44 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 18.9 p -127.91 73.21 1.45 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.422 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -87.1 41.96 1.0 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.258 -0.902 . . . . 0.0 109.515 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.549 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -116.89 97.95 6.23 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.915 . . . . 0.0 109.547 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.1 OUTLIER -80.37 145.56 31.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.23 -0.919 . . . . 0.0 109.165 179.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.923 ' HB2' HD22 ' B' ' 12' ' ' LEU . 4.5 m -43.98 110.21 0.2 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -0.917 . . . . 0.0 109.449 -179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.539 ' NE2' ' HD2' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -43.0 -26.79 0.15 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.402 -0.811 . . . . 0.0 109.586 -179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' B' ' 41' ' ' ILE . 56.3 m -127.18 65.02 1.31 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.275 -0.89 . . . . 0.0 109.447 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.923 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -43.75 -37.11 2.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.276 -0.89 . . . . 0.0 109.019 179.831 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . 0.499 ' O ' HG23 ' B' ' 14' ' ' THR . 15.0 pt20 -121.67 -174.97 2.99 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.379 -0.826 . . . . 0.0 108.843 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.678 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -160.1 151.45 19.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.073 -1.017 . . . . 0.0 109.789 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.536 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.2 mt -114.05 144.63 42.8 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.436 -0.79 . . . . 0.0 108.874 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.524 ' O ' ' CG2' ' B' ' 58' ' ' ILE . 1.1 tt0 -44.03 -26.8 0.32 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.246 -0.909 . . . . 0.0 109.353 -179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 1.028 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 142.46 -163.95 27.07 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.837 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -170.42 162.66 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.419 -1.048 . . . . 0.0 109.451 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.624 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 3.4 t60 -44.95 146.67 1.3 Allowed Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.624 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -79.15 -16.98 12.06 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.327 2.018 . . . . 0.0 109.452 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 7.7 mmtm -90.42 -19.38 23.99 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.507 ' O ' ' HA ' ' B' ' 44' ' ' LEU . 16.7 m-20 -78.25 -14.57 59.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.347 -0.845 . . . . 0.0 109.002 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.946 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 10.9 mt -91.68 168.01 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.439 -0.788 . . . . 0.0 110.129 -179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.593 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.1 OUTLIER -135.55 -40.79 0.71 Allowed 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 179.523 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.459 ' OG ' ' HB ' ' B' ' 43' ' ' THR . 6.4 p -123.54 172.51 8.7 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.533 ' CG1' HG13 ' B' ' 63' ' ' ILE . 97.2 t -144.23 88.1 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.142 -0.974 . . . . 0.0 109.719 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.499 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 4.0 t-20 -84.77 108.36 17.42 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.26 -0.9 . . . . 0.0 109.393 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.872 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -108.58 91.85 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.517 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.539 ' HD2' ' NE2' ' B' ' 10' ' ' GLN . 0.7 OUTLIER -92.51 128.1 38.24 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.221 -0.925 . . . . 0.0 109.463 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.443 ' CB ' ' HD2' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -76.8 171.59 11.93 Favored Pre-proline 0 N--CA 1.488 1.453 0 O-C-N 121.26 -0.9 . . . . 0.0 109.466 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.509 ' HB3' ' N ' ' B' ' 37' ' ' GLN . 36.0 Cg_endo -78.02 132.44 11.66 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.658 2.239 . . . . 0.0 110.391 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -134.54 -144.23 5.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.95 12.01 2.12 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.693 2.262 . . . . 0.0 111.051 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.549 ' CB ' ' HB3' ' B' ' 7' ' ' LEU . 5.8 p-80 -129.0 -33.46 1.98 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 109.614 179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 3.2 t -129.4 116.95 19.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.244 -0.91 . . . . 0.0 109.416 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -85.31 45.92 1.24 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.512 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.509 ' N ' ' HB3' ' B' ' 31' ' ' PRO . 0.9 OUTLIER -173.19 141.01 0.91 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.223 -0.923 . . . . 0.0 109.436 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . . . . . . . . . 2.2 m -58.14 153.55 14.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.306 -0.871 . . . . 0.0 109.503 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.457 ' HB2' ' SG ' ' B' ' 11' ' ' CYS . 15.3 pt-20 -142.19 107.92 5.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 1.044 HG11 HD11 ' B' ' 63' ' ' ILE . 55.7 t -90.85 153.36 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.256 -0.903 . . . . 0.0 109.34 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' B' ' 27' ' ' ASN . 3.6 mt -140.54 144.77 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.255 -0.903 . . . . 0.0 109.646 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.946 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -131.77 119.92 21.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.309 -0.869 . . . . 0.0 109.145 179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 7.9 m -89.41 97.92 11.47 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.015 -1.053 . . . . 0.0 109.095 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.513 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 85.5 mt -43.77 163.53 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.397 0 O-C-N 121.343 -0.848 . . . . 0.0 109.738 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -80.0 9.01 5.93 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.354 -0.841 . . . . 0.0 109.857 -179.685 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.513 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.46 27.43 9.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.127 -0.983 . . . . 0.0 109.215 179.739 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.33 9.43 72.81 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 -179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.513 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 3.4 mtt180 -99.56 163.2 12.6 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -1.174 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.529 ' N ' ' CD ' ' B' ' 49' ' ' LYS . 0.2 OUTLIER -137.7 151.89 48.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 0.0 109.219 179.804 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.536 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.23 127.98 11.69 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.288 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . . . . . . . . . 4.7 m -79.58 151.86 30.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.93 . . . . 0.0 109.077 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 1.028 HD22 ' HA2' ' B' ' 17' ' ' GLY . 19.3 mt -127.15 166.65 17.27 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.275 -0.891 . . . . 0.0 109.326 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.636 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.2 t-20 -93.43 115.91 65.72 Favored Pre-proline 0 C--N 1.301 -1.54 0 O-C-N 121.409 -0.807 . . . . 0.0 109.106 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -74.54 -1.24 10.79 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.11 1.873 . . . . 0.0 110.401 -179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -91.13 -12.18 36.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 108.867 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' B' ' 53' ' ' ASN . 1.0 OUTLIER -90.11 160.94 39.23 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.402 -0.812 . . . . 0.0 109.415 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.505 ' O ' ' HD2' ' B' ' 61' ' ' LYS . 36.1 Cg_endo -77.42 -31.27 3.56 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.584 2.189 . . . . 0.0 110.588 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.606 HG23 ' N ' ' B' ' 59' ' ' VAL . 4.1 tt -72.28 -45.16 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.032 -1.043 . . . . 0.0 109.37 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 1.0 ' HA ' HD12 ' B' ' 62' ' ' ILE . 19.6 t -56.88 -48.58 81.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.435 -0.791 . . . . 0.0 109.3 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.473 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 0.2 OUTLIER -61.14 -31.99 71.7 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.147 -0.97 . . . . 0.0 108.536 179.669 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.539 ' HD2' ' N ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -77.51 -19.1 56.35 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.922 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 1.0 HD12 ' HA ' ' B' ' 59' ' ' VAL . 16.3 mt -75.23 -38.74 41.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 1.044 HD11 HG11 ' B' ' 40' ' ' VAL . 1.9 mp -72.75 -56.04 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.367 -0.833 . . . . 0.0 108.975 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.533 ' CG ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -58.77 -38.42 78.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.3 -179.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' B' ' 61' ' ' LYS . 8.2 tttp -59.45 -41.07 88.81 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.232 -0.918 . . . . 0.0 109.157 179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.53 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.3 OUTLIER -61.37 -46.6 89.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.308 -0.87 . . . . 0.0 109.22 179.709 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.606 ' CD1' HG22 ' A' ' 63' ' ' ILE . 0.2 OUTLIER -44.0 -51.73 7.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.451 -0.781 . . . . 0.0 109.396 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -70.64 -30.33 66.94 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.352 -0.842 . . . . 0.0 109.571 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . . . . . . . . . 1.2 p -57.01 -19.5 18.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.457 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -83.28 -83.63 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.217 -0.927 . . . . 0.0 109.536 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 18.2 tptt -154.71 127.29 8.0 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.211 -0.931 . . . . 0.0 109.501 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.6 t -73.86 -82.55 0.06 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.246 -0.909 . . . . 0.0 109.493 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.9 -1.048 . . . . 0.0 109.464 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.662 ' O ' HG12 ' A' ' 3' ' ' VAL . 38.4 p -83.02 -154.69 0.14 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -0.906 . . . . 0.0 109.401 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.662 HG12 ' O ' ' A' ' 2' ' ' SER . 7.9 p 41.84 27.84 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.379 -0.826 . . . . 0.0 109.712 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.427 ' N ' ' O ' ' A' ' 2' ' ' SER . . . -160.67 160.48 31.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.359 -0.838 . . . . 0.0 109.412 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -167.31 26.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.285 -0.884 . . . . 0.0 109.517 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -128.59 -145.33 0.3 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.222 -0.923 . . . . 0.0 109.176 179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.596 ' HB3' ' CG ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -164.74 123.15 1.74 Allowed 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.353 -0.842 . . . . 0.0 109.649 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -112.18 149.74 31.81 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.333 -0.855 . . . . 0.0 108.909 179.564 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.403 ' C ' ' O ' ' A' ' 8' ' ' ARG . 89.0 m -44.5 95.41 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.115 -0.991 . . . . 0.0 109.385 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.552 ' HB2' ' CD ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -47.98 -22.79 0.65 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.337 -0.852 . . . . 0.0 109.753 -179.923 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.421 ' O ' ' C ' ' A' ' 12' ' ' LEU . 63.0 m -126.45 65.2 1.25 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.9 . . . . 0.0 109.872 -179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.421 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.2 OUTLIER -44.59 -43.74 8.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 108.866 179.459 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -122.97 124.86 44.12 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.488 HG22 ' O ' ' A' ' 52' ' ' LEU . 0.3 OUTLIER -96.44 167.36 11.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.203 -0.936 . . . . 0.0 110.014 -179.437 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.542 ' CD1' ' HB1' ' A' ' 50' ' ' ALA . 7.5 mt -118.92 146.27 45.08 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.617 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.2 OUTLIER -44.21 -41.28 5.69 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.223 -0.923 . . . . 0.0 109.281 -179.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.991 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 147.51 -164.33 28.75 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.952 ' CD1' HD11 ' A' ' 23' ' ' ILE . 1.3 pp -171.11 163.72 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.43 -1.041 . . . . 0.0 109.197 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.584 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -54.64 149.57 21.22 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.371 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.584 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -77.23 -4.11 14.43 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.502 2.135 . . . . 0.0 110.213 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.486 ' HG2' ' HB3' ' A' ' 19' ' ' HIS . 8.4 pttt -90.29 -24.03 21.02 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.339 -0.851 . . . . 0.0 109.118 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.521 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 2.6 m-20 -82.92 -5.5 59.07 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.282 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.952 HD11 ' CD1' ' A' ' 18' ' ' ILE . 9.2 mt -105.99 145.96 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 110.104 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.553 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -119.13 -25.42 6.18 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.553 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -143.0 -179.51 6.41 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.369 -0.832 . . . . 0.0 109.122 179.627 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 25' ' ' SER . 47.0 t -156.76 155.6 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.994 -1.066 . . . . 0.0 109.911 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' A' ' 41' ' ' ILE . 2.6 t-20 -138.71 114.14 9.66 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.405 -0.809 . . . . 0.0 109.266 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.47 108.47 25.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.193 -0.942 . . . . 0.0 109.471 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.552 ' CD ' ' HB2' ' A' ' 10' ' ' GLN . 4.2 ptmm? -113.39 108.33 17.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.27 -0.893 . . . . 0.0 109.47 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.414 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.0 OUTLIER -59.83 163.94 6.66 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.281 -0.887 . . . . 0.0 109.377 -179.957 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.51 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.8 Cg_endo -77.58 152.39 29.59 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.628 2.219 . . . . 0.0 110.336 179.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.25 -137.06 2.12 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.516 ' HD2' ' CE1' ' A' ' 34' ' ' HIS . 35.9 Cg_endo -77.56 8.17 3.48 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.515 2.144 . . . . 0.0 110.758 179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.596 ' CG ' ' HB3' ' A' ' 7' ' ' LEU . 2.5 p-80 -125.6 -24.34 3.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.023 -1.048 . . . . 0.0 109.733 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.51 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 1.8 t -160.06 107.31 1.63 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.049 -1.032 . . . . 0.0 109.305 179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.7 -5.59 26.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.269 -0.895 . . . . 0.0 109.69 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.445 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 2.2 mp0 -109.17 124.74 51.32 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.157 -0.964 . . . . 0.0 109.521 -179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.73 HG21 ' CB ' ' B' ' 70' ' ' ASP . 1.7 m -48.26 158.3 0.27 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -0.895 . . . . 0.0 109.293 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.515 ' HG3' ' NZ ' ' A' ' 29' ' ' LYS . 25.7 mm-40 -139.93 107.36 5.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.274 -0.891 . . . . 0.0 109.65 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.715 HG11 HD11 ' A' ' 63' ' ' ILE . 10.3 t -92.52 151.99 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.253 -0.904 . . . . 0.0 109.179 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.48 ' HA ' ' HA ' ' A' ' 51' ' ' CYS . 3.2 mt -140.19 156.13 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.113 -0.992 . . . . 0.0 109.883 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.759 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -142.65 117.87 10.15 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.418 -0.801 . . . . 0.0 109.015 179.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.595 HG22 ' O ' ' A' ' 43' ' ' THR . 1.2 m -89.11 96.03 10.56 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.982 -1.074 . . . . 0.0 108.736 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 89.6 mt -42.32 165.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.586 -0.696 . . . . 0.0 109.891 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -79.52 7.22 8.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.339 -0.851 . . . . 0.0 109.842 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.41 24.0 13.0 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.139 -0.976 . . . . 0.0 109.22 179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.36 -0.11 65.01 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.516 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 72.5 mtt85 -88.57 162.27 16.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.168 -1.195 . . . . 0.0 109.397 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.525 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 1.4 mptt -135.55 151.23 50.11 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.167 -0.958 . . . . 0.0 109.47 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.542 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.25 123.43 8.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.349 -0.844 . . . . 0.0 109.05 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 10.0 m -79.59 142.54 35.57 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.057 -1.027 . . . . 0.0 109.079 179.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.133 HD13 HD13 ' A' ' 62' ' ' ILE . 14.3 mt -120.43 167.74 12.04 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.243 -0.911 . . . . 0.0 109.62 -179.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.673 ' O ' HG21 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -99.57 122.62 50.86 Favored Pre-proline 0 C--N 1.299 -1.587 0 O-C-N 121.484 -0.76 . . . . 0.0 109.047 -179.911 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.455 ' O ' ' HE2' ' A' ' 60' ' ' LYS . 33.2 Cg_endo -75.11 -3.53 14.06 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.079 1.852 . . . . 0.0 110.354 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.59 -12.4 42.77 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.24 -0.913 . . . . 0.0 108.919 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -89.98 163.09 33.45 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.438 -0.789 . . . . 0.0 109.394 179.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.68 -38.98 0.57 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.696 2.264 . . . . 0.0 110.784 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.589 HG23 ' N ' ' A' ' 59' ' ' VAL . 20.6 tt -65.16 -45.92 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.226 -0.921 . . . . 0.0 109.346 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.052 ' HA ' HD12 ' A' ' 62' ' ' ILE . 44.7 t -57.42 -45.6 85.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.388 -0.82 . . . . 0.0 109.333 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.476 ' HG3' ' O ' ' A' ' 56' ' ' SER . 7.4 mttt -59.68 -29.53 68.14 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' O ' ' CG ' ' A' ' 65' ' ' LYS . 7.0 mmmm -79.53 -23.61 42.75 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.133 HD13 HD13 ' A' ' 52' ' ' LEU . 29.2 mt -72.1 -36.63 57.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.54 -0.725 . . . . 0.0 109.303 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.715 HD11 HG11 ' A' ' 40' ' ' VAL . 2.2 mp -75.87 -51.14 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -0.882 . . . . 0.0 109.752 -179.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.482 ' OE2' ' HE3' ' A' ' 61' ' ' LYS . 9.4 pt-20 -65.8 -29.0 69.42 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.035 -1.04 . . . . 0.0 109.347 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.517 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 4.4 mmtt -69.47 -46.11 67.43 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.307 -0.871 . . . . 0.0 108.994 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.409 ' O ' ' C ' ' A' ' 67' ' ' LEU . 0.3 OUTLIER -56.12 -45.29 79.57 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.438 -0.789 . . . . 0.0 109.076 179.532 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.591 ' CD1' ' CG2' ' B' ' 63' ' ' ILE . 0.3 OUTLIER -44.62 -51.85 8.7 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.421 -0.8 . . . . 0.0 109.478 179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.409 ' O ' ' C ' ' A' ' 69' ' ' SER . 6.8 t-20 -64.86 -37.29 87.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.403 -0.81 . . . . 0.0 109.476 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 68' ' ' ASN . 1.1 p -44.14 -26.59 0.32 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.247 -0.908 . . . . 0.0 109.478 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.745 ' CB ' HG21 ' B' ' 38' ' ' THR . 1.6 p30 -111.88 82.51 1.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.261 -0.899 . . . . 0.0 109.476 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -127.94 86.44 2.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.235 -0.916 . . . . 0.0 109.476 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.06 157.75 15.76 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.31 -0.869 . . . . 0.0 109.444 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.425 ' N ' ' ND2' ' A' ' 73' ' ' ASN . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.484 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.655 ' O ' HG12 ' B' ' 3' ' ' VAL . 38.8 p -83.02 -154.69 0.14 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.283 -0.886 . . . . 0.0 109.434 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.655 HG12 ' O ' ' B' ' 2' ' ' SER . 7.9 p 41.85 27.89 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.437 -0.789 . . . . 0.0 109.668 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.418 ' N ' ' O ' ' B' ' 2' ' ' SER . . . -160.75 160.44 31.33 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.496 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -167.21 26.31 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.307 -0.871 . . . . 0.0 109.534 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.474 ' O ' ' HG ' ' B' ' 7' ' ' LEU . 0.9 OUTLIER -128.51 -145.34 0.3 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.207 -0.933 . . . . 0.0 109.175 179.929 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.593 ' HB3' ' CG ' ' B' ' 34' ' ' HIS . 1.0 OUTLIER -164.68 123.22 1.76 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.283 -0.886 . . . . 0.0 109.619 179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.524 ' O ' ' N ' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -112.24 149.78 31.83 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 108.898 179.572 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.429 ' C ' ' O ' ' B' ' 8' ' ' ARG . 89.0 m -44.45 95.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.149 -0.969 . . . . 0.0 109.339 -179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.539 ' HB2' ' CD ' ' B' ' 29' ' ' LYS . 0.0 OUTLIER -48.03 -22.78 0.66 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.321 -0.862 . . . . 0.0 109.742 -179.948 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.417 ' O ' ' C ' ' B' ' 12' ' ' LEU . 63.3 m -126.42 65.22 1.24 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.21 -0.931 . . . . 0.0 109.825 -179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.417 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.2 OUTLIER -44.63 -43.79 8.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.252 -0.905 . . . . 0.0 108.818 179.513 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 9.8 mt-30 -122.86 124.88 44.28 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.477 HG22 ' O ' ' B' ' 52' ' ' LEU . 0.3 OUTLIER -96.45 167.43 11.17 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.236 -0.915 . . . . 0.0 109.968 -179.42 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.529 ' CD1' ' HB1' ' B' ' 50' ' ' ALA . 7.5 mt -119.04 146.21 45.24 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.597 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.2 OUTLIER -44.08 -41.31 5.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.197 -0.939 . . . . 0.0 109.372 -179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 1.024 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 147.53 -164.21 28.75 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 110.034 -1.226 . . . . 0.0 110.034 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.975 ' CD1' HD11 ' B' ' 23' ' ' ILE . 1.3 pp -171.19 163.64 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.473 -1.016 . . . . 0.0 109.166 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.59 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.2 OUTLIER -54.54 149.58 20.63 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.183 -0.948 . . . . 0.0 109.326 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.0 Cg_endo -77.22 -4.15 14.47 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.489 2.126 . . . . 0.0 110.257 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.489 ' HG2' ' HB3' ' B' ' 19' ' ' HIS . 8.4 pttt -90.26 -24.05 21.04 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.352 -0.843 . . . . 0.0 109.136 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.528 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 2.5 m-20 -82.92 -5.43 59.04 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.379 -0.826 . . . . 0.0 109.259 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.975 HD11 ' CD1' ' B' ' 18' ' ' ILE . 9.1 mt -105.98 145.87 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.268 -0.895 . . . . 0.0 110.114 -179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.55 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -119.12 -25.44 6.18 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.384 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.55 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.0 OUTLIER -142.98 -179.45 6.37 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.431 -0.793 . . . . 0.0 108.98 179.663 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.543 HG23 ' O ' ' B' ' 25' ' ' SER . 46.9 t -156.79 155.61 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.101 -0.999 . . . . 0.0 109.901 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.444 ' HB3' ' CD1' ' B' ' 41' ' ' ILE . 2.5 t-20 -138.72 114.23 9.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.364 -0.835 . . . . 0.0 109.21 179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 1.8 t -106.58 108.52 25.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.192 -0.943 . . . . 0.0 109.473 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.539 ' CD ' ' HB2' ' B' ' 10' ' ' GLN . 4.2 ptmm? -113.38 108.35 17.1 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 0.0 109.433 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.402 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.0 OUTLIER -59.8 163.92 6.63 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.223 -0.923 . . . . 0.0 109.425 179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.521 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.6 Cg_endo -77.64 152.45 29.42 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.56 2.173 . . . . 0.0 110.357 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -161.24 -136.97 2.1 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.519 ' HD2' ' CE1' ' B' ' 34' ' ' HIS . 36.2 Cg_endo -77.58 8.01 3.56 Favored 'Trans proline' 0 C--N 1.311 -1.414 0 C-N-CA 122.536 2.157 . . . . 0.0 110.79 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.593 ' CG ' ' HB3' ' B' ' 7' ' ' LEU . 2.4 p-80 -125.53 -24.25 3.93 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.128 -0.983 . . . . 0.0 109.734 179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.521 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 1.8 t -160.13 107.39 1.62 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.16 -0.963 . . . . 0.0 109.249 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.7 -5.67 26.56 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.29 -0.881 . . . . 0.0 109.717 -179.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.45 ' O ' ' OE2' ' B' ' 39' ' ' GLU . 2.2 mp0 -109.1 124.8 51.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.154 -0.967 . . . . 0.0 109.527 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.745 HG21 ' CB ' ' A' ' 70' ' ' ASP . 1.7 m -48.33 158.38 0.27 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.2 -0.938 . . . . 0.0 109.282 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.513 ' HG3' ' NZ ' ' B' ' 29' ' ' LYS . 25.7 mm-40 -139.92 107.32 5.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.11 -0.994 . . . . 0.0 109.716 -179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.721 HG11 HD11 ' B' ' 63' ' ' ILE . 10.5 t -92.56 151.95 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.264 -0.897 . . . . 0.0 109.18 179.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.476 ' HA ' ' HA ' ' B' ' 51' ' ' CYS . 3.2 mt -140.25 156.22 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.177 -0.952 . . . . 0.0 109.78 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.759 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -142.6 117.98 10.24 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 109.047 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.61 HG22 ' O ' ' B' ' 43' ' ' THR . 1.2 m -89.19 96.05 10.56 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.875 -1.141 . . . . 0.0 108.729 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 89.4 mt -42.27 165.71 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.614 -0.679 . . . . 0.0 109.917 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -79.63 7.23 8.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.452 -0.78 . . . . 0.0 109.804 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.49 24.06 12.91 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.249 179.859 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.31 0.06 65.33 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.512 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 72.3 mtt85 -88.67 162.22 16.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -1.157 . . . . 0.0 109.33 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.523 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 1.4 mptt -135.53 151.35 50.24 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.275 -0.89 . . . . 0.0 109.39 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.529 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.29 123.37 8.82 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.254 -0.904 . . . . 0.0 109.143 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.476 ' HA ' ' HA ' ' B' ' 41' ' ' ILE . 10.1 m -79.54 142.59 35.61 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.151 -0.968 . . . . 0.0 109.091 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 1.067 HD13 HD13 ' B' ' 62' ' ' ILE . 14.4 mt -120.45 167.72 12.07 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.345 -0.847 . . . . 0.0 109.561 -179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.674 ' O ' HG21 ' B' ' 59' ' ' VAL . 0.9 OUTLIER -99.55 122.5 51.28 Favored Pre-proline 0 C--N 1.3 -1.57 0 O-C-N 121.453 -0.779 . . . . 0.0 109.108 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.441 ' O ' ' HE2' ' B' ' 60' ' ' LYS . 33.4 Cg_endo -75.0 -3.6 14.16 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.185 1.923 . . . . 0.0 110.385 -179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.59 -12.24 43.23 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 108.993 179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.4 OUTLIER -90.06 163.06 33.37 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.407 -0.808 . . . . 0.0 109.382 179.901 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.63 -39.04 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.636 2.224 . . . . 0.0 110.746 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.6 HG23 ' N ' ' B' ' 59' ' ' VAL . 20.6 tt -65.2 -45.87 92.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.178 -0.951 . . . . 0.0 109.298 -179.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 1.056 ' HA ' HD12 ' B' ' 62' ' ' ILE . 44.2 t -57.48 -45.65 85.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.346 -0.847 . . . . 0.0 109.304 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' B' ' 56' ' ' SER . 7.4 mttt -59.57 -29.57 68.03 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.518 ' O ' ' CG ' ' B' ' 65' ' ' LYS . 7.0 mmmm -79.5 -23.66 42.8 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 1.067 HD13 HD13 ' B' ' 52' ' ' LEU . 29.4 mt -72.08 -36.6 57.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.57 -0.706 . . . . 0.0 109.284 179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.721 HD11 HG11 ' B' ' 40' ' ' VAL . 2.2 mp -75.86 -51.13 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.377 -0.827 . . . . 0.0 109.797 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.48 ' OE2' ' HE3' ' B' ' 61' ' ' LYS . 9.4 pt-20 -65.81 -29.0 69.41 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.023 -1.048 . . . . 0.0 109.303 -179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.518 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 4.4 mmtt -69.42 -46.19 67.39 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.218 -0.926 . . . . 0.0 108.943 179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.442 ' SD ' ' OG ' ' B' ' 69' ' ' SER . 0.3 OUTLIER -56.13 -45.22 79.62 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.379 -0.826 . . . . 0.0 109.051 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' A' ' 63' ' ' ILE . 0.3 OUTLIER -44.73 -51.85 8.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.423 -0.798 . . . . 0.0 109.418 179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.416 ' O ' ' C ' ' B' ' 69' ' ' SER . 6.9 t-20 -64.84 -37.25 87.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.486 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.442 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.1 p -44.17 -26.66 0.32 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.322 -0.861 . . . . 0.0 109.453 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.73 ' CB ' HG21 ' A' ' 38' ' ' THR . 1.6 p30 -111.83 82.52 1.63 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.272 -0.893 . . . . 0.0 109.434 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 2.6 tttp -127.95 86.47 2.48 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.849 . . . . 0.0 109.44 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.09 157.72 15.77 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 109.455 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . 0.428 ' ND2' ' N ' ' B' ' 73' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 118.048 -0.977 . . . . 0.0 109.527 179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.88 29.63 7.45 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 0.0 109.494 179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.707 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 1.1 m -116.75 -0.58 8.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.311 -0.868 . . . . 0.0 109.635 179.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 3' ' ' VAL . . . 76.16 83.82 0.09 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.508 179.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.1 t -106.52 30.71 5.78 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.22 -0.925 . . . . 0.0 109.401 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.83 129.66 0.09 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -0.9 . . . . 0.0 109.29 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.499 ' O ' ' HB2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -116.17 98.22 6.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.162 -0.961 . . . . 0.0 109.582 -179.983 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.435 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.0 OUTLIER -95.32 154.34 17.24 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.275 -0.891 . . . . 0.0 109.003 179.609 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.885 ' HB2' HD22 ' A' ' 12' ' ' LEU . 8.7 m -44.17 107.56 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.131 -0.981 . . . . 0.0 109.258 -179.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.538 ' HG3' ' CD ' ' A' ' 29' ' ' LYS . 13.8 mm100 -43.78 -24.89 0.15 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.827 . . . . 0.0 110.015 -179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.472 ' HB2' ' HG3' ' A' ' 39' ' ' GLU . 66.4 m -139.83 77.9 1.63 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.026 -1.047 . . . . 0.0 109.974 -179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.885 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -50.51 -43.95 55.9 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.93 . . . . 0.0 108.89 179.498 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.53 121.81 41.98 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.556 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.49 170.49 8.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.144 -0.972 . . . . 0.0 110.009 -179.403 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.975 HD12 ' O ' ' A' ' 51' ' ' CYS . 0.3 OUTLIER -127.54 148.84 50.34 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.803 ' O ' HG23 ' A' ' 59' ' ' VAL . 2.6 tt0 -44.43 -54.69 5.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 109.478 -179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 1.039 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 149.04 168.53 14.8 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 179.766 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.848 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -136.34 161.62 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.335 -1.097 . . . . 0.0 109.374 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.619 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -43.26 147.74 0.7 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.427 -0.795 . . . . 0.0 109.048 179.533 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.619 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 33.6 Cg_endo -75.59 -3.01 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.213 1.942 . . . . 0.0 110.009 179.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' O ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -90.44 -25.22 20.46 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.367 -0.833 . . . . 0.0 108.909 179.26 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.527 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 5.2 m-20 -81.92 -4.88 57.63 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.435 -0.79 . . . . 0.0 109.334 179.782 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.61 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 13.6 mt -107.0 149.6 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 0.0 110.294 -179.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.571 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -120.93 -28.1 4.87 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.248 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.571 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -135.93 169.17 18.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.204 -0.935 . . . . 0.0 109.105 179.323 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 25' ' ' SER . 48.9 t -156.66 126.27 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.718 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 55.5 t30 -108.49 157.93 18.0 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.305 -0.872 . . . . 0.0 109.339 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.07 95.47 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.932 . . . . 0.0 109.493 -179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.538 ' CD ' ' HG3' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -100.54 126.99 47.04 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.233 -0.917 . . . . 0.0 109.577 179.986 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.492 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.2 p -75.85 160.99 77.54 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.346 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.496 ' CB ' ' O ' ' A' ' 35' ' ' CYS . 35.2 Cg_endo -77.15 145.61 24.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.509 2.14 . . . . 0.0 110.425 179.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.39 -133.64 1.55 Allowed Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 -179.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.97 41.46 1.12 Allowed 'Trans proline' 0 C--N 1.311 -1.411 0 C-N-CA 122.719 2.279 . . . . 0.0 110.781 179.86 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 9.1 p-80 -162.11 -38.01 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.073 -1.017 . . . . 0.0 109.28 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.496 ' O ' ' CB ' ' A' ' 31' ' ' PRO . 2.7 t -145.71 101.18 3.52 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.301 -0.874 . . . . 0.0 109.176 179.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.17 -12.46 20.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.198 -0.939 . . . . 0.0 109.725 -179.678 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.459 ' O ' ' OE2' ' A' ' 39' ' ' GLU . 1.9 mp0 -106.92 129.39 54.75 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.526 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.848 HG21 ' HB2' ' B' ' 70' ' ' ASP . 0.6 OUTLIER -48.49 162.82 0.08 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.192 -0.942 . . . . 0.0 109.292 179.887 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.472 ' HG3' ' HB2' ' A' ' 11' ' ' CYS . 2.6 mp0 -136.95 114.44 11.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.153 -0.967 . . . . 0.0 109.643 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.844 HG11 HD11 ' A' ' 63' ' ' ILE . 19.5 t -104.86 144.57 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.16 179.798 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 26' ' ' VAL . 2.6 mp -133.34 152.35 35.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.239 -0.913 . . . . 0.0 109.705 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.61 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -137.6 116.49 12.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.315 -0.866 . . . . 0.0 109.173 179.76 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.534 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.8 m -89.12 97.51 11.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.956 -1.09 . . . . 0.0 108.785 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.527 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 93.1 mt -44.72 166.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.522 -0.736 . . . . 0.0 109.6 -179.787 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.2 ptpt -81.61 8.46 9.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.318 -0.864 . . . . 0.0 109.66 -179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -111.28 19.92 17.83 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.204 179.742 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 4.54 89.6 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.516 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 5.8 mtt180 -94.55 168.39 10.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.17 -1.194 . . . . 0.0 109.508 179.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.522 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.93 156.72 48.09 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.324 -0.86 . . . . 0.0 109.398 179.808 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.4 120.03 7.0 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.308 -0.87 . . . . 0.0 109.098 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.975 ' O ' HD12 ' A' ' 15' ' ' LEU . 8.0 m -79.74 139.08 37.43 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.077 -1.014 . . . . 0.0 108.948 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.039 HD22 ' HA2' ' A' ' 17' ' ' GLY . 10.4 mt -123.39 168.32 12.68 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.204 -0.935 . . . . 0.0 109.68 -179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.615 ' O ' HG21 ' A' ' 59' ' ' VAL . 28.9 t-20 -101.65 119.89 55.94 Favored Pre-proline 0 C--N 1.3 -1.572 0 O-C-N 121.5 -0.75 . . . . 0.0 109.334 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.444 ' HD2' ' OD1' ' A' ' 53' ' ' ASN . 33.6 Cg_endo -74.84 1.39 7.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.127 1.885 . . . . 0.0 110.542 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.53 -17.36 30.43 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.219 -0.926 . . . . 0.0 108.964 179.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.4 OUTLIER -90.16 164.06 29.26 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.344 -0.847 . . . . 0.0 109.456 179.913 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.29 -33.31 1.98 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.731 2.287 . . . . 0.0 110.671 -179.952 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.615 ' O ' HD13 ' A' ' 62' ' ' ILE . 0.2 OUTLIER -67.26 -48.33 78.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 O-C-N 121.104 -0.998 . . . . 0.0 108.99 -179.932 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.852 HG22 ' HB3' ' A' ' 52' ' ' LEU . 33.7 t -57.38 -48.73 82.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.474 -0.766 . . . . 0.0 108.983 179.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HG3' ' O ' ' A' ' 56' ' ' SER . 4.9 mmmt -53.6 -32.2 50.15 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 179.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.535 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 3.1 mmpt? -73.64 -34.03 64.78 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.505 -0.747 . . . . 0.0 109.193 179.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.615 HD13 ' O ' ' A' ' 58' ' ' ILE . 1.5 mp -59.9 -44.68 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.408 -0.807 . . . . 0.0 108.921 179.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.904 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -66.66 -62.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.31 -0.869 . . . . 0.0 109.897 -179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.46 ' OE2' ' O ' ' A' ' 60' ' ' LYS . 5.6 pt-20 -58.35 -15.81 12.01 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.992 -1.067 . . . . 0.0 109.517 -179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' CG ' ' O ' ' A' ' 61' ' ' LYS . 7.8 mmtt -83.32 -36.18 24.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.232 -0.917 . . . . 0.0 108.795 179.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.464 ' HA ' ' OG ' ' A' ' 69' ' ' SER . 0.2 OUTLIER -68.99 -44.83 72.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.402 -0.811 . . . . 0.0 108.946 179.429 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.908 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.4 OUTLIER -43.63 -50.74 7.32 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.463 -0.773 . . . . 0.0 109.328 179.68 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -72.84 -36.74 67.53 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.357 -0.84 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.464 ' OG ' ' HA ' ' A' ' 66' ' ' MET . 25.2 p -88.26 39.33 0.9 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.223 -0.923 . . . . 0.0 109.452 179.998 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.822 ' HB2' HG21 ' B' ' 38' ' ' THR . 5.0 p-10 -91.67 -13.67 31.37 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.86 . . . . 0.0 109.468 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' C ' ' OG ' ' A' ' 72' ' ' SER . 0.0 OUTLIER -145.0 44.3 1.34 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.26 -0.9 . . . . 0.0 109.493 179.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.43 ' O ' ' HB2' ' A' ' 73' ' ' ASN . 0.3 OUTLIER 65.32 103.36 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.266 -0.896 . . . . 0.0 109.459 179.968 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 72' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -119.91 29.69 7.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.31 -0.869 . . . . 0.0 109.529 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.709 ' O ' ' HB3' ' B' ' 4' ' ' ALA . 1.1 m -116.84 -0.58 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.221 -0.924 . . . . 0.0 109.544 -179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.709 ' HB3' ' O ' ' B' ' 3' ' ' VAL . . . 76.13 83.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.134 -0.979 . . . . 0.0 109.54 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 4.1 t -106.58 30.67 5.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.302 -0.874 . . . . 0.0 109.448 179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 179.92 129.61 0.09 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 109.353 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -116.06 98.3 6.55 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.127 -0.983 . . . . 0.0 109.608 179.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.437 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.0 OUTLIER -95.37 154.33 17.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.356 -0.84 . . . . 0.0 108.959 179.607 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.928 ' HB2' HD22 ' B' ' 12' ' ' LEU . 8.8 m -44.17 107.57 0.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.138 -0.976 . . . . 0.0 109.325 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.532 ' HG3' ' CD ' ' B' ' 29' ' ' LYS . 13.8 mm100 -43.78 -24.92 0.15 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.336 -0.853 . . . . 0.0 109.998 -179.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.469 ' HB2' ' HG3' ' B' ' 39' ' ' GLU . 66.3 m -139.8 77.97 1.64 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.072 -1.018 . . . . 0.0 109.986 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.928 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -50.53 -43.85 56.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 108.922 179.474 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -117.57 121.83 42.01 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 179.527 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -100.49 170.53 8.33 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.0 110.053 -179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.985 HD12 ' O ' ' B' ' 51' ' ' CYS . 0.3 OUTLIER -127.61 148.74 50.37 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.754 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.784 ' O ' HG23 ' B' ' 59' ' ' VAL . 2.6 tt0 -44.36 -54.74 5.56 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.97 . . . . 0.0 109.451 -179.89 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 1.041 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 149.1 168.59 14.88 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 110.006 -1.238 . . . . 0.0 110.006 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.829 HD13 ' N ' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -136.39 161.65 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.378 -1.072 . . . . 0.0 109.359 179.746 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.607 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.5 OUTLIER -43.34 147.85 0.71 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.394 -0.816 . . . . 0.0 109.005 179.561 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.607 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 33.1 Cg_endo -75.61 -3.08 13.39 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.264 1.976 . . . . 0.0 109.941 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HE3' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -90.49 -25.26 20.38 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.381 -0.825 . . . . 0.0 108.807 179.383 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.53 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 5.3 m-20 -81.77 -4.96 57.66 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.444 -0.785 . . . . 0.0 109.398 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.605 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 13.7 mt -107.05 149.62 10.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 110.213 -179.523 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.576 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -120.92 -28.03 4.88 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 179.267 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.576 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.0 OUTLIER -136.05 169.1 18.15 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.283 -0.886 . . . . 0.0 109.061 179.33 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.517 HG23 ' O ' ' B' ' 25' ' ' SER . 48.7 t -156.56 126.27 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.126 -0.984 . . . . 0.0 109.752 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 55.6 t30 -108.47 157.99 17.94 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.297 -0.877 . . . . 0.0 109.329 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . . . . . . . . . 2.6 t -143.13 95.42 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.207 -0.933 . . . . 0.0 109.525 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.532 ' CD ' ' HG3' ' B' ' 10' ' ' GLN . 0.0 OUTLIER -100.51 127.03 46.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.173 -0.954 . . . . 0.0 109.591 -179.969 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.478 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.2 p -75.87 160.99 77.47 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 0.0 109.332 179.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.495 ' CB ' ' O ' ' B' ' 35' ' ' CYS . 35.4 Cg_endo -77.11 145.55 24.67 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.575 2.183 . . . . 0.0 110.456 179.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -159.4 -133.63 1.54 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.823 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -80.0 41.53 1.14 Allowed 'Trans proline' 0 C--N 1.313 -1.34 0 C-N-CA 122.595 2.197 . . . . 0.0 110.807 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' B' ' 7' ' ' LEU . 9.0 p-80 -162.09 -38.05 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.026 -1.046 . . . . 0.0 109.269 179.916 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.495 ' O ' ' CB ' ' B' ' 31' ' ' PRO . 2.7 t -145.7 101.31 3.54 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.229 -0.919 . . . . 0.0 109.131 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -62.28 -12.39 20.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.254 -0.903 . . . . 0.0 109.737 -179.685 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.46 ' O ' ' OE1' ' B' ' 39' ' ' GLU . 1.9 mp0 -106.89 129.36 54.73 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.193 -0.942 . . . . 0.0 109.503 -179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.822 HG21 ' HB2' ' A' ' 70' ' ' ASP . 0.6 OUTLIER -48.44 162.83 0.08 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.267 -0.896 . . . . 0.0 109.227 179.843 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.469 ' HG3' ' HB2' ' B' ' 11' ' ' CYS . 2.6 mp0 -136.94 114.42 10.99 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.0 109.687 -179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.809 HG11 HD11 ' B' ' 63' ' ' ILE . 19.1 t -104.85 144.47 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.851 . . . . 0.0 109.184 179.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 2.6 mp -133.24 152.37 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.199 -0.938 . . . . 0.0 109.81 -179.85 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.605 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -137.62 116.43 12.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.279 -0.888 . . . . 0.0 109.179 179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.532 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 1.8 m -89.11 97.52 11.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.922 -1.111 . . . . 0.0 108.737 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.53 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 93.1 mt -44.62 166.75 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.556 -0.715 . . . . 0.0 109.628 -179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.455 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.2 ptpt -81.6 8.5 9.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.632 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -111.3 19.87 17.87 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.96 . . . . 0.0 109.228 179.71 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.93 4.59 89.6 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.671 -1.372 . . . . 0.0 109.671 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 5.8 mtt180 -94.59 168.35 10.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.162 -1.199 . . . . 0.0 109.55 179.94 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.518 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.89 156.74 48.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.353 -0.842 . . . . 0.0 109.345 179.82 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.39 120.08 7.02 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.335 -0.853 . . . . 0.0 109.052 -179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.985 ' O ' HD12 ' B' ' 15' ' ' LEU . 8.0 m -79.74 139.11 37.42 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.13 -0.981 . . . . 0.0 108.972 179.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 1.041 HD22 ' HA2' ' B' ' 17' ' ' GLY . 10.5 mt -123.47 168.36 12.67 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.149 -0.97 . . . . 0.0 109.67 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.611 ' O ' HG21 ' B' ' 59' ' ' VAL . 29.1 t-20 -101.68 119.89 55.89 Favored Pre-proline 0 C--N 1.299 -1.613 0 O-C-N 121.456 -0.778 . . . . 0.0 109.332 -179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.449 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.2 Cg_endo -74.84 1.3 7.79 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.183 1.922 . . . . 0.0 110.518 -179.696 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -88.48 -17.31 30.62 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.24 -0.912 . . . . 0.0 108.977 179.425 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.491 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.4 OUTLIER -90.2 164.01 29.3 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.389 -0.82 . . . . 0.0 109.383 179.915 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.32 -33.22 1.99 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.624 2.216 . . . . 0.0 110.694 -179.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.608 ' O ' HD13 ' B' ' 62' ' ' ILE . 0.2 OUTLIER -67.21 -48.33 78.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.105 -0.997 . . . . 0.0 108.995 179.991 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.859 HG22 ' HB3' ' B' ' 52' ' ' LEU . 33.8 t -57.42 -48.72 82.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.414 -0.804 . . . . 0.0 108.981 179.379 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' B' ' 56' ' ' SER . 4.9 mmmt -53.63 -32.19 50.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 179.319 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.539 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 3.1 mmpt? -73.57 -34.19 65.01 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.608 HD13 ' O ' ' B' ' 58' ' ' ILE . 1.5 mp -59.74 -44.79 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.43 -0.794 . . . . 0.0 108.955 179.717 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.908 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -66.72 -62.64 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.352 -0.842 . . . . 0.0 109.876 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.473 ' OE2' ' HA ' ' B' ' 61' ' ' LYS . 5.6 pt-20 -58.28 -15.85 11.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.115 -0.99 . . . . 0.0 109.576 -179.785 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.52 ' CG ' ' O ' ' B' ' 61' ' ' LYS . 7.7 mmtt -83.29 -36.21 24.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.932 . . . . 0.0 108.791 179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.47 ' HA ' ' OG ' ' B' ' 69' ' ' SER . 0.2 OUTLIER -69.0 -44.79 72.1 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.484 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.904 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.4 OUTLIER -43.68 -50.67 7.46 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.381 -0.824 . . . . 0.0 109.373 179.701 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -72.81 -36.73 67.61 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.286 -0.884 . . . . 0.0 109.482 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.47 ' OG ' ' HA ' ' B' ' 66' ' ' MET . 25.6 p -88.31 39.28 0.9 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.381 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.848 ' HB2' HG21 ' A' ' 38' ' ' THR . 4.9 p-10 -91.59 -13.69 31.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.411 ' C ' ' OG ' ' B' ' 72' ' ' SER . 0.0 OUTLIER -145.04 44.39 1.34 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.281 -0.887 . . . . 0.0 109.399 -179.974 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.426 ' O ' ' HB2' ' B' ' 73' ' ' ASN . 0.3 OUTLIER 65.23 103.42 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.289 -0.882 . . . . 0.0 109.467 -179.992 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' B' ' 72' ' ' SER . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 117.912 -1.042 . . . . 0.0 109.482 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -178.26 57.94 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.516 179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.703 ' O ' ' HB3' ' A' ' 4' ' ' ALA . 8.4 p -106.17 134.85 46.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.262 -0.899 . . . . 0.0 109.456 -179.93 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.703 ' HB3' ' O ' ' A' ' 3' ' ' VAL . . . 75.92 -153.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.247 -0.908 . . . . 0.0 109.552 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 4' ' ' ALA . 1.3 m -169.63 124.2 0.8 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.419 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.421 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 3.2 tt0 -119.92 -143.82 0.36 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.257 -0.902 . . . . 0.0 109.199 179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.681 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.8 OUTLIER -158.89 120.87 3.49 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.253 -0.904 . . . . 0.0 109.669 -179.908 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.427 ' O ' ' N ' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -133.98 159.1 41.77 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.4 -0.813 . . . . 0.0 109.001 179.789 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.44 ' HB3' ' OE2' ' A' ' 39' ' ' GLU . 58.4 m -44.55 101.24 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.189 -0.944 . . . . 0.0 109.289 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.537 ' HG3' ' CE ' ' A' ' 29' ' ' LYS . 22.1 mm100 -62.5 -10.01 10.45 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.891 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.462 ' SG ' ' HG2' ' A' ' 39' ' ' GLU . 39.7 m -138.83 67.93 1.39 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.005 -1.06 . . . . 0.0 109.851 -179.761 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' C ' ' O ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -45.13 -45.63 11.39 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.147 -0.97 . . . . 0.0 108.998 179.54 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.426 ' OE1' ' N ' ' A' ' 14' ' ' THR . 0.5 OUTLIER -118.14 116.9 27.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.463 -0.773 . . . . 0.0 108.95 179.541 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.426 ' N ' ' OE1' ' A' ' 13' ' ' GLN . 0.6 OUTLIER -90.24 171.08 9.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.259 -0.901 . . . . 0.0 110.048 -179.442 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.866 HD12 ' O ' ' A' ' 51' ' ' CYS . 1.0 OUTLIER -119.81 143.66 47.75 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.478 -0.763 . . . . 0.0 109.09 179.798 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.524 ' O ' HG23 ' A' ' 59' ' ' VAL . 0.9 OUTLIER -44.65 -38.27 4.22 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.084 -1.01 . . . . 0.0 109.287 -179.909 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 1.074 ' HA2' HD22 ' A' ' 52' ' ' LEU . . . 138.26 156.51 7.14 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.853 -1.299 . . . . 0.0 109.853 179.777 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.805 ' H ' HD13 ' A' ' 18' ' ' ILE . 0.2 OUTLIER -125.8 156.11 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.36 -1.082 . . . . 0.0 109.332 179.592 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.616 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.94 153.99 0.31 Allowed Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.336 -0.852 . . . . 0.0 109.298 179.82 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.616 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.1 Cg_endo -76.27 -5.03 15.81 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.417 2.078 . . . . 0.0 109.943 179.743 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -81.73 -22.28 37.42 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.047 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.906 ' O ' HD23 ' A' ' 44' ' ' LEU . 35.4 m-20 -98.58 60.03 1.3 Allowed 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.279 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.895 HD13 ' O ' ' A' ' 22' ' ' ASN . 2.6 mm -143.78 167.5 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.161 -0.962 . . . . 0.0 109.937 -179.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.754 ' HG2' HG22 ' A' ' 43' ' ' THR . 0.0 OUTLIER -160.18 -35.15 0.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.285 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.566 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 1.5 p -133.51 176.72 8.29 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.173 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.507 ' CG2' ' HG3' ' A' ' 66' ' ' MET . 54.6 t -151.29 92.11 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.976 -1.078 . . . . 0.0 109.868 -179.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.493 ' HB3' ' HB ' ' A' ' 41' ' ' ILE . 5.1 t-20 -94.03 110.63 22.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.922 . . . . 0.0 109.219 179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.581 HG13 HG22 ' A' ' 40' ' ' VAL . 1.9 t -121.77 100.15 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.215 -0.928 . . . . 0.0 109.584 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.537 ' CE ' ' HG3' ' A' ' 10' ' ' GLN . 9.6 ptpt -98.09 106.67 19.0 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.352 -0.843 . . . . 0.0 109.363 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.591 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.1 p -45.87 170.54 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.358 -0.839 . . . . 0.0 109.398 179.957 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.523 ' CB ' ' O ' ' A' ' 36' ' ' ALA . 35.6 Cg_endo -77.89 132.28 11.7 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.568 2.179 . . . . 0.0 110.407 -179.96 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.33 -142.7 4.15 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.908 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.21 8.12 3.38 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.584 2.189 . . . . 0.0 110.879 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.681 ' CD2' HD22 ' A' ' 7' ' ' LEU . 6.6 p-80 -124.44 -18.75 5.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.07 -1.019 . . . . 0.0 109.73 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -160.22 96.62 1.21 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.11 -0.994 . . . . 0.0 109.255 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.523 ' O ' ' CB ' ' A' ' 31' ' ' PRO . . . -55.17 -29.16 57.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.323 -0.861 . . . . 0.0 109.687 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.55 125.33 35.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.225 -0.922 . . . . 0.0 109.544 -179.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.591 HG23 ' HA ' ' A' ' 30' ' ' SER . 32.5 m -46.43 152.75 0.41 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.907 . . . . 0.0 109.401 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -129.31 121.67 27.98 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.65 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.687 HG11 HD11 ' A' ' 63' ' ' ILE . 16.2 t -108.14 150.34 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.852 . . . . 0.0 109.22 179.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.493 ' HB ' ' HB3' ' A' ' 27' ' ' ASN . 14.4 mt -143.15 143.12 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.077 -1.015 . . . . 0.0 109.846 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.684 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -130.99 123.02 27.87 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.389 -0.819 . . . . 0.0 108.932 179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.754 HG22 ' HG2' ' A' ' 24' ' ' GLN . 40.5 m -89.39 103.26 15.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.967 -1.083 . . . . 0.0 109.097 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.906 HD23 ' O ' ' A' ' 22' ' ' ASN . 73.1 mt -42.48 165.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.502 -0.749 . . . . 0.0 109.59 -179.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 10.4 ptpt -87.27 16.44 5.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.244 -0.91 . . . . 0.0 109.547 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.514 ' OD1' ' CB ' ' A' ' 44' ' ' LEU . 19.0 p-10 -117.27 6.02 12.7 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 109.399 179.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.53 14.46 44.04 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.776 -1.329 . . . . 0.0 109.776 179.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.674 ' HB2' HD12 ' A' ' 44' ' ' LEU . 9.8 mtp180 -111.32 174.23 5.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -1.203 . . . . 0.0 109.553 179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.434 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 6.8 mttt -138.26 156.69 47.44 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.25 120.48 7.29 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.331 -0.855 . . . . 0.0 109.058 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.866 ' O ' HD12 ' A' ' 15' ' ' LEU . 20.6 m -79.31 140.59 37.51 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.147 -0.971 . . . . 0.0 109.12 -179.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 1.074 HD22 ' HA2' ' A' ' 17' ' ' GLY . 10.2 mt -124.51 168.97 12.35 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.234 -0.916 . . . . 0.0 109.597 -179.894 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.75 HD22 ' HB3' ' A' ' 55' ' ' ALA . 7.1 t30 -105.61 127.39 28.61 Favored Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.381 -0.824 . . . . 0.0 109.255 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -75.71 2.21 7.22 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.236 1.957 . . . . 0.0 110.648 -179.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.75 ' HB3' HD22 ' A' ' 53' ' ' ASN . . . -86.0 -19.03 30.96 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.033 179.515 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.512 ' OG ' HG22 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -90.22 162.7 34.04 Favored Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.337 -0.852 . . . . 0.0 109.526 179.95 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.76 -32.98 2.44 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.722 2.281 . . . . 0.0 111.002 -179.751 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.512 HG22 ' OG ' ' A' ' 56' ' ' SER . 15.8 tt -70.54 -40.26 77.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.057 -1.027 . . . . 0.0 109.539 -179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 1.006 ' HA ' HD12 ' A' ' 62' ' ' ILE . 24.6 t -61.96 -48.19 89.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.343 -0.848 . . . . 0.0 108.951 179.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -60.9 -29.63 69.69 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.541 ' CE ' ' HA ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -81.92 -19.7 40.24 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.867 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 1.006 HD12 ' HA ' ' A' ' 59' ' ' VAL . 16.4 mt -72.71 -38.86 59.28 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.936 HG22 HD11 ' B' ' 67' ' ' LEU . 1.5 mp -75.27 -61.84 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.313 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.33 -47.82 25.61 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.342 -0.849 . . . . 0.0 109.294 179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.41 ' HB2' ' O ' ' A' ' 61' ' ' LYS . 21.8 tptt -52.0 -57.3 9.89 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.343 -0.848 . . . . 0.0 109.185 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.507 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -44.36 -48.45 9.73 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.353 -0.842 . . . . 0.0 109.2 179.747 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.899 HD11 HG22 ' B' ' 63' ' ' ILE . 0.4 OUTLIER -48.81 -54.66 14.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.346 -0.846 . . . . 0.0 109.49 179.895 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . 0.42 ' O ' ' C ' ' A' ' 69' ' ' SER . 18.5 t30 -56.14 -32.82 64.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.248 -0.907 . . . . 0.0 109.484 -179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 70' ' ' ASP . 1.1 p -43.9 -59.39 2.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.318 -0.864 . . . . 0.0 109.471 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 69' ' ' SER . 0.2 OUTLIER 77.66 -77.44 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.333 -0.855 . . . . 0.0 109.565 179.99 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.516 ' HG2' ' HG3' ' B' ' 31' ' ' PRO . 4.9 mtmt -155.43 -46.66 0.08 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -0.955 . . . . 0.0 109.478 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -148.1 148.56 30.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.339 -0.85 . . . . 0.0 109.47 179.98 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.415 179.997 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -178.21 58.01 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.208 -0.932 . . . . 0.0 109.412 179.998 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.705 ' O ' ' HB3' ' B' ' 4' ' ' ALA . 8.4 p -106.21 134.87 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.304 -0.872 . . . . 0.0 109.455 179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.705 ' HB3' ' O ' ' B' ' 3' ' ' VAL . . . 75.93 -153.51 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.489 179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.444 ' OG1' ' O ' ' B' ' 4' ' ' ALA . 1.3 m -169.65 124.21 0.8 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.417 179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.404 ' O ' ' HG ' ' B' ' 7' ' ' LEU . 3.2 tt0 -119.84 -143.84 0.36 Allowed 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.18 -0.95 . . . . 0.0 109.228 179.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.685 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.8 OUTLIER -158.85 120.94 3.52 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.233 -0.917 . . . . 0.0 109.658 -179.992 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.429 ' O ' ' N ' ' B' ' 10' ' ' GLN . 0.1 OUTLIER -133.98 159.19 41.5 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.379 -0.825 . . . . 0.0 108.99 179.707 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.448 ' HB3' ' OE2' ' B' ' 39' ' ' GLU . 58.8 m -44.63 101.29 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.153 -0.967 . . . . 0.0 109.34 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.529 ' HG3' ' CE ' ' B' ' 29' ' ' LYS . 22.1 mm100 -62.55 -9.94 10.4 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.34 -0.85 . . . . 0.0 109.889 -179.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.461 ' SG ' ' HG2' ' B' ' 39' ' ' GLU . 39.6 m -138.87 68.03 1.39 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.062 -1.024 . . . . 0.0 109.836 -179.79 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.43 ' C ' ' O ' ' B' ' 11' ' ' CYS . 0.3 OUTLIER -45.28 -45.63 12.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.253 -0.904 . . . . 0.0 108.883 179.609 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . 0.417 ' OE1' ' N ' ' B' ' 14' ' ' THR . 0.5 OUTLIER -118.03 116.87 27.76 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.438 -0.789 . . . . 0.0 108.928 179.643 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.417 ' N ' ' OE1' ' B' ' 13' ' ' GLN . 0.6 OUTLIER -90.24 171.1 9.73 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.221 -0.924 . . . . 0.0 110.042 -179.456 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.836 HD12 ' O ' ' B' ' 51' ' ' CYS . 1.0 OUTLIER -119.86 143.66 47.79 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.45 -0.781 . . . . 0.0 109.013 179.764 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.52 ' O ' HG23 ' B' ' 59' ' ' VAL . 0.9 OUTLIER -44.58 -38.29 4.14 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 -179.962 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 1.02 ' HA2' HD22 ' B' ' 52' ' ' LEU . . . 138.26 156.52 7.14 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.805 ' H ' HD13 ' B' ' 18' ' ' ILE . 0.2 OUTLIER -125.84 156.04 35.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.357 -1.084 . . . . 0.0 109.316 179.579 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.609 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -42.8 154.03 0.31 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.373 -0.829 . . . . 0.0 109.31 179.797 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.609 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 33.6 Cg_endo -76.38 -5.0 15.74 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.377 2.051 . . . . 0.0 109.862 179.762 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 0.1 OUTLIER -81.74 -22.2 37.44 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.902 ' O ' HD23 ' B' ' 44' ' ' LEU . 35.6 m-20 -98.54 59.94 1.31 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.217 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.881 HD13 ' O ' ' B' ' 22' ' ' ASN . 2.6 mm -143.78 167.54 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.185 -0.947 . . . . 0.0 109.963 -179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.746 ' HG2' HG22 ' B' ' 43' ' ' THR . 0.0 OUTLIER -160.24 -35.1 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.273 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.545 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 1.4 p -133.46 176.77 8.24 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 179.009 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.511 ' CG2' ' HG3' ' B' ' 66' ' ' MET . 54.0 t -151.31 92.16 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.897 -1.127 . . . . 0.0 109.86 -179.88 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.485 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 5.1 t-20 -94.1 110.62 22.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.221 -0.924 . . . . 0.0 109.249 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.595 HG13 HG22 ' B' ' 40' ' ' VAL . 1.9 t -121.76 100.16 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.155 -0.966 . . . . 0.0 109.605 -179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.529 ' CE ' ' HG3' ' B' ' 10' ' ' GLN . 9.6 ptpt -98.05 106.66 18.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.195 -0.94 . . . . 0.0 109.401 179.945 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.588 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -45.9 170.57 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.232 -0.917 . . . . 0.0 109.399 -179.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.525 ' CB ' ' O ' ' B' ' 36' ' ' ALA . 35.9 Cg_endo -77.79 132.21 11.76 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.594 2.196 . . . . 0.0 110.499 179.958 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -141.32 -142.7 4.15 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.2 8.1 3.39 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.524 2.15 . . . . 0.0 110.873 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.685 ' CD2' HD22 ' B' ' 7' ' ' LEU . 6.6 p-80 -124.44 -18.66 5.68 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.006 -1.059 . . . . 0.0 109.757 179.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.476 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -160.22 96.59 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.184 -0.948 . . . . 0.0 109.303 179.726 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.525 ' O ' ' CB ' ' B' ' 31' ' ' PRO . . . -55.19 -29.12 57.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.195 -0.941 . . . . 0.0 109.651 -179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -90.61 125.41 35.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.172 -0.955 . . . . 0.0 109.486 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.588 HG23 ' HA ' ' B' ' 30' ' ' SER . 32.4 m -46.41 152.74 0.41 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.302 -0.874 . . . . 0.0 109.424 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.461 ' HG2' ' SG ' ' B' ' 11' ' ' CYS . 0.0 OUTLIER -129.32 121.59 27.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.193 -0.942 . . . . 0.0 109.733 -179.929 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.688 HG11 HD11 ' B' ' 63' ' ' ILE . 16.2 t -108.17 150.36 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.249 -0.907 . . . . 0.0 109.24 179.76 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.485 ' HB ' ' HB3' ' B' ' 27' ' ' ASN . 14.5 mt -143.19 143.12 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 -179.835 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.673 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -131.03 123.03 27.85 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.33 -0.856 . . . . 0.0 108.862 179.722 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.746 HG22 ' HG2' ' B' ' 24' ' ' GLN . 41.8 m -89.31 103.24 15.88 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.943 -1.098 . . . . 0.0 109.182 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.902 HD23 ' O ' ' B' ' 22' ' ' ASN . 72.5 mt -42.46 165.56 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.538 -0.726 . . . . 0.0 109.582 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.522 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 10.4 ptpt -87.26 16.38 5.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.236 -0.915 . . . . 0.0 109.555 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.523 ' OD1' ' CB ' ' B' ' 44' ' ' LEU . 19.0 p-10 -117.33 6.17 12.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.306 -0.871 . . . . 0.0 109.375 179.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.47 14.61 43.68 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.696 ' HB2' HD12 ' B' ' 44' ' ' LEU . 9.7 mtp180 -111.43 174.26 5.95 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.148 -1.207 . . . . 0.0 109.495 179.892 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.42 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 6.7 mttt -138.24 156.81 47.32 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.479 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.33 120.52 7.27 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.387 -0.821 . . . . 0.0 109.02 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.836 ' O ' HD12 ' B' ' 15' ' ' LEU . 20.5 m -79.37 140.62 37.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.074 -1.016 . . . . 0.0 109.122 -179.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 1.032 HD13 HD13 ' B' ' 62' ' ' ILE . 10.2 mt -124.51 168.96 12.37 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.206 -0.934 . . . . 0.0 109.598 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.736 HD22 ' HB3' ' B' ' 55' ' ' ALA . 7.1 t30 -105.57 127.39 28.62 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.427 -0.795 . . . . 0.0 109.185 -179.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -75.74 2.27 7.17 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.208 1.939 . . . . 0.0 110.657 -179.563 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.736 ' HB3' HD22 ' B' ' 53' ' ' ASN . . . -85.98 -19.1 30.9 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.261 -0.899 . . . . 0.0 109.074 179.512 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.505 ' OG ' HG22 ' B' ' 58' ' ' ILE . 0.4 OUTLIER -90.29 162.76 33.7 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.356 -0.84 . . . . 0.0 109.503 179.997 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.73 -33.0 2.46 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.755 2.303 . . . . 0.0 111.006 -179.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.505 HG22 ' OG ' ' B' ' 56' ' ' SER . 15.9 tt -70.59 -40.16 76.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.109 -0.994 . . . . 0.0 109.51 -179.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 1.026 ' HA ' HD12 ' B' ' 62' ' ' ILE . 24.5 t -62.07 -48.17 89.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.378 -0.827 . . . . 0.0 108.913 179.861 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . . . . . . . . . 2.1 mtpp -60.92 -29.7 69.76 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.535 ' CE ' ' HA ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -81.81 -19.65 40.7 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.128 -0.694 . . . . 0.0 109.128 179.804 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 1.032 HD13 HD13 ' B' ' 52' ' ' LEU . 16.4 mt -72.76 -38.88 58.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.357 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.899 HG22 HD11 ' A' ' 67' ' ' LEU . 1.5 mp -75.16 -61.91 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 179.28 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -47.86 25.15 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.38 -0.825 . . . . 0.0 109.299 179.784 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.422 ' O ' ' C ' ' B' ' 66' ' ' MET . 21.9 tptt -51.85 -57.38 9.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 0.0 109.163 179.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.511 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 0.7 OUTLIER -44.39 -48.48 9.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.243 -0.911 . . . . 0.0 109.173 179.783 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.936 HD11 HG22 ' A' ' 63' ' ' ILE . 0.4 OUTLIER -48.77 -54.63 14.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.345 -0.847 . . . . 0.0 109.506 179.899 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.429 ' O ' ' C ' ' B' ' 69' ' ' SER . 18.5 t30 -56.27 -32.7 64.78 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 0.0 109.498 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.506 ' O ' ' CB ' ' B' ' 70' ' ' ASP . 1.1 p -44.07 -59.23 2.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.29 -0.881 . . . . 0.0 109.468 -179.97 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.506 ' CB ' ' O ' ' B' ' 69' ' ' SER . 0.2 OUTLIER 77.58 -77.42 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.354 -0.841 . . . . 0.0 109.586 179.906 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.512 ' HG2' ' HG3' ' A' ' 31' ' ' PRO . 4.9 mtmt -155.43 -46.6 0.08 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.201 -0.937 . . . . 0.0 109.494 179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 5.2 p -148.2 148.57 30.67 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.263 -0.898 . . . . 0.0 109.438 -179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.056 -0.973 . . . . 0.0 109.435 179.967 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 m -120.0 -29.39 4.94 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.917 . . . . 0.0 109.486 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.452 ' O ' ' HB2' ' A' ' 4' ' ' ALA . 2.0 t -68.17 169.79 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.291 -0.88 . . . . 0.0 109.468 179.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.655 ' O ' HG22 ' A' ' 5' ' ' THR . . . 178.12 140.26 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.427 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.655 HG22 ' O ' ' A' ' 4' ' ' ALA . 13.6 t 41.96 32.45 0.29 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.454 -0.779 . . . . 0.0 109.673 179.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -132.54 74.3 1.57 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.237 -0.914 . . . . 0.0 109.416 -179.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.546 ' HB3' ' CB ' ' A' ' 34' ' ' HIS . 0.1 OUTLIER -116.62 98.18 6.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.208 -0.933 . . . . 0.0 109.607 -179.972 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.433 ' O ' ' C ' ' A' ' 9' ' ' CYS . 0.6 OUTLIER -83.98 154.67 23.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -0.947 . . . . 0.0 108.991 179.586 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.986 ' HB2' HD22 ' A' ' 12' ' ' LEU . 7.2 m -44.38 126.17 5.1 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.078 -1.014 . . . . 0.0 109.414 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 39' ' ' GLU . 0.9 OUTLIER -41.08 -38.38 1.02 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.515 -0.741 . . . . 0.0 109.736 -179.954 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' A' ' 41' ' ' ILE . 72.3 m -136.56 78.21 1.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.365 -0.834 . . . . 0.0 109.695 -179.726 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.986 HD22 ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.87 -46.77 11.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.174 -0.954 . . . . 0.0 109.083 179.646 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -117.6 124.94 49.87 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.357 -0.839 . . . . 0.0 108.995 179.647 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.95 169.47 8.49 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.266 -0.896 . . . . 0.0 109.992 -179.543 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 51' ' ' CYS . 4.8 mt -113.86 -167.42 1.2 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 179.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.759 ' O ' HG23 ' A' ' 59' ' ' VAL . 1.4 mt-30 -88.92 -48.06 7.72 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.198 -0.939 . . . . 0.0 109.348 179.791 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.523 ' C ' HD13 ' A' ' 18' ' ' ILE . . . 154.2 161.57 10.54 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.864 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.853 ' N ' HD13 ' A' ' 18' ' ' ILE . 0.1 OUTLIER -142.98 149.67 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.378 -1.072 . . . . 0.0 109.311 179.666 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.597 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -42.94 152.08 0.38 Allowed Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.0 109.535 -179.865 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.597 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.8 Cg_endo -77.18 -2.65 12.88 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.584 2.189 . . . . 0.0 110.177 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.522 ' NZ ' ' HA ' ' A' ' 72' ' ' SER . 3.9 mmtt -90.19 -24.55 20.98 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.318 -0.864 . . . . 0.0 109.113 179.694 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.525 ' O ' ' CD2' ' A' ' 44' ' ' LEU . 6.1 m-20 -85.43 -5.88 59.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.366 -0.834 . . . . 0.0 109.323 179.75 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.798 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 9.4 mt -104.93 152.7 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.255 -0.903 . . . . 0.0 110.043 -179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.576 ' HG3' ' N ' ' A' ' 25' ' ' SER . 0.0 OUTLIER -124.98 -28.44 3.46 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 179.441 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.576 ' N ' ' HG3' ' A' ' 24' ' ' GLN . 0.9 OUTLIER -137.33 174.08 10.98 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.072 179.473 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.55 HG11 HG13 ' A' ' 63' ' ' ILE . 21.4 t -149.74 119.64 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.125 -0.985 . . . . 0.0 109.788 -179.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.629 ' O ' HD12 ' A' ' 41' ' ' ILE . 4.8 t-20 -112.85 112.7 24.37 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.361 -0.837 . . . . 0.0 109.338 179.768 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.841 HG13 HG22 ' A' ' 40' ' ' VAL . 1.8 t -116.33 109.89 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 0.0 109.489 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.567 ' CE ' ' NE2' ' A' ' 34' ' ' HIS . 7.4 tttt -107.68 107.79 18.74 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.445 -179.965 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.436 ' HA ' HG23 ' A' ' 38' ' ' THR . 1.1 p -50.66 168.42 0.23 Allowed Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.196 -0.94 . . . . 0.0 109.41 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.435 ' HD2' ' HB2' ' A' ' 30' ' ' SER . 35.8 Cg_endo -77.88 134.68 13.52 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.582 2.188 . . . . 0.0 110.422 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.8 -142.04 4.45 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.09 7.79 3.5 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.553 2.169 . . . . 0.0 110.88 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.567 ' NE2' ' CE ' ' A' ' 29' ' ' LYS . 8.0 p-80 -126.34 -7.55 6.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.079 -1.013 . . . . 0.0 109.628 179.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.446 ' SG ' ' OE2' ' A' ' 39' ' ' GLU . 4.2 t -160.3 146.47 15.46 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.288 179.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.3 0.84 23.4 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.265 -0.897 . . . . 0.0 109.708 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.432 ' CD ' ' N ' ' A' ' 37' ' ' GLN . 3.8 mp0 -126.88 124.91 40.67 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.004 . . . . 0.0 109.474 -179.868 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.436 HG23 ' HA ' ' A' ' 30' ' ' SER . 23.6 m -45.8 144.58 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.242 -0.911 . . . . 0.0 109.349 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 10' ' ' GLN . 4.6 mm-40 -122.47 107.24 11.81 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.251 -0.906 . . . . 0.0 109.664 -179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.866 HG11 HD11 ' A' ' 63' ' ' ILE . 38.5 t -91.89 150.39 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.267 -0.896 . . . . 0.0 109.135 179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.629 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.1 mt -139.87 154.67 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.11 -0.994 . . . . 0.0 109.802 -179.862 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.798 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -138.57 118.07 12.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.398 -0.814 . . . . 0.0 109.155 179.786 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.534 ' O ' ' CG ' ' A' ' 24' ' ' GLN . 1.9 m -89.16 97.83 11.42 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.907 -1.121 . . . . 0.0 108.912 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 90.8 mt -44.0 166.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.488 -0.758 . . . . 0.0 109.66 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 21' ' ' LYS . 14.3 ptpt -81.58 8.06 10.63 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.28 -0.888 . . . . 0.0 109.699 -179.839 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.515 ' ND2' ' HB2' ' A' ' 48' ' ' ARG . 0.6 OUTLIER -112.01 24.68 12.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.218 -0.926 . . . . 0.0 109.225 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.16 3.93 71.31 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 179.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.515 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 6.9 mtt180 -93.2 166.56 12.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.146 -1.208 . . . . 0.0 109.454 179.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.0 OUTLIER -136.4 155.6 49.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 0.0 109.433 -179.957 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' HB1' ' CD1' ' A' ' 15' ' ' LEU . . . -150.35 118.33 6.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.257 -0.902 . . . . 0.0 109.194 179.995 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.466 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 7.0 m -79.51 138.33 37.49 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.125 -0.984 . . . . 0.0 108.868 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.876 ' HB3' HG22 ' A' ' 59' ' ' VAL . 9.8 mt -124.0 168.61 12.6 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.214 -0.929 . . . . 0.0 109.511 -179.644 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.632 ' O ' HG21 ' A' ' 59' ' ' VAL . 65.5 t30 -101.49 121.38 51.67 Favored Pre-proline 0 C--N 1.3 -1.569 0 O-C-N 121.47 -0.769 . . . . 0.0 109.446 -179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.494 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.7 Cg_endo -74.67 -2.25 12.2 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.163 1.909 . . . . 0.0 110.488 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.58 ' HB3' ' ND2' ' A' ' 53' ' ' ASN . . . -83.8 -17.38 41.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.304 -0.873 . . . . 0.0 108.849 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.8 OUTLIER -90.27 163.08 32.76 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.471 -0.768 . . . . 0.0 109.443 179.919 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.475 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 35.9 Cg_endo -77.74 -35.32 1.51 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.638 2.226 . . . . 0.0 111.113 -179.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.626 ' O ' HD13 ' A' ' 62' ' ' ILE . 16.1 tt -67.9 -47.41 79.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 120.979 -1.076 . . . . 0.0 109.236 -179.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.876 HG22 ' HB3' ' A' ' 52' ' ' LEU . 32.7 t -55.04 -48.61 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.363 -0.835 . . . . 0.0 109.195 179.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.498 ' O ' ' HG2' ' A' ' 64' ' ' GLU . 12.0 mttt -57.36 -31.32 65.63 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.415 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.525 ' CE ' ' OE2' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -75.67 -27.59 58.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.655 -0.653 . . . . 0.0 109.342 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.65 HG23 ' CD1' ' A' ' 23' ' ' ILE . 1.7 mp -67.33 -43.25 88.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.404 -0.81 . . . . 0.0 108.832 179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.042 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.1 mp -69.53 -65.28 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.368 -0.833 . . . . 0.0 109.721 179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' OE2' ' CE ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -49.01 -35.32 15.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.131 -0.98 . . . . 0.0 109.643 -179.703 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.484 ' HB3' ' CB ' ' A' ' 20' ' ' PRO . 21.3 mmtm -63.38 -54.0 43.68 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.09 179.736 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.529 ' HG3' ' CG2' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -49.06 -46.53 44.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.314 -0.866 . . . . 0.0 109.146 179.599 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.053 HD11 ' CG2' ' B' ' 63' ' ' ILE . 1.0 OUTLIER -56.87 -47.56 80.18 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.509 179.904 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.53 31.36 2.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.267 -0.895 . . . . 0.0 109.532 -179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.437 ' O ' ' CG ' ' A' ' 70' ' ' ASP . 56.8 p -90.93 -40.53 11.65 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.138 -0.976 . . . . 0.0 109.372 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' OD2' ' O ' ' A' ' 70' ' ' ASP . 6.4 p-10 40.68 83.84 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.533 -0.73 . . . . 0.0 109.771 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 70' ' ' ASP . 12.5 mtmt 44.07 -148.99 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.54 -179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.522 ' HA ' ' NZ ' ' A' ' 21' ' ' LYS . 4.3 m -90.37 -42.63 10.82 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 109.538 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 118.002 -0.999 . . . . 0.0 109.473 179.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 6.4 m -119.97 -29.42 4.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.277 -0.89 . . . . 0.0 109.458 -179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' B' ' 4' ' ' ALA . 2.0 t -68.04 169.75 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.256 -0.902 . . . . 0.0 109.501 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . 0.654 ' O ' HG22 ' B' ' 5' ' ' THR . . . 178.06 140.29 0.09 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.198 -0.939 . . . . 0.0 109.457 179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . 0.654 HG22 ' O ' ' B' ' 4' ' ' ALA . 13.5 t 42.01 32.37 0.29 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.429 -0.794 . . . . 0.0 109.642 179.947 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -132.47 74.25 1.57 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.249 -0.907 . . . . 0.0 109.475 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.546 ' HB3' ' CB ' ' B' ' 34' ' ' HIS . 0.1 OUTLIER -116.55 98.14 6.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.594 -179.905 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.421 ' O ' ' C ' ' B' ' 9' ' ' CYS . 0.6 OUTLIER -83.96 154.74 23.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.295 -0.878 . . . . 0.0 109.019 179.579 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 1.002 ' HB2' HD22 ' B' ' 12' ' ' LEU . 7.0 m -44.44 126.18 5.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.173 -0.955 . . . . 0.0 109.374 -179.784 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.499 ' NE2' ' HG2' ' B' ' 29' ' ' LYS . 0.9 OUTLIER -41.02 -38.39 0.99 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.521 -0.737 . . . . 0.0 109.829 -179.975 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.464 ' SG ' HG13 ' B' ' 41' ' ' ILE . 72.5 m -136.58 78.26 1.69 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.343 -0.848 . . . . 0.0 109.736 -179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 1.002 HD22 ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -45.0 -46.74 11.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.059 179.71 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -117.57 125.06 50.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 108.968 179.587 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.99 169.42 8.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.215 -0.928 . . . . 0.0 109.992 -179.554 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' B' ' 51' ' ' CYS . 4.9 mt -113.89 -167.41 1.2 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 179.733 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.755 ' O ' HG23 ' B' ' 59' ' ' VAL . 1.4 mt-30 -88.86 -48.17 7.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.126 -0.984 . . . . 0.0 109.299 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.51 ' C ' HD13 ' B' ' 18' ' ' ILE . . . 154.26 161.55 10.53 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.843 HD13 ' N ' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -143.0 149.79 18.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.357 -1.084 . . . . 0.0 109.267 179.589 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.592 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 0.1 OUTLIER -42.98 152.12 0.38 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.356 -0.84 . . . . 0.0 109.468 -179.851 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.592 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.3 Cg_endo -77.28 -2.67 12.88 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.498 2.132 . . . . 0.0 110.092 179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.51 ' NZ ' ' HA ' ' B' ' 72' ' ' SER . 3.9 mmtt -90.06 -24.61 21.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.345 -0.847 . . . . 0.0 109.178 179.666 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.529 ' O ' ' CD2' ' B' ' 44' ' ' LEU . 6.1 m-20 -85.33 -5.96 59.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.296 -0.878 . . . . 0.0 109.364 179.748 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.8 ' CG2' ' HB1' ' B' ' 42' ' ' ALA . 9.2 mt -104.89 152.57 6.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.202 -0.936 . . . . 0.0 110.089 -179.627 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.572 ' HG3' ' N ' ' B' ' 25' ' ' SER . 0.0 OUTLIER -124.9 -28.46 3.48 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.479 -0.763 . . . . 0.0 109.084 179.355 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.572 ' N ' ' HG3' ' B' ' 24' ' ' GLN . 0.9 OUTLIER -137.24 174.2 10.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.258 -0.902 . . . . 0.0 109.076 179.436 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.541 HG11 HG13 ' B' ' 63' ' ' ILE . 21.4 t -149.86 119.66 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.045 -1.034 . . . . 0.0 109.707 -179.906 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.633 ' O ' HD12 ' B' ' 41' ' ' ILE . 4.8 t-20 -112.89 112.71 24.37 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.293 -0.88 . . . . 0.0 109.344 179.717 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.847 HG13 HG22 ' B' ' 40' ' ' VAL . 1.8 t -116.31 109.9 29.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.893 . . . . 0.0 109.403 -179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.573 ' CE ' ' NE2' ' B' ' 34' ' ' HIS . 7.4 tttt -107.62 107.8 18.78 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.31 -0.869 . . . . 0.0 109.444 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.447 ' HA ' HG23 ' B' ' 38' ' ' THR . 1.1 p -50.7 168.48 0.23 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 0.0 109.459 179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.419 ' HD2' ' HB2' ' B' ' 30' ' ' SER . 36.0 Cg_endo -77.89 134.65 13.49 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.666 2.244 . . . . 0.0 110.424 179.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -135.81 -142.01 4.44 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.922 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -77.1 7.75 3.52 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.651 2.234 . . . . 0.0 110.816 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.573 ' NE2' ' CE ' ' B' ' 29' ' ' LYS . 8.0 p-80 -126.35 -7.59 6.4 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.14 -0.975 . . . . 0.0 109.608 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.444 ' SG ' ' OE2' ' B' ' 39' ' ' GLU . 4.2 t -160.23 146.52 15.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.238 -0.914 . . . . 0.0 109.287 179.76 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.29 0.76 23.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.151 -0.968 . . . . 0.0 109.706 -179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.42 ' CD ' ' N ' ' B' ' 37' ' ' GLN . 3.9 mp0 -126.88 125.01 40.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.129 -0.982 . . . . 0.0 109.506 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.447 HG23 ' HA ' ' B' ' 30' ' ' SER . 23.8 m -45.78 144.58 1.67 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.263 -0.898 . . . . 0.0 109.307 179.875 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.493 ' HB2' ' HB2' ' B' ' 10' ' ' GLN . 4.6 mm-40 -122.48 107.24 11.8 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.169 -0.957 . . . . 0.0 109.624 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.847 HG22 HG13 ' B' ' 28' ' ' VAL . 38.6 t -91.84 150.35 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.265 -0.897 . . . . 0.0 109.199 179.772 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.633 HD12 ' O ' ' B' ' 27' ' ' ASN . 3.1 mt -139.89 154.79 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.157 -0.964 . . . . 0.0 109.785 -179.935 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.8 ' HB1' ' CG2' ' B' ' 23' ' ' ILE . . . -138.61 118.02 12.86 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.346 -0.846 . . . . 0.0 109.117 179.902 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.522 ' O ' ' CG ' ' B' ' 24' ' ' GLN . 1.8 m -89.18 97.74 11.37 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.036 -1.04 . . . . 0.0 108.966 -179.928 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 90.8 mt -43.95 166.73 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.456 -0.778 . . . . 0.0 109.617 -179.78 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.467 ' HE3' ' O ' ' B' ' 21' ' ' LYS . 14.3 ptpt -81.64 8.12 10.61 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.339 -0.851 . . . . 0.0 109.664 -179.794 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.509 ' ND2' ' HB2' ' B' ' 48' ' ' ARG . 0.6 OUTLIER -112.02 24.64 12.41 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 109.227 179.726 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 75.1 4.01 71.21 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.951 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.509 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 6.9 mtt180 -93.23 166.51 12.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.164 -1.197 . . . . 0.0 109.499 179.88 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.521 ' HD2' ' N ' ' B' ' 49' ' ' LYS . 0.0 OUTLIER -136.38 155.7 49.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.427 179.979 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . 0.413 ' HB1' ' CD1' ' B' ' 15' ' ' LEU . . . -150.4 118.39 6.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 109.143 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 6.9 m -79.56 138.31 37.44 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.124 -0.985 . . . . 0.0 108.83 179.69 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.84 ' HB3' HG22 ' B' ' 59' ' ' VAL . 9.7 mt -123.95 168.58 12.62 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.129 -0.982 . . . . 0.0 109.581 -179.673 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.63 ' O ' HG21 ' B' ' 59' ' ' VAL . 65.5 t30 -101.56 121.5 51.12 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.44 -0.787 . . . . 0.0 109.458 -179.744 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.491 ' HB3' HG21 ' B' ' 40' ' ' VAL . 33.2 Cg_endo -74.79 -2.18 12.14 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.182 1.921 . . . . 0.0 110.462 -179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . 0.569 ' HB3' ' ND2' ' B' ' 53' ' ' ASN . . . -83.85 -17.45 40.9 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.243 -0.911 . . . . 0.0 108.763 179.385 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.8 OUTLIER -90.25 163.15 32.53 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.442 -0.786 . . . . 0.0 109.433 179.963 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.471 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.74 -35.47 1.47 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.781 2.321 . . . . 0.0 111.082 -179.687 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.62 ' O ' HD13 ' B' ' 62' ' ' ILE . 16.2 tt -67.83 -47.56 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.001 -1.062 . . . . 0.0 109.189 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 0.84 HG22 ' HB3' ' B' ' 52' ' ' LEU . 33.1 t -54.97 -48.71 75.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.465 -0.772 . . . . 0.0 109.135 179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.497 ' O ' ' HG2' ' B' ' 64' ' ' GLU . 12.0 mttt -57.21 -31.37 65.4 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.22 -0.925 . . . . 0.0 108.514 179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.514 ' CE ' ' OE2' ' B' ' 64' ' ' GLU . 0.7 OUTLIER -75.67 -27.6 58.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.543 -0.723 . . . . 0.0 109.317 179.947 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 0.65 HG23 ' CD1' ' B' ' 23' ' ' ILE . 1.7 mp -67.44 -43.26 87.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 179.795 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 1.053 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.1 mp -69.56 -65.31 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.353 -0.842 . . . . 0.0 109.679 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.514 ' OE2' ' CE ' ' B' ' 61' ' ' LYS . 0.0 OUTLIER -49.04 -35.3 15.36 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.944 . . . . 0.0 109.538 -179.62 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.486 ' HB3' ' CB ' ' B' ' 20' ' ' PRO . 21.3 mmtm -63.35 -54.02 43.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.215 -0.928 . . . . 0.0 109.069 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.526 ' HG3' ' CG2' ' B' ' 26' ' ' VAL . 1.0 OUTLIER -49.2 -46.27 45.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.341 -0.849 . . . . 0.0 109.222 179.664 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 1.042 HD11 ' CG2' ' A' ' 63' ' ' ILE . 1.0 OUTLIER -56.96 -47.56 80.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.436 -0.79 . . . . 0.0 109.453 179.871 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -96.49 31.32 2.29 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.947 . . . . 0.0 109.572 -179.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.428 ' O ' ' C ' ' B' ' 70' ' ' ASP . 56.9 p -90.95 -40.64 11.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.364 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.446 ' OD2' ' O ' ' B' ' 70' ' ' ASP . 6.4 p-10 40.82 83.64 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.549 -0.719 . . . . 0.0 109.781 179.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 12.7 mtmt 44.27 -149.01 0.06 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 0.0 109.437 -179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.51 ' HA ' ' NZ ' ' B' ' 21' ' ' LYS . 4.3 m -90.35 -42.68 10.8 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.524 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.045 -0.979 . . . . 0.0 109.423 -179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.457 ' O ' ' O ' ' A' ' 1' ' ' ALA . 6.1 t 61.5 136.51 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.322 -0.861 . . . . 0.0 109.476 -179.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 3' ' ' VAL . 7.3 p -148.97 68.22 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.335 -0.853 . . . . 0.0 109.427 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.06 111.72 18.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 109.469 179.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.5 t -101.79 -32.07 10.45 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.24 -0.912 . . . . 0.0 109.438 -179.991 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.63 27.57 0.49 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.483 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.667 HD22 ' CD2' ' A' ' 34' ' ' HIS . 0.2 OUTLIER -132.28 106.01 7.66 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.278 -0.888 . . . . 0.0 109.601 -179.933 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.418 ' O ' ' C ' ' A' ' 9' ' ' CYS . 1.7 mtm180 -107.51 155.96 19.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.333 -0.854 . . . . 0.0 108.986 179.607 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.544 ' HB2' ' CD2' ' A' ' 12' ' ' LEU . 9.6 m -44.48 107.99 0.11 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.392 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.501 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 47.0 mm-40 -49.87 -21.21 1.08 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.281 -0.887 . . . . 0.0 109.646 -179.908 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.468 ' SG ' HG13 ' A' ' 41' ' ' ILE . 83.1 m -141.47 71.43 1.36 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.598 -179.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.544 ' CD2' ' HB2' ' A' ' 9' ' ' CYS . 0.2 OUTLIER -44.29 -44.58 8.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.0 109.219 179.727 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.54 121.12 37.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.418 -0.801 . . . . 0.0 109.228 179.805 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -98.02 160.53 14.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.333 -0.854 . . . . 0.0 109.807 -179.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.6 ' HB2' HD23 ' A' ' 52' ' ' LEU . 4.5 mt -103.69 142.78 33.75 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.426 ' C ' ' O ' ' A' ' 15' ' ' LEU . 1.4 tt0 -44.75 -26.59 0.41 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.124 -0.985 . . . . 0.0 109.125 179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.542 ' HA3' ' CG2' ' A' ' 58' ' ' ILE . . . 154.86 -178.91 31.31 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.644 ' H ' HD11 ' A' ' 62' ' ' ILE . 4.6 tp -155.72 170.62 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.501 -1.0 . . . . 0.0 108.925 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.59 ' CG ' ' HD2' ' A' ' 20' ' ' PRO . 1.6 t-80 -60.0 143.71 87.59 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.068 -1.02 . . . . 0.0 108.973 179.768 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.59 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 34.7 Cg_endo -77.26 -24.64 9.22 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.443 2.095 . . . . 0.0 110.267 -179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.464 ' O ' ' HE2' ' A' ' 45' ' ' LYS . 13.2 mttm -90.52 -13.74 34.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.405 -0.81 . . . . 0.0 109.175 179.782 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.571 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 92.4 m-20 -80.18 -15.34 57.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.374 -0.829 . . . . 0.0 109.506 -179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.921 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 6.9 mt -90.0 162.46 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.415 -0.803 . . . . 0.0 110.696 -178.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.521 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -128.61 -39.65 1.63 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.198 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 1.5 p -126.86 172.09 10.7 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.304 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 41' ' ' ILE . 78.4 t -143.97 93.52 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.993 -1.067 . . . . 0.0 109.716 -179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.481 ' O ' HD12 ' A' ' 41' ' ' ILE . 3.4 t-20 -86.85 108.72 18.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.234 -0.916 . . . . 0.0 109.319 179.747 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' B' ' 25' ' ' SER . 1.8 t -104.66 94.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.937 . . . . 0.0 109.545 -179.896 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.501 ' HE2' ' HG3' ' A' ' 10' ' ' GLN . 3.6 tppt? -90.6 92.58 8.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.207 -0.933 . . . . 0.0 109.443 179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.521 ' HB3' ' CE ' ' B' ' 66' ' ' MET . 1.0 OUTLIER -45.99 170.96 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.488 -179.971 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.482 ' HB3' ' O ' ' A' ' 36' ' ' ALA . 35.6 Cg_endo -77.76 140.08 18.27 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.644 2.229 . . . . 0.0 110.458 179.914 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.91 -142.44 3.66 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 -179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -79.82 39.22 0.81 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.689 2.259 . . . . 0.0 110.782 179.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.667 ' CD2' HD22 ' A' ' 7' ' ' LEU . 6.0 p-80 -158.67 -38.64 0.06 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.012 -1.055 . . . . 0.0 109.301 179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 31' ' ' PRO . 1.8 t -138.01 102.18 4.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.218 -0.926 . . . . 0.0 109.277 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.482 ' O ' ' HB3' ' A' ' 31' ' ' PRO . . . -62.99 -29.16 70.61 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.235 -0.916 . . . . 0.0 109.699 -179.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.71 125.73 34.57 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.21 -0.931 . . . . 0.0 109.528 -179.936 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.415 HG23 ' HA ' ' A' ' 30' ' ' SER . 73.5 m -48.54 148.81 1.87 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 0.0 109.269 179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.45 ' OE1' ' HB2' ' A' ' 11' ' ' CYS . 21.5 mm-40 -125.07 123.46 39.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.148 -0.97 . . . . 0.0 109.628 -179.901 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.605 HG11 HD11 ' A' ' 63' ' ' ILE . 16.8 t -107.55 145.53 14.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.263 -0.898 . . . . 0.0 109.266 179.907 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.481 HD12 ' O ' ' A' ' 27' ' ' ASN . 3.6 mp -134.88 144.29 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.634 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.921 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -131.27 117.71 19.35 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.344 -0.848 . . . . 0.0 109.301 179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 3.4 m -89.29 95.83 10.46 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.949 -1.094 . . . . 0.0 108.896 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' A' ' 22' ' ' ASN . 85.1 mt -42.16 163.69 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.548 -0.72 . . . . 0.0 109.962 -179.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.52 ' HB3' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -81.01 10.77 4.69 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.358 -0.838 . . . . 0.0 109.872 179.905 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.494 ' OD1' ' HB3' ' A' ' 44' ' ' LEU . 0.6 OUTLIER -110.71 14.0 22.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.13 -0.982 . . . . 0.0 109.225 179.61 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.07 15.82 68.8 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.471 ' HB2' ' ND2' ' A' ' 46' ' ' ASN . 8.9 mtp-105 -108.04 175.63 5.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.258 -1.142 . . . . 0.0 109.414 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.439 ' N ' ' CD ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -143.29 152.47 41.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 109.357 179.974 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.21 122.23 8.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.331 -0.856 . . . . 0.0 108.898 179.851 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.455 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 23.0 m -79.76 143.16 34.73 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.137 -0.977 . . . . 0.0 109.277 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.945 HD13 HD13 ' A' ' 62' ' ' ILE . 18.7 mt -128.19 168.03 16.01 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.444 -0.785 . . . . 0.0 109.081 179.791 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.641 ' O ' HG21 ' A' ' 59' ' ' VAL . 2.5 t-20 -104.87 127.72 28.23 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.272 -0.892 . . . . 0.0 109.47 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.527 ' O ' ' CE ' ' A' ' 60' ' ' LYS . 33.8 Cg_endo -75.46 -11.56 20.66 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.33 2.02 . . . . 0.0 110.49 -179.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.12 -17.41 61.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.102 -0.999 . . . . 0.0 108.969 179.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.485 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.6 OUTLIER -90.27 162.15 35.44 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.363 -0.836 . . . . 0.0 109.498 179.941 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -78.08 -35.08 1.43 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.702 2.268 . . . . 0.0 111.098 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.548 HG23 ' N ' ' A' ' 59' ' ' VAL . 2.9 tt -68.24 -45.15 83.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.065 -1.022 . . . . 0.0 109.397 -179.654 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.999 ' HA ' HD12 ' A' ' 62' ' ' ILE . 40.3 t -59.04 -45.87 92.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.301 -0.874 . . . . 0.0 109.024 179.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 54' ' ' PRO . 18.2 mttt -60.08 -29.39 68.54 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 179.346 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' O ' ' CB ' ' A' ' 65' ' ' LYS . 2.5 mmpt? -79.55 -23.54 42.75 Favored 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.784 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.999 HD12 ' HA ' ' A' ' 59' ' ' VAL . 20.5 mt -70.85 -37.91 70.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.92 ' CG2' HD11 ' B' ' 67' ' ' LEU . 2.2 mp -74.69 -56.74 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.475 -0.765 . . . . 0.0 109.296 179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.514 ' HG3' ' N ' ' A' ' 65' ' ' LYS . 0.2 OUTLIER -59.36 -28.12 66.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.162 -0.962 . . . . 0.0 109.226 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.514 ' N ' ' HG3' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -70.61 -52.06 23.95 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.273 -0.892 . . . . 0.0 108.914 179.611 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.528 ' CE ' ' HB3' ' B' ' 30' ' ' SER . 0.4 OUTLIER -49.58 -44.37 46.88 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.276 -0.89 . . . . 0.0 108.949 179.473 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.929 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -55.08 -59.17 5.13 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.547 -0.72 . . . . 0.0 109.566 179.921 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -79.89 5.33 14.1 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.725 -179.731 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.478 ' HB3' ' HA ' ' A' ' 66' ' ' MET . 85.6 p -55.43 -55.85 26.95 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -0.939 . . . . 0.0 109.393 -179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 72' ' ' SER . 80.0 m-20 -72.94 -9.92 59.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.314 -0.866 . . . . 0.0 109.507 -179.982 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 70' ' ' ASP . 4.2 mtpt 43.28 -94.15 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.314 -0.866 . . . . 0.0 109.657 179.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . 0.523 ' N ' ' O ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -166.08 -73.42 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.126 -0.984 . . . . 0.0 109.464 -179.988 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.472 179.987 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.46 ' O ' ' O ' ' B' ' 1' ' ' ALA . 6.1 t 61.46 136.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.231 -0.918 . . . . 0.0 109.499 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.618 HG13 ' O ' ' B' ' 3' ' ' VAL . 7.3 p -148.92 68.19 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.278 -0.889 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -120.06 111.61 18.09 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.32 -0.862 . . . . 0.0 109.489 179.954 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 9.4 t -101.61 -32.09 10.51 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.232 -0.918 . . . . 0.0 109.536 179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -153.64 27.64 0.49 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 0.0 109.522 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.659 HD22 ' CD2' ' B' ' 34' ' ' HIS . 0.2 OUTLIER -132.36 106.06 7.67 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.217 -0.927 . . . . 0.0 109.614 179.99 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 1.7 mtm180 -107.46 155.97 19.48 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.392 -0.817 . . . . 0.0 109.013 179.653 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.534 ' HB2' ' CD2' ' B' ' 12' ' ' LEU . 9.3 m -44.55 108.02 0.11 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.168 -0.958 . . . . 0.0 109.333 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.479 ' HG3' ' HE2' ' B' ' 29' ' ' LYS . 47.1 mm-40 -49.85 -21.13 1.04 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.308 -0.87 . . . . 0.0 109.713 -179.971 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.468 ' SG ' HG13 ' B' ' 41' ' ' ILE . 82.6 m -141.59 71.35 1.36 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.062 -1.024 . . . . 0.0 109.652 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' B' ' 9' ' ' CYS . 0.2 OUTLIER -44.25 -44.55 8.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.232 179.789 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -120.55 121.11 37.7 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.423 -0.798 . . . . 0.0 109.252 179.767 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.96 160.44 14.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.281 -0.887 . . . . 0.0 109.807 -179.671 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.59 ' HB2' HD23 ' B' ' 52' ' ' LEU . 4.4 mt -103.65 142.76 33.76 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.407 ' C ' ' O ' ' B' ' 15' ' ' LEU . 1.4 tt0 -44.73 -26.56 0.4 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.192 -0.942 . . . . 0.0 109.157 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.538 ' HA3' ' CG2' ' B' ' 58' ' ' ILE . . . 154.8 -178.92 31.26 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.664 -1.375 . . . . 0.0 109.664 179.647 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.631 ' H ' HD11 ' B' ' 62' ' ' ILE . 4.6 tp -155.7 170.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.467 -1.019 . . . . 0.0 108.963 -179.553 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.585 ' CG ' ' HD2' ' B' ' 20' ' ' PRO . 1.6 t-80 -59.98 143.71 87.5 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 108.993 179.723 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.585 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 34.8 Cg_endo -77.26 -24.69 9.17 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.51 2.14 . . . . 0.0 110.318 -179.887 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.455 ' O ' ' HE2' ' B' ' 45' ' ' LYS . 13.2 mttm -90.42 -13.81 34.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.819 . . . . 0.0 109.235 179.697 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.581 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 92.5 m-20 -80.12 -15.45 57.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.303 -0.873 . . . . 0.0 109.488 -179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.928 HG23 ' HB1' ' B' ' 42' ' ' ALA . 6.9 mt -90.08 162.43 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.43 -0.794 . . . . 0.0 110.668 -178.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.526 ' CB ' ' O ' ' B' ' 43' ' ' THR . 0.2 OUTLIER -128.61 -39.65 1.63 Allowed 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 179.273 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 1.5 p -126.79 172.07 10.68 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.321 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' B' ' 41' ' ' ILE . 77.8 t -144.05 93.6 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.004 -1.06 . . . . 0.0 109.703 -179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.475 ' HB3' ' HB ' ' B' ' 41' ' ' ILE . 3.4 t-20 -86.85 108.77 18.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.32 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 25' ' ' SER . 1.8 t -104.63 94.35 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.2 -0.938 . . . . 0.0 109.609 -179.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.479 ' HE2' ' HG3' ' B' ' 10' ' ' GLN . 3.6 tppt? -90.67 92.64 8.91 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.19 -0.944 . . . . 0.0 109.423 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.528 ' HB3' ' CE ' ' A' ' 66' ' ' MET . 1.0 OUTLIER -46.11 171.03 0.06 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.212 -0.93 . . . . 0.0 109.483 -179.919 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' B' ' 36' ' ' ALA . 35.9 Cg_endo -77.86 140.11 18.08 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.574 2.183 . . . . 0.0 110.473 179.983 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.9 -142.49 3.67 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.344 -1.503 . . . . 0.0 109.344 -179.921 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -79.74 39.16 0.8 Allowed 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.666 2.244 . . . . 0.0 110.893 179.746 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.659 ' CD2' HD22 ' B' ' 7' ' ' LEU . 6.0 p-80 -158.7 -38.52 0.06 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.07 -1.019 . . . . 0.0 109.32 179.98 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . 0.472 ' O ' ' HA ' ' B' ' 31' ' ' PRO . 1.8 t -138.14 102.21 4.61 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.293 -0.879 . . . . 0.0 109.231 179.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.483 ' O ' ' HB3' ' B' ' 31' ' ' PRO . . . -62.92 -29.23 70.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.332 -0.855 . . . . 0.0 109.706 -179.777 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -87.68 125.67 34.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.954 . . . . 0.0 109.561 -179.902 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.439 HG23 ' HA ' ' B' ' 30' ' ' SER . 71.8 m -48.53 148.77 1.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.917 . . . . 0.0 109.34 179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . 0.441 ' OE1' ' HB2' ' B' ' 11' ' ' CYS . 21.5 mm-40 -125.05 123.4 39.71 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.613 -179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.628 HG11 HD11 ' B' ' 63' ' ' ILE . 16.7 t -107.44 145.58 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.275 -0.89 . . . . 0.0 109.337 179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.475 ' HB ' ' HB3' ' B' ' 27' ' ' ASN . 3.6 mp -134.92 144.33 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.182 -0.949 . . . . 0.0 109.605 -179.865 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.928 ' HB1' HG23 ' B' ' 23' ' ' ILE . . . -131.37 117.73 19.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.276 -0.89 . . . . 0.0 109.292 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.526 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 3.4 m -89.36 95.88 10.47 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.894 -1.129 . . . . 0.0 108.949 179.966 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' B' ' 22' ' ' ASN . 85.1 mt -42.07 163.63 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.529 -0.732 . . . . 0.0 109.926 -179.721 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.509 ' HB3' ' NZ ' ' B' ' 45' ' ' LYS . 0.0 OUTLIER -81.02 10.83 4.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.377 -0.827 . . . . 0.0 109.838 179.873 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.489 ' OD1' ' HB3' ' B' ' 44' ' ' LEU . 0.6 OUTLIER -110.77 13.96 22.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.142 179.678 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.08 15.79 68.85 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.943 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.467 ' HB2' ' ND2' ' B' ' 46' ' ' ASN . 8.9 mtp-105 -108.05 175.57 5.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -1.135 . . . . 0.0 109.484 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.438 ' CD ' ' N ' ' B' ' 49' ' ' LYS . 0.3 OUTLIER -143.23 152.46 41.74 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.274 -0.891 . . . . 0.0 109.438 179.952 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.18 122.2 8.24 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.244 -0.91 . . . . 0.0 108.983 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.452 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 23.0 m -79.77 143.19 34.68 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.166 -0.959 . . . . 0.0 109.308 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.967 HD13 HD13 ' B' ' 62' ' ' ILE . 18.7 mt -128.24 167.97 16.13 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.343 -0.848 . . . . 0.0 109.013 179.946 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.637 ' O ' HG21 ' B' ' 59' ' ' VAL . 2.6 t-20 -104.96 127.81 27.98 Favored Pre-proline 0 C--N 1.3 -1.565 0 O-C-N 121.272 -0.892 . . . . 0.0 109.425 -179.383 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.526 ' O ' ' CE ' ' B' ' 60' ' ' LYS . 33.9 Cg_endo -75.5 -11.59 20.58 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.349 2.033 . . . . 0.0 110.45 -179.675 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -73.07 -17.36 61.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.226 -0.921 . . . . 0.0 109.09 179.542 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.487 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.6 OUTLIER -90.29 162.16 35.37 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.385 -0.822 . . . . 0.0 109.504 179.916 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.417 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.3 Cg_endo -78.1 -35.12 1.41 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.762 2.308 . . . . 0.0 111.086 -179.572 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . 0.566 HG23 ' N ' ' B' ' 59' ' ' VAL . 2.9 tt -68.19 -45.19 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.065 -1.022 . . . . 0.0 109.424 -179.684 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 1.018 ' HA ' HD12 ' B' ' 62' ' ' ILE . 40.5 t -58.9 -45.96 91.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.056 179.676 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' B' ' 54' ' ' PRO . 18.2 mttt -60.06 -29.47 68.57 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.468 ' O ' ' CB ' ' B' ' 65' ' ' LYS . 2.5 mmpt? -79.53 -23.44 42.87 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 1.018 HD12 ' HA ' ' B' ' 59' ' ' VAL . 20.5 mt -70.94 -37.81 69.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.643 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 0.929 ' CG2' HD11 ' A' ' 67' ' ' LEU . 2.2 mp -74.68 -56.73 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.318 -0.864 . . . . 0.0 109.322 179.895 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.515 ' HG3' ' N ' ' B' ' 65' ' ' LYS . 0.3 OUTLIER -59.35 -28.06 66.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.22 -0.925 . . . . 0.0 109.329 179.838 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.515 ' N ' ' HG3' ' B' ' 64' ' ' GLU . 0.0 OUTLIER -70.64 -52.09 23.6 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.242 -0.911 . . . . 0.0 108.909 179.603 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.521 ' CE ' ' HB3' ' A' ' 30' ' ' SER . 0.5 OUTLIER -49.59 -44.37 46.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.288 -0.882 . . . . 0.0 109.009 179.422 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.92 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -55.02 -59.19 5.09 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.49 -0.756 . . . . 0.0 109.65 179.84 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . 0.401 ' O ' ' HG3' ' B' ' 71' ' ' LYS . 4.3 t-20 -79.87 5.34 13.99 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.927 . . . . 0.0 109.76 -179.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.468 ' HB3' ' HA ' ' B' ' 66' ' ' MET . 85.5 p -55.42 -55.83 27.2 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.185 -0.947 . . . . 0.0 109.448 179.961 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.526 ' O ' ' N ' ' B' ' 72' ' ' SER . 79.9 m-20 -72.86 -10.12 59.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 0.0 109.43 179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . 0.401 ' HG3' ' O ' ' B' ' 68' ' ' ASN . 4.3 mtpt 43.35 -94.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.326 -0.859 . . . . 0.0 109.614 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . 0.526 ' N ' ' O ' ' B' ' 70' ' ' ASP . 1.0 OUTLIER -166.03 -73.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.184 -0.948 . . . . 0.0 109.476 179.977 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.495 -179.983 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.315 0.579 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.9 t -114.86 -48.29 2.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.921 . . . . 0.0 109.432 -179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 25.2 m -112.64 168.66 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.552 179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.22 134.25 14.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.189 -0.944 . . . . 0.0 109.463 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.6 m -157.74 115.66 3.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.337 -0.852 . . . . 0.0 109.459 -179.952 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.462 ' O ' ' HG ' ' A' ' 7' ' ' LEU . 1.7 tp10 -128.59 -144.12 0.28 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.264 -0.897 . . . . 0.0 109.187 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.711 HD22 ' CD2' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -159.96 121.07 3.11 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.285 -0.884 . . . . 0.0 109.585 179.996 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.419 ' O ' ' C ' ' A' ' 9' ' ' CYS . 4.4 mtm180 -134.52 159.68 40.4 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.368 -0.832 . . . . 0.0 108.984 179.728 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.498 ' HB2' HD23 ' A' ' 12' ' ' LEU . 18.7 m -44.57 105.23 0.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.12 -0.988 . . . . 0.0 109.297 -179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.498 ' HG3' ' HD3' ' A' ' 29' ' ' LYS . 19.1 mm-40 -64.68 -8.06 13.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.318 -0.864 . . . . 0.0 109.816 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.471 ' SG ' HG13 ' A' ' 41' ' ' ILE . 73.8 m -144.66 71.66 1.31 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.066 -1.021 . . . . 0.0 109.711 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.498 HD23 ' HB2' ' A' ' 9' ' ' CYS . 52.4 mt -46.29 -42.49 14.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 0.0 109.187 179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -119.76 122.09 40.62 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.317 -0.864 . . . . 0.0 109.114 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.46 ' OG1' ' OD1' ' A' ' 53' ' ' ASN . 0.6 OUTLIER -101.21 158.73 15.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.213 -0.929 . . . . 0.0 109.834 -179.702 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.527 ' HB2' HD23 ' A' ' 52' ' ' LEU . 3.5 mt -102.85 139.92 37.8 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.677 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.441 ' C ' ' O ' ' A' ' 15' ' ' LEU . 0.6 OUTLIER -43.96 -26.89 0.31 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.222 179.943 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 15' ' ' LEU . . . 157.98 -179.89 33.36 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.659 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.797 ' H ' HD11 ' A' ' 62' ' ' ILE . 4.6 tp -154.98 170.91 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.548 -0.972 . . . . 0.0 108.801 -179.517 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.58 ' CB ' ' ND2' ' A' ' 22' ' ' ASN . 3.4 t-80 -59.19 141.97 86.43 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 120.985 -1.072 . . . . 0.0 109.055 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 19' ' ' HIS . 35.3 Cg_endo -77.59 -23.62 9.63 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.499 2.133 . . . . 0.0 110.273 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.52 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 9.5 mmtp -90.25 -15.09 32.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.434 -0.791 . . . . 0.0 109.129 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.58 ' ND2' ' CB ' ' A' ' 19' ' ' HIS . 84.8 m-20 -78.94 -27.76 43.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.44 -0.788 . . . . 0.0 109.377 179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.804 HG12 ' HB1' ' A' ' 42' ' ' ALA . 6.5 mt -77.44 163.7 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 CA-C-O 121.828 0.823 . . . . 0.0 110.697 -179.014 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.555 ' N ' HG22 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -129.62 -41.26 1.35 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.109 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' B' ' 28' ' ' VAL . 10.9 p -124.97 166.69 15.88 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.075 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.738 ' O ' HG23 ' B' ' 28' ' ' VAL . 50.8 t -145.2 98.79 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.051 -1.03 . . . . 0.0 109.772 -179.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' B' ' 27' ' ' ASN . 49.8 t-20 -84.35 133.23 34.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.189 -0.944 . . . . 0.0 109.383 179.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.739 HG23 ' O ' ' B' ' 26' ' ' VAL . 2.2 t -118.08 82.34 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.128 -0.982 . . . . 0.0 109.516 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HD3' ' HG3' ' A' ' 10' ' ' GLN . 20.9 mtpt -87.32 103.62 15.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.524 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.459 ' HB3' ' O ' ' B' ' 24' ' ' GLN . 1.1 p -57.63 163.8 3.49 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 109.334 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.44 132.21 12.16 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.598 2.199 . . . . 0.0 110.473 179.933 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.73 -141.13 3.68 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.449 -1.461 . . . . 0.0 109.449 -179.818 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -77.06 7.61 3.57 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.663 2.242 . . . . 0.0 110.852 179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.711 ' CD2' HD22 ' A' ' 7' ' ' LEU . 6.4 p-80 -124.88 -14.82 6.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.059 -1.026 . . . . 0.0 109.775 179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.38 125.56 3.89 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.106 -0.996 . . . . 0.0 109.363 179.755 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.42 ' O ' ' CD ' ' A' ' 37' ' ' GLN . . . -87.19 17.49 4.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.617 -179.822 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . 0.42 ' CD ' ' O ' ' A' ' 36' ' ' ALA . 9.6 mm-40 -143.36 125.77 15.71 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.924 . . . . 0.0 109.524 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.502 ' HB ' ' HG3' ' A' ' 54' ' ' PRO . 3.2 m -44.32 157.68 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.0 109.313 179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -132.64 107.1 8.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -0.932 . . . . 0.0 109.576 -179.956 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 1.006 HG11 HD11 ' A' ' 63' ' ' ILE . 1.7 t -101.98 93.64 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.248 -0.907 . . . . 0.0 109.269 179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.471 HG13 ' SG ' ' A' ' 11' ' ' CYS . 3.4 mp -82.18 150.41 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.239 -0.913 . . . . 0.0 109.724 -179.773 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.804 ' HB1' HG12 ' A' ' 23' ' ' ILE . . . -132.65 114.91 14.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.404 -0.81 . . . . 0.0 108.994 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' GLN . 4.3 m -89.22 98.16 11.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.879 -1.138 . . . . 0.0 108.992 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 93.1 mt -41.14 163.28 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-O 121.305 0.574 . . . . 0.0 109.931 -179.715 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.52 ' CE ' ' O ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -82.06 11.09 5.52 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 0.0 109.921 -179.785 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' A' ' 44' ' ' LEU . 23.4 p-10 -112.56 8.09 19.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.076 -1.015 . . . . 0.0 109.419 179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.59 1.66 63.82 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.463 ' HB2' HD12 ' A' ' 44' ' ' LEU . 19.4 mtt180 -96.57 165.63 12.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.171 -1.194 . . . . 0.0 109.545 179.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.421 ' HG2' ' C ' ' A' ' 48' ' ' ARG . 2.2 mttt -133.02 153.16 51.76 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.198 -0.939 . . . . 0.0 109.466 -179.932 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.3 123.39 8.83 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.242 -0.911 . . . . 0.0 108.908 179.822 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' CYS . . . . . 0.46 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 35.6 m -79.62 140.94 36.94 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.072 -1.017 . . . . 0.0 109.305 -179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.958 HD13 HD13 ' A' ' 62' ' ' ILE . 16.0 mt -125.37 168.24 13.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.379 -0.826 . . . . 0.0 109.224 -179.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.621 ' O ' HG21 ' A' ' 59' ' ' VAL . 1.6 m-20 -106.28 124.84 34.53 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.308 -0.87 . . . . 0.0 109.434 -179.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.502 ' HG3' ' HB ' ' A' ' 38' ' ' THR . 33.5 Cg_endo -75.26 -7.01 18.57 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.359 2.039 . . . . 0.0 110.327 -179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.88 -17.52 50.36 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.227 -0.921 . . . . 0.0 108.963 179.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.49 ' O ' ' HG3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -90.11 163.7 30.75 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.413 -0.804 . . . . 0.0 109.321 179.866 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.443 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 36.2 Cg_endo -77.45 -36.55 1.23 Allowed 'Trans proline' 0 C--N 1.307 -1.605 0 C-N-CA 122.589 2.193 . . . . 0.0 110.678 -179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 52.4 mt -61.47 -48.07 90.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.909 . . . . 0.0 109.539 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.986 ' HA ' HD12 ' A' ' 62' ' ' ILE . 76.6 t -62.25 -50.0 81.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.353 -0.842 . . . . 0.0 109.615 -179.949 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 56' ' ' SER . 6.0 mttt -51.24 -30.72 18.43 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.122 -0.986 . . . . 0.0 108.722 179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.483 ' HA ' ' HG2' ' A' ' 64' ' ' GLU . 0.0 OUTLIER -78.45 -34.54 47.67 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.859 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.986 HD12 ' HA ' ' A' ' 59' ' ' VAL . 14.2 mt -59.68 -38.34 75.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 O-C-N 121.551 -0.718 . . . . 0.0 109.28 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 1.006 HD11 HG11 ' A' ' 40' ' ' VAL . 2.2 mp -74.52 -62.28 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.257 -0.902 . . . . 0.0 109.63 -179.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.483 ' HG2' ' HA ' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -53.14 -20.09 3.53 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.169 -0.957 . . . . 0.0 109.394 -179.931 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 61' ' ' LYS . 0.3 OUTLIER -79.64 -40.24 29.65 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.238 -0.913 . . . . 0.0 109.026 179.729 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.449 ' SD ' ' OG ' ' A' ' 69' ' ' SER . 0.6 OUTLIER -65.19 -45.79 83.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.364 -0.835 . . . . 0.0 108.995 179.613 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.697 HD11 ' CG2' ' B' ' 63' ' ' ILE . 0.5 OUTLIER -43.5 -50.28 7.12 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.527 -0.733 . . . . 0.0 109.487 179.822 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -76.81 -27.07 55.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.845 . . . . 0.0 109.614 -179.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.449 ' OG ' ' SD ' ' A' ' 66' ' ' MET . 1.2 p -76.25 0.78 17.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.317 -0.864 . . . . 0.0 109.676 -179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.451 ' O ' ' OG1' ' B' ' 38' ' ' THR . 14.1 p-10 -44.35 -35.76 2.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.185 -0.947 . . . . 0.0 109.45 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -114.58 109.74 18.72 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.297 -0.877 . . . . 0.0 109.461 179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 40.9 t -149.23 -56.22 0.19 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.213 -0.929 . . . . 0.0 109.452 179.946 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 . . . . . 0 N--CA 1.49 1.525 0 CA-C-O 117.926 -1.035 . . . . 0.0 109.489 -179.966 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.284 0.564 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 34.9 t -114.86 -48.22 2.85 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.225 -0.922 . . . . 0.0 109.416 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 25.7 m -112.75 168.63 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.262 -0.899 . . . . 0.0 109.47 -179.925 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 4' ' ' ALA . . . . . . . . . . . . . . . -48.2 134.38 14.47 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 109.49 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 5' ' ' THR . . . . . . . . . . . . . 17.6 m -157.85 115.71 3.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.261 -0.899 . . . . 0.0 109.447 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 6' ' ' GLU . . . . . 0.46 ' O ' ' HG ' ' B' ' 7' ' ' LEU . 1.7 tp10 -128.71 -144.07 0.28 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.241 -0.912 . . . . 0.0 109.153 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 7' ' ' LEU . . . . . 0.698 HD22 ' CD2' ' B' ' 34' ' ' HIS . 1.0 OUTLIER -159.95 121.04 3.11 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.233 -0.917 . . . . 0.0 109.654 -179.967 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.424 ' O ' ' C ' ' B' ' 9' ' ' CYS . 4.4 mtm180 -134.46 159.6 40.61 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.392 -0.818 . . . . 0.0 109.043 179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . 0.518 ' HB2' HD23 ' B' ' 12' ' ' LEU . 18.5 m -44.62 105.3 0.05 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.957 . . . . 0.0 109.217 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 10' ' ' GLN . . . . . 0.483 ' HG3' ' HD3' ' B' ' 29' ' ' LYS . 19.0 mm-40 -64.77 -8.0 13.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 0.0 109.78 -179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 11' ' ' CYS . . . . . 0.473 ' SG ' HG13 ' B' ' 41' ' ' ILE . 73.6 m -144.69 71.73 1.31 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.082 -1.011 . . . . 0.0 109.657 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.518 HD23 ' HB2' ' B' ' 9' ' ' CYS . 52.6 mt -46.29 -42.54 14.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.164 -0.96 . . . . 0.0 109.17 179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 13' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -119.73 122.06 40.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.298 -0.876 . . . . 0.0 109.123 179.756 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 14' ' ' THR . . . . . 0.439 ' OG1' ' OD1' ' B' ' 53' ' ' ASN . 0.6 OUTLIER -101.22 158.65 15.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.216 -0.928 . . . . 0.0 109.816 -179.692 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.531 ' HB2' HD23 ' B' ' 52' ' ' LEU . 3.5 mt -102.79 139.93 37.72 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 179.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 16' ' ' GLN . . . . . 0.418 ' C ' ' O ' ' B' ' 15' ' ' LEU . 0.6 OUTLIER -43.96 -26.95 0.32 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.934 . . . . 0.0 109.176 179.969 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 17' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' B' ' 15' ' ' LEU . . . 158.03 -179.89 33.41 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.779 ' H ' HD11 ' B' ' 62' ' ' ILE . 4.5 tp -155.03 170.9 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.571 -0.958 . . . . 0.0 108.745 -179.578 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.58 ' CB ' ' ND2' ' B' ' 22' ' ' ASN . 3.4 t-80 -59.14 142.03 86.22 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.028 -1.045 . . . . 0.0 109.109 179.764 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 20' ' ' PRO . . . . . 0.577 ' HD2' ' CG ' ' B' ' 19' ' ' HIS . 35.1 Cg_endo -77.73 -23.53 9.52 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.517 2.145 . . . . 0.0 110.238 -179.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.526 ' O ' ' CE ' ' B' ' 45' ' ' LYS . 9.5 mmtp -90.29 -15.0 32.08 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.404 -0.81 . . . . 0.0 109.139 179.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 22' ' ' ASN . . . . . 0.58 ' ND2' ' CB ' ' B' ' 19' ' ' HIS . 84.8 m-20 -78.99 -27.7 43.39 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.431 -0.793 . . . . 0.0 109.403 179.815 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.801 HG12 ' HB1' ' B' ' 42' ' ' ALA . 6.5 mt -77.45 163.73 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-O 121.751 0.786 . . . . 0.0 110.743 -179.029 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 24' ' ' GLN . . . . . 0.549 ' N ' HG22 ' B' ' 23' ' ' ILE . 0.2 OUTLIER -129.65 -41.25 1.35 Allowed 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.07 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 25' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 28' ' ' VAL . 11.0 p -124.92 166.72 15.79 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.034 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 26' ' ' VAL . . . . . 0.739 ' O ' HG23 ' A' ' 28' ' ' VAL . 51.3 t -145.26 98.78 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.998 -1.064 . . . . 0.0 109.779 -179.762 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 27' ' ' ASN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 27' ' ' ASN . 50.0 t-20 -84.4 133.21 34.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 28' ' ' VAL . . . . . 0.738 HG23 ' O ' ' A' ' 26' ' ' VAL . 2.2 t -118.02 82.25 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.142 -0.974 . . . . 0.0 109.591 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 29' ' ' LYS . . . . . 0.483 ' HD3' ' HG3' ' B' ' 10' ' ' GLN . 20.9 mtpt -87.36 103.64 15.67 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.264 -0.897 . . . . 0.0 109.523 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 30' ' ' SER . . . . . 0.468 ' HB3' ' O ' ' A' ' 24' ' ' GLN . 1.1 p -57.56 163.85 3.37 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.334 -0.854 . . . . 0.0 109.342 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 31' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.44 132.21 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.581 2.187 . . . . 0.0 110.436 179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 32' ' ' GLY . . . . . . . . . . . . . . . -144.74 -141.01 3.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.476 -1.45 . . . . 0.0 109.476 -179.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.18 7.69 3.58 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.592 2.194 . . . . 0.0 110.84 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 34' ' ' HIS . . . . . 0.698 ' CD2' HD22 ' B' ' 7' ' ' LEU . 6.4 p-80 -124.92 -14.74 6.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.007 -1.058 . . . . 0.0 109.761 179.767 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 35' ' ' CYS . . . . . . . . . . . . . 1.8 t -160.36 125.62 3.91 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.147 -0.97 . . . . 0.0 109.332 179.688 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 36' ' ' ALA . . . . . 0.42 ' O ' ' CD ' ' B' ' 37' ' ' GLN . . . -87.23 17.55 4.27 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.235 -0.916 . . . . 0.0 109.626 -179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 37' ' ' GLN . . . . . 0.426 ' O ' ' C ' ' B' ' 38' ' ' THR . 9.7 mm-40 -143.42 125.74 15.62 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.226 -0.921 . . . . 0.0 109.504 -179.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 38' ' ' THR . . . . . 0.494 ' HB ' ' HG3' ' B' ' 54' ' ' PRO . 3.2 m -44.32 157.71 0.06 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.283 -0.885 . . . . 0.0 109.309 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 39' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -132.61 107.01 8.15 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.143 -0.973 . . . . 0.0 109.571 -179.914 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 1.015 HG11 HD11 ' B' ' 63' ' ' ILE . 1.7 t -101.86 93.57 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.202 -0.936 . . . . 0.0 109.335 179.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 41' ' ' ILE . . . . . 0.474 ' O ' ' HA ' ' B' ' 26' ' ' VAL . 3.5 mp -82.19 150.42 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.233 -0.917 . . . . 0.0 109.726 -179.814 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 42' ' ' ALA . . . . . 0.801 ' HB1' HG12 ' B' ' 23' ' ' ILE . . . -132.68 114.9 14.72 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.338 -0.852 . . . . 0.0 109.004 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 43' ' ' THR . . . . . 0.522 ' O ' ' CB ' ' B' ' 24' ' ' GLN . 4.4 m -89.23 98.2 11.63 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.856 -1.152 . . . . 0.0 108.996 -179.852 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 44' ' ' LEU . . . . . 0.494 ' HA ' ' HA ' ' B' ' 23' ' ' ILE . 93.1 mt -41.16 163.33 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.686 -0.634 . . . . 0.0 109.877 -179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' B' ' 21' ' ' LYS . 0.0 OUTLIER -82.09 11.04 5.6 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.304 -0.873 . . . . 0.0 109.921 -179.818 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 46' ' ' ASN . . . . . 0.494 ' OD1' ' HB2' ' B' ' 44' ' ' LEU . 23.4 p-10 -112.44 7.98 19.27 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.034 -1.042 . . . . 0.0 109.535 179.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.56 1.84 63.76 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 48' ' ' ARG . . . . . 0.485 ' HB2' HD12 ' B' ' 44' ' ' LEU . 19.4 mtt180 -96.66 165.67 12.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.116 -1.226 . . . . 0.0 109.535 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.414 ' HG2' ' C ' ' B' ' 48' ' ' ARG . 2.2 mttt -132.99 153.2 51.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.892 . . . . 0.0 109.481 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 50' ' ' ALA . . . . . . . . . . . . . . . -150.27 123.4 8.85 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.272 -0.892 . . . . 0.0 108.91 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 51' ' ' CYS . . . . . 0.459 ' O ' ' HG ' ' B' ' 15' ' ' LEU . 35.7 m -79.6 140.93 36.98 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.035 -1.041 . . . . 0.0 109.299 -179.947 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 52' ' ' LEU . . . . . 0.966 HD13 HD13 ' B' ' 62' ' ' ILE . 15.9 mt -125.41 168.3 13.77 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.296 -0.877 . . . . 0.0 109.227 179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.614 ' O ' HG21 ' B' ' 59' ' ' VAL . 1.6 m-20 -106.41 124.87 34.38 Favored Pre-proline 0 C--N 1.301 -1.53 0 O-C-N 121.234 -0.916 . . . . 0.0 109.407 -179.54 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 54' ' ' PRO . . . . . 0.494 ' HG3' ' HB ' ' B' ' 38' ' ' THR . 34.1 Cg_endo -75.22 -6.92 18.49 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 C-N-CA 122.308 2.005 . . . . 0.0 110.422 -179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 55' ' ' ALA . . . . . . . . . . . . . . . -80.94 -17.58 49.99 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.261 -0.899 . . . . 0.0 108.915 179.398 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 56' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' B' ' 60' ' ' LYS . 0.0 OUTLIER -90.02 163.76 30.78 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.356 -0.84 . . . . 0.0 109.323 179.845 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 57' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' B' ' 61' ' ' LYS . 36.2 Cg_endo -77.57 -36.46 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.633 2.222 . . . . 0.0 110.667 -179.897 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 58' ' ' ILE . . . . . . . . . . . . . 52.6 mt -61.42 -48.14 90.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.277 -0.889 . . . . 0.0 109.652 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 59' ' ' VAL . . . . . 1.034 ' HA ' HD12 ' B' ' 62' ' ' ILE . 76.6 t -62.19 -50.05 81.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.373 -0.83 . . . . 0.0 109.617 -179.988 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 60' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' B' ' 56' ' ' SER . 6.0 mttt -51.2 -30.75 18.1 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.084 -1.01 . . . . 0.0 108.735 179.562 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.491 ' HA ' ' CG ' ' B' ' 64' ' ' GLU . 0.0 OUTLIER -78.45 -34.51 47.73 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 179.856 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . 1.034 HD12 ' HA ' ' B' ' 59' ' ' VAL . 14.2 mt -59.7 -38.43 75.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.543 -0.723 . . . . 0.0 109.229 179.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 63' ' ' ILE . . . . . 1.015 HD11 HG11 ' B' ' 40' ' ' VAL . 2.2 mp -74.5 -62.29 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.259 -0.901 . . . . 0.0 109.64 -179.942 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 64' ' ' GLU . . . . . 0.491 ' CG ' ' HA ' ' B' ' 61' ' ' LYS . 0.2 OUTLIER -53.14 -20.1 3.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.413 -179.922 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.465 ' HG3' ' O ' ' B' ' 61' ' ' LYS . 0.3 OUTLIER -79.64 -40.14 29.86 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.312 -0.868 . . . . 0.0 109.031 179.749 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 66' ' ' MET . . . . . 0.446 ' SD ' ' OG ' ' B' ' 69' ' ' SER . 0.6 OUTLIER -65.16 -45.87 83.19 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.355 -0.841 . . . . 0.0 108.994 179.552 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 67' ' ' LEU . . . . . 0.692 HD11 ' CG2' ' A' ' 63' ' ' ILE . 0.6 OUTLIER -43.42 -50.34 6.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.476 -0.765 . . . . 0.0 109.46 179.858 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 68' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -76.8 -27.09 55.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.366 -0.833 . . . . 0.0 109.558 -179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 69' ' ' SER . . . . . 0.446 ' OG ' ' SD ' ' B' ' 66' ' ' MET . 1.2 p -76.22 0.76 17.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.316 -0.865 . . . . 0.0 109.707 -179.995 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.463 ' O ' ' OG1' ' A' ' 38' ' ' THR . 14.2 p-10 -44.28 -35.86 2.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.258 -0.901 . . . . 0.0 109.416 179.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 71' ' ' LYS . . . . . . . . . . . . . 12.5 tttm -114.57 109.75 18.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.188 -0.945 . . . . 0.0 109.437 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 72' ' ' SER . . . . . . . . . . . . . 40.9 t -149.24 -56.3 0.19 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.463 -179.98 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 73' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.063 -0.97 . . . . 0.0 109.459 -179.996 . . . . . . . . 0 0 . 1 stop_ save_